Comparison (group1/group2),UniProtIds,ProteinDescriptions,Genes,Log2 Ratio,Standard Deviation,Pvalue,Qvalue, -log10(qvalue),GO Biological Process,GO Molecular Function,GO Cellular Component,# of Ratios,# Unique Total Peptides,# Unique Total EG.Id,EG.Id
SEN / CTL,P10145,Interleukin-8,CXCL8,10.85,2.30,1.13E-08,2.12E-09,8.67E+00,"angiogenesis,response to molecule of bacterial origin,movement of cell or subcellular component,chemotaxis,inflammatory response,immune response,cell cycle arrest,signal transduction,G-protein coupled receptor signaling pathway,negative regulation of cell proliferation,calcium-mediated signaling,regulation of cell adhesion,neutrophil chemotaxis,receptor internalization,response to endoplasmic reticulum stress,intracellular signal transduction,PERK-mediated unfolded protein response,neutrophil activation,cellular response to fibroblast growth factor stimulus,regulation of single stranded viral RNA replication via double stranded DNA intermediate,negative regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,embryonic digestive tract development,induction of positive chemotaxis,chemokine-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to interleukin-1,cellular response to tumor necrosis factor,positive regulation of neutrophil chemotaxis,regulation of entry of bacterium into host cell","interleukin-8 receptor binding,protein binding,chemokine activity","extracellular region,extracellular space,intracellular",12,1,2,VIESGPHC[CAM]ANTEIIVK.3|VIESGPHC[CAM]ANTEIIVK.2
SEN / CTL,Q86W92,Liprin-beta-1,PPFIBP1,10.47,2.08,8.29E-05,9.61E-06,5.02E+00,"cell adhesion,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"plasma membrane,cell-cell adherens junction,focal adhesion",6,49,73,FRDTEGLIQEINDLR.3|FRDTEGLIQEINDLR.2|ETSDGEKETIQK.3|ETSDGEKETIQK.2|RRPSDENTIAPSEVQK.4|RRPSDENTIAPSEVQK.3|RRPSDENTIAPSEVQK.2|RTASAPNLAETEK.3|RTASAPNLAETEK.2|GSGVHGGLMVLEPR.3|GSGVHGGLMVLEPR.2|IRDLEFC[CAM]LEEHREK.4|VSEMDSER.2|VSEM[Oxi]DSER.2|MKGEGVEIVDRDIEVQK.4|MKGEGVEIVDRDIEVQK.3|HLATHFNLLIGAEAQHQK.4|LDFNWVTR.2|ALHLVEDLR.2|IRDLEFC[CAM]LEEHR.3|ETAEHLDLAGASSRPK.3|ETAEHLDLAGASSRPK.2|MLHYMTVDDLLSLK.3|MLHYMTVDDLLSLK.2|RPSDENTIAPSEVQK.3|RPSDENTIAPSEVQK.2|KAVESLMAANEEKDR.3|KGFKPGLDMR.2|LAFSNFGNLR.2|TASAPNLAETEKETAEHLDLAGASSRPK.5|TASAPNLAETEKETAEHLDLAGASSRPK.4|DAMELPDYVLLTATAK.3|DAMELPDYVLLTATAK.2|GLLEMMETDEKEGLR.3|GLLEMMETDEKEGLR.2|LKVSEMDSER.2|MQDTVVLAQGK.2|M[Oxi]QDTVVLAQGK.2|FNVETMAQLLNIPPNK.3|FNVETMAQLLNIPPNK.2|TASAPNLAETEK.2|LDLMAEISNLK.2|QIGAFSEGINNLTHMLK.3|INNFEPNC[CAM]LR.2|KLAFSNFGNLR.2|AVESLMAANEEK.2|AVESLM[Oxi]AANEEK.2|LQLALQALGSEEETNHGK.3|LQLALQALGSEEETNHGK.2|GLLEMMETDEK.2|KKQEDGEEYVC[CAM]PMELGQASGSASK.4|KKQEDGEEYVC[CAM]PMELGQASGSASK.3|SPSASITDEDSNV.2|HWIASGQTLLQASQQDLEKELGIK.4|HWIASGQTLLQASQQDLEKELGIK.3|TSLETQKLDLMAEISNLK.3|TSLETQKLDLMAEISNLK.2|KLQLALQALGSEEETNHGK.3|LEQMEDSEGTVR.2|KAVESLMAANEEK.2|HWIASGQTLLQASQQDLEK.3|DTEGLIQEINDLR.2|EQVC[CAM]NWLMEQGLGSYLNSGK.3|EQVC[CAM]NWLMEQGLGSYLNSGK.2|AVESLMAANEEKDR.2|DLGQSNSDLDMPFAK.2|DLGQSNSDLDM[Oxi]PFAK.2|KQEDGEEYVC[CAM]PMELGQASGSASK.3|LYEEDDLDRLEQMEDSEGTVR.3|LYEEDDLDRLEQM[Oxi]EDSEGTVR.3|LENDKESLVLQVSVLTDQVEAQGEK.3|DGEYEELLNSSSISSLLDAQGFSDLEK.3|QEDGEEYVC[CAM]PMELGQASGSASK.2
SEN / CTL,P09341;P19875;P19876,Growth-regulated alpha protein;C-X-C motif chemokine 2;C-X-C motif chemokine 3,CXCL1;CXCL2;CXCL3,9.23,2.12,1.84E-08,3.35E-09,8.47E+00,"chemotaxis,inflammatory response,immune response,signal transduction,G-protein coupled receptor signaling pathway,nervous system development,cell proliferation,negative regulation of cell proliferation,actin cytoskeleton organization,response to lipopolysaccharide,intracellular signal transduction,positive regulation of catalytic activity,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;response to molecule of bacterial origin,chemotaxis,inflammatory response,immune response,G-protein coupled receptor signaling pathway,response to lipopolysaccharide,regulation of cell proliferation,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;inflammatory response,immune response,G-protein coupled receptor signaling pathway,neutrophil chemotaxis,response to lipopolysaccharide,regulation of cell proliferation,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis","receptor binding,chemokine activity,enzyme activator activity,growth factor activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding","extracellular region,extracellular space,intracellular;extracellular region,extracellular space;extracellular region,extracellular space",12,1,2,SPGPHC[CAM]AQTEVIATLK.3|SPGPHC[CAM]AQTEVIATLK.2
SEN / CTL,O75694,Nuclear pore complex protein Nup155,NUP155,8.13,1.81,7.71E-05,9.00E-06,5.05E+00,"transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,RNA export from nucleus,mRNA export from nucleus,tRNA export from nucleus,protein import into nucleus,nuclear envelope organization,mitotic nuclear envelope disassembly,regulation of glucose transport,viral process,protein sumoylation,viral transcription,gene silencing by RNA,protein targeting to nuclear inner membrane,intracellular transport of virus,atrial cardiac muscle cell action potential,regulation of cellular response to heat","transporter activity,structural constituent of nuclear pore","nuclear envelope,membrane,nuclear membrane,nuclear pore inner ring",6,54,87,GLQEFLDR.2|KFHEAQLSEK.3|ANELLQR.2|ISLQAIQQLVR.3|ISLQAIQQLVR.2|LLQVASPFLEPHLVR.4|LLQVASPFLEPHLVR.3|LLQVASPFLEPHLVR.2|YGGEAQMR.2|YGGEAQM[Oxi]R.2|KPLHLLDC[CAM]IHVLLIR.4|KDPQGLGLHFYK.3|KDPQGLGLHFYK.2|DHIPITDSPVVVQQHMLPPKK.5|DHIPITDSPVVVQQHMLPPKK.4|LRPVDQLR.2|YMDLLWR.2|AGIFQPHVR.2|FVLLSAQGSLMFHK.3|FVLLSAQGSLMFHK.2|FHEAQLSEK.2|LADMHSTEISLQQR.3|LADMHSTEISLQQR.2|LPPGFSASSTVEKPSK.3|SYQALALWK.2|C[CAM]ITDTLQELVNQSK.3|C[CAM]ITDTLQELVNQSK.2|NSQFAGGPLGNPNTTAK.3|NSQFAGGPLGNPNTTAK.2|DHIPITDSPVVVQQHMLPPK.4|DHIPITDSPVVVQQHMLPPK.3|PLHLLDC[CAM]IHVLLIR.3|HLLVSNVGGDGEEIER.3|HLLVSNVGGDGEEIER.2|VASVSQNAIVSAAGNIAR.3|VASVSQNAIVSAAGNIAR.2|ISNQVDLSNVC[CAM]AQYR.3|ISNQVDLSNVC[CAM]AQYR.2|LYGEFADPFK.2|LYFSTC[CAM]PFR.2|LYGEFADPFKLAEC[CAM]K.3|ELTGALIASLINC[CAM]YIR.3|ELTGALIASLINC[CAM]YIR.2|GVIQVYDLGQDGQGMSR.3|GVIQVYDLGQDGQGMSR.2|IITPLNKDHIPITDSPVVVQQHMLPPK.5|KPGPPVLSSDPNMLSNEEAGHHFEQMLK.5|HNGIC[CAM]IYFSR.2|LLEVYDQLFK.2|PSSLLGAAMPASTSAAALQEALENAGR.4|PSSLLGAAMPASTSAAALQEALENAGR.3|PSSLLGAAM[Oxi]PASTSAAALQEALENAGR.3|HGEPEEDIVGLQAFQER.3|HGEPEEDIVGLQAFQER.2|LLC[CAM]EHQFTIIVAELQK.3|LLC[CAM]EHQFTIIVAELQK.2|LPPGFSASSTVEK.2|DKELTGALIASLINC[CAM]YIR.3|IQLQIQETLQR.2|QYSHHSSVQDAVSQLDSELM[Oxi]DITK.4|QYSHHSSVQDAVSQLDSELMDITK.4|QYSHHSSVQDAVSQLDSELMDITK.3|RVPLPPELVEQFGHMQC[CAM]NC[CAM]MMGVFPPISR.5|RVPLPPELVEQFGHM[Oxi]QC[CAM]NC[CAM]MMGVFPPISR.4|RVPLPPELVEQFGHMQC[CAM]NC[CAM]M[Oxi]M[Oxi]GVFPPISR.4|RVPLPPELVEQFGHMQC[CAM]NC[CAM]M[Oxi]MGVFPPISR.4|RVPLPPELVEQFGHMQC[CAM]NC[CAM]MM[Oxi]GVFPPISR.4|RVPLPPELVEQFGHMQC[CAM]NC[CAM]MMGVFPPISR.4|RVPLPPELVEQFGHMQC[CAM]NC[CAM]MMGVFPPISR.3|ELSDSVTLSSSDR.2|LAIIHC[CAM]AGYSDPILVQTLWQDIIEK.4|LAIIHC[CAM]AGYSDPILVQTLWQDIIEK.3|SSTAISSIAADGEFLHELEEK.3|SSTAISSIAADGEFLHELEEK.2|DNAAVDGISLHLQDIC[CAM]PLLYSTDDAIC[CAM]SK.4|DNAAVDGISLHLQDIC[CAM]PLLYSTDDAIC[CAM]SK.3|IMGNIWDASLVVER.2|YVENPSQVLNC[CAM]ER.2|AAPQSPSVPKKPGPPVLSSDPNMLSNEEAGHHFEQMLK.5|FYEGVVELSLTAAEK.2|LIGFMRPENGNPQQMQQELQR.3|SVFKPIVQIAVIENSESLDC[CAM]QLLAVTHAGVR.4|SVFKPIVQIAVIENSESLDC[CAM]QLLAVTHAGVR.3|GLQEFLDRNSQFAGGPLGNPNTTAK.3|LHQEDQAC[CAM]ATC[CAM]LILAC[CAM]STAAC[CAM]DR.3|LHQEDQAC[CAM]ATC[CAM]LILAC[CAM]STAAC[CAM]DREVSAWATR.4|LHQEDQAC[CAM]ATC[CAM]LILAC[CAM]STAAC[CAM]DREVSAWATR.3
SEN / CTL,P03956,Interstitial collagenase,MMP1,7.85,3.61,1.95E-08,3.52E-09,8.45E+00,"proteolysis,viral process,extracellular matrix disassembly,collagen catabolic process,positive regulation of protein oligomerization,cellular protein metabolic process,leukocyte migration","endopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,calcium ion binding,zinc ion binding","extracellular region,proteinaceous extracellular matrix",18,6,6,AFQLWSNVTPLTFTK.2|DGFFYFFHGTR.3|SQNPVQPIGPQTPK.2|MIAHDFPGIGHK.3|TYFFVANK.2|VTGKPDAETLK.2
SEN / CTL,P52823,Stanniocalcin-1,STC1,7.53,0.80,3.33E-18,1.58E-18,1.78E+01,"ossification,endothelial cell morphogenesis,growth plate cartilage axis specification,cellular calcium ion homeostasis,embryo implantation,negative regulation of endothelial cell migration,negative regulation of cell migration,response to vitamin D,chondrocyte proliferation,regulation of anion transport,decidualization,negative regulation of calcium ion transport,bone development,cellular response to cAMP,cellular response to glucocorticoid stimulus,cellular response to hypoxia,regulation of cardiac muscle cell contraction,positive regulation of calcium ion import,negative regulation of renal phosphate excretion",hormone activity,"extracellular space,nucleus,cytoplasm,apical plasma membrane",18,2,3,RNPEAITEVVQLPNHFSNR.3|IGPNMASLFHILQTDHC[CAM]AQTHPR.5|IGPNMASLFHILQTDHC[CAM]AQTHPR.4
SEN / CTL,P11137,Microtubule-associated protein 2,MAP2,7.33,3.35,5.58E-03,4.96E-04,3.30E+00,"microtubule cytoskeleton organization,microtubule bundle formation,central nervous system neuron development,neuron projection development,dendrite morphogenesis","dystroglycan binding,structural molecule activity,calmodulin binding,microtubule binding","nucleolus,cytoplasm,microtubule,microtubule associated complex,neuron projection",6,13,15,DQGGAGEGLVR.2|VGSLDNAHHVPGGGNVK.4|VGSLDNAHHVPGGGNVK.3|SAILVPSEK.2|APHWTSAPLTEASAHSHPPEIK.5|ARVDHGAEIITQSPGR.3|LINQPLPDLK.2|TPGTPGTPSYPR.2|APLALFGHTLVASLEDMK.3|HAALVSQPETTK.2|EDEEGAFGEHGSQGTYSNTK.3|IVQVVTAEAVAVLK.2|ENGINGELTSADRETAEEVSAR.3|RLSNVSSSGSINLLESPQLATLAEDVTAALAK.4|RLSNVSSSGSINLLESPQLATLAEDVTAALAK.3
SEN / CTL,P42830,C-X-C motif chemokine 5,CXCL5,6.91,0.77,3.18E-06,4.42E-07,6.35E+00,"neutrophil mediated immunity,positive regulation of leukocyte chemotaxis,chemotaxis,inflammatory response,immune response,signal transduction,G-protein coupled receptor signaling pathway,cell-cell signaling,positive regulation of cell proliferation,response to lipopolysaccharide,cell chemotaxis,chemokine-mediated signaling pathway","chemokine activity,CXCR chemokine receptor binding","extracellular region,extracellular space",6,1,1,EIC[CAM]LDPEAPFLK.2
SEN / CTL,O75326,Semaphorin-7A,SEMA7A,6.75,0.82,4.80E-06,6.52E-07,6.19E+00,"osteoblast differentiation,neural crest cell migration,inflammatory response,immune response,integrin-mediated signaling pathway,olfactory lobe development,positive regulation of cell migration,positive regulation of axon extension,axon extension,regulation of inflammatory response,positive regulation of macrophage cytokine production,positive regulation of ERK1 and ERK2 cascade,negative regulation of axon extension involved in axon guidance,negative chemotaxis,semaphorin-plexin signaling pathway","integrin binding,protein binding,neuropilin binding,semaphorin receptor binding,chemorepellent activity","plasma membrane,external side of plasma membrane,membrane,anchored component of membrane,extracellular space",6,6,8,SEGLLAC[CAM]GTNAR.2|SVLQSINPAEPHK.3|SVLQSINPAEPHK.2|MQASHGETFHVLYLTTDR.4|GDQGGESSLSVSK.2|AMLVC[CAM]SDAATNK.2|VDFGQTEPHTVLFHEPGSSSVWVGGR.4|VDFGQTEPHTVLFHEPGSSSVWVGGR.3
SEN / CTL,P14780,Matrix metalloproteinase-9,MMP9,6.57,1.33,2.77E-18,1.32E-18,1.79E+01,"skeletal system development,ossification,positive regulation of protein phosphorylation,proteolysis,embryo implantation,extracellular matrix disassembly,macrophage differentiation,collagen catabolic process,endodermal cell differentiation,negative regulation of apoptotic process,positive regulation of DNA binding,positive regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,leukocyte migration,positive regulation of keratinocyte migration,positive regulation of release of cytochrome c from mitochondria,positive regulation of receptor binding,positive regulation of vascular smooth muscle cell proliferation,negative regulation of intrinsic apoptotic signaling pathway,negative regulation of cation channel activity,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway","endopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,metallopeptidase activity,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome",24,30,40,SLGPALLLLQK.2|RLDKLGLGADVAQVTGALR.3|RLDKLGLGADVAQVTGALR.4|QLSLPETGELDSATLK.2|QLSLPETGELDSATLK.3|GSRPQGPFLIADK.3|AYFC[CAM]QDR.2|LGLGADVAQVTGALR.3|LGLGADVAQVTGALR.2|AVIDDAFAR.2|FGFC[CAM]PSER.2|LFGFC[CAM]PTR.2|GSRPQGPFLIADKWPALPR.4|FQTFEGDLK.2|AFALWSAVTPLTFTR.3|AFALWSAVTPLTFTR.2|LWC[CAM]ATTSNFDSDKK.3|SYSAC[CAM]TTDGR.2|EYSTC[CAM]TSEGR.2|QLAEEYLYR.2|FTEGPPLHKDDVNGIR.3|FTEGPPLHKDDVNGIR.2|WC[CAM]ATTANYDRDKLFGFC[CAM]PTR.4|WC[CAM]ATTANYDRDKLFGFC[CAM]PTR.3|WC[CAM]ATTANYDR.2|MFPGVPLDTHDVFQYR.3|MFPGVPLDTHDVFQYR.2|FGNADGAAC[CAM]HFPFIFEGR.3|FGNADGAAC[CAM]HFPFIFEGR.2|QSTLVLFPGDLR.2|QVWVYTGASVLGPR.2|SDGLPWC[CAM]STTANYDTDDRFGFC[CAM]PSER.4|SDGLPWC[CAM]STTANYDTDDRFGFC[CAM]PSER.3|LWC[CAM]ATTSNFDSDK.2|DGLLAHAFPPGPGIQGDAHFDDDELWSLGK.4|ADSTVM[Oxi]GGNSAGELC[CAM]VFPFTFLGK.3|ADSTVMGGNSAGELC[CAM]VFPFTFLGK.3|SELNQVDQVGYVTYDILQC[CAM]PED.3|LYTQDGNADGKPC[CAM]QFPFIFQGQSYSAC[CAM]TTDGR.4|SDGLPWC[CAM]STTANYDTDDR.2
SEN / CTL,Q9HAV7,"GrpE protein homolog 1, mitochondrial",GRPEL1,6.33,1.72,1.98E-04,2.13E-05,4.67E+00,"protein folding,protein import into mitochondrial matrix,regulation of catalytic activity","adenyl-nucleotide exchange factor activity,protein homodimerization activity,unfolded protein binding,chaperone binding","presequence translocase-associated import motor,nucleus,mitochondrion,mitochondrial matrix",6,16,28,TLRPALVGVVKEA.3|TLRPALVGVVKEA.2|ATQC[CAM]VPKEEIKDDNPHLK.5|ATQC[CAM]VPKEEIKDDNPHLK.4|ATQC[CAM]VPKEEIKDDNPHLK.3|EEIKDDNPHLK.3|ALADTENLR.2|EPGTVALVSK.2|FDPYEHEALFHTPVEGK.4|FDPYEHEALFHTPVEGK.3|FDPYEHEALFHTPVEGK.2|VKLEEQLKETVEK.3|VKLEEQLKETVEK.2|LYGIQAFC[CAM]K.2|RALADTENLR.2|NLYEGLVMTEVQIQK.3|NLYEGLVMTEVQIQK.2|NLYEGLVM[Oxi]TEVQIQK.2|FDPYEHEALFHTPVEGKEPGTVALVSK.5|FDPYEHEALFHTPVEGKEPGTVALVSK.4|FDPYEHEALFHTPVEGKEPGTVALVSK.3|NSGQNLEEDMGQSEQK.3|NSGQNLEEDMGQSEQK.2|NSGQNLEEDM[Oxi]GQSEQK.2|DLLEVADVLEK.2|LVEEAKLYGIQAFC[CAM]KDLLEVADVLEK.4|LYGIQAFC[CAM]KDLLEVADVLEK.3|NSGQNLEEDMGQSEQKADPPATEK.3
SEN / CTL,P50281,Matrix metalloproteinase-14,MMP14,6.17,2.14,5.05E-06,6.83E-07,6.17E+00,"angiogenesis,ovarian follicle development,response to hypoxia,endothelial cell proliferation,endochondral ossification,proteolysis,response to oxidative stress,male gonad development,response to mechanical stimulus,response to hormone,positive regulation of myotube differentiation,positive regulation of peptidase activity,response to organic cyclic compound,protein processing,extracellular matrix disassembly,positive regulation of cell growth,lung development,positive regulation of cell migration,collagen catabolic process,zymogen activation,endodermal cell differentiation,chondrocyte proliferation,astrocyte cell migration,response to estrogen,positive regulation of B cell differentiation,negative regulation of Notch signaling pathway,embryonic cranial skeleton morphogenesis,branching morphogenesis of an epithelial tube,tissue remodeling,cell motility,negative regulation of focal adhesion assembly,craniofacial suture morphogenesis","metalloendopeptidase activity,serine-type endopeptidase activity,integrin binding,calcium ion binding,protein binding,zinc ion binding,peptidase activator activity,metalloaminopeptidase activity","Golgi lumen,plasma membrane,integral component of plasma membrane,focal adhesion,extracellular matrix,cytoplasmic vesicle,melanosome,macropinosome,cytoplasm",12,15,18,SPQSLSAAIAAMQK.2|FYGLQVTGK.2|AVDSEYPK.2|VGEYATYEAIRK.3|VWESATPLR.2|VWEGIPESPR.2|HWVFDEASLEPGYPK.3|HWVFDEASLEPGYPK.2|GLPASINTAYER.2|FREVPYAYIR.2|GLPTDKIDAALFWMPNGK.3|GLPTDKIDAALFWMPNGK.2|IDAALFWMPNGK.2|WQHNEITFC[CAM]IQNYTPK.3|WQHNEITFC[CAM]IQNYTPK.2|GSFMGSDEVFTYFYK.2|NNQVMDGYPMPIGQFWR.2|NPTYGPNIC[CAM]DGNFDTVAMLR.2
SEN / CTL,P40939,"Trifunctional enzyme subunit alpha, mitochondrial",HADHA,6.03,2.68,2.62E-03,2.46E-04,3.61E+00,"fatty acid beta-oxidation,response to insulin,cardiolipin acyl-chain remodeling,response to drug","fatty-acyl-CoA binding,3-hydroxyacyl-CoA dehydrogenase activity,acetyl-CoA C-acetyltransferase activity,enoyl-CoA hydratase activity,long-chain-enoyl-CoA hydratase activity,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,protein complex binding,NAD binding","mitochondrion,mitochondrial inner membrane,mitochondrial fatty acid beta-oxidation multienzyme complex,extracellular matrix,mitochondrial nucleoid",6,68,128,KTVLGTPEVLLGALPGAGGTQR.4|KTVLGTPEVLLGALPGAGGTQR.3|SAVLISSK.2|NKFGAPQKDVK.3|GLYPAPLK.2|HVAEDLGK.2|TSKDTSASAVAVGLKQGK.4|TSKDTSASAVAVGLKQGK.3|GFYIYQEGVKR.3|FGELVMTK.2|FGELVM[Oxi]TK.2|KYEAAYGK.2|LTAYAMTIPFVR.3|LTAYAMTIPFVR.2|LTAYAM[Oxi]TIPFVR.2|VIGMHYFSPVDK.3|VIGM[Oxi]HYFSPVDK.3|VIGM[Oxi]HYFSPVDK.2|VIGMHYFSPVDK.2|INSPNSKVNTLSK.3|INSPNSKVNTLSK.2|SEVSSDEDIQFR.3|SEVSSDEDIQFR.2|THINYGVK.2|TILKDATLTALDR.3|TILKDATLTALDR.2|DTSASAVAVGLKQGK.3|TSKDTSASAVAVGLK.3|TSKDTSASAVAVGLK.2|DATLTALDR.2|HVAEDLGKVFGER.3|HVAEDLGKVFGER.2|ADMVIEAVFEDLSLKHR.4|FGAPQKDVK.2|ALM[Oxi]GLYHGQVLC[CAM]K.3|ALMGLYHGQVLC[CAM]K.3|ALMGLYHGQVLC[CAM]K.2|ALM[Oxi]GLYHGQVLC[CAM]K.2|ILQEGVDPK.2|TVLGTPEVLLGALPGAGGTQR.4|TVLGTPEVLLGALPGAGGTQR.3|TVLGTPEVLLGALPGAGGTQR.2|DGPGFYTTR.2|DLNSDMDSILASLK.3|DLNSDMDSILASLK.2|DLNSDM[Oxi]DSILASLK.2|FVDLYGAQKIVDR.3|GLYPAPLKIIDVVK.3|FVDLYGAQK.2|MVGVPAALDMMLTGR.3|M[Oxi]VGVPAALDMMLTGR.3|M[Oxi]VGVPAALDMMLTGR.2|MVGVPAALDM[Oxi]MLTGR.2|MVGVPAALDMM[Oxi]LTGR.2|MVGVPAALDMMLTGR.2|QFTPC[CAM]QLLADHANSPNKK.4|QFTPC[CAM]QLLADHANSPNKK.3|QFTPC[CAM]QLLADHANSPNKK.2|FGGGNPELLTQMVSK.3|FGGGNPELLTQMVSK.2|FGGGNPELLTQM[Oxi]VSK.2|TIEYLEEVAITFAK.3|TIEYLEEVAITFAK.2|TLQEVTQLSQEAQR.3|TLQEVTQLSQEAQR.2|ADMVIEAVFEDLSLK.3|ADM[Oxi]VIEAVFEDLSLK.3|ADM[Oxi]VIEAVFEDLSLK.2|ADMVIEAVFEDLSLK.2|DTSASAVAVGLK.2|VIIVVKDGPGFYTTR.3|VIIVVKDGPGFYTTR.2|TILKDATLTALDRGQQQVFK.4|TILKDATLTALDRGQQQVFK.3|MGLVDQLVEPLGPGLKPPEER.4|M[Oxi]GLVDQLVEPLGPGLKPPEER.3|MGLVDQLVEPLGPGLKPPEER.3|MGLVDQLVEPLGPGLKPPEER.2|NFTGSSALLTR.2|TVLGTPEVLLGALPGAGGTQRLPK.4|TVLGTPEVLLGALPGAGGTQRLPK.3|DATLTALDRGQQQVFK.3|DATLTALDRGQQQVFK.2|ELHSEFSEVMNEIWASDQIR.4|ELHSEFSEVMNEIWASDQIR.3|GFYIYQEGVK.2|KM[Oxi]GLVDQLVEPLGPGLKPPEER.4|KMGLVDQLVEPLGPGLKPPEER.4|KMGLVDQLVEPLGPGLKPPEER.3|KM[Oxi]GLVDQLVEPLGPGLKPPEER.3|PGC[CAM]FIAGADINMLAAC[CAM]K.3|PGC[CAM]FIAGADINMLAAC[CAM]K.2|LPPKSEVSSDEDIQFR.3|TGIEQGSDAGYLC[CAM]ESQK.3|TGIEQGSDAGYLC[CAM]ESQK.2|TLQEVTQLSQEAQRIVEKLEK.4|GLVEKLTAYAMTIPFVR.3|C[CAM]LAPMMSEVIR.2|QFTPC[CAM]QLLADHANSPNK.3|SAVLISSKPGC[CAM]FIAGADINMLAAC[CAM]K.4|SAVLISSKPGC[CAM]FIAGADINMLAAC[CAM]K.3|SAVLISSKPGC[CAM]FIAGADINM[Oxi]LAAC[CAM]K.3|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.6|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.5|MQLLEIITTEK.2|M[Oxi]QLLEIITTEK.2|HLAILGAGLMGAGIAQVSVDK.3|HLAILGAGLM[Oxi]GAGIAQVSVDK.3|HLAILGAGLM[Oxi]GAGIAQVSVDK.2|HLAILGAGLMGAGIAQVSVDK.2|VIGMHYFSPVDKMQLLEIITTEK.4|DSIFSNLTGQLDYQGFEK.3|DSIFSNLTGQLDYQGFEK.2|STKPIVAAINGSC[CAM]LGGGLEVAISC[CAM]QYR.4|STKPIVAAINGSC[CAM]LGGGLEVAISC[CAM]QYR.3|KLDSLTTSFGFPVGAATLVDEVGVDVAK.4|KLDSLTTSFGFPVGAATLVDEVGVDVAK.3|DKGLVEKLTAYAMTIPFVR.3|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.5|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.4|KLDSLTTSFGFPVGAATLVDEVGVDVAKHVAEDLGK.5|KLDSLTTSFGFPVGAATLVDEVGVDVAKHVAEDLGK.4|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.4|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.3|DLNSDMDSILASLKLPPKSEVSSDEDIQFR.4|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.4|TGIEQGSDAGYLC[CAM]ESQKFGELVM[Oxi]TK.3|ALTSFERDSIFSNLTGQLDYQGFEK.3
SEN / CTL,Q96F07,Cytoplasmic FMR1-interacting protein 2,CYFIP2,5.63,1.97,3.96E-04,4.11E-05,4.39E+00,"apoptotic process,single organismal cell-cell adhesion,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of proteolysis,vascular endothelial growth factor receptor signaling pathway,activation of cysteine-type endopeptidase activity",protein binding,"nucleus,cytoplasm,cytosol,membrane,cell junction,neuron projection,synapse,perinuclear region of cytoplasm,extracellular exosome",6,31,39,DIIEYAELK.2|RFDLFDFC[CAM]YHLLK.4|RFDLFDFC[CAM]YHLLK.3|RFDLFDFC[CAM]YHLLK.2|SLDQAISR.2|SVETDSSTVEHVR.3|SVETDSSTVEHVR.2|TDVFQSLR.2|DFVSEAYLLTLGK.3|DFVSEAYLLTLGK.2|HMTLDSFDAMFR.3|HMTLDSFDAMFR.2|PLNIAYSHIYSSYR.3|SSLDGPIVLAIEDFHK.3|SSLDGPIVLAIEDFHK.2|SDEEYRELFDLALR.3|SYLQDPIWR.2|MESVFNQAIR.2|KYQILNNEVFAILNK.3|KYQILNNEVFAILNK.2|NVLISVLQAIR.2|TAIPFTQEPQR.2|DC[CAM]PGTAEEYER.2|KMADPQSIQESQNLSMFLANHNR.4|LVHPTDKFC[CAM]NKDC[CAM]PGTAEEYER.4|DKPANVQPYYLYGSKPLNIAYSHIYSSYR.5|DKPANVQPYYLYGSKPLNIAYSHIYSSYR.4|NYGVIIPYPPSNR.2|NYGVIIPYPPSNRYETLLK.3|NTIYAALQDFAQVTLREPLR.3|MADPQSIQESQNLSMFLANHNR.3|WTC[CAM]TQSSISPQYNIC[CAM]EQMVQIRDDHIR.4|YQILNNEVFAILNK.2|YSNSEVVTGSGLDSQK.2|YSNSEVVTGSGLDSQKSDEEYRELFDLALR.4|RKDFVSEAYLLTLGK.2|NTIYAALQDFAQVTLR.2|WTC[CAM]TQSSISPQYNIC[CAM]EQMVQIR.3|EPSMMEYVLYPLDLYNDSAYYALTK.3
SEN / CTL,P15151,Poliovirus receptor,PVR,5.50,2.14,1.38E-03,1.34E-04,3.87E+00,"positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,cell recognition,adherens junction organization,susceptibility to natural killer cell mediated cytotoxicity,positive regulation of natural killer cell mediated cytotoxicity,viral entry into host cell,regulation of immune response,susceptibility to T cell mediated cytotoxicity","virus receptor activity,receptor activity,receptor binding,protein binding,protein homodimerization activity,cell adhesion molecule binding","extracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,integral component of membrane,extracellular exosome",6,5,6,HGESGSMAVFHQTQGPSYSESK.4|HGESGSMAVFHQTQGPSYSESK.3|VLAKPQNTAEVQK.3|RLEFVAAR.2|VQLTGEPVPMAR.2|ENSSSQDPQTEGTR.2
SEN / CTL,P06703,Protein S100-A6,S100A6,5.22,3.37,4.66E-03,4.16E-04,3.38E+00,"signal transduction,axonogenesis,ion transmembrane transport,positive regulation of fibroblast proliferation","calcium ion binding,protein binding,tropomyosin binding,zinc ion binding,ion transmembrane transporter activity,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding","ruffle,nucleus,nuclear envelope,cytoplasm,cytosol,extrinsic component of cytoplasmic side of plasma membrane,perinuclear region of cytoplasm,extracellular exosome",12,12,14,ELKELIQKELTIGSK.3|ELTIGSKLQDAEIAR.3|LMEDLDR.2|LM[Oxi]EDLDR.2|ELIQKELTIGSK.3|ELIQKELTIGSK.2|LQDAEIAR.2|YSGREGDKHTLSK.3|ELKELIQK.2|EGDKHTLSK.2|KELKELIQK.2|LMEDLDRNK.2|EGDKHTLSKK.2|ELIQKELTIGSKLQDAEIAR.3
SEN / CTL,P62269,40S ribosomal protein S18,RPS18,5.16,1.67,5.01E-04,5.11E-05,4.29E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosome biogenesis","structural constituent of ribosome,protein binding,rRNA binding,protein kinase binding,poly(A) RNA binding","nucleus,nucleoplasm,cytosol,ribosome,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",6,17,23,IPDWFLNR.2|YAHVVLR.2|YSQVLANGLDNK.3|YSQVLANGLDNK.2|KADIDLTK.2|LREDLER.2|RAGELTEDEVER.3|RAGELTEDEVER.2|IAFAITAIK.2|QYKIPDWFLNR.3|VLNTNIDGR.2|KADIDLTKR.2|KIAFAITAIK.2|VITIMQNPR.2|VITIM[Oxi]QNPR.2|DGKYSQVLANGLDNK.3|DGKYSQVLANGLDNK.2|RAGELTEDEVERVITIMQNPR.4|RAGELTEDEVERVITIMQNPR.3|AGELTEDEVER.2|YSQVLANGLDNKLREDLER.3|AGELTEDEVERVITIMQNPR.3|AGELTEDEVERVITIM[Oxi]QNPR.3
SEN / CTL,Q13200,26S proteasome non-ATPase regulatory subunit 2,PSMD2,5.15,2.06,1.12E-05,1.47E-06,5.83E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","protein binding,enzyme regulator activity,endopeptidase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,proteasome storage granule,extracellular exosome",12,63,112,LVGSQEELASWGHEYVR.3|LVGSQEELASWGHEYVR.2|TITGFQTHTTPVLLAHGERAELATEEFLPVTPILEGFVILR.5|C[CAM]ALGVFR.2|HLAGEVAK.2|VPDDIYK.2|VPDDIYKTHLENNR.4|VPDDIYKTHLENNR.3|VQREPLLTLVK.3|VQREPLLTLVK.2|SETELKDTYAR.3|SETELKDTYAR.2|DKEQELSEEDK.3|DKEQELSEEDK.2|LKEIYENMAPGENKR.4|LKEIYENMAPGENKR.3|VQQLLHIC[CAM]SEHFDSK.4|VQQLLHIC[CAM]SEHFDSK.3|VQQLLHIC[CAM]SEHFDSK.2|GTLTLC[CAM]PYHSDR.3|GTLTLC[CAM]PYHSDR.2|WLPLGLGLNHLGK.3|WLPLGLGLNHLGK.2|ELDIMEPK.2|LLTDDGNKWLYK.3|LLTDDGNKWLYK.2|SSTTSMTSVPKPLK.3|SSTTSMTSVPKPLK.2|VGQAVDVVGQAGKPK.3|VGQAVDVVGQAGKPK.2|SGALLAC[CAM]GIVNSGVR.3|SGALLAC[CAM]GIVNSGVR.2|AVPLALALISVSNPR.3|AVPLALALISVSNPR.2|LNILDTLSK.2|DIDENAYAK.2|DTSLYRPALEELR.3|LAQGLTHLGK.2|TITGFQTHTTPVLLAHGER.4|TITGFQTHTTPVLLAHGER.3|TITGFQTHTTPVLLAHGER.2|EDVLTLLLPVMGDSK.3|EDVLTLLLPVMGDSK.2|EDVLTLLLPVM[Oxi]GDSK.2|LKEIYENMAPGENK.3|LKEIYENM[Oxi]APGENK.3|DPNNLFMVR.2|DPNNLFM[Oxi]VR.2|APVQPQQSPAAAPGGTDEKPSGK.4|APVQPQQSPAAAPGGTDEKPSGK.3|APVQPQQSPAAAPGGTDEKPSGK.2|RAVPLALALISVSNPR.3|SSTTSMTSVPK.2|DTSLYRPALEELRR.3|SHYVLYGLVAAM[Oxi]QPR.3|SHYVLYGLVAAMQPR.3|SHYVLYGLVAAMQPR.2|YRLVGSQEELASWGHEYVR.4|YRLVGSQEELASWGHEYVR.3|FAADIISVLAMTMSGEREC[CAM]LK.4|FAADIISVLAMTMSGEREC[CAM]LK.3|FGGSGSQVDSAR.2|ELDIMEPKVPDDIYK.3|FAADIISVLAMTMSGER.3|FAADIISVLAMTMSGER.2|DAGDKDKEQELSEEDK.3|DKAPVQPQQSPAAAPGGTDEKPSGK.4|DKAPVQPQQSPAAAPGGTDEKPSGK.3|VGQAVDVVGQAGK.2|APVQPQQSPAAAPGGTDEK.3|APVQPQQSPAAAPGGTDEK.2|RFAADIISVLAMTMSGEREC[CAM]LK.4|RFAADIISVLAMTMSGEREC[CAM]LK.3|EWQELDDAEK.2|NEC[CAM]DPALALLSDYVLHNSNTMR.4|NEC[CAM]DPALALLSDYVLHNSNTMR.3|NEC[CAM]DPALALLSDYVLHNSNTM[Oxi]R.3|AELATEEFLPVTPILEGFVILRK.4|AELATEEFLPVTPILEGFVILRK.3|YLYSSEDYIK.2|RFAADIISVLAMTMSGER.3|RFAADIISVLAM[Oxi]TMSGER.3|RFAADIISVLAMTMSGER.2|MLVTFDEELRPLPVSVR.3|M[Oxi]LVTFDEELRPLPVSVR.3|SFANTLVDVC[CAM]AYAGSGNVLK.3|SFANTLVDVC[CAM]AYAGSGNVLK.2|EIYENM[Oxi]APGENK.2|EIYENMAPGENK.2|MNLASSFVNGFVNAAFGQDK.3|M[Oxi]NLASSFVNGFVNAAFGQDK.3|M[Oxi]NLASSFVNGFVNAAFGQDK.2|MNLASSFVNGFVNAAFGQDK.2|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.5|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.4|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.3|LALMLNDMELVEDIFTSC[CAM]KDVVVQK.4|LALMLNDMELVEDIFTSC[CAM]KDVVVQK.3|LALMLNDMELVEDIFTSC[CAM]K.3|LALMLNDMELVEDIFTSC[CAM]K.2|QLQDELEMLVER.2|EIYENMAPGENKR.2|TITGFQTHTTPVLLAHGERAELATEEFLPVTPILEGFVILRK.6|LGSIFGLGLAYAGSNR.2|LGSIFGLGLAYAGSNREDVLTLLLPVMGDSK.4|LGSIFGLGLAYAGSNREDVLTLLLPVMGDSK.3|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTMR.5|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTM[Oxi]R.4|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTMR.4|AELATEEFLPVTPILEGFVILR.3|VC[CAM]LYLTSC[CAM]VNYVPEPENSALLR.3|FSHDADPEVSYNSIFAMGMVGSGTNNAR.3
SEN / CTL,P08254,Stromelysin-1,MMP3,5.09,1.65,1.15E-03,1.13E-04,3.95E+00,"proteolysis,negative regulation of hydrogen peroxide metabolic process,extracellular matrix disassembly,collagen catabolic process,positive regulation of protein oligomerization,cellular response to nitric oxide,positive regulation of oxidative stress-induced cell death","endopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,calcium ion binding,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space",6,1,1,GEDTSMNLVQK.2
SEN / CTL,Q99988,Growth/differentiation factor 15,GDF15,5.07,2.21,2.01E-09,4.09E-10,9.39E+00,"signal transduction,transforming growth factor beta receptor signaling pathway,cell-cell signaling,positive regulation of pathway-restricted SMAD protein phosphorylation,regulation of apoptotic process,regulation of MAPK cascade,cell development,SMAD protein signal transduction,positive regulation of myoblast fusion","cytokine activity,transforming growth factor beta receptor binding,protein binding,growth factor activity","extracellular region,extracellular space,nucleus,cytoplasm,extracellular exosome",18,7,7,LKPDTVPAPC[CAM]C[CAM]VPASYNPMVLIQK.3|LSPPPSQSDQLLAESSSARPQLELHLRPQAAR.5|ASLEDLGWADWVLSPR.2|ASFPGPSELHSEDSR.3|RYEDLLTR.2|AALPEGLPEASR.2|TDTGVSLQTYDDLLAK.2
SEN / CTL,Q8N1G4,Leucine-rich repeat-containing protein 47,LRRC47,5.04,1.47,1.10E-11,2.88E-12,1.15E+01,phenylalanyl-tRNA aminoacylation,"poly(A) RNA binding,phenylalanine-tRNA ligase activity",phenylalanine-tRNA ligase complex,18,28,40,ELLLTGPGLEER.2|VLHVSENPVPLTVR.3|VLHVSENPVPLTVR.2|NALGPGLSPELGPLPALR.2|NALGPGLSPELGPLPALR.3|AAGGQLPPR.2|DVRPYIVGAVVR.3|DVRPYIVGAVVR.2|RTAATLATHELR.3|RTAATLATHELR.2|SILEYLR.2|QLQLEAEEQRK.3|ELSPDIAHLASLK.3|ELSPDIAHLASLK.2|ADLATAPPHVTVVR.3|ADLATAPPHVTVVR.2|APGPGLAQGLPQLHSLVLR.4|APGPGLAQGLPQLHSLVLR.3|APGPGLAQGLPQLHSLVLR.2|DVMDALILK.2|LHEDLC[CAM]EK.2|GPLLYC[CAM]ARPPQDLK.3|GPLLYC[CAM]ARPPQDLK.2|REGGDGEEQDVGDAGR.3|GMDLQPGNALK.2|LRELPADLAR.2|TAATLATHELR.2|QLQLEAEEQR.2|PGALPLLSELAAADNC[CAM]LR.3|PGALPLLSELAAADNC[CAM]LR.2|RNALGPGLSPELGPLPALR.3|DGPSLLVVEQVR.2|LFTLPLLHYLEVSGC[CAM]GSLR.3|LFTLPLLHYLEVSGC[CAM]GSLR.2|EGGDGEEQDVGDAGR.2|TLDLSNNQLSEIPAELADC[CAM]PK.3|TLDLSNNQLSEIPAELADC[CAM]PK.2|YLHLLDGNENYPC[CAM]LVDADGDVISFPPITNSEK.4|VLDLSGNALEALPPGQGLGPAEPPGLPQLQSLNLSGNR.4|LQSLNLTGNC[CAM]LDSFPAELFRPGALPLLSELAAADNC[CAM]LR.4
SEN / CTL,P05120,Plasminogen activator inhibitor 2,SERPINB2,5.00,2.49,1.05E-22,7.38E-23,2.21E+01,"negative regulation of endopeptidase activity,wound healing,fibrinolysis,negative regulation of apoptotic process",serine-type endopeptidase inhibitor activity,"extracellular region,extracellular space,cytoplasm,plasma membrane",60,10,11,GKIPNLLPEGSVDGDTR.3|TGHGGPQFVADHPFLFLIMHK.4|YYSSEPQAVDFLEC[CAM]AEEAR.3|YYSSEPQAVDFLEC[CAM]AEEAR.2|IPNLLPEGSVDGDTR.2|TPVQMMYLR.2|MVLVNAVYFK.2|ITNC[CAM]ILFFGR.2|LNIGYIEDLK.2|GSYPDAILQAQAADK.2|SLSSAINASTGNYLLESVNK.2
SEN / CTL,Q9UQ80,Proliferation-associated protein 2G4,PA2G4,4.88,1.97,5.05E-08,8.57E-09,8.07E+00,"transcription, DNA-templated,rRNA processing,regulation of translation,cell cycle arrest,cell proliferation,negative regulation of apoptotic process,positive regulation of cell differentiation,negative regulation of transcription, DNA-templated","DNA binding,transcription factor activity, sequence-specific DNA binding,protein binding,ubiquitin protein ligase binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome",18,38,76,FDAMPFTLR.2|FDAM[Oxi]PFTLR.2|EGEFVAQFK.2|VAHSFNC[CAM]TPIEGMLSHQLK.4|VAHSFNC[CAM]TPIEGM[Oxi]LSHQLK.4|VAHSFNC[CAM]TPIEGMLSHQLK.3|VAHSFNC[CAM]TPIEGM[Oxi]LSHQLK.3|VAHSFNC[CAM]TPIEGMLSHQLK.2|MGGDIANR.2|M[Oxi]GGDIANR.2|RFDAMPFTLR.3|RFDAMPFTLR.2|MGVVEC[CAM]AK.2|M[Oxi]GVVEC[CAM]AK.2|FTVLLMPNGPMR.3|FTVLLM[Oxi]PNGPMR.2|FTVLLMPNGPM[Oxi]R.2|FTVLLMPNGPMR.2|FTVLLM[Oxi]PNGPM[Oxi]R.2|QHVIDGEK.2|ALLQSSASR.2|TIIQNPTDQQKK.3|TIIQNPTDQQKK.2|LVKPGNQNTQVTEAWNK.4|LVKPGNQNTQVTEAWNK.3|LVKPGNQNTQVTEAWNK.2|TIIQNPTDQQKKDHEK.4|TIIQNPTDQQKKDHEK.3|AFFSEVER.2|SDQDYILK.2|HELLQPFNVLYEK.3|HELLQPFNVLYEK.2|SDQDYILKEGDLVK.3|SDQDYILKEGDLVK.2|YKMGGDIANR.2|AFFSEVERR.2|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLK.4|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLK.3|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLK.2|AAHLC[CAM]AEAALR.2|GDAMIMEETGK.2|GDAM[Oxi]IMEETGK.2|GDAMIM[Oxi]EETGK.2|GDAM[Oxi]IM[Oxi]EETGK.2|TAENATSGETLEENEAGD.3|TAENATSGETLEENEAGD.2|KGIAFPTSISVNNC[CAM]VC[CAM]HFSPLK.4|KGIAFPTSISVNNC[CAM]VC[CAM]HFSPLK.3|SLVEASSSGVSVLSLC[CAM]EK.3|SLVEASSSGVSVLSLC[CAM]EK.2|MGVVEC[CAM]AKHELLQPFNVLYEK.4|MGVVEC[CAM]AKHELLQPFNVLYEK.3|SEMEVQDAELK.2|SEM[Oxi]EVQDAELK.2|TIIQNPTDQQK.2|IDLGVHVDGFIANVAHTFVVDVAQGTQVTGR.5|IDLGVHVDGFIANVAHTFVVDVAQGTQVTGR.4|IDLGVHVDGFIANVAHTFVVDVAQGTQVTGR.3|ITSGPFEPDLYKSEMEVQDAELK.4|ITSGPFEPDLYKSEM[Oxi]EVQDAELK.3|ITSGPFEPDLYKSEMEVQDAELK.3|HELLQPFNVLYEKEGEFVAQFK.4|HELLQPFNVLYEKEGEFVAQFK.3|ITSGPFEPDLYK.2|KGIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILK.5|KGIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILK.4|M[Oxi]GVVEC[CAM]AKHELLQPFNVLYEKEGEFVAQFK.5|MGVVEC[CAM]AKHELLQPFNVLYEKEGEFVAQFK.4|AEFEVHEVYAVDVLVSSGEGK.3|AEFEVHEVYAVDVLVSSGEGK.2|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILKEGDLVK.5|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILKEGDLVK.4|PGNQNTQVTEAWNK.2|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILK.4|GIAFPTSISVNNC[CAM]VC[CAM]HFSPLKSDQDYILK.3|SLVEASSSGVSVLSLC[CAM]EKGDAMIMEETGK.3
SEN / CTL,P01036;P01037,Cystatin-S;Cystatin-SN,CST4;CST1,4.80,1.50,3.10E-04,3.26E-05,4.49E+00,"detection of chemical stimulus involved in sensory perception of bitter taste,retina homeostasis,negative regulation of proteolysis,negative regulation of cysteine-type endopeptidase activity;detection of chemical stimulus involved in sensory perception of bitter taste,negative regulation of cysteine-type endopeptidase activity","protease binding,cysteine-type endopeptidase inhibitor activity;protease binding,cysteine-type endopeptidase inhibitor activity","extracellular space,extracellular exosome;extracellular space",6,1,2,ALHFAISEYNK.3|ALHFAISEYNK.2
SEN / CTL,O15240,Neurosecretory protein VGF,VGF,4.76,1.28,2.52E-04,2.68E-05,4.57E+00,"ovarian follicle development,response to dietary excess,generation of precursor metabolites and energy,response to cold,sexual reproduction,insulin secretion,response to insulin,carbohydrate homeostasis,glucose homeostasis,defense response to bacterium,regulation of synaptic plasticity,response to cAMP","molecular_function,hormone activity,neuropeptide hormone activity,growth factor activity","extracellular space,transport vesicle,cytoplasmic vesicle,intracellular membrane-bounded organelle",6,10,11,LADLASDLLLQYLLQGGAR.3|LADLASDLLLQYLLQGGAR.2|RAQEEAEAEER.3|RQQETAAAETETR.3|AYQGVAAPFPK.2|AQEEAEAEER.2|ARRPESALLGGSEAGER.3|THLGEALAPLSK.2|QQETAAAETETR.2|LHLPADDVVSIIEEVEEK.3|RLQEQEELENYIEHVLLR.3
SEN / CTL,O94915,Protein furry homolog-like,FRYL,4.75,1.54,5.91E-06,7.91E-07,6.10E+00,"cell morphogenesis,transcription, DNA-templated,regulation of transcription, DNA-templated,neuron projection development,actin filament reorganization",,"cell cortex,site of polarized growth",12,133,221,TLTDEEAK.2|IEVVMAEPLEK.2|HVVSVFK.2|RHDEDEDDSLKDR.4|RHDEDEDDSLKDR.3|RHDEDEDDSLKDR.2|ELMVTSR.2|TVASVLLR.2|RPQLSQR.2|ELIEELHPIIK.3|ELIEELHPIIK.2|NKEFISAVAQVK.3|NKEFISAVAQVK.2|GPLWNHEDVSAK.3|GPLWNHEDVSAK.2|LFQTIQR.2|TC[CAM]IAAIPR.2|HQYC[CAM]ALK.2|KALDSILR.2|KIEVVMAEPLEK.3|KIEVVM[Oxi]AEPLEK.3|KIEVVMAEPLEK.2|KIEVVM[Oxi]AEPLEK.2|IKC[CAM]ESNTVTQSR.3|IKC[CAM]ESNTVTQSR.2|IQTAHPAGR.2|RQNGTEDESYEYRPR.4|RQNGTEDESYEYRPR.3|VALESLYR.2|TFTINPER.2|WLDNILDSLDKK.3|WLDNILDSLDKK.2|INHSSSLAR.2|QFNLEIIK.2|RGPLWNHEDVSAK.3|TLFDWYR.2|EAAEQWLDDC[CAM]KR.3|EAAEQWLDDC[CAM]KR.2|AIANVFQNR.2|FGVLELQEHLDTYNVKR.4|FGVLELQEHLDTYNVKR.3|DTPLNIFVK.2|LINQVNTIK.2|PMGNMVSTGF.2|TDLIELLAR.2|LLIHLPLDK.2|LLWVYVIR.2|NQDTQHGVANGASHPPPLER.4|NQDTQHGVANGASHPPPLER.3|QLLEAENEKDSDTLKDIR.4|QLLEAENEKDSDTLKDIR.3|QLLEAENEKDSDTLKDIR.2|YGDQHSAAGR.2|EKIENVQSK.2|NEVNVPC[CAM]LK.2|QLLEAENEK.2|SIFPQQSLR.2|YVQSPYWK.2|KRGPLWNHEDVSAK.3|C[CAM]HFSALVANIIQNVPVHQR.4|C[CAM]HFSALVANIIQNVPVHQR.3|C[CAM]HFSALVANIIQNVPVHQR.2|EFISAVAQVK.2|ERDYLLER.2|EVTDVHPTLLDNAVK.3|LPEDTTSVLK.2|TLMEFITSR.2|TLM[Oxi]EFITSR.2|ALFALLEIPK.2|IIQFIAQER.2|SNTLDIMDGR.2|SNTLDIM[Oxi]DGR.2|LMELNLEIR.2|LMNVLSLC[CAM]GPESGLPK.3|LMNVLSLC[CAM]GPESGLPK.2|LM[Oxi]NVLSLC[CAM]GPESGLPK.2|SAEQLTTFLK.2|YAHKLEVQR.2|QLLEAENEKDSDTLK.3|QLLEAENEKDSDTLK.2|QNGTEDESYEYRPR.3|QNGTEDESYEYRPR.2|C[CAM]ESNTVTQSR.2|QIPVHPVPDPLVHEVLNLAFK.4|QIPVHPVPDPLVHEVLNLAFK.3|QIPVHPVPDPLVHEVLNLAFK.2|QSSSEGIHLEHHLSEVALQTALSC[CAM]SSR.5|QSSSEGIHLEHHLSEVALQTALSC[CAM]SSR.4|QSSSEGIHLEHHLSEVALQTALSC[CAM]SSR.3|HYDLLSALSQTSYHDPIMGNK.4|HYDLLSALSQTSYHDPIM[Oxi]GNK.4|HYDLLSALSQTSYHDPIM[Oxi]GNK.3|HYDLLSALSQTSYHDPIMGNK.3|HYDLLSALSQTSYHDPIMGNK.2|ALKQPLTATTLSDVLSR.3|ALKQPLTATTLSDVLSR.2|LMSIVSALFPK.2|LM[Oxi]SIVSALFPK.2|SASLVVPSDIPK.2|GFTSASTQEMTVHLLSK.3|GFTSASTQEM[Oxi]TVHLLSK.3|GFTSASTQEMTVHLLSK.2|KVNTTTSSDSYIGLWR.3|KVNTTTSSDSYIGLWR.2|LKWTNFPGLQQLFLK.3|LKWTNFPGLQQLFLK.2|TFGAKEDMYR.2|C[CAM]PTLVNLAHMMSLYSTHTYSR.4|C[CAM]PTLVNLAHMMSLYSTHTYSR.3|EIIFDLLSVGK.2|LQLLSPQVDINSPINAK.3|LQLLSPQVDINSPINAK.2|IIGIPSPSSLFK.2|LTIHMDEELR.2|FGVLELQEHLDTYNVK.3|FGVLELQEHLDTYNVK.2|MLVQLINQWK.2|M[Oxi]LVQLINQWK.2|AAQTTIETAIHSLIETLK.3|AAQTTIETAIHSLIETLK.2|ELIEELHPIIKEALER.3|ELIEELHPIIKEALER.2|HALAGLFVEILIPVAAAVK.3|HALAGLFVEILIPVAAAVK.2|HC[CAM]STAVSYAWMFAYTR.3|HC[CAM]STAVSYAWMFAYTR.2|TLDFHFDISETPIIGNK.3|TLDFHFDISETPIIGNK.2|EKLMNVLSLC[CAM]GPESGLPK.3|EKLMNVLSLC[CAM]GPESGLPK.2|NFVEMLYQTTFELSSR.3|NFVEM[Oxi]LYQTTFELSSR.2|NFVEMLYQTTFELSSR.2|EQSPHVVQSVISLIMGMK.3|EQSPHVVQSVISLIMGMK.2|FGEITNEAVSFLGDSLQR.3|FGEITNEAVSFLGDSLQR.2|WLDNILDSLDK.2|SLFAEFAVQAEK.2|C[CAM]HVNQMLSDTDGSSAVFTFHVFSR.4|C[CAM]HVNQMLSDTDGSSAVFTFHVFSR.3|C[CAM]NIAVILLTDLIIDHSVK.3|C[CAM]NIAVILLTDLIIDHSVK.2|DGEPPMPTTGVILPSGNTLR.3|DGEPPM[Oxi]PTTGVILPSGNTLR.2|DGEPPMPTTGVILPSGNTLR.2|SDSMPLYSNWR.2|VFLVIADSLQQK.2|MVQSYQLLAQAK.2|M[Oxi]VQSYQLLAQAK.2|C[CAM]SPPETLASTPDSGYSIDSK.3|C[CAM]SPPETLASTPDSGYSIDSK.2|HLDKEVGRPM[Oxi]C[CAM]MTSVQMSNKEPEDMITGER.5|HLDKEVGRPMC[CAM]MTSVQMSNKEPEDM[Oxi]ITGER.5|HLDKEVGRPMC[CAM]MTSVQMSNKEPEDMITGER.5|HLDKEVGRPMC[CAM]MTSVQMSNKEPEDMITGER.4|HSLALYPLITC[CAM]LLC[CAM]VSQK.3|HSLALYPLITC[CAM]LLC[CAM]VSQK.2|KFGEITNEAVSFLGDSLQR.3|KFGEITNEAVSFLGDSLQR.2|VIGMSVYYPQVR.2|VIGM[Oxi]SVYYPQVR.2|YSSSSGGSYEEEK.2|DC[CAM]SNWINVVC[CAM]R.2|GEDLQFDQLISSMSSVAEHC[CAM]LPSLLR.4|GEDLQFDQLISSM[Oxi]SSVAEHC[CAM]LPSLLR.3|GEDLQFDQLISSMSSVAEHC[CAM]LPSLLR.3|HALAGLFVEILIPVAAAVKNEVNVPC[CAM]LK.4|NEAEVINMSEELAQLESILK.3|NEAEVINM[Oxi]SEELAQLESILK.3|NEAEVINM[Oxi]SEELAQLESILK.2|NEAEVINMSEELAQLESILK.2|QKEQSPHVVQSVISLIMGMK.3|QPLTATTLSDVLSR.2|NYLILC[CAM]C[CAM]SAATSSSSTSAGSVR.3|NYLILC[CAM]C[CAM]SAATSSSSTSAGSVR.2|QVMLHYLLPWMNNIELVDLKPLPTAR.4|QVM[Oxi]LHYLLPWM[Oxi]NNIELVDLKPLPTAR.4|QVM[Oxi]LHYLLPWMNNIELVDLKPLPTAR.4|QVMLHYLLPWM[Oxi]NNIELVDLKPLPTAR.4|QVMLHYLLPWM[Oxi]NNIELVDLKPLPTAR.3|QVMLHYLLPWMNNIELVDLKPLPTAR.3|TDGVLSQLSPLPHLYSVSYYQLSEELAR.4|TDGVLSQLSPLPHLYSVSYYQLSEELAR.3|TYGGDTGSPEISFTK.2|VC[CAM]AEEKC[CAM]PTLVNLAHMMSLYSTHTYSR.4|WTNFPGLQQLFLK.2|ALFALLEIPKGDDELAIDVMDR.3|ALFALLEIPKGDDELAIDVM[Oxi]DR.3|EAESASENEEIDISK.2|GEGWGSPQATAMVLNNLMYMTAK.3|IFELLADAGVISHSASGGLDNETHFLNNTLLEYVDLTR.5|IFELLADAGVISHSASGGLDNETHFLNNTLLEYVDLTR.4|LINQVNTIKNEAEVINMSEELAQLESILK.4|LINQVNTIKNEAEVINM[Oxi]SEELAQLESILK.3|LINQVNTIKNEAEVINMSEELAQLESILK.3|QFFLNNWHIFLQNC[CAM]LSHLK.3|SESMEITESLVLGLGR.2|SESM[Oxi]EITESLVLGLGR.2|SLQRGEDLQFDQLISSMSSVAEHC[CAM]LPSLLR.4|SLQRGEDLQFDQLISSMSSVAEHC[CAM]LPSLLR.3|VNTTTSSDSYIGLWR.2|AMSAVLC[CAM]C[CAM]GPVADNVGLSSDGYLYK.3|AM[Oxi]SAVLC[CAM]C[CAM]GPVADNVGLSSDGYLYK.3|DETPTLEASLDNANSR.2|TMQLLEELVSELQLTDPVSSGVTHMDNPPYYR.4|TM[Oxi]QLLEELVSELQLTDPVSSGVTHMDNPPYYR.4|TMQLLEELVSELQLTDPVSSGVTHM[Oxi]DNPPYYR.4|YSSSSGGSYEEEKSDSMPLYSNWR.3|AYPELTLAIFSEISQR.2|KSTGQLNLSTSPINSSSYLGYNSNAR.3|DKTM[Oxi]QLLEELVSELQLTDPVSSGVTHMDNPPYYR.4|DKTMQLLEELVSELQLTDPVSSGVTHM[Oxi]DNPPYYR.4|DKTMQLLEELVSELQLTDPVSSGVTHMDNPPYYR.4|DYQC[CAM]DTVM[Oxi]LLNLILFK.2|IPSVTSGTTSSSNTMVAPTDGNPDNKPIK.3|LINQVNTIKNEAEVINMSEELAQLESILKEAESASENEEIDISK.5|STSSTSSGSNSNALVPVSWK.2|VM[Oxi]EHNQGEPLPFPPAGGC[CAM]WSPLVDYVPETSSPGLPLHR.4|VMEHNQGEPLPFPPAGGC[CAM]WSPLVDYVPETSSPGLPLHR.4|TLTDEEAKVIGMSVYYPQVR.2
SEN / CTL,P51148,Ras-related protein Rab-5C,RAB5C,4.73,0.99,5.26E-05,6.28E-06,5.20E+00,"small GTPase mediated signal transduction,protein transport,regulation of endocytosis,plasma membrane to endosome transport","GTPase activity,protein binding,GTP binding,GDP binding","lysosomal membrane,early endosome,lipid particle,plasma membrane,endocytic vesicle,early endosome membrane,melanosome,intracellular membrane-bounded organelle,extracellular exosome",6,13,23,QASPNIVIALAGNKADLASKR.4|QASPNIVIALAGNKADLASKR.3|NEPQNATGAPGR.3|NEPQNATGAPGR.2|GGAARPNGPAAGNK.3|GGAARPNGPAAGNK.2|KLPKNEPQNATGAPGR.4|QASPNIVIALAGNK.3|QASPNIVIALAGNK.2|NRGVDLQENNPASR.3|TAMNVNEIFMAIAK.3|TAMNVNEIFMAIAK.2|TAM[Oxi]NVNEIFMAIAK.2|TAMNVNEIFM[Oxi]AIAK.2|TAM[Oxi]NVNEIFM[Oxi]AIAK.2|GVDLQENNPASR.2|QASPNIVIALAGNKADLASK.3|GAQAAIVVYDITNTDTFAR.3|GAQAAIVVYDITNTDTFAR.2|AVEFQEAQAYADDNSLLFM[Oxi]ETSAK.3|AVEFQEAQAYADDNSLLFMETSAK.3|RAVEFQEAQAYADDNSLLFMETSAK.3|GQFHEYQESTIGAAFLTQTVC[CAM]LDDTTVK.3
SEN / CTL,Q9Y3U8,60S ribosomal protein L36,RPL36,4.71,1.14,1.23E-12,3.48E-13,1.25E+01,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleolus,cytoplasm,cytosol,membrane,cytosolic large ribosomal subunit",18,7,15,EELSNVLAAMR.2|EELSNVLAAM[Oxi]R.2|DMIREVC[CAM]GFAPYER.3|REELSNVLAAMR.3|REELSNVLAAM[Oxi]R.3|REELSNVLAAMR.2|ALRYPM[Oxi]AVGLNK.3|ALRYPMAVGLNK.3|ALRYPMAVGLNK.2|YPMAVGLNK.2|YPM[Oxi]AVGLNK.2|KREELSNVLAAMR.3|KREELSNVLAAM[Oxi]R.3|KREELSNVLAAMR.2|EVC[CAM]GFAPYER.2
SEN / CTL,P55268,Laminin subunit beta-2,LAMB2,4.69,1.72,6.00E-10,1.29E-10,9.89E+00,"cell adhesion,axon guidance,neuromuscular junction development,visual perception,astrocyte development,Schwann cell development,extracellular matrix organization,axon extension involved in regeneration,retina development in camera-type eye,metanephric glomerular visceral epithelial cell development,metanephric glomerular basement membrane development","integrin binding,structural molecule activity","extracellular region,basement membrane,basal lamina,laminin-3 complex,laminin-11 complex,synapse,extracellular exosome,extracellular matrix",18,53,60,SLADVDAILAR.2|GAVADTRDTEQTLYQVQER.3|TGGSAQPETPYSGPGLLIDSLVLLPR.3|ARHTQAELQR.3|VVQDLAAR.2|AETVQAALEEAQR.3|AETVQAALEEAQR.2|DLLQAAQDKLQR.3|C[CAM]EAC[CAM]APGHFGDPSRPGGR.4|AQGIAQGAIR.2|AQGVLAAQAR.2|HTQAELQR.2|TSGQC[CAM]LC[CAM]R.2|DLLQAAQDK.2|GQVLDVVER.2|HRTEALMDAQKEDFNSK.4|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.5|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.4|AAQLDGLEAR.2|AEQLLQDAR.2|ALAEGGSILSR.2|LGIVQGIVGAR.2|VLDPAIPIPDPYSSR.3|VLDPAIPIPDPYSSR.2|KAQGVLAAQAR.2|QLDALLEALK.2|GPTC[CAM]NEFTGQC[CAM]HC[CAM]R.3|LQEGQTLEFLVASVPK.3|LQEGQTLEFLVASVPK.2|RAEQLLQDAR.2|DGFFGLSISDR.2|GPLGDQYQTVK.2|VLELSIPASAEQIQHLAGAIAER.4|VLELSIPASAEQIQHLAGAIAER.3|AGNSLAASTAEETAGSAQGR.3|AGNSLAASTAEETAGSAQGR.2|SWAEDEKQKAETVQAALEEAQR.4|YLIFPNPVC[CAM]LEPGISYKLHLK.4|DLPWRPAEDGHSHAC[CAM]R.3|RAGNSLAASTAEETAGSAQGR.3|VLELSIPASAEQIQHLAGAIAERVR.4|GQVEQANQELQELIQSVK.3|GQVEQANQELQELIQSVK.2|IQNVVTSFAPQR.2|HSNFLGAYDSIR.2|GNC[CAM]FC[CAM]YGHASEC[CAM]APAPGAPAHAEGMVHGAC[CAM]IC[CAM]K.5|GQWGFPSC[CAM]RPC[CAM]VC[CAM]NGHADEC[CAM]NTHTGAC[CAM]LGC[CAM]R.5|GSC[CAM]YPATGDLLVGR.2|YYYALYELVVR.2|DTEQTLYQVQER.2|GLNC[CAM]EQC[CAM]QDFYR.2|LQELEGTYEENER.2|GFSGIFPAC[CAM]HPC[CAM]HAC[CAM]FGDWDR.3|AQELQQTGVLGAFESSFWHMQEK.3|LVTPGETPSWTGSGFVR.2|VLVLEMFSGGDAAALER.2|YSEIEPSTEGEVIYR.2|EIGEATEHLTQLEADLTDVQDENFNANHALSGLER.4|YLIFPNPVC[CAM]LEPGISYK.2|AQEAEQLLRGPLGDQYQTVK.2
SEN / CTL,P01112,GTPase HRas,HRAS,4.65,1.80,1.13E-21,7.20E-22,2.11E+01,"MAPK cascade,positive regulation of protein phosphorylation,stimulatory C-type lectin receptor signaling pathway,endocytosis,chemotaxis,cell cycle arrest,mitotic cell cycle checkpoint,signal transduction,cell surface receptor signaling pathway,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,axon guidance,cell proliferation,positive regulation of cell proliferation,negative regulation of cell proliferation,animal organ morphogenesis,negative regulation of gene expression,positive regulation of cell migration,positive regulation of interferon-gamma production,negative regulation of GTPase activity,social behavior,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,T-helper 1 type immune response,defense response to protozoan,positive regulation of MAP kinase activity,positive regulation of MAPK cascade,negative regulation of neuron apoptotic process,positive regulation of GTPase activity,positive regulation of DNA replication,positive regulation of transcription from RNA polymerase II promoter,positive regulation of JNK cascade,positive regulation of Ras protein signal transduction,ephrin receptor signaling pathway,regulation of long-term neuronal synaptic plasticity,positive regulation of epithelial cell proliferation,T cell receptor signaling pathway,leukocyte migration,protein heterooligomerization,positive regulation of ERK1 and ERK2 cascade,positive regulation of wound healing,cellular senescence,intrinsic apoptotic signaling pathway,positive regulation of ruffle assembly,positive regulation of actin cytoskeleton reorganization,positive regulation of miRNA metabolic process","GTPase activity,protein binding,GTP binding,protein C-terminus binding","Golgi membrane,nucleus,cytoplasm,Golgi apparatus,cytosol,plasma membrane,perinuclear region of cytoplasm",42,11,13,QGVEDAFYTLVR.2|SYGIPYIETSAK.2|TGEGFLC[CAM]VFAINNTK.2|SALTIQLIQNHFVDEYDPTIEDSYRK.4|SALTIQLIQNHFVDEYDPTIEDSYRK.3|SALTIQLIQNHFVDEYDPTIEDSYR.3|TRQGVEDAFYTLVR.3|TRQGVEDAFYTLVR.2|LVVVGAGGVGK.2|VKDSDDVPMVLVGNK.3|SFEDIHQYR.2|DSDDVPMVLVGNK.2|QVVIDGETC[CAM]LLDILDTAGQEEYSAMR.3
SEN / CTL,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,4.65,2.27,5.59E-11,1.35E-11,1.09E+01,"formation of translation preinitiation complex,translational initiation,regulation of translational initiation","translation initiation factor binding,poly(A) RNA binding,translation initiation factor activity","cytosol,eukaryotic translation initiation factor 3 complex,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex",30,47,79,ELLGQGLLLR.2|C[CAM]LEEFELLGK.2|RLDEEEEDNEGGEWER.3|RLDEEEEDNEGGEWER.2|VGERQPLLGPPESMREHVVAASK.5|VGERQPLLGPPESMREHVVAASK.4|TMVQLGIC[CAM]AFR.2|TM[Oxi]VQLGIC[CAM]AFR.2|DFESHITSYK.3|DFESHITSYK.2|EHVVAASK.2|TC[CAM]HSFIINEK.3|TC[CAM]HSFIINEK.2|YNRDFESHITSYK.4|YNRDFESHITSYK.3|YNRDFESHITSYK.2|GTEITHAVVIKK.3|GTEITHAVVIKK.2|RFEELTNLIR.3|RFEELTNLIR.2|AKELLGQGLLLR.3|AKELLGQGLLLR.2|MDEEFTK.2|APTTDEDKKAAEK.3|ILHTYYK.2|GTTEEVC[CAM]R.2|LNEILQAR.2|VWDLFPEADKVR.3|DAHNALLDIQSSGR.3|DAHNALLDIQSSGR.2|KIQEESLR.2|IMQNTDPHSQEYVEHLK.4|IMQNTDPHSQEYVEHLK.3|QGTYGGYFR.2|QLTPPEGSSK.2|GC[CAM]ILTLVER.2|KLNEILQAR.2|SIVDKEGVPR.2|QPLLLSEDEEDTKR.3|VGERQPLLGPPESMR.3|LGSLVENNER.2|FEELTNLIR.2|GTEITHAVVIK.2|TEPTAQQNLALQLAEK.3|TEPTAQQNLALQLAEK.2|QPLLGPPESMR.2|QPLLGPPESM[Oxi]R.2|VWDLFPEADK.2|MIINEELMASLDQPTQTVVMHR.4|M[Oxi]IINEELMASLDQPTQTVVMHR.4|M[Oxi]IINEELMASLDQPTQTVVM[Oxi]HR.3|M[Oxi]IINEELMASLDQPTQTVVMHR.3|MIINEELM[Oxi]ASLDQPTQTVVMHR.3|MIINEELMASLDQPTQTVVM[Oxi]HR.3|MIINEELMASLDQPTQTVVMHR.3|DEAQVC[CAM]AIIER.2|ILADLEDYLNELWEDK.3|ILADLEDYLNELWEDK.2|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.5|IM[Oxi]QNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.4|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.4|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.3|QGLTKDAHNALLDIQSSGR.3|QPLLGPPESMREHVVAASK.3|SEQDQAENEGEDSAVLMER.3|SEQDQAENEGEDSAVLM[Oxi]ER.3|SEQDQAENEGEDSAVLMER.2|DLM[Oxi]LMSHLQDNIQHADPPVQILYNR.4|DLMLM[Oxi]SHLQDNIQHADPPVQILYNR.4|DLMLMSHLQDNIQHADPPVQILYNR.4|DLM[Oxi]LM[Oxi]SHLQDNIQHADPPVQILYNR.4|DLM[Oxi]LMSHLQDNIQHADPPVQILYNR.3|DLMLM[Oxi]SHLQDNIQHADPPVQILYNR.3|DLMLMSHLQDNIQHADPPVQILYNR.3|ILADLEDYLNELWEDKEGK.3|QPLLLSEDEEDTK.2|LDEEEEDNEGGEWER.2|FNIIASLYDYNPNLATYMKPEMWGK.3|QLTPPEGSSKSEQDQAENEGEDSAVLMER.3
SEN / CTL,P02786,Transferrin receptor protein 1,TFRC,4.64,2.01,1.42E-03,1.38E-04,3.86E+00,"cellular iron ion homeostasis,osteoclast differentiation,positive regulation of B cell proliferation,receptor internalization,transferrin transport,cellular response to drug,positive regulation of T cell proliferation,positive regulation of bone resorption,positive regulation of isotype switching,viral entry into host cell,iron ion import,regulation of cell growth,regulation of cell proliferation","virus receptor activity,glycoprotein binding,double-stranded RNA binding,transferrin receptor activity,protein binding,transferrin transmembrane transporter activity,protein homodimerization activity,poly(A) RNA binding","extracellular region,extracellular space,endosome,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,membrane,cytoplasmic, membrane-bounded vesicle,basolateral plasma membrane,melanosome,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,extracellular vesicle,HFE-transferrin receptor complex",6,42,60,SSGLPNIPVQTISR.2|RLYWDDLKR.3|DAWGPGAAK.2|LTVSNVLK.2|QVDGDNSHVEMK.3|QVDGDNSHVEM[Oxi]K.3|QVDGDNSHVEMK.2|AVLGTSNFK.2|SGVGTALLLK.2|VSASPLLYTLIEK.3|VSASPLLYTLIEK.2|LTTDFGNAEKTDR.3|LVHANFGTK.2|ILNIFGVIK.2|LAVDEEENADNNTK.3|LAVDEEENADNNTK.2|VEYHFLSPYVSPK.3|VEYHFLSPYVSPK.2|HVFWGSGSHTLPALLENLK.4|HVFWGSGSHTLPALLENLK.3|HVFWGSGSHTLPALLENLK.2|DSAQNSVIIVDKNGR.3|LTHDVELNLDYER.3|LTHDVELNLDYER.2|AFTYINLDK.2|LSEKLDSTDFTGTIK.3|LTTDFGNAEK.2|GFVEPDHYVVVGAQR.3|GFVEPDHYVVVGAQR.2|RLYWDDLK.2|SAFSNLFGGEPLSYTR.3|SAFSNLFGGEPLSYTR.2|LVYLVENPGGYVAYSK.3|LVYLVENPGGYVAYSK.2|LDSTDFTGTIK.2|AAAEVAGQFVIK.2|LLNENSYVPR.2|EEPGEDFPAAR.2|YNSQLLSFVR.2|DSAQNSVIIVDK.2|LAQMFSDMVLK.2|LAQM[Oxi]FSDMVLK.2|LAQMFSDM[Oxi]VLK.2|HPVTGQFLYQDSNWASK.3|HPVTGQFLYQDSNWASK.2|ADIKEMGLSLQWLYSAR.3|ADIKEMGLSLQWLYSAR.2|AFTYINLDKAVLGTSNFK.3|TMQNVKHPVTGQFLYQDSNWASK.4|LAQMFSDMVLKDGFQPSR.3|LTHDVELNLDYERYNSQLLSFVR.4|VANAESLNAIGVLIYMDQTK.3|VANAESLNAIGVLIYMDQTK.2|EAGSQKDENLALYVENQFR.3|EAGSQKDENLALYVENQFR.2|EMGLSLQWLYSAR.2|EM[Oxi]GLSLQWLYSAR.2|DENLALYVENQFR.2|LFGNMEGDC[CAM]PSDWKTDSTC[CAM]R.3|LFGNMEGDC[CAM]PSDWK.2
SEN / CTL,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,4.53,1.86,8.40E-07,1.26E-07,6.90E+00,"cellular protein modification process,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase","zinc ion binding,glutaminyl-peptide cyclotransferase activity",extracellular exosome,12,7,8,QIAEGTSISEMWQNDLQPLLIER.3|VFVGATDSAVPC[CAM]AMMLELAR.3|VFVGATDSAVPC[CAM]AMMLELAR.2|HLVLAC[CAM]HYDSK.3|YPGSPGSYAAR.2|SFSNIISTLNPTAK.2|YFQNYSYGGVIQDDHIPFLR.3|GVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNK.4
SEN / CTL,P35754,Glutaredoxin-1,GLRX,4.44,1.40,2.60E-07,4.11E-08,7.39E+00,"nucleobase-containing small molecule interconversion,cell redox homeostasis,positive regulation of membrane potential,oxidation-reduction process,protein deglutathionylation,positive regulation of sodium ion transmembrane transporter activity","electron carrier activity,glutathione disulfide oxidoreductase activity,protein N-terminus binding,glutathione oxidoreductase activity","nucleus,mitochondrion,cytosol,extracellular exosome",12,7,11,VFIGKDC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.3|QGLLEFVDITATNHTNEIQDYLQQLTGAR.4|QGLLEFVDITATNHTNEIQDYLQQLTGAR.3|LKQIGALQ.2|RAQEILSQLPIK.3|RAQEILSQLPIK.2|VVVFIKPTC[CAM]PYC[CAM]R.3|VVVFIKPTC[CAM]PYC[CAM]R.2|AQEILSQLPIK.2|DC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.3|DC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.2
SEN / CTL,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,4.44,1.30,1.21E-10,2.77E-11,1.06E+01,"tRNA aminoacylation for protein translation,glutamyl-tRNA aminoacylation,prolyl-tRNA aminoacylation,protein complex assembly,negative regulation of translation,cellular response to interferon-gamma","glutamate-tRNA ligase activity,proline-tRNA ligase activity,protein binding,ATP binding,RNA stem-loop binding,GTPase binding","cytoplasm,cytosol,membrane,aminoacyl-tRNA synthetase multienzyme complex,intracellular ribonucleoprotein complex,GAIT complex",18,125,223,THVADFAPEVAWVTR.3|THVADFAPEVAWVTR.4|THVADFAPEVAWVTR.2|SLC[CAM]IPFKPLC[CAM]ELQPGAK.3|SLC[CAM]IPFKPLC[CAM]ELQPGAK.2|DLPIKLNQWC[CAM]NVVR.3|DLPIKLNQWC[CAM]NVVR.2|FPPEASGYLHIGHAK.4|FPPEASGYLHIGHAK.3|FPPEASGYLHIGHAK.2|KPYIWEYSR.3|KPYIWEYSR.2|LLSVNIR.2|TKVEATKNETSAPFK.4|TKVEATKNETSAPFK.3|TKVEATKNETSAPFK.2|AIQGGTSHHLGQNFSK.4|AIQGGTSHHLGQNFSK.3|AIQGGTSHHLGQNFSK.2|KAPKEDVDAAVK.3|KAPKEDVDAAVK.2|NSKHEELMLGDPC[CAM]LK.4|NSKHEELMLGDPC[CAM]LK.3|NSKHEELM[Oxi]LGDPC[CAM]LK.3|NETSAPFK.2|NSEPAGLETPEAK.3|NSEPAGLETPEAK.2|SLIGVEYKPVSATGAEDKDKK.5|SLIGVEYKPVSATGAEDKDKK.4|SLIGVEYKPVSATGAEDKDKK.3|INEAVEC[CAM]LLSLK.3|INEAVEC[CAM]LLSLK.2|YYTLFGR.2|DQDLEPGAPSMGAK.3|DQDLEPGAPSMGAK.2|DQDLEPGAPSM[Oxi]GAK.2|FDDTNPEKEKEDFEK.4|FDDTNPEKEKEDFEK.3|GDIIQLQR.2|VASQGEVVR.2|VAVQGDVVR.2|ADLRDNYSPGWK.3|ADLRDNYSPGWK.2|VEATKNETSAPFK.3|DNYSPGWK.2|FDDTNPEK.2|HEELMLGDPC[CAM]LK.3|HEELM[Oxi]LGDPC[CAM]LK.3|HEELMLGDPC[CAM]LK.2|HEELM[Oxi]LGDPC[CAM]LK.2|SC[CAM]QFVAVR.2|FNHWELK.2|DFFDAEIK.2|RGMTVEGLK.2|WEFKHPQPFLR.3|KVIDPVAPR.2|SVVNMEWDKIWAFNKK.4|SVVNMEWDKIWAFNKK.3|RGMTVEGLKQFIAAQGSSR.4|AALLNQHYQVNFK.3|AALLNQHYQVNFK.2|SLYDEVAAQGEVVR.3|SLYDEVAAQGEVVR.2|VLFDKVASQGEVVR.3|QFAYQNSWGLTTR.3|QFAYQNSWGLTTR.2|AKINEAVEC[CAM]LLSLK.3|AKINEAVEC[CAM]LLSLK.2|NQGGGLSSSGAGEGQGPK.3|NQGGGLSSSGAGEGQGPK.2|QFIAAQGSSR.2|RWFGFLEAQQAFQSVGTK.4|RWFGFLEAQQAFQSVGTK.3|RWFGFLEAQQAFQSVGTK.2|SLIGVEYKPVSATGAEDKDK.4|SLIGVEYKPVSATGAEDKDK.3|DQVDIAVQELLQLK.3|DQVDIAVQELLQLK.2|KDPSKNQGGGLSSSGAGEGQGPK.4|KDPSKNQGGGLSSSGAGEGQGPK.3|KGDIIQLQR.2|NPEVGLKPVWYSPK.3|NPEVGLKPVWYSPK.2|TIGVMTMVHGDNMGLVLPPR.4|TIGVMTMVHGDNMGLVLPPR.3|TIGVM[Oxi]TMVHGDNMGLVLPPR.3|TIGVMTM[Oxi]VHGDNMGLVLPPR.3|TIGVMTMVHGDNM[Oxi]GLVLPPR.3|TIGVM[Oxi]TMVHGDNMGLVLPPR.2|TIGVMTMVHGDNMGLVLPPR.2|VASQGEVVRK.2|THMVVANTMEDFQK.3|THM[Oxi]VVANTMEDFQK.3|THMVVANTM[Oxi]EDFQK.3|THMVVANTMEDFQK.2|THM[Oxi]VVANTMEDFQK.2|AKIDMSSNNGC[CAM]MRDPTLYR.4|LNLNNTVLSK.2|PLC[CAM]ELQPGAK.2|SLYDEVAAQGEVVRK.3|SLYDEVAAQGEVVRK.2|SVVNMEWDK.2|TELAEPIAIR.2|APKEDVDAAVK.2|ASEDLKTHMVVANTMEDFQK.4|ASEDLKTHMVVANTMEDFQK.3|EAPC[CAM]VLIYIPDGHTK.3|EAPC[CAM]VLIYIPDGHTK.2|EVIPVNVPEAQEEMK.3|EVIPVNVPEAQEEM[Oxi]K.2|EVIPVNVPEAQEEMK.2|GNAAWQEQLK.2|NQGGGLSSSGAGEGQGPKK.3|NQGGGLSSSGAGEGQGPKK.2|AYVDDTPAEQMKAER.3|AYVDDTPAEQMKAER.2|DTGEKLTVAENEAETK.3|DTGEKLTVAENEAETK.2|ENILHVSENVIFTDVNSILR.4|ENILHVSENVIFTDVNSILR.3|ENILHVSENVIFTDVNSILR.2|LQAILEDIQVTLFTR.3|LQAILEDIQVTLFTR.2|RGFFIC[CAM]DQPYEPVSPYSC[CAM]K.4|RGFFIC[CAM]DQPYEPVSPYSC[CAM]K.3|RGFFIC[CAM]DQPYEPVSPYSC[CAM]K.2|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGK.6|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGK.5|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGK.4|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGK.3|DDVSISVEEGK.2|FVELPGAEMGK.2|FVELPGAEM[Oxi]GK.2|LNQWC[CAM]NVVR.2|MFEIVFEDPKIPGEK.3|M[Oxi]FEIVFEDPKIPGEK.3|MFEIVFEDPKIPGEK.2|LTVAENEAETK.2|NLQMWEEMK.2|KEENLADWYSQVITK.3|KEENLADWYSQVITK.2|KEVIPVNVPEAQEEMK.3|TTARDQDLEPGAPSMGAK.3|SLIGVEYKPVSATGAEDK.3|SLIGVEYKPVSATGAEDK.2|SVVNMEWDKIWAFNK.3|EVIPVNVPEAQEEMKEVAKHPK.4|GMTVEGLKQFIAAQGSSR.3|MFEIVFEDPK.2|M[Oxi]FEIVFEDPK.2|APKDQVDIAVQELLQLK.3|LNLENKDYKK.2|IDMSSNNGC[CAM]MR.2|GSQFGQSC[CAM]C[CAM]LR.2|WFGFLEAQQAFQSVGTK.3|WFGFLEAQQAFQSVGTK.2|FAGGDYTTTIEAFISASGR.3|FAGGDYTTTIEAFISASGR.2|LTWFVNEGLVDGWDDPRFPTVR.4|LTWFVNEGLVDGWDDPRFPTVR.3|NLQMWEEMKK.2|TTEYHDRDEQFYWIIEALGIR.4|TTEYHDRDEQFYWIIEALGIR.3|VILEDVAM[Oxi]LHIKPDQFTYTSDHFETIMK.5|VILEDVAMLHIKPDQFTYTSDHFETIM[Oxi]K.5|VILEDVAMLHIKPDQFTYTSDHFETIMK.5|VILEDVAMLHIKPDQFTYTSDHFETIMK.4|VILEDVAMLHIKPDQFTYTSDHFETIMK.3|ERPTPSLNNNC[CAM]TTSEDSLVLYNR.4|ERPTPSLNNNC[CAM]TTSEDSLVLYNR.3|IDMSSNNGC[CAM]MRDPTLYR.3|AYVDDTPAEQMK.2|AYVDDTPAEQM[Oxi]K.2|EYIPGQPPLSQSSDSSPTR.3|EYIPGQPPLSQSSDSSPTR.2|KLTWFVNEGLVDGWDDPRFPTVR.4|KLTWFVNEGLVDGWDDPRFPTVR.3|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGKDEDFK.6|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGKDEDFK.5|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGKDEDFK.4|EVIPVNVPEAQEEMKEVAK.3|EVIPVNVPEAQEEM[Oxi]KEVAK.3|IVQIPFC[CAM]GEIDC[CAM]EDWIK.3|IVQIPFC[CAM]GEIDC[CAM]EDWIK.2|KGSQFGQSC[CAM]C[CAM]LR.2|NSKHEELMLGDPC[CAM]LKDLK.3|SGKTELAEPIAIRPTSETVM[Oxi]YPAYAK.4|SGKTELAEPIAIRPTSETVMYPAYAK.4|SGKTELAEPIAIRPTSETVMYPAYAK.3|GFFIC[CAM]DQPYEPVSPYSC[CAM]K.3|GFFIC[CAM]DQPYEPVSPYSC[CAM]K.2|PTSETVMYPAYAK.2|YNVYPTYDFAC[CAM]PIVDSIEGVTHALR.4|YNVYPTYDFAC[CAM]PIVDSIEGVTHALR.3|LGVENC[CAM]YFPMFVSQSALEK.3|LGVENC[CAM]YFPMFVSQSALEK.2|IVQIPFC[CAM]GEIDC[CAM]EDWIKK.3|VTWLAETTHALPIPVIC[CAM]VTYEHLITK.4|VTWLAETTHALPIPVIC[CAM]VTYEHLITK.3|TGQEYKPGNPPAEIGQNISSNSSASILESK.4|TGQEYKPGNPPAEIGQNISSNSSASILESK.3|KLGVENC[CAM]YFPM[Oxi]FVSQSALEK.3|KLGVENC[CAM]YFPMFVSQSALEK.3|KLGVENC[CAM]YFPMFVSQSALEK.2|VATTAGLYGSNLM[Oxi]EHTEIDHWLEFSATK.4|VATTAGLYGSNLMEHTEIDHWLEFSATK.4|VATTAGLYGSNLMEHTEIDHWLEFSATK.3|VAC[CAM]VQVVIIPC[CAM]GITNALSEEDK.3|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGKDEDFKQYVNK.6|VTWLAETTHALPIPVIC[CAM]VTYEHLITKPVLGKDEDFKQYVNK.5|LGLEAKKEENLADWYSQVITK.3|LSSC[CAM]DSFTSTINELNHC[CAM]LSLR.3|LGVENC[CAM]YFPMFVSQSALEKEK.3|SEMIEYHDISGC[CAM]YILRPWAYAIWEAIK.4|TGNKYNVYPTYDFAC[CAM]PIVDSIEGVTHALR.4|EENLADWYSQVITK.2|EKTGQEYKPGNPPAEIGQNISSNSSASILESK.4|TELAEPIAIRPTSETVM[Oxi]YPAYAK.3|TELAEPIAIRPTSETVMYPAYAK.3|NETSAPFKERPTPSLNNNC[CAM]TTSEDSLVLYNR.4|HEELMLGDPC[CAM]LKDLK.2|LTWFVNEGLVDGWDDPR.2|VAC[CAM]VQVVIIPC[CAM]GITNALSEEDKEALIAK.3
SEN / CTL,P80192,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,4.43,3.20,1.22E-02,1.03E-03,2.99E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,protein phosphorylation,apoptotic process,activation of JNKK activity,activation of JUN kinase activity,positive regulation of apoptotic process,protein autophosphorylation","protein serine/threonine kinase activity,JUN kinase kinase kinase activity,MAP kinase kinase activity,ATP binding,protein homodimerization activity","cellular_component,intracellular",6,21,25,WNTQQDSTLERPK.3|RWNTQQDSTLERPK.4|RWNTQQDSTLERPK.3|LGDVVEVLSK.2|RDPNQSLTPTHVTLTTPSQPSSHR.5|LDPWWFVSPSHAR.3|TPSDGALKPETLLASR.3|TPSDGALKPETLLASR.2|FKRDPNQSLTPTHVTLTTPSQPSSHR.5|HDPDEDISQTIENVR.3|SSPPASPTIIPR.2|FTVQASPTM[Oxi]DK.2|DPNQSLTPTHVTLTTPSQPSSHR.4|DPNQSLTPTHVTLTTPSQPSSHR.3|ELNIIIHQLC[CAM]QEKPR.3|LQHSPSQSYLC[CAM]IPFPR.3|VGIFPSNYVTPR.2|HEIQEMFDQLR.2|LPDPNVVFPPTPR.2|GIDGLAVAYGVAMNK.2|SPSSNGLSPSPGAGM[Oxi]LK.2|SPSSNGLSPSPGAGMLK.2|C[CAM]QLLPLEEPEPPAR.2|LALPIPSTC[CAM]PEPFAK.2|DSQVSGDEGWWTGQLNQR.2
SEN / CTL,Q9Y3I0,tRNA-splicing ligase RtcB homolog,RTCB,4.41,1.14,1.53E-04,1.67E-05,4.78E+00,"in utero embryonic development,placenta development,tRNA splicing, via endonucleolytic cleavage and ligation","RNA ligase (ATP) activity,ATP binding,vinculin binding,poly(A) RNA binding,metal ion binding","nucleus,nuclear envelope,nucleoplasm,cytoplasm,endoplasmic reticulum membrane,tRNA-splicing ligase complex",6,32,56,NLDFQDVLDKLADMGIAIR.3|NLDFQDVLDKLADMGIAIR.2|VEQHVVDGKER.3|VEQHVVDGKER.2|GQVC[CAM]VMIHSGSR.3|GQVC[CAM]VM[Oxi]IHSGSR.3|GQVC[CAM]VMIHSGSR.2|GQVC[CAM]VM[Oxi]IHSGSR.2|MLQADPNKVSAR.3|TNLDESDVQPVK.3|TNLDESDVQPVK.2|GMAAAGNYAWVNR.3|GMAAAGNYAWVNR.2|GM[Oxi]AAAGNYAWVNR.2|MLQADPNK.2|M[Oxi]LQADPNK.2|NVTDVVNTC[CAM]HDAGISKK.4|NVTDVVNTC[CAM]HDAGISKK.3|LMFEELR.2|LM[Oxi]FEELR.2|SSMTFLTR.2|LADMGIAIR.2|LADM[Oxi]GIAIR.2|QIGNVAALPGIVHR.3|QIGNVAALPGIVHR.2|VEQHVVDGK.2|EGYAWAEDK.2|EGYAWAEDKEHC[CAM]EEYGR.4|EGYAWAEDKEHC[CAM]EEYGR.3|EGYAWAEDKEHC[CAM]EEYGR.2|EHC[CAM]EEYGR.2|GGGVGGFLPAMK.2|GGGVGGFLPAM[Oxi]K.2|GLGHQVATDALVAMEK.3|GLGHQVATDALVAMEK.2|NVTDVVNTC[CAM]HDAGISK.3|NVTDVVNTC[CAM]HDAGISK.2|NLDFQDVLDK.2|IASPEGQDYLK.2|LVM[Oxi]EEAPESYKNVTDVVNTC[CAM]HDAGISKK.5|LVMEEAPESYKNVTDVVNTC[CAM]HDAGISKK.5|EQLAQAMFDHIPVGVGSK.3|EQLAQAMFDHIPVGVGSK.2|LVMEEAPESYK.2|LVM[Oxi]EEAPESYK.2|VFNTTPDDLDLHVIYDVSHNIAK.4|VFNTTPDDLDLHVIYDVSHNIAK.3|SYNDELQFLEK.2|KRGLPQLGTLGAGNHYAEIQVVDEIFNEYAAK.5|GFVPNMQVEGVFYVNDALEK.3|GFVPNMQVEGVFYVNDALEK.2|GLPQLGTLGAGNHYAEIQVVDEIFNEYAAK.4|GLPQLGTLGAGNHYAEIQVVDEIFNEYAAK.3|KGFVPNMQVEGVFYVNDALEK.3|TNLDESDVQPVKEQLAQAMFDHIPVGVGSK.4|RGLPQLGTLGAGNHYAEIQVVDEIFNEYAAK.4
SEN / CTL,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,4.37,2.22,6.08E-11,1.47E-11,1.08E+01,"positive regulation of protein phosphorylation,movement of cell or subcellular component,chemotaxis,signal transduction,blood coagulation,attachment of GPI anchor to protein,regulation of proteolysis,urokinase plasminogen activator signaling pathway,fibrinolysis,negative regulation of apoptotic process,positive regulation of DNA binding,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of release of cytochrome c from mitochondria,negative regulation of intrinsic apoptotic signaling pathway,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway","receptor activity,receptor binding,protein binding,enzyme binding,protein domain specific binding,urokinase plasminogen activator receptor activity","endoplasmic reticulum lumen,endoplasmic reticulum membrane,plasma membrane,integral component of plasma membrane,focal adhesion,integral component of membrane,extrinsic component of membrane,anchored component of membrane,extracellular exosome,invadopodium membrane",24,10,15,TNGDC[CAM]RVEEC[CAM]ALGQDLC[CAM]R.3|VEEC[CAM]ALGQDLC[CAM]R.2|YLEC[CAM]ISC[CAM]GSSDMSC[CAM]ER.2|ITSLTEVVC[CAM]GLDLC[CAM]NQGNSGR.3|ITSLTEVVC[CAM]GLDLC[CAM]NQGNSGR.2|SGC[CAM]NHPDLDVQYR.3|GPMNQC[CAM]LVATGTHEPK.3|GPM[Oxi]NQC[CAM]LVATGTHEPK.3|GPMNQC[CAM]LVATGTHEPK.2|GC[CAM]ATASMC[CAM]QHAHLGDAFSMNHIDVSC[CAM]C[CAM]TK.5|GC[CAM]ATASMC[CAM]QHAHLGDAFSMNHIDVSC[CAM]C[CAM]TK.4|SPEEQC[CAM]LDVVTHWIQEGEEGRPK.4|SPEEQC[CAM]LDVVTHWIQEGEEGRPK.3|LWEEGEELELVEK.2|C[CAM]NEGPILELENLPQNGR.2
SEN / CTL,P12429,Annexin A3,ANXA3,4.36,1.11,1.32E-04,1.46E-05,4.84E+00,"phagocytosis,positive regulation of endothelial cell migration,hippocampus development,animal organ regeneration,defense response to bacterium,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of angiogenesis,positive regulation of DNA metabolic process,positive regulation of sequence-specific DNA binding transcription factor activity,response to glucocorticoid,response to growth factor","calcium ion binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,calcium-dependent protein binding","cytoplasm,plasma membrane,membrane,axon,dendrite,phagocytic vesicle membrane,specific granule,neuronal cell body,extracellular exosome",6,31,45,SLGDDISSETSGDFRK.3|SLGDDISSETSGDFRK.4|SLGDDISSETSGDFRK.2|HYGYSLYSAIK.3|HYGYSLYSAIK.2|AGENRWGTDEDK.3|ALLTLADGR.2|DESLKVDEHLAK.3|EYQAAYGK.2|LTFDEYR.2|QDAQILYK.2|DISQAYYTVYKK.3|DISQAYYTVYKK.2|NTPAFLAER.2|ALKGIGTDEFTLNR.3|RDESLKVDEHLAK.3|RDESLKVDEHLAK.2|FTEILC[CAM]LR.2|MLISILTER.2|SEIDLLDIR.2|GAGTNEDALIEILTTR.3|GAGTNEDALIEILTTR.2|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.6|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.5|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.4|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.3|QMKDISQAYYTVYK.3|QMKDISQAYYTVYK.2|DYPDFSPSVDAEAIQK.3|DYPDFSPSVDAEAIQK.2|GIGTDEFTLNR.2|WGTDEDKFTEILC[CAM]LR.3|GDLSGHFEHLMVALVTPPAVFDAK.4|GDLSGHFEHLMVALVTPPAVFDAK.3|DISQAYYTVYK.2|SMKGAGTNEDALIEILTTR.3|NISQKDIVDSIK.2|GELSGHFEDLLLAIVNC[CAM]VR.3|GELSGHFEDLLLAIVNC[CAM]VR.2|KHYGYSLYSAIK.2|SDTSGDYEITLLK.2|GTVRDYPDFSPSVDAEAIQK.3|GTVRDYPDFSPSVDAEAIQK.2|DDLKGDLSGHFEHLMVALVTPPAVFDAK.4|SLGDDISSETSGDFR.2
SEN / CTL,Q9UMF0,Intercellular adhesion molecule 5,ICAM5,4.30,2.14,2.47E-03,2.32E-04,3.63E+00,"phagocytosis,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune response",integrin binding,"plasma membrane,integral component of plasma membrane",6,1,1,SGELGAVIEGLLR.2
SEN / CTL,Q8WUM4,Programmed cell death 6-interacting protein,PDCD6IP,4.29,1.86,2.83E-16,1.08E-16,1.60E+01,"cell separation after cytokinesis,apoptotic process,regulation of centrosome duplication,protein transport,viral life cycle,multivesicular body assembly,viral budding via host ESCRT complex,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,positive regulation of exosomal secretion,regulation of extracellular exosome assembly,positive regulation of extracellular exosome assembly,nucleus organization,mitotic metaphase plate congression,regulation of mitotic spindle assembly","protein binding,proteinase activated receptor binding,protein homodimerization activity,calcium-dependent protein binding","immunological synapse,cytoplasm,microtubule organizing center,cytosol,focal adhesion,membrane,melanosome,myelin sheath,extracellular exosome,endoplasmic reticulum exit site,extracellular vesicle",36,63,96,SVIEQGGIQTVDQLIKELPELLQR.3|SVIEQGGIQTVDQLIKELPELLQR.4|FIQQTYPSGGEEQAQYC[CAM]R.3|FIQQTYPSGGEEQAQYC[CAM]R.2|SVNFDMTSK.2|TPSNELYKPLRAEGTNFR.4|TPSNELYKPLRAEGTNFR.3|EREGLENDLK.3|EREGLENDLK.2|NREILDESLR.3|NREILDESLR.2|SLLSNLDEVKK.3|SLLSNLDEVKK.2|TSEVDLAK.2|TSEVDLAKPLVK.3|TSEVDLAKPLVK.2|KDNDFIYHDR.3|KDNDFIYHDR.2|NIQVSHQEFSK.3|NIQVSHQEFSK.2|TPSNELYKPLR.3|TPSNELYKPLR.2|FTDLFEK.2|AAVGRPLDK.2|AVQADGQVK.2|DLQQSIAR.2|EGLENDLK.2|KDNDFIYHDRVPDLK.4|DAFDKGSLFGGSVK.3|DAFDKGSLFGGSVK.2|KFGEEIAR.2|TPSNELYK.2|C[CAM]SDIVFAR.2|EILDESLR.2|ETVLSALSR.2|EVFPVLAAK.2|KTSEVDLAK.2|HC[CAM]IMQANAEYHQSILAK.4|HC[CAM]IM[Oxi]QANAEYHQSILAK.3|HC[CAM]IMQANAEYHQSILAK.3|HYQFASGAFLHIK.3|HYQFASGAFLHIK.2|AAVGRPLDKHEGALETLLR.4|AAVGRPLDKHEGALETLLR.3|LLDEEEATDNDLR.3|LLDEEEATDNDLR.2|LQHAAELIK.2|SLLSNLDEVKKER.3|YDEYVNVK.2|LALASLGYEK.2|QSNNEANLREEVLK.3|QSNNEANLREEVLK.2|SLLSNLDEVK.2|HEGALETLLR.2|LLDEEEATDNDLRAK.3|LLDEEEATDNDLRAK.2|SVIEQGGIQTVDQLIK.3|SVIEQGGIQTVDQLIK.2|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.5|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.4|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.3|STPVNVPISQK.2|TM[Oxi]PPTKPQPPARPPPPVLPANR.4|TMPPTKPQPPARPPPPVLPANR.4|DNDFIYHDR.2|MVPVSVQQSLAAYNQR.3|M[Oxi]VPVSVQQSLAAYNQR.3|MVPVSVQQSLAAYNQR.2|M[Oxi]VPVSVQQSLAAYNQR.2|AVQADGQVKEC[CAM]YQSHR.3|MKQSNNEANLREEVLK.3|NLATAYDNFVELVANLK.3|NLATAYDNFVELVANLK.2|DTIVLLC[CAM]KPEPELNAAIPSANPAK.4|DTIVLLC[CAM]KPEPELNAAIPSANPAK.3|TMQGSEVVNVLK.2|TM[Oxi]QGSEVVNVLK.2|SRSVIEQGGIQTVDQLIK.3|SRSVIEQGGIQTVDQLIK.2|EC[CAM]YQSHRDTIVLLC[CAM]KPEPELNAAIPSANPAK.5|FYNELTEILVR.2|LANQAADYFGDAFKQC[CAM]QYKDTLPK.4|YYDQIC[CAM]SIEPK.2|SC[CAM]VLFNC[CAM]AALASQIAAEQNLDNDEGLK.4|SC[CAM]VLFNC[CAM]AALASQIAAEQNLDNDEGLK.3|LANQAADYFGDAFK.2|DLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.5|DLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.4|NLATAYDNFVELVANLKEGTK.3|TVASRYDEYVNVK.2|FLTALAQDGVINEEALSVTELDRVYGGLTTK.4|FLTALAQDGVINEEALSVTELDRVYGGLTTK.3|FLTALAQDGVINEEALSVTELDR.3|EATTLANGVLASLNLPAAIEDVSGDTVPQSILTK.4|EATTLANGVLASLNLPAAIEDVSGDTVPQSILTK.3|STPVNVPISQKFTDLFEK.2
SEN / CTL,P98172,Ephrin-B1,EFNB1,4.29,1.43,5.56E-04,5.64E-05,4.25E+00,"neural crest cell migration,cell adhesion,cell-cell signaling,axon guidance,embryonic pattern specification,T cell costimulation,positive regulation of T cell proliferation,ephrin receptor signaling pathway","protein binding,ephrin receptor binding","nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,membrane raft,synapse,extracellular exosome",6,4,4,LYLVRPEQAAAC[CAM]STVLDPNVLVTC[CAM]NRPEQEIR.4|AAALSLSTLASPK.2|AEAGRPYEYYK.2|GGSGTAGTEPSDIIIPLR.2
SEN / CTL,P53602,Diphosphomevalonate decarboxylase,MVD,4.25,1.50,5.82E-04,5.89E-05,4.23E+00,"dolichyl diphosphate biosynthetic process,cholesterol biosynthetic process,positive regulation of cell proliferation,isoprenoid biosynthetic process,isopentenyl diphosphate biosynthetic process, mevalonate pathway","diphosphomevalonate decarboxylase activity,ATP binding,Hsp70 protein binding,protein homodimerization activity","cytosol,peroxisome",6,18,23,VYGVESDLSEVAR.2|TTTTAVISK.2|QVAPESHWPELR.3|ERDFPSFAQLTMK.3|ASVETSPLLR.2|VLILVVSAEK.2|IWLNGREEDVGQPR.3|PLAAVTC[CAM]TAPVNIAVIK.3|PLAAVTC[CAM]TAPVNIAVIK.2|DGDPLPSSLSC[CAM]K.2|DFPSFAQLTMK.2|GLQVRPAPLSAELQAALAMEPTPGGVK.4|GLQVRPAPLSAELQAALAMEPTPGGVK.3|PAPLSAELQAALAMEPTPGGVK.3|DSNQFHATC[CAM]LDTFPPISYLNAISWR.4|DSNQFHATC[CAM]LDTFPPISYLNAISWR.3|VHVASVNNFPTAAGLASSAAGYAC[CAM]LAYTLAR.4|VHVASVNNFPTAAGLASSAAGYAC[CAM]LAYTLAR.3|DEELVLPINSSLSVTLHQDQLK.3|YIIVTQVGPGPQILDDPC[CAM]AHLLGPDGLPKPAA.4|YIIVTQVGPGPQILDDPC[CAM]AHLLGPDGLPKPAA.3|RDEELVLPINSSLSVTLHQDQLK.3|YIIVTQVGPGPQILDDPC[CAM]AHLLGPDGLPK.3
SEN / CTL,P47756,F-actin-capping protein subunit beta,CAPZB,4.24,1.48,2.41E-17,1.04E-17,1.70E+01,"movement of cell or subcellular component,cytoskeleton organization,blood coagulation,regulation of lamellipodium assembly,regulation of cell morphogenesis,actin cytoskeleton organization,barbed-end actin filament capping,negative regulation of filopodium assembly,cell-cell adhesion","actin binding,actin filament binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,actin filament,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,sarcomere,extracellular exosome,WASH complex",36,22,40,RLPPQQIEKNLSDLIDLVPSLC[CAM]EDLLSSVDQPLK.4|SGSGTMNLGGSLTR.2|SGSGTM[Oxi]NLGGSLTR.2|SPWSNKYDPPLEDGAMPSAR.3|SPWSNKYDPPLEDGAMPSAR.4|SPWSNKYDPPLEDGAM[Oxi]PSAR.3|QMEKDETVSDC[CAM]SPHIANIGR.4|QMEKDETVSDC[CAM]SPHIANIGR.5|QM[Oxi]EKDETVSDC[CAM]SPHIANIGR.4|QMEKDETVSDC[CAM]SPHIANIGR.3|KLEVEANNAFDQYR.3|KLEVEANNAFDQYR.2|DKVVGKDYLLC[CAM]DYNR.4|DKVVGKDYLLC[CAM]DYNR.3|LVEDMENKIR.3|LPPQQIEK.2|IKGC[CAM]WDSIHVVEVQEK.4|IKGC[CAM]WDSIHVVEVQEK.3|IRSTLNEIYFGK.3|IRSTLNEIYFGK.2|LVEDMENK.2|LVEDM[Oxi]ENK.2|YDPPLEDGAMPSAR.3|YDPPLEDGAMPSAR.2|YDPPLEDGAM[Oxi]PSAR.2|VVGKDYLLC[CAM]DYNR.3|VVGKDYLLC[CAM]DYNR.2|RLPPQQIEK.2|GC[CAM]WDSIHVVEVQEK.3|GC[CAM]WDSIHVVEVQEK.2|STLNEIYFGK.2|DETVSDC[CAM]SPHIANIGR.3|DETVSDC[CAM]SPHIANIGR.2|DYLLC[CAM]DYNR.2|DYLLC[CAM]DYNRDGDSYR.3|DYLLC[CAM]DYNRDGDSYR.2|LTSTVM[Oxi]LWLQTNK.2|LTSTVMLWLQTNK.2|VVGKDYLLC[CAM]DYNRDGDSYR.3|LEVEANNAFDQYR.2
SEN / CTL,Q9NVD7,Alpha-parvin,PARVA,4.21,1.62,2.40E-05,3.00E-06,5.52E+00,"sprouting angiogenesis,outflow tract septum morphogenesis,establishment or maintenance of cell polarity,regulation of cell shape,actin cytoskeleton reorganization,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,cilium morphogenesis,actin-mediated cell contraction,smooth muscle cell chemotaxis","actin binding,protein binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,focal adhesion,Z disc",12,11,14,IIVKDLAEDLYDGQVLQK.3|TLITFVNK.2|TMVDPNSR.2|HERDAFDTLFDHAPDK.4|PRPEDIVNC[CAM]DLK.3|WNVDSVHAK.2|DLAEDLYDGQVLQK.3|DLAEDLYDGQVLQK.2|QIQEEITGNTEALSGRHER.4|QIQEEITGNTEALSGRHER.3|QIQEEITGNTEALSGR.3|QIQEEITGNTEALSGR.2|LNVAEVTQSEIAQK.2|VLIDWINDVLVGER.2
SEN / CTL,P05106,Integrin beta-3,ITGB3,4.20,2.81,4.38E-03,3.95E-04,3.40E+00,"positive regulation of protein phosphorylation,positive regulation of endothelial cell proliferation,platelet degranulation,cell-substrate junction assembly,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,blood coagulation,positive regulation of endothelial cell migration,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,smooth muscle cell migration,cell growth,cell migration,platelet activation,extracellular matrix organization,positive regulation of vascular endothelial growth factor receptor signaling pathway,cell-substrate adhesion,activation of protein kinase activity,negative regulation of lipid transport,cell adhesion mediated by integrin,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,tube development,apolipoprotein A-I-mediated signaling pathway,wound healing,regulation of bone resorption,negative regulation of low-density lipoprotein particle receptor biosynthetic process,viral entry into host cell,vascular endothelial growth factor receptor signaling pathway,mesodermal cell differentiation,positive regulation of peptidyl-tyrosine phosphorylation,negative regulation of lipoprotein metabolic process,leukocyte migration,negative chemotaxis,angiogenesis involved in wound healing,platelet aggregation","virus receptor activity,fibronectin binding,protease binding,protein disulfide isomerase activity,platelet-derived growth factor receptor binding,protein binding,coreceptor activity,enzyme binding,identical protein binding,vascular endothelial growth factor receptor 2 binding,cell adhesion molecule binding,extracellular matrix binding,fibroblast growth factor binding,C-X3-C chemokine binding,insulin-like growth factor I binding,neuregulin binding","nucleus,plasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,cell surface,platelet alpha granule membrane,lamellipodium membrane,filopodium membrane,microvillus membrane,ruffle membrane,integrin alphav-beta3 complex,alphav-beta3 integrin-IGF-1-IGF1R complex,melanosome,receptor complex,extracellular exosome,alphav-beta3 integrin-vitronectin complex",6,31,45,VLEDRPLSDKGSGDSSQVTQVSPQR.4|HVLTLTDQVTR.3|HVLTLTDQVTR.2|GALHDENTC[CAM]NR.3|GALHDENTC[CAM]NR.2|YC[CAM]RDEIESVK.3|YC[CAM]RDEIESVK.2|THIALDGR.2|EATSTFTNITYR.3|EATSTFTNITYR.2|AKWDTANNPLYK.3|AKWDTANNPLYK.2|C[CAM]PTC[CAM]PDAC[CAM]TFKK.3|GSGDSSQVTQVSPQR.3|GSGDSSQVTQVSPQR.2|NDASHLLVFTTDAK.3|NDASHLLVFTTDAK.2|EGQPVC[CAM]SQR.2|TDTC[CAM]MSSNGLLC[CAM]SGR.3|TDTC[CAM]MSSNGLLC[CAM]SGR.2|SFTIKPVGFK.2|VLEDRPLSDK.2|FQYYEDSSGK.2|TTC[CAM]LPMFGYK.2|WDTANNPLYK.2|IGDTVSFSIEAK.2|GEC[CAM]LC[CAM]GQC[CAM]VC[CAM]HSSDFGK.3|GEC[CAM]LC[CAM]GQC[CAM]VC[CAM]HSSDFGK.2|C[CAM]PTC[CAM]PDAC[CAM]TFK.2|DAPEGGFDAIMQATVC[CAM]DEK.3|DAPEGGFDAIMQATVC[CAM]DEK.2|DDLWSIQNLGTK.2|YC[CAM]EC[CAM]DDFSC[CAM]VR.2|NRDAPEGGFDAIMQATVC[CAM]DEK.3|NRDAPEGGFDAIMQATVC[CAM]DEK.2|C[CAM]EC[CAM]GSC[CAM]VC[CAM]IQPGSYGDTC[CAM]EK.3|C[CAM]EC[CAM]GSC[CAM]VC[CAM]IQPGSYGDTC[CAM]EK.2|QVEDYPVDIYYLMDLSYSMK.3|C[CAM]GPGWLGSQC[CAM]EC[CAM]SEEDYRPSQQDEC[CAM]SPR.4|C[CAM]GPGWLGSQC[CAM]EC[CAM]SEEDYRPSQQDEC[CAM]SPR.3|GKC[CAM]EC[CAM]GSC[CAM]VC[CAM]IQPGSYGDTC[CAM]EK.3|IGFGAFVDKPVSPYMYISPPEALENPC[CAM]YDMK.4|IGFGAFVDKPVSPYMYISPPEALENPC[CAM]YDMK.3|DNC[CAM]APESIEFPVSEAR.2|LAGIVQPNDGQC[CAM]HVGSDNHYSASTTMDYPSLGLMTEK.4
SEN / CTL,Q6UVK1,Chondroitin sulfate proteoglycan 4,CSPG4,4.16,2.15,1.98E-40,3.34E-40,3.95E+01,"activation of MAPK activity,angiogenesis,transmembrane receptor protein tyrosine kinase signaling pathway,cell proliferation,glial cell migration,cell migration,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,intracellular signal transduction,tissue remodeling,positive regulation of peptidyl-tyrosine phosphorylation","signal transducer activity,protein kinase binding","extracellular region,Golgi lumen,integral component of plasma membrane,focal adhesion,cell surface,apical plasma membrane,lamellipodium membrane,lysosomal lumen,extracellular exosome",138,46,56,GSLLLGGLDAEASR.2|HGELELDIPGAQAR.3|AHLQGPAGASVAGPQTSEAFAITVR.3|LSDGQGFTQDDIQAGR.2|SPPSAGYLVMVSR.2|QGAGGVEGAEWWATQAFHQR.3|VSGPYFPTLLGLSLQVLEPPQHGALQKEDGPQAR.4|DLLFGSIVAVDEPTRPIYR.3|GALADEPPSLDPVQSFSQEAVDTGR.3|VAIQPVNDHAPVQTISR.3|SLNSASYLYEVMERPR.3|VTGALQFGELQK.2|MFTLLDVVNR.2|GSQTLTVC[CAM]PGSVQPLSSQTLR.2|ELEAGSLVYVHR.2|RGDFIYVDIFEGHLR.3|ALLHVWAGGPWPQGATLR.3|ALLHVWAGGPWPQGATLR.2|SFTQAQLDGGLVLFSHR.3|SFTQAQLDGGLVLFSHR.2|AQLSVVDPDSAPGEIEYEVQR.2|AQLSVVDPDSAPGEIEYEVQR.3|APHNGFLSLVGGGLGPVTR.3|ITVAALDASNLLASVPSPQR.3|ITVAALDASNLLASVPSPQR.2|LEPLHTQNTQQETLTTAHLEATLEEAGPSPPTFHYEVVQAPR.5|LEPLHTQNTQQETLTTAHLEATLEEAGPSPPTFHYEVVQAPR.6|MFTLLDVVNRK.3|TLSAFSWR.2|GNLQLQGTR.2|SGDEVHYHVTAGPR.3|GQGTVLLHNSVPVADGQPHEVSVHINAHR.6|GQGTVLLHNSVPVADGQPHEVSVHINAHR.5|GVLSYLEPR.2|SSLSQQQLR.2|GGPAQDLTFR.2|LSDGEHTSPGHFFR.3|LVLGQEELR.2|FTQADVDSGR.2|VLFVHSGADR.2|ASEAVEDTFR.2|APLEVPQALGR.2|NGLAGDTETFR.2|SEHDVLFQVTQFPSR.3|SEHDVLFQVTQFPSR.2|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.7|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.6|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.5|VSDGLQASPPATLK.2|IYVFQGEAAEIR.2|VSGPYFPTLLGLSLQVLEPPQHGALQK.4|VSGPYFPTLLGLSLQVLEPPQHGALQK.3|DQPGEPATEFSC[CAM]R.2|ASSSAGTDPQLLLYR.2|TTMVTSFTNEDLLR.2|DQLEAAQEAVPPADIVFSVK.2
SEN / CTL,P23634,Plasma membrane calcium-transporting ATPase 4,ATP2B4,4.14,0.94,1.05E-04,1.19E-05,4.92E+00,"neural retina development,regulation of transcription from RNA polymerase II promoter,cellular calcium ion homeostasis,spermatogenesis,negative regulation of nitric oxide mediated signal transduction,hippocampus development,flagellated sperm motility,positive regulation of peptidyl-serine phosphorylation,ion transmembrane transport,negative regulation of nitric oxide biosynthetic process,negative regulation of nitric-oxide synthase activity,response to hydrostatic pressure,calcium ion transmembrane transport,negative regulation of calcineurin-NFAT signaling cascade,cellular response to epinephrine stimulus,calcium ion transmembrane import into cytosol,calcium ion import across plasma membrane,negative regulation of the force of heart contraction,negative regulation of arginine catabolic process,negative regulation of adrenergic receptor signaling pathway involved in heart process,calcium ion export,negative regulation of peptidyl-cysteine S-nitrosylation,regulation of sodium ion transmembrane transport,regulation of cell cycle G1/S phase transition,negative regulation of cardiac muscle hypertrophy in response to stress,negative regulation of citrulline biosynthetic process,regulation of cardiac conduction,positive regulation of cAMP-dependent protein kinase activity","calcium-transporting ATPase activity,protein binding,calmodulin binding,ATP binding,PDZ domain binding,protein phosphatase 2B binding,nitric-oxide synthase inhibitor activity,metal ion binding,nitric-oxide synthase binding,scaffold protein binding,sodium channel regulator activity","plasma membrane,integral component of plasma membrane,caveola,membrane,basolateral plasma membrane,Z disc,T-tubule,sperm flagellum,neuron projection,intracellular membrane-bounded organelle,protein complex,sperm principal piece",6,25,34,SLDKDPMLLSGTHVMEGSGR.4|GASEIILR.2|KGEAVPFK.2|AFHSSLHESIQKPYNQK.4|DALTQINVHYGGVQNLC[CAM]SR.4|DALTQINVHYGGVQNLC[CAM]SR.3|DALTQINVHYGGVQNLC[CAM]SR.2|MTVVQAYIGGIHYR.3|M[Oxi]TVVQAYIGGIHYR.3|MTVVQAYIGGIHYR.2|SIHSFMTHPEFAIEEELPR.4|SIHSFMTHPEFAIEEELPR.3|VLPANSMAESR.2|GIIDSTVGEHR.2|SRDALTQINVHYGGVQNLC[CAM]SR.4|SRDALTQINVHYGGVQNLC[CAM]SR.3|DAEGLDEIDHAEMELR.3|DAEGLDEIDHAEMELR.2|LKTSPVEGLSGNPADLEK.3|LKTSPVEGLSGNPADLEK.2|QIPSPDVFLPK.2|VLDLIVNGISINSAYTSK.3|VLDLIVNGISINSAYTSK.2|TPLLDEEEEENPDKASK.3|TVIEPMAC[CAM]DGLR.2|EGDFGC[CAM]TVMELR.2|QVGNKTEC[CAM]ALLGFVTDLKQDYQAVR.4|NGQLIQLPVAEIVVGDIAQVK.3|TEC[CAM]ALLGFVTDLK.2|TEC[CAM]ALLGFVTDLKQDYQAVR.3|TSPVEGLSGNPADLEK.2|TPLLDEEEEENPDK.2|TQDGVALEIQPLNSQEGIDNEEK.3|C[CAM]GILTPGDDFLC[CAM]LEGK.2
SEN / CTL,Q8NEM2,SHC SH2 domain-binding protein 1,SHCBP1,4.10,0.90,8.44E-05,9.75E-06,5.01E+00,"fibroblast growth factor receptor signaling pathway,regulation of neural precursor cell proliferation",SH2 domain binding,"cytoplasm,spindle,midbody",6,37,53,LHYDILEDRVPSGLIVDYHNLLSQC[CAM]EESYRK.5|LHYDILEDRVPSGLIVDYHNLLSQC[CAM]EESYRK.6|LHYDILEDRVPSGLIVDYHNLLSQC[CAM]EESYRK.4|FVQHDAVEGILIVHR.4|FVQHDAVEGILIVHR.3|FVQHDAVEGILIVHR.2|YVFGYQK.2|TSAEFLMK.2|VLEPSGWR.2|LIENPLLR.2|EGILIKDFLDEHYDIPK.4|EGILIKDFLDEHYDIPK.3|GKGDTFVDC[CAM]TGADIK.3|GKGDTFVDC[CAM]TGADIK.2|DKPGSSLQSFMPEGK.3|DKPGSSLQSFMPEGK.2|ITHVVSSTMMAGLLR.3|ITHVVSSTM[Oxi]MAGLLR.3|ITHVVSSTMM[Oxi]AGLLR.2|ITHVVSSTMMAGLLR.2|ASEVQEFTAEFLEK.3|ASEVQEFTAEFLEK.2|AVWHTNVFK.2|LYSEMEQLK.2|LYSEM[Oxi]EQLK.2|FFYQNIWR.2|LHYDILEDR.2|LC[CAM]QEPGEEER.2|GAGIEIYPGSQC[CAM]TLSDNGIHHC[CAM]K.4|GAGIEIYPGSQC[CAM]TLSDNGIHHC[CAM]K.3|IQTSGEPDVAER.2|VPSGLIVDYHNLLSQC[CAM]EESYRK.4|AYQDYILADC[CAM]K.2|DFLDEHYDIPK.2|TTLENC[CAM]VLQC[CAM]ETTGVTVR.3|TTLENC[CAM]VLQC[CAM]ETTGVTVR.2|GDTFVDC[CAM]TGADIK.2|LHYDILEDRVPSGLIVDYHNLLSQC[CAM]EESYR.5|TFFPEIFQTNQLLFYER.3|TFFPEIFQTNQLLFYER.2|VDLEELIEC[CAM]ATGK.2|GKTTLENC[CAM]VLQC[CAM]ETTGVTVR.3|VLVEITDVDFAALK.2|LAEPYLC[CAM]DSQVSTFTMEC[CAM]MK.3|SSLSNC[CAM]NSDSEQENISMVEGLK.3|VPSGLIVDYHNLLSQC[CAM]EESYR.3|ISMVNNIIHNNEGYGVVLVKPTIFSDLQENAEDGTEENK.5|ISMVNNIIHNNEGYGVVLVKPTIFSDLQENAEDGTEENK.4|TDPSEQVEGNC[CAM]EIVNELIAASTQK.3|GLFQDEDSC[CAM]SDC[CAM]SYR.2|IQTSGEPDVAERVDLEELIEC[CAM]ATGK.3|LSELGITQADDNLMSQEMFVGIVGNQFK.3|SWDEEEEDEYDYFVR.2
SEN / CTL,P62491;Q15907,Ras-related protein Rab-11A;Ras-related protein Rab-11B,RAB11A;RAB11B,4.07,1.72,1.61E-03,1.54E-04,3.81E+00,"cytokinesis,renal water homeostasis,mitotic metaphase plate congression,small GTPase mediated signal transduction,positive regulation of epithelial cell migration,regulation of multivesicular body size,positive regulation of G2/M transition of mitotic cell cycle,protein transport,vesicle-mediated transport,astral microtubule organization,neuron projection development,melanosome transport,multivesicular body assembly,positive regulation of axon extension,regulation of long-term neuronal synaptic plasticity,plasma membrane to endosome transport,regulation of protein transport,establishment of vesicle localization,regulation of vesicle-mediated transport,establishment of protein localization to organelle,protein localization to plasma membrane,establishment of protein localization to membrane,mitotic spindle assembly,exosomal secretion;receptor recycling,small GTPase mediated signal transduction,melanosome transport,transferrin transport,insulin secretion involved in cellular response to glucose stimulus,regulation of anion transport,constitutive secretory pathway,regulated exocytosis,cellular response to acidic pH,establishment of protein localization to membrane,cell-cell adhesion,retrograde transport, endosome to plasma membrane,regulation of protein localization to cell surface,regulation of endocytic recycling","GTPase activity,protein binding,GTP binding,microtubule binding,syntaxin binding,myosin V binding;GTPase activity,protein binding,GTP binding,GDP binding,myosin V binding,cadherin binding involved in cell-cell adhesion","spindle pole,mitochondrion,multivesicular body,Golgi apparatus,trans-Golgi network,cytosol,plasma membrane,transport vesicle,axon,cytoplasmic vesicle membrane,cytoplasmic vesicle,vesicle,cleavage furrow,protein complex,phagocytic vesicle,perinuclear region of cytoplasm,recycling endosome,recycling endosome membrane,extracellular exosome,centrosome,kinetochore microtubule;mitochondrion,microtubule organizing center,plasma membrane,cell-cell adherens junction,synaptic vesicle,aggresome,cell junction,phagocytic vesicle membrane,synaptic vesicle membrane,phagocytic vesicle,recycling endosome,recycling endosome membrane,extracellular exosome",6,1,1,STIGVEFATR.2
SEN / CTL,Q13162,Peroxiredoxin-4,PRDX4,4.04,1.58,7.67E-10,1.61E-10,9.79E+00,"I-kappaB phosphorylation,spermatogenesis,male gonad development,4-hydroxyproline metabolic process,protein maturation by protein folding,extracellular matrix organization,cell redox homeostasis,oxidation-reduction process,reactive oxygen species metabolic process,cellular oxidant detoxification,negative regulation of male germ cell proliferation","thioredoxin peroxidase activity,protein homodimerization activity","extracellular space,nucleus,mitochondrion,smooth endoplasmic reticulum,cytosol,extracellular exosome",24,17,29,TREEEC[CAM]HFYAGGQVYPGEASR.4|TREEEC[CAM]HFYAGGQVYPGEASR.3|QITLNDLPVGR.2|QITLNDLPVGR.3|SINTEVVAC[CAM]SVDSQFTHLAWINTPR.4|SINTEVVAC[CAM]SVDSQFTHLAWINTPR.3|VSVADHSLHLSK.3|VSVADHSLHLSK.2|IPLLSDLTHQISK.3|IPLLSDLTHQISK.2|ISKPAPYWEGTAVIDGEFK.4|ISKPAPYWEGTAVIDGEFK.3|ISKPAPYWEGTAVIDGEFK.2|DYGVYLEDSGHTLR.3|DYGVYLEDSGHTLR.2|QGGLGPIRIPLLSDLTHQISK.4|QGGLGPIRIPLLSDLTHQISK.3|PAPYWEGTAVIDGEFK.3|PAPYWEGTAVIDGEFK.2|RQGGLGPIRIPLLSDLTHQISK.4|HGEVC[CAM]PAGWKPGSETIIPDPAGK.4|HGEVC[CAM]PAGWKPGSETIIPDPAGK.3|LVQAFQYTDK.2|ISKPAPYWEGTAVIDGEFKELK.4|GLFIIDDKGILRQITLNDLPVGR.4|PGSETIIPDPAGK.2|LVQAFQYTDKHGEVC[CAM]PAGWKPGSETIIPDPAGK.5|EEEC[CAM]HFYAGGQVYPGEASR.3|EEEC[CAM]HFYAGGQVYPGEASR.2
SEN / CTL,O14786,Neuropilin-1,NRP1,4.03,1.49,1.81E-08,3.31E-09,8.48E+00,"angiogenesis,patterning of blood vessels,neuron migration,positive regulation of endothelial cell proliferation,sprouting angiogenesis,cell migration involved in sprouting angiogenesis,signal transduction,cell-cell signaling,axon guidance,axonal fasciculation,response to wounding,animal organ morphogenesis,positive regulation of endothelial cell migration,positive regulation of smooth muscle cell migration,dendrite development,facial nerve structural organization,trigeminal nerve structural organization,vestibulocochlear nerve structural organization,nerve development,branchiomotor neuron axon guidance,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,retinal ganglion cell axon guidance,cellular response to hepatocyte growth factor stimulus,endothelial cell chemotaxis,cellular response to vascular endothelial growth factor stimulus,ventral trunk neural crest cell migration,VEGF-activated neuropilin signaling pathway,negative regulation of neuron apoptotic process,platelet-derived growth factor receptor signaling pathway,vascular endothelial growth factor receptor signaling pathway,hepatocyte growth factor receptor signaling pathway,positive regulation of axon extension involved in axon guidance,negative regulation of axon extension involved in axon guidance,artery morphogenesis,axon extension involved in axon guidance,positive regulation of peptidyl-tyrosine phosphorylation,positive chemotaxis,positive regulation of cytokine activity,axonogenesis involved in innervation,regulation of vesicle-mediated transport,dichotomous subdivision of terminal units involved in salivary gland branching,angiogenesis involved in coronary vascular morphogenesis,coronary artery morphogenesis,retina vasculature morphogenesis in camera-type eye,renal artery morphogenesis,sympathetic ganglion development,trigeminal ganglion development,positive regulation of ERK1 and ERK2 cascade,semaphorin-plexin signaling pathway,commissural neuron axon guidance,regulation of retinal ganglion cell axon guidance,endothelial tip cell fate specification,sensory neuron axon guidance,sympathetic neuron projection extension,sympathetic neuron projection guidance,neural crest cell migration involved in autonomic nervous system development,toxin transport,semaphorin-plexin signaling pathway involved in neuron projection guidance,semaphorin-plexin signaling pathway involved in axon guidance,positive regulation of retinal ganglion cell axon guidance,VEGF-activated neuropilin signaling pathway involved in axon guidance,protein localization to early endosome,facioacoustic ganglion development,dorsal root ganglion morphogenesis,otic placode development,negative regulation of extrinsic apoptotic signaling pathway","vascular endothelial growth factor-activated receptor activity,heparin binding,coreceptor activity,semaphorin receptor activity,growth factor binding,cytokine binding,vascular endothelial growth factor binding,metal ion binding","semaphorin receptor complex,extracellular space,early endosome,cytosol,neurofilament,plasma membrane,focal adhesion,cell surface,integral component of membrane,axon,growth cone,cytoplasmic vesicle,neuronal cell body,receptor complex,sorting endosome",18,12,14,SFEGNNNYDTPELR.2|YDRLEIWDGFPDVGPHIGR.4|FVTAVGTQGAISK.2|IAPPPVVSSGPFLFIK.3|IAPPPVVSSGPFLFIK.2|FVSDYETHGAGFSIR.3|IESPGYLTSPGYPHSYHPSEK.4|IESPGYLTSPGYPHSYHPSEK.3|C[CAM]GDTIKIESPGYLTSPGYPHSYHPSEK.5|SSSGILSMVFYTDSAIAK.3|DKLNTQSTYSEA.2|LYQVIFEGEIGK.2|EGNKPVLFQGNTNPTDVVVAVFPKPLITR.4|EGNKPVLFQGNTNPTDVVVAVFPK.3
SEN / CTL,P23526,Adenosylhomocysteinase,AHCY,4.01,1.86,1.46E-10,3.28E-11,1.05E+01,"sulfur amino acid metabolic process,response to hypoxia,chronic inflammatory response to antigenic stimulus,one-carbon metabolic process,response to nutrient,S-adenosylhomocysteine catabolic process,methylation,S-adenosylmethionine cycle,circadian sleep/wake cycle,homocysteine biosynthetic process","adenosylhomocysteinase activity,protein binding,adenyl nucleotide binding,identical protein binding,NAD binding","nucleus,cytoplasm,cytosol,melanosome,neuron projection,extracellular exosome",24,34,62,ALDIAENEMPGLMR.2|ALDIAENEMPGLMR.3|ALDIAENEM[Oxi]PGLMR.2|ALDIAENEMPGLM[Oxi]R.2|ALDIAENEM[Oxi]PGLM[Oxi]R.2|VADIGLAAWGR.2|KALDIAENEMPGLMR.3|KALDIAENEMPGLMR.2|GISEETTTGVHNLYK.3|GISEETTTGVHNLYK.2|LDEAVAEAHLGK.3|LDEAVAEAHLGK.2|SKFDNLYGC[CAM]R.3|SKFDNLYGC[CAM]R.2|VADIGLAAWGRK.3|VPAINVNDSVTK.3|VPAINVNDSVTK.2|IILLAEGR.2|MMANGILK.2|M[Oxi]MANGILK.2|MM[Oxi]ANGILK.2|YSASKPLK.2|ATDVMIAGK.2|ATDVM[Oxi]IAGK.2|KLDEAVAEAHLGK.3|KLDEAVAEAHLGK.2|KLDEAVAEAHLGKLNVK.4|KLDEAVAEAHLGKLNVK.3|AGIPVYAWK.2|FDNLYGC[CAM]R.2|RIILLAEGR.2|RATDVMIAGK.2|RATDVM[Oxi]IAGK.2|YPQLLPGIR.2|VNIKPQVDR.2|WLNENAVEK.2|DGPLNMILDDGGDLTNLIHTK.4|DGPLNM[Oxi]ILDDGGDLTNLIHTK.3|DGPLNMILDDGGDLTNLIHTK.3|DGPLNMILDDGGDLTNLIHTK.2|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYR.4|QAQYLGMSC[CAM]DGPFKPDHYR.4|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYR.3|QAQYLGMSC[CAM]DGPFKPDHYR.3|QAQYLGMSC[CAM]DGPFKPDHYR.2|VAVVAGYGDVGK.2|HFEQM[Oxi]KDDAIVC[CAM]NIGHFDVEIDVK.5|HFEQMKDDAIVC[CAM]NIGHFDVEIDVK.4|YPVGVHFLPK.2|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYRY.4|QAQYLGMSC[CAM]DGPFKPDHYRY.4|QAQYLGMSC[CAM]DGPFKPDHYRY.3|VAVVAGYGDVGKGC[CAM]AQALR.3|MMANGILKVPAINVNDSVTK.3|M[Oxi]MANGILKVPAINVNDSVTK.3|MM[Oxi]ANGILKVPAINVNDSVTK.3|GETDEEYLWC[CAM]IEQTLYFK.3|GETDEEYLWC[CAM]IEQTLYFK.2|VAVVAGYGDVGKGC[CAM]AQALRGFGAR.3|DGPLNMILDDGGDLTNLIHTKYPQLLPGIR.4|LVNLGC[CAM]AMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPK.6|LVNLGC[CAM]AMGHPSFVMSNSFTNQVMAQIELWTHPDK.4
SEN / CTL,Q92973,Transportin-1,TNPO1,4.00,2.31,9.88E-03,8.54E-04,3.07E+00,"protein import into nucleus, docking,protein import into nucleus, translocation,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,viral process,regulation of mRNA stability","protein binding,nuclear localization sequence binding,Ran GTPase binding,protein transporter activity,poly(A) RNA binding","nucleus,cytoplasm,cytosol,nuclear membrane,nuclear periphery,extracellular exosome",6,43,65,TLLENTAITIGR.2|ATVGILITTIASK.3|ATVGILITTIASK.2|C[CAM]VNLVQK.2|RFSDQFPLPLK.3|RFSDQFPLPLK.2|DELLPHILPLLK.3|PLMTELLK.2|LLPHMHNIVEYMLQR.4|LLPHMHNIVEYM[Oxi]LQR.4|LLPHM[Oxi]HNIVEYMLQR.3|LLPHMHNIVEYM[Oxi]LQR.3|LLPHMHNIVEYMLQR.3|LLPHMHNIVEYMLQR.2|ELLFHHEWVVK.3|ELLFHHEWVVK.2|ERLAAFYGV.2|ALVMLLEVR.2|NIRDNEEKDSAFR.3|SHAVAC[CAM]VNQFIISR.3|SHAVAC[CAM]VNQFIISR.2|LIPVLVNGMK.2|GDVEEDETIPDSEQDIRPR.4|GDVEEDETIPDSEQDIRPR.3|GDVEEDETIPDSEQDIRPR.2|NQVGDENWR.2|SITC[CAM]WTLSR.2|AHFQNFPNGVTDFIK.3|AHFQNFPNGVTDFIK.2|YAHWVVSQPPDTYLKPLMTELLKR.5|YAHWVVSQPPDTYLKPLMTELLKR.4|SNILTLMYQC[CAM]MQDK.3|SNILTLMYQC[CAM]MQDK.2|FSDQFPLPLK.2|YSDIDIILLK.2|YAHWVVSQPPDTYLK.3|YAHWVVSQPPDTYLK.2|ESQSPDTTIQR.2|QSSFALLGDLTK.2|ATVGILITTIASKGELQNWPDLLPK.4|ATVGILITTIASKGELQNWPDLLPK.3|YAHWVVSQPPDTYLKPLMTELLK.4|YAHWVVSQPPDTYLKPLMTELLK.3|IC[CAM]EDSAEILDSDVLDRPLNIMIPK.4|IC[CAM]EDSAEILDSDVLDRPLNIMIPK.3|GELQNWPDLLPK.2|LGYVC[CAM]PQEVAPMLQQFIR.3|C[CAM]SAAALDVLANVYRDELLPHILPLLK.4|C[CAM]SAAALDVLANVYRDELLPHILPLLK.3|TLAQAMLNNAQPDQYEAPDK.3|TLAQAMLNNAQPDQYEAPDK.2|C[CAM]SAAALDVLANVYR.2|KC[CAM]SAAALDVLANVYRDELLPHILPLLK.4|LGYVC[CAM]PQEVAPMLQQFIRPWC[CAM]TSLR.4|LGYVC[CAM]PQEVAPM[Oxi]LQQFIRPWC[CAM]TSLR.3|LGYVC[CAM]PQEVAPMLQQFIRPWC[CAM]TSLR.3|SNILTLMYQC[CAM]MQDKMPEVR.3|LC[CAM]SLLDSEDYNTC[CAM]EGAFGALQK.3|LEQLNQYPDFNNYLIFVLTK.3|MEYEWKPDEQGLQQILQLLK.3|SEC[CAM]LNNIGDSSPLIR.2|IC[CAM]EDSAEILDSDVLDR.2|GDVEEDETIPDSEQDIR.2|TVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRK.4|TQDQDENVALEAC[CAM]EFWLTLAEQPIC[CAM]K.3
SEN / CTL,P05362,Intercellular adhesion molecule 1,ICAM1,4.00,2.26,6.29E-22,4.19E-22,2.14E+01,"ovarian follicle development,regulation of leukocyte mediated cytotoxicity,response to amphetamine,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,acute inflammatory response to antigenic stimulus,T cell antigen processing and presentation,positive regulation of cellular extravasation,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell aging,sensory perception of sound,regulation of cell shape,response to ionizing radiation,response to sulfur dioxide,response to organic cyclic compound,membrane to membrane docking,regulation of cell adhesion,extracellular matrix organization,positive regulation of actin filament polymerization,cellular response to nutrient levels,cell adhesion mediated by integrin,response to gonadotropin,response to drug,response to amino acid,positive regulation of GTPase activity,adhesion of symbiont to host,positive regulation of nitric oxide biosynthetic process,response to ethanol,positive regulation of vasoconstriction,response to copper ion,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,leukocyte migration,positive regulation of NF-kappaB transcription factor activity,negative regulation of calcium ion transport,interferon-gamma-mediated signaling pathway,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to lipopolysaccharide,cellular response to alkaloid,cellular response to glucose stimulus,cellular response to interleukin-1,cellular response to tumor necrosis factor,cellular response to hypoxia,establishment of Sertoli cell barrier,regulation of ruffle assembly,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of endothelial cell apoptotic process","virus receptor activity,receptor activity,transmembrane signaling receptor activity,integrin binding,protein binding","immunological synapse,extracellular space,plasma membrane,integral component of plasma membrane,focal adhesion,external side of plasma membrane,cell surface,membrane,membrane raft,extracellular exosome",54,18,22,VYELSNVQEDSQPMC[CAM]YSNC[CAM]PDGQSTAK.3|C[CAM]LKDGTFPLPIGESVTVTR.3|DLEGTYLC[CAM]R.2|GGSVLVTC[CAM]STSC[CAM]DQPK.2|ELKREPAVGEPAEVTTTVLVR.4|ELKREPAVGEPAEVTTTVLVR.3|LLGIETPLPK.2|ASVSVTAEDEGTQR.2|REPAVGEPAEVTTTVLVR.3|REPAVGEPAEVTTTVLVR.2|C[CAM]QVEGGAPR.2|AKVTLNGVPAQPLGPR.3|ELLLPGNNRK.2|SFSC[CAM]SATLEVAGQLIHK.3|SFSC[CAM]SATLEVAGQLIHK.2|GTPMKPNTQATPP.2|GTPM[Oxi]KPNTQATPP.2|TFLTVYWTPER.2|VTLNGVPAQPLGPR.2|VELAPLPSWQPVGK.2|DGTFPLPIGESVTVTR.2|EPAVGEPAEVTTTVLVR.2
SEN / CTL,P31948,Stress-induced-phosphoprotein 1,STIP1,3.99,2.82,2.35E-05,2.94E-06,5.53E+00,response to stress,"protein C-terminus binding,Hsp70 protein binding,poly(A) RNA binding,chaperone binding","nucleus,Golgi apparatus,myelin sheath,protein complex",24,71,131,ALDLDSSC[CAM]KEAADGYQR.3|ALDLDSSC[CAM]KEAADGYQR.2|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.5|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.6|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.4|LMDVGLIAIR.2|LM[Oxi]DVGLIAIR.2|AAALEAMK.2|AAALEAM[Oxi]K.2|IGNSYFKEEK.3|IGNSYFKEEK.2|TPDVLKK.2|HDSPEDVKRR.3|KETKPEPMEEDLPENKK.5|KETKPEPM[Oxi]EEDLPENKK.4|KETKPEPMEEDLPENKK.4|KETKPEPMEEDLPENKK.3|AYEDGC[CAM]K.2|TYEEGLK.2|AMDVYQK.2|AM[Oxi]DVYQK.2|HYTEAIK.2|YKDAIHFYNK.3|YKDAIHFYNK.2|AAALEAMKDYTK.3|AAALEAMKDYTK.2|AAALEFLNRFEEAKR.4|AAALEFLNRFEEAKR.3|GNEC[CAM]FQK.2|EAADGYQR.2|ELGNDAYK.2|GDYPQAMK.2|GDYPQAM[Oxi]K.2|GDYPQAMK.1|HDSPEDVK.2|DPQALSEHLKNPVIAQK.4|DPQALSEHLKNPVIAQK.3|KAAALEAMK.2|KDFDTALK.2|TYEEGLKHEANNPQLK.4|TYEEGLKHEANNPQLK.3|TYEEGLKHEANNPQLK.2|ETKPEPM[Oxi]EEDLPENKK.4|ETKPEPMEEDLPENKK.4|ETKPEPMEEDLPENKK.3|ETKPEPM[Oxi]EEDLPENKK.3|ETKPEPMEEDLPENKK.2|KAAALEAMKDYTK.3|KAAALEAMKDYTK.2|KETKPEPMEEDLPENK.4|KETKPEPMEEDLPENK.3|LDPHNHVLYSNR.3|LDPHNHVLYSNR.2|C[CAM]MMAQYNRHDSPEDVK.4|C[CAM]MMAQYNRHDSPEDVK.3|LAYINPDLALEEK.3|LAYINPDLALEEK.2|AAALEFLNR.2|LILEQMQK.2|LILEQM[Oxi]QK.2|RTYEEGLK.2|ALDLDSSC[CAM]K.2|DAIHFYNK.2|NKGNEC[CAM]FQKGDYPQAMK.4|NKGNEC[CAM]FQKGDYPQAM[Oxi]K.3|NKGNEC[CAM]FQKGDYPQAMK.3|NKGNEC[CAM]FQKGDYPQAMK.2|RTYEEGLKHEANNPQLK.4|RTYEEGLKHEANNPQLK.3|EGLQNMEAR.2|EGLQNM[Oxi]EAR.2|HEANNPQLK.2|LILEQMQKDPQALSEHLK.4|AAALEFLNRFEEAK.3|AAALEFLNRFEEAK.2|AIEVGRENREDYR.3|C[CAM]MMAQYNR.2|C[CAM]M[Oxi]MAQYNR.2|C[CAM]MM[Oxi]AQYNR.2|C[CAM]M[Oxi]M[Oxi]AQYNR.2|KKDFDTALK.2|LLEFQLALK.2|TLLSDPTYR.2|HDSPEDVKR.2|FM[Oxi]NPFNMPNLYQK.3|FMNPFNM[Oxi]PNLYQK.3|FMNPFNMPNLYQK.3|FM[Oxi]NPFNMPNLYQK.2|FMNPFNM[Oxi]PNLYQK.2|FMNPFNMPNLYQK.2|FM[Oxi]NPFNM[Oxi]PNLYQK.2|KAAALEFLNR.2|NKGNEC[CAM]FQK.2|DPQALSEHLK.2|LILEQMQKDPQALSEHLKNPVIAQK.5|LILEQM[Oxi]QKDPQALSEHLKNPVIAQK.5|LILEQM[Oxi]QKDPQALSEHLKNPVIAQK.4|LILEQMQKDPQALSEHLKNPVIAQK.4|KAAALEFLNRFEEAK.3|TVDLKPDWGK.2|DC[CAM]EEC[CAM]IQLEPTFIK.3|DC[CAM]EEC[CAM]IQLEPTFIK.2|KFMNPFNMPNLYQK.3|KFM[Oxi]NPFNMPNLYQK.3|ETKPEPM[Oxi]EEDLPENK.3|ETKPEPMEEDLPENK.3|ETKPEPMEEDLPENK.2|AMADPEVQQIMSDPAMR.3|AM[Oxi]ADPEVQQIMSDPAMR.3|AMADPEVQQIMSDPAM[Oxi]R.3|AM[Oxi]ADPEVQQIMSDPAMR.2|AMADPEVQQIM[Oxi]SDPAMR.2|AMADPEVQQIMSDPAM[Oxi]R.2|AMADPEVQQIMSDPAMR.2|LAYINPDLALEEKNKGNEC[CAM]FQK.4|TLLSDPTYRELIEQLR.3|AYEDGC[CAM]KTVDLKPDWGK.3|DFDTALKHYDK.2|RAMADPEVQQIMSDPAMR.3|SLAEHRTPDVLK.2|ALSVGNIDDALQC[CAM]YSEAIK.3|ALSVGNIDDALQC[CAM]YSEAIK.2|TYEEGLKHEANNPQLKEGLQNMEAR.4|AKELDPTNMTYITNQAAVYFEKGDYNK.4|ELDPTNM[Oxi]TYITNQAAVYFEK.3|ELDPTNMTYITNQAAVYFEK.3|ELDPTNM[Oxi]TYITNQAAVYFEK.2|ELDPTNMTYITNQAAVYFEK.2|AKELDPTNMTYITNQAAVYFEK.3|LLEFQLALKDC[CAM]EEC[CAM]IQLEPTFIK.3|ELDPTNMTYITNQAAVYFEKGDYNK.3
SEN / CTL,P14618,Pyruvate kinase PKM,PKM,3.98,1.91,1.04E-136,1.87E-135,1.35E+02,"programmed cell death,canonical glycolysis,cell-cell adhesion","magnesium ion binding,pyruvate kinase activity,protein binding,ATP binding,kinase activity,MHC class II protein complex binding,potassium ion binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,cell-cell adherens junction,cilium,extracellular matrix,vesicle,myelin sheath,extracellular exosome,extracellular vesicle",432,71,161,GDLGIEIPAEK.2|TATESFASDPILYRPVAVALDTKGPEIR.4|TATESFASDPILYRPVAVALDTKGPEIR.3|TATESFASDPILYRPVAVALDTKGPEIR.5|GDLGIEIPAEKVFLAQK.3|GDLGIEIPAEKVFLAQK.2|KGVNLPGAAVDLPAVSEKDIQDLK.4|KGVNLPGAAVDLPAVSEKDIQDLK.3|IYVDDGLISLQVK.2|IYVDDGLISLQVK.3|EAEAAIYHLQLFEELRR.4|EAEAAIYHLQLFEELRR.3|EAEAAIYHLQLFEELRR.2|QKGADFLVTEVENGGSLGSK.3|QKGADFLVTEVENGGSLGSK.2|LAPITSDPTEATAVGAVEASFK.3|LAPITSDPTEATAVGAVEASFK.2|LAPITSDPTEATAVGAVEASFK.4|GFFKKGDVVIVLTGWRPGSGFTNTMR.5|GFFKKGDVVIVLTGWRPGSGFTNTMR.4|TGLIKGSGTAEVELKK.4|TGLIKGSGTAEVELKK.3|LNFSHGTHEYHAETIKNVR.5|LNFSHGTHEYHAETIKNVR.4|GADFLVTEVENGGSLGSK.2|GADFLVTEVENGGSLGSK.3|SVETLKEMIK.2|GIFPVLC[CAM]KDPVQEAWAEDVDLR.3|GIFPVLC[CAM]KDPVQEAWAEDVDLR.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.6|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.5|NTGIIC[CAM]TIGPASR.2|NTGIIC[CAM]TIGPASR.3|TGLIKGSGTAEVELK.3|C[CAM]C[CAM]SGAIIVLTK.2|C[CAM]C[CAM]SGAIIVLTK.3|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.3|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.3|LDIDSPPITAR.2|LDIDSPPITAR.3|APIIAVTRNPQTAR.3|RFDEILEASDGIMVAR.3|RFDEILEASDGIMVAR.2|RFDEILEASDGIMVAR.4|RFDEILEASDGIM[Oxi]VAR.3|RFDEILEASDGIM[Oxi]VAR.4|RFDEILEASDGIM[Oxi]VAR.2|KGDVVIVLTGWRPGSGFTNTMR.4|KGDVVIVLTGWRPGSGFTNTMR.3|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.4|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.3|KGDVVIVLTGWRPGSGFTNTMR.2|TATESFASDPILYRPVAVALDTK.3|TATESFASDPILYRPVAVALDTK.4|APIIAVTR.2|AGKPVIC[CAM]ATQMLESMIK.3|AGKPVIC[CAM]ATQMLESMIK.2|AGKPVIC[CAM]ATQMLESMIK.4|AGKPVIC[CAM]ATQM[Oxi]LESMIK.3|AGKPVIC[CAM]ATQMLESM[Oxi]IK.3|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IK.3|AGKPVIC[CAM]ATQM[Oxi]LESMIK.2|AGKPVIC[CAM]ATQMLESM[Oxi]IK.2|GVNLPGAAVDLPAVSEKDIQDLK.3|GVNLPGAAVDLPAVSEKDIQDLK.4|GVNLPGAAVDLPAVSEKDIQDLK.2|QKGADFLVTEVENGGSLGSKK.4|QKGADFLVTEVENGGSLGSKK.3|VNFAMNVGK.2|VNFAM[Oxi]NVGK.2|FGVEQDVDMVFASFIR.3|FGVEQDVDMVFASFIR.2|FGVEQDVDM[Oxi]VFASFIR.3|FGVEQDVDM[Oxi]VFASFIR.2|RLAPITSDPTEATAVGAVEASFK.3|RLAPITSDPTEATAVGAVEASFK.4|RLAPITSDPTEATAVGAVEASFK.2|EAEAAIYHLQLFEELR.3|EAEAAIYHLQLFEELR.2|GADFLVTEVENGGSLGSKK.3|GADFLVTEVENGGSLGSKK.4|GADFLVTEVENGGSLGSKK.2|KGVNLPGAAVDLPAVSEK.3|KGVNLPGAAVDLPAVSEK.4|KGVNLPGAAVDLPAVSEK.2|C[CAM]DENILWLDYK.2|C[CAM]DENILWLDYK.3|AGKPVIC[CAM]ATQMLESMIKKPRPTR.5|AGKPVIC[CAM]ATQMLESMIKKPRPTR.6|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IKKPRPTR.6|GSGTAEVELK.2|FGVEQDVDMVFASFIRK.3|FGVEQDVDM[Oxi]VFASFIRK.3|FGVEQDVDM[Oxi]VFASFIRK.2|FGVEQDVDMVFASFIRK.2|GDVVIVLTGWRPGSGFTNTMR.3|GDVVIVLTGWRPGSGFTNTMR.4|GDVVIVLTGWRPGSGFTNTM[Oxi]R.4|GDVVIVLTGWRPGSGFTNTM[Oxi]R.3|GDVVIVLTGWRPGSGFTNTMR.2|FDEILEASDGIMVAR.2|FDEILEASDGIMVAR.3|FDEILEASDGIM[Oxi]VAR.2|AEGSDVANAVLDGADC[CAM]IMLSGETAK.3|AEGSDVANAVLDGADC[CAM]IMLSGETAK.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.3|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAMNVGK.4|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAM[Oxi]NVGK.4|ITLDNAYMEK.2|ITLDNAYM[Oxi]EK.2|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.5|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|MQHLIAR.2|M[Oxi]QHLIAR.2|ASDVHEVR.2|PVAVALDTK.2|IISKIENHEGVR.3|IISKIENHEGVR.2|GIFPVLC[CAM]K.2|GIFPVLC[CAM]K.1|LNFSHGTHEYHAETIK.4|LNFSHGTHEYHAETIK.3|LNFSHGTHEYHAETIK.2|YRPRAPIIAVTR.3|IENHEGVR.2|PVAVALDTKGPEIR.3|GDYPLEAVR.2|ASDVHEVRK.2|KASDVHEVR.2|TATESFASDPILYR.3|TATESFASDPILYR.2|PGSGFTNTMR.2|PVIC[CAM]ATQMLESMIK.3|PVIC[CAM]ATQMLESMIK.2|DPVQEAWAEDVDLR.3|DPVQEAWAEDVDLR.2|GVNLPGAAVDLPAVSEK.3|GVNLPGAAVDLPAVSEK.2|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.6|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAM[Oxi]ADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.4|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.3|GSGTAEVELKK.2|KASDVHEVRK.2|GDVVIVLTGWR.2|C[CAM]DENILWLDYKNIC[CAM]K.3|KGDVVIVLTGWR.2|IYVDDGLISLQVKQK.2|ITLDNAYMEKC[CAM]DENILWLDYK.3|ITLDNAYM[Oxi]EKC[CAM]DENILWLDYK.3|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4
SEN / CTL,Q15043,Zinc transporter ZIP14,SLC39A14,3.97,1.01,1.79E-04,1.94E-05,4.71E+00,"cellular zinc ion homeostasis,zinc II ion transmembrane transport,zinc II ion transmembrane import,ferrous iron transmembrane transport","zinc ion transmembrane transporter activity,ferrous iron transmembrane transporter activity","endoplasmic reticulum,Golgi apparatus,plasma membrane,integral component of plasma membrane,integral component of membrane,lamellipodium",6,4,6,IGSSELQEFC[CAM]PTILQQLDSR.3|IGSSELQEFC[CAM]PTILQQLDSR.2|ALLNHLDVGVGR.3|ALLNHLDVGVGR.2|YGEGDSLTLQQLK.2|VIVGSLSVQDLQASQSAC[CAM]YWLK.3
SEN / CTL,P61586,Transforming protein RhoA,RHOA,3.97,2.44,1.03E-10,2.38E-11,1.06E+01,"transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,viral process,cell migration,substantia nigra development,actin cytoskeleton organization,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,positive regulation of cytokinesis,regulation of actin cytoskeleton organization,regulation of osteoblast proliferation,Roundabout signaling pathway,cleavage furrow formation,apolipoprotein A-I-mediated signaling pathway,positive regulation of NF-kappaB import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,stress fiber assembly,apical junction assembly,endothelial cell migration,ossification involved in bone maturation,wound healing, spreading of cells,positive regulation of neuron differentiation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,phosphatidylinositol-mediated signaling,negative regulation of axonogenesis,positive regulation of axonogenesis,negative chemotaxis,regulation of small GTPase mediated signal transduction,positive regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,positive regulation of lipase activity,trabecula morphogenesis,positive regulation of protein serine/threonine kinase activity,negative regulation of cell migration involved in sprouting angiogenesis,mitotic spindle assembly,endothelial tube lumen extension,skeletal muscle satellite cell migration,mitotic cleavage furrow formation,regulation of cell motility","GTPase activity,protein binding,GTP binding,myosin binding","endosome,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,focal adhesion,cell cortex,lamellipodium,cell junction,midbody,extrinsic component of cytoplasmic side of plasma membrane,vesicle,apical junction complex,extracellular exosome,cell periphery,cleavage furrow",36,17,30,HFC[CAM]PNVPIILVGNKK.4|HFC[CAM]PNVPIILVGNKK.3|DGVREVFEMATR.3|DGVREVFEM[Oxi]ATR.3|IGAFGYMEC[CAM]SAK.2|IGAFGYM[Oxi]EC[CAM]SAK.2|DLRNDEHTRR.3|HFC[CAM]PNVPIILVGNK.3|HFC[CAM]PNVPIILVGNK.2|KLVIVGDGAC[CAM]GK.3|KLVIVGDGAC[CAM]GK.2|MKQEPVKPEEGRDMANR.5|MKQEPVKPEEGRDMANR.4|MKQEPVKPEEGRDMANR.3|KKLVIVGDGAC[CAM]GK.3|KKLVIVGDGAC[CAM]GK.2|MKQEPVKPEEGR.3|M[Oxi]KQEPVKPEEGR.3|MKQEPVKPEEGR.2|EVFEMATR.2|LVIVGDGAC[CAM]GK.2|TC[CAM]LLIVFSK.2|QEPVKPEEGR.2|QVELALWDTAGQEDYDR.3|QVELALWDTAGQEDYDR.2|DQFPEVYVPTVFENYVADIEVDGK.4|DQFPEVYVPTVFENYVADIEVDGK.3|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEK.4|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEK.3|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEKWTPEVK.4
SEN / CTL,Q13409,Cytoplasmic dynein 1 intermediate chain 2,DYNC1I2,3.95,0.77,6.58E-05,7.75E-06,5.11E+00,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based movement,viral process,antigen processing and presentation of exogenous peptide antigen via MHC class II",microtubule motor activity,"cytoplasm,centrosome,cytosol,cytoplasmic dynein complex,microtubule,vesicle",6,26,43,TLAEINANRADAEEEAATRIPA.3|TLAEINANRADAEEEAATRIPA.4|APPHELTEEEK.3|APPHELTEEEK.2|DLEDKEGEIQAGAK.3|DLEDKEGEIQAGAK.2|TLAEINANR.2|EAVAPVQEESDLEK.3|EAVAPVQEESDLEK.2|ADAEEEAATR.2|ITQVDFPPR.2|EAVAPVQEESDLEKK.3|EAVAPVQEESDLEKK.2|KDEENDSKAPPHELTEEEK.4|KEAVAPVQEESDLEK.3|QQILHSEEFLSFFDHSTR.4|QQILHSEEFLSFFDHSTR.3|QQILHSEEFLSFFDHSTR.2|TTPEYVFHC[CAM]QSAVMSATFAK.4|TTPEYVFHC[CAM]QSAVM[Oxi]SATFAK.3|TTPEYVFHC[CAM]QSAVMSATFAK.3|TTPEYVFHC[CAM]QSAVMSATFAK.2|ALSEQINIFFDYSGR.3|ALSEQINIFFDYSGR.2|ETQTPVMAQPK.2|ETQTPVM[Oxi]AQPK.2|IC[CAM]SWSLDMLSHPQDSMELVHK.4|IC[CAM]SWSLDMLSHPQDSMELVHK.3|SVSTPSEAGSQDSGDGAVGSR.3|SVSTPSEAGSQDSGDGAVGSR.2|ADAEEEAATRIPA.2|TLAEINANRADAEEEAATR.3|TPLSAAAHTHPVYC[CAM]VNVVGTQNAHNLISISTDGK.5|TPLSAAAHTHPVYC[CAM]VNVVGTQNAHNLISISTDGK.4|LDLWNLNNDTEVPTASISVEGNPALNR.4|LDLWNLNNDTEVPTASISVEGNPALNR.3|FHPNLVVGGTYSGQIVLWDNR.3|AVAVTSMSFPVGDVNNFVVGSEEGSVYTAC[CAM]R.4|AVAVTSMSFPVGDVNNFVVGSEEGSVYTAC[CAM]R.3|EDEEEDDDVVAPKPPIEPEEEK.3|EIAVGDSEGQIVIYDVGEQIAVPR.3|ETQTPVMAQPKEDEEEDDDVVAPKPPIEPEEEK.4|NNKPLYSFEDNADYVYDVMWSPTHPALFAC[CAM]VDGMGR.4
SEN / CTL,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,3.95,1.28,2.09E-07,3.36E-08,7.47E+00,"glyoxylate cycle,tricarboxylic acid cycle,isocitrate metabolic process,2-oxoglutarate metabolic process,NADPH regeneration,glutathione metabolic process,response to oxidative stress,female gonad development,response to steroid hormone,regulation of phospholipid catabolic process,regulation of phospholipid biosynthetic process,cell-cell adhesion","magnesium ion binding,isocitrate dehydrogenase (NADP+) activity,receptor binding,protein homodimerization activity,NADP binding,NAD binding,(R)-2-hydroxyglutarate dehydrogenase activity,cadherin binding involved in cell-cell adhesion","cytoplasm,mitochondrion,peroxisome,peroxisomal matrix,cytosol,cell-cell adherens junction,extracellular exosome",12,28,53,ISGGSVVEMQGDEMTR.2|ISGGSVVEM[Oxi]QGDEMTR.2|ISGGSVVEMQGDEM[Oxi]TR.2|KISGGSVVEMQGDEMTR.3|KISGGSVVEM[Oxi]QGDEMTR.3|KISGGSVVEM[Oxi]QGDEM[Oxi]TR.3|KISGGSVVEMQGDEMTR.2|DAAEAIKK.2|TVEAEAAHGTVTR.3|TVEAEAAHGTVTR.2|DATNDQVTKDAAEAIKK.4|IIWELIK.2|FKDIFQEIYDKQYK.4|FKDIFQEIYDKQYK.3|FKDIFQEIYDK.3|FKDIFQEIYDK.2|LVSGWVKPIIIGR.3|LVSGWVKPIIIGR.2|VEITYTPSDGTQK.3|VEITYTPSDGTQK.2|DATNDQVTK.2|HAYGDQYR.2|SDYLNTFEFMDK.3|SDYLNTFEFMDK.2|SDYLNTFEFM[Oxi]DK.2|C[CAM]ATITPDEK.2|GWPLYLSTK.2|ATDFVVPGPGK.2|DATNDQVTKDAAEAIK.3|DATNDQVTKDAAEAIK.2|SEGGFIWAC[CAM]K.2|DIFQEIYDK.2|SIEDFAHSSFQMALSK.3|SIEDFAHSSFQM[Oxi]ALSK.3|SIEDFAHSSFQMALSK.2|LIFPYVELDLHSYDLGIENR.4|LIFPYVELDLHSYDLGIENR.3|LIDDMVAQAMK.2|LIDDM[Oxi]VAQAMK.2|LIDDMVAQAM[Oxi]K.2|LIDDM[Oxi]VAQAM[Oxi]K.2|ATDFVVPGPGKVEITYTPSDGTQK.4|ATDFVVPGPGKVEITYTPSDGTQK.3|GQETSTNPIASIFAWTR.3|GQETSTNPIASIFAWTR.2|VTYLVHNFEEGGGVAMGMYNQDK.4|VTYLVHNFEEGGGVAM[Oxi]GM[Oxi]YNQDK.3|VTYLVHNFEEGGGVAM[Oxi]GMYNQDK.3|VTYLVHNFEEGGGVAMGM[Oxi]YNQDK.3|VTYLVHNFEEGGGVAMGMYNQDK.3|SDYLNTFEFMDKLGENLK.3|DLAAC[CAM]IK.1|AKLDNNKELAFFANALEEVSIETIEAGFM[Oxi]TK.4
SEN / CTL,P39019,40S ribosomal protein S19,RPS19,3.94,1.93,1.21E-07,1.99E-08,7.70E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),monocyte chemotaxis,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,nucleolus organization,Notch signaling pathway,response to extracellular stimulus,viral transcription,erythrocyte differentiation,maturation of SSU-rRNA,ribosomal small subunit biogenesis,protein tetramerization,positive regulation of cellular component movement,positive regulation of respiratory burst involved in inflammatory response,negative regulation of respiratory burst involved in inflammatory response","structural constituent of ribosome,protein binding,fibroblast growth factor binding,protein kinase binding,protein homodimerization activity,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",18,14,22,PGVTVKDVNQQEFVR.3|PGVTVKDVNQQEFVR.2|ELAPYDENWFYTR.2|ELAPYDENWFYTR.3|GGAGVGSMTK.2|GGAGVGSM[Oxi]TK.2|LKVPEWVDTVK.3|LKVPEWVDTVK.2|IAGQVAAANK.2|DLDRIAGQVAAANK.3|DLDRIAGQVAAANK.2|VLQALEGLK.2|HKELAPYDENWFYTR.4|HKELAPYDENWFYTR.3|HKELAPYDENWFYTR.2|IAGQVAAANKK.2|VPEWVDTVK.2|DVNQQEFVR.2|MVEKDQDGGR.2|NGVMPSHFSR.2|NGVM[Oxi]PSHFSR.2|RVLQALEGLK.2
SEN / CTL,P11021,78 kDa glucose-regulated protein,HSPA5,3.93,2.12,2.00E-65,5.69E-65,6.42E+01,"ER overload response,activation of signaling protein activity involved in unfolded protein response,cerebellum structural organization,cerebellar Purkinje cell layer development,substantia nigra development,positive regulation of cell migration,ER-associated ubiquitin-dependent protein catabolic process,negative regulation of transforming growth factor beta receptor signaling pathway,endoplasmic reticulum unfolded protein response,positive regulation of protein ubiquitination,protein folding in endoplasmic reticulum,maintenance of protein localization in endoplasmic reticulum,IRE1-mediated unfolded protein response,PERK-mediated unfolded protein response,ATF6-mediated unfolded protein response,cellular response to glucose starvation,negative regulation of apoptotic process,regulation of protein folding in endoplasmic reticulum,cellular response to antibiotic,cellular response to manganese ion,cellular response to interleukin-4,negative regulation of protein homodimerization activity,cell-cell adhesion,toxin transport,regulation of ATF6-mediated unfolded protein response,regulation of IRE1-mediated unfolded protein response,regulation of PERK-mediated unfolded protein response,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","glycoprotein binding,calcium ion binding,protein binding,ATP binding,ATPase activity,enzyme binding,protein domain specific binding,ubiquitin protein ligase binding,ribosome binding,unfolded protein binding,chaperone binding,misfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleus,mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,membrane,integral component of endoplasmic reticulum membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,myelin sheath,extracellular exosome,COP9 signalosome",276,68,133,VLEDSDLKKSDIDEIVLVGGSTR.4|VLEDSDLKKSDIDEIVLVGGSTR.3|IINEPTAAAIAYGLDKR.3|IINEPTAAAIAYGLDKR.2|TKPYIQVDIGGGQTK.2|TKPYIQVDIGGGQTK.3|TKPYIQVDIGGGQTK.4|TFAPEEISAMVLTK.2|TFAPEEISAMVLTK.3|TFAPEEISAM[Oxi]VLTK.3|TFAPEEISAM[Oxi]VLTK.2|LIGDAAKNQLTSNPENTVFDAKR.4|FEELNMDLFR.2|FEELNM[Oxi]DLFR.2|NQLTSNPENTVFDAK.2|NQLTSNPENTVFDAK.3|VTHAVVTVPAYFNDAQR.2|VTHAVVTVPAYFNDAQR.3|VTHAVVTVPAYFNDAQR.4|AKFEELNMDLFR.3|AKFEELNMDLFR.2|AKFEELNM[Oxi]DLFR.3|AKFEELNM[Oxi]DLFR.2|ITPSYVAFTPEGERLIGDAAK.3|SQIFSTASDNQPTVTIK.2|SQIFSTASDNQPTVTIK.3|SQIFSTASDNQPTVTIK.4|DAGTIAGLNVMR.2|DAGTIAGLNVMR.3|DAGTIAGLNVM[Oxi]R.2|IDTRNELESYAYSLK.3|IDTRNELESYAYSLK.2|ELEEIVQPIISK.2|ELEEIVQPIISK.3|ITPSYVAFTPEGER.2|ITPSYVAFTPEGER.3|QATKDAGTIAGLNVMR.3|NQLTSNPENTVFDAKR.3|NQLTSNPENTVFDAKR.2|KKELEEIVQPIISK.3|KKELEEIVQPIISK.4|KKELEEIVQPIISK.2|TWNDPSVQQDIK.2|TWNDPSVQQDIK.3|KVTHAVVTVPAYFNDAQR.4|KVTHAVVTVPAYFNDAQR.3|KVTHAVVTVPAYFNDAQR.2|KVTHAVVTVPAYFNDAQR.5|KSDIDEIVLVGGSTR.3|KSDIDEIVLVGGSTR.2|ITITNDQNRLTPEEIER.3|IEIESFYEGEDFSETLTR.2|IEIESFYEGEDFSETLTR.3|LYGSAGPPPTGEEDTAEKDEL.2|LYGSAGPPPTGEEDTAEKDEL.3|TWNDPSVQQDIKFLPFK.3|TWNDPSVQQDIKFLPFK.4|TWNDPSVQQDIKFLPFK.2|KELEEIVQPIISK.3|NGRVEIIANDQGNR.3|NGRVEIIANDQGNR.2|AVEEKIEWLESHQDADIEDFKAK.4|AVEEKIEWLESHQDADIEDFKAK.5|KTKPYIQVDIGGGQTK.4|KTKPYIQVDIGGGQTK.3|KTKPYIQVDIGGGQTK.2|IEWLESHQDADIEDFKAK.4|IEWLESHQDADIEDFKAK.3|IEWLESHQDADIEDFKAK.2|EFFNGKEPSR.3|EFFNGKEPSR.2|MKETAEAYLGK.3|MKETAEAYLGK.2|M[Oxi]KETAEAYLGK.2|MVNDAEKFAEEDKK.4|M[Oxi]VNDAEKFAEEDKK.4|MVNDAEKFAEEDKK.3|M[Oxi]VNDAEKFAEEDKK.3|MVNDAEKFAEEDKK.2|FAEEDKK.2|LSSEDKETMEK.3|LSSEDKETMEK.2|LSSEDKETM[Oxi]EK.2|NELESYAYSLK.3|NELESYAYSLK.2|NKITITNDQNR.3|NKITITNDQNR.2|NTVVPTKK.2|MKETAEAYLGKK.3|M[Oxi]KETAEAYLGKK.3|MKETAEAYLGKK.2|M[Oxi]KETAEAYLGKK.2|VMEHFIK.2|VM[Oxi]EHFIK.2|STMKPVQK.2|VLEDSDLK.2|DNHLLGTFDLTGIPPAPR.4|DNHLLGTFDLTGIPPAPR.3|DNHLLGTFDLTGIPPAPR.2|IQQLVKEFFNGKEPSR.4|SDIDEIVLVGGSTR.3|SDIDEIVLVGGSTR.2|ETAEAYLGK.2|KSQIFSTASDNQPTVTIK.4|KSQIFSTASDNQPTVTIK.3|KSQIFSTASDNQPTVTIK.2|LTPEEIER.2|ALSSQHQAR.2|MVNDAEKFAEEDK.3|MVNDAEKFAEEDK.2|ERIDTRNELESYAYSLK.4|ERIDTRNELESYAYSLK.3|VLEDSDLKK.2|ITITNDQNR.2|LGGKLSSEDKETMEK.3|ETAEAYLGKK.2|IINEPTAAAIAYGLDKREGEK.4|VYEGERPLTK.2|LYGSAGPPPTGEEDTAEK.3|LYGSAGPPPTGEEDTAEK.2|VYEGERPLTKDNHLLGTFDLTGIPPAPR.5|VYEGERPLTKDNHLLGTFDLTGIPPAPR.4|AVEEKIEWLESHQDADIEDFK.4|AVEEKIEWLESHQDADIEDFK.3|IEWLESHQDADIEDFK.3|IEWLESHQDADIEDFK.2|GVPQIEVTFEIDVNGILR.3|PYIQVDIGGGQTK.2|NELESYAYSLKNQIGDKEK.3|NKITITNDQNRLTPEEIER.3|LIGDAAKNQLTSNPENTVFDAK.3|MVNDAEK.1|KEDVGTVVGIDLGTTYSC[CAM]VGVFK.3
SEN / CTL,P78417,Glutathione S-transferase omega-1,GSTO1,3.92,3.02,1.85E-11,4.76E-12,1.13E+01,"glutathione metabolic process,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,L-ascorbic acid metabolic process,methylation,xenobiotic catabolic process,oxidation-reduction process,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,cellular response to arsenic-containing substance,cellular oxidant detoxification,glutathione derivative biosynthetic process","glutathione transferase activity,oxidoreductase activity,glutathione dehydrogenase (ascorbate) activity,methylarsonate reductase activity","cytoplasm,cytosol,extracellular exosome",48,28,41,VPSLVGSFIR.2|HEVININLK.2|GIRHEVININLK.3|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|SLGKGSAPPGPVPEGSIR.3|MILELFSKVPSLVGSFIR.3|M[Oxi]ILELFSKVPSLVGSFIR.3|MILELFSK.2|M[Oxi]ILELFSK.2|KLLPDDPYEK.3|KLLPDDPYEK.2|LNEC[CAM]VDHTPK.3|LNEC[CAM]VDHTPK.2|SQNKEDYAGLK.3|LWMAAMK.2|GSAPPGPVPEGSIR.3|GSAPPGPVPEGSIR.2|EDYAGLKEEFR.3|EDYAGLKEEFR.2|SQNKEDYAGLKEEFR.4|SQNKEDYAGLKEEFR.3|FC[CAM]PFAER.2|LEEVLTNK.2|EFTKLEEVLTNKK.3|EFTKLEEVLTNKK.2|LLPDDPYEKAC[CAM]QK.3|LEEVLTNKK.2|LLPDDPYEK.2|NKPEWFFK.2|LKLWMAAMKEDPTVSALLTSEK.4|EDPTVSALLTSEK.2|EFTKLEEVLTNK.2|LWMAAMKEDPTVSALLTSEK.3|LWM[Oxi]AAMKEDPTVSALLTSEK.3|LWMAAM[Oxi]KEDPTVSALLTSEK.3|LWMAAMKEDPTVSALLTSEK.2|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4
SEN / CTL,Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,3.92,1.10,2.75E-04,2.90E-05,4.54E+00,"protein peptidyl-prolyl isomerization,positive regulation of protein phosphorylation,cell cycle,regulation of mitotic nuclear division,neuron differentiation,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of protein binding,regulation of cytokinesis,negative regulation of type I interferon production,positive regulation of protein dephosphorylation,negative regulation of protein catabolic process,negative regulation of neuron apoptotic process,positive regulation of neuron apoptotic process,positive regulation of GTPase activity,positive regulation of transcription from RNA polymerase II promoter,synapse organization,protein stabilization,positive regulation of ubiquitin-protein transferase activity,regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of cell growth involved in cardiac muscle cell development,negative regulation of ERK1 and ERK2 cascade,positive regulation of canonical Wnt signaling pathway,regulation of protein localization to nucleus,regulation of signal transduction by p53 class mediator,negative regulation of cell motility","peptidyl-prolyl cis-trans isomerase activity,motor activity,protein binding,beta-catenin binding,mitogen-activated protein kinase kinase binding,GTPase activating protein binding,phosphoserine binding,phosphothreonine binding","nucleus,nucleoplasm,mitochondrion,cytosol,nuclear speck,midbody,neuron projection",6,12,19,IKSGEEDFESLASQFSDC[CAM]SSAK.3|GDLGAFSR.2|C[CAM]SHLLVK.2|ARGDLGAFSR.2|GQM[Oxi]QKPFEDASFALR.3|GQMQKPFEDASFALR.3|GQMQKPFEDASFALR.2|TKEEALELINGYIQK.3|TKEEALELINGYIQK.2|VYYFNHITNASQWER.3|VYYFNHITNASQWER.2|TGEMSGPVFTDSGIHIILR.3|TGEM[Oxi]SGPVFTDSGIHIILR.3|TGEMSGPVFTDSGIHIILR.2|VYYFNHITNASQWERPSGNSSSGGK.4|SGEEDFESLASQFSDC[CAM]SSAK.3|SGEEDFESLASQFSDC[CAM]SSAK.2|TGEMSGPVFTDSGIHIILRTE.3|EEALELINGYIQK.2
SEN / CTL,P22234,Multifunctional protein ADE2,PAICS,3.91,1.27,2.39E-13,7.51E-14,1.31E+01,"'de novo' IMP biosynthetic process,purine nucleobase biosynthetic process,purine ribonucleoside monophosphate biosynthetic process,adenine biosynthetic process,cell-cell adhesion","phosphoribosylaminoimidazole carboxylase activity,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,ATP binding,identical protein binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular exosome",24,31,54,IKAEYEGDGIPTVFVAVAGR.3|IKAEYEGDGIPTVFVAVAGR.4|IKAEYEGDGIPTVFVAVAGR.2|AAISNKITSC[CAM]IFQLLQEAGIK.3|VVVLMGSTSDLGHC[CAM]EK.3|VVVLM[Oxi]GSTSDLGHC[CAM]EK.3|VVVLM[Oxi]GSTSDLGHC[CAM]EK.2|VVVLMGSTSDLGHC[CAM]EK.2|KC[CAM]GETAFIAPQC[CAM]EMIPIEWVC[CAM]RR.4|ASILNTWISLK.3|ASILNTWISLK.2|IATGSFLK.2|FYPPKVELFFK.3|VTSAHKGPDETLR.3|VTSAHKGPDETLR.2|TKEVYELLDSPGK.3|TKEVYELLDSPGK.2|DQITAGNAAR.2|KAC[CAM]GNFGIPC[CAM]ELR.3|KAC[CAM]GNFGIPC[CAM]ELR.2|DLKEVTPEGLQMVK.3|DLKEVTPEGLQM[Oxi]VK.3|DLKEVTPEGLQM[Oxi]VK.2|DLKEVTPEGLQMVK.2|NFEWVAER.2|SWLPQNC[CAM]TLVDMK.3|SWLPQNC[CAM]TLVDM[Oxi]K.2|SWLPQNC[CAM]TLVDMK.2|EIVLADVIDNDSWR.3|EIVLADVIDNDSWR.2|IEFGVDVTTK.2|VLLQSKDQITAGNAAR.3|ITSC[CAM]IFQLLQEAGIK.3|ITSC[CAM]IFQLLQEAGIK.2|NFEWVAERVELLLK.3|KNFEWVAER.2|EVTPEGLQMVK.2|EVTPEGLQM[Oxi]VK.2|AEYEGDGIPTVFVAVAGR.3|AEYEGDGIPTVFVAVAGR.2|EVYELLDSPGK.2|DDANNDPQWSEEQLIAAK.3|DDANNDPQWSEEQLIAAK.2|AC[CAM]GNFGIPC[CAM]ELR.2|VELFFKDDANNDPQWSEEQLIAAK.4|VELFFKDDANNDPQWSEEQLIAAK.3|AAISNKITSC[CAM]IFQLLQEAGIKTAFTR.4|C[CAM]GETAFIAPQC[CAM]EMIPIEWVC[CAM]R.3|KC[CAM]GETAFIAPQC[CAM]EMIPIEWVC[CAM]R.3|KC[CAM]GETAFIAPQC[CAM]EM[Oxi]IPIEWVC[CAM]R.3|LPSGLGC[CAM]STVLSPEGSAQFAAQIFGLSNHLVWSK.4|LPSGLGC[CAM]STVLSPEGSAQFAAQIFGLSNHLVWSK.3|SNGLGPVM[Oxi]SGNTAYPVISC[CAM]PPLTPDWGVQDVWSSLR.4|SNGLGPVMSGNTAYPVISC[CAM]PPLTPDWGVQDVWSSLR.4
SEN / CTL,P07858,Cathepsin B,CTSB,3.90,1.24,5.67E-42,1.06E-41,4.10E+01,"toll-like receptor signaling pathway,proteolysis,collagen catabolic process,epithelial cell differentiation,regulation of apoptotic process,decidualization,viral entry into host cell,regulation of catalytic activity,proteolysis involved in cellular protein catabolic process,cellular response to thyroid hormone stimulus","cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,peptidase activity,cysteine-type peptidase activity,proteoglycan binding","extracellular region,extracellular space,intracellular,nucleolus,mitochondrion,lysosome,endolysosome lumen,melanosome,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",90,22,46,VMFTEDLKLPASFDAR.3|ILRGQDHC[CAM]GIESEVVAGIPR.4|ILRGQDHC[CAM]GIESEVVAGIPR.3|ILRGQDHC[CAM]GIESEVVAGIPR.5|GQDHC[CAM]GIESEVVAGIPR.3|GQDHC[CAM]GIESEVVAGIPR.2|GQDHC[CAM]GIESEVVAGIPR.4|LC[CAM]GTFLGGPKPPQR.3|EQWPQC[CAM]PTIK.2|SGVYQHVTGEMMGGHAIR.4|SGVYQHVTGEMMGGHAIR.3|SGVYQHVTGEMMGGHAIR.2|SGVYQHVTGEM[Oxi]MGGHAIR.4|SGVYQHVTGEMM[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]MGGHAIR.3|SGVYQHVTGEMM[Oxi]GGHAIR.3|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.3|SGVYQHVTGEMM[Oxi]GGHAIR.2|HYGYNSYSVSNSEKDIMAEIYK.4|HYGYNSYSVSNSEKDIM[Oxi]AEIYK.4|HYGYNSYSVSNSEKDIMAEIYK.3|EIRDQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|NGPVEGAFSVYSDFLLYK.2|NGPVEGAFSVYSDFLLYK.3|LPASFDAR.2|DIMAEIYK.2|DIM[Oxi]AEIYK.2|QDKHYGYNSYSVSNSEK.4|QDKHYGYNSYSVSNSEK.3|PSFHPLSDELVNYVNKR.4|PSFHPLSDELVNYVNKR.3|GLVSGGLYESHVGC[CAM]R.3|GLVSGGLYESHVGC[CAM]R.2|HYGYNSYSVSNSEK.3|HYGYNSYSVSNSEK.2|IC[CAM]EPGYSPTYKQDK.3|IC[CAM]EPGYSPTYKQDK.2|QDKHYGYNSYSVSNSEKDIMAEIYK.5|QDKHYGYNSYSVSNSEKDIMAEIYK.4|IC[CAM]EPGYSPTYK.2|SRPSFHPLSDELVNYVNK.3|LPASFDAREQWPQC[CAM]PTIK.3|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.2|ILGWGVENGTPYWLVANSWNTDWGDNGFFK.3
SEN / CTL,P49327,Fatty acid synthase,FASN,3.90,1.37,5.94E-30,6.55E-30,2.92E+01,"osteoblast differentiation,acetyl-CoA metabolic process,fatty acid metabolic process,fatty acid biosynthetic process,pantothenate metabolic process,mammary gland development,positive regulation of cellular metabolic process,long-chain fatty-acyl-CoA biosynthetic process,oxidation-reduction process,cellular response to interleukin-4,cell-cell adhesion","fatty acid synthase activity,[acyl-carrier-protein] S-acetyltransferase activity,[acyl-carrier-protein] S-malonyltransferase activity,3-oxoacyl-[acyl-carrier-protein] synthase activity,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,oleoyl-[acyl-carrier-protein] hydrolase activity,protein binding,drug binding,myristoyl-[acyl-carrier-protein] hydrolase activity,palmitoyl-[acyl-carrier-protein] hydrolase activity,phosphopantetheine binding,protein homodimerization activity,poly(A) RNA binding,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,NADPH binding,cadherin binding involved in cell-cell adhesion,3-oxo-pimeloyl-[acp] methyl ester reductase activity","cytoplasm,mitochondrion,Golgi apparatus,cytosol,plasma membrane,cell-cell adherens junction,membrane,melanosome,glycogen granule,extracellular exosome",60,162,312,WLSTSIPEAQWHSSLAR.3|WLSTSIPEAQWHSSLAR.4|WLSTSIPEAQWHSSLAR.2|TLLEGSGLESIISIIHSSLAEPR.3|TLLEGSGLESIISIIHSSLAEPR.4|LHLSGIDANPNALFPPVEFPAPR.3|LHLSGIDANPNALFPPVEFPAPR.5|LHLSGIDANPNALFPPVEFPAPR.4|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.5|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.4|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.3|ALGLGVEQLPVVFEDVVLHQATILPK.3|ALGLGVEQLPVVFEDVVLHQATILPK.4|TGTVSLEVR.2|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.5|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.6|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.4|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.5|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.6|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.4|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.3|LFDHPESPTPNPTEPLFLAQAEVYKELR.4|LFDHPESPTPNPTEPLFLAQAEVYKELR.3|FC[CAM]FTPHTEEGC[CAM]LSER.3|FC[CAM]FTPHTEEGC[CAM]LSER.2|QAHTM[Oxi]DPQLR.3|QAHTMDPQLR.3|QAHTMDPQLR.2|RGLKPSC[CAM]TIIPLMK.4|RGLKPSC[CAM]TIIPLMK.3|SEGVVAVLLTKK.3|VMGLVPAK.2|VM[Oxi]GLVPAK.2|FDASFFGVHPK.3|FDASFFGVHPK.2|LQVVDQPLPVR.3|LQVVDQPLPVR.2|VSVHVIEGDHR.3|VSVHVIEGDHR.2|AGLYGLPR.2|DIMLATGK.2|QRC[CAM]PPGVVPAC[CAM]HNSK.4|QRC[CAM]PPGVVPAC[CAM]HNSK.3|AKYHGNVMLLR.3|DTSFEQHVLWHTGGK.4|DTSFEQHVLWHTGGK.3|DTSFEQHVLWHTGGK.2|GMGLSLMR.2|GM[Oxi]GLSLMR.2|GMGLSLM[Oxi]R.2|SHQGLDRQELSFAAR.4|SHQGLDRQELSFAAR.3|SHQGLDRQELSFAAR.2|VYQWDDPDPR.3|VYQWDDPDPR.2|DGAWGAFR.2|DGVVRPLK.2|DHRDNLEFFLAGIGR.4|DHRDNLEFFLAGIGR.3|DHRDNLEFFLAGIGR.2|LYTLQDK.2|RAYLQAR.2|VTAIHIDPATHR.3|VTAIHIDPATHR.2|LSPDAIPGK.2|MKVVEVLAGHGHLYSR.4|AAEQYTPK.2|DNLEFFLAGIGR.3|DNLEFFLAGIGR.2|EGGFLLLHTLLR.3|EGGFLLLHTLLR.2|M[Oxi]VVPGLDGAQIPR.3|MVVPGLDGAQIPR.2|M[Oxi]VVPGLDGAQIPR.2|WVC[CAM]SSLR.2|ADEASELAC[CAM]PTPK.3|ADEASELAC[CAM]PTPK.2|GVDLVLNSLAEEK.3|GVDLVLNSLAEEK.2|GYAVLGGER.2|RVYATILNAGTNTDGFK.4|RVYATILNAGTNTDGFK.3|RVYATILNAGTNTDGFK.2|DLVEAVAHILGIR.3|DLVEAVAHILGIR.2|KDHRDNLEFFLAGIGR.4|KDHRDNLEFFLAGIGR.3|KLQELSSK.2|LSIPTYGLQC[CAM]TR.3|LSIPTYGLQC[CAM]TR.2|VLQGDLVMNVYR.3|VLQGDLVMNVYR.2|VLQGDLVM[Oxi]NVYR.2|VTVAGGVHISGLHTESAPR.4|VTVAGGVHISGLHTESAPR.3|VTVAGGVHISGLHTESAPR.2|C[CAM]PPGVVPAC[CAM]HNSK.3|C[CAM]PPGVVPAC[CAM]HNSK.2|SLLVNPEGPTLMR.3|SLLVNPEGPTLM[Oxi]R.3|SLLVNPEGPTLMR.2|SLLVNPEGPTLM[Oxi]R.2|GLVQALQTK.2|HGLYLPTR.2|FPQLDSTSFANSR.3|FPQLDSTSFANSR.2|GLKPSC[CAM]TIIPLMK.3|GLKPSC[CAM]TIIPLM[Oxi]K.3|GLKPSC[CAM]TIIPLMK.2|RQQEQQVPILEK.3|RQQEQQVPILEK.2|VLEALLPLK.2|VAAAVDLIIK.2|AC[CAM]LDTAVENMPSLK.3|AC[CAM]LDTAVENMPSLK.2|AC[CAM]LDTAVENM[Oxi]PSLK.2|AFEVSENGNLVVSGK.3|AFEVSENGNLVVSGK.2|VVEVLAGHGHLYSR.3|VVEVLAGHGHLYSR.2|AQVADVVVSR.2|ELNLVLSVR.2|GTPLISPLIK.2|VFTTVGSAEK.2|YSGTLNLDR.2|GILADEDSSR.2|PNTSVQFLR.2|VLEALLPLKGLEER.3|VLEALLPLKGLEER.2|VLFPATGYLSIVWK.3|VLFPATGYLSIVWK.2|AAPLDSIHSLAAYYIDC[CAM]IR.4|AAPLDSIHSLAAYYIDC[CAM]IR.3|AAPLDSIHSLAAYYIDC[CAM]IR.2|DPSQQELPR.2|EAHLPPGAMAAVGLSWEEC[CAM]K.4|EAHLPPGAM[Oxi]AAVGLSWEEC[CAM]K.3|EAHLPPGAMAAVGLSWEEC[CAM]K.3|EAHLPPGAMAAVGLSWEEC[CAM]K.2|EDGLAQQQTQLNLR.3|EDGLAQQQTQLNLR.2|HFLLEEDKPEEPTAHAFVSTLTR.5|HFLLEEDKPEEPTAHAFVSTLTR.4|HFLLEEDKPEEPTAHAFVSTLTR.3|LSFFFDFR.2|QVQPEGPYR.2|TGGMAFHSYFMEAIAPPLLQELKK.5|TGGM[Oxi]AFHSYFMEAIAPPLLQELKK.4|TGGMAFHSYFM[Oxi]EAIAPPLLQELKK.4|TGGMAFHSYFMEAIAPPLLQELKK.4|TGGM[Oxi]AFHSYFM[Oxi]EAIAPPLLQELKK.4|TGGM[Oxi]AFHSYFMEAIAPPLLQELKK.3|TGGMAFHSYFM[Oxi]EAIAPPLLQELKK.3|TGGMAFHSYFMEAIAPPLLQELKK.3|C[CAM]TVFHGAQVEDAFR.3|C[CAM]TVFHGAQVEDAFR.2|QEPLLIGSTK.2|VVVQVLAEEPEAVLK.3|VVVQVLAEEPEAVLK.2|IPGLLSPHPLLQLSYTATDR.4|IPGLLSPHPLLQLSYTATDR.3|IPGLLSPHPLLQLSYTATDR.2|RPTPQDSPIFLPVDDTSFR.4|RPTPQDSPIFLPVDDTSFR.3|RPTPQDSPIFLPVDDTSFR.2|SNMGHPEPASGLAALAK.3|SNM[Oxi]GHPEPASGLAALAK.3|SNMGHPEPASGLAALAK.2|SNM[Oxi]GHPEPASGLAALAK.2|YHGNVMLLR.2|SEGVVAVLLTK.2|AQVADVVVSRWLRVTVAGGVHISGLHTESAPR.6|AQVADVVVSRWLRVTVAGGVHISGLHTESAPR.5|DGLLENQTPEFFQDVC[CAM]KPK.4|DGLLENQTPEFFQDVC[CAM]KPK.3|DGLLENQTPEFFQDVC[CAM]KPK.2|GILADEDSSRPVWLK.3|GILADEDSSRPVWLK.2|VYATILNAGTNTDGFK.3|VYATILNAGTNTDGFK.2|DLSRFDASFFGVHPK.3|DPETLVGYSMVGC[CAM]QR.3|DPETLVGYSM[Oxi]VGC[CAM]QR.2|DPETLVGYSMVGC[CAM]QR.2|QKLYTLQDK.2|KLQELSSKADEASELAC[CAM]PTPK.4|KLQELSSKADEASELAC[CAM]PTPK.3|PLFLVHPIEGSTTVFHSLASR.4|PLFLVHPIEGSTTVFHSLASR.3|PSC[CAM]TIIPLMK.2|PSC[CAM]TIIPLM[Oxi]K.2|WTSQDSLLGM[Oxi]EFSGR.3|WTSQDSLLGM[Oxi]EFSGR.2|WTSQDSLLGMEFSGR.2|ALC[CAM]ATRQEPLLIGSTK.3|PNTQPPPAPAPHATLPR.3|DTVTISGPQAPVFEFVEQLRK.4|DTVTISGPQAPVFEFVEQLRK.3|DTVTISGPQAPVFEFVEQLRK.2|LPEDPLLSGLLDSPALK.3|LPEDPLLSGLLDSPALK.2|LQLNGNLQLELAQVLAQERPK.4|LQLNGNLQLELAQVLAQERPK.3|LQLNGNLQLELAQVLAQERPK.2|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.5|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.4|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.3|LGMLSPEGTC[CAM]K.2|LGM[Oxi]LSPEGTC[CAM]K.2|SDEAVKPFGLK.2|VFTTVGSAEKR.2|AINC[CAM]ATSGVVGLVNC[CAM]LR.3|AINC[CAM]ATSGVVGLVNC[CAM]LR.2|MVVPGLDGAQIPRDPSQQELPR.4|MVVPGLDGAQIPRDPSQQELPR.3|AFDTAGNGYC[CAM]R.2|FDLSQNHPLGM[Oxi]AIFLK.3|FDLSQNHPLGMAIFLK.3|FDLSQNHPLGMAIFLK.2|FDLSQNHPLGM[Oxi]AIFLK.2|EVWALVQAGIR.2|DSQRDLVEAVAHILGIR.3|FLEIGKFDLSQNHPLGMAIFLK.4|FLEIGKFDLSQNHPLGM[Oxi]AIFLK.4|FLEIGKFDLSQNHPLGMAIFLK.3|EQGVTFPSGDIQEQLIR.3|EQGVTFPSGDIQEQLIR.2|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFR.4|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFR.3|SLYQSAGVAPESFEYIEAHGTGTK.4|SLYQSAGVAPESFEYIEAHGTGTK.3|TGGMAFHSYFMEAIAPPLLQELK.4|TGGM[Oxi]AFHSYFMEAIAPPLLQELK.3|TGGMAFHSYFM[Oxi]EAIAPPLLQELK.3|TGGMAFHSYFMEAIAPPLLQELK.3|AALQEELQLC[CAM]K.2|AINC[CAM]ATSGVVGLVNC[CAM]LRR.3|QGVQVQVSTSNISSLEGAR.3|QGVQVQVSTSNISSLEGAR.2|VGDPQELNGITR.2|LRGYDYGPHFQGILEASLEGDSGR.4|LRGYDYGPHFQGILEASLEGDSGR.3|C[CAM]VLLSNLSSTSHVPEVDPGSAELQK.4|C[CAM]VLLSNLSSTSHVPEVDPGSAELQK.3|GGPEVQQVPAGER.2|PKLPEDPLLSGLLDSPALK.3|QQEQQVPILEK.2|SFYGSTLFLC[CAM]R.2|DGLLENQTPEFFQDVC[CAM]K.3|DGLLENQTPEFFQDVC[CAM]K.2|GVDLVLNSLAEEKLQASVR.3|HSQDLAFLSM[Oxi]LNDIAAVPATAMPFR.4|HSQDLAFLSMLNDIAAVPATAM[Oxi]PFR.4|HSQDLAFLSMLNDIAAVPATAMPFR.4|HSQDLAFLSM[Oxi]LNDIAAVPATAM[Oxi]PFR.3|HSQDLAFLSM[Oxi]LNDIAAVPATAMPFR.3|HSQDLAFLSMLNDIAAVPATAM[Oxi]PFR.3|HSQDLAFLSMLNDIAAVPATAMPFR.3|GTHTGVWVGVSGSETSEALSR.3|GTHTGVWVGVSGSETSEALSR.2|RQGVQVQVSTSNISSLEGAR.3|RQGVQVQVSTSNISSLEGAR.2|LFDHPESPTPNPTEPLFLAQAEVYK.4|LFDHPESPTPNPTEPLFLAQAEVYK.3|LQELSSKADEASELAC[CAM]PTPK.3|DTVTISGPQAPVFEFVEQLR.3|DTVTISGPQAPVFEFVEQLR.2|EAC[CAM]PELDYFVVFSSVSC[CAM]GR.3|EAC[CAM]PELDYFVVFSSVSC[CAM]GR.2|C[CAM]PPGVVPAC[CAM]HNSKDTVTISGPQAPVFEFVEQLRK.5|GLIAEAAQLGPVGGVFNLAVVLR.3|RVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.5|RVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.4|VLQGDLVMNVYRDGAWGAFR.3|GGPEVQQVPAGERPLWFIC[CAM]SGMGTQWR.4|GGPEVQQVPAGERPLWFIC[CAM]SGM[Oxi]GTQWR.3|GGPEVQQVPAGERPLWFIC[CAM]SGMGTQWR.3|LLLEVTYEAIVDGGINPDSLR.3|LLLEVTYEAIVDGGINPDSLR.2|TGGAYGEDLGADYNLSQVC[CAM]DGK.3|TGGAYGEDLGADYNLSQVC[CAM]DGK.2|VLLSLEHGLWAPNLHFHSPNPEIPALLDGRLQVVDQPLPVR.6|GYDYGPHFQGILEASLEGDSGR.3|GYDYGPHFQGILEASLEGDSGR.2|LPESENLQEFWDNLIGGVDMVTDDDRR.4|LPESENLQEFWDNLIGGVDM[Oxi]VTDDDRR.4|LPESENLQEFWDNLIGGVDMVTDDDRR.3|NVTFHGVLLDAFFNESSADWR.3|LQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALK.5|LQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALK.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDM[Oxi]EHNR.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDM[Oxi]EHNR.3|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.3|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFRDIMLATGK.4|TSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKR.6|LQVVDQPLPVRGGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.6|LSPDAIPGKWTSQDSLLGMEFSGR.3|AKLTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.4|GNAGQSNYGFANSAM[Oxi]ER.2|GNAGQSNYGFANSAMER.2|GPSIALDTAC[CAM]SSSLMALQNAYQAIHSGQC[CAM]PAAIVGGINVLLKPNTSVQFLR.6|GPSIALDTAC[CAM]SSSLMALQNAYQAIHSGQC[CAM]PAAIVGGINVLLKPNTSVQFLR.5|VYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.4|VYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.3|HSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGER.4|GHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSR.4|GTHTGVWVGVSGSETSEALSRDPETLVGYSM[Oxi]VGC[CAM]QR.4|GTHTGVWVGVSGSETSEALSRDPETLVGYSMVGC[CAM]QR.4|TSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLK.5|ADEASELAC[CAM]PTPKEDGLAQQQTQLNLR.3|WDHSLAWDVPAAEDFPNGSGSPSAAIYNIDTSSESPDHYLVDHTLDGR.5
SEN / CTL,P63000,Ras-related C3 botulinum toxin substrate 1,RAC1,3.89,1.51,2.85E-12,7.85E-13,1.21E+01,"positive regulation of protein phosphorylation,auditory receptor cell morphogenesis,mast cell chemotaxis,epithelial cell morphogenesis,movement of cell or subcellular component,inflammatory response,hyperosmotic response,cell adhesion,cell-matrix adhesion,G-protein coupled receptor signaling pathway,small GTPase mediated signal transduction,axon guidance,blood coagulation,cell proliferation,regulation of cell size,response to wounding,anatomical structure morphogenesis,regulation of hydrogen peroxide metabolic process,positive regulation of lamellipodium assembly,regulation of fibroblast migration,positive regulation of cell-substrate adhesion,regulation of neuron maturation,cerebral cortex radially oriented cell migration,embryonic olfactory bulb interneuron precursor migration,cerebral cortex GABAergic interneuron development,lamellipodium assembly,actin cytoskeleton organization,actin filament polymerization,platelet activation,regulation of cell migration,positive regulation of actin filament polymerization,T cell costimulation,ruffle organization,negative regulation of interleukin-23 production,substrate adhesion-dependent cell spreading,positive regulation of Rho protein signal transduction,intracellular signal transduction,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of apoptotic process,positive regulation of GTPase activity,positive regulation of phosphatidylinositol 3-kinase activity,engulfment of apoptotic cell,cell-cell junction organization,bone resorption,positive regulation of DNA replication,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,negative regulation of receptor-mediated endocytosis,anatomical structure arrangement,dendrite morphogenesis,cell motility,homeostasis of number of cells within a tissue,regulation of defense response to virus by virus,regulation of small GTPase mediated signal transduction,positive regulation of stress fiber assembly,localization within membrane,positive regulation of focal adhesion assembly,synaptic transmission, GABAergic,Wnt signaling pathway, planar cell polarity pathway,regulation of respiratory burst,cellular response to mechanical stimulus,semaphorin-plexin signaling pathway,protein localization to plasma membrane,positive regulation of neutrophil chemotaxis,cochlea morphogenesis,ruffle assembly,positive regulation of substrate adhesion-dependent cell spreading,midbrain dopaminergic neuron differentiation","GTPase activity,protein binding,GTP binding,Rab GTPase binding,enzyme binding,protein kinase binding,GTP-dependent protein binding,thioesterase binding,histone deacetylase binding,Rho GDP-dissociation inhibitor binding","Golgi membrane,phagocytic cup,nucleus,cytoplasm,endoplasmic reticulum membrane,trans-Golgi network,cytosol,plasma membrane,focal adhesion,membrane,extrinsic component of plasma membrane,lamellipodium,extracellular matrix,early endosome membrane,ruffle membrane,cytoplasmic ribonucleoprotein granule,melanosome,extracellular exosome,actin filament",24,12,21,EIGAVKYLEC[CAM]SALTQR.3|EIGAVKYLEC[CAM]SALTQR.2|GLKTVFDEAIR.3|LTPITYPQGLAMAK.2|LTPITYPQGLAMAK.3|LTPITYPQGLAM[Oxi]AK.2|KLTPITYPQGLAMAK.3|KLTPITYPQGLAM[Oxi]AK.3|KLTPITYPQGLAMAK.2|KLTPITYPQGLAM[Oxi]AK.2|TVFDEAIR.2|LDLRDDKDTIEK.3|LDLRDDKDTIEK.2|AVLC[CAM]PPPVK.2|C[CAM]VVVGDGAVGK.2|HHC[CAM]PNTPIILVGTK.3|HHC[CAM]PNTPIILVGTK.2|YLEC[CAM]SALTQR.2|PVNLGLWDTAGQEDYDR.3|PVNLGLWDTAGQEDYDR.2|LRPLSYPQTDVFLIC[CAM]FSLVSPASFENVR.3
SEN / CTL,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,3.83,2.14,4.70E-97,3.18E-96,9.55E+01,"microtubule cytoskeleton organization,gluconeogenesis,regulation of macroautophagy,negative regulation of translation,peptidyl-cysteine S-trans-nitrosylation,protein stabilization,neuron apoptotic process,canonical glycolysis,cellular response to interferon-gamma","glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,protein binding,microtubule binding,peptidyl-cysteine S-nitrosylase activity,NADP binding,NAD binding","nucleus,cytoplasm,lipid particle,cytosol,plasma membrane,microtubule cytoskeleton,membrane,intracellular ribonucleoprotein complex,extracellular matrix,nuclear membrane,vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,GAIT complex",276,51,166,LISWYDNEFGYSNR.2|LISWYDNEFGYSNR.3|VPTANVSVVDLTC[CAM]R.2|VPTANVSVVDLTC[CAM]R.3|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.6|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.5|GALQNIIPASTGAAK.2|GALQNIIPASTGAAK.3|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|GALQNIIPASTGAAKAVGK.3|LISWYDNEFGYSNRVVDLMAHMASKE.4|VIPELNGKLTGMAFRVPTANVSVVDLTC[CAM]R.4|IISNASC[CAM]TTNC[CAM]LAPLAK.3|IISNASC[CAM]TTNC[CAM]LAPLAK.2|IISNASC[CAM]TTNC[CAM]LAPLAK.4|DGRGALQNIIPASTGAAK.3|DGRGALQNIIPASTGAAK.2|DGRGALQNIIPASTGAAK.4|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.5|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.4|VIHDNFGIVEGLM[Oxi]TTVHAITATQKTVDGPSGK.5|YDNSLKIISNASC[CAM]TTNC[CAM]LAPLAK.3|VIHDNFGIVEGLMTTVHAITATQK.4|VIHDNFGIVEGLMTTVHAITATQK.3|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.4|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.5|VIHDNFGIVEGLMTTVHAITATQK.5|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.3|VVDLMAHMASKE.3|VVDLMAHMASKE.2|VVDLM[Oxi]AHMASKE.3|VVDLMAHM[Oxi]ASKE.3|VVDLM[Oxi]AHM[Oxi]ASKE.3|VVDLM[Oxi]AHMASKE.2|VVDLMAHM[Oxi]ASKE.2|VVDLM[Oxi]AHM[Oxi]ASKE.2|VIISAPSADAPMFVMGVNHEKYDNSLK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.3|VIISAPSADAPMFVMGVNHEKYDNSLK.5|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|VIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|VIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.5|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.4|IKWGDAGAEYVVESTGVFTTMEK.3|IKWGDAGAEYVVESTGVFTTMEK.4|IKWGDAGAEYVVESTGVFTTM[Oxi]EK.3|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.7|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.6|RVIISAPSADAPMFVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVMGVNHEKYDNSLK.4|RVIISAPSADAPMFVMGVNHEKYDNSLK.3|RVIISAPSADAPMFVMGVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.6|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.3|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.3|LTGMAFRVPTANVSVVDLTC[CAM]R.3|LTGMAFRVPTANVSVVDLTC[CAM]R.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]R.3|LTGMAFRVPTANVSVVDLTC[CAM]R.2|TVDGPSGKLWR.3|TVDGPSGKLWR.2|WGDAGAEYVVESTGVFTTMEK.3|WGDAGAEYVVESTGVFTTMEK.2|WGDAGAEYVVESTGVFTTM[Oxi]EK.3|WGDAGAEYVVESTGVFTTM[Oxi]EK.2|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.5|AAFNSGKVDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|VIISAPSADAPMFVMGVNHEK.3|VIISAPSADAPM[Oxi]FVMGVNHEK.4|VIISAPSADAPMFVM[Oxi]GVNHEK.4|VIISAPSADAPMFVMGVNHEK.4|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|VIISAPSADAPM[Oxi]FVMGVNHEK.3|VIISAPSADAPMFVM[Oxi]GVNHEK.3|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|VIISAPSADAPMFVMGVNHEK.2|VIISAPSADAPM[Oxi]FVMGVNHEK.2|VIISAPSADAPMFVM[Oxi]GVNHEK.2|LVINGNPITIFQERDPSK.3|LVINGNPITIFQERDPSK.4|LVINGNPITIFQERDPSK.2|RVIISAPSADAPMFVMGVNHEK.4|RVIISAPSADAPMFVMGVNHEK.3|RVIISAPSADAPMFVMGVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVMGVNHEK.5|RVIISAPSADAPMFVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|RVIISAPSADAPM[Oxi]FVMGVNHEK.4|RVIISAPSADAPMFVM[Oxi]GVNHEK.4|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.3|RVIISAPSADAPMFVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.2|RVIISAPSADAPMFVMGVNHEK.2|VPTANVSVVDLTC[CAM]RLEKPAK.4|VPTANVSVVDLTC[CAM]RLEKPAK.3|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.7|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.4|GKVKVGVNGFGR.3|LTGM[Oxi]AFR.2|VGVNGFGR.2|VVDLM[Oxi]AHMASK.3|VVDLMAHM[Oxi]ASK.3|VVDLMAHMASK.3|VVDLM[Oxi]AHM[Oxi]ASK.3|VVDLMAHMASK.2|VVDLM[Oxi]AHMASK.2|VVDLMAHM[Oxi]ASK.2|VVDLM[Oxi]AHM[Oxi]ASK.2|AVGKVIPELNGK.3|AVGKVIPELNGK.2|QASEGPLK.2|LEKPAKYDDIK.3|LEKPAKYDDIK.2|AGAHLQGGAK.2|PAKYDDIK.2|LEKPAKYDDIKK.3|LEKPAKYDDIKK.2|AGAHLQGGAKR.2|LVINGNPITIFQER.3|LVINGNPITIFQER.2|PAKYDDIKK.2|LWRDGRGALQNIIPASTGAAK.4|LWRDGRGALQNIIPASTGAAK.3|VIPELNGKLTGMAFR.3|VIPELNGKLTGM[Oxi]AFR.3|LVINGNPITIFQERDPSKIK.4|LVINGNPITIFQERDPSKIK.3|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEKPAK.5|LTGMAFRVPTANVSVVDLTC[CAM]RLEKPAK.5|AENGKLVINGNPITIFQERDPSK.4|AENGKLVINGNPITIFQERDPSK.3|VPTANVSVVDLTC[CAM]RLEK.3|VPTANVSVVDLTC[CAM]RLEK.2|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.4|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.3|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.3|AENGKLVINGNPITIFQER.3|AENGKLVINGNPITIFQER.2|VDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|VDIVAINDPFIDLNYMVYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.3|VDIVAINDPFIDLNYMVYMFQYDSTHGK.3|VDIVAINDPFIDLNYM[Oxi]VYM[Oxi]FQYDSTHGK.3
SEN / CTL,Q99832,T-complex protein 1 subunit eta,CCT7,3.82,1.88,1.04E-16,4.30E-17,1.64E+01,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,identical protein binding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,mitochondrion,cytosol,chaperonin-containing T-complex,microtubule,cell body,extracellular exosome",42,48,102,INALTAASEAAC[CAM]LIVSVDETIKNPR.3|INALTAASEAAC[CAM]LIVSVDETIKNPR.4|C[CAM]QVFEETQIGGER.2|C[CAM]QVFEETQIGGER.3|TIPGKQQLLIGAYAK.3|TIPGKQQLLIGAYAK.2|TMMAC[CAM]GGSIQTSVNALSADVLGR.3|TM[Oxi]M[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|TM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.3|TMM[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|TM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.2|TMMAC[CAM]GGSIQTSVNALSADVLGR.2|QVKPYVEEGLHPQIIIR.4|QVKPYVEEGLHPQIIIR.3|QVKPYVEEGLHPQIIIR.2|GGAEQFMEETER.2|GGAEQFMEETER.3|GGAEQFM[Oxi]EETER.2|ALEIIPR.2|VPEEDLK.2|TC[CAM]TFILR.2|GKATISNDGATILK.3|GKATISNDGATILK.2|TFSYAGFEMQPK.3|TFSYAGFEMQPK.2|TFSYAGFEM[Oxi]QPK.2|TATQLAVNK.2|C[CAM]AMTALSSK.2|C[CAM]AM[Oxi]TALSSK.2|VQGGALEDSQLVAGVAFKK.4|VQGGALEDSQLVAGVAFKK.3|VQGGALEDSQLVAGVAFKK.2|VPEEDLKR.2|IKEIAVTVK.2|KTFSYAGFEM[Oxi]QPK.3|KTFSYAGFEMQPK.3|KTFSYAGFEMQPK.2|KVQGGALEDSQLVAGVAFKK.4|KVQGGALEDSQLVAGVAFKK.3|LPIGDVATQYFADR.3|LPIGDVATQYFADR.2|STVDAPTAAGR.2|IALLNVELELKAEK.3|LLDVVHPAAK.2|RAIKNDSVVAGGGAIEMELSK.4|RAIKNDSVVAGGGAIEMELSK.3|QQLLIGAYAK.2|DMFC[CAM]AGRVPEEDLK.3|DMFC[CAM]AGRVPEEDLK.2|PYVEEGLHPQIIIR.3|PYVEEGLHPQIIIR.2|SQDAEVGDGTTSVTLLAAEFLK.4|SQDAEVGDGTTSVTLLAAEFLK.3|SQDAEVGDGTTSVTLLAAEFLK.2|YNFFTGC[CAM]PK.2|IALLNVELELKAEKDNAEIR.4|IALLNVELELKAEKDNAEIR.3|SLHDAIMIVR.2|SLHDAIM[Oxi]IVR.2|QLC[CAM]DNAGFDATNILNK.3|QLC[CAM]DNAGFDATNILNK.2|VQGGALEDSQLVAGVAFK.3|VQGGALEDSQLVAGVAFK.2|ATISNDGATILK.2|DMFC[CAM]AGRVPEEDLKR.3|M[Oxi]VVDAVM[Oxi]MLDDLLQLK.3|M[Oxi]VVDAVMM[Oxi]LDDLLQLK.3|M[Oxi]VVDAVMMLDDLLQLK.3|MVVDAVM[Oxi]M[Oxi]LDDLLQLK.3|MVVDAVM[Oxi]MLDDLLQLK.3|MVVDAVMMLDDLLQLK.2|M[Oxi]VVDAVM[Oxi]M[Oxi]LDDLLQLK.2|M[Oxi]VVDAVM[Oxi]MLDDLLQLK.2|M[Oxi]VVDAVMMLDDLLQLK.2|MVVDAVM[Oxi]M[Oxi]LDDLLQLK.2|MVVDAVM[Oxi]MLDDLLQLK.2|IALLNVELELK.2|RTMMAC[CAM]GGSIQTSVNALSADVLGR.4|RTMMAC[CAM]GGSIQTSVNALSADVLGR.3|RTM[Oxi]M[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|RTM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.3|RTMM[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|VHTVEDYQAIVDAEWNILYDK.4|VHTVEDYQAIVDAEWNILYDK.3|KVQGGALEDSQLVAGVAFK.3|KVQGGALEDSQLVAGVAFK.2|AIKNDSVVAGGGAIEM[Oxi]ELSK.3|AIKNDSVVAGGGAIEMELSK.3|AIKNDSVVAGGGAIEMELSK.2|EGTDSSQGIPQLVSNISAC[CAM]QVIAEAVR.4|EGTDSSQGIPQLVSNISAC[CAM]QVIAEAVR.3|VHTVEDYQAIVDAEWNILYDKLEK.4|VHTVEDYQAIVDAEWNILYDKLEK.3|INALTAASEAAC[CAM]LIVSVDETIK.3|INALTAASEAAC[CAM]LIVSVDETIK.2|LPIGDVATQYFADRDMFC[CAM]AGR.3|LPIGDVATQYFADRDM[Oxi]FC[CAM]AGR.3|LPIGDVATQYFADRDMFC[CAM]AGRVPEEDLK.4|NDSVVAGGGAIEM[Oxi]ELSK.2|NDSVVAGGGAIEMELSK.2|C[CAM]QVFEETQIGGERYNFFTGC[CAM]PK.3|HAQGGTWYGVDINNEDIADNFEAFVWEPAMVR.4
SEN / CTL,O60925,Prefoldin subunit 1,PFDN1,3.81,0.82,9.83E-05,1.12E-05,4.95E+00,"regulation of transcription, DNA-templated,protein folding,cell cycle","transcription factor activity, sequence-specific DNA binding,protein binding involved in protein folding,unfolded protein binding",prefoldin complex,6,9,10,LADIQIEQLNR.2|MFILQSK.2|AFTELQAK.2|KAFTELQAK.2|EAEDNIREMLMAR.3|KHAHLTDTEIMTLVDETNMYEGVGR.5|KHAHLTDTEIMTLVDETNMYEGVGR.4|EAIHSQLLEK.2|HAHLTDTEIMTLVDETNMYEGVGR.4|VKLADIQIEQLNR.2
SEN / CTL,P14324,Farnesyl pyrophosphate synthase,FDPS,3.81,1.06,1.44E-07,2.34E-08,7.63E+00,"cholesterol biosynthetic process,viral process,geranyl diphosphate biosynthetic process,farnesyl diphosphate biosynthetic process","dimethylallyltranstransferase activity,geranyltranstransferase activity,poly(A) RNA binding,metal ion binding","nucleoplasm,cytoplasm,cytosol",12,17,27,VLTEDEMGHPEIGDAIAR.3|VLTEDEMGHPEIGDAIAR.2|VLTEDEMGHPEIGDAIAR.4|VLTEDEM[Oxi]GHPEIGDAIAR.3|C[CAM]SWLVVQC[CAM]LQR.3|C[CAM]SWLVVQC[CAM]LQR.2|GLTVVVAFR.2|LKEVLEYNAIGGK.3|LKEVLEYNAIGGK.2|IGTDIQDNK.2|QDFVQHFSQIVR.3|QDFVQHFSQIVR.2|KQDADSLQR.2|ATPEQYQILKENYGQKEAEK.4|ATPEQYQILKENYGQKEAEK.3|ATPEQYQILK.2|EVLEYNAIGGK.2|ATPEQYQILKENYGQK.3|ATPEQYQILKENYGQK.2|TAFYSFYLPIAAAMYMAGIDGEKEHANAKK.5|TAFYSFYLPIAAAMYMAGIDGEKEHANAKK.4|PGVGLDAINDANLLEAC[CAM]IYR.3|PGVGLDAINDANLLEAC[CAM]IYR.2|TAFYSFYLPIAAAMYMAGIDGEKEHANAK.4|SVGVFLLPAPYWAPR.2|RGQIC[CAM]WYQKPGVGLDAINDANLLEAC[CAM]IYR.4|GQIC[CAM]WYQKPGVGLDAINDANLLEAC[CAM]IYR.3
SEN / CTL,P07602,Prosaposin,PSAP,3.80,1.64,2.95E-14,9.84E-15,1.40E+01,"platelet degranulation,glycosphingolipid metabolic process,lipid transport,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,regulation of autophagy,regulation of lipid metabolic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,prostate gland growth,epithelial cell differentiation involved in prostate gland development,cellular response to organic substance,negative regulation of hydrogen peroxide-induced cell death","G-protein coupled receptor binding,protein binding,enzyme activator activity,lipid binding","extracellular region,extracellular space,cytoplasm,mitochondrion,lysosome,lysosomal membrane,integral component of membrane,lysosomal lumen,extracellular exosome",30,30,59,C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]KR.4|NVIPALELVEPIKK.3|NVIPALELVEPIKK.2|EIVDSYLPVILDIIK.2|EIVDSYLPVILDIIK.3|SDVYC[CAM]EVC[CAM]EFLVK.2|SDVYC[CAM]EVC[CAM]EFLVK.3|NYISQYSEIAIQMMMHMQPK.3|NYISQYSEIAIQM[Oxi]MMHMQPK.4|NYISQYSEIAIQMM[Oxi]MHMQPK.4|NYISQYSEIAIQMMM[Oxi]HMQPK.4|NYISQYSEIAIQMMMHM[Oxi]QPK.4|NYISQYSEIAIQMMMHMQPK.4|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.4|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.4|NYISQYSEIAIQM[Oxi]M[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]M[Oxi]MHMQPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.3|NYISQYSEIAIQM[Oxi]MMHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MMHMQPK.3|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQMM[Oxi]MHMQPK.3|NYISQYSEIAIQMMM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQMMM[Oxi]HMQPK.3|NYISQYSEIAIQMMMHM[Oxi]QPK.3|DGGFC[CAM]EVC[CAM]KK.3|DGGFC[CAM]EVC[CAM]KK.2|IGAC[CAM]PSAHKPLLGTEK.4|IGAC[CAM]PSAHKPLLGTEK.3|IGAC[CAM]PSAHKPLLGTEK.2|LVGYLDR.2|LPALTVHVTQPK.3|LPALTVHVTQPK.2|GC[CAM]SFLPDPYQK.3|GC[CAM]SFLPDPYQK.2|LVGYLDRNLEK.3|LVGYLDRNLEK.2|EILDAFDK.2|KLVGYLDR.2|KLVGYLDRNLEK.3|EILDAFDKMC[CAM]SK.3|SLPC[CAM]DIC[CAM]K.2|QEILAALEK.2|LGPGMADIC[CAM]K.2|LGPGM[Oxi]ADIC[CAM]K.2|DGGFC[CAM]EVC[CAM]K.2|HLAELNHQK.2|DVVTAAGDMLK.2|DVVTAAGDM[Oxi]LK.2|GSAVWC[CAM]QNVK.2|HEVPAKSDVYC[CAM]EVC[CAM]EFLVK.4|EEC[CAM]DRLGPGMADIC[CAM]K.3|EMPMQTLVPAK.2|SLPC[CAM]DIC[CAM]KDVVTAAGDMLK.3|NVIPALELVEPIK.2|EIC[CAM]ALVGFC[CAM]DEVK.2|GEMSRPGEVC[CAM]SALNLC[CAM]ESLQK.3|C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]K.3
SEN / CTL,O75937,DnaJ homolog subfamily C member 8,DNAJC8,3.80,1.76,2.58E-03,2.42E-04,3.62E+00,"mRNA splicing, via spliceosome",,"nucleoplasm,cytoplasm,intercellular bridge",6,21,31,LTRPGSSYFNLNPFEVLQIDPEVTDEEIKKR.5|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKKR.4|ALDVIQAGK.2|QREEEIEAQEK.3|QREEEIEAQEK.2|LFAELEIK.2|KEGKPTIVEEDDPELFK.4|KEGKPTIVEEDDPELFK.3|LLLDQEQK.2|QLSILVHPDKNQDDADR.4|QLSILVHPDKNQDDADR.3|EYVEHTVK.2|RQREEEIEAQEK.3|RALDVIQAGK.2|ALDVIQAGKEYVEHTVKER.4|EEEIEAQEK.2|LLLDQEQKK.2|QLSILVHPDKNQDDADRAQK.4|QLSILVHPDKNQDDADRAQK.3|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.6|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.5|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.4|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.3|QLSILVHPDK.2|EGKPTIVEEDDPELFK.3|EGKPTIVEEDDPELFK.2|ALDVIQAGKEYVEHTVK.3|PTIVEEDDPELFK.2|LTRPGSSYFNLNPFEVLQIDPEVTDEEIK.4|LTRPGSSYFNLNPFEVLQIDPEVTDEEIK.3|PGSSYFNLNPFEVLQIDPEVTDEEIK.3
SEN / CTL,P67809,Nuclease-sensitive element-binding protein 1,YBX1,3.80,1.95,1.88E-05,2.40E-06,5.62E+00,"negative regulation of transcription from RNA polymerase II promoter,mRNA splicing, via spliceosome,in utero embryonic development,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter,negative regulation of striated muscle cell differentiation,positive regulation of cell division,CRD-mediated mRNA stabilization,protein localization to cytoplasmic stress granule","RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,DNA binding,chromatin binding,double-stranded DNA binding,single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,RNA binding,protein binding,poly(A) RNA binding,GTPase binding","nucleus,nucleoplasm,U12-type spliceosomal complex,cytoplasm,cytoplasmic stress granule,intracellular ribonucleoprotein complex,nuclear membrane,intracellular membrane-bounded organelle,extracellular exosome,CRD-mediated mRNA stability complex,histone pre-mRNA 3'end processing complex",12,29,58,RPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYR.5|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.4|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.6|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGRPVR.6|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.5|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGRPVR.4|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.3|RPENPKPQDGKETK.4|RPENPKPQDGKETK.3|RPENPKPQDGK.3|RPENPKPQDGK.2|EDVFVHQTAIK.3|EDVFVHQTAIK.2|NDTKEDVFVHQTAIK.4|NDTKEDVFVHQTAIK.3|NDTKEDVFVHQTAIK.2|RRPENPKPQDGKETK.4|RRPENPKPQDGKETK.3|EDVFVHQTAIKK.3|EDVFVHQTAIKK.2|NDTKEDVFVHQTAIKK.4|NDTKEDVFVHQTAIKK.3|NDTKEDVFVHQTAIKK.2|NGYGFINR.2|NGYGFINRNDTK.3|NGYGFINRNDTK.2|RRPENPKPQDGK.3|FPPYYMR.2|NEGSESAPEGQAQQR.3|NEGSESAPEGQAQQR.2|NGYGFINRNDTKEDVFVHQTAIK.5|NGYGFINRNDTKEDVFVHQTAIK.4|GAEAANVTGPGGVPVQGSK.3|GAEAANVTGPGGVPVQGSK.2|NYQQNYQNSESGEK.3|NYQQNYQNSESGEK.2|ENQGDETQGQQPPQR.3|ENQGDETQGQQPPQR.2|SVGDGETVEFDVVEGEK.3|SVGDGETVEFDVVEGEK.2|ENQGDETQGQQPPQRR.3|AADPPAENSSAPEAEQGGAE.3|AADPPAENSSAPEAEQGGAE.2|EDGNEEDKENQGDETQGQQPPQR.4|EDGNEEDKENQGDETQGQQPPQR.3|PGTTGSGAGSGGPGGLTSAAPAGGDK.3|PGTTGSGAGSGGPGGLTSAAPAGGDK.2|EDGNEEDKENQGDETQGQQPPQRR.4|EDGNEEDKENQGDETQGQQPPQRR.3|RPQYSNPPVQGEVMEGADNQGAGEQGR.4|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGR.3|RPQYSNPPVQGEVMEGADNQGAGEQGR.3|PGTTGSGAGSGGPGGLTSAAPAGGDKK.3|QPREDGNEEDKENQGDETQGQQPPQR.4|NYQQNYQNSESGEKNEGSESAPEGQAQQR.4|NYQQNYQNSESGEKNEGSESAPEGQAQQR.3|SVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSK.4|SVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSK.3
SEN / CTL,Q9UKK9,ADP-sugar pyrophosphatase,NUDT5,3.78,2.31,6.48E-09,1.25E-09,8.90E+00,"chromatin remodeling,nucleotide metabolic process,ribonucleoside diphosphate catabolic process,D-ribose catabolic process,nucleobase-containing small molecule catabolic process,ATP generation from poly-ADP-D-ribose","magnesium ion binding,protein binding,nucleotidyltransferase activity,ADP-sugar diphosphatase activity,snoRNA binding,protein homodimerization activity,8-oxo-dGDP phosphatase activity,ADP-ribose diphosphatase activity,m7G(5')pppN diphosphatase activity","intracellular,nucleus,cytosol,extracellular exosome",24,17,27,TLHYEC[CAM]IVLVK.3|TLHYEC[CAM]IVLVK.2|TTRKEQTADGVAVIPVLQR.4|EQTADGVAVIPVLQR.2|EQTADGVAVIPVLQR.3|HANAKPFEVPFLKF.4|HANAKPFEVPFLKF.3|HANAKPFEVPFLKF.2|PFEVPFLK.2|HANAKPFEVPFLK.3|HANAKPFEVPFLK.2|TTYMDPTGK.2|VYSYALALK.2|ELEEETGYK.2|LDALVAEEHLTVDAR.3|LDALVAEEHLTVDAR.2|PFEVPFLKF.2|PKPGDGEFVEVISLPK.3|PKPGDGEFVEVISLPK.2|KEQTADGVAVIPVLQR.3|KEQTADGVAVIPVLQR.2|NDLLQRLDALVAEEHLTVDAR.4|NDLLQRLDALVAEEHLTVDAR.3|PGDGEFVEVISLPK.2|QYIISEELISEGK.2|QFRPPMGGYC[CAM]IEFPAGLIDDGETPEAAALR.4|QFRPPMGGYC[CAM]IEFPAGLIDDGETPEAAALR.3
SEN / CTL,Q15102,Platelet-activating factor acetylhydrolase IB subunit gamma,PAFAH1B3,3.78,1.41,7.15E-07,1.08E-07,6.97E+00,"lipid metabolic process,spermatogenesis,nervous system development,brain development,lipid catabolic process","1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipase A2 activity,protein binding,identical protein binding,protein heterodimerization activity,platelet-activating factor acetyltransferase activity","cytoplasm,cytosol,membrane,extracellular exosome",12,14,23,AHFLDADPGFVHSDGTISHHDMYDYLHLSR.6|AHFLDADPGFVHSDGTISHHDMYDYLHLSR.7|AHFLDADPGFVHSDGTISHHDMYDYLHLSR.5|AHFLDADPGFVHSDGTISHHDMYDYLHLSR.4|LLAQDQGQGAPLLEPAP.2|LLAQDQGQGAPLLEPAP.3|ALHSLLLR.2|LENGELEHIRPK.3|LENGELEHIRPK.2|LGYTPVC[CAM]R.2|VVVLGLLPR.2|AIVQLVNER.2|AIVQLVNERQPQAR.3|NRQVNELVR.2|IVVVWVGTNNHGHTAEQVTGGIK.4|IVVVWVGTNNHGHTAEQVTGGIK.3|PTPVQDVQGDGR.2|ELFSPLHALNFGIGGDGTQHVLWR.4|ELFSPLHALNFGIGGDGTQHVLWR.3|FVADSKDKEPEVVFIGDSLVQLMHQC[CAM]EIWR.5|FVADSKDKEPEVVFIGDSLVQLMHQC[CAM]EIWR.4|DKEPEVVFIGDSLVQLMHQC[CAM]EIWR.4|DKEPEVVFIGDSLVQLMHQC[CAM]EIWR.3
SEN / CTL,P49773,Histidine triad nucleotide-binding protein 1,HINT1,3.77,1.87,2.49E-13,7.77E-14,1.31E+01,"transcription, DNA-templated,regulation of transcription, DNA-templated,signal transduction,purine ribonucleotide catabolic process,positive regulation of calcium-mediated signaling,intrinsic apoptotic signaling pathway by p53 class mediator","nucleotide binding,protein kinase C binding,hydrolase activity","histone deacetylase complex,nucleus,cytoplasm,cytoskeleton,plasma membrane,extracellular exosome",30,13,35,MVVNEGSDGGQSVYHVHLHVLGGR.5|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.5|MVVNEGSDGGQSVYHVHLHVLGGR.4|MVVNEGSDGGQSVYHVHLHVLGGR.3|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.4|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.3|KHISQISVAEDDDESLLGHLMIVGKK.5|KHISQISVAEDDDESLLGHLM[Oxi]IVGKK.5|KHISQISVAEDDDESLLGHLMIVGKK.4|C[CAM]AADLGLNKGYR.3|C[CAM]AADLGLNKGYR.2|PGGDTIFGK.2|IIFEDDR.2|C[CAM]LAFHDISPQAPTHFLVIPK.5|C[CAM]LAFHDISPQAPTHFLVIPK.4|C[CAM]LAFHDISPQAPTHFLVIPK.3|C[CAM]LAFHDISPQAPTHFLVIPK.2|AQVARPGGDTIFGK.3|AQVARPGGDTIFGK.2|C[CAM]AADLGLNK.2|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.6|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.5|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.4|KC[CAM]AADLGLNK.2|HISQISVAEDDDESLLGHLMIVGKK.5|HISQISVAEDDDESLLGHLMIVGKK.4|HISQISVAEDDDESLLGHLM[Oxi]IVGKK.4|KHISQISVAEDDDESLLGHLM[Oxi]IVGK.5|KHISQISVAEDDDESLLGHLMIVGK.5|KHISQISVAEDDDESLLGHLMIVGK.4|KHISQISVAEDDDESLLGHLM[Oxi]IVGK.4|KHISQISVAEDDDESLLGHLMIVGK.3|HISQISVAEDDDESLLGHLMIVGK.4|HISQISVAEDDDESLLGHLM[Oxi]IVGK.4|HISQISVAEDDDESLLGHLMIVGK.3
SEN / CTL,Q13418,Integrin-linked protein kinase,ILK,3.75,1.47,2.22E-06,3.17E-07,6.50E+00,"branching involved in ureteric bud morphogenesis,positive regulation of cell-matrix adhesion,outflow tract morphogenesis,protein phosphorylation,negative regulation of protein kinase activity,cell cycle arrest,cell-matrix adhesion,integrin-mediated signaling pathway,cell aging,cell proliferation,positive regulation of cell proliferation,negative regulation of cardiac muscle cell apoptotic process,fibroblast migration,negative regulation of smooth muscle cell migration,peptidyl-serine phosphorylation,nerve development,myelination in peripheral nervous system,positive regulation of cell migration,positive regulation of BMP signaling pathway,myelin assembly,regulation of actin cytoskeleton organization,cell junction assembly,substrate adhesion-dependent cell spreading,positive regulation of phosphorylation,extracellular fibril organization,positive regulation of MAP kinase activity,protein kinase B signaling,negative regulation of neuron apoptotic process,establishment or maintenance of epithelial cell apical/basal polarity,positive regulation of myoblast differentiation,positive regulation of osteoblast differentiation,positive regulation of axon extension,positive regulation of transcription, DNA-templated,negative regulation of smooth muscle cell proliferation,neuron projection morphogenesis,positive regulation of dendrite morphogenesis,protein heterooligomerization,positive regulation of protein kinase B signaling,platelet aggregation,positive regulation of canonical Wnt signaling pathway,negative regulation of neural precursor cell proliferation","protein serine/threonine kinase activity,signal transducer activity,integrin binding,protein binding,ATP binding,SH3 domain binding,protein kinase binding","stress fiber,nucleoplasm,cytoplasm,cytosol,plasma membrane,cell-cell junction,focal adhesion,membrane,sarcomere,lamellipodium,cell junction,extracellular matrix,neuronal cell body,costamere,terminal bouton,dendritic shaft,protein complex",12,21,36,SVMIDEDMTAR.2|SVM[Oxi]IDEDMTAR.2|FDMIVPILEK.2|FDM[Oxi]IVPILEK.2|HSGIDFK.2|EGNAVAVR.2|GRWQGNDIVVK.3|LNENHSGELWK.3|LNENHSGELWK.2|INVMNRGDDTPLHLAASHGHR.5|INVM[Oxi]NRGDDTPLHLAASHGHR.5|INVMNRGDDTPLHLAASHGHR.4|YGEMPVDK.2|FSFQC[CAM]PGR.2|GDDTPLHLAASHGHR.3|GDDTPLHLAASHGHR.2|GMAFLHTLEPLIPR.3|GM[Oxi]AFLHTLEPLIPR.3|GMAFLHTLEPLIPR.2|MYAPAWVAPEALQK.3|MYAPAWVAPEALQK.2|M[Oxi]YAPAWVAPEALQK.2|WQGNDIVVK.2|DFNEEC[CAM]PR.2|IC[CAM]MNEDPAK.2|IC[CAM]M[Oxi]NEDPAK.2|VALEGLRPTIPPGISPHVC[CAM]K.4|VALEGLRPTIPPGISPHVC[CAM]K.3|VALEGLRPTIPPGISPHVC[CAM]K.2|EVPFADLSNMEIGMK.3|EVPFADLSNMEIGMK.2|SAVVEMLIMR.2|SRDFNEEC[CAM]PR.2|LWLDNTENDLNQGDDHGFSPLHWAC[CAM]R.4|LWLDNTENDLNQGDDHGFSPLHWAC[CAM]R.3|ADINAVNEHGNVPLHYAC[CAM]FWGQDQVAEDLVANGALVSIC[CAM]NK.4
SEN / CTL,Q9BRA2,Thioredoxin domain-containing protein 17,TXNDC17,3.74,2.28,3.40E-08,5.92E-09,8.23E+00,"tumor necrosis factor-mediated signaling pathway,oxidation-reduction process,cellular oxidant detoxification","peroxidase activity,protein binding,protein-disulfide reductase activity","cytosol,extracellular exosome",30,11,18,SWC[CAM]PDC[CAM]VQAEPVVR.3|SWC[CAM]PDC[CAM]VQAEPVVR.2|NLKVTAVPTLLK.3|YEEVSVSGFEEFHR.3|YEEVSVSGFEEFHR.2|TIFAYFTGSK.2|DPNNDFR.2|VTAVPTLLK.2|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.6|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.5|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.4|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.3|HISEGC[CAM]VFIYC[CAM]QVGEKPYWK.4|HISEGC[CAM]VFIYC[CAM]QVGEKPYWK.3|HISEGC[CAM]VFIYC[CAM]QVGEK.3|HISEGC[CAM]VFIYC[CAM]QVGEK.2|AVEQHNGKTIFAYFTGSK.3|LVESEC[CAM]LQANLVEMLFSED.2
SEN / CTL,O43175,D-3-phosphoglycerate dehydrogenase,PHGDH,3.74,2.00,1.63E-14,5.64E-15,1.42E+01,"glutamine metabolic process,glycine metabolic process,L-serine biosynthetic process,threonine metabolic process,brain development,serine family amino acid biosynthetic process,gamma-aminobutyric acid metabolic process,regulation of gene expression,taurine metabolic process,spinal cord development,glial cell development,neural tube development,neuron projection development,oxidation-reduction process,G1 to G0 transition","phosphoglycerate dehydrogenase activity,electron carrier activity,NAD binding","cytosol,myelin sheath,extracellular exosome",42,33,65,AGTGVDNVDLEAATR.2|AGTGVDNVDLEAATR.3|SATKVTADVINAAEKLQVVGR.4|SATKVTADVINAAEKLQVVGR.3|VLISDSLDPC[CAM]C[CAM]R.2|DLPLLLFR.2|ALVDHENVISC[CAM]PHLGASTK.4|ALVDHENVISC[CAM]PHLGASTK.3|ALVDHENVISC[CAM]PHLGASTK.2|GGIVDEGALLR.2|TQTSDPAMLPTMIGLLAEAGVR.3|TQTSDPAM[Oxi]LPTMIGLLAEAGVR.3|TQTSDPAMLPTM[Oxi]IGLLAEAGVR.3|TQTSDPAM[Oxi]LPTM[Oxi]IGLLAEAGVR.3|TQTSDPAM[Oxi]LPTMIGLLAEAGVR.2|TQTSDPAMLPTMIGLLAEAGVR.2|ILQDGGLQVVEK.3|ILQDGGLQVVEK.2|GTIQVITQGTSLK.3|GTIQVITQGTSLK.2|TLGILGLGR.2|QHVTEAFQFHF.3|QHVTEAFQFHF.2|KILQDGGLQVVEK.3|KILQDGGLQVVEK.2|FM[Oxi]GTELNGK.2|PWIGLAEALGTLMR.3|PWIGLAEALGTLM[Oxi]R.3|PWIGLAEALGTLMR.2|PWIGLAEALGTLM[Oxi]R.2|SATKVTADVINAAEK.3|SLTGVVNAQALTSAFSPHTK.4|SLTGVVNAQALTSAFSPHTK.3|SLTGVVNAQALTSAFSPHTK.2|KVLISDSLDPC[CAM]C[CAM]R.3|VLISDSLDPC[CAM]C[CAM]RK.3|VLISDSLDPC[CAM]C[CAM]RK.2|AGTGVDNVDLEAATRK.3|AGTGVDNVDLEAATRK.2|QADVNLVNAK.2|QIPQATASMK.2|C[CAM]GEEIAVQFVDMVK.3|C[CAM]GEEIAVQFVDMVK.2|NAGNC[CAM]LSPAVIVGLLK.3|NAGNC[CAM]LSPAVIVGLLK.2|KFMGTELNGK.2|VTADVINAAEK.2|ALQSGQC[CAM]AGAALDVFTEEPPRDR.4|ALQSGQC[CAM]AGAALDVFTEEPPRDR.3|EELIAELQDC[CAM]EGLIVR.3|EELIAELQDC[CAM]EGLIVR.2|ALQSGQC[CAM]AGAALDVFTEEPPR.3|ALQSGQC[CAM]AGAALDVFTEEPPR.2|GILVMNTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.4|GILVM[Oxi]NTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.3|GILVMNTPNGNSLSAAELTC[CAM]GMIM[Oxi]C[CAM]LAR.3|GILVMNTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.3|KGILVMNTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.4|KGILVM[Oxi]NTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.3|KGILVMNTPNGNSLSAAELTC[CAM]GMIMC[CAM]LAR.3|QNLSKEELIAELQDC[CAM]EGLIVR.3|LLSYQTSLVSDGETWHVMGISSLLPSLEAWK.4|LLSYQTSLVSDGETWHVMGISSLLPSLEAWK.3|SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLM[Oxi]R.4|SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMR.4
SEN / CTL,P02656,Apolipoprotein C-III,APOC3,3.73,1.21,5.06E-11,1.23E-11,1.09E+01,"retinoid metabolic process,triglyceride metabolic process,G-protein coupled receptor signaling pathway,negative regulation of triglyceride catabolic process,negative regulation of very-low-density lipoprotein particle remodeling,negative regulation of very-low-density lipoprotein particle clearance,negative regulation of high-density lipoprotein particle clearance,negative regulation of low-density lipoprotein particle clearance,triglyceride catabolic process,regulation of Cdc42 protein signal transduction,cholesterol efflux,phospholipid efflux,high-density lipoprotein particle remodeling,very-low-density lipoprotein particle assembly,chylomicron remnant clearance,lipoprotein metabolic process,cholesterol homeostasis,reverse cholesterol transport,negative regulation of fatty acid biosynthetic process,negative regulation of lipid metabolic process,negative regulation of receptor-mediated endocytosis,negative regulation of lipid catabolic process,negative regulation of lipoprotein lipase activity,negative regulation of cholesterol import,triglyceride homeostasis","phospholipid binding,cholesterol binding,enzyme regulator activity,lipase inhibitor activity,high-density lipoprotein particle receptor binding","extracellular region,extracellular space,early endosome,very-low-density lipoprotein particle,intermediate-density lipoprotein particle,spherical high-density lipoprotein particle,chylomicron,extracellular exosome",18,3,4,DALSSVQESQVAQQAR.3|DALSSVQESQVAQQAR.2|TAKDALSSVQESQVAQQAR.3|GWVTDGFSSLK.2
SEN / CTL,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,3.72,2.31,9.20E-04,9.08E-05,4.04E+00,"movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,cellular response to nerve growth factor stimulus","structural constituent of cytoskeleton,protein binding,actin filament binding","cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,lamellipodium,growth cone,extracellular exosome",18,16,27,PAYHSSLMDPDTKLIGNMALLPIR.4|LIGNMALLPIR.2|LIGNMALLPIR.3|LIGNM[Oxi]ALLPIR.2|ETKDTDIVDEAIYYFK.3|ETKDTDIVDEAIYYFK.2|NYEIKNEADR.3|NYEIKNEADR.2|VFDPQNDKPSK.3|VFDPQNDKPSK.2|PANKQEDEVMR.3|PANKQEDEVM[Oxi]R.3|PANKQEDEVMR.2|AYLQQLR.2|PAYHSSLMDPDTK.3|PAYHSSLM[Oxi]DPDTK.3|PAYHSSLMDPDTK.2|WWTC[CAM]FVK.2|AYLQQLRQETGLR.3|DTDIVDEAIYYFK.3|DTDIVDEAIYYFK.2|VFDPQNDKPSKWWTC[CAM]FVK.4|EM[Oxi]YTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAKPANKQEDEVMR.4|EMYTLGITNFPIPGEPGFPLNAIYAKPANK.3|SQGEKEMYTLGITNFPIPGEPGFPLNAIYAK.3
SEN / CTL,O00303,Eukaryotic translation initiation factor 3 subunit F,EIF3F,3.71,2.39,3.71E-04,3.86E-05,4.41E+00,"formation of translation preinitiation complex,translational initiation,regulation of translational initiation,protein deubiquitination,IRES-dependent viral translational initiation","translation initiation factor activity,thiol-dependent ubiquitin-specific protease activity,protein binding,translation initiation factor binding","cytosol,eukaryotic translation initiation factor 3 complex,membrane,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex,eukaryotic translation initiation factor 3 complex, eIF3m",12,16,32,LHPVILASIVDSYER.3|LHPVILASIVDSYER.2|LHPVILASIVDSYERR.3|LHPVILASIVDSYERR.4|TC[CAM]FSPNR.2|IGVDLIMK.2|IGVDLIM[Oxi]K.2|IGVDLIMK.1|VSADNTVGR.2|NMYELHK.2|YAYYDTER.2|VIGLSSDLQQVGGASAR.3|VIGLSSDLQQVGGASAR.2|VIGTLLGTVDK.2|KVSPNELILGWYATGHDITEHSVLIHEYYSR.6|KVSPNELILGWYATGHDITEHSVLIHEYYSR.5|KVSPNELILGWYATGHDITEHSVLIHEYYSR.4|AYVSTLMGVPGR.2|AYVSTLM[Oxi]GVPGR.2|FLMSLVNQVPK.2|FLM[Oxi]SLVNQVPK.2|EAPNPIHLTVDTSLQNGR.3|EAPNPIHLTVDTSLQNGR.2|TMGVMFTPLTVK.2|TM[Oxi]GVMFTPLTVK.2|TMGVM[Oxi]FTPLTVK.2|TM[Oxi]GVM[Oxi]FTPLTVK.2|VSPNELILGWYATGHDITEHSVLIHEYYSR.5|VSPNELILGWYATGHDITEHSVLIHEYYSR.4|HSVEVTNC[CAM]FSVPHNESEDEVAVDM[Oxi]EFAK.4|HSVEVTNC[CAM]FSVPHNESEDEVAVDMEFAK.4|HSVEVTNC[CAM]FSVPHNESEDEVAVDMEFAK.3
SEN / CTL,Q99536,Synaptic vesicle membrane protein VAT-1 homolog,VAT1,3.70,2.34,2.56E-07,4.07E-08,7.39E+00,"negative regulation of mitochondrial fusion,oxidation-reduction process","zinc ion binding,oxidoreductase activity","mitochondrial outer membrane,integral component of membrane,extracellular exosome",24,28,53,LQSRPAAPPAPGPGQLTLR.3|LQSRPAAPPAPGPGQLTLR.4|GVDIVMDPLGGSDTAK.2|GVDIVM[Oxi]DPLGGSDTAK.3|GVDIVMDPLGGSDTAK.3|GVDIVM[Oxi]DPLGGSDTAK.2|AC[CAM]GLNFADLMAR.2|AC[CAM]GLNFADLM[Oxi]AR.2|VLLVPGPEK.2|PAAPPAPGPGQLTLR.3|PAAPPAPGPGQLTLR.2|VVTYGMANLLTGPK.3|VVTYGMANLLTGPK.2|VVTYGM[Oxi]ANLLTGPK.2|ENGVTHPIDYHTTDYVDEIKK.5|ENGVTHPIDYHTTDYVDEIKK.4|ENGVTHPIDYHTTDYVDEIKK.3|HEALKENGVTHPIDYHTTDYVDEIKK.6|HEALKENGVTHPIDYHTTDYVDEIKK.5|HEALKENGVTHPIDYHTTDYVDEIKK.4|C[CAM]LVLTGFGGYDKVK.3|LLALYNQGHIKPHIDSVWPFEK.5|LLALYNQGHIKPHIDSVWPFEK.4|LLALYNQGHIKPHIDSVWPFEK.3|TVENVTVFGTASASKHEALK.4|TVENVTVFGTASASKHEALK.3|VKLQSRPAAPPAPGPGQLTLR.4|EVAEAATGEDASSPPPK.3|EVAEAATGEDASSPPPK.2|ENGVTHPIDYHTTDYVDEIK.4|ENGVTHPIDYHTTDYVDEIK.3|HEALKENGVTHPIDYHTTDYVDEIK.5|HEALKENGVTHPIDYHTTDYVDEIK.4|VLLVPGPEKEN.2|AVC[CAM]GFHLGYLDGEVELVSGVVAR.4|AVC[CAM]GFHLGYLDGEVELVSGVVAR.3|LLALYNQGHIK.2|TEAASDPQHPAASEGAAAAAASPPLLR.4|TEAASDPQHPAASEGAAAAAASPPLLR.3|C[CAM]LVLTGFGGYDK.2|LPPLPVTPGMEGAGVVIAVGEGVSDRK.4|LPPLPVTPGMEGAGVVIAVGEGVSDRK.3|PHIDSVWPFEK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.5|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.4|QGLYDRLPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDRK.4|TWWNQFSVTALQLLQANR.3|TVENVTVFGTASASK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.4|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.3|LPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDR.3|LPPLPVTPGMEGAGVVIAVGEGVSDR.3|EVAEAATGEDASSPPPKTEAASDPQHPAASEGAAAAAASPPLLR.4
SEN / CTL,P50990,T-complex protein 1 subunit theta,CCT8,3.70,2.19,4.89E-17,2.08E-17,1.67E+01,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,cell-cell adhesion,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,ATPase activity, coupled,unfolded protein binding,cadherin binding involved in cell-cell adhesion","zona pellucida receptor complex,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,cell-cell adherens junction,cilium,cell body,intermediate filament cytoskeleton,extracellular exosome",78,59,110,FAEAFEAIPR.2|NLRDIDEVSSLLR.3|NLRDIDEVSSLLR.2|DIDEVSSLLR.2|AIADTGANVVVTGGK.2|AIADTGANVVVTGGK.3|LFVTNDAATILRELEVQHPAAK.4|LFVTNDAATILR.2|LFVTNDAATILR.3|GSTDNLMDDIERAVDDGVNTFK.3|LATNAAVTVLR.2|IAVYSC[CAM]PFDGMITETK.2|IAVYSC[CAM]PFDGMITETK.3|IAVYSC[CAM]PFDGM[Oxi]ITETK.2|GSTDNLMDDIER.2|GSTDNLM[Oxi]DDIER.2|HFSGLEEAVYR.3|HFSGLEEAVYR.2|VADMALHYANK.3|VADM[Oxi]ALHYANK.3|VADMALHYANK.2|VADM[Oxi]ALHYANK.2|KFAEAFEAIPR.3|KFAEAFEAIPR.2|KAHEILPNLVC[CAM]C[CAM]SAK.4|KAHEILPNLVC[CAM]C[CAM]SAK.3|KAHEILPNLVC[CAM]C[CAM]SAK.2|TVGATALPR.2|ALAENSGVK.2|ILGSGISSSSVLHGMVFK.4|ILGSGISSSSVLHGMVFK.3|ILGSGISSSSVLHGM[Oxi]VFK.3|ILGSGISSSSVLHGM[Oxi]VFK.2|ILGSGISSSSVLHGMVFK.2|LVPGGGATEIELAK.3|LVPGGGATEIELAK.2|YNIMLVR.2|YNIM[Oxi]LVR.2|ETEGDVTSVKDAK.3|ETEGDVTSVKDAK.2|VDQIIMAK.2|VDQIIM[Oxi]AK.2|VDQIIMAKPAGGPKPPSGK.4|VDQIIMAKPAGGPKPPSGK.3|APGFAQMLK.2|APGFAQM[Oxi]LK.2|ILGSGISSSSVLHGMVFKK.4|ILGSGISSSSVLHGM[Oxi]VFKK.4|ILGSGISSSSVLHGMVFKK.3|NVGLDIEAEVPAVK.3|NVGLDIEAEVPAVK.2|MVINHLEK.2|M[Oxi]VINHLEK.2|PAGGPKPPSGK.2|RLVPGGGATEIELAK.3|RLVPGGGATEIELAK.2|DMLEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.2|DMLEAGILDTYLGK.2|NIQAC[CAM]KELAQTTR.3|NIQAC[CAM]KELAQTTR.2|HEKEDGAISTIVLR.3|HEKEDGAISTIVLR.2|ETEGDVTSVK.2|TAYGPNGMNK.2|TAYGPNGM[Oxi]NK.2|VADMALHYANKYNIMLVR.4|AHEILPNLVC[CAM]C[CAM]SAK.3|AHEILPNLVC[CAM]C[CAM]SAK.2|AVDDGVNTFK.2|ALAENSGVKANEVISK.3|ALAENSGVKANEVISK.2|QITSYGETC[CAM]PGLEQYAIKK.4|QITSYGETC[CAM]PGLEQYAIKK.3|QITSYGETC[CAM]PGLEQYAIKK.2|ELEVQHPAAK.2|KDWDDDQND.2|LYAVHQEGNK.2|EDGAISTIVLR.2|QYGNEVFLAK.2|TAEELMNFSK.2|TAEELM[Oxi]NFSK.2|KETEGDVTSVK.2|GEENLMDAQVK.2|GEENLM[Oxi]DAQVK.2|LIAQAC[CAM]VSIFPDSGHFNVDNIR.4|LIAQAC[CAM]VSIFPDSGHFNVDNIR.3|IGLSVSEVIEGYEIAC[CAM]R.3|IGLSVSEVIEGYEIAC[CAM]R.2|LYAVHQEGNKNVGLDIEAEVPAVK.4|LYAVHQEGNKNVGLDIEAEVPAVK.3|IGLSVSEVIEGYEIAC[CAM]RK.3|IGLSVSEVIEGYEIAC[CAM]RK.2|LATNAAVTVLRVDQIIMAK.3|LATNAAVTVLRVDQIIM[Oxi]AK.3|QITSYGETC[CAM]PGLEQYAIK.3|QITSYGETC[CAM]PGLEQYAIK.2|DMLEAGILDTYLGKYWAIK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEK.5|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.6|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.5|TAEELM[Oxi]NFSKGEENLMDAQVK.3|TAEELMNFSKGEENLM[Oxi]DAQVK.3|TAEELMNFSKGEENLMDAQVK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.4|LTPPVLEEM[Oxi]GHC[CAM]DSVYLSEVGDTQVVVFK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.3|LYAVHQEGNKNVGLDIEAEVPAVKDMLEAGILDTYLGK.5|NVGLDIEAEVPAVKDMLEAGILDTYLGK.3
SEN / CTL,O00154,Cytosolic acyl coenzyme A thioester hydrolase,ACOT7,3.70,2.19,4.17E-13,1.25E-13,1.29E+01,"coenzyme A biosynthetic process,long-chain fatty-acyl-CoA biosynthetic process,medium-chain fatty-acyl-CoA catabolic process,long-chain fatty-acyl-CoA catabolic process,medium-chain fatty acid biosynthetic process,palmitic acid biosynthetic process","fatty-acyl-CoA binding,protein binding,palmitoyl-CoA hydrolase activity,long-chain fatty acyl-CoA binding,protein homodimerization activity,acyl-CoA hydrolase activity,carboxylic ester hydrolase activity","nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",42,22,42,IMRPDDANVAGNVHGGTILK.4|IMRPDDANVAGNVHGGTILK.3|IM[Oxi]RPDDANVAGNVHGGTILK.4|IM[Oxi]RPDDANVAGNVHGGTILK.3|NVDKVLEVPPVVYSR.3|LMDEVAGIVAAR.2|LMDEVAGIVAAR.3|LM[Oxi]DEVAGIVAAR.2|MIEEAGAIISTR.2|MIEEAGAIISTR.3|M[Oxi]IEEAGAIISTR.2|ATLWYVPLSLK.2|TNIVTASVDAINFHDKIR.4|TNIVTASVDAINFHDKIR.3|TNIVTASVDAINFHDKIR.2|VLEVPPVVYSR.3|VLEVPPVVYSR.2|GC[CAM]VITISGR.2|SLPVPQLVPETEDEKKR.4|SLPVPQLVPETEDEKKR.3|RQGHAEPQP.2|KGC[CAM]VITISGR.2|SLPVPQLVPETEDEK.3|SLPVPQLVPETEDEK.2|AASAFFTYVSLSQEGR.3|AASAFFTYVSLSQEGR.2|TNIVTASVDAINFHDK.3|TNIVTASVDAINFHDK.2|SLPVPQLVPETEDEKK.3|HSVEVQVNVMSENILTGAK.3|HSVEVQVNVM[Oxi]SENILTGAK.3|HSVEVQVNVM[Oxi]SENILTGAK.2|HSVEVQVNVMSENILTGAK.2|ADLPPC[CAM]GAC[CAM]ITGR.2|SM[Oxi]EIEVLVDADPVVDSSQKR.3|SMEIEVLVDADPVVDSSQKR.3|SMEIEVLVDADPVVDSSQKR.2|NGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.6|NGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.5|WRNGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.6|TDFLSPMC[CAM]IGEVAHVSAEITYTSK.3|SMEIEVLVDADPVVDSSQK.2
SEN / CTL,P30050,60S ribosomal protein L12,RPL12,3.69,2.06,1.69E-14,5.80E-15,1.42E+01,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,rRNA binding,poly(A) RNA binding","nucleolus,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",36,9,17,QAQIEVVPSASALIIK.2|QAQIEVVPSASALIIK.3|HSGNITFDEIVNIAR.3|HSGNITFDEIVNIAR.2|HSGNITFDEIVNIAR.4|C[CAM]TGGEVGATSALAPK.2|C[CAM]TGGEVGATSALAPK.3|NIKHSGNITFDEIVNIAR.4|NIKHSGNITFDEIVNIAR.3|KVGDDIAK.2|IGPLGLSPK.2|EILGTAQSVGC[CAM]NVDGR.3|EILGTAQSVGC[CAM]NVDGR.2|ELSGTIKEILGTAQSVGC[CAM]NVDGR.4|ELSGTIKEILGTAQSVGC[CAM]NVDGR.3|HPHDIIDDINSGAVEC[CAM]PAS.3|HPHDIIDDINSGAVEC[CAM]PAS.2
SEN / CTL,P62820,Ras-related protein Rab-1A,RAB1A,3.68,1.94,1.16E-05,1.50E-06,5.82E+00,"autophagosome assembly,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,endocytosis,autophagy,Golgi organization,small GTPase mediated signal transduction,vesicle-mediated transport,cell migration,virion assembly,growth hormone secretion,melanosome transport,substrate adhesion-dependent cell spreading,defense response to bacterium,vesicle transport along microtubule,COPII vesicle coating,interleukin-8 secretion,cargo loading into COPII-coated vesicle,cell-cell adhesion,positive regulation of glycoprotein metabolic process,cilium assembly,establishment of endothelial intestinal barrier","GTPase activity,protein binding,GTP binding,cadherin binding involved in cell-cell adhesion","Golgi membrane,early endosome,endoplasmic reticulum membrane,Golgi apparatus,cytosol,cell-cell adherens junction,melanosome,extracellular exosome",12,9,19,KVVDYTTAKEFADSLGIPFLETSAK.4|KVVDYTTAKEFADSLGIPFLETSAK.3|TITSSYYR.2|RM[Oxi]GPGATAGGAEK.3|RMGPGATAGGAEK.2|RM[Oxi]GPGATAGGAEK.2|KVVDYTTAK.2|MGPGATAGGAEK.2|M[Oxi]GPGATAGGAEK.2|GAHGIIVVYDVTDQESFNNVK.4|GAHGIIVVYDVTDQESFNNVK.3|GAHGIIVVYDVTDQESFNNVK.2|NATNVEQSFMTMAAEIK.3|NATNVEQSFM[Oxi]TMAAEIK.3|NATNVEQSFM[Oxi]TMAAEIK.2|NATNVEQSFMTMAAEIK.2|NATNVEQSFMTMAAEIKK.3|NATNVEQSFMTMAAEIKK.2|VVDYTTAKEFADSLGIPFLETSAK.3
SEN / CTL,P07711,Cathepsin L1,CTSL,3.67,0.90,1.52E-08,2.82E-09,8.55E+00,"toll-like receptor signaling pathway,adaptive immune response,proteolysis,antigen processing and presentation,antigen processing and presentation of exogenous peptide antigen via MHC class II,extracellular matrix disassembly,collagen catabolic process,proteolysis involved in cellular protein catabolic process,macrophage apoptotic process,cellular response to thyroid hormone stimulus","fibronectin binding,cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,cysteine-type peptidase activity,histone binding,proteoglycan binding,serpin family protein binding","extracellular region,extracellular space,nucleus,lysosome,endolysosome lumen,lysosomal lumen,extracellular exosome",12,9,13,VFQEPLFYEAPR.2|VFQEPLFYEAPR.3|NSWGEEWGMGGYVK.2|NSWGEEWGM[Oxi]GGYVK.2|MIELHNQEYR.3|MIELHNQEYR.2|RNHC[CAM]GIASAASYPTV.3|LYGMNEEGWR.2|NHC[CAM]GIASAASYPTV.2|AVATVGPISVAIDAGHESFLFYK.3|AVATVGPISVAIDAGHESFLFYK.2|NQGQC[CAM]GSC[CAM]WAFSATGALEGQMFR.3|NQGQC[CAM]GSC[CAM]WAFSATGALEGQMFRK.3
SEN / CTL,P13647,"Keratin, type II cytoskeletal 5",KRT5,3.67,2.28,9.20E-04,9.08E-05,4.04E+00,"cytoskeleton organization,epidermis development,hemidesmosome assembly","structural constituent of cytoskeleton,protein binding,scaffold protein binding","nucleus,cytoplasm,mitochondrion,cytosol,intermediate filament,plasma membrane,membrane,keratin filament,extracellular exosome",12,31,51,ISISTSGGSFR.2|SFSTASAITPSVSR.2|SFSTASAITPSVSR.3|RISISTSGGSFR.3|RISISTSGGSFR.2|SGGGGGGGFGR.2|TSFTSVSR.2|NTKHEISEMNR.3|NTKHEISEM[Oxi]NR.3|NTKHEISEMNR.2|NKLAELEEALQK.3|NKLAELEEALQK.2|SLYNLGGSK.2|TTAENEFVMLKK.3|TTAENEFVM[Oxi]LKK.3|TTAENEFVMLKK.2|TTAENEFVM[Oxi]LKK.2|VSLAGAC[CAM]GVGGYGSR.3|VSLAGAC[CAM]GVGGYGSR.2|FVSTTSSSR.2|SRTEAESWYQTK.3|SRTEAESWYQTK.2|HEISEMNR.2|HEISEM[Oxi]NR.2|LLREYQELMNTK.3|LLREYQELMNTK.2|AQYEEIANR.2|SLYNLGGSKR.2|LAELEEALQK.2|QC[CAM]ANLQNAIADAEQR.3|QC[CAM]ANLQNAIADAEQR.2|EYQELMNTK.2|EYQELM[Oxi]NTK.2|YEELQQTAGR.2|NMQDLVEDFK.2|NM[Oxi]QDLVEDFK.2|TEAESWYQTK.2|TTAENEFVMLK.2|TTAENEFVM[Oxi]LK.2|QC[CAM]ANLQNAIADAEQRGELALKDAR.4|SRTEAESWYQTKYEELQQTAGR.4|SRTEAESWYQTKYEELQQTAGR.3|VDALMDEINFMK.2|VDALM[Oxi]DEINFMK.2|VDALMDEINFM[Oxi]K.2|VDALM[Oxi]DEINFM[Oxi]K.2|GLGVGFGSGGGSSSSVK.2|QC[CAM]ANLQNAIADAEQRGELALK.3|NLDLDSIIAEVKAQYEEIANR.3|TEAESWYQTKYEELQQTAGR.3|MFFDAELSQMQTHVSDTSVVLSMDNNR.3
SEN / CTL,P52789,Hexokinase-2,HK2,3.67,2.74,1.03E-02,8.90E-04,3.05E+00,"cellular glucose homeostasis,response to ischemia,glycolytic process,lactation,apoptotic mitochondrial changes,glucose transport,negative regulation of mitochondrial membrane permeability,regulation of glucose import,carbohydrate phosphorylation,glucose 6-phosphate metabolic process,canonical glycolysis,establishment of protein localization to mitochondrion,maintenance of protein location in mitochondrion,positive regulation of mitophagy in response to mitochondrial depolarization,negative regulation of reactive oxygen species metabolic process","glucokinase activity,hexokinase activity,protein binding,ATP binding,glucose binding,fructokinase activity,mannokinase activity","mitochondrial outer membrane,cytosol,membrane",6,40,55,LSDETLLEISKR.3|GLGATTHPTAAVK.3|GLGATTHPTAAVK.2|VDQYLYHMR.3|VDQYLYHMR.2|HIDMVEGDEGR.3|HIDMVEGDEGR.2|STIGVDGSVYKK.3|STIGVDGSVYKK.2|EELLFGGK.2|LVPGC[CAM]DVR.2|ETHASAPVK.2|EVC[CAM]TVVAR.2|KLPLGFTFSFPC[CAM]HQTK.4|TLEHLQLSHDQLLEVK.4|TLEHLQLSHDQLLEVK.3|TLEHLQLSHDQLLEVK.2|IC[CAM]QIVSTR.2|DISDIEGEK.2|SASLC[CAM]AATLAAVLQR.3|SASLC[CAM]AATLAAVLQR.2|WGGVEMHNK.2|LSPELLNTGRFETK.3|LSPELLNTGRFETK.2|GAALITAVAC[CAM]R.2|LSPELLNTGR.2|GSGTQLFDHIAEC[CAM]LANFMDK.4|GSGTQLFDHIAEC[CAM]LANFMDK.3|GSGTQLFDHIAEC[CAM]LANFMDK.2|STIGVDGSVYK.2|LGLDPTQEDC[CAM]VATHR.3|LGLDPTQEDC[CAM]VATHR.2|VTVGVDGTLYK.2|LPLGFTFSFPC[CAM]HQTK.3|NVELVEGEEGR.2|FLSQIESDC[CAM]LALLQVR.3|FLSQIESDC[CAM]LALLQVR.2|LSDETLLEISK.2|VEMENQIYAIPEDIMR.3|VEMENQIYAIPEDIMR.2|LDESFLVSWTK.2|VMHETVKDLAPK.2|MISGMYMGELVR.2|AILQHLGLESTC[CAM]DDSIIVK.3|AILQHLGLESTC[CAM]DDSIIVK.2|DISDIEGEKDGIR.2|AAQLC[CAM]GAGMAAVVDR.2|ASGC[CAM]EGEDVVTLLK.2|C[CAM]DVSFLQSEDGSGK.2|STPDGTEHGEFLALDLGGTNFR.3|MLPTYVC[CAM]ATPDGTEK.2|M[Oxi]LPTYVC[CAM]ATPDGTEK.2|TEFDVAVDELSLNPGK.2|TEFDQEIDMGSLNPGK.2|GVSLPLGFTFSFPC[CAM]QQNSLDESILLK.3
SEN / CTL,Q12906,Interleukin enhancer-binding factor 3,ILF3,3.66,1.84,5.33E-05,6.34E-06,5.20E+00,"transcription, DNA-templated,protein phosphorylation,negative regulation of translation,negative regulation of viral genome replication,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,defense response to virus","DNA binding,RNA binding,double-stranded RNA binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrion,membrane,intracellular ribonucleoprotein complex",12,70,118,VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EKEATDAIGHLDR.4|HSSVYPTQEELEAVQNMVSHTER.4|HSSVYPTQEELEAVQNMVSHTER.5|HSSVYPTQEELEAVQNM[Oxi]VSHTER.4|HSSVYPTQEELEAVQNM[Oxi]VSHTER.3|HSSVYPTQEELEAVQNMVSHTER.3|EATDAIGHLDR.3|EATDAIGHLDR.2|RPMEEDGEEK.3|RPMEEDGEEK.2|RPMEEDGEEKSPSK.4|RPMEEDGEEKSPSK.3|SC[CAM]VIVIR.2|LNQLKPGLQYK.3|LNQLKPGLQYK.2|PTTALLDK.2|AEPPQAMNALMR.3|AEPPQAMNALMR.2|AEPPQAMNALM[Oxi]R.2|EPPLSLTIHLTSPVVR.4|EPPLSLTIHLTSPVVR.3|EPPLSLTIHLTSPVVR.2|IFVNDDR.2|SIGTANRPMGAGEALRR.4|QQREDITQSAQHALR.4|QQREDITQSAQHALR.3|QQREDITQSAQHALR.2|EDITQSAQHALR.3|EDITQSAQHALR.2|HGKNPVMELNEK.3|HGKNPVM[Oxi]ELNEK.3|HGKNPVMELNEK.2|KEEKAEPPQAMNALMR.4|VPTWGPLR.2|FNYSGSGGR.2|NADHSM[Oxi]NYQYR.3|NADHSMNYQYR.3|NADHSMNYQYR.2|NADHSM[Oxi]NYQYR.2|GLKYELISETGGSHDKR.4|GLKYELISETGGSHDKR.3|IFVNDDRHVMAK.3|IFVNDDRHVMAK.2|RFVMEVEVDGQK.3|RFVMEVEVDGQK.2|VLQDMGLPTGAEGR.3|VLQDMGLPTGAEGR.2|VLQDM[Oxi]GLPTGAEGR.2|YELISETGGSHDK.3|YELISETGGSHDK.2|C[CAM]LAALASLR.2|EGAGEQKTEHMTR.3|LAAFGQLHK.2|AYAALAALEK.2|LFPDTPLALDANKK.3|LFPDTPLALDANKK.2|DSSKGEDSAEETEAK.3|NTKEPPLSLTIHLTSPVVR.4|NTKEPPLSLTIHLTSPVVR.3|VLGMDPLPSK.2|VLGM[Oxi]DPLPSK.2|YELISETGGSHDKR.3|YELISETGGSHDKR.2|NPVMELNEK.2|SIGTANRPM[Oxi]GAGEALR.3|SIGTANRPMGAGEALR.3|SIGTANRPMGAGEALR.2|NTKEPPLSLTIHLTSPVVREEMEK.5|NTKEPPLSLTIHLTSPVVREEMEK.4|EKPTTALLDK.2|EEKAEPPQAMNALMR.3|GLKYELISETGGSHDK.3|RPMEEDGEEKSPSKK.3|EPPLSLTIHLTSPVVREEM[Oxi]EK.4|EPPLSLTIHLTSPVVREEMEK.4|EPPLSLTIHLTSPVVREEMEK.3|GWPLELLC[CAM]EK.2|VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.4|VLEC[CAM]LASGIVM[Oxi]PDGSGIYDPC[CAM]EK.3|VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.3|AYAALAALEKLFPDTPLALDANKK.4|VLAGETLSVNDPPDVLDR.3|VLAGETLSVNDPPDVLDR.2|FVMEVEVDGQK.2|AVSDWIDEQEK.2|GDLDLELVLLC[CAM]K.2|GSSEQAESDNMDVPPEDDSK.3|GSSEQAESDNMDVPPEDDSK.2|LFPDTPLALDANK.2|VLAGETLSVNDPPDVLDRQK.3|KQPHGGQQKPSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.6|KQPHGGQQKPSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.5|EKPTTALLDKVADNLAIQLAAVTEDKYEILQSVDDAAIVIK.6|EKPTTALLDKVADNLAIQLAAVTEDKYEILQSVDDAAIVIK.5|AYAALAALEKLFPDTPLALDANK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSK.4|LVSQTGPVHAPIFTM[Oxi]SVEVDGNSFEASGPSK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSKK.4|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSKK.3|PAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.4|PAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.3|VADNLAIQLAAVTEDKYEILQSVDDAAIVIK.4|VADNLAIQLAAVTEDKYEILQSVDDAAIVIK.3|VADNLAIQLAAVTEDK.2|YEILQSVDDAAIVIK.2|NENPVDYTVQIPPSTTYAITPMK.3|PSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.4|PSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.3|QGGYSQSNYNSPGSGQNYSGPPSSYQSSQGGYGR.4|QGGYSQSNYNSPGSGQNYSGPPSSYQSSQGGYGR.3|QKGYNHGQGSYSYSNSYNSPGGGGGSDYNYESK.4|RVLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.3|GSSEQAESDNMDVPPEDDSKEGAGEQK.3|DSSKGEDSAEETEAKPAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.5|SGGNSYGSGGASYNPGSHGGYGGGSGGGSSYQGK.3|GEDSAEETEAKPAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.4|GYNHGQGSYSYSNSYNSPGGGGGSDYNYESK.3
SEN / CTL,O75533,Splicing factor 3B subunit 1,SF3B1,3.65,2.08,2.96E-03,2.73E-04,3.56E+00,"spliceosomal complex assembly,RNA splicing, via transesterification reactions,mRNA splicing, via spliceosome,positive regulation of gene expression, epigenetic","mRNA binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex,U2 snRNP,U12-type spliceosomal complex,nuclear speck,U11/U12 snRNP,U2-type prespliceosome,catalytic step 2 spliceosome",6,77,139,VVNGAAASQPPSK.2|THEDIEAQIR.3|THEDIEAQIR.2|VRQQAADLISR.3|VRQQAADLISR.2|GAEYVSAR.2|VLPPPAGYVPIR.3|VLPPPAGYVPIR.2|GDTPGHATPGHGGATSSAR.4|GDTPGHATPGHGGATSSAR.3|IVDDLKDEAEQYRK.4|IVDDLKDEAEQYRK.3|IVDDLKDEAEQYRK.2|EFQSPDEEMKK.3|IMGNLGAADIDHK.3|IMGNLGAADIDHK.2|LDDLVRPYVHK.3|LDDLVRPYVHK.2|IWDPTPSHTPAGAATPGR.4|IWDPTPSHTPAGAATPGR.3|LDPFADGGK.2|TERDTPGHGSGWAETPR.4|TERDTPGHGSGWAETPR.3|TYMDVMR.2|VGAAEIISR.2|VVNGAAASQPPSKR.3|IYNDDKNTYIR.3|IYNDDKNTYIR.2|TMIISPER.2|DTPGHGSGWAETPR.3|DTPGHGSGWAETPR.2|LDPFADGGKTPDPK.3|EVMLILIR.2|MVMETIEK.2|KLSSWDQAETPGHTPSLR.4|KLSSWDQAETPGHTPSLR.3|KLSSWDQAETPGHTPSLR.2|KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.7|KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.6|KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.5|KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.4|KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.3|QQAADLISR.2|WDQTADQTPGATPK.3|WDQTADQTPGATPK.2|IVQQIAILMGC[CAM]AILPHLR.4|IVQQIAILMGC[CAM]AILPHLR.3|IVQQIAILM[Oxi]GC[CAM]AILPHLR.3|SLVEIIEHGLVDEQQKVR.4|IVDDLKDEAEQYR.3|IVDDLKDEAEQYR.2|PYLPQIC[CAM]GTVLWR.3|PYLPQIC[CAM]GTVLWR.2|AIVNVIGMHK.2|AIVNVIGM[Oxi]HK.2|GSETPGATPGSK.2|AIGPHDVLATLLNNLKVQER.4|AIGPHDVLATLLNNLKVQER.3|IYNSIYIGSQDALIAHYPR.4|IYNSIYIGSQDALIAHYPR.3|IYNSIYIGSQDALIAHYPR.2|TEILPPFFK.2|RWDQTADQTPGATPK.3|RWDQTADQTPGATPK.2|AIGPHDVLATLLNNLK.3|AIGPHDVLATLLNNLK.2|MLQYC[CAM]LQGLFHPAR.3|M[Oxi]LQYC[CAM]LQGLFHPAR.3|MLQYC[CAM]LQGLFHPAR.2|TDRGGDSIGETPTPGASK.3|TDRGGDSIGETPTPGASK.2|ATVNTFGYIAK.2|IWDPTPSHTPAGAATPGRGDTPGHATPGHGGATSSAR.6|IWDPTPSHTPAGAATPGRGDTPGHATPGHGGATSSAR.5|IWDPTPSHTPAGAATPGRGDTPGHATPGHGGATSSAR.4|KLTATPTPLGGMTGFHMQTEDR.4|KLTATPTPLGGM[Oxi]TGFHMQTEDR.4|KLTATPTPLGGMTGFHM[Oxi]QTEDR.4|KLTATPTPLGGM[Oxi]TGFHMQTEDR.3|KLTATPTPLGGMTGFHMQTEDR.3|LLVDVDESTLSPEEQK.3|LLVDVDESTLSPEEQK.2|RRWDQTADQTPGATPK.3|SLVEIIEHGLVDEQQK.3|SLVEIIEHGLVDEQQK.2|TMIISPERLDPFADGGK.3|TMIISPERLDPFADGGK.2|VKPYLPQIC[CAM]GTVLWR.3|LSSWDQAETPGHTPSLR.3|AFAVVASALGIPSLLPFLK.3|AFAVVASALGIPSLLPFLK.2|IC[CAM]FELLELLK.2|AKGSETPGATPGSK.2|VQENC[CAM]IDLVGR.2|DYIYAVTPLLEDALMDRDLVHR.4|VPELNVQNGVLK.2|DYIYAVTPLLEDALMDR.3|DYIYAVTPLLEDALM[Oxi]DR.3|DYIYAVTPLLEDALMDR.2|QLVDTTVELANK.2|ILVVIEPLLIDEDYYAR.3|ILVVIEPLLIDEDYYAR.2|WDETPASQMGGSTPVLTPGK.3|WDETPASQMGGSTPVLTPGK.2|GGDSIGETPTPGASK.2|LLVDVDESTLSPEEQKER.3|LLVDVDESTLSPEEQKER.2|NRPLSDEELDAMFPEGYK.3|NRPLSDEELDAM[Oxi]FPEGYK.3|NRPLSDEELDAMFPEGYK.2|QLVDTTVELANKVGAAEIISR.3|AIGYLIPLMDAEYANYYTR.3|AIGYLIPLMDAEYANYYTR.2|LTATPTPLGGMTGFHMQTEDR.3|AREFGAGPLFNQILPLLMSPTLEDQER.4|AREFGAGPLFNQILPLLM[Oxi]SPTLEDQER.3|AREFGAGPLFNQILPLLMSPTLEDQER.3|SRWDETPASQMGGSTPVLTPGK.3|FAGYVTSIAATELEDDDDDYSSSTSLLGQK.4|FAGYVTSIAATELEDDDDDYSSSTSLLGQK.3|QC[CAM]C[CAM]GTDGVEANYIK.2|SLSFLFEYIGEM[Oxi]GK.2|SLSFLFEYIGEMGK.2|TPIGTPAMNMATPTPGHIMSMTPEQLQAWR.4|TPIGTPAM[Oxi]NMATPTPGHIMSMTPEQLQAWR.4|TPIGTPAMNM[Oxi]ATPTPGHIMSMTPEQLQAWR.4|TPIGTPAM[Oxi]NMATPTPGHIMSMTPEQLQAWR.3|TPIGTPAMNM[Oxi]ATPTPGHIMSMTPEQLQAWR.3|TPIGTPAMNMATPTPGHIM[Oxi]SMTPEQLQAWR.3|TPIGTPAMNMATPTPGHIMSMTPEQLQAWR.3|AAGLATMISTMRPDIDNMDEYVR.3|SVNDQPSGNLPFLKPDDIQYFDK.3|QC[CAM]C[CAM]GTDGVEANYIKTEILPPFFK.3|EFGAGPLFNQILPLLMSPTLEDQER.3|EFGAGPLFNQILPLLM[Oxi]SPTLEDQER.3|AALDEAQGVGLDSTGYYDQEIYGGSDSR.3|KAALDEAQGVGLDSTGYYDQEIYGGSDSR.3|SRWDETPASQMGGSTPVLTPGKTPIGTPAM[Oxi]NMATPTPGHIMSMTPEQLQAWR.5|SRWDETPASQMGGSTPVLTPGKTPIGTPAMNMATPTPGHIMSMTPEQLQAWR.5
SEN / CTL,Q9H173,Nucleotide exchange factor SIL1,SIL1,3.64,1.30,9.10E-04,9.02E-05,4.04E+00,"protein folding,intracellular protein transport",unfolded protein binding,"extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen",6,9,11,RLDINTNTYTSQDLK.3|RLDINTNTYTSQDLK.2|LGGLQVLR.2|VLQTLGVLLTTC[CAM]R.3|VLQTLGVLLTTC[CAM]R.2|VLFALC[CAM]SLLR.2|VQVEAIEGGALQK.2|VVTLLYDLVTEK.2|LLVILATEQPLTAK.2|LDINTNTYTSQDLK.2|QVHLLPGLWEQGWC[CAM]EITAHLLALPEHDAR.4
SEN / CTL,P28838,Cytosol aminopeptidase,LAP3,3.62,1.65,2.55E-11,6.37E-12,1.12E+01,proteolysis,"aminopeptidase activity,metalloexopeptidase activity,manganese ion binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,trans-Golgi network,focal adhesion,extracellular exosome",24,44,80,QVVDC[CAM]QLADVNNIGKYR.3|GITFDSGGISIK.2|TFYGLHQDFPSVVLVGLGKK.4|TFYGLHQDFPSVVLVGLGKK.3|LNLPINIIGLAPLC[CAM]ENMPSGK.3|LNLPINIIGLAPLC[CAM]ENM[Oxi]PSGK.3|LNLPINIIGLAPLC[CAM]ENM[Oxi]PSGK.2|LNLPINIIGLAPLC[CAM]ENMPSGK.2|FAEIIEK.2|KAAGIDEQENWHEGK.4|KAAGIDEQENWHEGK.3|EFVTHPK.2|TIQVDNTDAEGR.3|TIQVDNTDAEGR.2|LILADALC[CAM]YAHTFNPK.4|LILADALC[CAM]YAHTFNPK.3|LILADALC[CAM]YAHTFNPK.2|GLVLGIYSK.2|ANKPGDVVR.2|LRETLNISGPPLK.3|LRETLNISGPPLK.2|TEVHIRPK.2|WAHLDIAGVMTNK.3|WAHLDIAGVMTNK.2|TRTFYGLHQDFPSVVLVGLGKK.5|TRTFYGLHQDFPSVVLVGLGKK.4|WAHLDIAGVMTNKDEVPYLRK.5|WAHLDIAGVMTNKDEVPYLRK.4|WAHLDIAGVM[Oxi]TNKDEVPYLRK.4|WAHLDIAGVMTNKDEVPYLRK.3|SAGAC[CAM]TAAAFLKEFVTHPK.4|TLIEFLLR.2|ASANMDLMR.2|ASANM[Oxi]DLMR.2|ASANMDLM[Oxi]R.2|GSPNANEPPLVFVGK.3|GSPNANEPPLVFVGK.2|AAGIDEQENWHEGKENIR.4|AAGIDEQENWHEGKENIR.3|AAGIDEQENWHEGKENIR.2|TFYGLHQDFPSVVLVGLGK.4|TFYGLHQDFPSVVLVGLGK.3|TFYGLHQDFPSVVLVGLGK.2|AAGIDEQENWHEGK.3|AAGIDEQENWHEGK.2|GSDEPPVFLEIHYK.3|GSDEPPVFLEIHYK.2|QLMETPANEMTPTR.3|QLM[Oxi]ETPANEMTPTR.2|QLMETPANEM[Oxi]TPTR.2|QLMETPANEMTPTR.2|KAAGIDEQENWHEGKENIR.4|QVVDC[CAM]QLADVNNIGK.3|QVVDC[CAM]QLADVNNIGK.2|ADMGGAATIC[CAM]SAIVSAAK.3|ADMGGAATIC[CAM]SAIVSAAK.2|ADM[Oxi]GGAATIC[CAM]SAIVSAAK.2|ETLNISGPPLK.2|SAGAC[CAM]TAAAFLK.2|TRTFYGLHQDFPSVVLVGLGK.4|TRTFYGLHQDFPSVVLVGLGK.3|WAHLDIAGVM[Oxi]TNKDEVPYLR.4|WAHLDIAGVMTNKDEVPYLR.4|WAHLDIAGVMTNKDEVPYLR.3|SWIEEQAMGSFLSVAK.3|SWIEEQAMGSFLSVAK.2|MPLFEHYTR.2|GVLFASGQNLAR.2|LFEASIETGDR.2|TIQVDNTDAEGRLILADALC[CAM]YAHTFNPK.5|TIQVDNTDAEGRLILADALC[CAM]YAHTFNPK.4|EKEDDVPQFTSAGENFDKLLAGK.4|EKEDDVPQFTSAGENFDKLLAGK.3|EKEDDVPQFTSAGENFDK.3|EKEDDVPQFTSAGENFDK.2|LYGSGDQEAWQK.2|LYGSGDQEAWQKGVLFASGQNLAR.3|EDDVPQFTSAGENFDK.2|QIQDLELSSVEVDPC[CAM]GDAQAAAEGAVLGLYEYDDLK.4|VILNAATLTGAMDVALGSGATGVFTNSSWLWNK.3
SEN / CTL,P21810,Biglycan,BGN,3.62,1.52,3.99E-27,3.99E-27,2.64E+01,"blood vessel remodeling,negative regulation of protein kinase activity,biological_process,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,negative regulation of JAK-STAT cascade","protein kinase inhibitor activity,extracellular matrix structural constituent,glycosaminoglycan binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,cytoplasm,Golgi lumen,cell surface,transport vesicle,sarcolemma,lysosomal lumen,extracellular exosome,extracellular matrix",60,23,37,LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.6|LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.5|LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.4|SVPKEISPDTTLLDLQNNDISELRK.4|VVQC[CAM]SDLGLK.2|VGVNDFC[CAM]PMGFGVK.2|VGVNDFC[CAM]PM[Oxi]GFGVK.2|DLPETLNELHLDHNKIQAIELEDLLR.5|DLPETLNELHLDHNKIQAIELEDLLR.4|DLPETLNELHLDHNKIQAIELEDLLR.3|IQAIELEDLLR.2|AYYNGISLFNNPVPYWEVQPATFR.3|AYYNGISLFNNPVPYWEVQPATFR.4|NHLVEIPPNLPSSLVELR.3|NHLVEIPPNLPSSLVELR.2|GLQHLYALVLVNNK.3|GLQHLYALVLVNNK.2|ELHLDNNKLAR.3|DLPETLNELHLDHNK.4|DLPETLNELHLDHNK.3|DLPETLNELHLDHNK.2|VPSGLPDLK.2|LGLGHNQIR.2|DDFKGLQHLYALVLVNNK.4|DDFKGLQHLYALVLVNNK.3|LAIQFGNYK.2|VGVNDFC[CAM]PM[Oxi]GFGVKR.3|DDFKGLQHLYALVLVNNKISK.4|EISPDTTLLDLQNNDISELRK.4|EISPDTTLLDLQNNDISELRK.3|LYISKNHLVEIPPNLPSSLVELR.4|RAYYNGISLFNNPVPYWEVQPATFR.4|RAYYNGISLFNNPVPYWEVQPATFR.3|EISPDTTLLDLQNNDISELR.3|EISPDTTLLDLQNNDISELR.2|C[CAM]VTDRLAIQFGNYK.2|NMNC[CAM]IEMGGNPLENSGFEPGAFDGLK.3
SEN / CTL,O75396,Vesicle-trafficking protein SEC22b,SEC22B,3.61,2.17,2.28E-04,2.44E-05,4.61E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,protein transport,regulation of organelle organization,positive regulation of protein catabolic process,COPII vesicle coating,vesicle fusion with Golgi apparatus,exocytosis","SNARE binding,SNAP receptor activity,protein binding,syntaxin binding","Golgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,ER to Golgi transport vesicle membrane,integral component of membrane,transport vesicle,SNARE complex,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome",12,15,21,NLGSINTELQDVQR.2|IMVANIEEVLQR.2|IMVANIEEVLQR.3|IM[Oxi]VANIEEVLQR.2|VLLTMIAR.2|VLLTM[Oxi]IAR.2|ANNLSSLSK.2|LNEQSPTR.2|GEALSALDSK.2|KLNEQSPTR.2|RNLGSINTELQDVQR.3|RNLGSINTELQDVQR.2|DLQQYQSQAK.2|KVPTVSRPYSFIEFDTFIQK.4|KVPTVSRPYSFIEFDTFIQK.3|VADGLPLAASMQEDEQSGR.3|VADGLPLAASMQEDEQSGR.2|VPTVSRPYSFIEFDTFIQK.3|IMVANIEEVLQRGEALSALDSK.3|PYSFIEFDTFIQK.2|VADGLPLAASMQEDEQSGRDLQQYQSQAK.3
SEN / CTL,Q8TF09;Q9NP97,Dynein light chain roadblock-type 2;Dynein light chain roadblock-type 1,DYNLRB2;DYNLRB1,3.61,0.75,3.17E-09,6.28E-10,9.20E+00,"transport,microtubule-based movement;transport,microtubule-based movement,visual behavior","microtubule motor activity,dynein intermediate chain binding;microtubule motor activity,dynein intermediate chain binding","cytoplasm,cytoplasmic dynein complex,microtubule,dynein complex,extracellular exosome,ciliary tip;cytoplasm,centrosome,cytoplasmic dynein complex,microtubule,membrane,dynein complex,ciliary tip",12,2,3,STVRDIDPQNDLTFLR.3|DIDPQNDLTFLR.2|DIDPQNDLTFLR.3
SEN / CTL,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,3.60,2.05,1.08E-06,1.59E-07,6.80E+00,"renal water homeostasis,blood coagulation,activation of protein kinase A activity,intracellular signal transduction,cellular response to glucagon stimulus,negative regulation of cAMP-dependent protein kinase activity","cAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit binding","cytoplasm,centrosome,cytosol,plasma membrane,focal adhesion,cAMP-dependent protein kinase complex,membrane,nucleotide-activated protein kinase complex,plasma membrane raft,extracellular exosome,ciliary base",18,22,29,NLDQEQLSQVLDAMFER.3|NLDQEQLSQVLDAMFER.2|MFESFIESVPLLK.2|MFESFIESVPLLK.3|M[Oxi]FESFIESVPLLK.2|QQPPDLVEFAVEYFTR.3|QQPPDLVEFAVEYFTR.2|SLEVSER.2|SVGQYDNR.2|QSLGHPPPEPGPDR.3|GTYDILVTK.2|RNISHYEEQLVK.3|RNISHYEEQLVK.2|SNKDGGNQEVEIAR.3|AASAYAVGDVK.2|GTYDILVTKDNQTR.3|KMFESFIESVPLLK.3|APASVLPAATPR.2|DGGNQEVEIAR.2|LLGPC[CAM]MDIMK.2|MFGSSVDLGNLGQ.2|M[Oxi]FGSSVDLGNLGQ.2|C[CAM]LVMDVQAFER.2|NISHYEEQLVK.2|ADEHVIDQGDDGDNFYVIER.3|VSVC[CAM]AETYNPDEEEEDTDPR.3|VSVC[CAM]AETYNPDEEEEDTDPR.2|RVSVC[CAM]AETYNPDEEEEDTDPR.3|AATIVATSEGSLWGLDR.2
SEN / CTL,O00244,Copper transport protein ATOX1,ATOX1,3.60,2.63,7.72E-04,7.71E-05,4.11E+00,"copper ion transport,cellular copper ion homeostasis,response to oxidative stress,intracellular copper ion transport,copper ion transmembrane transport","copper ion transmembrane transporter activity,copper ion binding,protein binding,metallochaperone activity,copper chaperone activity,copper-dependent protein binding",cytosol,18,11,18,PKHEFSVDMTC[CAM]GGC[CAM]AEAVSR.4|VC[CAM]IESEHSMDTLLATLKK.4|VC[CAM]IESEHSMDTLLATLKK.3|VC[CAM]IESEHSMDTLLATLK.3|VC[CAM]IESEHSMDTLLATLK.2|KVC[CAM]IESEHSMDTLLATLKK.5|KVC[CAM]IESEHSMDTLLATLKK.4|TVSYLGLE.2|LGGVKYDIDLPNK.3|LGGVKYDIDLPNK.2|YDIDLPNK.2|KVC[CAM]IESEHSMDTLLATLK.4|KVC[CAM]IESEHSMDTLLATLK.3|KVC[CAM]IESEHSMDTLLATLK.2|LGGVKYDIDLPNKK.3|LGGVKYDIDLPNKK.2|YDIDLPNKK.2|HEFSVDMTC[CAM]GGC[CAM]AEAVSR.3
SEN / CTL,P50479,PDZ and LIM domain protein 4,PDLIM4,3.60,1.87,7.09E-13,2.05E-13,1.27E+01,,"protein binding,zinc ion binding",,30,14,19,VKPPEGYDVVAVYPNAK.3|AALAALC[CAM]PGDLIQAINGESTELMTHLEAQNR.4|AALAALC[CAM]PGDLIQAINGESTELMTHLEAQNR.3|DFSAPLTISR.2|GYFFLDER.2|GC[CAM]HDHLTLSVSRPEGR.4|GC[CAM]HDHLTLSVSRPEGR.3|GPSPWGFR.2|LYC[CAM]ESHAK.2|MLREPAEPVAAEPK.3|VDLGSEVYR.2|SWPSAPDDSK.2|LGAPLSGLQGLPEC[CAM]TR.3|LGAPLSGLQGLPEC[CAM]TR.2|IHIDPEIQDGSPTTSR.3|IHIDPEIQDGSPTTSR.2|LYHPEC[CAM]FMC[CAM]SDC[CAM]GLNLK.3|YLQGMLEAGEGGDWPGPGGPR.3|YLQGMLEAGEGGDWPGPGGPR.2
SEN / CTL,Q13753,Laminin subunit gamma-2,LAMC2,3.59,0.64,3.59E-05,4.40E-06,5.36E+00,"cell adhesion,positive regulation of cell proliferation,epidermis development,extracellular matrix disassembly,extracellular matrix organization,positive regulation of cell migration,hemidesmosome assembly",heparin binding,"extracellular region,laminin-2 complex,extracellular space,cell cortex,membrane,perinuclear region of cytoplasm",6,14,15,AQGGDGVVPDTELEGR.2|GGRHPSAHDVILEGAGLR.4|GHLHLLETSIDGILADVK.4|GHLHLLETSIDGILADVK.3|KAEAEEAMK.2|ALGSAAADAQR.2|HQDVFSSAQR.2|LDPVYFVAPAK.2|EATQAEIEADR.2|NLGNWKEEAQQLLQNGK.3|TQINSQLRPMMSELEER.3|ALHEGVGSGSGSPDGAVVQGLVEK.3|AGYFGDPLAPNPADK.2|LQGVSDQSFQVEEAK.2|PGFGGPNC[CAM]EHGAFSC[CAM]PAC[CAM]YNQVK.3
SEN / CTL,Q92597,Protein NDRG1,NDRG1,3.59,1.93,3.82E-18,1.79E-18,1.77E+01,"negative regulation of cell proliferation,response to metal ion,DNA damage response, signal transduction by p53 class mediator,peripheral nervous system myelin maintenance,regulation of apoptotic process,mast cell activation,cellular response to hypoxia,positive regulation of spindle checkpoint,cell-cell adhesion","protein binding,microtubule binding,Rab GTPase binding,gamma-tubulin binding,cadherin binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,centrosome,cytosol,microtubule,plasma membrane,cell-cell adherens junction,microtubule cytoskeleton,myelin sheath,perinuclear region of cytoplasm,recycling endosome membrane,extracellular exosome",48,18,49,SIIGMGTGAGAYILTR.2|SIIGMGTGAGAYILTR.3|SIIGM[Oxi]GTGAGAYILTR.3|SIIGM[Oxi]GTGAGAYILTR.2|TASGSSVTSLDGTR.2|SHTSEGAHLDITPNSGAAGNSAGPK.4|SHTSEGAHLDITPNSGAAGNSAGPK.3|SHTSEGAHLDITPNSGAAGNSAGPK.2|MADC[CAM]GGLPQISQPAK.2|MADC[CAM]GGLPQISQPAK.3|M[Oxi]ADC[CAM]GGLPQISQPAK.2|YFVQGMGYMPSASMTR.2|YFVQGMGYMPSASM[Oxi]TR.3|YFVQGM[Oxi]GYMPSASMTR.2|YFVQGMGYM[Oxi]PSASMTR.2|YFVQGMGYMPSASM[Oxi]TR.2|EMQDVDLAEVKPLVEK.3|EM[Oxi]QDVDLAEVKPLVEK.3|EMQDVDLAEVKPLVEK.2|QHIVNDMNPGNLHLFINAYNSR.4|QHIVNDM[Oxi]NPGNLHLFINAYNSR.4|QHIVNDM[Oxi]NPGNLHLFINAYNSR.3|QHIVNDMNPGNLHLFINAYNSR.3|EEMQSNVEVVHTYR.4|EEMQSNVEVVHTYR.3|EEM[Oxi]QSNVEVVHTYR.3|EEMQSNVEVVHTYR.2|GNRPVILTYHDIGM[Oxi]NHK.4|GNRPVILTYHDIGMNHK.4|GNRPVILTYHDIGMNHK.3|SRSHTSEGAHLDITPNSGAAGNSAGPK.5|SRSHTSEGAHLDITPNSGAAGNSAGPK.4|SRSHTSEGAHLDITPNSGAAGNSAGPK.3|SRTASGSSVTSLDGTR.3|SRTASGSSVTSLDGTR.2|ISGWTQALPDMVVSHLFGK.3|ISGWTQALPDM[Oxi]VVSHLFGK.3|ISGWTQALPDM[Oxi]VVSHLFGK.2|ISGWTQALPDMVVSHLFGK.2|ISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYR.5|ISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYR.4|LAEAFKYFVQGMGYMPSASMTR.3|DLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.5|DLEIERPM[Oxi]PGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|DLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|PMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|PMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.3|RDLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.5|GETITGLLQEFDVQEQDIETLHGSVHVTLC[CAM]GTPK.4
SEN / CTL,Q63ZY3,KN motif and ankyrin repeat domain-containing protein 2,KANK2,3.58,2.19,4.34E-02,3.55E-03,2.45E+00,"negative regulation of transcription from RNA polymerase II promoter,transcription, DNA-templated,apoptotic process,negative regulation of cell proliferation,negative regulation of intracellular estrogen receptor signaling pathway,negative regulation of programmed cell death,negative regulation of vitamin D receptor signaling pathway,negative regulation of G1/S transition of mitotic cell cycle",protein binding,"cytoplasm,mitochondrion",6,15,17,VAYTTVLQEWLR.2|SSGLSTPVPPSAGHLAHVR.4|STGRVPTQEPTHREPTR.4|EVEVVASTAAGAPAQR.3|EVEVVASTAAGAPAQR.2|ALQELQAAQAR.2|VPSVAEAPQLRPAGTAAAK.3|AQSLEPYGTGLR.2|YLDNPNALTER.2|GFYPQYGALETR.2|VVEGPREVEVVASTAAGAPAQR.3|ESQHIPTAEGASGSNTEEEIR.3|AGYSPIMLTALATLK.2|AGYSPIM[Oxi]LTALATLK.2|TQDDIETVLQLFR.2|ERDLGMPDGEAALAAK.2|MELSPDLISAC[CAM]LALEK.2
SEN / CTL,Q04826,"HLA class I histocompatibility antigen, B-40 alpha chain",HLA-B,3.58,1.47,6.16E-18,2.82E-18,1.75E+01,,,,36,5,6,APWIEQEGPEYWDRETQISK.3|SWTAADTAAQITQR.2|SWTAADTAAQITQR.3|DGEDQTQDTELVETRPAGDRTFQK.4|WAAVVVPSGEEQR.2|AYLEGEC[CAM]VEWLR.2
SEN / CTL,Q13641,Trophoblast glycoprotein,TPBG,3.57,1.85,4.72E-08,8.10E-09,8.09E+00,"cell adhesion,positive regulation of synapse assembly",,"endoplasmic reticulum,integral component of plasma membrane,cell surface",18,5,9,NLFLTGNQLAVLPAGAFAR.2|NLFLTGNQLAVLPAGAFAR.3|DVLAQLPSLR.2|AGAFEHLPSLR.3|AGAFEHLPSLR.2|RLELASNHFLYLPR.4|RLELASNHFLYLPR.3|SFEGMVVAALLAGR.3|SFEGMVVAALLAGR.2
SEN / CTL,Q14764,Major vault protein,MVP,3.54,1.99,3.10E-53,7.28E-53,5.21E+01,"protein transport,negative regulation of signaling,negative regulation of protein autophosphorylation,ERBB signaling pathway,mRNA transport,negative regulation of protein tyrosine kinase activity","protein binding,protein kinase binding,protein phosphatase binding","nucleus,nuclear pore,cytoplasm,cytoskeleton,membrane,intracellular ribonucleoprotein complex,perinuclear region of cytoplasm,extracellular exosome",180,78,128,VASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.4|VASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.3|QAIPLDENEGIYVQDVK.2|QAIPLDENEGIYVQDVK.3|SFFLQPGEQLEQGIQDVYVLSEQQGLLLR.3|SFFLQPGEQLEQGIQDVYVLSEQQGLLLR.4|ELELVYAR.2|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.4|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.5|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.6|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.4|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.5|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.3|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.6|LFSVPDFVGDAC[CAM]K.2|ALQPLEEGEDEEKVSHQAGDHWLIR.5|ALQPLEEGEDEEKVSHQAGDHWLIR.4|ALQPLEEGEDEEKVSHQAGDHWLIR.3|ALC[CAM]LLLGPDFFTDVITIETADHAR.3|RALC[CAM]LLLGPDFFTDVITIETADHAR.4|RALC[CAM]LLLGPDFFTDVITIETADHAR.3|TAVFGFETSEAKGPDGMALPRPR.4|SVQLAIEITTNSQEAAAKHEAQRLEQEAR.5|SVQLAIEITTNSQEAAAKHEAQRLEQEAR.4|VRELELVYAR.3|VRELELVYAR.2|VVFGPELVSLGPEEQFTVLSLSAGRPK.3|VVFGPELVSLGPEEQFTVLSLSAGRPK.4|VVFGPELVSLGPEEQFTVLSLSAGRPK.5|AQLELEVSK.2|IPPYHYIHVLDQNSNVSR.3|IPPYHYIHVLDQNSNVSR.4|VPHNAAVQVYDYR.3|VPHNAAVQVYDYR.2|GPLEYVPSAKVEVVEER.3|VRGAVASVTFDDFHKNSAR.4|VRGAVASVTFDDFHKNSAR.3|GAVASVTFDDFHKNSAR.4|LKAQALAIETEAELQR.3|LKAQALAIETEAELQR.2|LKAQALAIETEAELQR.4|AQQLAEVEVKK.3|AQQLAEVEVKK.2|VRGAVASVTFDDFHK.4|VRGAVASVTFDDFHK.3|VLFAPMR.2|HADLEIR.2|HYC[CAM]TVANPVSR.3|HYC[CAM]TVANPVSR.2|LLQSLGLK.2|VEVVEER.2|SLQPLAPR.2|VPHNAAVQVYDYREK.4|VPHNAAVQVYDYREK.3|GPDGMALPR.2|HEAQRLEQEAR.3|HEAQRLEQEAR.2|GAVASVTFDDFHK.3|GAVASVTFDDFHK.2|DITPLQVVLPNTALHLK.4|DITPLQVVLPNTALHLK.3|DITPLQVVLPNTALHLK.2|ALLDFEDK.2|VSHQAGDHWLIR.3|VSHQAGDHWLIR.2|AQALAIETEAELQR.3|AQALAIETEAELQR.2|ILDQSEAEK.2|FKQM[Oxi]TEAIGPSTIR.3|GPLEYVPSAK.2|EVEVVEIIQATIIR.3|EVEVVEIIQATIIR.2|GQDPLADRGEKDTAK.3|VVAGDEWLFEGPGTYIPRK.4|VVAGDEWLFEGPGTYIPRK.3|VVAGDEWLFEGPGTYIPRK.2|VVSYRVPHNAAVQVYDYR.4|VVSYRVPHNAAVQVYDYR.3|AEAARIEGEGSVLQAK.3|AEAARIEGEGSVLQAK.2|AQLELEVSKAQQLAEVEVKK.4|AQLELEVSKAQQLAEVEVKK.3|AQQLAEVEVK.2|IEGEGSVLQAK.2|LRHADLEIR.2|KEVEVVEIIQATIIR.3|KEVEVVEIIQATIIR.2|GPDGMALPRPR.2|VVSYRVPHNAAVQVYDYREK.4|LAQDPFPLYPGEVLEK.3|LAQDPFPLYPGEVLEK.2|VSHQAGDHWLIRGPLEYVPSAK.4|DLAVAGPEMQVK.2|DLAVAGPEM[Oxi]QVK.2|SVQLAIEITTNSQEAAAK.3|SVQLAIEITTNSQEAAAK.2|TAVFGFETSEAK.2|QMTEAIGPSTIR.2|QM[Oxi]TEAIGPSTIR.2|ELLELEALSMAVESTGTAK.3|ELLELEALSM[Oxi]AVESTGTAK.3|ELLELEALSM[Oxi]AVESTGTAK.2|ELLELEALSMAVESTGTAK.2|ELPPGVEELLNK.2|VVAGDEWLFEGPGTYIPR.3|VVAGDEWLFEGPGTYIPR.2|ALLDFEDKDGDK.2|AVIGSTYMLTQDEVLWEK.3|AVIGSTYM[Oxi]LTQDEVLWEK.2|AVIGSTYMLTQDEVLWEK.2|IPPYHYIHVLDQNSNVSRVEVGPK.4|KELLELEALSMAVESTGTAK.3|ALQPLEEGEDEEK.2|VRAVIGSTYMLTQDEVLWEK.3|DAQGLVLFDVTGQVR.2|STLITDGSTPINLFNTAFGLLGM[Oxi]GPEGQPLGR.4|STLITDGSTPINLFNTAFGLLGM[Oxi]GPEGQPLGR.3|SVQLAIEITTNSQEAAAKHEAQR.3|ALLDFEDKDGDKVVAGDEWLFEGPGTYIPR.4|ALLDFEDKDGDKVVAGDEWLFEGPGTYIPR.3|QMTEAIGPSTIRDLAVAGPEMQVK.3|VVFGPELVSLGPEEQFTVLSLSAGR.3|TGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.6|RTGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.6|RTGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.5|DQAVFPQNGLVVSSVDVQSVEPVDQR.3|VEVVEERQAIPLDENEGIYVQDVK.3|ARVVFGPELVSLGPEEQFTVLSLSAGRPK.3
SEN / CTL,Q8NBJ5,Procollagen galactosyltransferase 1,COLGALT1,3.53,1.51,3.20E-10,7.12E-11,1.01E+01,,procollagen galactosyltransferase activity,"endoplasmic reticulum lumen,membrane",18,30,43,NSDVLQSPLDSAARDEL.2|NAAHALPTTLGALER.3|NAAHALPTTLGALER.2|ALQAQEIEC[CAM]R.3|ALQAQEIEC[CAM]R.2|LVEAVDGK.2|HPVSEYK.2|VLIALLAR.2|HPPAEPSR.2|SLYHSVEWRPAEEPR.4|SLYHSVEWRPAEEPR.3|TPAYIPIR.2|LLAAEPLSK.2|MQVEHPEK.2|EGLDWDLIYVGRK.3|KLLAAEPLSK.2|TVVAPMLDSR.2|TVVAPM[Oxi]LDSR.2|SLVFEDDLR.2|MLPVDEFLPVMFDK.3|MLPVDEFLPVMFDK.2|M[Oxi]LPVDEFLPVMFDK.2|GELGC[CAM]FLSHYNIWK.3|GELGC[CAM]FLSHYNIWK.2|DPYHGRPLTK.2|MLPVDEFLPVMFDKHPVSEYK.4|MLPVDEFLPVMFDKHPVSEYK.3|AHSTLQDEAESFMHVQLEVMVK.4|AHSTLQDEAESFMHVQLEVMVK.3|WSPESPLQAPR.2|EEYGFLPVPLR.2|GC[CAM]FAVPM[Oxi]VHSTFLIDLR.3|GC[CAM]FAVPMVHSTFLIDLR.3|GC[CAM]FAVPM[Oxi]VHSTFLIDLR.2|AAYSNFWC[CAM]GMTSQGYYK.3|AAYSNFWC[CAM]GMTSQGYYK.2|QAEVQMYVC[CAM]NK.2|EGLDWDLIYVGR.2|MGFDEVFMINLR.2|NSDVLQSPLDSAAR.2|NLHAFSVEPLLIYPTHYTGDDGYVSDTETSVVWNNEHVK.5|NLHAFSVEPLLIYPTHYTGDDGYVSDTETSVVWNNEHVK.4|QAEVQMYVC[CAM]NKEEYGFLPVPLR.3
SEN / CTL,P06733,Alpha-enolase,ENO1,3.50,2.38,8.80E-80,3.39E-79,7.85E+01,"gluconeogenesis,transcription, DNA-templated,response to virus,negative regulation of cell growth,negative regulation of transcription, DNA-templated,canonical glycolysis,cell-cell adhesion","magnesium ion binding,DNA binding,phosphopyruvate hydratase activity,protein binding,poly(A) RNA binding,GTPase binding,cadherin binding involved in cell-cell adhesion","phosphopyruvate hydratase complex,extracellular space,nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,M band,extracellular exosome",390,52,112,AAVPSGASTGIYEALELRDNDKTR.4|AAVPSGASTGIYEALELRDNDKTR.3|VNQIGSVTESLQAC[CAM]K.2|VNQIGSVTESLQAC[CAM]K.3|SFIKDYPVVSIEDPFDQDDWGAWQK.3|SFIKDYPVVSIEDPFDQDDWGAWQK.4|YNQLLRIEEELGSK.3|YNQLLRIEEELGSK.2|GNPTVEVDLFTSK.2|GNPTVEVDLFTSK.3|EIFDSRGNPTVEVDLFTSK.3|EIFDSRGNPTVEVDLFTSK.2|EIFDSRGNPTVEVDLFTSK.4|YISPDQLADLYK.2|YISPDQLADLYK.3|YGKDATNVGDEGGFAPNILENKEGLELLK.4|YGKDATNVGDEGGFAPNILENKEGLELLK.3|YGKDATNVGDEGGFAPNILENKEGLELLK.5|FTASAGIQVVGDDLTVTNPKR.3|FTASAGIQVVGDDLTVTNPKR.4|FTASAGIQVVGDDLTVTNPKR.2|SGKYDLDFKSPDDPSR.4|SGKYDLDFKSPDDPSR.3|SGKYDLDFKSPDDPSR.2|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFMILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFM[Oxi]ILPVGAANFR.5|YNQLLRIEEELGSKAK.4|YNQLLRIEEELGSKAK.3|YNQLLRIEEELGSKAK.2|IGAEVYHNLKNVIKEK.4|IGAEVYHNLKNVIKEK.3|AVEHINKTIAPALVSK.3|AVEHINKTIAPALVSK.4|AVEHINKTIAPALVSK.2|TIAPALVSK.2|LNVTEQEKIDKLMIEMDGTENK.4|LAMQEFMILPVGAANFR.3|LAMQEFMILPVGAANFR.2|LAMQEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFMILPVGAANFR.3|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.2|LAM[Oxi]QEFMILPVGAANFR.2|LAMQEFM[Oxi]ILPVGAANFR.2|LAMQEFMILPVGAANFR.4|YDLDFKSPDDPSR.3|YDLDFKSPDDPSR.2|LAKYNQLLRIEEELGSK.4|LAKYNQLLRIEEELGSK.3|YGKDATNVGDEGGFAPNILENK.3|IGAEVYHNLKNVIK.4|IGAEVYHNLKNVIK.3|AGYTDKVVIGMDVAASEFFR.3|AGYTDKVVIGMDVAASEFFR.2|AGYTDKVVIGMDVAASEFFR.4|AGYTDKVVIGM[Oxi]DVAASEFFR.3|AGYTDKVVIGM[Oxi]DVAASEFFR.2|DATNVGDEGGFAPNILENK.2|DATNVGDEGGFAPNILENK.3|DATNVGDEGGFAPNILENKEGLELLK.3|DATNVGDEGGFAPNILENKEGLELLK.4|SPDDPSRYISPDQLADLYK.3|SPDDPSRYISPDQLADLYK.2|AVNEKSC[CAM]NC[CAM]LLLK.3|HIADLAGNSEVILPVPAFNVINGGSHAGNK.3|HIADLAGNSEVILPVPAFNVINGGSHAGNK.4|HIADLAGNSEVILPVPAFNVINGGSHAGNK.5|FTASAGIQVVGDDLTVTNPK.3|FTASAGIQVVGDDLTVTNPK.2|LAQANGWGVMVSHR.3|LAQANGWGVMVSHR.2|LAQANGWGVM[Oxi]VSHR.3|LAQANGWGVM[Oxi]VSHR.2|LMIEMDGTENKSK.3|LMIEMDGTENK.2|LM[Oxi]IEMDGTENK.2|LMIEM[Oxi]DGTENK.2|LM[Oxi]IEM[Oxi]DGTENK.2|AVEHINK.2|EGLELLK.2|EGLELLK.1|AGAVEKGVPLYR.3|LNVTEQEKIDK.3|LNVTEQEKIDK.2|IEEELGSK.2|KLNVTEQEKIDK.3|KLNVTEQEKIDK.2|LNVTEQEK.2|NFRNPLAK.2|SC[CAM]NC[CAM]LLLK.2|VVIGMDVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.2|VVIGMDVAASEFFR.2|SGKYDLDFK.2|IDKLMIEMDGTENK.3|IDKLM[Oxi]IEMDGTENK.3|IDKLMIEM[Oxi]DGTENK.3|IDKLM[Oxi]IEM[Oxi]DGTENK.3|IDKLMIEMDGTENK.2|KLNVTEQEK.2|AAVPSGASTGIYEALELRDNDK.4|AAVPSGASTGIYEALELRDNDK.3|AAVPSGASTGIYEALELRDNDK.2|IGAEVYHNLK.2|YISPDQLADLYKSFIK.3|EKYGKDATNVGDEGGFAPNILENK.4|YDLDFKSPDDPSRYISPDQLADLYK.4|DATNVGDEGGFAPNILENKEGLELLKTAIGK.4|DYPVVSIEDPFDQDDWGAWQK.3|IHAREIFDSRGNPTVEVDLFTSK.3
SEN / CTL,Q92945,Far upstream element-binding protein 2,KHSRP,3.50,3.01,2.67E-03,2.49E-04,3.60E+00,"RNA splicing, via transesterification reactions,transcription, DNA-templated,regulation of transcription, DNA-templated,mRNA processing,mRNA catabolic process,RNA splicing,regulation of mRNA stability,negative regulation of nitric oxide biosynthetic process,mRNA transport,positive regulation of mRNA catabolic process,3'-UTR-mediated mRNA destabilization,cellular response to cytokine stimulus,regulation of miRNA metabolic process","DNA binding,protein binding,mRNA 3'-UTR AU-rich region binding,poly(A) RNA binding","nucleoplasm,cytosol,cytoplasmic stress granule,membrane,exosome (RNase complex)",18,42,79,IINDLLQSLR.2|IGGGIDVPVPR.2|MMLDDIVSR.2|M[Oxi]MLDDIVSR.2|MM[Oxi]LDDIVSR.2|M[Oxi]M[Oxi]LDDIVSR.2|IIGDPYK.2|VQISPDSGGLPER.3|VQISPDSGGLPER.2|ERDQGGFGDRNEYGSR.4|ERDQGGFGDRNEYGSR.3|HSVGVVIGR.2|QLEDGDQPESKK.3|RQLEDGDQPESK.3|RQLEDGDQPESK.2|IQFKQDDGTGPEK.3|DAFADAVQR.2|RQLEDGDQPESKK.3|TSMTEEYR.2|TSM[Oxi]TEEYR.2|AINQQTGAFVEISR.3|AINQQTGAFVEISR.2|LASQGDSISSQLGPIHPPPR.4|LASQGDSISSQLGPIHPPPR.3|LASQGDSISSQLGPIHPPPR.2|MILIQDGSQNTNVDKPLR.4|M[Oxi]ILIQDGSQNTNVDKPLR.3|MILIQDGSQNTNVDKPLR.3|MILIQDGSQNTNVDKPLR.2|DQGGFGDRNEYGSR.3|DQGGFGDRNEYGSR.2|GQGNWGPPGGEMTFSIPTHK.4|GQGNWGPPGGEM[Oxi]TFSIPTHK.3|GQGNWGPPGGEMTFSIPTHK.3|GQGNWGPPGGEMTFSIPTHK.2|VQQAC[CAM]EMVMDILR.3|VQQAC[CAM]EM[Oxi]VMDILR.2|VQQAC[CAM]EMVM[Oxi]DILR.2|VQQAC[CAM]EMVMDILR.2|GSPQQIDHAK.2|IAHIMGPPDR.2|KLASQGDSISSQLGPIHPPPR.4|KLASQGDSISSQLGPIHPPPR.3|KDAFADAVQR.2|MILIQDGSQNTNVDK.3|MILIQDGSQNTNVDK.2|TSMTEEYRVPDGMVGLIIGR.4|TSMTEEYRVPDGMVGLIIGR.3|TSM[Oxi]TEEYRVPDGM[Oxi]VGLIIGR.3|TSM[Oxi]TEEYRVPDGMVGLIIGR.3|TSMTEEYRVPDGM[Oxi]VGLIIGR.3|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.4|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.3|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.2|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIRK.4|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIRK.3|QLPPNGDPNFK.2|VPDGMVGLIIGR.2|QLEDGDQPESK.2|SVSLTGAPESVQK.2|IGQQPQQPGAPPQQDYTK.3|IGQQPQQPGAPPQQDYTK.2|GGPPGQFHDNANGGQNGTVQEIMIPAGK.4|GGPPGQFHDNANGGQNGTVQEIM[Oxi]IPAGK.3|GGPPGQFHDNANGGQNGTVQEIMIPAGK.3|KIGQQPQQPGAPPQQDYTK.3|KIGQQPQQPGAPPQQDYTK.2|IGGDAATTVNNSTPDFGFGGQK.3|IGGDAATTVNNSTPDFGFGGQK.2|SGPPGPPGGPGMPPGGR.2|SGPPGPPGGPGM[Oxi]PPGGR.2|GRGGPPGQFHDNANGGQNGTVQEIM[Oxi]IPAGK.4|GRGGPPGQFHDNANGGQNGTVQEIMIPAGK.4|IGGDAATTVNNSTPDFGFGGQKR.3|AAAAAADPNAAWAAYYSHYYQQPPGPVPGPAPAPAAPPAQGEPPQPPPTGQSDYTK.7|IIGDPYKVQQAC[CAM]EMVMDILR.3|IIGDPYKVQQAC[CAM]EMVMDILR.2|QAQVATGGGPGAPPGSQPDYSAAWAEYYR.3|KQAQVATGGGPGAPPGSQPDYSAAWAEYYR.3
SEN / CTL,Q15008,26S proteasome non-ATPase regulatory subunit 6,PSMD6,3.49,1.20,4.39E-07,6.83E-08,7.17E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,proteolysis,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",ATPase activity,"proteasome complex,nucleoplasm,cytosol,proteasome regulatory particle,proteasome accessory complex,extracellular exosome",12,34,48,PLENLEEEGLPKNPDLR.3|IGLFYMDNDLITR.2|IGLFYM[Oxi]DNDLITR.2|DWLFAPHYR.3|DWLFAPHYR.2|ANEDELK.2|IGDKEGALTAFR.3|IGDKEGALTAFR.2|RLDEELEDAEK.3|RLDEELEDAEK.2|DELMAAVR.2|IDKVNEIVETNRPDSK.4|IDKVNEIVETNRPDSK.3|KGDLLLNR.2|NLGESEIR.2|IGDKEGALTAFRK.3|SLIEEGGDWDRR.3|SLIEEGGDWDRR.2|VIKGAEILEVLHSLPAVR.4|GDAAVRDELMAAVR.3|GDAAVRDELM[Oxi]AAVR.3|GDAAVRDELMAAVR.2|IHAYSQLLESYR.3|IHAYSQLLESYR.2|VNEIVETNRPDSK.3|VNEIVETNRPDSK.2|NLGESEIRDAMMAK.3|NLGESEIRDAMMAK.2|NWQYQETIKKGDLLLNR.4|GAEILEVLHSLPAVR.3|GAEILEVLHSLPAVR.2|FLLSLPEHR.2|LDIVFYLLR.2|LDEELEDAEK.2|NWQYQETIK.2|SLIEEGGDWDR.2|YSVFFQSLAVVEQEMK.3|YSVFFQSLAVVEQEMK.2|NWQYQETIKK.2|VYQGLYC[CAM]VAIR.2|PLENLEEEGLPK.2|YSVFFQSLAVVEQEMKK.3|QYLFSLYEC[CAM]R.2|RLDEELEDAEKNLGESEIR.3|SLDWQIDVDLLNK.2|DNNM[Oxi]APYYEALC[CAM]K.2|DNNMAPYYEALC[CAM]K.2|QAAELFLDTVSTFTSYELMDYK.3
SEN / CTL,Q14697,Neutral alpha-glucosidase AB,GANAB,3.49,2.50,1.02E-19,5.45E-20,1.93E+01,"carbohydrate metabolic process,protein folding","carbohydrate binding,glucan 1,3-alpha-glucosidase activity,poly(A) RNA binding","endoplasmic reticulum lumen,Golgi apparatus,membrane,glucosidase II complex,extracellular matrix,melanosome,extracellular exosome",108,70,141,YRVPDVLVADPPIAR.3|YRVPDVLVADPPIAR.2|YRVPDVLVADPPIAR.4|VPDVLVADPPIAR.2|SLLLSVNAR.2|LSFQHDPETSVLVLRKPGINVASDWSIHLR.6|LSFQHDPETSVLVLR.3|LSFQHDPETSVLVLR.2|LSFQHDPETSVLVLR.4|VVIIGAGKPAAVVLQTK.3|VVIIGAGKPAAVVLQTK.2|YFTWDPSRFPQPR.3|HHGPQTLYLPVTLSSIPVFQR.4|HHGPQTLYLPVTLSSIPVFQR.3|HHGPQTLYLPVTLSSIPVFQR.2|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.3|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.4|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTM[Oxi]R.3|RFSFSGNTLVSSSADPEGHFETPIWIER.4|RFSFSGNTLVSSSADPEGHFETPIWIER.5|RFSFSGNTLVSSSADPEGHFETPIWIER.3|KPGINVASDWSIHLR.4|KPGINVASDWSIHLR.3|KPGINVASDWSIHLR.2|ALLDSLQLGPDSLTVHLIHEVTK.4|ALLDSLQLGPDSLTVHLIHEVTK.3|MMDYLQGSGETPQTDVR.2|MMDYLQGSGETPQTDVR.3|M[Oxi]M[Oxi]DYLQGSGETPQTDVR.3|M[Oxi]MDYLQGSGETPQTDVR.3|MM[Oxi]DYLQGSGETPQTDVR.3|M[Oxi]MDYLQGSGETPQTDVR.2|MM[Oxi]DYLQGSGETPQTDVR.2|DGDKPEETQGK.3|DGDKPEETQGK.2|NLGLYVK.2|KLVAIVDPHIK.3|KLVAIVDPHIK.2|RYFTWDPSR.3|LKVTEGGEPYR.3|LKVTEGGEPYR.2|PFRLDLLEDR.3|IDELEPR.2|TC[CAM]EESSFC[CAM]KR.3|TC[CAM]EESSFC[CAM]KR.2|AFFAGSQR.2|LDLLEDR.2|SGGMERPFVLAR.3|SGGM[Oxi]ERPFVLAR.3|SGGMERPFVLAR.2|LVAIVDPHIKVDSGYR.4|DAQHYGGWEHR.3|DAQHYGGWEHR.2|VLLVLELQGLQK.3|VLLVLELQGLQK.2|PAAVVLQTK.2|RYFTWDPSRFPQPR.4|RYFTWDPSRFPQPR.3|LSFQHDPETSVLVLRK.4|REPWLLPSQHNDIIR.4|REPWLLPSQHNDIIR.3|REPWLLPSQHNDIIR.2|AHAHLDTGRREPWLLPSQHNDIIR.6|AHAHLDTGRREPWLLPSQHNDIIR.5|AHAHLDTGRREPWLLPSQHNDIIR.4|AHAHLDTGR.2|VDSGYRVHEELR.3|VTEGGEPYR.2|DPAEGDGAQPEETPR.3|DPAEGDGAQPEETPR.2|PGINVASDWSIHLR.3|WYQMGAYQPFFR.3|WYQM[Oxi]GAYQPFFR.3|WYQM[Oxi]GAYQPFFR.2|WYQMGAYQPFFR.2|DVHNIYGLYVHMATADGLR.4|DVHNIYGLYVHM[Oxi]ATADGLR.4|DVHNIYGLYVHM[Oxi]ATADGLR.3|DVHNIYGLYVHMATADGLR.3|DVHNIYGLYVHMATADGLR.2|NPEPELLVR.2|VSQGSKDPAEGDGAQPEETPR.4|VSQGSKDPAEGDGAQPEETPR.3|YFTWDPSR.2|AEKDEPGAWEETFK.3|AEKDEPGAWEETFK.2|LVAIVDPHIK.2|DENSVELTMAEGPYK.3|DENSVELTMAEGPYK.2|DENSVELTM[Oxi]AEGPYK.2|GLLEFEHQR.2|EPWLLPSQHNDIIR.3|EPWLLPSQHNDIIR.2|SIRPGLSPYR.2|TC[CAM]EESSFC[CAM]K.2|FRIDELEPR.2|EPWLLPSQHNDIIRDALGQR.4|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.6|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.6|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.5|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.5|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.4|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.4|REPWLLPSQHNDIIRDALGQR.4|QYASLTGTQALPPLFSLGYHQSR.4|QYASLTGTQALPPLFSLGYHQSR.3|FGAVWTGDNTAEWDHLK.3|FGAVWTGDNTAEWDHLK.2|IILTARPFRLDLLEDR.3|DEPGAWEETFK.2|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.6|THSDSKPYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.6|THSDSKPYGPMSVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.6|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.5|THSDSKPYGPM[Oxi]SVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.5|THSDSKPYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.5|THSDSKPYGPMSVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.5|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.4|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.5|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.4|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.3|DPAEGDGAQPEETPRDGDKPEETQGK.4|DPAEGDGAQPEETPRDGDKPEETQGK.3|YSLLPFWYTLLYQAHR.3|YSLLPFWYTLLYQAHR.2|DAQHYGGWEHRDVHNIYGLYVHMATADGLR.5|DAQHYGGWEHRDVHNIYGLYVHMATADGLR.4|DGDKPEETQGKAEKDEPGAWEETFK.4|DGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.4|DGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.3|FSFSGNTLVSSSADPEGHFETPIWIER.4|FSFSGNTLVSSSADPEGHFETPIWIER.3|LSVSGRDENSVELTM[Oxi]AEGPYK.3|LSVSGRDENSVELTMAEGPYK.3|PYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.4|PYGPMSVGLDFSLPGMEHVYGIPEHADNLR.4|PYGPMSVGLDFSLPGMEHVYGIPEHADNLR.3|WNYRDEADVLEVDQGFDDHNLPC[CAM]DVIWLDIEHADGK.5|WNYRDEADVLEVDQGFDDHNLPC[CAM]DVIWLDIEHADGK.4|RSSEC[CAM]MKDDPITLFVALSPQGTAQGELFLDDGHTFNYQTR.5|SSEC[CAM]MKDDPITLFVALSPQGTAQGELFLDDGHTFNYQTR.4
SEN / CTL,P01892,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,3.49,1.88,1.14E-25,1.06E-25,2.50E+01,,,,66,20,34,APWIEQEGPEYWDGETR.2|APWIEQEGPEYWDGETR.3|APWIEQEGPEYWDGETRK.3|WEAAHVAEQLR.3|DGEDQTQDTELVETRPAGDGTFQK.3|DGEDQTQDTELVETRPAGDGTFQK.4|WAAVVVPSGQEQR.2|MYGC[CAM]DVGSDWR.2|AYLEGTC[CAM]VEWLR.2|SWTAADMAAQTTK.2|SWTAADMAAQTTK.3|SWTAADM[Oxi]AAQTTK.2|GYHQYAYDGKDYIALKEDLR.5|FIAVGYVDDTQFVR.2|FIAVGYVDDTQFVR.3|GYHQYAYDGK.3|GYHQYAYDGK.2|YLENGKETLQR.3|YLENGKETLQR.2|THM[Oxi]THHAVSDHEATLR.4|THMTHHAVSDHEATLR.4|THMTHHAVSDHEATLR.3|THM[Oxi]THHAVSDHEATLR.3|THMTHHAVSDHEATLR.2|GYHQYAYDGKDYIALK.4|GYHQYAYDGKDYIALK.3|GYHQYAYDGKDYIALK.2|FDSDAASQR.2|RYLENGKETLQR.3|HKWEAAHVAEQLR.3|HKWEAAHVAEQLR.2|KGGSYSQAASSDSAQGSDVSLTAC[CAM]K.3|KGGSYSQAASSDSAQGSDVSLTAC[CAM]KV.3|C[CAM]WALSFYPAEITLTWQR.2
SEN / CTL,P49257,Protein ERGIC-53,LMAN1,3.47,1.32,1.12E-10,2.58E-11,1.06E+01,"protein folding,ER to Golgi vesicle-mediated transport,endoplasmic reticulum organization,Golgi organization,blood coagulation,positive regulation of organelle organization,protein N-linked glycosylation via asparagine,COPII vesicle coating,protein exit from endoplasmic reticulum,early endosome to Golgi transport","protein binding,mannose binding,metal ion binding,unfolded protein binding","Golgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,ER to Golgi transport vesicle membrane,membrane,integral component of membrane,sarcomere,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,host cell perinuclear region of cytoplasm,extracellular exosome",18,23,41,YSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIR.5|YSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIR.4|YVSSLTEEISKR.3|YVSSLTEEISKR.2|GPHLVQSDGTVPFWAHAGNAIPSSDQIR.4|GPHLVQSDGTVPFWAHAGNAIPSSDQIR.5|GPHLVQSDGTVPFWAHAGNAIPSSDQIR.3|EHLHIVK.2|TQHEILR.2|NSMSETVR.2|GDGVGGDPAVALPHR.3|QLDMILDEQRR.3|DIDNLVQR.2|QVFEGQNR.2|LVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKR.7|LVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKR.6|RDIDNLVQR.2|RGAGM[Oxi]PGQHGQITQQELDTVVK.4|RGAGMPGQHGQITQQELDTVVK.4|RGAGM[Oxi]PGQHGQITQQELDTVVK.3|RGAGMPGQHGQITQQELDTVVK.3|RGAGM[Oxi]PGQHGQITQQELDTVVK.2|YQEEFEHFQQELDK.3|YQEEFEHFQQELDK.2|QLDMILDEQR.2|YVSSLTEEISK.2|LVSGMQHPGSAGGVYETTQHFIDIK.4|LVSGM[Oxi]QHPGSAGGVYETTQHFIDIK.4|LVSGMQHPGSAGGVYETTQHFIDIK.3|NNPAIVIIGNNGQIHYDHQNDGASQALASC[CAM]QR.5|NNPAIVIIGNNGQIHYDHQNDGASQALASC[CAM]QR.4|NNPAIVIIGNNGQIHYDHQNDGASQALASC[CAM]QR.3|KNNPAIVIIGNNGQIHYDHQNDGASQALASC[CAM]QR.5|KNNPAIVIIGNNGQIHYDHQNDGASQALASC[CAM]QR.4|GAGMPGQHGQITQQELDTVVK.3|GAGM[Oxi]PGQHGQITQQELDTVVK.3|GHPDLQGQPAEEIFESVGDR.3|GHPDLQGQPAEEIFESVGDR.2|AAFENWEVEVTFR.2|ITYYQNTLTVMINNGFTPDKNDYEFC[CAM]AK.4|ITYYQNTLTVMINNGFTPDKNDYEFC[CAM]AK.3
SEN / CTL,P18669,Phosphoglycerate mutase 1,PGAM1,3.46,2.03,1.51E-40,2.63E-40,3.96E+01,"gluconeogenesis,glycolytic process,regulation of glycolytic process,regulation of pentose-phosphate shunt,respiratory burst,canonical glycolysis","bisphosphoglycerate mutase activity,phosphoglycerate mutase activity,hydrolase activity,protein kinase binding,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity","cytoplasm,cytosol,membrane,extracellular exosome",144,38,83,YADLTEDQLPSC[CAM]ESLKDTIAR.3|YADLTEDQLPSC[CAM]ESLKDTIAR.4|ALPFWNEEIVPQIK.2|ALPFWNEEIVPQIK.3|RYADLTEDQLPSC[CAM]ESLKDTIAR.4|RYADLTEDQLPSC[CAM]ESLKDTIAR.3|SYDVPPPPMEPDHPFYSNISKDR.4|FSGWYDADLSPAGHEEAK.3|FSGWYDADLSPAGHEEAK.2|ALPFWNEEIVPQIKEGK.3|GGQALRDAGYEFDIC[CAM]FTSVQKR.4|GGQALRDAGYEFDIC[CAM]FTSVQKR.3|ALPFWNEEIVPQIKEGKR.4|ALPFWNEEIVPQIKEGKR.2|FSGWYDADLSPAGHEEAKR.4|FSGWYDADLSPAGHEEAKR.3|FSGWYDADLSPAGHEEAKR.2|SYDVPPPPMEPDHPFYSNISK.3|SYDVPPPPMEPDHPFYSNISK.4|SYDVPPPPM[Oxi]EPDHPFYSNISK.4|SYDVPPPPM[Oxi]EPDHPFYSNISK.3|TLWTVLDAIDQM[Oxi]WLPVVR.3|RSYDVPPPPMEPDHPFYSNISK.4|RSYDVPPPPM[Oxi]EPDHPFYSNISK.4|RSYDVPPPPMEPDHPFYSNISK.3|HGESAWNLENRFSGWYDADLSPAGHEEAKR.5|HGESAWNLENRFSGWYDADLSPAGHEEAKR.6|NLKPIKPMQFLGDEETVRK.5|NLKPIKPMQFLGDEETVRK.4|NLKPIKPM[Oxi]QFLGDEETVRK.5|NLKPIKPM[Oxi]QFLGDEETVRK.4|NLKPIKPMQFLGDEETVRK.3|NLKPIKPMQFLGDEETVRK.2|NLKPIKPMQFLGDEETVR.4|NLKPIKPM[Oxi]QFLGDEETVR.4|NLKPIKPMQFLGDEETVR.3|NLKPIKPM[Oxi]QFLGDEETVR.3|NLKPIKPMQFLGDEETVR.2|HGEAQVKIWR.3|HYGGLTGLNKAETAAK.4|HYGGLTGLNKAETAAK.3|LNERHYGGLTGLNKAETAAK.5|LNERHYGGLTGLNKAETAAK.4|LNERHYGGLTGLNKAETAAK.3|RVLIAAHGNSLR.3|RVLIAAHGNSLR.2|HGESAWNLENR.3|HGESAWNLENR.2|PIKPMQFLGDEETVRK.4|PIKPM[Oxi]QFLGDEETVRK.4|PIKPMQFLGDEETVRK.3|PIKPM[Oxi]QFLGDEETVRK.3|LVLIRHGESAWNLENR.4|LVLIRHGESAWNLENR.3|LVLIRHGESAWNLENR.2|AMEAVAAQGK.2|AM[Oxi]EAVAAQGK.2|PMQFLGDEETVRK.3|PM[Oxi]QFLGDEETVRK.3|PMQFLGDEETVRK.2|LNERHYGGLTGLNK.3|HYGGLTGLNK.2|KAMEAVAAQGK.2|KAM[Oxi]EAVAAQGK.2|VLIAAHGNSLR.2|PIKPMQFLGDEETVR.3|DAGYEFDIC[CAM]FTSVQK.3|DAGYEFDIC[CAM]FTSVQK.2|YADLTEDQLPSC[CAM]ESLK.3|YADLTEDQLPSC[CAM]ESLK.2|RGGQALRDAGYEFDIC[CAM]FTSVQK.4|DAGYEFDIC[CAM]FTSVQKR.3|DAGYEFDIC[CAM]FTSVQKR.2|HGESAWNLENRFSGWYDADLSPAGHEEAK.5|HGESAWNLENRFSGWYDADLSPAGHEEAK.4|RYADLTEDQLPSC[CAM]ESLK.3|PMQFLGDEETVR.2|PM[Oxi]QFLGDEETVR.2|HLEGLSEEAIMELNLPTGIPIVYELDK.4|HLEGLSEEAIM[Oxi]ELNLPTGIPIVYELDK.4|HLEGLSEEAIM[Oxi]ELNLPTGIPIVYELDK.3|HLEGLSEEAIMELNLPTGIPIVYELDK.3|HLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVR.5
SEN / CTL,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,3.46,2.19,1.01E-02,8.70E-04,3.06E+00,"G1/S transition of mitotic cell cycle,aspartate biosynthetic process,cell proliferation,branched-chain amino acid biosynthetic process,branched-chain amino acid catabolic process,leucine biosynthetic process,valine biosynthetic process","branched-chain-amino-acid transaminase activity,pyridoxal phosphate binding,identical protein binding,L-leucine transaminase activity,L-valine transaminase activity,L-isoleucine transaminase activity","mitochondrion,cytosol",6,17,26,DLIVTPATILK.2|RC[CAM]ILDLAHQWGEFK.4|RC[CAM]ILDLAHQWGEFK.3|ATLPVFDK.2|AKDLIVTPATILK.3|AKDLIVTPATILK.2|LTDIQYGR.2|GETIHIPTMENGPK.3|GETIHIPTMENGPK.2|C[CAM]ILDLAHQWGEFK.3|YLTMDDLTTALEGNR.3|YLTMDDLTTALEGNR.2|ATLPVFDKEELLEC[CAM]IQQLVK.4|ATLPVFDKEELLEC[CAM]IQQLVK.3|ATLPVFDKEELLEC[CAM]IQQLVK.2|LFQPNLNMDR.2|PTFIGTEPSLGVK.2|MKDC[CAM]SNGC[CAM]SAEC[CAM]TGEGGSK.3|PLQNLSLHPGSSALHYAVELFEGLK.4|PLQNLSLHPGSSALHYAVELFEGLK.3|EMFGSGTAC[CAM]VVC[CAM]PVSDILYK.3|EMFGSGTAC[CAM]VVC[CAM]PVSDILYK.2|EELLEC[CAM]IQQLVK.2|LDQEWVPYSTSASLYIRPTFIGTEPSLGVK.4|LDQEWVPYSTSASLYIRPTFIGTEPSLGVK.3|DC[CAM]SNGC[CAM]SAEC[CAM]TGEGGSK.2
SEN / CTL,Q7KZF4,Staphylococcal nuclease domain-containing protein 1,SND1,3.46,2.02,9.01E-19,4.55E-19,1.83E+01,"osteoblast differentiation,transcription, DNA-templated,regulation of transcription, DNA-templated,RNA catabolic process,viral process,gene silencing by RNA,nucleic acid phosphodiester bond hydrolysis,cell-cell adhesion","transcription cofactor activity,nuclease activity,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cell-cell adherens junction,membrane,RISC complex,melanosome,extracellular exosome,dense body",66,71,115,YRQDDDQRSSHYDELLAAEAR.4|YGDFRADDADEFGYSR.3|VITEYLNAQESAK.2|VITEYLNAQESAK.3|VWAHYEEQPVEEVMPVLEEKER.4|LMENMRNDIASHPPVEGSYAPR.4|IHVFYIDYGNREVLPSTR.4|IHVFYIDYGNREVLPSTR.3|AGRSEAVVEYVFSGSR.3|AGRSEAVVEYVFSGSR.2|QFLPFLQR.2|EVC[CAM]FTIENK.2|LRPLYDIPYMFEAR.3|LRPLYDIPYM[Oxi]FEAR.3|LRPLYDIPYMFEAR.2|NLPGLVQEGEPFSEEATLFTK.3|NLPGLVQEGEPFSEEATLFTK.2|ADDADEFGYSR.3|ADDADEFGYSR.2|GDVGLGLVK.2|VHFTAER.2|YTIENPR.2|HFVDSHHQKPVNAIIEHVR.5|HFVDSHHQKPVNAIIEHVR.4|HFVDSHHQKPVNAIIEHVR.3|ANNPEQNR.2|DTPDEPWAFPAR.3|DTPDEPWAFPAR.2|IHVFYIDYGNR.3|IHVFYIDYGNR.2|VMQVLNADAIVVK.3|VMQVLNADAIVVK.2|VM[Oxi]QVLNADAIVVK.2|SEAVVEYVFSGSR.3|SEAVVEYVFSGSR.2|GM[Oxi]WSEGNGSHTIR.3|GMWSEGNGSHTIR.3|GM[Oxi]WSEGNGSHTIR.2|GMWSEGNGSHTIR.2|KLRPLYDIPYMFEAR.4|KLRPLYDIPYMFEAR.3|QINLSNIR.2|TDAVDSVVR.2|SSHYDELLAAEAR.3|SSHYDELLAAEAR.2|RGEFC[CAM]IAK.2|SLLSAEEAAK.2|EGLVMVEVR.2|EGLVM[Oxi]VEVR.2|LEGENTQDK.2|VADISGDTQK.2|KGMWSEGNGSHTIR.3|DYVAPTANLDQKDK.3|DYVAPTANLDQKDK.2|EYGMIYLGK.2|FVDGEWYR.2|EADGSETPEPFAAEAK.3|EADGSETPEPFAAEAK.2|LSEC[CAM]EEQAK.2|EVC[CAM]FTIENKTPQGR.3|HFVDSHHQK.2|NDIASHPPVEGSYAPR.3|NDIASHPPVEGSYAPR.2|PVNAIIEHVR.2|LGTLSPAFSTR.2|IWRDYVAPTANLDQK.3|RAAATQPDAKDTPDEPWAFPAR.4|RAAATQPDAKDTPDEPWAFPAR.3|READGSETPEPFAAEAK.3|MVLSGC[CAM]AIIVR.2|M[Oxi]VLSGC[CAM]AIIVR.2|VWAHYEEQPVEEVMPVLEEK.4|VWAHYEEQPVEEVMPVLEEK.3|ETC[CAM]LITFLLAGIEC[CAM]PR.3|ETC[CAM]LITFLLAGIEC[CAM]PR.2|TC[CAM]ATVTIGGINIAEALVSK.3|TC[CAM]ATVTIGGINIAEALVSK.2|EVEVEVESMDK.2|EVEVEVESM[Oxi]DK.2|VLPAQATEYAFAFIQVPQDDDAR.4|VLPAQATEYAFAFIQVPQDDDAR.3|DTNGENIAESLVAEGLATR.3|DTNGENIAESLVAEGLATR.2|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.5|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.4|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.3|VNVTVDYIRPASPATETVPAFSER.4|VNVTVDYIRPASPATETVPAFSER.3|DYVAPTANLDQK.2|ALLLPDYYLVTVM[Oxi]LSGIK.3|ANNPEQNRLSEC[CAM]EEQAK.3|EKVWAHYEEQPVEEVMPVLEEK.4|C[CAM]VDWSIAVYTR.2|AGNFIGWLHIDGANLSVLLVEHALSK.4|AGNFIGWLHIDGANLSVLLVEHALSK.3|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.6|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.5|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.4|KVNVTVDYIRPASPATETVPAFSER.4|KVNVTVDYIRPASPATETVPAFSER.3|DTNGENIAESLVAEGLATRR.3|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.5|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.4|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.3|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.5|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.4|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.3|AAATQPDAKDTPDEPWAFPAR.3|EYGMIYLGKDTNGENIAESLVAEGLATR.4|EYGMIYLGKDTNGENIAESLVAEGLATR.3|ERSASYKPVFVTEITDDLHFYVQDVETGTQLEK.5|PASPATETVPAFSER.2|EYGMIYLGKDTNGENIAESLVAEGLATRR.4|DVQIILESC[CAM]HNQNILGTILHPNGNITELLLK.4|DVQIILESC[CAM]HNQNILGTILHPNGNITELLLK.3
SEN / CTL,P04075,Fructose-bisphosphate aldolase A,ALDOA,3.45,1.75,6.22E-69,2.10E-68,6.77E+01,"platelet degranulation,fructose metabolic process,gluconeogenesis,glycolytic process,ATP biosynthetic process,striated muscle contraction,actin filament organization,regulation of cell shape,fructose 1,6-bisphosphate metabolic process,muscle cell cellular homeostasis,protein homotetramerization,canonical glycolysis,cell-cell adhesion","actin binding,fructose-bisphosphate aldolase activity,cytoskeletal protein binding,tubulin binding,identical protein binding,poly(A) RNA binding,fructose binding,cadherin binding involved in cell-cell adhesion","extracellular region,extracellular space,nucleus,cytosol,cell-cell adherens junction,actin cytoskeleton,membrane,platelet alpha granule lumen,M band,I band,extracellular exosome",270,51,110,PYQYPALTPEQKKELSDIAHR.5|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.4|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.3|VDKGVVPLAGTNGETTTQGLDGLSER.3|VDKGVVPLAGTNGETTTQGLDGLSER.4|IVAPGKGILAADESTGSIAK.3|IVAPGKGILAADESTGSIAK.2|IVAPGKGILAADESTGSIAK.4|YTPSGQAGAAASESLFVSNHAY.3|YTPSGQAGAAASESLFVSNHAY.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.3|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.6|IGEHTPSALAIMENANVLAR.3|IGEHTPSALAIMENANVLAR.2|IGEHTPSALAIMENANVLAR.4|IGEHTPSALAIM[Oxi]ENANVLAR.3|IGEHTPSALAIM[Oxi]ENANVLAR.4|IGEHTPSALAIM[Oxi]ENANVLAR.2|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.4|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.3|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.6|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.5|GVVPLAGTNGETTTQGLDGLSER.3|GVVPLAGTNGETTTQGLDGLSER.2|GVVPLAGTNGETTTQGLDGLSER.4|GILAADESTGSIAK.2|GILAADESTGSIAK.3|GILAADESTGSIAKR.3|GILAADESTGSIAKR.2|C[CAM]QYVTEKVLAAVYK.3|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.3|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.3|FSHEEIAMATVTALRR.4|FSHEEIAMATVTALRR.3|FSHEEIAMATVTALRR.2|FSHEEIAM[Oxi]ATVTALRR.4|FSHEEIAM[Oxi]ATVTALRR.3|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.4|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.3|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.5|ALANSLAC[CAM]QGK.2|PYQYPALTPEQKK.3|PYQYPALTPEQKK.2|FSHEEIAMATVTALR.3|FSHEEIAMATVTALR.4|FSHEEIAM[Oxi]ATVTALR.3|FSHEEIAM[Oxi]ATVTALR.2|FSHEEIAMATVTALR.2|C[CAM]PLLKPWALTFSYGR.3|C[CAM]PLLKPWALTFSYGR.2|ADDGRPFPQVIK.3|ADDGRPFPQVIK.2|QLLLTADDR.2|PYQYPALTPEQK.2|PYQYPALTPEQK.3|ALQASALK.2|ALSDHHIYLEGTLLK.4|ALSDHHIYLEGTLLK.3|ALSDHHIYLEGTLLK.2|KDGADFAK.2|ALQASALKAWGGK.3|ALQASALKAWGGK.2|RALANSLAC[CAM]QGK.3|RALANSLAC[CAM]QGK.2|RLQSIGTENTEENRR.4|RLQSIGTENTEENRR.3|RLQSIGTENTEENRR.2|C[CAM]QYVTEK.2|AAQEEYVK.2|ELSDIAHR.2|ALQASALKAWGGKK.3|ENLKAAQEEYVK.3|ENLKAAQEEYVK.2|PNMVTPGHAC[CAM]TQK.3|PNM[Oxi]VTPGHAC[CAM]TQK.3|PNMVTPGHAC[CAM]TQK.2|GGVVGIKVDK.2|LQSIGTENTEENR.3|LQSIGTENTEENR.2|VNPC[CAM]IGGVILFHETLYQK.4|VNPC[CAM]IGGVILFHETLYQK.3|VNPC[CAM]IGGVILFHETLYQK.2|ENLKAAQEEYVKR.3|DGADFAKWR.2|KELSDIAHR.2|RC[CAM]QYVTEK.2|AAQEEYVKR.2|LQSIGTENTEENRR.3|LQSIGTENTEENRR.2|RLQSIGTENTEENR.3|RLQSIGTENTEENR.2|AWGGKKENLK.2|SKGGVVGIKVDK.2|PWALTFSYGR.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.3|RTVPPAVTGITFLSGGQSEEEASINLNAINK.5|RTVPPAVTGITFLSGGQSEEEASINLNAINK.4|RTVPPAVTGITFLSGGQSEEEASINLNAINK.3|TVPPAVTGITFLSGGQSEEEASINLNAINK.4|TVPPAVTGITFLSGGQSEEEASINLNAINK.3
SEN / CTL,P21589,5'-nucleotidase,NT5E,3.44,1.82,6.21E-26,5.88E-26,2.52E+01,"purine nucleotide catabolic process,AMP catabolic process,DNA metabolic process,leukocyte cell-cell adhesion,dephosphorylation,adenosine biosynthetic process,pyrimidine nucleoside catabolic process,negative regulation of inflammatory response","nucleotide binding,5'-nucleotidase activity,metal ion binding","cytoplasm,plasma membrane,cell surface,membrane,anchored component of membrane,extracellular exosome",66,28,42,TIVYLDGSSQSC[CAM]R.2|FREC[CAM]NMGNLIC[CAM]DAMINNNLR.3|VPVVQAYAFGK.2|GPLASQISGLYLPYK.3|GPLASQISGLYLPYK.2|ETPFLSNPGTNLVFEDEITALQPEVDKLK.3|ETPFLSNPGTNLVFEDEITALQPEVDKLK.4|HDSGDQDINVVSTYISK.3|HDSGDQDINVVSTYISK.2|VLPVGDEVVGIVGYTSK.3|VLPVGDEVVGIVGYTSK.2|FPILSANIK.2|YGQSTGEFLQVGGIHVVYDLSR.3|C[CAM]RVPSYDPLK.3|MKVIYPAVEGR.3|KVPVVQAYAFGK.3|GAEVAHFMNALR.3|GAEVAHFMNALR.2|GAEVAHFM[Oxi]NALR.2|IIALGHSGFEMDK.3|IIALGHSGFEMDK.2|AFEHSVHR.2|IIALGHSGFEMDKLIAQK.4|IIALGHSGFEMDKLIAQK.3|VIYPAVEGR.2|GVDVVVGGHSNTFLYTGNPPSK.4|GVDVVVGGHSNTFLYTGNPPSK.3|GVDVVVGGHSNTFLYTGNPPSK.2|LEQTSEDSSK.2|VPSYDPLKMDEVYK.3|EVPAGKYPFIVTSDDGR.3|YPFIVTSDDGR.2|VILPNFLANGGDGFQMIK.3|VILPNFLANGGDGFQMIK.2|VILPNFLANGGDGFQMIKDELLR.4|VILPNFLANGGDGFQM[Oxi]IKDELLR.3|VILPNFLANGGDGFQMIKDELLR.3|C[CAM]RVPSYDPLKMDEVYK.3|YPFIVTSDDGRK.2|YDAMALGNHEFDNGVEGLIEPLLK.3|YDAM[Oxi]ALGNHEFDNGVEGLIEPLLK.3|ETPFLSNPGTNLVFEDEITALQPEVDK.3
SEN / CTL,P52907,F-actin-capping protein subunit alpha-1,CAPZA1,3.44,1.46,1.63E-17,7.14E-18,1.71E+01,"protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping,cell-cell adhesion","actin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,extracellular exosome,WASH complex",42,20,42,FITHAPPGEFNEVFNDVR.3|FITHAPPGEFNEVFNDVR.2|FITHAPPGEFNEVFNDVR.4|FTITPPTAQVVGVLK.2|FTITPPTAQVVGVLK.3|TIDGQQTIIAC[CAM]IESHQFQPK.3|TIDGQQTIIAC[CAM]IESHQFQPK.4|TIDGQQTIIAC[CAM]IESHQFQPK.2|EASDPQPEEADGGLKSWR.3|LLLNNDNLLR.3|LLLNNDNLLR.2|SWRESC[CAM]DSALR.3|SWRESC[CAM]DSALR.2|ESC[CAM]DSALR.2|TKIDWNKILSYK.3|AYVKDHYSNGFC[CAM]TVYAK.4|AYVKDHYSNGFC[CAM]TVYAK.3|IQVHYYEDGNVQLVSHK.4|IQVHYYEDGNVQLVSHK.3|IQVHYYEDGNVQLVSHK.2|EASDPQPEEADGGLK.3|EASDPQPEEADGGLK.2|DHYSNGFC[CAM]TVYAK.3|DHYSNGFC[CAM]TVYAK.2|EGAAHAFAQYNMDQFTPVK.4|EGAAHAFAQYNM[Oxi]DQFTPVK.3|EGAAHAFAQYNMDQFTPVK.3|EGAAHAFAQYNMDQFTPVK.2|KEASDPQPEEADGGLK.3|IEGYEDQVLITEHGDLGNSR.4|IEGYEDQVLITEHGDLGNSR.3|IEGYEDQVLITEHGDLGNSR.2|DVQDSLTVSNEAQTAK.3|DVQDSLTVSNEAQTAK.2|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.5|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.4|IIENAENEYQTAISENYQTMSDTTFK.4|IIENAENEYQTAISENYQTM[Oxi]SDTTFK.3|IIENAENEYQTAISENYQTMSDTTFK.3|FITHAPPGEFNEVFNDVRLLLNNDNLLR.4|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.5|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.4
SEN / CTL,Q96TA1,Niban-like protein 1,FAM129B,3.44,1.78,2.27E-16,8.81E-17,1.61E+01,"negative regulation of apoptotic process,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,adherens junction,cell-cell adherens junction,actin cytoskeleton,extracellular exosome",42,38,58,FQELIFEDFAR.2|FDVSSTSVFK.2|ILTSVDQYLELIGNSLPGTTAK.3|ILTSVDQYLELIGNSLPGTTAK.2|C[CAM]PTQFPLILWHPYAR.3|C[CAM]PTQFPLILWHPYAR.2|NRFSLVPHNYGLVLYENK.4|NRFSLVPHNYGLVLYENK.3|HC[CAM]NNGIPEDSKVEGPAFTDAIR.4|HC[CAM]NNGIPEDSKVEGPAFTDAIR.3|HEIEGTGLPQAQLLWR.3|HEIEGTGLPQAQLLWR.2|FEEVLSK.2|KVPLDER.2|WQAVLQDC[CAM]IR.3|WQAVLQDC[CAM]IR.2|KYDYDSSSVRK.3|KYDYDSSSVRK.2|AVINSAGYK.2|IVFSGNLFQHQEDSKK.4|IVFSGNLFQHQEDSKK.3|AAPEASSPPASPLQHLLPGK.4|AAPEASSPPASPLQHLLPGK.3|GPTKEELC[CAM]K.2|ARFEEVLSK.2|EALLQISIPFLLKK.3|YDYDSSSVR.2|TDMDQIITSK.2|TDM[Oxi]DQIITSK.2|IVFSGNLFQHQEDSK.3|IVFSGNLFQHQEDSK.2|VEGPAFTDAIR.2|KYDYDSSSVR.2|HYYFC[CAM]MMTEAEQDK.3|QRQWIQISDAVYHMVYEQAK.4|QRQWIQISDAVYHMVYEQAK.3|FSLVPHNYGLVLYENK.3|FSLVPHNYGLVLYENK.2|HC[CAM]NNGIPEDSK.2|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.5|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.4|EQMDNAVYTFETLLHQELGKGPTK.4|FILVENTYEEVVLQTVMK.3|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.4|NHVQPYIPSILEALMVPTSQGFTEVR.4|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.3|NHVQPYIPSILEALMVPTSQGFTEVR.3|VQQVQPAMQAVIR.2|VQQVQPAM[Oxi]QAVIR.2|EALLQISIPFLLK.2|QWIQISDAVYHMVYEQAK.3|QWIQISDAVYHMVYEQAK.2|EQMDNAVYTFETLLHQELGK.3|EQMDNAVYTFETLLHQELGK.2|EVTDMNLNVINEGGIDKLGEYMEK.3|EVTDMNLNVINEGGIDK.2|GLLAQGLRPESPPPAGPLLNGAPAGESPQPK.3|QVVSVVQDEEVGLPFEASPESPPPASPDGVTEIR.3
SEN / CTL,O95571,"Persulfide dioxygenase ETHE1, mitochondrial",ETHE1,3.44,1.47,1.74E-03,1.67E-04,3.78E+00,"glutathione metabolic process,sulfide oxidation, using sulfide:quinone oxidoreductase,hydrogen sulfide metabolic process","iron ion binding,sulfur dioxygenase activity","nucleoplasm,cytoplasm,mitochondrion,mitochondrial matrix",6,17,38,EAVLIDPVLETAPR.2|EAVLIDPVLETAPR.3|GGSGAPILLR.2|LLYAVNTHC[CAM]HADHITGSGLLR.5|LLYAVNTHC[CAM]HADHITGSGLLR.4|LLYAVNTHC[CAM]HADHITGSGLLR.3|LLYAVNTHC[CAM]HADHITGSGLLR.2|PQQIDFAVPANMR.3|PQQIDFAVPANMR.2|PQQIDFAVPANM[Oxi]R.2|IMGNLNLPK.2|IM[Oxi]GNLNLPK.2|TDFQQGC[CAM]AK.2|LSGAQADLHIEDGDSIRFGR.4|TLYHSVHEK.2|LSGAQADLHIEDGDSIR.3|LSGAQADLHIEDGDSIR.2|LTLSC[CAM]EEFVK.2|ASPGHTPGC[CAM]VTFVLNDHSMAFTGDALLIR.5|ASPGHTPGC[CAM]VTFVLNDHSM[Oxi]AFTGDALLIR.4|ASPGHTPGC[CAM]VTFVLNDHSMAFTGDALLIR.4|ASPGHTPGC[CAM]VTFVLNDHSM[Oxi]AFTGDALLIR.3|ASPGHTPGC[CAM]VTFVLNDHSMAFTGDALLIR.3|IMGNLNLPKPQQIDFAVPANMR.4|IM[Oxi]GNLNLPKPQQIDFAVPANMR.3|IMGNLNLPKPQQIDFAVPANM[Oxi]R.3|IMGNLNLPKPQQIDFAVPANMR.3|IFTLPGDC[CAM]LIYPAHDYHGFTVSTVEEER.5|IFTLPGDC[CAM]LIYPAHDYHGFTVSTVEEER.4|IFTLPGDC[CAM]LIYPAHDYHGFTVSTVEEER.3|SLLPGC[CAM]QSVISR.2|QM[Oxi]FEPVSC[CAM]TFTYLLGDR.3|QMFEPVSC[CAM]TFTYLLGDR.3|QM[Oxi]FEPVSC[CAM]TFTYLLGDR.2|QMFEPVSC[CAM]TFTYLLGDR.2|IFTLPGDC[CAM]LIYPAHDYHGFTVSTVEEERTLNPR.5|QM[Oxi]FEPVSC[CAM]TFTYLLGDRESR.3|QMFEPVSC[CAM]TFTYLLGDRESR.3
SEN / CTL,P62263,40S ribosomal protein S14,RPS14,3.43,1.33,4.66E-16,1.76E-16,1.58E+01,"ribosomal small subunit assembly,negative regulation of transcription from RNA polymerase II promoter,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,regulation of translation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,erythrocyte differentiation,maturation of SSU-rRNA","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,translation regulator activity,mRNA 5'-UTR binding,small ribosomal subunit rRNA binding","nucleoplasm,nucleolus,cytoplasm,mitochondrion,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",30,15,31,IGRIEDVTPIPSDSTR.3|IGRIEDVTPIPSDSTR.2|IGRIEDVTPIPSDSTRR.4|IGRIEDVTPIPSDSTRR.3|VKADRDESSPYAAMLAAQDVAQR.4|VKADRDESSPYAAMLAAQDVAQR.3|VKADRDESSPYAAM[Oxi]LAAQDVAQR.4|VKADRDESSPYAAM[Oxi]LAAQDVAQR.3|ADRDESSPYAAMLAAQDVAQR.3|ADRDESSPYAAMLAAQDVAQR.4|ADRDESSPYAAM[Oxi]LAAQDVAQR.3|ADRDESSPYAAMLAAQDVAQR.2|TKTPGPGAQSALR.3|C[CAM]KELGITALHIK.3|C[CAM]KELGITALHIK.2|IEDVTPIPSDSTR.3|IEDVTPIPSDSTR.2|IEDVTPIPSDSTRR.3|IEDVTPIPSDSTRR.2|TPGPGAQSALR.2|ELGITALHIK.2|DESSPYAAMLAAQDVAQR.3|DESSPYAAMLAAQDVAQR.2|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.6|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.5|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.4|EKKEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.6|EKKEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.5|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGKETIC[CAM]R.6|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGKETIC[CAM]R.5|EEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.4
SEN / CTL,P38646,"Stress-70 protein, mitochondrial",HSPA9,3.43,1.71,1.04E-22,7.38E-23,2.21E+01,"protein folding,protein export from nucleus,erythrocyte differentiation,negative regulation of apoptotic process,negative regulation of erythrocyte differentiation","protein binding,ATP binding,ubiquitin protein ligase binding,poly(A) RNA binding,unfolded protein binding","nucleolus,cytoplasm,mitochondrion,focal adhesion,extracellular matrix,mitochondrial nucleoid,myelin sheath,extracellular exosome",54,68,123,NAVITVPAYFNDSQR.2|NAVITVPAYFNDSQR.3|DAGQISGLNVLR.2|DAGQISGLNVLR.3|TTPSVVAFTADGER.2|TTPSVVAFTADGER.3|AMQDAEVSKSDIGEVILVGGMTR.3|AMQDAEVSKSDIGEVILVGGMTR.4|AM[Oxi]QDAEVSKSDIGEVILVGGMTR.3|VINEPTAAALAYGLDK.2|VINEPTAAALAYGLDK.3|AQFEGIVTDLIR.2|AQFEGIVTDLIR.3|ETGVDLTKDNMALQR.3|ETGVDLTKDNM[Oxi]ALQR.3|ETGVDLTKDNMALQR.2|ETGVDLTKDNM[Oxi]ALQR.2|M[Oxi]KETAENYLGHTAK.4|MKETAENYLGHTAK.3|M[Oxi]KETAENYLGHTAK.3|M[Oxi]KETAENYLGHTAK.2|MKETAENYLGHTAK.2|QAASSLQQASLK.3|QAASSLQQASLK.2|TIAPC[CAM]QK.2|VQQTVQDLFGRAPSK.4|VQQTVQDLFGRAPSK.3|VQQTVQDLFGRAPSK.2|DNMALQR.2|DNM[Oxi]ALQR.2|ETGVDLTK.2|VQQTVQDLFGR.3|VQQTVQDLFGR.2|ASNGDAWVEAHGK.3|ASNGDAWVEAHGK.2|ETAENYLGHTAK.3|ETAENYLGHTAK.2|YDDPEVQKDIK.3|YDDPEVQKDIK.2|LFEM[Oxi]AYK.2|NAEKYAEEDRR.3|LINRNTTIPTKK.3|RQAVTNPNNTFYATKR.4|YAEEDRR.2|DDIENMVK.2|DDIENM[Oxi]VK.2|SDIGEVILVGGMTR.3|SDIGEVILVGGMTR.2|SDIGEVILVGGM[Oxi]TR.2|VLENAEGAR.2|AMQDAEVSK.2|AM[Oxi]QDAEVSK.2|RTIAPC[CAM]QK.2|EQQIVIQSSGGLSK.3|EQQIVIQSSGGLSK.2|EGSGSSGTGEQKEDQKEEK.4|RYDDPEVQKDIK.3|RYDDPEVQKDIK.2|YDDPEVQK.2|AQFEGIVTDLIRR.3|AQFEGIVTDLIRR.2|RETGVDLTK.2|DSETGENIR.2|LFEMAYKK.2|LYSPSQIGAFVLM[Oxi]K.3|LYSPSQIGAFVLMK.3|LYSPSQIGAFVLMK.2|LYSPSQIGAFVLM[Oxi]K.2|QAVTNPNNTFYATK.3|QAVTNPNNTFYATK.2|LLGQFTLIGIPPAPR.3|LLGQFTLIGIPPAPR.2|ERVEAVNMAEGIIHDTETK.4|ERVEAVNM[Oxi]AEGIIHDTETK.4|ERVEAVNMAEGIIHDTETK.3|ERVEAVNM[Oxi]AEGIIHDTETK.3|ERVEAVNMAEGIIHDTETK.2|EGSGSSGTGEQK.2|MASEREGSGSSGTGEQK.3|QAASSLQQASLKLFEMAYKK.4|KDSETGENIR.2|QAVTNPNNTFYATKR.3|QAVTNPNNTFYATKR.2|RQAVTNPNNTFYATK.3|RQAVTNPNNTFYATK.2|RYDDPEVQK.2|DQLPADEC[CAM]NK.2|EQQIVIQSSGGLSKDDIENMVK.4|EQQIVIQSSGGLSKDDIENM[Oxi]VK.3|EQQIVIQSSGGLSKDDIENMVK.3|SQVFSTAADGQTQVEIK.3|SQVFSTAADGQTQVEIK.2|RETGVDLTKDNMALQR.3|M[Oxi]EEFKDQLPADEC[CAM]NK.3|MEEFKDQLPADEC[CAM]NK.3|MEEFKDQLPADEC[CAM]NK.2|VEAVNMAEGIIHDTETK.3|VEAVNM[Oxi]AEGIIHDTETK.3|VEAVNM[Oxi]AEGIIHDTETK.2|VEAVNMAEGIIHDTETK.2|KSQVFSTAADGQTQVEIK.3|KSQVFSTAADGQTQVEIK.2|STNGDTFLGGEDFDQALLR.3|STNGDTFLGGEDFDQALLR.2|GAVVGIDLGTTNSC[CAM]VAVMEGK.3|GAVVGIDLGTTNSC[CAM]VAVM[Oxi]EGK.2|GAVVGIDLGTTNSC[CAM]VAVMEGK.2|ERVEAVNMAEGIIHDTETKMEEFK.4|GTGREQQIVIQSSGGLSKDDIENMVK.4|GTGREQQIVIQSSGGLSKDDIENMVK.3|VINEPTAAALAYGLDKSEDK.3|DSETGENIRQAASSLQQASLK.3|VEAVNMAEGIIHDTETKMEEFKDQLPADEC[CAM]NK.5|VIAVYDLGGGTFDISILEIQK.3|VIAVYDLGGGTFDISILEIQK.2|GVPQIEVTFDIDANGIVHVSAK.3|GVPQIEVTFDIDANGIVHVSAK.2|EMAGDNKLLGQFTLIGIPPAPR.3|QATKDAGQISGLNVLR.2|C[CAM]ELSSSVQTDINLPYLTMDSSGPK.3|SEDKVIAVYDLGGGTFDISILEIQK.3|AKC[CAM]ELSSSVQTDINLPYLTMDSSGPK.3|VINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQK.4
SEN / CTL,P32119,Peroxiredoxin-2,PRDX2,3.43,1.94,1.53E-18,7.56E-19,1.81E+01,"response to reactive oxygen species,response to oxidative stress,removal of superoxide radicals,cellular response to oxidative stress,hydrogen peroxide catabolic process,regulation of apoptotic process,negative regulation of apoptotic process,cell redox homeostasis,oxidation-reduction process","thioredoxin peroxidase activity,antioxidant activity","cytoplasm,cytosol,extracellular exosome",66,24,40,RLSEDYGVLKTDEGIAYR.4|RLSEDYGVLKTDEGIAYR.3|RLSEDYGVLKTDEGIAYR.2|LSEDYGVLKTDEGIAYR.3|KEGGLGPLNIPLLADVTR.3|KEGGLGPLNIPLLADVTR.2|ATAVVDGAFKEVK.3|ATAVVDGAFKEVK.2|GLFIIDGKGVLRQITVNDLPVGR.4|EGGLGPLNIPLLADVTRR.3|EGGLGPLNIPLLADVTR.2|EGGLGPLNIPLLADVTR.3|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.4|GLFIIDGK.2|GLFIIDGKGVLR.3|GLFIIDGKGVLR.2|IGKPAPDFKATAVVDGAFKEVK.5|TDEGIAYR.2|ATAVVDGAFK.2|ATAVVDGAFK.1|IGKPAPDFK.2|PGSDTIKPNVDDSK.3|PGSDTIKPNVDDSK.2|KEGGLGPLNIPLLADVTRR.4|KEGGLGPLNIPLLADVTRR.3|LSEDYGVLK.2|RLSEDYGVLK.2|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.3|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIK.4|LVQAFQYTDEHGEVC[CAM]PAGWK.3
SEN / CTL,Q96HE7,ERO1-like protein alpha,ERO1L,3.42,1.32,1.14E-06,1.67E-07,6.78E+00,"response to reactive oxygen species,protein folding,cellular protein modification process,response to temperature stimulus,animal organ senescence,4-hydroxyproline metabolic process,protein maturation by protein folding,extracellular matrix organization,endoplasmic reticulum unfolded protein response,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,cell redox homeostasis,brown fat cell differentiation,chaperone mediated protein folding requiring cofactor,release of sequestered calcium ion into cytosol,oxidation-reduction process,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,cellular response to hypoxia","protein disulfide isomerase activity,protein disulfide oxidoreductase activity,disulfide oxidoreductase activity,oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,membrane,dendrite,intracellular membrane-bounded organelle",12,31,49,LGAVDESLSEETQK.2|LLESDYFR.2|AVLQWTK.2|NLLQNIH.2|YTGYKGPDAWK.3|YTGYKGPDAWK.2|MLLLEILHEIK.3|MLLLEILHEIK.2|QEIVSLFNAFGR.3|QEIVSLFNAFGR.2|FDGILTEGEGPRR.3|YLLQETWLEKK.3|SFPLHFDENSFFAGDKK.4|SFPLHFDENSFFAGDKK.3|SFPLHFDENSFFAGDKK.2|VLPFFERPDFQLFTGNK.4|VLPFFERPDFQLFTGNK.3|VLPFFERPDFQLFTGNK.2|RDC[CAM]AVKPC[CAM]QSDEVPDGIK.4|RDC[CAM]AVKPC[CAM]QSDEVPDGIK.3|IWNVIYEENC[CAM]FKPQTIK.4|IWNVIYEENC[CAM]FKPQTIK.3|IWNVIYEENC[CAM]FKPQTIK.2|IMDC[CAM]VGC[CAM]FK.2|LISGLHASINVHLSAR.3|LKNLYFLYLIELR.3|LQTQGLGTALK.2|RPC[CAM]PFWNDISQC[CAM]GR.3|RPC[CAM]PFWNDISQC[CAM]GR.2|SFPLHFDENSFFAGDK.3|DC[CAM]AVKPC[CAM]QSDEVPDGIK.3|DC[CAM]AVKPC[CAM]QSDEVPDGIK.2|FDGILTEGEGPR.2|YLLQETWLEK.2|LIANM[Oxi]PESGPSYEFHLTR.3|LIANMPESGPSYEFHLTR.3|LIANMPESGPSYEFHLTR.2|YSEEANNLIEEC[CAM]EQAER.3|YSEEANNLIEEC[CAM]EQAER.2|ISTSVKELENFR.2|NLYFLYLIELR.2|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEK.4|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEK.3|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEKR.4|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEKR.3|C[CAM]FC[CAM]QVSGYLDDC[CAM]TC[CAM]DVETIDR.3|HDDSSDNFC[CAM]EADDIQSPEAEYVDLLLNPER.4|HDDSSDNFC[CAM]EADDIQSPEAEYVDLLLNPER.3|C[CAM]FC[CAM]QVSGYLDDC[CAM]TC[CAM]DVETIDRFNNYR.3
SEN / CTL,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,3.42,1.96,2.38E-36,3.67E-36,3.54E+01,"G2/M transition of mitotic cell cycle,neuron migration,skeletal muscle contraction,mitochondrial transport,receptor-mediated endocytosis,response to unfolded protein,signal transduction,response to heat,response to cold,response to salt stress,positive regulation of lamellipodium assembly,cardiac muscle cell apoptotic process,peptidyl-tyrosine phosphorylation,regulation of protein ubiquitination,positive regulation of protein import into nucleus, translocation,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,protein refolding,response to cocaine,response to drug,regulation of protein complex assembly,protein unfolding,response to estrogen,protein import into mitochondrial outer membrane,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,response to antibiotic,vascular endothelial growth factor receptor signaling pathway,protein stabilization,regulation of nitric-oxide synthase activity,chaperone-mediated protein complex assembly,positive regulation of cardiac muscle contraction,chaperone-mediated autophagy,regulation of cellular response to heat","nucleotide binding,glycoprotein binding,UTP binding,CTP binding,mRNA binding,protein tyrosine kinase activity,protein binding,ATP binding,GTP binding,ATPase activity,sulfonylurea receptor binding,protein kinase binding,protein phosphatase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,identical protein binding,protein homodimerization activity,histone deacetylase binding,ion channel binding,poly(A) RNA binding,tau protein binding,GTPase binding,Rho GDP-dissociation inhibitor binding,unfolded protein binding","extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,cell surface,membrane,basolateral plasma membrane,apical plasma membrane,extracellular matrix,brush border membrane,ruffle membrane,melanosome,neuron projection,neuronal cell body,lysosomal lumen,myelin sheath,protein complex,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumen,sperm mitochondrial sheath,sperm plasma membrane",144,69,151,HLEINPDHSIIETLR.3|HLEINPDHSIIETLR.2|HLEINPDHSIIETLR.4|APFDLFENR.2|NPDDITNEEYGEFYK.2|NPDDITNEEYGEFYK.3|HIYYITGETKDQVANSAFVER.4|HIYYITGETKDQVANSAFVER.3|LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVTSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|KHLEINPDHSIIETLR.4|KHLEINPDHSIIETLR.3|KHLEINPDHSIIETLR.2|TLTIVDTGIGMTKADLINNLGTIAK.4|TLTIVDTGIGMTKADLINNLGTIAK.3|TLTIVDTGIGM[Oxi]TKADLINNLGTIAK.3|ELISNSSDALDKIR.3|ELISNSSDALDKIR.2|TLTIVDTGIGMTK.2|TLTIVDTGIGMTK.3|TLTIVDTGIGM[Oxi]TK.3|TLTIVDTGIGM[Oxi]TK.2|TKPIWTRNPDDITNEEYGEFYK.4|TKPIWTRNPDDITNEEYGEFYK.3|VFIMDNC[CAM]EELIPEYLNFIR.3|VFIMDNC[CAM]EELIPEYLNFIR.4|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|YYTSASGDEMVSLKDYC[CAM]TR.3|YYTSASGDEMVSLKDYC[CAM]TR.2|YYTSASGDEM[Oxi]VSLKDYC[CAM]TR.3|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.5|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.4|RVFIMDNC[CAM]EELIPEYLNFIR.3|RVFIMDNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|VTVITKHNDDEQYAWESSAGGSFTVR.4|VTVITKHNDDEQYAWESSAGGSFTVR.3|ALLFVPR.2|APFDLFENRK.3|APFDLFENRK.2|DQVANSAFVER.3|DQVANSAFVER.2|HIYYITGETK.3|HIYYITGETK.2|LDSGKELHINLIPNKQDR.5|LDSGKELHINLIPNKQDR.4|LDSGKELHINLIPNKQDR.3|LDSGKELHINLIPNKQDR.2|LDSGKELHINLIPNK.4|LDSGKELHINLIPNK.3|LDSGKELHINLIPNK.2|RAPFDLFENR.3|RAPFDLFENR.2|KLSELLR.2|LGIHEDSQNRK.3|LGIHEDSQNRK.2|HSQFIGYPITLFVEK.4|HSQFIGYPITLFVEK.3|HSQFIGYPITLFVEK.2|RAPFDLFENRK.3|RAPFDLFENRK.2|FYEQFSK.2|FYEQFSK.1|KHSQFIGYPITLFVEK.4|KHSQFIGYPITLFVEK.3|KHSQFIGYPITLFVEK.2|TDTGEPMGR.2|TDTGEPM[Oxi]GR.2|C[CAM]LELFTELAEDK.3|C[CAM]LELFTELAEDK.2|IMKDILEK.2|IM[Oxi]KDILEK.2|HSQFIGYPITLFVEKER.4|HSQFIGYPITLFVEKER.3|HSQFIGYPITLFVEKER.2|YYTSASGDEMVSLK.3|YYTSASGDEM[Oxi]VSLK.3|YYTSASGDEMVSLK.2|YYTSASGDEM[Oxi]VSLK.2|TKFENLC[CAM]K.2|ELHINLIPNKQDR.3|ELHINLIPNKQDR.2|C[CAM]LELFTELAEDKENYKK.4|C[CAM]LELFTELAEDKENYKK.3|C[CAM]LELFTELAEDKENYKK.2|KC[CAM]LELFTELAEDKENYK.4|KC[CAM]LELFTELAEDKENYK.3|KFYEQFSK.2|YESLTDPSKLDSGKELHINLIPNK.5|KHSQFIGYPITLFVEKER.4|KHSQFIGYPITLFVEKER.3|AQALRDNSTMGYMAAK.3|AQALRDNSTM[Oxi]GYM[Oxi]AAK.3|AQALRDNSTM[Oxi]GYMAAK.3|AQALRDNSTMGYM[Oxi]AAK.3|AQALRDNSTMGYMAAK.2|ENQKHIYYITGETK.3|ESEDKPEIEDVGSDEEEEKK.4|ESEDKPEIEDVGSDEEEEKK.3|EVSDDEAEEK.2|KTKFENLC[CAM]K.2|LGIHEDSQNR.2|QDRTLTIVDTGIGMTK.3|DNSTMGYMAAK.2|DNSTM[Oxi]GYMAAK.2|DNSTMGYM[Oxi]AAK.2|DNSTM[Oxi]GYM[Oxi]AAK.2|ELHINLIPNK.2|ELISNSSDALDK.2|ELISNSSDALDKIRYESLTDPSK.4|ELISNSSDALDKIRYESLTDPSK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.3|EIFLRELISNSSDALDK.3|EIFLRELISNSSDALDK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.5|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|C[CAM]LELFTELAEDKENYK.3|C[CAM]LELFTELAEDKENYK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|KHGLEVIYMIEPIDEYC[CAM]VQQLK.3|ESEDKPEIEDVGSDEEEEKKDGDK.4|EVSDDEAEEKEDKEEEK.3|DKEVSDDEAEEK.2|LGIHEDSQNRKK.2|TLVSVTKEGLELPEDEEEK.3|ESEDKPEIEDVGSDEEEEK.3|DLVILLYETALLSSGFSLEDPQTHANR.4|DLVILLYETALLSSGFSLEDPQTHANR.3|NIKLGIHEDSQNR.2|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.3|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|KC[CAM]LELFTELAEDK.2|PIWTRNPDDITNEEYGEFYK.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRMEEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD.4
SEN / CTL,P07942,Laminin subunit beta-1,LAMB1,3.40,1.58,7.69E-54,1.89E-53,5.27E+01,"cell adhesion,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,extracellular matrix organization,positive regulation of cell migration,neuron projection development,substrate adhesion-dependent cell spreading,endodermal cell differentiation,odontogenesis,positive regulation of epithelial cell proliferation","structural molecule activity,extracellular matrix structural constituent","extracellular region,basement membrane,laminin-1 complex,laminin-2 complex,extracellular space,extracellular matrix,laminin-8 complex,laminin-10 complex,perinuclear region of cytoplasm,extracellular exosome",156,76,100,ISGVIGPYRETVDSVER.3|C[CAM]GNTIPDDDNQVVSLSPGSR.3|C[CAM]GNTIPDDDNQVVSLSPGSR.2|SC[CAM]YQDPVTLQLAC[CAM]VC[CAM]DPGYIGSR.3|TC[CAM]SEC[CAM]QELFWGDPDVEC[CAM]R.2|GIETPQC[CAM]DQSTGQC[CAM]VC[CAM]VEGVEGPR.3|ALDPAFKIEDPYSPR.3|ALDPAFKIEDPYSPR.2|GLNC[CAM]ELC[CAM]MDFYHDLPWRPAEGR.4|IPSWTGAGFVR.2|YSDIEPSTEGEVIFR.2|YSDIEPSTEGEVIFR.3|SLDIFTVGGSGDGVVTNSAWETFQR.3|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.5|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.4|AMDLDQDVLSALAEVEQLSK.3|AMDLDQDVLSALAEVEQLSK.2|AM[Oxi]DLDQDVLSALAEVEQLSK.3|AM[Oxi]DLDQDVLSALAEVEQLSK.2|C[CAM]APGTFGFGPSGC[CAM]KPC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.5|NFLTQDSADLDSIEAVANEVLK.3|NFLTQDSADLDSIEAVANEVLK.2|QYIQDRIPSWTGAGFVR.3|ISELERNVEELKR.4|TLLAQANSKLQLLKDLER.3|TLLAQANSKLQLLKDLER.4|C[CAM]FIC[CAM]NSQDPYHETLNPDSHLIENVVTTFAPNR.4|VESLSQVEVILQHSAADIAR.3|VESLSQVEVILQHSAADIAR.2|YVVLPRPVC[CAM]FEK.3|YFAYDC[CAM]EASFPGISTGPMKK.3|GALDSITK.2|PFYYQHPER.3|PFYYQHPER.2|LLDELAGK.2|TFRPAAMLIER.3|DIRDPNFC[CAM]ER.3|RKAEM[Oxi]LQNEAK.3|YLEDKAQELAR.3|YLEDKAQELAR.2|KVENLIAK.2|LHTLGDNLLDSR.3|LHTLGDNLLDSR.2|VAVYSTC[CAM]L.2|EALEEAEK.2|ETVDSVER.2|SSDFGKTWGVYR.3|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.4|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.3|TLLAQANSK.2|ISGVIGPYR.2|IEDPYSPR.2|LNVEGEHC[CAM]DVC[CAM]K.3|LNVEGEHC[CAM]DVC[CAM]K.2|TPMTDVC[CAM]R.2|KVSEIKDILAQSPAAEPLK.4|KVSEIKDILAQSPAAEPLK.3|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.6|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.5|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.4|QSAEDILLK.2|TLDGELDEK.2|AEMLLEEAK.2|AEM[Oxi]LLEEAK.2|AEMLQNEAK.2|AEM[Oxi]LQNEAK.2|KAAQNSGEAEYIEK.3|KAAQNSGEAEYIEK.2|NC[CAM]EQC[CAM]KPFYYQHPER.4|EALEEAEKAQVAAEK.3|ESQFKEKQEEQAR.3|ESQFKEKQEEQAR.2|VDDIIC[CAM]DSR.2|KAAQNSGEAEYIEKVVYTVK.4|KAAQNSGEAEYIEKVVYTVK.3|FGYYGDALQQDC[CAM]RK.3|KAEMLQNEAK.2|LIKDVTEMMAQVEVK.3|ELAEQLEFIK.2|KVDDIIC[CAM]DSR.2|ELDSLQTEAESLDNTVK.3|ELDSLQTEAESLDNTVK.2|DRVEDVMMER.2|NIGNLFEEAEK.2|VSEIKDILAQSPAAEPLK.3|C[CAM]GGPGC[CAM]GGLVTVAHNAWQK.3|TLDGELDEKYK.2|DILAQSPAAEPLK.2|DVTEMMAQVEVK.2|AAQNSGEAEYIEK.2|AAQNSGEAEYIEKVVYTVK.3|YFQMSLEAEER.2|YYYAVYDMVVR.2|ERVESLSQVEVILQHSAADIAR.3|C[CAM]LAGYYGDPIIGSGDHC[CAM]RPC[CAM]PC[CAM]PDGPDSGR.4|EGFYDLSSEDPFGC[CAM]K.2|PC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.4|SC[CAM]AC[CAM]NPLGTIPGGNPC[CAM]DSETGHC[CAM]YC[CAM]K.3|ATGQC[CAM]LC[CAM]LPNVIGQNC[CAM]DR.2|LELPQYTSSDSDVESPYTLIDSLVLMPYC[CAM]K.3
SEN / CTL,P01033,Metalloproteinase inhibitor 1,TIMP1,3.40,2.07,8.76E-18,3.98E-18,1.74E+01,"cell activation,platelet degranulation,aging,positive regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,response to cytokine,wound healing,negative regulation of apoptotic process,negative regulation of catalytic activity,response to peptide hormone,negative regulation of membrane protein ectodomain proteolysis,cartilage development,negative regulation of trophoblast cell migration,regulation of integrin-mediated signaling pathway","protease binding,cytokine activity,protein binding,growth factor activity,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,platelet alpha granule lumen,extracellular exosome",66,7,11,EPGLC[CAM]TWQSLR.2|TYTVGC[CAM]EEC[CAM]TVFPC[CAM]LSIPC[CAM]K.3|GFQALGDAADIR.2|LQSGTHC[CAM]LWTDQLLQGSEK.3|LQSGTHC[CAM]LWTDQLLQGSEK.2|LQDGLLHITTC[CAM]SFVAPWNSLSLAQR.3|FVYTPAMESVC[CAM]GYFHR.3|FVYTPAMESVC[CAM]GYFHR.2|FVYTPAM[Oxi]ESVC[CAM]GYFHR.3|FVYTPAMESVC[CAM]GYFHR.4|SEEFLIAGK.2
SEN / CTL,P02751,Fibronectin,FN1,3.40,1.80,6.22E-122,5.59E-121,1.20E+02,"angiogenesis,regulation of protein phosphorylation,platelet degranulation,acute-phase response,cell-substrate junction assembly,cell adhesion,calcium-independent cell-matrix adhesion,positive regulation of cell proliferation,regulation of cell shape,response to wounding,positive regulation of gene expression,positive regulation of peptidase activity,peptide cross-linking,extracellular matrix disassembly,extracellular matrix organization,integrin activation,substrate adhesion-dependent cell spreading,endodermal cell differentiation,wound healing,positive regulation of axon extension,positive regulation of fibroblast proliferation,leukocyte migration,regulation of ERK1 and ERK2 cascade,positive regulation of substrate-dependent cell migration, cell attachment to substrate,negative regulation of transforming growth factor-beta secretion","protease binding,integrin binding,protein binding,collagen binding,heparin binding,peptidase activator activity","extracellular region,fibrinogen complex,basal lamina,extracellular space,endoplasmic reticulum-Golgi intermediate compartment,apical plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticle",480,126,209,TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.3|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.4|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.4|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.3|GLAFTDVDVDSIK.2|TAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTNIDRPK.5|TKTETITGFQVDAVPANGQTPIQR.3|TYLGNALVC[CAM]TC[CAM]YGGSR.2|TYLGNALVC[CAM]TC[CAM]YGGSR.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.6|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.5|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.4|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.4|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.3|VGDTYERPKDSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.4|VTWAPPPSIDLTNFLVR.2|VTWAPPPSIDLTNFLVR.3|WLPSSSPVTGYR.2|C[CAM]FDHAAGTSYVVGETWEKPYQGWMMVDC[CAM]TC[CAM]LGEGSGR.4|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.2|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.3|SYTITGLQPGTDYKIYLYTLNDNAR.3|YSFC[CAM]TDHTVLVQTR.3|YSFC[CAM]TDHTVLVQTR.2|LLC[CAM]QC[CAM]LGFGSGHFR.3|LLC[CAM]QC[CAM]LGFGSGHFR.2|HTSVQTTSSGSGPFTDVR.3|HTSVQTTSSGSGPFTDVR.2|SSPVVIDASTAIDAPSNLR.2|SSPVVIDASTAIDAPSNLR.3|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.4|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.5|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGM[Oxi]QWLK.4|STTPDITGYR.2|NTFAEVTGLSPGVTYYFK.3|NTFAEVTGLSPGVTYYFK.2|IAWESPQGQVSR.2|RPGGEPSPEGTTGQSYNQYSQR.3|FLATTPNSLLVSWQPPR.3|FLATTPNSLLVSWQPPR.2|GEWTC[CAM]IAYSQLR.2|GEWTC[CAM]IAYSQLR.3|QKTGLDSPTGIDFSDITANSFTVHWIAPR.4|GNLLQC[CAM]IC[CAM]TGNGRGEWK.3|DSMIWDC[CAM]TC[CAM]IGAGR.2|DSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.2|NLQPASEYTVSLVAIK.2|NLQPASEYTVSLVAIK.3|SYTITGLQPGTDYK.2|SYTITGLQPGTDYK.3|WSRPQAPITGYR.3|IGDQWDKQHDMGHMMR.4|IGDQWDKQHDM[Oxi]GHMMR.4|DAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.4|VDVIPVNLPGEHGQRLPISR.4|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.4|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.3|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.4|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVM[Oxi]YR.3|NLQPASEYTVSLVAIKGNQESPK.3|NLQPASEYTVSLVAIKGNQESPK.4|IYLYTLNDNAR.2|IYLYTLNDNAR.3|FTQVTPTSLSAQWTPPNVQLTGYR.3|FTQVTPTSLSAQWTPPNVQLTGYR.4|DGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.5|ITYGETGGNSPVQEFTVPGSK.2|ITYGETGGNSPVQEFTVPGSK.3|VVTPLSPPTNLHLEANPDTGVLTVSWER.3|TEIDKPSQMQVTDVQDNSISVK.3|TEIDKPSQMQVTDVQDNSISVK.4|TEIDKPSQM[Oxi]QVTDVQDNSISVK.3|QYNVGPSVSKYPLR.3|QYNVGPSVSKYPLR.2|C[CAM]TC[CAM]VGNGRGEWTC[CAM]IAYSQLR.3|NTFAEVTGLSPGVTYYFKVFAVSHGR.4|TFYSC[CAM]TTEGR.2|VPGTSTSATLTGLTR.2|VPGTSTSATLTGLTR.3|STATISGLKPGVDYTITVYAVTGR.3|STATISGLKPGVDYTITVYAVTGR.4|HYQINQQWER.3|HYQINQQWER.2|DLQFVEVTDVK.2|GLKPGVVYEGQLISIQQYGHQEVTR.4|GLKPGVVYEGQLISIQQYGHQEVTR.3|QDGHLWC[CAM]STTSNYEQDQK.3|QDGHLWC[CAM]STTSNYEQDQK.4|QDGHLWC[CAM]STTSNYEQDQK.2|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.4|RPHETGGYM[Oxi]LEC[CAM]VC[CAM]LGNGK.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.2|FTNIGPDTMR.2|ISC[CAM]TIANR.2|WKEATIPGHLNSYTIK.4|WKEATIPGHLNSYTIK.3|TETITGFQVDAVPANGQTPIQR.3|TETITGFQVDAVPANGQTPIQR.2|ITGYIIK.2|PAQGVVTTLENVSPPR.4|PAQGVVTTLENVSPPR.3|PAQGVVTTLENVSPPR.2|TYHVGEQWQK.3|TYHVGEQWQK.2|IGDQWDK.2|SDTVPSPR.2|VFAVSHGR.2|WC[CAM]HDNGVNYK.3|WC[CAM]HDNGVNYK.2|GEWTC[CAM]KPIAEK.3|GEWTC[CAM]KPIAEK.2|LGVRPSQGGEAPR.3|LGVRPSQGGEAPR.2|YTGNTYR.2|DGQERDAPIVNK.3|DGQERDAPIVNK.2|ESKPLTAQQTTK.3|ESKPLTAQQTTK.2|ITGYIIKYEKPGSPPR.4|ITGYIIKYEKPGSPPR.3|PAQGVVTTLENVSPPRR.4|PAQGVVTTLENVSPPRR.3|PAQGVVTTLENVSPPRR.2|C[CAM]TC[CAM]VGNGR.2|HRPRPYPPNVGEEIQIGHIPR.5|HRPRPYPPNVGEEIQIGHIPR.4|PLTAQQTTK.2|EATIPGHLNSYTIK.3|EATIPGHLNSYTIK.2|C[CAM]DPHEATC[CAM]YDDGK.3|C[CAM]DPHEATC[CAM]YDDGK.2|GDSPASSKPISINYR.3|GDSPASSKPISINYR.2|VGDTYERPK.2|C[CAM]HEGGQSYK.2|QYNVGPSVSK.2|YEVSVYALK.2|PRPYPPNVGEEIQIGHIPR.4|VDVIPVNLPGEHGQR.3|VDVIPVNLPGEHGQR.2|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.4|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.6|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.5|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.4|QHDMGHMMR.2|DTLTSRPAQGVVTTLENVSPPR.4|DTLTSRPAQGVVTTLENVSPPR.3|DTLTSRPAQGVVTTLENVSPPR.2|YQC[CAM]YC[CAM]YGR.2|VTIMWTPPESAVTGYR.3|VTIM[Oxi]WTPPESAVTGYR.3|VTIM[Oxi]WTPPESAVTGYR.2|VTIMWTPPESAVTGYR.2|DDKESVPISDTIIPAVPPPTDLR.4|DDKESVPISDTIIPAVPPPTDLR.3|DTLTSRPAQGVVTTLENVSPPRR.4|DTLTSRPAQGVVTTLENVSPPRR.3|EESPLLIGQQSTVSDVPR.3|EESPLLIGQQSTVSDVPR.2|GEFKC[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|C[CAM]FDHAAGTSYVVGETWEK.3|GFNC[CAM]ESKPEAEETC[CAM]FDK.3|GFNC[CAM]ESKPEAEETC[CAM]FDK.2|EINLAPDSSSVVVSGLMVATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.2|EINLAPDSSSVVVSGLMVATK.2|ESVPISDTIIPAVPPPTDLR.3|ESVPISDTIIPAVPPPTDLR.2|YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR.5|PRPGVTEATITGLEPGTEYTIYVIALK.4|PRPGVTEATITGLEPGTEYTIYVIALK.3|GNLLQC[CAM]IC[CAM]TGNGR.2|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.3|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.2|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]K.4|TGLDSPTGIDFSDITANSFTVHWIAPR.4|TGLDSPTGIDFSDITANSFTVHWIAPR.3|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.6|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.5|RQAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.4|YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK.6|QGENGQMMSC[CAM]TC[CAM]LGNGKGEFK.3|TDELPQLVTLPHPNLHGPEILDVPSTVQK.4|VTDATETTITISWR.2|WC[CAM]GTTQNYDADQK.2|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADR.3|DLEVVAATPTSLLISWDAPAVTVR.3|NSITLTNLTPGTEYVVSIVALNGR.3|VTIMWTPPESAVTGYRVDVIPVNLPGEHGQR.4|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.4|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.3|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGR.4|QGENGQMMSC[CAM]TC[CAM]LGNGK.2|C[CAM]DPVDQC[CAM]QDSETGTFYQIGDSWEK.3|QAQQM[Oxi]VQPQSPVAVSQSKPGC[CAM]YDNGK.3|QAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.3|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRK.4|EVTSDSGSIVVSGLTPGVEYVYTIQVLR.3|EEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4|LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR.4|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFR.4|NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR.4|QMLC[CAM]TC[CAM]LGNGVSC[CAM]QETAVTQTYGGNSNGEPC[CAM]VLPFTYNGR.4|VREEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4
SEN / CTL,Q16851,UTP--glucose-1-phosphate uridylyltransferase,UGP2,3.40,2.06,7.97E-05,9.28E-06,5.03E+00,"glycogen biosynthetic process,UDP-glucose metabolic process,UDP-glucuronate biosynthetic process,glucose 1-phosphate metabolic process","UTP:glucose-1-phosphate uridylyltransferase activity,protein binding,glucose binding,pyrimidine ribonucleotide binding,identical protein binding,metal ion binding","nucleus,cytosol,extracellular exosome",12,37,59,SFENSLGINVPR.2|SFENSLGINVPR.3|EFPTVPLVK.2|ILTTASSHEFEHTK.4|ILTTASSHEFEHTK.3|ILTTASSHEFEHTK.2|INKESLLPVAK.3|INKESLLPVAK.2|AHVDEFK.2|GPSVDWGK.2|GTVIIIANHGDR.3|GTVIIIANHGDR.2|LRLVEIAQVPK.3|ILTTASSHEFEHTKK.4|ILTTASSHEFEHTKK.3|RC[CAM]EFVMEVTNK.3|RC[CAM]EFVM[Oxi]EVTNK.3|RC[CAM]EFVMEVTNK.2|ARGLPDNISSVLNK.3|FLQEKGPSVDWGK.3|LVEIAQVPK.2|LGSSFTKVQDYLR.3|IYTFNQSR.2|GGTLTQYEGK.2|AMSQDGASQFQEVIR.3|AMSQDGASQFQEVIR.2|IQRPPEDSIQPYEK.3|IQRPPEDSIQPYEK.2|IFNTNNLWISLAAVK.3|IFNTNNLWISLAAVK.2|REFPTVPLVK.2|LNGGLGTSMGC[CAM]K.2|LNGGLGTSM[Oxi]GC[CAM]K.2|IFNTNNLWISLAAVKR.3|C[CAM]EFVMEVTNK.2|GLPDNISSVLNK.2|GTVIIIANHGDRIDIPPGAVLENK.4|GTVIIIANHGDRIDIPPGAVLENK.3|IDIPPGAVLENK.2|RLQEQNAIDM[Oxi]EIIVNAK.3|RLQEQNAIDMEIIVNAK.3|RLQEQNAIDMEIIVNAK.2|TLDGGLNVIQLETAVGAAIK.3|TLDGGLNVIQLETAVGAAIK.2|RFESIPDMLELDHLTVSGDVTFGK.4|RFESIPDM[Oxi]LELDHLTVSGDVTFGK.4|RFESIPDMLELDHLTVSGDVTFGK.3|TTSDLLLVMSNLYSLNAGSLTMSEK.4|TTSDLLLVMSNLYSLNAGSLTMSEK.3|TTSDLLLVMSNLYSLNAGSLTM[Oxi]SEK.3|AMSQDGASQFQEVIRQELELSVKK.4|SLIGVRNENTFLDLTVQQIEHLNK.4|SLIGVRNENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.2|TYNTDVPLVLMNSFNTDEDTK.3|AMSQDGASQFQEVIRQELELSVK.3|TYNTDVPLVLMNSFNTDEDTKK.3|LQEQNAIDMEIIVNAK.2
SEN / CTL,O43396,Thioredoxin-like protein 1,TXNL1,3.39,1.58,5.65E-06,7.59E-07,6.12E+00,"sulfate assimilation,protein folding,glycerol ether metabolic process,cellular response to oxidative stress,cell redox homeostasis,oxidation-reduction process","protein disulfide oxidoreductase activity,disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor","proteasome complex,nucleus,cytoplasm,mitochondrion,extracellular exosome",18,21,33,VGVKPVGSDPDFQPELSGAGSR.3|VGVKPVGSDPDFQPELSGAGSR.4|VGVKPVGSDPDFQPELSGAGSR.2|ISYFTFIGTPVQATNMNDFKR.3|ISYFTFIGTPVQATNM[Oxi]NDFKR.3|VRIDQYQGADAVGLEEK.3|VRIDQYQGADAVGLEEK.2|IFINLPR.2|EDGIVPLR.2|IKQHLENDPGSNEDTDIPK.4|IKQHLENDPGSNEDTDIPK.3|IDQYQGADAVGLEEK.3|IDQYQGADAVGLEEK.2|SMDFEEAER.2|FQGPDNGQGPK.2|IAPAFSSMSNK.2|IAPAFSSM[Oxi]SNK.2|AGC[CAM]EC[CAM]LNESDEHGFDNC[CAM]LRK.4|AGC[CAM]EC[CAM]LNESDEHGFDNC[CAM]LRK.3|QHLENDPGSNEDTDIPK.3|QHLENDPGSNEDTDIPK.2|SEPTQALELTEDDIKEDGIVPLR.4|SEPTQALELTEDDIKEDGIVPLR.3|GYMDLMPFINK.2|GYM[Oxi]DLMPFINK.2|AGC[CAM]EC[CAM]LNESDEHGFDNC[CAM]LR.3|ISYFTFIGTPVQATNMNDFK.3|ISYFTFIGTPVQATNMNDFK.2|MVGVKPVGSDPDFQPELSGAGSR.3|FQNVNSVTIFVQSNQGEEETTR.3|SEPTQALELTEDDIK.2|PVGSDPDFQPELSGAGSR.2|SMDFEEAERSEPTQALELTEDDIKEDGIVPLR.4
SEN / CTL,P35527,"Keratin, type I cytoskeletal 9",KRT9,3.39,2.25,2.01E-21,1.26E-21,2.09E+01,"spermatogenesis,epidermis development,skin development,intermediate filament organization",structural constituent of cytoskeleton,"extracellular space,nucleus,intermediate filament,membrane,extracellular exosome",108,54,121,GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK.4|GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK.3|GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR.3|GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR.4|QGVDADINGLR.2|TLNDMRQEYEQLIAK.3|TLNDMRQEYEQLIAK.2|TLNDM[Oxi]RQEYEQLIAK.3|TLNDM[Oxi]RQEYEQLIAK.2|NYSPYYNTIDDLKDQIVDLTVGNNK.4|NYSPYYNTIDDLKDQIVDLTVGNNK.3|HGVQELEIELQSQLSKK.3|HGVQELEIELQSQLSKK.4|HGVQELEIELQSQLSKK.2|HGVQELEIELQSQLSK.3|HGVQELEIELQSQLSK.2|EIETYHNLLEGGQEDFESSGAGK.3|EIETYHNLLEGGQEDFESSGAGK.4|IKFEM[Oxi]EQNLR.3|IKFEMEQNLR.3|IKFEMEQNLR.2|IKFEM[Oxi]EQNLR.2|M[Oxi]RLEKEIETYHNLLEGGQEDFESSGAGK.4|MRLEKEIETYHNLLEGGQEDFESSGAGK.4|MRLEKEIETYHNLLEGGQEDFESSGAGK.3|DIENQYETQITQIEHEVSSSGQEVQSSAK.4|DIENQYETQITQIEHEVSSSGQEVQSSAK.3|KGPAAIQK.2|FSSSSGYGGGSSR.3|FSSSSGYGGGSSR.2|SGGGGGGGLGSGGSIR.3|SGGGGGGGLGSGGSIR.2|IQDWYDKKGPAAIQK.4|IQDWYDKKGPAAIQK.3|IGLGGRGGSGGSYGR.3|MTLDDFR.2|M[Oxi]TLDDFR.2|IQDWYDK.2|FSSSGGGGGGGR.2|TLLDIDNTR.2|VQALEEANNDLENK.3|VQALEEANNDLENK.2|FEMEQNLR.2|FEM[Oxi]EQNLR.2|NYSPYYNTIDDLK.3|NYSPYYNTIDDLK.2|QFSSSYLSR.2|STMQELNSR.2|STM[Oxi]QELNSR.2|IQDWYDKK.2|NHKEEMSQLTGQNSGDVNVEINVAPGKDLTK.6|NHKEEM[Oxi]SQLTGQNSGDVNVEINVAPGKDLTK.5|NHKEEMSQLTGQNSGDVNVEINVAPGKDLTK.5|NHKEEM[Oxi]SQLTGQNSGDVNVEINVAPGKDLTK.4|NHKEEMSQLTGQNSGDVNVEINVAPGKDLTK.4|NHKEEM[Oxi]SQLTGQNSGDVNVEINVAPGKDLTK.3|NHKEEMSQLTGQNSGDVNVEINVAPGKDLTK.3|QEYEQLIAK.2|SDLEMQYETLQEELMALKK.4|SDLEM[Oxi]QYETLQEELM[Oxi]ALKK.4|SDLEMQYETLQEELMALKK.3|SDLEM[Oxi]QYETLQEELM[Oxi]ALKK.3|SDLEM[Oxi]QYETLQEELMALKK.3|SDLEMQYETLQEELM[Oxi]ALKK.3|SDLEM[Oxi]QYETLQEELM[Oxi]ALKK.2|SDLEM[Oxi]QYETLQEELMALKK.2|SDLEMQYETLQEELM[Oxi]ALKK.2|SDLEMQYETLQEELMALKK.2|LASYLDKVQALEEANNDLENK.4|LASYLDKVQALEEANNDLENK.3|LASYLDKVQALEEANNDLENK.2|GGSGGSYGGGGSGGGYGGGSGSR.3|GGSGGSYGGGGSGGGYGGGSGSR.2|QVLDNLTMEK.2|QVLDNLTM[Oxi]EK.2|SGGGGGGGLGSGGSIRSSYSR.3|EVTQLRHGVQELEIELQSQLSK.4|EVTQLRHGVQELEIELQSQLSK.3|DQIVDLTVGNNK.2|VQALEEANNDLENKIQDWYDKK.4|VQALEEANNDLENKIQDWYDKK.3|YC[CAM]GQLQMIQEQISNLEAQITDVR.4|YC[CAM]GQLQM[Oxi]IQEQISNLEAQITDVR.4|YC[CAM]GQLQM[Oxi]IQEQISNLEAQITDVR.3|YC[CAM]GQLQMIQEQISNLEAQITDVR.3|QVLDNLTMEKSDLEMQYETLQEELMALKK.5|QVLDNLTMEKSDLEMQYETLQEELM[Oxi]ALKK.4|QVLDNLTMEKSDLEMQYETLQEELMALKK.4|GSRGGSGGSYGGGGSGGGYGGGSGSR.3|QEIEC[CAM]QNQEYSLLLSIK.3|QEIEC[CAM]QNQEYSLLLSIK.2|LEKEIETYHNLLEGGQEDFESSGAGK.4|LEKEIETYHNLLEGGQEDFESSGAGK.3|NHKEEMSQLTGQNSGDVNVEINVAPGK.4|NHKEEM[Oxi]SQLTGQNSGDVNVEINVAPGK.4|NHKEEMSQLTGQNSGDVNVEINVAPGK.3|NHKEEM[Oxi]SQLTGQNSGDVNVEINVAPGK.3|SDLEMQYETLQEELMALK.3|SDLEM[Oxi]QYETLQEELM[Oxi]ALK.3|SDLEM[Oxi]QYETLQEELMALK.3|SDLEMQYETLQEELM[Oxi]ALK.3|SDLEM[Oxi]QYETLQEELM[Oxi]ALK.2|SDLEM[Oxi]QYETLQEELMALK.2|SDLEMQYETLQEELM[Oxi]ALK.2|SDLEMQYETLQEELMALK.2|FSSSGGGGGGGRFSSSSGYGGGSSR.3|NRKDIENQYETQITQIEHEVSSSGQEVQSSAK.5|NRKDIENQYETQITQIEHEVSSSGQEVQSSAK.4|KNHKEEMSQLTGQNSGDVNVEINVAPGK.4|QGVDADINGLRQVLDNLTMEK.3|QGVDADINGLRQVLDNLTM[Oxi]EK.3|QGVDADINGLRQVLDNLTMEK.2|LASYLDKVQALEEANNDLENKIQDWYDK.4|LASYLDKVQALEEANNDLENKIQDWYDK.3|VQALEEANNDLENKIQDWYDK.3|KDIENQYETQITQIEHEVSSSGQEVQSSAK.4|KDIENQYETQITQIEHEVSSSGQEVQSSAK.3|GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGKSSHS.4|DIENQYETQITQIEHEVSSSGQEVQSSAKEVTQLR.4|GGSGGSYGGGSGSGGGSGGGYGGGSGGGHSGGSGGGHSGGSGGNYGGGSGSGGGSGGGYGGGSGSR.5|NYSPYYNTIDDLKDQIVDLTVGNNKTLLDIDNTR.4
SEN / CTL,P13798,Acylamino-acid-releasing enzyme,APEH,3.39,1.00,4.57E-14,1.49E-14,1.38E+01,"translational termination,proteolysis,beta-amyloid metabolic process","serine-type endopeptidase activity,omega peptidase activity,poly(A) RNA binding","cytoplasm,cytosol,nuclear membrane,extracellular exosome",24,34,45,ALDVSASDDEIAR.2|ALDVSASDDEIAR.3|QVLLSEPEEAAALYR.2|QVLLSEPEEAAALYR.3|TPLLLMLGQEDR.2|TPLLLM[Oxi]LGQEDR.2|TVHTEWTQRDLER.4|VGFLPSAGK.2|VVFDSAQR.2|AESFFQTK.2|RSALYYVDLIGGK.3|RSALYYVDLIGGK.2|SFNLSALEK.2|TPLLLMLGQEDRR.3|QFLEVWEK.2|C[CAM]ELLSDDSLAVSSPR.3|C[CAM]ELLSDDSLAVSSPR.2|TVHTEWTQR.2|VTSVVVDVVPR.2|LKKPDQAIKGDQFVFYEDWGENMVSK.5|MGFAVLLVNYR.2|M[Oxi]GFAVLLVNYR.2|SALYYVDLIGGK.2|AGGTGPGEEKQFLEVWEK.3|HGPVYEDDC[CAM]FGC[CAM]LSWSHSETHLLYVAEK.5|HGPVYEDDC[CAM]FGC[CAM]LSWSHSETHLLYVAEK.4|GSTGFGQDSILSLPGNVGHQDVK.3|GSTGFGQDSILSLPGNVGHQDVK.2|QPALSAAC[CAM]LGPEVTTQYGGQYR.3|QPALSAAC[CAM]LGPEVTTQYGGQYR.2|QYLVFHDGDSVVFAGPAGNSVETRGELLSR.4|DVQFAVEQVLQEEHFDASHVALMGGSHGGFISC[CAM]HLIGQYPETYR.6|DVQFAVEQVLQEEHFDASHVALMGGSHGGFISC[CAM]HLIGQYPETYR.5|IVYLQYPSLIPHHQC[CAM]SQLC[CAM]LYDWYTK.4|IVYLQYPSLIPHHQC[CAM]SQLC[CAM]LYDWYTK.3|LLTIDQDLMVAQFSTPSLPPTLK.3|TQVPMVVMPHGGPHSSFVTAWMLFPAMLC[CAM]K.4|QDLFAVDTQVGTVTSLTAGGSGGSWK.3|QYLVFHDGDSVVFAGPAGNSVETR.3|STHALSEVEVESDSFMNAVLWLR.3|EQSVLWVSLEEAEPIPDIHWGIR.3|QLGENFSGIYC[CAM]SLLPLGC[CAM]WSADSQR.3|SRQDLFAVDTQVGTVTSLTAGGSGGSWK.3|GDQFVFYEDWGENMVSK.2|VLQPPPEQENVQYAGLDFEAILLQPGSPPDK.3
SEN / CTL,P49368,T-complex protein 1 subunit gamma,CCT3,3.38,1.45,6.39E-30,6.90E-30,2.92E+01,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,toxin transport,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,protein binding involved in protein folding,poly(A) RNA binding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,cytosol,chaperonin-containing T-complex,cytoskeleton,microtubule,plasma membrane,myelin sheath,cell body,extracellular exosome",66,49,102,TAVETAVLLLR.2|AVAQALEVIPR.2|VEKIPGGIIEDSC[CAM]VLR.3|VEKIPGGIIEDSC[CAM]VLR.2|WSSLAC[CAM]NIALDAVK.2|WSSLAC[CAM]NIALDAVK.3|TLIQNC[CAM]GASTIR.2|TLIQNC[CAM]GASTIR.3|NVLLDPQLVPGGGASEMAVAHALTEK.3|NVLLDPQLVPGGGASEM[Oxi]AVAHALTEK.4|NVLLDPQLVPGGGASEMAVAHALTEK.4|NVLLDPQLVPGGGASEM[Oxi]AVAHALTEK.3|ISIPVDISDSDMMLNIINSSITTK.3|ISIPVDISDSDM[Oxi]M[Oxi]LNIINSSITTK.3|ISIPVDISDSDM[Oxi]MLNIINSSITTK.3|ISIPVDISDSDMM[Oxi]LNIINSSITTK.3|IVSRPEELREDDVGTGAGLLEIK.4|IVSRPEELREDDVGTGAGLLEIK.5|IVSRPEELREDDVGTGAGLLEIK.3|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.4|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.5|ILQM[Oxi]EEEYIQQLC[CAM]EDIIQLKPDVVITEK.4|ILQM[Oxi]EEEYIQQLC[CAM]EDIIQLKPDVVITEK.3|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.3|ALDDMISTLK.2|ALDDM[Oxi]ISTLK.2|MLLDPMGGIVMTNDGNAILR.3|M[Oxi]LLDPM[Oxi]GGIVMTNDGNAILR.3|M[Oxi]LLDPMGGIVM[Oxi]TNDGNAILR.3|M[Oxi]LLDPMGGIVMTNDGNAILR.3|MLLDPM[Oxi]GGIVMTNDGNAILR.3|MLLDPMGGIVM[Oxi]TNDGNAILR.3|MLLDPM[Oxi]GGIVMTNDGNAILR.2|MLLDPMGGIVM[Oxi]TNDGNAILR.2|MLLDPMGGIVMTNDGNAILR.2|TIADIIR.2|ALDDMISTLKK.3|ALDDMISTLKK.2|KALDDMISTLK.3|KALDDMISTLK.2|MVQFEENGRK.3|MVQFEENGRK.2|NLQDAMQVC[CAM]R.3|NLQDAMQVC[CAM]R.2|NLQDAM[Oxi]QVC[CAM]R.2|SMIEISR.2|SM[Oxi]IEISR.2|AC[CAM]TILLR.2|GASKEILSEVER.3|GASKEILSEVER.2|KALDDMISTLKK.3|KALDDMISTLKK.2|KGESQTDIEITR.3|KGESQTDIEITR.2|QGGAPDAGQE.2|GISDLAQHYLMR.3|GISDLAQHYLM[Oxi]R.3|GISDLAQHYLMR.2|GISDLAQHYLM[Oxi]R.2|IVLLDSSLEYKK.3|IVLLDSSLEYKK.2|IPGGIIEDSC[CAM]VLR.3|IPGGIIEDSC[CAM]VLR.2|EILSEVER.2|IDDIVSGHK.2|VQSGNINAAK.2|KIGDEYFTFITDC[CAM]KDPK.4|KIGDEYFTFITDC[CAM]KDPK.3|IVSRPEELREDDVGTGAGLLEIKK.5|IVSRPEELREDDVGTGAGLLEIKK.4|IVSRPEELREDDVGTGAGLLEIKK.3|IGDEYFTFITDC[CAM]K.3|IGDEYFTFITDC[CAM]K.2|KGESQTDIEITREEDFTR.4|KGESQTDIEITREEDFTR.3|PVLVLSQNTK.2|EIQVQHPAAK.2|IDDIVSGHKK.2|MVQFEENGR.2|M[Oxi]VQFEENGR.2|KVQSGNINAAK.2|KIGDEYFTFITDC[CAM]K.3|KIGDEYFTFITDC[CAM]K.2|ELGIWEPLAVK.2|GESQTDIEITR.2|IVLLDSSLEYK.2|IGDEYFTFITDC[CAM]KDPK.3|IGDEYFTFITDC[CAM]KDPK.2|AMTGVEQWPYR.2|AM[Oxi]TGVEQWPYR.2|AKHTQENC[CAM]ETWGVNGETGTLVDMK.4|AKHTQENC[CAM]ETWGVNGETGTLVDMK.3|GESQTDIEITREEDFTR.3|KISIPVDISDSDMMLNIINSSITTK.4|KISIPVDISDSDM[Oxi]MLNIINSSITTK.3|KISIPVDISDSDMM[Oxi]LNIINSSITTK.3|KISIPVDISDSDMMLNIINSSITTK.3|KISIPVDISDSDM[Oxi]M[Oxi]LNIINSSITTK.3|EDDVGTGAGLLEIK.2|EILSEVERNLQDAMQVC[CAM]R.3|HTQENC[CAM]ETWGVNGETGTLVDM[Oxi]K.3|HTQENC[CAM]ETWGVNGETGTLVDMK.3
SEN / CTL,P17096,High mobility group protein HMG-I/HMG-Y,HMGA1,3.38,1.17,3.78E-12,1.03E-12,1.20E+01,"DNA unwinding involved in DNA replication,nucleosome disassembly,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,protein complex assembly,negative regulation of cell proliferation,response to virus,negative regulation of chromatin silencing,senescence-associated heterochromatin focus assembly,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,nuclear transport,establishment of integrated proviral latency,oncogene-induced cell senescence,positive regulation of cellular senescence","transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,DNA binding,AT DNA binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein binding,transcription factor binding,enzyme binding,ligand-dependent nuclear receptor transcription coactivator activity,retinoic acid receptor binding,peroxisome proliferator activated receptor binding,retinoid X receptor binding","nucleus,nucleoplasm,transcription factor complex,cytosol,focal adhesion,senescence-associated heterochromatin focus,RNA polymerase II transcription factor complex",24,9,13,KQPPVSPGTALVGSQKEPSEVPTPK.4|KQPPVSPGTALVGSQKEPSEVPTPK.3|KQPPVSPGTALVGSQKEPSEVPTPK.5|KLEKEEEEGISQESSEEEQ.3|SSQPLASKQEK.3|SSQPLASKQEK.2|SSQPLASK.2|EPSEVPTPK.2|KQPPVSPGTALVGSQK.3|KQPPVSPGTALVGSQK.2|SSQPLASKQEKDGTEK.3|QPPVSPGTALVGSQK.2|QPPVSPGTALVGSQKEPSEVPTPK.3
SEN / CTL,O00299,Chloride intracellular channel protein 1,CLIC1,3.37,1.92,1.85E-35,2.71E-35,3.46E+01,"chloride transport,signal transduction,regulation of ion transmembrane transport,positive regulation of osteoblast differentiation,regulation of cell cycle,regulation of mitochondrial membrane potential,platelet aggregation,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,cadherin binding involved in cell-cell adhesion,glutathione transferase activity","extracellular space,nucleus,nuclear envelope,cytoplasm,mitochondrion,plasma membrane,brush border,cell-cell adherens junction,membrane,nuclear membrane,vesicle,chloride channel complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle",114,24,42,LAALNPESNTAGLDIFAK.2|LAALNPESNTAGLDIFAK.3|GFTIPEAFR.2|FLDGNELTLADC[CAM]NLLPK.2|FLDGNELTLADC[CAM]NLLPK.3|GVTFNVTTVDTK.2|GVTFNVTTVDTK.3|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.5|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.4|KFLDGNELTLADC[CAM]NLLPK.3|KFLDGNELTLADC[CAM]NLLPK.2|VLDNYLTSPLPEEVDETSAEDEGVSQR.3|VLDNYLTSPLPEEVDETSAEDEGVSQR.4|VLDNYLTSPLPEEVDETSAEDEGVSQRK.3|VLDNYLTSPLPEEVDETSAEDEGVSQRK.4|GVTFNVTTVDTKR.3|GVTFNVTTVDTKR.2|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.3|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.4|YRGFTIPEAFR.3|YRGFTIPEAFR.2|NSNPALNDNLEKGLLK.2|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.4|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.3|EEFASTC[CAM]PDDEEIELAYEQVAK.3|EEFASTC[CAM]PDDEEIELAYEQVAK.4|LHIVQVVC[CAM]KK.3|LHIVQVVC[CAM]KK.2|YLSNAYAR.2|IEEFLEAVLC[CAM]PPRYPK.4|IEEFLEAVLC[CAM]PPRYPK.3|IEEFLEAVLC[CAM]PPRYPK.2|IEEFLEAVLC[CAM]PPR.3|IEEFLEAVLC[CAM]PPR.2|LFMVLWLK.2|LFM[Oxi]VLWLK.2|IGNC[CAM]PFSQR.2|LHIVQVVC[CAM]K.2|LC[CAM]PGGQLPFLLYGTEVHTDTNK.4|LC[CAM]PGGQLPFLLYGTEVHTDTNK.3|NSNPALNDNLEK.2|IGNC[CAM]PFSQRLFMVLWLKGVTFNVTTVDTK.4
SEN / CTL,P09496,Clathrin light chain A,CLTA,3.36,2.08,1.05E-06,1.55E-07,6.81E+00,"intracellular protein transport,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,negative regulation of epidermal growth factor receptor signaling pathway,clathrin-dependent endocytosis","molecular_function,structural molecule activity,clathrin heavy chain binding,peptide binding","cytosol,plasma membrane,membrane,cytoplasmic, membrane-bounded vesicle,clathrin coat,clathrin vesicle coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,trans-Golgi network membrane,endolysosome membrane,intracellular membrane-bounded organelle,clathrin complex",18,13,15,AIKELEEWYARQDEQLQK.4|AIKELEEWYARQDEQLQK.2|SVLISLKQAPLVH.3|AIKELEEWYAR.3|AIKELEEWYAR.2|LC[CAM]DFNPK.2|QDEQLQK.2|KQEAEWK.2|LEALDANSR.2|LQSEPESIR.2|ELEEWYAR.2|WREEQMER.2|LQSEPESIRK.2|ELEEWYARQDEQLQK.3|WREEQMERLEALDANSR.3
SEN / CTL,P01034,Cystatin-C,CST3,3.35,1.71,1.18E-15,4.39E-16,1.54E+01,"eye development,response to hypoxia,cell activation,apoptotic process,defense response,brain development,salivary gland development,embryo implantation,positive regulation of cell proliferation,response to toxic substance,response to carbohydrate,negative regulation of peptidase activity,negative regulation of collagen catabolic process,negative regulation of extracellular matrix disassembly,response to nutrient levels,response to estradiol,regulation of tissue remodeling,response to drug,circadian sleep/wake cycle, REM sleep,regulation of programmed cell death,extracellular fibril organization,cellular protein metabolic process,positive regulation of DNA replication,negative regulation of proteolysis,response to axon injury,Sertoli cell development,negative regulation of elastin catabolic process,negative regulation of blood vessel remodeling,negative regulation of cell death,cellular response to hydrogen peroxide,negative regulation of cysteine-type endopeptidase activity","beta-amyloid binding,protease binding,endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,protein binding,identical protein binding","extracellular region,basement membrane,extracellular space,lysosome,multivesicular body,endoplasmic reticulum,axon,nuclear membrane,neuronal cell body,contractile fiber,perinuclear region of cytoplasm,extracellular exosome",36,7,11,ALDFAVGEYNK.2|LVGGPMDASVEEEGVR.2|LVGGPMDASVEEEGVRR.3|LVGGPM[Oxi]DASVEEEGVRR.3|TQPNLDNC[CAM]PFHDQPHLK.4|TQPNLDNC[CAM]PFHDQPHLK.3|AFC[CAM]SFQIYAVPWQGTMTLSK.3|AFC[CAM]SFQIYAVPWQGTM[Oxi]TLSK.3|AFC[CAM]SFQIYAVPWQGTMTLSK.2|ASNDMYHSR.2|KQIVAGVNYFLDVELGR.3
SEN / CTL,P11216,"Glycogen phosphorylase, brain form",PYGB,3.35,1.91,4.29E-14,1.41E-14,1.39E+01,glycogen catabolic process,"protein binding,glycogen phosphorylase activity,pyridoxal phosphate binding","cytoplasm,membrane,extracellular exosome",36,59,102,HLEIIYAINQR.3|HLEIIYAINQR.2|VLYPNDNFFEGKELR.3|APNDFKLQDFNVGDYIEAVLDRNLAENISR.4|GLAGLGDVAEVR.2|LLPLVSDEVFIRDVAK.3|LLPLVSDEVFIRDVAK.2|IHSEIVK.2|ILVDVEK.2|FSAFLEK.2|HLDHVAALFPGDVDR.4|HLDHVAALFPGDVDR.3|HLDHVAALFPGDVDR.2|GLAGLGDVAEVRK.3|GLAGLGDVAEVRK.2|ARPEYMLPVHFYGR.4|ARPEYM[Oxi]LPVHFYGR.4|ARPEYMLPVHFYGR.3|ARPEYMLPVHFYGR.2|EYYDHLPELK.3|EYYDHLPELK.2|MSVIEEGDC[CAM]KR.3|M[Oxi]SVIEEGDC[CAM]KR.2|DYFFALAHTVR.3|DYFFALAHTVR.2|RM[Oxi]SVIEEGDC[CAM]K.3|RMSVIEEGDC[CAM]K.2|INPSSM[Oxi]FDVHVK.3|INPSSMFDVHVK.3|INPSSM[Oxi]FDVHVK.2|INPSSMFDVHVK.2|LLPLVSDEVFIR.3|LLPLVSDEVFIR.2|NNTVNTMR.2|NNTVNTM[Oxi]R.2|HLDHVAALFPGDVDRLR.4|HLDHVAALFPGDVDRLR.3|ILVDVEKVDWDK.3|ILVDVEKVDWDK.2|KLLPLVSDEVFIRDVAK.4|KLLPLVSDEVFIRDVAK.3|VEHTPDGVK.2|IGEEFLTDLSQLK.3|IGEEFLTDLSQLK.2|KTC[CAM]AYTNHTVLPEALER.4|KTC[CAM]AYTNHTVLPEALER.3|INMAHLC[CAM]VIGSHAVNGVAR.4|INMAHLC[CAM]VIGSHAVNGVAR.3|INMAHLC[CAM]VIGSHAVNGVAR.2|KLLPLVSDEVFIR.3|KLLPLVSDEVFIR.2|QAVDQISSGFFSPK.3|QAVDQISSGFFSPK.2|WPVSMFEK.2|VEDVEALDR.2|LVTSIGDVVNHDPVVGDRLK.4|LVTSIGDVVNHDPVVGDRLK.3|EPDC[CAM]FKDIVNMLMHHDR.4|IGEEFLTDLSQLKK.3|IGEEFLTDLSQLKK.2|RINMAHLC[CAM]VIGSHAVNGVAR.4|ILVDVEKVDWDKAWEITK.4|QSVFKDFYELEPEKFQNK.4|QSVFKDFYELEPEKFQNK.3|TC[CAM]FETFPDK.2|QLLNC[CAM]LHVVTLYNR.3|QLLNC[CAM]LHVVTLYNR.2|DFYELEPEK.2|MSVIEEGDC[CAM]K.2|M[Oxi]SVIEEGDC[CAM]K.2|VEDVEALDRK.2|IVNGWQVEEADDWLR.3|IVNGWQVEEADDWLR.2|QAVDQISSGFFSPKEPDC[CAM]FKDIVNMLMHHDR.6|VIPAADLSQQISTAGTEASGTGNMK.4|VIPAADLSQQISTAGTEASGTGNMK.3|VIPAADLSQQISTAGTEASGTGNM[Oxi]K.3|WLLLC[CAM]NPGLADTIVEK.3|WLLLC[CAM]NPGLADTIVEK.2|LQDFNVGDYIEAVLDR.3|LQDFNVGDYIEAVLDR.2|FSAFLEKEYK.2|LVTSIGDVVNHDPVVGDR.3|LVTSIGDVVNHDPVVGDR.2|RWLLLC[CAM]NPGLADTIVEK.3|RWLLLC[CAM]NPGLADTIVEK.2|DYFFALAHTVRDHLVGR.3|VAIQLNDTHPALSIPELM[Oxi]R.3|VAIQLNDTHPALSIPELMR.3|VAIQLNDTHPALSIPELMR.2|RMSVIEEGDC[CAM]KR.2|EIWGVEPSDLQIPPPNIPRD.3|EIWGVEPSDLQIPPPNIPRD.2|QAVDQISSGFFSPKEPDC[CAM]FK.3|WLDTQVVLAMPYDTPVPGYK.3|WLDTQVVLAMPYDTPVPGYK.2|TC[CAM]FETFPDKVAIQLNDTHPALSIPELMR.4|TC[CAM]FETFPDKVAIQLNDTHPALSIPELMR.3|VFADYEAYMQC[CAM]QAQVDQLYR.3|APNDFKLQDFNVGDYIEAVLDR.3|LQDFNVGDYIEAVLDRNLAENISR.3|VFADYEAYMQC[CAM]QAQVDQLYRNPK.3
SEN / CTL,O60664,Perilipin-3,PLIN3,3.34,1.88,1.55E-15,5.72E-16,1.52E+01,"vesicle-mediated transport,cell-cell adhesion","protein binding,cadherin binding involved in cell-cell adhesion","cytoplasm,endosome,Golgi apparatus,lipid particle,cytosol,cell-cell adherens junction,endosome membrane,membrane,transport vesicle,intracellular membrane-bounded organelle",48,35,63,TLTAAAVSGAQPILSKLEPQIASASEYAHR.4|IATSLDGFDVASVQQQR.3|IATSLDGFDVASVQQQR.2|RQVEDLQATFSSIHSFQDLSSSILAQSR.4|RQVEDLQATFSSIHSFQDLSSSILAQSR.5|RQVEDLQATFSSIHSFQDLSSSILAQSR.3|LGQMVLSGVDTVLGKSEEWADNHLPLTDAELAR.4|LGQM[Oxi]VLSGVDTVLGKSEEWADNHLPLTDAELAR.4|GLDKLEENLPILQQPTEK.3|GLDKLEENLPILQQPTEK.2|IATSLDGFDVASVQQQRQEQSYFVR.3|SVVTGGVQSVMGSR.2|SVVTGGVQSVMGSR.3|SVVTGGVQSVM[Oxi]GSR.2|TVC[CAM]DAAEKGVR.3|EPPKPEQVESR.3|EPPKPEQVESR.2|GAVQSGVDK.2|VLADTKELVSSK.3|TVC[CAM]DAAEK.2|LRQHAYEHSLGK.3|LHQMWLSWNQK.3|LHQMWLSWNQK.2|LHQM[Oxi]WLSWNQK.2|LGQMVLSGVDTVLGK.3|LGQM[Oxi]VLSGVDTVLGK.2|LGQMVLSGVDTVLGK.2|TLTAAAVSGAQPILSK.3|TLTAAAVSGAQPILSK.2|SEEWADNHLPLTDAELAR.4|SEEWADNHLPLTDAELAR.3|SEEWADNHLPLTDAELAR.2|LEPQIASASEYAHR.3|LEPQIASASEYAHR.2|QLQGPEKEPPKPEQVESR.4|QLQGPEKEPPKPEQVESR.3|DTVATQLSEAVDATR.3|DTVATQLSEAVDATR.2|QEQSYFVR.2|GAVQSGVDKTK.2|LEENLPILQQPTEK.3|LEENLPILQQPTEK.2|QHAYEHSLGK.2|QRAQEALLQLSQVLSLMETVK.4|QRAQEALLQLSQVLSLMETVK.3|VSGAQEMVSSAK.2|VSGAQEM[Oxi]VSSAK.2|DIAQQLQATC[CAM]TSLGSSIQGLPTNVK.4|DIAQQLQATC[CAM]TSLGSSIQGLPTNVK.3|AQEALLQLSQVLSLMETVK.3|AQEALLQLSQVLSLMETVK.2|QVEDLQATFSSIHSFQDLSSSILAQSR.4|QVEDLQATFSSIHSFQDLSSSILAQSR.3|VASMPLISSTC[CAM]DMVSAAYASTK.3|VASMPLISSTC[CAM]DMVSAAYASTK.2|EALDHMVEYVAQNTPVTWLVGPFAPGITEKAPEEKK.5|EALDHMVEYVAQNTPVTWLVGPFAPGITEKAPEEKK.4|EALDHMVEYVAQNTPVTWLVGPFAPGITEK.4|EALDHMVEYVAQNTPVTWLVGPFAPGITEK.3|DIAQQLQATC[CAM]TSLGSSIQGLPTNVKDQVQQAR.4|DIAQQLQATC[CAM]TSLGSSIQGLPTNVKDQVQQAR.3|VSGAQEMVSSAKDTVATQLSEAVDATR.3|EALDHMVEYVAQNTPVTWLVGPFAPGITEKAPEEK.4
SEN / CTL,P15531,Nucleoside diphosphate kinase A,NME1,3.34,0.91,2.42E-04,2.58E-05,4.59E+00,"negative regulation of myeloid leukocyte differentiation,purine nucleotide metabolic process,nucleoside diphosphate phosphorylation,GTP biosynthetic process,pyrimidine nucleotide metabolic process,UTP biosynthetic process,CTP biosynthetic process,DNA metabolic process,endocytosis,negative regulation of cell proliferation,nucleoside triphosphate biosynthetic process,negative regulation of gene expression,positive regulation of neuron projection development,response to amine,nucleobase-containing small molecule interconversion,hippocampus development,response to testosterone,cellular response to drug,regulation of apoptotic process,positive regulation of DNA binding,positive regulation of epithelial cell proliferation,response to cAMP,cellular response to glucose stimulus,cellular response to fatty acid","magnesium ion binding,RNA polymerase II regulatory region sequence-specific DNA binding,single-stranded DNA binding,deoxyribonuclease activity,nucleoside diphosphate kinase activity,protein binding,ATP binding,GTP binding,intermediate filament binding,protein kinase binding,identical protein binding,gamma-tubulin binding,ribosomal small subunit binding,poly(A) RNA binding","nucleus,cytoplasm,mitochondrial outer membrane,centrosome,cytosol,intermediate filament,membrane,ruffle membrane,perinuclear region of cytoplasm,extracellular exosome",6,9,22,YMHSGPVVAMVWEGLNVVK.3|YMHSGPVVAMVWEGLNVVK.4|YM[Oxi]HSGPVVAMVWEGLNVVK.4|YM[Oxi]HSGPVVAMVWEGLNVVK.3|YMHSGPVVAM[Oxi]VWEGLNVVK.3|YM[Oxi]HSGPVVAM[Oxi]VWEGLNVVK.3|YM[Oxi]HSGPVVAM[Oxi]VWEGLNVVK.2|YM[Oxi]HSGPVVAMVWEGLNVVK.2|YMHSGPVVAM[Oxi]VWEGLNVVK.2|YMHSGPVVAMVWEGLNVVK.2|EHYVDLK.2|NIIHGSDSVESAEK.3|NIIHGSDSVESAEK.2|EHYVDLKDRPFFAGLVK.4|FMQASEDLLKEHYVDLK.4|FMQASEDLLKEHYVDLK.2|FMQASEDLLKEHYVDLKDRPFFAGLVK.6|FMQASEDLLKEHYVDLKDRPFFAGLVK.5|DRPFFAGLVK.2|FMQASEDLLK.2|FM[Oxi]QASEDLLK.2|EIGLWFHPEELVDYTSC[CAM]AQNWIYE.3
SEN / CTL,P48643,T-complex protein 1 subunit epsilon,CCT5,3.32,1.71,1.33E-25,1.21E-25,2.49E+01,"protein folding,binding of sperm to zona pellucida,response to virus,positive regulation of telomere maintenance via telomerase,protein stabilization,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,G-protein beta-subunit binding,beta-tubulin binding,unfolded protein binding","zona pellucida receptor complex,nucleolus,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome",66,49,103,DVDFELIKVEGK.3|DVDFELIKVEGK.2|AFADALEVIPMALSENSGM[Oxi]NPIQTMTEVR.3|AFADALEVIPM[Oxi]ALSENSGMNPIQTMTEVR.3|AFADALEVIPMALSENSGMNPIQTMTEVR.3|AFADALEVIPMALSENSGM[Oxi]NPIQTMTEVR.4|AFADALEVIPM[Oxi]ALSENSGMNPIQTMTEVR.4|AFADALEVIPMALSENSGMNPIQTMTEVR.4|AFADALEVIPMALSENSGMNPIQTM[Oxi]TEVR.3|WVGGPEIELIAIATGGR.2|WVGGPEIELIAIATGGR.3|QQISLATQMVR.2|QQISLATQM[Oxi]VR.2|IAILTC[CAM]PFEPPKPK.4|IAILTC[CAM]PFEPPKPK.3|IAILTC[CAM]PFEPPKPK.2|AVTIFIR.2|LMVELSK.2|LM[Oxi]VELSK.2|MIIEEAK.2|TKHKLDVTSVEDYK.4|TKHKLDVTSVEDYK.3|GVIVDKDFSHPQMPK.4|GVIVDKDFSHPQM[Oxi]PK.4|GVIVDKDFSHPQMPK.3|GVIVDKDFSHPQM[Oxi]PK.3|QQHVIETLIGK.3|QQHVIETLIGK.2|LM[Oxi]GLEALK.2|RSLHDALC[CAM]VIR.3|RSLHDALC[CAM]VIR.2|FSELTAEK.2|IDDIRKPGESEE.3|IDDIRKPGESEE.2|QQHVIETLIGKK.3|QQHVIETLIGKK.2|VAIEHLDK.2|HKLDVTSVEDYKALQK.4|HKLDVTSVEDYKALQK.3|KQQISLATQMVR.3|KQQISLATQMVR.2|EKFEEMIQQIK.3|EKFEEMIQQIK.2|EKFEEM[Oxi]IQQIK.2|GTNDMKQQHVIETLIGK.4|GTNDMKQQHVIETLIGK.3|HKLDVTSVEDYK.3|HKLDVTSVEDYK.2|MIIEEAKR.2|EMNPALGIDC[CAM]LHK.3|EM[Oxi]NPALGIDC[CAM]LHK.3|EMNPALGIDC[CAM]LHK.2|EM[Oxi]NPALGIDC[CAM]LHK.2|TSLGPNGLDK.2|MLVIEQC[CAM]K.2|M[Oxi]LVIEQC[CAM]K.2|EMNPALGIDC[CAM]LHKGTNDMK.4|DFSHPQMPK.2|DFSHPQM[Oxi]PK.2|ISDSVLVDIK.2|IADGYEQAAR.2|ISDSVLVDIKDTEPLIQTAK.4|ISDSVLVDIKDTEPLIQTAK.3|ISDSVLVDIKDTEPLIQTAK.2|DTEPLIQTAK.2|LGFAGLVQEISFGTTK.3|LGFAGLVQEISFGTTK.2|RDVDFELIK.2|FEEMIQQIK.2|FEEM[Oxi]IQQIK.2|LDVTSVEDYK.2|SLHDALC[CAM]VIR.2|VAIEHLDKISDSVLVDIKDTEPLIQTAK.5|VAIEHLDKISDSVLVDIKDTEPLIQTAK.4|VAIEHLDKISDSVLVDIKDTEPLIQTAK.3|C[CAM]PTLEQYAMR.2|C[CAM]PTLEQYAM[Oxi]R.2|LGFAGLVQEISFGTTKDK.3|QM[Oxi]AEIAVNAVLTVADMER.3|QMAEIAVNAVLTVADM[Oxi]ER.3|QMAEIAVNAVLTVADMER.3|QM[Oxi]AEIAVNAVLTVADM[Oxi]ER.3|QMAEIAVNAVLTVADMER.2|DGDVTVTNDGATILSMMDVDHQIAK.4|DGDVTVTNDGATILSMMDVDHQIAK.3|DGDVTVTNDGATILSMM[Oxi]DVDHQIAK.3|QMAEIAVNAVLTVADMERR.3|VVYGGGAAEISC[CAM]ALAVSQEADK.3|VVYGGGAAEISC[CAM]ALAVSQEADK.2|M[Oxi]MVDKDGDVTVTNDGATILSMMDVDHQIAK.4|MM[Oxi]VDKDGDVTVTNDGATILSMMDVDHQIAK.4|MMVDKDGDVTVTNDGATILSM[Oxi]MDVDHQIAK.4|MMVDKDGDVTVTNDGATILSMMDVDHQIAK.4|M[Oxi]M[Oxi]VDKDGDVTVTNDGATILSMMDVDHQIAK.4|MMVDKDGDVTVTNDGATILSMMDVDHQIAK.3|ETGANLAIC[CAM]QWGFDDEANHLLLQNNLPAVR.4|ETGANLAIC[CAM]QWGFDDEANHLLLQNNLPAVR.3|FSELTAEKLGFAGLVQEISFGTTK.3|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAMR.4|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAM[Oxi]R.4|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAM[Oxi]R.3|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAMR.3|YEKEKFEEMIQQIK.2
SEN / CTL,O60568,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,3.32,1.80,1.15E-33,1.54E-33,3.28E+01,"in utero embryonic development,endothelial cell morphogenesis,protein localization,neural tube development,collagen fibril organization,cellular response to hormone stimulus,vasodilation,epidermis morphogenesis,oxidation-reduction process,lung morphogenesis,basement membrane assembly","iron ion binding,protein binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding,procollagen glucosyltransferase activity,procollagen galactosyltransferase activity","endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",114,41,68,TLGLGEEWRGGDVAR.3|GRDPVNPEKLLVITVATAETEGYLR.4|VFLAVFVEQPTPFLPR.2|VFLAVFVEQPTPFLPR.3|LAGGYENVPTVDIHMK.3|LAGGYENVPTVDIHMK.2|QVGYEDQWLQLLR.2|QVGYEDQWLQLLR.3|SEDYVELVQR.2|LVGPEEALSPGEAR.2|VGVWNVPYISQAYVIR.3|VGVWNVPYISQAYVIR.2|FLNSGGFIGFATTIHQIVR.3|FLNSGGFIGFATTIHQIVR.2|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGKR.4|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGKR.3|RVGVWNVPYISQAYVIR.3|IFQNLNGALDEVVLKFDR.3|TYVGPMTESLFPGYHTK.3|TYVGPM[Oxi]TESLFPGYHTK.3|TYVGPM[Oxi]TESLFPGYHTK.2|YKDDDDDQLFYTR.3|YKDDDDDQLFYTR.2|DKGIFLHLSNQHEFGR.4|DKGIFLHLSNQHEFGR.3|GIFLHLSNQHEFGR.4|GIFLHLSNQHEFGR.3|GIFLHLSNQHEFGR.2|LTHYHEGLPTTWGTR.4|LTHYHEGLPTTWGTR.3|VIAPMLSR.2|AVMNFVVR.2|AVM[Oxi]NFVVR.2|LSLNLDHK.2|LYLDPGLR.2|NVAYDTLPIVVHGNGPTK.4|NVAYDTLPIVVHGNGPTK.3|NVAYDTLPIVVHGNGPTK.2|GWALLHPGR.2|DMAMDLC[CAM]R.2|GRDPVNPEK.2|TLPGGQPPPR.2|TLGLGEEWR.2|YRPDEQPSLRPHHDSSTFTLNVALNHK.6|YRPDEQPSLRPHHDSSTFTLNVALNHK.5|YRPDEQPSLRPHHDSSTFTLNVALNHK.4|GLDYEGGGC[CAM]R.2|IRNVAYDTLPIVVHGNGPTK.4|YDC[CAM]VISSPR.2|IFQNLNGALDEVVLK.3|IFQNLNGALDEVVLK.2|LLVITVATAETEGYLR.3|LLVITVATAETEGYLR.2|DVFSGSDTDPDMAFC[CAM]K.3|DVFSGSDTDPDMAFC[CAM]K.2|DVFSGSDTDPDM[Oxi]AFC[CAM]K.2|LLLLDYPPDR.2|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.6|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.5|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.4|YDTEHLHPDLWQIFDNPVDWK.4|YDTEHLHPDLWQIFDNPVDWK.3|LWSNFWGALSPDEYYAR.3|LWSNFWGALSPDEYYAR.2|RFLNSGGFIGFATTIHQIVR.3|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGK.4|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGK.3|LQLNYLGNYVPNGWTPEGGC[CAM]GFC[CAM]NQDRR.3
SEN / CTL,Q99627,COP9 signalosome complex subunit 8,COPS8,3.32,1.85,4.69E-04,4.83E-05,4.32E+00,"nucleotide-excision repair, DNA damage recognition,transcription-coupled nucleotide-excision repair,activation of NF-kappaB-inducing kinase activity,negative regulation of cell proliferation,COP9 signalosome assembly,cullin deneddylation",,"nucleus,nucleoplasm,cytoplasm,COP9 signalosome,perinuclear region of cytoplasm,extracellular exosome",12,11,17,KPVAGALDVSFNK.3|KPVAGALDVSFNK.2|FIPLSEPAPVPPIPNEQQLAR.3|FIPLSEPAPVPPIPNEQQLAR.4|FIPLSEPAPVPPIPNEQQLAR.2|PVAVM[Oxi]AESAFSFKK.3|PVAVMAESAFSFKK.3|GILEQGWQADSTTR.3|GILEQGWQADSTTR.2|SANSELGGIWSVGQR.3|SANSELGGIWSVGQR.2|LTDYVAFLEN.2|PVAVMAESAFSFK.2|DFPGIYTTINAHQWSETVQPIMEALRDATR.4|KPVAGALDVSFNKFIPLSEPAPVPPIPNEQQLAR.4|DFPGIYTTINAHQWSETVQPIMEALR.3|LLDQC[CAM]ENQELEAPGGIATPPVYGQLLALYLLHNDMNNAR.4
SEN / CTL,P68032,"Actin, alpha cardiac muscle 1",ACTC1,3.31,3.18,3.70E-58,9.51E-58,5.70E+01,"apoptotic process,positive regulation of gene expression,actin filament-based movement,muscle filament sliding,skeletal muscle thin filament assembly,actomyosin structure organization,actin-myosin filament sliding,response to drug,negative regulation of apoptotic process,response to ethanol,cardiac myofibril assembly,cardiac muscle tissue morphogenesis,heart contraction,cardiac muscle contraction,mesenchyme migration","ATP binding,ATPase activity,myosin binding","extracellular space,cytoplasm,cytosol,actin filament,focal adhesion,membrane,sarcomere,lamellipodium,filopodium,I band,actomyosin, actin portion,cell body,extracellular exosome,blood microparticle",384,27,97,SYELPDGQVITIGNER.2|SYELPDGQVITIGNER.3|HQGVMVGMGQKDSYVGDEAQSKR.5|HQGVMVGMGQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.4|HQGVMVGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.3|VAPEEHPTLLTEAPLNPK.3|VAPEEHPTLLTEAPLNPK.2|VAPEEHPTLLTEAPLNPK.4|HQGVMVGMGQKDSYVGDEAQSK.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.4|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.4|HQGVMVGMGQKDSYVGDEAQSK.3|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.3|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.3|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.3|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.6|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.5|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|LDLAGRDLTDYLMK.3|LDLAGRDLTDYLMK.2|LDLAGRDLTDYLM[Oxi]K.3|LDLAGRDLTDYLM[Oxi]K.2|YPIEHGIITNWDDMEKIWHHTFYNELR.6|YPIEHGIITNWDDMEKIWHHTFYNELR.5|YPIEHGIITNWDDMEKIWHHTFYNELR.4|YPIEHGIITNWDDMEKIWHHTFYNELR.3|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.5|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.4|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.3|EITALAPSTMK.2|EITALAPSTM[Oxi]K.2|DLTDYLMK.2|DLTDYLMK.1|DLTDYLM[Oxi]K.2|AVFPSIVGRPR.3|AVFPSIVGRPR.2|EKLC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|AGFAGDDAPR.2|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.3|SYELPDGQVITIGNERFR.3|SYELPDGQVITIGNERFR.4|MQKEITALAPSTMKIK.4|M[Oxi]QKEITALAPSTM[Oxi]KIK.4|GILTLKYPIEHGIITNWDDMEK.4|GILTLKYPIEHGIITNWDDMEK.3|GILTLKYPIEHGIITNWDDM[Oxi]EK.4|MQKEITALAPSTMK.3|MQKEITALAPSTMK.2|M[Oxi]QKEITALAPSTMK.3|MQKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.2|M[Oxi]QKEITALAPSTMK.2|MQKEITALAPSTM[Oxi]K.2|RGILTLKYPIEHGIITNWDDMEK.5|RGILTLKYPIEHGIITNWDDMEK.4|RGILTLKYPIEHGIITNWDDMEK.3|IWHHTFYNELR.3|IWHHTFYNELR.2|YPIEHGIITNWDDMEK.3|YPIEHGIITNWDDMEK.2|YPIEHGIITNWDDM[Oxi]EK.3|YPIEHGIITNWDDMEK.4|YPIEHGIITNWDDM[Oxi]EK.2|GYSFVTTAEREIVR.3|GYSFVTTAEREIVR.2|LDLAGRDLTDYLMKILTER.3|LDLAGRDLTDYLMKILTER.4|LDLAGRDLTDYLM[Oxi]KILTER.4|LDLAGRDLTDYLM[Oxi]KILTER.3|AGFAGDDAPRAVFPSIVGRPR.4|GYSFVTTAER.2|TTGIVLDSGDGVTHNVPIYEGYALPHAIMR.4|TTGIVLDSGDGVTHNVPIYEGYALPHAIMR.5|TTGIVLDSGDGVTHNVPIYEGYALPHAIM[Oxi]R.5|TTGIVLDSGDGVTHNVPIYEGYALPHAIM[Oxi]R.4|TTGIVLDSGDGVTHNVPIYEGYALPHAIM[Oxi]R.3|TTGIVLDSGDGVTHNVPIYEGYALPHAIMR.3|DLYANNVLSGGTTMYPGIADR.3|DLYANNVLSGGTTMYPGIADR.4|DLYANNVLSGGTTM[Oxi]YPGIADR.3|DLYANNVLSGGTTM[Oxi]YPGIADR.2|DLYANNVLSGGTTMYPGIADR.2|KDLYANNVLSGGTTMYPGIADR.3|KDLYANNVLSGGTTM[Oxi]YPGIADR.3
SEN / CTL,P55290,Cadherin-13,CDH13,3.31,1.09,2.08E-06,2.98E-07,6.53E+00,"mitotic cell cycle,positive regulation of endothelial cell proliferation,positive regulation of cell-matrix adhesion,sprouting angiogenesis,homophilic cell adhesion via plasma membrane adhesion molecules,negative regulation of cell adhesion,Rho protein signal transduction,negative regulation of cell proliferation,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,Rac protein signal transduction,lamellipodium assembly,regulation of endocytosis,positive regulation of cell migration,adherens junction organization,regulation of epidermal growth factor receptor signaling pathway,endothelial cell migration,keratinocyte proliferation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of smooth muscle cell proliferation,positive regulation of calcium-mediated signaling,positive regulation of positive chemotaxis,localization within membrane,low-density lipoprotein particle mediated signaling","calcium ion binding,low-density lipoprotein particle binding,protein homodimerization activity,cadherin binding,adiponectin binding,lipoprotein particle binding","extracellular space,cytoplasm,plasma membrane,caveola,focal adhesion,external side of plasma membrane,anchored component of membrane,neuron projection,perinuclear region of cytoplasm,extracellular exosome",12,7,9,SIVVSPILIPENQR.2|TLEGPVPLEVIVIDQNDNRPIFR.3|TLEGPVPLEVIVIDQNDNRPIFR.4|DLHPNTDPFKFEIHK.4|TLDREVIAVYQLFVETTDVNGK.4|TLDREVIAVYQLFVETTDVNGK.3|DIQGSLQDIFK.2|INENTGSVSVTR.2|SIVVSPILIPENQRQPFPR.3
SEN / CTL,P30041,Peroxiredoxin-6,PRDX6,3.31,2.37,5.92E-20,3.26E-20,1.95E+01,"response to reactive oxygen species,lipid catabolic process,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process,cell-cell adhesion,cellular oxidant detoxification","glutathione peroxidase activity,protein binding,hydrolase activity,ubiquitin protein ligase binding,peroxiredoxin activity,cadherin binding involved in cell-cell adhesion","extracellular space,cytoplasm,lysosome,cytosol,cell-cell adherens junction,membrane,cytoplasmic, membrane-bounded vesicle,extracellular exosome",78,31,62,PGGLLLGDVAPNFEANTTVGR.3|PGGLLLGDVAPNFEANTTVGR.2|PGGLLLGDVAPNFEANTTVGR.4|FHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|FHDFLGDSWGILFSHPR.3|FHDFLGDSWGILFSHPR.4|FHDFLGDSWGILFSHPR.2|DFTPVC[CAM]TTELGR.2|DFTPVC[CAM]TTELGR.3|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.6|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.4|IRFHDFLGDSWGILFSHPR.4|IRFHDFLGDSWGILFSHPR.3|VATPVDWKDGDSVMVLPTIPEEEAK.3|VATPVDWKDGDSVMVLPTIPEEEAK.4|LIALSIDSVEDHLAWSK.3|LIALSIDSVEDHLAWSK.2|ELAILLGMLDPAEKDEK.3|ELAILLGM[Oxi]LDPAEKDEK.3|ELAILLGM[Oxi]LDPAEKDEK.2|ELAILLGMLDPAEKDEK.2|LPFPIIDDRNR.3|NFDEILR.2|VVISLQLTAEKR.3|VVISLQLTAEKR.2|VATPVDWK.2|LKLSILYPATTGR.3|LKLSILYPATTGR.2|ELAILLGMLDPAEK.3|ELAILLGMLDPAEK.2|ELAILLGM[Oxi]LDPAEK.2|VVFVFGPDK.2|DINAYNC[CAM]EEPTEK.3|DINAYNC[CAM]EEPTEK.2|NRELAILLGMLDPAEKDEK.4|NRELAILLGM[Oxi]LDPAEKDEK.3|NRELAILLGMLDPAEKDEK.3|RVATPVDWK.2|LPFPIIDDR.2|NFDEILRVVISLQLTAEKR.4|NFDEILRVVISLQLTAEKR.3|VVFVFGPDKK.2|NRELAILLGMLDPAEK.3|NRELAILLGM[Oxi]LDPAEK.3|NRELAILLGMLDPAEK.2|LSILYPATTGR.2|VVISLQLTAEK.2|DGDSVM[Oxi]VLPTIPEEEAK.3|DGDSVMVLPTIPEEEAK.3|DGDSVMVLPTIPEEEAK.2|DGDSVM[Oxi]VLPTIPEEEAK.2|DGDSVMVLPTIPEEEAKK.3|DGDSVM[Oxi]VLPTIPEEEAKK.3|DGDSVMVLPTIPEEEAKK.2|DINAYNC[CAM]EEPTEKLPFPIIDDR.4|DINAYNC[CAM]EEPTEKLPFPIIDDR.3|VATPVDWKDGDSVMVLPTIPEEEAKK.4|RVATPVDWKDGDSVM[Oxi]VLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.3|DINAYNC[CAM]EEPTEKLPFPIIDDRNR.4
SEN / CTL,Q95604,"HLA class I histocompatibility antigen, Cw-17 alpha chain",HLA-C,3.30,0.57,4.87E-10,1.05E-10,9.98E+00,"antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,viral process,antigen processing and presentation,regulation of immune response,interferon-gamma-mediated signaling pathway,type I interferon signaling pathway","antigen binding,peptide antigen binding","Golgi membrane,endoplasmic reticulum,Golgi apparatus,plasma membrane,cell surface,ER to Golgi transport vesicle membrane,phagocytic vesicle membrane,early endosome membrane,MHC class I protein complex,integral component of lumenal side of endoplasmic reticulum membrane",12,2,2,APWVEQEGPEYWDRETQK.3|SWTAADTAAQISQR.2
SEN / CTL,P17301,Integrin alpha-2,ITGA2,3.30,0.85,2.27E-20,1.28E-20,1.99E+01,"response to hypoxia,positive regulation of leukocyte migration,substrate-dependent cell migration,hypotonic response,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,female pregnancy,blood coagulation,cell proliferation,animal organ morphogenesis,positive regulation of epithelial cell migration,positive regulation of alkaline phosphatase activity,response to amine,response to muscle activity,positive regulation of smooth muscle cell migration,extracellular matrix organization,mammary gland development,positive regulation of cell projection organization,cell-substrate adhesion,positive regulation of collagen biosynthetic process,positive regulation of collagen binding,response to L-ascorbic acid,cell adhesion mediated by integrin,collagen-activated signaling pathway,response to drug,positive regulation of DNA binding,skin morphogenesis,establishment of protein localization,positive regulation of translation,positive regulation of cell adhesion,positive regulation of smooth muscle contraction,viral entry into host cell,focal adhesion assembly,mesodermal cell differentiation,positive regulation of smooth muscle cell proliferation,positive regulation of inflammatory response,positive regulation of positive chemotaxis,detection of mechanical stimulus involved in sensory perception of pain,positive regulation of transmission of nerve impulse,positive regulation of phagocytosis, engulfment,hepatocyte differentiation,response to parathyroid hormone,cellular response to mechanical stimulus,cellular response to estradiol stimulus","virus receptor activity,integrin binding,protein binding,collagen binding,protein complex binding,collagen receptor activity,laminin binding,metal ion binding,protein heterodimerization activity,collagen binding involved in cell-matrix adhesion","nucleus,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,integrin alpha2-beta1 complex,axon terminus,basal part of cell,perinuclear region of cytoplasm",30,27,31,IFSGPSSEQFGYAVQQFINPK.3|IFSGPSSEQFGYAVQQFINPK.2|FGIAVLGYLNR.2|AGDISC[CAM]NADINPLK.2|VMVVVTDGESHDGSMLK.3|NAQIILK.2|ADNLVNLK.2|ILGSDGAFR.2|SVAC[CAM]DVGYPALKR.3|YAYSAASGGR.2|AVIDQC[CAM]NHDNILR.3|AVIDQC[CAM]NHDNILR.2|IPLLYDAEIHLTR.3|VVFNLNTYK.2|IGQTSSSVSFK.2|FVQGLDIGPTK.2|GNWLLVGSPWSGFPENR.3|GNWLLVGSPWSGFPENR.2|DC[CAM]GEDGLC[CAM]ISDLVLDVR.3|DC[CAM]GEDGLC[CAM]ISDLVLDVR.2|SVAC[CAM]DVGYPALK.2|C[CAM]PVDLSTATC[CAM]EK.2|NPDEIDETTELSS.2|KGILGQHQFLEGPEGIENTR.3|NPLMYLTGVQTDK.2|TQVGLIQYANNPR.2|VTTGSVPVSMATVIIHIPQYTK.3|NMVVNQAQSC[CAM]PEHIIYIQEPSDVVNSLDLR.4|QIPAAQEQPFIVSNQNK.2|STNINFYEISSDGNVPSIVHSFEDVGPK.3|VDISLENPGTSPALEAYSETAK.2
SEN / CTL,P04899,Guanine nucleotide-binding protein G(i) subunit alpha-2,GNAI2,3.28,1.07,6.42E-11,1.53E-11,1.08E+01,"activation of MAPKK activity,adenosine receptor signaling pathway,protein folding,cell cycle,signal transduction,G-protein coupled receptor signaling pathway,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,negative regulation of adenylate cyclase activity,G-protein coupled acetylcholine receptor signaling pathway,gamma-aminobutyric acid signaling pathway,response to nutrient,cell proliferation,positive regulation of cell proliferation,intracellular signal transduction,negative regulation of synaptic transmission,cell division,regulation of calcium ion transport","G-protein coupled receptor binding,GTPase activity,signal transducer activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,metal ion binding","nucleoplasm,cytoplasm,centrosome,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,midbody,cell body,membrane raft,extracellular exosome,extracellular vesicle",18,27,44,IAQSDYIPTQQDVLR.2|IAQSDYIPTQQDVLR.3|SREYQLNDSAAYYLNDLER.3|SREYQLNDSAAYYLNDLER.2|AMGNLQIDFADPSRADDAR.3|RLWADHGVQAC[CAM]FGR.4|RLWADHGVQAC[CAM]FGR.3|RLWADHGVQAC[CAM]FGR.2|MFDVGGQR.2|M[Oxi]FDVGGQR.2|TTGIVETHFTFK.3|TTGIVETHFTFK.2|DTKEIYTHFTC[CAM]ATDTK.4|DTKEIYTHFTC[CAM]ATDTK.3|MIDKNLREDGEK.3|LWADHGVQAC[CAM]FGR.3|LWADHGVQAC[CAM]FGR.2|AMGNLQIDFADPSR.3|AMGNLQIDFADPSR.2|IIHEDGYSEEEC[CAM]RQYR.4|EIYTHFTC[CAM]ATDTK.3|EIYTHFTC[CAM]ATDTK.2|VKTTGIVETHFTFK.3|IIHEDGYSEEEC[CAM]R.3|IIHEDGYSEEEC[CAM]R.2|NNLKDC[CAM]GLF.2|LFDSIC[CAM]NNK.2|NVQFVFDAVTDVIIK.3|NVQFVFDAVTDVIIK.2|AVVYSNTIQSIMAIVK.3|AVVYSNTIQSIM[Oxi]AIVK.2|AVVYSNTIQSIMAIVK.2|WFTDTSIILFLNKK.3|YDEAASYIQSK.2|ITHSPLTIC[CAM]FPEYTGANK.3|ITHSPLTIC[CAM]FPEYTGANK.2|EYQLNDSAAYYLNDLER.3|EYQLNDSAAYYLNDLER.2|NVQFVFDAVTDVIIKNNLK.3|WFTDTSIILFLNK.2|ITHSPLTIC[CAM]FPEYTGANKYDEAASYIQSK.4|ITHSPLTIC[CAM]FPEYTGANKYDEAASYIQSK.3|QLFALSC[CAM]TAEEQGVLPDDLSGVIR.3|QLFALSC[CAM]TAEEQGVLPDDLSGVIRR.3
SEN / CTL,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,3.28,1.51,4.02E-23,3.10E-23,2.25E+01,"response to reactive oxygen species,apoptotic process,inflammatory response,response to oxidative stress,negative regulation of transcription from RNA polymerase III promoter,cellular response to reactive oxygen species,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","RNA polymerase III regulatory region DNA binding,peroxidase activity,receptor binding,thioredoxin peroxidase activity,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,protein dimerization activity","extracellular space,nucleus,cytoplasm,mitochondrion,mitochondrial matrix,peroxisome,cytosol,cytoplasmic vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",54,19,35,THLPGFVEQAEALKAK.4|THLPGFVEQAEALKAK.3|LLADPTGAFGKETDLLLDDSLVSIFGNR.3|LLADPTGAFGKETDLLLDDSLVSIFGNR.4|FSMVVQDGIVK.2|FSM[Oxi]VVQDGIVK.2|GVLFGVPGAFTPGC[CAM]SK.2|GVLFGVPGAFTPGC[CAM]SK.3|LLADPTGAFGKETDLLLDDSLVSIFGNRR.4|LLADPTGAFGKETDLLLDDSLVSIFGNRR.5|LLADPTGAFGKETDLLLDDSLVSIFGNRR.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.2|KGVLFGVPGAFTPGC[CAM]SK.3|KGVLFGVPGAFTPGC[CAM]SK.2|VRLLADPTGAFGK.3|RFSM[Oxi]VVQDGIVK.3|RFSMVVQDGIVK.3|RFSMVVQDGIVK.2|RFSM[Oxi]VVQDGIVK.2|VNLAELFK.2|THLPGFVEQAEALK.3|THLPGFVEQAEALK.2|LLADPTGAFGK.2|LLADPTGAFGK.1|VGDAIPAVEVFEGEPGNK.3|VGDAIPAVEVFEGEPGNK.2|ETDLLLDDSLVSIFGNR.3|ETDLLLDDSLVSIFGNR.2|VGDAIPAVEVFEGEPGNKVNLAELFK.4|VGDAIPAVEVFEGEPGNKVNLAELFK.3|ETDLLLDDSLVSIFGNRR.3|VGDAIPAVEVFEGEPGNKVNLAELFKGK.4|GVQVVAC[CAM]LSVNDAFVTGEWGR.3|VRLLADPTGAFGKETDLLLDDSLVSIFGNR.4
SEN / CTL,Q16643,Drebrin,DBN1,3.27,1.28,1.70E-15,6.25E-16,1.52E+01,"actin filament organization,cell communication by chemical coupling,cell communication by electrical coupling,maintenance of protein location in cell,regulation of neuronal synaptic plasticity,regulation of dendrite development,neural precursor cell proliferation,cell-cell adhesion","actin binding,protein binding,profilin binding,cadherin binding involved in cell-cell adhesion","cytoplasm,plasma membrane,cell-cell adherens junction,gap junction,cell cortex,actin cytoskeleton,dendrite,growth cone,actomyosin",30,35,56,YVLINWVGEDVPDAR.2|YVLINWVGEDVPDAR.3|YVLINWVGEDVPDARK.3|MAPTPIPTRSPSDSSTASTPVAEQIER.3|M[Oxi]APTPIPTRSPSDSSTASTPVAEQIER.3|DSQAALPK.2|QQTLEAEEAKR.3|TDAAVEMK.2|TDAAVEM[Oxi]K.2|RKQQTLEAEEAK.3|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHR.6|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHR.5|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHR.4|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHR.3|LKEQSIFGDHRDEEEETHMK.5|MAPTPIPTR.2|M[Oxi]APTPIPTR.2|MEQERQEQEER.3|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHRR.6|VASASAGSC[CAM]DVPSPFNHRPGSHLDSHRR.5|LRLREDENAEPVGTTYQK.4|LRLREDENAEPVGTTYQK.3|EQQIEEHR.2|SESEVEEAAAIIAQRPDNPR.4|SESEVEEAAAIIAQRPDNPR.3|SESEVEEAAAIIAQRPDNPR.2|VMYGFC[CAM]SVK.2|VM[Oxi]YGFC[CAM]SVK.2|EQSIFGDHRDEEEETHMK.4|EQSIFGDHRDEEEETHMK.3|KSESEVEEAAAIIAQRPDNPREFFK.5|KSESEVEEAAAIIAQRPDNPREFFK.4|QQTLEAEEAK.2|KSESEVEEAAAIIAQRPDNPR.4|KSESEVEEAAAIIAQRPDNPR.3|LREDENAEPVGTTYQK.3|LREDENAEPVGTTYQK.2|SPSDSSTASTPVAEQIER.3|SPSDSSTASTPVAEQIER.2|KQQTLEAEEAK.2|EREQQIEEHR.2|SESEVEEAAAIIAQRPDNPREFFK.4|LAASGEGGLQELSGHFENQK.3|LAASGEGGLQELSGHFENQK.2|LELLAAYEEVIR.2|AAAPQAWAGPMEEPPQAQAPPR.3|AAAPQAWAGPMEEPPQAQAPPR.2|EESAADWALYTYEDGSDDLK.3|EESAADWALYTYEDGSDDLK.2|ALDEVTSSQPPPLPPPPPPAQETQEPSPILDSEETR.5|ALDEVTSSQPPPLPPPPPPAQETQEPSPILDSEETR.4|EDENAEPVGTTYQK.2|EQSIFGDHRDEEEETHMKK.3|APPPVFYNKPPEIDITC[CAM]WDADPVPEEEEGFEGGD.4|VAEFFQGVDVIVNASSVEDIDAGAIGQR.3|EGTQASEGYFSQSQEEEFAQSEELC[CAM]AK.3
SEN / CTL,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,3.27,1.44,5.49E-13,1.61E-13,1.28E+01,"MAPK cascade,mitotic cytokinesis,ER to Golgi vesicle-mediated transport,plasma membrane organization,cytoskeleton organization,common-partner SMAD protein phosphorylation,SMAD protein import into nucleus,axon guidance,Golgi to plasma membrane protein transport,positive regulation of GTPase activity,actin filament capping,membrane assembly,protein targeting to plasma membrane,cell-cell adhesion,positive regulation of interleukin-2 secretion,regulation of protein localization to plasma membrane,positive regulation of protein localization to plasma membrane","actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,calmodulin binding,phospholipid binding,ankyrin binding,protein complex binding,poly(A) RNA binding,GTPase binding,cadherin binding involved in cell-cell adhesion","nucleolus,cytoplasm,cytosol,cell-cell adherens junction,spectrin,spectrin-associated cytoskeleton,axolemma,M band,cuticular plate,protein complex,extracellular exosome",36,217,362,VQAVVAVAR.2|HQILEQAVEDYAETVHQLSK.4|HQILEQAVEDYAETVHQLSK.3|FMELLEPLNER.2|FM[Oxi]ELLEPLNER.2|LSDLQKEAEKLESEHPDQAQAILSR.5|LSDLQKEAEKLESEHPDQAQAILSR.4|LSDLQKEAEKLESEHPDQAQAILSR.3|MHTTFEHDIQALGTQVR.3|MHTTFEHDIQALGTQVR.4|M[Oxi]HTTFEHDIQALGTQVR.4|M[Oxi]HTTFEHDIQALGTQVR.3|MHTTFEHDIQALGTQVR.2|DGMAFNALIHK.3|DGM[Oxi]AFNALIHK.3|DGMAFNALIHK.2|DGM[Oxi]AFNALIHK.2|HRPDLIDFDKLKK.4|LISDINK.2|LSGIEER.2|DLTSVMR.2|EVAELTR.2|LILEVHQFSR.3|LILEVHQFSR.2|HRPDLIDFDK.3|HRPDLIDFDK.2|LEDLEVIQHR.3|LEDLEVIQHR.2|LLEVLSGERLPKPTK.4|LLEVLSGERLPKPTK.3|LLEVLSGERLPKPTK.2|QLMHSGHPSEK.3|QLM[Oxi]HSGHPSEK.3|QLMHSGHPSEK.2|HLLGVEDLLQK.3|HLLGVEDLLQK.2|LLQLTEK.2|AKDEQSAVSMLK.3|AKDEQSAVSMLK.2|AKDEQSAVSM[Oxi]LK.2|LISDINKAWERLEK.4|VDKLYAGLKDLAEER.4|VDKLYAGLKDLAEER.3|VDKLYAGLKDLAEER.2|VRLVDTGDKFR.3|ALVADSHPESER.3|ALVADSHPESER.2|LQAAYAGDKADDIQKR.4|LQAAYAGDKADDIQKR.3|NRETASELLMR.3|NRETASELLM[Oxi]R.3|NRETASELLMR.2|QRLEMNLGLQK.3|HQAFMAELASNK.3|HQAFM[Oxi]AELASNK.3|HQAFMAELASNK.2|HQAFM[Oxi]AELASNK.2|HRAFEDEM[Oxi]SGR.3|HRAFEDEMSGR.3|KHEAIETDIAAYEER.4|KHEAIETDIAAYEER.3|KHEAIETDIAAYEER.2|LISDINKAWER.3|LTTLELLEVRR.3|RLVSDGNINSDR.3|RLVSDGNINSDR.2|ELEAENYHDIK.3|ELEAENYHDIK.2|IDDIFER.2|KHNLLASK.2|QRLQALDTGWNELHK.4|QRLQALDTGWNELHK.3|RLEEAHR.2|TALPAQSAATLPAR.3|TALPAQSAATLPAR.2|AEHERELALRNELIR.4|FYHDAKEIFGR.3|KQALQDTLALYK.3|KQALQDTLALYK.2|RHEAFEK.2|TQILAASYELHK.3|TQILAASYELHK.2|EIHQFNR.2|LQAAYAGDK.2|SAATWDER.2|EAVC[CAM]EVALDYKK.3|EAVC[CAM]EVALDYKK.2|LSGIEERYKEVAELTR.4|LSGIEERYKEVAELTR.3|LSGIEERYKEVAELTR.2|EIQGHQPR.2|INAVVETGR.2|ITDLYTDLRDGR.3|VHLENMGSHDIVDGNHR.4|VHLENM[Oxi]GSHDIVDGNHR.4|VHLENMGSHDIVDGNHR.3|DVEDEILWVGER.3|DVEDEILWVGER.2|GNLEVLLFTIQSK.3|GNLEVLLFTIQSK.2|HYASEEIK.2|MWEVLESTTQTK.3|M[Oxi]WEVLESTTQTK.2|MWEVLESTTQTK.2|VAVVNQIAR.2|DTGNIGQER.2|EMIDKWEDRWEWLR.4|EMIDKWEDRWEWLR.3|EVDDLEQWIAER.3|EVDDLEQWIAER.2|HRPDLIDFDKLK.3|ILSSDDYGK.2|ELEAENYHDIKR.3|ELEAENYHDIKR.2|FMELLEPLNERK.3|FMELLEPLNERK.2|LLEVLSGER.2|LQALDTGWNELHK.3|LQALDTGWNELHK.2|PRDVSSVELLMNNHQGIK.4|PRDVSSVELLM[Oxi]NNHQGIK.4|PRDVSSVELLMNNHQGIK.3|SGHFEQAIK.2|FQIQDISVETEDNKEKK.4|HEVSASTQSTPASSR.3|HEVSASTQSTPASSR.2|KQQMLENQMEVR.3|KQQMLENQMEVR.2|AFEDEMSGR.2|AFEDEM[Oxi]SGR.2|EQWANLEQLSAIR.3|EQWANLEQLSAIR.2|HTLVEADIGIQAER.3|HTLVEADIGIQAER.2|KSNAHYNLQNAFNLAEQHLGLTK.5|KSNAHYNLQNAFNLAEQHLGLTK.4|KSNAHYNLQNAFNLAEQHLGLTK.3|LEMNLGLQK.2|AAMRETWLSENQR.3|AAMRETWLSENQR.2|EIGQSVDEVEKLIK.3|ETASELLMR.2|HEWEAHNK.2|KLPEELGRDQNTVETLQR.4|KLPEELGRDQNTVETLQR.3|KLPEELGRDQNTVETLQR.2|SLLDAC[CAM]ESR.2|EAEKLESEHPDQAQAILSR.4|EAEKLESEHPDQAQAILSR.3|EGMQLISEKPETEAVVKEK.4|KHEAIETDIAAYEERVQAVVAVAR.5|KHEAIETDIAAYEERVQAVVAVAR.4|KKEIEELQSQAQALSQEGK.4|KKEIEELQSQAQALSQEGK.3|LADLKQLWGLLIEETEKR.4|LADLKQLWGLLIEETEKR.3|LQAAYAGDKADDIQK.3|QLWGLLIEETEKR.3|IVSSSDVGHDEYSTQSLVKK.4|IVSSSDVGHDEYSTQSLVKK.3|SGHFEQAIKEGEDMIAEEHFGSEK.5|SGHFEQAIKEGEDMIAEEHFGSEK.4|SGHFEQAIKEGEDMIAEEHFGSEK.3|KHYASEEIK.2|LLTQHENIK.2|QIEAQEKPR.2|SAATWDERFSALER.3|TQILAASYELHKFYHDAKEIFGR.5|TVEKPPKFTEKGNLEVLLFTIQSK.5|TVEKPPKFTEKGNLEVLLFTIQSK.4|TVEKPPKFTEKGNLEVLLFTIQSK.3|DEQSAVSMLK.2|DLTSVNILLK.2|EASLGEASKLQQFLR.3|EASLGEASKLQQFLR.2|ENEVLEAWK.2|IHC[CAM]LENVDKALQFLKEQR.4|INAVVETGRR.2|ITDLYTDLR.2|LRLNDGNEYLFQAK.3|LRLNDGNEYLFQAK.2|NQTLQKEIQGHQPR.3|EQWANLEQLSAIRK.3|IHC[CAM]LENVDK.2|LESEHPDQAQAILSR.3|LESEHPDQAQAILSR.2|LVSDGNINSDRIQEK.3|VLDNAIETEK.2|VLVLSQDYGK.2|EGEDMIAEEHFGSEK.3|LLDPEDISVDHPDEK.3|LLDPEDISVDHPDEK.2|SWHNVYC[CAM]VINNQEMGFYK.4|SWHNVYC[CAM]VINNQEMGFYK.3|SWHNVYC[CAM]VINNQEM[Oxi]GFYK.3|TQETPSAQMEGFLNR.3|TQETPSAQM[Oxi]EGFLNR.2|TQETPSAQMEGFLNR.2|DALLSALSIQNYHLEC[CAM]NETK.4|DALLSALSIQNYHLEC[CAM]NETK.3|DALLSALSIQNYHLEC[CAM]NETK.2|ETWLSENQR.2|MPLATSTDHGHNLQTVQLLIK.4|M[Oxi]PLATSTDHGHNLQTVQLLIK.4|M[Oxi]PLATSTDHGHNLQTVQLLIK.3|MPLATSTDHGHNLQTVQLLIK.3|MPLATSTDHGHNLQTVQLLIK.2|NREASLGEASK.2|GEQVSQNGLPAEQGSPR.3|GEQVSQNGLPAEQGSPR.2|TAASGIPYHSEVPVSLK.3|TAASGIPYHSEVPVSLK.2|KHEWEAHNK.2|LTTLELLEVR.2|LVSDGNINSDR.2|SQNIVTDSSSLSAEAIR.3|SQNIVTDSSSLSAEAIR.2|DVSSVELLMNNHQGIK.3|DVSSVELLMNNHQGIK.2|EIHQFNRDVEDEILWVGER.4|EIHQFNRDVEDEILWVGER.3|EIHQFNRDVEDEILWVGER.2|HQAFMAELASNKEWLDKIEK.4|ILSSDDYGKDLTSVMR.3|ILSSDDYGKDLTSVMR.2|DQNTVETLQR.2|KQEDFMTTMDANEEK.3|KQEDFMTTMDANEEK.2|SLLDAC[CAM]ESRR.2|VAHM[Oxi]EFC[CAM]YQELC[CAM]QLAAERR.4|VAHMEFC[CAM]YQELC[CAM]QLAAERR.4|MPLATSTDHGHNLQTVQLLIKK.4|QNLLSQSHAYQQFLR.3|QNLLSQSHAYQQFLR.2|RLVSDGNINSDRIQEK.3|DLTSVNILLKK.2|EIGQSVDEVEK.2|KHQILEQAVEDYAETVHQLSK.4|KHQILEQAVEDYAETVHQLSK.3|SNAHYNLQNAFNLAEQHLGLTK.4|SNAHYNLQNAFNLAEQHLGLTK.3|EGMQLISEKPETEAVVK.3|EGM[Oxi]QLISEKPETEAVVK.3|EGMQLISEKPETEAVVK.2|EIEELQSQAQALSQEGK.3|EIEELQSQAQALSQEGK.2|LAEISDVWEEMKTTLK.3|SIITYVVTYYHYFSK.3|SIITYVVTYYHYFSK.2|WLHGLESQIQSDDYGK.3|WLHGLESQIQSDDYGK.2|AQTLPTSVVTITSESSPGK.3|AQTLPTSVVTITSESSPGK.2|DALLLWC[CAM]QMK.2|DALLLWC[CAM]QM[Oxi]K.2|DRVAHMEFC[CAM]YQELC[CAM]QLAAER.4|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.5|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.4|EVVAGSHELGQDYEHVTM[Oxi]LQER.4|EVVAGSHELGQDYEHVTMLQER.4|EVVAGSHELGQDYEHVTM[Oxi]LQER.3|EVVAGSHELGQDYEHVTMLQER.3|QALQDTLALYK.2|TAASGIPYHSEVPVSLKEAVC[CAM]EVALDYKK.5|FLQDC[CAM]QELSLWINEK.3|FLQDC[CAM]QELSLWINEK.2|FQIQDISVETEDNKEK.3|KKDALLSALSIQNYHLEC[CAM]NETK.4|KKDALLSALSIQNYHLEC[CAM]NETK.3|EAVC[CAM]EVALDYK.2|FATDGEGYKPC[CAM]DPQVIR.3|FATDGEGYKPC[CAM]DPQVIR.2|SWHNVYC[CAM]VINNQEMGFYKDAK.4|SWHNVYC[CAM]VINNQEMGFYKDAK.3|LLTQHENIKNEIDNYEEDYQK.4|LLTQHENIKNEIDNYEEDYQK.3|MAETVDTSEMVNGATEQR.3|MAETVDTSEMVNGATEQR.2|TAGYPNVNIHNFTTSWR.3|TAGYPNVNIHNFTTSWR.2|LPEELGRDQNTVETLQR.3|LPEELGRDQNTVETLQR.2|HQAFMAELASNKEWLDK.3|LVSQDNFGFDLPAVEAATK.3|LVSQDNFGFDLPAVEAATK.2|LWEYLLELLR.2|ALADEREAVQKK.2|AQTLPTSVVTITSESSPGKR.3|AQTLPTSVVTITSESSPGKR.2|HKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|HKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.5|IVSSSDVGHDEYSTQSLVK.3|IVSSSDVGHDEYSTQSLVK.2|KHYASEEIKEK.2|TQTAIASEDMPNTLTEAEK.3|TQTAIASEDM[Oxi]PNTLTEAEK.3|TQTAIASEDM[Oxi]PNTLTEAEK.2|TQTAIASEDMPNTLTEAEK.2|DLDDFQSWLSR.2|EQWLNNMQIPEKLEDLEVIQHR.4|EQWLNNMQIPEKLEDLEVIQHR.3|LYAGLKDLAEER.2|NDSFTTC[CAM]IELGK.2|SQNIVTDSSSLSAEAIRQR.3|DASVAEAWLLGQEPYLSSR.3|DASVAEAWLLGQEPYLSSR.2|KHKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|LNDGNEYLFQAK.2|QQMLENQMEVR.2|QQM[Oxi]LENQMEVR.2|VDTVNHLADELINSGHSDAATIAEWK.4|VDTVNHLADELINSGHSDAATIAEWK.3|DLMLWMEDVIR.2|VIESTQDLGNDLAGVMALQR.3|VIESTQDLGNDLAGVM[Oxi]ALQR.3|VIESTQDLGNDLAGVMALQR.2|LAEISDVWEEMK.2|LAEISDVWEEM[Oxi]K.2|LLDPEDISVDHPDEKSIITYVVTYYHYFSK.5|LLDPEDISVDHPDEKSIITYVVTYYHYFSK.4|LQQFLRDLDDFQSWLSR.3|LVSQDNFGFDLPAVEAATKK.3|FANSLVGVQQQLQAFNTYR.3|FANSLVGVQQQLQAFNTYR.2|LFDANKAELFTQSC[CAM]ADLDK.3|QLWGLLIEETEK.2|DMGEMVTQGQTDAQYMFLR.3|DMGEMVTQGQTDAQYMFLR.2|IIYIREQWANLEQLSAIR.3|AELFTQSC[CAM]ADLDK.2|DDEEMNTWIQAISSAISSDK.3|DDEEMNTWIQAISSAISSDK.2|DTGNIGQERVDTVNHLADELINSGHSDAATIAEWK.5|VAHMEFC[CAM]YQELC[CAM]QLAAER.3|VAHM[Oxi]EFC[CAM]YQELC[CAM]QLAAER.3|VAHMEFC[CAM]YQELC[CAM]QLAAER.2|EASLGEASKLQQFLRDLDDFQSWLSR.4|EQWLNNMQIPEK.2|MLTAQDMSYDEAR.2|M[Oxi]LTAQDMSYDEAR.2|MLTAQDM[Oxi]SYDEAR.2|TAASGIPYHSEVPVSLKEAVC[CAM]EVALDYK.4|KFANSLVGVQQQLQAFNTYR.3|NEIDNYEEDYQK.2|TKVIESTQDLGNDLAGVMALQR.3|EVDDLEQWIAEREVVAGSHELGQDYEHVTMLQER.5|LFDANKAELFTQSC[CAM]ADLDKWLHGLESQIQSDDYGK.5|LFDANKAELFTQSC[CAM]ADLDKWLHGLESQIQSDDYGK.4|FESLEPEMNNQASR.2|FESLEPEM[Oxi]NNQASR.2|FQIQDISVETEDNK.2|QAEAFLNNQEYVLAHTEMPTTLEGAEAAIK.4|QAEAFLNNQEYVLAHTEMPTTLEGAEAAIK.3|QEDFMTTMDANEEK.2|FFWEMAEEEGWIR.2|WDVDDWDNENSSAR.2|VSEEAESQQQWDTSK.2|VSEEAESQQQWDTSKGEQVSQNGLPAEQGSPR.4|IDDIFERSQNIVTDSSSLSAEAIR.3|MFSEADAC[CAM]ELWIDEK.2|DDEEMNTWIQAISSAISSDKHEVSASTQSTPASSR.4
SEN / CTL,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,3.27,1.90,7.96E-22,5.24E-22,2.13E+01,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,NADH metabolic process","malic enzyme activity,L-malate dehydrogenase activity,diiodophenylpyruvate reductase activity,NAD binding","extracellular space,cytoplasm,mitochondrion,centrosome,cytosol,myelin sheath,extracellular exosome",60,23,39,FVEGLPINDFSR.2|SVKVIVVGNPANTNC[CAM]LTASK.3|VIVVGNPANTNC[CAM]LTASK.2|VIVVGNPANTNC[CAM]LTASK.3|FVEGLPINDFSREK.3|EVGVYEALKDDSWLKGEFVTTVQQR.4|EVGVYEALKDDSWLKGEFVTTVQQR.3|NVIIWGNHSSTQYPDVNHAK.4|NVIIWGNHSSTQYPDVNHAK.5|NVIIWGNHSSTQYPDVNHAK.3|NVIIWGNHSSTQYPDVNHAK.2|ELTEEKESAFEFLSSA.2|ELTEEKESAFEFLSSA.3|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.5|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.6|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.4|SAPSIPKENFSC[CAM]LTR.3|SAPSIPKENFSC[CAM]LTR.2|AIC[CAM]DHVR.2|LSSAMSAAK.2|LGVTANDVK.2|DVIATDKEDVAFK.3|DVIATDKEDVAFK.2|KLSSAMSAAK.2|KLSSAM[Oxi]SAAK.2|EVGVYEALK.2|ENFSC[CAM]LTR.2|ESAFEFLSSA.2|SQGAALDKYAK.2|EVGVYEALKDDSWLK.3|EVGVYEALKDDSWLK.2|GEFVTTVQQR.2|VLVTGAAGQIAYSLLYSIGNGSVFGK.4|VLVTGAAGQIAYSLLYSIGNGSVFGK.3|DLDVAILVGSMPR.2|DLDVAILVGSM[Oxi]PR.2|DVIATDKEDVAFKDLDVAILVGSMPR.4|DVIATDKEDVAFKDLDVAILVGSM[Oxi]PR.4|DVIATDKEDVAFKDLDVAILVGSMPR.3
SEN / CTL,Q9BWD1,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,3.27,1.38,2.57E-09,5.18E-10,9.29E+00,"lipid metabolic process,fatty acid beta-oxidation",acetyl-CoA C-acetyltransferase activity,"nucleus,nucleolus,cytoplasm,mitochondrion,extracellular exosome",18,22,41,ATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.3|ATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4|TIIGSFNGALAAVPVQDLGSTVIKEVLKR.4|ILVTLLHTLER.3|ILVTLLHTLER.2|AGHFDKEIVPVLVSTR.4|AGHFDKEIVPVLVSTR.3|VAVLSQNR.2|APHLAYLR.2|GLIEVKTDEFPR.3|VNIEGGAIALGHPLGASGC[CAM]R.4|VNIEGGAIALGHPLGASGC[CAM]R.3|VNIEGGAIALGHPLGASGC[CAM]R.2|EDQDKVAVLSQNR.3|EDQDKVAVLSQNR.2|HGSNIEAMSK.2|HGSNIEAM[Oxi]SK.2|EIVPVLVSTR.2|TIIGSFNGALAAVPVQDLGSTVIK.4|TIIGSFNGALAAVPVQDLGSTVIK.3|TIIGSFNGALAAVPVQDLGSTVIK.2|IVSWSQVGVEPSIMGIGPIPAIK.4|IVSWSQVGVEPSIM[Oxi]GIGPIPAIK.3|IVSWSQVGVEPSIMGIGPIPAIK.3|IVSWSQVGVEPSIM[Oxi]GIGPIPAIK.2|IVSWSQVGVEPSIMGIGPIPAIK.2|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.5|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.4|LKPYFLTDGTGTVTPANASGINDGAAAVVLM[Oxi]K.3|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.3|ELGLNPEKVNIEGGAIALGHPLGASGC[CAM]R.4|RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4|RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.3|IGEMPLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAKK.5|VAVLSQNRTENAQK.2|IGEM[Oxi]PLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAK.4|IGEMPLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAK.4|QASVGAGIPYSVPAWSC[CAM]QM[Oxi]IC[CAM]GSGLK.3|QASVGAGIPYSVPAWSC[CAM]QMIC[CAM]GSGLK.3|TIIGSFNGALAAVPVQDLGSTVIKEVLK.3|PYFLTDGTGTVTPANASGINDGAAAVVLMK.3
SEN / CTL,P62906,60S ribosomal protein L10a,RPL10A,3.26,3.08,6.11E-05,7.21E-06,5.14E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,response to ethanol","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular exosome",24,19,35,YDAFLASESLIK.2|KYDAFLASESLIK.3|KYDAFLASESLIK.2|FSVC[CAM]VLGDQQHC[CAM]DEAK.3|FSVC[CAM]VLGDQQHC[CAM]DEAK.2|AVDIPHM[Oxi]DIEALKK.4|AVDIPHMDIEALKK.3|AVDIPHMDIEALKK.2|ILGPGLNK.2|RFSGTVR.2|VLC[CAM]LAVAVGHVK.3|VLC[CAM]LAVAVGHVK.2|VSRDTLYEAVR.3|VSRDTLYEAVR.2|AGKFPSLLTHNENMVAK.4|AGKFPSLLTHNENM[Oxi]VAK.4|AGKFPSLLTHNENMVAK.3|AGKFPSLLTHNENM[Oxi]VAK.3|AGKFPSLLTHNENMVAK.2|KVLC[CAM]LAVAVGHVK.3|EVLHGNQR.2|AVDIPHMDIEALK.3|AVDIPHM[Oxi]DIEALK.3|AVDIPHM[Oxi]DIEALK.2|AVDIPHMDIEALK.2|DTLYEAVR.2|AGKFPSLLTHNENMVAKVDEVK.5|KYDAFLASESLIKQIPR.4|KFLETVELQISLK.3|KFLETVELQISLK.2|FPSLLTHNENM[Oxi]VAK.3|FPSLLTHNENMVAK.3|FPSLLTHNENMVAK.2|VSRDTLYEAVREVLHGNQR.4|FLETVELQISLK.2
SEN / CTL,O15460,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,3.25,1.73,2.98E-13,9.19E-14,1.30E+01,"peptidyl-proline hydroxylation,oxidation-reduction process","procollagen-proline 4-dioxygenase activity,iron ion binding,electron carrier activity,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,L-ascorbic acid binding","nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,intracellular membrane-bounded organelle",36,21,24,SSWLEEDDDPVVAR.2|QFFPTDEDEIGAAK.2|YYDVMSDEEIER.2|TGVLTVASYR.2|SAADAEGYLAHPVNAYK.3|GQEFLRPC[CAM]GSTEVD.2|HAAC[CAM]PVLVGC[CAM]K.3|HAAC[CAM]PVLVGC[CAM]K.2|LDPGTISR.2|RLLSLDPSHER.3|KGTAVFWYNLLR.3|YFEQLLEEEREK.3|APQLLIAPFK.2|SQVLDYLSYAVFQLGDLHR.4|SQVLDYLSYAVFQLGDLHR.3|MQHITGLTVK.2|LLSLDPSHER.2|QLDAGEEATTTK.2|APQLLIAPFKEEDEWDSPHIVR.4|APQLLIAPFKEEDEWDSPHIVR.3|GTAVFWYNLLR.2|YFEQLLEEER.2|SAYNEGDYYHTVLWMEQVLK.3|TAELLQVANYGVGGQYEPHFDFSR.3
SEN / CTL,Q12904,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1,AIMP1,3.25,1.07,4.72E-13,1.40E-13,1.29E+01,"angiogenesis,negative regulation of endothelial cell proliferation,glucose metabolic process,tRNA aminoacylation for protein translation,apoptotic process,chemotaxis,inflammatory response,cell adhesion,signal transduction,cell-cell signaling,response to wounding,leukocyte migration,defense response to virus","tRNA binding,cytokine activity,protein binding,protein homodimerization activity,GTPase binding","extracellular space,nucleus,cytoplasm,endoplasmic reticulum,Golgi apparatus,cytosol,cell surface,membrane,aminoacyl-tRNA synthetase multienzyme complex,methionyl glutamyl tRNA synthetase complex,transport vesicle",24,25,43,KHPDADSLYVEEVDVGEIAPR.4|KHPDADSLYVEEVDVGEIAPR.3|TVVSGLVNHVPLEQMQNR.3|TVVSGLVNHVPLEQMQNR.4|TVVSGLVNHVPLEQM[Oxi]QNR.3|TVVSGLVNHVPLEQM[Oxi]QNR.2|TVVSGLVNHVPLEQMQNR.2|GAEADQIIEYLK.2|GAEADQIIEYLK.3|QQVSLLK.2|AILQATLREEK.3|AILQATLREEK.2|AILQATLR.2|IGC[CAM]IITAR.2|KQQSIAGSADSKPIDVSR.4|KQQSIAGSADSKPIDVSR.3|KQQSIAGSADSKPIDVSR.2|MVILLC[CAM]NLKPAK.3|IEILAPPNGSVPGDR.3|IEILAPPNGSVPGDR.2|AQTMSNSGIK.2|AQTM[Oxi]SNSGIK.2|MVILLC[CAM]NLK.2|GVLSQAMVMC[CAM]ASSPEK.3|GVLSQAMVMC[CAM]ASSPEK.2|QQSIAGSADSKPIDVSR.3|QQSIAGSADSKPIDVSR.2|ITFDAFPGEPDKELNPK.3|KIWEQIQPDLHTNDEC[CAM]VATYK.4|KIWEQIQPDLHTNDEC[CAM]VATYK.3|ITFDAFPGEPDK.2|MRGVLSQAMVMC[CAM]ASSPEK.3|GAEADQIIEYLKQQVSLLK.3|QELIQAEIQNGVK.2|EIEELKQELIQAEIQNGVK.3|EIEELKQELIQAEIQNGVK.2|HPDADSLYVEEVDVGEIAPR.3|GVLSQAMVMC[CAM]ASSPEKIEILAPPNGSVPGDR.4|IWEQIQPDLHTNDEC[CAM]VATYK.3|QIPFPSGTPLHANSM[Oxi]VSENVIQSTAVTTVSSGTK.4|QIPFPSGTPLHANSMVSENVIQSTAVTTVSSGTK.4|QIPFPSGTPLHANSM[Oxi]VSENVIQSTAVTTVSSGTK.3|QIPFPSGTPLHANSMVSENVIQSTAVTTVSSGTK.3
SEN / CTL,P15144,Aminopeptidase N,ANPEP,3.25,1.78,7.00E-08,1.17E-08,7.93E+00,"angiogenesis,proteolysis,cell differentiation,peptide catabolic process,viral entry into host cell","virus receptor activity,aminopeptidase activity,receptor activity,metallopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","extracellular space,lysosomal membrane,endoplasmic reticulum-Golgi intermediate compartment,cytosol,integral component of plasma membrane,external side of plasma membrane,extracellular exosome",18,60,99,DLTALSNMLPK.2|DLTALSNM[Oxi]LPK.2|FSTEYELQQLEQFKKDNEETGFGSGTR.4|GVGGSQPPDIDKTELVEPTEYLVVHLK.4|GVGGSQPPDIDKTELVEPTEYLVVHLK.5|GVGGSQPPDIDKTELVEPTEYLVVHLK.3|AQIINDAFNLASAHK.4|AQIINDAFNLASAHK.3|AQIINDAFNLASAHK.2|YRLPNTLKPDSYR.4|YRLPNTLKPDSYR.3|EATDVIIIHSK.3|EATDVIIIHSK.2|QVTPLFIHFR.3|QVTPLFIHFR.2|LPNTLKPDSYR.3|IQTQLQR.2|ALEQALEK.2|SEVYGPMK.2|VNYDEENWRK.3|VNYDEENWRK.2|VVATTQMQAADAR.3|VVATTQMQAADAR.2|VVATTQM[Oxi]QAADAR.2|ELWILNR.2|KDNEETGFGSGTR.3|QASNGVLIR.2|VTLRPYLTPNDR.3|YLSYTLNPDLIR.3|YLSYTLNPDLIR.2|EVVLQWFTENSK.3|EVVLQWFTENSK.2|KVVATTQM[Oxi]QAADAR.3|KVVATTQMQAADAR.3|KVVATTQMQAADAR.2|KVVATTQM[Oxi]QAADAR.2|VVATTQMQAADARK.3|SIQLPTTVR.2|RFSTEYELQQLEQFKK.4|RFSTEYELQQLEQFKK.3|YLSYTLNPDLIRK.3|YLSYTLNPDLIRK.2|VTLRPYLTPNDRGLYVFK.4|KVVATTQM[Oxi]QAADARK.3|KVVATTQMQAADARK.3|SEYMEGNVR.2|SEYM[Oxi]EGNVR.2|AALAC[CAM]SKELWILNR.3|ALEQALEKTK.2|DHSAIPVINR.2|WVKENKEVVLQWFTENSK.4|ENSLLFDPLSSSSSNK.3|ENSLLFDPLSSSSSNK.2|GVGGSQPPDIDK.2|TELVEPTEYLVVHLK.3|TELVEPTEYLVVHLK.2|DGRQQQDYWLIDVR.3|VNYDEENWR.2|DLMVLNDVYR.2|DLM[Oxi]VLNDVYR.2|ENKEVVLQWFTENSK.3|ENKEVVLQWFTENSK.2|DNEETGFGSGTR.2|FSTEYELQQLEQFKK.3|FSTEYELQQLEQFKK.2|PSEFNYVWIVPITSIR.3|PSEFNYVWIVPITSIR.2|QYM[Oxi]PWEAALSSLSYFK.3|QYMPWEAALSSLSYFK.3|QYM[Oxi]PWEAALSSLSYFK.2|QYMPWEAALSSLSYFK.2|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.6|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.5|VM[Oxi]AVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|RFSTEYELQQLEQFK.3|RFSTEYELQQLEQFK.2|QWMENPNNNPIHPNLR.3|QWM[Oxi]ENPNNNPIHPNLR.3|SFPC[CAM]FDEPAMK.2|ENSLLFDPLSSSSSNKER.3|ENSLLFDPLSSSSSNKER.2|MLSSFLSEDVFK.2|M[Oxi]LSSFLSEDVFK.2|QQQDYWLIDVR.2|LFNDYGGGSFSFSNLIQAVTR.3|LFNDYGGGSFSFSNLIQAVTR.2|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.4|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.3|ELWILNRYLSYTLNPDLIR.3|KLFNDYGGGSFSFSNLIQAVTR.3|KQDATSTIISITNNVIGQGLVWDFVQSNWK.4|KQDATSTIISITNNVIGQGLVWDFVQSNWK.3|SDQIGLPDFNAGAMENWGLVTYR.3|KQDATSTIISITNNVIGQGLVWDFVQSNWKK.4|DSQYEMDSEFEGELADDLAGFYR.3|FSTEYELQQLEQFK.2|STVYC[CAM]NAIAQGGEEEWDFAWEQFR.3|EIPENLMDQYSEVNAISTAC[CAM]SNGVPEC[CAM]EEMVSGLFK.4
SEN / CTL,Q01813,"ATP-dependent 6-phosphofructokinase, platelet type",PFKP,3.25,1.85,4.65E-21,2.82E-21,2.05E+01,"fructose 6-phosphate metabolic process,canonical glycolysis,cell-cell adhesion","6-phosphofructokinase activity,ATP binding,protein complex binding,metal ion binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular matrix,extracellular exosome",72,54,91,EWSGLLEELAR.2|NVIFQPVAELK.2|FTTDDSIC[CAM]VLGISKR.3|FTTDDSIC[CAM]VLGISKR.2|TFVLEVMGR.2|TFVLEVM[Oxi]GR.2|YLEEIATQMR.2|YLEEIATQM[Oxi]R.2|IIEVVDAIMTTAQSHQR.3|IIEVVDAIM[Oxi]TTAQSHQR.3|IIEVVDAIMTTAQSHQR.2|IKELVVTQLGYDTR.3|IKELVVTQLGYDTR.2|AIGVLTSGGDAQGMNAAVR.2|AIGVLTSGGDAQGMNAAVR.3|AIGVLTSGGDAQGM[Oxi]NAAVR.3|AIGVLTSGGDAQGM[Oxi]NAAVR.2|MLAIYDGFDGFAK.2|M[Oxi]LAIYDGFDGFAK.2|KEWSGLLEELAR.3|KEWSGLLEELAR.2|TNC[CAM]NVAVINVGAPAAGMNAAVR.2|TNC[CAM]NVAVINVGAPAAGMNAAVR.3|TNC[CAM]NVAVINVGAPAAGM[Oxi]NAAVR.3|TNC[CAM]NVAVINVGAPAAGM[Oxi]NAAVR.2|NGQIDKEAVQK.3|NGQIDKEAVQK.2|VGIADGHR.2|SFAGNLNTYKR.3|SFAGNLNTYKR.2|LAIKLPDDQIPK.3|LAIKLPDDQIPK.2|RFQDAVR.2|ELVVTQLGYDTR.3|ELVVTQLGYDTR.2|KFTTDDSIC[CAM]VLGISKR.4|LPDDQIPK.2|NVIFQPVAELKK.3|DLQSNVEHLTEK.3|DLQSNVEHLTEK.2|RNVIFQPVAELK.3|RNVIFQPVAELK.2|AAC[CAM]NLLQR.2|AMEWITAK.2|RLAIKLPDDQIPK.3|RNVIFQPVAELKK.3|VTILGHVQR.2|FLEHLSGAGK.2|KQTDFEHR.2|SFAGNLNTYK.2|KFTTDDSIC[CAM]VLGISK.3|KFTTDDSIC[CAM]VLGISK.2|LNIIIVAEGAIDTQNKPITSEK.4|LNIIIVAEGAIDTQNKPITSEK.3|NVLGHM[Oxi]QQGGAPSPFDRNFGTK.4|NVLGHMQQGGAPSPFDRNFGTK.4|NVLGHMQQGGAPSPFDRNFGTK.3|LPLMEC[CAM]VQMTQDVQK.3|LPLMEC[CAM]VQMTQDVQK.2|NVLGHMQQGGAPSPFDR.3|NVLGHM[Oxi]QQGGAPSPFDR.3|NVLGHM[Oxi]QQGGAPSPFDR.2|NVLGHMQQGGAPSPFDR.2|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.5|MGVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.4|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.4|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.3|MGVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.3|RLNIIIVAEGAIDTQNKPITSEK.4|RLNIIIVAEGAIDTQNKPITSEK.3|QTDFEHRIPK.2|GQIKEIGWTDVGGWTGQGGSILGTKR.4|GQIKEIGWTDVGGWTGQGGSILGTKR.3|EIGWTDVGGWTGQGGSILGTK.3|EIGWTDVGGWTGQGGSILGTK.2|GITNLC[CAM]VIGGDGSLTGANLFR.3|GITNLC[CAM]VIGGDGSLTGANLFR.2|GITNLC[CAM]VIGGDGSLTGANLFRK.3|GITNLC[CAM]VIGGDGSLTGANLFRK.2|EIGWTDVGGWTGQGGSILGTKR.3|FTTDDSIC[CAM]VLGISK.2|YKASYDVSDSGQLEHVQPWSV.3|GQIKEIGWTDVGGWTGQGGSILGTK.3|NESC[CAM]SENYTTDFIYQLYSEEGK.3|NESC[CAM]SENYTTDFIYQLYSEEGKGVFDC[CAM]RK.4|ASYDVSDSGQLEHVQPWSV.2|GLVLRNESC[CAM]SENYTTDFIYQLYSEEGK.3|EKHEEFC[CAM]VPMVMVPATVSNNVPGSDFSIGADTALNTITDTC[CAM]DR.4|HEEFC[CAM]VPMVMVPATVSNNVPGSDFSIGADTALNTITDTC[CAM]DR.4|NESC[CAM]SENYTTDFIYQLYSEEGKGVFDC[CAM]R.3|YAYLNVVGMVGSIDNDFC[CAM]GTDMTIGTDSALHR.3
SEN / CTL,Q96AG4,Leucine-rich repeat-containing protein 59,LRRC59,3.25,2.25,6.85E-07,1.05E-07,6.98E+00,cell-cell adhesion,"poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nuclear envelope,endoplasmic reticulum,endoplasmic reticulum membrane,cell-cell adherens junction,membrane,integral component of membrane,organelle membrane,mitochondrial nucleoid",18,20,32,ATILDLSC[CAM]NKLTTLPSDFC[CAM]GLTHLVK.4|LVNLQHLDLLNNKLVTLPVSFAQLK.4|WLDLKDNPLDPVLAK.3|WLDLKDNPLDPVLAK.2|AVQADQERER.3|AVQADQERER.2|RLEVEREAEK.3|LVTLPVSFAQLK.3|LVTLPVSFAQLK.2|AVQADQER.2|NKLQQLPADFGR.3|NKLQQLPADFGR.2|VAGDC[CAM]LDEK.2|LVNLQHLDLLNNK.3|LVNLQHLDLLNNK.2|ATILDLSC[CAM]NK.2|LQQLPADFGR.2|DKLDGNELDLSLSDLNEVPVK.4|DKLDGNELDLSLSDLNEVPVK.3|DKLDGNELDLSLSDLNEVPVK.2|LTTLPSDFC[CAM]GLTHLVK.3|LTTLPSDFC[CAM]GLTHLVK.2|RHEILQWVLQTDSQQ.3|RHEILQWVLQTDSQQ.2|LDGNELDLSLSDLNEVPVK.3|LDGNELDLSLSDLNEVPVK.2|GGNLRDKLDGNELDLSLSDLNEVPVK.4|GGNLRDKLDGNELDLSLSDLNEVPVK.3|DKLDGNELDLSLSDLNEVPVKELAALPK.4|DKLDGNELDLSLSDLNEVPVKELAALPK.3|HEILQWVLQTDSQQ.2|VTELQQQPLC[CAM]TSVNTIYDNAVQGLR.3
SEN / CTL,P09104,Gamma-enolase,ENO2,3.24,1.85,3.45E-19,1.79E-19,1.87E+01,"gluconeogenesis,canonical glycolysis","magnesium ion binding,phosphopyruvate hydratase activity","phosphopyruvate hydratase complex,photoreceptor inner segment,extracellular space,cytosol,plasma membrane,perikaryon,myelin sheath,extracellular exosome",66,20,33,AAVPSGASTGIYEALELRDGDKQR.4|GNPTVEVDLYTAK.2|VNQIGSVTEAIQAC[CAM]K.2|VNQIGSVTEAIQAC[CAM]K.3|LAMQEFMILPVGAESFR.2|LAMQEFMILPVGAESFR.3|YITGDQLGALYQDFVR.2|YITGDQLGALYQDFVR.3|IEEELGDEAR.2|DGKYDLDFKSPTDPSR.4|DGKYDLDFKSPTDPSR.3|EILDSRGNPTVEVDLYTAK.2|EAIDKAGYTEK.3|EAIDKAGYTEK.2|AGAAERELPLYR.3|LAQENGWGVMVSHR.3|LAQENGWGVM[Oxi]VSHR.3|LAQENGWGVMVSHR.2|LGAEVYHTLK.2|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.5|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.4|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.3|AVDHINSTIAPALISSGLSVVEQEK.4|AVDHINSTIAPALISSGLSVVEQEK.3|FTANVGIQIVGDDLTVTNPK.3|FTANVGIQIVGDDLTVTNPK.2|IVIGMDVAASEFYR.2|IVIGM[Oxi]DVAASEFYR.2|LDNLMLELDGTENK.2|LDNLM[Oxi]LELDGTENK.2|DYPVVSIEDPFDQDDWAAWSK.3|DATNVGDEGGFAPNILENSEALELVK.3|AVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENK.4
SEN / CTL,P48307,Tissue factor pathway inhibitor 2,TFPI2,3.24,1.34,2.58E-06,3.64E-07,6.44E+00,"blood coagulation,negative regulation of endopeptidase activity,cellular response to fluid shear stress","serine-type endopeptidase inhibitor activity,extracellular matrix structural constituent","proteinaceous extracellular matrix,nucleus,extracellular matrix",12,4,4,TC[CAM]DAFTYTGC[CAM]GGNDNNFVSR.2|LQVSVDDQC[CAM]EGSTEK.2|DEGLC[CAM]SANVTR.2|YFFNLSSMTC[CAM]EK.2
SEN / CTL,P16152,Carbonyl reductase [NADPH] 1,CBR1,3.24,2.15,2.55E-19,1.34E-19,1.89E+01,"drug metabolic process,cyclooxygenase pathway,epithelial cell differentiation,vitamin K metabolic process,oxidation-reduction process","carbonyl reductase (NADPH) activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,prostaglandin-E2 9-reductase activity","cytosol,extracellular exosome,extracellular vesicle",48,26,43,FHQLDIDDLQSIR.3|FHQLDIDDLQSIR.2|DVTRGQAAVQQLQAEGLSPR.3|DVTRGQAAVQQLQAEGLSPR.4|TNFFGTRDVC[CAM]TELLPLIKPQGR.4|GQAAVQQLQAEGLSPR.2|GQAAVQQLQAEGLSPR.3|DVC[CAM]TELLPLIKPQGR.3|DVC[CAM]TELLPLIKPQGR.2|GIGLAIVR.2|TNFFGTR.2|IGVTVLSR.2|KGDKILLNAC[CAM]C[CAM]PGWVR.4|KGDKILLNAC[CAM]C[CAM]PGWVR.3|ILLNAC[CAM]C[CAM]PGWVR.3|ILLNAC[CAM]C[CAM]PGWVR.2|SC[CAM]SPELQQK.2|SETITEEELVGLMNK.3|SETITEEELVGLMNK.2|SETITEEELVGLM[Oxi]NK.2|EYGGLDVLVNNAGIAFK.3|EYGGLDVLVNNAGIAFK.2|LFSGDVVLTAR.2|VADPTPFHIQAEVTM[Oxi]K.3|VADPTPFHIQAEVTMK.3|VADPTPFHIQAEVTMK.2|VADPTPFHIQAEVTM[Oxi]K.2|VVNVSSIMSVR.2|VVNVSSIM[Oxi]SVR.2|GVHQKEGWPSSAYGVTK.3|KEYGGLDVLVNNAGIAFK.3|KEYGGLDVLVNNAGIAFK.2|SETITEEELVGLMNKFVEDTKK.4|EGWPSSAYGVTK.2|DVC[CAM]TELLPLIK.2|FRSETITEEELVGLMNK.3|FRSETITEEELVGLM[Oxi]NK.3|FRSETITEEELVGLMNK.2|ALKSC[CAM]SPELQQK.2|SPEEGAETPVYLALLPPDAEGPHGQFVSEK.4|SPEEGAETPVYLALLPPDAEGPHGQFVSEK.3|SPEEGAETPVYLALLPPDAEGPHGQFVSEKR.4|ATKSPEEGAETPVYLALLPPDAEGPHGQFVSEK.4
SEN / CTL,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,3.24,0.65,4.84E-05,5.83E-06,5.23E+00,"cholesterol biosynthetic process,blood circulation,L-ascorbic acid metabolic process,oxidation-reduction process","cytochrome-b5 reductase activity, acting on NAD(P)H,AMP binding,ADP binding,flavin adenine dinucleotide binding,NAD binding","cytoplasm,mitochondrion,mitochondrial outer membrane,mitochondrial inner membrane,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,hemoglobin complex,membrane,extracellular exosome",6,25,51,SVGMIAGGTGITPMLQVIR.3|SVGM[Oxi]IAGGTGITPMLQVIR.3|SVGMIAGGTGITPM[Oxi]LQVIR.3|SVGM[Oxi]IAGGTGITPM[Oxi]LQVIR.3|SVGM[Oxi]IAGGTGITPM[Oxi]LQVIR.2|SVGM[Oxi]IAGGTGITPMLQVIR.2|SVGMIAGGTGITPM[Oxi]LQVIR.2|SVGMIAGGTGITPMLQVIR.2|LIDREIISHDTRR.4|LIDREIISHDTRR.3|FKLWYTLDR.3|GFVDLVIK.2|STPAITLESPDIKYPLR.4|STPAITLESPDIKYPLR.3|STPAITLESPDIKYPLR.2|LWYTLDR.2|EIISHDTR.2|LIDREIISHDTR.3|DILLRPELEELR.3|DILLRPELEELR.2|FALPSPQHILGLPVGQHIYLSAR.5|FALPSPQHILGLPVGQHIYLSAR.4|FALPSPQHILGLPVGQHIYLSAR.3|AIMKDPDDHTVC[CAM]HLLFANQTEK.5|AIMKDPDDHTVC[CAM]HLLFANQTEK.4|AIMKDPDDHTVC[CAM]HLLFANQTEK.3|DPDDHTVC[CAM]HLLFANQTEK.4|DPDDHTVC[CAM]HLLFANQTEK.3|DPDDHTVC[CAM]HLLFANQTEK.2|GPSGLLVYQGK.2|FRFALPSPQHILGLPVGQHIYLSAR.5|DILLRPELEELRNK.3|PYTPISSDDDK.2|AIMKDPDDHTVC[CAM]HLLFANQTEKDILLRPELEELR.6|MSQYLESMQIGDTIEFR.3|M[Oxi]SQYLESMQIGDTIEFR.2|MSQYLESMQIGDTIEFR.2|STPAITLESPDIK.2|APEAWDYGQGFVNEEMIR.3|APEAWDYGQGFVNEEM[Oxi]IR.3|APEAWDYGQGFVNEEM[Oxi]IR.2|APEAWDYGQGFVNEEMIR.2|IDGNLVVRPYTPISSDDDK.3|IDGNLVVRPYTPISSDDDK.2|PYTPISSDDDKGFVDLVIK.3|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.6|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.5|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.4|IDGNLVVRPYTPISSDDDKGFVDLVIK.4|IDGNLVVRPYTPISSDDDKGFVDLVIK.3|LWYTLDRAPEAWDYGQGFVNEEMIR.3
SEN / CTL,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,3.23,1.96,7.11E-28,7.24E-28,2.71E+01,"response to hypoxia,cellular protein modification process,epidermis development,hydroxylysine biosynthetic process,oxidation-reduction process","iron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding,protein homodimerization activity","endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",156,37,56,SEDYVDIVQGR.2|FLGSGGFIGYAPNLSK.2|FLGSGGFIGYAPNLSK.3|FWTFETGC[CAM]TVC[CAM]DEGLR.2|IFQNLDGALDEVVLKFEMGHVR.4|SQVVFSAEELIYPDRR.3|QQDVFMFLTNR.2|AQVEEFLAQHGSEYQSVK.3|AQVEEFLAQHGSEYQSVK.2|AQVEEFLAQHGSEYQSVK.4|FLLEYIAPMTEK.2|RVGVWNVPYISNIYLIK.3|HTLGHLLSLDSYR.3|HTLGHLLSLDSYR.2|LQLNYLGNYIPR.2|LQLNYLGNYIPR.3|IFQNLDGALDEVVLK.2|IFQNLDGALDEVVLK.3|AQFDLAFVVR.2|IQGGYENVPTIDIHMNQIGFER.3|VGVWNVPYISNIYLIK.3|VGVWNVPYISNIYLIK.2|TTHLHNDLWEVFSNPEDWKEK.4|TTHLHNDLWEVFSNPEDWKEK.3|LDPDMAFC[CAM]ANIR.2|IQALGLGEDWNVEK.2|NLAYDTLPVLIHGNGPTK.3|NLAYDTLPVLIHGNGPTK.4|NLAYDTLPVLIHGNGPTK.2|YKPDEQPSLMPHHDASTFTINIALNR.4|YKPDEQPSLMPHHDASTFTINIALNR.5|YKPDEQPSLM[Oxi]PHHDASTFTINIALNR.5|YPVVSDGK.2|NMGADLC[CAM]R.2|LTHYHEGLPTTR.3|LTHYHEGLPTTR.2|LFIHNHEQHHK.3|LFIHNHEQHHK.2|GELQSSDLFHHSK.3|GELQSSDLFHHSK.2|GSALRGELQSSDLFHHSK.4|GSALRGELQSSDLFHHSK.3|SAQFFNYK.2|IFLDPEKR.2|NVIAPLMTR.2|LYPGYYTR.2|VGVDYEGGGC[CAM]R.2|TTHLHNDLWEVFSNPEDWK.4|TTHLHNDLWEVFSNPEDWK.3|TTHLHNDLWEVFSNPEDWK.2|RFLGSGGFIGYAPNLSK.3|HADKEDLVILFADSYDVLFASGPR.4|LVAEWEGQDSDSDQLFYTK.3|LVAEWEGQDSDSDQLFYTK.2|SQVVFSAEELIYPDR.2|LWSNFWGALSADGYYAR.2
SEN / CTL,Q96NY7;Q9NZA1,Chloride intracellular channel protein 6;Chloride intracellular channel protein 5,CLIC6;CLIC5,3.23,1.43,7.54E-06,9.98E-07,6.00E+00,"regulation of ion transmembrane transport,chloride transmembrane transport,glutathione metabolic process;diet induced thermogenesis,transport,chloride transport,female pregnancy,sensory perception of sound,protein localization,regulation of ion transmembrane transport,neuromuscular process controlling balance,auditory receptor cell stereocilium organization,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,dopamine receptor binding,glutathione transferase activity;voltage-gated ion channel activity,chloride channel activity,protein binding,glutathione transferase activity","cytoplasm,plasma membrane,chloride channel complex,extracellular exosome,nucleus;Golgi apparatus,microtubule organizing center,cell cortex,actin cytoskeleton,stereocilium,chloride channel complex,extracellular exosome,nucleus",12,1,2,FLDGDELTLADC[CAM]NLLPK.2|FLDGDELTLADC[CAM]NLLPK.3
SEN / CTL,P05455,Lupus La protein,SSB,3.23,1.68,1.21E-04,1.35E-05,4.87E+00,"tRNA modification,histone mRNA metabolic process,IRES-dependent viral translational initiation,protein localization to cytoplasmic stress granule","tRNA binding,nucleotide binding,mRNA binding,protein binding,poly(A) RNA binding","nuclear chromosome, telomeric region,nucleus,intracellular ribonucleoprotein complex",12,48,85,IC[CAM]HQIEYYFGDFNLPR.3|IC[CAM]HQIEYYFGDFNLPR.4|IC[CAM]HQIEYYFGDFNLPR.2|EQIKLDEGWVPLEIMIK.3|EQIKLDEGWVPLEIM[Oxi]IK.3|EQIKLDEGWVPLEIMIK.2|QKLEEDAEMK.3|QKLEEDAEM[Oxi]K.3|QKLEEDAEMK.2|SKAELMEISEDKTK.4|SKAELMEISEDKTK.3|SKAELM[Oxi]EISEDKTK.3|EDLHILFSNHGEIK.4|EDLHILFSNHGEIK.3|EDLHILFSNHGEIK.2|EETDKEEPASK.3|EETDKEEPASK.2|TKFASDDEHDEHDENGATGPVKR.6|TKFASDDEHDEHDENGATGPVKR.5|AKDANNGNLQLR.3|AKDANNGNLQLR.2|RSPSKPLPEVTDEYK.4|RSPSKPLPEVTDEYK.3|RSPSKPLPEVTDEYKNDVK.5|RSPSKPLPEVTDEYKNDVK.4|RSPSKPLPEVTDEYKNDVK.3|GAKEGIILFKEK.3|FVETPGQK.2|AELMEISEDKTK.3|FASDDEHDEHDENGATGPVKR.5|FASDDEHDEHDENGATGPVKR.4|SKAELMEISEDK.3|SKAELMEISEDK.2|YKETDLLILFK.3|YKETDLLILFK.2|KIIEDQQESLNK.3|KIIEDQQESLNK.2|LEEDAEMK.2|AREETDKEEPASK.3|GSIFVVFDSIESAK.3|GSIFVVFDSIESAK.2|EVTWEVLEGEVEK.3|EVTWEVLEGEVEK.2|KFVETPGQK.2|LDEGWVPLEIMIK.3|LDEGWVPLEIMIK.2|LDEGWVPLEIM[Oxi]IK.2|LTTDFNVIVEALSK.3|LTTDFNVIVEALSK.2|SPSKPLPEVTDEYKNDVK.4|SPSKPLPEVTDEYKNDVK.3|EVTWEVLEGEVEKEALKK.4|EVTWEVLEGEVEKEALKK.3|GQVLNIQMR.2|GQVLNIQM[Oxi]R.2|SPSKPLPEVTDEYK.3|SPSKPLPEVTDEYK.2|YKETDLLILFKDDYFAK.4|YKETDLLILFKDDYFAK.3|FASDDEHDEHDENGATGPVK.4|GSIFVVFDSIESAKK.3|GSIFVVFDSIESAKK.2|IIEDQQESLNKWK.3|IIEDQQESLNKWK.2|ETDLLILFK.2|DANNGNLQLR.2|NKEVTWEVLEGEVEKEALK.4|NKEVTWEVLEGEVEKEALK.3|SPSKPLPEVTDEYKNDVKNR.4|AELMEISEDK.2|AELM[Oxi]EISEDK.2|FSGDLDDQTC[CAM]REDLHILFSNHGEIK.5|FSGDLDDQTC[CAM]REDLHILFSNHGEIK.4|FSGDLDDQTC[CAM]REDLHILFSNHGEIK.3|NKEVTWEVLEGEVEK.3|NKEVTWEVLEGEVEK.2|PLPEVTDEYK.2|ETDLLILFKDDYFAK.3|GFPTDATLDDIK.2|FSGDLDDQTC[CAM]R.2|IIEDQQESLNK.2|EVTWEVLEGEVEKEALK.3|GFPTDATLDDIKEWLEDK.3|GFPTDATLDDIKEWLEDKGQVLNIQMR.4|EGIILFK.1
SEN / CTL,P62879,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,GNB2,3.23,1.27,1.85E-09,3.79E-10,9.42E+00,"protein folding,G-protein coupled receptor signaling pathway,cellular response to glucagon stimulus","GTPase activity,signal transducer activity,calcium channel regulator activity,protein binding,protein complex binding,GTPase binding","extracellular space,lysosomal membrane,cytosol,plasma membrane,focal adhesion,membrane,vesicle,myelin sheath,protein complex,cell body,perinuclear region of cytoplasm,extracellular exosome",18,18,31,AC[CAM]GDSTLTQITAGLDPVGR.3|AC[CAM]GDSTLTQITAGLDPVGR.2|LLLAGYDDFNC[CAM]NIWDAMKGDR.3|VHAIPLR.2|QEAEQLR.2|GDRAGVLAGHDNR.3|IYAMHWGTDSR.3|IYAM[Oxi]HWGTDSR.3|IYAMHWGTDSR.2|IYAM[Oxi]HWGTDSR.2|AGVLAGHDNR.2|LLVSASQDGK.2|ELPGHTGYLSC[CAM]C[CAM]R.3|ELPGHTGYLSC[CAM]C[CAM]R.2|TFVSGAC[CAM]DASIK.2|LIIWDSYTTNK.2|ADQELLMYSHDNIIC[CAM]GITSVAFSR.4|ADQELLMYSHDNIIC[CAM]GITSVAFSR.3|ADQELLM[Oxi]YSHDNIIC[CAM]GITSVAFSR.3|KAC[CAM]GDSTLTQITAGLDPVGR.3|KAC[CAM]GDSTLTQITAGLDPVGR.2|LLLAGYDDFNC[CAM]NIWDAMK.3|LLLAGYDDFNC[CAM]NIWDAM[Oxi]K.2|LLLAGYDDFNC[CAM]NIWDAMK.2|VSC[CAM]LGVTDDGMAVATGSWDSFLK.3|VSC[CAM]LGVTDDGM[Oxi]AVATGSWDSFLK.3|LFDLRADQELLMYSHDNIIC[CAM]GITSVAFSR.4|SSWVMTC[CAM]AYAPSGNFVAC[CAM]GGLDNIC[CAM]SIYSLK.4|SSWVMTC[CAM]AYAPSGNFVAC[CAM]GGLDNIC[CAM]SIYSLK.3|QTFIGHESDINAVAFFPNGYAFTTGSDDATC[CAM]R.4|QTFIGHESDINAVAFFPNGYAFTTGSDDATC[CAM]R.3
SEN / CTL,O95782,AP-2 complex subunit alpha-1,AP2A1,3.22,1.04,2.11E-07,3.38E-08,7.47E+00,"intracellular protein transport,Golgi to endosome transport,endocytosis,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,negative regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,clathrin-dependent endocytosis,negative regulation of hyaluronan biosynthetic process","protein binding,protein C-terminus binding,protein transporter activity,protein kinase binding,protein complex binding,clathrin adaptor activity","cytosol,plasma membrane,membrane,basolateral plasma membrane,apical plasma membrane,AP-2 adaptor complex,clathrin coat of trans-Golgi network vesicle,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,filopodium tip,endolysosome membrane",12,48,68,LLGFGSALLDNVDPNPENFVGAGIIQTK.3|LLGFGSALLDNVDPNPENFVGAGIIQTK.4|EMGEAFAADIPR.2|EM[Oxi]GEAFAADIPR.2|ANHPMDAEVTK.3|ANHPM[Oxi]DAEVTK.3|ANHPMDAEVTK.2|ANHPM[Oxi]DAEVTK.2|THIDTVINALK.3|THIDTVINALK.2|ATIQGVLR.2|SSPPVQFSLLHSK.3|SSPPVQFSLLHSK.2|DDVQGYAAK.2|AC[CAM]NQLGQFLQHR.3|AC[CAM]NQLGQFLQHR.2|TC[CAM]VSLAVSR.2|GLAVFISDIRNC[CAM]K.3|ALLLSTYIK.2|ALQVGC[CAM]LLR.2|GRLVEC[CAM]LETVLNK.3|GRLVEC[CAM]LETVLNK.2|QSAALC[CAM]LLR.2|MYLFYGNK.2|M[Oxi]YLFYGNK.2|GPGAGSALDDGR.2|LLQC[CAM]YPPPEDAAVK.3|LLQC[CAM]YPPPEDAAVK.2|NADVELQQR.2|THIDTVINALKTER.3|THIDTVINALKTER.2|GLAVFISDIR.2|FINLFPETK.2|YGGAPQALTLK.2|KGPGAGSALDDGR.2|NNGVLFENQLLQIGVK.3|NNGVLFENQLLQIGVK.2|LLQC[CAM]YPPPEDAAVKGR.3|YLETADYAIR.2|FFQPTEMAAQDFFQR.3|FFQPTEMAAQDFFQR.2|ILVAGDSMDSVK.2|VGGYILGEFGNLIAGDPR.3|VGGYILGEFGNLIAGDPR.2|DFLTPPLLSVR.2|HLC[CAM]ELLAQQF.2|VLQIVTNRDDVQGYAAK.3|VLQIVTNRDDVQGYAAK.2|QLSLPQQEAQK.2|AADLLYAMC[CAM]DR.2|TVFEALQAPAC[CAM]HENMVK.3|LEPNAQAQMYR.2|LVEC[CAM]LETVLNK.2|NDLASRNPTFMC[CAM]LALHC[CAM]IANVGSR.4|NPTFMC[CAM]LALHC[CAM]IANVGSR.3|NPTFMC[CAM]LALHC[CAM]IANVGSR.2|VVHLLNDQHMGVVTAAVSLITC[CAM]LC[CAM]K.4|VVHLLNDQHM[Oxi]GVVTAAVSLITC[CAM]LC[CAM]K.4|VVHLLNDQHM[Oxi]GVVTAAVSLITC[CAM]LC[CAM]K.3|TSVQFQNFSPTVVHPGDLQTQLAVQTK.4|TSVQFQNFSPTVVHPGDLQTQLAVQTK.3|ASPDLVPMGEWTAR.2|YLALESMC[CAM]TLASSEFSHEAVK.3|IAGDYVSEEVWYR.2|RVAAQVDGGAQVQQVLNIEC[CAM]LR.3|RVAAQVDGGAQVQQVLNIEC[CAM]LRDFLTPPLLSVR.4|IVSSASTDLQDYTYYFVPAPWLSVK.3|RDPSSNDINGGMEPTPSTVSTPSPSADLLGLR.3
SEN / CTL,P11766,Alcohol dehydrogenase class-3,ADH5,3.21,1.48,2.61E-05,3.25E-06,5.49E+00,"retinoid metabolic process,respiratory system process,ethanol oxidation,peptidyl-cysteine S-nitrosylation,response to lipopolysaccharide,positive regulation of blood pressure,formaldehyde catabolic process,response to nitrosative stress,response to redox state","alcohol dehydrogenase (NAD) activity,fatty acid binding,zinc ion binding,electron carrier activity,formaldehyde dehydrogenase activity,protein homodimerization activity,S-(hydroxymethyl)glutathione dehydrogenase activity","mitochondrion,cytosol,extracellular exosome",12,27,42,AAVAWEAGKPLSIEEIEVAPPKAHEVR.5|AAVAWEAGKPLSIEEIEVAPPKAHEVR.4|LKAGDTVIPLYIPQC[CAM]GEC[CAM]K.3|GTAFGGWK.2|TWKGTAFGGWK.3|IIGVDINK.2|AALEAC[CAM]HK.2|AAVAWEAGK.2|IDPLAPLDK.2|IDPLAPLDK.1|IIGVDINKDKFAR.3|AFELMHSGK.2|AFELM[Oxi]HSGK.2|IKVDEFVTHNLSFDEINK.4|IKVDEFVTHNLSFDEINK.3|IKVDEFVTHNLSFDEINK.2|IIGVDINKDK.2|KIKVDEFVTHNLSFDEINK.4|AAVAWEAGKPLSIEEIEVAPPK.4|AAVAWEAGKPLSIEEIEVAPPK.3|AAVAWEAGKPLSIEEIEVAPPK.2|VDEFVTHNLSFDEINKAFELMHSGK.5|VDEFVTHNLSFDEINKAFELMHSGK.4|VDEFVTHNLSFDEINK.3|VDEFVTHNLSFDEINK.2|AGDTVIPLYIPQC[CAM]GEC[CAM]K.3|AGDTVIPLYIPQC[CAM]GEC[CAM]K.2|AGDTVIPLYIPQC[CAM]GEC[CAM]KFC[CAM]LNPK.4|AGDTVIPLYIPQC[CAM]GEC[CAM]KFC[CAM]LNPK.3|VC[CAM]LLGC[CAM]GISTGYGAAVNTAK.3|VC[CAM]LLGC[CAM]GISTGYGAAVNTAK.2|GWGVSVVVGVAASGEEIATRPFQLVTGR.4|GWGVSVVVGVAASGEEIATRPFQLVTGR.3|PLSIEEIEVAPPK.2|AALEAC[CAM]HKGWGVSVVVGVAASGEEIATRPFQLVTGR.5|IIATAVC[CAM]HTDAYTLSGADPEGC[CAM]FPVILGHEGAGIVESVGEGVTK.6|IIATAVC[CAM]HTDAYTLSGADPEGC[CAM]FPVILGHEGAGIVESVGEGVTK.5|IIATAVC[CAM]HTDAYTLSGADPEGC[CAM]FPVILGHEGAGIVESVGEGVTK.4|EFGATEC[CAM]INPQDFSK.2|TILHYMGTSTFSEYTVVADISVAK.3|PIQEVLIEMTDGGVDYSFEC[CAM]IGNVK.3|IDPLAPLDKVC[CAM]LLGC[CAM]GISTGYGAAVNTAK.3
SEN / CTL,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,3.21,0.92,1.30E-10,2.95E-11,1.05E+01,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,nuclear-transcribed mRNA poly(A) tail shortening,behavioral fear response,translational initiation,regulation of translational initiation,viral process,regulation of mRNA stability,positive regulation of neuron differentiation,cell-cell adhesion","translation initiation factor activity,protein binding,translation factor activity, RNA binding,eukaryotic initiation factor 4E binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,membrane,eukaryotic translation initiation factor 4F complex",18,71,114,IRDPNQGGKDITEEIMSGAR.4|IRDPNQGGKDITEEIM[Oxi]SGAR.4|IRDPNQGGKDITEEIM[Oxi]SGAR.3|IRDPNQGGKDITEEIMSGAR.2|GLPLVDDGGWNTVPISK.2|GLPLVDDGGWNTVPISK.3|FMLQDVLDLR.2|FM[Oxi]LQDVLDLR.2|DKDDDEVFEK.3|DKDDDEVFEK.2|GSNWVPR.2|VQQLMAK.2|AALSEEELEKK.3|AALSEEELEKK.2|GGPGGELPR.2|PLNLEEK.2|TAADKDRGEEDADGSK.4|TAADKDRGEEDADGSK.3|LKGVIDLIFEK.3|LKGVIDLIFEK.2|AASLTEDR.2|ERPSQPEGLRK.3|VPTTEKPTVTVNFRK.4|IIATVLMTEDIK.3|IIATVLMTEDIK.2|IIATVLM[Oxi]TEDIK.2|DKDDDEVFEKK.3|LTPQMFQQLMK.3|LTPQMFQQLMK.2|LTPQM[Oxi]FQQLMK.2|LTPQMFQQLM[Oxi]K.2|GGPPGPPISR.2|QVTQLAIDTEER.3|QVTQLAIDTEER.2|YLC[CAM]DEQK.2|AQPPSSAASR.2|PSDAASEAAR.2|GSRPIDTSR.2|IHNAENIQPGEQK.3|IHNAENIQPGEQK.2|KIIATVLMTEDIK.3|KIIATVLM[Oxi]TEDIK.3|KIIATVLMTEDIK.2|SDQWKPLNLEEK.3|SDQWKPLNLEEK.2|QKEMDEAATAEER.3|QKEMDEAATAEER.2|ALPSEELNR.2|EAEMEEHREHIK.3|GVIDLIFEK.2|HGVESTLER.2|IHNAENIQPGEQKYEYK.4|IHNAENIQPGEQKYEYK.3|LKEELEEARDIAR.3|AIIEEYLHLNDMK.3|AIIEEYLHLNDM[Oxi]K.3|AIIEEYLHLNDMK.2|VPTTEKPTVTVNFR.3|VPTTEKPTVTVNFR.2|PGSIDSNNQLFAPGGR.3|PGSIDSNNQLFAPGGR.2|QVTQLAIDTEERLK.3|AALSEEELEK.2|GSSGGSGAKPSDAASEAAR.3|LKEELEEAR.2|VEYTLGEESEAPGQR.3|VEYTLGEESEAPGQR.2|EAALPPVSPLK.2|EAVQC[CAM]VQELASPSLLFIFVR.4|EAVQC[CAM]VQELASPSLLFIFVR.3|EAVQC[CAM]VQELASPSLLFIFVR.2|ERPSQPEGLR.2|EAVGDLLDAFK.2|EFEKDKDDDEVFEK.3|FSALQQAVPTESTDNR.3|FSALQQAVPTESTDNR.2|PSDAASEAARPATSTLNR.3|AISEPNFSVAYANMC[CAM]R.3|AISEPNFSVAYANMC[CAM]R.2|AISEPNFSVAYANM[Oxi]C[CAM]R.2|DITEEIMSGAR.2|DITEEIM[Oxi]SGAR.2|EFLPEGQDIGAFVAEQK.3|EFLPEGQDIGAFVAEQK.2|EMDEAATAEER.2|EM[Oxi]DEAATAEER.2|GSSGGSGAKPSDAASEAARPATSTLNR.4|GSSGGSGAKPSDAASEAARPATSTLNR.3|REAALPPVSPLK.2|FSALQQAVPTESTDNRR.3|FSALQQAVPTESTDNRR.2|KEAVGDLLDAFK.2|ITKPGSIDSNNQLFAPGGR.3|ITKPGSIDSNNQLFAPGGR.2|GRLKEELEEAR.2|EDAFYSWESSK.2|ALMTAVC[CAM]YSAIIFETPLR.3|ALMTAVC[CAM]YSAIIFETPLR.2|LQGINC[CAM]GPDFTPSFANLGR.3|LQGINC[CAM]GPDFTPSFANLGR.2|EDAFYSWESSKDPAEQQGK.3|MFFDALYDEDVVK.2|TPLRPLDPTRLQGINC[CAM]GPDFTPSFANLGR.4|VFDWIEANLSEQQIVSNTLVR.3|TASTPTPPQTGGGLEPQANGETPQVAVIVRPDDR.4|TASTPTPPQTGGGLEPQANGETPQVAVIVRPDDR.3|EAGLSWKEFLPEGQDIGAFVAEQK.3|VQSAAPARPGPAAHVYPAGSQVMMIPSQISYPASQGAYYIPGQGR.5|VQSAAPARPGPAAHVYPAGSQVM[Oxi]M[Oxi]IPSQISYPASQGAYYIPGQGR.4|VQSAAPARPGPAAHVYPAGSQVM[Oxi]MIPSQISYPASQGAYYIPGQGR.4|VQSAAPARPGPAAHVYPAGSQVMMIPSQISYPASQGAYYIPGQGR.4|MFFDALYDEDVVKEDAFYSWESSKDPAEQQGK.4|EFLPEGQDIGAFVAEQKVEYTLGEESEAPGQR.3|GGEELLPPESTPIPANLSQNLEAAAATQVAVSVPK.3
SEN / CTL,Q00839,Heterogeneous nuclear ribonucleoprotein U,HNRNPU,3.19,1.97,2.93E-06,4.09E-07,6.39E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA processing,gene expression,positive regulation of gene expression,negative regulation of telomere maintenance via telomerase,circadian regulation of gene expression,cardiac muscle cell development,CRD-mediated mRNA stabilization,cellular response to dexamethasone stimulus,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity","core promoter binding,DNA binding,RNA binding,protein binding,ATP binding,poly(G) binding,enhancer binding,ribonucleoprotein complex binding,poly(A) RNA binding,telomerase RNA binding","nucleus,nucleoplasm,cell surface,membrane,intracellular ribonucleoprotein complex,extracellular matrix,cytoplasmic ribonucleoprotein granule,CRD-mediated mRNA stability complex,catalytic step 2 spliceosome,telomerase holoenzyme complex",24,64,129,SSGPTSLFAVTVAPPGAR.2|SSGPTSLFAVTVAPPGAR.3|EKPYFPIPEEYTFIQNVPLEDR.3|EKPYFPIPEEYTFIQNVPLEDR.4|GYFEYIEENKYSR.3|GYFEYIEENKYSR.2|M[Oxi]MVAGFK.2|VSELKEELKK.3|VSELKEELKK.2|AEVEGKDLPEHAVLK.4|AEVEGKDLPEHAVLK.3|FIEIAAR.2|KAEGGGGGGRPGAPAAGDGK.4|KAEGGGGGGRPGAPAAGDGK.3|KAEGGGGGGRPGAPAAGDGK.2|KMC[CAM]LFAGFQR.3|KMC[CAM]LFAGFQR.2|AVVVC[CAM]PKDEDYKQR.4|AVVVC[CAM]PKDEDYKQR.3|AVVVC[CAM]PKDEDYKQR.2|LLEQYKEESK.3|LLEQYKEESK.2|KAEGGGGGGRPGAPAAGDGKTEQK.5|KAEGGGGGGRPGAPAAGDGKTEQK.4|KAEGGGGGGRPGAPAAGDGKTEQK.3|LNTLLQR.2|KAEVEGKDLPEHAVLK.4|KAEVEGKDLPEHAVLK.3|LKVSELKEELK.3|LKVSELKEELK.2|KAVVVC[CAM]PK.2|KKAEGGGGGGRPGAPAAGDGK.4|MMVAGFKK.2|RNFILDQTNVSAAAQR.4|RNFILDQTNVSAAAQR.3|RNFILDQTNVSAAAQR.2|LLEQYKEESKK.3|LLEQYKEESKK.2|YNILGTNTIMDK.3|YNILGTNTIMDK.2|YNILGTNTIM[Oxi]DK.2|AVVVC[CAM]PKDEDYK.3|AVVVC[CAM]PKDEDYK.2|PWSQHYHQGYY.3|PWSQHYHQGYY.2|DIDIHEVR.2|LSDKGLKAELMER.3|AEGGGGGGRPGAPAAGDGKTEQK.4|AEGGGGGGRPGAPAAGDGKTEQK.3|AEGGGGGGRPGAPAAGDGK.3|AEGGGGGGRPGAPAAGDGK.2|DLPEHAVLK.2|KAVVVC[CAM]PKDEDYK.3|KAVVVC[CAM]PKDEDYK.2|GLKAELMER.2|NGQDLGVAFK.2|APQC[CAM]LGKFIEIAAR.3|DC[CAM]EVVMMIGLPGAGK.3|DC[CAM]EVVMMIGLPGAGK.2|DC[CAM]EVVM[Oxi]MIGLPGAGK.2|DC[CAM]EVVMM[Oxi]IGLPGAGK.2|QMADTGKLNTLLQR.3|QM[Oxi]ADTGKLNTLLQR.3|QM[Oxi]ADTGKLNTLLQR.2|QMADTGKLNTLLQR.2|VSELKEELK.2|HAAENPGKYNILGTNTIM[Oxi]DK.4|HAAENPGKYNILGTNTIMDK.4|HAAENPGKYNILGTNTIM[Oxi]DK.3|HAAENPGKYNILGTNTIMDK.3|HAAENPGKYNILGTNTIMDK.2|NFILDQTNVSAAAQR.3|NFILDQTNVSAAAQR.2|GPEEKKDC[CAM]EVVMM[Oxi]IGLPGAGK.4|GPEEKKDC[CAM]EVVMMIGLPGAGK.4|GPEEKKDC[CAM]EVVMM[Oxi]IGLPGAGK.3|GPEEKKDC[CAM]EVVMMIGLPGAGK.3|GPEEKKDC[CAM]EVVMMIGLPGAGK.2|ISKEVLAGRPLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.6|ISKEVLAGRPLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.5|MC[CAM]LFAGFQR.2|M[Oxi]C[CAM]LFAGFQR.2|KDC[CAM]EVVM[Oxi]MIGLPGAGK.3|KDC[CAM]EVVMM[Oxi]IGLPGAGK.3|KDC[CAM]EVVMMIGLPGAGK.3|KDC[CAM]EVVM[Oxi]M[Oxi]IGLPGAGK.3|KDC[CAM]EVVM[Oxi]MIGLPGAGK.2|KDC[CAM]EVVMM[Oxi]IGLPGAGK.2|KDC[CAM]EVVMMIGLPGAGK.2|NFILDQTNVSAAAQRR.3|PLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.4|PLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.3|EVLAGRPLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.5|EVLAGRPLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.4|EVLAGRPLFPHVLC[CAM]HNC[CAM]AVEFNFGQK.3|EDHGRGYFEYIEENK.3|LQAALDDEEAGGRPAMEPGNGSLDLGGDSAGR.5|LQAALDDEEAGGRPAM[Oxi]EPGNGSLDLGGDSAGR.4|LQAALDDEEAGGRPAMEPGNGSLDLGGDSAGR.4|LQAALDDEEAGGRPAM[Oxi]EPGNGSLDLGGDSAGR.3|LQAALDDEEAGGRPAMEPGNGSLDLGGDSAGR.3|GYFEYIEENK.2|KRNFILDQTNVSAAAQR.3|GNFTLPEVAEC[CAM]FDEITYVELQK.4|GNFTLPEVAEC[CAM]FDEITYVELQK.3|LQAALDDEEAGGR.2|LSASSLTMESFAFLWAGGR.3|LSASSLTM[Oxi]ESFAFLWAGGR.3|LSASSLTM[Oxi]ESFAFLWAGGR.2|LSASSLTMESFAFLWAGGR.2|EKPYFPIPEEYTFIQNVPLEDRVR.4|EKPYFPIPEEYTFIQNVPLEDRVR.3|NQSQGYNQWQQGQFWGQK.3|NQSQGYNQWQQGQFWGQK.2|TC[CAM]NC[CAM]ETEDYGEK.2|DRLSASSLTM[Oxi]ESFAFLWAGGR.3|DRLSASSLTMESFAFLWAGGR.3|GNFTLPEVAEC[CAM]FDEITYVELQKEEAQK.4|GNFTLPEVAEC[CAM]FDEITYVELQKEEAQK.3|PYFPIPEEYTFIQNVPLEDR.3|MKGNFTLPEVAEC[CAM]FDEITYVELQKEEAQK.4|M[Oxi]KGNFTLPEVAEC[CAM]FDEITYVELQKEEAQK.4|MKGNFTLPEVAEC[CAM]FDEITYVELQKEEAQK.3|IGWSLTTSGMLLGEEEFSYGYSLK.3|NQSQGYNQWQQGQFWGQKPWSQHYHQGYY.4|PAMEPGNGSLDLGGDSAGR.2|SPQPPVEEEDEHFDDTVVC[CAM]LDTYNC[CAM]DLHFK.4|FDENDVITC[CAM]FANFESDEVELSYAK.3|TC[CAM]NC[CAM]ETEDYGEKFDENDVITC[CAM]FANFESDEVELSYAK.4
SEN / CTL,Q15836,Vesicle-associated membrane protein 3,VAMP3,3.19,1.85,1.64E-05,2.09E-06,5.68E+00,"positive regulation of receptor recycling,protein complex assembly,exocytosis,vesicle docking involved in exocytosis,vesicle fusion,vesicle-mediated transport,calcium ion regulated exocytosis,substrate adhesion-dependent cell spreading,SNARE complex assembly,retrograde transport, endosome to Golgi,Golgi to plasma membrane protein transport,membrane fusion,negative regulation of secretion by cell,positive regulation of immunoglobulin secretion,mucus secretion,regulation of histamine secretion by mast cell","SNARE binding,SNAP receptor activity,protein binding,syntaxin-1 binding","intracellular,cytosol,plasma membrane,cell surface,integral component of membrane,apical plasma membrane,cell junction,transport vesicle,clathrin-coated vesicle,secretory granule,clathrin-coated vesicle membrane,SNARE complex,trans-Golgi network membrane,neuron projection,intracellular membrane-bounded organelle,synapse,recycling endosome",12,2,4,RLQQTQNQVDEVVDIMR.3|LQQTQNQVDEVVDIMR.2|LQQTQNQVDEVVDIMR.3|LQQTQNQVDEVVDIM[Oxi]R.2
SEN / CTL,Q14204,Cytoplasmic dynein 1 heavy chain 1,DYNC1H1,3.19,1.73,4.18E-33,5.25E-33,3.23E+01,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based movement,mitotic spindle organization,antigen processing and presentation of exogenous peptide antigen via MHC class II,cytoplasmic mRNA processing body assembly,stress granule assembly,establishment of spindle localization","microtubule motor activity,ATP binding,ATPase activity,poly(A) RNA binding,dynein light intermediate chain binding","centrosome,cytosol,cytoplasmic dynein complex,microtubule,membrane,filopodium,extracellular matrix,extracellular exosome",102,337,531,FGNPLLVQDVESYDPVLNPVLNR.3|FLSDPQVHTVLVER.3|FLSDPQVHTVLVER.2|TTDLLTDWEK.2|ILDDDTIITTLENLKR.3|ILDDDTIITTLENLKR.2|GKEDEGEEAASPMLQIQR.3|GKEDEGEEAASPMLQIQR.2|GNEIVLSAGSTPR.2|TPVIDADKPVSSQLR.3|TPVIDADKPVSSQLR.2|PVTGNLRPEEALQALTIYEGK.3|VLTLSEDSPYETLHSFISNAVAPFFK.4|VLTLSEDSPYETLHSFISNAVAPFFK.3|VLLTTQGVDMISK.2|VLLTTQGVDMISK.3|VLLTTQGVDM[Oxi]ISK.2|KLVPLLLEDGGEAPAALEAALEEK.3|KLVPLLLEDGGEAPAALEAALEEK.4|ENFIPTIVNFSAEEISDAIREK.3|GIFEALRPLETLPVEGLIR.3|GIFEALRPLETLPVEGLIR.4|GIFEALRPLETLPVEGLIR.2|NYMSNPSYNYEIVNR.2|NYMSNPSYNYEIVNR.3|NYM[Oxi]SNPSYNYEIVNR.2|IQGLTVEQAEAVVR.2|IQGLTVEQAEAVVR.3|SRQELEQHSVDTASTSDAVTFITYVQSLK.4|SRQELEQHSVDTASTSDAVTFITYVQSLK.3|AERPDVDEKR.3|IKETVDQVEELRR.4|IKETVDQVEELRR.3|KLEHLITELVHQR.4|KLEHLITELVHQR.3|NLESALR.2|TSFLDDAFRK.3|TSFLDDAFRK.2|VPVNLLR.2|KYEFGESDLR.3|KYEFGESDLR.2|MRAELGEYIR.3|QM[Oxi]VEHGGFYR.3|QMVEHGGFYR.3|QMVEHGGFYR.2|RSELEEQQMHLNVGLRK.5|RSELEEQQMHLNVGLRK.4|RSELEEQQMHLNVGLRK.3|NTISLLVAGLKK.3|SALEQMR.2|SQELEVK.2|ALGHQLGR.2|GVAVLC[CAM]TE.2|GVAVLC[CAM]TE.1|QALVAIFTHLR.3|QALVAIFTHLR.2|SLETC[CAM]MYDHK.3|SLETC[CAM]MYDHK.2|TAEVLANK.2|VPLAIVNK.2|NVVHELR.2|SFDSEFK.2|TFDHYC[CAM]EYR.3|TFDHYC[CAM]EYR.2|VDGHKDIQMPDGIRR.4|VKDDIESLHDK.3|VKDDIESLHDK.2|ADLAAVEAK.2|DLEASIAR.2|KFLSDPQVHTVLVER.4|KFLSDPQVHTVLVER.3|NANEMFR.2|QHLVEVR.2|RKLEHLITELVHQR.4|SLLQALNEVKGR.3|SNSLAFIK.2|AISKDHLYGTLDPNTR.4|AISKDHLYGTLDPNTR.3|AISKDHLYGTLDPNTR.2|LLLIQAFRPDR.3|RTPVIDADKPVSSQLR.4|RTPVIDADKPVSSQLR.3|SNLPDNLK.2|TVENIKDPLFR.3|TVENIKDPLFR.2|GVTDHTQR.2|GVWSELSK.2|LDMEIER.2|MVVLSLPR.2|VEPAVIEAQNAVK.3|VEPAVIEAQNAVK.2|DYIPVDQEELR.3|DYIPVDQEELR.2|ETVDQVEELRR.3|GMLHQDHITFAMLLAR.4|GM[Oxi]LHQDHITFAMLLAR.4|GM[Oxi]LHQDHITFAMLLAR.3|GMLHQDHITFAMLLAR.3|LMHVAYEEFEK.3|LM[Oxi]HVAYEEFEK.3|LM[Oxi]HVAYEEFEK.2|LMHVAYEEFEK.2|RVEDVLGK.2|RVEPLRNELQK.3|DHLYGTLDPNTR.3|DHLYGTLDPNTR.2|IQFVGAC[CAM]NPPTDPGRKPLSHR.5|IQFVGAC[CAM]NPPTDPGRKPLSHR.4|LSC[CAM]LPAFK.2|AELGEYIR.2|ALGEYLER.2|QLQNISLAAASGGAK.3|QLQNISLAAASGGAK.2|ALEHAFQLEHIMDLTR.4|ALEHAFQLEHIM[Oxi]DLTR.4|ALEHAFQLEHIM[Oxi]DLTR.3|ALEHAFQLEHIMDLTR.3|ALEHAFQLEHIMDLTR.2|EVDGLDVSK.2|IFTIESTR.2|TLHTTASNWLHLIPQTLSHLK.5|TLHTTASNWLHLIPQTLSHLK.4|TLHTTASNWLHLIPQTLSHLK.3|TSDQTWVK.2|ALERLEGVEGVAHIIDPK.4|ALERLEGVEGVAHIIDPK.3|AWTQVLLGQAEDK.3|AWTQVLLGQAEDK.2|IKETVDQVEELR.3|KYTGEDFDEDLRTVLR.4|RSELEEQQMHLNVGLR.4|RSELEEQQMHLNVGLR.3|SIPLDEGEDEAQR.3|SIPLDEGEDEAQR.2|SVLVSAGNVK.2|TFSEILNR.2|VMSQEIQEQLHK.3|VMSQEIQEQLHK.2|EWTDGLFTHVLR.3|EWTDGLFTHVLR.2|GTFDNAETK.2|KYTGEDFDEDLR.3|KYTGEDFDEDLR.2|LEGVEGVAHIIDPK.3|LEGVEGVAHIIDPK.2|LEHLITELVHQR.3|LEHLITELVHQR.2|LQGEFQLR.2|LSC[CAM]LPAFKDLIAK.3|RTVENIKDPLFR.3|SMANPPAAVK.2|SM[Oxi]ANPPAAVK.2|TDSTSDGRPAWMR.3|TSFLDDAFRKNLESALR.4|YATLATVSR.2|GWDDLFNK.2|GWDDLFNK.1|IFRQPQGHLLLIGVSGAGK.4|IWAHEALR.2|LLNTFLER.2|LRDQLGTAK.2|SSLQSQC[CAM]LNEVLK.3|SSLQSQC[CAM]LNEVLK.2|TFSSIPVSR.2|FQSISTEFLALMK.3|FQSISTEFLALM[Oxi]K.2|FQSISTEFLALMK.2|KLMHVAYEEFEK.3|KLMHVAYEEFEK.2|LGEDLNKWQALLVQIRK.4|LGEDLNKWQALLVQIRK.3|LLTLPNGER.2|SLAMTKPDR.2|ASLAC[CAM]GPMVK.2|ASLAC[CAM]GPM[Oxi]VK.2|FHATVSFDTDTGLK.3|FHATVSFDTDTGLK.2|HYLDFINHYANLFHEK.4|HYLDFINHYANLFHEK.3|HYLDFINHYANLFHEK.2|LLAESVTEVEIFGK.3|LLAESVTEVEIFGK.2|LRQNLDALLNQLK.3|LRQNLDALLNQLK.2|NLHVVFTM[Oxi]NPSSEGLKDR.4|NLHVVFTMNPSSEGLKDR.4|NLHVVFTMNPSSEGLKDR.3|NLHVVFTM[Oxi]NPSSEGLKDR.3|NLHVVFTMNPSSEGLKDR.2|RTPNGVVLAPVQLGK.3|SNLPDNLKK.2|TLHTTASNWLHLIPQTLSHLKR.5|VDNEFDQR.2|AATSPALFNR.2|DIQMPDGIR.2|EGLMLDSHEELYK.3|EGLMLDSHEELYK.2|LRQYASYEFVQR.3|LRQYASYEFVQR.2|LVQTPLTDR.2|RVEDVLGKGWENHVEGQK.4|RWTDENIDTVALK.3|TMTLFSALR.2|TM[Oxi]TLFSALR.2|VAAPDVVVPTLDTVR.3|VAAPDVVVPTLDTVR.2|WFTSQVIR.2|AERPDVDEK.2|ASVVTLPVYLNFTR.3|ASVVTLPVYLNFTR.2|DSAIQQQVANLQMK.3|DSAIQQQVANLQMK.2|GAIREYQTQLIQR.3|KGKEDEGEEAASPMLQIQR.4|QPQGHLLLIGVSGAGK.3|QPQGHLLLIGVSGAGK.2|TAEVLANKIVPFFK.3|VKDDIESLHDKFK.3|VKDDIESLHDKFK.2|EWTDGLFTHVLRK.3|HEALLYTWLAEHK.3|HEALLYTWLAEHK.2|INMLVIELK.2|KVMSQEIQEQLHK.3|LKQDGDSFR.2|LKVNFLPEIITLSK.3|QNISPDKIPWSALK.3|SIPLDEGEDEAQRR.3|TSFLDDAFR.2|AHQANQLYPFAISLIESVR.4|AHQANQLYPFAISLIESVR.3|AHQANQLYPFAISLIESVR.2|AISKDHLYGTLDPNTREWTDGLFTHVLR.6|AISKDHLYGTLDPNTREWTDGLFTHVLR.5|AISKDHLYGTLDPNTREWTDGLFTHVLR.4|ANEVEQMIR.2|ANEVEQM[Oxi]IR.2|LNTQEIFDDWARK.3|NVHLAPGWLMQLEK.3|NVHLAPGWLM[Oxi]QLEK.3|NVHLAPGWLMQLEK.2|NVHLAPGWLM[Oxi]QLEK.2|QALETVNDYNPLMK.3|QALETVNDYNPLMK.2|RESPEVLLTLDILK.3|RESPEVLLTLDILK.2|SSLQSQC[CAM]LNEVLKAERPDVDEKR.5|AEVDMDTDAPQVSHKPGGEPK.4|AEVDMDTDAPQVSHKPGGEPK.3|AVDDLNLHSYSNLPIWVNK.4|AVDDLNLHSYSNLPIWVNK.3|AVDDLNLHSYSNLPIWVNK.2|HLLPVETQR.2|LKGTVGEPTYDAEFQHFLR.4|QLIAQVMLYSQGFR.3|QLIAQVMLYSQGFR.2|QLIAQVM[Oxi]LYSQGFR.2|YQVGVHYELTEEEKFYR.4|YQVGVHYELTEEEKFYR.3|AMSRPILYSNWLSK.3|AMSRPILYSNWLSK.2|C[CAM]LGSLFSMLHQAC[CAM]R.3|C[CAM]LGSLFSM[Oxi]LHQAC[CAM]R.3|C[CAM]LGSLFSMLHQAC[CAM]R.2|DLFQVAFNR.2|EHINSVSAMK.2|EHINSVSAM[Oxi]K.2|GTFDNAETKK.2|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.5|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.4|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.3|IKQLQNISLAAASGGAK.3|LQGATC[CAM]NNNK.2|NIHVC[CAM]LGGLFVPEAYITATR.4|NIHVC[CAM]LGGLFVPEAYITATR.3|NIHVC[CAM]LGGLFVPEAYITATR.2|SLLQALNEVK.2|SPLVMDVLNIQGVQR.3|SPLVM[Oxi]DVLNIQGVQR.3|SPLVM[Oxi]DVLNIQGVQR.2|SPLVMDVLNIQGVQR.2|STLKEDVGDEGEEEK.3|TPVSITEHPK.2|YEFGESDLR.2|DFPLNDLLSATELDK.3|DFPLNDLLSATELDK.2|IMFEVQDLK.2|IM[Oxi]FEVQDLK.2|LGGSPFGPAGTGKTESVK.3|NTISLLVAGLK.2|RFHATVSFDTDTGLK.3|RFHATVSFDTDTGLK.2|SAC[CAM]DTVDTWLDDTAK.3|SAC[CAM]DTVDTWLDDTAK.2|WAIAQLNYADMLKR.3|WQALLVQIR.2|EAIVNSC[CAM]VFVHQTLHQANAR.4|EAIVNSC[CAM]VFVHQTLHQANAR.3|EAIVNSC[CAM]VFVHQTLHQANAR.2|ILDDDTIITTLENLK.3|ILDDDTIITTLENLK.2|KASVVTLPVYLNFTR.3|KASVVTLPVYLNFTR.2|LGGSPFGPAGTGK.2|ATSIDPNTYITWIDK.3|ATSIDPNTYITWIDK.2|TKPVTGNLRPEEALQALTIYEGKFGR.5|YQVGVHYELTEEEK.3|YQVGVHYELTEEEK.2|FTQDTQPHYIYSPR.3|FTQDTQPHYIYSPR.2|LVPLLLEDGGEAPAALEAALEEK.4|LVPLLLEDGGEAPAALEAALEEK.3|LVPLLLEDGGEAPAALEAALEEK.2|TPVSITEHPKINEWLTLVEK.4|EYQTQLIQR.2|GWENHVEGQK.2|NLHVVFTMNPSSEGLK.3|NLHVVFTM[Oxi]NPSSEGLK.3|NLHVVFTM[Oxi]NPSSEGLK.2|NLHVVFTMNPSSEGLK.2|PLVLC[CAM]GPPGSGK.2|QNLFTTWSHHLQQANIQFR.4|QNLFTTWSHHLQQANIQFR.3|SELEEQQMHLNVGLR.3|SFEWLSQMR.2|SFEWLSQM[Oxi]R.2|VDDLLIIEEK.2|VPQIEVETHK.2|VTFVNFTVTR.2|VWEQIDQMK.2|LSLSNAISTALPLTQLR.3|LSLSNAISTALPLTQLR.2|QTDVLQQLSIQMANAK.3|QTDVLQQLSIQMANAK.2|TEYLSNADER.2|TLMAQSIYGGR.2|TLM[Oxi]AQSIYGGR.2|EALELTDTGLLSGSEER.3|EALELTDTGLLSGSEER.2|LFLTMEINPK.2|LYQEMFAWK.2|VEDPTFLNQLQSGVNR.3|VEDPTFLNQLQSGVNR.2|VQYPQSQAC[CAM]K.2|ALPDMEVVGLNFSSATTPELLLK.4|ALPDMEVVGLNFSSATTPELLLK.3|ALPDM[Oxi]EVVGLNFSSATTPELLLK.3|AWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPK.6|AWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPK.5|EFGPVVIDYGK.2|EGTEAWEAAMK.2|EQPWVSVQPR.2|ETVDQVEELR.2|IFVFEPPPGVK.2|PILYSNWLSK.2|EDVGDEGEEEK.2|INEWLTLVEK.2|RKDSAIQQQVANLQMK.3|RKDSAIQQQVANLQMK.2|VFEEDALSWEDKLNR.3|YKEEYAVLISEAQAIK.3|YKEEYAVLISEAQAIK.2|DYIPVDQEELRDYVK.3|DYIPVDQEELRDYVK.2|DVLLVAQGEMALEEFLK.3|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.6|KIAELEMGLLHLQQNIEIPEISLPIHPM[Oxi]ITNVAK.5|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.5|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.4|LGEDLNKWQALLVQIR.3|LGEDLNKWQALLVQIR.2|QMSVKEDLDKVEPAVIEAQNAVK.4|QNLDALLNQLK.2|SSLQSQC[CAM]LNEVLKAERPDVDEK.4|TKPVTGNLRPEEALQALTIYEGK.4|TKPVTGNLRPEEALQALTIYEGK.3|GRILDDDTIITTLENLK.3|QYASYEFVQR.2|VSPDMAIFITMNPGYAGR.3|VSPDMAIFITMNPGYAGR.2|VTDFGDKVEDPTFLNQLQSGVNR.4|VTDFGDKVEDPTFLNQLQSGVNR.3|ANEVEQMIRDLEASIAR.3|DAATIMQPYFTSNGLVTK.3|DAATIM[Oxi]QPYFTSNGLVTK.2|DAATIMQPYFTSNGLVTK.2|DFPLNDLLSATELDKIR.3|FYFVGDEDLLEIIGNSK.3|FYFVGDEDLLEIIGNSK.2|ITNQVIYLNPPIEEC[CAM]R.3|ITNQVIYLNPPIEEC[CAM]R.2|VLQLYQITQINHGLM[Oxi]MVGPSGSGK.4|VLQLYQITQINHGLM[Oxi]MVGPSGSGK.3|VLQLYQITQINHGLMM[Oxi]VGPSGSGK.3|VLQLYQITQINHGLMMVGPSGSGK.3|VLQLYQITQINHGLM[Oxi]M[Oxi]VGPSGSGK.3|DRAATSPALFNR.2|EDLDKVEPAVIEAQNAVK.3|EDLDKVEPAVIEAQNAVK.2|GTVGEPTYDAEFQHFLR.3|GTVGEPTYDAEFQHFLR.2|MLSAVSQQVQC[CAM]IQEALR.3|M[Oxi]LSAVSQQVQC[CAM]IQEALR.2|MLSAVSQQVQC[CAM]IQEALR.2|LAETVFNFQEK.2|MDLEKPNYIVPDYMPVVYDKLPQPPSHR.5|VLRPQVTAVAQQNQGEVPEPQDMK.4|VLRPQVTAVAQQNQGEVPEPQDM[Oxi]K.4|VLRPQVTAVAQQNQGEVPEPQDM[Oxi]K.3|VLRPQVTAVAQQNQGEVPEPQDMK.3|AKEALELTDTGLLSGSEER.3|AKEALELTDTGLLSGSEER.2|EVWNTYELDLVNYQNK.3|EVWNTYELDLVNYQNK.2|HVPVVYVDYPGPASLTQIYGTFNR.4|HVPVVYVDYPGPASLTQIYGTFNR.3|KEFGPVVIDYGK.2|MQMLEDEDDLAYAETEK.3|MQMLEDEDDLAYAETEK.2|SWSHYTVPAGMTVIQWVSDFSER.4|SWSHYTVPAGMTVIQWVSDFSER.3|SWSHYTVPAGM[Oxi]TVIQWVSDFSER.3|TSAPITC[CAM]ELLNK.2|VAEVLFDAADANAIEEVNLAYENVK.4|VAEVLFDAADANAIEEVNLAYENVK.3|VDNEFDQRLLNTFLER.3|FGQM[Oxi]LGSNMTEFHSQISK.3|FGQMLGSNM[Oxi]TEFHSQISK.3|FGQMLGSNMTEFHSQISK.3|FGQMLGSNMTEFHSQISK.2|IAFIMDESNVLDSGFLER.3|IAFIM[Oxi]DESNVLDSGFLER.3|IAFIMDESNVLDSGFLER.2|LALESIC[CAM]LLLGESTTDWK.3|LALESIC[CAM]LLLGESTTDWK.2|LC[CAM]DEQLSSQSHYDFGLR.3|LC[CAM]DEQLSSQSHYDFGLR.2|SRQELEQHSVDTASTSDAVTFITYVQSLKR.5|SRQELEQHSVDTASTSDAVTFITYVQSLKR.4|YKEEYAVLISEAQAIKADLAAVEAK.4|YKEEYAVLISEAQAIKADLAAVEAK.3|YTGEDFDEDLR.2|DLPPVSGSIIWAK.2|VNFLPEIITLSK.2|VQVALEELQDLK.2|TPNGVVLAPVQLGK.2|WTDENIDTVALK.2|AM[Oxi]SRPILYSNWLSKDYIPVDQEELRDYVK.5|DHLYGTLDPNTREWTDGLFTHVLR.4|DPASGTALQEISFWLNLER.3|EVDGLDVSKEGTEAWEAAMK.3|MQMLEDEDDLAYAETEKK.3|VAAPDVVVPTLDTVRHEALLYTWLAEHKPLVLC[CAM]GPPGSGK.6|VAAPDVVVPTLDTVRHEALLYTWLAEHKPLVLC[CAM]GPPGSGK.5|C[CAM]YLTMTQALEAR.2|ESPEVLLTLDILK.2|LLQDVRQDLADVVQVC[CAM]EGK.3|QDLADVVQVC[CAM]EGK.2|RFNRYPLIIDPSGQATEFIM[Oxi]NEYK.4|RFNRYPLIIDPSGQATEFIMNEYK.4|RFNRYPLIIDPSGQATEFIMNEYK.3|TLMAQSIYGGRVDNEFDQR.3|VFEEDALSWEDK.2|IAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.5|IAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.4|AMSRPILYSNWLSKDYIPVDQEELR.4|DHLYGTLDPNTREWTDGLFTHVLRK.4|ENFIPTIVNFSAEEISDAIR.3|ENFIPTIVNFSAEEISDAIR.2|FNRYPLIIDPSGQATEFIMNEYKDR.4|LNTQEIFDDWAR.2|TTDLLTDWEKTKPVTGNLRPEEALQALTIYEGK.5|WQASSLPADDLC[CAM]TENAIMLK.3|WQASSLPADDLC[CAM]TENAIM[Oxi]LK.3|WQASSLPADDLC[CAM]TENAIMLK.2|C[CAM]VLNWFGDWSTEALYQVGK.3|C[CAM]VLNWFGDWSTEALYQVGK.2|DPTVEFPPDLC[CAM]SR.2|MLSAVSQQVQC[CAM]IQEALREHSNPNYDK.4|VQVALEELQDLKGVWSELSK.3|VTDFGDKVEDPTFLNQLQSGVNRWIR.4|AVDDLNLHSYSNLPIWVNKLDMEIER.4|WAIAQLNYADM[Oxi]LK.2|WAIAQLNYADMLK.2|YPLIIDPSGQATEFIMNEYK.3|YPLIIDPSGQATEFIMNEYK.2|EEYAVLISEAQAIK.2|FNYGFEYLGVQDK.2|FYFVGDEDLLEIIGNSKNVAK.3|QELEQHSVDTASTSDAVTFITYVQSLKR.4|SIIM[Oxi]RENFIPTIVNFSAEEISDAIREK.4|TYAEPLTAAMVEFYTMSQER.3|TYAEPLTAAMVEFYTMSQER.2|EEFVQWVELLPDTQTPSWLGLPNNAER.4|EEFVQWVELLPDTQTPSWLGLPNNAER.3|MFAGVSSIILNEDNSVVLGISSR.3|QDLADVVQVC[CAM]EGKK.2|VWEQIDQMKEQPWVSVQPR.3|EHSNPNYDKTSAPITC[CAM]ELLNK.3|IQFVGAC[CAM]NPPTDPGR.2|LALESIC[CAM]LLLGESTTDWKQIR.3|MDLEKPNYIVPDYMPVVYDK.3|TTDLLTDWEKTKPVTGNLRPEEALQALTIYEGKFGR.5|FVAWMNGLSVYQIK.2|FVAWM[Oxi]NGLSVYQIK.2|REEFVQWVELLPDTQTPSWLGLPNNAER.4|REEFVQWVELLPDTQTPSWLGLPNNAER.3|LDRDPASGTALQEISFWLNLER.3|NVAQYNANHPDFPM[Oxi]QIEQLER.3|NVAQYNANHPDFPMQIEQLER.3|ITTVPLPTAPNIPIIDYEVSISGEWSPWQAK.4|ITTVPLPTAPNIPIIDYEVSISGEWSPWQAK.3|WVYLEGIFTGSADIK.2|FNYGFEYLGVQDKLVQTPLTDR.3|YPLIIDPSGQATEFIMNEYKDR.3|MKLNTQEIFDDWAR.2|QALETVNDYNPLMKDFPLNDLLSATELDKIR.4|DLSSQLLK.1|FNRYPLIIDPSGQATEFIMNEYK.3|PNYIVPDYMPVVYDK.2|IFVGLC[CAM]QVGAWGC[CAM]FDEFNRLEER.3|C[CAM]VLNWFGDWSTEALYQVGKEFTSK.3|MNTLLANGEVPGLFEGDEYATLMTQC[CAM]K.3|QELEQHSVDTASTSDAVTFITYVQSLK.3|QWIVFDGDVDPEWVENLNSVLDDNK.3|RQWIVFDGDVDPEWVENLNSVLDDNK.3|DIQMPDGIRREEFVQWVELLPDTQTPSWLGLPNNAER.4|EALELTDTGLLSGSEERVQVALEELQDLK.3|GEAVDEGEIAENLPEQEILIQSVC[CAM]ETMVPK.3|VQADEQFGIWLDSSSPEQTVPYLWSEETPATPIGQAIHR.4
SEN / CTL,P46783,40S ribosomal protein S10,RPS10,3.19,2.25,1.09E-02,9.29E-04,3.03E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",24,15,25,SAVPPGADKKAEAGAGSATEFQFR.4|SAVPPGADKKAEAGAGSATEFQFR.3|KAEAGAGSATEFQFR.3|KAEAGAGSATEFQFR.2|IAIYELLFK.2|HPELADK.2|DVHMPKHPELADKNVPNLHVMK.6|DYLHLPPEIVPATLR.4|DYLHLPPEIVPATLR.3|DYLHLPPEIVPATLR.2|HPELADKNVPNLHVMK.4|HPELADKNVPNLHVMK.3|HPELADKNVPNLHVM[Oxi]K.3|NRIAIYELLFK.3|DYLHLPPEIVPATLRR.4|DYLHLPPEIVPATLRR.3|AEAGAGSATEFQFR.3|AEAGAGSATEFQFR.2|GLEGERPAR.2|HFYWYLTNEGIQYLR.4|HFYWYLTNEGIQYLR.3|HFYWYLTNEGIQYLR.2|DVHMPKHPELADK.3|NVPNLHVMK.2|IAIYELLFKEGVMVAK.3
SEN / CTL,P59998,Actin-related protein 2/3 complex subunit 4,ARPC4,3.19,1.43,8.96E-11,2.09E-11,1.07E+01,"actin filament polymerization,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,actin nucleation,ephrin receptor signaling pathway","structural constituent of cytoskeleton,protein binding,enzyme binding,protein binding, bridging,actin filament binding","cytosol,Arp2/3 protein complex,cell projection,extracellular exosome",24,12,18,VLIEGSINSVR.2|IVAEEFLKNF.2|ELLLQPVTISR.2|ELLLQPVTISR.3|RKPVEGYDISFLITNFHTEQM[Oxi]YK.4|RKPVEGYDISFLITNFHTEQMYK.5|RKPVEGYDISFLITNFHTEQMYK.4|RKPVEGYDISFLITNFHTEQMYK.3|IVAEEFLK.2|ARIVAEEFLKNF.3|AENFFILR.2|SSKELLLQPVTISR.3|HNKPEVEVR.2|LVDFVIHFMEEIDK.3|LVDFVIHFMEEIDK.2|KPVEGYDISFLITNFHTEQMYK.4|ATLQAALC[CAM]LENFSSQVVER.3|ATLQAALC[CAM]LENFSSQVVER.2
SEN / CTL,P00749,Urokinase-type plasminogen activator,PLAU,3.18,3.25,4.56E-03,4.09E-04,3.39E+00,"response to hypoxia,proteolysis,chemotaxis,signal transduction,blood coagulation,regulation of receptor activity,smooth muscle cell migration,regulation of smooth muscle cell migration,positive regulation of cell migration,regulation of cell adhesion mediated by integrin,regulation of cell proliferation,fibrinolysis,regulation of wound healing,regulation of smooth muscle cell-matrix adhesion","serine-type endopeptidase activity,protein binding","extracellular region,extracellular space,plasma membrane,focal adhesion,cell surface,extracellular exosome",18,6,7,IIGGEFTTIENQPWFAAIYR.3|DYSADTLAHHNDIALLK.3|DYSADTLAHHNDIALLK.4|SRLNSNTQGEMKFEVENLILHK.5|VSHFLPWIR.2|SHTKEENGLAL.2|YFSNIHWC[CAM]NC[CAM]PK.2
SEN / CTL,Q15063,Periostin,POSTN,3.18,2.05,1.07E-09,2.21E-10,9.66E+00,"skeletal system development,response to hypoxia,negative regulation of cell-matrix adhesion,regulation of systemic arterial blood pressure,cell adhesion,regulation of Notch signaling pathway,response to mechanical stimulus,response to muscle activity,positive regulation of smooth muscle cell migration,extracellular matrix organization,response to estradiol,cellular response to fibroblast growth factor stimulus,cellular response to vitamin K,cellular response to tumor necrosis factor,cellular response to transforming growth factor beta stimulus,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of chemokine (C-C motif) ligand 2 secretion,neuron projection extension,bone regeneration","protein binding,heparin binding,metal ion binding,cell adhesion molecule binding","proteinaceous extracellular matrix,extracellular space,trans-Golgi network,extracellular matrix,neuromuscular junction",30,48,80,IIDGVPVEITEKETREER.3|GSFTYFAPSNEAWDNLDSDIRR.3|AAAITSDILEALGR.2|GRDQGPNVC[CAM]ALQQILGTK.3|GRDQGPNVC[CAM]ALQQILGTK.2|DGHFTLFAPTNEAFEKLPR.4|DGHFTLFAPTNEAFEKLPR.3|DGHFTLFAPTNEAFEKLPR.2|VASEALMK.2|IITGPEIK.2|IITGPEIKYTR.3|QVIELAGK.2|EIIKPAEK.2|NGAIHIFR.2|ISTGGGETEETLKK.3|ISTGGGETEETLKK.2|LLQEEVTK.2|IIHGNQIATNGVVHVIDR.4|IIHGNQIATNGVVHVIDR.3|IIHGNQIATNGVVHVIDR.2|GLESNVNVELLNALHSHMINKR.5|NALQNIILYHLTPGVFIGK.4|NALQNIILYHLTPGVFIGK.3|NALQNIILYHLTPGVFIGK.2|LILQNHILK.2|IRGRDQGPNVC[CAM]ALQQILGTK.4|IIDGVPVEITEKETR.3|RFSTFLSLLEAADLK.3|RFSTFLSLLEAADLK.2|DQGPNVC[CAM]ALQQILGTK.3|DQGPNVC[CAM]ALQQILGTK.2|ESDIMTTNGVIHVVDK.3|ESDIMTTNGVIHVVDK.2|GFEPGVTNILK.2|GLESNVNVELLNALHSHM[Oxi]INK.4|GLESNVNVELLNALHSHMINK.4|GLESNVNVELLNALHSHMINK.3|GLESNVNVELLNALHSHM[Oxi]INK.3|DIVTNNGVIHLIDQVLIPDSAK.4|DIVTNNGVIHLIDQVLIPDSAK.3|DIVTNNGVIHLIDQVLIPDSAK.2|DKNALQNIILYHLTPGVFIGK.4|DKNALQNIILYHLTPGVFIGK.3|EGETITEVIHGEPIIK.3|DGHFTLFAPTNEAFEK.3|DGHFTLFAPTNEAFEK.2|FIEGGDGHLFEDEEIK.3|DQGPNVC[CAM]ALQQILGTKK.3|RGLESNVNVELLNALHSHMINK.4|EGETITEVIHGEPIIKK.3|KDIVTNNGVIHLIDQVLIPDSAK.4|KDIVTNNGVIHLIDQVLIPDSAK.3|VGLNELYNGQILETIGGK.3|VGLNELYNGQILETIGGK.2|AAAITSDILEALGRDGHFTLFAPTNEAFEK.5|AAAITSDILEALGRDGHFTLFAPTNEAFEK.3|VLTQIGTSIQDFIEAEDDLSSFR.4|VLTQIGTSIQDFIEAEDDLSSFR.3|GC[CAM]PAVLPIDHVYGTLGIVGATTTQR.4|GC[CAM]PAVLPIDHVYGTLGIVGATTTQR.3|IIDGVPVEITEK.2|SKESDIMTTNGVIHVVDK.3|ISTGGGETEETLK.2|AAAITSDILEALGRDGHFTLFAPTNEAFEKLPR.5|AAAITSDILEALGRDGHFTLFAPTNEAFEKLPR.4|TAVC[CAM]IENSC[CAM]MEK.2|TAVC[CAM]IENSC[CAM]M[Oxi]EK.2|LLYPADTPVGNDQLLEILNK.3|LLYPADTPVGNDQLLEILNK.2|ELLTQPGDWTLFVPTNDAFK.3|ELLTQPGDWTLFVPTNDAFK.2|FSTFLSLLEAADLK.2|GSFTYFAPSNEAWDNLDSDIR.3|TTVLYEC[CAM]C[CAM]PGYM[Oxi]R.2|TTVLYEC[CAM]C[CAM]PGYMR.2|NGMIIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.4|NGM[Oxi]IIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.4|NGM[Oxi]IIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.3|NGMIIPSM[Oxi]YNNLGLFINHYPNGVVTVNC[CAM]AR.3|NGMIIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.3
SEN / CTL,P47755,F-actin-capping protein subunit alpha-2,CAPZA2,3.17,1.28,1.02E-05,1.34E-06,5.87E+00,"protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping",actin binding,"extracellular region,cytosol,brush border,F-actin capping protein complex,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular exosome",12,16,29,FIIHAPPGEFNEVFNDVR.3|FIIHAPPGEFNEVFNDVR.4|FIIHAPPGEFNEVFNDVR.2|FTITPSTTQVVGILK.2|FTITPSTTQVVGILK.3|TSVETALR.2|KIDGQQTIIAC[CAM]IESHQFQAK.5|KIDGQQTIIAC[CAM]IESHQFQAK.4|KIDGQQTIIAC[CAM]IESHQFQAK.3|KIDGQQTIIAC[CAM]IESHQFQAK.2|EHYPNGVC[CAM]TVYGK.3|EHYPNGVC[CAM]TVYGK.2|EGAAHAFAQYNLDQFTPVK.4|EGAAHAFAQYNLDQFTPVK.3|EGAAHAFAQYNLDQFTPVK.2|DIQDSLTVSNEVQTAK.3|DIQDSLTVSNEVQTAK.2|AYVKEHYPNGVC[CAM]TVYGK.3|EATDPRPC[CAM]EVENAVESWR.3|IDGQQTIIAC[CAM]IESHQFQAK.3|IEGYEDQVLITEHGDLGNGK.3|IEGYEDQVLITEHGDLGNGK.2|PC[CAM]EVENAVESWR.2|IQVHYYEDGNVQLVSHKDIQDSLTVSNEVQTAK.5|IVEAAENEYQTAISENYQTMSDTTFK.4|IVEAAENEYQTAISENYQTMSDTTFK.3|FIIHAPPGEFNEVFNDVRLLLNNDNLLR.4|EGAAHAFAQYNLDQFTPVKIEGYEDQVLITEHGDLGNGK.5|EGAAHAFAQYNLDQFTPVKIEGYEDQVLITEHGDLGNGK.4
SEN / CTL,Q9H4M9,EH domain-containing protein 1,EHD1,3.17,1.73,2.75E-11,6.82E-12,1.12E+01,"intracellular protein transport,endocytosis,blood coagulation,positive regulation of cholesterol storage,neuron projection development,endocytic recycling,low-density lipoprotein particle clearance,cilium assembly,cholesterol homeostasis,protein homooligomerization,protein localization to cilium,cell-cell adhesion,positive regulation of myoblast fusion,cellular response to nerve growth factor stimulus,positive regulation of endocytic recycling","calcium ion binding,protein binding,ATP binding,GTP binding,Rab GTPase binding,cadherin binding involved in cell-cell adhesion","lipid particle,plasma membrane,cell-cell adherens junction,endosome membrane,membrane,ciliary pocket membrane,platelet dense tubular network membrane,early endosome membrane,recycling endosome membrane,extracellular exosome",24,26,51,LLDTVDDMLANDIAR.2|LLDTVDDMLANDIAR.3|LLDTVDDM[Oxi]LANDIAR.2|IGPEPTTDSFIAVMHGPTEGVVPGNALVVDPR.3|IGPEPTTDSFIAVMHGPTEGVVPGNALVVDPR.4|EHQISPGDFPSLRK.4|EHQISPGDFPSLRK.3|EHQISPGDFPSLRK.2|KKEPELFQTVAEGLR.4|KKEPELFQTVAEGLR.3|KKEPELFQTVAEGLR.2|HLIEQDFPGMR.3|HLIEQDFPGMR.2|HLIEQDFPGM[Oxi]R.2|VKLEGHELPADLPPHLVPPSK.5|VKLEGHELPADLPPHLVPPSK.4|VKLEGHELPADLPPHLVPPSK.3|EHQISPGDFPSLR.3|EHQISPGDFPSLR.2|EPELFQTVAEGLR.3|EPELFQTVAEGLR.2|IEREHQISPGDFPSLRK.4|IEREHQISPGDFPSLRK.3|KLFEAEEQDLFK.3|KLFEAEEQDLFK.2|LEGHELPADLPPHLVPPSK.4|LEGHELPADLPPHLVPPSK.3|IINTPEVVR.2|KEPELFQTVAEGLR.3|KEPELFQTVAEGLR.2|LFEAEEQDLFKDIQSLPR.4|LFEAEEQDLFKDIQSLPR.3|LFEAEEQDLFKDIQSLPR.2|KKELVNNLGEIYQK.3|KLFEAEEQDLFKDIQSLPR.4|KLFEAEEQDLFKDIQSLPR.3|DGLLDDEEFALANHLIK.3|LADVDKDGLLDDEEFALANHLIK.4|LADVDKDGLLDDEEFALANHLIK.3|LFEAEEQDLFK.2|DKPTYDEIFYTLSPVNGK.3|DKPTYDEIFYTLSPVNGK.2|QEESLMPSQVVK.2|ELVNNLGEIYQK.2|FMC[CAM]AQLPNPVLDSISIIDTPGILSGEK.4|FM[Oxi]C[CAM]AQLPNPVLDSISIIDTPGILSGEK.3|FMC[CAM]AQLPNPVLDSISIIDTPGILSGEK.3|MQELLQTQDFSK.2|M[Oxi]QELLQTQDFSK.2|KMQELLQTQDFSK.2|GGAFDGTMNGPFGHGYGEGAGEGIDDVEWVVGK.3
SEN / CTL,P25787,Proteasome subunit alpha type-2,PSMA2,3.15,1.76,1.41E-08,2.63E-09,8.58E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to virus,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",24,15,31,RLTPTEVKDYLAAIA.3|KLAQQYYLVYQEPIPTAQLVQR.3|KLAQQYYLVYQEPIPTAQLVQR.4|LVQIEYALAAVAGGAPSVGIK.3|LVQIEYALAAVAGGAPSVGIK.4|LVQIEYALAAVAGGAPSVGIK.2|AANGVVLATEKK.3|AANGVVLATEKK.2|GYSFSLTTFSPSGK.3|GYSFSLTTFSPSGK.2|HIGLVYSGMGPDYR.3|HIGLVYSGM[Oxi]GPDYR.3|HIGLVYSGM[Oxi]GPDYR.2|HIGLVYSGMGPDYR.2|AANGVVLATEK.2|YNEDLELEDAIHTAILTLK.4|YNEDLELEDAIHTAILTLK.3|YNEDLELEDAIHTAILTLK.2|SVHKVEPITK.2|RYNEDLELEDAIHTAILTLK.4|RYNEDLELEDAIHTAILTLK.3|RYNEDLELEDAIHTAILTLK.2|LAQQYYLVYQEPIPTAQLVQR.4|LAQQYYLVYQEPIPTAQLVQR.3|PYLFQSDPSGAYFAWK.3|PYLFQSDPSGAYFAWK.2|ESFEGQMTEDNIEVGIC[CAM]NEAGFRR.4|ESFEGQMTEDNIEVGIC[CAM]NEAGFRR.3|LTPTEVKDYLAAIA.2|ESFEGQM[Oxi]TEDNIEVGIC[CAM]NEAGFR.3|ESFEGQMTEDNIEVGIC[CAM]NEAGFR.3
SEN / CTL,Q15181,Inorganic pyrophosphatase,PPA1,3.14,2.47,6.78E-03,5.97E-04,3.22E+00,"tRNA aminoacylation for protein translation,phosphate-containing compound metabolic process,diphosphate metabolic process","magnesium ion binding,inorganic diphosphatase activity","cytoplasm,cytosol,extracellular exosome",12,30,65,GQYISPFHDIPIYADKDVFHMVVEVPR.5|GQYISPFHDIPIYADKDVFHM[Oxi]VVEVPR.5|GQYISPFHDIPIYADKDVFHM[Oxi]VVEVPR.4|GQYISPFHDIPIYADKDVFHMVVEVPR.4|GQYISPFHDIPIYADKDVFHMVVEVPR.3|LKPGYLEATVDWFR.3|LKPGYLEATVDWFR.2|DPLNPIKQDVK.3|DPLNPIKQDVK.2|DVFHMVVEVPR.3|DVFHM[Oxi]VVEVPR.3|DVFHMVVEVPR.2|DVFHM[Oxi]VVEVPR.2|STHDHWK.2|LKPGYLEATVDWFRR.4|LKPGYLEATVDWFRR.3|LRYVANLFPYK.3|RLKPGYLEATVDWFR.4|RLKPGYLEATVDWFR.3|DFAIDIIK.2|MEIATKDPLNPIK.3|MEIATKDPLNPIK.2|M[Oxi]EIATKDPLNPIK.2|MEIATKDPLNPIKQDVK.4|MEIATKDPLNPIKQDVK.3|M[Oxi]EIATKDPLNPIKQDVK.3|MEIATKDPLNPIKQDVK.2|VPDGKPENEFAFNAEFK.4|VPDGKPENEFAFNAEFK.3|VPDGKPENEFAFNAEFK.2|AAPFSLEYR.2|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.6|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.5|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.4|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.3|GISC[CAM]MNTTLSESPFK.3|GISC[CAM]M[Oxi]NTTLSESPFK.2|GISC[CAM]MNTTLSESPFK.2|YKVPDGKPENEFAFNAEFK.4|YKVPDGKPENEFAFNAEFK.3|YKVPDGKPENEFAFNAEFK.2|YVANLFPYK.2|VIAINVDDPDAANYNDINDVK.4|VIAINVDDPDAANYNDINDVK.3|VIAINVDDPDAANYNDINDVK.2|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.4|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.3|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.2|DKDFAIDIIK.2|VLGILAMIDEGETDWK.3|VLGILAMIDEGETDWK.2|VLGILAM[Oxi]IDEGETDWK.2|VIAINVDDPDAANYNDINDVKR.4|VIAINVDDPDAANYNDINDVKR.3|GQYISPFHDIPIYADK.3|GQYISPFHDIPIYADK.2|YKVPDGKPENEFAFNAEFKDK.4|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQKN.5|HTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.3|HTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.2|PGYLEATVDWFR.2|GISC[CAM]M[Oxi]NTTLSESPFKC[CAM]DPDAAR.3|GISC[CAM]MNTTLSESPFKC[CAM]DPDAAR.3|GYIWNYGAIPQTWEDPGHNDK.3|GYIWNYGAIPQTWEDPGHNDKHTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.5
SEN / CTL,P25786,Proteasome subunit alpha type-1,PSMA1,3.14,1.74,1.19E-09,2.44E-10,9.61E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","RNA binding,threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,centrosome,cytosol,proteasome core complex,polysome,proteasome core complex, alpha-subunit complex,extracellular exosome",30,25,45,NQYDNDVTVWSPQGR.2|NQYDNDVTVWSPQGR.3|ALRETLPAEQDLTTK.3|ALRETLPAEQDLTTK.2|HMSEFMEC[CAM]NLNELVK.3|HM[Oxi]SEFM[Oxi]EC[CAM]NLNELVK.3|HMSEFM[Oxi]EC[CAM]NLNELVK.3|HMSEFMEC[CAM]NLNELVK.2|HM[Oxi]SEFMEC[CAM]NLNELVK.2|HMSEFM[Oxi]EC[CAM]NLNELVK.2|NVSIGIVGK.2|LVSLIGSK.2|RAQSELAAHQK.3|RAQSELAAHQK.2|QGSATVGLK.2|SKTHAVLVALKR.3|FVFDRPLPVSR.3|AQPAQPADEPAEK.3|AQPAQPADEPAEK.2|LLC[CAM]NFMR.2|LLC[CAM]NFM[Oxi]R.2|THAVLVALK.2|IHQIEYAM[Oxi]EAVK.3|IHQIEYAMEAVK.3|IHQIEYAM[Oxi]EAVK.2|IHQIEYAMEAVK.2|ILHVDNHIGISIAGLTADAR.4|ILHVDNHIGISIAGLTADAR.3|ILHVDNHIGISIAGLTADAR.2|AQSELAAHQK.2|KILHVDNHIGISIAGLTADAR.4|THAVLVALKR.2|KAQPAQPADEPAEKADEPMEH.4|KAQPAQPADEPAEKADEPMEH.3|ETLPAEQDLTTK.2|AQPAQPADEPAEKADEPMEH.3|AQPAQPADEPAEKADEPM[Oxi]EH.3|RPYGVGLLIAGYDDMGPHIFQTC[CAM]PSANYFDC[CAM]R.5|RPYGVGLLIAGYDDM[Oxi]GPHIFQTC[CAM]PSANYFDC[CAM]R.4|RPYGVGLLIAGYDDMGPHIFQTC[CAM]PSANYFDC[CAM]R.4|IHQIEYAMEAVKQGSATVGLK.3|DLEFTIYDDDDVSPFLEGLEERPQRK.4|DLEFTIYDDDDVSPFLEGLEERPQRK.3|YGRRPYGVGLLIAGYDDMGPHIFQTC[CAM]PSANYFDC[CAM]R.5|DLEFTIYDDDDVSPFLEGLEERPQR.3
SEN / CTL,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,3.14,2.30,2.87E-24,2.42E-24,2.36E+01,"response to hypoxia,cellular protein modification process,oxidation-reduction process","iron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding","endoplasmic reticulum,endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",84,33,47,YLNSGGFIGYAPYVNR.2|DKLDPDMALC[CAM]R.3|SEDYVDIVQGNR.2|IFTENIVEQPC[CAM]PDVFWFPIFSEK.3|IVGPEENLSQAEAR.2|IVGPEENLSQAEAR.3|VLGQGEEWRGGDGINSIGGGQK.3|IVQQWNLQDNDDDQLFYTK.3|IVQQWNLQDNDDDQLFYTK.2|AC[CAM]DELVEEMEHYGK.3|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.5|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.4|ISGGYENVPTDDIHMK.3|ISGGYENVPTDDIHM[Oxi]K.3|ISGGYENVPTDDIHMK.2|VGVWNVPYMANVYLIK.2|VGVWNVPYMANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.2|LTHLHEGLPVK.3|LTHLHEGLPVK.2|VFAGYYTK.2|LLVITVATK.2|VYIDPLKR.2|EFIAPVTLK.2|NMGMDFC[CAM]R.2|YIAVSFIDP.2|VVFAADGILWPDKR.3|VLGQGEEWR.2|IFQTLNGAVDEVVLK.3|IFQTLNGAVDEVVLK.2|GFALLNFVVK.2|QVDLENVWLHFIR.3|GGDGINSIGGGQK.2|C[CAM]KIFQTLNGAVDEVVLKFENGK.4|NTFYETLPVAINGNGPTK.3|NTFYETLPVAINGNGPTK.2|RYLNSGGFIGYAPYVNR.3|RYLNSGGFIGYAPYVNR.2|LWSNFWGALSPDGYYAR.3|LWSNFWGALSPDGYYAR.2|AKNTFYETLPVAINGNGPTK.3|VVFAADGILWPDK.2|FLDILLTLDYPK.2|IFQTLNGAVDEVVLKFENGK.3|IFQTLNGAVDEVVLKFENGK.2|NMGMDFC[CAM]RQDEK.2
SEN / CTL,P08648,Integrin alpha-5,ITGA5,3.14,1.71,3.93E-10,8.56E-11,1.01E+01,"angiogenesis,cell-substrate junction assembly,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,integrin-mediated signaling pathway,memory,positive regulation of cell-substrate adhesion,extracellular matrix organization,positive regulation of cell migration,positive regulation of vascular endothelial growth factor receptor signaling pathway,cell-substrate adhesion,cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,heterotypic cell-cell adhesion,wound healing, spreading of epidermal cells,endodermal cell differentiation,viral entry into host cell,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive regulation of sprouting angiogenesis,negative regulation of anoikis","virus receptor activity,epidermal growth factor receptor binding,platelet-derived growth factor receptor binding,integrin binding,protein binding,vascular endothelial growth factor receptor 2 binding,metal ion binding","ruffle,endoplasmic reticulum,Golgi apparatus,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,cytoplasmic vesicle,synapse,alphav-beta3 integrin-vitronectin complex,cell-cell junction,ruffle membrane",24,23,32,LLESSLSSSEGEEPVEYK.2|SLQWFGATVR.2|VYVYLQHPAGIEPTPTLTLTGHDEFGR.4|VYVYLQHPAGIEPTPTLTLTGHDEFGR.3|EHQPFSLQC[CAM]EAVYK.3|EHQPFSLQC[CAM]EAVYK.2|TPDGRPQEVGR.3|GLELDPEGSLHHQQK.4|GLELDPEGSLHHQQK.2|AGASLWGGLR.2|ILEYAPC[CAM]R.2|LRC[CAM]ELGPLHQQESQSLQLHFR.5|LRC[CAM]ELGPLHQQESQSLQLHFR.4|C[CAM]PEAEC[CAM]FR.2|SSASSGPQILK.2|AQLKPPATSDA.2|QVATAVQWTK.2|C[CAM]ELGPLHQQESQSLQLHFR.4|C[CAM]ELGPLHQQESQSLQLHFR.2|AHGSSILAC[CAM]APLYSWR.3|AHGSSILAC[CAM]APLYSWR.2|LLVC[CAM]DLGNPMK.2|PSQVLQPLWAASHTPDFFGSALR.4|PSQVLQPLWAASHTPDFFGSALR.3|DLDGNGYPDLIVGSFGVDK.3|DLDGNGYPDLIVGSFGVDK.2|TIQFDFQILSK.2|VTAPPEAEYSGLVR.2|LSVEAQAQVTLNGVSKPEAVLFPVSDWHPR.4|QATLTQTLLIQNGAR.2|GRPIVSASASLTIFPAMFNPEER.3|GRPIVSASASLTIFPAM[Oxi]FNPEER.3
SEN / CTL,P84098,60S ribosomal protein L19,RPL19,3.13,1.45,2.75E-08,4.84E-09,8.32E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,liver regeneration","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,large ribosomal subunit rRNA binding,5.8S rRNA binding","nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit",18,12,18,KVWLDPNETNEIANANSR.3|KVWLDPNETNEIANANSR.2|VWLDPNETNEIANANSR.3|VWLDPNETNEIANANSR.2|HM[Oxi]YHSLYLK.3|HMYHSLYLK.2|RLASSVLR.2|KPVTVHSR.2|LLADQAEAR.2|ILMEHIHK.2|ILM[Oxi]EHIHK.2|DGLIIRKPVTVHSR.3|KKVWLDPNETNEIANANSR.4|KKVWLDPNETNEIANANSR.3|KKVWLDPNETNEIANANSR.2|KLLADQAEAR.2|RILMEHIHK.2|KKLLADQAEAR.2
SEN / CTL,P62913,60S ribosomal protein L11,RPL11,3.13,1.65,2.60E-05,3.24E-06,5.49E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,protein targeting,SRP-dependent cotranslational protein targeting to membrane,viral transcription,protein localization to nucleus,ribosomal large subunit biogenesis","RNA binding,structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",12,20,23,VLEQLTGQTPVFSK.2|VLEQLTGQTPVFSK.3|AEEILEK.2|HRISKEEAMR.3|PGFSIADK.2|NEKIAVHC[CAM]TVR.3|IAVHC[CAM]TVR.2|PGFSIADKK.2|VREYELR.2|ISKEEAM[Oxi]R.2|YDGIILPGK.2|GAKAEEILEK.2|KLC[CAM]LNIC[CAM]VGESGDR.3|KLC[CAM]LNIC[CAM]VGESGDR.2|WFQQKYDGIILPGK.3|AAKVLEQLTGQTPVFSK.3|LC[CAM]LNIC[CAM]VGESGDRLTR.3|KNNFSDTGNFGFGIQEHIDLGIK.4|KNNFSDTGNFGFGIQEHIDLGIK.3|LC[CAM]LNIC[CAM]VGESGDR.2|YDPSIGIYGLDFYVVLGRPGFSIADKK.4|NNFSDTGNFGFGIQEHIDLGIK.3|YDPSIGIYGLDFYVVLGRPGFSIADK.3
SEN / CTL,P35232,Prohibitin,PHB,3.12,1.84,1.22E-10,2.79E-11,1.06E+01,"negative regulation of transcription from RNA polymerase II promoter,osteoblast differentiation,regulation of transcription, DNA-templated,mitochondrion organization,signal transduction,negative regulation of cell proliferation,positive regulation of gene expression,positive regulation of cell death,negative regulation of transcription by competitive promoter binding,histone deacetylation,negative regulation of cell growth,negative regulation of protein catabolic process,regulation of apoptotic process,positive regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of complement activation,protein stabilization,progesterone receptor signaling pathway,negative regulation of androgen receptor signaling pathway,negative regulation of ERK1 and ERK2 cascade,positive regulation of ERK1 and ERK2 cascade,cellular response to interleukin-6,DNA biosynthetic process,negative regulation of glucocorticoid receptor signaling pathway","RNA polymerase II transcription factor activity, sequence-specific DNA binding,complement component C3a binding,complement component C3b binding,protein binding,protein C-terminus binding,enzyme binding,proteinase activated receptor binding,histone deacetylase binding,transcription regulatory region DNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial inner membrane,early endosome,plasma membrane,integral component of plasma membrane,cell surface,membrane,myelin sheath,extracellular exosome",24,36,61,AAIISAEGDSKAAELIANSLATAGDGLIELR.4|AAIISAEGDSKAAELIANSLATAGDGLIELR.3|FDAGELITQR.2|KLEAAEDIAYQLSR.3|KLEAAEDIAYQLSR.2|NVPVITGSKDLQNVNITLR.3|NVPVITGSKDLQNVNITLR.2|VLPSITTEILK.3|VLPSITTEILK.2|PVASQLPR.2|PIIFDC[CAM]R.2|ILFRPVASQLPR.3|ILFRPVASQLPR.2|IFTSIGEDYDER.3|IFTSIGEDYDER.2|LEAAEDIAYQLSR.3|LEAAEDIAYQLSR.2|AAELIANSLATAGDGLIELR.4|AAELIANSLATAGDGLIELR.3|AAELIANSLATAGDGLIELR.2|EFTEAVEAK.2|AAIISAEGDSK.2|AATFGLILDDVSLTHLTFGK.4|AATFGLILDDVSLTHLTFGK.3|AATFGLILDDVSLTHLTFGK.2|QVAQQEAER.2|QVSDDLTER.2|GVQDIVVGEGTHFLIPWVQK.4|GVQDIVVGEGTHFLIPWVQK.3|GVQDIVVGEGTHFLIPWVQK.2|FDAGELITQRELVSR.3|DLQNVNITLR.2|FGLALAVAGGVVNSALYNVDAGHR.4|FGLALAVAGGVVNSALYNVDAGHR.3|FGLALAVAGGVVNSALYNVDAGHR.2|KAAIISAEGDSK.2|FVVEKAEQQK.2|NITYLPAGQSVLLQLPQ.3|NITYLPAGQSVLLQLPQ.2|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.4|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.3|FRGVQDIVVGEGTHFLIPWVQK.4|FRGVQDIVVGEGTHFLIPWVQK.3|FVVEKAEQQKK.2|FRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|FRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.4|AVIFDRFRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.6|AVIFDRFRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|SRNITYLPAGQSVLLQLPQ.3|SRNITYLPAGQSVLLQLPQ.2|AAELIANSLATAGDGLIELRK.3|AAELIANSLATAGDGLIELRK.2|AATFGLILDDVSLTHLTFGKEFTEAVEAK.4|AATFGLILDDVSLTHLTFGKEFTEAVEAK.3|VFESIGKFGLALAVAGGVVNSALYNVDAGHR.4|VFESIGKFGLALAVAGGVVNSALYNVDAGHR.3|KAAIISAEGDSKAAELIANSLATAGDGLIELR.4|SVVARFDAGELITQR.2|QVSDDLTERAATFGLILDDVSLTHLTFGKEFTEAVEAK.5|IFTSIGEDYDERVLPSITTEILK.3
SEN / CTL,P22061,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,PCMT1,3.11,1.14,1.19E-17,5.26E-18,1.73E+01,"protein methylation,protein repair,cell-cell adhesion","protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,extracellular exosome,extracellular vesicle",36,19,49,ALDVGSGSGILTAC[CAM]FAR.2|ALDVGSGSGILTAC[CAM]FAR.3|MGYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGR.4|M[Oxi]GYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGR.4|MGYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGR.5|M[Oxi]GYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGR.3|MGYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGR.3|LILPVGPAGGNQMLEQYDKLQDGSIK.3|LILPVGPAGGNQMLEQYDKLQDGSIK.4|LILPVGPAGGNQM[Oxi]LEQYDKLQDGSIK.4|LILPVGPAGGNQM[Oxi]LEQYDKLQDGSIK.3|SGGASHSELIHNLRK.4|SGGASHSELIHNLRK.3|SGGASHSELIHNLRK.2|VIGIDHIK.2|ELVDDSVNNVRK.3|VQLVVGDGR.2|PLMGVIYVPLTDK.3|PLMGVIYVPLTDK.2|PLM[Oxi]GVIYVPLTDK.2|M[Oxi]KPLMGVIYVPLTDKEK.4|MKPLMGVIYVPLTDKEK.4|M[Oxi]KPLM[Oxi]GVIYVPLTDKEK.4|M[Oxi]KPLMGVIYVPLTDKEK.3|MKPLM[Oxi]GVIYVPLTDKEK.3|MKPLMGVIYVPLTDKEK.3|M[Oxi]KPLM[Oxi]GVIYVPLTDKEK.3|MKPLMGVIYVPLTDKEK.2|SGGASHSELIHNLR.3|SGGASHSELIHNLR.2|TDKVFEVMLATDR.3|TDKVFEVM[Oxi]LATDR.3|TDKVFEVMLATDR.2|DDPTLLSSGR.2|M[Oxi]KPLMGVIYVPLTDK.3|MKPLM[Oxi]GVIYVPLTDK.3|MKPLMGVIYVPLTDK.3|MKPLMGVIYVPLTDK.2|KDDPTLLSSGR.2|VFEVMLATDR.2|VFEVM[Oxi]LATDR.2|ELVDDSVNNVRKDDPTLLSSGR.4|ELVDDSVNNVRKDDPTLLSSGR.3|ELVDDSVNNVR.2|LILPVGPAGGNQM[Oxi]LEQYDK.3|LILPVGPAGGNQMLEQYDK.3|LILPVGPAGGNQM[Oxi]LEQYDK.2|LILPVGPAGGNQMLEQYDK.2|MGYAEEAPYDAIHVGAAAPVVPQALIDQLK.3
SEN / CTL,P23142,Fibulin-1,FBLN1,3.11,2.13,1.50E-08,2.78E-09,8.56E+00,"negative regulation of protein phosphorylation,negative regulation of cell adhesion,embryo implantation,positive regulation of peptidase activity,viral process,extracellular matrix organization,negative regulation of ERK1 and ERK2 cascade,blood coagulation, fibrin clot formation,negative regulation of substrate adhesion-dependent cell spreading,negative regulation of cell motility,negative regulation of stem cell proliferation,integrin-mediated signaling pathway","fibronectin binding,extracellular matrix structural constituent,calcium ion binding,protein C-terminus binding,peptidase activator activity,protein complex binding,identical protein binding,fibrinogen binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular exosome,elastic fiber,fibrinogen complex,extracellular matrix",66,25,36,RGYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.4|GYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.3|YMDGMTVGVVR.2|EFTRPEEIIFLR.3|EFTRPEEIIFLR.2|AITPPHPASQANIIFDITEGNLRDSFDIIKR.5|AITPPHPASQANIIFDITEGNLR.3|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.5|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.4|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.3|MC[CAM]VDVNEC[CAM]QR.2|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.3|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.2|C[CAM]C[CAM]HC[CAM]C[CAM]LLGR.3|SAATLQQEK.2|C[CAM]VNSPGSFR.2|SAATLQQEKTDTVR.3|SAATLQQEKTDTVR.2|LEMNYVVGGVVSHR.3|LEMNYVVGGVVSHR.2|GYHLNEEGTR.2|TGYYFDGISR.2|DC[CAM]SLPYATESK.2|DSSC[CAM]GTGYELTEDNSC[CAM]K.3|DSSC[CAM]GTGYELTEDNSC[CAM]K.2|IIEVEEEQEDPYLNDR.3|IIEVEEEQEDPYLNDR.2|C[CAM]LAFEC[CAM]PENYR.2|AITPPHPASQANIIFDITEGNLRDSFDIIK.4|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|SQETGDLDVGGLQETDK.2|SQETGDLDVGGLQETDKIIEVEEEQEDPYLNDR.4|DIDEC[CAM]ESGIHNC[CAM]LPDFIC[CAM]QNTLGSFR.3
SEN / CTL,P05452,Tetranectin,CLEC3B,3.10,1.40,7.57E-05,8.85E-06,5.05E+00,"ossification,platelet degranulation,positive regulation of plasminogen activation,bone mineralization,cellular response to organic substance,cellular response to transforming growth factor beta stimulus","calcium ion binding,heparin binding,carbohydrate binding,kringle domain binding","granular component,extracellular region,extracellular space,cytoplasm,platelet dense granule lumen,extracellular exosome,extracellular matrix",12,11,14,GGTLGTPQTGSENDALYEYLR.2|GGTLGTPQTGSENDALYEYLR.3|TFHEASEDC[CAM]ISR.3|NWETEITAQPDGGK.3|NWETEITAQPDGGK.2|SRLDTLAQEVALLK.3|SRLDTLAQEVALLK.2|C[CAM]FLAFTQTK.2|EQQALQTVC[CAM]LK.2|LDTLAQEVALLK.2|TENC[CAM]AVLSGAANGK.2|DQLPYIC[CAM]QFGIV.2|C[CAM]RDQLPYIC[CAM]QFGIV.2|NWETEITAQPDGGKTENC[CAM]AVLSGAANGK.3
SEN / CTL,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,3.08,1.76,8.08E-13,2.32E-13,1.26E+01,"negative regulation of endothelial cell proliferation,lipid metabolic process,ATP biosynthetic process,embryo development,mitochondrial ATP synthesis coupled proton transport","protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,poly(A) RNA binding,proton-transporting ATP synthase activity, rotational mechanism,ATPase activity","mitochondrion,mitochondrial inner membrane,mitochondrial proton-transporting ATP synthase complex,mitochondrial matrix,plasma membrane,membrane,extracellular matrix,myelin sheath,proton-transporting ATP synthase complex, catalytic core F(1),extracellular exosome,COP9 signalosome",36,55,105,TGAIVDVPVGEELLGR.2|TGAIVDVPVGEELLGR.3|VVDALGNAIDGKGPIGSK.3|VVDALGNAIDGKGPIGSK.2|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.4|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.5|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.3|EVAAFAQFGSDLDAATQQLLSR.3|EVAAFAQFGSDLDAATQQLLSR.4|EVAAFAQFGSDLDAATQQLLSR.2|TGTAEMSSILEER.2|TGTAEMSSILEER.3|TGTAEM[Oxi]SSILEER.2|GIRPAINVGLSVSR.3|GIRPAINVGLSVSR.2|EGDIVKR.2|ELIIGDRQTGK.3|ELIIGDRQTGK.2|ADGKISEQSDAK.3|ADGKISEQSDAK.2|DNGKHALIIYDDLSK.4|DNGKHALIIYDDLSK.3|DNGKHALIIYDDLSK.2|RPPGREAYPGDVFYLHSR.5|RPPGREAYPGDVFYLHSR.4|RVGLKAPGIIPR.3|STVAQLVK.2|HALIIYDDLSK.3|HALIIYDDLSK.2|ISEQSDAK.2|LTDADAM[Oxi]K.2|TSIAIDTIINQK.3|TSIAIDTIINQK.2|LELAQYR.2|AVDSLVPIGRGQR.3|FNDGSDEK.2|ISVREPMQTGIK.3|ISVREPM[Oxi]QTGIK.3|ISVREPMQTGIK.2|ISVREPM[Oxi]QTGIK.2|KLYC[CAM]IYVAIGQK.3|KLYC[CAM]IYVAIGQK.2|HALIIYDDLSKQAVAYR.4|HALIIYDDLSKQAVAYR.3|TSIAIDTIINQKR.3|TSIAIDTIINQKR.2|GYLDKLEPSKITK.3|RSTVAQLVK.2|VLSIGDGIAR.2|AVDSLVPIGR.2|RLTDADAMK.2|RLTDADAM[Oxi]K.2|EAYPGDVFYLHSR.3|EAYPGDVFYLHSR.2|LKEIVTNFLAGFEA.3|LKEIVTNFLAGFEA.2|ILGADTSVDLEETGR.3|ILGADTSVDLEETGR.2|RPPGREAYPGDVFYLHSRLLER.5|QVAGTMKLELAQYR.3|QVAGTMKLELAQYR.2|RFNDGSDEK.2|ITKFENAFLSHVVSQHQALLGTIR.5|ITKFENAFLSHVVSQHQALLGTIR.4|ITKFENAFLSHVVSQHQALLGTIR.3|FENAFLSHVVSQHQALLGTIRADGK.5|FENAFLSHVVSQHQALLGTIRADGK.4|FENAFLSHVVSQHQALLGTIRADGK.3|NVQAEEMVEFSSGLK.3|NVQAEEM[Oxi]VEFSSGLK.2|NVQAEEMVEFSSGLK.2|PAINVGLSVSR.2|VGLKAPGIIPR.2|GYLDKLEPSK.2|QGQYSPMAIEEQVAVIYAGVR.4|QGQYSPM[Oxi]AIEEQVAVIYAGVR.3|QGQYSPMAIEEQVAVIYAGVR.3|QGQYSPM[Oxi]AIEEQVAVIYAGVR.2|QGQYSPMAIEEQVAVIYAGVR.2|VVDALGNAIDGK.2|FENAFLSHVVSQHQALLGTIR.4|FENAFLSHVVSQHQALLGTIR.3|FENAFLSHVVSQHQALLGTIR.2|RTGAIVDVPVGEELLGR.3|RTGAIVDVPVGEELLGR.2|ISVREPM[Oxi]QTGIKAVDSLVPIGR.4|ISEQSDAKLKEIVTNFLAGFEA.4|ISEQSDAKLKEIVTNFLAGFEA.3|EIVTNFLAGFEA.2|LYC[CAM]IYVAIGQK.2|GMSLNLEPDNVGVVVFGNDK.3|GM[Oxi]SLNLEPDNVGVVVFGNDK.3|GM[Oxi]SLNLEPDNVGVVVFGNDK.2|GMSLNLEPDNVGVVVFGNDK.2|LELAQYREVAAFAQFGSDLDAATQQLLSR.4|LELAQYREVAAFAQFGSDLDAATQQLLSR.3|GM[Oxi]SLNLEPDNVGVVVFGNDKLIK.3|GMSLNLEPDNVGVVVFGNDKLIK.3|YTIVVSATASDAAPLQYLAPYSGC[CAM]SMGEYFR.4|YTIVVSATASDAAPLQYLAPYSGC[CAM]SM[Oxi]GEYFR.4|YTIVVSATASDAAPLQYLAPYSGC[CAM]SM[Oxi]GEYFR.3|YTIVVSATASDAAPLQYLAPYSGC[CAM]SMGEYFR.3|ILGADTSVDLEETGRVLSIGDGIAR.3|QVAGTM[Oxi]KLELAQYREVAAFAQFGSDLDAATQQLLSR.4|QVAGTMKLELAQYREVAAFAQFGSDLDAATQQLLSR.4
SEN / CTL,P13726,Tissue factor,F3,3.08,0.48,2.03E-05,2.57E-06,5.59E+00,"positive regulation of endothelial cell proliferation,activation of plasma proteins involved in acute inflammatory response,activation of blood coagulation via clotting cascade,activation of cysteine-type endopeptidase activity involved in apoptotic process,blood coagulation,blood coagulation, extrinsic pathway,positive regulation of platelet-derived growth factor receptor signaling pathway,protein processing,cytokine-mediated signaling pathway,positive regulation of cell migration,positive regulation of angiogenesis,positive regulation of positive chemotaxis,positive regulation of protein kinase B signaling","protease binding,cytokine receptor activity,protein binding,phospholipid binding,serine-type endopeptidase activity","extracellular space,plasma membrane,cell surface,integral component of membrane,extracellular matrix,intrinsic component of external side of plasma membrane,extracellular exosome,serine-type peptidase complex",6,3,3,TILEWEPKPVNQVYTVQISTK.3|DLIYTLYYWK.2|C[CAM]FYTTDTEC[CAM]DLTDEIVK.2
SEN / CTL,O00754,Lysosomal alpha-mannosidase,MAN2B1,3.07,1.59,1.26E-07,2.06E-08,7.69E+00,"mannose metabolic process,cellular protein modification process,protein deglycosylation,oligosaccharide catabolic process","alpha-mannosidase activity,zinc ion binding,carbohydrate binding","extracellular space,lysosomal lumen,extracellular exosome",18,32,45,FQVIVYNPLGR.2|LQETTLVANQLR.2|ELVDYFLNVATAQGR.3|ELVDYFLNVATAQGR.2|GRFYTDSNGREILER.4|GRFYTDSNGREILER.3|RSWSPALTIENEHIR.4|GRHLVLLDTAQAAAAGHR.4|FDTPLETK.2|VAWHIDPFGHSR.3|LEHQFAVGEDSGR.3|LEHQFAVGEDSGR.2|WAQIHLVK.2|FLEDTFGNDGRPR.3|FLEDTFGNDGRPR.2|QHVANDYAR.2|LEMEQVWR.2|TFLASVQWK.2|HLVLLDTAQAAAAGHR.3|HLVLLDTAQAAAAGHR.2|LPVSEGVFVVKDPNGR.3|LPVSEGVFVVK.2|DLFSTFTITR.2|HDDFFPYADGPHQFWTGYFSSRPALK.5|HDDFFPYADGPHQFWTGYFSSRPALK.4|HDDFFPYADGPHQFWTGYFSSRPALK.3|TVDQYFYGIK.2|RDLPPSVHLLTLASWGPEMVLLR.4|HDDFFPYADGPHQFWTGYFSSR.4|HDDFFPYADGPHQFWTGYFSSR.3|QLAAGWGPC[CAM]EVLLSNALAR.3|QLAAGWGPC[CAM]EVLLSNALAR.2|DDGRGVSEPLMENGSGAWVR.3|HLELEWSVGPIPVGDTWGK.3|HLELEWSVGPIPVGDTWGK.2|NLC[CAM]WDVLC[CAM]VDQPLVEDPR.3|NLC[CAM]WDVLC[CAM]VDQPLVEDPR.2|GSSVHVLYSTPAC[CAM]YLWELNK.3|GSSVHVLYSTPAC[CAM]YLWELNK.2|DLPPSVHLLTLASWGPEMVLLR.3|DLPPSVHLLTLASWGPEM[Oxi]VLLR.3|GVSEPLMENGSGAWVR.2|ASTSLKPPTADLFTGVLPNGYNPPR.3|IYITDGNMQLTVLTDR.2|NLC[CAM]WDVLC[CAM]VDQPLVEDPRSPEYNAK.3
SEN / CTL,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,3.06,2.11,1.03E-09,2.14E-10,9.67E+00,"nicotinamide metabolic process,signal transduction,cell-cell signaling,female pregnancy,circadian rhythm,positive regulation of cell proliferation,NAD biosynthetic process,response to organic cyclic compound,circadian regulation of gene expression,positive regulation of transcription from RNA polymerase II promoter,positive regulation of smooth muscle cell proliferation,positive regulation of nitric-oxide synthase biosynthetic process,insulin receptor signaling pathway,adipose tissue development","nicotinate-nucleotide diphosphorylase (carboxylating) activity,cytokine activity,drug binding,protein homodimerization activity,nicotinamide phosphoribosyltransferase activity","extracellular space,nucleoplasm,cytosol,cell junction,extracellular exosome",24,37,65,NAQLNIELEAAHH.3|NAQLNIELEAAHH.2|STQAPLIIRPDSGNPLDTVLK.3|STQAPLIIRPDSGNPLDTVLK.2|TPAGNFVTLEEGKGDLEEYGQDLLHTVFK.4|TPAGNFVTLEEGKGDLEEYGQDLLHTVFK.3|DPVADPNK.2|GTDTVAGLALIKK.3|GTDTVAGLALIKK.2|LHDFGYR.2|EHFQDDVFNEK.3|EHFQDDVFNEK.2|DVYKEHFQDDVFNEK.4|DVYKEHFQDDVFNEK.3|DVYKEHFQDDVFNEK.2|GVSSQETAGIGASAHLVNFK.4|GVSSQETAGIGASAHLVNFK.3|GVSSQETAGIGASAHLVNFK.2|DLLNC[CAM]SFK.2|SYSFDEIR.2|GWNYILEK.2|KFPVTENSK.2|AVPEGFVIPR.2|YYGTKDPVPGYSVPAAEHSTITAWGKDHEK.6|YYGTKDPVPGYSVPAAEHSTITAWGKDHEK.5|YYGTKDPVPGYSVPAAEHSTITAWGKDHEK.4|C[CAM]SYVVTNGLGINVFK.3|C[CAM]SYVVTNGLGINVFK.2|VYSYFEC[CAM]R.2|LHDFGYRGVSSQETAGIGASAHLVNFK.5|SYSFDEIRK.2|YLLETSGNLDGLEYK.3|YLLETSGNLDGLEYK.2|GTDTVAGLALIK.2|KYYGTKDPVPGYSVPAAEHSTITAWGK.5|KYYGTKDPVPGYSVPAAEHSTITAWGK.4|YDGHLPIEIK.2|GDLEEYGQDLLHTVFK.3|GDLEEYGQDLLHTVFK.2|YEETVFYGLQYILNK.3|YEETVFYGLQYILNK.2|MWSIENIAFGSGGGLLQK.3|M[Oxi]WSIENIAFGSGGGLLQK.2|MWSIENIAFGSGGGLLQK.2|C[CAM]SYVVTNGLGINVFKDPVADPNKR.4|C[CAM]SYVVTNGLGINVFKDPVADPNKR.3|DAFEHIVTQFSSVPVSVVSDSYDIYNAC[CAM]EK.5|DAFEHIVTQFSSVPVSVVSDSYDIYNAC[CAM]EK.4|DAFEHIVTQFSSVPVSVVSDSYDIYNAC[CAM]EK.3|TPAGNFVTLEEGK.2|VKYEETVFYGLQYILNK.3|VKYEETVFYGLQYILNK.2|YYGTKDPVPGYSVPAAEHSTITAWGK.4|YYGTKDPVPGYSVPAAEHSTITAWGK.3|VIQGDGVDINTLQEIVEGM[Oxi]K.3|VIQGDGVDINTLQEIVEGMK.3|VIQGDGVDINTLQEIVEGM[Oxi]K.2|VIQGDGVDINTLQEIVEGMK.2|DPVPGYSVPAAEHSTITAWGK.3|DPVPGYSVPAAEHSTITAWGK.2|DVYKEHFQDDVFNEKGWNYILEK.4|GVSSQETAGIGASAHLVNFKGTDTVAGLALIK.4|DHEKDAFEHIVTQFSSVPVSVVSDSYDIYNAC[CAM]EK.5|DHEKDAFEHIVTQFSSVPVSVVSDSYDIYNAC[CAM]EK.4|C[CAM]SYVVTNGLGINVFKDPVADPNK.3
SEN / CTL,P17987,T-complex protein 1 subunit alpha,TCP1,3.06,1.99,1.33E-18,6.64E-19,1.82E+01,"protein folding,tubulin complex assembly,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,translocation of peptides or proteins into host cell cytoplasm,protein stabilization,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body,regulation of macrophage apoptotic process","protein binding,ATP binding,ubiquitin protein ligase binding,poly(A) RNA binding,unfolded protein binding","pericentriolar material,acrosomal vesicle,zona pellucida receptor complex,nuclear heterochromatin,Golgi apparatus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome",66,42,75,SLLVIPNTLAVNAAQDSTDLVAKLR.3|EQLAIAEFAR.2|SLLVIPNTLAVNAAQDSTDLVAK.3|SLLVIPNTLAVNAAQDSTDLVAK.2|SLLVIPNTLAVNAAQDSTDLVAK.4|SQNVMAAASIANIVK.2|SQNVMAAASIANIVK.3|SQNVM[Oxi]AAASIANIVK.3|SQNVM[Oxi]AAASIANIVK.2|FATEAAITILR.2|FATEAAITILR.3|IC[CAM]DDELILIK.2|YINENLIVNTDELGRDC[CAM]LINAAK.3|TSASIILR.2|GANDFMC[CAM]DEMER.2|GANDFM[Oxi]C[CAM]DEMER.2|GANDFMC[CAM]DEM[Oxi]ER.2|LGVQVVITDPEKLDQIR.3|LGVQVVITDPEKLDQIR.2|IHPTSVISGYR.3|LRAFHNEAQVNPER.4|LRAFHNEAQVNPER.3|SLHDALC[CAM]VVKR.3|DC[CAM]LINAAK.2|LRAFHNEAQVNPERK.4|LRAFHNEAQVNPERK.3|WIGLDLSNGKPR.3|WIGLDLSNGKPR.2|AFHNEAQVNPER.3|AFHNEAQVNPER.2|DDKHGSYEDAVHSGALND.4|DDKHGSYEDAVHSGALND.3|SSLGPVGLDK.2|AFHNEAQVNPERK.3|AFHNEAQVNPERK.2|DNKQAGVFEPTIVK.3|DNKQAGVFEPTIVK.2|HGSYEDAVHSGALND.3|HGSYEDAVHSGALND.2|LLEVEHPAAK.2|MKLGVQVVITDPEKLDQIR.4|SLHDALC[CAM]VVK.2|YPVNSVNILK.2|QAGVFEPTIVK.2|YINENLIVNTDELGR.3|YINENLIVNTDELGR.2|IAC[CAM]LDFSLQK.2|EVGDGTTSVVIIAAELLK.3|EVGDGTTSVVIIAAELLK.2|YFVEAGAMAVR.2|YFVEAGAM[Oxi]AVR.2|LGVQVVITDPEK.2|VLC[CAM]ELADLQDK.2|SVVPGGGAVEAALSIYLENYATSMGSR.4|SVVPGGGAVEAALSIYLENYATSM[Oxi]GSR.3|SVVPGGGAVEAALSIYLENYATSMGSR.3|MLVDDIGDVTITNDGATILK.3|M[Oxi]LVDDIGDVTITNDGATILK.3|M[Oxi]LVDDIGDVTITNDGATILK.2|MLVDDIGDVTITNDGATILK.2|ILATGANVILTTGGIDDM[Oxi]C[CAM]LK.3|ILATGANVILTTGGIDDMC[CAM]LK.3|ILATGANVILTTGGIDDM[Oxi]C[CAM]LK.2|ILATGANVILTTGGIDDMC[CAM]LK.2|IIGINGDFFANM[Oxi]VVDAVLAIK.3|VLC[CAM]ELADLQDKEVGDGTTSVVIIAAELLK.4|VLC[CAM]ELADLQDKEVGDGTTSVVIIAAELLK.3|SQMESMLISGYALNC[CAM]VVGSQGMPK.3|SQM[Oxi]ESMLISGYALNC[CAM]VVGSQGMPK.3|SQMESM[Oxi]LISGYALNC[CAM]VVGSQGMPK.3|SQMESMLISGYALNC[CAM]VVGSQGM[Oxi]PK.3|LHPESKDDKHGSYEDAVHSGALND.3|ASGATILSTLANLEGEETFEAAMLGQAEEVVQER.4|ASGATILSTLANLEGEETFEAAMLGQAEEVVQER.3|SQMESMLISGYALNC[CAM]VVGSQGMPKR.3
SEN / CTL,Q9Y230,RuvB-like 2,RUVBL2,3.05,1.40,3.23E-10,7.15E-11,1.01E+01,"box C/D snoRNP assembly,DNA repair,DNA recombination,chromatin remodeling,transcription, DNA-templated,protein folding,DNA duplex unwinding,cellular response to UV,positive regulation of histone acetylation,regulation of growth,histone H4 acetylation,histone H2A acetylation,positive regulation of transcription from RNA polymerase II promoter,establishment of protein localization to chromatin,cellular response to estradiol stimulus,transcriptional activation by promoter-enhancer looping,negative regulation of estrogen receptor binding,positive regulation of telomerase RNA localization to Cajal body","RNA polymerase II core promoter sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,DNA helicase activity,ATP-dependent DNA helicase activity,protein binding,ATP binding,chromatin DNA binding,identical protein binding,ATP-dependent 5'-3' DNA helicase activity,unfolded protein binding,ATPase activity","Swr1 complex,intracellular,nucleus,nucleoplasm,nuclear euchromatin,cytoplasm,membrane,nuclear matrix,Ino80 complex,NuA4 histone acetyltransferase complex,extracellular exosome,MLL1 complex,R2TP complex",24,42,67,GLGLDDALEPR.2|TTEMETIYDLGTK.2|TTEMETIYDLGTK.3|TTEM[Oxi]ETIYDLGTK.2|ALESDMAPVLIMATNR.3|ALESDMAPVLIMATNR.2|IRC[CAM]EEEDVEMSEDAYTVLTR.3|IRC[CAM]EEEDVEM[Oxi]SEDAYTVLTR.3|RAAGVVLEMIR.3|RAAGVVLEMIR.2|MIESLTK.2|GTEVQVDDIKR.3|GTEVQVDDIKR.2|ARDYDAMGSQTK.3|ARDYDAMGSQTK.2|IGAHSHIR.2|IGLETSLR.2|RKEVVHTVSLHEIDVINSR.5|RKEVVHTVSLHEIDVINSR.4|RKEVVHTVSLHEIDVINSR.3|KGTEVQVDDIKR.3|KGTEVQVDDIKR.2|RKGTEVQVDDIK.3|RVYSLFLDESR.3|RVYSLFLDESR.2|DKVQAGDVITIDK.3|DKVQAGDVITIDK.2|EVVHTVSLHEIDVINSR.4|EVVHTVSLHEIDVINSR.3|EVVHTVSLHEIDVINSR.2|FVQC[CAM]PDGELQKR.3|EYQDAFLFNELK.3|EYQDAFLFNELK.2|KEVVHTVSLHEIDVINSR.4|TEALTQAFR.2|AAGVVLEMIR.2|AAGVVLEM[Oxi]IR.2|YAIQLITAASLVC[CAM]R.3|YAIQLITAASLVC[CAM]R.2|IRGTSYQSPHGIPIDLLDR.4|IRGTSYQSPHGIPIDLLDR.3|GTEVQVDDIK.2|VAEWREEGK.2|AVLIAGQPGTGK.2|DYDAMGSQTK.2|DYDAM[Oxi]GSQTK.2|LLIVSTTPYSEKDTK.3|LLIVSTTPYSEKDTK.2|TQGFLALFSGDTGEIK.3|TQGFLALFSGDTGEIK.2|YAIQLITAASLVC[CAM]RK.3|VQAGDVITIDK.2|KGTEVQVDDIK.2|VYSLFLDESR.2|GTSYQSPHGIPIDLLDR.3|GTSYQSPHGIPIDLLDR.2|FVQC[CAM]PDGELQK.2|QASQGMVGQLAAR.2|QASQGM[Oxi]VGQLAAR.2|LLIVSTTPYSEK.2|IRGTSYQSPHGIPIDLLDRLLIVSTTPYSEK.5|TQGFLALFSGDTGEIKSEVR.3|TQGFLALFSGDTGEIKSEVR.2|IKEETEIIEGEVVEIQIDRPATGTGSK.4|IKEETEIIEGEVVEIQIDRPATGTGSK.3|TAIAMGMAQALGPDTPFTAIAGSEIFSLEMSK.3|EYQDAFLFNELKGETMDTS.2
SEN / CTL,Q99497,Protein deglycase DJ-1,PARK7,3.05,1.51,1.05E-22,7.38E-23,2.21E+01,"negative regulation of protein phosphorylation,negative regulation of protein kinase activity,proteolysis,protein deglycosylation,autophagy,inflammatory response,mitochondrion organization,Ras protein signal transduction,single fertilization,adult locomotory behavior,methylglyoxal metabolic process,detoxification of copper ion,positive regulation of gene expression,negative regulation of gene expression,enzyme active site formation via L-cysteine sulfinic acid,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,lactate biosynthetic process,negative regulation of protein ubiquitination,negative regulation of protein binding,activation of protein kinase B activity,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of interleukin-8 production,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein sumoylation,cellular response to oxidative stress,cellular response to glyoxal,peptidyl-cysteine deglycation,peptidyl-arginine deglycation,peptidyl-lysine deglycation,protein deglycation, glyoxal removal,protein deglycation, methylglyoxal removal,glutathione deglycation,hydrogen peroxide metabolic process,negative regulation of apoptotic process,regulation of neuron apoptotic process,negative regulation of neuron apoptotic process,positive regulation of transcription from RNA polymerase II promoter,glycolate biosynthetic process,negative regulation of protein export from nucleus,regulation of inflammatory response,detoxification of mercury ion,protein stabilization,positive regulation of sequence-specific DNA binding transcription factor activity,negative regulation of ubiquitin-protein transferase activity,dopamine uptake involved in synaptic transmission,regulation of mitochondrial membrane potential,positive regulation of protein kinase B signaling,membrane depolarization,membrane hyperpolarization,negative regulation of cell death,regulation of androgen receptor signaling pathway,cellular response to hydrogen peroxide,positive regulation of protein homodimerization activity,cell-cell adhesion,cellular oxidant detoxification,positive regulation of protein localization to nucleus,negative regulation of neuron death,positive regulation of superoxide dismutase activity,negative regulation of protein acetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,regulation of fibril organization,positive regulation of mitochondrial electron transport, NADH to ubiquinone,negative regulation of death-inducing signaling complex assembly,negative regulation of protein K48-linked deubiquitination,negative regulation of TRAIL-activated apoptotic signaling pathway,positive regulation of pyrroline-5-carboxylate reductase activity,positive regulation of tyrosine 3-monooxygenase activity,positive regulation of dopamine biosynthetic process,glyoxal metabolic process,glyoxal catabolic process,positive regulation of L-dopa biosynthetic process,positive regulation of L-dopa decarboxylase activity,negative regulation of oxidative stress-induced cell death,negative regulation of hydrogen peroxide-induced cell death,negative regulation of hydrogen peroxide-induced neuron death,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,positive regulation of reactive oxygen species biosynthetic process,positive regulation of mitophagy,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,negative regulation of ubiquitin-specific protease activity,positive regulation of oxidative phosphorylation uncoupler activity,positive regulation of transcription regulatory region DNA binding,positive regulation of androgen receptor activity,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,regulation of TRAIL receptor biosynthetic process","transcription coactivator activity,mRNA binding,receptor binding,copper ion binding,protein binding,transcription factor binding,peptidase activity,superoxide dismutase copper chaperone activity,oxidoreductase activity, acting on peroxide as acceptor,glyoxalase III activity,enzyme binding,kinase binding,cytokine binding,tyrosine 3-monooxygenase activator activity,L-dopa decarboxylase activator activity,protein deglycase activity,identical protein binding,protein homodimerization activity,small protein activating enzyme binding,ubiquitin-like protein conjugating enzyme binding,mercury ion binding,androgen receptor binding,peroxiredoxin activity,repressing transcription factor binding,scaffold protein binding,cadherin binding involved in cell-cell adhesion,cupric ion binding,cuprous ion binding,ubiquitin-specific protease binding,glyoxalase (glycolic acid-forming) activity,core promoter binding,double-stranded DNA binding,single-stranded DNA binding","chromatin,nucleus,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,endoplasmic reticulum,cytosol,plasma membrane,cell-cell adherens junction,PML body,axon,cell body,membrane raft,perinuclear region of cytoplasm,extracellular exosome,presynapse,mitochondrial respiratory chain complex I",66,27,55,AGIKVTVAGLAGKDPVQC[CAM]SR.4|AGIKVTVAGLAGKDPVQC[CAM]SR.3|MMNGGHYTYSENRVEKDGLILTSR.4|DGLILTSR.2|GAEEMETVIPVDVMR.2|GAEEMETVIPVDVMR.3|GAEEMETVIPVDVM[Oxi]R.3|GAEEM[Oxi]ETVIPVDVMR.2|GAEEMETVIPVDVM[Oxi]R.2|GAEEM[Oxi]ETVIPVDVM[Oxi]R.2|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.4|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.3|DVVIC[CAM]PDASLEDAKK.3|DVVIC[CAM]PDASLEDAKK.4|DVVIC[CAM]PDASLEDAKK.2|GLIAAIC[CAM]AGPTALLAHEIGFGSK.3|GLIAAIC[CAM]AGPTALLAHEIGFGSK.4|GLIAAIC[CAM]AGPTALLAHEIGFGSK.2|VTVAGLAGKDPVQC[CAM]SR.3|VTVAGLAGKDPVQC[CAM]SR.4|VTVAGLAGKDPVQC[CAM]SR.2|VTVAGLAGK.2|DPVQC[CAM]SR.2|VTTHPLAK.2|RALVILAK.2|DKMMNGGHYTYSENR.4|DKMMNGGHYTYSENR.3|M[Oxi]MNGGHYTYSENRVEK.4|MMNGGHYTYSENRVEK.3|M[Oxi]MNGGHYTYSENRVEK.3|MM[Oxi]NGGHYTYSENRVEK.3|DVVIC[CAM]PDASLEDAK.3|DVVIC[CAM]PDASLEDAK.2|MMNGGHYTYSENR.3|M[Oxi]M[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.3|MM[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.2|MMNGGHYTYSENR.2|EILKEQENR.2|GAEEMETVIPVDVMRR.3|GAEEM[Oxi]ETVIPVDVM[Oxi]RR.3|GAEEMETVIPVDVM[Oxi]RR.3|VEKDGLILTSR.2|EGPYDVVVLPGGNLGAQNLSESAAVK.4|EGPYDVVVLPGGNLGAQNLSESAAVK.3|GPGTSFEFALAIVEALNGK.3|GPGTSFEFALAIVEALNGK.2|GPGTSFEFALAIVEALNGKEVAAQVK.4|GPGTSFEFALAIVEALNGKEVAAQVK.3|DGLILTSRGPGTSFEFALAIVEALNGKEVAAQVK.4|KEGPYDVVVLPGGNLGAQNLSESAAVK.3|EGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENR.4|EGPYDVVVLPGGNLGAQNLSESAAVKEILK.3|DVVIC[CAM]PDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVK.4
SEN / CTL,Q9BS26,Endoplasmic reticulum resident protein 44,ERP44,3.04,1.27,2.25E-08,4.01E-09,8.40E+00,"protein folding,response to unfolded protein,glycoprotein metabolic process,response to endoplasmic reticulum stress,cell redox homeostasis",protein disulfide isomerase activity,"endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,cell surface,extracellular exosome",18,22,40,TPADC[CAM]PVIAIDSFR.2|TPADC[CAM]PVIAIDSFR.3|VANILHDDC[CAM]AFLSAFGDVSKPER.4|VANILHDDC[CAM]AFLSAFGDVSKPER.3|ALADYIR.2|GTINFLHADC[CAM]DKFR.4|GTINFLHADC[CAM]DKFR.3|RNIIGYFEQK.3|RNIIGYFEQK.2|GTINFLHADC[CAM]DK.3|GTINFLHADC[CAM]DK.2|HMYVFGDFKDVLIPGK.4|HMYVFGDFKDVLIPGK.3|HM[Oxi]YVFGDFKDVLIPGK.3|HMYVFGDFKDVLIPGK.2|SDPIQEIR.2|VDC[CAM]DQHSDIAQR.3|VDC[CAM]DQHSDIAQR.2|HPLLHIQK.2|NIIGYFEQK.2|DLAEITTLDR.2|HMYVFGDFK.2|HM[Oxi]YVFGDFK.2|EDTESLEIFQNEVAR.3|EDTESLEIFQNEVAR.2|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.6|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.5|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.5|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.4|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.4|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.3|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.3|QFVFDLHSGK.2|FSQMLHPIFEEASDVIK.3|SDPIQEIRDLAEITTLDR.3|LHREFHHGPDPTDTAPGEQAQDVASSPPESSFQK.5|LHREFHHGPDPTDTAPGEQAQDVASSPPESSFQK.4|EEFPNENQVVFAR.2|EFHHGPDPTDTAPGEQAQDVASSPPESSFQK.4|EITFENGEELTEEGLPFLILFHMK.3
SEN / CTL,Q9Y696,Chloride intracellular channel protein 4,CLIC4,3.03,1.59,2.05E-17,8.95E-18,1.70E+01,"angiogenesis,endothelial cell morphogenesis,chloride transport,apoptotic process,vacuolar acidification,fertilization,cell differentiation,keratinocyte differentiation,negative regulation of cell migration,regulation of ion transmembrane transport,establishment or maintenance of apical/basal cell polarity,multicellular organism growth,branching morphogenesis of an epithelial tube,regulation of cytoskeleton organization,retina vasculature morphogenesis in camera-type eye,cellular response to calcium ion,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,glutathione transferase activity","intracellular,cytoplasm,mitochondrion,centrosome,cytosol,plasma membrane,microvillus,cell-cell junction,cell surface,actin cytoskeleton,nuclear matrix,midbody,cytoplasmic vesicle membrane,chloride channel complex,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,microtubule cytoskeleton",42,24,43,YLTNAYSRDEFTNTC[CAM]PSDKEVEIAYSDVAK.4|FLDGNEMTLADC[CAM]NLLPK.2|FLDGNEMTLADC[CAM]NLLPK.3|KFLDGNEMTLADC[CAM]NLLPK.3|KFLDGNEM[Oxi]TLADC[CAM]NLLPK.3|KFLDGNEMTLADC[CAM]NLLPK.2|LSPKHPESNTAGMDIFAK.4|LSPKHPESNTAGMDIFAK.3|LSPKHPESNTAGM[Oxi]DIFAK.4|LSPKHPESNTAGMDIFAK.2|HPESNTAGMDIFAK.3|HPESNTAGM[Oxi]DIFAK.3|HPESNTAGM[Oxi]DIFAK.2|HPESNTAGMDIFAK.2|DEFTNTC[CAM]PSDK.3|DEFTNTC[CAM]PSDK.2|NSRPEANEALER.3|NSRPEANEALER.2|GVVFSVTTVDLKR.3|YLTNAYSR.2|EEDKEPLIELFVK.3|EEDKEPLIELFVK.2|IEEFLEEVLC[CAM]PPK.3|IEEFLEEVLC[CAM]PPK.2|NFDIPKEM[Oxi]TGIWR.3|TDVNKIEEFLEEVLC[CAM]PPK.4|TDVNKIEEFLEEVLC[CAM]PPK.3|TDVNKIEEFLEEVLC[CAM]PPK.2|AGSDGESIGNC[CAM]PFSQR.3|AGSDGESIGNC[CAM]PFSQR.2|RKPADLQNLAPGTHPPFITFNSEVK.5|RKPADLQNLAPGTHPPFITFNSEVK.4|RKPADLQNLAPGTHPPFITFNSEVK.3|EVEIAYSDVAK.2|GVVFSVTTVDLK.2|TDVNKIEEFLEEVLC[CAM]PPKYLK.4|KPADLQNLAPGTHPPFITFNSEVK.4|KPADLQNLAPGTHPPFITFNSEVK.3|FSAYIKNSRPEANEALER.3|YLTNAYSRDEFTNTC[CAM]PSDK.3|KPADLQNLAPGTHPPFITFNSEVKTDVNKIEEFLEEVLC[CAM]PPK.6|DEFTNTC[CAM]PSDKEVEIAYSDVAK.3|LDEYLNSPLPDEIDENSMEDIK.3
SEN / CTL,Q13509,Tubulin beta-3 chain,TUBB3,3.03,1.55,2.68E-11,6.67E-12,1.12E+01,"cytoskeleton organization,microtubule-based process,mitotic nuclear division,axon guidance","GTPase activity,structural constituent of cytoskeleton,GTP binding,peptide binding","nucleus,cytoplasm,microtubule,axon,dendrite,neuronal cell body,extracellular exosome,cell periphery",24,12,23,SGAFGHLFRPDNFIFGQSGAGNNWAK.4|SGAFGHLFRPDNFIFGQSGAGNNWAK.3|LATPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.5|FWEVISDEHGIDPSGNYVGDSDLQLER.3|FWEVISDEHGIDPSGNYVGDSDLQLER.4|ISVYYNEASSHK.3|ISVYYNEASSHK.2|ISVYYNEASSHKYVPR.4|LHFFMPGFAPLTAR.3|LHFFM[Oxi]PGFAPLTAR.3|LHFFMPGFAPLTAR.2|MSMKEVDEQMLAIQSK.3|MSSTFIGNSTAIQELFK.3|MSSTFIGNSTAIQELFK.2|M[Oxi]SSTFIGNSTAIQELFK.2|LATPTYGDLNHLVSATMSGVTTSLR.4|LATPTYGDLNHLVSATM[Oxi]SGVTTSLR.4|LATPTYGDLNHLVSATM[Oxi]SGVTTSLR.3|LATPTYGDLNHLVSATMSGVTTSLR.3|MSSTFIGNSTAIQELFKR.3|EC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|KEC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4
SEN / CTL,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,3.03,1.25,1.74E-03,1.66E-04,3.78E+00,"nuclear-transcribed mRNA poly(A) tail shortening,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,telomere maintenance via telomerase,cell-cell adhesion","enzyme binding,ankyrin binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,nuclear telomeric heterochromatin,cytoplasm,cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,CCR4-NOT complex",6,62,73,GVGQADWTPDLGLR.2|HNGSLSPGLEAR.3|HNGSLSPGLEAR.2|SKDLAEVGEGGGHSQAR.4|SKDLAEVGEGGGHSQAR.3|KIPSVEDSLGEGSRDAGRPGER.5|DVSLGDWEFGKR.3|DAELQDQEFGKR.3|GDAHLRPTSLVQR.3|DLAEVGEGGGHSQAR.3|DLAEVGEGGGHSQAR.2|DSLGTYSSR.2|KIPSVEDSLGEGSR.3|KIPSVEDSLGEGSR.2|GPLAELPSAR.2|VSGAGFSPSSK.2|DEDGSTLFR.2|DVSLGTYGSR.2|YGQGAGEGSTR.2|EHGVGGVSQC[CAM]PEPGLR.3|EHGVGGVSQC[CAM]PEPGLR.2|DFC[CAM]IEASER.2|LTFNHDGSSR.2|NLEVSSC[CAM]VGSGGSSEAR.3|NLEVSSC[CAM]VGSGGSSEAR.2|SAEEGELAESK.2|ELGVGQMDWGNNLGLR.3|ELGVGQMDWGNNLGLR.2|AASSELPADISK.2|RDVSLGTYGSR.2|VSAPGVLTAQDR.2|RFSEGVLQSPSQDQEK.3|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.7|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.6|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.5|AAEPQEQEFGK.2|WSDQGPAQTSR.2|DVSLGDWEFGK.2|DAELQDQEFGK.2|SYQFGIIGNDR.2|FAATTVEEILAK.2|HNGSLSPGLEARDPLEAR.3|SPAEC[CAM]REEHSKTPEER.3|TYGTTTAPRDEDGSTLFR.3|GSGGLFSPSTAHVPDGALGQR.3|GSGGLFSPSTAHVPDGALGQR.2|VNLFPGLSPSALK.2|YESQEPLAGQESPLPLATR.3|YESQEPLAGQESPLPLATR.2|NMAPGAVC[CAM]SPGESK.2|QQAGAQGPGSADLEDGEMGKR.3|SLPSDLAFNGDLAK.2|MNMLAGPQPYGGSK.2|DSLGAYASQDANEQGQDLGKR.3|EAAFSPGQQDWSR.2|DQSSWQNSDASQEVGGHQER.3|SQEADVQDWEFR.2|APVIRPGGTLGLSEAADSDAHLFQDSTEPR.4|TTAGSVDWTDQLGLR.2|C[CAM]PARPPPSGSQGLLEEMLAASSSK.3|SSGSEGSSPNWLQALK.2|FSEGVLQSPSQDQEK.2|WLDDLLASPPPSGGGAR.2|DLEVTC[CAM]DPDSGGSQGLR.2|EMEEELVPTGSEPGDTR.2|YSSQDADEQDWEFQK.2|SFGTRPLSSGFSPEEAQQQDEEFEK.3|C[CAM]GIGQEEMEASSSQDQSK.2|DLQSEFGITGDPQPSSFSPSSWC[CAM]QGASQDYGLGGASPR.4|DTQSPSTC[CAM]SEGLLGWSQK.2|ESGVGQTDWSGVEAGEFLK.2|QQAGAQGPGSADLEDGEMGK.2|DSLGAYASQDANEQGQDLGK.2
SEN / CTL,Q99829,Copine-1,CPNE1,3.03,1.45,1.41E-05,1.80E-06,5.74E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,proteolysis,lipid metabolic process,negative regulation of gene expression,vesicle-mediated transport,regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of DNA binding,positive regulation of neuron differentiation,glycerophospholipid biosynthetic process,positive regulation of protein kinase B signaling,cellular response to calcium ion,negative regulation of NIK/NF-kappaB signaling,positive regulation of tumor necrosis factor-mediated signaling pathway,neuron projection extension","phosphatidylserine binding,endopeptidase activity,transporter activity,calcium ion binding,protein binding,calcium-dependent phospholipid binding,protein homodimerization activity,NF-kappaB binding","nucleus,cytoplasm,cytosol,plasma membrane,membrane,extracellular exosome",12,23,37,EALAQTVLAEVPTQLVSYFR.3|EALAQTVLAEVPTQLVSYFR.4|EALAQTVLAEVPTQLVSYFR.2|SDPFLEFFR.2|DIVQFVPYRR.3|LRFGIYDIDNK.3|TLQLEYR.2|DNRVVTMEVEAR.3|NNLNPTWK.2|GTITVSAQELKDNR.3|SEVIKNNLNPTWK.3|VVTMEVEAR.2|VVTM[Oxi]EVEAR.2|AQGWAPLKPLPPSAK.3|AQGWAPLKPLPPSAK.2|NC[CAM]SSPEFSK.2|FGIYDIDNK.2|DIVQFVPYR.2|GTITVSAQELK.2|LYGPTNFAPIINHVAR.3|LYGPTNFAPIINHVAR.2|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.6|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.6|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.5|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.5|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.4|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.5|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.4|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.4|SDPLC[CAM]VLLQDVGGGSWAELGR.3|SDPLC[CAM]VLLQDVGGGSWAELGR.2|AQGWAPLKPLPPSAKDPAQAPQA.3|FAAQAAHQGTASQYFM[Oxi]LLLLTDGAVTDVEATR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATR.3|ASNLPMSVIIVGVGGADFEAMEQLDADGGPLHTR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATREAVVR.4
SEN / CTL,P20618,Proteasome subunit beta type-1,PSMB1,3.02,1.98,1.29E-05,1.66E-06,5.78E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,extracellular exosome",18,17,37,LVKDVFISAAERDVYTGDALR.4|LVKDVFISAAERDVYTGDALR.3|NMQNVEHVPLSLDR.2|NMQNVEHVPLSLDR.3|NM[Oxi]QNVEHVPLSLDR.3|NM[Oxi]QNVEHVPLSLDR.2|AAGPLQLR.2|DVFISAAER.2|DVYTGDALR.2|GAVYSFDPVGSYQR.3|GAVYSFDPVGSYQR.2|LSEGFSIHTR.2|RFFPYYVYNIIGGLDEEGK.4|RFFPYYVYNIIGGLDEEGK.3|RFFPYYVYNIIGGLDEEGK.2|LTDKTVIGC[CAM]SGFHGDC[CAM]LTLTK.4|LTDKTVIGC[CAM]SGFHGDC[CAM]LTLTK.3|TVIGC[CAM]SGFHGDC[CAM]LTLTK.3|TVIGC[CAM]SGFHGDC[CAM]LTLTK.2|AM[Oxi]TTGAIAAMLSTILYSR.3|AMTTGAIAAM[Oxi]LSTILYSR.3|AMTTGAIAAMLSTILYSR.3|AM[Oxi]TTGAIAAM[Oxi]LSTILYSR.3|AMTTGAIAAMLSTILYSR.2|AM[Oxi]TTGAIAAMLSTILYSR.2|AMTTGAIAAM[Oxi]LSTILYSR.2|EGIREETVSLR.2|AGGSASAMLQPLLDNQVGFK.3|AGGSASAM[Oxi]LQPLLDNQVGFK.3|AGGSASAMLQPLLDNQVGFK.2|AGGSASAM[Oxi]LQPLLDNQVGFK.2|DVFISAAERDVYTGDALR.3|DVFISAAERDVYTGDALR.2|LVKDVFISAAER.2|FFPYYVYNIIGGLDEEGK.3|FFPYYVYNIIGGLDEEGK.2|RFFPYYVYNIIGGLDEEGKGAVYSFDPVGSYQR.4
SEN / CTL,P02768,Serum albumin,ALB,3.01,3.70,2.44E-06,3.45E-07,6.46E+00,"retina homeostasis,platelet degranulation,transport,receptor-mediated endocytosis,cellular response to starvation,bile acid and bile salt transport,hemolysis by symbiont of host erythrocytes,lipoprotein metabolic process,negative regulation of apoptotic process,negative regulation of programmed cell death,sodium-independent organic anion transport,maintenance of mitochondrion location,cellular oxidant detoxification","DNA binding,fatty acid binding,copper ion binding,protein binding,drug binding,toxic substance binding,antioxidant activity,pyridoxal phosphate binding,identical protein binding,chaperone binding,oxygen binding","extracellular region,extracellular space,nucleus,endoplasmic reticulum,Golgi apparatus,platelet alpha granule lumen,myelin sheath,protein complex,extracellular exosome,blood microparticle",54,107,232,KVPQVSTPTLVEVSR.3|KVPQVSTPTLVEVSR.2|KVPQVSTPTLVEVSR.4|VPQVSTPTLVEVSR.2|VPQVSTPTLVEVSR.3|YLYEIAR.2|C[CAM]C[CAM]TESLVNR.2|YIC[CAM]ENQDSISSKLK.3|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.6|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.7|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.5|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.4|ADDKETC[CAM]FAEEGKK.4|ADDKETC[CAM]FAEEGKK.3|ADDKETC[CAM]FAEEGKK.2|ETC[CAM]FAEEGKK.3|ETC[CAM]FAEEGKK.2|FKDLGEENFK.3|FKDLGEENFK.2|FPKAEFAEVSK.3|EC[CAM]C[CAM]EKPLLEK.3|EC[CAM]C[CAM]EKPLLEK.2|LAKTYETTLEK.3|LSQRFPKAEFAEVSK.4|LSQRFPKAEFAEVSK.3|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.6|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.5|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.3|AEFAEVSK.2|HPDYSVVLLLR.3|HPDYSVVLLLR.2|AVMDDFAAFVEK.3|AVM[Oxi]DDFAAFVEK.3|AVMDDFAAFVEK.2|AVM[Oxi]DDFAAFVEK.2|AAC[CAM]LLPKLDELRDEGK.4|AAC[CAM]LLPKLDELRDEGK.3|AAFTEC[CAM]C[CAM]QAADK.3|AAFTEC[CAM]C[CAM]QAADK.2|LVRPEVDVMC[CAM]TAFHDNEETFLKK.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.5|LVRPEVDVMC[CAM]TAFHDNEETFLKK.5|LVRPEVDVMC[CAM]TAFHDNEETFLKK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.3|LVRPEVDVMC[CAM]TAFHDNEETFLKK.3|DDNPNLPR.2|LC[CAM]TVATLR.2|DLGEENFK.2|HPYFYAPELLFFAKR.4|HPYFYAPELLFFAKR.3|LKC[CAM]ASLQK.2|RHPYFYAPELLFFAK.4|RHPYFYAPELLFFAK.3|RHPYFYAPELLFFAK.2|ETYGEM[Oxi]ADC[CAM]C[CAM]AK.3|ETYGEMADC[CAM]C[CAM]AK.3|ETYGEMADC[CAM]C[CAM]AK.2|ETYGEM[Oxi]ADC[CAM]C[CAM]AK.2|FQNALLVR.2|RPC[CAM]FSALEVDETYVPK.4|RPC[CAM]FSALEVDETYVPK.3|RPC[CAM]FSALEVDETYVPK.2|SLHTLFGDKLC[CAM]TVATLR.4|SLHTLFGDKLC[CAM]TVATLR.3|SLHTLFGDKLC[CAM]TVATLR.2|YIC[CAM]ENQDSISSK.3|YIC[CAM]ENQDSISSK.2|RHPDYSVVLLLR.3|RHPDYSVVLLLR.2|TYETTLEK.2|ADDKETC[CAM]FAEEGK.3|ADDKETC[CAM]FAEEGK.2|NEC[CAM]FLQHKDDNPNLPR.4|NEC[CAM]FLQHKDDNPNLPR.3|QTALVELVK.2|TC[CAM]VADESAENC[CAM]DK.3|TC[CAM]VADESAENC[CAM]DK.2|TPVSDRVTK.2|AFKAWAVAR.2|LDELRDEGKASSAK.3|LDELRDEGKASSAK.2|LVAASQAALGL.2|SLHTLFGDK.2|YTKKVPQVSTPTLVEVSR.4|YTKKVPQVSTPTLVEVSR.3|KVPQVSTPTLVEVSRNLGK.4|LKEC[CAM]C[CAM]EKPLLEK.3|LKEC[CAM]C[CAM]EKPLLEK.2|RHPYFYAPELLFFAKR.4|RHPYFYAPELLFFAKR.3|VFDEFKPLVEEPQNLIK.4|VFDEFKPLVEEPQNLIK.3|VFDEFKPLVEEPQNLIK.2|C[CAM]C[CAM]AAADPHEC[CAM]YAK.3|C[CAM]C[CAM]AAADPHEC[CAM]YAK.2|QNC[CAM]ELFEQLGEYKFQNALLVR.5|QNC[CAM]ELFEQLGEYKFQNALLVR.4|QNC[CAM]ELFEQLGEYKFQNALLVR.3|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDR.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDR.3|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.4|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.3|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.2|KYLYEIAR.2|LVRPEVDVMC[CAM]TAFHDNEETFLK.5|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLK.4|LVRPEVDVMC[CAM]TAFHDNEETFLK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLK.3|LVRPEVDVMC[CAM]TAFHDNEETFLK.3|ATKEQLKAVMDDFAAFVEK.4|ATKEQLKAVM[Oxi]DDFAAFVEK.4|ATKEQLKAVMDDFAAFVEK.3|ATKEQLKAVMDDFAAFVEK.2|ETC[CAM]FAEEGK.2|LDELRDEGK.2|NEC[CAM]FLQHK.2|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.5|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.5|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|DVFLGMFLYEYAR.3|DVFLGM[Oxi]FLYEYAR.3|DVFLGMFLYEYAR.2|DVFLGM[Oxi]FLYEYAR.2|AEFAEVSKLVTDLTK.3|AEFAEVSKLVTDLTK.2|QNC[CAM]ELFEQLGEYK.3|QNC[CAM]ELFEQLGEYK.2|LVTDLTKVHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.6|LVTDLTKVHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.4|YKAAFTEC[CAM]C[CAM]QAADK.3|YKAAFTEC[CAM]C[CAM]QAADK.2|KQTALVELVK.2|KLVAASQAALGL.2|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.6|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.5|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.4|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.3|DAHKSEVAHR.2|HPYFYAPELLFFAK.3|HPYFYAPELLFFAK.2|LVNEVTEFAK.2|NYAEAKDVFLGMFLYEYAR.4|NYAEAKDVFLGMFLYEYAR.3|NYAEAKDVFLGM[Oxi]FLYEYAR.3|NYAEAKDVFLGM[Oxi]FLYEYAR.2|NYAEAKDVFLGMFLYEYAR.2|YIC[CAM]ENQDSISSKLKEC[CAM]C[CAM]EKPLLEK.5|YIC[CAM]ENQDSISSKLKEC[CAM]C[CAM]EKPLLEK.3|AVMDDFAAFVEKC[CAM]C[CAM]K.3|DVC[CAM]KNYAEAK.2|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.5|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.5|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.3|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.3|YKAAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.4|YKAAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.3|EQLKAVMDDFAAFVEK.3|EQLKAVM[Oxi]DDFAAFVEK.3|EQLKAVM[Oxi]DDFAAFVEK.2|LVRPEVDVMC[CAM]TAFHDNEETFLKKYLYEIAR.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKKYLYEIAR.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKKYLYEIAR.5|LVRPEVDVMC[CAM]TAFHDNEETFLKKYLYEIAR.5|NYAEAKDVFLGMFLYEYARR.4|NYAEAKDVFLGMFLYEYARR.3|ALVLIAFAQYLQQC[CAM]PFEDHVK.4|ALVLIAFAQYLQQC[CAM]PFEDHVK.3|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.6|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.5|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|TC[CAM]VADESAENC[CAM]DKSLHTLFGDK.4|TC[CAM]VADESAENC[CAM]DKSLHTLFGDK.3|TYETTLEKC[CAM]C[CAM]AAADPHEC[CAM]YAK.4|TYETTLEKC[CAM]C[CAM]AAADPHEC[CAM]YAK.3|EFNAETFTFHADIC[CAM]TLSEKER.4|EFNAETFTFHADIC[CAM]TLSEKER.3|PLVEEPQNLIK.2|HPDYSVVLLLRLAKTYETTLEK.4|QEPERNEC[CAM]FLQHKDDNPNLPR.4|QEPERNEC[CAM]FLQHKDDNPNLPR.3|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.5|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.5|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.7|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.6|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.5|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAKYIC[CAM]ENQDSISSK.6|SLHTLFGDKLC[CAM]TVATLRETYGEM[Oxi]ADC[CAM]C[CAM]AK.5|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.5|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.5|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.4|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.3|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.3|DVC[CAM]KNYAEAKDVFLGMFLYEYAR.4|DVC[CAM]KNYAEAKDVFLGMFLYEYAR.3|ETYGEM[Oxi]ADC[CAM]C[CAM]AKQEPER.3|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDRVTK.5|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDRVTK.5|TPVSDRVTKC[CAM]C[CAM]TESLVNR.3|ALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.5|ALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.4|EFNAETFTFHADIC[CAM]TLSEK.3|EFNAETFTFHADIC[CAM]TLSEK.2|C[CAM]C[CAM]TESLVNRRPC[CAM]FSALEVDETYVPK.4|C[CAM]C[CAM]TESLVNRRPC[CAM]FSALEVDETYVPK.3|LC[CAM]TVATLRETYGEM[Oxi]ADC[CAM]C[CAM]AK.3|LC[CAM]TVATLRETYGEMADC[CAM]C[CAM]AK.3|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.3|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEK.5|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEK.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]KNYAEAK.5|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.4|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.3|PC[CAM]FSALEVDETYVPK.2|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.5|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYK.4
SEN / CTL,A5A3E0,POTE ankyrin domain family member F,POTEF,3.01,1.23,2.18E-05,2.75E-06,5.56E+00,retina homeostasis,,"extracellular space,cell cortex,extracellular exosome,blood microparticle",12,2,2,VAPEEHPVLLTEATLNPK.3|LC[CAM]YVALDFEQEMATVASSSSLEK.3
SEN / CTL,O43399,Tumor protein D54,TPD52L2,3.01,1.83,5.22E-14,1.69E-14,1.38E+01,,poly(A) RNA binding,,42,18,28,TPAVEGLTEAEEEELRAELTKVEEEIVTLR.4|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.5|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.3|LGLSTLGELK.2|LGLSTLGELKQNLSR.3|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.3|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.4|SWHDVQVSSAYVK.3|SWHDVQVSSAYVK.2|TSAALSTVGSAISR.2|TSAALSTVGSAISR.3|KTQETLSQAGQK.3|KTQETLSQAGQK.2|LGEWNEK.2|TSEKLGEWNEK.3|VTQSDLYK.2|TSAALSTVGSAISRK.3|VEEEIVTLR.2|VTQSDLYKK.2|TPAVEGLTEAEEEELR.3|TPAVEGLTEAEEEELR.2|TQETLSQAGQK.2|GLLSDSMTDVPVDTGVAAR.3|GLLSDSM[Oxi]TDVPVDTGVAAR.2|GLLSDSMTDVPVDTGVAAR.2|VVGDRENGSDNLPSSAGSGDK.3|TPAVEGLTEAEEEELRAELTK.3|TPAVEGLTEAEEEELRAELTK.2
SEN / CTL,Q9Y6C2,EMILIN-1,EMILIN1,3.01,1.93,1.93E-08,3.50E-09,8.46E+00,cell adhesion,"protein binding,extracellular matrix constituent conferring elasticity","extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular matrix,extracellular exosome",30,36,48,QATLEGLQEVVGR.2|QATLEGLQEVVGR.3|LVGSGLHTVEAAGEAR.3|LVGSGLHTVEAAGEAR.2|FRGLEEGQAQAGQC[CAM]PSLEGR.3|RGTELGGAAGQGGHPPGYTSLASR.4|RGTELGGAAGQGGHPPGYTSLASR.3|YLLSAVLTGHRHEK.4|YLLSAVLTGHRHEK.3|YLLSAVLTGHR.3|LAEDVQR.2|RPPQEC[CAM]C[CAM]SPELGRR.4|RPPQEC[CAM]C[CAM]SPELGRR.3|GVLQGLSGR.2|HLAGLAVGR.2|LLASVEER.2|LVGGQAGLGR.2|AVETAFNGR.2|RLDVVAGSVTVLSGR.3|RLDVVAGSVTVLSGR.2|VLDSEGQLR.2|RPPQEC[CAM]C[CAM]SPELGR.3|GPGAGPGVGGPSR.2|HVAGLWAGLR.2|APAPASAPPGPSEELLR.3|APAPASAPPGPSEELLR.2|C[CAM]SC[CAM]PLLPPR.2|SEPGTVPFDR.2|DRIISEINR.2|LQQEATEHATESEER.3|LQQEATEHATESEER.2|PGVHETLNEIQHQLQLLDTR.4|PGVHETLNEIQHQLQLLDTR.3|RVLDSEGQLR.2|LGRLEGVC[CAM]ER.2|LDTVAGGLQGLR.2|LQESC[CAM]SVC[CAM]LAGLDGFR.3|LQESC[CAM]SVC[CAM]LAGLDGFR.2|GLEEGQAQAGQC[CAM]PSLEGR.3|GLEEGQAQAGQC[CAM]PSLEGR.2|VSTHDQELGHLNNHHGGSSSSGGSR.4|VSTHDQELGHLNNHHGGSSSSGGSR.3|GTELGGAAGQGGHPPGYTSLASR.3|VQQLEEQVQSLTK.2|GFSLYTGSSGALSPGGPQAQIAPR.3|LQQEATEHATESEERFRGLEEGQAQAGQC[CAM]PSLEGR.5|VLLNDGGYYDPETGVFTAPLAGR.3|LGQLEGLLQAHGDEGC[CAM]GAC[CAM]GGVQEELGR.3
SEN / CTL,P61604,"10 kDa heat shock protein, mitochondrial",HSPE1,3.00,1.95,8.11E-07,1.22E-07,6.91E+00,"osteoblast differentiation,protein folding,activation of cysteine-type endopeptidase activity involved in apoptotic process,response to unfolded protein,chaperone mediated protein folding requiring cofactor","protein binding,ATP binding,poly(A) RNA binding,metal ion binding,unfolded protein binding,chaperone binding","mitochondrion,mitochondrial matrix,membrane,extracellular exosome",24,19,27,VLQATVVAVGSGSK.2|VLQATVVAVGSGSK.3|FLPLFDR.2|DGDILGKYVD.2|GKGGEIQPVSVK.3|GKGGEIQPVSVK.2|SAAETVTK.2|GGIMLPEK.2|GGIM[Oxi]LPEK.2|VGDKVLLPEYGGTK.3|VGDKVLLPEYGGTK.2|FLPLFDRVLVER.3|GGEIQPVSVK.2|VVLDDKDYFLFR.3|VVLDDKDYFLFR.2|DYFLFRDGDILGK.3|DYFLFRDGDILGK.2|KFLPLFDR.2|VLLPEYGGTK.2|KFLPLFDRVLVER.3|VVLDDKDYFLFRDGDILGK.4|VVLDDKDYFLFRDGDILGK.3|VVLDDKDYFLFRDGDILGK.2|GGIM[Oxi]LPEKSQGKVLQATVVAVGSGSK.4|VLLPEYGGTKVVLDDKDYFLFR.4|SAAETVTKGGIM[Oxi]LPEKSQGK.3|VLQATVVAVGSGSKGK.2
SEN / CTL,Q14914,Prostaglandin reductase 1,PTGR1,3.00,1.93,1.88E-02,1.57E-03,2.80E+00,"leukotriene metabolic process,prostaglandin metabolic process,oxidation-reduction process","zinc ion binding,2-alkenal reductase [NAD(P)] activity,13-prostaglandin reductase activity,15-oxoprostaglandin 13-oxidase activity","cytoplasm,extracellular exosome",6,22,35,HFVGYPTNSDFELK.3|HFVGYPTNSDFELK.2|TVESLEETLKK.3|TVESLEETLKK.2|TAELPPLK.2|KHFVGYPTNSDFELK.4|KHFVGYPTNSDFELK.3|KHFVGYPTNSDFELK.2|VVGAVGSDEK.2|MEAFVVYR.2|LKEGDTMMGQQVAK.3|LKEGDTM[Oxi]M[Oxi]GQQVAK.3|VVGAVGSDEKVAYLQK.3|TVESLEETLK.2|VVESKNVALPK.2|GTIVLASPGWTTHSISDGKDLEK.4|GTIVLASPGWTTHSISDGKDLEK.3|LGFDVVFNYK.2|LGFDVVFNYKTVESLEETLKK.4|GTIVLASPGWTTHSISDGK.3|GTIVLASPGWTTHSISDGK.2|EGDTMMGQQVAK.2|EGDTM[Oxi]MGQQVAK.2|EGDTMM[Oxi]GQQVAK.2|EGDTM[Oxi]M[Oxi]GQQVAK.2|IAIC[CAM]GAISTYNR.2|GGETVMVNAAAGAVGSVVGQIAK.3|GGETVMVNAAAGAVGSVVGQIAK.2|TGPLPPGPPPEIVIYQELR.3|TGPLPPGPPPEIVIYQELR.2|NGEVLLEALFLTVDPYM[Oxi]R.3|EYIIEGFENMPAAFMGMLK.3|EYIIEGFENMPAAFMGMLK.2|IQYKEYIIEGFENMPAAFMGMLK.3|KASPDGYDC[CAM]YFDNVGGEFSNTVIGQMK.3
SEN / CTL,P17655,Calpain-2 catalytic subunit,CAPN2,3.00,2.13,3.26E-24,2.71E-24,2.36E+01,"response to hypoxia,blastocyst development,proteolysis,myoblast fusion,protein autoprocessing,extracellular matrix disassembly,regulation of cytoskeleton organization,proteolysis involved in cellular protein catabolic process,cellular response to amino acid stimulus","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,cytoskeletal protein binding,cysteine-type peptidase activity,protein heterodimerization activity","chromatin,nucleus,cytoplasm,lysosome,endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,focal adhesion,dendrite,cortical actin cytoskeleton,pseudopodium,membrane raft,extracellular exosome,perinuclear endoplasmic reticulum",90,45,77,FADDQLIIDFDNFVR.3|FADDQLIIDFDNFVR.2|NPWGEVEWTGR.2|SDTFINLREVLNR.3|RPTEIC[CAM]ADPQFIIGGATR.3|RPTEIC[CAM]ADPQFIIGGATR.4|RPTEIC[CAM]ADPQFIIGGATR.2|LEIC[CAM]NLTPDTLTSDTYKK.3|LEIC[CAM]NLTPDTLTSDTYKK.2|IRNPWGEVEWTGR.3|IRNPWGEVEWTGR.2|GHAYSVTGAEEVESNGSLQK.3|GHAYSVTGAEEVESNGSLQK.2|KMGEDMHTIGFGIYEVPEELSGQTNIHLSK.5|KM[Oxi]GEDMHTIGFGIYEVPEELSGQTNIHLSK.5|KMGEDM[Oxi]HTIGFGIYEVPEELSGQTNIHLSK.5|RHEDGEFWMSFSDFLR.3|RHEDGEFWMSFSDFLR.4|EFYILWTK.2|ALEEAGFKMPC[CAM]QLHQVIVAR.3|ALEEAGFKMPC[CAM]QLHQVIVAR.4|ERSDTFINLR.3|ERSDTFINLR.2|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.4|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.5|M[Oxi]GEDMHTIGFGIYEVPEELSGQTNIHLSK.4|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.3|ALEEAGFK.2|DGDFC[CAM]IR.2|NFFLTNR.2|DREAAEGLGSHDR.3|MPC[CAM]QLHQVIVAR.3|M[Oxi]PC[CAM]QLHQVIVAR.3|MPC[CAM]QLHQVIVAR.2|SDTFINLR.2|KALEEAGFK.2|LGLKEFYILWTK.3|LGLKEFYILWTK.2|FKLPPGEYILVPSTFEPNK.4|FKLPPGEYILVPSTFEPNK.3|FKLPPGEYILVPSTFEPNK.2|QDIKSDGFSIETC[CAM]K.3|SDGFSIETC[CAM]K.2|SGTMNSYEMR.2|SGTM[Oxi]NSYEMR.2|SGTMNSYEM[Oxi]R.2|RQDIKSDGFSIETC[CAM]K.3|LPPGEYILVPSTFEPNK.3|LPPGEYILVPSTFEPNK.2|NYPNTFWMNPQYLIK.3|NYPNTFWM[Oxi]NPQYLIK.3|NYPNTFWMNPQYLIK.2|NYPNTFWM[Oxi]NPQYLIK.2|YLNQDYEALR.2|LFAQLAGEDAEISAFELQTILRR.4|LFAQLAGEDAEISAFELQTILRR.3|LEIC[CAM]NLTPDTLTSDTYK.3|LEIC[CAM]NLTPDTLTSDTYK.2|IMVDMLDSDGSGK.2|IM[Oxi]VDMLDSDGSGK.2|IMVDM[Oxi]LDSDGSGK.2|LEEEDEDEEDGESGC[CAM]TFLVGLIQK.4|LEEEDEDEEDGESGC[CAM]TFLVGLIQK.3|FKLPPGEYILVPSTFEPNKDGDFC[CAM]IR.4|FKLPPGEYILVPSTFEPNKDGDFC[CAM]IR.3|WNDNC[CAM]PSWNTIDPEERER.3|GSLLGC[CAM]SIDITSAADSEAITFQK.3|GSLLGC[CAM]SIDITSAADSEAITFQK.2|LFAQLAGEDAEISAFELQTILR.3|DGELLFVHSAEGSEFWSALLEK.3|RLFAQLAGEDAEISAFELQTILR.3|KADYQAVDDEIEANLEEFDISEDDIDDGFRR.4|NEC[CAM]LEAGTLFQDPSFPAIPSALGFK.3|LPPGEYILVPSTFEPNKDGDFC[CAM]IR.3|YLNQDYEALRNEC[CAM]LEAGTLFQDPSFPAIPSALGFK.4|WNDNC[CAM]PSWNTIDPEER.2|INGC[CAM]YEALSGGATTEGFEDFTGGIAEWYELK.3
SEN / CTL,Q16363,Laminin subunit alpha-4,LAMA4,2.99,1.10,3.11E-11,7.63E-12,1.11E+01,"cell adhesion,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,regulation of embryonic development","receptor binding,extracellular matrix structural constituent","extracellular region,basement membrane,basal lamina,extracellular exosome,extracellular matrix",24,42,51,SLLSDVEELVEKENQASR.3|ELVDEEADEAYELLSQAESWQR.3|LAALSIEEGK.2|TLFPVVLEQLDDYNAK.2|TLFPVVLEQLDDYNAK.3|SGVLSVSSGAAAHR.3|LHSSDMNGLVQK.3|LHSSDMNGLVQK.2|HFVIDGHPVSFSK.3|VDRDVEVEDFQR.3|YHEISIIYHNDK.3|AESSSDEAVADTSRR.3|MLYYGEEHELSPK.3|MLYYGEEHELSPK.2|VFLTVPSLSSTAEEK.3|VFLTVPSLSSTAEEK.2|AIEHAYQYGGTANSR.3|C[CAM]APGYYGDAR.2|QDPPETSEPR.2|HIYNMDPSTSVPC[CAM]AR.3|HIYNMDPSTSVPC[CAM]AR.2|VHTSLYEC[CAM]PIESSPLFLLHK.4|VHTSLYEC[CAM]PIESSPLFLLHK.3|AHLPLDINFR.2|GKIEQTQASEK.2|IYDAVSGIDTQIIYHK.3|LSDLQEALDQALNYVR.3|LSDLQEALDQALNYVR.2|LTLSELDDIIK.2|C[CAM]LDGYIGDSIR.2|IQINNAENTMK.2|DESENLLNQAR.2|QYNDGLSHFVISSVSPTR.3|VFLTVPSLSSTAEEKFIK.3|SLLSDVEELVEK.2|IPFTDIYIGGAPPEILQSR.3|IPFTDIYIGGAPPEILQSR.2|RPELTETADQFILYLGSK.3|AESSSDEAVADTSR.2|QYNDGLSHFVISSVSPTRYELIVDK.4|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.4|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.3|NDNLVYVYNLGTK.2|AYFNGQSFIASIQK.2|AASYFFDGSGYAVVR.2|DVEIPLDSKPVSSWPAYFSIVK.3|ISFFDGFEGGFNFR.2|C[CAM]IC[CAM]NENYAGPNC[CAM]ER.2|C[CAM]APGYYGNPLLIGSTC[CAM]K.2|KC[CAM]DC[CAM]SGNSDPNLIFEDC[CAM]DEVTGQC[CAM]R.3|KGEFSGDDSLLDLDPEDTVFYVGGVPSNFK.3
SEN / CTL,P07686,Beta-hexosaminidase subunit beta,HEXB,2.99,1.54,7.00E-13,2.03E-13,1.27E+01,"skeletal system development,glycosphingolipid metabolic process,ganglioside catabolic process,cellular calcium ion homeostasis,lysosome organization,penetration of zona pellucida,sensory perception of sound,locomotory behavior,male courtship behavior,regulation of cell shape,phospholipid biosynthetic process,oligosaccharide catabolic process,lipid storage,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process,myelination,astrocyte cell migration,cellular protein metabolic process,positive regulation of transcription from RNA polymerase II promoter,oogenesis,neuromuscular process controlling balance","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein homodimerization activity,protein heterodimerization activity","acrosomal vesicle,extracellular space,membrane,azurophil granule,lysosomal lumen,extracellular exosome",36,27,38,GIAAQPLYAGYC[CAM]NHENM.2|LAPGTIVEVWKDSAYPEELSR.3|LAPGTIVEVWKDSAYPEELSR.4|LAPGTIVEVWKDSAYPEELSR.2|VLDIIATINK.2|EISEVFPDQFIHLGGDEVEFK.3|LESFYIQK.2|LAPGTIVEVWK.3|LAPGTIVEVWK.2|YHGYIFGFYK.3|YHGYIFGFYK.2|GILIDTSR.2|DVRDMDDAYDR.3|C[CAM]WESNPK.2|WHHEPAEFQAK.3|WHHEPAEFQAK.2|RYHGYIFGFYK.3|TLDAMAFNK.2|GSIVWQEVFDDKAK.3|GSIVWQEVFDDKAK.2|YYKVEPLDFGGTQK.3|YYKVEPLDFGGTQK.2|DLLTPC[CAM]YSR.2|GSYSLSHVYTPNDVR.3|GSYSLSHVYTPNDVR.2|DVRDMDDAYDRLTR.3|KLESFYIQK.2|DSAYPEELSR.2|KYYKVEPLDFGGTQK.3|VEPLDFGGTQK.2|VLPEFDTPGHTLSWGK.3|VLPEFDTPGHTLSWGK.2|PGPALWPLPLSVK.2|GSIVWQEVFDDK.2|VTASGFPVILSAPWYLDLISYGQDWRK.4|VTASGFPVILSAPWYLDLISYGQDWRK.3|FNVLHWHIVDDQSFPYQSITFPELSNK.4|FNVLHWHIVDDQSFPYQSITFPELSNK.3
SEN / CTL,P29692,Elongation factor 1-delta,EEF1D,2.99,1.59,7.04E-15,2.51E-15,1.46E+01,"transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,cellular response to ionizing radiation,cell-cell adhesion","DNA binding,translation elongation factor activity,signal transducer activity,translation factor activity, RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,cell-cell adherens junction,endoplasmic reticulum",42,24,46,IASLEVENQSLRGVVQELQQAISKLEAR.4|SIQLDGLVWGASK.2|SIQLDGLVWGASK.3|GVVQELQQAISKLEAR.3|GVVQELQQAISKLEAR.2|SLAGSSGPGASSGTSGDHGELVVR.3|SLAGSSGPGASSGTSGDHGELVVR.4|SLAGSSGPGASSGTSGDHGELVVR.2|IASLEVENQSLR.2|IASLEVENQSLR.3|GVVQELQQAISK.2|GVVQELQQAISK.3|FKYDDAERR.3|LQIQC[CAM]VVEDDK.3|LQIQC[CAM]VVEDDK.2|ATAPQTQHVSPMR.3|ATAPQTQHVSPM[Oxi]R.3|ATAPQTQHVSPMR.2|ATAPQTQHVSPM[Oxi]R.2|LVPVGYGIR.2|KLQIQC[CAM]VVEDDK.3|KLQIQC[CAM]VVEDDK.2|FYEQMNGPVAGASR.3|FYEQMNGPVAGASR.2|FYEQM[Oxi]NGPVAGASR.2|QENGASVILR.2|RFYEQMNGPVAGASR.3|RFYEQMNGPVAGASR.2|FEEHVQSVDIAAFNK.3|FEEHVQSVDIAAFNK.2|FEEHVQSVDIAAFNKI.3|FEEHVQSVDIAAFNKI.2|IASLEVENQSLRGVVQELQQAISK.4|IASLEVENQSLRGVVQELQQAISK.3|VGTDLLEEEITK.2|SSILLDVKPWDDETDMAQLEAC[CAM]VR.4|SSILLDVKPWDDETDMAQLEAC[CAM]VR.3|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.6|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.5|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.4|VGTDLLEEEITKFEEHVQSVDIAAFNK.4|VGTDLLEEEITKFEEHVQSVDIAAFNK.3|VGTDLLEEEITKFEEHVQSVDIAAFNKI.4|VGTDLLEEEITKFEEHVQSVDIAAFNKI.3|LQIQC[CAM]VVEDDKVGTDLLEEEITK.3|KPATPAEDDEDDDIDLFGSDNEEEDK.3
SEN / CTL,P13639,Elongation factor 2,EEF2,2.98,1.71,5.07E-84,2.74E-83,8.26E+01,"hematopoietic progenitor cell differentiation,response to ischemia,skeletal muscle contraction,translational elongation,aging,glial cell proliferation,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,response to estradiol,response to endoplasmic reticulum stress,skeletal muscle cell differentiation,response to hydrogen peroxide,response to ethanol,positive regulation of translation,response to folic acid,cell-cell adhesion,cellular response to brain-derived neurotrophic factor stimulus,positive regulation of cytoplasmic translation","p53 binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,5S rRNA binding,protein kinase binding,ribosome binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,aggresome,intracellular ribonucleoprotein complex,extracellular matrix,polysomal ribosome,membrane raft,extracellular exosome",282,83,182,YLAEKYEWDVAEAR.3|YLAEKYEWDVAEAR.2|EGIPALDNFLDKL.2|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|C[CAM]LYASVLTAQPR.2|C[CAM]LYASVLTAQPR.3|VFSGLVSTGLK.2|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.3|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.4|NMSVIAHVDHGKSTLTDSLVC[CAM]K.4|GHVFEESQVAGTPMFVVK.3|GHVFEESQVAGTPMFVVK.2|GHVFEESQVAGTPMFVVK.4|GHVFEESQVAGTPM[Oxi]FVVK.3|GHVFEESQVAGTPM[Oxi]FVVK.2|SDPVVSYRETVSEESNVLC[CAM]LSK.3|GLKEGIPALDNFLDKL.3|GLKEGIPALDNFLDKL.2|IMGPNYTPGKKEDLYLKPIQR.5|IMGPNYTPGKKEDLYLKPIQR.4|IM[Oxi]GPNYTPGKKEDLYLKPIQR.4|IM[Oxi]GPNYTPGKKEDLYLKPIQR.5|IMGPNYTPGKKEDLYLKPIQR.3|KIWC[CAM]FGPDGTGPNILTDITK.3|KIWC[CAM]FGPDGTGPNILTDITK.2|ALLELQLEPEELYQTFQR.3|ALLELQLEPEELYQTFQR.2|AYLPVNESFGFTADLR.3|AYLPVNESFGFTADLR.2|ETVSEESNVLC[CAM]LSK.2|ETVSEESNVLC[CAM]LSK.3|STAISLFYELSENDLNFIKQSK.3|YEWDVAEAR.2|C[CAM]ELLYEGPPDDEAAMGIK.2|C[CAM]ELLYEGPPDDEAAMGIK.3|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|ARPFPDGLAEDIDKGEVSAR.4|ARPFPDGLAEDIDKGEVSAR.3|ARPFPDGLAEDIDKGEVSAR.2|IWC[CAM]FGPDGTGPNILTDITK.3|IWC[CAM]FGPDGTGPNILTDITK.2|WLPAGDALLQMITIHLPSPVTAQK.3|WLPAGDALLQMITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.3|ARPFPDGLAEDIDKGEVSARQELK.4|ARPFPDGLAEDIDKGEVSARQELK.5|RWLPAGDALLQMITIHLPSPVTAQK.4|RWLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|RWLPAGDALLQMITIHLPSPVTAQK.3|YRC[CAM]ELLYEGPPDDEAAMGIK.3|YRC[CAM]ELLYEGPPDDEAAMGIK.4|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|YRC[CAM]ELLYEGPPDDEAAMGIK.2|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|RGHVFEESQVAGTPMFVVK.4|RGHVFEESQVAGTPMFVVK.3|RGHVFEESQVAGTPM[Oxi]FVVK.4|RGHVFEESQVAGTPM[Oxi]FVVK.3|RGHVFEESQVAGTPM[Oxi]FVVK.2|RGHVFEESQVAGTPMFVVK.2|GVQYLNEIKDSVVAGFQWATK.3|GVQYLNEIKDSVVAGFQWATK.4|GVQYLNEIKDSVVAGFQWATK.2|STAISLFYELSENDLNFIK.3|STAISLFYELSENDLNFIK.2|STAISLFYELSENDLNFIK.4|STLTDSLVC[CAM]K.2|TFC[CAM]QLILDPIFK.2|TFC[CAM]QLILDPIFK.3|YLAEKYEWDVAEARK.4|YLAEKYEWDVAEARK.3|IMGPNYTPGKK.3|IMGPNYTPGKK.2|IM[Oxi]GPNYTPGKK.2|TGTITTFEHAHNMR.4|TGTITTFEHAHNM[Oxi]R.4|TGTITTFEHAHNMR.3|TGTITTFEHAHNM[Oxi]R.3|TGTITTFEHAHNM[Oxi]R.2|TGTITTFEHAHNMR.2|VFDAIMNFKK.3|VFDAIM[Oxi]NFKK.3|VFDAIMNFKK.2|TILMMGR.2|TILM[Oxi]MGR.2|TILMM[Oxi]GR.2|KLWGDRYFDPANGK.4|KLWGDRYFDPANGK.3|EDLYLKPIQR.3|EDLYLKPIQR.2|YEWDVAEARK.3|YEWDVAEARK.2|LDSEDKDKEGKPLLK.4|LDSEDKDKEGKPLLK.3|NMSVIAHVDHGK.3|NM[Oxi]SVIAHVDHGK.3|NMSVIAHVDHGK.2|NM[Oxi]SVIAHVDHGK.2|DSVVAGFQWATK.3|DSVVAGFQWATK.2|FDVHDVTLHADAIHR.4|FDVHDVTLHADAIHR.3|FDVHDVTLHADAIHR.2|KVEDMMK.2|KVEDM[Oxi]MK.2|KVEDMM[Oxi]K.2|VFDAIMNFKKEETAK.4|VFDAIMNFKKEETAK.3|VFDAIMNFKKEETAK.2|FSVSPVVR.2|KRGHVFEESQVAGTPMFVVK.5|KRGHVFEESQVAGTPMFVVK.4|KRGHVFEESQVAGTPMFVVK.3|VAVEAKNPADLPK.3|VAVEAKNPADLPK.2|VFSGLVSTGLKVR.3|SDPVVSYR.2|KEDLYLKPIQR.3|KEDLYLKPIQR.2|FAAKGEGQLGPAER.3|FAAKGEGQLGPAER.2|FTDTRKDEQER.3|FTDTRKDEQER.2|LDIKLDSEDKDK.3|LDIKLDSEDKDK.2|DLEEDHAC[CAM]IPIK.3|DLEEDHAC[CAM]IPIK.2|IMGPNYTPGKKEDLYLK.4|IMGPNYTPGKKEDLYLK.3|PSQVVAETR.2|GEGQLGPAER.2|KVEDMMKK.2|ARPFPDGLAEDIDK.3|ARPFPDGLAEDIDK.2|LWGDRYFDPANGK.3|RC[CAM]LYASVLTAQPR.3|RC[CAM]LYASVLTAQPR.2|DLEEDHAC[CAM]IPIKK.3|DLEEDHAC[CAM]IPIKK.2|GPLMMYISK.2|GPLM[Oxi]MYISK.2|GPLMM[Oxi]YISK.2|GPLM[Oxi]M[Oxi]YISK.2|GVQYLNEIK.2|KSDPVVSYR.2|IMGPNYTPGK.2|IM[Oxi]GPNYTPGK.2|QFAEMYVAK.2|QFAEM[Oxi]YVAK.2|VFDAIMNFK.2|VFDAIM[Oxi]NFK.2|VNFTVDQIR.2|LDIKLDSEDK.2|EGALC[CAM]EENMR.2|EGALC[CAM]EENM[Oxi]R.2|MVNFTVDQIR.2|PFPDGLAEDIDKGEVSAR.3|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.4|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.3|KSDPVVSYRETVSEESNVLC[CAM]LSK.4|KSDPVVSYRETVSEESNVLC[CAM]LSK.3|PFPDGLAEDIDK.2|EGIPALDNFLDK.2|DGAGFLINLIDSPGHVDFSSEVTAALR.4|DGAGFLINLIDSPGHVDFSSEVTAALR.3|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.6|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.4|QSKDGAGFLINLIDSPGHVDFSSEVTAALR.4|SDPMVQC[CAM]IIEESGEHIIAGAGELHLEIC[CAM]LK.4|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.4|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSR.3
SEN / CTL,P46940,Ras GTPase-activating-like protein IQGAP1,IQGAP1,2.98,1.98,1.03E-17,4.61E-18,1.73E+01,"regulation of cytokine production,signal transduction,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,negative regulation of GTPase activity,negative regulation of dephosphorylation,cellular response to platelet-derived growth factor stimulus,positive regulation of MAP kinase activity,positive regulation of GTPase activity,positive regulation of protein kinase activity,platelet-derived growth factor receptor signaling pathway,positive regulation of focal adhesion assembly,cellular response to calcium ion,cellular response to epidermal growth factor stimulus,glomerular visceral epithelial cell development,cell-cell adhesion,positive regulation of dendrite development,positive regulation of peptidyl-tyrosine autophosphorylation,positive regulation of cellular protein localization,positive regulation of vascular associated smooth muscle cell migration,neuron projection extension,response to angiotensin","GTPase inhibitor activity,GTPase activator activity,calcium ion binding,protein binding,calmodulin binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,protein phosphatase binding,protein domain specific binding,protein complex binding,protein serine/threonine kinase activator activity,S100 protein binding,Rac GTPase binding,mitogen-activated protein kinase binding,cadherin binding involved in cell-cell adhesion","ruffle,nucleus,cytoplasm,cytosol,microtubule,actin filament,plasma membrane,cell-cell adherens junction,focal adhesion,lateral plasma membrane,axon,growth cone,midbody,extrinsic component of cytoplasmic side of plasma membrane,slit diaphragm,cytoplasmic ribonucleoprotein granule,neuron projection,protein complex,membrane raft,extracellular exosome,actin cytoskeleton,microtubule cytoskeleton",72,128,200,NKYQELINDIAR.3|NKYQELINDIAR.2|QNVAYEYLC[CAM]HLEEAKR.4|SNQQLENDLNLMDIK.2|SNQQLENDLNLMDIK.3|SNQQLENDLNLM[Oxi]DIK.2|LEGVLAEVAQHYQDTLIR.3|LEGVLAEVAQHYQDTLIR.4|LEGVLAEVAQHYQDTLIR.2|FQPGETLTEILETPATSEQEAEHQR.3|FQPGETLTEILETPATSEQEAEHQR.4|EQLWLANEGLITR.2|EQLWLANEGLITR.3|IFYPETTDIYDRK.3|IFYPETTDIYDRK.2|YQELINDIAR.2|HTDNVIQWLNAMDEIGLPK.3|HTDNVIQWLNAM[Oxi]DEIGLPK.3|HTDNVIQWLNAMDEIGLPK.2|MREEVITLIR.3|MREEVITLIR.2|ATGLHFR.2|KLTELGTVDPK.3|KLTELGTVDPK.2|RIPADTFAALK.3|RIPADTFAALK.2|TILLNTK.2|ITLQDVVSHSK.3|ITLQDVVSHSK.2|LIVDVIR.2|ELATLQR.2|RQSGQTDPLQK.3|RQSGQTDPLQK.2|MVVSFNR.2|LAAVALINAAIQK.3|LAAVALINAAIQK.2|LGNFFSPK.2|YLDELMK.2|LAVGDNNSK.2|TALQEEIK.2|TDPVDIYK.2|DHINDIIK.2|RLAAVALINAAIQK.3|RLAAVALINAAIQK.2|DSLHEKFPDAGEDELLK.4|DSLHEKFPDAGEDELLK.3|NKITLQDVVSHSK.3|ATFYGEQVDYYK.3|ATFYGEQVDYYK.2|GLQQQNSDWYLK.3|GLQQQNSDWYLK.2|RLIVDVIR.2|SKVDQIQEIVTGNPTVIK.4|SKVDQIQEIVTGNPTVIK.3|SKVDQIQEIVTGNPTVIK.2|MLQHAASNK.2|SLNIKTDPVDIYK.3|SLNIKTDPVDIYK.2|SVKEDSNLTLQEK.3|SVKEDSNLTLQEK.2|VNVNLLIFLLNKK.3|ALQSPALGLR.2|TC[CAM]LDNLASK.2|IPADTFAALK.2|KLAVGDNNSK.2|TLINAEDPPMVVVR.3|TLINAEDPPMVVVR.2|TLINAEDPPM[Oxi]VVVR.2|NKEQLSDMMMINK.3|NKEQLSDMMMINK.2|AKVNVNLLIFLLNK.3|LTELGTVDPK.2|QIPAITC[CAM]IQSQWR.3|QIPAITC[CAM]IQSQWR.2|RQNVAYEYLC[CAM]HLEEAKR.4|SVKEDSNLTLQEKK.3|LTAEEMDER.2|LTAEEM[Oxi]DER.2|QSGQTDPLQK.2|TEVSLTLTNK.2|AVTDKFLSAIVSSVDK.3|LIFQMPQNK.2|LIFQM[Oxi]PQNK.2|LQYFRDHINDIIK.3|FFQTAC[CAM]DVPELQDK.3|FFQTAC[CAM]DVPELQDK.2|IIGNLLYYR.2|TLINAEDPPMVVVRK.3|VLKDSLHEKFPDAGEDELLK.4|YGIQMPAFSK.2|YGIQM[Oxi]PAFSK.2|EEIQSSISGVTAAYNR.3|EEIQSSISGVTAAYNR.2|TLQALQIPAAK.2|FLSAIVSSVDK.2|GVLLEIEDLQVNQFK.3|GVLLEIEDLQVNQFK.2|VDQIQEIVTGNPTVIK.3|VDQIQEIVTGNPTVIK.2|EDSNLTLQEK.2|LAAVALINAAIQKGVAEK.3|QSPEHNLTHPELSVAVEMLSSVALINR.5|QSPEHNLTHPELSVAVEMLSSVALINR.4|QSPEHNLTHPELSVAVEM[Oxi]LSSVALINR.4|QSPEHNLTHPELSVAVEMLSSVALINR.3|AVTDKFLSAIVSSVDKIPYGMR.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.3|AVTDKFLSAIVSSVDKIPYGMR.3|C[CAM]IYC[CAM]IHALSLYLFK.3|C[CAM]IYC[CAM]IHALSLYLFK.2|LEAYQHLFYLLQTNPTYLAK.4|LEAYQHLFYLLQTNPTYLAK.3|FVHLLDQSDQDFQEELDLMK.4|FVHLLDQSDQDFQEELDLMK.3|FVHLLDQSDQDFQEELDLM[Oxi]K.3|FPDAGEDELLK.2|LQQTYAALNSK.2|QNVAYEYLC[CAM]HLEEAK.3|QNVAYEYLC[CAM]HLEEAK.2|FLSAIVSSVDKIPYGMR.3|FLSAIVSSVDKIPYGM[Oxi]R.3|ILAIGLINEALDEGDAQK.3|ILAIGLINEALDEGDAQK.2|FALGIFAINEAVESGDVGK.3|FALGIFAINEAVESGDVGK.2|KFVHLLDQSDQDFQEELDLMK.4|KFVHLLDQSDQDFQEELDLMK.3|LPYDVTPEQALAHEEVK.3|LPYDVTPEQALAHEEVK.2|MFLGDNAHLSIINEYLSQSYQK.4|M[Oxi]FLGDNAHLSIINEYLSQSYQK.3|MFLGDNAHLSIINEYLSQSYQK.3|PHYGSVLDNER.2|ALESGDVNTVWK.2|EKLEAYQHLFYLLQTNPTYLAK.4|EKLEAYQHLFYLLQTNPTYLAK.3|EQLSDMMMINK.2|EQLSDMMM[Oxi]INK.2|RQNVAYEYLC[CAM]HLEEAK.3|NVIFEISPTEEVGDFEVK.3|NVIFEISPTEEVGDFEVK.2|DVYEELLTQAEIQGNINK.3|DVYEELLTQAEIQGNINK.2|EELQSGVDAANSAAQQYQR.3|EELQSGVDAANSAAQQYQR.2|FM[Oxi]DSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.2|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.6|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|VDFTEEEINNMKTELEK.3|VNVNLLIFLLNK.2|LGLAPQIQDLYGK.2|SPDVGLYGVIPEC[CAM]GETYHSDLAEAKK.4|QLSSSVTGLTNIEEENC[CAM]QR.3|QLSSSVTGLTNIEEENC[CAM]QR.2|TALQEEIKSKVDQIQEIVTGNPTVIK.4|TVLELMNPEAQLPQVYPFAADLYQK.4|TVLELM[Oxi]NPEAQLPQVYPFAADLYQK.3|TVLELMNPEAQLPQVYPFAADLYQK.3|VDFTEEEINNMK.2|VDFTEEEINNM[Oxi]K.2|ILAIGLINEALDEGDAQKTLQALQIPAAK.4|ILAIGLINEALDEGDAQKTLQALQIPAAK.3|DSLHEKFPDAGEDELLKIIGNLLYYR.4|IFYPETTDIYDR.2|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.4|ERDVYEELLTQAEIQGNINK.3|ERDVYEELLTQAEIQGNINK.2|FDVPGDENAEM[Oxi]DAR.2|FDVPGDENAEMDAR.2|QSGQTDPLQKEELQSGVDAANSAAQQYQR.4|QSGQTDPLQKEELQSGVDAANSAAQQYQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.4|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.3|TLQALQIPAAKLEGVLAEVAQHYQDTLIR.4|FNVDEYSDLVTLTK.2|RQSGQTDPLQKEELQSGVDAANSAAQQYQR.4|RWMEAC[CAM]LGEDLPPTTELEEGLRNGVYLAK.4|SWVNQMESQTGEASK.2|TLSALRSPDVGLYGVIPEC[CAM]GETYHSDLAEAK.4|FALGIFAINEAVESGDVGKTLSALR.3|VNTFSALANIDLALEQGDALALFR.3|LGLAPQIQDLYGKVDFTEEEINNMKTELEK.4|RWMEAC[CAM]LGEDLPPTTELEEGLR.3|TEVSLTLTNKFDVPGDENAEMDAR.3|SPDVGLYGVIPEC[CAM]GETYHSDLAEAK.3|SWVNQMESQTGEASKLPYDVTPEQALAHEEVK.4|GGYYYYHNLETQEGGWDEPPNFVQNSMQLSR.4|AQEIQDESAVLWLDEIQGGIWQSNK.3|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|LGLAPQIQDLYGKVDFTEEEINNMK.3|NPNAMLVNLEEPLASTYQDILYQAK.3|EKAQEIQDESAVLWLDEIQGGIWQSNKDTQEAQK.4|YM[Oxi]NPAIVAPDAFDIIDLSAGGQLTTDQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQR.3|RIPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAKQDK.4
SEN / CTL,P11142,Heat shock cognate 71 kDa protein,HSPA8,2.98,2.20,4.27E-69,1.54E-68,6.78E+01,"mRNA splicing, via spliceosome,transcription, DNA-templated,protein folding,response to unfolded protein,neurotransmitter secretion,cellular response to starvation,viral process,regulation of protein stability,protein refolding,regulation of protein complex assembly,regulation of mRNA stability,negative regulation of transcription, DNA-templated,ATP metabolic process,positive regulation of mRNA splicing, via spliceosome,chaperone mediated protein folding requiring cofactor,regulation of cell cycle,regulation of protein complex stability,chaperone-mediated autophagy,late endosomal microautophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,chaperone-mediated protein transport involved in chaperone-mediated autophagy,clathrin coat disassembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of fibril organization,regulation of protein import,chaperone-mediated autophagy translocation complex disassembly","G-protein coupled receptor binding,phosphatidylserine binding,protein binding,ATP binding,ATPase activity,enzyme binding,MHC class II protein complex binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,poly(A) RNA binding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion","Prp19 complex,extracellular space,intracellular,nucleus,nucleoplasm,spliceosomal complex,nucleolus,lysosomal membrane,late endosome,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular matrix,melanosome,lysosomal lumen,myelin sheath,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,extracellular exosome,blood microparticle,lumenal side of lysosomal membrane,presynapse,ubiquitin ligase complex",276,53,124,IINEPTAAAIAYGLDKK.3|IINEPTAAAIAYGLDKK.2|TVTNAVVTVPAYFNDSQR.2|TVTNAVVTVPAYFNDSQR.3|TVTNAVVTVPAYFNDSQR.4|ARFEELNADLFRGTLDPVEK.4|ARFEELNADLFRGTLDPVEK.3|ARFEELNADLFR.3|ARFEELNADLFR.2|SQIHDIVLVGGSTR.3|SQIHDIVLVGGSTR.2|IINEPTAAAIAYGLDK.2|IINEPTAAAIAYGLDK.3|LDKSQIHDIVLVGGSTR.4|LDKSQIHDIVLVGGSTR.3|LDKSQIHDIVLVGGSTR.2|DAGTIAGLNVLR.2|DAGTIAGLNVLR.3|IINEPTAAAIAYGLDKKVGAER.4|FEELNADLFR.2|FEELNADLFR.3|QATKDAGTIAGLNVLR.3|SFYPEEVSSMVLTK.2|SFYPEEVSSMVLTK.3|SFYPEEVSSM[Oxi]VLTK.3|SFYPEEVSSM[Oxi]VLTK.2|DAKLDKSQIHDIVLVGGSTR.4|DAKLDKSQIHDIVLVGGSTR.3|DAKLDKSQIHDIVLVGGSTR.2|RFDDAVVQSDMKHWPFMVVNDAGRPK.5|RFDDAVVQSDMKHWPFMVVNDAGRPK.6|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDMKHWPFMVVNDAGRPK.4|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.4|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.6|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.6|RFDDAVVQSDM[Oxi]KHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.4|RFDDAVVQSDMKHWPFMVVNDAGRPK.3|MKEIAEAYLGK.3|MKEIAEAYLGK.2|M[Oxi]KEIAEAYLGK.3|M[Oxi]KEIAEAYLGK.2|EIAEAYLGK.2|FDDAVVQSDMKHWPFMVVNDAGRPK.4|FDDAVVQSDMKHWPFMVVNDAGRPK.5|FDDAVVQSDMKHWPFMVVNDAGRPK.3|NQVAMNPTNTVFDAKR.3|NQVAM[Oxi]NPTNTVFDAKR.3|NQVAMNPTNTVFDAKR.2|MVNHFIAEFKR.3|MVNHFIAEFKR.2|STAGDTHLGGEDFDNR.3|STAGDTHLGGEDFDNR.2|LLQDFFNGKELNK.3|LLQDFFNGKELNK.2|NQVAMNPTNTVFDAK.2|NQVAMNPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.2|NSLESYAFNMK.2|NSLESYAFNMK.3|NSLESYAFNM[Oxi]K.2|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.3|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.4|QTQTFTTYSDNQPGVLIQVYEGER.3|QTQTFTTYSDNQPGVLIQVYEGER.4|RFDDAVVQSDMK.3|RFDDAVVQSDM[Oxi]K.3|RFDDAVVQSDMK.2|RFDDAVVQSDM[Oxi]K.2|FDDAVVQSDMK.2|FDDAVVQSDMK.3|FDDAVVQSDM[Oxi]K.2|MVNHFIAEFK.3|M[Oxi]VNHFIAEFK.3|MVNHFIAEFK.2|M[Oxi]VNHFIAEFK.2|GRLSKEDIER.3|GRLSKEDIER.2|HWPFMVVNDAGRPK.4|HWPFM[Oxi]VVNDAGRPK.4|HWPFMVVNDAGRPK.3|HWPFM[Oxi]VVNDAGRPK.3|HWPFMVVNDAGRPK.2|GTLDPVEK.2|GTLDPVEK.1|NQTAEKEEFEHQQK.4|NQTAEKEEFEHQQK.3|NQTAEKEEFEHQQK.2|VC[CAM]NPIITK.2|HWPFMVVNDAGR.3|LSKEDIER.2|EEFEHQQK.2|GPAVGIDLGTTYSC[CAM]VGVFQHGK.4|GPAVGIDLGTTYSC[CAM]VGVFQHGK.3|GPAVGIDLGTTYSC[CAM]VGVFQHGK.2|MVQEAEKYKAEDEK.3|MVQEAEKYKAEDEK.2|NQTAEKEEFEHQQKELEK.4|NQTAEKEEFEHQQKELEK.3|SINPDEAVAYGAAVQAAILSGDK.4|SINPDEAVAYGAAVQAAILSGDK.3|SINPDEAVAYGAAVQAAILSGDK.2|YKAEDEKQR.2|ILDKC[CAM]NEIINWLDK.3|ILDKC[CAM]NEIINWLDK.2|FELTGIPPAPR.2|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.5|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.4|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.3|ILDKC[CAM]NEIINWLDKNQTAEK.4|C[CAM]NEIINWLDK.2|DNNLLGKFELTGIPPAPR.3|C[CAM]NEIINWLDKNQTAEK.3|C[CAM]NEIINWLDKNQTAEK.2|ELEKVC[CAM]NPIITK.2|RTLSSSTQASIEIDSLYEGIDFYTSITR.4|RTLSSSTQASIEIDSLYEGIDFYTSITR.3|GVPQIEVTFDIDANGILNVSAVDK.3|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.4|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.3|TLSSSTQASIEIDSLYEGIDFYTSITR.3
SEN / CTL,P53396,ATP-citrate synthase,ACLY,2.98,1.34,8.65E-22,5.63E-22,2.12E+01,"acetyl-CoA biosynthetic process,citrate metabolic process,oxaloacetate metabolic process,fatty acid biosynthetic process,cholesterol biosynthetic process,lipid biosynthetic process,positive regulation of cellular metabolic process,long-chain fatty-acyl-CoA biosynthetic process","ATP citrate synthase activity,protein binding,ATP binding,metal ion binding,cofactor binding","nucleoplasm,cytoplasm,cytosol,plasma membrane,citrate lyase complex,membrane,extracellular exosome",48,85,146,TIAIIAEGIPEALTR.2|TIAIIAEGIPEALTR.3|SGGMSNELNNIISR.2|SGGMSNELNNIISR.3|SGGM[Oxi]SNELNNIISR.2|GVTIIGPATVGGIKPGC[CAM]FK.3|GVTIIGPATVGGIKPGC[CAM]FK.2|TTDGVYEGVAIGGDRYPGSTFMDHVLR.4|TTDGVYEGVAIGGDRYPGSTFM[Oxi]DHVLR.4|TTDGVYEGVAIGGDRYPGSTFMDHVLR.3|LLQDHPWLLSQNLVVKPDQLIK.4|LLQDHPWLLSQNLVVKPDQLIK.5|LLQDHPWLLSQNLVVKPDQLIK.3|IGNTGGMLDNILASK.2|IGNTGGMLDNILASK.3|IGNTGGM[Oxi]LDNILASK.2|HPEVDVLINFASLR.3|HPEVDVLINFASLR.2|GKLGLVGVNLTLDGVK.3|GKLGLVGVNLTLDGVK.2|ADEVAPAK.2|LTLLNPK.2|STTLFSR.2|DYQGPLK.2|NC[CAM]GSFTR.2|RGGPNYQEGLR.3|RGGPNYQEGLR.2|HLLVHAPEDKK.3|HLLVHAPEDKK.2|KHPEVDVLINFASLR.4|KHPEVDVLINFASLR.3|KHPEVDVLINFASLR.2|LLVGVDEK.2|EAGVFVPR.2|FIC[CAM]TTSAIQNR.3|FIC[CAM]TTSAIQNR.2|TASFSESR.2|FYWGHKEILIPVFK.4|FYWGHKEILIPVFK.3|LIMGIGHR.2|LIM[Oxi]GIGHR.2|TASFSESRADEVAPAKK.4|LGQEATVGK.2|LLVGVDEKLNPEDIKK.4|LLVGVDEKLNPEDIKK.3|LYRPGSVAYVSR.3|LYRPGSVAYVSR.2|YQDTPGVK.2|FGGALDAAAK.2|SMGFIGHYLDQK.3|SM[Oxi]GFIGHYLDQK.3|SM[Oxi]GFIGHYLDQK.2|SMGFIGHYLDQK.2|LGLVGVNLTLDGVK.3|LGLVGVNLTLDGVK.2|TILSLMTR.2|NQALKEAGVFVPR.3|SINNPDMR.2|SINNPDM[Oxi]R.2|YPGSTFMDHVLR.3|YPGSTFMDHVLR.2|DYQGPLKEHEVTIFVR.4|DYQGPLKEHEVTIFVR.3|DYQGPLKEHEVTIFVR.2|EILIPVFK.2|LNPEDIKK.2|AKPAMPQDSVPSPR.3|AKPAM[Oxi]PQDSVPSPR.3|AKPAMPQDSVPSPR.2|KPASFMTSIC[CAM]DER.3|KPASFM[Oxi]TSIC[CAM]DER.3|KPASFMTSIC[CAM]DER.2|AIVWGMQTR.2|AIVWGM[Oxi]QTR.2|VTPDTDWAR.2|GGPNYQEGLR.2|DLVSSLTSGLLTIGDR.3|DLVSSLTSGLLTIGDR.2|MIVVLGEIGGTEEYK.3|MIVVLGEIGGTEEYK.2|M[Oxi]IVVLGEIGGTEEYK.2|VKWGDIEFPPPFGR.3|VKWGDIEFPPPFGR.2|AVQGMLDFDYVC[CAM]SR.3|AVQGMLDFDYVC[CAM]SR.2|AVQGM[Oxi]LDFDYVC[CAM]SR.2|TASFSESRADEVAPAK.3|TASFSESRADEVAPAK.2|EAYPEEAYIADLDAK.3|EAYPEEAYIADLDAK.2|EGDYVLFHHEGGVDVGDVDAK.4|EGDYVLFHHEGGVDVGDVDAK.3|EGDYVLFHHEGGVDVGDVDAK.2|EHEVTIFVR.2|TIAIIAEGIPEALTRK.3|AIRDYQGPLKEHEVTIFVR.4|AIRDYQGPLKEHEVTIFVR.3|HLLVHAPEDK.2|VDATADYIC[CAM]K.2|DGVYVLDLAAK.2|GKLGLVGVNLTLDGVKSWLKPR.4|GQELIYAGMPITEVFK.3|GQELIYAGMPITEVFK.2|GQELIYAGM[Oxi]PITEVFK.2|DEPSVAAMVYPFTGDHK.3|DEPSVAAM[Oxi]VYPFTGDHK.3|DEPSVAAMVYPFTGDHK.2|QHFPATPLLDYALEVEKITTSK.4|SAYDSTMETMNYAQIR.3|SAYDSTMETMNYAQIR.2|SAYDSTM[Oxi]ETMNYAQIR.2|SAYDSTMETM[Oxi]NYAQIR.2|AGKDLVSSLTSGLLTIGDR.3|AGKDLVSSLTSGLLTIGDR.2|LLQDHPWLLSQNLVVK.3|GVTIIGPATVGGIK.2|PAMPQDSVPSPR.2|QGLYRHPWDDISYVLPEHMSM.4|HPWDDISYVLPEHMSM.3|HPWDDISYVLPEHM[Oxi]SM.3|HPWDDISYVLPEHMSM.2|ILIIGGSIANFTNVAATFK.3|ILIIGGSIANFTNVAATFK.2|QHFPATPLLDYALEVEK.3|QHFPATPLLDYALEVEK.2|QHFPATPLLDYALEVEKITTSKK.4|AGKDLVSSLTSGLLTIGDRFGGALDAAAK.4|PASFMTSIC[CAM]DER.2|WGDIEFPPPFGR.2|EEADEYIDIGALNGIFVLGR.3|AISEQTGKELLYK.2|TTDGVYEGVAIGGDR.2|AFDSGIIPM[Oxi]EFVNK.2|AFDSGIIPMEFVNK.2|KPASFMTSIC[CAM]DERGQELIYAGMPITEVFK.4|TTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSR.7|TTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSR.6|DLVSSLTSGLLTIGDRFGGALDAAAK.3|AVQGMLDFDYVC[CAM]SRDEPSVAAMVYPFTGDHK.4|YSC[CAM]QFIEMC[CAM]LM[Oxi]VTADHGPAVSGAHNTIIC[CAM]AR.4|YSC[CAM]QFIEMC[CAM]LMVTADHGPAVSGAHNTIIC[CAM]AR.4|YSC[CAM]QFIEMC[CAM]LMVTADHGPAVSGAHNTIIC[CAM]AR.3|EEMGIGGVLGLLWFQK.2|NFLIEPFVPHSQAEEFYVC[CAM]IYATR.3|NC[CAM]GSFTREEADEYIDIGALNGIFVLGR.3|LTKPIVC[CAM]WC[CAM]IGTC[CAM]ATMFSSEVQFGHAGAC[CAM]ANQASETAVAK.4
SEN / CTL,P62701,"40S ribosomal protein S4, X isoform",RPS4X,2.98,1.96,4.66E-04,4.81E-05,4.32E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,multicellular organism development,positive regulation of cell proliferation,viral transcription,positive regulation of translation","structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,cytosol,ribosome,polysome,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,cytoplasmic ribonucleoprotein granule,extracellular exosome",12,30,47,ERHPGSFDVVHVKDANGNSFATR.5|LREC[CAM]LPLIIFLR.3|LREC[CAM]LPLIIFLR.2|GIPHLVTHDAR.3|GIPHLVTHDAR.2|TIRYPDPLIK.3|TIRYPDPLIK.2|HPGSFDVVHVK.3|HPGSFDVVHVK.2|LTIAEER.2|YPDPLIK.2|LTGVFAPR.2|LKYALTGDEVKK.3|LKYALTGDEVKK.2|HWMLDKLTGVFAPRPSTGPHK.5|HWM[Oxi]LDKLTGVFAPRPSTGPHK.5|LSNIFVIGK.2|ERHPGSFDVVHVK.3|ERHPGSFDVVHVK.2|YALTGDEVK.2|LTGVFAPRPSTGPHK.3|DANGNSFATR.2|LSNIFVIGKGNKPWISLPR.4|LSNIFVIGKGNKPWISLPR.3|LTIAEERDK.2|VRTDITYPAGFMDVISIDK.4|VRTDITYPAGFMDVISIDK.3|VRTDITYPAGFMDVISIDK.2|HWMLDKLTGVFAPR.3|YALTGDEVKK.2|GNKPWISLPR.2|FDTGNLC[CAM]MVTGGANLGR.3|FDTGNLC[CAM]M[Oxi]VTGGANLGR.3|FDTGNLC[CAM]MVTGGANLGR.2|FDTGNLC[CAM]M[Oxi]VTGGANLGR.2|LKYALTGDEVK.2|TDITYPAGFMDVISIDK.3|TDITYPAGFM[Oxi]DVISIDK.2|TDITYPAGFMDVISIDK.2|EC[CAM]LPLIIFLR.2|VRTDITYPAGFMDVISIDKTGENFR.4|VRTDITYPAGFMDVISIDKTGENFR.3|VNDTIQIDLETGK.2|VNDTIQIDLETGKITDFIK.3|VNDTIQIDLETGKITDFIK.2|ITDFIKFDTGNLC[CAM]MVTGGANLGR.3|TDITYPAGFMDVISIDKTGENFR.3
SEN / CTL,P56537,Eukaryotic translation initiation factor 6,EIF6,2.97,1.50,5.11E-09,9.96E-10,9.00E+00,"ribosomal subunit export from nucleus,maturation of 5.8S rRNA,maturation of LSU-rRNA,regulation of glycolytic process,translational initiation,response to insulin,gene silencing by miRNA,miRNA mediated inhibition of translation,mature ribosome assembly,regulation of fatty acid biosynthetic process,regulation of megakaryocyte differentiation,positive regulation of translation,assembly of large subunit precursor of preribosome,regulation of reactive oxygen species metabolic process","translation initiation factor activity,protein binding,ribosome binding,ribosomal large subunit binding","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,preribosome, large subunit precursor,extracellular exosome",18,13,23,HGLLVPNNTTDQELQHIR.4|HGLLVPNNTTDQELQHIR.3|TSIEDQDELSSLLQVPLVAGTVNR.3|TSIEDQDELSSLLQVPLVAGTVNR.4|DSLIDSLT.2|LNEAQPSTIATSMR.3|LNEAQPSTIATSMR.2|LNEAQPSTIATSM[Oxi]R.2|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.5|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.4|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.3|ASFENNC[CAM]EIGC[CAM]FAK.3|ASFENNC[CAM]EIGC[CAM]FAK.2|NSLPDTVQIR.2|ETEEILADVLK.2|LSALGNVTTC[CAM]NDYVALVHPDLDR.4|LSALGNVTTC[CAM]NDYVALVHPDLDR.3|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLK.5|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLK.4|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLKVEVFR.5|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLKVEVFR.4|LTNTYC[CAM]LVAIGGSENFYSVFEGELSDTIPVVHASIAGC[CAM]R.4|LNEAQPSTIATSMRDSLIDSLT.2
SEN / CTL,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,2.96,1.86,3.19E-13,9.69E-14,1.30E+01,"brainstem development,nucleobase-containing compound metabolic process,'de novo' IMP biosynthetic process,nucleoside metabolic process,purine ribonucleoside monophosphate biosynthetic process,response to inorganic substance,cerebellum development,cerebral cortex development,animal organ regeneration,dihydrofolate metabolic process,tetrahydrofolate biosynthetic process,cell-cell adhesion","IMP cyclohydrolase activity,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,protein homodimerization activity,cadherin binding involved in cell-cell adhesion","mitochondrion,cytosol,cell-cell adherens junction,membrane,extracellular exosome",36,53,87,NLTALGLNLVASGGTAK.2|NLTALGLNLVASGGTAK.3|SGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.4|SGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.5|AFTHTAQYDEAISDYFR.3|AFTHTAQYDEAISDYFR.2|TVASPGVTVEEAVEQIDIGGVTLLR.3|TVASPGVTVEEAVEQIDIGGVTLLR.4|EVSDGIIAPGYEEEALTILSK.3|EVSDGIIAPGYEEEALTILSK.4|EVSDGIIAPGYEEEALTILSK.2|DTSLETR.2|GVSQMPLR.2|GVSQM[Oxi]PLR.2|YTQSNSVC[CAM]YAK.3|YTQSNSVC[CAM]YAK.2|DLPESALR.2|LDFNLIR.2|TGLVEFAR.2|TLHPAVHAGILAR.3|TLHPAVHAGILAR.2|HVSPAGAAVGIPLSEDEAK.4|HVSPAGAAVGIPLSEDEAK.3|HVSPAGAAVGIPLSEDEAK.2|NGQVIGIGAGQQSR.3|NGQVIGIGAGQQSR.2|LAGDKANYWWLR.3|SLFSNVVTK.2|ANYWWLR.2|ELKEALGIPAAASFK.3|DLIVATIAVK.2|DVSELTGFPEMLGGR.3|DVSELTGFPEM[Oxi]LGGR.3|DVSELTGFPEMLGGR.2|DVSELTGFPEM[Oxi]LGGR.2|HHPQVLSMK.2|AFTHTAQYDEAISDYFRK.4|AFTHTAQYDEAISDYFRK.3|RSGVAYIAAPSGSAADK.3|RSGVAYIAAPSGSAADK.2|ALFEEVPELLTEAEK.3|ALFEEVPELLTEAEK.2|LTEVSISSDAFFPFR.3|LTEVSISSDAFFPFR.2|NKDLPESALR.2|TLFGLHLSQK.2|EALGIPAAASFK.2|TLTPISAAYAR.2|VC[CAM]MVYDLYK.2|VC[CAM]M[Oxi]VYDLYK.2|ALFEEVPELLTEAEKK.3|NIPEDNADMAR.2|NIPEDNADM[Oxi]AR.2|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.6|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.5|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.4|ALFEEVPELLTEAEKKEWVEK.4|VVAC[CAM]NLYPFVK.2|APGQLALFSVSDK.2|RAEISNAIDQYVTGTIGEDEDLIK.4|RAEISNAIDQYVTGTIGEDEDLIK.3|KNGNYC[CAM]VLQMDQSYKPDENEVR.4|KNGNYC[CAM]VLQMDQSYKPDENEVR.3|YGMNPHQTPAQLYTLQPK.3|YGM[Oxi]NPHQTPAQLYTLQPK.3|YGMNPHQTPAQLYTLQPK.2|KKNGNYC[CAM]VLQMDQSYKPDENEVR.4|VVIEAC[CAM]DELGIILAHTNLR.3|VVIEAC[CAM]DELGIILAHTNLR.2|M[Oxi]SSFGDFVALSDVC[CAM]DVPTAK.3|MSSFGDFVALSDVC[CAM]DVPTAK.3|M[Oxi]SSFGDFVALSDVC[CAM]DVPTAK.2|MSSFGDFVALSDVC[CAM]DVPTAK.2|APGQLALFSVSDKTGLVEFAR.3|MAPGQLALFSVSDK.2|SGVAYIAAPSGSAADK.2|RAEISNAIDQYVTGTIGEDEDLIKWK.4|RAEISNAIDQYVTGTIGEDEDLIKWK.3|LTEVSISSDAFFPFRDNVDR.3|AEISNAIDQYVTGTIGEDEDLIK.3|NGNYC[CAM]VLQM[Oxi]DQSYKPDENEVR.3|NGNYC[CAM]VLQMDQSYKPDENEVR.3|VTVVC[CAM]EPEDYVVVSTEMQSSESKDTSLETR.4|VTVVC[CAM]EPEDYVVVSTEMQSSESKDTSLETR.3|VTVVC[CAM]EPEDYVVVSTEMQSSESK.3|AEISNAIDQYVTGTIGEDEDLIKWK.3|LPITVLNGAPGFINLC[CAM]DALNAWQLVK.3
SEN / CTL,P49588,"Alanine--tRNA ligase, cytoplasmic",AARS,2.95,1.10,7.38E-07,1.12E-07,6.95E+00,"hair follicle development,tRNA modification,tRNA aminoacylation for protein translation,alanyl-tRNA aminoacylation,regulation of translational fidelity,protein folding,tRNA processing,cerebellar Purkinje cell layer development,endoplasmic reticulum unfolded protein response,response to amino acid,negative regulation of neuron apoptotic process,neuromuscular process controlling balance","tRNA binding,aminoacyl-tRNA editing activity,alanine-tRNA ligase activity,ATP binding,zinc ion binding,amino acid binding","cytoplasm,cytosol,membrane,extracellular exosome,mitochondrion",12,62,112,NVGC[CAM]LQEALQLATSFAQLR.3|NVGC[CAM]LQEALQLATSFAQLR.4|NVGC[CAM]LQEALQLATSFAQLR.2|VGAEDADGIDMAYR.2|VGAEDADGIDMAYR.3|VGAEDADGIDM[Oxi]AYR.2|GSLVAPDR.2|RIVAVTGAEAQK.3|RIVAVTGAEAQK.2|PIFLNTIDPSHPMAK.4|PIFLNTIDPSHPMAK.3|PIFLNTIDPSHPM[Oxi]AK.3|PIFLNTIDPSHPMAK.2|DVSAQATGK.2|LVSVLQNK.2|AVYTQDC[CAM]PLAAAK.3|AVYTQDC[CAM]PLAAAK.2|C[CAM]LSVMEAK.2|SVLGEADQK.2|GAMSTQQIK.2|GAM[Oxi]STQQIK.2|KIQSLGDSK.2|GTGARPYTGK.2|HNDLDDVGK.2|KAEEIANEMIEAAK.3|KAEEIANEM[Oxi]IEAAK.3|KAEEIANEMIEAAK.2|RPIMSNHTATHILNFALR.4|RPIMSNHTATHILNFALR.3|GLEVTDDSPK.2|VGDQVWLFIDEPR.3|VGDQVWLFIDEPR.2|GGYVLHIGTIYGDLK.3|GGYVLHIGTIYGDLK.2|SIDTGMGLER.2|SIDTGM[Oxi]GLER.2|VDDSSEDKTEFTVK.3|VDDSSEDKTEFTVK.2|ASEWVQQVSGLMDGK.3|ASEWVQQVSGLMDGK.2|ASEWVQQVSGLM[Oxi]DGK.2|GLVVDMDGFEEERK.3|GLVVDM[Oxi]DGFEEERK.3|GLVVDMDGFEEERK.2|IVAVTGAEAQK.2|ITC[CAM]LC[CAM]QVPQNAANR.3|ITC[CAM]LC[CAM]QVPQNAANR.2|KDPDMVKDIINEEEVQFLK.4|KDPDMVKDIINEEEVQFLK.3|TITVALADGGRPDNTGR.3|TITVALADGGRPDNTGR.2|SVLGEADQKGSLVAPDR.3|VGDQVWLFIDEPRR.3|YNYHLDSSGSYVFENTVATVMALRR.5|YNYHLDSSGSYVFENTVATVMALRR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALRR.4|EADGILKPLPK.2|GGGKDVSAQATGK.2|KSIDTGMGLER.2|NSSHAGAFVIVTEEAIAK.3|NSSHAGAFVIVTEEAIAK.2|MALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.2|MALELLTQEFGIPIER.2|EIADLGEALATAVIPQWQKDELR.4|EIADLGEALATAVIPQWQKDELR.3|MFVEEVSTGQEC[CAM]GVVLDK.3|M[Oxi]FVEEVSTGQEC[CAM]GVVLDK.2|MFVEEVSTGQEC[CAM]GVVLDK.2|SVLGEADQKGSLVAPDRLR.3|EIADLGEALATAVIPQWQK.3|EIADLGEALATAVIPQWQK.2|YNYHLDSSGSYVFENTVATVMALR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALR.3|YNYHLDSSGSYVFENTVATVMALR.3|GAGGEDLIMLDIYAIEELR.3|M[Oxi]HSPQTSAMLFTVDNEAGK.3|MHSPQTSAM[Oxi]LFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.2|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.5|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.4|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.3|AVFDETYPDPVR.2|AEEIANEMIEAAK.2|QIWQNLGLDDTK.2|M[Oxi]SNYDTDLFVPYFEAIQK.3|MSNYDTDLFVPYFEAIQK.3|M[Oxi]SNYDTDLFVPYFEAIQK.2|MSNYDTDLFVPYFEAIQK.2|DIINEEEVQFLK.2|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.5|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.4|GLVVDM[Oxi]DGFEEER.2|GLVVDMDGFEEER.2|TC[CAM]FYAEQGGQIYDEGYLVK.3|TC[CAM]FYAEQGGQIYDEGYLVK.2|EIADLGEALATAVIPQWQKDELRETLK.4|EKMFVEEVSTGQEC[CAM]GVVLDK.3|LYVTYFGGDEAAGLEADLEC[CAM]K.3|LYVTYFGGDEAAGLEADLEC[CAM]K.2|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|QFIDSNPNQPLVILEMESGASAK.3|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|DNFWEMGDTGPC[CAM]GPC[CAM]SEIHYDR.3|TKQFIDSNPNQPLVILEMESGASAK.3|GLEVTDDSPKYNYHLDSSGSYVFENTVATVMALR.4|DAAHLVNQDDPNVLEIWNLVFIQYNR.3|TIPGDTAWLLYDTYGFPVDLTGLIAEEK.3
SEN / CTL,P05556,Integrin beta-1,ITGB1,2.95,1.90,6.63E-19,3.38E-19,1.85E+01,"G1/S transition of mitotic cell cycle,in utero embryonic development,cell fate specification,cell migration involved in sprouting angiogenesis,cellular defense response,homophilic cell adhesion via plasma membrane adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,calcium-independent cell-matrix adhesion,integrin-mediated signaling pathway,positive regulation of cell proliferation,germ cell migration,visual learning,regulation of collagen catabolic process,cell migration,formation of radial glial scaffolds,B cell differentiation,extracellular matrix organization,cell-substrate adhesion,receptor internalization,cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,heterotypic cell-cell adhesion,negative regulation of Rho protein signal transduction,positive regulation of apoptotic process,positive regulation of GTPase activity,sarcomere organization,negative regulation of cell differentiation,viral entry into host cell,mesodermal cell differentiation,axon extension,dendrite morphogenesis,regulation of immune response,leukocyte migration,leukocyte tethering or rolling,regulation of cell cycle,cardiac muscle cell differentiation,cellular response to low-density lipoprotein particle stimulus,positive regulation of establishment of protein localization to plasma membrane,negative regulation of anoikis,transforming growth factor beta receptor signaling pathway,stress fiber assembly","virus receptor activity,fibronectin binding,protease binding,actin binding,integrin binding,protein binding,coreceptor activity,protein complex binding,laminin binding,metal ion binding,protein heterodimerization activity,cell adhesion molecule binding,collagen binding involved in cell-matrix adhesion,cadherin binding involved in cell-cell adhesion,C-X3-C chemokine binding","ruffle,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,integrin complex,external side of plasma membrane,cell surface,intercalated disc,membrane,lamellipodium,filopodium,neuromuscular junction,cleavage furrow,ruffle membrane,integrin alpha1-beta1 complex,integrin alpha2-beta1 complex,integrin alpha3-beta1 complex,integrin alpha7-beta1 complex,integrin alpha8-beta1 complex,integrin alpha10-beta1 complex,integrin alpha11-beta1 complex,myelin sheath abaxonal region,sarcolemma,melanosome,dendritic spine,receptor complex,membrane raft,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,invadopodium membrane,synaptic membrane",60,36,53,LKPEDITQIQPQQLVLR.3|LKPEDITQIQPQQLVLR.2|LKPEDITQIQPQQLVLR.4|SLGTDLMNEMR.2|SLGTDLM[Oxi]NEMR.2|SLGTDLMNEM[Oxi]R.2|RAEDYPIDLYYLMDLSYSMKDDLENVK.4|GTAEKLKPEDITQIQPQQLVLR.4|LSENNIQTIFAVTEEFQPVYKELK.3|LSENNIQTIFAVTEEFQPVYKELK.4|NVLSLTNKGEVFNELVGK.3|NVLSLTNKGEVFNELVGK.2|TVMPYISTTPAK.2|TVM[Oxi]PYISTTPAK.2|HC[CAM]EC[CAM]STDEVNSEDMDAYC[CAM]R.3|HC[CAM]EC[CAM]STDEVNSEDM[Oxi]DAYC[CAM]R.3|NVLSLTNK.2|DKLPQPVQPDPVSHC[CAM]K.4|DKLPQPVQPDPVSHC[CAM]K.3|DKLPQPVQPDPVSHC[CAM]K.2|LRSGEPQTFTLK.3|KGC[CAM]PPDDIENPR.3|KGC[CAM]PPDDIENPR.2|KRDNTNEIYSGK.3|KRDNTNEIYSGK.2|C[CAM]DDLEALK.2|IGFGSFVEK.2|SAVTTVVNPKYEGK.3|SAVTTVVNPK.2|LPQPVQPDPVSHC[CAM]K.3|LPQPVQPDPVSHC[CAM]K.2|C[CAM]DDLEALKK.2|GEVFNELVGK.2|GIC[CAM]EC[CAM]GVC[CAM]K.2|LSEGVTISYK.2|KGC[CAM]PPDDIENPRGSK.3|SGEPQTFTLK.2|DNTNEIYSGK.2|LLVFSTDAGFHFAGDGK.3|LLVFSTDAGFHFAGDGK.2|WDTGENPIYK.2|GC[CAM]PPDDIENPR.2|RDNTNEIYSGK.2|SNGLIC[CAM]GGNGVC[CAM]K.2|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.6|LGGIVLPNDGQC[CAM]HLENNM[Oxi]YTM[Oxi]SHYYDYPSIAHLVQK.5|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.5|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.4|FC[CAM]EC[CAM]DNFNC[CAM]DR.2|FQGQTC[CAM]EMC[CAM]QTC[CAM]LGVC[CAM]AEHK.3|LSENNIQTIFAVTEEFQPVYK.3|RAEDYPIDLYYLMDLSYSMK.3|LSENNIQTIFAVTEEFQPVYKELKNLIPK.4
SEN / CTL,P48681,Nestin,NES,2.95,1.89,9.12E-15,3.22E-15,1.45E+01,"G2/M transition of mitotic cell cycle,central nervous system development,brain development,positive regulation of intermediate filament depolymerization,embryonic camera-type eye development,negative regulation of protein binding,negative regulation of catalytic activity,negative regulation of neuron apoptotic process,cell projection morphogenesis,stem cell proliferation,positive regulation of neural precursor cell proliferation","molecular_function,structural molecule activity,intermediate filament binding","cytoplasm,intermediate filament,extracellular matrix,intermediate filament cytoskeleton",54,70,89,TSLSFQDPKLELQFPR.3|SLEEDLETLK.2|C[CAM]PAPPRGPPAPAPEVEELAR.3|LLEEENQESLR.2|NLEEEENLGKGEYQESLR.3|ALEEQNELLSAELGGLR.3|ALEEQNELLSAELGGLR.2|SLETEILESLK.2|RLGSLLPVLSPTSLPSPLPATLETPVPAFLK.4|RLGSLLPVLSPTSLPSPLPATLETPVPAFLK.3|SLKEESVEAVK.3|SLKEESVEAVK.2|GLVEGASVK.2|SPEEVDKESQR.3|VAHMETSLGQAR.3|VAHM[Oxi]ETSLGQAR.3|VAHMETSLGQAR.2|LELQFPR.2|TLENQSHETLER.3|TLENQSHETLER.2|RLEAYLAR.2|NQEFLQAR.2|QGLQSQIAQVLEGR.3|QGLQSQIAQVLEGR.2|AQSADTSWR.2|TLLEAENSR.2|TSLSFQDPK.2|AQDAPLSLLQTQGGR.3|AQDAPLSLLQTQGGR.2|EGRLELQQLQAER.3|EGRLELQQLQAER.2|ERTTEEVAR.2|AQDAPLSLLQTQGGRK.3|EAVGQLKPTGK.2|TLEEEDQSIVRPLETENHK.4|TLEEEDQSIVRPLETENHK.3|TLEKETQQR.2|NLEEEENLGK.2|AHADDELAALR.2|DVEVVRPLEK.2|TLENQSHETLERENQEC[CAM]PR.4|TLENQSHETLERENQEC[CAM]PR.3|VAIPASVLPGPEEPGGQR.3|VAIPASVLPGPEEPGGQR.2|EAVGQLKPTGKEDTQTLQSLQK.4|EAVGQLKPTGKEDTQTLQSLQK.3|SAGQENLETLK.2|TSWAGAPVHLGQGQFLK.3|TSWAGAPVHLGQGQFLK.2|WGPGSSVGSLQALSSSQR.3|WGPGSSVGSLQALSSSQR.2|LELQQLQAER.2|VGLNAQAAC[CAM]APR.2|SLGEEIQESLK.2|ENQEPLRSPEVGDEEALRPLTK.4|ENQEPLRSPEVGDEEALRPLTK.3|WDPTGEQRPPPQGETGK.3|MSLSLEVATYR.2|SLEEEGQELPQSADVQR.3|SLEEEGQELPQSADVQR.2|SLGAWNLENLR.2|SLGAWNLENLRSPEEVDKESQR.4|EDTQTLQSLQK.2|EIQDSQVPLEK.2|KDLEEAGGLGTEFSELPGK.3|SLEKENQEPLK.2|SLEDENKEAFR.2|SLEEQDQETLR.2|DNLAEELEGVAGR.2|EIQEPLESVEVNQETFR.3|EIQEPLESVEVNQETFR.2|FQLAVEALEQEK.2|GEGEGQIWGLVEK.2|GEGEGQIWGLVEKETAIEGK.3|GPPAPAPEVEELAR.2|FQLAVEALEQEKQGLQSQIAQVLEGR.4|FQLAVEALEQEKQGLQSQIAQVLEGR.3|VVSSLQQEIWEEEDLNRK.3|SLDQEIARPLENENQEFLK.3|ATEKFQLAVEALEQEKQGLQSQIAQVLEGR.4|ELLKDVEVVRPLEK.2|TPTLASTPIPPTPQAPSPAVDAEIR.3|SPETQAPLWTPEEINQGAMNPLEK.3|DLEEAGGLGTEFSELPGK.2|EEVMEPPLEEESLEAK.2|LGSLLPVLSPTSLPSPLPATLETPVPAFLK.3|LGSLLPVLSPTSLPSPLPATLETPVPAFLKNQEFLQAR.4|EDKVPGPLEIPSGMEDAGPGADIIGVNGQGPNLEGK.3|GEFLESDSVSVSVPWDDSLR.2
SEN / CTL,P17812,CTP synthase 1,CTPS1,2.95,2.11,1.47E-04,1.61E-05,4.79E+00,"nucleobase-containing compound metabolic process,CTP biosynthetic process,glutamine metabolic process,nucleobase-containing small molecule interconversion,T cell proliferation,B cell proliferation,response to drug,'de novo' CTP biosynthetic process","CTP synthase activity,ATP binding","cytosol,membrane",12,34,52,GLGLSPDLVVC[CAM]R.2|GLGLSPDLVVC[CAM]R.3|GIIASSVGTILK.2|LC[CAM]SAHGVLVPGGFGVR.4|LC[CAM]SAHGVLVPGGFGVR.3|LC[CAM]SAHGVLVPGGFGVR.2|DNNLTTGK.2|LLETC[CAM]SIALVGK.3|LLETC[CAM]SIALVGK.2|HRFEVNPVWK.3|ALEHSALAINHKLEIK.4|LSHYLQK.2|IQAIAWAR.2|YHEAWQK.2|C[CAM]LEEQGLK.2|KLYGDADYLEER.3|KLYGDADYLEER.2|FEVNPVWK.2|RLDLPIER.2|YIDSADLEPITSQEEPVR.4|YIDSADLEPITSQEEPVR.3|YIDSADLEPITSQEEPVR.2|IYQYVINK.2|PSPPYFGLLLASVGR.3|PSPPYFGLLLASVGR.2|SC[CAM]GLHVTSIK.2|C[CAM]SNPLDTSVK.2|FSDSYASVIK.2|FVGQDVEGER.2|ENFC[CAM]NIHVSLVPQPSSTGEQK.4|ENFC[CAM]NIHVSLVPQPSSTGEQK.3|ENFC[CAM]NIHVSLVPQPSSTGEQK.2|VPLLLEEQGVVDYFLR.3|VPLLLEEQGVVDYFLR.2|PIKPSPPYFGLLLASVGR.3|RENFC[CAM]NIHVSLVPQPSSTGEQK.4|RENFC[CAM]NIHVSLVPQPSSTGEQK.3|LYGDADYLEER.2|VKRENFC[CAM]NIHVSLVPQPSSTGEQK.4|ISM[Oxi]FC[CAM]HVEPEQVIC[CAM]VHDVSSIYR.4|ISMFC[CAM]HVEPEQVIC[CAM]VHDVSSIYR.4|ISMFC[CAM]HVEPEQVIC[CAM]VHDVSSIYR.3|TVQVVPHITDAIQEWVM[Oxi]R.3|TVQVVPHITDAIQEWVMR.3|TVQVVPHITDAIQEWVMR.2|SGSSSPDSEITELK.2|MEIVELEDHPFFVGVQYHPEFLSR.4|MEIVELEDHPFFVGVQYHPEFLSR.3|YIDSADLEPITSQEEPVRYHEAWQK.4|YIDSADLEPITSQEEPVRYHEAWQK.3|ISMFC[CAM]HVEPEQVIC[CAM]VHDVSSIYRVPLLLEEQGVVDYFLR.5|NVLGWQDANSTEFDPTTSHPVVVDMPEHNPGQMGGTMR.4
SEN / CTL,P62081,40S ribosomal protein S7,RPS7,2.95,2.00,1.00E-10,2.33E-11,1.06E+01,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,neural tube closure,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cell differentiation,ribosomal small subunit biogenesis","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,microtubule organizing center,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,90S preribosome,extracellular matrix,small-subunit processome,extracellular exosome",30,21,35,TLTAVHDAILEDLVFPSEIVGKR.4|TLTAVHDAILEDLVFPSEIVGKR.3|LTGKDVNFEFPEFQL.2|SRTLTAVHDAILEDLVFPSEIVGKR.4|AIIIFVPVPQLK.2|AIIIFVPVPQLK.3|VHLDKAQQNNVEHK.4|AQLRELNITAAK.3|AQQNNVEHKVETFSGVYKK.5|AQQNNVEHKVETFSGVYKK.4|AQQNNVEHKVETFSGVYKK.3|EIEVGGGRK.2|HVVFIAQR.2|VETFSGVYK.2|AQQNNVEHKVETFSGVYK.4|AQQNNVEHKVETFSGVYK.3|AQQNNVEHKVETFSGVYK.2|VHLDKAQQNNVEHKVETFSGVYK.5|VHLDKAQQNNVEHKVETFSGVYK.4|VETFSGVYKK.2|TLTAVHDAILEDLVFPSEIVGK.4|TLTAVHDAILEDLVFPSEIVGK.3|TLTAVHDAILEDLVFPSEIVGK.2|KLTGKDVNFEFPEFQL.3|SRTLTAVHDAILEDLVFPSEIVGK.4|SRTLTAVHDAILEDLVFPSEIVGK.3|IVKPNGEKPDEFESGISQALLELEMNSDLK.5|IVKPNGEKPDEFESGISQALLELEM[Oxi]NSDLK.5|IVKPNGEKPDEFESGISQALLELEMNSDLK.4|IVKPNGEKPDEFESGISQALLELEM[Oxi]NSDLK.4|IVKPNGEKPDEFESGISQALLELEMNSDLK.3|DVNFEFPEFQL.2|KAIIIFVPVPQLK.2|IVKPNGEKPDEFESGISQALLELEMNSDLKAQLR.5|PNGEKPDEFESGISQALLELEMNSDLK.3
SEN / CTL,P50552,Vasodilator-stimulated phosphoprotein,VASP,2.95,1.89,8.43E-13,2.41E-13,1.26E+01,"neural tube closure,axon guidance,actin polymerization or depolymerization,positive regulation of actin filament polymerization,cell junction assembly,protein homotetramerization,cell-cell adhesion","actin binding,protein binding,profilin binding,SH3 domain binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,bicellular tight junction,focal adhesion,actin cytoskeleton,lamellipodium membrane,filopodium membrane,extracellular exosome",36,28,48,KMQPDQQVVINC[CAM]AIVR.3|KMQPDQQVVINC[CAM]AIVR.2|SSSSVTTSETQPC[CAM]TPSSSDYSDLQR.3|SGGGGLMEEMNAMLAR.2|SGGGGLMEEMNAMLAR.3|SGGGGLM[Oxi]EEMNAMLAR.2|SGGGGLMEEMNAM[Oxi]LAR.2|VKEEIIEAFVQELR.3|VKEEIIEAFVQELR.2|MQPDQQVVINC[CAM]AIVR.2|MQPDQQVVINC[CAM]AIVR.3|M[Oxi]QPDQQVVINC[CAM]AIVR.2|QQPGPSEHIER.3|QQPGPSEHIER.2|VKQELLEEVKK.3|VKQELLEEVKK.2|ATVMLYDDGNKR.3|ATVMLYDDGNKR.2|VKEEIIEAFVQELRK.4|VKEEIIEAFVQELRK.3|RQQPGPSEHIER.3|RQQPGPSEHIER.2|VPAQSESVR.2|VSKQEEASGGPTAPK.3|VSKQEEASGGPTAPK.2|RWLPAGTGPQAFSR.3|VQIYHNPTANSFR.3|VQIYHNPTANSFR.2|YNQATPNFHQWR.3|YNQATPNFHQWR.2|EEIIEAFVQELRK.3|KVSKQEEASGGPTAPK.3|KVSKQEEASGGPTAPK.2|QELLEEVKK.2|TPKDESANQEEPEAR.3|QVWGLNFGSK.2|QEEASGGPTAPK.2|ATQVGEKTPKDESANQEEPEAR.4|ATVMLYDDGNK.2|ATVM[Oxi]LYDDGNK.2|DESANQEEPEAR.2|WLPAGTGPQAFSR.2|EEIIEAFVQELR.2|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.6|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.5|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.4|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKR.6|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKR.4
SEN / CTL,P08729,"Keratin, type II cytoskeletal 7",KRT7,2.94,2.20,2.88E-04,3.04E-05,4.52E+00,viral process,"structural molecule activity,protein binding","nucleus,cytoplasm,intermediate filament,keratin filament,extracellular exosome",12,52,77,LALDIEIATYR.2|LQAEIDNIK.2|VRQEESEQIK.3|VRQEESEQIK.2|SLDLDGIIAEVK.3|SLDLDGIIAEVK.2|NKYEDEINHR.3|NKYEDEINHR.2|FETLQAQAGKHGDDLR.4|TAAENEFVVLKK.3|TAAENEFVVLKK.2|NTRNEISEMNR.3|NTRNEISEMNR.2|NTRNEISEM[Oxi]NR.2|VRQEESEQIKTLNNK.4|VRQEESEQIKTLNNK.3|AKQEELEAALQR.3|AKQEELEAALQR.2|AKLEAAIAEAEER.3|AKLEAAIAEAEER.2|LALDIEIATYRK.3|LALDIEIATYRK.2|LPDIFEAQIAGLR.3|LPDIFEAQIAGLR.2|LQAEIDNIKNQR.3|LQAEIDNIKNQR.2|AQYEEMAK.2|EVTINQSLLAPLR.3|EVTINQSLLAPLR.2|NEISEMNR.2|AKLEAAIAEAEERGELALK.4|AKLEAAIAEAEERGELALK.3|DVDAAYMSK.2|DVDAAYM[Oxi]SK.2|LDADPSLQR.2|QLREYQELMSVK.3|QLREYQELMSVK.2|WTLLQEQK.2|LEAAIAEAEERGELALKDAR.4|LEAAIAEAEERGELALKDAR.3|FETLQAQAGK.2|SAYGGPVGAGIR.2|KDVDAAYMSK.2|LSSARPGGLGSSSLYGLGASRPR.4|EYQELMSVK.2|PGGLGSSSLYGLGASRPR.3|QEELEAALQR.2|SSRLPDIFEAQIAGLR.3|SSRLPDIFEAQIAGLR.2|AEAEAWYQTK.2|SMQDVVEDFK.2|SM[Oxi]QDVVEDFK.2|LEAAIAEAEER.2|LEAAIAEAEERGELALK.3|EVTINQSLLAPLRLDADPSLQR.4|EVTINQSLLAPLRLDADPSLQR.3|TAAENEFVVLK.2|GQLEALQVDGGR.2|FLEQQNKLLETKWTLLQEQK.4|FLEQQNKLLETKWTLLQEQK.3|SMQDVVEDFKNKYEDEINHR.4|SMQDVVEDFKNKYEDEINHR.3|AIQRLQAEIDNIKNQR.3|GQLEALQVDGGRLEAELR.3|LSSARPGGLGSSSLYGLGASR.3|VELEAKVDALNDEINFLR.3|VELEAKVDALNDEINFLR.2|VDALNDEINFLR.2|SMQDVVEDFKNK.2|PGGLGSSSLYGLGASR.2|SLDLDGIIAEVKAQYEEMAK.3|TLNETELTELQSQISDTSVVLSMDNSR.4|TLNETELTELQSQISDTSVVLSMDNSR.3|TLNETELTELQSQISDTSVVLSM[Oxi]DNSR.3|AEAEAWYQTKFETLQAQAGK.3|C[CAM]SRAEAEAWYQTK.2|SAYGGPVGAGIREVTINQSLLAPLRLDADPSLQR.4
SEN / CTL,P24593,Insulin-like growth factor-binding protein 5,IGFBP5,2.94,1.62,1.61E-04,1.75E-05,4.76E+00,"regulation of cell growth,osteoblast differentiation,glucose metabolic process,signal transduction,female pregnancy,aging,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,negative regulation of translation,negative regulation of cell migration,hair follicle morphogenesis,intracellular signal transduction,glucose homeostasis,positive regulation of insulin-like growth factor receptor signaling pathway,negative regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,negative regulation of osteoblast differentiation,negative regulation of growth,lung alveolus development,negative regulation of smooth muscle cell proliferation,striated muscle cell differentiation,positive regulation of protein kinase B signaling,mammary gland involution,response to growth hormone,cellular response to cAMP,cellular response to organic cyclic compound,negative regulation of muscle tissue development,negative regulation of skeletal muscle hypertrophy","fibronectin binding,protein binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,intracellular,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex",12,3,3,ALSMC[CAM]PPSPLGC[CAM]ELVK.2|HMEASLQELK.2|FVGGAENTAHPR.3
SEN / CTL,P62310,U6 snRNA-associated Sm-like protein LSm3,LSM3,2.93,0.41,1.07E-05,1.40E-06,5.85E+00,"mRNA splicing, via spliceosome,mRNA processing,cytoplasmic mRNA processing body assembly,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay","RNA binding,protein binding,poly(A) RNA binding","cytoplasmic mRNA processing body,nucleus,nucleoplasm,U6 snRNP,cytosol,U4/U6 x U5 tri-snRNP complex,precatalytic spliceosome,catalytic step 2 spliceosome,Lsm1-7-Pat1 complex",6,4,4,GDGVVLVAPPLRVG.2|NIPMLFVR.2|RNIPMLFVR.2|GDGVVLVAPPLR.2
SEN / CTL,Q13885,Tubulin beta-2A chain,TUBB2A,2.93,1.85,4.18E-24,3.42E-24,2.35E+01,"cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytoplasm,microtubule,extracellular exosome,extracellular vesicle",96,12,25,AILVDLEPGTMDSVR.2|AILVDLEPGTMDSVR.3|AILVDLEPGTM[Oxi]DSVR.2|AILVDLEPGTM[Oxi]DSVR.3|REIVHIQAGQC[CAM]GNQIGAK.4|MREIVHIQAGQC[CAM]GNQIGAK.4|MREIVHIQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.4|MREIVHIQAGQC[CAM]GNQIGAK.2|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.3|IREEYPDRIMNTFSVMPSPK.4|ESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|ESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|EIVHIQAGQC[CAM]GNQIGAK.3|EIVHIQAGQC[CAM]GNQIGAK.2|EIVHIQAGQC[CAM]GNQIGAK.4|YLTVAAIFR.2|INVYYNEAAGNKYVPR.3|INVYYNEAAGNKYVPR.2|FWEVISDEHGIDPTGSYHGDSDLQLER.4|FWEVISDEHGIDPTGSYHGDSDLQLER.3|ALTVPELTQQMFDSK.3|ALTVPELTQQMFDSK.2|INVYYNEAAGNK.2|KESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4
SEN / CTL,P14314,Glucosidase 2 subunit beta,PRKCSH,2.93,0.99,8.67E-24,6.98E-24,2.32E+01,"protein folding,N-glycan processing,intracellular signal transduction","protein kinase C binding,calcium ion binding,ion channel binding,phosphoprotein binding","intracellular,endoplasmic reticulum,endoplasmic reticulum lumen",48,34,64,SLEDQVEMLR.2|SLEDQVEM[Oxi]LR.2|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]KEK.3|ESLQQMAEVTR.2|ESLQQM[Oxi]AEVTR.2|LGGSPTSLGTWGSWIGPDHDKFSAMKYEQGTGC[CAM]WQGPNR.5|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]KYEQGTGC[CAM]WQGPNR.5|LGGSPTSLGTWGSWIGPDHDKFSAMKYEQGTGC[CAM]WQGPNR.4|LWEEQLAAAK.2|LGGSPTSLGTWGSWIGPDHDKFSAMK.4|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]K.4|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]K.3|LGGSPTSLGTWGSWIGPDHDKFSAMK.3|SLKDMEESIR.3|SLKDMEESIR.2|SLKDM[Oxi]EESIR.2|GVSLTNHHFYDESK.4|GVSLTNHHFYDESK.3|GVSLTNHHFYDESK.2|TVKEEAEKPEREAK.4|TVKEEAEKPEREAK.3|LIELQAGK.2|DMEESIR.2|DM[Oxi]EESIR.2|TVKEEAEKPER.3|TVKEEAEKPER.2|AQQEQELAADAFK.3|AQQEQELAADAFK.2|KLIELQAGK.2|LIELQAGKK.2|NKFEEAER.2|ILIEDWKK.2|KILIEDWK.2|YEQGTGC[CAM]WQGPNR.3|YEQGTGC[CAM]WQGPNR.2|ERESLQQM[Oxi]AEVTR.3|ERESLQQMAEVTR.3|ERESLQQMAEVTR.2|ERESLQQM[Oxi]AEVTR.2|KLIELQAGKK.2|KILIEDWKK.2|ETM[Oxi]VTSTTEPSR.2|ETMVTSTTEPSR.2|SEALPTDLPAPSAPDLTEPK.3|SEALPTDLPAPSAPDLTEPK.2|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.5|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.4|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.3|PFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.4|PFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.3|LGGSPTSLGTWGSWIGPDHDK.3|LGGSPTSLGTWGSWIGPDHDK.2|M[Oxi]PPYDEQTQAFIDAAQEAR.3|MPPYDEQTQAFIDAAQEAR.3|MPPYDEQTQAFIDAAQEAR.2|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]K.4|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]K.3|YRSEALPTDLPAPSAPDLTEPK.3|YRSEALPTDLPAPSAPDLTEPK.2|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYK.3|GVSLTNHHFYDESKPFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.5|GVSLTNHHFYDESKPFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.4|ILIEDWK.1|C[CAM]EYLMELMTPAAC[CAM]PEPPPEAPTEDDHDEL.3
SEN / CTL,Q562R1,Beta-actin-like protein 2,ACTBL2,2.93,1.57,1.85E-20,1.05E-20,2.00E+01,biological_process,"molecular_function,ATP binding","extracellular space,cytoplasm,cytoskeleton,extracellular exosome",54,9,17,KDLYANTVLSGGSTM[Oxi]YPGIADR.3|VAPDEHPILLTEAPLNPK.3|VAPDEHPILLTEAPLNPK.4|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.3|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.5|DLYANTVLSGGSTM[Oxi]YPGIADR.2|DLYANTVLSGGSTM[Oxi]YPGIADR.3|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.5|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.6|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.4|HQGVMVGMGQKDC[CAM]YVGDEAQSK.4|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSK.4|IWYHTFYNELR.3|FRC[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.4|C[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.3
SEN / CTL,Q9Y490,Talin-1,TLN1,2.92,1.92,6.24E-100,4.82E-99,9.83E+01,"platelet degranulation,movement of cell or subcellular component,muscle contraction,cytoskeletal anchoring at plasma membrane,cell-cell junction assembly,cell-substrate junction assembly,viral process,cortical actin cytoskeleton organization,IRE1-mediated unfolded protein response,platelet aggregation","integrin binding,structural constituent of cytoskeleton,protein binding,vinculin binding,LIM domain binding,actin filament binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular region,cytoplasm,microtubule organizing center,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,cell surface,ruffle membrane,extracellular exosome",444,186,355,AVAAGNSC[CAM]RQEDVIATANLSR.3|AVAEQIPLLVQGVR.2|AVAEQIPLLVQGVR.3|GLAGAVSELLR.2|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.4|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.3|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.5|TLAESALQLLYTAK.2|TLAESALQLLYTAK.3|NLGTALAELR.2|TLREQGVEEHETLLLR.4|TLREQGVEEHETLLLR.3|AVASAAAALVLK.2|RQFVQSAKEVANSTANLVK.4|VGAIPANALDDGQWSQGLISAAR.3|VGAIPANALDDGQWSQGLISAAR.2|VGAIPANALDDGQWSQGLISAAR.4|LNEAAAGLNQAATELVQASR.3|LNEAAAGLNQAATELVQASR.2|LNEAAAGLNQAATELVQASR.4|TMLESAGGLIQTAR.2|TMLESAGGLIQTAR.3|TM[Oxi]LESAGGLIQTAR.2|AVSSAIAQLLGEVAQGNENYAGIAAR.3|AVSSAIAQLLGEVAQGNENYAGIAAR.4|ALEATTEHIRQELAVFC[CAM]SPEPPAKTSTPEDFIR.4|VLGEAMTGISQNAK.2|VLGEAM[Oxi]TGISQNAK.2|ALSTDPAAPNLKSQLAAAAR.3|ALSTDPAAPNLKSQLAAAAR.2|GSQAQPDSPSAQLALIAASQSFLQPGGK.3|GSQAQPDSPSAQLALIAASQSFLQPGGK.4|QFVQSAKEVANSTANLVK.3|QVAASTAQLLVAC[CAM]K.2|QVAASTAQLLVAC[CAM]K.3|AGALQC[CAM]SPSDAYTKKELIEC[CAM]AR.4|AKPKEADESLNFEEQILEAAK.4|ALDGAFTEENRAQC[CAM]R.3|AAAFEEQENETVVVKEK.3|TMQFEPSTMVYDAC[CAM]R.2|TMQFEPSTMVYDAC[CAM]R.3|TM[Oxi]QFEPSTMVYDAC[CAM]R.2|VSQMAQYFEPLTLAAVGAASK.3|VSQMAQYFEPLTLAAVGAASK.2|VSQMAQYFEPLTLAAVGAASK.4|VSQM[Oxi]AQYFEPLTLAAVGAASK.3|VSQM[Oxi]AQYFEPLTLAAVGAASK.2|LASEAKPAAVAAENEEIGSHIK.4|LASEAKPAAVAAENEEIGSHIK.3|LASEAKPAAVAAENEEIGSHIK.2|ASVPTIQDQASAMQLSQC[CAM]AK.2|ASVPTIQDQASAMQLSQC[CAM]AK.3|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.3|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.2|VVAPTISSPVC[CAM]QEQLVEAGR.2|VVAPTISSPVC[CAM]QEQLVEAGR.4|VVAPTISSPVC[CAM]QEQLVEAGR.3|NGNLPEFGDAISTASK.2|NGNLPEFGDAISTASK.3|QAAASATQTIAAAQHAASTPK.3|QAAASATQTIAAAQHAASTPK.2|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.4|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.5|LLAALLEDEGGSGRPLLQAAK.3|LLAALLEDEGGSGRPLLQAAK.4|LLAALLEDEGGSGRPLLQAAK.2|SKDHFGLEGDEESTMLEDSVSPK.4|SKDHFGLEGDEESTMLEDSVSPK.3|SKDHFGLEGDEESTM[Oxi]LEDSVSPK.4|ALAVNPRDPPSWSVLAGHSR.4|ALAVNPRDPPSWSVLAGHSR.3|VMVTNVTSLLK.2|VM[Oxi]VTNVTSLLK.2|ILAQATSDLVNAIKADAEGESDLENSR.4|ILAQATSDLVNAIKADAEGESDLENSR.3|QEDVIATANLSR.2|QEDVIATANLSR.3|SIAAATSALVK.2|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.4|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.3|LAQAAQSSVATITR.2|LAQAAQSSVATITR.3|VLVQNAAGSQEKLAQAAQSSVATITR.3|ALDGAFTEENR.2|KGIWLEAGK.2|TLSHPQQMALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.2|TLSHPQQMALLDQTK.2|EGISQEALHTQMLTAVQEISHLIEPLANAAR.4|EGISQEALHTQMLTAVQEISHLIEPLANAAR.5|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.4|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.3|EGISQEALHTQMLTAVQEISHLIEPLANAAR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.4|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.2|GVGAAATAVTQALNELLQHVK.3|GVGAAATAVTQALNELLQHVK.4|GVGAAATAVTQALNELLQHVK.2|LHTDDELNWLDHGR.4|LHTDDELNWLDHGR.3|LHTDDELNWLDHGR.2|AIAVTVQEMVTK.2|AIAVTVQEM[Oxi]VTK.2|DLDQASLAAVSQQLAPR.2|DLDQASLAAVSQQLAPR.3|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVR.4|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.4|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.3|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.4|QKLHTDDELNWLDHGR.4|QKLHTDDELNWLDHGR.3|MVAAATNNLC[CAM]EAANAAVQGHASQEK.3|MVAAATNNLC[CAM]EAANAAVQGHASQEK.4|M[Oxi]VAAATNNLC[CAM]EAANAAVQGHASQEK.3|VGKVEHGSVALPAIMR.4|VGKVEHGSVALPAIMR.3|EQGVEEHETLLLR.3|EQGVEEHETLLLR.2|RVAGSVTELIQAAEAMK.3|RVAGSVTELIQAAEAM[Oxi]K.3|RVAGSVTELIQAAEAMK.2|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.4|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.6|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.5|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALM[Oxi]QLAK.4|ALSTDPAAPNLK.3|ALSTDPAAPNLK.2|DVDNALR.2|HTSALC[CAM]NSC[CAM]R.3|HTSALC[CAM]NSC[CAM]R.2|MATNAAAQNAIK.3|MATNAAAQNAIK.2|M[Oxi]ATNAAAQNAIK.2|VLVEDTK.2|FLPSELRDEH.3|FLPSELRDEH.2|ISIGNVVK.2|LKPLPGETMEK.3|LKPLPGETM[Oxi]EK.3|LKPLPGETMEK.2|VKADQDSEAM[Oxi]K.3|VKADQDSEAMK.3|VKADQDSEAMK.2|VLVQNAAGSQEK.3|VLVQNAAGSQEK.2|AC[CAM]KEAAYHPEVAPDVRLR.5|AQVVSNLK.2|AVEDEATK.2|AVTQALNR.2|GTPQDLAR.2|LQAAGNAVK.2|GIWLEAGK.2|AAGHPGDPESQQR.3|AAGHPGDPESQQR.2|HRVQELGHGC[CAM]AALVTK.4|MATNAAAQNAIKK.3|MATNAAAQNAIKK.2|VSHVLAALQAGNR.3|VSHVLAALQAGNR.2|AGFLDLKDFLPK.3|AGFLDLKDFLPK.2|AVAAGNSC[CAM]R.2|KSTVLQQQYNR.3|KSTVLQQQYNR.2|RASDNLVK.2|TIMVDDSK.2|TIM[Oxi]VDDSK.2|ADAEGESDLENSR.3|ADAEGESDLENSR.2|VEHGSVALPAIM[Oxi]R.3|VEHGSVALPAIMR.3|VEHGSVALPAIMR.2|VKADQDSEAMKR.3|VKADQDSEAMKR.2|AASAAQRELVAQGK.3|AASAAQRELVAQGK.2|AEASQLGHK.2|AGFLDLKDFLPKEYVK.4|AGFLDLKDFLPKEYVK.3|DPPSWSVLAGHSR.3|DPPSWSVLAGHSR.2|TKEVIQEWNLTNIKR.4|TVTDMLMTIC[CAM]AR.3|TVTDMLMTIC[CAM]AR.2|TVTDM[Oxi]LMTIC[CAM]AR.2|ASSLIEEAK.2|RAIADMLR.2|AHATGAGPAGR.2|RQFVQSAK.2|AGALQC[CAM]SPSDAYTK.3|AGALQC[CAM]SPSDAYTK.2|ASAGPQPLLVQSC[CAM]K.3|ASAGPQPLLVQSC[CAM]K.2|EAAYHPEVAPDVR.3|EAAYHPEVAPDVR.2|ILAQATSDLVNAIK.3|ILAQATSDLVNAIK.2|ALGDLISATK.2|EVIQEWNLTNIK.3|EVIQEWNLTNIK.2|KAAGHPGDPESQQR.3|KAAGHPGDPESQQR.2|NGDTMEYR.2|VQELGHGC[CAM]AALVTK.3|VQELGHGC[CAM]AALVTK.2|ADQDSEAMK.2|KFFYSDQNVDSR.3|KFFYSDQNVDSR.2|ADAEGESDLENSRK.3|ADAEGESDLENSRK.2|DPVQLNLLYVQAR.3|DPVQLNLLYVQAR.2|GAAAHPDSEEQQQR.3|GAAAHPDSEEQQQR.2|IGITNHDEYSLVR.3|IGITNHDEYSLVR.2|KLEQLKPR.2|LREAAEGLR.2|SAQPASAEPR.2|DDILNGSHPVSFDK.3|DDILNGSHPVSFDK.2|RLQAAGNAVK.2|ALDYYMLR.2|ALDYYM[Oxi]LR.2|KEEITGTLR.2|QELAVFC[CAM]SPEPPAK.3|QELAVFC[CAM]SPEPPAK.2|AGALQC[CAM]SPSDAYTKK.3|AGALQC[CAM]SPSDAYTKK.2|ASSLIEEAKK.2|C[CAM]VSC[CAM]LPGQR.2|EC[CAM]DNALRELETVR.3|TSTPEDFIR.2|ERIPEAPAGPPSDFGLFLSDDDPKK.5|ERIPEAPAGPPSDFGLFLSDDDPKK.4|ERIPEAPAGPPSDFGLFLSDDDPKK.3|PAAVAAENEEIGSHIK.3|PAAVAAENEEIGSHIK.2|VAGSVTELIQAAEAM[Oxi]K.3|VAGSVTELIQAAEAMK.3|VAGSVTELIQAAEAM[Oxi]K.2|VAGSVTELIQAAEAMK.2|EVIQEWNLTNIKR.3|EVIQEWNLTNIKR.2|LGAASLGAEDPETQVVLINAVK.4|LGAASLGAEDPETQVVLINAVK.3|LGAASLGAEDPETQVVLINAVK.2|AAAFEEQENETVVVK.3|AAAFEEQENETVVVK.2|EC[CAM]ANGYLELLDHVLLTLQK.4|EC[CAM]ANGYLELLDHVLLTLQK.3|EC[CAM]ANGYLELLDHVLLTLQK.2|AAMEPIVISAK.2|AAM[Oxi]EPIVISAK.2|C[CAM]TQDLGNSTK.2|ALEATTEHIR.2|EGTETFADHREGILK.3|EVANSTANLVK.2|TKEVIQEWNLTNIK.3|TKEVIQEWNLTNIK.2|ADQDSEAMKR.2|AVTDSINQLITMC[CAM]TQQAPGQK.4|AVTDSINQLITM[Oxi]C[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.2|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.5|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.4|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.3|EGTETFADHR.2|TYGVSFFLVK.2|AVEDEATKGTR.2|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.4|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.3|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.2|AC[CAM]KEAAYHPEVAPDVR.3|IPEAPAGPPSDFGLFLSDDDPKK.4|IPEAPAGPPSDFGLFLSDDDPKK.3|M[Oxi]VGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEM[Oxi]LR.3|MVGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEMLR.2|M[Oxi]VGGIAQIIAAQEEMLR.2|MVGGIAQIIAAQEEM[Oxi]LR.2|VGDDPAVWQLK.2|GVAALTSDPAVQAIVLDTASDVLDK.4|GVAALTSDPAVQAIVLDTASDVLDK.3|STVLQQQYNR.2|EC[CAM]ANGYLELLDHVLLTLQKPSPELKQQLTGHSK.6|NC[CAM]GQMSEIEAK.2|NC[CAM]GQM[Oxi]SEIEAK.2|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.5|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.4|ANQAIQM[Oxi]AC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|EADESLNFEEQILEAAK.3|EADESLNFEEQILEAAK.2|LGAASLGAEDPETQVVLINAVKDVAK.4|LGAASLGAEDPETQVVLINAVKDVAK.3|MVGGIAQIIAAQEEMLRK.3|M[Oxi]VGGIAQIIAAQEEMLRK.3|MVGGIAQIIAAQEEM[Oxi]LRK.3|MVGGIAQIIAAQEEMLRK.2|ALEATTEHIRQELAVFC[CAM]SPEPPAK.4|ALEATTEHIRQELAVFC[CAM]SPEPPAK.3|VLVEDTKVLVQNAAGSQEK.3|FGQDFSTFLEAGVEMAGQAPSQEDR.4|FGQDFSTFLEAGVEM[Oxi]AGQAPSQEDR.3|FGQDFSTFLEAGVEMAGQAPSQEDR.3|LLSDSLPPSTGTFQEAQSR.3|LLSDSLPPSTGTFQEAQSR.2|APGQLEC[CAM]ETAIAALNSC[CAM]LR.3|APGQLEC[CAM]ETAIAALNSC[CAM]LR.2|AVEGC[CAM]VSASQAATEDGQLLR.3|AVEGC[CAM]VSASQAATEDGQLLR.2|FFYSDQNVDSR.2|LLAALLEDEGGSGR.2|FFYSDQNVDSRDPVQLNLLYVQAR.4|FFYSDQNVDSRDPVQLNLLYVQAR.3|RLLSDSLPPSTGTFQEAQSR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.4|SGASGPENFQVGSMPPAQQQITSGQMHR.4|SGASGPENFQVGSM[Oxi]PPAQQQITSGQMHR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.3|SGASGPENFQVGSMPPAQQQITSGQMHR.3|TLAESALQLLYTAKEAGGNPK.3|ILAQATSDLVNAIKADAEGESDLENSRK.4|ILAQATSDLVNAIKADAEGESDLENSRK.3|KFFYSDQNVDSRDPVQLNLLYVQAR.4|SNTSPEELGPLANQLTSDYGR.3|SNTSPEELGPLANQLTSDYGR.2|IPEAPAGPPSDFGLFLSDDDPK.3|IPEAPAGPPSDFGLFLSDDDPK.2|DHFGLEGDEESTMLEDSVSPK.3|DHFGLEGDEESTM[Oxi]LEDSVSPK.3|DHFGLEGDEESTMLEDSVSPK.2|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.4|ELLENPVQPINDM[Oxi]SYFGC[CAM]LDSVMENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVM[Oxi]ENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.2|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.6|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.4|DHFGLEGDEESTMLEDSVSPKK.3|LADVVKLGAASLGAEDPETQVVLINAVKDVAK.4|ERIPEAPAGPPSDFGLFLSDDDPK.3|VLVEDTKVLVQNAAGSQEKLAQAAQSSVATITR.4|APGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|YDQATDTILTVTENIFSSM[Oxi]GDAGEMVR.3|YDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|GTEWVDPEDPTVIAENELLGAAAAIEAAAK.3|LLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASR.4
SEN / CTL,O14672,Disintegrin and metalloproteinase domain-containing protein 10,ADAM10,2.92,2.35,2.56E-04,2.72E-05,4.57E+00,"in utero embryonic development,protein phosphorylation,membrane protein ectodomain proteolysis,negative regulation of cell adhesion,Notch signaling pathway,Notch receptor processing,integrin-mediated signaling pathway,cell-cell signaling,positive regulation of cell proliferation,positive regulation of T cell chemotaxis,protein processing,extracellular matrix disassembly,positive regulation of cell growth,positive regulation of cell migration,response to tumor necrosis factor,monocyte activation,ephrin receptor signaling pathway,PMA-inducible membrane protein ectodomain proteolysis,constitutive protein ectodomain proteolysis","endopeptidase activity,metalloendopeptidase activity,receptor binding,integrin binding,protein binding,metallopeptidase activity,SH3 domain binding,protein kinase binding,protein homodimerization activity,metal ion binding","nucleus,cytoplasm,Golgi apparatus,Golgi-associated vesicle,plasma membrane,focal adhesion,cell surface,postsynaptic density,membrane,integral component of membrane,intracellular membrane-bounded organelle,extracellular exosome,perinuclear endoplasmic reticulum,tetraspanin-enriched microdomain",12,21,28,EAVIAQISSHVK.2|EAVIAQISSHVK.3|ELC[CAM]HVC[CAM]C[CAM]MK.3|ELC[CAM]HVC[CAM]C[CAM]MK.2|LPPPKPLPGTLK.3|RAVSHEDQFLR.3|RRPPQPIQQPQR.3|LVDADGPLAR.2|GYC[CAM]DVFMR.2|VSHITFAHEVGHNFGSPHDSGTEC[CAM]TPGESK.6|VSHITFAHEVGHNFGSPHDSGTEC[CAM]TPGESK.5|YGPQGGC[CAM]ADHSVFER.3|AIDTIYQTTDFSGIR.3|AIDTIYQTTDFSGIR.2|ESYQMGHMR.2|HYEGLSYNVDSLHQK.3|HYEGLSYNVDSLHQK.2|GGTFYVEPAER.2|NTC[CAM]QLYIQTDHLFFK.3|NTC[CAM]QLYIQTDHLFFK.2|YGLEEC[CAM]TC[CAM]ASSDGKDDK.3|HTQVC[CAM]INGQC[CAM]AGSIC[CAM]EK.3|HTQVC[CAM]INGQC[CAM]AGSIC[CAM]EK.2|VLDYDTSHIYTGHIYGEEGSFSHGSVIDGR.5|SLNTGIITVQNYGSHVPPK.3|DEC[CAM]C[CAM]FDANQPEGR.2|TITLQPGSPC[CAM]NDFR.2|QC[CAM]SPSQGPC[CAM]C[CAM]TAQC[CAM]AFK.2
SEN / CTL,P17900,Ganglioside GM2 activator,GM2A,2.92,2.09,6.83E-04,6.87E-05,4.16E+00,"glycosphingolipid metabolic process,ganglioside catabolic process,lipid transport,learning or memory,oligosaccharide catabolic process,lipid storage,neuromuscular process controlling balance,positive regulation of hydrolase activity","lipid transporter activity,phospholipase activator activity,sphingolipid activator protein activity,beta-N-acetylgalactosaminidase activity","mitochondrion,hydrogen:potassium-exchanging ATPase complex,cytoplasmic side of plasma membrane,lysosomal lumen,apical cortex,extracellular exosome",12,10,12,SEFVVPDLELPSWLTTGNYR.3|SEFVVPDLELPSWLTTGNYR.2|SEFVVPDLELPSWLTTGNYRIESVLSSSGKR.4|EGTYSLPK.2|EVAGLWIK.2|TYGLPC[CAM]HC[CAM]PFK.3|TYGLPC[CAM]HC[CAM]PFK.2|IESVLSSSGK.2|KPSQLSSFSWDNC[CAM]DEGKDPAVIR.4|TYGLPC[CAM]HC[CAM]PFKEGTYSLPK.3|IPC[CAM]TDYIGSC[CAM]TFEHFC[CAM]DVLDMLIPTGEPC[CAM]PEPLR.4|SEFVVPDLELPSWLTTGNYRIESVLSSSGK.3
SEN / CTL,P62273,40S ribosomal protein S29,RPS29,2.92,0.61,7.31E-05,8.58E-06,5.07E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,zinc ion binding","nucleoplasm,cytoplasm,cytosol,focal adhesion,small ribosomal subunit,cytosolic small ribosomal subunit,extracellular exosome",6,3,4,DIGFIKLD.2|YGLNM[Oxi]C[CAM]R.2|GHQQLYWSHPR.3|GHQQLYWSHPR.2
SEN / CTL,P30520,Adenylosuccinate synthetase isozyme 2,ADSS,2.92,1.57,6.43E-20,3.51E-20,1.95E+01,"immune system process,AMP biosynthetic process,aspartate metabolic process,purine ribonucleoside monophosphate biosynthetic process,response to purine-containing compound,'de novo' AMP biosynthetic process,IMP metabolic process,response to ammonium ion,cellular response to electrical stimulus","magnesium ion binding,adenylosuccinate synthase activity,GTP binding,phosphate ion binding","cytoplasm,cytosol,plasma membrane,extracellular exosome",48,27,41,VGIGAFPTEQDNEIGELLQTR.3|VGIGAFPTEQDNEIGELLQTR.2|VVDLLAQDADIVC[CAM]R.2|VVDLLAQDADIVC[CAM]R.3|MC[CAM]DLVSDFDGFSER.2|M[Oxi]C[CAM]DLVSDFDGFSER.2|TLPGWNTDISNAR.2|TLPGWNTDISNAR.3|FIEDELQIPVKWIGVGK.3|FIEDELQIPVK.2|ELPVNAQNYVR.2|ELPVNAQNYVR.3|GLEGWEK.2|EFGVTTGR.2|RLIISDR.2|GIGPVYSSK.2|DGVYFLYEALHGPPKK.4|DGVYFLYEALHGPPKK.3|DGVYFLYEALHGPPKK.2|KGIGPVYSSK.2|GREFGVTTGR.2|AHIVFDFHQAADGIQEQQR.4|AHIVFDFHQAADGIQEQQR.3|AHIVFDFHQAADGIQEQQR.2|VTVVLGAQWGDEGKGK.3|YAHMINGFTALALTK.3|YAHMINGFTALALTK.2|SRESMIQLF.2|DGVYFLYEALHGPPK.3|DGVYFLYEALHGPPK.2|GKVVDLLAQDADIVC[CAM]R.3|C[CAM]GWLDLVLLK.2|LDGEIIPHIPANQEVLNK.3|LDGEIIPHIPANQEVLNK.2|LDILDMFTEIK.2|LDILDM[Oxi]FTEIK.2|LDGEIIPHIPANQEVLNKVEVQYK.4|LDGEIIPHIPANQEVLNKVEVQYK.3|AHIVFDFHQAADGIQEQQRQEQAGK.4|VTVVLGAQWGDEGK.2|SIYPTLEIDIEGELQK.2
SEN / CTL,P08865,40S ribosomal protein SA,RPSA,2.91,2.11,1.33E-12,3.75E-13,1.24E+01,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,rRNA export from nucleus,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,cell adhesion,viral transcription,viral entry into host cell","virus receptor activity,structural constituent of ribosome,laminin receptor activity,protein binding,ribosome binding,laminin binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,cytosolic small ribosomal subunit,90S preribosome,extracellular exosome",60,21,46,AIVAIENPADVSVISSR.2|AIVAIENPADVSVISSR.3|LLVVTDPRADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4|FTPGTFTNQIQAAFREPR.3|FTPGTFTNQIQAAFREPR.4|FTPGTFTNQIQAAFREPR.2|SDGIYIINLKR.3|SDGIYIINLK.2|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.3|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.5|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4|RKSDGIYIINLK.3|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.4|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.4|GAHSVGLMWWMLAR.3|GAHSVGLM[Oxi]WWMLAR.3|GAHSVGLMWWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWMLAR.2|GAHSVGLMWWMLAR.2|GAHSVGLM[Oxi]WWM[Oxi]LAR.2|FAAATGATPIAGR.3|FAAATGATPIAGR.2|KSDGIYIINLK.3|KSDGIYIINLK.2|DPEEIEK.2|LLVVTDPR.2|AVLKFAAATGATPIAGR.3|FTPGTFTNQIQAAFR.3|FTPGTFTNQIQAAFR.2|DPEEIEKEEQAAAEK.3|DPEEIEKEEQAAAEK.2|EHPWEVMPDLYFYR.3|EHPWEVMPDLYFYR.2|YVDIAIPC[CAM]NNK.2|FLAAGTHLGGTNLDFQMEQYIYK.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYK.3|FLAAGTHLGGTNLDFQMEQYIYK.3|EHPWEVM[Oxi]PDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.3|FLAAGTHLGGTNLDFQMEQYIYKR.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYKR.4|FLAAGTHLGGTNLDFQMEQYIYKR.3
SEN / CTL,Q01518,Adenylyl cyclase-associated protein 1,CAP1,2.89,1.93,1.73E-20,9.93E-21,2.00E+01,"cell morphogenesis,ameboidal-type cell migration,receptor-mediated endocytosis,establishment or maintenance of cell polarity,signal transduction,activation of adenylate cyclase activity,actin polymerization or depolymerization","actin binding,adenylate cyclase binding","plasma membrane,focal adhesion,cortical actin cytoskeleton,extracellular exosome",60,51,99,LVTTVTEIAG.2|NSLDC[CAM]EIVSAK.2|C[CAM]VNTTLQIK.2|AGAAPYVQAFDSLLAGPVAEYLK.3|AGAAPYVQAFDSLLAGPVAEYLK.2|AGAAPYVQAFDSLLAGPVAEYLK.4|LGLVFDDVVGIVEIINSKDVK.3|SSEMNVLIPTEGGDFNEFPVPEQFK.3|SSEMNVLIPTEGGDFNEFPVPEQFK.4|SSEM[Oxi]NVLIPTEGGDFNEFPVPEQFK.3|KLGLVFDDVVGIVEIINSKDVK.4|KLGLVFDDVVGIVEIINSKDVK.3|VPTISINKTDGC[CAM]HAYLSK.4|VPTISINKTDGC[CAM]HAYLSK.3|EPAVLELEGKK.3|KEPAVLELEGK.3|KEPAVLELEGK.2|GYADSPSK.2|HVSDDMK.2|EFHTTGLAWSK.3|EFHTTGLAWSK.2|EIGGDVQK.2|TLWNGQK.2|INSITVDNC[CAM]KK.3|INSITVDNC[CAM]KK.2|ALLVTASQC[CAM]QQPAENK.4|ALLVTASQC[CAM]QQPAENK.3|ALLVTASQC[CAM]QQPAENK.2|AVGRLEAVSHTSDMHR.4|AVGRLEAVSHTSDM[Oxi]HR.3|AVGRLEAVSHTSDMHR.3|QVAYIYK.2|GKINSITVDNC[CAM]K.3|GKINSITVDNC[CAM]K.2|KEPAVLELEGKK.3|KEPAVLELEGKK.2|KHVDWVK.2|LEAVSHTSDMHR.3|LEAVSHTSDM[Oxi]HR.3|LEAVSHTSDMHR.2|LEAVSHTSDM[Oxi]HR.2|SGPKPFSAPKPQTSPSPK.4|SGPKPFSAPKPQTSPSPK.3|LSDLLAPISEQIK.3|LSDLLAPISEQIK.2|EMNDAAMFYTNR.3|EM[Oxi]NDAAMFYTNR.3|EMNDAAM[Oxi]FYTNR.3|EMNDAAMFYTNR.2|EM[Oxi]NDAAMFYTNR.2|EMNDAAM[Oxi]FYTNR.2|EM[Oxi]NDAAM[Oxi]FYTNR.2|PFSAPKPQTSPSPK.3|GKINSITVDNC[CAM]KK.3|GKINSITVDNC[CAM]KK.2|ATKKEPAVLELEGK.3|ATKKEPAVLELEGK.2|HAEMVHTGLKLER.3|KLGLVFDDVVGIVEIINSK.4|KLGLVFDDVVGIVEIINSK.3|KLGLVFDDVVGIVEIINSK.2|VENQENVSNLVIEDTELK.4|VENQENVSNLVIEDTELK.3|VENQENVSNLVIEDTELK.2|EPAVLELEGK.2|HAEMVHTGLK.2|HAEM[Oxi]VHTGLK.2|TDGC[CAM]HAYLSK.2|INSITVDNC[CAM]K.2|ISKEIGGDVQK.2|LSDLLAPISEQIKEVITFREK.4|WRVENQENVSNLVIEDTELK.4|WRVENQENVSNLVIEDTELK.3|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.6|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.5|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.4|LFNHLSAVSESIQALGWVAMAPK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.3|LFNHLSAVSESIQALGWVAMAPK.3|LFNHLSAVSESIQALGWVAMAPKPGPYVK.5|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.5|LFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.3|LFNHLSAVSESIQALGWVAMAPKPGPYVK.3|KWRVENQENVSNLVIEDTELK.4|KWRVENQENVSNLVIEDTELK.3|LGLVFDDVVGIVEIINSK.3|LGLVFDDVVGIVEIINSK.2|EIGGDVQKHAEMVHTGLK.3|SSLFAQINQGESITHALK.3|SSLFAQINQGESITHALK.2|LSDLLAPISEQIKEVITFR.3|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.4|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.3|GSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|AYLSIWTELQAYIK.2|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIKEVITFR.4
SEN / CTL,P10809,"60 kDa heat shock protein, mitochondrial",HSPD1,2.89,1.51,3.64E-45,7.55E-45,4.41E+01,"response to hypoxia,detection of misfolded protein,B cell cytokine production,MyD88-dependent toll-like receptor signaling pathway,positive regulation of T cell mediated immune response to tumor cell,response to ischemia,'de novo' protein folding,activation of cysteine-type endopeptidase activity involved in apoptotic process,response to unfolded protein,apoptotic mitochondrial changes,response to heat,response to cold,response to activity,viral process,response to lipopolysaccharide,positive regulation of interferon-alpha production,positive regulation of interferon-gamma production,positive regulation of interleukin-10 production,positive regulation of interleukin-12 production,positive regulation of interleukin-6 production,response to ATP,protein refolding,B cell proliferation,T cell activation,B cell activation,response to cocaine,response to drug,response to hydrogen peroxide,positive regulation of macrophage activation,positive regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of neuron apoptotic process,response to estrogen,isotype switching to IgG isotypes,positive regulation of inflammatory response,protein stabilization,positive regulation of T cell activation,chaperone mediated protein folding requiring cofactor,chaperone-mediated protein complex assembly,response to glucocorticoid,protein maturation,negative regulation of apoptotic process in bone marrow,negative regulation of reactive oxygen species biosynthetic process,positive regulation of tumor necrosis factor secretion,positive regulation of interleukin-6 secretion","lipopolysaccharide binding,protease binding,p53 binding,DNA replication origin binding,single-stranded DNA binding,double-stranded RNA binding,protein binding,ATP binding,ATPase activity,ubiquitin protein ligase binding,protein complex binding,insulin binding,poly(A) RNA binding,protein heterodimerization activity,unfolded protein binding,chaperone binding,misfolded protein binding","extracellular space,cytoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,early endosome,peroxisomal matrix,rough endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,clathrin-coated pit,cell surface,membrane,mitochondrial crista,coated vesicle,secretory granule,extracellular matrix,zymogen granule,myelin sheath,protein complex,membrane raft,lipopolysaccharide receptor complex,extracellular exosome,cyclin-dependent protein kinase activating kinase holoenzyme complex",126,80,188,NAGVEGSLIVEK.2|LVQDVANNTNEEAGDGTTTATVLAR.3|LVQDVANNTNEEAGDGTTTATVLAR.4|AAVEEGIVLGGGC[CAM]ALLR.2|AAVEEGIVLGGGC[CAM]ALLR.3|TVIIEQSWGSPK.2|TVIIEQSWGSPK.3|IQEIIEQLDVTTSEYEKEKLNER.4|IQEIIEQLDVTTSEYEKEKLNER.3|ALMLQGVDLLADAVAVTMGPK.3|ALMLQGVDLLADAVAVTMGPK.2|ALMLQGVDLLADAVAVTM[Oxi]GPK.3|ALM[Oxi]LQGVDLLADAVAVTMGPK.3|ALM[Oxi]LQGVDLLADAVAVTM[Oxi]GPK.3|ALM[Oxi]LQGVDLLADAVAVTM[Oxi]GPK.2|ALM[Oxi]LQGVDLLADAVAVTMGPK.2|ALMLQGVDLLADAVAVTM[Oxi]GPK.2|C[CAM]EFQDAYVLLSEKK.3|C[CAM]EFQDAYVLLSEKK.2|VGLQVVAVK.2|TLNDELEIIEGMKFDR.3|TLNDELEIIEGM[Oxi]KFDR.3|TLNDELEIIEGMKFDR.2|ISSIQSIVPALEIANAHR.3|ISSIQSIVPALEIANAHR.4|ISSIQSIVPALEIANAHR.2|GVMLAVDAVIAELKK.3|GVM[Oxi]LAVDAVIAELKK.3|GVMLAVDAVIAELKK.2|GVM[Oxi]LAVDAVIAELKK.2|DGKTLNDELEIIEGMK.3|ISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR.5|ISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR.4|VGEVIVTKDDAMLLK.3|VGEVIVTKDDAM[Oxi]LLK.3|VGEVIVTKDDAMLLK.2|VGEVIVTKDDAM[Oxi]LLK.2|RGVMLAVDAVIAELK.2|RGVMLAVDAVIAELK.3|RGVM[Oxi]LAVDAVIAELK.3|C[CAM]EFQDAYVLLSEK.2|C[CAM]EFQDAYVLLSEK.3|C[CAM]IPALDSLTPANEDQKIGIEIIKR.4|C[CAM]IPALDSLTPANEDQKIGIEIIKR.3|DDAMLLK.2|DDAM[Oxi]LLK.2|TLKIPAM[Oxi]TIAK.3|DRVTDALNATR.3|DRVTDALNATR.2|KISSIQSIVPALEIANAHR.5|KISSIQSIVPALEIANAHR.4|KISSIQSIVPALEIANAHR.3|KISSIQSIVPALEIANAHR.2|VGGTSDVEVNEK.3|VGGTSDVEVNEK.2|VGGTSDVEVNEKKDR.4|VGGTSDVEVNEKKDR.3|VGGTSDVEVNEKKDR.2|APGFGDNR.2|GANPVEIR.2|IPAMTIAK.2|IPAM[Oxi]TIAK.2|RGVMLAVDAVIAELKK.4|RGVM[Oxi]LAVDAVIAELKK.4|RGVMLAVDAVIAELKK.3|RGVM[Oxi]LAVDAVIAELKK.3|VGEVIVTK.2|KISSIQSIVPALEIANAHRK.5|KISSIQSIVPALEIANAHRK.4|KISSIQSIVPALEIANAHRK.3|EIGNIISDAMKK.3|EIGNIISDAM[Oxi]KK.3|EIGNIISDAMKK.2|KDRVTDALNATR.3|KDRVTDALNATR.2|LSDGVAVLK.2|VGGTSDVEVNEKK.3|VGGTSDVEVNEKK.2|GYISPYFINTSK.3|GYISPYFINTSK.2|VGLQVVAVKAPGFGDNRK.4|VGLQVVAVKAPGFGDNRK.3|IGIEIIKR.2|GVMLAVDAVIAELK.3|GVM[Oxi]LAVDAVIAELK.3|GVMLAVDAVIAELK.2|GVM[Oxi]LAVDAVIAELK.2|APGFGDNRK.2|VTDALNATR.2|TLNDELEIIEGMK.3|TLNDELEIIEGM[Oxi]K.3|TLNDELEIIEGMK.2|TLNDELEIIEGM[Oxi]K.2|GANPVEIRR.2|SIAKEGFEK.2|VTKDGVTVAK.2|GQKC[CAM]EFQDAYVLLSEKK.4|GQKC[CAM]EFQDAYVLLSEKK.3|GRTVIIEQSWGSPK.3|GRTVIIEQSWGSPK.2|KGVITVKDGK.2|RIQEIIEQLDVTTSEYEK.4|RIQEIIEQLDVTTSEYEK.3|RIQEIIEQLDVTTSEYEK.2|DGKTLNDELEIIEGMKFDR.4|DGKTLNDELEIIEGMKFDR.3|SIDLKDKYK.2|LKVGLQVVAVK.2|VGLQVVAVKAPGFGDNR.3|C[CAM]IPALDSLTPANEDQK.3|C[CAM]IPALDSLTPANEDQK.2|KPLVIIAEDVDGEALSTLVLNR.4|KPLVIIAEDVDGEALSTLVLNR.3|KPLVIIAEDVDGEALSTLVLNR.2|EIGNIISDAMK.2|EIGNIISDAM[Oxi]K.2|QSKPVTTPEEIAQVATISANGDK.4|QSKPVTTPEEIAQVATISANGDK.3|QSKPVTTPEEIAQVATISANGDK.2|FDRGYISPYFINTSK.3|FDRGYISPYFINTSK.2|KQSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.6|KQSKPVTTPEEIAQVATISANGDKEIGNIISDAM[Oxi]K.5|KQSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.5|KQSKPVTTPEEIAQVATISANGDKEIGNIISDAM[Oxi]K.4|KQSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.4|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMKK.6|QSKPVTTPEEIAQVATISANGDKEIGNIISDAM[Oxi]KK.5|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMKK.5|QSKPVTTPEEIAQVATISANGDKEIGNIISDAM[Oxi]KK.4|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMKK.4|RIQEIIEQLDVTTSEYEKEK.4|RIQEIIEQLDVTTSEYEKEK.3|TALLDAAGVASLLTTAEVVVTEIPK.4|TALLDAAGVASLLTTAEVVVTEIPK.3|KQSKPVTTPEEIAQVATISANGDK.4|KQSKPVTTPEEIAQVATISANGDK.3|GQKC[CAM]EFQDAYVLLSEK.3|GQKC[CAM]EFQDAYVLLSEK.2|KPLVIIAEDVDGEALSTLVLNRLK.4|KPLVIIAEDVDGEALSTLVLNRLK.3|IQEIIEQLDVTTSEYEK.3|IQEIIEQLDVTTSEYEK.2|ISSIQSIVPALEIANAHRK.3|PVTTPEEIAQVATISANGDK.3|PVTTPEEIAQVATISANGDK.2|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.5|QSKPVTTPEEIAQVATISANGDKEIGNIISDAM[Oxi]K.4|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.4|QSKPVTTPEEIAQVATISANGDKEIGNIISDAMK.3|TALLDAAGVASLLTTAEVVVTEIPKEEK.4|TALLDAAGVASLLTTAEVVVTEIPKEEK.3|KISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR.6|KISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR.5|KISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNR.4|PLVIIAEDVDGEALSTLVLNR.3|PLVIIAEDVDGEALSTLVLNR.2|IQEIIEQLDVTTSEYEKEK.3|IQEIIEQLDVTTSEYEKEK.2|DMAIATGGAVFGEEGLTLNLEDVQPHDLGK.4|DM[Oxi]AIATGGAVFGEEGLTLNLEDVQPHDLGK.4|DM[Oxi]AIATGGAVFGEEGLTLNLEDVQPHDLGK.3|DMAIATGGAVFGEEGLTLNLEDVQPHDLGK.3|PVTTPEEIAQVATISANGDKEIGNIISDAMK.4|PVTTPEEIAQVATISANGDKEIGNIISDAMK.3|C[CAM]IPALDSLTPANEDQKIGIEIIK.3|DPGM[Oxi]GAMGGMGGGMGGGMF.2|DPGMGAM[Oxi]GGMGGGMGGGMF.2|DPGMGAMGGM[Oxi]GGGMGGGMF.2|DPGMGAMGGMGGGM[Oxi]GGGMF.2|DPGMGAMGGMGGGMGGGM[Oxi]F.2|DPGMGAMGGMGGGMGGGMF.2|DPGM[Oxi]GAMGGMGGGMGGGM[Oxi]F.2|DPGMGAMGGM[Oxi]GGGM[Oxi]GGGMF.2|DPGMGAMGGMGGGM[Oxi]GGGM[Oxi]F.2|IM[Oxi]QSSSEVGYDAM[Oxi]AGDFVNMVEK.3|IM[Oxi]QSSSEVGYDAMAGDFVNM[Oxi]VEK.3|IM[Oxi]QSSSEVGYDAMAGDFVNMVEK.3|IMQSSSEVGYDAM[Oxi]AGDFVNM[Oxi]VEK.3|IMQSSSEVGYDAM[Oxi]AGDFVNMVEK.3|IMQSSSEVGYDAMAGDFVNM[Oxi]VEK.3|IMQSSSEVGYDAMAGDFVNMVEK.3|IM[Oxi]QSSSEVGYDAM[Oxi]AGDFVNM[Oxi]VEK.3|PVTTPEEIAQVATISANGDKEIGNIISDAMKK.4|GYISPYFINTSKGQK.2|NQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGK.4|NQLKDM[Oxi]AIATGGAVFGEEGLTLNLEDVQPHDLGK.4|EEKDPGMGAMGGMGGGMGGGMF.2
SEN / CTL,P54578,Ubiquitin carboxyl-terminal hydrolase 14,USP14,2.89,1.53,7.23E-06,9.59E-07,6.02E+00,"ubiquitin-dependent protein catabolic process,chemical synaptic transmission,negative regulation of endopeptidase activity,protein deubiquitination,regulation of chemotaxis,regulation of proteasomal protein catabolic process,negative regulation of ER-associated ubiquitin-dependent protein catabolic process","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,endopeptidase inhibitor activity,protein binding,tRNA guanylyltransferase activity,proteasome binding","proteasome complex,cytoplasm,plasma membrane,cell surface,cytoplasmic, membrane-bounded vesicle,synapse,extracellular exosome",12,37,54,RVEIMEEESEQ.2|RVEIM[Oxi]EEESEQ.2|LPAYLTIQMVR.2|LPAYLTIQM[Oxi]VR.2|YLFTGLK.2|LQEEITK.2|SSSSGHYVSWVK.3|SSSSGHYVSWVK.2|AQLFALTGVQPAR.3|AQLFALTGVQPAR.2|PLYSVTVK.2|GGTLKDDDWGNIK.3|GGTLKDDDWGNIK.2|DDDWGNIK.2|LSGGGDWHIAYVLLYGPR.4|LSGGGDWHIAYVLLYGPR.3|LSGGGDWHIAYVLLYGPR.2|ASGEMASAQYITAALR.3|ASGEM[Oxi]ASAQYITAALR.2|ASGEMASAQYITAALR.2|LEAIEDDSVK.2|LRLQEEITK.2|VNQQPNTSDK.2|VEIMEEESEQ.2|ENQLQLSC[CAM]FINQEVK.3|ENQLQLSC[CAM]FINQEVK.2|FDDDKVSIVTPEDILR.3|FDDDKVSIVTPEDILR.2|VSIVTPEDILR.2|KVNQQPNTSDK.2|SLIDQFFGVEFETTMK.3|SLIDQFFGVEFETTMK.2|C[CAM]TESEEEEVTK.2|ETDSSSASAATPSK.2|GKENQLQLSC[CAM]FINQEVK.3|EKFEGVELNTDEPPMVFK.3|EKFEGVELNTDEPPMVFK.2|NGMTLLMMGSADALPEEPSAK.3|NGMTLLMMGSADALPEEPSAK.2|FPLMLDMYELC[CAM]TPELQEK.3|FPLMLDMYELC[CAM]TPELQEK.2|IKNGMTLLMMGSADALPEEPSAK.3|LEAIEDDSVKETDSSSASAATPSK.3|GEQGQYLQQDANEC[CAM]WIQMMR.3|C[CAM]TESEEEEVTKGKENQLQLSC[CAM]FINQEVK.4|YEPFSFADDIGSNNC[CAM]GYYDLQAVLTHQGR.4|YEPFSFADDIGSNNC[CAM]GYYDLQAVLTHQGR.3|ASGEMASAQYITAALRDLFDSMDK.3|LEAIEDDSVKETDSSSASAATPSKK.3|DVKFPLMLDMYELC[CAM]TPELQEK.3|TSSSIPPIILLQFLHM[Oxi]AFPQFAEK.3|EVKYEPFSFADDIGSNNC[CAM]GYYDLQAVLTHQGR.4|FEGVELNTDEPPM[Oxi]VFK.2|FEGVELNTDEPPMVFK.2
SEN / CTL,O00764,Pyridoxal kinase,PDXK,2.88,1.21,1.35E-08,2.53E-09,8.60E+00,"cell proliferation,pyridoxal 5'-phosphate salvage,phosphorylation,vitamin B6 metabolic process,pyridoxal phosphate biosynthetic process","magnesium ion binding,ATP binding,zinc ion binding,pyridoxal kinase activity,pyridoxal phosphate binding,potassium ion binding,sodium ion binding,lithium ion binding,protein homodimerization activity","nucleus,nucleoplasm,cytoplasm,cytosol,extracellular exosome",18,21,33,VVPLADIITPNQFEAELLSGR.3|VVPLADIITPNQFEAELLSGR.2|VVPLADIITPNQFEAELLSGR.4|DKSFLAMVVDIVQELKQQNPR.4|DKSFLAM[Oxi]VVDIVQELKQQNPR.4|KIHSQEEALR.3|KIHSQEEALR.2|RNPAGSVVMER.3|RNPAGSVVMER.2|TVSTLHHVLQR.3|TVSTLHHVLQR.2|NPAGSVVMER.2|SFLAM[Oxi]VVDIVQELK.3|SFLAM[Oxi]VVDIVQELK.2|IHSQEEALR.2|VLSIQSHVIR.2|VVPLADIITPNQFEAELLSGRK.4|VVPLADIITPNQFEAELLSGRK.3|AQAGEGVRPSPMQLELR.3|AQAGEGVRPSPM[Oxi]QLELR.3|DKSFLAM[Oxi]VVDIVQELK.3|YDYVLTGYTR.2|GQVLNSDELQELYEGLR.3|GQVLNSDELQELYEGLR.2|LNNMNKYDYVLTGYTR.3|LNNMNKYDYVLTGYTR.2|LVYVC[CAM]DPVLGDK.2|DIEDPEIVVQATVL.2|AATFPLQVLGFEIDAVNSVQFSNHTGYAHWK.4|LVYVC[CAM]DPVLGDKWDGEGSMYVPEDLLPVYK.4|LVYVC[CAM]DPVLGDKWDGEGSMYVPEDLLPVYK.3|VMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQR.4|WDGEGSMYVPEDLLPVYK.2
SEN / CTL,Q15942,Zyxin,ZYX,2.88,1.48,3.54E-09,6.96E-10,9.16E+00,"cell adhesion,cell-matrix adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,cell-cell signaling,viral process,stress fiber assembly,regulation of inflammatory response","protein binding,zinc ion binding,poly(A) RNA binding","stress fiber,nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion",24,31,53,VNPFRPGDSEPPPAPGAQR.3|VNPFRPGDSEPPPAPGAQR.4|VNPFRPGDSEPPPAPGAQR.2|LGHPEALSAGTGSPQPPSFTYAQQR.3|LGHPEALSAGTGSPQPPSFTYAQQR.5|LGHPEALSAGTGSPQPPSFTYAQQR.4|AYHPHC[CAM]FTC[CAM]VVC[CAM]ARPLEGTSFIVDQANRPHC[CAM]VPDYHK.7|AYHPHC[CAM]FTC[CAM]VVC[CAM]ARPLEGTSFIVDQANRPHC[CAM]VPDYHK.6|AYHPHC[CAM]FTC[CAM]VVC[CAM]ARPLEGTSFIVDQANRPHC[CAM]VPDYHK.5|VSSGYVPPPVATPFSSK.2|VSSGYVPPPVATPFSSK.3|FGPVVAPK.2|PAAGGTAPLPPWK.3|PAAGGTAPLPPWK.2|QHPVPPPAQNQNQVR.4|QHPVPPPAQNQNQVR.3|QHPVPPPAQNQNQVR.2|C[CAM]HQPLAR.2|AYHPHC[CAM]FTC[CAM]VVC[CAM]AR.4|AYHPHC[CAM]FTC[CAM]VVC[CAM]AR.3|FSPGAPGGSGSQPNQK.3|FSPGAPGGSGSQPNQK.2|FGPVVAPKPK.2|SPGAPGPLTLK.2|GPPASSPAPAPK.2|SSTKPAAGGTAPLPPWK.3|PQVQLHVQSQTQPVSLANTQPR.4|PQVQLHVQSQTQPVSLANTQPR.3|QNVAVNELC[CAM]GR.2|PSPAISVSVSAPAFYAPQK.3|PSPAISVSVSAPAFYAPQK.2|EVEELEQLTQQLMQDMEHPQR.4|EVEELEQLTQQLM[Oxi]QDMEHPQR.3|EVEELEQLTQQLMQDMEHPQR.3|C[CAM]NTC[CAM]GEPITDR.2|PLEGTSFIVDQANRPHC[CAM]VPDYHK.4|PLEGTSFIVDQANRPHC[CAM]VPDYHK.3|PSPAISVSVSAPAFYAPQKK.3|SPGAPGPLTLKEVEELEQLTQQLMQDMEHPQR.5|SPGAPGPLTLKEVEELEQLTQQLMQDMEHPQR.4|VSSIDLEIDSLSSLLDDMTK.3|VSSIDLEIDSLSSLLDDMTK.2|C[CAM]SVC[CAM]SEPIMPEPGRDETVR.3|EKVSSIDLEIDSLSSLLDDMTKNDPFK.4|C[CAM]EDC[CAM]GKPLSIEADDNGC[CAM]FPLDGHVLC[CAM]R.4|C[CAM]EDC[CAM]GKPLSIEADDNGC[CAM]FPLDGHVLC[CAM]R.3|PLSIEADDNGC[CAM]FPLDGHVLC[CAM]R.3|SPSSSQPLPQVPAPAQSQTQFHVQPQPQPK.4|SPSSSQPLPQVPAPAQSQTQFHVQPQPQPK.3|EKVSSIDLEIDSLSSLLDDMTK.3|ALGQLFHIAC[CAM]FTC[CAM]HQC[CAM]AQQLQGQQFYSLEGAPYC[CAM]EGC[CAM]YTDTLEK.6|ALGQLFHIAC[CAM]FTC[CAM]HQC[CAM]AQQLQGQQFYSLEGAPYC[CAM]EGC[CAM]YTDTLEK.5|SPSSSQPLPQVPAPAQSQTQFHVQPQPQPKPQVQLHVQSQTQPVSLANTQPR.5
SEN / CTL,P27635,60S ribosomal protein L10,RPL10,2.88,1.27,9.49E-07,1.41E-07,6.85E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,protein binding,poly(A) RNA binding","endoplasmic reticulum,cytosol,membrane,cytosolic large ribosomal subunit",18,11,23,AKVDEFPLC[CAM]GHMVSDEYEQLSSEALEAAR.4|AKVDEFPLC[CAM]GHM[Oxi]VSDEYEQLSSEALEAAR.4|AKVDEFPLC[CAM]GHM[Oxi]VSDEYEQLSSEALEAAR.3|AKVDEFPLC[CAM]GHMVSDEYEQLSSEALEAAR.3|VDEFPLC[CAM]GHMVSDEYEQLSSEALEAAR.3|VDEFPLC[CAM]GHMVSDEYEQLSSEALEAAR.4|VDEFPLC[CAM]GHM[Oxi]VSDEYEQLSSEALEAAR.3|VHIGQVIMSIR.3|VHIGQVIM[Oxi]SIR.3|VHIGQVIMSIR.2|VHIGQVIM[Oxi]SIR.2|EHVIEALR.2|MLSC[CAM]AGADR.2|M[Oxi]LSC[CAM]AGADR.2|RLIPDGC[CAM]GVK.2|EHVIEALRR.2|FNADEFEDMVAEKR.3|FNADEFEDM[Oxi]VAEKR.3|FNADEFEDMVAEKR.2|GAFGKPQGTVAR.2|LQNKEHVIEALR.2|FNADEFEDMVAEK.2|FNADEFEDM[Oxi]VAEK.2
SEN / CTL,P08670,Vimentin,VIM,2.86,2.13,1.76E-156,9.49E-155,1.54E+02,"movement of cell or subcellular component,positive regulation of gene expression,negative regulation of neuron projection development,astrocyte development,viral process,muscle filament sliding,intermediate filament organization,Bergmann glial cell differentiation,SMAD protein signal transduction,lens fiber cell development","glycoprotein binding,double-stranded RNA binding,structural constituent of cytoskeleton,structural constituent of eye lens,protein binding,protein C-terminus binding,identical protein binding,scaffold protein binding,keratin filament binding","cytoplasm,peroxisome,cytosol,cytoskeleton,intermediate filament,focal adhesion,extracellular matrix,cell leading edge,neuron projection,intermediate filament cytoskeleton,extracellular exosome,plasma membrane",666,93,188,ILLAELEQLKGQGK.3|ILLAELEQLKGQGK.2|FLEQQNKILLAELEQLKGQGK.4|FLEQQNKILLAELEQLKGQGK.3|KVESLQEEIAFLK.3|KVESLQEEIAFLK.2|RQVQSLTC[CAM]EVDALKGTNESLER.4|RQVQSLTC[CAM]EVDALKGTNESLER.3|SRLGDLYEEEMRELR.3|SRLGDLYEEEMRELR.4|QVQSLTC[CAM]EVDALKGTNESLER.3|QVQSLTC[CAM]EVDALKGTNESLER.2|QVQSLTC[CAM]EVDALKGTNESLER.4|KVESLQEEIAFLKK.3|KVESLQEEIAFLKK.4|KVESLQEEIAFLKK.2|HLREYQDLLNVK.2|HLREYQDLLNVK.3|VELQELNDRFANYIDKVR.4|VELQELNDRFANYIDKVR.3|DGQVINETSQHHDDLE.3|DGQVINETSQHHDDLE.2|LLEGEESRISLPLPNFSSLNLR.3|ETNLDSLPLVDTHSKR.4|ETNLDSLPLVDTHSKR.3|ETNLDSLPLVDTHSKR.2|EYQDLLNVK.2|TVETRDGQVINETSQHHDDLE.4|TVETRDGQVINETSQHHDDLE.3|EMEENFAVEAANYQDTIGRLQDEIQNMKEEMAR.4|QMREMEENFAVEAANYQDTIGR.3|LGDLYEEEMRELRR.4|LGDLYEEEMRELRR.3|LGDLYEEEM[Oxi]RELRR.3|NLQEAEEWYK.2|NLQEAEEWYK.3|ILLAELEQLK.2|VEVERDNLAEDIMR.3|VEVERDNLAEDIMR.2|VEVERDNLAEDIM[Oxi]R.3|VEVERDNLAEDIM[Oxi]R.2|LQEEMLQREEAENTLQSFRQDVDNASLAR.4|LQEEMLQREEAENTLQSFRQDVDNASLAR.5|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.4|LQEEMLQREEAENTLQSFRQDVDNASLAR.3|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.3|TNEKVELQELNDR.3|TNEKVELQELNDR.2|ISLPLPNFSSLNLR.2|ISLPLPNFSSLNLR.3|LGDLYEEEMRELR.3|LGDLYEEEMRELR.2|LGDLYEEEM[Oxi]RELR.3|FADLSEAANRNNDALR.3|FADLSEAANRNNDALR.2|FADLSEAANRNNDALR.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.6|LLQDSVDFSLADAINTEFKNTR.3|LLQDSVDFSLADAINTEFKNTR.4|SKFADLSEAANRNNDALR.4|SKFADLSEAANRNNDALR.3|FADLSEAANR.2|MALDIEIATYR.2|M[Oxi]ALDIEIATYR.2|VESLQEEIAFLKK.3|VESLQEEIAFLKK.2|LGDLYEEEMR.2|LGDLYEEEM[Oxi]R.2|TNEKVELQELNDRFANYIDK.4|TNEKVELQELNDRFANYIDK.3|VESLQEEIAFLK.2|VESLQEEIAFLK.3|NLQEAEEWYKSK.3|NLQEAEEWYKSK.2|ETNLDSLPLVDTHSK.3|ETNLDSLPLVDTHSK.2|MALDIEIATYRK.3|MALDIEIATYRK.2|M[Oxi]ALDIEIATYRK.3|M[Oxi]ALDIEIATYRK.2|EKLQEEMLQREEAENTLQSFR.4|EKLQEEMLQREEAENTLQSFR.3|EKLQEEM[Oxi]LQREEAENTLQSFR.4|EEAENTLQSFRQDVDNASLAR.3|EEAENTLQSFRQDVDNASLAR.4|EEAENTLQSFRQDVDNASLAR.2|FADLSEAANRNNDALRQAK.3|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.7|LQDEIQNMKEEMAR.3|LQDEIQNMKEEMAR.2|LQDEIQNM[Oxi]KEEMAR.3|LQDEIQNMKEEM[Oxi]AR.3|LQDEIQNM[Oxi]KEEM[Oxi]AR.3|LQDEIQNM[Oxi]KEEMAR.2|LQDEIQNMKEEM[Oxi]AR.2|SRLGDLYEEEMR.3|SRLGDLYEEEMR.2|SRLGDLYEEEM[Oxi]R.3|SRLGDLYEEEM[Oxi]R.2|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|KLLEGEESRISLPLPNFSSLNLR.4|KLLEGEESRISLPLPNFSSLNLR.3|SVSSSSYR.2|ARVEVERDNLAEDIMR.4|ARVEVERDNLAEDIMR.3|ARVEVERDNLAEDIM[Oxi]R.4|ARVEVERDNLAEDIM[Oxi]R.3|ARVEVERDNLAEDIMR.2|LQEEMLQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.4|LQEEM[Oxi]LQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.2|DNLAEDIMR.2|DNLAEDIM[Oxi]R.2|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|FANYIDKVR.2|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|SLYASSPGGVYATR.2|SLYASSPGGVYATR.3|QVQSLTC[CAM]EVDALK.2|QVQSLTC[CAM]EVDALK.3|DVRQQYESVAAK.3|DVRQQYESVAAK.2|EMEENFAVEAANYQDTIGR.3|EMEENFAVEAANYQDTIGR.2|EMEENFAVEAANYQDTIGR.4|EM[Oxi]EENFAVEAANYQDTIGR.3|EM[Oxi]EENFAVEAANYQDTIGR.2|LLQDSVDFSLADAINTEFK.3|LLQDSVDFSLADAINTEFK.2|VELQELNDRFANYIDK.3|VELQELNDRFANYIDK.2|RQVDQLTNDK.3|RQVDQLTNDK.2|RMFGGPGTASRPSSSR.4|RMFGGPGTASRPSSSR.3|PDLTAALR.2|ARVEVER.2|FANYIDK.2|QVDQLTNDKAR.3|QVDQLTNDKAR.2|EEAENTLQSFR.3|EEAENTLQSFR.2|SKFADLSEAANR.3|SKFADLSEAANR.2|GTNESLER.2|SYVTTSTR.2|QAKQESTEYRR.3|LLEGEESR.2|RQVDQLTNDKAR.3|TYSLGSALR.2|MFGGPGTASR.2|M[Oxi]FGGPGTASR.2|MFGGPGTASRPSSSR.3|M[Oxi]FGGPGTASRPSSSR.3|TYSLGSALRPSTSR.3|QQYESVAAK.2|LQEEMLQR.2|LQEEM[Oxi]LQR.2|KLLEGEESR.2|QVDQLTNDK.2|QESTEYRR.2|QDVDNASLAR.2|RQVQSLTC[CAM]EVDALK.3|RQVQSLTC[CAM]EVDALK.2|LQDEIQNMK.2|LQDEIQNM[Oxi]K.2|VELQELNDR.2|RMFGGPGTASR.2|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.3|EKLQEEMLQR.2|NTRTNEKVELQELNDR.3|FLEQQNKILLAELEQLK.3|SSVPGVRLLQDSVDFSLADAINTEFKNTR.4|LLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|TYSLGSALRPSTSRSLYASSPGGVYATR.3|EMEENFAVEAANYQDTIGRLQDEIQNMK.3
SEN / CTL,P60709;P63261,"Actin, cytoplasmic 1;Actin, cytoplasmic 2",ACTB;ACTG1,2.86,2.00,8.04E-83,3.95E-82,8.14E+01,"retina homeostasis,movement of cell or subcellular component,cytoskeleton organization,substantia nigra development,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,ATP-dependent chromatin remodeling,positive regulation of gene expression, epigenetic,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation;retina homeostasis,movement of cell or subcellular component,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,sarcomere organization,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation","structural constituent of cytoskeleton,protein binding,ATP binding,kinesin binding,Tat protein binding,identical protein binding,nitric-oxide synthase binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,nucleosomal DNA binding;structural constituent of cytoskeleton,protein binding,ATP binding,ubiquitin protein ligase binding","nuclear chromatin,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,intracellular ribonucleoprotein complex,cortical cytoskeleton,NuA4 histone acetyltransferase complex,cytoplasmic ribonucleoprotein granule,myelin sheath,protein complex,extracellular exosome,MLL5-L complex,blood microparticle,dense body;extracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,myofibril,extracellular matrix,filamentous actin,myelin sheath,extracellular exosome,blood microparticle,dense body",312,19,74,VAPEEHPVLLTEAPLNPK.3|VAPEEHPVLLTEAPLNPK.2|VAPEEHPVLLTEAPLNPK.4|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.4|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.3|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.5|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.3|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.5|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.6|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.6|GYSFTTTAEREIVR.3|GYSFTTTAEREIVR.2|GYSFTTTAER.2|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.4|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.3|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.4|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.3|KDLYANTVLSGGTTMYPGIADR.3|KDLYANTVLSGGTTMYPGIADR.2|KDLYANTVLSGGTTMYPGIADR.4|KDLYANTVLSGGTTM[Oxi]YPGIADR.3|KDLYANTVLSGGTTM[Oxi]YPGIADR.2|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.6|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.6|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|VAPEEHPVLLTEAPLNPKANREK.5|VAPEEHPVLLTEAPLNPKANREK.4|VAPEEHPVLLTEAPLNPKANREK.3|YPIEHGIVTNWDDMEKIWHHTFYNELR.5|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.5|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.4|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.6|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.4|YSVWIGGSILASLSTFQQM[Oxi]WISKQEYDESGPSIVHR.4|VAPEEHPVLLTEAPLNPKANR.4|VAPEEHPVLLTEAPLNPKANR.5|GYSFTTTAEREIVRDIK.3|DLYANTVLSGGTTMYPGIADR.2|DLYANTVLSGGTTMYPGIADR.3|DLYANTVLSGGTTM[Oxi]YPGIADR.3|DLYANTVLSGGTTM[Oxi]YPGIADR.4|DLYANTVLSGGTTMYPGIADR.4|DLYANTVLSGGTTM[Oxi]YPGIADR.2|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.3|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|ILTERGYSFTTTAEREIVR.4|ILTERGYSFTTTAEREIVR.3|ILTERGYSFTTTAER.3|ILTERGYSFTTTAER.2|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.5|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.6|KYSVWIGGSILASLSTFQQM[Oxi]WISKQEYDESGPSIVHR.5|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.4|YPIEHGIVTNWDDMEK.2|YPIEHGIVTNWDDMEK.3|YPIEHGIVTNWDDM[Oxi]EK.3
SEN / CTL,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,2.85,1.80,5.51E-10,1.19E-10,9.92E+00,"keratinocyte development,epidermis development,keratinization,keratinocyte activation,keratinocyte proliferation,intermediate filament organization,keratinocyte migration","structural constituent of cytoskeleton,protein binding,cytoskeletal protein binding","extracellular space,nucleus,cytoplasm,Golgi apparatus,intermediate filament,membrane,keratin filament,intermediate filament cytoskeleton,extracellular exosome",36,52,97,YEELQVTVGR.2|VDLLNQEIEFLK.2|VDLLNQEIEFLK.3|GFSSGSAVVSGGSR.2|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.4|WELLQQMNVGTRPINLEPIFQGYIDSLKR.4|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.3|WELLQQMNVGTRPINLEPIFQGYIDSLKR.3|NKLNDLEEALQQAKEDLAR.3|NKLNDLEEALQQAKEDLAR.4|NKLNDLEEALQQAKEDLAR.2|SLVGLGGTK.2|RSTSSFSC[CAM]LSR.3|RSTSSFSC[CAM]LSR.2|HGGGGGGFGGGGFGSR.3|HGGGGGGFGGGGFGSR.2|NVQDAIADAEQR.3|NVQDAIADAEQR.2|TAAENDFVTLKK.3|TAAENDFVTLKK.2|LNDLEEALQQAK.3|LNDLEEALQQAK.2|SKEEAEALYHSK.3|SKEEAEALYHSK.2|GGSISGGGYGSGGGKHSSGGGSR.4|GGSISGGGYGSGGGKHSSGGGSR.3|IEISELNR.2|HGDSLKEIKIEISELNR.4|HGDSLKEIKIEISELNR.3|HGDSLKEIKIEISELNR.2|NVQDAIADAEQRGEHALK.4|NVQDAIADAEQRGEHALK.3|GEHALKDAR.2|LQGEIAHVK.2|HGDSLKEIK.2|VDPEIQNVK.2|YLDGLTAER.2|GGSSSGGGYGSGGGGSSSVK.3|GGSSSGGGYGSGGGGSSSVK.2|DVDNAYMIK.2|DVDNAYM[Oxi]IK.2|NKLNDLEEALQQAK.3|NKLNDLEEALQQAK.2|LQGEIAHVKK.2|STSSFSC[CAM]LSR.2|TSQNSELNNMQDLVEDYKK.4|TSQNSELNNMQDLVEDYKK.3|TSQNSELNNM[Oxi]QDLVEDYKK.3|TSQNSELNNM[Oxi]QDLVEDYKK.2|TSQNSELNNMQDLVEDYKK.2|GGSGGGGSISGGGYGSGGGSGGR.3|GGSGGGGSISGGGYGSGGGSGGR.2|GSSSGGGYSSGSSSYGSGGR.3|GSSSGGGYSSGSSSYGSGGR.2|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.4|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.3|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.2|NVQDAIADAEQRGEHALKDAR.4|NVQDAIADAEQRGEHALKDAR.3|EEAEALYHSK.2|GGSISGGGYGSGGGK.2|KDVDNAYMIK.2|KDVDNAYM[Oxi]IK.2|RYLDGLTAER.2|TSQNSELNNMQDLVEDYKKK.4|TSQNSELNNMQDLVEDYKKK.3|TAAENDFVTLK.2|PINLEPIFQGYIDSLK.3|SISISVAGGGGGFGAAGGFGGR.3|SISISVAGGGGGFGAAGGFGGR.2|YGSGGGSKGGSISGGGYGSGGGK.3|SKEEAEALYHSKYEELQVTVGR.4|SKEEAEALYHSKYEELQVTVGR.3|LNDLEEALQQAKEDLAR.3|LNDLEEALQQAKEDLAR.2|PINLEPIFQGYIDSLKR.3|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.6|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.5|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.4|TSQNSELNNM[Oxi]QDLVEDYK.3|TSQNSELNNMQDLVEDYK.3|TSQNSELNNM[Oxi]QDLVEDYK.2|TSQNSELNNMQDLVEDYK.2|QSGSRGGSGGGGSISGGGYGSGGGSGGR.3|QSGSRGGSGGGGSISGGGYGSGGGSGGR.2|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.4|VLYDAEISQIHQSVTDTNVILSMDNSR.4|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.3|VLYDAEISQIHQSVTDTNVILSMDNSR.3|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.3|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.2|M[Oxi]SGDLSSNVTVSVTSSTISSNVASK.3|MSGDLSSNVTVSVTSSTISSNVASK.3|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLK.4|AAFGGSGGRGSSSGGGYSSGSSSYGSGGR.3|FLEQQNQVLQTKWELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.5|FLEQQNQVLQTKWELLQQMNVGTRPINLEPIFQGYIDSLKR.5
SEN / CTL,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,2.85,1.07,6.50E-14,2.09E-14,1.37E+01,"response to reactive oxygen species,mesoderm formation,selenium compound metabolic process,signal transduction,cell proliferation,nucleobase-containing small molecule interconversion,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","thioredoxin-disulfide reductase activity,electron carrier activity,protein disulfide oxidoreductase activity,flavin adenine dinucleotide binding,methylselenol reductase activity,methylseleninic acid reductase activity","nucleus,mitochondrion,cytosol,extracellular exosome",30,37,60,QFVPIKVEQIEAGTPGR.3|VVGFHVLGPNAGEVTQGFAAALK.3|VVGFHVLGPNAGEVTQGFAAALK.4|VVGFHVLGPNAGEVTQGFAAALK.2|VMVLDFVTPTPLGTR.2|VMVLDFVTPTPLGTR.3|VM[Oxi]VLDFVTPTPLGTR.2|TGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4|WGLGGTC[CAM]VNVGC[CAM]IPK.2|IIC[CAM]NTKDNER.3|LYAGSTVK.2|IGEHMEEHGIK.3|IGEHMEEHGIK.2|IGGHGPTLK.2|IGLETVGVK.2|KLMHQAALLGQALQDSR.4|KLMHQAALLGQALQDSR.3|KLM[Oxi]HQAALLGQALQDSR.3|KLMHQAALLGQALQDSR.2|KVVYENAYGQFIGPHR.4|KVVYENAYGQFIGPHR.3|VEETVKHDWDR.3|MNGPEDLPK.2|GFDQDMANK.2|GFDQDM[Oxi]ANK.2|KIGLETVGVK.2|GFDQDMANKIGEHMEEHGIK.4|FLIATGERPR.2|VEQIEAGTPGR.2|LMHQAALLGQALQDSR.3|LM[Oxi]HQAALLGQALQDSR.3|LMHQAALLGQALQDSR.2|LM[Oxi]HQAALLGQALQDSR.2|VVYENAYGQFIGPHR.3|VVYENAYGQFIGPHR.2|KVMVLDFVTPTPLGTR.3|KVMVLDFVTPTPLGTR.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.3|VELTPVAIQAGR.2|SYDYDLIIIGGGSGGLAAAK.3|SYDYDLIIIGGGSGGLAAAK.2|KQLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|M[Oxi]IEAVQNHIGSLNWGYR.3|MIEAVQNHIGSLNWGYR.3|M[Oxi]IEAVQNHIGSLNWGYR.2|MIEAVQNHIGSLNWGYR.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTKR.4|NYGWKVEETVK.2|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.3|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.2|FGEENIEVYHSYFWPLEWTIPSR.4|FGEENIEVYHSYFWPLEWTIPSR.3|ALEGTLSELAAETDLPVVFVK.3|ALEGTLSELAAETDLPVVFVK.2|IPVTDEEQTNVPYIYAIGDILEDK.3|VVAQSTNSEEIIEGEYNTVMLAIGR.3|C[CAM]DYENVPTTVFTPLEYGAC[CAM]GLSEEK.3|IPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4|YLGIPGDKEYC[CAM]ISSDDLFSLPYC[CAM]PGK.3
SEN / CTL,P00558,Phosphoglycerate kinase 1,PGK1,2.84,2.00,1.29E-80,5.35E-80,7.93E+01,"gluconeogenesis,phosphorylation,epithelial cell differentiation,canonical glycolysis","phosphoglycerate kinase activity,ATP binding","cytosol,membrane,membrane raft,extracellular exosome",258,59,126,VLPGVDALSNI.2|AC[CAM]ANPAAGSVILLENLR.2|AC[CAM]ANPAAGSVILLENLR.3|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.2|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.3|WNTEDKVSHVSTGGGASLELLEGK.4|WNTEDKVSHVSTGGGASLELLEGK.3|LGDVYVNDAFGTAHR.3|LGDVYVNDAFGTAHR.2|LGDVYVNDAFGTAHR.4|SLLGKDVLFLKDC[CAM]VGPEVEK.4|SLLGKDVLFLKDC[CAM]VGPEVEK.3|SLLGKDVLFLKDC[CAM]VGPEVEK.2|ELNYFAK.2|QIVWNGPVGVFEWEAFAR.3|QIVWNGPVGVFEWEAFAR.2|ALESPERPFLAILGGAK.3|ALESPERPFLAILGGAK.2|ALESPERPFLAILGGAK.4|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.6|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.3|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.4|WNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI.4|VLNNMEIGTSLFDEEGAKIVKDLMSK.4|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSKK.3|AKQIVWNGPVGVFEWEAFAR.3|AKQIVWNGPVGVFEWEAFAR.4|AKQIVWNGPVGVFEWEAFAR.2|VDFNVPMKNNQITNNQR.3|VDFNVPMKNNQITNNQR.2|VDFNVPM[Oxi]KNNQITNNQR.3|VDFNVPM[Oxi]KNNQITNNQR.2|ITLPVDFVTADKFDENAK.3|ITLPVDFVTADKFDENAK.4|ITLPVDFVTADKFDENAK.2|ALMDEVVKATSR.3|ALM[Oxi]DEVVKATSR.3|ALM[Oxi]DEVVKATSR.2|VLNNMEIGTSLFDEEGAK.2|VLNNMEIGTSLFDEEGAK.3|VLNNM[Oxi]EIGTSLFDEEGAK.3|VLNNM[Oxi]EIGTSLFDEEGAK.2|TGQATVASGIPAGWMGLDC[CAM]GPESSK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSK.3|DVLFLKDC[CAM]VGPEVEK.3|DVLFLKDC[CAM]VGPEVEK.2|IKAAVPSIKFC[CAM]LDNGAK.4|IKAAVPSIKFC[CAM]LDNGAK.3|VADKIQLINNMLDKVNEMIIGGGM[Oxi]AFTFLK.4|VADKIQLINNMLDKVNEM[Oxi]IIGGGMAFTFLK.4|VADKIQLINNMLDKVNEM[Oxi]IIGGGM[Oxi]AFTFLK.4|ASLSKLGDVYVNDAFGTAHR.4|SLLGKDVLFLK.2|SLLGKDVLFLK.3|NGVKITLPVDFVTADKFDENAK.4|AHSSMVGVNLPQK.3|AHSSM[Oxi]VGVNLPQK.3|AHSSMVGVNLPQK.2|AHSSM[Oxi]VGVNLPQK.2|AAVPSIKFC[CAM]LDNGAK.3|AAVPSIKFC[CAM]LDNGAK.2|ALMDEVVK.2|ALM[Oxi]DEVVK.2|YAEAVTR.2|AGGFLMKK.2|AGGFLMKKELNYFAK.4|AGGFLM[Oxi]KKELNYFAK.3|AGGFLMKKELNYFAK.2|FHVEEEGKGKDASGNK.4|FHVEEEGKGKDASGNK.3|VSHVSTGGGASLELLEGK.4|VSHVSTGGGASLELLEGK.3|VSHVSTGGGASLELLEGK.2|VKAEPAKIEAFR.3|VKAEPAKIEAFR.2|FC[CAM]LDNGAK.2|IKAAVPSIK.2|KYAEAVTR.2|VDFNVPMK.2|VDFNVPM[Oxi]K.2|VDFNVPMK.1|PDGVPMPDK.2|FHVEEEGK.2|PFLAILGGAK.2|KELNYFAK.2|SVVLMSHLGRPDGVPMPDK.4|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.4|SVVLMSHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPM[Oxi]PDK.3|SVVLMSHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPMPDK.2|DC[CAM]VGPEVEK.2|LTLDKLDVK.2|VADKIQLINNMLDK.3|VADKIQLINNMLDK.2|AEPAKIEAFRASLSK.3|NNQITNNQR.2|AEPAKIEAFR.2|FHVEEEGKGK.2|VNEMIIGGGMAFTFLK.3|VNEM[Oxi]IIGGGMAFTFLK.3|VNEMIIGGGM[Oxi]AFTFLK.3|VNEMIIGGGMAFTFLK.2|VNEM[Oxi]IIGGGM[Oxi]AFTFLK.2|VNEM[Oxi]IIGGGMAFTFLK.2|VNEMIIGGGM[Oxi]AFTFLK.2|AC[CAM]ANPAAGSVILLENLRFHVEEEGKGK.5|LGDVYVNDAFGTAHRAHSSM[Oxi]VGVNLPQK.5|IQLINNMLDK.2|IQLINNM[Oxi]LDK.2|YSLEPVAVELK.2|VVM[Oxi]RVDFNVPM[Oxi]KNNQITNNQR.4|AKQIVWNGPVGVFEWEAFARGTK.4|ITLPVDFVTADK.2|QIVWNGPVGVFEWEAFARGTK.3
SEN / CTL,P55072,Transitional endoplasmic reticulum ATPase,VCP,2.84,1.83,7.63E-60,2.06E-59,5.87E+01,"DNA repair,double-strand break repair,NADH metabolic process,ER to Golgi vesicle-mediated transport,autophagy,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,positive regulation of mitochondrial membrane potential,protein ubiquitination,protein N-linked glycosylation via asparagine,viral genome replication,translesion synthesis,ER-associated ubiquitin-dependent protein catabolic process,endoplasmic reticulum unfolded protein response,retrograde protein transport, ER to cytosol,positive regulation of protein complex assembly,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein hexamerization,ERAD pathway,regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,establishment of protein localization,positive regulation of protein catabolic process,ATP metabolic process,protein homooligomerization,aggresome assembly,error-free translesion synthesis,ER-associated misfolded protein catabolic process,flavin adenine dinucleotide catabolic process,autophagosome maturation,positive regulation of protein K63-linked deubiquitination,positive regulation of Lys63-specific deubiquitinase activity,regulation of aerobic respiration,positive regulation of oxidative phosphorylation,positive regulation of ubiquitin-specific protease activity,positive regulation of ATP biosynthetic process","protein binding,ATP binding,lipid binding,ATPase activity,protein phosphatase binding,protein domain specific binding,polyubiquitin binding,ubiquitin protein ligase binding,deubiquitinase activator activity,K48-linked polyubiquitin binding,MHC class I protein binding,identical protein binding,ADP binding,ubiquitin-like protein ligase binding,poly(A) RNA binding,BAT3 complex binding,ubiquitin-specific protease binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytosol,VCP-NPL4-UFD1 AAA ATPase complex,site of double-strand break,Derlin-1 retrotranslocation complex,myelin sheath,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,VCP-NSFL1C complex",216,94,187,QAAPC[CAM]VLFFDELDSIAK.3|QAAPC[CAM]VLFFDELDSIAK.2|SPVAKDVDLEFLAK.3|WALSQSNPSALRETVVEVPQVTWEDIGGLEDVKR.4|LGDVISIQPC[CAM]PDVK.2|LGDVISIQPC[CAM]PDVK.3|VRLGDVISIQPC[CAM]PDVK.3|VRLGDVISIQPC[CAM]PDVK.2|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.4|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.6|DVDLEFLAK.2|IVSQLLTLMDGLKQR.3|YEMFAQTLQQSR.2|GGNIGDGGGAADRVINQILTEMDGMSTKK.4|MDELQLFR.2|M[Oxi]DELQLFR.2|AFEEAEKNAPAIIFIDELDAIAPKR.4|AFEEAEKNAPAIIFIDELDAIAPKR.3|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.4|ELQELVQYPVEHPDKFLK.4|ELQELVQYPVEHPDKFLK.3|GGNIGDGGGAADRVINQILTEMDGMSTK.3|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.6|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.4|NRPNRLIVDEAINEDNSVVSLSQPK.4|ETVVEVPQVTWEDIGGLEDVKR.3|ETVVEVPQVTWEDIGGLEDVKR.4|EVDIGIPDATGRLEILQIHTK.4|EVDIGIPDATGRLEILQIHTK.3|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.7|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.5|IVSQLLTLMDGLK.2|IVSQLLTLMDGLK.3|IVSQLLTLM[Oxi]DGLK.2|MTNGFSGADLTEIC[CAM]QR.2|MTNGFSGADLTEIC[CAM]QR.3|M[Oxi]TNGFSGADLTEIC[CAM]QR.3|M[Oxi]TNGFSGADLTEIC[CAM]QR.2|AFEEAEKNAPAIIFIDELDAIAPK.3|GDIFLVR.2|MDELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.2|MDELQLFRGDTVLLK.2|NAPAIIFIDELDAIAPK.2|NAPAIIFIDELDAIAPK.3|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.4|KYEMFAQTLQQSR.3|KYEM[Oxi]FAQTLQQSR.3|KYEMFAQTLQQSR.2|KYEM[Oxi]FAQTLQQSR.2|NAPAIIFIDELDAIAPKR.3|NAPAIIFIDELDAIAPKR.2|AHVIVMAATNRPNSIDPALRR.4|AHVIVM[Oxi]AATNRPNSIDPALRR.5|AHVIVMAATNRPNSIDPALRR.5|AHVIVMAATNRPNSIDPALRR.3|EMVELPLRHPALFK.4|EM[Oxi]VELPLRHPALFK.4|EMVELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.2|EMVELPLRHPALFK.2|LAGESESNLRK.3|LAGESESNLRK.2|RDHFEEAM[Oxi]R.3|RDHFEEAMR.2|AFEEAEK.2|AIGVKPPR.2|GVLFYGPPGC[CAM]GK.3|GVLFYGPPGC[CAM]GK.2|WALSQSNPSALR.3|WALSQSNPSALR.2|ARGGNIGDGGGAADR.3|ARGGNIGDGGGAADR.2|ELQELVQYPVEHPDK.4|ELQELVQYPVEHPDK.3|ELQELVQYPVEHPDK.2|SVSDNDIR.2|KGDIFLVR.2|PYFLEAYRPIR.3|ESIESEIR.2|EMVELPLR.2|RELQELVQYPVEHPDK.4|RELQELVQYPVEHPDK.3|RELQELVQYPVEHPDK.2|FGRFDREVDIGIPDATGR.4|NVFIIGATNRPDIIDPAILRPGR.5|NVFIIGATNRPDIIDPAILRPGR.4|NVFIIGATNRPDIIDPAILRPGR.3|GDDLSTAILK.2|DHFEEAMR.2|DHFEEAM[Oxi]R.2|AIANEC[CAM]QANFISIK.3|AIANEC[CAM]QANFISIK.2|KNVFIIGATNRPDIIDPAILRPGR.5|KNVFIIGATNRPDIIDPAILRPGR.4|RIVSQLLTLMDGLK.3|RIVSQLLTLM[Oxi]DGLK.2|RIVSQLLTLMDGLK.2|RSVSDNDIR.2|AHVIVMAATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.3|AHVIVMAATNRPNSIDPALR.3|LAGESESNLR.2|FDREVDIGIPDATGRLEILQIHTK.5|FDREVDIGIPDATGRLEILQIHTK.4|FDREVDIGIPDATGRLEILQIHTK.3|LEILQIHTK.2|ESIESEIRR.2|FDREVDIGIPDATGR.3|FDREVDIGIPDATGR.2|GGNIGDGGGAADR.2|VINQILTEMDGMSTK.3|VINQILTEMDGM[Oxi]STK.3|VINQILTEM[Oxi]DGMSTK.2|VINQILTEMDGM[Oxi]STK.2|VINQILTEMDGMSTK.2|VINQILTEM[Oxi]DGM[Oxi]STK.2|QTNPSAMEVEEDDPVPEIRR.4|QTNPSAMEVEEDDPVPEIRR.3|GILLYGPPGTGK.2|LDQLIYIPLPDEKSR.3|VINQILTEMDGMSTKK.3|VINQILTEMDGM[Oxi]STKK.3|VINQILTEMDGMSTKK.2|EAVC[CAM]IVLSDDTC[CAM]SDEK.3|EAVC[CAM]IVLSDDTC[CAM]SDEK.2|EVDIGIPDATGR.2|REDEEESLNEVGYDDIGGC[CAM]RK.4|REDEEESLNEVGYDDIGGC[CAM]RK.3|GPELLTMWFGESEANVR.3|GPELLTM[Oxi]WFGESEANVR.3|GPELLTMWFGESEANVR.2|GPELLTM[Oxi]WFGESEANVR.2|IHVLPIDDTVEGITGNLFEVYLK.4|IHVLPIDDTVEGITGNLFEVYLK.3|ERQTNPSAMEVEEDDPVPEIRR.4|ERQTNPSAMEVEEDDPVPEIRR.3|REAVC[CAM]IVLSDDTC[CAM]SDEK.3|KAFEEAEKNAPAIIFIDELDAIAPK.4|KAFEEAEKNAPAIIFIDELDAIAPK.3|RIHVLPIDDTVEGITGNLFEVYLK.4|RIHVLPIDDTVEGITGNLFEVYLK.3|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.5|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|EAVC[CAM]IVLSDDTC[CAM]SDEKIR.3|ARQAAPC[CAM]VLFFDELDSIAK.3|LIVDEAINEDNSVVSLSQPK.3|LIVDEAINEDNSVVSLSQPK.2|QTNPSAM[Oxi]EVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.2|EDEEESLNEVGYDDIGGC[CAM]R.3|EDEEESLNEVGYDDIGGC[CAM]R.2|ARGGNIGDGGGAADRVINQILTEMDGM[Oxi]STK.4|ARGGNIGDGGGAADRVINQILTEMDGMSTK.4|AVANETGAFFFLINGPEIMSK.3|AVANETGAFFFLINGPEIM[Oxi]SK.3|AVANETGAFFFLINGPEIM[Oxi]SK.2|AVANETGAFFFLINGPEIMSK.2|EDEEESLNEVGYDDIGGC[CAM]RK.3|EDEEESLNEVGYDDIGGC[CAM]RK.2|LDQLIYIPLPDEK.2|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIKR.4|ETVVEVPQVTWEDIGGLEDVK.3|ETVVEVPQVTWEDIGGLEDVK.2|REDEEESLNEVGYDDIGGC[CAM]R.3|REDEEESLNEVGYDDIGGC[CAM]R.2|ERQTNPSAMEVEEDDPVPEIR.3|ERQTNPSAM[Oxi]EVEEDDPVPEIR.3|GPELLTM[Oxi]WFGESEANVREIFDK.3|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIK.3|FPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG.3|AIANEC[CAM]QANFISIKGPELLTM[Oxi]WFGESEANVR.3
SEN / CTL,Q9UBG0,C-type mannose receptor 2,MRC2,2.84,1.05,7.21E-09,1.38E-09,8.86E+00,"osteoblast differentiation,endocytosis,signal transduction,collagen catabolic process","transmembrane signaling receptor activity,protein binding,collagen binding,carbohydrate binding","integral component of plasma membrane,focal adhesion,membrane",18,30,39,TLGDQLSLLLGAR.2|TPLWIGLAGEEGSRR.3|WSDGVGFSYHNFDR.3|WSDGVGFSYHNFDR.2|FFEHHSTWAQAQR.4|FFEHHSTWAQAQR.3|FFEHHSTWAQAQR.2|AGQLSQGAAEEDHGC[CAM]RK.4|C[CAM]VYMTASR.2|GTDVREPDDSPQGR.3|GTDVREPDDSPQGR.2|SC[CAM]TEETHGFIC[CAM]QK.3|SC[CAM]TEETHGFIC[CAM]QK.2|TESSGGWQNR.2|AGQLSQGAAEEDHGC[CAM]R.3|LC[CAM]TDHGSQLVTITNR.3|YDNQWFHGC[CAM]TSTGR.3|YDNQWFHGC[CAM]TSTGR.2|KAGQLSQGAAEEDHGC[CAM]R.3|RISYHGSC[CAM]PQGLADSAWIPFR.4|C[CAM]LTALPYIC[CAM]K.2|GAWLGMNFNPK.2|KAGQLSQGAAEEDHGC[CAM]RK.3|IFGESEPEIHEQHWFWIGLNR.4|IFGESEPEIHEQHWFWIGLNR.3|DC[CAM]SIALPYVC[CAM]K.2|VEC[CAM]EPSWQPFQGHC[CAM]YR.3|C[CAM]FQVQGQEPQSR.2|TPLWIGLAGEEGSR.2|ISYHGSC[CAM]PQGLADSAWIPFR.3|ISYHGSC[CAM]PQGLADSAWIPFR.2|IYGSEEDLC[CAM]ALPYHEVYTIQGNSHGKPC[CAM]TIPFK.5|LQGAVC[CAM]GVSSGPPPPR.2|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.4|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.3|YLNWESDQPDNPSEENC[CAM]GVIR.3|DSLEDC[CAM]VTIWGPEGR.2|ETQPPDLPTTALGGC[CAM]PSDWIQFLNK.3|GWTWHSPSC[CAM]YWLGEDQVTYSEAR.3
SEN / CTL,Q06323,Proteasome activator complex subunit 1,PSME1,2.83,1.88,3.50E-04,3.65E-05,4.44E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycle",endopeptidase activator activity,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,extracellular exosome",12,26,39,LKPEIKDVIEQLNLVTTWLQLQIPR.4|LKPEIKDVIEQLNLVTTWLQLQIPR.3|NAYAVLYDIILK.2|NAYAVLYDIILK.3|IVVLLQR.2|VFELMTSLHTK.3|VFELM[Oxi]TSLHTK.3|VFELMTSLHTK.2|VFELM[Oxi]TSLHTK.2|LMVMEIR.2|LM[Oxi]VMEIR.2|LMVM[Oxi]EIR.2|VDVFREDLC[CAM]TK.3|VDVFREDLC[CAM]TK.2|EPALNEANLSNLK.3|EPALNEANLSNLK.2|QLVHELDEAEYRDIR.4|QPHVGDYR.2|QLVHELDEAEYR.3|QLVHELDEAEYR.2|APLDIPVPDPVKEK.3|ISELDAFLK.2|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.4|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|LEGFHTQISK.2|KISELDAFLK.2|APLDIPVPDPVK.2|KISELDAFLKEPALNEANLSNLK.4|KISELDAFLKEPALNEANLSNLK.3|NAYAVLYDIILKNFEK.3|TENLLGSYFPK.2|YFSERGDAVTK.2|IEDGNNFGVAVQEKVFELMTSLHTKLEGFHTQISK.6|VDVFREDLC[CAM]TKTENLLGSYFPK.4|VDVFREDLC[CAM]TKTENLLGSYFPK.3|GEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|GPPC[CAM]GPVNC[CAM]NEK.2|IEDGNNFGVAVQEK.2|ISELDAFLKEPALNEANLSNLK.3
SEN / CTL,P10147;P16619,C-C motif chemokine 3;C-C motif chemokine 3-like 1,CCL3;CCL3L1,2.83,2.61,1.54E-02,1.30E-03,2.89E+00,"MAPK cascade,osteoblast differentiation,cell activation,monocyte chemotaxis,calcium ion transport,cellular calcium ion homeostasis,exocytosis,chemotaxis,inflammatory response,cytoskeleton organization,G-protein coupled receptor signaling pathway,cell-cell signaling,behavior,regulation of cell shape,response to toxic substance,positive regulation of gene expression,negative regulation of gene expression,T cell chemotaxis,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,calcium-mediated signaling,signaling,positive regulation of cell migration,negative regulation of bone mineralization,neutrophil chemotaxis,lipopolysaccharide-mediated signaling pathway,positive regulation of tumor necrosis factor production,eosinophil degranulation,protein kinase B signaling,positive regulation of neuron apoptotic process,positive regulation of GTPase activity,astrocyte cell migration,negative regulation by host of viral transcription,negative regulation of osteoclast differentiation,eosinophil chemotaxis,macrophage chemotaxis,lymphocyte chemotaxis,positive regulation of interleukin-1 beta secretion,positive regulation of inflammatory response,positive regulation of calcium-mediated signaling,positive chemotaxis,positive regulation of protein kinase B signaling,positive regulation of calcium ion transport,regulation of sensory perception of pain,chemokine-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,response to cholesterol,cellular response to interferon-gamma,cellular response to interleukin-1,cellular response to tumor necrosis factor,cellular response to organic cyclic compound,granulocyte chemotaxis,positive regulation of calcium ion import,positive regulation of natural killer cell chemotaxis;monocyte chemotaxis,inflammatory response,G-protein coupled receptor signaling pathway,negative regulation of cell proliferation,neutrophil chemotaxis,positive regulation of GTPase activity,lymphocyte chemotaxis,positive regulation of inflammatory response,chemokine-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,cellular response to interferon-gamma,cellular response to interleukin-1,cellular response to tumor necrosis factor","protein kinase activity,calcium-dependent protein kinase C activity,protein binding,chemokine activity,phospholipase activator activity,kinase activity,CCR1 chemokine receptor binding,CCR5 chemokine receptor binding,chemoattractant activity,identical protein binding;chemokine activity,CCR chemokine receptor binding","extracellular region,extracellular space,intracellular,cytoplasm,cytosol;extracellular region,extracellular space",6,1,1,QVC[CAM]ADPSEEWVQK.2
SEN / CTL,O00584,Ribonuclease T2,RNASET2,2.83,1.86,1.19E-04,1.33E-05,4.88E+00,"RNA catabolic process,RNA phosphodiester bond hydrolysis, endonucleolytic","RNA binding,ribonuclease activity,ribonuclease T2 activity","extracellular region,extracellular space,lysosome,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",12,17,29,ELDLNSVLLK.2|LGIKPSINYYQVADFKDALAR.4|VC[CAM]EDGPVFYPPPKK.4|VC[CAM]EDGPVFYPPPKK.3|HGTC[CAM]AAQVDALNSQKK.4|HGTC[CAM]AAQVDALNSQKK.3|HGTC[CAM]AAQVDALNSQKK.2|LGIKPSINYYQVADFK.4|LGIKPSINYYQVADFK.3|LGIKPSINYYQVADFK.2|KLIMVQHWPETVC[CAM]EK.4|KLIMVQHWPETVC[CAM]EK.3|KLIMVQHWPETVC[CAM]EK.2|HGTC[CAM]AAQVDALNSQK.3|HGTC[CAM]AAQVDALNSQK.2|LIMVQHWPETVC[CAM]EK.3|LIM[Oxi]VQHWPETVC[CAM]EK.3|LIMVQHWPETVC[CAM]EK.2|DPPDYWTIHGLWPDK.3|DPPDYWTIHGLWPDK.2|SLELYRELDLNSVLLK.3|SWPFNLEEIK.2|IQNDC[CAM]RDPPDYWTIHGLWPDK.4|IQNDC[CAM]RDPPDYWTIHGLWPDK.3|SWPFNLEEIKDLLPEMR.3|PSINYYQVADFK.2|QEVWLANGAAESR.2|VC[CAM]EDGPVFYPPPK.2|IQC[CAM]LPPSQDEEVQTIGQIELC[CAM]LTK.3
SEN / CTL,P52788,Spermine synthase,SMS,2.83,1.05,4.07E-10,8.82E-11,1.01E+01,"methionine metabolic process,polyamine metabolic process,spermine biosynthetic process",spermine synthase activity,"cytosol,extracellular exosome",18,28,36,TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLKR.4|IYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEER.5|IYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEER.4|MVTMVEIDQMVIDGC[CAM]KK.3|HSTLDFMLGAK.3|HSTLDFMLGAK.2|HSTLDFM[Oxi]LGAK.2|ADGETILK.2|M[Oxi]KELSQDSTGR.3|AIMGSGKEDYTGK.3|AIMGSGKEDYTGK.2|LILDLSMK.2|GGAIDRYWPTADGR.3|EEIDSILNK.2|EEIDSILNKVEER.3|TC[CAM]GDVLDNLK.2|LYC[CAM]PVEFSK.2|DVLILGGGDGGILC[CAM]EIVK.3|DVLILGGGDGGILC[CAM]EIVK.2|GDC[CAM]YQVLIEDC[CAM]IPVLK.3|GDC[CAM]YQVLIEDC[CAM]IPVLK.2|TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.4|TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.3|IYPHGLVLLDLQSYDGDAQGK.3|AIMGSGKEDYTGKDVLILGGGDGGILC[CAM]EIVK.4|KTC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.4|EDYTGKDVLILGGGDGGILC[CAM]EIVK.3|IYPHGLVLLDLQSYDGDAQGKEEIDSILNK.4|QFGNILILSGDVNLAESDLAYTR.3|GLQSIFQEQGMAESVHTWQDHGYLATYTNK.4|GLQSIFQEQGMAESVHTWQDHGYLATYTNK.3|LVEYDIDEVVYDEDSPYQNIK.3|EGREFDYVINDLTAVPISTSPEEDSTWEFLR.4|YFTQGNC[CAM]VNLTEALSLYEEQLGR.3|MVTMVEIDQMVIDGC[CAM]K.2|EFDYVINDLTAVPISTSPEEDSTWEFLR.3
SEN / CTL,Q96FW1,Ubiquitin thioesterase OTUB1,OTUB1,2.83,1.03,7.12E-07,1.08E-07,6.97E+00,"adaptive immune response,DNA repair,cellular response to DNA damage stimulus,protein K48-linked deubiquitination,cellular response to interleukin-1,negative regulation of histone H2A K63-linked ubiquitination,negative regulation of double-strand break repair","thiol-dependent ubiquitin-specific protease activity,protein binding,NEDD8-specific protease activity,ubiquitin protein ligase binding,ubiquitin binding","nucleus,cytoplasm,extracellular exosome",12,13,23,AFGFSHLEALLDDSKELQR.4|AFGFSHLEALLDDSKELQR.3|FFEHFIEGGR.3|FFEHFIEGGR.2|TRPDGNC[CAM]FYR.3|TRPDGNC[CAM]FYR.2|LELSVLYK.2|VYLLYRPGHYDILYK.4|VYLLYRPGHYDILYK.3|VYLLYRPGHYDILYK.2|EYAEDDNIYQQK.3|EYAEDDNIYQQK.2|LLTSGYLQR.2|AFGFSHLEALLDDSK.3|AFGFSHLEALLDDSK.2|IQQEIAVQNPLVSER.3|IQQEIAVQNPLVSER.2|GEGGTTNPHIFPEGSEPK.3|GEGGTTNPHIFPEGSEPK.2|TVKEFC[CAM]QQEVEPMC[CAM]K.3|EFC[CAM]QQEVEPM[Oxi]C[CAM]K.2|EFC[CAM]QQEVEPMC[CAM]K.2|QEPLGSDSEGVNC[CAM]LAYDEAIMAQQDR.3
SEN / CTL,Q6EMK4,Vasorin,VASN,2.82,1.54,3.55E-12,9.68E-13,1.20E+01,"negative regulation of epithelial to mesenchymal transition,negative regulation of transforming growth factor beta receptor signaling pathway,cellular response to hypoxia,cellular response to redox state,cell-cell adhesion","transforming growth factor beta binding,cadherin binding involved in cell-cell adhesion","extracellular space,mitochondrion,lysosomal membrane,plasma membrane,cell-cell adherens junction,cell surface,integral component of membrane,extracellular exosome",30,8,8,SLTLGIEPVSPTSLR.2|NPFNC[CAM]VC[CAM]PLSWFGPWVR.3|LLLLDLSHNSLLALEPGILDTANVEALR.3|LAGLGLQQLDEGLFSR.2|NLHDLDVSDNQLER.3|ESHVTLASPEETR.3|YLQGSSVQLR.2|HIQPGAFDTLDR.2
SEN / CTL,P22392,Nucleoside diphosphate kinase B,NME2,2.82,1.99,3.28E-09,6.47E-10,9.19E+00,"negative regulation of myeloid leukocyte differentiation,purine nucleotide metabolic process,nucleoside diphosphate phosphorylation,GTP biosynthetic process,pyrimidine nucleotide metabolic process,UTP biosynthetic process,CTP biosynthetic process,transcription, DNA-templated,regulation of transcription, DNA-templated,cell adhesion,integrin-mediated signaling pathway,nucleoside triphosphate biosynthetic process,positive regulation of neuron projection development,nucleobase-containing small molecule interconversion,peptidyl-histidine phosphorylation,positive regulation of cAMP biosynthetic process,cellular response to oxidative stress,negative regulation of apoptotic process,positive regulation of keratinocyte differentiation,regulation of epidermis development,positive regulation of transcription from RNA polymerase II promoter,protein autophosphorylation,positive regulation of epithelial cell proliferation,protein oligomerization,response to growth hormone,cellular response to glucose stimulus,cellular response to fatty acid","DNA binding,transcription factor activity, sequence-specific DNA binding,nucleoside diphosphate kinase activity,protein histidine kinase activity,protein serine/threonine kinase activity,fatty acid binding,protein binding,ATP binding,drug binding,intermediate filament binding,enzyme binding,metal ion binding","ruffle,nucleus,cytoplasm,cytosol,intermediate filament,lamellipodium,mitochondrial membrane,myelin sheath,perinuclear region of cytoplasm,extracellular exosome,cell periphery,focal adhesion",36,19,36,GDFC[CAM]IQVGR.2|TFIAIKPDGVQR.3|TFIAIKPDGVQR.2|SAEKEISLWFKPEELVDYK.4|SAEKEISLWFKPEELVDYK.3|SAEKEISLWFKPEELVDYK.2|VMLGETNPADSKPGTIR.3|VMLGETNPADSKPGTIR.4|VM[Oxi]LGETNPADSKPGTIR.3|VMLGETNPADSKPGTIR.2|VM[Oxi]LGETNPADSKPGTIR.2|YMNSGPVVAMVWEGLNVVK.3|YM[Oxi]NSGPVVAMVWEGLNVVK.3|YMNSGPVVAM[Oxi]VWEGLNVVK.3|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.3|YMNSGPVVAMVWEGLNVVK.2|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.2|YM[Oxi]NSGPVVAMVWEGLNVVK.2|YMNSGPVVAM[Oxi]VWEGLNVVK.2|ASEEHLK.2|GLVGEIIK.2|GLVGEIIK.1|QHYIDLK.2|GLVGEIIKR.2|QHYIDLKDRPFFPGLVK.4|NIIHGSDSVK.2|ASEEHLKQHYIDLK.3|ASEEHLKQHYIDLKDRPFFPGLVK.5|SC[CAM]AHDWVYE.2|DRPFFPGLVK.2|TGRVM[Oxi]LGETNPADSKPGTIRGDFC[CAM]IQVGR.5|VMLGETNPADSK.2|VM[Oxi]LGETNPADSK.2|EISLWFKPEELVDYK.3|EISLWFKPEELVDYK.2|SAEKEISLWFKPEELVDYKSC[CAM]AHDWVYE.4
SEN / CTL,Q16181,Septin-7,7-Sep,2.82,1.90,1.84E-08,3.35E-09,8.47E+00,"cytokinesis,mitotic nuclear division,regulation of embryonic cell shape,protein heterooligomerization,cilium morphogenesis,cell-cell adhesion,positive regulation of nonmotile primary cilium assembly","structural molecule activity,protein binding,GTP binding,cadherin binding involved in cell-cell adhesion","condensed chromosome kinetochore,stress fiber,nucleus,nucleolus,cytoplasm,spindle,cytosol,plasma membrane,cell-cell adherens junction,axoneme,actin cytoskeleton,microtubule cytoskeleton,midbody,septin complex,cleavage furrow,extracellular exosome,apical plasma membrane",24,39,59,THMQDLKDVTNNVHYENYR.4|IYEFPETDDEEENKLVK.3|STLINSLFLTDLYSPEYPGPSHR.3|STLINSLFLTDLYSPEYPGPSHR.4|NLEGYVGFANLPNQVYR.2|NLEGYVGFANLPNQVYR.3|THMQDLK.2|SPLAQMEEERR.3|SPLAQM[Oxi]EEERR.3|SPLAQMEEERR.2|TVQVEQSK.2|DSEAELQR.2|NLEAQHKELEEK.3|NLEAQHKELEEK.2|LHEKVNIIPLIAK.3|LHEKVNIIPLIAK.2|VNIIPLIAK.2|ANWEAQQR.2|KLAAVTYNGVDNNK.3|KLAAVTYNGVDNNK.2|DVTNNVHYENYR.3|DVTNNVHYENYR.2|NLEGYVGFANLPNQVYRK.4|NLEGYVGFANLPNQVYRK.3|NLEGYVGFANLPNQVYRK.2|ILEQQNSSR.2|LAAVTYNGVDNNKNK.3|IYEFPETDDEEENKLVKK.4|ADTLTPEEC[CAM]QQFKK.3|ADTLTPEEC[CAM]QQFKK.2|KMEMEMEQVFEMK.3|LPLAVVGSNTIIEVNGK.3|LPLAVVGSNTIIEVNGK.2|IKIYEFPETDDEEENKLVK.4|IKIYEFPETDDEEENKLVK.3|IYEFPETDDEEENK.3|IYEFPETDDEEENK.2|LKDSEAELQR.2|QFEDEKANWEAQQR.3|SPLAQMEEER.2|FEDYLNAESR.2|VQC[CAM]C[CAM]LYFIAPSGHGLK.3|LPLAVVGSNTIIEVNGKR.3|QIMKEIQEHK.2|SVNSSTMVAQQK.2|DRLPLAVVGSNTIIEVNGK.3|DRLPLAVVGSNTIIEVNGK.2|GRQYPWGVAEVENGEHC[CAM]DFTILR.4|GRQYPWGVAEVENGEHC[CAM]DFTILR.3|LAAVTYNGVDNNK.2|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFM[Oxi]K.4|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFMK.4|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFM[Oxi]K.3|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFMK.3|ADTLTPEEC[CAM]QQFK.2|MEMEMEQVFEMK.2|GFEFTLM[Oxi]VVGESGLGK.2|GFEFTLMVVGESGLGK.2|QYPWGVAEVENGEHC[CAM]DFTILR.3
SEN / CTL,Q9BUF5,Tubulin beta-6 chain,TUBB6,2.82,1.98,1.02E-20,5.91E-21,2.02E+01,"cytoskeleton organization,microtubule-based process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytoplasm,microtubule,extracellular exosome",72,25,55,YLTVATVFR.2|AALVDLEPGTMDSVR.2|AALVDLEPGTMDSVR.3|AALVDLEPGTM[Oxi]DSVR.2|GHYTEGAELVDAVLDVVR.3|GHYTEGAELVDAVLDVVR.2|M[Oxi]ASTFIGNSTAIQELFKR.3|MASTFIGNSTAIQELFKR.3|MASTFIGNSTAIQELFKR.2|SGPFGQLFRPDNFIFGQTGAGNNWAK.3|SGPFGQLFRPDNFIFGQTGAGNNWAK.4|FWEVISDEHGIDPAGGYVGDSALQLER.3|FWEVISDEHGIDPAGGYVGDSALQLER.4|INVYYNESSSQK.2|INVYYNESSSQK.3|EVDEQMLAIQSK.2|EVDEQM[Oxi]LAIQSK.2|LTTPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.5|LTTPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.6|IMNTFSVMPSPK.3|IMNTFSVMPSPK.2|IM[Oxi]NTFSVMPSPK.2|IMNTFSVM[Oxi]PSPK.2|IM[Oxi]NTFSVM[Oxi]PSPK.2|RISEQFSAMFR.3|RISEQFSAMFR.2|SGPFGQLFR.2|VAVC[CAM]DIPPR.2|GHYTEGAELVDAVLDVVRK.4|GHYTEGAELVDAVLDVVRK.3|GHYTEGAELVDAVLDVVRK.2|M[Oxi]REIVHIQAGQC[CAM]GNQIGTK.4|MREIVHIQAGQC[CAM]GNQIGTK.4|MREIVHIQAGQC[CAM]GNQIGTK.3|YLTVATVFRGPMSMK.3|ALTVPELTQQMFDAR.3|ALTVPELTQQMFDAR.2|ALTVPELTQQM[Oxi]FDAR.2|IREEFPDRIMNTFSVMPSPK.4|ISEQFSAMFR.2|EIVHIQAGQC[CAM]GNQIGTK.3|EIVHIQAGQC[CAM]GNQIGTK.2|MASTFIGNSTAIQELFK.3|M[Oxi]ASTFIGNSTAIQELFK.3|M[Oxi]ASTFIGNSTAIQELFK.2|MASTFIGNSTAIQELFK.2|LTTPTYGDLNHLVSATMSGVTTSLR.4|LTTPTYGDLNHLVSATMSGVTTSLR.3|LTTPTYGDLNHLVSATM[Oxi]SGVTTSLR.3|GPMSMKEVDEQMLAIQSK.3|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|KEC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|KEC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3
SEN / CTL,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,2.82,1.15,1.15E-19,6.08E-20,1.92E+01,"angiogenesis,translation,tRNA aminoacylation for protein translation,tryptophanyl-tRNA aminoacylation,negative regulation of cell proliferation,regulation of angiogenesis","tryptophan-tRNA ligase activity,protein binding,ATP binding","nucleus,cytoplasm,cytosol,extracellular exosome",48,36,61,ALIEVLQPLIAEHQAR.3|ALIEVLQPLIAEHQAR.2|IGYPKPALLHSTFFPALQGAQTK.4|IGYPKPALLHSTFFPALQGAQTK.3|EVTDEIVKEFMTPR.3|PNSEPASLLELFNSIATQGELVR.3|PNSEPASLLELFNSIATQGELVR.4|DRTDIQC[CAM]LIPC[CAM]AIDQDPYFR.3|DRTDIQC[CAM]LIPC[CAM]AIDQDPYFR.4|MSASDPNSSIFLTDTAK.2|M[Oxi]SASDPNSSIFLTDTAK.2|TDIQC[CAM]LIPC[CAM]AIDQDPYFR.3|TDIQC[CAM]LIPC[CAM]AIDQDPYFR.2|ISFPAIQAAPSFSNSFPQIFR.3|ISFPAIQAAPSFSNSFPQIFR.4|ISFPAIQAAPSFSNSFPQIFR.2|HAFSGGRDTIEEHR.4|RKEVTDEIVK.3|AAAGEDYK.2|KDYTSGAMLTGELKK.4|KDYTSGAMLTGELKK.3|ATGQRPHHFLR.3|DEIDSAVK.2|KLSFDFQ.2|AGNASKDEIDSAVK.3|AGNASKDEIDSAVK.2|EVTDEIVK.2|KALIEVLQPLIAEHQAR.4|KALIEVLQPLIAEHQAR.3|PALLHSTFFPALQGAQTK.4|PALLHSTFFPALQGAQTK.3|PALLHSTFFPALQGAQTK.2|HVTFNQVK.2|IDKELINR.2|DYTSGAMLTGELKK.3|DYTSGAMLTGELKK.2|DMNQVLDAYENKK.3|GPSSEAM[Oxi]HVGHLIPFIFTK.4|GPSSEAMHVGHLIPFIFTK.4|GPSSEAM[Oxi]HVGHLIPFIFTK.3|GPSSEAMHVGHLIPFIFTK.3|GPSSEAMHVGHLIPFIFTK.2|SLKAGNASKDEIDSAVK.3|DLTLDQAYSYAVENAK.3|DLTLDQAYSYAVENAK.2|GIDYDKLIVR.2|DIIAC[CAM]GFDINK.2|DMNQVLDAYENKKPFYLYTGR.4|DMNQVLDAYENKKPFYLYTGR.3|DYTSGAMLTGELK.2|TFIFSDLDYMGMSSGFYK.3|TFIFSDLDYMGM[Oxi]SSGFYK.3|TFIFSDLDYMGMSSGFYK.2|GIFGFTDSDC[CAM]IGK.2|DMNQVLDAYENK.2|DM[Oxi]NQVLDAYENK.2|WLQDVFNVPLVIQMTDDEK.3|WLQDVFNVPLVIQM[Oxi]TDDEK.3|WLQDVFNVPLVIQMTDDEK.2|ADC[CAM]PPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAK.4|AAAGEDYKADC[CAM]PPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAK.4
SEN / CTL,P46781,40S ribosomal protein S9,RPS9,2.82,1.64,6.97E-03,6.11E-04,3.21E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,positive regulation of cell proliferation,viral transcription,positive regulation of translational fidelity","structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding,translation regulator activity","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",6,19,26,QVVNIPSFIVR.2|QVVNIPSFIVR.3|M[Oxi]KLDYILGLK.3|MKLDYILGLK.2|M[Oxi]KLDYILGLK.2|IGVLDEGK.2|LQTQVFK.2|ELLTLDEKDPR.3|ELLTLDEKDPR.2|HIDFSLR.2|IEDFLER.2|LIGEYGLR.2|KQVVNIPSFIVR.3|KQVVNIPSFIVR.2|LDYILGLK.2|LDYILGLK.1|SRLDQELKLIGEYGLR.4|SRLDQELKLIGEYGLR.3|ELLTLDEK.2|LDSQKHIDFSLR.3|RLQTQVFK.2|LFEGNALLR.2|RLFEGNALLR.2|GQGGAGAGDDEEED.2|IGVLDEGKMKLDYILGLK.3|KGQGGAGAGDDEEED.2
SEN / CTL,Q96CG8,Collagen triple helix repeat-containing protein 1,CTHRC1,2.80,1.04,5.63E-06,7.58E-07,6.12E+00,"cell migration,positive regulation of protein binding,positive regulation of osteoblast proliferation,ossification involved in bone remodeling,positive regulation of osteoblast differentiation,Wnt signaling pathway, planar cell polarity pathway,inner ear receptor stereocilium organization,negative regulation of canonical Wnt signaling pathway,cochlea morphogenesis,establishment of planar polarity involved in neural tube closure","frizzled binding,Wnt-protein binding","proteinaceous extracellular matrix,collagen trimer,extracellular space,cytoplasm",12,3,3,IIIEELPK.2|QC[CAM]SWSSLNYGIDLGK.2|GDASTGWNSVSR.2
SEN / CTL,P35998,26S protease regulatory subunit 7,PSMC2,2.79,1.40,9.02E-11,2.10E-11,1.07E+01,"MAPK cascade,protein polyubiquitination,osteoblast differentiation,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,viral process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process","protein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,intracellular membrane-bounded organelle",24,40,63,FVVDLSDQVAPTDIEEGMR.3|FVVDLSDQVAPTDIEEGMR.2|FVVDLSDQVAPTDIEEGM[Oxi]R.3|FVVDLSDQVAPTDIEEGM[Oxi]R.2|IINADSEDPKYIINVK.3|IINADSEDPKYIINVK.2|ALDEGDIALLK.2|VLMATNR.2|YQIHIPLPPK.3|YQIHIPLPPK.2|LREVVETPLLHPER.4|LREVVETPLLHPER.3|LREVVETPLLHPER.2|INELTGIK.2|TDAC[CAM]FIR.2|SVC[CAM]TEAGMFAIR.3|SVC[CAM]TEAGMFAIR.2|SVC[CAM]TEAGM[Oxi]FAIR.2|FDDGAGGDNEVQR.3|FDDGAGGDNEVQR.2|DFLEAVNK.2|KIEFSLPDLEGR.3|KIEFSLPDLEGR.2|EVVETPLLHPER.3|EVVETPLLHPER.2|QVEDDIQQLLKK.3|VIGSELVQK.2|IATEKDFLEAVNK.3|IATEKDFLEAVNK.2|TKEDEKDDKPIR.3|TKEDEKDDKPIR.2|QTLQSEQPLQVAR.3|QTLQSEQPLQVAR.2|KINELTGIK.2|PDYLGADQR.2|TYGQSTYSR.2|KIATEKDFLEAVNK.3|IINADSEDPK.2|FVNLGIEPPK.2|FVNLGIEPPKGVLLFGPPGTGK.4|FVNLGIEPPKGVLLFGPPGTGK.3|GVLLFGPPGTGK.2|PDYLGADQRK.2|TMLELINQLDGFDPR.3|TM[Oxi]LELINQLDGFDPR.3|TMLELINQLDGFDPR.2|TM[Oxi]LELINQLDGFDPR.2|AC[CAM]LIFFDEIDAIGGAR.3|AC[CAM]LIFFDEIDAIGGAR.2|LC[CAM]PNSTGAEIR.2|ESDTGLAPPALWDLAADK.3|ESDTGLAPPALWDLAADK.2|IEFSLPDLEGR.2|KAC[CAM]LIFFDEIDAIGGAR.3|KAC[CAM]LIFFDEIDAIGGAR.2|QVEDDIQQLLK.2|YQIHIPLPPKIDPTVTMMQVEEKPDVTYSDVGGC[CAM]KEQIEK.6|YQIHIPLPPKIDPTVTMMQVEEKPDVTYSDVGGC[CAM]K.5|ESDTGLAPPALWDLAADKQTLQSEQPLQVAR.4|ESDTGLAPPALWDLAADKQTLQSEQPLQVAR.3|IDPTVTMMQVEEKPDVTYSDVGGC[CAM]KEQIEK.4|IDPTVTMMQVEEKPDVTYSDVGGC[CAM]K.3|INELTGIKESDTGLAPPALWDLAADKQTLQSEQPLQVAR.4
SEN / CTL,Q9UBR2,Cathepsin Z,CTSZ,2.78,1.52,5.54E-07,8.49E-08,7.07E+00,"angiotensin maturation,proteolysis,ER to Golgi vesicle-mediated transport,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,epithelial tube branching involved in lung morphogenesis","cysteine-type endopeptidase activity,protein binding,cysteine-type peptidase activity","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum,endoplasmic reticulum lumen,plasma membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,intracellular membrane-bounded organelle,extracellular exosome",18,16,25,STYPRPHEYLSPADLPK.4|STYPRPHEYLSPADLPK.3|NVDGVNYASITR.2|NVDGVNYASITR.3|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.3|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.3|VGDYGSLSGREK.3|VGDYGSLSGR.2|FNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.5|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|NSWGEPWGER.2|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADRINIK.5|SWDWRNVDGVNYASITR.3|FNQC[CAM]GTC[CAM]NEFK.2|IVTSTYKDGKGAR.2|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFK.3|M[Oxi]MAEIYANGPISC[CAM]GIMATER.3|MM[Oxi]AEIYANGPISC[CAM]GIMATER.3|MMAEIYANGPISC[CAM]GIMATER.3|MMAEIYANGPISC[CAM]GIMATER.2|YNLAIEEHC[CAM]TFGDPIV.2|KGAWPSTLLSVQNVIDC[CAM]GNAGSC[CAM]EGGNDLSVWDYAHQHGIPDETC[CAM]NNYQAK.5
SEN / CTL,P33176,Kinesin-1 heavy chain,KIF5B,2.77,1.83,1.97E-09,4.01E-10,9.40E+00,"microtubule-based movement,cytoplasm organization,axon guidance,cytoskeleton-dependent intracellular transport,positive regulation of vesicle fusion,positive regulation of synaptic transmission, GABAergic,stress granule disassembly,positive regulation of insulin secretion involved in cellular response to glucose stimulus,regulation of membrane potential,positive regulation of potassium ion transport,vesicle transport along microtubule,plus-end-directed vesicle transport along microtubule,positive regulation of establishment of protein localization to plasma membrane,positive regulation of intracellular protein transport,cell-cell adhesion,positive regulation of voltage-gated sodium channel activity","microtubule motor activity,protein binding,ATP binding,microtubule binding,JUN kinase binding,ATP-dependent microtubule motor activity, plus-end-directed,cadherin binding involved in cell-cell adhesion","cytoplasm,microtubule organizing center,kinesin complex,microtubule,cell-cell adherens junction,membrane,endocytic vesicle,vesicle,ciliary rootlet,axonal growth cone,perinuclear region of cytoplasm",30,140,283,FQGEDTVVIASKPYAFDR.3|FQGEDTVVIASKPYAFDR.2|LYLVDLAGSEK.2|QLEESVDALSEELVQLR.3|QLEESVDALSEELVQLR.2|SLTEYLQNVEQK.2|SLTEYLQNVEQK.3|TGAEGAVLDEAKNINK.3|TGAEGAVLDEAKNINK.2|ALESALKEAKENASR.4|ALESALKEAKENASR.3|ALESALKEAKENASR.2|PGQHPAASPTHPSAIR.4|LHELTVMQDR.3|LHELTVM[Oxi]QDR.3|LHELTVMQDR.2|LHELTVM[Oxi]QDR.2|C[CAM]KQLESTQTESNKK.4|C[CAM]KQLESTQTESNKK.3|FRPLNESEVNRGDK.4|FRPLNESEVNRGDK.3|FRPLNESEVNRGDK.2|DNADLRC[CAM]ELPKLEK.4|DNADLRC[CAM]ELPKLEK.3|FRPLNESEVNRGDKYIAK.5|FRPLNESEVNRGDKYIAK.4|FRPLNESEVNRGDKYIAK.3|GLEETVAK.2|VKALESALKEAK.3|VKALESALKEAK.2|C[CAM]EEEIAK.2|QAVEQQIQSHR.3|QAVEQQIQSHR.2|TNLSVHEDKNR.3|TNLSVHEDKNR.2|DQDNMQAELNR.3|DQDNMQAELNR.2|DQDNM[Oxi]QAELNR.2|LHDPEGM[Oxi]GIIPR.3|LHDPEGMGIIPR.3|LHDPEGMGIIPR.2|LHDPEGM[Oxi]GIIPR.2|SATLASIDAELQK.3|SATLASIDAELQK.2|VQTANEVK.2|FRPLNESEVNR.3|FRPLNESEVNR.2|KLHELTVMQDR.3|KLHELTVM[Oxi]QDR.3|KLHELTVMQDR.2|KLHELTVM[Oxi]QDR.2|VHEMEKEHLNKVQTANEVK.5|VHEMEKEHLNKVQTANEVK.4|VHEM[Oxi]EKEHLNKVQTANEVK.4|VHEMEKEHLNKVQTANEVK.3|VHEM[Oxi]EKEHLNKVQTANEVK.3|AQEKVHEMEKEHLNK.4|AQEKVHEMEKEHLNK.3|GHSAQIAKPIRPGQHPAASPTHPSAIR.6|GHSAQIAKPIRPGQHPAASPTHPSAIR.5|GHSAQIAKPIRPGQHPAASPTHPSAIR.4|GHSAQIAKPIRPGQHPAASPTHPSAIR.3|KMEENEKELAAC[CAM]QLR.4|KM[Oxi]EENEKELAAC[CAM]QLR.4|KM[Oxi]EENEKELAAC[CAM]QLR.3|KMEENEKELAAC[CAM]QLR.3|KM[Oxi]EENEKELAAC[CAM]QLR.2|KMEENEKELAAC[CAM]QLR.2|QISSLRDEVEAK.3|QISSLRDEVEAK.2|QLESTQTESNKK.3|QLESTQTESNKK.2|SNRHVAVTNMNEHSSR.4|STLLFGQR.2|VHEMEKEHLNK.3|VHEM[Oxi]EKEHLNK.3|VHEM[Oxi]EKEHLNK.2|VHEMEKEHLNK.2|MMLEQER.2|M[Oxi]MLEQER.2|MM[Oxi]LEQER.2|M[Oxi]M[Oxi]LEQER.2|YQQEVDR.2|TNLSVHEDKNRVPYVK.4|TNLSVHEDKNRVPYVK.3|TNLSVHEDKNRVPYVK.2|ELAAC[CAM]QLR.2|KSAEIDSDDTGGSAAQKQK.4|VKALESALK.2|LQAENDASK.2|LQAENDASKEEVK.3|LQAENDASKEEVK.2|QAVEQQIQSHRETHQK.4|QAVEQQIQSHRETHQK.3|RGHSAQIAKPIRPGQHPAASPTHPSAIR.6|RGHSAQIAKPIRPGQHPAASPTHPSAIR.5|RGHSAQIAKPIRPGQHPAASPTHPSAIR.4|EYELLSDELNQK.3|EYELLSDELNQK.2|GGGAFVQNSQPVAVR.3|GGGAFVQNSQPVAVR.2|HVAVTNMNEHSSR.3|HVAVTNM[Oxi]NEHSSR.3|HVAVTNMNEHSSR.2|HVAVTNM[Oxi]NEHSSR.2|KC[CAM]EEEIAK.2|PIRPGQHPAASPTHPSAIR.4|PIRPGQHPAASPTHPSAIR.3|RDQDNM[Oxi]QAELNR.3|RDQDNMQAELNR.3|RDQDNMQAELNR.2|RDQDNM[Oxi]QAELNR.2|C[CAM]ELPKLEK.2|DLAEIGIAVGNNDVK.3|DLAEIGIAVGNNDVK.2|EHLNKVQTANEVK.3|KLHELTVMQDRR.3|KLHELTVMQDRR.2|LKTQMLDQEELLASTRR.4|LKTQMLDQEELLASTRR.3|LKTQMLDQEELLASTRR.2|NTIQWLENELNR.3|NTIQWLENELNR.2|ISFLENNLEQLTK.3|ISFLENNLEQLTK.2|VSYFEIYLDKIR.3|VSYFEIYLDKIR.2|C[CAM]KQLESTQTESNK.3|C[CAM]KQLESTQTESNK.2|GLEETVAKELQTLHNLRK.4|GLEETVAKELQTLHNLRK.3|GLEETVAKELQTLHNLRK.2|SAEIDSDDTGGSAAQK.3|SAEIDSDDTGGSAAQK.2|TNLSVHEDK.2|WRNGETVPIDEQFDKEK.4|WRNGETVPIDEQFDKEK.3|AAEMMASLLK.2|AAEM[Oxi]MASLLK.2|AAEMM[Oxi]ASLLK.2|AAEM[Oxi]M[Oxi]ASLLK.2|ALESALKEAK.2|IRDLLDVSK.2|LFVQDLATR.2|QLDDKDEEINQQSQLVEK.4|QLDDKDEEINQQSQLVEK.3|QLDDKDEEINQQSQLVEK.2|TQMLDQEELLASTR.3|TQM[Oxi]LDQEELLASTR.3|TQMLDQEELLASTR.2|TQM[Oxi]LDQEELLASTR.2|FVC[CAM]SPDEVMDTIDEGKSNR.4|FVC[CAM]SPDEVMDTIDEGKSNR.3|FVC[CAM]SPDEVM[Oxi]DTIDEGKSNR.3|FVC[CAM]SPDEVM[Oxi]DTIDEGKSNR.2|FVC[CAM]SPDEVMDTIDEGKSNR.2|RYQQEVDR.2|VQTANEVKQAVEQQIQSHR.4|VQTANEVKQAVEQQIQSHR.3|ANLEAFTVDK.2|KSAEIDSDDTGGSAAQK.3|KSAEIDSDDTGGSAAQK.2|ELQTLHNLR.2|IKSLTEYLQNVEQK.3|IKSLTEYLQNVEQK.2|KRQLEESVDALSEELVQLR.4|KRQLEESVDALSEELVQLR.3|KRQLEESVDALSEELVQLR.2|SHSIFLINVKQENTQTEQK.4|SHSIFLINVKQENTQTEQK.3|SHSIFLINVKQENTQTEQK.2|VQTANEVKQAVEQQIQSHRETHQK.5|MEENEKELAAC[CAM]QLR.3|M[Oxi]EENEKELAAC[CAM]QLR.3|MEENEKELAAC[CAM]QLR.2|M[Oxi]EENEKELAAC[CAM]QLR.2|SLSALGNVISALAEGSTYVPYR.4|SLSALGNVISALAEGSTYVPYR.3|SLSALGNVISALAEGSTYVPYR.2|TKEYELLSDELNQK.3|TKEYELLSDELNQK.2|SHSIFLINVK.2|TGAEGAVLDEAK.2|VSYFEIYLDKIRDLLDVSK.4|VSYFEIYLDKIRDLLDVSK.3|VSYFEIYLDKIRDLLDVSK.2|C[CAM]ELPKLEKR.2|NGETVPIDEQFDKEK.3|NGETVPIDEQFDKEK.2|QPEGTGMIDEEFTVAR.3|QPEGTGM[Oxi]IDEEFTVAR.3|QPEGTGM[Oxi]IDEEFTVAR.2|QPEGTGMIDEEFTVAR.2|YQQEVDRIK.2|KLFVQDLATR.2|NTVC[CAM]VNVELTAEQWK.3|NTVC[CAM]VNVELTAEQWK.2|QLDDKDEEINQQSQLVEKLK.4|QLDDKDEEINQQSQLVEKLK.3|TQMLDQEELLASTRR.3|TQM[Oxi]LDQEELLASTRR.3|TQMLDQEELLASTRR.2|QKISFLENNLEQLTK.3|QKISFLENNLEQLTK.2|SAEIDSDDTGGSAAQKQK.3|FVC[CAM]SPDEVMDTIDEGK.3|FVC[CAM]SPDEVM[Oxi]DTIDEGK.3|FVC[CAM]SPDEVM[Oxi]DTIDEGK.2|FVC[CAM]SPDEVMDTIDEGK.2|QDLKGLEETVAKELQTLHNLR.4|RAAEMMASLLK.2|EVLQALEELAVNYDQK.3|EVLQALEELAVNYDQK.2|ILQDSLGGNC[CAM]R.2|ELQTLHNLRK.2|LKTQM[Oxi]LDQEELLASTR.3|LKTQMLDQEELLASTR.3|LKTQMLDQEELLASTR.2|LKTQM[Oxi]LDQEELLASTR.2|QLESTQTESNK.2|SQEVEDKTKEYELLSDELNQK.4|SQEVEDKTKEYELLSDELNQK.3|VSYFEIYLDK.2|FQGEDTVVIASK.2|KIVKDVLEGYNGTIFAYGQTSSGK.4|KIVKDVLEGYNGTIFAYGQTSSGK.3|LYKQLDDKDEEINQQSQLVEK.4|LYKQLDDKDEEINQQSQLVEK.3|NTVC[CAM]VNVELTAEQWKK.3|NTVC[CAM]VNVELTAEQWKK.2|GLEETVAKELQTLHNLR.3|SLSALGNVISALAEGSTYVPYRDSK.4|SLSALGNVISALAEGSTYVPYRDSK.3|LITDLQDQNQK.2|SHSIFLINVKQENTQTEQKLSGK.4|DNADLRC[CAM]ELPK.2|LQAENDASKEEVKEVLQALEELAVNYDQK.5|LQAENDASKEEVKEVLQALEELAVNYDQK.4|LQAENDASKEEVKEVLQALEELAVNYDQK.3|QDLKGLEETVAK.2|VFQSSTSQEQVYNDC[CAM]AK.3|VFQSSTSQEQVYNDC[CAM]AK.2|DITLTNDKPATAIGVIGNFTDAERR.4|TTIVIC[CAM]C[CAM]SPSSYNESETK.3|TTIVIC[CAM]C[CAM]SPSSYNESETK.2|DVLEGYNGTIFAYGQTSSGK.3|DVLEGYNGTIFAYGQTSSGK.2|KC[CAM]EEEIAKLYK.2|LHELTVMQDRR.2|RQLEESVDALSEELVQLR.3|RQLEESVDALSEELVQLR.2|VFQSSTSQEQVYNDC[CAM]AKK.3|VFQSSTSQEQVYNDC[CAM]AKK.2|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.6|AAEM[Oxi]MASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.5|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.5|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.5|AAEM[Oxi]MASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.4|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAER.5|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAER.4|QLESTQTESNKKMEENEK.3|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERR.5|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERR.4|NGETVPIDEQFDK.2|AKLITDLQDQNQK.2|DEEINQQSQLVEK.2|EEVKEVLQALEELAVNYDQK.3|EEVKEVLQALEELAVNYDQK.2|SLTEYLQNVEQKK.2|SATLASIDAELQKLK.2|IVKDVLEGYNGTIFAYGQTSSGK.3|PATAIGVIGNFTDAER.2|YQQEVDRIKEAVR.2|DLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|DLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.3|DLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.3|DITLTNDKPATAIGVIGNFTDAER.3|AAEMMASLLKDLAEIGIAVGNNDVK.3|IVQDIFNYIYSM[Oxi]DENLEFHIK.3|IVQDIFNYIYSMDENLEFHIK.3|NINKSLSALGNVISALAEGSTYVPYR.3
SEN / CTL,P35442,Thrombospondin-2,THBS2,2.77,1.62,4.27E-05,5.19E-06,5.28E+00,"cell adhesion,negative regulation of angiogenesis,positive regulation of synapse assembly","calcium ion binding,heparin binding","extracellular region,basement membrane,platelet alpha granule",12,9,11,SC[CAM]DVTSNTC[CAM]LGPSIQTR.2|GLLQNVHLVFENSVEDILSK.3|AC[CAM]VGDVQER.2|NALWHTGNTPGQVR.3|NALWHTGNTPGQVR.2|LGPHVTTEYVGPSSER.3|DDDYAGFVFGYQSSSR.3|DDDYAGFVFGYQSSSR.2|GNQPVGVGLEAAK.2|VSNDNQFLWELIGGPPK.3|GTLLALEGPGLSQR.2
SEN / CTL,P61970,Nuclear transport factor 2,NUTF2,2.77,1.97,8.94E-04,8.87E-05,4.05E+00,"protein import into nucleus, translocation,protein import into nucleus,protein export from nucleus,positive regulation of protein import into nucleus,protein transmembrane transport,protein localization to nuclear pore,negative regulation of vascular endothelial growth factor production","protein binding,protein transmembrane transporter activity,Ran GTPase binding","nuclear outer membrane,nucleoplasm,cytosol,nuclear membrane,nuclear pore central transport channel,extracellular exosome",12,8,20,NINDAWVC[CAM]TNDMFR.2|NINDAWVC[CAM]TNDMFR.3|NINDAWVC[CAM]TNDM[Oxi]FR.2|LSSLPFQK.2|AAIVEKLSSLPFQK.3|AAIVEKLSSLPFQK.2|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.5|IQHSITAQDHQPTPDSC[CAM]IISM[Oxi]VVGQLK.4|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.4|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.3|IQHSITAQDHQPTPDSC[CAM]IISM[Oxi]VVGQLK.3|ADEDPIMGFHQMFLLK.3|ADEDPIM[Oxi]GFHQMFLLK.3|ADEDPIMGFHQM[Oxi]FLLK.3|ADEDPIMGFHQMFLLK.2|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQM[Oxi]FLLK.6|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQMFLLK.6|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQMFLLK.5|TQLGAIYIDASC[CAM]LTWEGQQFQGK.3|PIWEQIGSSFIQHYYQLFDNDR.3
SEN / CTL,P13929,Beta-enolase,ENO3,2.76,1.49,1.46E-16,5.89E-17,1.62E+01,"gluconeogenesis,aging,response to drug,skeletal muscle tissue regeneration,canonical glycolysis","magnesium ion binding,phosphopyruvate hydratase activity,protein homodimerization activity,protein heterodimerization activity","phosphopyruvate hydratase complex,extracellular space,cytoplasm,cytosol,plasma membrane,extracellular exosome",48,18,28,VNQIGSVTESIQAC[CAM]K.2|VNQIGSVTESIQAC[CAM]K.3|AAVPSGASTGIYEALELR.2|AAVPSGASTGIYEALELR.3|YGKDATNVGDEGGFAPNILENNEALELLK.4|SGETEDTFIADLVVGLC[CAM]TGQIK.3|SGETEDTFIADLVVGLC[CAM]TGQIK.2|SGETEDTFIADLVVGLC[CAM]TGQIK.4|AC[CAM]NC[CAM]LLLK.2|NGKYDLDFKSPDDPAR.4|FGANAILGVSLAVC[CAM]K.3|FGANAILGVSLAVC[CAM]K.2|LAQSNGWGVMVSHR.3|LAQSNGWGVM[Oxi]VSHR.3|LAQSNGWGVM[Oxi]VSHR.2|KLSVVDQEK.2|TAIQAAGYPDK.2|SKFGANAILGVSLAVC[CAM]K.3|SKFGANAILGVSLAVC[CAM]K.2|IGAEVYHHLK.2|LAMQEFMILPVGASSFK.3|LAMQEFMILPVGASSFK.2|GNPTVEVDLHTAK.2|AAVPSGASTGIYEALELRDGDK.3|HIADLAGNPDLILPVPAFNVINGGSHAGNK.4|HIADLAGNPDLILPVPAFNVINGGSHAGNK.3|AVENINNTLGPALLQK.2|DATNVGDEGGFAPNILENNEALELLK.3
SEN / CTL,P00750,Tissue-type plasminogen activator,PLAT,2.75,2.16,1.27E-04,1.41E-05,4.85E+00,"response to hypoxia,cellular protein modification process,proteolysis,blood coagulation,smooth muscle cell migration,plasminogen activation,fibrinolysis,negative regulation of proteolysis,platelet-derived growth factor receptor signaling pathway","glycoprotein binding,serine-type endopeptidase activity,receptor binding,protein binding,phosphoprotein binding","extracellular region,extracellular space,cytoplasm,cell surface,secretory granule,apical part of cell,extracellular exosome,extracellular matrix",18,5,5,GTHSLTESGASC[CAM]LPWNSMILIGK.3|ATC[CAM]YEDQGISYR.2|GGLFADIASHPWQAAIFAK.3|VTNYLDWIR.2|VYTAQNPSAQALGLGK.2
SEN / CTL,P62753,40S ribosomal protein S6,RPS6,2.74,2.37,1.58E-01,1.21E-02,1.92E+00,"G1/S transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,placenta development,T cell proliferation involved in immune response,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,activation-induced cell death of T cells,mitotic nuclear division,mitotic cell cycle checkpoint,gastrulation,viral transcription,oogenesis stage,TOR signaling,T cell differentiation in thymus,ribosomal small subunit biogenesis,glucose homeostasis,positive regulation of apoptotic process,negative regulation of apoptotic process,erythrocyte development","structural constituent of ribosome,protein binding,protein kinase binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,polysome,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,dendrite,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,cell body,perinuclear region of cytoplasm",12,18,39,MATEVAADALGEEWKGYVVR.3|M[Oxi]ATEVAADALGEEWKGYVVR.3|MATEVAADALGEEWKGYVVR.2|MKLNISFPATGC[CAM]QK.3|M[Oxi]KLNISFPATGC[CAM]QK.2|MKLNISFPATGC[CAM]QK.2|DIPGLTDTTVPR.3|DIPGLTDTTVPR.2|KNKEEAAEYAK.3|KNKEEAAEYAK.2|KGEKDIPGLTDTTVPR.4|KGEKDIPGLTDTTVPR.3|QGVLTHGR.2|LFNLSKEDDVR.3|LFNLSKEDDVR.2|LNISFPATGC[CAM]QK.3|LNISFPATGC[CAM]QK.2|ISGGNDKQGFPMK.3|ISGGNDKQGFPMK.2|KLFNLSKEDDVR.3|KLFNLSKEDDVR.2|LFNLSKEDDVRQYVVR.4|LFNLSKEDDVRQYVVR.3|LIEVDDER.2|M[Oxi]ATEVAADALGEEWK.3|MATEVAADALGEEWK.3|M[Oxi]ATEVAADALGEEWK.2|MATEVAADALGEEWK.2|LIEVDDERK.2|NKEEAAEYAK.2|RMATEVAADALGEEWK.3|RM[Oxi]ATEVAADALGEEWK.3|RM[Oxi]ATEVAADALGEEWK.2|RMATEVAADALGEEWK.2|RM[Oxi]ATEVAADALGEEWKGYVVR.4|RMATEVAADALGEEWKGYVVR.4|RMATEVAADALGEEWKGYVVR.3|GC[CAM]IVDANLSVLNLVIVK.3|GC[CAM]IVDANLSVLNLVIVK.2
SEN / CTL,P62873,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,GNB1,2.74,0.95,7.57E-10,1.60E-10,9.80E+00,"protein folding,signal transduction,adenylate cyclase-activating dopamine receptor signaling pathway,phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,G-protein coupled acetylcholine receptor signaling pathway,Wnt signaling pathway, calcium modulating pathway,Ras protein signal transduction,cell proliferation,cardiac muscle cell apoptotic process,rhodopsin mediated signaling pathway,platelet activation,sensory perception of taste,retina development in camera-type eye,protein heterotrimerization,cellular response to glucagon stimulus,cellular response to prostaglandin E stimulus,cellular response to hypoxia,cellular response to catecholamine stimulus","GTPase activity,signal transducer activity,spectrin binding,type 1 angiotensin receptor binding,protein complex binding,alkylglycerophosphoethanolamine phosphodiesterase activity,GTPase binding","photoreceptor inner segment,intracellular,lysosomal membrane,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,photoreceptor outer segment membrane,myelin sheath,cell body,extracellular exosome,photoreceptor disc membrane,extracellular vesicle",18,11,19,LLLAGYDDFNC[CAM]NVWDALKADR.3|LFVSGAC[CAM]DASAK.2|KAC[CAM]ADATLSQITNNIDPVGR.3|KAC[CAM]ADATLSQITNNIDPVGR.2|ADRAGVLAGHDNR.3|ELAGHTGYLSC[CAM]C[CAM]R.3|ELAGHTGYLSC[CAM]C[CAM]R.2|AC[CAM]ADATLSQITNNIDPVGR.3|AC[CAM]ADATLSQITNNIDPVGR.2|LLLAGYDDFNC[CAM]NVWDALK.3|LLLAGYDDFNC[CAM]NVWDALK.2|LFDLRADQELMTYSHDNIIC[CAM]GITSVSFSK.4|QTFTGHESDINAIC[CAM]FFPNGNAFATGSDDATC[CAM]R.4|QTFTGHESDINAIC[CAM]FFPNGNAFATGSDDATC[CAM]R.3|SSWVMTC[CAM]AYAPSGNYVAC[CAM]GGLDNIC[CAM]SIYNLK.4|SSWVM[Oxi]TC[CAM]AYAPSGNYVAC[CAM]GGLDNIC[CAM]SIYNLK.3|SSWVMTC[CAM]AYAPSGNYVAC[CAM]GGLDNIC[CAM]SIYNLK.3|ADQELM[Oxi]TYSHDNIIC[CAM]GITSVSFSK.3|ADQELMTYSHDNIIC[CAM]GITSVSFSK.3
SEN / CTL,O43776,"Asparagine--tRNA ligase, cytoplasmic",NARS,2.74,1.39,8.05E-11,1.90E-11,1.07E+01,"tRNA aminoacylation for protein translation,asparaginyl-tRNA aminoacylation","nucleic acid binding,asparagine-tRNA ligase activity,ATP binding","cytoplasm,mitochondrion,cytosol,extracellular exosome",30,33,60,IFDSEEILAGYKR.3|IFDSEEILAGYKR.2|LMTDTINEPILLC[CAM]R.2|LMTDTINEPILLC[CAM]R.3|LM[Oxi]TDTINEPILLC[CAM]R.3|LM[Oxi]TDTINEPILLC[CAM]R.2|ALMTVGKEPFPTIYVDSQKENER.4|ALM[Oxi]TVGKEPFPTIYVDSQKENER.4|ALMTVGKEPFPTIYVDSQKENER.3|C[CAM]FRDHFFDR.3|IGALEGYR.2|VFGWVHR.2|DVC[CAM]LYPR.2|IFDSEEILAGYK.3|IFDSEEILAGYK.2|EPFPTIYVDSQK.3|EPFPTIYVDSQK.2|ITIKNDPSLPEPK.3|SPAGSIVHELNPNFQPPK.4|SPAGSIVHELNPNFQPPK.3|SPAGSIVHELNPNFQPPK.2|NDPSLPEPK.2|NLMFLVLR.2|NLM[Oxi]FLVLR.2|RMNYSDAIVWLK.3|RMNYSDAIVWLK.2|FLTWILNR.2|KITIKNDPSLPEPK.3|YGTC[CAM]PHGGYGLGLER.3|YGTC[CAM]PHGGYGLGLER.2|KEDGTFYEFGEDIPEAPER.4|KEDGTFYEFGEDIPEAPER.3|KEDGTFYEFGEDIPEAPER.2|EHDVKKEDGTFYEFGEDIPEAPER.5|EHDVKKEDGTFYEFGEDIPEAPER.4|EHDVKKEDGTFYEFGEDIPEAPER.3|VLAELYVSDR.2|KYGTC[CAM]PHGGYGLGLER.3|EGIDPTPYYWYTDQR.3|EGIDPTPYYWYTDQR.2|EPFPTIYVDSQKENER.3|EPFPTIYVDSQKENER.2|LEDLVC[CAM]DVVDR.2|EGIDPTPYYWYTDQRK.3|MNYSDAIVWLK.2|M[Oxi]NYSDAIVWLK.2|EDGTFYEFGEDIPEAPER.3|EDGTFYEFGEDIPEAPER.2|HLAEYTHVEAEC[CAM]PFLTFDDLLNR.4|HLAEYTHVEAEC[CAM]PFLTFDDLLNR.3|ALMTVGKEPFPTIYVDSQK.3|ALMTVGKEPFPTIYVDSQK.2|LTESVDVLMPNVGEIVGGSMR.3|LTESVDVLM[Oxi]PNVGEIVGGSMR.3|LTESVDVLMPNVGEIVGGSM[Oxi]R.3|LTESVDVLMPNVGEIVGGSMR.2|VLAELYVSDREGSDATGDGTK.3|VLAELYVSDREGSDATGDGTK.2|GYYEVTPPTLVQTQVEGGATLFK.3|C[CAM]PEDSRLTESVDVLMPNVGEIVGGSMR.3
SEN / CTL,P35606,Coatomer subunit beta',COPB2,2.73,0.63,9.37E-05,1.07E-05,4.97E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,toxin transport",structural molecule activity,"Golgi membrane,endoplasmic reticulum membrane,cytosol,COPI vesicle coat,transport vesicle",6,61,94,TFEVC[CAM]DLPVR.2|TFEVC[CAM]DLPVR.3|TMYLLGYIPK.3|TMYLLGYIPK.2|TM[Oxi]YLLGYIPK.2|AMGDAEIK.2|VAHFLEK.2|AMGDAEIKDGER.3|TGRLPEAAFLAR.3|TGRLPEAAFLAR.2|RIEIQPK.2|IWDYQNK.2|QLAELAISK.2|RDFSMADK.2|LPEAAFLAR.2|QQALTVSTDPEHR.3|QQALTVSTDPEHR.2|VWC[CAM]VASLR.2|VHMFEAHSDYIR.3|VHM[Oxi]FEAHSDYIR.3|VHMFEAHSDYIR.2|NNVAFMSYFLQGK.3|NNVAFMSYFLQGK.2|NNVAFM[Oxi]SYFLQGK.2|NVMEEGKDFQPSR.3|NVM[Oxi]EEGKDFQPSR.3|IAYQLAVEAESEQK.3|IAYQLAVEAESEQK.2|IWHSSTYR.2|PASPTPVIVASHTANK.3|TYLPSQVSR.2|LGREEPAMSMDANGK.3|LGREEPAMSM[Oxi]DANGK.3|KNWVVTGADDMQIR.3|KNWVVTGADDMQIR.2|SFGSAQEFAWAHDSSEYAIR.4|SFGSAQEFAWAHDSSEYAIR.3|SFGSAQEFAWAHDSSEYAIR.2|KSFKPDFGAESIYGGFLLGVR.4|KSFKPDFGAESIYGGFLLGVR.3|GSNNVALGYDEGSIIVK.3|GSNNVALGYDEGSIIVK.2|HSEVQQANLK.2|VFNYNTLER.2|ETHADLWPAK.2|EAFVVEEWVKETHADLWPAK.4|DGKNNVAFMSYFLQGK.3|STAQQELDGKPASPTPVIVASHTANKEEK.5|STAQQELDGKPASPTPVIVASHTANKEEK.4|VDAC[CAM]LELLIR.2|EAFVVEEWVK.2|FELALQLGELK.2|IAYQLAVEAESEQKWK.3|AMGDAEIKDGERLPLAVK.3|EEPAMSMDANGK.2|LNYYVGGEIVTIAHLDR.3|LNYYVGGEIVTIAHLDR.2|LESTLNYGMER.2|LESTLNYGM[Oxi]ER.2|DNNQFASASLDR.2|STAQQELDGKPASPTPVIVASHTANK.4|QYPLVTPNEER.2|SVNGLAFYDWDNTELIR.3|SVNGLAFYDWDNTELIR.2|VWQLGSSSPNFTLEGHEK.3|VWQLGSSSPNFTLEGHEK.2|QQALTVSTDPEHRFELALQLGELK.4|QQALTVSTDPEHRFELALQLGELK.3|AAESLADPTEYENLFPGLK.3|AAESLADPTEYENLFPGLK.2|KWSC[CAM]SQVFEGHTHYVMQIVINPK.4|GVNC[CAM]IDYYSGGDK.2|SFKPDFGAESIYGGFLLGVR.3|SFKPDFGAESIYGGFLLGVR.2|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANMVNK.5|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANM[Oxi]VNK.4|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANMVNK.4|DM[Oxi]GSC[CAM]EIYPQTIQHNPNGR.3|DMGSC[CAM]EIYPQTIQHNPNGR.3|SVDLHPTEPWMLASLYNGSVC[CAM]VWNHETQTLVK.5|SVDLHPTEPWMLASLYNGSVC[CAM]VWNHETQTLVK.4|NWVVTGADDMQIR.2|TC[CAM]VQTLEGHAQNVSC[CAM]ASFHPELPIIITGSEDGTVR.5|TC[CAM]VQTLEGHAQNVSC[CAM]ASFHPELPIIITGSEDGTVR.4|C[CAM]IAVHPTQPFILTSSDDM[Oxi]LIK.3|C[CAM]IAVHPTQPFILTSSDDMLIK.3|C[CAM]IAVHPTQPFILTSSDDMLIK.2|QGFKQQALTVSTDPEHRFELALQLGELK.4|GVNC[CAM]IDYYSGGDKPYLISGADDR.3|VLAAQETHEGVTEDGIEDAFEVLGEIQEIVK.4|VLAAQETHEGVTEDGIEDAFEVLGEIQEIVK.3|WSC[CAM]SQVFEGHTHYVMQIVINPK.3|GVNC[CAM]IDYYSGGDKPYLISGADDRLVK.3|TGLWVGDC[CAM]FIYTSSVNR.2
SEN / CTL,P24534,Elongation factor 1-beta,EEF1B2,2.73,1.36,3.26E-10,7.16E-11,1.01E+01,"translational elongation,response to ethanol","translation elongation factor activity,protein binding","cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,nucleus,endoplasmic reticulum",24,13,25,SSILLDVKPWDDETDMAKLEEC[CAM]VR.4|SSILLDVKPWDDETDMAKLEEC[CAM]VR.3|SSILLDVKPWDDETDM[Oxi]AKLEEC[CAM]VR.4|SIQADGLVWGSSK.2|SIQADGLVWGSSK.3|GFGDLKSPAGLQVLNDYLADK.3|LAQYESK.2|LVPVGYGIK.2|LAQYESKK.2|SPAGLQVLNDYLADK.3|SPAGLQVLNDYLADK.2|YGPADVEDTTGSGATDSK.3|YGPADVEDTTGSGATDSK.2|SSILLDVKPWDDETDM[Oxi]AK.3|SSILLDVKPWDDETDMAK.3|SSILLDVKPWDDETDM[Oxi]AK.2|SSILLDVKPWDDETDMAK.2|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.5|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.4|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.3|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNKI.4|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNKI.3|SPAGLQVLNDYLADKSYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.5|VGTDM[Oxi]LEEQITAFEDYVQSMDVAAFNK.3|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNK.3
SEN / CTL,P01130,Low-density lipoprotein receptor,LDLR,2.73,0.62,9.10E-05,1.04E-05,4.98E+00,"lipid metabolic process,endocytosis,receptor-mediated endocytosis,cholesterol metabolic process,positive regulation of gene expression,negative regulation of gene expression,positive regulation of triglyceride biosynthetic process,regulation of phosphatidylcholine catabolic process,phospholipid transport,intestinal cholesterol absorption,cholesterol transport,low-density lipoprotein particle clearance,lipoprotein catabolic process,cholesterol homeostasis,viral entry into host cell,positive regulation of inflammatory response,cholesterol import,cellular response to fatty acid,regulation of cholesterol homeostasis","virus receptor activity,glycoprotein binding,protease binding,receptor activity,low-density lipoprotein receptor activity,calcium ion binding,protein binding,low-density lipoprotein particle binding,very-low-density lipoprotein particle receptor activity,clathrin heavy chain binding,identical protein binding","lysosome,early endosome,late endosome,Golgi apparatus,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,endosome membrane,membrane,basolateral plasma membrane,clathrin-coated endocytic vesicle membrane,low-density lipoprotein particle,receptor complex,apical part of cell,PCSK9-LDLR complex",6,18,20,NVVALDTEVASNR.2|AHGVSSYDTVISR.3|AHGVSSYDTVISR.2|SGDFSC[CAM]GGR.2|RLAHPFSLAVFEDK.3|MIC[CAM]STQLDR.2|NEFQC[CAM]QDGK.2|C[CAM]QC[CAM]EEGFQLDPHTK.3|TTEDEVHIC[CAM]HNQDGYSYPSR.4|VFWTDIINEAIFSANR.3|VFWTDIINEAIFSANR.2|SEYTSLIPNLR.2|C[CAM]HSGEC[CAM]ITLDK.2|AVGSIAYLFFTNR.2|FTC[CAM]AC[CAM]PDGMLLAR.2|AIVVDPVHGFMYWTDWGTPAK.3|NINSINFDNPVYQK.2|GLYVFQGDSSPC[CAM]SAFEFHC[CAM]LSGEC[CAM]IHSSWR.4|TTLSNGGC[CAM]QYLC[CAM]LPAPQINPHSPK.3|IGYEC[CAM]LC[CAM]PDGFQLVAQR.2
SEN / CTL,P05198,Eukaryotic translation initiation factor 2 subunit 1,EIF2S1,2.73,1.61,3.47E-03,3.16E-04,3.50E+00,"translational initiation,aging,negative regulation of translational initiation in response to stress,cellular response to amino acid starvation,cellular response to heat,cellular response to UV,response to endoplasmic reticulum stress,PERK-mediated unfolded protein response,protein autophosphorylation,transmembrane transport,positive regulation of neuron death,negative regulation of guanyl-nucleotide exchange factor activity,response to manganese-induced endoplasmic reticulum stress,positive regulation of type B pancreatic cell apoptotic process","translation initiation factor activity,protein binding,ribosome binding,poly(A) RNA binding","nucleus,cytosol,ribosome,polysome,eukaryotic translation initiation factor 2 complex,cytoplasmic stress granule,membrane,eukaryotic 48S preinitiation complex,multi-eIF complex,translation initiation ternary complex,extracellular exosome,glial limiting end-foot,eukaryotic translation initiation factor 2B complex",6,34,49,AGLNC[CAM]STENMPIKINLIAPPR.3|RPGYGAYDAFK.3|RPGYGAYDAFK.2|DEQLESLFQR.3|DEQLESLFQR.2|RGVFNVQMEPK.3|RGVFNVQMEPK.2|RGVFNVQM[Oxi]EPK.2|VSPEEAIK.2|IGRNEC[CAM]VVVIR.3|IGRNEC[CAM]VVVIR.2|INLIAPPR.2|VSPEEAIKC[CAM]EDK.3|NEC[CAM]VVVIR.2|TAWVFDDK.2|TEGLSVLSQAMAVIK.3|TEGLSVLSQAMAVIK.2|TEGLSVLSQAM[Oxi]AVIK.2|YKRPGYGAYDAFK.3|EVLINNINR.2|GVFNVQMEPK.2|HVAEVLEYTK.2|VSPEEAIKC[CAM]EDKFTK.3|TEGLSVLSQAMAVIKEK.3|YVMTTTTLER.2|YVM[Oxi]TTTTLER.2|HVAEVLEYTKDEQLESLFQR.4|HVAEVLEYTKDEQLESLFQR.3|ADIEVAC[CAM]YGYEGIDAVK.3|ADIEVAC[CAM]YGYEGIDAVK.2|TAWVFDDKYKRPGYGAYDAFK.4|EALRAGLNC[CAM]STENMPIK.3|TAWVFDDKYK.2|IRADIEVAC[CAM]YGYEGIDAVKEALR.4|IRADIEVAC[CAM]YGYEGIDAVKEALR.3|HAVSDPSILDSLDLNEDEREVLINNINRR.5|HAVSDPSILDSLDLNEDEREVLINNINRR.4|VVTDTDETELAR.2|HAVSDPSILDSLDLNEDER.3|HAVSDPSILDSLDLNEDER.2|AGLNC[CAM]STENMPIK.2|AGLNC[CAM]STENM[Oxi]PIK.2|FYQHKFPEVEDVVMVNVR.3|LERENAEVDGDDDAEEMEAK.3|FPEVEDVVMVNVR.2|HAVSDPSILDSLDLNEDEREVLINNINR.4|HAVSDPSILDSLDLNEDEREVLINNINR.3|LERENAEVDGDDDAEEMEAKAED.3|ENAEVDGDDDAEEMEAK.2
SEN / CTL,P34096,Ribonuclease 4,RNASE4,2.72,1.67,1.15E-04,1.29E-05,4.89E+00,"mRNA cleavage,RNA phosphodiester bond hydrolysis, endonucleolytic","nucleic acid binding,endonuclease activity,ribonuclease A activity,ribonuclease activity","extracellular region,extracellular exosome",18,5,6,RVVIAC[CAM]EGNPQVPVHFDG.3|VVIAC[CAM]EGNPQVPVHFDG.2|RFNTFIHEDIWNIR.3|RFNTFIHEDIWNIR.4|MNC[CAM]HEGVVK.2|SIC[CAM]STTNIQC[CAM]K.2
SEN / CTL,O95394,Phosphoacetylglucosamine mutase,PGM3,2.72,0.84,5.52E-04,5.62E-05,4.25E+00,"carbohydrate metabolic process,glucosamine metabolic process,UDP-N-acetylglucosamine biosynthetic process,protein N-linked glycosylation,protein O-linked glycosylation,spermatogenesis,glucose 1-phosphate metabolic process,hemopoiesis","magnesium ion binding,phosphoacetylglucosamine mutase activity,phosphoglucomutase activity","cellular_component,cytosol",6,32,47,VYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF.4|VYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF.5|AFVELTK.2|AFVELTK.1|AEHLDHVMFR.3|AEHLDHVM[Oxi]FR.3|AEHLDHVMFR.2|LNHLC[CAM]GADFVK.3|LNHLC[CAM]GADFVK.2|MGLLAVLR.2|YLEEVMK.2|SHQKPPQGMEIK.3|VLIDISEK.2|AFVRPSGTEDVVR.3|AFVRPSGTEDVVR.2|PSGTEDVVR.2|SLKVDC[CAM]ANGIGALK.3|GKLNHLC[CAM]GADFVK.3|VISTTDAER.2|QSAEQLEDK.2|ATIEGYYQK.2|IATLISSFLK.2|VDC[CAM]ANGIGALK.2|IVYYYHDADGHFHLIDGDK.4|IVYYYHDADGHFHLIDGDK.3|IVYYYHDADGHFHLIDGDK.2|YSALHAKPNGLILQYGTAGFR.4|QASC[CAM]SGDEYR.2|YLEEVMKVPVYC[CAM]TK.3|QAVTPPGLQEAINDLVK.3|QAVTPPGLQEAINDLVK.2|C[CAM]C[CAM]SFDGDADR.2|IKQSAEQLEDK.2|QAVTPPGLQEAINDLVKK.3|GLTVQQWDALYTDLPNR.3|GLTVQQWDALYTDLPNR.2|STIGVMVTASHNPEEDNGVK.3|STIGVM[Oxi]VTASHNPEEDNGVK.3|STIGVMVTASHNPEEDNGVK.2|PNGLILQYGTAGFR.2|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYC[CAM]R.5|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYC[CAM]R.4|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYM[Oxi]VYC[CAM]R.4|EAVNLQQDAFVVIGR.2|LREMEHYFSQGLSVQLFNDGSK.3|LVDPLGEMLAPSWEEHATC[CAM]LANAEEQDMQR.4|LVDPLGEMLAPSWEEHATC[CAM]LANAEEQDMQR.3
SEN / CTL,P80723,Brain acid soluble protein 1,BASP1,2.72,0.65,1.59E-08,2.93E-09,8.53E+00,"thorax and anterior abdomen determination,gonad development,substantia nigra development,negative regulation of transcription, DNA-templated,mesenchymal to epithelial transition,positive regulation of heart growth,diaphragm development,metanephric mesenchyme development,glomerular visceral epithelial cell differentiation,positive regulation of metanephric ureteric bud development","transcription corepressor activity,protein binding,protein domain specific binding,transcription regulatory region DNA binding","nucleus,cytoplasm,cytoskeleton,plasma membrane,nuclear speck,cell junction,growth cone,vesicle,extracellular exosome,COP9 signalosome",12,28,41,AQGPAASAEEPKPVEAPAANSDQTVTVKE.3|AQGPAASAEEPKPVEAPAANSDQTVTVKE.4|DAAAAKEEAPKAEPEK.4|DAAAAKEEAPKAEPEK.3|AEPEKTEGAAEAK.3|ETPAATEAPSSTPK.3|ETPAATEAPSSTPK.2|EEAPKAEPEKTEGAAEAK.4|EEAPKAEPEKTEGAAEAK.3|GYNVNDEK.2|KTEAPAAPAAQETK.3|KTEAPAAPAAQETK.2|ESEPQAAAEPAEAK.3|ESEPQAAAEPAEAK.2|KAEGAATEEEGTPK.3|KAEGAATEEEGTPK.2|EKPDQDAEGKAEEKEGEK.4|EKPDQDAEGKAEEK.3|KGYNVNDEK.2|DAAAAKEEAPK.2|DKKAEGAATEEEGTPK.3|DKKAEGAATEEEGTPK.2|EEAPKAEPEK.2|AEPPKAPEQEQAAPGPAAGGEAPK.4|AEPPKAPEQEQAAPGPAAGGEAPK.3|ESEPQAAAEPAEAKEGK.3|APEQEQAAPGPAAGGEAPK.3|APEQEQAAPGPAAGGEAPK.2|AEGAATEEEGTPK.2|SDGAPASDSKPGSSEAAPSSK.3|TEAPAAPAAQETK.2|AAEAAAAPAESAAPAAGEEPSK.3|AAEAAAAPAESAAPAAGEEPSK.2|AAEAAAAPAESAAPAAGEEPSKEEGEPK.4|AAEAAAAPAESAAPAAGEEPSKEEGEPK.3|KTEAPAAPAAQETKSDGAPASDSKPGSSEAAPSSK.5|AAEAAAAPAESAAPAAGEEPSKEEGEPKK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.3|KAEGAATEEEGTPKESEPQAAAEPAEAK.4|AEGAATEEEGTPKESEPQAAAEPAEAK.3
SEN / CTL,P11047,Laminin subunit gamma-1,LAMC1,2.72,1.52,1.23E-43,2.47E-43,4.26E+01,"protein complex assembly,cell adhesion,endoderm development,cell migration,extracellular matrix disassembly,extracellular matrix organization,hemidesmosome assembly,substrate adhesion-dependent cell spreading,positive regulation of epithelial cell proliferation",extracellular matrix structural constituent,"extracellular region,basement membrane,laminin-1 complex,extracellular space,extracellular matrix,laminin-10 complex,laminin-11 complex,extracellular exosome",126,77,97,TREDGPWIPYQYYSGSC[CAM]ENTYSK.3|SQEC[CAM]YFDPELYR.2|RC[CAM]ELC[CAM]DDGYFGDPLGR.3|DTRLSAEDLVLEGAGLR.3|LGNNEAC[CAM]SSC[CAM]HC[CAM]SPVGSLSTQC[CAM]DSYGR.3|LSAEDLVLEGAGLR.2|LSAEDLVLEGAGLR.3|C[CAM]ELC[CAM]DDGYFGDPLGR.2|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NRLTGEC[CAM]LK.3|TLPSGC[CAM]FNTPSIEKP.2|C[CAM]IYNTAGFYC[CAM]DR.2|LHEATDYPWRPALTPFEFQK.4|LHEATDYPWRPALTPFEFQK.3|LNTFGDEVFNDPKVLK.3|NTIEETGNLAEQAR.2|NTIEETGNLAEQAR.3|LQNIRNTIEETGNLAEQAR.3|LQNIRNTIEETGNLAEQAR.4|LNTFGDEVFNDPK.2|EAQQALGSAAADATEAKNKAHEAER.5|QDIAVISDSYFPR.2|AHVENTERLIEIASR.4|EAQQALGSAAADATEAK.2|EAQQALGSAAADATEAK.3|ALAEEAAK.2|HKQEADDIVR.3|HKQEADDIVR.2|YFIAPAKFLGK.3|LIEIASRELEK.3|TAAEEALR.2|SAGYLDDVTLASAR.3|SAGYLDDVTLASAR.2|TKEVVC[CAM]TNC[CAM]PTGTTGKR.4|AFDITYVR.2|RDTRLSAEDLVLEGAGLR.4|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.5|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.4|VSDLENEAK.2|GKTEQQTADQLLAR.3|GKTEQQTADQLLAR.2|SYYYAISDFAVGGR.3|SYYYAISDFAVGGR.2|FHTSRPESFAIYK.3|C[CAM]KDGFFGNPLAPNPADKC[CAM]K.4|DTLQEANDILNNLK.3|DTLQEANDILNNLK.2|C[CAM]KPGFFNLESSNPR.3|C[CAM]KPGFFNLESSNPR.2|DVDQNLMDR.2|DVDQNLM[Oxi]DR.2|AHVENTERLIEIASRELEK.4|C[CAM]SC[CAM]KPGVMGDKC[CAM]DR.3|KVSDLENEAK.2|LNEIEGTLNK.2|GRDTLQEANDILNNLKDFDR.4|TKEVVC[CAM]TNC[CAM]PTGTTGK.3|EAQDVKDVDQNLMDR.3|LVKDKVADHR.2|C[CAM]VC[CAM]KDNVEGFNC[CAM]ER.3|GRDTLQEANDILNNLK.3|GRDTLQEANDILNNLK.2|HNTYGVDC[CAM]EK.2|C[CAM]DC[CAM]HALGSTNGQC[CAM]DIR.3|C[CAM]SC[CAM]KPGVMGDK.2|DGFFGNPLAPNPADKC[CAM]K.3|DGFFGNPLAPNPADKC[CAM]K.2|DNVEGFNC[CAM]ER.2|EAQQALGSAAADATEAKNK.3|TREAQQALGSAAADATEAK.3|VSVPLIAQGNSYPSETTVKYVFR.4|VSVPLIAQGNSYPSETTVKYVFR.3|TFAEVTDLDNEVNNMLK.3|TFAEVTDLDNEVNNMLK.2|LKFHTSRPESFAIYKR.3|VSVPLIAQGNSYPSETTVK.3|VSVPLIAQGNSYPSETTVK.2|TGQC[CAM]EC[CAM]QPGITGQHC[CAM]ER.3|RATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.3|TEQQTADQLLAR.2|VTLNRLNTFGDEVFNDPK.3|DTLQEANDILNNLKDFDR.3|DGSEASLEWSSER.2|KQEAAIMDYNRDIEEIMK.3|KQEAAIM[Oxi]DYNRDIEEIMK.3|EVVC[CAM]TNC[CAM]PTGTTGK.2|DGFFGNPLAPNPADK.2|M[Oxi]EAENLEQLIDQK.2|MEAENLEQLIDQK.2|TFAEVTDLDNEVNNMLKQLQEAEKELK.4|EVVC[CAM]TNC[CAM]PTGTTGKR.2|PSAYNFDNSPVLQEWVTATDIR.3|SWPGC[CAM]QEC[CAM]PAC[CAM]YR.2|C[CAM]EVNHFGFGPEGC[CAM]KPC[CAM]DC[CAM]HPEGSLSLQC[CAM]K.4|ATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.2|LQELESLIANLGTGDEMVTDQAFEDR.3|AVEIYASVAQLSPLDSETLENEANNIK.3|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NR.2
SEN / CTL,P62888,60S ribosomal protein L30,RPL30,2.72,1.37,2.47E-09,4.99E-10,9.30E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",18,10,19,VC[CAM]TLAIIDPGDSDIIR.2|VC[CAM]TLAIIDPGDSDIIR.3|SEIEYYAMLAK.2|SEIEYYAM[Oxi]LAK.2|LVILANNC[CAM]PALR.3|LVILANNC[CAM]PALR.2|SLESINSR.2|KSEIEYYAMLAK.3|KSEIEYYAM[Oxi]LAK.3|KSEIEYYAMLAK.2|KSEIEYYAM[Oxi]LAK.2|LVILANNC[CAM]PALRK.3|LVILANNC[CAM]PALRK.2|SMPEQTGEK.2|TGVHHYSGNNIELGTAC[CAM]GK.4|TGVHHYSGNNIELGTAC[CAM]GK.3|TGVHHYSGNNIELGTAC[CAM]GK.2|KSLESINSR.2|AKLVILANNC[CAM]PALR.3
SEN / CTL,P68402,Platelet-activating factor acetylhydrolase IB subunit beta,PAFAH1B2,2.71,2.48,1.87E-03,1.78E-04,3.75E+00,"lipid metabolic process,spermatogenesis,brain development,lipid catabolic process,positive regulation of macroautophagy","1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipase A2 activity,protein homodimerization activity,protein heterodimerization activity,platelet-activating factor acetyltransferase activity","nucleolus,cytoplasm,cytosol,plasma membrane,extracellular exosome",18,10,21,IIVLGLLPR.2|ELFSPLHALNFGIGGDTTR.3|ELFSPLHALNFGIGGDTTR.4|ELFSPLHALNFGIGGDTTR.2|LANVQLLDTDGGFVHSDGAISC[CAM]HDMFDFLHLTGGGYAK.5|LANVQLLDTDGGFVHSDGAISC[CAM]HDM[Oxi]FDFLHLTGGGYAK.5|LANVQLLDTDGGFVHSDGAISC[CAM]HDMFDFLHLTGGGYAK.4|LKNGELENIKPK.3|LKNGELENIKPK.2|IIVLGLLPRGEKPNPLR.4|PLHELIMQLLEETPEEK.4|PLHELIMQLLEETPEEK.3|PLHELIM[Oxi]QLLEETPEEK.3|PLHELIMQLLEETPEEK.2|NGELENIKPK.2|IC[CAM]KPLHELIMQLLEETPEEK.4|IC[CAM]KPLHELIM[Oxi]QLLEETPEEK.4|IC[CAM]KPLHELIMQLLEETPEEK.3|IC[CAM]KPLHELIM[Oxi]QLLEETPEEK.3|DKEPDVLFVGDSMVQLMQQYEIWR.3|IC[CAM]KPLHELIMQLLEETPEEKQTTIA.3
SEN / CTL,Q07812,Apoptosis regulator BAX,BAX,2.70,1.74,5.99E-03,5.31E-04,3.27E+00,"ovarian follicle development,neuron migration,T cell homeostatic proliferation,B cell homeostasis,B cell apoptotic process,kidney development,release of cytochrome c from mitochondria,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,blood vessel remodeling,myeloid cell homeostasis,B cell negative selection,B cell homeostatic proliferation,positive regulation of B cell apoptotic process,glycosphingolipid metabolic process,regulation of nitrogen utilization,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,activation of signaling protein activity involved in unfolded protein response,germ cell development,mitochondrial fusion,extrinsic apoptotic signaling pathway via death domain receptors,intrinsic apoptotic signaling pathway in response to DNA damage,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,apoptotic mitochondrial changes,fertilization,response to toxic substance,response to salt stress,establishment or maintenance of transmembrane electrochemical gradient,response to gamma radiation,viral process,hypothalamus development,cerebral cortex development,negative regulation of protein binding,positive regulation of protein oligomerization,endoplasmic reticulum calcium ion homeostasis,negative regulation of endoplasmic reticulum calcium ion concentration,release of matrix enzymes from mitochondria,negative regulation of peptidyl-serine phosphorylation,regulation of mammary gland epithelial cell proliferation,cellular response to UV,ectopic germ cell programmed cell death,odontogenesis of dentin-containing tooth,regulation of apoptotic process,positive regulation of apoptotic process,regulation of protein homodimerization activity,regulation of protein heterodimerization activity,negative regulation of neuron apoptotic process,positive regulation of neuron apoptotic process,mitochondrial fragmentation involved in apoptotic process,development of secondary sexual characteristics,retinal cell programmed cell death,positive regulation of developmental pigmentation,negative regulation of fibroblast proliferation,spermatid differentiation,post-embryonic camera-type eye morphogenesis,response to axon injury,homeostasis of number of cells within a tissue,protein oligomerization,protein homooligomerization,positive regulation of release of sequestered calcium ion into cytosol,neuron apoptotic process,regulation of mitochondrial membrane potential,Sertoli cell proliferation,retina development in camera-type eye,positive regulation of apoptotic process involved in mammary gland involution,vagina development,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,thymocyte apoptotic process,mitochondrion morphogenesis,intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of release of cytochrome c from mitochondria,apoptotic signaling pathway,extrinsic apoptotic signaling pathway,extrinsic apoptotic signaling pathway in absence of ligand,intrinsic apoptotic signaling pathway,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,positive regulation of endoplasmic reticulum unfolded protein response,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,apoptotic process involved in patterning of blood vessels,apoptotic process involved in embryonic digit morphogenesis,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,positive regulation of apoptotic DNA fragmentation,positive regulation of IRE1-mediated unfolded protein response,B cell receptor apoptotic signaling pathway,negative regulation of apoptotic signaling pathway,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,positive regulation of intrinsic apoptotic signaling pathway","protein binding,lipid binding,channel activity,identical protein binding,protein homodimerization activity,protein heterodimerization activity,BH3 domain binding","nucleus,nuclear envelope,cytoplasm,mitochondrion,mitochondrial outer membrane,mitochondrial permeability transition pore complex,endoplasmic reticulum,endoplasmic reticulum membrane,cytosol,membrane,pore complex,extracellular exosome,Bcl-2 family protein complex,BAX complex",6,8,14,IGDELDSNMELQR.2|IGDELDSNM[Oxi]ELQR.2|RIGDELDSNMELQR.3|RIGDELDSNMELQR.2|TGALLLQGFIQDRAGR.3|MIAAVDTDSPR.2|M[Oxi]IAAVDTDSPR.2|GGGPTSSEQIMK.2|GGGPTSSEQIM[Oxi]K.2|MGGEAPELALDPVPQDASTK.3|M[Oxi]GGEAPELALDPVPQDASTK.2|MGGEAPELALDPVPQDASTK.2|TIMGWTLDFLR.2|TGALLLQGFIQDR.2
SEN / CTL,P28066,Proteasome subunit alpha type-5,PSMA5,2.70,1.73,1.68E-07,2.72E-08,7.57E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",18,17,34,LFQVEYAIEAIK.2|LFQVEYAIEAIK.3|SEYDRGVNTFSPEGR.3|AIGSASEGAQSSLQEVYHK.3|AIGSASEGAQSSLQEVYHK.4|AIGSASEGAQSSLQEVYHK.2|PFGVALLFGGVDEK.3|PFGVALLFGGVDEK.2|EELEEVIK.2|GVNTFSPEGR.2|RITSPLMEPSSIEK.3|RITSPLM[Oxi]EPSSIEK.3|RITSPLM[Oxi]EPSSIEK.2|RITSPLMEPSSIEK.2|GPQLFHMDPSGTFVQC[CAM]DAR.4|GPQLFHMDPSGTFVQC[CAM]DAR.3|GPQLFHM[Oxi]DPSGTFVQC[CAM]DAR.3|EELEEVIKDI.2|LNATNIELATVQPGQNFHM[Oxi]FTK.4|LNATNIELATVQPGQNFHMFTK.4|LNATNIELATVQPGQNFHM[Oxi]FTK.3|LNATNIELATVQPGQNFHMFTK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.2|IVEIDAHIGC[CAM]AMSGLIADAK.3|IVEIDAHIGC[CAM]AM[Oxi]SGLIADAK.3|IVEIDAHIGC[CAM]AMSGLIADAK.2|ITSPLM[Oxi]EPSSIEK.2|ITSPLMEPSSIEK.2|LGSTAIGIQTSEGVC[CAM]LAVEKR.3|LNATNIELATVQPGQNFHMFTKEELEEVIK.4|LNATNIELATVQPGQNFHMFTKEELEEVIK.3|PFGVALLFGGVDEKGPQLFHMDPSGTFVQC[CAM]DAR.4|LNATNIELATVQPGQNFHMFTKEELEEVIKDI.4
SEN / CTL,P55957,BH3-interacting domain death agonist,BID,2.70,1.68,3.59E-03,3.26E-04,3.49E+00,"release of cytochrome c from mitochondria,protein targeting to mitochondrion,activation of cysteine-type endopeptidase activity involved in apoptotic process,brain development,extrinsic apoptotic signaling pathway via death domain receptors,apoptotic mitochondrial changes,response to estradiol,positive regulation of protein oligomerization,positive regulation of protein homooligomerization,glial cell apoptotic process,regulation of cell proliferation,signal transduction in response to DNA damage,regulation of apoptotic process,positive regulation of apoptotic process,protein homooligomerization,neuron apoptotic process,establishment of protein localization to membrane,positive regulation of release of cytochrome c from mitochondria,hepatocyte apoptotic process,mitochondrial outer membrane permeabilization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,regulation of G1/S transition of mitotic cell cycle,positive regulation of extrinsic apoptotic signaling pathway,positive regulation of intrinsic apoptotic signaling pathway","death receptor binding,protein binding,ubiquitin protein ligase binding","mitochondrion,mitochondrial outer membrane,cytosol,membrane,integral component of mitochondrial membrane,extracellular exosome",6,10,18,LGRIEADSESQEDIIR.3|HLAQVGDSMDR.3|HLAQVGDSM[Oxi]DR.3|HLAQVGDSMDR.2|HLAQVGDSM[Oxi]DR.2|IEADSESQEDIIR.3|IEADSESQEDIIR.2|SIPPGLVNGLALQLR.3|SIPPGLVNGLALQLR.2|VASHTPSLLR.2|DLATALEQLLQAYPR.3|DLATALEQLLQAYPR.2|TMLVLALLLAK.2|DVFHTTVNFINQNLR.3|DVFHTTVNFINQNLR.2|NRDLATALEQLLQAYPR.3|ELDALGHELPVLAPQWEGYDELQTDGNR.4|ELDALGHELPVLAPQWEGYDELQTDGNR.3
SEN / CTL,P04083,Annexin A1,ANXA1,2.70,2.03,4.93E-19,2.54E-19,1.86E+01,"DNA strand renaturation,neutrophil homeostasis,adaptive immune response,monocyte chemotaxis,regulation of leukocyte migration,phagocytosis,inflammatory response,signal transduction,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,regulation of cell shape,response to X-ray,myoblast migration involved in skeletal muscle regeneration,peptide cross-linking,insulin secretion,keratinocyte differentiation,prostate gland development,endocrine pancreas development,positive regulation of vesicle fusion,positive regulation of prostaglandin biosynthetic process,actin cytoskeleton reorganization,response to estradiol,DNA duplex unwinding,regulation of interleukin-1 production,positive regulation of interleukin-2 production,positive regulation of neutrophil apoptotic process,DNA rewinding,gliogenesis,positive regulation of T cell proliferation,response to drug,negative regulation of apoptotic process,response to peptide hormone,estrous cycle,innate immune response,positive regulation of T-helper 1 cell differentiation,negative regulation of T-helper 2 cell differentiation,negative regulation of exocytosis,alpha-beta T cell differentiation,regulation of hormone secretion,arachidonic acid secretion,regulation of inflammatory response,cellular response to hydrogen peroxide,hepatocyte differentiation,prolactin secretion,response to interleukin-1,cellular response to glucocorticoid stimulus,granulocyte chemotaxis,positive regulation of wound healing,neutrophil clearance,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of phospholipase A2 activity,negative regulation of interleukin-8 secretion","single-stranded DNA binding,single-stranded RNA binding,helicase activity,receptor binding,structural molecule activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,protein binding, bridging,double-stranded DNA-dependent ATPase activity,annealing helicase activity,protein homodimerization activity,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","cornified envelope,phagocytic cup,extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endosome,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,extrinsic component of membrane,cytoplasmic vesicle membrane,extrinsic component of external side of plasma membrane,extrinsic component of endosome membrane,motile cilium,early endosome membrane,mitochondrial membrane,vesicle,sarcolemma,mast cell granule,protein complex,extracellular exosome",102,38,69,GVDEATIIDILTKR.3|GLGTDEDTLIEILASR.2|GLGTDEDTLIEILASR.3|GDRSEDFGVNEDLADSDAR.3|GDRSEDFGVNEDLADSDAR.2|DLAKDITSDTSGDFR.3|DLAKDITSDTSGDFR.2|GVDEATIIDILTK.2|GVDEATIIDILTK.3|GTDVNVFNTILTTR.2|GTDVNVFNTILTTR.3|QAWFIENEEQEYVQTVK.3|QAWFIENEEQEYVQTVK.2|SSKGGPGSAVSPYPTFNPSSDVAALHK.4|SSKGGPGSAVSPYPTFNPSSDVAALHK.3|KGTDVNVFNTILTTR.3|KGTDVNVFNTILTTR.2|GGPGSAVSPYPTFNPSSDVAALHK.3|GGPGSAVSPYPTFNPSSDVAALHK.4|GGPGSAVSPYPTFNPSSDVAALHK.2|DLAKDITSDTSGDFRNALLSLAK.4|ALTGHLEEVVLALLK.3|ALTGHLEEVVLALLK.4|ALTGHLEEVVLALLK.2|RKGTDVNVFNTILTTR.3|RKGTDVNVFNTILTTR.4|RKGTDVNVFNTILTTR.2|C[CAM]LTAIVK.2|DITSDTSGDFR.3|DITSDTSGDFR.2|PAFFAEK.2|NALLSLAK.2|VLDLELK.2|KALTGHLEEVVLALLK.4|KALTGHLEEVVLALLK.3|KALTGHLEEVVLALLK.2|ALYEAGER.2|C[CAM]ATSKPAFFAEK.3|C[CAM]ATSKPAFFAEK.2|VLDLELKGDIEK.3|VLDLELKGDIEK.2|ILVALC[CAM]GGN.2|ILVALC[CAM]GGN.1|PLDETLKK.2|AAYLQETGKPLDETLKK.4|AAYLQETGKPLDETLKK.3|AAYLQETGKPLDETLKK.2|AAYLQETGK.2|YSKHDMNK.2|ALYEAGERR.2|SEIDMNDIK.2|SEIDM[Oxi]NDIK.2|TPAQFDADELRAAM[Oxi]K.3|TPAQFDADELRAAMK.3|SEIDMNDIKAFYQK.3|MYGISLC[CAM]QAILDETK.3|M[Oxi]YGISLC[CAM]QAILDETK.2|MYGISLC[CAM]QAILDETK.2|SEDFGVNEDLADSDAR.3|SEDFGVNEDLADSDAR.2|AAYLQETGKPLDETLK.3|AAYLQETGKPLDETLK.2|TPAQFDADELR.2|DITSDTSGDFRNALLSLAK.3|DITSDTSGDFRNALLSLAK.2|ALTGHLEEVVLALLKTPAQFDADELR.4|MYGISLC[CAM]QAILDETKGDYEK.3|M[Oxi]YGISLC[CAM]QAILDETKGDYEK.3|MYGISLC[CAM]QAILDETKGDYEK.2
SEN / CTL,P49591,"Serine--tRNA ligase, cytoplasmic",SARS,2.70,2.17,1.22E-04,1.36E-05,4.87E+00,"translation,tRNA aminoacylation for protein translation,seryl-tRNA aminoacylation,tRNA processing,selenocysteine metabolic process,selenocysteinyl-tRNA(Sec) biosynthetic process","RNA binding,serine-tRNA ligase activity,ATP binding,selenocysteine-tRNA ligase activity","cytoplasm,cytosol,extracellular exosome",18,41,63,VLDLDLFR.2|KKEPVGDDESVPENVLSFDDLTADALANLK.4|KKEPVGDDESVPENVLSFDDLTADALANLK.3|LLIDEAILK.2|GGDPALIR.2|PAPIEQEPSKK.3|DVTLENR.2|VRLLIDEAILK.3|VDKGGDPALIRETQEK.4|VDKGGDPALIRETQEK.3|FKDPGLVDQLVK.3|FKDPGLVDQLVK.2|GYIPIYTPFFMR.3|GYIPIYTPFFMR.2|GYIPIYTPFFM[Oxi]R.2|IWGDC[CAM]TVR.2|DEWLRPEDLPIK.3|DEWLRPEDLPIK.2|IKLEAERFENLR.3|RFKDPGLVDQLVK.3|LQNMEVTDA.2|IEQFVYSSPHDNK.3|IEQFVYSSPHDNK.2|TIC[CAM]AILENYQTEK.3|TIC[CAM]AILENYQTEK.2|SDDNSYDEK.2|YAGLSTC[CAM]FR.2|DPGLVDQLVK.2|PAPIEQEPSK.2|KLDLEAWFPGSGAFR.3|KLDLEAWFPGSGAFR.2|YLIATSEQPIAALHR.3|YLIATSEQPIAALHR.2|ELVSC[CAM]SNC[CAM]TDYQAR.3|ELVSC[CAM]SNC[CAM]TDYQAR.2|EFMPPGLQELIPFVK.3|EFMPPGLQELIPFVK.2|MMDKVEFVHMLNATMC[CAM]ATTR.4|VEFVHMLNATMC[CAM]ATTR.3|VEFVHMLNATM[Oxi]C[CAM]ATTR.3|VEFVHMLNATMC[CAM]ATTR.2|LKEFMPPGLQELIPFVKPAPIEQEPSKK.5|LKEFM[Oxi]PPGLQELIPFVKPAPIEQEPSKK.4|LKEFMPPGLQELIPFVKPAPIEQEPSKK.4|YLIATSEQPIAALHRDEWLRPEDLPIK.5|YLIATSEQPIAALHRDEWLRPEDLPIK.4|YLIATSEQPIAALHRDEWLRPEDLPIK.3|YSHVDLVVMVDGFEGEK.3|EIGNLLHPSVPISNDEDVDNKVER.4|EIGNLLHPSVPISNDEDVDNKVER.3|EFMPPGLQELIPFVKPAPIEQEPSK.4|EFMPPGLQELIPFVKPAPIEQEPSK.3|GGDPALIRETQEK.2|EVMQEVAQLSQFDEELYK.3|EVM[Oxi]QEVAQLSQFDEELYK.2|EVMQEVAQLSQFDEELYK.2|EFMPPGLQELIPFVKPAPIEQEPSKK.4|EIGNLLHPSVPISNDEDVDNK.3|KEVMQEVAQLSQFDEELYK.3|LDLEAWFPGSGAFR.2|EPVGDDESVPENVLSFDDLTADALANLK.3|KEPVGDDESVPENVLSFDDLTADALANLK.3|KYSHVDLVVMVDGFEGEK.2
SEN / CTL,P08238,Heat shock protein HSP 90-beta,HSP90AB1,2.69,1.88,9.89E-68,3.14E-67,6.65E+01,"placenta development,protein folding,response to unfolded protein,response to salt stress,virion attachment to host cell,regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of phosphoprotein phosphatase activity,positive regulation of protein import into nucleus, translocation,cellular response to drug,Fc-gamma receptor signaling pathway involved in phagocytosis,response to cocaine,negative regulation of neuron apoptotic process,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,protein stabilization,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,cellular response to interleukin-4,cellular response to organic cyclic compound,positive regulation of protein serine/threonine kinase activity,fibril organization,cell-cell adhesion,regulation of cellular response to heat,negative regulation of complement-dependent cytotoxicity","glycoprotein binding,UTP binding,CTP binding,double-stranded RNA binding,protein binding,ATP binding,GTP binding,drug binding,sulfonylurea receptor binding,protein kinase regulator activity,kinase binding,protein kinase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,unfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleoplasm,cytoplasm,mitochondrion,lysosomal membrane,cytosol,cell-cell adherens junction,cell surface,membrane,inclusion body,basolateral plasma membrane,apical plasma membrane,brush border membrane,melanosome,extracellular exosome,sperm head plasma membrane,ooplasm,COP9 signalosome",264,84,175,YIDQEELNKTKPIWTRNPDDITQEEYGEFYK.5|GVVDSEDLPLNISR.2|GVVDSEDLPLNISR.3|ELISNASDALDKIR.3|ELISNASDALDKIR.2|HLEINPDHPIVETLR.4|HLEINPDHPIVETLR.2|HLEINPDHPIVETLR.3|KHLEINPDHPIVETLR.4|KHLEINPDHPIVETLR.3|KHLEINPDHPIVETLR.2|YHTSQSGDEMTSLSEYVSR.3|YHTSQSGDEMTSLSEYVSR.2|YHTSQSGDEMTSLSEYVSR.4|YHTSQSGDEM[Oxi]TSLSEYVSR.3|YHTSQSGDEM[Oxi]TSLSEYVSR.2|VILHLKEDQTEYLEER.4|VILHLKEDQTEYLEER.3|VILHLKEDQTEYLEER.2|TLTLVDTGIGMTKADLINNLGTIAK.3|TLTLVDTGIGMTKADLINNLGTIAK.4|NPDDITQEEYGEFYK.2|NPDDITQEEYGEFYK.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVSSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|ADLINNLGTIAK.2|ADLINNLGTIAK.3|YIDQEELNKTKPIWTR.4|YIDQEELNKTKPIWTR.3|APFDLFENK.2|RVFIMDSC[CAM]DELIPEYLNFIR.3|RVFIMDSC[CAM]DELIPEYLNFIR.4|RVFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|VILHLKEDQTEYLEERR.4|VILHLKEDQTEYLEERR.3|VILHLKEDQTEYLEERR.5|TLTLVDTGIGMTK.2|TLTLVDTGIGMTK.3|TLTLVDTGIGM[Oxi]TK.3|TLTLVDTGIGM[Oxi]TK.2|SIYYITGESKEQVANSAFVER.3|SIYYITGESKEQVANSAFVER.4|SIYYITGESKEQVANSAFVER.2|SLTNDWEDHLAVK.3|SLTNDWEDHLAVK.2|TKPIWTRNPDDITQEEYGEFYK.4|TKPIWTRNPDDITQEEYGEFYK.3|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.3|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.4|EQVANSAFVER.2|EQVANSAFVER.3|ELISNASDALDK.2|ELISNASDALDK.3|SIYYITGESK.2|VFIMDSC[CAM]DELIPEYLNFIR.3|VFIMDSC[CAM]DELIPEYLNFIR.4|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.2|VFIMDSC[CAM]DELIPEYLNFIR.2|HSQFIGYPITLYLEK.3|HSQFIGYPITLYLEK.4|HSQFIGYPITLYLEK.2|GFEVVYMTEPIDEYC[CAM]VQQLK.3|GFEVVYMTEPIDEYC[CAM]VQQLK.4|GFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|C[CAM]LELFSELAEDKENYKK.4|C[CAM]LELFSELAEDKENYKK.3|C[CAM]LELFSELAEDKENYKK.2|HSQFIGYPITLYLEKER.4|HSQFIGYPITLYLEKER.3|APFDLFENKK.3|APFDLFENKK.2|ALLFIPR.2|RAPFDLFENK.3|RAPFDLFENK.2|EGLELPEDEEEKKK.4|EGLELPEDEEEKKK.3|EGLELPEDEEEKKK.2|EMLQQSK.2|LGIHEDSTNRR.3|EDQTEYLEER.3|EDQTEYLEER.2|IRYESLTDPSK.3|IRYESLTDPSK.2|RLSELLR.2|FYEAFSK.2|FYEAFSK.1|HFSVEGQLEFR.3|HFSVEGQLEFR.2|GEKEEEDKDDEEKPK.4|GEKEEEDKDDEEKPK.3|IRYESLTDPSKLDSGK.4|IRYESLTDPSKLDSGK.3|IRYESLTDPSKLDSGK.2|RAPFDLFENKK.3|RAPFDLFENKK.2|EGLELPEDEEEK.3|EGLELPEDEEEK.2|EKYIDQEELNK.3|EKYIDQEELNK.2|IEDVGSDEEDDSGKDKK.4|IEDVGSDEEDDSGKDKK.3|ADHGEPIGR.2|YESLTDPSKLDSGKELK.4|YESLTDPSKLDSGKELK.3|YESLTDPSKLDSGKELK.2|EDQTEYLEERR.3|EDQTEYLEERR.2|KHSQFIGYPITLYLEK.4|KHSQFIGYPITLYLEK.3|KHSQFIGYPITLYLEK.2|LMKEILDK.2|NLKLGIHEDSTNR.3|AKFENLC[CAM]K.2|KFYEAFSK.2|EGLELPEDEEEKK.3|EGLELPEDEEEKK.2|YESLTDPSKLDSGK.3|YESLTDPSKLDSGK.2|ELKIDIIPNPQER.3|ELKIDIIPNPQER.2|YESLTDPSK.2|KC[CAM]LELFSELAEDKENYK.4|KC[CAM]LELFSELAEDKENYK.3|IKEKYIDQEELNK.3|KHSQFIGYPITLYLEKER.4|KHSQFIGYPITLYLEKER.3|HNDDEQYAWESSAGGSFTVR.4|HNDDEQYAWESSAGGSFTVR.3|HNDDEQYAWESSAGGSFTVR.2|SLVSVTKEGLELPEDEEEKK.4|LGIHEDSTNR.2|IEDVGSDEEDDSGKDK.3|YIDQEELNK.2|AQALRDNSTMGYMMAK.3|AQALRDNSTM[Oxi]GYMMAK.3|AQALRDNSTMGYM[Oxi]MAK.3|AQALRDNSTMGYMM[Oxi]AK.3|AQALRDNSTMGYMMAK.2|IDIIPNPQER.2|DNSTMGYMMAK.2|DNSTM[Oxi]GYMMAK.2|DNSTMGYM[Oxi]MAK.2|DNSTMGYMM[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]MAK.2|DNSTM[Oxi]GYMM[Oxi]AK.2|DNSTMGYM[Oxi]M[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]M[Oxi]AK.2|EIFLRELISNASDALDK.3|EISDDEAEEEK.2|RGFEVVYMTEPIDEYC[CAM]VQQLK.4|RGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|RGFEVVYMTEPIDEYC[CAM]VQQLK.3|C[CAM]LELFSELAEDKENYK.3|KRGFEVVYMTEPIDEYC[CAM]VQQLK.4|KRGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.4|KRGFEVVYMTEPIDEYC[CAM]VQQLK.3|LDSGKELKIDIIPNPQER.3|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.5|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.3|SLTNDWEDHLAVKHFSVEGQLEFR.4|SLTNDWEDHLAVKHFSVEGQLEFR.3|SLVSVTKEGLELPEDEEEK.3|VVVITKHNDDEQYAWESSAGGSFTVR.4|VVVITKHNDDEQYAWESSAGGSFTVR.3|C[CAM]LELFSELAEDK.2|DLVVLLFETALLSSGFSLEDPQTHSNR.4|DLVVLLFETALLSSGFSLEDPQTHSNR.3|IEDVGSDEEDDSGK.2|KC[CAM]LELFSELAEDK.2|PIWTRNPDDITQEEYGEFYK.3|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRM[Oxi]EEVD.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD.4
SEN / CTL,P61077;P62837,Ubiquitin-conjugating enzyme E2 D3;Ubiquitin-conjugating enzyme E2 D2,UBE2D3;UBE2D2,2.69,1.77,1.92E-04,2.07E-05,4.68E+00,"negative regulation of transcription from RNA polymerase II promoter,protein polyubiquitination,DNA repair,cellular protein modification process,ubiquitin-dependent protein catabolic process,protein monoubiquitination,apoptotic process,protein ubiquitination,BMP signaling pathway,TRIF-dependent toll-like receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,protein autoubiquitination,regulation of transcription from RNA polymerase II promoter in response to hypoxia,protein K48-linked ubiquitination,protein K11-linked ubiquitination,positive regulation of protein targeting to mitochondrion;protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,cellular protein modification process,ubiquitin-dependent protein catabolic process,protein ubiquitination,TRIF-dependent toll-like receptor signaling pathway,Fc-epsilon receptor signaling pathway,T cell receptor signaling pathway,protein autoubiquitination,regulation of transcription from RNA polymerase II promoter in response to hypoxia,protein K48-linked ubiquitination","ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin conjugating enzyme activity;ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin conjugating enzyme activity","nucleoplasm,cytosol,plasma membrane,endosome membrane,extracellular exosome;ubiquitin ligase complex,nucleoplasm,cytosol,protein complex,extracellular exosome",12,3,7,VLLSIC[CAM]SLLC[CAM]DPNPDDPLVPEIAR.3|VLLSIC[CAM]SLLC[CAM]DPNPDDPLVPEIAR.4|IYHPNINSNGSIC[CAM]LDILR.3|IYHPNINSNGSIC[CAM]LDILR.4|IYHPNINSNGSIC[CAM]LDILR.2|SQWSPALTISK.3|SQWSPALTISK.2
SEN / CTL,P41250,Glycine--tRNA ligase,GARS,2.68,1.45,1.15E-11,2.99E-12,1.15E+01,"tRNA aminoacylation for protein translation,glycyl-tRNA aminoacylation,diadenosine tetraphosphate biosynthetic process","bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,glycine-tRNA ligase activity,ATP binding,protein dimerization activity","nucleoplasm,cytoplasm,mitochondrial matrix,cytosol,secretory granule,axon,extracellular exosome",30,46,82,TFFSFPAVVAPFK.2|TFFSFPAVVAPFK.3|TLYVEEVVPNVIEPSFGLGR.3|TLYVEEVVPNVIEPSFGLGR.2|TLYVEEVVPNVIEPSFGLGR.4|LGDAVEQGVINNTVLGYFIGR.3|LGDAVEQGVINNTVLGYFIGR.2|SPITGNDLSPPVSFNLMFK.3|SPITGNDLSPPVSFNLM[Oxi]FK.3|SPITGNDLSPPVSFNLM[Oxi]FK.2|SPITGNDLSPPVSFNLMFK.2|TSGHVDKFADFM[Oxi]VK.4|TSGHVDKFADFMVK.3|TSGHVDKFADFMVK.2|HGVSHKVDDSSGSIGR.4|IMYTVFEHTFHVR.4|IM[Oxi]YTVFEHTFHVR.4|IMYTVFEHTFHVR.3|IM[Oxi]YTVFEHTFHVR.3|IMYTVFEHTFHVR.2|SC[CAM]YDLSC[CAM]HAR.3|SC[CAM]YDLSC[CAM]HAR.2|APQVDVDK.2|ATKVPLVAEKPLKEPK.4|HGVSHKVDDSSGSIGRR.4|IYLYLTK.2|LPFAAAQIGNSFR.3|LPFAAAQIGNSFR.2|YPLFEGQETGKK.3|YPLFEGQETGKK.2|LLEFNQGK.2|EFTMAEIEHFVDPSEKDHPK.5|EFTMAEIEHFVDPSEKDHPK.4|VPLVAEKPLKEPK.3|VPLVAEKPLKEPK.2|APQVDVDKAVAELK.3|LKEDKAPQVDVDK.3|VDDSSGSIGR.2|ELALQPKDDIVDR.3|ELALQPKDDIVDR.2|NNIIQTWR.2|VREFTMAEIEHFVDPSEKDHPK.5|VREFTMAEIEHFVDPSEKDHPK.4|VREFTMAEIEHFVDPSEKDHPK.3|VREFTMAEIEHFVDPSEK.4|VREFTMAEIEHFVDPSEK.3|RLLEFNQGK.2|GEFTIETEGK.2|TVNVVQFEPSKGAIGK.3|FQNVADLHLYLYSAK.3|FQNVADLHLYLYSAK.2|RLLEFNQGKLPFAAAQIGNSFR.4|RLLEFNQGKLPFAAAQIGNSFR.3|QHMENEMAHYAC[CAM]DC[CAM]WDAESK.4|TVNVVQFEPSK.2|EFTMAEIEHFVDPSEK.3|EFTMAEIEHFVDPSEK.2|YPLFEGQETGK.2|YPLFEGQETGKKETIEE.3|C[CAM]SVLPLSQNQEFMPFVK.3|C[CAM]SVLPLSQNQEFM[Oxi]PFVK.3|C[CAM]SVLPLSQNQEFM[Oxi]PFVK.2|C[CAM]SVLPLSQNQEFMPFVK.2|AEISELPSIVQDLANGNITWADVEAR.4|AEISELPSIVQDLANGNITWADVEAR.3|FRQHMENEMAHYAC[CAM]DC[CAM]WDAESK.4|FRQHMENEM[Oxi]AHYAC[CAM]DC[CAM]WDAESK.4|TFIGPGGNM[Oxi]PGYLRPETAQGIFLNFK.4|TFIGPGGNMPGYLRPETAQGIFLNFK.4|TFIGPGGNM[Oxi]PGYLRPETAQGIFLNFK.3|TFIGPGGNMPGYLRPETAQGIFLNFK.3|NGEC[CAM]FRADHLLK.2|TFIGPGGNMPGYLRPETAQGIFLNFKR.4|LLEFNQGKLPFAAAQIGNSFR.3|SSMDGAGAEEVLAPLR.2|TSYGWIEIVGC[CAM]ADR.2|KSEMESVLAQLDNYGQQELADLFVNYNVK.4|KSEM[Oxi]ESVLAQLDNYGQQELADLFVNYNVK.3|KSEMESVLAQLDNYGQQELADLFVNYNVK.3|MRLGDAVEQGVINNTVLGYFIGR.3|QHFIQEEQILEIDC[CAM]TM[Oxi]LTPEPVLK.3|QHFIQEEQILEIDC[CAM]TMLTPEPVLK.3
SEN / CTL,Q969H8,Myeloid-derived growth factor,MYDGF,2.68,2.34,1.01E-02,8.72E-04,3.06E+00,"angiogenesis,positive regulation of protein phosphorylation,positive regulation of endothelial cell proliferation,apoptotic process,positive regulation of phosphatidylinositol 3-kinase signaling,IRE1-mediated unfolded protein response,negative regulation of apoptotic process,positive regulation of MAPK cascade,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of protein kinase B signaling",protein binding,"extracellular space,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,extracellular exosome",18,8,13,SYLYFTQFK.2|GAEIEYAMAYSK.2|GAEIEYAM[Oxi]AYSK.2|AAFERESDVPLKTEEFEVTK.4|AAFERESDVPLKTEEFEVTK.3|PGGVVHSFSHNVGPGDK.4|PGGVVHSFSHNVGPGDK.3|PGGVVHSFSHNVGPGDK.2|TEEFEVTK.2|TAVAHRPGAFK.2|ESDVPLKTEEFEVTK.3|ESDVPLKTEEFEVTK.2|YTC[CAM]MFTYASQGGTNEQWQMSLGTSEDHQHFTC[CAM]TIWRPQGK.5
SEN / CTL,Q92626,Peroxidasin homolog,PXDN,2.67,1.66,5.90E-31,6.93E-31,3.02E+01,"negative regulation of cytokine-mediated signaling pathway,immune response,response to oxidative stress,extracellular matrix organization,hydrogen peroxide catabolic process,oxidation-reduction process,cellular oxidant detoxification","peroxidase activity,interleukin-1 receptor antagonist activity,extracellular matrix structural constituent,heme binding,metal ion binding","proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum,extracellular matrix,extracellular exosome",108,30,36,EQINQLTSYIDASNVYGSTEHEAR.3|SPNDLLALFR.2|ISGVALHDQGQYEC[CAM]QAVNIIGSQK.3|LDSNTLHC[CAM]DC[CAM]EILWLADLLK.3|LYGSTLNIDLFPALVVEDLVPGSR.3|IVNEGGIDPLLR.2|C[CAM]MHLLLEAVPAVAPQTSILDLR.3|RLYGSTLNIDLFPALVVEDLVPGSR.3|NLNTLLLNNNQIK.2|SSPVC[CAM]GSGMTSLLMNSVYPR.3|AEGNPKPEIIWLR.3|TLGEYHGYDPGINAGIFNAFATAAFR.3|LDENFQPIAQDHLPLHK.4|LFSM[Oxi]AHTVALDLAAINIQR.3|LFSMAHTVALDLAAINIQR.3|LFSMAHTVALDLAAINIQR.2|NGDPFVATSIVEAIATVDR.3|LWYENPGVFSPAQLTQIK.3|IVGAEIQHITYQHWLPK.4|IVGAEIQHITYQHWLPK.3|AGEIFER.2|AFFSPFR.2|ITHLVPGTFNHLESMK.4|ITHLVPGTFNHLESMK.3|FGHTLVNPLLYR.3|DGVQVTESGK.2|RIPSGAFEDLENLK.3|DAC[CAM]TIC[CAM]EC[CAM]K.2|ANEQLGLTSMHTLWFR.3|ANEQLGLTSMHTLWFR.2|LSTTEC[CAM]VDAGGESHANNTK.3|VWQDC[CAM]C[CAM]EDC[CAM]R.2|FHISPEGFLTINDVGPADAGR.3|VPSQLLNTELTER.2|LGPTLMC[CAM]LLSTQFK.2|LGPTLM[Oxi]C[CAM]LLSTQFK.2
SEN / CTL,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,2.67,1.59,3.68E-133,4.96E-132,1.31E+02,"regulation of RNA splicing,protein oligomerization,cell-cell adhesion,regulation of voltage-gated calcium channel activity","protein binding,S100 protein binding,poly(A) RNA binding,structural molecule activity conferring elasticity,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,lysosomal membrane,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,T-tubule,vesicle,sarcolemma,costamere,cell-cell contact zone,extracellular exosome,membrane raft",498,433,666,IKGDVPSVGLEGPDVDLQGPEAK.3|ISIPDVDLDLKGPK.3|ISMPDLDLNLKGPK.3|ISMPDLDLNLKGPK.2|TVIRLPSGSGAASPTGSAVDIR.3|GLDLGGRGGVQVPAVDISSSLGGR.3|ISMPDIDLNLKGPK.3|ISMPDIDLNLKGPK.2|ISM[Oxi]PDIDLNLKGPK.3|MSLPDVDLDLKGPK.3|M[Oxi]SLPDVDLDLKGPK.3|ISMPEVDLNLKGPK.3|LKSEDGVEGDLGETQSR.3|LKSEDGVEGDLGETQSR.2|VDIKAPDVEGQGLDWSLKIPK.4|ISMPDIDLNLTGPK.2|ISMPDIDLNLTGPK.3|VNVEAPDVNLEGLGGK.2|VNVEAPDVNLEGLGGK.3|ADLGVSGPKVDIDVPDVNLEAPEGK.3|VSVGAPDLSLEASEGSIKLPK.3|VSVGAPDLSLEASEGSIKLPK.4|VSVGAPDLSLEASEGSIKLPK.2|ANVDISAPKVDTNAPDLSLEGPEGK.3|VDINAPDVEVQGK.2|ISMPDVDLHLKGPK.3|ISMPDVDLHLKGPK.2|ISM[Oxi]PDVDLHLKGPK.3|MDVNVGDIDIEGPEGK.2|M[Oxi]DVNVGDIDIEGPEGK.2|VDIETPNLEGTLTGPR.2|VDIETPNLEGTLTGPR.3|ASLGSLEGEAEAEASSPK.2|ASLGSLEGEAEAEASSPK.3|VSMPDVDLNLKGPK.3|VSMPDVDLNLKGPK.2|ADLDVSGPKVDIDVPDVNIEGPEGK.3|ADLDVSGPKVDIDVPDVNIEGPDAK.3|ISMSEVDLNVAAPK.2|ISM[Oxi]SEVDLNVAAPK.2|HELTEISNVDVETQSGK.3|HELTEISNVDVETQSGK.2|FSMPSLKGEGPEFDVNLSK.3|VDIKAPEVNLNAPDVDVHGPDWNLK.4|VKGEYDVTVPKLEGELK.4|VDIKAPDVEGQGLDWSLK.3|VTAYTVDVTGR.2|ISMQDVDLSLGSPK.2|ISMQDVDLSLGSPK.3|ISM[Oxi]QDVDLSLGSPK.2|ISMPDVDLNLKGPK.3|ISM[Oxi]PDVDLNLKGPK.3|ISMPDVDLNLKGPK.2|ISMPDLDLNLK.2|ISM[Oxi]PDLDLNLK.2|ISAPNVDFNLEGPK.2|ISAPNVDFNLEGPK.3|SPQISMSDIDLNLKGPK.3|SPQISMSDIDLNLKGPK.2|VGVEVPDVNIEGPEGK.2|VGVEVPDVNIEGPEGK.3|MDAEVPDVNIEGPDAK.2|MDAEVPDVNIEGPDAK.3|M[Oxi]DAEVPDVNIEGPDAK.2|VDVEVPDVSLEGPEGK.2|VDVEVPDVSLEGPEGK.3|IDVTAPDVSIEEPEGK.2|IDVTAPDVSIEEPEGK.3|ISMPDIDLNLK.2|ISMPDIDLNLK.3|ISM[Oxi]PDIDLNLK.2|VGIDTPDIDIHGPEGK.3|VGIDTPDIDIHGPEGK.2|VDIDVPDVNIEGPEGK.2|VDIDVPDVNIEGPEGK.3|VDIDVPDVNIEGPDAK.2|VDIDVPDVNIEGPDAK.3|VQANLGAPDINIEGLDAK.2|VQANLGAPDINIEGLDAK.3|ADIDVSGPKVDVDIPDVNIEGPDAK.3|MPFLSISSPK.2|M[Oxi]PFLSISSPK.2|VKGDADVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VDVSAPDVEAHGPEWNLK.3|VDVSAPDVEAHGPEWNLK.2|VDINAPDVGVQGPDWHLK.3|VDINAPDVGVQGPDWHLK.2|VDVNAPDVQAPDWHLK.2|VDVNAPDVQAPDWHLK.3|IEGEMQVPDVDIRGPK.3|ISMPDVDFNLKGPK.3|ISM[Oxi]PDVDFNLKGPK.3|FSMPGFKGEGPEVDVKLPK.4|FSMPGFKGEGPDVDVNLPK.3|FSM[Oxi]PGFKGEGPDVDVNLPK.3|FSMPGFKGEGPDVDVNLPK.2|VDINAPDVDVQGPDWHLK.3|VDINAPDVDVQGPDWHLK.4|VDINAPDVDVQGPDWHLK.2|VKGDLDIAGPNLEGDFKGPK.4|VKGDLDIAGPNLEGDFKGPK.3|VKGDLDIAGPNLEGDFKGPK.2|VDIDAPDVDVHGPDWHLK.4|VDIDAPDVDVHGPDWHLK.3|VDIDAPDVDVHGPDWHLK.2|GGVQVPAVDISSSLGGR.2|GGVQVPAVDISSSLGGR.3|FSMPGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.4|FSM[Oxi]PGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.2|MDIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.4|M[Oxi]DIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.2|GSRVDIETPNLEGTLTGPR.3|GSRVDIETPNLEGTLTGPR.2|ISMPGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.4|ISM[Oxi]PGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.2|MDIDVPDVEVQGPDWHLK.3|M[Oxi]DIDVPDVEVQGPDWHLK.3|FSMPGFKGEGPEVDMNLPK.3|FSMPGFKGEGPEVDM[Oxi]NLPK.3|MDIDAPDVDVHGPDWHLK.4|MDIDAPDVDVHGPDWHLK.3|MDIDAPDVDVHGPDWHLK.2|ISMPDIDFNLKGPK.3|ISMPDIDFNLKGPK.2|FSMPGFKGEGPEVDVTLPK.3|FSMPGFKGEGPEVDVTLPK.4|FSM[Oxi]PGFKGEGPEVDVTLPK.3|VDINAPDVDVHGPDWHLK.4|VDINAPDVDVHGPDWHLK.3|FSVPGFKAEGPEVDVNLPK.3|FSVPGFKAEGPEVDVNLPK.2|VDISAPDVDVHGPDWHLK.4|VDISAPDVDVHGPDWHLK.3|VDISAPDVDVHGPDWHLK.2|RVTAYTVDVTGR.3|RVTAYTVDVTGR.2|VKGDMDISLPK.3|VKGDMDISLPK.2|ISMPDFDLHLK.3|ISM[Oxi]PDFDLHLK.3|ISMPDFDLHLK.2|ISM[Oxi]PDFDLHLK.2|AVEVQGPSLESGDHGK.4|AVEVQGPSLESGDHGK.3|AVEVQGPSLESGDHGK.2|FSMPGFK.2|FSM[Oxi]PGFK.2|FSMPGFKGEGR.3|FSMPGFKGEGR.2|IKGDMDISVPK.3|IKGDMDISVPK.2|IPMPDFDLHLKGPK.4|IPMPDFDLHLKGPK.3|ISM[Oxi]PDFDLHLKGPK.4|ISMPDFDLHLKGPK.4|ISM[Oxi]PDFDLHLKGPK.3|ISMPDFDLHLKGPK.3|LKTDVDVSLPK.3|LKTDVDVSLPK.2|MPDMHVNMPK.3|MPDMHVNMPK.2|VPDVDIR.2|VPDVEIK.2|VPDVELK.2|VTAPDVDLHLK.3|VTAPDVDLHLK.2|AGAISASGPELQGAGHSK.4|AGAISASGPELQGAGHSK.3|AGAISASGPELQGAGHSK.2|LEGGEVDLKGPK.3|VEGDLKGPEADIKGPK.4|VEGDLKGPEADIKGPK.3|VKGEYDVTVPK.3|VKGEYDVTVPK.2|ISMPDVDLHVK.3|ISMPDVDLHVK.2|MKGDYDVTVPK.3|MKGDYDVTVPK.2|VEGDLKGPEVDIKGPK.4|VEGDLKGPEVDIKGPK.3|VEGDLKGPEVDLKGPK.4|VEGDLKGPEVDLKGPK.3|ADLGVSGPK.2|AEGPEVDVNLPK.3|AEGPEVDVNLPK.2|GEGPDVHMTLPK.3|GEGPDVHMTLPK.2|GKKPDIDITGPK.3|GPDWHLK.2|ISMPDLDLHLK.3|ISM[Oxi]PDLDLHLK.3|ISMPDLDLHLK.2|ISM[Oxi]PDVDLHLK.3|ISMPDVDLHLK.3|ISMPDVDLHLK.2|ISM[Oxi]PDVDLHLK.2|MEGDLKGPEVDIKGPK.4|MEGDLKGPEVDIKGPK.3|VEGDLKGPEIDVKAPK.4|VEGEIKAPDVDIKGPK.4|VEGTLKGPEVDLKGPR.4|VEGTLKGPEVDLKGPR.3|VKGEYDMTVPK.3|VKGEYDMTVPK.2|ADVVVSGPK.2|GPRLDFEGPDAK.3|ISMPDVDLHMK.3|ISMPDVDLHMK.2|MPEMNIK.2|M[Oxi]PEMNIK.2|MPEM[Oxi]NIK.2|VEGDMKVPDVDIKGPK.4|VEGEMKVPDVDIKGPK.4|VHAPGLNLSGVGGK.3|VHAPGLNLSGVGGK.2|ADVDVSGPK.2|GDISISGPK.2|GDVDVSAPK.2|GDVDVSGPK.2|IKGDVDVTGPKVEGDLK.4|IPMPDFDLHLK.3|IPM[Oxi]PDFDLHLK.3|IPMPDFDLHLK.2|ISMPDVDLHLKGPNVK.4|ISMPDVDLHLKGPNVK.3|LKGDVDVSGPKLEGDIK.4|LKGDVDVSGPKLEGDIK.3|VEGEMKVPDVEIKGPK.4|VEGEMKVPDVEIKGPK.3|VKMPDVDISVPK.3|VKVPEVDVRGPK.3|GNVDISAPK.2|GPGVDVNLK.2|IKGDVDVSAPKLEGELK.4|IKGDVDVSAPKLEGELK.3|MQVGGDGVK.2|ADIDVSGPK.2|ADLDVSGPK.2|ADVDISGPK.2|AEAPLPSPK.2|AKGEVDVDVPKLEGDLK.4|AKGEVDVDVPKLEGDLK.3|ANVDISAPK.2|EVDVNLPK.2|GDVVVSLPK.2|GGVDVTLPR.2|GPQVSGELK.2|LEVPDMNIRGPK.3|VEGDLKGPEADIK.3|VEGDLKGPEADIK.2|VPGIDATTK.2|ADIEISGPK.2|FKMPFLSISSPK.3|GDVDVSLPK.2|GDVDVSVPK.2|GEGPEVDVK.2|GPKVDIDAPDVDVHGPDWHLK.5|GPKVDIDAPDVDVHGPDWHLK.4|GPKVDIDAPDVDVHGPDWHLK.3|GPKVDIDAPDVDVHGPDWHLK.2|MPEMHFK.2|VEGTLKGPEVDLK.3|VKGDMDVSVPKVEGEMK.4|GDVDISLPK.2|GDVDVTLPK.2|GSLGATGEIK.2|LEGDLKGPEVDIK.3|LPQFGISTPGSDLHVNAK.4|LPQFGISTPGSDLHVNAK.3|LPQFGISTPGSDLHVNAK.2|VEGDLKGPEIDIK.3|VEGDLKGPEIDVK.3|VEGDLKGPEIDVK.2|VEGDLKGPEVDIK.3|VEGDLKGPEVDIK.2|VEGDLKGPEVDLK.3|VEGDLKGPEVDLK.2|GDMDVSVPK.2|GPKVDIDAPDVEVHDPDWHLK.5|LEGELKGPELDVK.3|MEGDLKGPEVDIK.3|VEGDLKGPEVDIR.3|GDFDVSVPK.2|GDMDISVPK.2|GDMDVSLPK.2|GEVDVDVPK.2|GGLKGSEVGFHGAAPDISVK.4|GKGGVTGSPEASISGSKGDLK.4|GPHVDVSGPDIDIEGPEGK.4|GPHVDVSGPDIDIEGPEGK.3|GPHVDVSGPDIDIEGPEGK.2|IGFSGPKLEGGEVDLKGPK.4|IGFSGPKLEGGEVDLKGPK.3|LEGGEVDLK.2|LEGPDVSLK.2|MEGDLKAPEVDIK.3|M[Oxi]EGDLKAPEVDIK.3|TPEMIIQK.2|VEGDMKVPDVDIK.3|FGTFGGLGSK.2|GDMDISLPK.2|TDVDVSLPK.2|VEGEMKVPDVDIK.3|GDRSPEPGQTWTR.3|GDRSPEPGQTWTR.2|GPEVDVSGPK.2|ISIPDVGLHLKGPK.3|ISMPDVGLNLKAPK.3|LDFEGPDAK.2|LQVTMPGIK.2|LQVTM[Oxi]PGIK.2|VEGEMKVPDVDIR.3|VESEIKVPDVELK.3|VESEIKVPDVELK.2|FSMPGFKGEGPDGDVKLPK.4|GDYDVTVPK.2|GHYEVTGSDDETGK.3|GHYEVTGSDDETGK.2|ISMPGFKGEGPDVDVNLPK.4|ISMPGFKGEGPDVDVNLPK.3|ISM[Oxi]PGFKGEGPDVDVNLPK.3|ISMPGFKGEGPDVDVNLPK.2|VGGSGVNVNAK.2|VTAPDVDLHLKAPK.3|VTAPDVDLHLKAPK.2|APDVEGQGLDWSLK.3|APDVEGQGLDWSLK.2|GEYDVTVPK.2|GKGGVTGSPEASISGSK.3|GKGGVTGSPEASISGSK.2|ISMPDVNLNLKGPK.3|LKGPDVKLPDMSVK.3|VQTPEVDVK.2|EGAKDIDISSPEFK.3|GPNVKGEYDVTMPK.3|ISMPEIDLNLKGSK.3|VDIDVPDVDVQGPDWHLK.4|VDIDVPDVDVQGPDWHLK.3|VDIDVPDVDVQGPDWHLK.2|VDINAPDVDVRGPDWHLK.4|VDINAPDVDVRGPDWHLK.3|VDINAPDVEVHGPDWHLK.4|VDINAPDVEVHGPDWHLK.3|VDINAPDVEVHGPDWHLK.2|VDINTPDVDVHGPDWHLK.4|VDINTPDVDVHGPDWHLK.3|APDVDIKGPK.2|GEYDMTVPK.2|GEYDVTMPK.2|GEYDVTM[Oxi]PK.2|GPEVDIKGPK.2|GSEVGFHGAAPDISVK.3|GSEVGFHGAAPDISVK.2|IKGDVDVSVPEVEGK.3|IKGDVDVSVPEVEGK.2|ISMPDVDLHMKGPK.3|ISMPDVDLHMKGPK.2|LQGSGVSLASK.2|MPTFSTPGAK.2|SPQISMSDIDLNLK.3|SPQISM[Oxi]SDIDLNLK.2|SPQISMSDIDLNLK.2|VSMPDVELNLKSPK.3|GPQVSGELKGPGVDVNLKGPR.4|ISMPDFDLNLKGPK.3|VDIDAPDVEVHDPDWHLK.4|VDIDAPDVEVHDPDWHLK.3|VSAPGVQGDVK.2|GEVDVDVPKLEGDLK.3|GPSLKGDLDASVPSMK.3|GPSLKGDLDASVPSMK.2|M[Oxi]KLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.3|M[Oxi]KLPQFGISTPGSDLHVNAK.3|MPSLEISAPK.2|VPDVDIKGPK.2|ELLLPNWQGSGSHGLTIAQR.4|ELLLPNWQGSGSHGLTIAQR.3|ELLLPNWQGSGSHGLTIAQR.2|KPDIDITGPK.2|LEVPDMNIR.2|VDTNAPDLSLEGPEGKLKGPK.4|VGVEVPDVNIEGPEGKLKGPK.4|IGFSGPKLEGGEVDLK.3|LPSGSGAASPTGSAVDIR.3|LPSGSGAASPTGSAVDIR.2|MPDVDISVPK.2|SKGHYEVTGSDDETGKLQGSGVSLASK.5|VDIEAPDVSLEGPEGK.3|VDIEAPDVSLEGPEGK.2|VDTNAPDLSLEGPEGK.3|VDTNAPDLSLEGPEGK.2|VDVEGPDVNIEGPEGK.3|VDVEGPDVNIEGPEGK.2|VDVEVPDVSLEGPEGKLKGPK.4|FAGGLHFSGPK.2|FSMPGFKGEGPDGDVK.3|FSMPGFKGEGPDGDVK.2|GDLDASVPSMK.2|IDVTAPDVSIEEPEGKLKGPK.4|ISMPDVDLHLKGPNVKGEYDVTMPK.5|LKGDVDVSGPK.2|VDIEGPDVNIEGPEGK.3|VDIEGPDVNIEGPEGK.2|VDVDVPDVNIEGPDAK.3|VDVDVPDVNIEGPDAK.2|VKGDADVSVPK.2|VSAPEVSVGHK.2|GPKVDVSAPDVEAHGPEWNLK.4|GPKVDVSAPDVEAHGPEWNLK.3|IDVDAPDIDIHGPDAK.3|IDVDAPDIDIHGPDAK.2|IKGDVDVSAPK.2|IKGDVDVTGPK.2|IPRHELTEISNVDVETQSGK.4|IPRHELTEISNVDVETQSGK.3|VDIDTPDINIEGSEGKFKGPK.4|APSLDIKGPEVDVSGPK.3|APSLDIKGPEVDVSGPK.2|GPKVDISAPDVDVHGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.3|LEGELKGPELDVKGPK.3|SKGHYEVTGSDDETGK.3|VDIDTPDIDIHGPEGK.3|VDIDTPDINIEGSEGK.3|VDIDTPDINIEGSEGK.2|VDIDVPDVNLEAPEGK.3|VDIDVPDVNLEAPEGK.2|VKGDVDVSVPK.2|VKGGVDVTLPR.2|AKGEVDVDVPK.2|DIDISSPEFK.2|EMGVDVHFPK.2|FSM[Oxi]PGFKGEGPEVDVK.3|FSMPGFKGEGPEVDVK.3|GPKVDINAPDVDVQGPDWHLK.4|GPKVDINAPDVEVHGPDWHLK.4|LNVGAPDVTLR.2|MEGDLKAPEVDIKGPK.3|MKGNVDISAPK.2|M[Oxi]KGNVDISAPK.2|MPTFSTPGAKGEGPDVHMTLPK.4|SPEPGQTWTR.2|VEGDMQVPDLDIKGPK.3|VEGDMQVPDLDIKGPK.2|VKGDVDVSLPK.2|GPKVDIDVPDVDVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.3|MKGDVVVSLPK.2|M[Oxi]KGDVVVSLPK.2|QGFDLNVPGGEIDASLK.3|QGFDLNVPGGEIDASLK.2|VDVEC[CAM]PDVNIEGPEGK.3|VDVEC[CAM]PDVNIEGPEGK.2|VKGDMDVSVPK.2|VKGDM[Oxi]DVSVPK.2|VKGDVDISLPK.2|VKGDVDVTLPK.2|VSAPGVQGDVKGPQVALK.3|VSGPDLDLNLK.2|FKAEAPLPSPK.2|ISMPDVGLNLK.2|LEGDIKAPSLDIKGPEVDVSGPK.4|MKGDVDVSLPK.2|MPEMSIKPQK.2|MPSMNIQTHK.2|MQVGGDGVKVPGIDATTK.3|M[Oxi]QVGGDGVKVPGIDATTK.3|TPEMIIQKPK.2|VKGDMDVSLPK.2|EVDVNLPKADIDVSGPK.3|GPQVSGELKGPGVDVNLK.3|GPQVSGELKGPGVDVNLK.2|ISIPDVGLHLK.2|VKGDFDVSVPK.2|VKGDLDIAGPNLEGDFK.3|VKGDLDIAGPNLEGDFK.2|AEGPDVAVDLPK.2|APNISMPDVDLNLKGPK.3|APNISMPDVDLNLKGPK.2|GEGPDVDVSLPK.2|GGQIGLQAPGLSVSGPQGHLESGSGK.4|GGQIGLQAPGLSVSGPQGHLESGSGK.3|LKGPQITGPSLEGDLGLK.3|LKGPQITGPSLEGDLGLK.2|MKGEVDVSLANVEGDLK.3|VDINAPDVDVR.2|VKGDVDVSVPKVEGEMK.3|DDGVFVQEVTQNSPAAR.3|DDGVFVQEVTQNSPAAR.2|GDLDIAGPNLEGDFKGPK.3|GEGPDVDVTLPK.2|GPEVDIEGPEGK.2|GPTVGGGLPGIGVQGLEGNLQMPGIK.4|GPTVGGGLPGIGVQGLEGNLQMPGIK.3|GPTVGGGLPGIGVQGLEGNLQM[Oxi]PGIK.3|IKGGADVSGGVSAPDISLGEGHLSVK.4|ISIPDVDLDLK.2|VSMPDVDLNLK.2|GEGPDVDVNLPK.2|GEGPEVDVTLPK.2|ISMPDVDLNLK.2|ISMPDVNLNLK.2|LPTGQISGPEIK.2|MSLPDVDLDLK.2|TPSFGISAPQVSIPDVNVNLKGPK.4|TPSFGISAPQVSIPDVNVNLKGPK.3|VEAPSLDVHMDSPDINIEGPDVK.4|VEAPSLDVHM[Oxi]DSPDINIEGPDVK.3|VEAPSLDVHMDSPDINIEGPDVK.3|VGIQLPEVELSVSTKKE.3|VSMPDVELNLK.2|GEGPEVDVNLPK.2|GHYEVTGSDDETGKLQGSGVSLASK.4|GHYEVTGSDDETGKLQGSGVSLASK.3|ISMPEVDLNLK.2|KQGFDLNVPGGEIDASLK.3|KQGFDLNVPGGEIDASLK.2|M[Oxi]KGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.3|GPAFNMASPESDFGINLK.3|GPAFNM[Oxi]ASPESDFGINLK.2|GPAFNMASPESDFGINLK.2|ISMPDVDFNLK.2|ISMPEIDLNLK.2|VESDLKGPEVDIEGPEGK.3|VESDLKGPEVDIEGPEGK.2|FSVSGLKAEGPDVAVDLPK.3|GEGPEFDVNLSK.2|GEGPEVDMNLPK.2|GPKLDADMPEVAVEGPNGK.3|ISMPDFDLNLK.2|ISMPDIDFNLK.2|LKGEIDASVPELEGDLRGPQVDVK.4|M[Oxi]EGGGAEVHAQLPSLEGDLRGPDVK.4|MEGGGAEVHAQLPSLEGDLRGPDVK.4|SPSLDVTVPEAELNLETPEISVGGK.4|SPSLDVTVPEAELNLETPEISVGGK.3|ADIDVSGPKVDIDTPDIDIHGPEGK.4|ADIDVSGPKVDIDTPDIDIHGPEGK.3|GPSLDIDTPDVNIEGPEGK.3|GPSLDIDTPDVNIEGPEGK.2|LKGDVDVSLPEVEGEMKVPDVDIK.4|GKKPDIDITGPKVDINAPDVEVQGK.4|GKKPDIDITGPKVDINAPDVEVQGK.3|IKGDVDVSVPEVEGKLEVPDMNIR.4|FSMPGFKGEGPDVDVSLPK.3|FSM[Oxi]PGFKGEGPDVDVSLPK.3|GDVDVSVPEVEGK.2|GGVTGSPEASISGSK.2|GPKVDIDTPDINIEGSEGK.3|VDVSAPDVEMQGPDWNLK.3|VDVSAPDVEMQGPDWNLK.2|FSMPGFKGEGPDVDVTLPK.3|FSM[Oxi]PGFKGEGPDVDVTLPK.3|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.5|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.3|LEGELQAPDLELSLPAIHVEGLDIK.4|LEGELQAPDLELSLPAIHVEGLDIK.3|VKTPSFGISAPQVSIPDVNVNLKGPK.4|FSMPGFKGEGPEVDVNLPK.3|FSM[Oxi]PGFKGEGPEVDVNLPK.2|FSMPGFKGEGPEVDVNLPK.2|FSMPSLKGEGPEVDVNLPK.3|FSM[Oxi]PSLKGEGPEVDVNLPK.3|VDIDVPDVNVQGPDWHLK.3|VDIDVPDVNVQGPDWHLK.2|AEASIQAGAGDGEWEESEVK.3|AEASIQAGAGDGEWEESEVK.2|GPFVEAEVPDVDLEC[CAM]PDAK.3|GPFVEAEVPDVDLEC[CAM]PDAK.2|MEGGGAEVHAQLPSLEGDLR.3|VSGPDLDLNLKGPSLKGDLDASVPSMK.4|VSGPDLDLNLKGPSLKGDLDASVPSMK.3|EETTRELLLPNWQGSGSHGLTIAQR.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.3|MEGGGAEVHAQLPSLEGDLRGPDVKLEGPDVSLK.5|MYFPDVEFDIK.2|M[Oxi]YFPDVEFDIK.2|VEAPSLDVHMDSPDINIEGPDVKIPK.4|GPQVSSALNLDTSK.2|GSGGEWKGPQVSSALNLDTSK.3|GSGGEWKGPQVSSALNLDTSK.2|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.6|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|AEGPEVDVNLPKADVDISGPK.3|AEGPEVDVNLPKADVDISGPK.2|FSMPSLKGEGPEVDVNLPKADVVVSGPK.4|FSMPSLKGEGPEVDVNLPKADVVVSGPK.3|SSGC[CAM]DVNLPGVNVK.2|FSVPGFKAEGPEVDVNLPKADVDISGPK.4|GPAFNMASPESDFGINLKGPK.3|GPSLQGDLAVSGDIK.2|TPSFGISAPQVSIPDVNVNLK.3|TPSFGISAPQVSIPDVNVNLK.2|VEGDMQVPDLDIK.2|VEGEMKVPDVEIK.2|GGADVSGGVSAPDISLGEGHLSVK.3|GPGVDLPSVNLSMPK.2|GPGVDLPSVNLSM[Oxi]PK.2|IEGEMQVPDVDIR.2|IEGEM[Oxi]QVPDVDIR.2|APEVNLNAPDVDVHGPDWNLK.3|APEVNLNAPDVDVHGPDWNLK.2|APNISMPDVDLNLK.2|APNISM[Oxi]PDVDLNLK.2|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|GEIDASVPELEGDLRGPQVDVK.3|GEVDVSLANVEGDLK.2|VSAPEVSVGHKGGKPGLTIQAPQLEVSVPSANIEGLEGK.5|APDVDVNIAGPDAALK.2|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.5|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.4|GDLDIAGPNLEGDFK.2|GPQITGPSLEGDLGLK.2|SEDGVEGDLGETQSR.2|GEIDASVPELEGDLR.2|VGIQLPEVELSVSTK.2|VKTPSFGISAPQVSIPDVNVNLK.3|EVFSSC[CAM]SSEVVLSGDDEEYQR.3|LEGPDVSLKGPGVDLPSVNLSMPK.3|LDADM[Oxi]PEVAVEGPNGK.2|LDADMPEVAVEGPNGK.2|VDIDAPDVSIEGPDAK.2|ADIDVSGPSVDTDAPDLDIEGPEGK.3|ADVDVSGPKVDVEGPDVNIEGPEGK.3|ADVDVSGPKVDVEVPDVSLEGPEGK.3|ADVVVSGPKVDIEAPDVSLEGPEGK.3|ADVVVSGPKVDVEVPDVSLEGPEGK.3|EFSGPSTPTGTLEFEGGEVSLEGGK.3|VDVDIPDVNIEGPDAK.2|ADIDISGPNVDVDVPDVNIEGPDAK.3|ADIDVSGPKVDIEGPDVNIEGPEGK.3|ADIDVSGPKVDVDVPDVNIEGPDAK.3|ADIDVSGPKVDVEVPDVSLEGPEGK.3|ADLDVSGPKVDVDVPDVNIEGPDAK.3|ADVDISGPKVDIEGPDVNIEGPEGK.3|LNVGAPDVTLRGPSLQGDLAVSGDIK.3|PGLTIQAPQLEVSVPSANIEGLEGK.3|ADIDVSGPKVDVEC[CAM]PDVNIEGPEGK.3|LEGDLTGPSVGVEVPDVELEC[CAM]PDAK.3|VSVGAPDLSLEASEGSIK.2|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.4|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.3|LEGDLTGPSVDVEVPDVELEC[CAM]PDAK.3|VKGSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|VKGDVDVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VKGDVDVSLPKLEGDLTGPSVDVEVPDVELEC[CAM]PDAK.4|ADIKSPSLDVTVPEAELNLETPEISVGGK.3|ELLLPNWQGSGSHGLTIAQRDDGVFVQEVTQNSPAAR.4|GDVPSVGLEGPDVDLQGPEAK.2|SNSFSDEREFSGPSTPTGTLEFEGGEVSLEGGK.3
SEN / CTL,Q14152,Eukaryotic translation initiation factor 3 subunit A,EIF3A,2.67,1.66,1.41E-04,1.56E-05,4.81E+00,"formation of translation preinitiation complex,formation of cytoplasmic translation initiation complex,translation reinitiation,translational initiation,regulation of translational initiation,negative regulation of ERK1 and ERK2 cascade,IRES-dependent viral translational initiation,viral translational termination-reinitiation","RNA binding,mRNA binding,structural molecule activity,protein binding,receptor tyrosine kinase binding,poly(A) RNA binding,translation initiation factor activity","nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation initiation factor 3 complex,microtubule,membrane,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex,multi-eIF complex,eukaryotic translation initiation factor 3 complex, eIF3e,eukaryotic translation initiation factor 3 complex, eIF3m",12,97,150,VLLATLSIPITPERTDIAR.3|LLDMDGIIVEK.2|LLDM[Oxi]DGIIVEK.2|QRELEIEER.3|QRELEIEER.2|HADDDRPPRR.3|NTDDDRPPRR.3|SLEDVVR.2|ERLESLNIQR.3|ERLESLNIQR.2|KNLTQDEMQR.3|KNLTQDEMQR.2|LGDSSLSR.2|NQLTAMSSVLAK.3|NQLTAM[Oxi]SSVLAK.2|NQLTAMSSVLAK.2|RGPAEESSSWR.3|RGPAEESSSWR.2|RGPEEDRFSR.3|SEREEVSSWR.3|QVEQLEK.2|RGADDDRPSWR.3|RGADDDRPSWR.2|RGAEDDRGPWR.3|SAYEEQR.2|YLELC[CAM]VDLRK.3|YLELC[CAM]VDLRK.2|GPPLRSEREEVSSWR.4|GPPLRSEREEVSSWR.3|LATLLGLQAPPTR.3|LATLLGLQAPPTR.2|LYHDIAQQAFK.3|LYHDIAQQAFK.2|RGLDDDRGPWR.3|RGLDEDRGSWR.3|KLEEVER.2|TKNETDEDGWTTVRR.4|TKNETDEDGWTTVRR.3|WGDRDSEGTWR.3|WGDRDSEGTWR.2|DDRVEERDPPR.3|ELEIEER.2|HC[CAM]DLQVR.2|KLC[CAM]DNLR.2|QC[CAM]LDLLR.2|RGDDSRPGPWRPLVKPGGWR.5|RIADEDRGNWR.3|AVEDIHGLFSLSK.3|AVEDIHGLFSLSK.2|PAHILQEK.2|SGNALFHASTLHR.3|SGNALFHASTLHR.2|ERILQEHEQIK.3|ERILQEHEQIK.2|LEEIPLIK.2|MLEDRDLFVMR.3|EESWGPPR.2|FNVLQYVVPEVK.3|FNVLQYVVPEVK.2|PAYFQRPENALK.3|PAYFQRPENALK.2|KIDYFER.2|LESLNIQR.2|LLLTPWVK.2|FC[CAM]LQYTR.2|IHEPIMLK.2|ITTMQLER.2|ITTM[Oxi]QLER.2|RLGDSSLSR.2|RVPPPALSR.2|ANEFLEVGK.2|FLWESYR.2|LGDDEDREPSLRPDDDR.4|RAEEQMLK.2|RAEEQM[Oxi]LK.2|RLATLLGLQAPPTR.3|EEQHQLAVTAYLK.3|EEQHQLAVTAYLK.2|KQPALDVLYDVMK.3|KQPALDVLYDVM[Oxi]K.3|KQPALDVLYDVMK.2|MHLSQIQR.2|M[Oxi]HLSQIQR.2|VLLATLSIPITPER.3|VLLATLSIPITPER.2|ALEVIKPAHILQEKEEQHQLAVTAYLK.6|ALEVIKPAHILQEKEEQHQLAVTAYLK.5|ALEVIKPAHILQEKEEQHQLAVTAYLK.4|IGLINDMVR.2|IGLINDM[Oxi]VR.2|REEELREYQER.3|GPEADSEWR.2|ALEVIKPAHILQEK.3|ALEVIKPAHILQEK.2|HHNQSTAINLNNPESQSMHLETR.5|HHNQSTAINLNNPESQSM[Oxi]HLETR.4|HHNQSTAINLNNPESQSMHLETR.4|HHNQSTAINLNNPESQSMHLETR.3|GPAEESSSWR.2|TKNETDEDGWTTVR.3|TKNETDEDGWTTVR.2|NIC[CAM]QQVNIK.2|RLEEIPLIK.2|KPPKPQLMANYYNK.3|NLTQDEMQR.2|NLTQDEM[Oxi]QR.2|ANEFLEVGKK.2|ILQEHEQIK.2|LTSLVPFVDAFQLER.3|LTSLVPFVDAFQLER.2|RGLDDDRGPR.2|EKEELEQREAELQK.3|KGPEADSEWR.2|RANEFLEVGK.2|RGMDDDRGPR.2|AREESWGPPR.2|DLYNWLEVEFNPLK.3|DLYNWLEVEFNPLK.2|IKDM[Oxi]DLWEQQEEER.3|IKDMDLWEQQEEER.3|IKDMDLWEQQEEER.2|ILQEHEQIKK.2|LLQQVSQIYQSIEFSR.3|LLQQVSQIYQSIEFSR.2|EDAPIGPHLQSMPSEQIR.3|EDAPIGPHLQSM[Oxi]PSEQIR.3|EDAPIGPHLQSMPSEQIR.2|QPALDVLYDVMK.2|QPALDVLYDVM[Oxi]K.2|EQPEKEPELQQYVPQLQNNTILR.4|EQPEKEPELQQYVPQLQNNTILR.3|LVQLDSAISMELWQEAFK.3|LVQLDSAISM[Oxi]ELWQEAFK.3|LVQLDSAISM[Oxi]ELWQEAFK.2|LVQLDSAISMELWQEAFK.2|DIDIEDLEELDPDFIM[Oxi]AK.3|DIDIEDLEELDPDFIMAK.3|DIDIEDLEELDPDFIM[Oxi]AK.2|DIDIEDLEELDPDFIMAK.2|NETDEDGWTTVR.2|TLSFGSDLNYATR.2|EPELQQYVPQLQNNTILR.3|EPELQQYVPQLQNNTILR.2|DMDLWEQQEEER.2|DM[Oxi]DLWEQQEEER.2|AFKDIDIEDLEELDPDFIM[Oxi]AK.3|AFKDIDIEDLEELDPDFIMAK.3|DMDLWEQQEEERITTMQLER.3|TLSFGSDLNYATREDAPIGPHLQSMPSEQIR.4|EESQQMVLDIEDLDNIQTPESVLLSAVSGEDTQDR.4
SEN / CTL,P10768,S-formylglutathione hydrolase,ESD,2.66,1.51,3.03E-13,9.29E-14,1.30E+01,"biological_process,formaldehyde catabolic process,glutathione derivative biosynthetic process","protein binding,hydrolase activity, acting on ester bonds,S-formylglutathione hydrolase activity,methylumbelliferyl-acetate deacetylase activity,carboxylic ester hydrolase activity","endoplasmic reticulum lumen,cytoplasmic, membrane-bounded vesicle,extracellular exosome",42,20,39,SVSAFAPIC[CAM]NPVLC[CAM]PWGK.2|SVSAFAPIC[CAM]NPVLC[CAM]PWGK.3|LQEGYDHSYYFIATFITDHIR.4|LQEGYDHSYYFIATFITDHIR.3|SGYHQSASEHGLVVIAPDTSPR.4|SGYHQSASEHGLVVIAPDTSPR.5|SGYHQSASEHGLVVIAPDTSPR.3|SGYHQSASEHGLVVIAPDTSPR.2|MYSYVTEELPQLINANFPVDPQR.3|M[Oxi]YSYVTEELPQLINANFPVDPQR.3|MYSYVTEELPQLINANFPVDPQR.4|VFEHDSVELNC[CAM]K.3|VFEHDSVELNC[CAM]K.2|C[CAM]FGGLQK.2|FAVYLPPK.2|KAFSGYLGTDQSK.3|KAFSGYLGTDQSK.2|FAVYLPPKAETGK.3|M[Oxi]SIFGHSMGGHGALIC[CAM]ALK.4|MSIFGHSM[Oxi]GGHGALIC[CAM]ALK.4|MSIFGHSMGGHGALIC[CAM]ALK.4|M[Oxi]SIFGHSMGGHGALIC[CAM]ALK.3|MSIFGHSM[Oxi]GGHGALIC[CAM]ALK.3|MSIFGHSMGGHGALIC[CAM]ALK.3|MSIFGHSMGGHGALIC[CAM]ALK.2|AYDATHLVK.2|AFSGYLGTDQSKWK.3|AFSGYLGTDQSKWK.2|C[CAM]PALYWLSGLTC[CAM]TEQNFISK.4|C[CAM]PALYWLSGLTC[CAM]TEQNFISK.3|C[CAM]PALYWLSGLTC[CAM]TEQNFISK.2|AFSGYLGTDQSK.2|SVSAFAPIC[CAM]NPVLC[CAM]PWGKK.3|AETGKC[CAM]PALYWLSGLTC[CAM]TEQNFISK.4|AETGKC[CAM]PALYWLSGLTC[CAM]TEQNFISK.3|SYPGSQLDILIDQGK.2|DDQFLLDGQLLPDNFIAAC[CAM]TEK.3|FAVYLPPKAETGKC[CAM]PALYWLSGLTC[CAM]TEQNFISK.4|GC[CAM]NIKGEDESWDFGTGAGFYVDATEDPWK.3
SEN / CTL,P13797,Plastin-3,PLS3,2.66,1.40,5.84E-20,3.25E-20,1.95E+01,"actin filament bundle assembly,actin filament network formation,actin crosslink formation,bone development","calcium ion binding,actin filament binding","cytoplasm,actin filament,actin filament bundle",60,45,74,VYALPEDLVEVKPK.3|VYALPEDLVEVKPK.2|MINLSVPDTIDER.2|MINLSVPDTIDER.3|M[Oxi]INLSVPDTIDER.2|YTLNVLEDLGDGQKANDDIIVNWVNR.3|RYTLNVLEDLGDGQKANDDIIVNWVNR.4|RYTLNVLEDLGDGQKANDDIIVNWVNR.3|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.4|HVIPMNPNTDDLFK.3|HVIPM[Oxi]NPNTDDLFK.3|HVIPMNPNTDDLFK.2|MVMTVFAC[CAM]LMGR.2|M[Oxi]VMTVFAC[CAM]LMGR.2|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.3|LMLDGDR.2|RAESMLQQADK.3|RAESMLQQADK.2|RAESM[Oxi]LQQADK.2|STSIQSFK.2|INNFSADIKDSK.3|INNFSADIKDSK.2|LENC[CAM]NYAVELGKHPAK.4|LENC[CAM]NYAVELGKHPAK.3|AYFHLLNQIAPK.3|AYFHLLNQIAPK.2|NEALAALLR.2|QFVTPADVVSGNPK.3|QFVTPADVVSGNPK.2|SGNLTEDDK.2|KLENC[CAM]NYAVELGKHPAK.4|KLENC[CAM]NYAVELGKHPAK.3|AVGDGIVLC[CAM]K.2|INNFSADIK.2|SGNLTEDDKHNNAK.3|AESMLQQADKLGC[CAM]R.3|WANFHLENSGWQK.3|WANFHLENSGWQK.2|AESMLQQADK.2|AESM[Oxi]LQQADK.2|EANMPLPGYK.2|EANM[Oxi]PLPGYK.2|IDINMSGFNETDDLK.3|IDINMSGFNETDDLK.2|RYTLNVLEDLGDGQK.3|RYTLNVLEDLGDGQK.2|DGETLEELMK.2|DGETLEELM[Oxi]K.2|ISFDEFVYIFQEVK.3|ISFDEFVYIFQEVK.2|AGKPHLVLGLLWQIIK.3|IDINMSGFNETDDLKR.3|IDINM[Oxi]SGFNETDDLKR.3|IDINMSGFNETDDLKR.2|LNLAFVANLFNK.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.4|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.3|NEALAALLRDGETLEELMK.3|ANDDIIVNWVNR.2|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|YPALTKPENQDIDWTLLEGETREER.4|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|VDLNSNGFIC[CAM]DYELHELFK.3|VDLNSNGFIC[CAM]DYELHELFK.2|YTLNVLEDLGDGQK.2|YPALTKPENQDIDWTLLEGETR.3|NWMNSLGVNPHVNHLYADLQDALVILQLYER.4|PENQDIDWTLLEGETR.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEKYAFVNWINK.4|DKTISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3
SEN / CTL,P04792,Heat shock protein beta-1,HSPB1,2.66,0.67,2.47E-40,4.05E-40,3.94E+01,"retina homeostasis,regulation of translational initiation,negative regulation of protein kinase activity,movement of cell or subcellular component,response to unfolded protein,response to virus,regulation of autophagy,positive regulation of interleukin-1 beta production,intracellular signal transduction,cellular response to vascular endothelial growth factor stimulus,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,positive regulation of tumor necrosis factor biosynthetic process,negative regulation of apoptotic process,regulation of I-kappaB kinase/NF-kappaB signaling,regulation of mRNA stability,positive regulation of blood vessel endothelial cell migration,positive regulation of angiogenesis,vascular endothelial growth factor receptor signaling pathway,platelet aggregation,negative regulation of protein serine/threonine kinase activity,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,positive regulation of endothelial cell chemotaxis","protein kinase C binding,protein kinase C inhibitor activity,protein kinase binding,identical protein binding,ubiquitin binding,poly(A) RNA binding","proteasome complex,extracellular space,nucleus,cytoplasm,spindle,cytosol,cytoskeleton,plasma membrane,focal adhesion,Z disc,extracellular matrix,extracellular exosome",66,23,44,LATQSNEITIPVTFESR.2|LATQSNEITIPVTFESR.3|LFDQAFGLPR.2|VSLDVNHFAPDELTVK.3|VSLDVNHFAPDELTVK.2|KYTLPPGVDPTQVSSSLSPEGTLTVEAPMPK.4|KYTLPPGVDPTQVSSSLSPEGTLTVEAPMPK.3|KYTLPPGVDPTQVSSSLSPEGTLTVEAPM[Oxi]PK.5|KYTLPPGVDPTQVSSSLSPEGTLTVEAPM[Oxi]PK.3|LPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSR.4|LPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSR.6|LPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSR.5|YTLPPGVDPTQVSSSLSPEGTLTVEAPMPK.3|YTLPPGVDPTQVSSSLSPEGTLTVEAPMPK.4|YTLPPGVDPTQVSSSLSPEGTLTVEAPM[Oxi]PK.3|GPSWDPFRDWYPHSR.4|GPSWDPFRDWYPHSR.3|GPSWDPFRDWYPHSR.2|DGVVEITGKHEERQDEHGYISR.5|DGVVEITGKHEERQDEHGYISR.6|DGVVEITGKHEERQDEHGYISR.4|HEERQDEHGYISR.4|HEERQDEHGYISR.3|HEERQDEHGYISR.2|VPFSLLR.2|TKDGVVEITGKHEER.4|TKDGVVEITGKHEER.3|TKDGVVEITGKHEER.2|DGVVEITGK.2|AQLGGPEAAK.2|GPSWDPFR.2|DGVVEITGKHEER.3|DGVVEITGKHEER.2|RVPFSLLR.2|QLSSGVSEIR.2|AQLGGPEAAKSDETAAK.3|AQLGGPEAAKSDETAAK.2|QDEHGYISR.2|TKDGVVEITGK.2|PLPPAAIESPAVAAPAYSR.3|PLPPAAIESPAVAAPAYSR.2|VSLDVNHFAPDELTVKTK.3|LPEEWSQWLGGSSWPGYVR.3|LPEEWSQWLGGSSWPGYVR.2
SEN / CTL,Q9NVA2,Septin-11,11-Sep,2.66,1.53,2.72E-03,2.53E-04,3.60E+00,"cell cycle,protein heterooligomerization,cell division","protein binding,GTP binding","stress fiber,cytoplasm,cell junction,axon,dendritic spine,extracellular exosome",12,28,45,STLMDTLFNTKFESDPATHNEPGVR.4|STLMDTLFNTKFESDPATHNEPGVR.3|NLSLSGHVGFDSLPDQLVNK.3|NLSLSGHVGFDSLPDQLVNK.2|ADTIAKNELHK.3|KKELEEEVNNFQK.4|KKELEEEVNNFQK.3|KKELEEEVNNFQK.2|RNEFLGELQK.3|RNEFLGELQK.2|EKEAELKEAEK.3|RSLFNYHDTR.3|VNMEDLR.2|VNM[Oxi]EDLR.2|IHAC[CAM]LYFIAPTGHSLK.4|IHAC[CAM]LYFIAPTGHSLK.3|IHAC[CAM]LYFIAPTGHSLK.2|SLDLVTMK.2|ELEEEVNNFQK.3|ELEEEVNNFQK.2|ARSYELQESNVR.3|VNIIPIIAK.2|AAAQLLQSQAQQSGAQQTKK.4|AAAQLLQSQAQQSGAQQTKK.3|FESDPATHNEPGVR.3|FESDPATHNEPGVR.2|LEEMGFKDTDPDSK.3|SLFNYHDTR.2|QYPWGVVQVENENHC[CAM]DFVK.4|QYPWGVVQVENENHC[CAM]DFVK.3|SYELQESNVR.2|STLMDTLFNTK.2|STLM[Oxi]DTLFNTK.2|ARQYPWGVVQVENENHC[CAM]DFVK.4|ARQYPWGVVQVENENHC[CAM]DFVK.3|AAAQLLQSQAQQSGAQQTK.3|AAAQLLQSQAQQSGAQQTK.2|PFSLQETYEAK.2|DTDPDSKPFSLQETYEAK.3|DTDPDSKPFSLQETYEAK.2|KAAAQLLQSQAQQSGAQQTK.3|STSQGFC[CAM]FNILC[CAM]VGETGIGK.3|STSQGFC[CAM]FNILC[CAM]VGETGIGK.2|LEEMGFKDTDPDSKPFSLQETYEAK.4|LTIVDTVGFGDQINK.2
SEN / CTL,P62857,40S ribosomal protein S28,RPS28,2.65,1.96,1.84E-06,2.64E-07,6.58E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,maturation of SSU-rRNA,ribosome biogenesis,ribosomal small subunit biogenesis","RNA binding,structural constituent of ribosome,poly(A) RNA binding","nucleoplasm,cytoplasm,cytosol,small ribosomal subunit,cytosolic small ribosomal subunit,extracellular exosome",24,8,13,TGSQGQC[CAM]TQVRVEFMDDTSR.3|GPVREGDVLTLLESEREAR.4|GPVREGDVLTLLESEREAR.3|GPVREGDVLTLLESER.3|GPVREGDVLTLLESER.2|EGDVLTLLESER.2|EGDVLTLLESER.3|TGSQGQC[CAM]TQVR.3|TGSQGQC[CAM]TQVR.2|VEFMDDTSR.2|VEFM[Oxi]DDTSR.2|EGDVLTLLESEREAR.3|NVKGPVREGDVLTLLESER.3
SEN / CTL,P61758,Prefoldin subunit 3,VBP1,2.65,2.01,7.45E-04,7.46E-05,4.13E+00,"protein folding,microtubule-based process,tubulin complex assembly","protein binding,tubulin binding","nucleus,cytoplasm,polysome,prefoldin complex,intracellular membrane-bounded organelle",12,17,24,FLLADNLYC[CAM]K.2|NLDSLEEDLDFLRDQFTTTEVNMAR.4|NLDSLEEDLDFLRDQFTTTEVNM[Oxi]AR.4|NLDSLEEDLDFLRDQFTTTEVNMAR.3|QTLEILK.2|VYNWDVK.2|YKFMELNLAQK.3|QPGNETADTVLKK.3|DSC[CAM]GKGEMATGNGR.3|ESTNSMETR.2|KLDEQYQK.2|LHLGIPEAVFVEDVDSFMK.4|LHLGIPEAVFVEDVDSFM[Oxi]K.3|LHLGIPEAVFVEDVDSFMK.3|FMELNLAQK.2|FM[Oxi]ELNLAQK.2|RLHLGIPEAVFVEDVDSFMK.4|RLHLGIPEAVFVEDVDSFMK.3|QPGNETADTVLK.2|DQFTTTEVNM[Oxi]AR.2|DQFTTTEVNMAR.2|RLHLGIPEAVFVEDVDSFMKQPGNETADTVLK.5|NLDSLEEDLDFLR.2|LHLGIPEAVFVEDVDSFMKQPGNETADTVLK.4
SEN / CTL,O14818,Proteasome subunit alpha type-7,PSMA7,2.65,1.85,2.03E-11,5.11E-12,1.13E+01,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",42,16,28,KIC[CAM]ALDDNVC[CAM]MAFAGLTADAR.3|LTVEDPVTVEYITR.2|LTVEDPVTVEYITR.3|GRDIVVLGVEKK.3|AITVFSPDGHLFQVEYAQEAVKK.4|AITVFSPDGHLFQVEYAQEAVKK.3|NYTDEAIETDDLTIK.2|NYTDEAIETDDLTIK.3|AITVFSPDGHLFQVEYAQEAVK.3|AITVFSPDGHLFQVEYAQEAVK.4|LYQTDPSGTYHAWK.4|LYQTDPSGTYHAWK.3|LYQTDPSGTYHAWK.2|YVAEIEK.2|YVAEIEKEKEENEK.4|YVAEIEKEKEENEK.3|YVAEIEKEKEENEK.2|NIELAVMR.2|NIELAVM[Oxi]R.2|DIVVLGVEK.2|ILNPEEIEK.2|ALLEVVQSGGK.2|GRDIVVLGVEK.2|RPFGISALIVGFDFDGTPR.3|IC[CAM]ALDDNVC[CAM]M[Oxi]AFAGLTADAR.3|IC[CAM]ALDDNVC[CAM]MAFAGLTADAR.3|IC[CAM]ALDDNVC[CAM]M[Oxi]AFAGLTADAR.2|IC[CAM]ALDDNVC[CAM]MAFAGLTADAR.2
SEN / CTL,P12109,Collagen alpha-1(VI) chain,COL6A1,2.65,2.15,9.24E-36,1.39E-35,3.49E+01,"osteoblast differentiation,cell adhesion,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,protein heterotrimerization,cellular response to amino acid stimulus",platelet-derived growth factor binding,"extracellular region,collagen type VI trimer,lysosomal membrane,endoplasmic reticulum lumen,membrane,extracellular matrix,sarcolemma,protein complex,extracellular exosome",204,49,69,VFSVAITPDHLEPR.3|VFSVAITPDHLEPR.2|LLLFSDGNSQGATPAAIEK.2|LLLFSDGNSQGATPAAIEK.3|RLLLFSDGNSQGATPAAIEK.3|NLVWNAGALHYSDEVEIIQGLTR.3|IALVITDGR.2|TAEYDVAYGESHLFR.3|TAEYDVAYGESHLFR.2|TAEYDVAYGESHLFR.4|GLEQLLVGGSHLKENK.4|TAEYDVAYGESHLFRVPSYQALLR.4|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.4|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.3|SLQWMAGGTFTGEALQYTR.3|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.4|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.3|VPSYQALLR.2|C[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTKR.4|GLEQLLVGGSHLK.3|GLEQLLVGGSHLK.2|DALKSSVDAVKYFGK.2|LSIIATDHTYR.3|LSIIATDHTYR.2|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.3|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.2|TDPAHDVRVAVVQYSGTGQQRPER.4|VAVVQYSGTGQQRPER.3|VAVVQYSGTGQQRPER.4|VAVVQYSGTGQQRPER.2|LSIIATDHTYRR.3|AVAFQDC[CAM]PVDLFFVLDTSESVALR.3|LAERFLTAGRTDPAHDVR.4|KGLEQLLVGGSHLK.3|DAEEAISQTIDTIVDM[Oxi]IK.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.2|PYGALVDK.2|LKPYGALVDKVK.3|LKPYGALVDKVK.2|TDPAHDVR.2|RFIDNLR.2|GDPGFEGER.2|QVNEPHIR.2|GTYTDC[CAM]AIK.2|GVFHQTVSR.2|ENYAELLEDAFLK.3|ENYAELLEDAFLK.2|LKPYGALVDK.2|DALKSSVDAVK.2|GDEGPPGSEGAR.2|MC[CAM]SC[CAM]C[CAM]EC[CAM]K.2|YLIVVTDGHPLEGYK.3|YLIVVTDGHPLEGYK.2|AGIEIFVVVVGR.2|DQLLPPSPNNR.2|GDEGEAGDPGDDNNDIAPR.3|GDEGEAGDPGDDNNDIAPR.2|GDPGEAGPQGDQGR.2|FEPGQSYAGVVQYSHSQMQEHVSLRSPSIR.5|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.4|FEPGQSYAGVVQYSHSQMQEHVSLR.4|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.3|FEPGQSYAGVVQYSHSQMQEHVSLR.3|EPC[CAM]GGLEDAVNEAK.2|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.4|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.3|SDTQRDTTPLNVLC[CAM]SPGIQVVSVGIK.3|KC[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTK.4
SEN / CTL,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,2.65,2.65,2.50E-07,3.98E-08,7.40E+00,"protein peptidyl-prolyl isomerization,positive regulation of multicellular organism growth,positive regulation by host of viral process,positive regulation by host of viral genome replication,protein stabilization,bone development,chaperone-mediated protein folding,regulation of post-translational protein modification","peptidyl-prolyl cis-trans isomerase activity,protein binding,protein complex binding,peptide binding,poly(A) RNA binding,unfolded protein binding,RNA polymerase binding,collagen binding","nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,focal adhesion,membrane,macromolecular complex,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome",48,28,56,VLEGMEVVR.2|VLEGM[Oxi]EVVR.2|VIKDFMIQGGDFTRGDGTGGK.4|VIKDFM[Oxi]IQGGDFTRGDGTGGK.4|VIKDFMIQGGDFTRGDGTGGK.3|TVDNFVALATGEK.2|TVDNFVALATGEK.3|HYGPGWVSMANAGKDTNGSQFFITTVK.4|HYGPGWVSM[Oxi]ANAGKDTNGSQFFITTVK.4|HYGPGWVSMANAGKDTNGSQFFITTVK.3|VIKDFM[Oxi]IQGGDFTR.3|VIKDFMIQGGDFTR.3|VIKDFMIQGGDFTR.2|IEVEKPFAIAK.3|IEVEKPFAIAK.2|IGDEDVGR.2|LKHYGPGWVSMANAGK.4|LKHYGPGWVSMANAGK.3|VIFGLFGK.2|FPDENFK.2|FPDENFK.1|IEVEKPFAIAKE.3|IEVEKPFAIAKE.2|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.6|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.5|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.4|DTNGSQFFITTVK.3|DTNGSQFFITTVK.2|DVIIADC[CAM]GK.2|HYGPGWVSMANAGK.3|HYGPGWVSM[Oxi]ANAGK.3|HYGPGWVSM[Oxi]ANAGK.2|HYGPGWVSMANAGK.2|DKPLKDVIIADC[CAM]GK.3|DKPLKDVIIADC[CAM]GK.2|SIYGERFPDENFK.3|SIYGERFPDENFK.2|DVIIADC[CAM]GKIEVEKPFAIAK.4|DVIIADC[CAM]GKIEVEKPFAIAK.3|TVDNFVALATGEKGFGYKNSK.4|TVDNFVALATGEKGFGYKNSK.3|IGDEDVGRVIFGLFGK.3|VLEGMEVVRK.2|DVIIADC[CAM]GKIEVEKPFAIAKE.4|DVIIADC[CAM]GKIEVEKPFAIAKE.3|DFMIQGGDFTRGDGTGGK.3|DFM[Oxi]IQGGDFTRGDGTGGK.3|DFM[Oxi]IQGGDFTRGDGTGGK.2|DFMIQGGDFTRGDGTGGK.2|TVDNFVALATGEKGFGYK.3|TVDNFVALATGEKGFGYK.2|DFMIQGGDFTR.2|DFM[Oxi]IQGGDFTR.2|DVIIADC[CAM]GKIEVEK.2|TAWLDGKHVVFGKVLEGMEVVR.3|TVPKTVDNFVALATGEK.2
SEN / CTL,P08133,Annexin A6,ANXA6,2.65,1.64,3.17E-14,1.05E-14,1.40E+01,"calcium ion transport,regulation of muscle contraction,ion transmembrane transport,protein homooligomerization,mitochondrial calcium ion homeostasis,apoptotic signaling pathway","calcium ion binding,protein binding,GTP binding,calcium-dependent phospholipid binding,lipid binding,ligand-gated ion channel activity,cholesterol binding,protein homodimerization activity,calcium-dependent protein binding","mitochondrion,lysosomal membrane,focal adhesion,membrane,late endosome membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",48,72,121,GLGTDEDTIIDIITHR.3|GLGTDEDTIIDIITHR.2|VELKGTVRPANDFNPDADAK.4|VELKGTVRPANDFNPDADAK.3|GFGSDKEAILDIITSR.3|GFGSDKEAILDIITSR.2|YRGSIHDFPGFDPNQDAEALYTAMK.4|YRGSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|YRGSIHDFPGFDPNQDAEALYTAMK.3|SEIDLLNIR.2|DLMTDLKSEISGDLAR.3|DLM[Oxi]TDLKSEISGDLAR.3|DLMTDLKSEISGDLAR.2|EMSGDVRDAFVAIVQSVK.3|EM[Oxi]SGDVRDAFVAIVQSVK.3|SEIDLLNIRR.3|DLMTDLK.2|LILGLMMPPAHYDAK.4|LILGLMMPPAHYDAK.3|LILGLM[Oxi]MPPAHYDAK.3|LILGLMM[Oxi]PPAHYDAK.3|LILGLMMPPAHYDAK.2|PLFFADK.2|SLYSMIK.2|QRQEVC[CAM]QSYK.3|QRQEVC[CAM]QSYK.2|MTNYDVEHTIK.3|MTNYDVEHTIK.2|SLEDALSSDTSGHFRR.4|SLEDALSSDTSGHFRR.3|SLEDALSSDTSGHFRR.2|SLYGKDLIADLK.3|SLYGKDLIADLK.2|VFQEFIK.2|SEISGDLAR.2|AINEAYKEDYHK.3|DLIADLKYELTGK.3|DLIADLKYELTGK.2|EIKDAISGIGTDEK.3|EIKDAISGIGTDEK.2|GELSGDFEK.2|MTNYDVEHTIKK.3|M[Oxi]TNYDVEHTIKK.3|MTNYDVEHTIKK.2|M[Oxi]TNYDVEHTIKK.2|ALIEILATR.2|ALLALC[CAM]GGED.2|ALLALC[CAM]GGED.1|AMEGAGTDEK.2|SLYGKDLIADLKYELTGK.4|SLYGKDLIADLKYELTGK.3|LVFDEYLK.2|TNEQM[Oxi]HQLVAAYK.3|TNEQMHQLVAAYK.3|TNEQMHQLVAAYK.2|TNEQM[Oxi]HQLVAAYK.2|FMTILC[CAM]TR.2|FM[Oxi]TILC[CAM]TR.2|QEVC[CAM]QSYK.2|C[CAM]LIEILASR.2|RVFQEFIK.2|TTGKPIEASIRGELSGDFEK.4|TTGKPIEASIRGELSGDFEK.3|ILISLATGHR.2|NKPLFFADK.2|SELDMLDIR.2|SELDM[Oxi]LDIR.2|SELDMLDIREIFR.3|SELDM[Oxi]LDIREIFR.3|SLEDALSSDTSGHFR.3|SLEDALSSDTSGHFR.2|TNEQMHQLVAAYKDAYER.4|TNEQMHQLVAAYKDAYER.3|DAISGIGTDEK.2|STPEYFAER.2|EAILDIITSR.2|GTVRPANDFNPDADAK.3|GTVRPANDFNPDADAK.2|MLVVLLQGTR.2|M[Oxi]LVVLLQGTR.2|GAGTDEKTLTR.2|ILISLATGHREEGGENLDQAR.4|ILISLATGHREEGGENLDQAR.3|KAMEGAGTDEK.2|LIVGLM[Oxi]RPPAYC[CAM]DAK.3|LIVGLMRPPAYC[CAM]DAK.3|LIVGLM[Oxi]RPPAYC[CAM]DAK.2|SLHQAIEGDTSGDFLK.3|SLHQAIEGDTSGDFLK.2|TTGKPIEASIRGELSGDFEKLMLAVVK.5|DLEADIIGDTSGHFQK.3|DLEADIIGDTSGHFQK.2|TTGKPIEASIR.2|DAFVAIVQSVK.2|WGTDEAQFIYILGNR.3|WGTDEAQFIYILGNR.2|DAYERDLEADIIGDTSGHFQK.4|DAYERDLEADIIGDTSGHFQK.3|EEGGENLDQAR.2|DLIADLKYELTGKFER.3|EIKDAISGIGTDEKC[CAM]LIEILASR.4|EIKDAISGIGTDEKC[CAM]LIEILASR.3|GSIHDFPGFDPNQDAEALYTAMK.4|GSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|GSIHDFPGFDPNQDAEALYTAMK.3|PANDFNPDADAK.2|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.6|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.4|AM[Oxi]EGAGTDEKALIEILATR.3|EDAQVAAEILEIADTPSGDK.3|EDAQVAAEILEIADTPSGDK.2|EDAQVAAEILEIADTPSGDKTSLETR.4|EDAQVAAEILEIADTPSGDKTSLETR.3|DAISGIGTDEKC[CAM]LIEILASR.3|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.4|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.3|ILISLATGHREEGGENLDQAREDAQVAAEILEIADTPSGDK.5|EEDDVVSEDLVQQDVQDLYEAGELK.3|EEGGENLDQAREDAQVAAEILEIADTPSGDKTSLETR.4|M[Oxi]LVVLLQGTREEDDVVSEDLVQQDVQDLYEAGELK.4|EEGGENLDQAREDAQVAAEILEIADTPSGDK.3
SEN / CTL,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,2.64,1.54,2.79E-35,3.96E-35,3.44E+01,"angiogenesis,osteoblast differentiation,generation of precursor metabolites and energy,lipid metabolic process,ATP biosynthetic process,negative regulation of cell adhesion involved in substrate-bound cell migration,mitochondrion organization,proton transport,mitochondrial ATP synthesis coupled proton transport,regulation of intracellular pH","transporter activity,protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase activity","nucleus,mitochondrion,mitochondrial proton-transporting ATP synthase complex,mitochondrial proton-transporting ATP synthase, catalytic core,mitochondrial matrix,plasma membrane,cell surface,membrane,extracellular matrix,mitochondrial membrane,mitochondrial nucleoid,myelin sheath,extracellular exosome",132,47,115,AIAELGIYPAVDPLDSTSR.2|AIAELGIYPAVDPLDSTSR.3|VLDSGAPIKIPVGPETLGR.3|VLDSGAPIKIPVGPETLGR.2|VLDSGAPIKIPVGPETLGR.4|LVLEVAQHLGESTVR.3|LVLEVAQHLGESTVR.2|FTQAGSEVSALLGR.2|FTQAGSEVSALLGR.3|AHGGYSVFAGVGER.3|AHGGYSVFAGVGER.2|FTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQER.4|TVLIMELINNVAK.2|TVLIMELINNVAK.3|TVLIM[Oxi]ELINNVAK.2|IMDPNIVGSEHYDVAR.3|IMDPNIVGSEHYDVAR.4|IM[Oxi]DPNIVGSEHYDVAR.3|IM[Oxi]DPNIVGSEHYDVAR.2|IMDPNIVGSEHYDVAR.2|TIAMDGTEGLVR.2|TIAM[Oxi]DGTEGLVR.2|GQKVLDSGAPIKIPVGPETLGR.4|IMNVIGEPIDERGPIKTK.4|IM[Oxi]NVIGEPIDERGPIKTK.4|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.6|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.5|FLSQPFQVAEVFTGHMGK.3|FLSQPFQVAEVFTGHM[Oxi]GK.4|FLSQPFQVAEVFTGHMGK.4|FLSQPFQVAEVFTGHM[Oxi]GK.3|FLSQPFQVAEVFTGHM[Oxi]GK.2|FLSQPFQVAEVFTGHMGK.2|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.4|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.5|ILQDYKSLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|IGLFGGAGVGK.2|IPSAVGYQPTLATDMGTMQER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTMQER.3|IPSAVGYQPTLATDMGTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.2|IPSAVGYQPTLATDM[Oxi]GTMQER.2|IPSAVGYQPTLATDMGTM[Oxi]QER.2|IPSAVGYQPTLATDMGTMQER.2|TREGNDLYHEMIESGVINLK.4|TREGNDLYHEM[Oxi]IESGVINLK.4|TREGNDLYHEMIESGVINLK.3|TREGNDLYHEMIESGVINLK.2|TREGNDLYHEMIESGVINLKDATSK.4|TREGNDLYHEMIESGVINLKDATSK.5|TREGNDLYHEM[Oxi]IESGVINLKDATSK.5|TREGNDLYHEM[Oxi]IESGVINLKDATSK.4|TREGNDLYHEM[Oxi]IESGVINLKDATSK.3|GGKIGLFGGAGVGK.3|VLDSGAPIK.2|IMNVIGEPIDER.3|IMNVIGEPIDER.2|IM[Oxi]NVIGEPIDER.2|VALTGLTVAEYFR.3|VALTGLTVAEYFR.2|ETRLVLEVAQHLGESTVR.4|ETRLVLEVAQHLGESTVR.3|ETRLVLEVAQHLGESTVR.2|IPVGPETLGR.2|TIAM[Oxi]DGTEGLVRGQK.3|TIAM[Oxi]DGTEGLVRGQK.2|VALVYGQMNEPPGAR.3|VALVYGQM[Oxi]NEPPGAR.3|VALVYGQMNEPPGAR.2|VALVYGQM[Oxi]NEPPGAR.2|ADKLAEEHSS.2|VVDLLAPYAK.2|IMNVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.2|IMNVIGEPIDERGPIK.2|DQEGQDVLLFIDNIFR.3|DQEGQDVLLFIDNIFR.2|GGKIGLFGGAGVGKTVLIMELINNVAK.4|SLQDIIAILGMDELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.3|SLQDIIAILGMDELSEEDKLTVSR.3|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.3|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.3|EGNDLYHEM[Oxi]IESGVINLK.3|EGNDLYHEMIESGVINLK.3|EGNDLYHEMIESGVINLK.2|SLQDIIAILGM[Oxi]DELSEEDK.3|SLQDIIAILGMDELSEEDK.3|SLQDIIAILGMDELSEEDK.2|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.5|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.3|QFAPIHAEAPEFMEMSVEQEILVTGIK.4|QFAPIHAEAPEFM[Oxi]EM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFM[Oxi]EMSVEQEILVTGIK.3|QFAPIHAEAPEFMEM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFMEMSVEQEILVTGIK.3|LTPSASLPPAQLLLR.2|IGLFGGAGVGKTVLIMELINNVAK.3|TKQFAPIHAEAPEFMEMSVEQEILVTGIK.4|EGNDLYHEM[Oxi]IESGVINLKDATSK.3|LVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAEEHSS.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADK.4|GSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|ETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4
SEN / CTL,Q15631,Translin,TSN,2.62,1.86,2.62E-02,2.15E-03,2.67E+00,"DNA recombination,RNA metabolic process,gene silencing by RNA,nucleic acid phosphodiester bond hydrolysis","DNA binding,single-stranded DNA binding,mRNA binding,endonuclease activity,protein binding,protein complex binding,sequence-specific DNA binding","nucleus,cytosol",12,16,25,KVEEVVYDLSIR.3|KVEEVVYDLSIR.2|LSVNSVTAGDYSRPLHISTFINELDSGFR.4|LSVNSVTAGDYSRPLHISTFINELDSGFR.3|THLTSLK.2|KVVQSLEQTAR.3|KVVQSLEQTAR.2|TKFPAEQYYR.3|GFNKETAAAC[CAM]VEK.3|GFNKETAAAC[CAM]VEK.2|EAVTEILGIEPDR.3|EAVTEILGIEPDR.2|ETAAAC[CAM]VEK.2|FPAEQYYR.2|EILTLLQGVHQGAGFQDIPK.4|EILTLLQGVHQGAGFQDIPK.3|EILTLLQGVHQGAGFQDIPK.2|EAVTEILGIEPDREK.3|VVQSLEQTAR.2|EILTLLQGVHQGAGFQDIPKR.4|EILTLLQGVHQGAGFQDIPKR.3|PLHISTFINELDSGFR.3|PLHISTFINELDSGFR.2|VEEVVYDLSIR.2|LSVNSVTAGDYSR.2
SEN / CTL,Q96C90,Protein phosphatase 1 regulatory subunit 14B,PPP1R14B,2.62,0.60,1.03E-04,1.17E-05,4.93E+00,"regulation of protein dephosphorylation,regulation of phosphorylation,negative regulation of catalytic activity,innate immune response",protein serine/threonine phosphatase inhibitor activity,cytoplasm,6,9,14,VYFQSPPGAAGEGPGGADDEGPVRR.3|LNLEEWILEQLTR.3|LNLEEWILEQLTR.2|RLNLEEWILEQLTR.3|RLNLEEWILEQLTR.2|VKELLVDC[CAM]YKPTEAFISGLLDK.4|PTEAFISGLLDK.2|VKELLVDC[CAM]YKPTEAFISGLLDKIR.4|ELLVDC[CAM]YKPTEAFISGLLDK.3|ELLVDC[CAM]YKPTEAFISGLLDK.2|VYFQSPPGAAGEGPGGADDEGPVR.3|VYFQSPPGAAGEGPGGADDEGPVR.2|LYDC[CAM]QEEEIPELEIDVDELLDM[Oxi]ESDDAR.3|LYDC[CAM]QEEEIPELEIDVDELLDMESDDAR.3
SEN / CTL,P46821,Microtubule-associated protein 1B,MAP1B,2.62,2.23,2.05E-13,6.51E-14,1.32E+01,"microtubule bundle formation,cellular process,dendrite development,negative regulation of intracellular transport,positive regulation of axon extension,mitochondrion transport along microtubule,axon extension,establishment of monopolar cell polarity","structural molecule activity,protein binding,microtubule binding","photoreceptor outer segment,cytoplasm,cytosol,microtubule,microtubule associated complex,plasma membrane,postsynaptic density,cell junction,dendritic spine",66,110,158,TATC[CAM]HSSSSPPIDAASAEPYGFR.3|AVLDALLEGK.2|AIGNIELGIR.2|HLDRVDSILLTHIGDDNLPGINSMLQR.4|HLDRVDSILLTHIGDDNLPGINSMLQR.5|HLDRVDSILLTHIGDDNLPGINSM[Oxi]LQR.4|HLDRVDSILLTHIGDDNLPGINSMLQR.3|KESKEETPEVTK.3|SPPLIGSESAYESFLSADDKASGR.3|KIAELEEEQSQGSTTNSDWMK.3|SVGNTIDPVILFQK.2|SVGNTIDPVILFQK.3|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAKELEAER.4|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAKELEAER.3|SSYYVVSGNDPAAEEPSR.2|SSYYVVSGNDPAAEEPSR.3|LSMKPEPLFR.3|AEEVDVTK.2|LMITDAAR.2|ESLKPAAKPLPSK.3|HMDPPPAPVQDR.3|HM[Oxi]DPPPAPVQDR.3|HMDPPPAPVQDR.2|SKPLAASPKPAGLK.3|ASVLFDTMQHHLALNR.4|ASVLFDTM[Oxi]QHHLALNR.4|ASVLFDTMQHHLALNR.3|SSTPLSEAK.2|STDFAPIKEDFGQEKK.4|STDFAPIKEDFGQEKK.3|ESVASGDDR.2|DAYC[CAM]SEVK.2|EVPSKEEPSPVKAEVAEK.4|FSPEVPGQK.2|SDISPLTPR.2|GAESPFEEK.2|DSISAVSSEK.2|LSKPC[CAM]C[CAM]YIFPGGR.3|HSPTEDEESAKAEADAYIR.4|HSPTEDEESAKAEADAYIR.3|DFEELKAEEVDVTK.3|DFEELKAEEVDVTK.2|LKETEPVEAYVIQK.3|LKETEPVEAYVIQK.2|TETKPSVTEK.2|TPDTSTYC[CAM]YETAEK.3|TPDTSTYC[CAM]YETAEK.2|DIKPQLELIEDEEK.3|DIKPQLELIEDEEK.2|M[Oxi]GVGKLEMYVLNPVK.3|MGVGKLEMYVLNPVK.2|AAKPTTTPEVK.2|STDFAPIKEDFGQEK.3|STDFAPIKEDFGQEK.2|MSISEGTVSDK.2|M[Oxi]SISEGTVSDK.2|LEMYVLNPVK.2|HSPTEDEESAK.2|PC[CAM]C[CAM]YIFPGGR.2|ASTTLDIKDSISAVSSEK.3|HNLQDFINIK.2|DLTGQVPTPVVK.2|AEEDMDEAIEK.2|AEEDM[Oxi]DEAIEK.2|KLGDVSPTQIDVSQFGSFKEDTK.4|AETEEAEEPEEDGEEHVC[CAM]VSASK.4|AETEEAEEPEEDGEEHVC[CAM]VSASK.3|ITSFPESEGYSYETSTK.3|ITSFPESEGYSYETSTK.2|TSDVGGYYYEK.2|TTSPPEVSGYSYEKTER.3|AAEAGGAEEQYGFLTTPTK.3|AAEAGGAEEQYGFLTTPTK.2|NSNLDRHNLQDFINIK.3|TDDVEAMSSQPALALDER.3|TDDVEAMSSQPALALDER.2|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAK.4|AAEAVAAAVGTGATTAAVM[Oxi]AAAGIAAIGPAK.3|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAK.3|SSAVPPGLPVYLDLC[CAM]YIPNHSNSK.4|SSAVPPGLPVYLDLC[CAM]YIPNHSNSK.3|SWDTNLIEC[CAM]NLDQELK.3|SWDTNLIEC[CAM]NLDQELK.2|DIKPQLELIEDEEKLKETEPVEAYVIQK.5|DIKPQLELIEDEEKLKETEPVEAYVIQK.4|TPGDFSYAYQKPEETTR.3|ASVSPM[Oxi]DEPVPDSESPIEK.3|ASVSPMDEPVPDSESPIEK.3|ASVSPMDEPVPDSESPIEK.2|DMSLYASLTSEK.2|DM[Oxi]SLYASLTSEK.2|SSHLPTEVIEKPPAVPVSFEFSDAKDENER.5|SSHLPTEVIEKPPAVPVSFEFSDAKDENER.4|SVNFSLTPNEIK.2|VLFPGNSTQYNILEGLEK.3|VLFPGNSTQYNILEGLEK.2|KLGDVSPTQIDVSQFGSFK.3|PLTQSGGAPPPPGGK.2|SSHLPTEVIEKPPAVPVSFEFSDAK.4|SSHLPTEVIEKPPAVPVSFEFSDAK.3|KTDDVEAMSSQPALALDER.3|KTDDVEAM[Oxi]SSQPALALDER.3|KTDDVEAMSSQPALALDER.2|NLISPDLGVVFLNVPENLK.3|NLISPDLGVVFLNVPENLK.2|ETEPVEAYVIQK.2|SALRDAYC[CAM]SEVK.2|SPPLIGSESAYESFLSADDK.3|SPPLIGSESAYESFLSADDK.2|SPSLSPSPPSPLEK.2|GDSALFAVNGFNMLINGGSER.3|GDSALFAVNGFNMLINGGSER.2|NLISPDLGVVFLNVPENLKNPEPNIK.4|NLISPDLGVVFLNVPENLKNPEPNIK.3|SPSDSGYSYETIGK.2|TLEVVSPSQSVTGSAGHTPYYQSPTDEK.4|TLEVVSPSQSVTGSAGHTPYYQSPTDEK.3|YESSLYSQEYSK.2|MEAEDYVMAVVDK.2|IAELEEEQSQGSTTNSDWMK.3|IAELEEEQSQGSTTNSDWMK.2|TDATDGKDYNASASTISPPSSMEEDKFSR.4|TPQASTYSYETSDLC[CAM]YTAEK.3|TPQASTYSYETSDLC[CAM]YTAEK.2|TTSPPEVSGYSYEK.2|SDVLETVVLINPSDEAVSTEVR.3|SDVLETVVLINPSDEAVSTEVR.2|TPEEGGYSYDISEK.2|VSAEAEVAPVSPEVTQEVVEEHC[CAM]ASPEDK.4|VSAEAEVAPVSPEVTQEVVEEHC[CAM]ASPEDK.3|AQWGSNMQVTLIPTHDSEVMR.3|LGDVSPTQIDVSQFGSFKEDTK.3|QGSPDQVSPVSEMTSTSLYQDK.3|QGSPDQVSPVSEMTSTSLYQDK.2|DYNASASTISPPSSMEEDKFSR.3|QSPDHPTVGAGVLHITENGPTEVDYSPSDMQDSSLSHK.5|TPQASTYSYETSDLC[CAM]YTAEKK.3|ASLTLFC[CAM]PEEGDWK.2|TPEDGDYSYEIIEK.2|EEEYEPEKMEAEDYVMAVVDK.3|GPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.4|GPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.3|VDSILLTHIGDDNLPGINSMLQR.3|QDVDLC[CAM]LVSSC[CAM]EYK.2|SIEEAC[CAM]FTLQYLNK.2|EMQYFMQQWTGTNK.2|RLLDDISNGYDDSEDGGHTLGDPSYSYETTEK.4|SPDEEDYDYESYEK.2|DVMSDETNNEETESPSQEFVNITK.3|TDATDGKDYNASASTISPPSSMEEDK.3|AEFILPNGQEVDLPISYLTSVSSLIVWHPANPAEK.4|ESSPLYSPTFSDSTSAVK.2|EVTKGPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.4|LGDVSPTQIDVSQFGSFK.2|QGSPDQVSPVSEMTSTSLYQDKQEGK.3|YESSLYSQEYSKPADVTPLNGFSEGSK.3|DKAEFILPNGQEVDLPISYLTSVSSLIVWHPANPAEK.4|LLDDISNGYDDSEDGGHTLGDPSYSYETTEK.3
SEN / CTL,P46459,Vesicle-fusing ATPase,NSF,2.62,1.26,2.75E-03,2.55E-04,3.59E+00,"positive regulation of receptor recycling,potassium ion transport,intracellular protein transport,exocytosis,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,vesicle-mediated transport,regulation of exocytosis,Golgi to plasma membrane protein transport,plasma membrane fusion,positive regulation of protein catabolic process,COPII vesicle coating,Golgi vesicle docking","protein binding,ATP binding,ATPase activity,syntaxin-1 binding,Rab GTPase binding,protein kinase binding,PDZ domain binding,protein complex binding,ATPase activity, coupled,metal ion binding","Golgi membrane,cytoplasm,lysosomal membrane,Golgi stack,cytosol,plasma membrane,postsynaptic density,dendritic shaft,myelin sheath,extracellular exosome",6,52,72,VLDDGELLVQQTK.2|VLDDGELLVQQTK.3|LQILHIHTAR.3|LQILHIHTAR.2|ASTKVEVDMEK.3|ASTKVEVDMEK.2|DFQSGQHVIVR.3|DFQSGQHVIVR.2|GHQLLSADVDIK.3|GHQLLSADVDIK.2|IFDDAYK.2|TTIAQQVK.2|AESLQVTR.2|LFADAEEEQRR.3|AAQSTAMNR.2|LLIIGTTSR.2|MIGFSETAK.2|KIFDDAYK.2|KLFADAEEEQRR.3|DIEAMDPSILKGEPATGKR.4|SQLSC[CAM]VVVDDIER.3|SQLSC[CAM]VVVDDIER.2|MEIGLPDEK.2|VFPPEIVEQMGC[CAM]K.3|VFPPEIVEQMGC[CAM]K.2|ASTKVEVDMEKAESLQVTR.4|ASTKVEVDMEKAESLQVTR.3|MRGHQLLSADVDIK.3|NSDRTPLVSVLLEGPPHSGK.4|NSDRTPLVSVLLEGPPHSGK.3|EEGASPLDFD.2|TPLVSVLLEGPPHSGK.3|TPLVSVLLEGPPHSGK.2|VVNGPEILNK.2|FSNLVLQALLVLLKK.3|MGIGGLDKEFSDIFR.3|AENSSLNLIGK.2|LLDYVPIGPR.2|QRGSMAGSTGVHDTVVNQLLSK.4|YVGESEANIR.2|ERTTIAQQVK.2|THPSVVPGSIAFSLPQR.3|THPSVVPGSIAFSLPQR.2|LFADAEEEQR.2|DIEAMDPSILK.2|GILLYGPPGC[CAM]GK.2|SIDSNPYDTDK.2|YVGESEANIRK.2|NFSGAELEGLVR.2|C[CAM]PTDELSLTNC[CAM]AVVNEK.3|C[CAM]PTDELSLTNC[CAM]AVVNEK.2|IAEESNFPFIK.2|IDGVEQLNNILVIGMTNRPDLIDEALLRPGRLEVK.6|IDGVEQLNNILVIGMTNRPDLIDEALLRPGRLEVK.5|QKIEVGLVVGNSQVAFEK.3|QKIEVGLVVGNSQVAFEK.2|GDFLASLENDIK.2|GSMAGSTGVHDTVVNQLLSK.3|GSM[Oxi]AGSTGVHDTVVNQLLSK.3|GSMAGSTGVHDTVVNQLLSK.2|IDGVEQLNNILVIGMTNRPDLIDEALLRPGR.5|IDGVEQLNNILVIGMTNRPDLIDEALLRPGR.4|IDGVEQLNNILVIGM[Oxi]TNRPDLIDEALLRPGR.4|LGANSGLHIIIFDEIDAIC[CAM]K.3|PAFGTNQEDYASYIMNGIIK.3|PAFGTNQEDYASYIMNGIIK.2|QSIINPDWNFEK.2|C[CAM]PTDELSLTNC[CAM]AVVNEKDFQSGQHVIVR.4|IEVGLVVGNSQVAFEK.2|FLALLREEGASPLDFD.2|GDFLASLENDIKPAFGTNQEDYASYIMNGIIK.4|GDFLASLENDIKPAFGTNQEDYASYIMNGIIK.3
SEN / CTL,A8MWD9;P62308,Putative small nuclear ribonucleoprotein G-like protein 15;Small nuclear ribonucleoprotein G,SNRPGP15;SNRPG,2.62,0.79,4.72E-04,4.85E-05,4.31E+00,"mRNA splicing, via spliceosome;spliceosomal complex assembly,spliceosomal snRNP assembly,mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,histone mRNA metabolic process,RNA splicing,nuclear import","RNA binding;protein binding,poly(A) RNA binding,RNA binding","spliceosomal complex,small nucleolar ribonucleoprotein complex;nucleoplasm,spliceosomal complex,U5 snRNP,U7 snRNP,U1 snRNP,U2 snRNP,U4 snRNP,U12-type spliceosomal complex,small nucleolar ribonucleoprotein complex,cytosol,small nuclear ribonucleoprotein complex,methylosome,SMN-Sm protein complex,P granule,U2-type prespliceosome,precatalytic spliceosome,catalytic step 2 spliceosome,spliceosomal tri-snRNP complex",6,3,5,GNSIIMLEALERV.2|GNSIIM[Oxi]LEALERV.2|HVQGILR.2|GNSIIMLEALER.2|GNSIIM[Oxi]LEALER.2
SEN / CTL,Q16658,Fascin,FSCN1,2.61,2.06,4.15E-23,3.16E-23,2.25E+01,"cell-cell junction assembly,cell proliferation,anatomical structure morphogenesis,positive regulation of lamellipodium assembly,cell migration,microspike assembly,actin cytoskeleton organization,regulation of microvillus assembly,regulation of actin cytoskeleton organization,establishment of apical/basal cell polarity,cell motility,actin filament bundle assembly,positive regulation of filopodium assembly,positive regulation of podosome assembly,positive regulation of extracellular matrix disassembly,cell-cell adhesion","actin binding,drug binding,protein binding, bridging,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,ruffle,podosome,cytoplasm,cytosol,cytoskeleton,microvillus,cell-cell junction,cell-cell adherens junction,actin cytoskeleton,lamellipodium,filopodium,growth cone,cell projection membrane,filamentous actin,myelin sheath,microspike,extracellular exosome,invadopodium",96,44,69,VGKDELFALEQSC[CAM]AQVVLQAANER.3|VGKDELFALEQSC[CAM]AQVVLQAANER.4|YAHLSARPADEIAVDRDVPWGVDSLITLAFQDQR.5|YAHLSARPADEIAVDRDVPWGVDSLITLAFQDQR.4|YLAADKDGNVTC[CAM]EREVPGPDC[CAM]R.4|VGKDELFALEQSC[CAM]AQVVLQAANERNVSTR.4|QIWTLEQPPDEAGSAAVC[CAM]LR.2|QIWTLEQPPDEAGSAAVC[CAM]LR.3|LVARPEPATGYTLEFR.3|LVARPEPATGYTLEFR.2|LVARPEPATGYTLEFR.4|KQIWTLEQPPDEAGSAAVC[CAM]LR.3|KQIWTLEQPPDEAGSAAVC[CAM]LR.2|KQIWTLEQPPDEAGSAAVC[CAM]LR.4|YFGGTEDRLSC[CAM]FAQTVSPAEK.3|QGMDLSANQDEETDQETFQLEIDRDTKK.4|KKQIWTLEQPPDEAGSAAVC[CAM]LR.4|KKQIWTLEQPPDEAGSAAVC[CAM]LR.3|YLTAEAFGFK.2|YLKGDHAGVLK.3|YLKGDHAGVLK.2|LINRPIIVFR.3|LINRPIIVFR.2|VNASASSLK.2|YAHLSARPADEIAVDR.4|YAHLSARPADEIAVDR.3|YFGGTEDR.2|DGNVTC[CAM]ER.2|VTGTLDANR.2|LSC[CAM]FAQTVSPAEK.3|LSC[CAM]FAQTVSPAEK.2|RYAHLSARPADEIAVDR.4|RYAHLSARPADEIAVDR.3|PADEIAVDR.2|GEHGFIGC[CAM]R.2|KVTGTLDANR.2|WSVHIAM[Oxi]HPQVNIYSVTR.4|WSVHIAMHPQVNIYSVTR.4|WSVHIAMHPQVNIYSVTR.3|WSVHIAM[Oxi]HPQVNIYSVTR.3|WSVHIAMHPQVNIYSVTR.2|YLAADKDGNVTC[CAM]ER.3|YLAADKDGNVTC[CAM]ER.2|YSVQTADHR.2|RYFGGTEDR.2|WSLQSEAHR.2|LINRPIIVFRGEHGFIGC[CAM]R.4|FLIVAHDDGR.2|VAFRDC[CAM]EGRYLAPSGPSGTLK.4|YWTLTATGGVQSTASSK.3|YWTLTATGGVQSTASSK.2|YLAPSGPSGTLK.2|DGNVTC[CAM]EREVPGPDC[CAM]R.3|DVPWGVDSLITLAFQDQR.3|DVPWGVDSLITLAFQDQR.2|NGQLAASVETAGDSELFLMK.3|NGQLAASVETAGDSELFLMK.2|SSYDVFQLEFNDGAYNIK.3|SSYDVFQLEFNDGAYNIK.2|NASC[CAM]YFDIEWR.2|KNGQLAASVETAGDSELFLM[Oxi]K.3|KNGQLAASVETAGDSELFLMK.3|KNGQLAASVETAGDSELFLMK.2|PADEIAVDRDVPWGVDSLITLAFQDQR.4|PADEIAVDRDVPWGVDSLITLAFQDQR.3|THTGKYWTLTATGGVQSTASSK.3|ASAETVDPASLWEY.2|DELFALEQSC[CAM]AQVVLQAANER.3|QGMDLSANQDEETDQETFQLEIDRDTK.3
SEN / CTL,P18065,Insulin-like growth factor-binding protein 2,IGFBP2,2.61,1.81,1.15E-16,4.69E-17,1.63E+01,"regulation of cell growth,signal transduction,female pregnancy,aging,response to nutrient,response to mechanical stimulus,response to lithium ion,response to estradiol,response to retinoic acid,cellular response to hormone stimulus,positive regulation of activated T cell proliferation,response to drug,regulation of insulin-like growth factor receptor signaling pathway,response to estrogen,cellular protein metabolic process,response to glucocorticoid,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,apical plasma membrane,cytoplasmic vesicle,extracellular exosome",36,11,14,TPC[CAM]QQELDQVLER.2|LEGEAC[CAM]GVYTPR.2|MPC[CAM]AELVREPGC[CAM]GC[CAM]C[CAM]SVC[CAM]AR.3|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.3|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.2|LIQGAPTIRGDPEC[CAM]HLFYNEQQEAR.4|GPLEHLYSLHIPNC[CAM]DK.4|GPLEHLYSLHIPNC[CAM]DK.3|LPDERGPLEHLYSLHIPNC[CAM]DK.5|LPDERGPLEHLYSLHIPNC[CAM]DK.4|C[CAM]PPC[CAM]TPER.2|GDPEC[CAM]HLFYNEQQEAR.3|GEC[CAM]WC[CAM]VNPNTGK.2|C[CAM]YPHPGSELPLQALVMGEGTC[CAM]EK.3
SEN / CTL,Q9UK76,Hematological and neurological expressed 1 protein,HN1,2.61,1.10,8.19E-08,1.37E-08,7.86E+00,,,"nucleus,nucleolus,nuclear membrane",18,9,18,VLRPPGGGSNFSLGFDEPTEQPVRK.4|VLRPPGGGSNFSLGFDEPTEQPVRK.3|VLRPPGGGSNFSLGFDEPTEQPVRK.5|VLRPPGGGSNFSLGFDEPTEQPVRK.6|PVPAAPVPSPVAPAPVPSR.4|PVPAAPVPSPVAPAPVPSR.3|PVPAAPVPSPVAPAPVPSR.2|SSGGREDLESSGLQR.3|SSGGREDLESSGLQR.2|EDLESSGLQR.2|VLRPPGGGSNFSLGFDEPTEQPVR.4|VLRPPGGGSNFSLGFDEPTEQPVR.3|MASNIFGTPEENQASWAK.3|M[Oxi]ASNIFGTPEENQASWAK.2|MASNIFGTPEENQASWAK.2|NSSEASSGDFLDLK.2|GEGDIHENVDTDLPGSLGQSEEK.3|GEGDIHENVDTDLPGSLGQSEEKPVPAAPVPSPVAPAPVPSR.4
SEN / CTL,Q15365,Poly(rC)-binding protein 1,PCBP1,2.60,1.78,2.14E-16,8.39E-17,1.61E+01,"mRNA splicing, via spliceosome,gene expression,viral RNA genome replication,positive regulation of transcription from RNA polymerase II promoter,cell-cell adhesion","RNA polymerase II transcription factor activity, sequence-specific DNA binding,single-stranded DNA binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion,sequence-specific single stranded DNA binding","nucleoplasm,cytoplasm,cell-cell adherens junction,membrane,intracellular ribonucleoprotein complex,intracellular membrane-bounded organelle,extracellular exosome",54,16,53,AITIAGVPQSVTEC[CAM]VK.2|AITIAGVPQSVTEC[CAM]VK.3|IITLTGPTNAIFK.2|IITLTGPTNAIFK.3|AITIAGVPQSVTEC[CAM]VKQIC[CAM]LVMLETLSQSPQGR.4|LVVPATQC[CAM]GSLIGKGGC[CAM]K.3|VMTIPYQPMPASSPVIC[CAM]AGGQDR.3|VMTIPYQPMPASSPVIC[CAM]AGGQDR.4|VM[Oxi]TIPYQPMPASSPVIC[CAM]AGGQDR.3|VMTIPYQPM[Oxi]PASSPVIC[CAM]AGGQDR.3|VM[Oxi]TIPYQPM[Oxi]PASSPVIC[CAM]AGGQDR.3|ESTGAQVQVAGDMLPNSTER.2|ESTGAQVQVAGDM[Oxi]LPNSTER.3|ESTGAQVQVAGDMLPNSTER.3|ESTGAQVQVAGDM[Oxi]LPNSTER.2|LVVPATQC[CAM]GSLIGK.2|LVVPATQC[CAM]GSLIGK.3|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.6|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.6|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.3|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.3|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.3|QGANINEIR.2|QQSHFAMMHGGTGFAGIDSSSPEVK.5|QQSHFAMMHGGTGFAGIDSSSPEVK.4|QQSHFAM[Oxi]M[Oxi]HGGTGFAGIDSSSPEVK.4|QQSHFAMM[Oxi]HGGTGFAGIDSSSPEVK.4|QQSHFAM[Oxi]MHGGTGFAGIDSSSPEVK.3|QQSHFAMM[Oxi]HGGTGFAGIDSSSPEVK.3|QQSHFAMMHGGTGFAGIDSSSPEVK.3|IANPVEGSSGR.2|QVTITGSAASISLAQYLINAR.4|QVTITGSAASISLAQYLINAR.3|QVTITGSAASISLAQYLINAR.2|LEEDINSSMTNSTAASRPPVTLR.4|LEEDINSSMTNSTAASRPPVTLR.3|LEEDINSSM[Oxi]TNSTAASRPPVTLR.3|QIC[CAM]LVMLETLSQSPQGR.3|QIC[CAM]LVM[Oxi]LETLSQSPQGR.2|QIC[CAM]LVMLETLSQSPQGR.2|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.6|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.5|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.4|GYWASLDASTQTTHELTIPNNLIGC[CAM]IIGR.4|GYWASLDASTQTTHELTIPNNLIGC[CAM]IIGR.3
SEN / CTL,O75347,Tubulin-specific chaperone A,TBCA,2.60,1.67,2.91E-09,5.78E-10,9.24E+00,"protein folding,tubulin complex assembly,post-chaperonin tubulin folding pathway","poly(A) RNA binding,beta-tubulin binding,chaperone binding","nucleolus,cytoplasm,microtubule,microtubule cytoskeleton,extracellular exosome",36,14,23,ILENEKDLEEAEEYKEAR.4|ILENEKDLEEAEEYKEAR.3|LVLDSVKLEA.2|LEAAYLDLQR.2|RLEAAYLDLQR.3|RLEAAYLDLQR.2|AEDGENYDIKK.3|AEDGENYDIKK.2|MRAEDGENYDIK.3|M[Oxi]RAEDGENYDIK.3|DLEEAEEYKEAR.3|DLEEAEEYKEAR.2|MRAEDGENYDIKK.3|M[Oxi]RAEDGENYDIKK.3|MMIPDC[CAM]QR.2|MM[Oxi]IPDC[CAM]QR.2|M[Oxi]M[Oxi]IPDC[CAM]QR.2|QAEILQESR.2|DLEEAEEYK.2|AEDGENYDIK.2|KQAEILQESR.2|ILENEKDLEEAEEYK.3|ILENEKDLEEAEEYK.2
SEN / CTL,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,2.60,2.38,1.29E-05,1.67E-06,5.78E+00,"glutamate biosynthetic process,glutamate catabolic process,glutamine metabolic process,cellular amino acid biosynthetic process,substantia nigra development,positive regulation of insulin secretion,oxidation-reduction process,tricarboxylic acid metabolic process","glutamate dehydrogenase (NAD+) activity,glutamate dehydrogenase [NAD(P)+] activity,protein binding,ATP binding,GTP binding,identical protein binding,ADP binding,NAD+ binding,leucine binding","cytoplasm,mitochondrion,mitochondrial matrix",30,50,98,YSTDVSVDEVK.2|AKPYEGSILEADC[CAM]DILIPAASEK.3|AKPYEGSILEADC[CAM]DILIPAASEK.4|HGGTIPIVPTAEFQDR.3|HGGTIPIVPTAEFQDR.4|HGGTIPIVPTAEFQDR.2|GASIVEDKLVEDLR.3|GASIVEDKLVEDLR.2|LQHGSILGFPK.3|LQHGSILGFPK.2|AGVKINPK.2|GASIVEDK.2|IIKPC[CAM]NHVLSLSFPIRR.5|IIKPC[CAM]NHVLSLSFPIRR.4|FTM[Oxi]ELAK.2|FTMELAK.1|GASIVEDKLVEDLRTR.4|GASIVEDKLVEDLRTR.3|DDGSWEVIEGYRAQHSQHR.5|DDGSWEVIEGYRAQHSQHR.3|TAM[Oxi]KYNLGLDLR.3|DDGSWEVIEGYR.3|DDGSWEVIEGYR.2|IIKPC[CAM]NHVLSLSFPIR.4|IIKPC[CAM]NHVLSLSFPIR.3|YNLGLDLR.2|ELEDFKLQHGSILGFPK.4|ALASLMTYK.2|ALASLM[Oxi]TYK.2|DIVHSGLAYTM[Oxi]ER.3|DIVHSGLAYTMER.3|DIVHSGLAYTM[Oxi]ER.2|DIVHSGLAYTMER.2|MVEGFFDR.2|M[Oxi]VEGFFDR.2|NYTDNELEKITR.3|RFTMELAK.2|RFTM[Oxi]ELAK.2|DSNYHLLMSVQESLERK.4|DSNYHLLMSVQESLERK.3|PC[CAM]NHVLSLSFPIR.3|PC[CAM]NHVLSLSFPIR.2|IIAEGANGPTTPEADK.3|IIAEGANGPTTPEADK.2|NLNHVSYGR.2|RDDGSWEVIEGYR.3|RDDGSWEVIEGYR.2|GGIRYSTDVSVDEVK.3|ISGASEKDIVHSGLAYTMER.4|ISGASEKDIVHSGLAYTMER.3|ISGASEKDIVHSGLAYTMER.2|TAAYVNAIEK.2|VYNEAGVTFT.2|IIAEGANGPTTPEADKIFLER.4|IIAEGANGPTTPEADKIFLER.3|NYTDNELEK.2|TFVVQGFGNVGLHSMR.3|TFVVQGFGNVGLHSM[Oxi]R.3|TFVVQGFGNVGLHSMR.2|AKIIAEGANGPTTPEADK.3|YERDSNYHLLMSVQESLER.4|YERDSNYHLLMSVQESLER.3|MVEGFFDRGASIVEDK.3|AKIIAEGANGPTTPEADKIFLER.4|AKIIAEGANGPTTPEADKIFLER.3|C[CAM]AVVDVPFGGAK.2|GFIGPGIDVPAPDMSTGER.3|GFIGPGIDVPAPDM[Oxi]STGER.3|GFIGPGIDVPAPDM[Oxi]STGER.2|GFIGPGIDVPAPDMSTGER.2|DSNYHLLM[Oxi]SVQESLER.3|DSNYHLLMSVQESLER.3|DSNYHLLMSVQESLER.2|EM[Oxi]SWIADTYASTIGHYDINAHAC[CAM]VTGKPISQGGIHGR.6|EMSWIADTYASTIGHYDINAHAC[CAM]VTGKPISQGGIHGR.6|EMSWIADTYASTIGHYDINAHAC[CAM]VTGKPISQGGIHGR.5|EM[Oxi]SWIADTYASTIGHYDINAHAC[CAM]VTGKPISQGGIHGR.5|EMSWIADTYASTIGHYDINAHAC[CAM]VTGKPISQGGIHGR.4|KGFIGPGIDVPAPDMSTGER.3|KGFIGPGIDVPAPDM[Oxi]STGER.3|KGFIGPGIDVPAPDMSTGER.2|C[CAM]IAVGESDGSIWNPDGIDPK.3|C[CAM]IAVGESDGSIWNPDGIDPK.2|AKPYEGSILEADC[CAM]DILIPAASEKQLTK.4|YSTDVSVDEVKALASLM[Oxi]TYK.3|GVFHGIENFINEASYMSILGM[Oxi]TPGFGDK.4|GVFHGIENFINEASYMSILGMTPGFGDK.4|GVFHGIENFINEASYM[Oxi]SILGM[Oxi]TPGFGDK.3|GVFHGIENFINEASYM[Oxi]SILGMTPGFGDK.3|GVFHGIENFINEASYMSILGM[Oxi]TPGFGDK.3|GVFHGIENFINEASYMSILGMTPGFGDK.3|PYEGSILEADC[CAM]DILIPAASEK.3|PYEGSILEADC[CAM]DILIPAASEK.2|C[CAM]IAVGESDGSIWNPDGIDPKELEDFKLQHGSILGFPK.5|NIMVIPDLYLNAGGVTVSYFEWLK.3|NIM[Oxi]VIPDLYLNAGGVTVSYFEWLK.3|NIM[Oxi]VIPDLYLNAGGVTVSYFEWLKNLNHVSYGR.4|NIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGR.4
SEN / CTL,P22314,Ubiquitin-like modifier-activating enzyme 1,UBA1,2.59,1.94,4.14E-38,6.57E-38,3.72E+01,"cellular response to DNA damage stimulus,protein ubiquitination,modification-dependent protein catabolic process","ubiquitin activating enzyme activity,ubiquitin-protein transferase activity,protein binding,ATP binding,poly(A) RNA binding","nucleus,cytoplasm,mitochondrion,cytosol,extracellular exosome,heterochromatin,lysosomal membrane,endosome membrane,desmosome,rough endoplasmic reticulum membrane",162,67,128,LAGTQPLEVLEAVQR.3|LAGTQPLEVLEAVQR.2|ALPAVQQNNLDEDLIR.2|ALPAVQQNNLDEDLIR.3|SLVASLAEPDFVVTDFAK.3|SLVASLAEPDFVVTDFAK.2|VGPDTERIYDDDFFQNLDGVANALDNVDAR.4|VGPDTERIYDDDFFQNLDGVANALDNVDAR.3|AAVATFLQSVQVPEFTPK.3|AAVATFLQSVQVPEFTPK.2|AAVATFLQSVQVPEFTPK.4|QFLDYFK.2|NEEDAAELVALAQAVNAR.3|NEEDAAELVALAQAVNAR.2|LQTSSVLVSGLR.2|NGSEADIDEGLYSR.2|LAYVAAGDLAPINAFIGGLAAQEVMK.3|LAYVAAGDLAPINAFIGGLAAQEVMK.4|LAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.4|LAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.3|VGEFC[CAM]HNR.2|DNPGVVTC[CAM]LDEAR.2|DNPGVVTC[CAM]LDEAR.3|QNRYDGQVAVFGSDLQEK.3|QNRYDGQVAVFGSDLQEK.2|KLAYVAAGDLAPINAFIGGLAAQEVMK.3|KLAYVAAGDLAPINAFIGGLAAQEVMK.4|KLAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.4|KLAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.3|ALPAVQQNNLDEDLIRK.3|ALPAVQQNNLDEDLIRK.4|ALPAVQQNNLDEDLIRK.2|IYDDDFFQNLDGVANALDNVDAR.3|IYDDDFFQNLDGVANALDNVDAR.4|ERLDQPMTEIVSR.3|ERLDQPM[Oxi]TEIVSR.3|ERLDQPMTEIVSR.2|YDGQVAVFGSDLQEK.2|YDGQVAVFGSDLQEK.3|LDQPMTEIVSR.2|LDQPM[Oxi]TEIVSR.2|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.6|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.5|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.4|RLQTSSVLVSGLR.3|RLQTSSVLVSGLR.2|NIILGGVK.2|ATLPSPDK.2|KPLLESGTLGTK.3|KPLLESGTLGTK.2|AENYDIPSADR.3|AENYDIPSADR.2|QLYVLGHEAM[Oxi]K.3|QLYVLGHEAMK.3|QLYVLGHEAMK.2|QLYVLGHEAM[Oxi]K.2|SDTAAAAVR.2|ATLPSPDKLPGFK.3|ATLPSPDKLPGFK.2|QFLFRPWDVTK.3|QFLFRPWDVTK.2|DEFEGLFK.2|AENYDIPSADRHK.3|AENYDIPSADRHK.2|MYPIDFEK.2|NRAEVSQPR.2|QPAENVNQYLTDPK.3|QPAENVNQYLTDPK.2|YFLVGAGAIGC[CAM]ELLK.3|YFLVGAGAIGC[CAM]ELLK.2|FSRPAQLHIGFQALHQFC[CAM]AQHGRPPRPR.6|FSRPAQLHIGFQALHQFC[CAM]AQHGRPPRPR.5|LKSDTAAAAVR.2|PLLESGTLGTK.2|NFPNAIEHTLQWAR.3|NFPNAIEHTLQWAR.2|NGFLNLALPFFGFSEPLAAPR.4|NGFLNLALPFFGFSEPLAAPR.3|NGFLNLALPFFGFSEPLAAPR.2|QNRYDGQVAVFGSDLQEKLGK.4|QNRYDGQVAVFGSDLQEKLGK.3|FEVQGLQPNGEEMTLK.3|FEVQGLQPNGEEM[Oxi]TLK.2|FEVQGLQPNGEEMTLK.2|HQYYNQEWTLWDR.3|HQYYNQEWTLWDR.2|QKYFLVGAGAIGC[CAM]ELLK.3|QKYFLVGAGAIGC[CAM]ELLK.2|AVTLHDQGTAQWADLSSQFYLR.4|AVTLHDQGTAQWADLSSQFYLR.3|GNVQVVIPFLTESYSSSQDPPEK.4|GNVQVVIPFLTESYSSSQDPPEK.3|QLLHNFPPDQLTSSGAPFWSGPK.4|QLLHNFPPDQLTSSGAPFWSGPK.3|YDGQVAVFGSDLQEKLGK.3|IHVSDQELQSANASVDDSRLEELK.4|IHVSDQELQSANASVDDSRLEELK.3|AVTLHDQGTAQWADLSSQFYLREEDIGKNR.5|AVTLHDQGTAQWADLSSQFYLREEDIGKNR.4|DDDSNFHMDFIVAASNLR.3|IHVSDQELQSANASVDDSR.3|IHVSDQELQSANASVDDSR.2|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.6|RC[CAM]PHPLTFDVNNPLHLDYVM[Oxi]AAANLFAQTYGLTGSQDR.5|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.5|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.4|TEHKLEITMLSQGVSMLYSFFMPAAK.4|QLDSYKNGFLNLALPFFGFSEPLAAPR.4|QLDSYKNGFLNLALPFFGFSEPLAAPR.3|IIPAIATTTAAVVGLVC[CAM]LELYK.3|M[Oxi]YPIDFEKDDDSNFHMDFIVAASNLR.4|MYPIDFEKDDDSNFHMDFIVAASNLR.4|PQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.4|VLGPYTFSIC[CAM]DTSNFSDYIR.3|VLGPYTFSIC[CAM]DTSNFSDYIR.2|AVTLHDQGTAQWADLSSQFYLREEDIGK.4|AVTLHDQGTAQWADLSSQFYLREEDIGK.3|VSGPDPKPGSNC[CAM]SPAQSVLSEVPSVPTNGMAK.4|VSGPDPKPGSNC[CAM]SPAQSVLSEVPSVPTNGMAK.3|ALVLELC[CAM]C[CAM]NDESGEDVEVPYVR.3|DEFEGLFKQPAENVNQYLTDPK.3|NFAM[Oxi]IGLGC[CAM]GEGGEIIVTDMDTIEK.3|NFAMIGLGC[CAM]GEGGEIIVTDMDTIEK.3|HQYYNQEWTLWDRFEVQGLQPNGEEMTLK.4|C[CAM]PHPLTFDVNNPLHLDYVM[Oxi]AAANLFAQTYGLTGSQDR.4|C[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.4|HGFESGDFVSFSEVQGMVELNGNQPM[Oxi]EIK.3|HGFESGDFVSFSEVQGMVELNGNQPMEIK.3
SEN / CTL,Q00610,Clathrin heavy chain 1,CLTC,2.59,1.85,2.09E-33,2.69E-33,3.26E+01,"osteoblast differentiation,intracellular protein transport,receptor-mediated endocytosis,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,receptor internalization,transferrin transport,retrograde transport, endosome to Golgi,Wnt signaling pathway, planar cell polarity pathway,regulation of mitotic spindle organization,negative regulation of hyaluronan biosynthetic process,negative regulation of protein localization to plasma membrane","double-stranded RNA binding,structural molecule activity,protein binding,protein kinase binding,clathrin light chain binding,poly(A) RNA binding","spindle,cytosol,plasma membrane,focal adhesion,membrane,clathrin coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,clathrin-coated vesicle,clathrin-coated endocytic vesicle membrane,extracellular matrix,trans-Golgi network membrane,endolysosome membrane,melanosome,intracellular membrane-bounded organelle,protein complex,extracellular exosome,clathrin complex,extracellular vesicle,mitotic spindle microtubule",180,154,302,SVDPTLALSVYLR.2|LLLPWLEAR.2|NNLAGAEELFAR.2|NNLAGAEELFAR.3|GQC[CAM]DLELINVC[CAM]NENSLFK.3|GQC[CAM]DLELINVC[CAM]NENSLFK.2|KFNALFAQGNYSEAAK.3|KFNALFAQGNYSEAAK.2|SVNESLNNLFITEEDYQALR.3|SVNESLNNLFITEEDYQALR.2|GQFSTDELVAEVEKR.3|GQFSTDELVAEVEKR.2|LASTLVHLGEYQAAVDGAR.3|LASTLVHLGEYQAAVDGAR.4|LASTLVHLGEYQAAVDGAR.2|GQAGGKLHIIEVGTPPTGNQPFPK.4|GQAGGKLHIIEVGTPPTGNQPFPK.3|WLLLTGISAQQNR.2|WLLLTGISAQQNR.3|WLKEDKLEC[CAM]SEELGDLVK.4|WLKEDKLEC[CAM]SEELGDLVK.3|WLKEDKLEC[CAM]SEELGDLVK.2|LHIIEVGTPPTGNQPFPK.3|LHIIEVGTPPTGNQPFPK.4|LHIIEVGTPPTGNQPFPK.2|TLQIFNIEMK.2|TLQIFNIEM[Oxi]K.2|HSSLAGC[CAM]QIINYR.3|HSSLAGC[CAM]QIINYR.2|NLILVVR.2|KFDVNTSAVQVLIEHIGNLDR.4|KFDVNTSAVQVLIEHIGNLDR.3|KFDVNTSAVQVLIEHIGNLDR.2|ISGETIFVTAPHEATAGIIGVNRK.4|ISGETIFVTAPHEATAGIIGVNRK.5|ISGETIFVTAPHEATAGIIGVNRK.3|AFMTADLPNELIELLEK.2|AFMTADLPNELIELLEK.3|AFM[Oxi]TADLPNELIELLEK.3|AFM[Oxi]TADLPNELIELLEK.2|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|ISGETIFVTAPHEATAGIIGVNR.3|ISGETIFVTAPHEATAGIIGVNR.4|ISGETIFVTAPHEATAGIIGVNR.2|KVGYTPDWIFLLR.3|KVGYTPDWIFLLR.2|NLQNLLILTAIKADR.3|NLQNLLILTAIKADR.2|FNALFAQGNYSEAAK.2|FNALFAQGNYSEAAK.3|NLQNLLILTAIK.2|NLQNLLILTAIK.3|VVGAMQLYSVDR.2|VVGAM[Oxi]QLYSVDR.2|LLEMNLMHAPQVADAILGNQMFTHYDR.4|LLEMNLMHAPQVADAILGNQMFTHYDR.5|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQMFTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.3|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.3|LLEMNLMHAPQVADAILGNQMFTHYDR.3|HNIMDFAMPYFIQVMK.3|HNIMDFAMPYFIQVMK.4|HNIM[Oxi]DFAMPYFIQVMK.3|HNIMDFAM[Oxi]PYFIQVMK.3|HNIMDFAMPYFIQVM[Oxi]K.3|HNIM[Oxi]DFAM[Oxi]PYFIQVMK.3|HNIM[Oxi]DFAMPYFIQVMK.2|HNIMDFAM[Oxi]PYFIQVMK.2|HNIMDFAMPYFIQVM[Oxi]K.2|HNIMDFAMPYFIQVMK.2|ALEHFTDLYDIKR.4|ALEHFTDLYDIKR.3|ALEHFTDLYDIKR.2|EHLELFWSR.3|EHLELFWSR.2|AVNYFSK.2|IAAYLFK.2|QLPLVKPYLR.3|QLPLVKPYLR.2|VDKLDASESLR.3|VDKLDASESLR.2|YC[CAM]EKRDPHLAC[CAM]VAYER.5|YC[CAM]EKRDPHLAC[CAM]VAYER.4|YC[CAM]EKRDPHLAC[CAM]VAYER.3|IAAYLFKGNNR.3|YIQAAC[CAM]K.2|AMLSANIR.2|AM[Oxi]LSANIR.2|AYEFAER.2|DPHLAC[CAM]VAYER.3|DPHLAC[CAM]VAYER.2|LEKHELIEFR.3|LEKHELIEFR.2|IHEGC[CAM]EEPATHNALAK.4|IHEGC[CAM]EEPATHNALAK.3|IHEGC[CAM]EEPATHNALAK.2|IYIDSNNNPER.3|IYIDSNNNPER.2|LDASESLR.2|LKLLLPWLEAR.3|LKLLLPWLEAR.2|NNRPSEGPLQTR.3|NNRPSEGPLQTR.2|VDKLDASESLRK.3|VDKLDASESLRK.2|FLRENPYYDSRVVGK.4|KVSQPIEGHAASFAQFK.4|KVSQPIEGHAASFAQFK.3|VMEYINR.2|VM[Oxi]EYINR.2|EAIDSYIK.2|HELIEFR.2|IVLDNSVFSEHR.3|IVLDNSVFSEHR.2|AHTMTDDVTFWK.3|AHTM[Oxi]TDDVTFWK.3|AHTM[Oxi]TDDVTFWK.2|AHTMTDDVTFWK.2|NNLAGAEELFARK.3|NNLAGAEELFARK.2|ALEHFTDLYDIK.3|ALEHFTDLYDIK.2|FLRENPYYDSR.3|FLRENPYYDSR.2|VKQLPLVKPYLR.3|VVGAMQLYSVDRK.3|VVGAM[Oxi]QLYSVDRK.3|VVGAMQLYSVDRK.2|QSVELC[CAM]KK.2|RDPHLAC[CAM]VAYER.3|RDPHLAC[CAM]VAYER.2|MREHLELFWSR.3|M[Oxi]REHLELFWSR.3|VIQC[CAM]FAETGQVQK.3|VIQC[CAM]FAETGQVQK.2|LDASESLRK.2|TWKEVC[CAM]FAC[CAM]VDGKEFR.4|ENPYYDSR.2|GQFSTDELVAEVEK.3|GQFSTDELVAEVEK.2|LHIIEVGTPPTGNQPFPKK.4|LHIIEVGTPPTGNQPFPKK.3|LTDQLPLIIVC[CAM]DR.3|LTDQLPLIIVC[CAM]DR.2|MFDRHSSLAGC[CAM]QIINYR.4|RPISADSAIMNPASK.3|RPISADSAIM[Oxi]NPASK.3|RPISADSAIM[Oxi]NPASK.2|RPISADSAIMNPASK.2|PLLLNDLLMVLSPR.3|PLLLNDLLM[Oxi]VLSPR.3|PLLLNDLLM[Oxi]VLSPR.2|PLLLNDLLMVLSPR.2|TGQIKEVER.2|YIEIYVQK.2|AHIAQLC[CAM]EK.2|ESYVETELIFALAK.3|ESYVETELIFALAK.2|HDVVFLITK.2|TWKEVC[CAM]FAC[CAM]VDGK.3|TWKEVC[CAM]FAC[CAM]VDGK.2|YESLELC[CAM]R.2|KDPELWGSVLLESNPYRR.4|RKDPELWGSVLLESNPYR.4|RKDPELWGSVLLESNPYR.3|RKDPELWGSVLLESNPYR.2|YHEQLSTQSLIELFESFK.4|YHEQLSTQSLIELFESFK.3|YHEQLSTQSLIELFESFK.2|DAMQYASESK.2|DAM[Oxi]QYASESK.2|FDFVHDLVLYLYR.3|FDFVHDLVLYLYR.2|VANVELYYR.2|AHMGMFTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.3|AHMGM[Oxi]FTELAILYSK.3|AHM[Oxi]GM[Oxi]FTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.2|AHMGM[Oxi]FTELAILYSK.2|AHMGMFTELAILYSK.2|AHM[Oxi]GM[Oxi]FTELAILYSK.2|DTELAEELLQWFLQEEKR.4|DTELAEELLQWFLQEEKR.3|MKAHTMTDDVTFWK.3|MKAHTMTDDVTFWK.2|VSQPIEGHAASFAQFK.3|VSQPIEGHAASFAQFK.2|RPLIDQVVQTALSETQDPEEVSVTVK.5|RPLIDQVVQTALSETQDPEEVSVTVK.4|RPLIDQVVQTALSETQDPEEVSVTVK.3|ESNC[CAM]YDPER.2|QKWLLLTGISAQQNR.3|EDKLEC[CAM]SEELGDLVK.3|EDKLEC[CAM]SEELGDLVK.2|EVC[CAM]FAC[CAM]VDGK.2|ARESYVETELIFALAK.3|ARESYVETELIFALAK.2|LAELEEFINGPNNAHIQQVGDR.4|LAELEEFINGPNNAHIQQVGDR.3|MEGNAEESTLFC[CAM]FAVR.3|M[Oxi]EGNAEESTLFC[CAM]FAVR.2|MEGNAEESTLFC[CAM]FAVR.2|YESLELC[CAM]RPVLQQGR.3|YESLELC[CAM]RPVLQQGR.2|DPELWGSVLLESNPYR.3|DPELWGSVLLESNPYR.2|KFDVNTSAVQVLIEHIGNLDRAYEFAER.5|KFDVNTSAVQVLIEHIGNLDRAYEFAER.4|LLYNNVSNFGR.2|TSIDAYDNFDNISLAQR.3|TSIDAYDNFDNISLAQR.2|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.4|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.3|AAEQAHLWAELVFLYDK.3|KDPELWGSVLLESNPYR.3|KDPELWGSVLLESNPYR.2|GMVKEAIDSYIK.2|LPVVIGGLLDVDC[CAM]SEDVIK.3|LPVVIGGLLDVDC[CAM]SEDVIK.2|PLIDQVVQTALSETQDPEEVSVTVK.4|PLIDQVVQTALSETQDPEEVSVTVK.3|IVLDNSVFSEHRNLQNLLILTAIK.4|IVLDNSVFSEHRNLQNLLILTAIK.3|LEC[CAM]SEELGDLVK.2|QNLQIC[CAM]VQVASK.2|C[CAM]NEPAVWSQLAK.2|ESNC[CAM]YDPERVK.2|PISADSAIMNPASK.2|ANVPNKVIQC[CAM]FAETGQVQK.3|DTELAEELLQWFLQEEK.3|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.3|TNRLAELEEFINGPNNAHIQQVGDR.4|TNRLAELEEFINGPNNAHIQQVGDR.3|TNRLAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.5|VGEQAQVVIIDMNDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.2|VGEQAQVVIIDMNDPSNPIR.2|VGYTPDWIFLLR.2|FDVNTSAVQVLIEHIGNLDR.3|FDVNTSAVQVLIEHIGNLDR.2|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.5|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.4|FDVNTSAVQVLIEHIGNLDRAYEFAER.4|TSIDAYDNFDNISLAQRLEK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.3|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.4|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.3|LAQMC[CAM]GLHIVVHADELEELINYYQDR.4|LAQMC[CAM]GLHIVVHADELEELINYYQDR.3|EKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.5|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|WISLNTVALVTDNAVYHWSMEGESQPVK.4|WISLNTVALVTDNAVYHWSMEGESQPVK.3|YGYIHLYDLETGTC[CAM]IYM[Oxi]NR.3|YGYIHLYDLETGTC[CAM]IYMNR.3|YGYIHLYDLETGTC[CAM]IYMNR.2|EKVGEQAQVVIIDMNDPSNPIR.3|EKVGEQAQVVIIDM[Oxi]NDPSNPIR.3|LLYNNVSNFGRLASTLVHLGEYQAAVDGAR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|YEEYDNAIITMMNHPTDAWK.3|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|SVQNHNNKSVNESLNNLFITEEDYQALR.4|DAMQYASESKDTELAEELLQWFLQEEKR.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|AVDVFFPPEAQNDFPVAMQISEK.3|VNPSRLPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.3|DSLYKDAMQYASESK.2|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.5|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.4|ADDPSSYMEVVQAANTSGNWEELVK.3|ADDPSSYM[Oxi]EVVQAANTSGNWEELVK.3|EAIDSYIKADDPSSYMEVVQAANTSGNWEELVK.4|KAVDVFFPPEAQNDFPVAMQISEK.3|RAVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|VGEQAQVVIIDM[Oxi]NDPSNPIRRPISADSAIMNPASK.4|VGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.4|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDKFIC[CAM]IR.4|FQEHLQLQNLGINPANIGFSTLTMESDKFIC[CAM]IR.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGR.5|EC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGRK.5|DPELWGSVLLESNPYRRPLIDQVVQTALSETQDPEEVSVTVK.4
SEN / CTL,O15143,Actin-related protein 2/3 complex subunit 1B,ARPC1B,2.59,1.24,2.19E-12,6.10E-13,1.22E+01,"movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,response to estrogen,ephrin receptor signaling pathway","structural constituent of cytoskeleton,actin filament binding","cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,tubulobulbar complex,extracellular exosome",30,21,39,ASSEGGTAAGAGLDSLHKNSVSQISVLSGGK.4|VAWVSHDSTVC[CAM]LADADKK.4|VAWVSHDSTVC[CAM]LADADKK.3|VAWVSHDSTVC[CAM]LADADKK.2|VHELKEHNGQVTGIDWAPESNR.4|VHELKEHNGQVTGIDWAPESNR.5|C[CAM]SQFC[CAM]TTGMDGGMSIWDVK.3|C[CAM]SQFC[CAM]TTGMDGGMSIWDVK.2|TQIAIC[CAM]PNNHEVHIYEK.4|TQIAIC[CAM]PNNHEVHIYEK.3|TQIAIC[CAM]PNNHEVHIYEK.2|TWKPTLVILR.3|NSVSQISVLSGGK.3|NSVSQISVLSGGK.2|KASSEGGTAAGAGLDSLHK.4|KASSEGGTAAGAGLDSLHK.3|KASSEGGTAAGAGLDSLHK.2|IVTC[CAM]GTDR.2|DRTQIAIC[CAM]PNNHEVHIYEK.5|DRTQIAIC[CAM]PNNHEVHIYEK.4|DRTQIAIC[CAM]PNNHEVHIYEK.3|DRTQIAIC[CAM]PNNHEVHIYEK.2|NAYVWTLK.2|EVEERPAPTPWGSK.3|EVEERPAPTPWGSK.2|ASSEGGTAAGAGLDSLHK.3|ASSEGGTAAGAGLDSLHK.2|WAPNENKFAVGSGSR.3|SLESALKDLK.2|IFSAYIKEVEERPAPTPWGSK.4|VAWVSHDSTVC[CAM]LADADK.3|VAWVSHDSTVC[CAM]LADADK.2|EHNGQVTGIDWAPESNR.3|EHNGQVTGIDWAPESNR.2|IVTC[CAM]GTDRNAYVWTLK.3|VISIC[CAM]YFEQENDWWVC[CAM]K.3|VISIC[CAM]YFEQENDWWVC[CAM]K.2|MPFGELMFESSSSC[CAM]GWVHGVC[CAM]FSASGSR.4|MPFGELMFESSSSC[CAM]GWVHGVC[CAM]FSASGSR.3
SEN / CTL,Q9Y240,C-type lectin domain family 11 member A,CLEC11A,2.59,2.35,9.57E-09,1.82E-09,8.74E+00,positive regulation of cell proliferation,"growth factor activity,carbohydrate binding","extracellular region,extracellular space,cytoplasm",60,12,16,DFEAQAAAQAR.2|VVELTQGLR.2|AALAPYNWPVWLGVHDR.3|AALAPYNWPVWLGVHDR.2|LAGLDAGLHQLHVR.3|LAGLDAGLHQLHVR.2|AEGLYLFENGQR.2|RLYYVC[CAM]EFPF.2|DAVQALQEAQGR.2|DAVQALQEAQGR.3|LYYVC[CAM]EFPF.2|HLQEALGLPAGR.3|HLQEALGLPAGR.2|GGSLAQPADR.2|RAEGLYLFENGQR.3|GDENPAGTVEGK.2
SEN / CTL,Q16543,Hsp90 co-chaperone Cdc37,CDC37,2.58,1.16,2.46E-12,6.81E-13,1.22E+01,"regulation of cyclin-dependent protein serine/threonine kinase activity,protein folding,protein targeting,posttranscriptional regulation of gene expression,peptidyl-tyrosine phosphorylation,ERBB2 signaling pathway,protein stabilization,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,mitophagy in response to mitochondrial depolarization","protein tyrosine kinase activity,protein binding,protein kinase regulator activity,kinase binding,protein kinase binding,heat shock protein binding,unfolded protein binding,chaperone binding,Hsp90 protein binding","cytoplasm,cytosol,extracellular exosome,HSP90-CDC37 chaperone complex",30,26,48,LGPGGLDPVEVYESLPEELQK.3|LGPGGLDPVEVYESLPEELQK.2|LGPGGLDPVEVYESLPEELQK.4|TADRQYMEGFNDELEAFKER.4|TADRQYMEGFNDELEAFKER.3|C[CAM]IDSGLWVPNSK.2|AM[Oxi]KEYEEEER.3|AMKEYEEEER.3|AMKEYEEEER.2|AM[Oxi]KEYEEEER.2|ELEVAEGGK.2|TGDEKDVSV.2|TEEDSEEVREQK.3|ELEVAEGGKAELER.3|ELEVAEGGKAELER.2|SMVNTKPEK.2|LQAEAQQLR.2|SM[Oxi]VNTKPEKTEEDSEEVR.4|SMVNTKPEKTEEDSEEVR.4|SMVNTKPEKTEEDSEEVR.3|SM[Oxi]VNTKPEKTEEDSEEVR.3|TEEDSEEVR.2|EGEEAGPGDPLLEAVPK.3|EGEEAGPGDPLLEAVPK.2|LKELEVAEGGK.2|LQAEAQQLRK.2|RLGPGGLDPVEVYESLPEELQK.4|RLGPGGLDPVEVYESLPEELQK.3|SMVNTKPEKTEEDSEEVREQK.4|SM[Oxi]VNTKPEKTEEDSEEVREQK.4|SMVNTKPEKTEEDSEEVREQK.3|DVQMLQDAISK.2|DVQM[Oxi]LQDAISK.2|C[CAM]FDVKDVQMLQDAISK.3|SMPWNVDTLSK.2|SM[Oxi]PWNVDTLSK.2|QYMEGFNDELEAFKER.3|QYM[Oxi]EGFNDELEAFKER.3|QYMEGFNDELEAFKER.2|SWEQKLEEMR.2|TADRQYMEGFNDELEAFK.3|TADRQYMEGFNDELEAFK.2|ASEAKEGEEAGPGDPLLEAVPK.3|ASEAKEGEEAGPGDPLLEAVPK.2|C[CAM]ALM[Oxi]EQVAHQTIVMQFILELAK.3|C[CAM]ALMEQVAHQTIVMQFILELAK.3|QYMEGFNDELEAFK.2|QYM[Oxi]EGFNDELEAFK.2
SEN / CTL,P55786,Puromycin-sensitive aminopeptidase,NPEPPS,2.58,2.21,5.39E-13,1.59E-13,1.28E+01,"protein polyubiquitination,proteolysis,peptide catabolic process,cellular response to hypoxia,positive regulation of protein targeting to mitochondrion","aminopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","nucleus,cytosol,plasma membrane,extracellular exosome",54,55,85,TIQQC[CAM]C[CAM]ENILLNAAWLKR.3|LNLGTVGFYR.2|VLGATLLPDLIQK.2|VLGATLLPDLIQK.3|AGIISTVEVLK.2|NAATEDLWESLENASGKPIAAVMNTWTK.4|NAATEDLWESLENASGKPIAAVMNTWTK.3|LGLQNDLFSLAR.2|YAAVTQFEATDARR.3|YAAVTQFEATDARR.2|ATFDISLVVPK.2|DAESIHQYLLQR.3|DAESIHQYLLQR.2|RDAESIHQYLLQR.4|RDAESIHQYLLQR.3|RDAESIHQYLLQR.2|HGDGTTLDIMLK.3|HGDGTTLDIM[Oxi]LK.3|HGDGTTLDIMLK.2|HGDGTTLDIM[Oxi]LK.2|LEAAAQVR.2|QILSADLR.2|LGWDPKPGEGHLDALLR.4|LGWDPKPGEGHLDALLR.3|LGWDPKPGEGHLDALLR.2|AFFESHPAPSAER.3|AFFESHPAPSAER.2|GMNMYLTK.2|YAAVTQFEATDAR.3|YAAVTQFEATDAR.2|ATFDISLVVPKDR.3|DRVALSNMNVIDR.3|DRVALSNMNVIDR.2|ETALLIDPK.2|RAFPC[CAM]WDEPAIK.3|RAFPC[CAM]WDEPAIK.2|DLSLPPVDR.2|DVFSPIGER.2|ILMDKPEMNVVLK.3|ILMDKPEMNVVLK.2|SPVYLTVLK.2|YTTPSGEVR.2|KPYPDDENLVEVK.3|KPYPDDENLVEVK.2|YQGGFLISR.2|LSVEGFAVDK.2|LSVEGFAVDK.1|FIKDNWEELYNR.3|FIKDNWEELYNR.2|MLHDYIGDK.2|NVKPDQWVK.2|IDFVGELNDK.2|VTLSFPSTLQTGTGTLK.3|VTLSFPSTLQTGTGTLK.2|PGEGHLDALLR.2|TQYSSAMLESLLPGIR.3|TQYSSAMLESLLPGIR.2|TQYSSAM[Oxi]LESLLPGIR.2|DRVALSNMNVIDRKPYPDDENLVEVK.5|DRVALSNMNVIDRKPYPDDENLVEVK.4|PIAAVMNTWTK.2|SKYTTPSGEVR.2|VALSNMNVIDR.2|VALSNM[Oxi]NVIDR.2|DNWEELYNR.2|AFPC[CAM]WDEPAIK.2|FIKDNWEELYNRYQGGFLISR.4|DYFNVPYPLPK.2|VLTFALSEEVRPQDTVSVIGGVAGGSK.4|VLTFALSEEVRPQDTVSVIGGVAGGSK.3|TIQQC[CAM]C[CAM]ENILLNAAWLK.3|TIQQC[CAM]C[CAM]ENILLNAAWLK.2|VALSNMNVIDRKPYPDDENLVEVK.4|TLPFYKDYFNVPYPLPK.3|TLPFYKDYFNVPYPLPK.2|QMGFPLIYVEAEQVEDDR.3|QM[Oxi]GFPLIYVEAEQVEDDR.2|QMGFPLIYVEAEQVEDDR.2|LPADVSPINYSLC[CAM]LKPDLLDFTFEGK.4|LPADVSPINYSLC[CAM]LKPDLLDFTFEGK.3|DNWEELYNRYQGGFLISR.3|MLHDYIGDKDFKK.2|QMGFPLIYVEAEQVEDDRLLR.3|AQELDALDNSHPIEVSVGHPSEVDEIFDAISYSK.4|KFC[CAM]AGGSYVGEDC[CAM]PQWMVPITISTSEDPNQAK.3
SEN / CTL,Q9Y3B8,"Oligoribonuclease, mitochondrial",REXO2,2.58,0.90,9.18E-07,1.37E-07,6.86E+00,"nucleobase-containing compound metabolic process,nucleotide metabolic process,RNA phosphodiester bond hydrolysis, exonucleolytic","3'-5'-exoribonuclease activity,nucleic acid binding,3'-5' exonuclease activity","nucleus,nucleolus,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,focal adhesion",12,14,18,ALDDISESIKELQFYR.3|ALDDISESIKELQFYR.2|AVKESTITLQQAEYEFLSFVR.3|IIDVSTVK.2|IIENGENEK.2|RWYPEEYEFAPK.3|RWYPEEYEFAPK.2|ALDDISESIK.2|QQTPPGLC[CAM]PLAGNSVHEDKK.4|QQTPPGLC[CAM]PLAGNSVHEDKK.3|KIIENGENEK.2|QQTPPGLC[CAM]PLAGNSVHEDK.3|EGGAAMAAGESMAQR.2|ESTITLQQAEYEFLSFVR.3|ESTITLQQAEYEFLSFVR.2|WYPEEYEFAPK.2|QPDELLDSMSDWC[CAM]K.2|MVWVDLEMTGLDIEK.2
SEN / CTL,A6NHL2,Tubulin alpha chain-like 3,TUBAL3,2.58,0.61,1.77E-04,1.92E-05,4.72E+00,"cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule",6,4,7,KLAEQC[CAM]GGLQGFLIFRSFGGGTGSGFTSLLMER.4|SLFHPEQLLSGK.3|SLFHPEQLLSGK.2|SFGGGTGSGFTSLLMER.3|SFGGGTGSGFTSLLM[Oxi]ER.2|SFGGGTGSGFTSLLMER.2|FEGPLNVDLIEFQTNLVPYPR.3
SEN / CTL,Q04917,14-3-3 protein eta,YWHAH,2.58,1.61,2.30E-08,4.09E-09,8.39E+00,"regulation of sodium ion transport,glucocorticoid catabolic process,intracellular protein transport,substantia nigra development,glucocorticoid receptor signaling pathway,regulation of neuron differentiation,positive regulation of transcription, DNA-templated,regulation of synaptic plasticity,negative regulation of dendrite morphogenesis,membrane organization,membrane depolarization during action potential,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of sodium ion transmembrane transporter activity","actin binding,insulin-like growth factor receptor binding,protein binding,sodium channel regulator activity,enzyme binding,protein domain specific binding,glucocorticoid receptor binding,ion channel binding,protein heterodimerization activity","cytoplasm,mitochondrion,cytosol,plasma membrane,intercalated disc,cytoplasmic vesicle membrane,extracellular exosome",24,18,35,AVTELNEPLSNEDRNLLSVAYK.3|LAEQAERYDDMASAMK.3|LAEQAERYDDMASAMK.2|NSVVEASEAAYKEAFEISK.3|NSVVEASEAAYKEAFEISK.2|EQMQPTHPIR.3|EQM[Oxi]QPTHPIR.3|EQMQPTHPIR.2|EQM[Oxi]QPTHPIR.2|NSVVEASEAAYK.3|NSVVEASEAAYK.2|KNSVVEASEAAYK.3|KNSVVEASEAAYK.2|EAFEISKEQMQPTHPIR.4|YDDMASAMK.2|YDDM[Oxi]ASAMK.2|YDDMASAM[Oxi]K.2|YDDM[Oxi]ASAM[Oxi]K.2|AVTELNEPLSNEDR.3|AVTELNEPLSNEDR.2|YLAEVASGEK.2|KNSVVEASEAAYKEAFEISK.4|KNSVVEASEAAYKEAFEISK.3|ELETVC[CAM]NDVLSLLDK.3|ELETVC[CAM]NDVLSLLDK.2|YLAEVASGEKK.2|NC[CAM]NDFQYESK.2|DNLTLWTSDQQDEEAGEGN.3|DNLTLWTSDQQDEEAGEGN.2|IEKELETVC[CAM]NDVLSLLDK.3|QAFDDAIAELDTLNEDSYK.3|QAFDDAIAELDTLNEDSYK.2|QAFDDAIAELDTLNEDSYKDSTLIMQLLR.4|QAFDDAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.4|QAFDDAIAELDTLNEDSYKDSTLIMQLLR.3
SEN / CTL,Q15691,Microtubule-associated protein RP/EB family member 1,MAPRE1,2.57,2.43,1.61E-05,2.06E-06,5.69E+00,"G2/M transition of mitotic cell cycle,sister chromatid cohesion,mitotic nuclear division,cell proliferation,positive regulation of cell migration,negative regulation of microtubule polymerization,protein localization to microtubule,cell division,cell-cell adhesion,positive regulation of microtubule plus-end binding,negative regulation of microtubule binding","protein binding,protein C-terminus binding,identical protein binding,poly(A) RNA binding,microtubule plus-end binding,cadherin binding involved in cell-cell adhesion","cytoplasm,Golgi apparatus,centrosome,cytosol,microtubule,cytoplasmic microtubule,cell-cell adherens junction,cortical microtubule cytoskeleton,cell projection membrane,microtubule plus-end,spindle",42,24,48,NIELIC[CAM]QENEGENDPVLQR.3|NIELIC[CAM]QENEGENDPVLQR.2|LTVEDLEK.2|FFDANYDGKDYDPVAAR.3|FFDANYDGKDYDPVAAR.2|LTVEDLEKERDFYFGK.3|LTVEDLEKERDFYFGK.4|LTVEDLEKERDFYFGK.2|KNPGVGNGDDEAAELMQQVNVLK.3|KNPGVGNGDDEAAELMQQVNVLK.4|KNPGVGNGDDEAAELM[Oxi]QQVNVLK.3|KFFDANYDGK.3|KFFDANYDGK.2|LTVEDLEKER.3|LTVEDLEKER.2|LEHEYIQNFK.3|LEHEYIQNFK.2|DYDPVAAR.2|KPLTSSSAAPQRPISTQR.4|KPLTSSSAAPQRPISTQR.3|GKFQDNFEFVQWFKK.4|GKFQDNFEFVQWFKK.3|QGQETAVAPSLVAPALNKPK.4|QGQETAVAPSLVAPALNKPK.3|QGQETAVAPSLVAPALNKPK.2|KFFDANYDGKDYDPVAAR.4|KFFDANYDGKDYDPVAAR.3|FFDANYDGK.2|FQDNFEFVQWFK.3|FQDNFEFVQWFK.2|FQDNFEFVQWFKK.3|QGQETAVAPSLVAPALNK.3|QGQETAVAPSLVAPALNK.2|GKFQDNFEFVQWFK.3|GKFQDNFEFVQWFK.2|LRNIELIC[CAM]QENEGENDPVLQR.4|LRNIELIC[CAM]QENEGENDPVLQR.3|HDMLAWINESLQLNLTK.3|HDM[Oxi]LAWINESLQLNLTK.3|HDM[Oxi]LAWINESLQLNLTK.2|HDMLAWINESLQLNLTK.2|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALKK.4|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALKK.3|IVDILYATDEGFVIPDEGGPQEEQEEY.4|IVDILYATDEGFVIPDEGGPQEEQEEY.3|NPGVGNGDDEAAELMQQVNVLK.3|NPGVGNGDDEAAELMQQVNVLK.2|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALK.3
SEN / CTL,P13489,Ribonuclease inhibitor,RNH1,2.57,1.33,2.13E-31,2.61E-31,3.06E+01,"mRNA catabolic process,negative regulation of catalytic activity,regulation of angiogenesis","protein binding,ribonuclease inhibitor activity","nucleoplasm,cytoplasm,angiogenin-PRI complex,extracellular exosome",96,31,55,WAELLPLLQQC[CAM]QVVR.2|WAELLPLLQQC[CAM]QVVR.3|AKPDFKELTVSNNDINEAGVR.4|AKESLKELSLAGNELGDEGAR.4|AKESLKELSLAGNELGDEGAR.3|TLPTLQELHLSDNLLGDAGLQLLC[CAM]EGLLDPQC[CAM]R.4|VNPALAELNLR.2|VNPALAELNLR.3|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.3|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.4|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.2|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.3|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.4|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.2|ESLKELSLAGNELGDEGAR.3|ESLKELSLAGNELGDEGAR.2|ELTVSNNDINEAGVR.2|ELTVSNNDINEAGVR.3|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.2|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.3|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.4|LGDVGMAELC[CAM]PGLLHPSSR.3|LGDVGMAELC[CAM]PGLLHPSSR.4|LGDVGM[Oxi]AELC[CAM]PGLLHPSSR.3|LGDVGMAELC[CAM]PGLLHPSSR.2|ELDLSNNC[CAM]LGDAGILQLVESVR.3|ELDLSNNC[CAM]LGDAGILQLVESVR.4|ELC[CAM]QGLGQPGSVLR.2|ELC[CAM]QGLGQPGSVLR.3|ASLRELALGSNK.3|GC[CAM]GDLC[CAM]R.2|LESC[CAM]GVTSDNC[CAM]R.3|LESC[CAM]GVTSDNC[CAM]R.2|DLC[CAM]GIVASK.2|ELSLAGNELGDEGAR.3|ELSLAGNELGDEGAR.2|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.4|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.3|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.2|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.4|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.3|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.2|DSPC[CAM]QLEALK.2|LDDC[CAM]GLTEAR.2|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.5|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.4|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.3|VLC[CAM]QGLKDSPC[CAM]QLEALK.3|FLLELQISNNR.2|TLWIWEC[CAM]GITAK.2|LEDAGVRELC[CAM]QGLGQPGSVLR.3|LESC[CAM]GVTSDNC[CAM]RDLC[CAM]GIVASK.3|DSPC[CAM]QLEALKLESC[CAM]GVTSDNC[CAM]R.3|VLC[CAM]QGLKDSPC[CAM]QLEALKLESC[CAM]GVTSDNC[CAM]R.4|QPGC[CAM]LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR.5
SEN / CTL,Q06830,Peroxiredoxin-1,PRDX1,2.57,2.10,1.79E-29,1.89E-29,2.87E+01,"response to reactive oxygen species,skeletal system development,retina homeostasis,cell proliferation,removal of superoxide radicals,regulation of stress-activated MAPK cascade,erythrocyte homeostasis,natural killer cell mediated cytotoxicity,regulation of NF-kappaB import into nucleus,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process,cell-cell adhesion","peroxidase activity,protein binding,thioredoxin peroxidase activity,identical protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,extracellular matrix,melanosome,myelin sheath,extracellular exosome",138,29,60,GLFIIDDKGILR.3|GLFIIDDKGILR.2|LVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.6|LVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.5|TIAQDYGVLKADEGISFR.3|TIAQDYGVLKADEGISFR.2|TIAQDYGVLKADEGISFR.4|QITVNDLPVGR.2|QITVNDLPVGR.3|GLFIIDDKGILRQITVNDLPVGR.4|GLFIIDDKGILRQITVNDLPVGR.3|KQGGLGPMNIPLVSDPKR.4|KQGGLGPMNIPLVSDPKR.3|KQGGLGPM[Oxi]NIPLVSDPKR.4|KQGGLGPM[Oxi]NIPLVSDPKR.3|ATAVMPDGQFKDISLSDYKGK.4|ATAVMPDGQFKDISLSDYK.3|ATAVM[Oxi]PDGQFKDISLSDYK.3|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.5|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.4|QGGLGPMNIPLVSDPKR.3|QGGLGPM[Oxi]NIPLVSDPKR.3|QGGLGPMNIPLVSDPKR.2|LVQAFQFTDK.2|LVQAFQFTDK.3|KQGGLGPMNIPLVSDPK.3|KQGGLGPM[Oxi]NIPLVSDPK.3|KQGGLGPMNIPLVSDPK.2|KQGGLGPM[Oxi]NIPLVSDPK.2|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.4|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.5|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.3|SVDETLRLVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.7|SVDETLRLVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.5|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.5|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.4|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.3|HGEVC[CAM]PAGWKPGSDTIKPDVQK.5|HGEVC[CAM]PAGWKPGSDTIKPDVQK.4|HGEVC[CAM]PAGWKPGSDTIKPDVQK.3|SVDETLR.2|RTIAQDYGVLK.3|RTIAQDYGVLK.2|PGSDTIKPDVQK.3|PGSDTIKPDVQK.2|ADEGISFR.2|GLFIIDDK.2|GLFIIDDK.1|DISLSDYK.2|IGHPAPNFK.2|RTIAQDYGVLKADEGISFR.4|RTIAQDYGVLKADEGISFR.3|QGGLGPMNIPLVSDPK.3|QGGLGPMNIPLVSDPK.2|QGGLGPM[Oxi]NIPLVSDPK.2|TIAQDYGVLK.2|HGEVC[CAM]PAGWK.2|ATAVMPDGQFK.2|ATAVM[Oxi]PDGQFK.2|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.5
SEN / CTL,P52943,Cysteine-rich protein 2,CRIP2,2.57,1.26,1.78E-08,3.27E-09,8.49E+00,"positive regulation of cell proliferation,hemopoiesis",zinc ion binding,"cell cortex,extracellular matrix",18,12,18,GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.4|GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.3|GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.5|GVNTGAVGSYIYDRDPEGKVQP.3|KVYFAEK.2|TLTPGGHAEHDGKPFC[CAM]HKPC[CAM]YATLFGPK.6|TLTPGGHAEHDGKPFC[CAM]HKPC[CAM]YATLFGPK.5|TLTPGGHAEHDGQPYC[CAM]HKPC[CAM]YGILFGPK.6|TLTPGGHAEHDGQPYC[CAM]HKPC[CAM]YGILFGPK.5|PC[CAM]YATLFGPK.2|PC[CAM]YGILFGPK.2|PLAEGPQVTGPIEVPAAR.3|PLAEGPQVTGPIEVPAAR.2|GVNTGAVGSYIYDRDPEGK.3|GVNTGAVGSYIYDRDPEGK.2|GVNIGGAGSYIYEK.2|GVNTGAVGSYIYDR.2|ASSVTTFTGEPNTC[CAM]PR.2
SEN / CTL,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,2.56,2.04,1.07E-08,2.01E-09,8.70E+00,"glucose metabolic process,pentose-phosphate shunt,lipid metabolic process,cholesterol biosynthetic process,NADP metabolic process,NADPH regeneration,glutathione metabolic process,pentose-phosphate shunt, oxidative branch,response to iron(III) ion,negative regulation of protein glutathionylation,response to organic cyclic compound,pentose biosynthetic process,substantia nigra development,response to food,cellular response to oxidative stress,erythrocyte maturation,regulation of neuron apoptotic process,response to ethanol,ribose phosphate biosynthetic process,glucose 6-phosphate metabolic process,oxidation-reduction process,negative regulation of cell growth involved in cardiac muscle cell development,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,negative regulation of reactive oxygen species metabolic process","glucose-6-phosphate dehydrogenase activity,glucose binding,identical protein binding,protein homodimerization activity,NADP binding","nucleus,cytoplasm,centrosome,microtubule organizing center,cytosol,cytoplasmic side of plasma membrane,membrane,intracellular membrane-bounded organelle,extracellular exosome",36,50,86,NSYVAGQYDDAASYQR.3|NSYVAGQYDDAASYQR.2|LFYLALPPTVYEAVTK.2|LFYLALPPTVYEAVTK.3|VGFQYEGTYK.2|KPGMFFNPEESELDLTYGNR.3|KPGM[Oxi]FFNPEESELDLTYGNR.3|KPGM[Oxi]FFNPEESELDLTYGNR.2|KPGMFFNPEESELDLTYGNR.2|NIHESC[CAM]MSQIGWNR.3|NIHESC[CAM]M[Oxi]SQIGWNR.3|NIHESC[CAM]M[Oxi]SQIGWNR.2|NIHESC[CAM]MSQIGWNR.2|NVKLPDAYER.3|IDHYLGK.2|LPDAYER.2|PKPIPYIYGSR.3|LNSHMNALHLGSQANR.4|LNSHM[Oxi]NALHLGSQANR.4|LNSHMNALHLGSQANR.3|LNSHM[Oxi]NALHLGSQANR.3|LNSHMNALHLGSQANR.2|LEDFFAR.2|RNELVIR.2|RVGFQYEGTYK.3|RVGFQYEGTYK.2|WVNPHKL.2|LILDVFC[CAM]GSQMHFVR.4|LILDVFC[CAM]GSQMHFVR.3|LILDVFC[CAM]GSQM[Oxi]HFVR.3|LILDVFC[CAM]GSQMHFVR.2|LILDVFC[CAM]GSQM[Oxi]HFVR.2|TQVC[CAM]GILR.2|PASTNSDDVRDEK.3|PASTNSDDVRDEK.2|LQFHDVAGDIFHQQC[CAM]K.4|LQFHDVAGDIFHQQC[CAM]K.3|LQFHDVAGDIFHQQC[CAM]K.2|LSNHISSLFREDQIYR.4|LSNHISSLFREDQIYR.3|IFGPIWNR.2|KQSEPFFK.2|IFTPLLHQIELEK.3|IFTPLLHQIELEK.2|IIVEKPFGR.2|DNIAC[CAM]VILTFKEPFGTEGR.4|DNIAC[CAM]VILTFKEPFGTEGR.3|DNIAC[CAM]VILTFKEPFGTEGR.2|GPTEADELMK.2|GPTEADELM[Oxi]K.2|KKIYPTIWWLFR.3|WDGVPFILR.2|DGLLPENTFIVGYAR.3|DGLLPENTFIVGYAR.2|GYLDDPTVPR.2|IFTPLLHQIELEKPKPIPYIYGSR.5|IFTPLLHQIELEKPKPIPYIYGSR.4|IFTPLLHQIELEKPKPIPYIYGSR.3|LKLEDFFAR.2|VQPNEAVYTK.2|LSNHISSLFR.2|EMVQNLMVLR.2|EM[Oxi]VQNLMVLR.2|GPTEADELMKR.2|GGYFDEFGIIR.2|DNIAC[CAM]VILTFK.2|GSTTATFAAVVLYVENER.3|GSTTATFAAVVLYVENER.2|DLQSSDRLSNHISSLFR.3|KPGMFFNPEESELDLTYGNRYK.4|IDHYLGKEMVQNLMVLR.3|IYPTIWWLFR.2|LQFHDVAGDIFHQQC[CAM]KR.3|DVMQNHLLQMLC[CAM]LVAMEK.3|DVM[Oxi]QNHLLQMLC[CAM]LVAMEK.3|DVMQNHLLQM[Oxi]LC[CAM]LVAMEK.3|DVMQNHLLQMLC[CAM]LVAM[Oxi]EK.3|DVMQNHLLQMLC[CAM]LVAMEK.2|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVRDEK.5|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVRDEK.4|GSTTATFAAVVLYVENERWDGVPFILR.4|GSTTATFAAVVLYVENERWDGVPFILR.3|IFGPIWNRDNIAC[CAM]VILTFKEPFGTEGR.4|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVR.4|C[CAM]ISEVQANNVVLGQYVGNPDGEGEATK.3|C[CAM]ISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPR.4
SEN / CTL,P04264,"Keratin, type II cytoskeletal 1",KRT1,2.56,2.03,5.03E-42,9.71E-42,4.10E+01,"complement activation, lectin pathway,retina homeostasis,response to oxidative stress,fibrinolysis,regulation of angiogenesis,negative regulation of inflammatory response,establishment of skin barrier","receptor activity,structural molecule activity,protein binding,carbohydrate binding","extracellular space,nucleus,cytoskeleton,plasma membrane,membrane,extracellular matrix,keratin filament,extracellular exosome,blood microparticle",210,65,118,SISISVAR.2|SLNNQFASFIDKVR.3|SLNNQFASFIDKVR.2|SLDLDSIIAEVK.2|SLDLDSIIAEVK.3|SKAEAESLYQSKYEELQITAGR.4|SKAEAESLYQSKYEELQITAGR.3|SGGGGGRFSSC[CAM]GGGGGSFGAGGGFGSR.3|YEELQITAGR.2|YEELQITAGR.1|THNLEPYFESFINNLR.3|THNLEPYFESFINNLR.2|THNLEPYFESFINNLR.4|SLVNLGGSKSISISVAR.3|SLVNLGGSKSISISVAR.2|LALDLEIATYR.2|THNLEPYFESFINNLRR.3|THNLEPYFESFINNLRR.4|WELLQQVDTSTR.2|WELLQQVDTSTR.3|FLEQQNQVLQTKWELLQQVDTSTR.4|FLEQQNQVLQTKWELLQQVDTSTR.3|FLEQQNQVLQTK.2|FLEQQNQVLQTK.3|AEAESLYQSKYEELQITAGR.3|AEAESLYQSKYEELQITAGR.2|NKLNDLEDALQQAKEDLAR.4|NKLNDLEDALQQAKEDLAR.3|NKLNDLEDALQQAKEDLAR.2|SLDLDSIIAEVKAQYEDIAQK.3|SLDLDSIIAEVKAQYEDIAQK.4|SLDLDSIIAEVKAQYEDIAQK.2|MSGEC[CAM]APNVSVSVSTSHTTISGGGSR.3|M[Oxi]SGEC[CAM]APNVSVSVSTSHTTISGGGSR.3|MSGEC[CAM]APNVSVSVSTSHTTISGGGSR.4|FSSC[CAM]GGGGGSFGAGGGFGSR.2|FSSC[CAM]GGGGGSFGAGGGFGSR.3|SLNNQFASFIDK.2|SLNNQFASFIDK.3|SGGGFSSGSAGIINYQRR.3|SLVNLGGSK.2|SGGGFSSGSAGIINYQR.2|SGGGFSSGSAGIINYQR.3|GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR.3|GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR.2|LRSEIDNVKK.3|LRSEIDNVKK.2|SDQSRLDSELK.3|SDQSRLDSELK.2|TNAENEFVTIK.3|TNAENEFVTIK.2|NSKIEISELNR.3|NSKIEISELNR.2|RVDQLKSDQSR.3|SKAEAESLYQSK.3|SKAEAESLYQSK.2|LNDLEDALQQAK.3|LNDLEDALQQAK.2|TNAENEFVTIKK.3|TNAENEFVTIKK.2|SEIDNVKK.2|GENALKDAK.2|RTNAENEFVTIK.3|DVDGAYMTK.2|DVDGAYM[Oxi]TK.2|GGSGGGGGGSSGGR.2|LLRDYQELMNTK.3|LLRDYQELM[Oxi]NTK.3|LLRDYQELMNTK.2|LLRDYQELM[Oxi]NTK.2|RTNAENEFVTIKK.3|TLLEGEESR.2|AQYEDIAQK.2|EQIKSLNNQFASFIDKVR.4|EQIKSLNNQFASFIDKVR.3|LRSEIDNVK.2|NKLNDLEDALQQAK.3|NKLNDLEDALQQAK.2|GSGGGSSGGSIGGR.2|AEAESLYQSK.2|KDVDGAYMTK.2|KDVDGAYM[Oxi]TK.2|DYQELMNTK.2|DYQELM[Oxi]NTK.2|QISNLQQSISDAEQR.3|QISNLQQSISDAEQR.2|GSGGGSSGGSIGGRGSSSGGVK.3|TNAENEFVTIKKDVDGAYMTK.4|TNAENEFVTIKKDVDGAYMTK.3|FVSTTYSGVTR.2|KQISNLQQSISDAEQR.3|KQISNLQQSISDAEQR.2|KQISNLQQSISDAEQRGENALK.4|VDQLKSDQSRLDSELK.3|SDQSRLDSELKNMQDMVEDYR.4|SLDLDSIIAEVKAQYEDIAQKSK.4|LNDLEDALQQAKEDLAR.3|LNDLEDALQQAKEDLAR.2|NMQDMVEDYR.2|NM[Oxi]QDMVEDYR.2|NMQDM[Oxi]VEDYR.2|NM[Oxi]QDM[Oxi]VEDYR.2|LDSELKNM[Oxi]QDMVEDYR.3|LDSELKNMQDM[Oxi]VEDYR.3|LDSELKNMQDMVEDYR.3|LDSELKNM[Oxi]QDM[Oxi]VEDYR.3|LDSELKNM[Oxi]QDMVEDYR.2|LDSELKNMQDM[Oxi]VEDYR.2|LDSELKNMQDMVEDYR.2|LDSELKNM[Oxi]QDM[Oxi]VEDYR.2|QISNLQQSISDAEQRGENALKDAK.4|QISNLQQSISDAEQRGENALKDAK.3|GGSGGGGGGSSGGRGSGGGSSGGSIGGRGSSSGGVK.4|GGSGGGGGGSSGGRGSGGGSSGGSIGGR.3|QISNLQQSISDAEQRGENALK.3|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR.4|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR.3|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYRGGSGGGGGGSSGGR.4
SEN / CTL,P31150,Rab GDP dissociation inhibitor alpha,GDI1,2.54,1.68,1.23E-14,4.27E-15,1.44E+01,"signal transduction,protein transport,Rab protein signal transduction,positive regulation of GTPase activity,negative regulation of axonogenesis,regulation of small GTPase mediated signal transduction,response to calcium ion,oxidation-reduction process,negative regulation of protein targeting to membrane","GDP-dissociation inhibitor activity,Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,Rab GTPase binding","cytoplasm,Golgi apparatus,cytosol,midbody,neuron projection,myelin sheath,protein complex",60,28,53,IIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.4|VLHMDRNPYYGGESSSITPLEELYKR.5|VLHMDRNPYYGGESSSITPLEELYKR.4|FQLLEGPPESMGR.2|FQLLEGPPESM[Oxi]GR.2|KSDIYVC[CAM]MISYAHNVAAQGK.4|KSDIYVC[CAM]MISYAHNVAAQGK.3|TDDYLDQPC[CAM]LETVNR.2|TDDYLDQPC[CAM]LETVNR.3|SDIYVC[CAM]MISYAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISYAHNVAAQGK.3|SDIYVC[CAM]MISYAHNVAAQGK.2|YIAIASTTVETTDPEKEVEPALELLEPIDQK.4|YIAIASTTVETTDPEKEVEPALELLEPIDQK.3|MAGTAFDFENMKR.3|M[Oxi]AGTAFDFENMKR.3|MAGTAFDFENMKR.2|RMAGTAFDFENMK.3|RMAGTAFDFENMK.2|VVEGSFVYK.2|RFQLLEGPPESMGR.3|RFQLLEGPPESM[Oxi]GR.3|RFQLLEGPPESMGR.2|EVEPALELLEPIDQK.3|EVEPALELLEPIDQK.2|QNDVFGEAEQ.2|YIAIASTTVETTDPEK.3|YIAIASTTVETTDPEK.2|IIC[CAM]ILSHPIK.2|IYKVPSTETEALASNLMGMFEK.4|IYKVPSTETEALASNLMGM[Oxi]FEK.3|IYKVPSTETEALASNLMGMFEK.3|KQNDVFGEAEQ.2|TFEGVDPQTTSMRDVYR.3|MAGTAFDFENMK.2|M[Oxi]AGTAFDFENMK.2|MAGTAFDFENM[Oxi]K.2|VPSTETEALASNLMGMFEK.3|VPSTETEALASNLM[Oxi]GMFEK.3|VPSTETEALASNLMGM[Oxi]FEK.3|VPSTETEALASNLMGMFEK.2|RKQNDVFGEAEQ.2|NPYYGGESSSITPLEELYK.3|NPYYGGESSSITPLEELYK.2|VLHMDRNPYYGGESSSITPLEELYK.4|VLHMDRNPYYGGESSSITPLEELYK.3|TFEGVDPQTTSMR.2|TFEGVDPQTTSM[Oxi]R.2|QLIC[CAM]DPSYIPDR.2|NPYYGGESSSITPLEELYKR.3|FLVFVANFDENDPK.2|LSAIYGGTYMLNKPVDDIIMENGK.3|LSAIYGGTYM[Oxi]LNKPVDDIIM[Oxi]ENGK.3
SEN / CTL,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,2.53,1.42,9.04E-09,1.73E-09,8.76E+00,"glucose metabolic process,cellular aldehyde metabolic process,glucuronate catabolic process to xylulose 5-phosphate,L-ascorbic acid biosynthetic process,D-glucuronate catabolic process,aldehyde catabolic process,oxidation-reduction process,glutathione derivative biosynthetic process","alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,electron carrier activity,L-glucuronate reductase activity","extracellular space,cytosol,apical plasma membrane,extracellular exosome",24,26,45,MPLIGLGTWK.2|M[Oxi]PLIGLGTWK.2|GLEVTAYSPLGSSDR.2|GLEVTAYSPLGSSDR.3|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.5|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.6|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.4|HIDC[CAM]AAIYGNEPEIGEALKEDVGPGK.4|HIDC[CAM]AAIYGNEPEIGEALKEDVGPGK.3|ALEALVAK.2|AAVKYALSVGYR.3|HHPEDVEPALR.3|SPAQILLR.2|AVPREELFVTSK.3|AVPREELFVTSK.2|YALSVGYR.2|YIVPMLTVDGKR.3|YIVPM[Oxi]LTVDGKR.3|HHPEDVEPALRK.3|GLVQALGLSNFNSR.3|GLVQALGLSNFNSR.2|AVPREELFVTSKLWNTK.4|NADGTIC[CAM]YDSTHYK.3|NADGTIC[CAM]YDSTHYK.2|NADGTIC[CAM]YDSTHYKETWK.4|NADGTIC[CAM]YDSTHYKETWK.3|PAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.5|PAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.4|AWRDPDEPVLLEEPVVLALAEK.4|AWRDPDEPVLLEEPVVLALAEK.3|YIVPMLTVDGK.2|YIVPM[Oxi]LTVDGK.2|QIDDILSVASVR.2|DPDEPVLLEEPVVLALAEK.3|DPDEPVLLEEPVVLALAEK.2|HIDC[CAM]AAIYGNEPEIGEALK.3|HIDC[CAM]AAIYGNEPEIGEALK.2|AWRDPDEPVLLEEPVVLALAEKYGR.4|AWRDPDEPVLLEEPVVLALAEKYGR.3|TLADLQLEYLDLYLM[Oxi]HWPYAFER.4|TLADLQLEYLDLYLMHWPYAFER.4|TLADLQLEYLDLYLMHWPYAFER.3|VFDFTFSPEEMK.2|VFDFTFSPEEM[Oxi]K.2|DAGHPLYPFNDPY.2
SEN / CTL,P68371,Tubulin beta-4B chain,TUBB4B,2.53,1.96,7.24E-48,1.56E-47,4.68E+01,"G2/M transition of mitotic cell cycle,movement of cell or subcellular component,cytoskeleton organization,microtubule-based process,natural killer cell mediated cytotoxicity","double-stranded RNA binding,GTPase activity,structural constituent of cytoskeleton,GTP binding,MHC class I protein binding,unfolded protein binding","nucleus,cytosol,cytoskeleton,microtubule,extracellular matrix,myelin sheath,extracellular exosome,extracellular vesicle",258,42,123,GHYTEGAELVDSVLDVVRKEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.6|YLTVAAVFR.2|SGPFGQIFRPDNFVFGQSGAGNNWAK.3|SGPFGQIFRPDNFVFGQSGAGNNWAK.4|INVYYNEATGGKYVPR.3|NSSYFVEWIPNNVK.2|NSSYFVEWIPNNVK.3|AVLVDLEPGTMDSVR.2|AVLVDLEPGTMDSVR.3|AVLVDLEPGTM[Oxi]DSVR.3|AVLVDLEPGTM[Oxi]DSVR.2|GHYTEGAELVDSVLDVVRK.4|GHYTEGAELVDSVLDVVRK.3|GHYTEGAELVDSVLDVVRK.2|IREEYPDRIMNTFSVVPSPK.4|IREEYPDRIMNTFSVVPSPK.3|IREEYPDRIM[Oxi]NTFSVVPSPK.4|IREEYPDRIM[Oxi]NTFSVVPSPK.3|MREIVHLQAGQC[CAM]GNQIGAK.4|MREIVHLQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.4|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.3|MREIVHLQAGQC[CAM]GNQIGAK.2|REIVHLQAGQC[CAM]GNQIGAK.4|REIVHLQAGQC[CAM]GNQIGAK.3|GHYTEGAELVDSVLDVVR.3|GHYTEGAELVDSVLDVVR.4|GHYTEGAELVDSVLDVVR.2|LHFFMPGFAPLTSR.3|LHFFMPGFAPLTSR.2|LHFFM[Oxi]PGFAPLTSR.3|LHFFMPGFAPLTSR.4|LHFFM[Oxi]PGFAPLTSR.2|FWEVISDEHGIDPTGTYHGDSDLQLER.4|FWEVISDEHGIDPTGTYHGDSDLQLER.5|FWEVISDEHGIDPTGTYHGDSDLQLER.3|ALTVPELTQQMFDAK.2|ALTVPELTQQMFDAK.3|ALTVPELTQQM[Oxi]FDAK.3|ALTVPELTQQM[Oxi]FDAK.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.3|LAVNMVPFPR.2|LAVNM[Oxi]VPFPR.2|LAVNMVPFPR.1|EIVHLQAGQC[CAM]GNQIGAK.3|EIVHLQAGQC[CAM]GNQIGAK.2|EIVHLQAGQC[CAM]GNQIGAK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.3|INVYYNEATGGK.2|INVYYNEATGGK.3|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLR.4|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLR.5|ISEQFTAMFR.2|ISEQFTAMFR.3|ISEQFTAM[Oxi]FR.2|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|TLKLTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|IMNTFSVVPSPK.2|IMNTFSVVPSPK.3|IM[Oxi]NTFSVVPSPK.3|IM[Oxi]NTFSVVPSPK.2|MSMKEVDEQMLNVQNK.3|MSMKEVDEQMLNVQNK.2|M[Oxi]SMKEVDEQMLNVQNK.3|MSM[Oxi]KEVDEQMLNVQNK.3|MSMKEVDEQM[Oxi]LNVQNK.3|M[Oxi]SM[Oxi]KEVDEQMLNVQNK.3|M[Oxi]SMKEVDEQM[Oxi]LNVQNK.3|MSM[Oxi]KEVDEQM[Oxi]LNVQNK.3|M[Oxi]SM[Oxi]KEVDEQM[Oxi]LNVQNK.3|MSMKEVDEQM[Oxi]LNVQNK.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.5|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.6|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LRFPGQLNADLRK.5|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LRFPGQLNADLRK.4|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.4|MSATFIGNSTAIQELFKR.3|M[Oxi]SATFIGNSTAIQELFKR.3|M[Oxi]SATFIGNSTAIQELFKR.2|MSATFIGNSTAIQELFKR.2|HGRYLTVAAVFRGR.4|FPGQLNADLRK.3|FPGQLNADLRK.2|KLAVNMVPFPR.3|KLAVNM[Oxi]VPFPR.3|KLAVNMVPFPR.2|TAVC[CAM]DIPPRGLK.3|HGRYLTVAAVFR.3|RISEQFTAMFR.3|RISEQFTAM[Oxi]FR.3|RISEQFTAMFR.2|RISEQFTAM[Oxi]FR.2|EVDEQMLNVQNK.3|EVDEQM[Oxi]LNVQNK.3|EVDEQMLNVQNK.2|EVDEQM[Oxi]LNVQNK.2|TAVC[CAM]DIPPR.2|IREEYPDR.2|NMMAAC[CAM]DPR.2|NM[Oxi]MAAC[CAM]DPR.2|NMM[Oxi]AAC[CAM]DPR.2|NM[Oxi]M[Oxi]AAC[CAM]DPR.2|FPGQLNADLR.2|PDNFVFGQSGAGNNWAK.3|PDNFVFGQSGAGNNWAK.2|MSATFIGNSTAIQELFK.3|M[Oxi]SATFIGNSTAIQELFK.3|M[Oxi]SATFIGNSTAIQELFK.2|MSATFIGNSTAIQELFK.2|KLAVNMVPFPRLHFFMPGFAPLTSR.4|VSDTVVEPYNATLSVHQLVENTDETYC[CAM]IDNEALYDIC[CAM]FR.5|VSDTVVEPYNATLSVHQLVENTDETYC[CAM]IDNEALYDIC[CAM]FR.4
SEN / CTL,P62241,40S ribosomal protein S8,RPS8,2.52,1.55,7.36E-10,1.56E-10,9.81E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",30,23,39,IIDVVYNASNNELVR.2|IIDVVYNASNNELVR.3|ISSLLEEQFQQGK.2|ISSLLEEQFQQGK.3|ELEFYLR.2|NC[CAM]IVLIDSTPYRQWYESHYALPLGR.4|NC[CAM]IVLIDSTPYRQWYESHYALPLGR.3|LTPEEEEILNKKR.4|LTPEEEEILNKKR.3|LTPEEEEILNKKR.2|YELGRPAANTK.3|YELGRPAANTK.2|LTPEEEEILNK.3|LTPEEEEILNK.2|KYELGRPAANTK.3|KYELGRPAANTK.2|LLAC[CAM]IASR.2|ADGYVLEGK.2|LTPEEEEILNKK.3|LTPEEEEILNKK.2|NC[CAM]IVLIDSTPYR.3|NC[CAM]IVLIDSTPYR.2|LLAC[CAM]IASRPGQC[CAM]GR.3|LLAC[CAM]IASRPGQC[CAM]GR.2|QWYESHYALPLGR.3|QWYESHYALPLGR.2|ELEFYLRK.2|ALRLDVGNFSWGSEC[CAM]C[CAM]TRK.4|LDVGNFSWGSEC[CAM]C[CAM]TR.3|LDVGNFSWGSEC[CAM]C[CAM]TR.2|LDVGNFSWGSEC[CAM]C[CAM]TRK.3|LDVGNFSWGSEC[CAM]C[CAM]TRK.2|TRIIDVVYNASNNELVR.3|TRIIDVVYNASNNELVR.2|ADGYVLEGKELEFYLRK.3|ALRLDVGNFSWGSEC[CAM]C[CAM]TR.3|ALRLDVGNFSWGSEC[CAM]C[CAM]TR.2|ISSLLEEQFQQGKLLAC[CAM]IASRPGQC[CAM]GR.4|ADGYVLEGKELEFYLR.2
SEN / CTL,P36578,60S ribosomal protein L4,RPL4,2.52,1.87,1.15E-06,1.69E-07,6.77E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",18,42,74,NNRQPYAVSELAGHQTSAESWGTGR.4|NNRQPYAVSELAGHQTSAESWGTGR.3|LDELYGTWR.2|YAIC[CAM]SALAASALPALVMSK.3|YAIC[CAM]SALAASALPALVM[Oxi]SK.3|YAIC[CAM]SALAASALPALVMSK.2|YAIC[CAM]SALAASALPALVM[Oxi]SK.2|KPTTEEKKPAA.3|KPAPEKKPAEKKPTTEEK.5|KPAPEKKPAEKKPTTEEK.4|AAATKKPAPEKKPAEK.4|AAVAGKKPVVGKK.3|KLDELYGTWR.3|KLDELYGTWR.2|NIPGITLLNVSK.3|NIPGITLLNVSK.2|LAPGGHVGR.2|VDKAAAAAAALQAK.3|VDKAAAAAAALQAK.2|AWNDIKK.2|KPAEKKPTTEEKKPAA.4|EAVLLLKK.2|APIRPDIVNFVHTNLR.4|APIRPDIVNFVHTNLR.3|APIRPDIVNFVHTNLR.2|KLDELYGTWRK.3|MINTDLSR.2|M[Oxi]INTDLSR.2|AAAAAAALQAK.2|FC[CAM]IWTESAFRK.3|GHRIEEVPELPLVVEDK.4|GHRIEEVPELPLVVEDK.3|GHRIEEVPELPLVVEDK.2|NVTLPAVFK.2|NVTLPAVFKAPIRPDIVNFVHTNLRK.6|NVTLPAVFKAPIRPDIVNFVHTNLRK.5|NVTLPAVFKAPIRPDIVNFVHTNLRK.4|APIRPDIVNFVHTNLRK.4|APIRPDIVNFVHTNLRK.3|TKEAVLLLK.2|LRVDKAAAAAAALQAK.3|PLISVYSEK.2|PLISVYSEKGESSGK.3|PLISVYSEKGESSGK.2|GPC[CAM]IIYNEDNGIIK.3|GPC[CAM]IIYNEDNGIIK.2|IEEVPELPLVVEDK.3|IEEVPELPLVVEDK.2|AFRNIPGITLLNVSK.3|SNYNLPMHK.2|SNYNLPM[Oxi]HK.2|NVTLPAVFKAPIRPDIVNFVHTNLR.5|NVTLPAVFKAPIRPDIVNFVHTNLR.4|KNNRQPYAVSELAGHQTSAESWGTGR.5|KNNRQPYAVSELAGHQTSAESWGTGR.4|IEEVPELPLVVEDKVEGYKK.4|IEEVPELPLVVEDKVEGYKK.3|IEEVPELPLVVEDKVEGYKK.2|QPYAVSELAGHQTSAESWGTGR.4|QPYAVSELAGHQTSAESWGTGR.3|QPYAVSELAGHQTSAESWGTGR.2|RGPC[CAM]IIYNEDNGIIK.3|RGPC[CAM]IIYNEDNGIIK.2|SGQGAFGNMC[CAM]R.2|SGQGAFGNM[Oxi]C[CAM]R.2|NIPGITLLNVSKLNILK.3|GHRIEEVPELPLVVEDKVEGYK.4|GHRIEEVPELPLVVEDKVEGYK.3|FC[CAM]IWTESAFR.2|RYAIC[CAM]SALAASALPALVM[Oxi]SK.3|RYAIC[CAM]SALAASALPALVMSK.3|RYAIC[CAM]SALAASALPALVMSK.2|IEEVPELPLVVEDKVEGYK.3|IEEVPELPLVVEDKVEGYK.2
SEN / CTL,P23396,40S ribosomal protein S3,RPS3,2.51,1.70,1.36E-06,1.98E-07,6.70E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,DNA repair,transcription, DNA-templated,regulation of transcription, DNA-templated,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,apoptotic process,cellular response to DNA damage stimulus,response to oxidative stress,chromosome segregation,mitotic nuclear division,positive regulation of gene expression,negative regulation of translation,viral transcription,positive regulation of microtubule polymerization,negative regulation of protein ubiquitination,positive regulation of endodeoxyribonuclease activity,DNA damage response, detection of DNA damage,regulation of apoptotic process,positive regulation of JUN kinase activity,negative regulation of DNA repair,positive regulation of DNA repair,spindle assembly,cell division,response to TNF agonist,cellular response to hydrogen peroxide,positive regulation of NIK/NF-kappaB signaling,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,positive regulation of DNA N-glycosylase activity,positive regulation of base-excision repair,positive regulation of apoptotic signaling pathway,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis","DNA binding,damaged DNA binding,RNA binding,mRNA binding,structural constituent of ribosome,DNA-(apurinic or apyrimidinic site) lyase activity,endodeoxyribonuclease activity,protein binding,microtubule binding,transcription factor binding,tubulin binding,enzyme binding,kinase binding,protein kinase binding,Hsp70 protein binding,SUMO binding,oxidized purine DNA binding,oxidized pyrimidine DNA binding,ubiquitin-like protein conjugating enzyme binding,poly(A) RNA binding,protein kinase A binding,iron-sulfur cluster binding,Hsp90 protein binding,small ribosomal subunit rRNA binding,supercoiled DNA binding,DNA N-glycosylase activity","nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrial inner membrane,mitochondrial matrix,cytosol,ribosome,polysome,plasma membrane,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,ruffle membrane,extracellular exosome,mitotic spindle",30,31,52,ELAEDGYSGVEVR.2|ELAEDGYSGVEVR.3|VTPTRTEIIILATR.3|VTPTRTEIIILATR.2|FVDGLMIHSGDPVNYYVDTAVR.3|FVDGLMIHSGDPVNYYVDTAVR.4|FVDGLM[Oxi]IHSGDPVNYYVDTAVR.3|FGFPEGSVELYAEK.2|FGFPEGSVELYAEK.3|GLC[CAM]AIAQAESLR.2|GLC[CAM]AIAQAESLR.3|LLGGLAVR.2|AC[CAM]YGVLR.2|ELTAVVQK.2|FIMESGAK.2|FIM[Oxi]ESGAK.2|IRELTAVVQKR.3|FVADGIFK.2|FVADGIFK.1|TQNVLGEK.2|IGPKKPLPDHVSIVEPK.4|GC[CAM]EVVVSGK.2|KPLPDHVSIVEPK.3|KPLPDHVSIVEPK.2|DEILPTTPISEQK.3|DEILPTTPISEQK.2|RAC[CAM]YGVLR.2|KFVADGIFK.2|TEIIILATR.2|GGKPEPPAMPQPVPTA.3|GGKPEPPAMPQPVPTA.2|GGKPEPPAM[Oxi]PQPVPTA.2|KFVADGIFKAELNEFLTR.4|KFVADGIFKAELNEFLTR.3|KFVADGIFKAELNEFLTR.2|RFGFPEGSVELYAEKVATR.4|AELNEFLTR.2|IGPKKPLPDHVSIVEPKDEILPTTPISEQK.6|IGPKKPLPDHVSIVEPKDEILPTTPISEQK.5|IGPKKPLPDHVSIVEPKDEILPTTPISEQK.4|IMLPWDPTGK.2|IM[Oxi]LPWDPTGK.2|IRELTAVVQK.2|RFGFPEGSVELYAEK.3|RFGFPEGSVELYAEK.2|KPLPDHVSIVEPKDEILPTTPISEQK.5|KPLPDHVSIVEPKDEILPTTPISEQK.4|KPLPDHVSIVEPKDEILPTTPISEQK.3|FVADGIFKAELNEFLTR.3|FVADGIFKAELNEFLTR.2|FGFPEGSVELYAEKVATR.3|PLPDHVSIVEPKDEILPTTPISEQK.3
SEN / CTL,O00410,Importin-5,IPO5,2.51,2.35,7.04E-09,1.36E-09,8.87E+00,"protein import into nucleus, docking,protein import into nucleus, translocation,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,viral process,negative regulation of GTPase activity,positive regulation of protein import into nucleus,cellular response to amino acid stimulus","GTPase inhibitor activity,protein binding,nuclear localization sequence binding,Ran GTPase binding,protein transporter activity,poly(A) RNA binding","nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,Golgi apparatus,membrane,nuclear membrane,nuclear periphery,intracellular membrane-bounded organelle",36,60,117,ITFLLQAIR.2|AIGTEPDSDVLSEIMHSFAK.3|AIGTEPDSDVLSEIMHSFAK.2|VC[CAM]DIAAELAR.2|VIAALLQTMEDQGNQR.3|VIAALLQTMEDQGNQR.2|VIAALLQTM[Oxi]EDQGNQR.2|VAAAESMPLLLEC[CAM]AR.3|VAAAESMPLLLEC[CAM]AR.2|VAAAESM[Oxi]PLLLEC[CAM]AR.2|FLFDSVSSQNVGLR.2|FLFDSVSSQNVGLR.3|LVLPMIK.2|AKLEEHFKNQELR.4|AKLEEHFKNQELR.3|KVC[CAM]DIAAELAR.3|KVC[CAM]DIAAELAR.2|LQELIQK.2|VSDILHSIFSSYKEK.4|VSDILHSIFSSYKEK.3|ATAAFILANEHNVALFK.4|ATAAFILANEHNVALFK.3|ATAAFILANEHNVALFK.2|SLLIPYLDNLVK.3|SLLIPYLDNLVK.2|HIVENAVQKELR.3|NTTAAEEAR.2|STAC[CAM]QMLVC[CAM]YAK.3|STAC[CAM]QM[Oxi]LVC[CAM]YAK.2|STAC[CAM]QMLVC[CAM]YAK.2|VQAHAAAALINFTEDC[CAM]PK.4|VQAHAAAALINFTEDC[CAM]PK.3|VQAHAAAALINFTEDC[CAM]PK.2|TIEC[CAM]ISLIGLAVGK.3|TIEC[CAM]ISLIGLAVGK.2|VSDILHSIFSSYK.3|VSDILHSIFSSYK.2|IFSIIAEGEMHEAIKHEDPC[CAM]AK.5|IFSIIAEGEMHEAIKHEDPC[CAM]AK.4|IFSIIAEGEMHEAIKHEDPC[CAM]AK.3|RMLVQC[CAM]MQDQEHPSIR.4|FYFHDGVR.2|HIVENAVQK.2|QAEETYENIPGQSK.3|QAEETYENIPGQSK.2|FVPYYDLFMPSLK.3|FVPYYDLFM[Oxi]PSLK.2|FVPYYDLFMPSLK.2|FM[Oxi]QDASDVMQLLLK.3|FMQDASDVMQLLLK.3|FM[Oxi]QDASDVMQLLLK.2|FMQDASDVMQLLLK.2|EHIMQMLQNPDWK.3|EHIMQM[Oxi]LQNPDWK.3|EHIM[Oxi]QMLQNPDWK.2|EHIMQM[Oxi]LQNPDWK.2|EHIMQMLQNPDWK.2|IFSIIAEGEMHEAIK.3|KQAEETYENIPGQSK.3|KQAEETYENIPGQSK.2|SLVEIADTVPK.2|EFQQYLPVVMGPLMK.3|EFQQYLPVVM[Oxi]GPLMK.2|EFQQYLPVVMGPLM[Oxi]K.2|EFQQYLPVVMGPLMK.2|YLRPHLEATLQLSLK.3|YLRPHLEATLQLSLK.2|ELKEGFVEYTEQVVK.3|ELKEGFVEYTEQVVK.2|NLIDEDGNNQWPEGLK.3|NLIDEDGNNQWPEGLK.2|SLLIPYLDNLVKHLHSIMVLK.4|TKENVNATENC[CAM]ISAVGK.3|TKENVNATENC[CAM]ISAVGK.2|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.5|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.4|LVLPMIKEHIMQMLQNPDWK.4|LVLPMIKEHIMQMLQNPDWK.3|MLVQC[CAM]MQDQEHPSIR.3|MLVQC[CAM]MQDQEHPSIR.2|VRGPEYLTQM[Oxi]WHFMC[CAM]DALIK.4|VRGPEYLTQMWHFM[Oxi]C[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.3|SELLMIIQMETQSSMR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.4|YAEYFLRPM[Oxi]LQYVC[CAM]DNSPEVR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.3|LC[CAM]GDTSLNNMQR.2|LC[CAM]GDTSLNNM[Oxi]QR.2|LVLEQVVTSIASVADTAEEK.3|LVLEQVVTSIASVADTAEEK.2|YAAC[CAM]NAVGQM[Oxi]ATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.2|ILGKEFQQYLPVVMGPLMK.3|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.4|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.3|GPEYLTQMWHFMC[CAM]DALIK.3|EAALHIFWNFPGIFGNQQQHYLDVIK.4|EAALHIFWNFPGIFGNQQQHYLDVIK.3|LLSSAFDEVYPALPSDVQTAIK.3|LLSSAFDEVYPALPSDVQTAIK.2|ENVNATENC[CAM]ISAVGK.2|QWGLC[CAM]IFDDVIEHC[CAM]SPASFK.3|RQDEDYDEQVEESLQDEDDNDVYILTK.4|RQDEDYDEQVEESLQDEDDNDVYILTK.3|RLLSSAFDEVYPALPSDVQTAIK.3|PMLQYVC[CAM]DNSPEVR.2|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.4|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.3|C[CAM]IEVMGDGC[CAM]LNNEHFEELGGILK.3|C[CAM]IEVM[Oxi]GDGC[CAM]LNNEHFEELGGILK.3|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.4|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.3|TQTDFNDMEDDDPQISYMISAWAR.3|TASIKPEVALLDTQDMENMSDDDGWEFVNLGDQQSFGIK.4
SEN / CTL,P09972,Fructose-bisphosphate aldolase C,ALDOC,2.49,1.39,2.91E-23,2.27E-23,2.26E+01,"fructose metabolic process,gluconeogenesis,fructose 1,6-bisphosphate metabolic process,epithelial cell differentiation,canonical glycolysis","fructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein binding","mitochondrion,cytosol,cytoskeleton,extracellular exosome",60,27,42,VDKGVVPLAGTDGETTTQGLDGLSER.3|VDKGVVPLAGTDGETTTQGLDGLSER.4|ISERTPSALAILENANVLAR.3|GVVPLAGTDGETTTQGLDGLSER.3|GVVPLAGTDGETTTQGLDGLSER.2|GVVPLAGTDGETTTQGLDGLSER.4|TPSALAILENANVLAR.2|TPSALAILENANVLAR.3|C[CAM]PLPRPWALTFSYGR.3|DNAGAATEEFIK.2|GILAADESVGSMAK.2|GILAADESVGSM[Oxi]AK.2|PHSYPALSAEQK.3|PHSYPALSAEQK.2|RLSQIGVENTEENRR.4|RLSQIGVENTEENRR.3|ELSDIALR.2|PNMVTPGHAC[CAM]PIK.3|DDNGVPFVR.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.4|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.4|AEVNGLAAQGK.2|QVLFSADDR.2|LSQIGVENTEENRR.3|RLSQIGVENTEENR.3|YTPEEIAMATVTALR.3|YTPEEIAMATVTALR.2|ALSDHHVYLEGTLLK.3|ALQASALNAWR.2|C[CAM]IGGVIFFHETLYQK.3|C[CAM]IGGVIFFHETLYQK.2|RAEVNGLAAQGK.2|YTPEEIAMATVTALRR.3|DNAGAATEEFIKR.2|LSQIGVENTEENR.2|YEGSGEDGGAAAQSLYIANHAY.3|YEGSGEDGGAAAQSLYIANHAY.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIKYTPEEIAMATVTALR.6
SEN / CTL,P21964,Catechol O-methyltransferase,COMT,2.49,1.51,1.08E-02,9.22E-04,3.04E+00,"female pregnancy,learning,short-term memory,estrogen metabolic process,response to organic cyclic compound,cellular response to phosphate starvation,methylation,response to lipopolysaccharide,developmental process,negative regulation of renal sodium excretion,neurotransmitter catabolic process,dopamine catabolic process,response to drug,negative regulation of dopamine metabolic process,response to pain,multicellular organismal reproductive process,negative regulation of smooth muscle cell proliferation,positive regulation of homocysteine metabolic process,regulation of sensory perception of pain","magnesium ion binding,methyltransferase activity,O-methyltransferase activity,catechol O-methyltransferase activity","mitochondrion,cytosol,plasma membrane,membrane,integral component of membrane,axon,dendritic spine,cell body,postsynaptic membrane,extracellular exosome",6,21,38,KGTVLLADNVIC[CAM]PGAPDFLAHVR.4|KGTVLLADNVIC[CAM]PGAPDFLAHVR.3|KYDVDTLDMVFLDHWK.4|KYDVDTLDMVFLDHWK.3|KKYDVDTLDMVFLDHWK.4|KKYDVDTLDMVFLDHWK.3|DRYLPDTLLLEEC[CAM]GLLRK.4|DRYLPDTLLLEEC[CAM]GLLRK.3|VTLVVGASQDIIPQLK.3|VTLVVGASQDIIPQLK.2|AIYKGPGSEAGP.2|KYDVDTLDMVFLDHWKDR.4|GTVLLADNVIC[CAM]PGAPDFLAHVR.4|GTVLLADNVIC[CAM]PGAPDFLAHVR.3|GTVLLADNVIC[CAM]PGAPDFLAHVR.2|EWAMNVGDKK.2|VTLVVGASQDIIPQLKK.3|YLPDTLLLEEC[CAM]GLLR.3|YLPDTLLLEEC[CAM]GLLR.2|LITIEINPDC[CAM]AAITQR.3|LITIEINPDC[CAM]AAITQR.2|YDVDTLDMVFLDHWK.3|YDVDTLDMVFLDHWK.2|DKVTLVVGASQDIIPQLK.3|DKVTLVVGASQDIIPQLK.2|YLPDTLLLEEC[CAM]GLLRK.3|YLPDTLLLEEC[CAM]GLLRK.2|DRYLPDTLLLEEC[CAM]GLLR.3|GSSC[CAM]FEC[CAM]THYQSFLEYR.3|GSSC[CAM]FEC[CAM]THYQSFLEYR.2|ILNHVLQHAEPGNAQSVLEAIDTYC[CAM]EQKEWAMNVGDKK.6|ILNHVLQHAEPGNAQSVLEAIDTYC[CAM]EQKEWAM[Oxi]NVGDKK.6|ILNHVLQHAEPGNAQSVLEAIDTYC[CAM]EQKEWAMNVGDKK.5|IVDAVIQEHQPSVLLELGAYC[CAM]GYSAVR.4|IVDAVIQEHQPSVLLELGAYC[CAM]GYSAVR.3|GKIVDAVIQEHQPSVLLELGAYC[CAM]GYSAVR.4|ILNHVLQHAEPGNAQSVLEAIDTYC[CAM]EQK.4|ILNHVLQHAEPGNAQSVLEAIDTYC[CAM]EQK.3
SEN / CTL,Q9BR76,Coronin-1B,CORO1B,2.49,1.91,2.73E-09,5.45E-10,9.26E+00,"cell migration,actin cytoskeleton organization,ruffle organization,regulation of Arp2/3 complex-mediated actin nucleation,negative regulation of Arp2/3 complex-mediated actin nucleation,endothelial cell chemotaxis,cellular response to platelet-derived growth factor stimulus,wound healing,actin filament bundle assembly,negative regulation of smooth muscle cell chemotaxis,actin filament branching,cell-cell adhesion,protein localization to cell leading edge,positive regulation of lamellipodium morphogenesis","protein binding,identical protein binding,actin filament binding,Arp2/3 complex binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,cytosol,actin filament,plasma membrane,cell-cell adherens junction,focal adhesion,lamellipodium,cell leading edge,perinuclear region of cytoplasm,extracellular exosome,cell periphery",30,27,44,AGEAGKLEEVMQELR.3|AGEAGKLEEVMQELR.2|DADPILISLR.2|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.4|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.6|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.5|NVLSDSRPAM[Oxi]APGSSHLGAPASTTTAADATPSGSLAR.4|NVLSDSRPAM[Oxi]APGSSHLGAPASTTTAADATPSGSLAR.3|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.3|VTWDSTFC[CAM]AVNPK.2|VTWDSTFC[CAM]AVNPK.3|VGIIAWHPTAR.3|VGIIAWHPTAR.2|AIFLADGK.2|IC[CAM]RLEEQLGR.3|LEEQLGR.2|KC[CAM]EPIVMTVPR.3|KC[CAM]EPIVM[Oxi]TVPR.3|KC[CAM]EPIVMTVPR.2|HVFGQPVK.2|RGTLVAER.2|VFTTGFSR.2|NDQC[CAM]YEDIRVSR.3|HVFGQPVKNDQC[CAM]YEDIR.4|HVFGQPVKNDQC[CAM]YEDIR.3|LEEVMQELR.2|AIFLADGKVFTTGFSR.3|C[CAM]EPIVMTVPR.2|NDQC[CAM]YEDIR.2|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.5|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.4|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.3|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]KDK.5|PAMAPGSSHLGAPASTTTAADATPSGSLAR.4|PAMAPGSSHLGAPASTTTAADATPSGSLAR.3|RNVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.5|RNVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.4|YFEITEEPPYIHFLNTFTSKEPQR.4|YFEITEEPPYIHFLNTFTSKEPQR.3|KSDLFQDDLYPDTAGPEAALEAEEWVSGR.4|KSDLFQDDLYPDTAGPEAALEAEEWVSGR.3|YFEITEEPPYIHFLNTFTSK.3|SDLFQDDLYPDTAGPEAALEAEEWVSGR.3|QLALWDPENLEEPMALQELDSSNGALLPFYDPDTSVVYVC[CAM]GK.4
SEN / CTL,Q96AC1,Fermitin family homolog 2,FERMT2,2.49,1.08,1.95E-11,4.95E-12,1.13E+01,"cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,regulation of cell shape,Wnt signaling pathway,integrin activation,cell junction assembly,substrate adhesion-dependent cell spreading,focal adhesion assembly,protein localization to membrane","protein binding,phosphatidylinositol-3,4,5-trisphosphate binding","stress fiber,nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,cell cortex,cell surface,extrinsic component of cytoplasmic side of plasma membrane,lamellipodium membrane,I band,filamentous actin",24,35,55,SLMEQDVKENEALLLR.3|SLMEQDVKENEALLLR.2|LLIPVAEGMNEIWLR.2|LLIPVAEGMNEIWLR.3|LLIPVAEGM[Oxi]NEIWLR.2|FIQAWQSLPEFGITHFIAR.3|FIQAWQSLPEFGITHFIAR.4|FIQAWQSLPEFGITHFIAR.2|MQHLNPDPQLIPEQITTDITPEC[CAM]LVSPR.3|MQHLNPDPQLIPEQITTDITPEC[CAM]LVSPR.4|M[Oxi]QHLNPDPQLIPEQITTDITPEC[CAM]LVSPR.3|TFNIRHPEELSLLK.4|TFNIRHPEELSLLK.3|KEELIGIAYNR.3|KEELIGIAYNR.2|QYAHWMAAC[CAM]R.3|QYAHWMAAC[CAM]R.2|YGIQADAK.2|SKEESSGTPAHQMNLR.4|SKEESSGTPAHQM[Oxi]NLR.4|SKEESSGTPAHQMNLR.3|VTGEVHIGGVMLK.3|VTGEVHIGGVMLK.2|SLMEQDVK.2|ENEALLLR.2|DTSISC[CAM]YK.2|DWSDHALWWEK.3|MDASTGDAIK.2|QYWC[CAM]TFK.2|EESSGTPAHQMNLR.3|HPEELSLLK.2|INQLYEQAK.2|LSIMTSENHLNNSDK.3|VVHEFIGGYIFLSTR.3|INQGWLDSSR.2|EELIGIAYNR.2|FQGGKKEELIGIAYNR.3|AKDQNESLDEEMFYK.3|ILEAHQNVAQMSLIEAK.3|ILEAHQNVAQMSLIEAK.2|MVTVEFADEVR.2|M[Oxi]VTVEFADEVR.2|LSFIC[CAM]TEVDC[CAM]K.2|TSTILGDITSIPELADYIK.3|TSTILGDITSIPELADYIK.2|EVDEVDAALSDLEITLEGGK.3|EVDEVDAALSDLEITLEGGK.2|TMADSSYNLEVQNILSFLK.3|TM[Oxi]ADSSYNLEVQNILSFLK.3|TMADSSYNLEVQNILSFLK.2|GC[CAM]EVTPDVNISGQK.2|DQNESLDEEMFYK.2|KLDDQSEDEALELEGPLITPGSGSIYSSPGLYSK.4|KLDDQSEDEALELEGPLITPGSGSIYSSPGLYSK.3|LSIMTSENHLNNSDKEVDEVDAALSDLEITLEGGK.4
SEN / CTL,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,2.49,1.37,6.32E-03,5.58E-04,3.25E+00,"GMP biosynthetic process,GTP biosynthetic process,purine ribonucleoside monophosphate biosynthetic process,lymphocyte proliferation,protein homotetramerization,oxidation-reduction process,retina development in camera-type eye,cellular response to interleukin-4","nucleotide binding,DNA binding,RNA binding,IMP dehydrogenase activity,metal ion binding","nucleus,cytoplasm,peroxisomal membrane,cytosol,membrane,extracellular exosome",6,39,77,NLIDAGVDALR.2|ARHGFC[CAM]GIPITDTGR.4|ARHGFC[CAM]GIPITDTGR.3|RTSSAQVEGGVHSLHSYEK.5|RTSSAQVEGGVHSLHSYEK.4|RTSSAQVEGGVHSLHSYEK.3|TSSAQVEGGVHSLHSYEKR.5|TSSAQVEGGVHSLHSYEKR.4|TSSAQVEGGVHSLHSYEKR.3|KQLLC[CAM]GAAIGTHEDDKYR.5|KQLLC[CAM]GAAIGTHEDDKYR.4|LVGIISSR.2|PQATAVYK.2|KYEQGFITDPVVLSPK.4|KYEQGFITDPVVLSPK.3|KYEQGFITDPVVLSPK.2|FGVPVIADGGIQNVGHIAK.4|FGVPVIADGGIQNVGHIAK.3|FGVPVIADGGIQNVGHIAK.2|HGFC[CAM]GIPITDTGR.3|HGFC[CAM]GIPITDTGR.2|AM[Oxi]MYSGELKFEK.3|AMMYSGELKFEK.3|TSSAQVEGGVHSLHSYEK.4|TSSAQVEGGVHSLHSYEK.3|TSSAQVEGGVHSLHSYEK.2|EANEILQR.2|QLLC[CAM]GAAIGTHEDDKYR.4|QLLC[CAM]GAAIGTHEDDKYR.3|REDLVVAPAGITLK.3|REDLVVAPAGITLK.2|AMMYSGELK.2|AM[Oxi]MYSGELK.2|AMM[Oxi]YSGELK.2|GMGSLDAMDK.2|GM[Oxi]GSLDAMDK.2|GMGSLDAM[Oxi]DK.2|RFGVPVIADGGIQNVGHIAK.4|RFGVPVIADGGIQNVGHIAK.3|RFGVPVIADGGIQNVGHIAK.2|DKYPNLQVIGGNVVTAAQAK.4|DKYPNLQVIGGNVVTAAQAK.3|DKYPNLQVIGGNVVTAAQAK.2|KGKLPIVNEDDELVAIIAR.4|KGKLPIVNEDDELVAIIAR.3|FVPYLIAGIQHSC[CAM]QDIGAK.4|FVPYLIAGIQHSC[CAM]QDIGAK.3|FVPYLIAGIQHSC[CAM]QDIGAK.2|NRDYPLASK.2|QLLC[CAM]GAAIGTHEDDK.3|QLLC[CAM]GAAIGTHEDDK.2|YEQGFITDPVVLSPK.3|YEQGFITDPVVLSPK.2|VAQGVSGAVQDK.2|LPIVNEDDELVAIIAR.3|LPIVNEDDELVAIIAR.2|EEEHDC[CAM]FLEEIMTK.3|EEEHDC[CAM]FLEEIMTK.2|GMGSLDAMDKHLSSQNR.3|YPNLQVIGGNVVTAAQAK.3|YPNLQVIGGNVVTAAQAK.2|YIKDKYPNLQVIGGNVVTAAQAK.4|DIDFLKEEEHDC[CAM]FLEEIMTK.4|DIDFLKEEEHDC[CAM]FLEEIMTK.3|GKLPIVNEDDELVAIIAR.3|GKLPIVNEDDELVAIIAR.2|EDLVVAPAGITLK.2|DIDFLKEEEHDC[CAM]FLEEIMTKR.4|YRGMGSLDAMDK.2|VKKYEQGFITDPVVLSPK.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.4|VGM[Oxi]GSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.4|VGM[Oxi]GSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.3|ALALGASTVMMGSLLAATTEAPGEYFFSDGIR.4|ALALGASTVMMGSLLAATTEAPGEYFFSDGIR.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GR.2
SEN / CTL,P61158,Actin-related protein 3,ACTR3,2.49,1.67,2.27E-21,1.41E-21,2.09E+01,"movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,spindle localization,cilium morphogenesis","structural constituent of cytoskeleton,ATP binding,actin filament binding","cytosol,Arp2/3 protein complex,brush border,cell-cell junction,focal adhesion,actin cytoskeleton,membrane,lamellipodium,extracellular exosome",90,34,61,LGYAGNTEPQFIIPSC[CAM]IAIKESAK.3|DITYFIQQLLR.2|DITYFIQQLLR.3|LKPKPIDVQVITHHMQR.5|LKPKPIDVQVITHHMQR.4|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.3|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.4|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.5|LGYAGNTEPQFIIPSC[CAM]IAIK.3|LGYAGNTEPQFIIPSC[CAM]IAIK.2|LKLSEELSGGR.2|NIVLSGGSTMFR.2|NIVLSGGSTMFR.3|NIVLSGGSTM[Oxi]FR.2|DYEEIGPSIC[CAM]R.2|DYEEIGPSIC[CAM]R.3|FMEQVIFK.2|FM[Oxi]EQVIFK.2|HGIVEDWDLMER.3|HGIVEDWDLMER.2|HGIVEDWDLM[Oxi]ER.2|GVDDLDFFIGDEAIEKPTYATK.3|GVDDLDFFIGDEAIEKPTYATK.4|QYTGINAISKK.3|QYTGINAISKK.2|EFNKYDTDGSK.3|EFNKYDTDGSK.2|KEFSIDVGYER.3|KEFSIDVGYER.2|LSEELSGGR.2|KDYEEIGPSIC[CAM]R.3|KDYEEIGPSIC[CAM]R.2|HNPVFGVMS.2|HNPVFGVM[Oxi]S.2|ERYSYVC[CAM]PDLVK.3|ERYSYVC[CAM]PDLVK.2|LPAC[CAM]VVDC[CAM]GTGYTK.3|LPAC[CAM]VVDC[CAM]GTGYTK.2|WPIRHGIVEDWDLMER.4|PIDVQVITHHM[Oxi]QR.3|PIDVQVITHHMQR.3|PIDVQVITHHMQR.2|HIPIAGRDITYFIQQLLR.4|QYTGINAISK.2|DREVGIPPEQSLETAK.3|DREVGIPPEQSLETAK.2|EFSIDVGYER.2|AEPEDHYFLLTEPPLNTPENR.4|AEPEDHYFLLTEPPLNTPENR.3|YSYVC[CAM]PDLVK.2|YSYVC[CAM]PDLVKEFNKYDTDGSK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTK.4|YAVWFGGSM[Oxi]LASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.3|YLRAEPEDHYFLLTEPPLNTPENR.4|YLRAEPEDHYFLLTEPPLNTPENR.3|EVGIPPEQSLETAK.2|GVDDLDFFIGDEAIEKPTYATKWPIR.4|GVDDLDFFIGDEAIEK.2
SEN / CTL,P30153,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,2.48,2.06,6.73E-13,1.96E-13,1.27E+01,"G2/M transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,inactivation of MAPK activity,regulation of DNA replication,regulation of transcription, DNA-templated,protein complex assembly,protein dephosphorylation,ceramide metabolic process,apoptotic process,chromosome segregation,mitotic nuclear envelope reassembly,female meiotic division,RNA splicing,response to organic substance,second-messenger-mediated signaling,regulation of Wnt signaling pathway,regulation of cell adhesion,negative regulation of cell growth,regulation of protein phosphatase type 2A activity,regulation of growth,negative regulation of tyrosine phosphorylation of Stat3 protein,regulation of cell differentiation,meiotic spindle elongation,mitotic sister chromatid separation,meiotic sister chromatid cohesion, centromeric,peptidyl-serine dephosphorylation,regulation of meiotic cell cycle process involved in oocyte maturation,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","antigen binding,protein serine/threonine phosphatase activity,protein binding,protein phosphatase type 2A regulator activity,protein heterodimerization activity","protein phosphatase type 2A complex,chromosome, centromeric region,nucleus,mitochondrion,cytosol,microtubule cytoskeleton,membrane,extracellular exosome",48,41,75,AISHEHSPSDLEAHFVPLVKR.5|AVGPEITKTDLVPAFQNLMKDC[CAM]EAEVR.4|LSTIALALGVER.2|LSTIALALGVER.3|VLELDNVKSEIIPMFSNLASDEQDSVR.4|VLELDNVKSEIIPMFSNLASDEQDSVR.3|TSAC[CAM]GLFSVC[CAM]YPR.2|DEC[CAM]PEVR.2|IGPILDNSTLQSEVKPILEK.3|IGPILDNSTLQSEVKPILEK.2|KLSTIALALGVER.3|KLSTIALALGVER.2|ELVSDANQHVK.3|ELVSDANQHVK.2|AISHEHSPSDLEAHFVPLVK.5|AISHEHSPSDLEAHFVPLVK.4|AISHEHSPSDLEAHFVPLVK.3|AISHEHSPSDLEAHFVPLVK.2|DC[CAM]EAEVR.2|NEDVQLR.2|VLELDNVK.2|DNTIEHLLPLFLAQLK.4|DNTIEHLLPLFLAQLK.3|DNTIEHLLPLFLAQLK.2|VLAM[Oxi]SGDPNYLHR.3|VLAMSGDPNYLHR.3|VLAMSGDPNYLHR.2|VLAM[Oxi]SGDPNYLHR.2|YM[Oxi]VADKFTELQK.3|YMVADKFTELQK.3|YMVADKFTELQK.2|FGKEWAHATIIPK.3|FGKEWAHATIIPK.2|ENVIMSQILPC[CAM]IK.3|ENVIMSQILPC[CAM]IK.2|ENVIM[Oxi]SQILPC[CAM]IK.2|LNSLC[CAM]MAWLVDHVYAIR.4|LNSLC[CAM]M[Oxi]AWLVDHVYAIR.3|LNSLC[CAM]MAWLVDHVYAIR.3|LNSLC[CAM]MAWLVDHVYAIR.2|MAGDPVANVR.2|M[Oxi]AGDPVANVR.2|SALASVIMGLSPILGK.3|SALASVIM[Oxi]GLSPILGK.3|SALASVIMGLSPILGK.2|SALASVIM[Oxi]GLSPILGK.2|VKEFC[CAM]ENLSADC[CAM]R.3|VKEFC[CAM]ENLSADC[CAM]R.2|LAGGDWFTSR.2|LTQDQDVDVK.2|EWAHATIIPK.2|RLAGGDWFTSR.2|QLSQSLLPAIVELAEDAK.3|QLSQSLLPAIVELAEDAK.2|LNIISNLDC[CAM]VNEVIGIR.3|LNIISNLDC[CAM]VNEVIGIR.2|NLC[CAM]SDDTPMVR.2|NLC[CAM]SDDTPM[Oxi]VR.2|DNTIEHLLPLFLAQLKDEC[CAM]PEVR.4|DNTIEHLLPLFLAQLKDEC[CAM]PEVR.3|TDLVPAFQNLMK.2|TDLVPAFQNLM[Oxi]K.2|EFC[CAM]ENLSADC[CAM]R.2|SEIIPMFSNLASDEQDSVR.3|SEIIPM[Oxi]FSNLASDEQDSVR.2|SEIIPMFSNLASDEQDSVR.2|YFAQEALTVLSLA.2|AVGPEITKTDLVPAFQNLMK.3|AVGPEITKTDLVPAFQNLMK.2|TDLVPAFQNLMKDC[CAM]EAEVR.3|QLSQSLLPAIVELAEDAKWR.3|VKEFC[CAM]ENLSADC[CAM]RENVIMSQILPC[CAM]IK.4|IGPILDNSTLQSEVK.2|EFC[CAM]ENLSADC[CAM]RENVIMSQILPC[CAM]IK.3|LLAVEAC[CAM]VNIAQLLPQEDLEALVMPTLR.3
SEN / CTL,P07355,Annexin A2,ANXA2,2.47,1.77,1.98E-30,2.27E-30,2.96E+01,"angiogenesis,membrane raft assembly,positive regulation of protein phosphorylation,negative regulation of receptor internalization,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,positive regulation of fibroblast proliferation,positive regulation of binding,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,negative regulation of receptor binding,positive regulation of receptor activity","protease binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity","ruffle,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft",150,49,99,GLGTDEDSLIEIIC[CAM]SR.2|GLGTDEDSLIEIIC[CAM]SR.3|GVDEVTIVNILTNR.2|GVDEVTIVNILTNR.3|TDLEKDIISDTSGDFRK.4|TDLEKDIISDTSGDFRK.3|TDLEKDIISDTSGDFRK.2|QDIAFAYQR.2|RAEDGSVIDYELIDQDAR.3|RAEDGSVIDYELIDQDAR.2|RAEDGSVIDYELIDQDAR.4|LSLEGDHSTPPSAYGSVK.3|LSLEGDHSTPPSAYGSVK.2|AYTNFDAERDALNIETAIKTK.4|TKGVDEVTIVNILTNR.3|TKGVDEVTIVNILTNR.2|TKGVDEVTIVNILTNR.4|TDLEKDIISDTSGDFR.3|TDLEKDIISDTSGDFR.2|TDLEKDIISDTSGDFR.4|SNAQRQDIAFAYQR.3|SNAQRQDIAFAYQR.2|GTDVPKWISIMTER.3|GTDVPKWISIMTER.2|RAEDGSVIDYELIDQDARDLYDAGVK.4|RAEDGSVIDYELIDQDARDLYDAGVK.3|AEDGSVIDYELIDQDARDLYDAGVKR.4|DALNIETAIK.2|GRRAEDGSVIDYELIDQDAR.4|GRRAEDGSVIDYELIDQDAR.3|GRRAEDGSVIDYELIDQDAR.2|SALSGHLETVILGLLK.3|SALSGHLETVILGLLK.4|SALSGHLETVILGLLK.2|SLYYYIQQDTKGDYQK.3|SLYYYIQQDTKGDYQK.2|KGTDVPKWISIMTER.3|KGTDVPKWISIM[Oxi]TER.4|KGTDVPKWISIM[Oxi]TER.3|SEVDMLK.2|TPAQYDASELK.3|TPAQYDASELK.2|TNQELQEINR.3|TNQELQEINR.2|KELASALK.2|DLYDAGVK.2|KLMVALAK.2|PLYFADR.2|DIISDTSGDFRK.3|DIISDTSGDFRK.2|YKSYSPYDMLESIRK.4|YKSYSPYDMLESIRK.3|SLYYYIQQDTK.3|SLYYYIQQDTK.2|SYSPYDMLESIR.3|SYSPYDM[Oxi]LESIR.3|SYSPYDMLESIR.2|SYSPYDM[Oxi]LESIR.2|DLYDAGVKR.2|WISIMTER.2|WISIM[Oxi]TER.2|SYSPYDMLESIRK.3|SYSPYDM[Oxi]LESIRK.3|SYSPYDM[Oxi]LESIRK.2|SYSPYDMLESIRK.2|AYTNFDAERDALNIETAIK.4|AYTNFDAERDALNIETAIK.3|AYTNFDAERDALNIETAIK.2|AYTNFDAER.2|TNQELQEINRVYK.3|TNQELQEINRVYK.2|ALLYLC[CAM]GGDD.2|TPAQYDASELKASM[Oxi]K.3|TPAQYDASELKASMK.3|TPAQYDASELKASM[Oxi]K.2|TPAQYDASELKASMK.2|EMYKTDLEK.2|EVKGDLENAFLNLVQC[CAM]IQNK.4|EVKGDLENAFLNLVQC[CAM]IQNK.3|ELASALKSALSGHLETVILGLLK.4|ELASALKSALSGHLETVILGLLK.3|DIISDTSGDFR.2|AEDGSVIDYELIDQDAR.3|AEDGSVIDYELIDQDAR.2|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.3|GDLENAFLNLVQC[CAM]IQNK.3|GDLENAFLNLVQC[CAM]IQNK.2|SALSGHLETVILGLLKTPAQYDASELKASM[Oxi]K.5|SALSGHLETVILGLLKTPAQYDASELKASMK.5|SALSGHLETVILGLLKTPAQYDASELKASMK.4|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|AEDGSVIDYELIDQDARDLYDAGVK.4|AEDGSVIDYELIDQDARDLYDAGVK.3|GDLENAFLNLVQC[CAM]IQNKPLYFADR.4|GDLENAFLNLVQC[CAM]IQNKPLYFADR.3|SALSGHLETVILGLLKTPAQYDASELK.4
SEN / CTL,P40227,T-complex protein 1 subunit zeta,CCT6A,2.47,2.52,1.21E-16,4.91E-17,1.63E+01,"protein folding,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,protein binding involved in protein folding,poly(A) RNA binding,unfolded protein binding,WD40-repeat domain binding","cytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,extracellular exosome",66,42,77,VATAQDDITGDGTTSNVLIIGELLKQADLYISEGLHPR.4|GIDPFSLDALSKEGIVALRR.4|QADLYISEGLHPR.3|QADLYISEGLHPR.2|GIDPFSLDALSK.2|MLVSGAGDIKLTK.3|EMDRETLIDVAR.3|EM[Oxi]DRETLIDVAR.3|EMDRETLIDVAR.2|ALQFLEEVKVSR.3|NAIDDGC[CAM]VVPGAGAVEVAMAEALIK.3|NAIDDGC[CAM]VVPGAGAVEVAMAEALIK.4|NAIDDGC[CAM]VVPGAGAVEVAM[Oxi]AEALIK.3|DGNVLLHEMQIQHPTASLIAK.4|DGNVLLHEM[Oxi]QIQHPTASLIAK.3|DGNVLLHEMQIQHPTASLIAK.3|DGNVLLHEM[Oxi]QIQHPTASLIAK.2|DGNVLLHEMQIQHPTASLIAK.2|VATAQDDITGDGTTSNVLIIGELLK.3|VATAQDDITGDGTTSNVLIIGELLK.4|GLQDVLR.2|GPNKHTLTQIK.3|AQAALAVNISAAR.3|AQAALAVNISAAR.2|HTLTQIK.2|HKSETDTSLIR.3|HKSETDTSLIR.2|IITEGFEAAKEK.3|KVC[CAM]GDSDKGFVVINQK.4|KVC[CAM]GDSDKGFVVINQK.3|KVC[CAM]GDSDKGFVVINQK.2|GFVVINQK.2|GLVLDHGAR.2|MLVSGAGDIK.2|M[Oxi]LVSGAGDIK.2|GLVLDHGARHPDMK.3|GLVLDHGARHPDMK.2|SETDTSLIR.2|LTKDGNVLLHEMQIQHPTASLIAK.5|LTKDGNVLLHEMQIQHPTASLIAK.4|ALQFLEEVK.2|ALQFLEEVK.1|IITEGFEAAK.2|VC[CAM]GDSDKGFVVINQK.3|VC[CAM]GDSDKGFVVINQK.2|KRVEDAYILTC[CAM]NVSLEYEK.4|KRVEDAYILTC[CAM]NVSLEYEK.3|KRVEDAYILTC[CAM]NVSLEYEK.2|VHAELADVLTEAVVDSILAIKK.4|VHAELADVLTEAVVDSILAIKK.3|VHAELADVLTEAVVDSILAIKK.2|VLAQNSGFDLQETLVK.3|VLAQNSGFDLQETLVK.2|AQLGVQAFADALLIIPK.3|AQLGVQAFADALLIIPK.2|TEVNSGFFYK.2|TKVHAELADVLTEAVVDSILAIK.4|TKVHAELADVLTEAVVDSILAIK.3|KQLLHSC[CAM]TVIATNILLVDEIMR.4|KQLLHSC[CAM]TVIATNILLVDEIMR.3|TKVHAELADVLTEAVVDSILAIKK.4|GRAQLGVQAFADALLIIPK.3|VEDAYILTC[CAM]NVSLEYEK.3|VEDAYILTC[CAM]NVSLEYEK.2|KQDEPIDLFMIEIMEMK.3|KQDEPIDLFM[Oxi]IEIMEMK.3|KQDEPIDLFMIEIM[Oxi]EMK.3|KQDEPIDLFMIEIMEM[Oxi]K.3|KQDEPIDLFM[Oxi]IEIM[Oxi]EM[Oxi]K.3|RVEDAYILTC[CAM]NVSLEYEK.3|RVEDAYILTC[CAM]NVSLEYEK.2|VHAELADVLTEAVVDSILAIK.3|QLLHSC[CAM]TVIATNILLVDEIM[Oxi]R.3|QLLHSC[CAM]TVIATNILLVDEIMR.3|RVEDAYILTC[CAM]NVSLEYEKTEVNSGFFYK.4|RVEDAYILTC[CAM]NVSLEYEKTEVNSGFFYK.3|LTLAC[CAM]GGVALNSFDDLSPDC[CAM]LGHAGLVYEYTLGEEK.4
SEN / CTL,Q9H299,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,2.47,1.16,1.04E-15,3.90E-16,1.54E+01,"regulation of actin filament depolymerization,regulation of actin cytoskeleton organization,regulation of blood vessel endothelial cell migration,positive regulation of GTPase activity,cell redox homeostasis,oxidation-reduction process","GTPase activator activity,electron carrier activity,protein disulfide oxidoreductase activity,semaphorin receptor binding","nucleus,cytoplasm,lamellipodium,extracellular exosome",42,7,15,IQYQLVDISQDNALRDEMR.3|IQYQLVDISQDNALRDEMR.2|IQYQLVDISQDNALRDEMR.4|IQYQLVDISQDNALRDEM[Oxi]R.3|ATPPQIVNGDQYC[CAM]GDYELFVEAVEQNTLQEFLK.4|RIQYQLVDISQDNALRDEMR.4|RIQYQLVDISQDNALRDEMR.3|RIQYQLVDISQDNALRDEM[Oxi]R.4|RIQYQLVDISQDNALRDEM[Oxi]R.3|SQQSEVTR.2|VYSTSVTGSR.2|IQYQLVDISQDNALR.3|IQYQLVDISQDNALR.2|RIQYQLVDISQDNALR.3|RIQYQLVDISQDNALR.2
SEN / CTL,Q00796,Sorbitol dehydrogenase,SORD,2.47,1.34,5.56E-03,4.95E-04,3.31E+00,"glucose metabolic process,sorbitol catabolic process,response to osmotic stress,response to hormone,glucuronate catabolic process to xylulose 5-phosphate,flagellated sperm motility,response to nutrient levels,response to drug,fructose biosynthetic process,response to cadmium ion,response to copper ion,L-xylitol catabolic process,L-xylitol metabolic process,oxidation-reduction process","L-iditol 2-dehydrogenase activity,zinc ion binding,carbohydrate binding,identical protein binding,D-xylulose reductase activity,NAD binding","extracellular space,cytosol,membrane,motile cilium,mitochondrial membrane,extracellular exosome",6,25,43,ESPQEIAR.2|KPM[Oxi]VLGHEASGTVEK.4|KPMVLGHEASGTVEK.3|KPM[Oxi]VLGHEASGTVEK.3|KPMVLGHEASGTVEK.2|SVNVKPLVTHR.3|SVNVKPLVTHR.2|PLVTHRFPLEK.3|VAIEPGAPR.2|SVNVKPLVTHRFPLEK.4|AKEIGADLVLQISK.3|AKEIGADLVLQISK.2|HNAAFC[CAM]YK.2|ALEAFETFK.2|AMGAAQVVVTDLSATR.3|AM[Oxi]GAAQVVVTDLSATR.2|AMGAAQVVVTDLSATR.2|PNNLSLVVHGPGDLR.3|PNNLSLVVHGPGDLR.2|MHSVGIC[CAM]GSDVHYWEYGR.4|MHSVGIC[CAM]GSDVHYWEYGR.3|ALEAFETFKKGLGLK.3|YC[CAM]NTWPVAISMLASK.3|YC[CAM]NTWPVAISM[Oxi]LASK.2|YC[CAM]NTWPVAISMLASK.2|ALEAFETFKK.2|AKEIGADLVLQISKESPQEIAR.4|VLVC[CAM]GAGPIGMVTLLVAK.3|VLVC[CAM]GAGPIGM[Oxi]VTLLVAK.3|VLVC[CAM]GAGPIGM[Oxi]VTLLVAK.2|VLVC[CAM]GAGPIGMVTLLVAK.2|VAIEPGAPRENDEFC[CAM]K.3|EIGADLVLQISK.2|LENYPIPEPGPNEVLLR.3|LENYPIPEPGPNEVLLR.2|LPDNVTFEEGALIEPLSVGIHAC[CAM]R.4|LPDNVTFEEGALIEPLSVGIHAC[CAM]R.3|LPDNVTFEEGALIEPLSVGIHAC[CAM]RR.4|YNLSPSIFFC[CAM]ATPPDDGNLC[CAM]R.3|KVEGQLGC[CAM]KPEVTIEC[CAM]TGAEASIQAGIYATR.4|KVEGQLGC[CAM]KPEVTIEC[CAM]TGAEASIQAGIYATR.3|SGGNLVLVGLGSEM[Oxi]TTVPLLHAAIR.3|SGGNLVLVGLGSEMTTVPLLHAAIR.3
SEN / CTL,P04632,Calpain small subunit 1,CAPNS1,2.47,1.71,3.18E-13,9.69E-14,1.30E+01,"proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding","cytosol,plasma membrane,membrane,extracellular exosome",42,18,39,VVTRHPDLKTDGFGIDTC[CAM]R.4|VVTRHPDLKTDGFGIDTC[CAM]R.5|VVTRHPDLKTDGFGIDTC[CAM]R.3|RLFAQLAGDDMEVSATELMNILNK.3|LFAQLAGDDMEVSATELMNILNK.3|LFAQLAGDDM[Oxi]EVSATELMNILNK.3|LFAQLAGDDMEVSATELM[Oxi]NILNK.3|THYSNIEANESEEVRQFR.4|THYSNIEANESEEVRQFR.3|THYSNIEANESEEVR.3|THYSNIEANESEEVR.2|LGFEEFK.2|THYSNIEANESEEVRQFRR.5|THYSNIEANESEEVRQFRR.4|YLWNNIK.2|TDGFGIDTC[CAM]R.2|HPDLKTDGFGIDTC[CAM]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.6|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.3|ILGGVISAISEAAAQYNPEPPPPR.4|ILGGVISAISEAAAQYNPEPPPPR.3|SMVAVMDSDTTGK.2|SM[Oxi]VAVMDSDTTGK.2|SMVAVM[Oxi]DSDTTGK.2|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.5|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.4|SMVAVMDSDTTGKLGFEEFK.3|YSDESGNMDFDNFISC[CAM]LVR.3|YSDESGNM[Oxi]DFDNFISC[CAM]LVR.2|YSDESGNMDFDNFISC[CAM]LVR.2|RYSDESGNMDFDNFISC[CAM]LVR.3|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNM[Oxi]IIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.3
SEN / CTL,P68363,Tubulin alpha-1B chain,TUBA1B,2.46,1.79,7.23E-50,1.63E-49,4.88E+01,"microtubule cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division,cellular response to interleukin-4","double-stranded RNA binding,GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,ubiquitin protein ligase binding","microtubule,cytoplasmic microtubule,myelin sheath,extracellular exosome",222,23,55,AVFVDLEPTVIDEVR.2|AVFVDLEPTVIDEVR.3|QLFHPEQLITGKEDAANNYAR.3|QLFHPEQLITGKEDAANNYAR.4|AVFVDLEPTVIDEVRTGTYR.3|AVFVDLEPTVIDEVRTGTYR.4|VGINYQPPTVVPGGDLAK.2|VGINYQPPTVVPGGDLAK.3|VGINYQPPTVVPGGDLAK.4|DVNAAIATIK.2|SIQFVDWC[CAM]PTGFK.2|SIQFVDWC[CAM]PTGFK.3|TIGGGDDSFNTFFSETGAGKHVPR.4|TIGGGDDSFNTFFSETGAGKHVPR.3|AVC[CAM]MLSNTTAIAEAWAR.2|AVC[CAM]MLSNTTAIAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.2|NLDIERPTYTNLNR.3|NLDIERPTYTNLNR.2|NLDIERPTYTNLNR.4|SIQFVDWC[CAM]PTGFKVGINYQPPTVVPGGDLAK.3|TGTYRQLFHPEQLITGKEDAANNYAR.5|TGTYRQLFHPEQLITGKEDAANNYAR.4|TGTYRQLFHPEQLITGKEDAANNYAR.3|IHFPLATYAPVISAEK.3|IHFPLATYAPVISAEK.2|IHFPLATYAPVISAEK.4|GDVVPKDVNAAIATIK.3|GDVVPKDVNAAIATIK.2|TIGGGDDSFNTFFSETGAGK.2|TIGGGDDSFNTFFSETGAGK.3|VGINYQPPTVVPGGDLAKVQR.3|GHYTIGKEIIDLVLDR.3|GHYTIGKEIIDLVLDR.4|GHYTIGKEIIDLVLDR.2|YMAC[CAM]C[CAM]LLYRGDVVPK.3|YM[Oxi]AC[CAM]C[CAM]LLYRGDVVPK.3|EIIDLVLDR.2|LISQIVSSITASLR.2|LISQIVSSITASLR.3|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|AYHEQLSVAEITNAC[CAM]FEPANQMVK.3|AYHEQLSVAEITNAC[CAM]FEPANQMVK.4|AYHEQLSVAEITNAC[CAM]FEPANQMVK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.4|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.3|FDGALNVDLTEFQTNLVPYPR.3|FDGALNVDLTEFQTNLVPYPR.4|RSIQFVDWC[CAM]PTGFK.3|RSIQFVDWC[CAM]PTGFK.4|RSIQFVDWC[CAM]PTGFK.2
SEN / CTL,P55735,Protein SEC13 homolog,SEC13,2.46,1.44,7.26E-04,7.29E-05,4.14E+00,"antigen processing and presentation of peptide antigen via MHC class I,intracellular protein transport,sister chromatid cohesion,antigen processing and presentation of exogenous peptide antigen via MHC class II,positive regulation of TOR signaling,COPII vesicle coating,mRNA transport",protein binding,"Golgi membrane,nuclear envelope,nucleoplasm,endoplasmic reticulum membrane,cytosol,ER to Golgi transport vesicle membrane,nuclear pore outer ring,intracellular membrane-bounded organelle,GATOR2 complex,extracellular exosome,kinetochore",12,17,30,DVAWAPSIGLPTSTIASC[CAM]SQDGR.3|DVAWAPSIGLPTSTIASC[CAM]SQDGR.2|RFASGGC[CAM]DNLIK.3|RFASGGC[CAM]DNLIK.2|LATC[CAM]SSDR.2|LWKEEEDGQWKEEQK.4|LEAHSDWVR.2|GQGSVSASVTEGQQNEQ.3|GQGSVSASVTEGQQNEQ.2|NGGQILIADLR.2|FASGGC[CAM]DNLIK.2|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIK.6|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIK.5|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIK.4|GHEGPVWQVAWAHPMYGNILASC[CAM]SYDRK.5|GHEGPVWQVAWAHPM[Oxi]YGNILASC[CAM]SYDRK.5|GHEGPVWQVAWAHPM[Oxi]YGNILASC[CAM]SYDRK.4|GHEGPVWQVAWAHPMYGNILASC[CAM]SYDRK.4|GHEGPVWQVAWAHPMYGNILASC[CAM]SYDRK.3|KINNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIK.6|KINNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIK.5|VFIWTC[CAM]DDASSNTWSPK.3|VFIWTC[CAM]DDASSNTWSPK.2|GHEGPVWQVAWAHPMYGNILASC[CAM]SYDR.4|GHEGPVWQVAWAHPMYGNILASC[CAM]SYDR.3|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQK.4|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQK.3|INNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQKPNYIKR.5|KINNAHTIGC[CAM]NAVSWAPAVVPGSLIDHPSGQK.4|ESVDGQWVC[CAM]ISDVNK.2
SEN / CTL,Q6NZI2,Polymerase I and transcript release factor,PTRF,2.46,2.25,4.78E-06,6.51E-07,6.19E+00,"regulation of transcription, DNA-templated,transcription initiation from RNA polymerase I promoter,termination of RNA polymerase I transcription","protein binding,rRNA primary transcript binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,endoplasmic reticulum,cytosol,caveola,protein complex,membrane raft",36,15,23,LEVNEAELLR.2|KLEVNEAELLR.3|KLEVNEAELLR.2|QAEMEGAVQSIQGELSK.2|QAEMEGAVQSIQGELSK.3|QAEM[Oxi]EGAVQSIQGELSK.2|VMIYQDEVKLPAK.3|VM[Oxi]IYQDEVKLPAK.3|VMIYQDEVKLPAK.2|ATEMVEVGADDDEGGAERGEAGDLR.3|SFTPDHVVYAR.3|SFTPDHVVYAR.2|EGQVEVLK.2|KLEVNEAELLRR.3|AHATTSNTVSK.2|VMIYQDEVK.2|VM[Oxi]IYQDEVK.2|IREGQVEVLK.2|IIGAVDQIQLTQAQLEER.3|IIGAVDQIQLTQAQLEER.2|SDQVNGVLVLSLLDK.2|ATEMVEVGADDDEGGAER.2|IIGAVDQIQLTQAQLEERQAEMEGAVQSIQGELSK.4
SEN / CTL,P62333,26S protease regulatory subunit 10B,PSMC6,2.46,2.05,9.36E-07,1.39E-07,6.86E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process","protein binding,ATP binding,ATPase activity,TBP-class protein binding,protein binding, bridging,proteasome-activating ATPase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome",18,28,44,ADHDFVVQEDFMK.3|ADHDFVVQEDFM[Oxi]K.3|ADHDFVVQEDFMK.2|VVSSSIVDKYIGESAR.3|HGEIDYEAIVK.3|HGEIDYEAIVK.2|LLEHKEIDGR.3|IHAGPITK.2|IHIDLPNEQAR.3|IHIDLPNEQAR.2|KLESKLDYKPV.3|VVSSSIVDK.2|ALQSVGQIVGEVLK.3|ALQSVGQIVGEVLK.2|KIHIDLPNEQAR.3|KIHIDLPNEQAR.2|FSEGTSADR.2|FSEGTSADREIQR.3|TLMELLNQMDGFDTLHR.4|TLM[Oxi]ELLNQMDGFDTLHR.3|TLMELLNQMDGFDTLHR.3|TLMELLNQMDGFDTLHR.2|RFSEGTSADREIQR.3|DHQPC[CAM]IIFMDEIDAIGGRR.4|DHQPC[CAM]IIFMDEIDAIGGRR.3|M[Oxi]IMATNRPDTLDPALLRPGR.4|RFSEGTSADR.2|LSDGFNGADLR.2|EVIELPLTNPELFQR.3|EVIELPLTNPELFQR.2|GC[CAM]LLYGPPGTGK.2|VGIIPPKGC[CAM]LLYGPPGTGK.3|AVASQLDC[CAM]NFLK.2|NVC[CAM]TEAGMFAIR.2|NVC[CAM]TEAGM[Oxi]FAIR.2|VALDMTTLTIMR.2|VALDMTTLTIM[Oxi]R.2|DHQPC[CAM]IIFMDEIDAIGGR.3|DHQPC[CAM]IIFMDEIDAIGGR.2|ELREVIELPLTNPELFQR.3|AVASQLDC[CAM]NFLKVVSSSIVDKYIGESAR.4|AVASQLDC[CAM]NFLKVVSSSIVDKYIGESAR.3|EVDPLVYNMSHEDPGNVSYSEIGGLSEQIR.4|EVDPLVYNMSHEDPGNVSYSEIGGLSEQIR.3
SEN / CTL,P50395,Rab GDP dissociation inhibitor beta,GDI2,2.46,2.19,1.87E-25,1.68E-25,2.48E+01,"signal transduction,small GTPase mediated signal transduction,protein transport,vesicle-mediated transport,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,oxidation-reduction process","Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,small GTPase binding,poly(A) RNA binding","cytoplasm,Golgi apparatus,cytosol,focal adhesion,membrane,vesicle,myelin sheath,extracellular exosome",150,56,113,TYDATTHFETTC[CAM]DDIKNIYKR.5|TYDATTHFETTC[CAM]DDIKNIYKR.4|DLGTESQIFISR.2|YGKSPYLYPLYGLGELPQGFAR.3|SPYLYPLYGLGELPQGFAR.3|SPYLYPLYGLGELPQGFAR.2|SPYLYPLYGLGELPQGFAR.4|VLHMDRNPYYGGESASITPLEDLYKR.5|VLHMDRNPYYGGESASITPLEDLYKR.4|VLHM[Oxi]DRNPYYGGESASITPLEDLYKR.5|FVSISDLLVPK.2|FVSISDLLVPK.3|KFDLGQDVIDFTGHALALYR.4|KFDLGQDVIDFTGHALALYR.3|KFDLGQDVIDFTGHALALYR.2|TDDYLDQPC[CAM]YETINR.2|TDDYLDQPC[CAM]YETINR.3|MTGSEFDFEEMKR.3|MTGSEFDFEEMKR.2|M[Oxi]TGSEFDFEEMKR.3|MTGSEFDFEEM[Oxi]KR.3|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.4|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.5|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.3|FVSISDLLVPKDLGTESQIFISR.3|DWNVDLIPK.2|MLLYTEVTR.2|M[Oxi]LLYTEVTR.2|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.5|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.4|IYKVPSTEAEALASSLMGLFEK.3|IYKVPSTEAEALASSLM[Oxi]GLFEK.4|IYKVPSTEAEALASSLMGLFEK.4|IYKVPSTEAEALASSLM[Oxi]GLFEK.3|IYKVPSTEAEALASSLMGLFEK.2|FDLGQDVIDFTGHALALYR.3|FDLGQDVIDFTGHALALYR.4|FDLGQDVIDFTGHALALYR.2|KSDIYVC[CAM]MISFAHNVAAQGK.4|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.4|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|KSDIYVC[CAM]MISFAHNVAAQGK.3|KSDIYVC[CAM]MISFAHNVAAQGK.2|GRDWNVDLIPK.2|GRDWNVDLIPK.3|VTEGSFVYKGGK.3|TFEGIDPK.2|FKIPGSPPESMGR.3|LYSESLAR.2|KNDIYGED.2|QLIC[CAM]DPSYVKDR.3|VTEGSFVYK.2|RMTGSEFDFEEMK.3|RMTGSEFDFEEMK.2|KKNDIYGED.2|FLMANGQLVK.2|FLM[Oxi]ANGQLVK.2|EPEKEIRPALELLEPIEQK.4|EPEKEIRPALELLEPIEQK.3|IPGSPPESMGR.2|IPGSPPESM[Oxi]GR.2|YLDFKVTEGSFVYK.3|FLVYVANFDEKDPR.3|FLVYVANFDEKDPR.2|NTNDANSC[CAM]QIIIPQNQVNRK.4|NTNDANSC[CAM]QIIIPQNQVNRK.3|NTNDANSC[CAM]QIIIPQNQVNRK.2|RMTGSEFDFEEMKR.3|RM[Oxi]TGSEFDFEEMKR.3|RMTGSEFDFEEM[Oxi]KR.3|EIRPALELLEPIEQK.3|EIRPALELLEPIEQK.2|VIC[CAM]ILSHPIK.2|YIAIVSTTVETKEPEK.3|YIAIVSTTVETKEPEK.2|QLIC[CAM]DPSYVK.2|TYDATTHFETTC[CAM]DDIKNIYK.4|TYDATTHFETTC[CAM]DDIKNIYK.3|PIEEIIVQNGK.2|TYDATTHFETTC[CAM]DDIK.3|TYDATTHFETTC[CAM]DDIK.2|VPSTEAEALASSLMGLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.2|VPSTEAEALASSLMGLFEK.2|LSAIYGGTYMLNKPIEEIIVQNGK.4|LSAIYGGTYM[Oxi]LNKPIEEIIVQNGK.3|LSAIYGGTYMLNKPIEEIIVQNGK.3|YIAIVSTTVETK.2|FLVYVANFDEK.2|PALELLEPIEQK.2|NPYYGGESASITPLEDLYK.3|NPYYGGESASITPLEDLYK.2|SDIYVC[CAM]MISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.2|SDIYVC[CAM]MISFAHNVAAQGK.2|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.5|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.4|LSAIYGGTYMLNK.2|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.4|VLHMDRNPYYGGESASITPLEDLYK.4|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.3|VLHMDRNPYYGGESASITPLEDLYK.3|M[Oxi]TGSEFDFEEMK.2|MTGSEFDFEEM[Oxi]K.2|MTGSEFDFEEMK.2|NTNDANSC[CAM]QIIIPQNQVNR.3|NTNDANSC[CAM]QIIIPQNQVNR.2|EIRPALELLEPIEQKFVSISDLLVPK.4|KVLHMDRNPYYGGESASITPLEDLYK.4|NPYYGGESASITPLEDLYKR.3|NPYYGGESASITPLEDLYKR.2
SEN / CTL,P62195,26S protease regulatory subunit 8,PSMC5,2.46,1.21,1.74E-06,2.54E-07,6.60E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,transcription from RNA polymerase II promoter,regulation of cellular amino acid metabolic process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,negative regulation of programmed cell death,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of inclusion body assembly,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process","transcription cofactor activity,protein binding,ATP binding,transcription factor binding,ATPase activity,TBP-class protein binding,thyrotropin-releasing hormone receptor binding,proteasome-activating ATPase activity","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,inclusion body,proteasome accessory complex,cytoplasmic vesicle,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome,blood microparticle",12,32,57,LLREELQLLQEQGSYVGEVVR.3|LLREELQLLQEQGSYVGEVVR.4|FVVDVDKNIDINDVTPNC[CAM]R.3|FVVDVDKNIDINDVTPNC[CAM]R.2|VIMATNR.2|RVHVTQEDFEMAVAK.4|RVHVTQEDFEMAVAK.3|IAELMPGASGAEVK.3|IAELMPGASGAEVK.2|IAELM[Oxi]PGASGAEVK.2|AVAHHTDC[CAM]TFIR.3|AVAHHTDC[CAM]TFIR.2|KIEFPPPNEEAR.3|KIEFPPPNEEAR.2|VALRNDSYTLHK.3|VSGSELVQK.2|IDILDSALLRPGR.3|IDILDSALLRPGR.2|NDSYTLHK.2|KIAELMPGASGAEVK.3|VPDSTYEMIGGLDK.3|VPDSTYEMIGGLDK.2|VPDSTYEM[Oxi]IGGLDK.2|HPELFEALGIAQPK.3|HPELFEALGIAQPK.2|VHVTQEDFEMAVAK.3|VHVTQEDFEM[Oxi]AVAK.3|VHVTQEDFEMAVAK.2|EIKEVIELPVKHPELFEALGIAQPK.5|EIKEVIELPVKHPELFEALGIAQPK.4|EIKEVIELPVKHPELFEALGIAQPK.3|IDILDSALLR.2|GVLLYGPPGTGK.2|TMLELLNQLDGFEATK.3|TMLELLNQLDGFEATK.2|TM[Oxi]LELLNQLDGFEATK.2|EVIELPVKHPELFEALGIAQPK.4|EVIELPVKHPELFEALGIAQPK.3|ILPNKVDPLVSLMMVEK.3|ILPNKVDPLVSLM[Oxi]MVEK.3|ILPNKVDPLVSLMM[Oxi]VEK.3|ILPNKVDPLVSLMMVEK.2|LEGGSGGDSEVQR.2|IEFPPPNEEAR.2|IEELQLIVNDK.2|GVC[CAM]TEAGMYALR.2|GVC[CAM]TEAGM[Oxi]YALR.2|VDPLVSLMMVEK.2|EELQLLQEQGSYVGEVVR.3|EELQLLQEQGSYVGEVVR.2|EHAPSIIFMDEIDSIGSSR.3|EHAPSIIFM[Oxi]DEIDSIGSSR.3|EHAPSIIFMDEIDSIGSSR.2|NIDINDVTPNC[CAM]R.2|EHAPSIIFMDEIDSIGSSRLEGGSGGDSEVQR.4|ILPNKVDPLVSLMMVEKVPDSTYEMIGGLDK.4|VRLLREELQLLQEQGSYVGEVVR.3
SEN / CTL,O75369,Filamin-B,FLNB,2.46,1.42,1.47E-41,2.64E-41,4.06E+01,"keratinocyte development,epithelial cell morphogenesis,cytoskeletal anchoring at plasma membrane,signal transduction,skeletal muscle tissue development,actin cytoskeleton organization,cell-cell adhesion","actin binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,cell cortex,actin cytoskeleton,integral component of membrane,Z disc,extracellular matrix,extracellular exosome",192,207,344,AGGPGLERGEAGVPAEFSIWTR.3|AGGPGLERGEAGVPAEFSIWTR.2|LVSPGSANETSSILVESVTR.3|LVSPGSANETSSILVESVTR.2|EATTDFTVDSRPLTQVGGDHIK.4|EATTDFTVDSRPLTQVGGDHIK.3|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.5|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.4|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.6|VLFASQEIPASPFR.2|VLFASQEIPASPFR.3|GLHVVEVTYDDVPIPNSPFK.3|GLHVVEVTYDDVPIPNSPFK.4|GLHVVEVTYDDVPIPNSPFK.2|SPFTVGVAAPLDLSK.2|SPFTVGVAAPLDLSK.3|SGC[CAM]IVNNLAEFTVDPK.2|SGC[CAM]IVNNLAEFTVDPK.3|QKDFLDGVYAFEYYPSTPGR.3|QKDFLDGVYAFEYYPSTPGR.2|VQAQGPGLKEAFTNKPNVFTVVTR.4|IGNLQTDLSDGLR.2|EAFTNKPNVFTVVTR.3|EAFTNKPNVFTVVTR.2|VLQSFTVDSSKAGLAPLEVR.3|VLQSFTVDSSKAGLAPLEVR.2|HVGNQQYNVTYVVK.3|HVGNQQYNVTYVVK.2|VLQSFTVDSSK.2|IGNLQTDLSDGLRLIALLEVLSQKR.4|TGEEVGFVVDAK.2|IKVFGPGIEGKDVFR.4|TFEMSDFIVDTR.2|TFEMSDFIVDTR.3|TFEM[Oxi]SDFIVDTR.2|VSYFPTVPGVYIVSTK.2|VSYFPTVPGVYIVSTK.3|FNDEHIPESPYLVPVIAPSDDAR.3|FNDEHIPESPYLVPVIAPSDDAR.4|VTASGPGLSSYGVPASLPVDFAIDAR.3|VTASGPGLSSYGVPASLPVDFAIDAR.4|YMIGVTYGGDDIPLSPYR.2|YM[Oxi]IGVTYGGDDIPLSPYR.2|WGEEHIPGSPFHVTVP.3|WGEEHIPGSPFHVTVP.2|AHGPGLEGGLVGKPAEFTIDTK.4|AHGPGLEGGLVGKPAEFTIDTK.3|GAGIGGLGITVEGPSESK.2|GAGIGGLGITVEGPSESK.3|SPFEVQVGPEAGMQK.2|SPFEVQVGPEAGMQK.3|SPFEVQVGPEAGM[Oxi]QK.2|VTVLFAGQHISK.3|VTVLFAGQHISK.2|AAGSGELGVTMK.2|AAGSGELGVTM[Oxi]K.2|FIPHENGVHTIDVK.4|FIPHENGVHTIDVK.3|VAVTEGC[CAM]QPSR.3|VAVTEGC[CAM]QPSR.2|VKVEPAVDTSR.3|VKVEPAVDTSR.2|YAPTEVGLHEMHIK.4|YAPTEVGLHEM[Oxi]HIK.4|YAPTEVGLHEMHIK.3|YAPTEVGLHEM[Oxi]HIK.3|YAPTEVGLHEM[Oxi]HIK.2|AIVDGNLK.2|EVGEHLVSIKK.3|EVGEHLVSIKK.2|LDVTILSPSRK.3|LDVTILSPSRK.2|LNGLENR.2|RLPNNHIGISFIPR.4|RLPNNHIGISFIPR.3|AYGPGLEK.2|AWGPGLHGGIVGR.3|AWGPGLHGGIVGR.2|FNGSHVVGSPFK.3|FNGSHVVGSPFK.2|GDYVLAVK.2|PVTEKDLAEDAPWKK.4|PVTEKDLAEDAPWKK.3|VFGPGVER.2|VVPC[CAM]LVTPVTGR.3|VVPC[CAM]LVTPVTGR.2|AGVENGKPTHFTVYTK.4|AGVENGKPTHFTVYTK.3|APSGRDEPC[CAM]LLK.3|APSGRDEPC[CAM]LLK.2|GAGGQGKLDVTILSPSRK.4|GEITGEVHMPSGK.3|GEITGEVHMPSGK.2|VQAQGPGLK.2|YGGELVPHFPAR.3|YGGELVPHFPAR.2|VFGPGIEGK.2|AGLAPLEVR.2|GQHVTGSPFQFTVGPLGEGGAHK.5|GQHVTGSPFQFTVGPLGEGGAHK.4|GQHVTGSPFQFTVGPLGEGGAHK.3|YGGPNHIVGSPFK.3|YGGPNHIVGSPFK.2|AGPGTLSVTIEGPSK.3|AGPGTLSVTIEGPSK.2|KVVPC[CAM]LVTPVTGR.3|VFGPGIEGKDVFR.3|VDPSHDASK.2|YADEEIPRSPFK.3|YADEEIPRSPFK.2|YRGQHVTGSPFQFTVGPLGEGGAHKVR.6|YRGQHVTGSPFQFTVGPLGEGGAHKVR.5|AIVHDNKDGTYAVTYIPDKTGR.5|AIVHDNKDGTYAVTYIPDKTGR.4|IRETTDFKVDTK.3|KGEITGEVHMPSGK.3|KGEITGEVHM[Oxi]PSGK.3|LLGWIQNK.2|RLTVMSLQESGLK.3|RLTVMSLQESGLK.2|RLTVM[Oxi]SLQESGLK.2|VEPAVDTSR.2|IAGPGLGSGVR.2|IPEINSSDMSAHVTSPSGR.4|IPEINSSDM[Oxi]SAHVTSPSGR.3|IPEINSSDMSAHVTSPSGR.3|LPNNHIGISFIPR.3|WC[CAM]NEHLK.2|YADEEIPR.2|AEVSIQNNK.2|HTIAVVWGGVNIPHSPYR.4|HTIAVVWGGVNIPHSPYR.3|HTIAVVWGGVNIPHSPYR.2|VLPTYDASK.2|IQQNTFTR.2|SPFEVSVDK.2|FADEHVPGSPFTVK.3|FADEHVPGSPFTVK.2|KVVPC[CAM]LVTPVTGRENSTAK.4|NGNHVANSPVSIMVVQSEIGDARR.5|NGNHVANSPVSIMVVQSEIGDARR.4|NGNHVANSPVSIM[Oxi]VVQSEIGDARR.4|PAEFTIDTK.2|DLAEDAPWK.2|FVPQEMGVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.2|FVPQEMGVHTVSVK.2|GIEPTGNMVK.2|GIEPTGNM[Oxi]VK.2|RIGNLQTDLSDGLR.3|RIGNLQTDLSDGLR.2|SSFLVDC[CAM]SK.2|AEISC[CAM]IDNK.2|AIVHDNKDGTYAVTYIPDK.4|AIVHDNKDGTYAVTYIPDK.3|DAGEGLLAVQITDQEGKPKR.4|DAGEGLLAVQITDQEGKPKR.3|VKMDC[CAM]QETPEGYK.3|VKMDC[CAM]QETPEGYK.2|YRGQHVTGSPFQFTVGPLGEGGAHK.5|YRGQHVTGSPFQFTVGPLGEGGAHK.4|YSIAITWGGHHIPK.3|YSIAITWGGHHIPK.2|AEITFDDHK.2|PGTYVIYVR.2|PVTEKDLAEDAPWK.3|ASSDASKVTSK.2|TATPEIVDNK.2|VDIQTEDLEDGTC[CAM]K.3|VDIQTEDLEDGTC[CAM]K.2|VEVGKDQEFTVDTR.3|VEVGKDQEFTVDTR.2|APSVATVGSIC[CAM]DLNLK.3|APSVATVGSIC[CAM]DLNLK.2|GAGGQGKLDVTILSPSR.3|GAGGQGKLDVTILSPSR.2|IEYNDQNDGSC[CAM]DVK.3|IEYNDQNDGSC[CAM]DVK.2|LDVTILSPSR.2|TYSVEYLPK.2|VHSPSGAVEEC[CAM]HVSELEPDK.4|VHSPSGAVEEC[CAM]HVSELEPDK.3|VNQPASFAIR.2|DQEFTVDTR.2|EVGEHLVSIK.2|IFAQDGEGQR.2|IFFAGDTIPK.2|SPFEVSVDKAQGDASK.3|SPFEVSVDKAQGDASK.2|IKVFGPGIEGK.2|IRATQTGDASK.2|KIQQNTFTR.2|RAIVHDNKDGTYAVTYIPDK.4|AIKHTIAVVWGGVNIPHSPYR.4|DGTC[CAM]TVTYLPTLPGDYSILVK.4|DGTC[CAM]TVTYLPTLPGDYSILVK.3|DGTC[CAM]TVTYLPTLPGDYSILVK.2|DSPYMAFIHPATGGYNPDLVR.4|DSPYMAFIHPATGGYNPDLVR.3|DSPYM[Oxi]AFIHPATGGYNPDLVR.3|DSPYMAFIHPATGGYNPDLVR.2|DVFREATTDFTVDSRPLTQVGGDHIK.5|DVFREATTDFTVDSRPLTQVGGDHIK.4|ERGDYVLAVK.2|NTVELLVEDK.2|VVASGPGLEHGK.2|DLAEDAPWKK.2|DVFREATTDFTVDSR.3|NRMDGTYAC[CAM]SYTPVK.3|NRM[Oxi]DGTYAC[CAM]SYTPVK.3|NRMDGTYAC[CAM]SYTPVK.2|VNIGQGSHPQK.2|VTEAEIVPMGK.2|VTEAEIVPM[Oxi]GK.2|APLNVQFNSPLPGDAVK.3|APLNVQFNSPLPGDAVK.2|VKVDPSHDASK.2|VPVKDVVDPSK.2|ADIEMPFDPSKVVASGPGLEHGK.4|AHGPGLEGGLVGK.2|VMYTPM[Oxi]APGNYLISVK.3|VMYTPMAPGNYLISVK.3|VMYTPMAPGNYLISVK.2|VM[Oxi]YTPM[Oxi]APGNYLISVK.2|VM[Oxi]YTPMAPGNYLISVK.2|VMYTPM[Oxi]APGNYLISVK.2|DLDIIDNYDYSHTVK.3|DLDIIDNYDYSHTVK.2|TATPEIVDNKDGTVTVR.3|TATPEIVDNKDGTVTVR.2|VKAHGPGLEGGLVGKPAEFTIDTK.4|VKAHGPGLEGGLVGKPAEFTIDTK.3|EATTDFTVDSR.2|IFAQDGEGQRIDIQMK.3|ADIEMPFDPSK.2|ADIEM[Oxi]PFDPSK.2|EAGAGGLSIAVEGPSKAEITFDDHK.4|EAGAGGLSIAVEGPSKAEITFDDHK.3|KNGNHVANSPVSIMVVQSEIGDAR.4|NTVELLVEDKGNQVYR.3|NTVELLVEDKGNQVYR.2|QMQLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.2|QMQLENVSVALEFLDR.2|VRAGGPGLERGEAGVPAEFSIWTR.4|C[CAM]LATGPGIASTVK.2|PFDLVIPFAVR.2|RLTVMSLQESGLKVNQPASFAIR.4|RLTVM[Oxi]SLQESGLKVNQPASFAIR.4|SPFVVQVGEAC[CAM]NPNAC[CAM]R.3|SPFVVQVGEAC[CAM]NPNAC[CAM]R.2|VFGPGIEGKDVFREATTDFTVDSRPLTQVGGDHIK.6|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.6|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.5|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|VVPC[CAM]LVTPVTGRENSTAK.3|LTVMSLQESGLK.2|LTVM[Oxi]SLQESGLK.2|DAGEGLLAVQITDQEGKPK.3|DAGEGLLAVQITDQEGKPK.2|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|TSRAPSVATVGSIC[CAM]DLNLK.3|DGTYAVTYIPDK.2|EPGEYAVHIMC[CAM]DDEDIK.3|SSTETC[CAM]YSAIPK.2|FNDEHIPESPYLVPVIAPSDDARR.4|FNDEHIPESPYLVPVIAPSDDARR.3|IPYLPITNFNQNWQDGK.3|IPYLPITNFNQNWQDGK.2|M[Oxi]DC[CAM]QETPEGYK.2|MDC[CAM]QETPEGYK.2|GAGKAPLNVQFNSPLPGDAVK.3|YTIKVLFASQEIPASPFR.3|DFLDGVYAFEYYPSTPGR.3|DFLDGVYAFEYYPSTPGR.2|AAGSGELGVTM[Oxi]KGPK.2|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.4|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.3|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.4|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.5|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|EAGAGGLSIAVEGPSK.2|LLGWIQNKIPYLPITNFNQNWQDGK.4|LLGWIQNKIPYLPITNFNQNWQDGK.3|M[Oxi]DGTYAC[CAM]SYTPVK.2|MDGTYAC[CAM]SYTPVK.2|DAGYGGISLAVEGPSK.2|DGTYAVTYVPLTAGMYTLTMK.3|DGTYAVTYVPLTAGMYTLTM[Oxi]K.3|DGTYAVTYVPLTAGM[Oxi]YTLTMK.2|DGTYAVTYVPLTAGMYTLTMK.2|GEAGVPAEFSIWTR.2|NGSC[CAM]GVSYIAQEPGNYEVSIK.3|NGSC[CAM]GVSYIAQEPGNYEVSIK.2|GLEELVKQKDFLDGVYAFEYYPSTPGR.4|QM[Oxi]QLENVSVALEFLDRESIK.3|QMQLENVSVALEFLDRESIK.3|QMQLENVSVALEFLDRESIK.2|TSRAPSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|YNDKHIPGSPFTAK.2|LTVMSLQESGLKVNQPASFAIR.3|NGNHVANSPVSIMVVQSEIGDAR.3|NGNHVANSPVSIMVVQSEIGDAR.2|YTPTQQGNMQVLVTYGGDPIPK.3|YTPTQQGNM[Oxi]QVLVTYGGDPIPK.3|AGSNM[Oxi]LLIGVHGPTTPC[CAM]EEVSMK.3|AGSNMLLIGVHGPTTPC[CAM]EEVSM[Oxi]K.3|AGSNMLLIGVHGPTTPC[CAM]EEVSMK.3|LNGLENRVEVGKDQEFTVDTR.3|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.3|LGSAADFLLDISETDLSSLTASIK.3|TATFTIVTEDAGEGGLDLAIEGPSK.3|ANEPTHFTVDC[CAM]TEAGEGDVSVGIK.3|EPGEYAVHIMC[CAM]DDEDIKDSPYMAFIHPATGGYNPDLVR.5|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.4|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.3|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.4|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.3|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.4|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.3|VLPTYDASKVTASGPGLSSYGVPASLPVDFAIDAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQK.3|APLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|SADFVVESIGSEVGSLGFAIEGPSQAK.3|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.5|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.4|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.5|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.4|VGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|VLSEDEEDVDFDIIHNANDTFTVK.3|LGSAADFLLDISETDLSSLTASIKAPSGRDEPC[CAM]LLK.4|FTVDTISAGQGDVMVFVEDPEGNKEEAQVTPDSDKNK.4|VRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|YM[Oxi]GSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|YMGSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|DAGYGGISLAVEGPSKVDIQTEDLEDGTC[CAM]K.3|AEISC[CAM]IDNKDGTC[CAM]TVTYLPTLPGDYSILVK.3|EEGLYAVDVTYDGHPVPGSPYTVEASLPPDPSK.3
SEN / CTL,P68104,Elongation factor 1-alpha 1,EEF1A1,2.45,2.05,9.11E-66,2.73E-65,6.46E+01,"transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,cellular response to epidermal growth factor stimulus,regulation of chaperone-mediated autophagy","tRNA binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,protein kinase binding,poly(A) RNA binding","extracellular space,nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,membrane,cortical actin cytoskeleton,ruffle membrane,extracellular exosome,cytoplasmic side of lysosomal membrane",246,52,144,EHALLAYTLGVK.3|EHALLAYTLGVK.2|IGGIGTVPVGR.2|QTVAVGVIK.2|DMRQTVAVGVIK.3|DMRQTVAVGVIK.2|DM[Oxi]RQTVAVGVIK.3|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|VETGVLKPGMVVTFAPVNVTTEVK.3|VETGVLKPGMVVTFAPVNVTTEVK.4|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.3|VETGVLKPGMVVTFAPVNVTTEVK.5|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|THINIVVIGHVDSGK.2|THINIVVIGHVDSGK.3|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.5|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|THINIVVIGHVDSGKSTTTGHLIYK.5|THINIVVIGHVDSGKSTTTGHLIYK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.7|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.4|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.5|IGGIGTVPVGRVETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|TIEKFEKEAAEMGK.3|TIEKFEKEAAEMGK.4|TIEKFEKEAAEMGK.2|TIEKFEKEAAEM[Oxi]GK.3|TIEKFEKEAAEM[Oxi]GK.2|YEEIVKEVSTYIK.3|YEEIVKEVSTYIK.2|YYVTIIDAPGHRDFIK.4|YYVTIIDAPGHRDFIK.3|YYVTIIDAPGHRDFIK.2|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.3|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|YEEIVKEVSTYIKK.4|YEEIVKEVSTYIKK.3|YEEIVKEVSTYIKK.2|SGDAAIVDMVPGK.3|SGDAAIVDM[Oxi]VPGK.3|SGDAAIVDMVPGK.2|SGDAAIVDM[Oxi]VPGK.2|QLIVGVNK.2|FAVRDMRQTVAVGVIK.4|PLRLPLQDVYK.3|PLRLPLQDVYK.2|TIEKFEK.2|YAWVLDK.2|EKTHINIVVIGHVDSGK.4|NGQTREHALLAYTLGVK.4|NGQTREHALLAYTLGVK.3|NGQTREHALLAYTLGVK.2|RYEEIVK.2|YYVTIIDAPGHR.3|YYVTIIDAPGHR.2|EVSTYIKK.2|LPLQDVYK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|STTTGHLIYK.2|FEKEAAEMGK.2|GITIDISLWK.2|PMC[CAM]VESFSDYPPLGR.3|PMC[CAM]VESFSDYPPLGR.2|PM[Oxi]C[CAM]VESFSDYPPLGR.2|RYEEIVKEVSTYIK.3|RYEEIVKEVSTYIK.2|PGM[Oxi]VVTFAPVNVTTEVK.3|PGMVVTFAPVNVTTEVK.2|PGM[Oxi]VVTFAPVNVTTEVK.2|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|SVEMHHEALSEALPGDNVGFNVK.4|SVEM[Oxi]HHEALSEALPGDNVGFNVK.4|SVEMHHEALSEALPGDNVGFNVK.3|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|MDSTEPPYSQK.2|M[Oxi]DSTEPPYSQK.2|FETSKYYVTIIDAPGHR.3|LPLQDVYKIGGIGTVPVGR.3|QLIVGVNKMDSTEPPYSQK.3|MDSTEPPYSQKR.2|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|DGNASGTTLLEALDC[CAM]ILPPTR.3|DGNASGTTLLEALDC[CAM]ILPPTR.2|KDGNASGTTLLEALDC[CAM]ILPPTR.3|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISKNGQTR.4
SEN / CTL,Q13561,Dynactin subunit 2,DCTN2,2.44,1.48,1.90E-11,4.83E-12,1.13E+01,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based process,mitotic spindle organization,mitotic nuclear division,cell proliferation,antigen processing and presentation of exogenous peptide antigen via MHC class II,melanosome transport,protein localization to centrosome","motor activity,protein binding,spectrin binding","kinetochore,cytoplasm,centrosome,cytosol,dynactin complex,microtubule,membrane,dynein complex,growth cone,vesicle,extracellular exosome",36,28,43,WSPIASTLPELVQR.2|VSALDLAVLDQVEAR.2|VSALDLAVLDQVEAR.3|LLHEVQELTTEVEK.3|LLHEVQELTTEVEK.2|LLGPDAAINLTDPDGALAKR.3|LLLQLEATK.2|LTPVLLAK.2|VHQLYETIQR.3|VHQLYETIQR.2|HKASVEDADTQSK.3|LLHEVQELTTEVEKIK.4|LLHEVQELTTEVEKIK.3|YADLPGIAR.2|LTELETAVR.2|DNTTLLTQVQTTMR.3|DNTTLLTQVQTTMR.2|ASVEDADTQSK.2|QQLVASHLEK.2|ENLATVEGNFASIDER.3|ENLATVEGNFASIDER.2|RLLLQLEATK.2|RLTELETAVR.2|TTVKESATEEK.2|LLGPDAAINLTDPDGALAK.3|LLGPDAAINLTDPDGALAK.2|TGYESGEYEMLGEGLGVK.3|TGYESGEYEM[Oxi]LGEGLGVK.2|TGYESGEYEMLGEGLGVK.2|TTGTPPDSSLVTYELHSRPEQDKFSQAAK.5|TTGTPPDSSLVTYELHSRPEQDKFSQAAK.4|TTGTPPDSSLVTYELHSRPEQDK.4|TTGTPPDSSLVTYELHSRPEQDK.3|RTGYESGEYEMLGEGLGVK.3|RTGYESGEYEMLGEGLGVK.2|LQSVLGKVNEIAK.2|VSALDLAVLDQVEARLQSVLGK.3|QLHEQAM[Oxi]QFGQLLTHLDTTQQMIANSLK.4|QLHEQAMQFGQLLTHLDTTQQM[Oxi]IANSLK.4|QLHEQAMQFGQLLTHLDTTQQMIANSLK.4|QLHEQAMQFGQLLTHLDTTQQMIANSLK.3|C[CAM]DQDAQNPLSAGLQGAC[CAM]LMETVELLQAK.3|DNTTLLTQVQTTMRENLATVEGNFASIDER.3
SEN / CTL,P25398,40S ribosomal protein S12,RPS12,2.44,1.47,9.91E-10,2.07E-10,9.68E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleoplasm,cytosol,membrane,cytosolic small ribosomal subunit",36,13,28,QAHLC[CAM]VLASNC[CAM]DEPMYVK.3|QAHLC[CAM]VLASNC[CAM]DEPM[Oxi]YVK.3|QAHLC[CAM]VLASNC[CAM]DEPMYVK.2|LVEALC[CAM]AEHQINLIKVDDNKK.5|LVEALC[CAM]AEHQINLIKVDDNKK.4|ESQAKDVIEEYFK.3|ESQAKDVIEEYFK.2|LVEALC[CAM]AEHQINLIK.3|LVEALC[CAM]AEHQINLIK.4|LVEALC[CAM]AEHQINLIK.2|KVVGC[CAM]SC[CAM]VVVK.3|KVVGC[CAM]SC[CAM]VVVK.2|RQAHLC[CAM]VLASNC[CAM]DEPMYVK.5|RQAHLC[CAM]VLASNC[CAM]DEPMYVK.4|RQAHLC[CAM]VLASNC[CAM]DEPM[Oxi]YVK.4|RQAHLC[CAM]VLASNC[CAM]DEPMYVK.3|RQAHLC[CAM]VLASNC[CAM]DEPM[Oxi]YVK.3|RQAHLC[CAM]VLASNC[CAM]DEPMYVK.2|DYGKESQAKDVIEEYFK.4|DYGKESQAKDVIEEYFK.3|DVIEEYFK.2|LGEWVGLC[CAM]K.2|LGEWVGLC[CAM]K.1|TALIHDGLAR.2|VVGC[CAM]SC[CAM]VVVK.2|LVEALC[CAM]AEHQINLIKVDDNK.4|LVEALC[CAM]AEHQINLIKVDDNK.3|KLGEWVGLC[CAM]K.2
SEN / CTL,P31946,14-3-3 protein beta/alpha,YWHAB,2.43,2.03,9.23E-13,2.62E-13,1.26E+01,"MAPK cascade,protein targeting,viral process,negative regulation of protein dephosphorylation,hippo signaling,positive regulation of catalytic activity,regulation of mRNA stability,negative regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,cytoplasmic sequestering of protein,protein heterooligomerization,membrane organization,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","transcription corepressor activity,protein binding,protein C-terminus binding,enzyme binding,protein domain specific binding,protein complex binding,histone deacetylase binding,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,membrane,transcriptional repressor complex,cytoplasmic vesicle membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",78,37,87,NLLSVAYKNVVGAR.3|NLLSVAYKNVVGAR.2|AVTEQGHELSNEERNLLSVAYKNVVGAR.5|AVTEQGHELSNEERNLLSVAYKNVVGAR.4|AVTEQGHELSNEERNLLSVAYKNVVGAR.3|LAEQAERYDDMAAAMK.3|LAEQAERYDDMAAAMK.2|LAEQAERYDDM[Oxi]AAAM[Oxi]K.3|LAEQAERYDDM[Oxi]AAAMK.3|LAEQAERYDDMAAAM[Oxi]K.3|LAEQAERYDDM[Oxi]AAAMK.2|LAEQAERYDDMAAAM[Oxi]K.2|LAEQAERYDDM[Oxi]AAAM[Oxi]K.2|NLLSVAYK.2|NLLSVAYK.1|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.5|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.3|AVTEQGHELSNEERNLLSVAYK.4|AVTEQGHELSNEERNLLSVAYK.3|DSTLIMQLLR.2|DSTLIM[Oxi]QLLR.2|DSTLIMQLLR.1|YLSEVASGDNK.1|YLSEVASGDNK.2|AKLAEQAERYDDMAAAMK.4|AKLAEQAERYDDMAAAM[Oxi]K.3|AKLAEQAERYDDMAAAMK.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.2|AKLAEQAERYDDM[Oxi]AAAMK.2|AKLAEQAERYDDMAAAM[Oxi]K.2|AKLAEQAERYDDMAAAMK.2|KEMQPTHPIR.3|KEM[Oxi]QPTHPIR.3|KEMQPTHPIR.2|KEM[Oxi]QPTHPIR.2|LAEQAER.2|VISSIEQKTERNEK.4|VISSIEQKTERNEK.3|VISSIEQKTERNEK.2|VISSIEQK.2|YLIPNATQPESK.3|YLIPNATQPESK.2|MKGDYFR.2|M[Oxi]KGDYFR.2|AKLAEQAER.2|YDDMAAAMK.2|YDDM[Oxi]AAAMK.2|YDDMAAAM[Oxi]K.2|YDDM[Oxi]AAAM[Oxi]K.2|VFYLKMKGDYFR.3|AVTEQGHELSNEER.3|AVTEQGHELSNEER.2|NLLSVAYKNVVGARR.3|EMQPTHPIR.2|EM[Oxi]QPTHPIR.2|QTTVSNSQQAYQEAFEISKK.4|QTTVSNSQQAYQEAFEISKK.3|QTTVSNSQQAYQEAFEISKK.2|TMDKSELVQK.2|EKIEAELQDIC[CAM]NDVLELLDK.4|EKIEAELQDIC[CAM]NDVLELLDK.3|EKIEAELQDIC[CAM]NDVLELLDK.2|VISSIEQKTER.2|YDDM[Oxi]AAAM[Oxi]KAVTEQGHELSNEER.4|EYREKIEAELQDIC[CAM]NDVLELLDK.4|EYREKIEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.2|QTTVSNSQQAYQEAFEISK.3|QTTVSNSQQAYQEAFEISK.2|TAFDEAIAELDTLNEESYK.3|TAFDEAIAELDTLNEESYK.2|LGLALNFSVFYYEILNSPEK.3|LGLALNFSVFYYEILNSPEK.2|DNLTLWTSENQGDEGDAGEGEN.3|TAFDEAIAELDTLNEESYKDSTLIMQLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.3|TAFDEAIAELDTLNEESYKDSTLIMQLLR.3|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.3|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.3|EKIEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|LGLALNFSVFYYEILNSPEKAC[CAM]SLAK.3
SEN / CTL,P45974,Ubiquitin carboxyl-terminal hydrolase 5,USP5,2.43,2.10,2.05E-11,5.16E-12,1.13E+01,"ubiquitin-dependent protein catabolic process,protein deubiquitination,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein K48-linked deubiquitination","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,zinc ion binding,ubiquitin binding",lysosome,36,54,78,LGHGLLSGEYSKPVPESGDGERVPEQKEVQDGIAPR.6|LGHGLLSGEYSKPVPESGDGERVPEQKEVQDGIAPR.5|IFQNAPTDPTQDFSTQVAK.2|IFQNAPTDPTQDFSTQVAK.3|SAADSISESVPVGPK.2|SAADSISESVPVGPK.3|DGLGGLPDIVR.2|DGLGGLPDIVRDRVTSAVEALLSADSASR.4|RPKEEDPATGTGDPPR.4|RPKEEDPATGTGDPPR.3|KFTFGLDWVPK.3|KFTFGLDWVPK.2|ATNNSLER.2|YFDGSGGNNHAVEHYR.4|YFDGSGGNNHAVEHYR.3|DGLGGLPDIVRDR.3|MALPELVR.2|KQEVQAWDGEVR.3|KQEVQAWDGEVR.2|EEDPATGTGDPPRK.3|EVQDGIAPR.2|RYFDGSGGNNHAVEHYR.4|TRRPKEEDPATGTGDPPR.4|FELDEDVK.2|VC[CAM]ASEKPPK.2|FASFPDYLVIQIK.3|FASFPDYLVIQIK.2|GHPEFSTNR.2|VTSAVEALLSADSASR.3|VTSAVEALLSADSASR.2|WVIYNDQK.2|FASFPDYLVIQIKK.3|LGHGLLSGEYSKPVPESGDGER.4|LGHGLLSGEYSKPVPESGDGER.3|LGHGLLSGEYSKPVPESGDGERVPEQK.5|LGHGLLSGEYSKPVPESGDGERVPEQK.4|LGHGLLSGEYSKPVPESGDGERVPEQK.3|VTSAVEALLSADSASRK.3|EELLEYEEK.2|PLFGPGYTGIR.2|SSENPNEVFR.2|FTFGLDWVPK.2|DRVTSAVEALLSADSASR.3|DRVTSAVEALLSADSASR.2|ENLWLNLTDGSILC[CAM]GR.3|ENLWLNLTDGSILC[CAM]GR.2|LGHGLLSGEYSK.2|VDYIMQLPVPMDAALNK.3|VDYIMQLPVPMDAALNK.2|QEVQAWDGEVR.2|DLGYIYFYQR.2|LDVSIEMPEELDISQLR.3|EEDPATGTGDPPR.2|YFDGSGGNNHAVEHYRETGYPLAVK.4|KLDVSIEMPEELDISQLR.3|KLDVSIEM[Oxi]PEELDISQLR.3|KLDVSIEMPEELDISQLR.2|IGEWELIQESGVPLKPLFGPGYTGIR.4|IGEWELIQESGVPLKPLFGPGYTGIR.3|IVILPDYLEIAR.2|QQDAQEFFLHLINM[Oxi]VER.3|QQDAQEFFLHLINMVER.3|QQDAQEFFLHLINMVER.2|TMTELEIDMNQR.2|TM[Oxi]TELEIDMNQR.2|VDYIMQLPVPMDAALNKEELLEYEEK.4|VDYIM[Oxi]QLPVPMDAALNKEELLEYEEK.3|VDYIMQLPVPMDAALNKEELLEYEEK.3|LAIGVEGGFDLSEEKFELDEDVK.3|IGEWELIQESGVPLK.2|GTGLQPGEEELPDIAPPLVTPDEPK.3|AVDWIFSHIDDLDAEAAM[Oxi]DISEGR.3|AVDWIFSHIDDLDAEAAMDISEGR.3|NLGNSC[CAM]YLNSVVQVLFSIPDFQR.3|YTQRVDYIMQLPVPMDAALNKEELLEYEEK.4|NLGNSC[CAM]YLNSVVQVLFSIPDFQRK.3|LGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLK.4|AQVPFSSC[CAM]LEAYGAPEQVDDFWSTALQAK.3
SEN / CTL,Q9H3K6,BolA-like protein 2,BOLA2,2.43,2.23,5.21E-03,4.65E-04,3.33E+00,,,extracellular exosome,12,5,9,DLEAEHVEVEDTTLNR.3|DLEAEHVEVEDTTLNR.2|HRLVNAC[CAM]LAEELPHIHAFEQK.5|HRLVNAC[CAM]LAEELPHIHAFEQK.4|HRLVNAC[CAM]LAEELPHIHAFEQK.3|FEGKPLLQR.2|TLTPDQWAR.2|LVNAC[CAM]LAEELPHIHAFEQK.4|LVNAC[CAM]LAEELPHIHAFEQK.3
SEN / CTL,P27816,Microtubule-associated protein 4,MAP4,2.43,1.36,1.86E-16,7.32E-17,1.61E+01,"mitotic spindle organization,neuron projection development,microtubule sliding,establishment of spindle orientation,cell division,negative regulation of nonmotile primary cilium assembly","structural molecule activity,microtubule binding,poly(A) RNA binding","cytoplasm,microtubule,microtubule associated complex,plasma membrane,axoneme,microtubule cytoskeleton,neuron projection,extracellular exosome,mitotic spindle",48,68,96,NVVLPTETEVAPAKDVTLLKETER.4|NVVLPTETEVAPAKDVTLLK.3|NVC[CAM]LPPEMEVALTEDQVPALK.3|NVC[CAM]LPPEMEVALTEDQVPALK.2|DGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQK.4|ATPMPSRPSTTPFIDKKPTSAKPSSTTPR.6|C[CAM]SLPAEEDSVLEK.2|TTTLSGTAPAAGVVPSR.2|TTTLSGTAPAAGVVPSR.3|VGSLDNVGHLPAGGAVK.3|VGSLDNVGHLPAGGAVK.2|ASPSKPASAPASR.3|SPSTLLPK.2|TTDMAPSK.2|VGSTENIK.2|MDLAPSKDMGPPKENK.4|HVPGGGNVQIQNK.3|VALSSETEVALAR.3|VALSSETEVALAR.2|KPTSAKPSSTTPR.3|PLATTQPAK.2|RASPSKPASAPASR.3|TTTAAAVASTGPSSR.3|TTTAAAVASTGPSSR.2|TAGPIASAQK.2|DMELPTEK.2|NVVLPTETEVAPAK.3|NVVLPTETEVAPAK.2|DKALPLEAEVAPVK.3|PSTTPFIDK.2|DMAQLPETEIAPAK.3|DM[Oxi]AQLPETEIAPAK.2|DMAQLPETEIAPAK.2|DMESPTKLDVTLAK.3|DMESPTKLDVTLAK.2|DVTPPPETEVVLIK.3|DVTPPPETEVVLIK.2|RPAVASARPSILPSK.3|KPMSLASGLVPAAPPK.3|KPM[Oxi]SLASGLVPAAPPK.3|KPMSLASGLVPAAPPK.2|DMEIAQTQK.2|DM[Oxi]EIAQTQK.2|SVPADLSRPK.2|LATNTSAPDLK.2|KTTTLSGTAPAAGVVPSR.3|TKPLATTQPAK.2|TTDMAPSKETEMALAK.3|TTDMAPSKETEMALAK.2|ATPMPSRPSTTPFIDK.3|ATPMPSRPSTTPFIDK.2|DVKPKPIADAK.2|QPAPTTIGGLNK.2|WPTETDVSSAK.2|ALPLEAEVAPVK.2|KKPC[CAM]SETSQIEDTPSSK.3|KPC[CAM]NSQPSELSSETSGIAR.3|KPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.6|KPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.5|DGVLTLANNVTPAK.2|TDYIPLLDVDEK.2|PEEGRPVVSGTGNDITTPPNK.3|PMSLASGLVPAAPPK.2|DFIATLEAEAFDDVVGETVGK.3|DFIATLEAEAFDDVVGETVGK.2|DKALPLEAEVAPVKDMAQLPETEIAPAK.4|DMSPLSETEMALGK.2|DM[Oxi]SPLSETEMALGK.2|DMSPLSETEM[Oxi]ALGK.2|DMSPLSETEMALGKDVTPPPETEVVLIK.4|DMSPLSETEMALGKDVTPPPETEVVLIK.3|DM[Oxi]AQLPETEIAPAKDVAPSTVK.3|DMAQLPETEIAPAKDVAPSTVK.3|KKPC[CAM]SETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEK.6|KKPC[CAM]SETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEK.5|LGERKPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.6|DMQPSMESDMALVK.2|DM[Oxi]QPSMESDMALVK.2|DMQPSM[Oxi]ESDMALVK.2|DMQPSMESDM[Oxi]ALVK.2|DMTLPPETNVILTK.2|DM[Oxi]TLPPETNVILTK.2|EAQTLDSQIQETSI.2|RDFIATLEAEAFDDVVGETVGK.3|EIEMASEERPPAQALEIMMGLK.3|DVPPLSETEATPVPIK.2|MYHDDDLADLVFPSSATADTSIFAGQNDPLK.4|MYHDDDLADLVFPSSATADTSIFAGQNDPLK.3|ALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVK.4|ALPLEAEVAPVKDMAQLPETEIAPAK.3|DVPPLSETEATPVPIKDMEIAQTQK.3|GISEDSHLESLQDVGQSAAPTFM[Oxi]ISPETVTGTGKK.4|GISEDSHLESLQDVGQSAAPTFMISPETVTGTGKK.4|NVC[CAM]LPPEMEVALTEDQVPALKTEAPLAK.3|GISEDSHLESLQDVGQSAAPTFMISPETVTGTGK.3|TEGGGSEAPLC[CAM]PGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQR.4
SEN / CTL,Q12931,"Heat shock protein 75 kDa, mitochondrial",TRAP1,2.43,1.18,3.48E-05,4.28E-06,5.37E+00,"response to stress,translational attenuation,chaperone-mediated protein folding,negative regulation of cellular respiration,negative regulation of reactive oxygen species biosynthetic process,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide","tumor necrosis factor receptor binding,protein binding,ATP binding,protein kinase binding,poly(A) RNA binding,unfolded protein binding","nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space,mitochondrial matrix,lipid particle,membrane,extracellular exosome",12,53,85,GVVDSEDIPLNLSR.2|GVVDSEDIPLNLSR.3|LNELLVK.2|HLAEHSPYYEAMKK.4|NIYYLC[CAM]APNR.3|NIYYLC[CAM]APNR.2|YTLHYKTDAPLNIR.4|YTLHYKTDAPLNIR.3|ELLQESALIRK.3|ELLQESALIRK.2|EWQHEEFYR.3|EWQHEEFYR.2|FFIDQSK.2|SDC[CAM]KEFSSEAR.3|SLYSEKEVFIR.3|KLLDIVAR.2|HEFQAETK.2|AQLLQPTLEINPR.3|AQLLQPTLEINPR.2|FFIDQSKK.2|LISVETDIVVDHYKEEK.4|LISVETDIVVDHYKEEK.3|LISVETDIVVDHYKEEK.2|LRDVLQQR.2|ELISNASDALEKLR.3|AFLDALQNQAEASSK.3|AFLDALQNQAEASSK.2|HLAEHSPYYEAM[Oxi]K.3|HLAEHSPYYEAMK.3|HLAEHSPYYEAMK.2|KLISVETDIVVDHYKEEK.4|KLISVETDIVVDHYKEEK.3|LISVETDIVVDHYK.3|SPAAEC[CAM]LSEK.2|FEDRSPAAEC[CAM]LSEK.3|FEDRSPAAEC[CAM]LSEK.2|SIFYVPDMK.2|HEFQAETKK.2|YSNFVSFPLYLNGR.3|YSNFVSFPLYLNGR.2|VTLRLDTHPAMVTVLEMGAAR.4|VTLRLDTHPAMVTVLEMGAAR.3|RMNTLQAIWMMDPK.3|RMNTLQAIWMMDPK.2|ELLQESALIR.2|ELGSSVALYSR.2|SPAAEC[CAM]LSEKETEELMAWMR.4|SPAAEC[CAM]LSEKETEELMAWMR.3|SPAAEC[CAM]LSEKETEELMAWMR.2|YVAQAHDKPR.2|LDTHPAMVTVLEMGAAR.3|LDTHPAM[Oxi]VTVLEM[Oxi]GAAR.3|LDTHPAM[Oxi]VTVLEMGAAR.3|LDTHPAMVTVLEM[Oxi]GAAR.3|LDTHPAMVTVLEMGAAR.2|YSNFVSFPLYLNGRR.3|EGIVTATEQEVKEDIAK.3|EGIVTATEQEVKEDIAK.2|ELISNASDALEK.2|FIRGVVDSEDIPLNLSR.3|EGIVTATEQEVK.2|ETEELMAWMR.2|HKLVSDGQALPEMEIHLQTNAEK.4|HKLVSDGQALPEMEIHLQTNAEK.3|FFEDYGLFMR.2|FFEDYGLFM[Oxi]R.2|SIFYVPDMKPSMFDVSR.3|SIFYVPDM[Oxi]KPSM[Oxi]FDVSR.3|SIFYVPDMKPSM[Oxi]FDVSR.3|SIFYVPDMKPSMFDVSR.2|KKDTEVLFC[CAM]FEQFDELTLLHLR.4|EEPLHSIISSTESVQGSTSK.3|YESSALPSGQLTSLSEYASR.3|YESSALPSGQLTSLSEYASR.2|FEDRSPAAEC[CAM]LSEKETEELMAWMR.4|FFIDQSKKDAEK.2|LVSDGQALPEMEIHLQTNAEK.3|LVSDGQALPEM[Oxi]EIHLQTNAEK.3|LVSDGQALPEMEIHLQTNAEK.2|MNTLQAIWMMDPK.2|DVREWQHEEFYR.2|LLRYESSALPSGQLTSLSEYASR.3|GTITIQDTGIGM[Oxi]TQEELVSNLGTIAR.3|GTITIQDTGIGMTQEELVSNLGTIAR.3|SAAPGSLGYQWLSDGSGVFEIAEASGVR.3
SEN / CTL,P21291,Cysteine and glycine-rich protein 1,CSRP1,2.43,1.44,7.41E-23,5.41E-23,2.23E+01,platelet aggregation,"zinc ion binding,poly(A) RNA binding","nucleus,focal adhesion,extracellular exosome",72,16,31,NLDSTTVAVHGEEIYC[CAM]K.3|NLDSTTVAVHGEEIYC[CAM]K.2|GFGFGQGAGALVHSE.2|GFGFGQGAGALVHSE.3|TVYFAEEVQC[CAM]EGNSFHK.3|TVYFAEEVQC[CAM]EGNSFHK.2|TVYFAEEVQC[CAM]EGNSFHK.4|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.4|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.3|GLESTTLADKDGEIYC[CAM]K.3|GLESTTLADKDGEIYC[CAM]K.2|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.6|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.7|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.5|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.4|KNLDSTTVAVHGEEIYC[CAM]K.3|DGEIYC[CAM]K.2|HEEAPGHRPTTNPNASK.4|HEEAPGHRPTTNPNASK.3|HEEAPGHRPTTNPNASK.2|GESLGIKHEEAPGHRPTTNPNASK.5|GESLGIKHEEAPGHRPTTNPNASK.4|GESLGIKHEEAPGHRPTTNPNASK.3|GLESTTLADK.2|C[CAM]SQAVYAAEKVIGAGK.3|C[CAM]SQAVYAAEK.2|SC[CAM]FLC[CAM]MVC[CAM]K.2|SC[CAM]FLC[CAM]M[Oxi]VC[CAM]K.2|GYGYGQGAGTLSTDKGESLGIK.3|GYGYGQGAGTLSTDKGESLGIK.2|GYGYGQGAGTLSTDK.2
SEN / CTL,Q92688,Acidic leucine-rich nuclear phosphoprotein 32 family member B,ANP32B,2.43,1.72,4.05E-02,3.32E-03,2.48E+00,"vasculature development,nucleosome assembly,activation of cysteine-type endopeptidase activity involved in apoptotic process,ventricular system development,histone exchange,negative regulation of cell differentiation,positive regulation of protein export from nucleus,inner ear development,palate development","protein binding,histone binding,RNA polymerase binding","nucleus,cytoplasm,extracellular exosome,nucleolus",6,10,17,SLDLFNC[CAM]EVTNLNDYRESVFK.3|LKDISTLEPLK.3|LKDISTLEPLK.2|LKDISTLEPLKK.3|LKDISTLEPLKK.2|LPNLTHLNLSGNK.3|LPNLTHLNLSGNK.2|ELVLDNC[CAM]K.2|KLELSENR.2|DISTLEPLK.2|DISTLEPLKK.2|IFGGLDMLAEK.2|IFGGLDM[Oxi]LAEK.2|IFGGLDM[Oxi]LAEKLPNLTHLNLSGNK.4|IFGGLDMLAEKLPNLTHLNLSGNK.4|IFGGLDM[Oxi]LAEKLPNLTHLNLSGNK.3|IFGGLDMLAEKLPNLTHLNLSGNK.3
SEN / CTL,O76003,Glutaredoxin-3,GLRX3,2.42,1.34,1.59E-04,1.73E-05,4.76E+00,"regulation of the force of heart contraction,negative regulation of cardiac muscle hypertrophy,cell redox homeostasis,oxidation-reduction process","protein kinase C binding,protein binding,electron carrier activity,protein disulfide oxidoreductase activity,poly(A) RNA binding,metal ion binding,iron-sulfur cluster binding","nucleus,cell cortex,Z disc,dendrite,extracellular exosome",12,27,37,HASSGSFLPSANEHLKEDLNLR.5|HASSGSFLPSANEHLKEDLNLR.4|HASSGSFLPSANEHLK.4|HASSGSFLPSANEHLK.3|HASSGSFLPSANEHLK.2|LDGAHAPELTKK.3|ASVMLFMK.2|ASVM[Oxi]LFMK.2|ASVMLFM[Oxi]K.2|LTHAAPC[CAM]MLFMK.3|NSQKIDRLDGAHAPELTK.4|QMVEILHK.2|ELKENGELLPILR.3|IDRLDGAHAPELTK.3|ELPQVSFVK.2|ELEASEELDTIC[CAM]PK.3|ELEASEELDTIC[CAM]PK.2|GELVGGLDIVK.2|ENGELLPILR.2|LDGAHAPELTK.2|HNIQFSSFDIFSDEEVRQGLK.4|HNIQFSSFDIFSDEEVRQGLK.3|LEAEGVPEVSEK.2|GELVGGLDIVKELKENGELLPILR.4|HNIQFSSFDIFSDEEVR.3|HNIQFSSFDIFSDEEVR.2|LEAEGVPEVSEKYEISSVPTFLFFK.4|LEAEGVPEVSEKYEISSVPTFLFFK.3|ENGELLPILRGEN.2|YEISSVPTFLFFK.2|QILEILNSTGVEYETFDILEDEEVRQGLK.4|QILEILNSTGVEYETFDILEDEEVRQGLK.3|AYSNWPTYPQLYVK.2|AYSSWPTYPQLYVSGELIGGLDIIK.3|ELPQVSFVKLEAEGVPEVSEKYEISSVPTFLFFK.4|QILEILNSTGVEYETFDILEDEEVR.3|SLLVVHFWAPWAPQC[CAM]AQMNEVMAELAK.3
SEN / CTL,P43034,Platelet-activating factor acetylhydrolase IB subunit alpha,PAFAH1B1,2.42,1.95,3.21E-05,3.95E-06,5.40E+00,"G2/M transition of mitotic cell cycle,establishment of mitotic spindle orientation,microtubule cytoskeleton organization,ameboidal-type cell migration,acrosome assembly,neuron migration,positive regulation of cytokine-mediated signaling pathway,microtubule-based process,sister chromatid cohesion,mitotic nuclear division,nuclear migration,chemical synaptic transmission,germ cell development,neuroblast proliferation,learning or memory,retrograde axonal transport,adult locomotory behavior,protein secretion,negative regulation of neuron projection development,lipid catabolic process,stem cell division,transmission of nerve impulse,corpus callosum morphogenesis,hippocampus development,layer formation in cerebral cortex,cerebral cortex neuron differentiation,cerebral cortex development,actin cytoskeleton organization,microtubule organizing center organization,osteoclast development,positive regulation of embryonic development,establishment of planar polarity of embryonic epithelium,regulation of GTPase activity,cortical microtubule organization,positive regulation of axon extension,positive regulation of mitotic cell cycle,negative regulation of JNK cascade,platelet activating factor metabolic process,vesicle transport along microtubule,brain morphogenesis,neuromuscular process controlling balance,nuclear envelope disassembly,establishment of centrosome localization,auditory receptor cell development,positive regulation of dendritic spine morphogenesis,regulation of microtubule cytoskeleton organization,cochlea development,microtubule cytoskeleton organization involved in establishment of planar polarity,regulation of microtubule motor activity","phospholipase A2 activity,protein binding,microtubule binding,heparin binding,protein complex binding,dynactin binding,protein homodimerization activity,phospholipase binding,dynein binding,dynein intermediate chain binding,phosphoprotein binding","astral microtubule,kinetochore,nuclear envelope,centrosome,cytosol,kinesin complex,microtubule associated complex,cell cortex,growth cone,nuclear membrane,neuronal cell body,perinuclear region of cytoplasm,extracellular exosome,axon cytoplasm,cell leading edge",24,27,45,LWDFQGFEC[CAM]IR.2|MVRPNQDGTLIASC[CAM]SNDQTVR.3|M[Oxi]VRPNQDGTLIASC[CAM]SNDQTVR.3|TAPYVVTGSVDQTVK.2|TAPYVVTGSVDQTVK.3|EAELDVNEELDKK.3|EAELDVNEELDKK.2|VWVVATK.2|AIADYLR.2|VMELESK.2|GHTDSVQDISFDHSGK.4|GHTDSVQDISFDHSGK.3|GHTDSVQDISFDHSGK.2|SGKPGPFLLSGSR.3|SGKPGPFLLSGSR.2|KYAGLLEK.2|TM[Oxi]HGHDHNVSSVAIMPNGDHIVSASR.6|TMHGHDHNVSSVAIMPNGDHIVSASR.6|TM[Oxi]HGHDHNVSSVAIMPNGDHIVSASR.5|TMHGHDHNVSSVAIM[Oxi]PNGDHIVSASR.5|TMHGHDHNVSSVAIMPNGDHIVSASR.5|TMHGHDHNVSSVAIMPNGDHIVSASR.4|TMHGHDHNVSSVAIMPNGDHIVSASR.3|TLNAHEHFVTSLDFHK.4|TLNAHEHFVTSLDFHK.3|TLNAHEHFVTSLDFHK.2|KVMELESK.2|SNGYEEAYSVFKK.3|SNGYEEAYSVFKK.2|PGPFLLSGSR.2|TLKGHTDSVQDISFDHSGK.4|TLKGHTDSVQDISFDHSGK.3|FILSC[CAM]ADDK.2|LNEAKEEFTSGGPLGQK.3|LNEAKEEFTSGGPLGQK.2|EEFTSGGPLGQK.2|LLASC[CAM]SADMTIK.2|EAELDVNEELDK.2|MWEVQTGYC[CAM]VK.2|SNGYEEAYSVFK.2|VWDYETGDFER.2|VIFHPVFSVMVSASEDATIK.3|EHEHVVEC[CAM]ISWAPESSYSSISEATGSETK.4|M[Oxi]WDVSTGMC[CAM]LMTLVGHDNWVR.3|MWDVSTGMC[CAM]LMTLVGHDNWVR.3
SEN / CTL,P07996,Thrombospondin-1,THBS1,2.42,2.01,5.87E-15,2.13E-15,1.47E+01,"activation of MAPK activity,response to hypoxia,negative regulation of endothelial cell proliferation,negative regulation of cell-matrix adhesion,sprouting angiogenesis,chronic inflammatory response,platelet degranulation,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,negative regulation of dendritic cell antigen processing and presentation,inflammatory response,immune response,response to unfolded protein,cell cycle arrest,cell adhesion,positive regulation of cell proliferation,response to mechanical stimulus,response to glucose,positive regulation of endothelial cell migration,negative regulation of endothelial cell migration,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of nitric oxide mediated signal transduction,negative regulation of cGMP-mediated signaling,negative regulation of plasminogen activation,positive regulation of macrophage chemotaxis,positive regulation of fibroblast migration,cell migration,negative regulation of angiogenesis,peptide cross-linking,positive regulation of blood coagulation,extracellular matrix organization,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,regulation of cGMP metabolic process,response to magnesium ion,response to progesterone,negative regulation of interleukin-12 production,positive regulation of transforming growth factor beta1 production,response to testosterone,cellular response to heat,response to endoplasmic reticulum stress,protein O-linked fucosylation,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of phosphorylation,response to drug,positive regulation of tumor necrosis factor biosynthetic process,positive regulation of macrophage activation,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of blood vessel endothelial cell migration,negative regulation of blood vessel endothelial cell migration,engulfment of apoptotic cell,positive regulation of translation,positive regulation of angiogenesis,behavioral response to pain,positive regulation of smooth muscle cell proliferation,positive regulation of chemotaxis,response to calcium ion,negative regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of fibrinolysis,cellular response to tumor necrosis factor,cellular response to growth factor stimulus,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of endothelial cell apoptotic process,positive regulation of reactive oxygen species metabolic process,negative regulation of endothelial cell chemotaxis,negative regulation of extrinsic apoptotic signaling pathway","phosphatidylserine binding,glycoprotein binding,fibronectin binding,integrin binding,calcium ion binding,protein binding,heparin binding,fibroblast growth factor binding,low-density lipoprotein particle binding,identical protein binding,laminin binding,proteoglycan binding,transforming growth factor beta binding,fibrinogen binding,collagen V binding","extracellular region,fibrinogen complex,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,external side of plasma membrane,cell surface,sarcoplasmic reticulum,secretory granule,extracellular matrix,platelet alpha granule,platelet alpha granule lumen,extracellular exosome",96,62,87,FVFGTTPEDILR.2|TIVTTLQDSIR.2|GGVNDNFQGVLQNVR.2|TKDLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|FYVVMWK.2|GFLLLASLR.2|IEDANLIPPVPDDKFQDLVDAVR.3|IEDANLIPPVPDDKFQDLVDAVR.4|FQMIPLDPK.2|QVTQSYWDTNPTR.2|TIVTTLQDSIRK.3|QHVVSVEEALLATGQWK.3|QHVVSVEEALLATGQWK.4|QHVVSVEEALLATGQWK.2|SITLFVQEDR.2|AQGYSGLSVK.2|FTGSQPFGQGVEHATANK.3|FTGSQPFGQGVEHATANK.2|C[CAM]NYLGHYSDPMYR.2|C[CAM]NYLGHYSDPMYR.3|C[CAM]NYLGHYSDPM[Oxi]YR.3|KVTEENKELANELR.4|KVTEENKELANELR.3|KVTEENKELANELR.2|GTLLALER.2|KIMADSGPIYDK.3|KIMADSGPIYDK.2|TC[CAM]HIQEC[CAM]DKR.3|TC[CAM]HIQEC[CAM]DKR.2|LVKGPDPSSPAFR.3|LVPNPDQK.2|NPC[CAM]TDGTHDC[CAM]NK.3|NPC[CAM]TDGTHDC[CAM]NK.2|SC[CAM]DSLNNR.2|DHSGQVFSVVSNGK.3|DHSGQVFSVVSNGK.2|C[CAM]EGSSVQTR.2|GPDPSSPAFR.2|VTEENKELANELR.3|VTEENKELANELR.2|FQDLVDAVR.2|KDHSGQVFSVVSNGK.3|KDHSGQVFSVVSNGK.2|RPPLC[CAM]YHNGVQYR.3|RPPLC[CAM]YHNGVQYR.2|EVPDAC[CAM]FNHNGEHR.3|PRNPC[CAM]TDGTHDC[CAM]NK.3|AQLYIDC[CAM]EK.2|C[CAM]TSYPDGSWK.2|TC[CAM]HIQEC[CAM]DK.2|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.3|IMADSGPIYDK.2|MENAELDVPIQSVFTR.3|M[Oxi]ENAELDVPIQSVFTR.2|MENAELDVPIQSVFTR.2|AGTLDLSLTVQGK.2|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.3|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.2|SC[CAM]DSLNNRC[CAM]EGSSVQTR.3|FTGSQPFGQGVEHATANKQVC[CAM]KPR.4|LC[CAM]NNPTPQFGGK.2|DGKGDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|DNC[CAM]PFHYNPAQYDYDRDDVGDR.4|GTSQNDPNWVVR.2|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.3|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.2|IPESGGDNSVFDIFELTGAAR.3|IPESGGDNSVFDIFELTGAAR.2|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|IEDANLIPPVPDDK.2|DNC[CAM]QYVYNVDQR.2|DLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|DC[CAM]VGDVTENQIC[CAM]NK.2|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.4|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.3|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|GPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVR.4|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.5|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.4|DNC[CAM]PNLPNSGQEDYDK.2|NNEEWTVDSC[CAM]TEC[CAM]HC[CAM]QNSVTIC[CAM]K.3|C[CAM]DNC[CAM]PYNHNPDQADTDNNGEGDAC[CAM]AADIDGDGILNER.4|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDK.4|DDFDHDSVPDIDDIC[CAM]PENVDISETDFR.3
SEN / CTL,Q6IBS0,Twinfilin-2,TWF2,2.42,1.42,4.01E-07,6.26E-08,7.20E+00,"positive regulation of lamellipodium assembly,positive regulation of neuron projection development,cell projection organization,negative regulation of actin filament polymerization,regulation of microvillus length,regulation of actin cytoskeleton organization,sequestering of actin monomers,positive regulation of axon extension,barbed-end actin filament capping,cellular response to retinoic acid,cellular response to growth factor stimulus,cell-cell adhesion","actin monomer binding,protein kinase C binding,ATP binding,phosphatidylinositol-4,5-bisphosphate binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytoskeleton,cell-cell adherens junction,myofibril,lamellipodium,filopodium,growth cone,stereocilium,perinuclear region of cytoplasm,extracellular exosome",18,26,45,LDLERETIELVHTEPTDVAQLPSRVPR.4|LDLERETIELVHTEPTDVAQLPSRVPR.5|HTHEGDPLESVVFIYSMPGYK.4|HTHEGDPLESVVFIYSM[Oxi]PGYK.4|HTHEGDPLESVVFIYSMPGYK.3|MLYAATR.2|MLYSSC[CAM]K.2|TEISVESK.2|HQTLQGLAFPLQPEAQR.4|HQTLQGLAFPLQPEAQR.3|HQTLQGLAFPLQPEAQR.2|INEVKTEISVESK.3|SRLLDSVEQDFHLEIAK.4|SRLLDSVEQDFHLEIAK.3|YHFFLYK.2|MVNYIQMK.2|M[Oxi]VNYIQMK.2|ETIELVHTEPTDVAQLPSR.4|ETIELVHTEPTDVAQLPSR.3|ETIELVHTEPTDVAQLPSR.2|HLSSC[CAM]AAPAPLTSAER.3|HLSSC[CAM]AAPAPLTSAER.2|DDLSFAGYQK.2|EFGGGHIKDELFGTVK.3|EFGGGHIKDELFGTVK.2|LLDSVEQDFHLEIAK.3|LLDSVEQDFHLEIAK.2|HLSSC[CAM]AAPAPLTSAERELQQIR.4|HLSSC[CAM]AAPAPLTSAERELQQIR.3|LIRGPGENGDDS.2|ETIELVHTEPTDVAQLPSRVPR.4|ETIELVHTEPTDVAQLPSRVPR.3|KIEIGDGAELTAEFLYDEVHPK.4|KIEIGDGAELTAEFLYDEVHPK.3|AVLPLLDAQQPC[CAM]YLLYR.3|AVLPLLDAQQPC[CAM]YLLYR.2|VVIEDEQLVLGASQEPVGR.3|VVIEDEQLVLGASQEPVGR.2|LDLERETIELVHTEPTDVAQLPSR.4|LDLERETIELVHTEPTDVAQLPSR.3|EFGGGHIKDELFGTVKDDLSFAGYQK.4|EFGGGHIKDELFGTVKDDLSFAGYQK.3|IEIGDGAELTAEFLYDEVHPK.3|LDSQNAQGFEWLFLAWSPDNSPVR.3|WDQDYDRAVLPLLDAQQPC[CAM]YLLYR.3
SEN / CTL,Q6UXS9,Inactive caspase-12,CASP12,2.42,1.01,2.46E-03,2.31E-04,3.64E+00,"endoplasmic reticulum unfolded protein response,regulation of apoptotic process,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,self proteolysis,regulation of inflammatory response",cysteine-type endopeptidase activity involved in apoptotic process,"endoplasmic reticulum,IPAF inflammasome complex,NLRP3 inflammasome complex,AIM2 inflammasome complex",6,1,2,AGADTHGRLLQGNIC[CAM]NDAVTK.3|AGADTHGRLLQGNIC[CAM]NDAVTK.4
SEN / CTL,P0DMV8;P0DMV9,Heat shock 70 kDa protein 1A;Heat shock 70 kDa protein 1B,HSPA1A;HSPA1B,2.40,1.96,4.25E-23,3.19E-23,2.25E+01,"positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,regulation of mRNA stability,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,positive regulation of endoribonuclease activity,positive regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death;positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,regulation of cellular response to heat,positive regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death","virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion;virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding","nucleoplasm,cytoplasm,mitochondrion,centriole,cytosol,cell-cell adherens junction,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex;nucleoplasm,cytoplasm,centriole,cytosol,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex",168,60,132,IINEPTAAAIAYGLDR.2|IINEPTAAAIAYGLDR.3|FEELC[CAM]SDLFR.2|ARFEELC[CAM]SDLFR.3|ARFEELC[CAM]SDLFR.2|TTPSYVAFTDTER.2|TTPSYVAFTDTER.3|QATKDAGVIAGLNVLR.3|QATKDAGVIAGLNVLR.2|DAGVIAGLNVLR.2|DAGVIAGLNVLR.3|DAGVIAGLNVLR.1|VEIIANDQGNRTTPSYVAFTDTER.3|AFYPEEISSMVLTK.2|AFYPEEISSMVLTK.3|AFYPEEISSM[Oxi]VLTK.3|AFYPEEISSM[Oxi]VLTK.2|AQIHDLVLVGGSTR.3|AQIHDLVLVGGSTR.2|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.3|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.3|NQVALNPQNTVFDAK.2|NQVALNPQNTVFDAK.3|VEIIANDQGNR.2|VEIIANDQGNR.3|NALESYAFNMK.2|NALESYAFNM[Oxi]K.3|NALESYAFNMK.3|NALESYAFNM[Oxi]K.2|TTPSYVAFTDTERLIGDAAK.3|TTPSYVAFTDTERLIGDAAK.2|LLQDFFNGR.2|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|KFGDPVVQSDMKHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.6|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.4|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|KFGDPVVQSDMKHWPFQVINDGDKPK.3|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.5|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.4|C[CAM]QEVISWLDANTLAEKDEFEHK.4|C[CAM]QEVISWLDANTLAEKDEFEHK.3|ATAGDTHLGGEDFDNRLVNHFVEEFKR.6|ATAGDTHLGGEDFDNRLVNHFVEEFKR.5|ATAGDTHLGGEDFDNRLVNHFVEEFKR.4|FGDPVVQSDMKHWPFQVINDGDKPK.5|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|FGDPVVQSDMKHWPFQVINDGDKPK.4|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|FGDPVVQSDMKHWPFQVINDGDKPK.3|GRLSKEEIER.3|GRLSKEEIER.2|HWPFQVINDGDKPK.4|HWPFQVINDGDKPK.3|HWPFQVINDGDKPK.2|LVNHFVEEFK.3|LVNHFVEEFK.2|MVQEAEK.2|M[Oxi]VQEAEK.2|AEDEVQR.2|ANKITITNDKGR.3|ANKITITNDKGR.2|KFGDPVVQSDMK.3|KFGDPVVQSDM[Oxi]K.3|KFGDPVVQSDMK.2|KFGDPVVQSDM[Oxi]K.2|LDKAQIHDLVLVGGSTR.4|LDKAQIHDLVLVGGSTR.3|LDKAQIHDLVLVGGSTR.2|STLEPVEK.2|LVNHFVEEFKR.3|LVNHFVEEFKR.2|SAVEDEGLK.2|YKAEDEVQRER.3|YKAEDEVQRER.2|MVQEAEKYKAEDEVQR.4|M[Oxi]VQEAEKYKAEDEVQR.4|MVQEAEKYKAEDEVQR.3|M[Oxi]VQEAEKYKAEDEVQR.3|MVQEAEKYKAEDEVQR.2|LSKEEIER.2|ITITNDKGR.2|LLQDFFNGRDLNK.3|LLQDFFNGRDLNK.2|DAKLDKAQIHDLVLVGGSTR.4|DAKLDKAQIHDLVLVGGSTR.3|ATAGDTHLGGEDFDNR.3|ATAGDTHLGGEDFDNR.2|AAAIGIDLGTTYSC[CAM]VGVFQHGK.4|AAAIGIDLGTTYSC[CAM]VGVFQHGK.3|AAAIGIDLGTTYSC[CAM]VGVFQHGK.2|C[CAM]QEVISWLDANTLAEKDEFEHKR.5|C[CAM]QEVISWLDANTLAEKDEFEHKR.4|C[CAM]QEVISWLDANTLAEKDEFEHKR.3|MVQEAEKYK.2|SAVEDEGLKGK.2|VQVSYKGETK.2|YKAEDEVQR.2|ATAGDTHLGGEDFDNRLVNHFVEEFK.5|ATAGDTHLGGEDFDNRLVNHFVEEFK.4|ATAGDTHLGGEDFDNRLVNHFVEEFK.3|FELSGIPPAPR.2|GGSGSGPTIEEVD.2|NQVALNPQNTVFDAKR.3|NQVALNPQNTVFDAKR.2|FGDPVVQSDMK.2|FGDPVVQSDM[Oxi]K.2|AMTKDNNLLGR.2|C[CAM]QEVISWLDANTLAEK.3|C[CAM]QEVISWLDANTLAEK.2|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|QTQIFTTYSDNQPGVLIQVYEGER.4|QTQIFTTYSDNQPGVLIQVYEGER.3|EIAEAYLGYPVTNAVITVPAYFNDSQR.4|EIAEAYLGYPVTNAVITVPAYFNDSQR.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.3|SINPDEAVAYGAAVQAAILMGDK.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.2|SINPDEAVAYGAAVQAAILMGDK.2|RTLSSSTQASLEIDSLFEGIDFYTSITR.4|RTLSSSTQASLEIDSLFEGIDFYTSITR.3|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|DAGVIAGLNVLRIINEPTAAAIAYGLDR.3|TLSSSTQASLEIDSLFEGIDFYTSITR.3
SEN / CTL,P62280,40S ribosomal protein S11,RPS11,2.40,1.03,4.15E-06,5.69E-07,6.24E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,osteoblast differentiation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,rRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",12,16,23,DVQIGDIVTVGEC[CAM]RPLSK.3|DVQIGDIVTVGEC[CAM]RPLSK.2|ILSGVVTK.2|EAIEGTYIDKK.3|EAIEGTYIDKK.2|KC[CAM]PFTGNVSIR.3|KC[CAM]PFTGNVSIR.2|NMSVHLSPC[CAM]FR.3|NM[Oxi]SVHLSPC[CAM]FR.3|NMSVHLSPC[CAM]FR.2|VLLGETGKEKLPR.3|VLLGETGKEKLPR.2|AYQKQPTIFQNK.3|AYQKQPTIFQNK.2|DYLHYIR.2|QPTIFQNK.2|RVLLGETGK.2|VLLGETGKEK.2|EAIEGTYIDK.2|C[CAM]PFTGNVSIR.2|YYKNIGLGFK.2|NMSVHLSPC[CAM]FRDVQIGDIVTVGEC[CAM]RPLSK.5|DVQIGDIVTVGEC[CAM]R.2
SEN / CTL,Q9GZX9,Twisted gastrulation protein homolog 1,TWSG1,2.40,0.67,3.74E-11,9.14E-12,1.10E+01,"ossification,mesoderm formation,salivary gland morphogenesis,hemopoiesis,cell differentiation,BMP signaling pathway,positive regulation of BMP signaling pathway,negative regulation of BMP signaling pathway,forebrain development,camera-type eye development,negative regulation of osteoblast differentiation",,"extracellular space,extracellular exosome",18,4,6,STVEELHEPIPSLFR.3|STVEELHEPIPSLFR.2|WFHNAC[CAM]C[CAM]EC[CAM]IGPEC[CAM]IDYGSK.3|ALC[CAM]ASDVSK.2|ISC[CAM]ESMGASK.2|ISC[CAM]ESM[Oxi]GASK.2
SEN / CTL,P07477;P07478;Q8NHM4,Trypsin-1;Trypsin-2;Putative trypsin-6,PRSS1;PRSS2;PRSS3P2,2.39,1.08,3.33E-03,3.04E-04,3.52E+00,"proteolysis,digestion,cobalamin metabolic process,extracellular matrix disassembly;proteolysis,digestion,extracellular matrix disassembly,positive regulation of cell growth,collagen catabolic process,positive regulation of cell adhesion;proteolysis,digestion,endothelial cell migration","serine-type endopeptidase activity,serine-type peptidase activity,metal ion binding;serine-type endopeptidase activity,calcium ion binding,protein binding,serine-type peptidase activity;serine-type endopeptidase activity,metal ion binding","extracellular region,extracellular exosome,blood microparticle;extracellular region,extracellular space,extracellular matrix;extracellular space",6,1,1,LGEHNIEVLEGNEQFINAAK.3
SEN / CTL,Q96QK1,Vacuolar protein sorting-associated protein 35,VPS35,2.39,1.79,5.12E-05,6.13E-06,5.21E+00,"intracellular protein transport,Wnt signaling pathway,regulation of macroautophagy,regulation of protein stability,retrograde transport, endosome to Golgi,transcytosis,positive regulation of dopamine receptor signaling pathway,positive regulation of Wnt protein secretion,positive regulation of canonical Wnt signaling pathway,neurotransmitter receptor transport, endosome to plasma membrane,negative regulation of late endosome to lysosome transport,retrograde transport, endosome to plasma membrane","protein binding,protein transporter activity,D1 dopamine receptor binding","lysosomal membrane,endosome,early endosome,late endosome,cytosol,endosome membrane,retromer complex,retromer, cargo-selective complex,extracellular exosome,tubular endosome",18,41,64,SEDPDQQYLILNTAR.2|SEDPDQQYLILNTAR.3|LLKIPVDTYNNILTVLK.3|LLKIPVDTYNNILTVLK.2|IREDLPNLESSEETEQINKHFHNTLEHLR.6|IREDLPNLESSEETEQINKHFHNTLEHLR.5|LSQLEGVNVER.3|LSQLEGVNVER.2|HFHNTLEHLR.3|HFHNTLEHLR.2|VQSFQMK.2|AC[CAM]AELHQNVNVK.3|AC[CAM]AELHQNVNVK.2|HFHPLFEYFDYESR.4|HFHPLFEYFDYESR.3|HFHPLFEYFDYESR.2|C[CAM]FSEENHEPLR.3|C[CAM]FSEENHEPLR.2|TQC[CAM]ALAASK.2|LALFAHREDGPGIPADIK.4|LALFAHREDGPGIPADIK.3|LNLEHIATSSAVSK.3|LNLEHIATSSAVSK.2|ILVGTNLVR.2|AVSTC[CAM]AHLFWSGR.3|AVSTC[CAM]AHLFWSGR.2|AELAELPLR.2|HFHPLFEYFDYESRK.4|HFHPLFEYFDYESRK.3|KDILKDLVEMC[CAM]R.3|KVADLYELVQYAGNIIPR.4|KVADLYELVQYAGNIIPR.3|NIIIALIDR.2|IFSFAHQTISALIK.3|IFSFAHQTISALIK.2|AQLAAITLIIGTFER.3|AQLAAITLIIGTFER.2|IPVDTYNNILTVLK.3|IPVDTYNNILTVLK.2|NYLLQC[CAM]TR.2|LLDEAIQAVK.2|EDGPGIPADIK.2|HASNMLGELR.2|HASNM[Oxi]LGELR.2|QIVLTGILEQVVNC[CAM]R.3|QIVLTGILEQVVNC[CAM]R.2|C[CAM]FSEENHEPLRTQC[CAM]ALAASK.4|ENDAVTIQVLNQLIQK.3|ENDAVTIQVLNQLIQK.2|LFDIFSQQVATVIQSR.3|LFDIFSQQVATVIQSR.2|VADLYELVQYAGNIIPR.3|VADLYELVQYAGNIIPR.2|VLETTVEIFNK.2|VLETTVEIFNKLNLEHIATSSAVSK.4|YKQIVLTGILEQVVNC[CAM]R.3|IRFTLPPLVFAAYQLAFR.3|IREDLPNLESSEETEQINK.3|IREDLPNLESSEETEQINK.2|PTTQQSPQDEQEK.2|QDMPSEDVVSLQVSLINLAMK.3|ESPESEGPIYEGLIL.2|PTTQQSPQDEQEKLLDEAIQAVK.3|EDLPNLESSEETEQINK.2
SEN / CTL,P10619,Lysosomal protective protein,CTSA,2.39,0.93,2.41E-03,2.28E-04,3.64E+00,"proteolysis,glycosphingolipid metabolic process,intracellular protein transport,regulation of protein stability,positive regulation of catalytic activity,proteolysis involved in cellular protein catabolic process,regulation of chaperone-mediated autophagy,negative regulation of chaperone-mediated autophagy","carboxypeptidase activity,serine-type carboxypeptidase activity,exo-alpha-sialidase activity,enzyme activator activity","nucleoplasm,lysosome,endoplasmic reticulum,membrane,lysosomal lumen,intracellular membrane-bounded organelle,extracellular exosome,lumenal side of lysosomal membrane",6,15,29,C[CAM]NFYDNKDLEC[CAM]VTNLQEVAR.3|EFSHIAFLTIK.3|EFSHIAFLTIK.2|C[CAM]NFYDNK.2|SMNSQYLK.2|SM[Oxi]NSQYLK.2|HLHYWFVESQK.3|HLHYWFVESQK.2|DLEC[CAM]VTNLQEVAR.3|DLEC[CAM]VTNLQEVAR.2|GAGHM[Oxi]VPTDKPLAAFTMFSR.4|GAGHMVPTDKPLAAFTM[Oxi]FSR.4|GAGHMVPTDKPLAAFTMFSR.4|GAGHM[Oxi]VPTDKPLAAFTM[Oxi]FSR.4|GAGHMVPTDKPLAAFTMFSR.3|GAGHM[Oxi]VPTDKPLAAFTMFSR.3|GAGHMVPTDKPLAAFTM[Oxi]FSR.3|PLAAFTMFSR.2|PLAAFTM[Oxi]FSR.2|LWSSLQTHC[CAM]C[CAM]SQNK.3|LWSSLQTHC[CAM]C[CAM]SQNK.2|YGDSGEQIAGFVKEFSHIAFLTIK.4|IVGNSGLNIYNLYAPC[CAM]AGGVPSHFR.4|YGDSGEQIAGFVK.2|ALNIPEQLPQWDMC[CAM]NFLVNLQYR.4|ALNIPEQLPQWDM[Oxi]C[CAM]NFLVNLQYR.3|ALNIPEQLPQWDMC[CAM]NFLVNLQYR.3|DTVVVQDLGNIFTR.2|KALNIPEQLPQWDMC[CAM]NFLVNLQYR.3
SEN / CTL,P50991,T-complex protein 1 subunit delta,CCT4,2.38,1.52,6.11E-21,3.63E-21,2.04E+01,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","ATP binding,poly(A) RNA binding,unfolded protein binding","zona pellucida receptor complex,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,melanosome,cell projection,cell body,extracellular exosome",60,44,86,VIDPATATSVDLRDIK.3|ALIAGGGAPEIELALR.2|ALIAGGGAPEIELALR.3|SILKIDDVVNTR.3|SILKIDDVVNTR.2|TLSGMESYC[CAM]VR.2|TLSGMESYC[CAM]VR.3|TLSGM[Oxi]ESYC[CAM]VR.2|AFADAMEVIPSTLAENAGLNPISTVTELR.4|AFADAMEVIPSTLAENAGLNPISTVTELR.3|AFADAMEVIPSTLAENAGLNPISTVTELR.5|AFADAM[Oxi]EVIPSTLAENAGLNPISTVTELR.3|KLGGTIDDC[CAM]ELVEGLVLTQK.3|KLGGTIDDC[CAM]ELVEGLVLTQK.4|KLGGTIDDC[CAM]ELVEGLVLTQK.2|VIDPATATSVDLR.2|VIDPATATSVDLR.3|LGGTIDDC[CAM]ELVEGLVLTQK.3|LGGTIDDC[CAM]ELVEGLVLTQK.2|VVSQYSSLLSPMSVNAVMK.3|VVSQYSSLLSPM[Oxi]SVNAVMK.3|VVSQYSSLLSPMSVNAVM[Oxi]K.3|VVSQYSSLLSPM[Oxi]SVNAVM[Oxi]K.3|VVSQYSSLLSPM[Oxi]SVNAVM[Oxi]K.2|VVSQYSSLLSPM[Oxi]SVNAVMK.2|VVSQYSSLLSPMSVNAVM[Oxi]K.2|VVSQYSSLLSPMSVNAVMK.2|MLVELSK.2|M[Oxi]LVELSK.2|VSNSGITR.2|KTGC[CAM]NVLLIQK.3|KTGC[CAM]NVLLIQK.2|SGATAGAAGGR.2|GSNKLVIEEAER.3|IGLIQFC[CAM]LSAPK.3|IGLIQFC[CAM]LSAPK.2|ITGC[CAM]ASPGK.2|AYILNLVK.2|IDDVVNTR.2|GDVTITNDGATILK.3|GDVTITNDGATILK.2|LVIEEAER.2|DALSDLALHFLNK.3|DALSDLALHFLNK.2|GIHPTIISESFQK.3|GIHPTIISESFQK.2|ETLLNSATTSLNSK.3|ETLLNSATTSLNSK.2|GAYQDRDKPAQIR.3|AKIGLIQFC[CAM]LSAPK.3|DIEREDIEFIC[CAM]K.3|DIEREDIEFIC[CAM]K.2|EDIEFIC[CAM]K.2|IMVIKDIEREDIEFIC[CAM]K.4|IMVIKDIEREDIEFIC[CAM]K.3|GIEILTDMSR.2|RALIAGGGAPEIELALR.3|TGC[CAM]NVLLIQK.2|QMQVLHPAAR.2|SIHDALC[CAM]VIR.2|VSNSGITRVEK.2|GIEILTDMSRPVELSDR.3|GIEILTDM[Oxi]SRPVELSDR.3|GIEILTDMSRPVELSDR.2|SILRDALSDLALHFLNK.3|TDMDNQIVVSDYAQMDR.3|TDM[Oxi]DNQIVVSDYAQM[Oxi]DR.3|TDM[Oxi]DNQIVVSDYAQMDR.3|TDMDNQIVVSDYAQM[Oxi]DR.3|TDMDNQIVVSDYAQMDR.2|TDM[Oxi]DNQIVVSDYAQMDR.2|TDMDNQIVVSDYAQM[Oxi]DR.2|M[Oxi]IQDGKGDVTITNDGATILK.3|MIQDGKGDVTITNDGATILK.3|MIQDGKGDVTITNDGATILK.2|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.5|TIGTKPVAHIDQFTADM[Oxi]LGSAELAEEVNLNGSGK.4|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.4|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.3|PVELSDRETLLNSATTSLNSK.3|ALIAGGGAPEIELALRLTEYSR.3|GIEILTDMSRPVELSDRETLLNSATTSLNSK.4|GIEILTDM[Oxi]SRPVELSDRETLLNSATTSLNSK.4|GIEILTDMSRPVELSDRETLLNSATTSLNSK.3|AQDIEAGDGTTSVVIIAGSLLDSC[CAM]TK.3|PVAHIDQFTADMLGSAELAEEVNLNGSGK.3
SEN / CTL,P53621,Coatomer subunit alpha,COPA,2.38,2.23,4.71E-07,7.29E-08,7.14E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,pancreatic juice secretion","hormone activity,structural molecule activity","Golgi membrane,extracellular space,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesicle,extracellular exosome",36,92,167,VTTVTEIGKDVIGLR.3|VTTVTEIGKDVIGLR.2|TLDLPIYVTR.2|SSGLTAVWVAR.2|LLHDQVGVIQFGPYK.3|LLHDQVGVIQFGPYK.4|LLHDQVGVIQFGPYK.2|M[Oxi]C[CAM]TLIDKFDEHDGPVR.3|MC[CAM]TLIDKFDEHDGPVR.4|M[Oxi]C[CAM]TLIDKFDEHDGPVR.4|MC[CAM]TLIDKFDEHDGPVR.3|MC[CAM]TLIDKFDEHDGPVR.2|KLDALC[CAM]NIHENIR.4|KLDALC[CAM]NIHENIR.3|KLDALC[CAM]NIHENIR.2|TGVQTFR.2|GHYNNVSC[CAM]AVFHPR.4|GHYNNVSC[CAM]AVFHPR.3|GHYNNVSC[CAM]AVFHPR.2|GYPEVALHFVK.3|GYPEVALHFVK.2|MHSLLIK.2|ALDDKNC[CAM]WEK.3|ALDDKNC[CAM]WEK.2|FEEAVEK.2|ISPLQFR.2|KYDEVLHMVR.3|KYDEVLHMVR.2|KYDEVLHM[Oxi]VR.2|LNDLIQR.2|RSSGLTAVWVAR.3|YAVTTGDHGIIR.3|YAVTTGDHGIIR.2|KGYPEVALHFVKDEK.4|KGYPEVALHFVKDEK.3|KGYPEVALHFVKDEK.2|LVGQSIIAYLQK.3|LVGQSIIAYLQK.2|KGYPEVALHFVK.3|KGYPEVALHFVK.2|RLLELGPKPEVAQQTR.4|RLLELGPKPEVAQQTR.3|RLLELGPKPEVAQQTR.2|DVAVMQLR.2|DVAVM[Oxi]QLR.2|ERPAYAVHGNMLHYVK.4|ERPAYAVHGNMLHYVK.3|TALNLFFK.2|VTTVTEIGK.2|VWDISGLR.2|HVLEGHDR.2|VLTIDPTEFKFK.3|LDALC[CAM]NIHENIR.3|VWNWQSR.2|HAIVIC[CAM]NR.2|DADSQNPDAPEGKR.3|DADSQNPDAPEGKR.2|C[CAM]PLSGAC[CAM]YSPEFK.3|C[CAM]PLSGAC[CAM]YSPEFK.2|LSFLYLITGNLEK.3|LSFLYLITGNLEK.2|SILLSVPLLVVDNK.3|SILLSVPLLVVDNK.2|AWEVDTC[CAM]R.2|GFFEGTIASK.2|SLAYLTAATHGLDEEAESLK.4|SLAYLTAATHGLDEEAESLK.3|SLAYLTAATHGLDEEAESLK.2|FDEHDGPVR.2|C[CAM]LFTLLGHLDYIR.3|C[CAM]LFTLLGHLDYIR.2|DADSITLFDVQQKR.3|DADSITLFDVQQKR.2|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.6|DHDRFWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.5|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.5|KDMSGHYQNALYLGDVSER.4|KDMSGHYQNALYLGDVSER.3|GNNVYC[CAM]LDR.2|LLELGPKPEVAQQTR.3|LLELGPKPEVAQQTR.2|QEIAEAQQLITIC[CAM]R.3|QEIAEAQQLITIC[CAM]R.2|TKNFDKLSFLYLITGNLEK.4|TKNFDKLSFLYLITGNLEK.3|QLFLQTYAR.2|YDEVLHMVR.2|VKSGAWDESGVFIYTTSNHIK.4|VKSGAWDESGVFIYTTSNHIK.3|VLTIDPTEFK.2|LGEVALLQGNHQIVEMC[CAM]YQR.4|LGEVALLQGNHQIVEMC[CAM]YQR.3|LGEVALLQGNHQIVEMC[CAM]YQR.2|RPWILTSLHNGVIQLWDYR.4|RPWILTSLHNGVIQLWDYR.3|ETIPDIDPNAK.2|KVQVPNC[CAM]DEIFYAGTGNLLLR.4|KVQVPNC[CAM]DEIFYAGTGNLLLR.3|YVIWSADM[Oxi]SHVALLAK.3|YVIWSADMSHVALLAK.3|YVIWSADMSHVALLAK.2|ASNLENSTYDLYTIPK.3|ASNLENSTYDLYTIPK.2|LLQPPAPIMPLDTNWPLLTVSK.4|LLQPPAPIMPLDTNWPLLTVSK.3|LLQPPAPIM[Oxi]PLDTNWPLLTVSK.3|NLSPGAVESDVR.2|QLDFNSSKDVAVMQLR.3|QELILSNSEDK.2|TTFFHHEYPWILSASDDQTIR.4|TTFFHHEYPWILSASDDQTIR.3|DADSQNPDAPEGK.2|NFDKLSFLYLITGNLEK.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.4|SGSKFPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.3|DMSGHYQNALYLGDVSER.3|DM[Oxi]SGHYQNALYLGDVSER.3|DMSGHYQNALYLGDVSER.2|ETFDPEKETIPDIDPNAK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.4|FWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.3|IC[CAM]EMAAYFTHSNLQPVHMILVLR.4|IC[CAM]EM[Oxi]AAYFTHSNLQPVHMILVLR.4|IC[CAM]EMAAYFTHSNLQPVHMILVLR.3|KNLSPGAVESDVR.2|EYIVGLSVETER.2|SGAWDESGVFIYTTSNHIK.3|SGAWDESGVFIYTTSNHIK.2|LLHDQVGVIQFGPYKQLFLQTYAR.4|LQLC[CAM]YQLTTVGK.2|TTYQALPC[CAM]LPSMYGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.2|TTYQALPC[CAM]LPSMYGYPNR.2|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.6|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|QQPLFVSGGDDYK.2|DADSITLFDVQQK.2|SLAYLTAATHGLDEEAESLKETFDPEK.4|SLAYLTAATHGLDEEAESLKETFDPEK.3|GVNWAAFHPTMPLIVSGADDR.3|GVNWAAFHPTM[Oxi]PLIVSGADDR.3|GVNWAAFHPTMPLIVSGADDR.2|LQLC[CAM]YQLTTVGKFEEAVEK.3|LQLC[CAM]YQLTTVGKFEEAVEK.2|EYIVGLSVETERK.2|VQVPNC[CAM]DEIFYAGTGNLLLR.3|VQVPNC[CAM]DEIFYAGTGNLLLR.2|FPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.2|GRTTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|GRTTYQALPC[CAM]LPSMYGYPNR.3|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.4|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.3|GITGVDLFGTTDAVVK.2|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.4|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.3|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.5|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.4|ILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|NPTDAYQLNYDM[Oxi]HNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.3|FSLALEC[CAM]GNIEIALEAAK.2
SEN / CTL,Q9NVN3,Synembryn-B,RIC8B,2.38,1.00,2.44E-03,2.30E-04,3.64E+00,"regulation of G-protein coupled receptor protein signaling pathway,positive regulation of GTPase activity","G-protein alpha-subunit binding,guanyl-nucleotide exchange factor activity,GTPase activator activity","cytoplasm,centrosome,cytosol,plasma membrane,cell cortex",6,1,1,GSSYREGLTPVLSLLTEC[CAM]SR.3
SEN / CTL,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,2.37,1.93,8.00E-12,2.11E-12,1.17E+01,"positive regulation of neuron projection development,negative regulation of neuron projection development,negative regulation of cell migration,neuron development,response to axon injury,actin filament bundle assembly,protein homooligomerization,positive regulation of filopodium assembly,actin crosslink formation,cellular response to cytokine stimulus","hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,SH3 domain binding,filamin binding,chondroitin sulfate binding","extracellular space,cytosol,lamellipodium,growth cone,filamentous actin,cell body,exocytic vesicle",54,28,42,IMLEDGNLHVTQGAGR.3|IM[Oxi]LEDGNLHVTQGAGR.3|AIGKDNFTAIPEGTNGVEER.3|NLHQSGFSLSGTQVDEGVR.3|NLHQSGFSLSGTQVDEGVR.2|GMYDGPVFDLTTTPK.2|GM[Oxi]YDGPVFDLTTTPK.2|MDENQFVAVTSTNAAK.2|MDENQFVAVTSTNAAK.3|M[Oxi]DENQFVAVTSTNAAK.2|AITIASQTNC[CAM]PLYVTK.2|AITIASQTNC[CAM]PLYVTK.3|MLEMGITGPEGHVLSRPEELEAEAVFR.4|MLEMGITGPEGHVLSRPEELEAEAVFR.3|NHQSAAEYNIFEGMELR.3|NHQSAAEYNIFEGMELR.2|IFNLYPR.2|QEVQNLIK.2|MADLHAVPR.2|M[Oxi]ADLHAVPR.2|SAADLISQAR.2|M[Oxi]VIPGGIDVHTHFQMPYK.4|MVIPGGIDVHTHFQMPYK.4|GAPLVVIC[CAM]QGK.2|SC[CAM]C[CAM]DYALHVDITHWNDSVK.4|SC[CAM]C[CAM]DYALHVDITHWNDSVK.3|FIPC[CAM]SPFSDYVYKR.3|KGNVVFGEPITASLGIDGTHYWSK.4|KGNVVFGEPITASLGIDGTHYWSK.3|QIGDNLIVPGGVK.2|KKGNVVFGEPITASLGIDGTHYWSK.4|GVNSFMVYMAYK.2|GRISVGSDSDLVIWDPDAVK.3|GMTTVDDFFQGTK.2|GM[Oxi]TTVDDFFQGTK.2|AALAGGTTMIIDHVVPEPESSLTEAYEK.4|AALAGGTTMIIDHVVPEPESSLTEAYEK.3|FIPC[CAM]SPFSDYVYK.2|GNVVFGEPITASLGIDGTHYWSK.3|DKGVNSFMVYMAYK.2|DNFTAIPEGTNGVEER.2|ISVGSDSDLVIWDPDAVK.2
SEN / CTL,P05156,Complement factor I,CFI,2.37,0.68,3.49E-04,3.65E-05,4.44E+00,"proteolysis,receptor-mediated endocytosis,complement activation, classical pathway,regulation of complement activation,innate immune response","serine-type endopeptidase activity,scavenger receptor activity,protein binding,metal ion binding","extracellular region,extracellular space,membrane,extracellular exosome",6,26,36,GLETSLAEC[CAM]TFTK.2|HGNTDSEGIVEVK.3|HGNTDSEGIVEVK.2|IVIEYVDR.2|YTHLSC[CAM]DK.2|RAQLGDLPWQVAIK.3|YQIWTTVVDWIHPDLKR.4|YQIWTTVVDWIHPDLKR.3|VFC[CAM]QPWQR.2|C[CAM]IEGTC[CAM]VC[CAM]K.2|SLEC[CAM]LHPGTK.2|ADSPMDDFFQC[CAM]VNGK.3|ADSPMDDFFQC[CAM]VNGK.2|KYTHLSC[CAM]DK.2|SFPTYC[CAM]QQK.2|VANYFDWISYHVGR.3|RIVIEYVDR.2|VFSLQWGEVK.2|TMGYQDFADVVC[CAM]YTQK.3|TMGYQDFADVVC[CAM]YTQK.2|TM[Oxi]GYQDFADVVC[CAM]YTQK.2|YQIWTTVVDWIHPDLK.3|YQIWTTVVDWIHPDLK.2|RTMGYQDFADVVC[CAM]YTQK.3|RTM[Oxi]GYQDFADVVC[CAM]YTQK.3|AC[CAM]DGINDC[CAM]GDQSDELC[CAM]C[CAM]K.3|AC[CAM]DGINDC[CAM]GDQSDELC[CAM]C[CAM]K.2|EANVAC[CAM]LDLGFQQGADTQR.3|EANVAC[CAM]LDLGFQQGADTQR.2|VTYTSQEDLVEK.2|AQLGDLPWQVAIK.2|IIFHENYNAGTYQNDIALIEMK.3|VANYFDWISYHVGRPFISQYNV.3|DASGITC[CAM]GGIYIGGC[CAM]WILTAAHC[CAM]LR.3|EM[Oxi]EC[CAM]AGTYDGSIDAC[CAM]K.2|EMEC[CAM]AGTYDGSIDAC[CAM]K.2
SEN / CTL,P00441,Superoxide dismutase [Cu-Zn],SOD1,2.37,1.02,9.94E-18,4.47E-18,1.73E+01,"activation of MAPK activity,response to reactive oxygen species,response to superoxide,ovarian follicle development,positive regulation of cytokine production,placenta development,retina homeostasis,response to amphetamine,myeloid cell homeostasis,platelet degranulation,glutathione metabolic process,superoxide metabolic process,cellular iron ion homeostasis,spermatogenesis,embryo implantation,cell aging,sensory perception of sound,locomotory behavior,anterograde axonal transport,retrograde axonal transport,regulation of blood pressure,response to heat,response to organic substance,transmission of nerve impulse,removal of superoxide radicals,response to nutrient levels,peripheral nervous system myelin maintenance,positive regulation of superoxide anion generation,regulation of T cell differentiation in thymus,response to carbon monoxide,cellular response to potassium ion,regulation of multicellular organism growth,response to drug,response to hydrogen peroxide,superoxide anion generation,positive regulation of apoptotic process,positive regulation of catalytic activity,regulation of GTPase activity,negative regulation of neuron apoptotic process,response to ethanol,negative regulation of cholesterol biosynthetic process,regulation of protein kinase activity,regulation of organ growth,response to antibiotic,response to copper ion,muscle cell cellular homeostasis,thymus development,response to axon injury,hydrogen peroxide biosynthetic process,regulation of mitochondrial membrane potential,oxidation-reduction process,heart contraction,neurofilament cytoskeleton organization,relaxation of vascular smooth muscle,auditory receptor cell stereocilium organization,cellular response to cadmium ion,cellular response to ATP,reactive oxygen species metabolic process,response to antipsychotic drug,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","superoxide dismutase activity,copper ion binding,protein binding,zinc ion binding,protein phosphatase 2B binding,identical protein binding,protein homodimerization activity,Rac GTPase binding,chaperone binding","extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,lysosome,peroxisome,cytosol,extracellular matrix,dense core granule,cytoplasmic vesicle,dendrite cytoplasm,neuronal cell body,myelin sheath,protein complex,extracellular exosome,axon cytoplasm,plasma membrane",48,20,39,LAC[CAM]GVIGIAQ.2|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.6|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.5|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.4|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.3|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.4|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.5|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.6|AVC[CAM]VLKGDGPVQGIINFEQK.3|AVC[CAM]VLKGDGPVQGIINFEQK.2|HVGDLGNVTADK.3|HVGDLGNVTADK.2|TLVVHEK.2|DEERHVGDLGNVTADK.4|DEERHVGDLGNVTADK.3|TLVVHEKADDLGKGGNEESTK.5|TLVVHEKADDLGKGGNEESTK.4|TLVVHEKADDLGKGGNEESTK.3|ADDLGKGGNEESTK.3|ADDLGKGGNEESTK.2|TLVVHEKADDLGK.3|TLVVHEKADDLGK.2|GDGPVQGIINFEQK.3|GDGPVQGIINFEQK.2|ADDLGKGGNEESTKTGNAGSR.4|ADDLGKGGNEESTKTGNAGSR.3|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.5|HGGPKDEERHVGDLGNVTADK.4|HGGPKDEERHVGDLGNVTADK.3|DGVADVSIEDSVISLSGDHC[CAM]IIGR.4|DGVADVSIEDSVISLSGDHC[CAM]IIGR.3|ESNGPVKVWGSIK.2|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.4|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.3|GDGPVQGIINFEQKESNGPVKVWGSIK.4|GGNEESTKTGNAGSRLAC[CAM]GVIGIAQ.3|TGNAGSRLAC[CAM]GVIGIAQ.2
SEN / CTL,Q8NBJ7,Sulfatase-modifying factor 2,SUMF2,2.37,2.04,1.39E-05,1.78E-06,5.75E+00,post-translational protein modification,metal ion binding,"endoplasmic reticulum,endoplasmic reticulum lumen",24,14,22,LPTEEEWEFAAR.2|SVLWWLPVEK.2|MGNTPDSASDNLGFR.2|M[Oxi]GNTPDSASDNLGFR.2|ERLEHPVLHVSWNDAR.4|ERLEHPVLHVSWNDAR.3|LEHPVLHVSWNDAR.4|LEHPVLHVSWNDAR.3|LEHPVLHVSWNDAR.2|QPAGPGSGIR.2|GASWIDTADGSANHR.3|GASWIDTADGSANHR.2|RLPTEEEWEFAAR.3|RLPTEEEWEFAAR.2|EATVKPFAIDIFPVTNKDFRDFVR.5|EATVKPFAIDIFPVTNKDFR.4|C[CAM]AADAGRPPGEL.2|FLMGTNSPDSR.2|FLM[Oxi]GTNSPDSR.2|EATVKPFAIDIFPVTNK.3|EATVKPFAIDIFPVTNK.2|PFAIDIFPVTNK.2
SEN / CTL,P36871,Phosphoglucomutase-1,PGM1,2.37,2.16,6.36E-08,1.07E-08,7.97E+00,"glycogen biosynthetic process,glycogen catabolic process,glucose metabolic process,gluconeogenesis,glycolytic process,galactose catabolic process","magnesium ion binding,phosphoglucomutase activity","cytoplasm,cytosol,actin cytoskeleton,extracellular exosome",36,47,76,HGFFVNPSDSVAVIAANIFSIPYFQQTGVR.3|HGFFVNPSDSVAVIAANIFSIPYFQQTGVR.4|HGFFVNPSDSVAVIAANIFSIPYFQQTGVR.5|SGEHDFGAAFDGDGDRNMILGK.4|SGEHDFGAAFDGDGDRNMILGK.3|DLEALMFDR.2|DLEALM[Oxi]FDR.2|SIFDFSALKELLSGPNR.3|SIFDFSALKELLSGPNR.2|INQDPQVMLAPLISIALK.3|INQDPQVM[Oxi]LAPLISIALK.3|INQDPQVM[Oxi]LAPLISIALK.2|INQDPQVMLAPLISIALK.2|VDLGVLGK.2|IRIDAMHGVVGPYVK.4|IRIDAMHGVVGPYVK.3|IAAANGIGR.2|VSQLQER.2|ELLSGPNR.2|KQSVEDILKDHWQK.4|KQSVEDILKDHWQK.3|EAIQLIAR.2|LIFTDGSR.2|IDAMHGVVGPYVK.3|IDAM[Oxi]HGVVGPYVK.3|IDAMHGVVGPYVK.2|QSVEDILK.2|LYIDSYEKDVAK.3|LYIDSYEKDVAK.2|MMKDLEALMFDR.3|QFSANDKVYTVEK.3|QFSANDKVYTVEK.2|YDYEEVEAEGANK.3|YDYEEVEAEGANK.2|LYIDSYEK.2|SIFDFSALK.2|SMPTSGALDR.2|KQSVEDILK.2|LSLC[CAM]GEESFGTGSDHIREK.4|LSLC[CAM]GEESFGTGSDHIREK.3|EKDGLWAVLAWLSILATRK.4|EKDGLWAVLAWLSILATRK.3|LSGTGSAGATIR.2|AIGGIILTASHNPGGPNGDFGIK.4|AIGGIILTASHNPGGPNGDFGIK.3|AIGGIILTASHNPGGPNGDFGIK.2|SGEHDFGAAFDGDGDR.3|SGEHDFGAAFDGDGDR.2|TQAYQDQKPGTSGLR.3|TQAYQDQKPGTSGLR.2|FFGNLMDASK.2|FFGNLM[Oxi]DASK.2|FKPFTVEIVDSVEAYATMLR.4|FKPFTVEIVDSVEAYATM[Oxi]LR.3|FKPFTVEIVDSVEAYATMLR.3|ADNFEYSDPVDGSISR.3|ADNFEYSDPVDGSISR.2|QEATLVVGGDGR.2|LSLC[CAM]GEESFGTGSDHIR.3|LSLC[CAM]GEESFGTGSDHIR.2|IALYETPTGWK.2|LVIGQNGILSTPAVSC[CAM]IIR.3|LVIGQNGILSTPAVSC[CAM]IIR.2|VFQSSANYAENFIQSIISTVEPAQR.4|VFQSSANYAENFIQSIISTVEPAQR.3|LVIGQNGILSTPAVSC[CAM]IIRK.3|TIEEYAVC[CAM]PDLK.2|NFFTRYDYEEVEAEGANK.3|TIEEYAVC[CAM]PDLKVDLGVLGK.3|FNISNGGPAPEAITDKIFQISK.3|FNISNGGPAPEAITDK.2|ILC[CAM]EELGAPANSAVNC[CAM]VPLEDFGGHHPDPNLTYAADLVETMK.5|ILC[CAM]EELGAPANSAVNC[CAM]VPLEDFGGHHPDPNLTYAADLVETMK.4|KILC[CAM]EELGAPANSAVNC[CAM]VPLEDFGGHHPDPNLTYAADLVETMK.5|VFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGR.4|VKVFQSSANYAENFIQSIISTVEPAQR.3
SEN / CTL,P48444,Coatomer subunit delta,ARCN1,2.37,1.58,9.32E-09,1.78E-09,8.75E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,adult locomotory behavior,cerebellar Purkinje cell layer maturation,pigmentation",poly(A) RNA binding,"Golgi membrane,cytoplasm,endoplasmic reticulum membrane,Golgi apparatus,cytosol,membrane,COPI vesicle coat,transport vesicle,intracellular membrane-bounded organelle",36,40,66,VLLAAAVC[CAM]TK.2|NTLEWC[CAM]LPVIDAK.2|NTLEWC[CAM]LPVIDAK.3|NSNILEDLETLR.2|NSNILEDLETLR.3|LFTAESLIGLKNPEK.3|LFTAESLIGLKNPEK.2|RNTLEWC[CAM]LPVIDAK.3|RNTLEWC[CAM]LPVIDAK.2|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.4|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.5|KAPGFGGFGSSAVSGGSTAAM[Oxi]ITETIIETDKPK.4|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.3|ITLTC[CAM]GR.2|M[Oxi]HAPPINMESVHMK.4|MHAPPINMESVHMK.3|M[Oxi]HAPPINMESVHMK.3|MHAPPINM[Oxi]ESVHMK.3|MHAPPINMESVHM[Oxi]K.3|VAPAPARPSGPSK.3|IRLHVENEDK.3|KNYC[CAM]NIQVTK.3|KLFTAESLIGLK.3|KLFTAESLIGLK.2|TRIEGLLAAFPK.3|TRIEGLLAAFPK.2|GVQLQTHPNVDK.3|GVQLQTHPNVDK.2|QHTFVETESVR.3|QHTFVETESVR.2|TFTEM[Oxi]DSHEEK.3|TFTEMDSHEEK.3|TFTEMDSHEEK.2|GKEVDNFVDKLK.3|GKEVDNFVDKLK.2|IRLHVENEDKK.3|EVDNFVDK.2|GVQLQTHPNVDKK.3|GVQLQTHPNVDKK.2|KGVQLQTHPNVDK.3|KGVQLQTHPNVDK.2|LHVENEDK.2|ENVNLAQIR.2|IEGLLAAFPK.2|LKSEGETIMSSSMGK.3|LKSEGETIMSSSMGK.2|YVYQPMEK.2|LYMVLITTK.2|LHVENEDKK.2|NYC[CAM]NIQVTK.2|GKEVDNFVDK.2|VTQVDGNSPVR.2|KLFTAESLIGLKNPEK.3|LFTAESLIGLK.2|DGGLQNMELHGMIMLR.3|DGGLQNMELHGMIM[Oxi]LR.3|DGGLQNMELHGMIMLR.2|SFPVNSDVGVLK.2|FSTETTFLVDK.2|SEGETIMSSSMGK.2|SEGETIM[Oxi]SSSMGK.2|SEGETIMSSSM[Oxi]GK.2|APGFGGFGSSAVSGGSTAAMITETIIETDKPK.4|APGFGGFGSSAVSGGSTAAMITETIIETDKPK.3|SGSLEFSIAGQPNDFFPVQVSFVSK.3|FSTETTFLVDKYEIL.2
SEN / CTL,P09382,Galectin-1,LGALS1,2.36,2.32,1.34E-12,3.75E-13,1.24E+01,"plasma cell differentiation,apoptotic process,signal transduction,negative regulation of cell-substrate adhesion,negative regulation of neuron projection development,T cell costimulation,multicellular organismal response to stress,positive regulation of erythrocyte aggregation,response to drug,regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,myoblast differentiation,positive regulation of viral entry into host cell,response to axon injury,cellular response to glucose stimulus,cellular response to organic cyclic compound,positive regulation of dendritic cell differentiation","glycoprotein binding,signal transducer activity,protein binding,lactose binding,protein homodimerization activity,laminin binding,poly(A) RNA binding","proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,cell surface,extracellular matrix,extracellular exosome",126,17,33,FNAHGDANTIVC[CAM]NSKDGGAWGTEQR.4|SFVLNLGKDSNNLC[CAM]LHFNPR.4|SFVLNLGKDSNNLC[CAM]LHFNPR.3|DSNNLC[CAM]LHFNPR.3|DSNNLC[CAM]LHFNPR.2|LPDGYEFKFPNR.3|LPDGYEFKFPNR.2|SFVLNLGK.2|FNAHGDANTIVC[CAM]NSK.3|FNAHGDANTIVC[CAM]NSK.2|FNAHGDANTIVC[CAM]NSK.4|VRGEVAPDAKSFVLNLGK.4|VRGEVAPDAKSFVLNLGK.3|FPNRLNLEAINYMAADGDFKIK.4|FPNRLNLEAINYMAADGDFKIK.3|LNLEAINYMAADGDFKIK.3|LNLEAINYM[Oxi]AADGDFKIK.3|LNLEAINYMAADGDFKIK.2|EAVFPFQPGSVAEVC[CAM]ITFDQANLTVK.3|EAVFPFQPGSVAEVC[CAM]ITFDQANLTVK.4|LNLEAINYMAADGDFK.3|LNLEAINYMAADGDFK.2|LNLEAINYM[Oxi]AADGDFK.3|LNLEAINYM[Oxi]AADGDFK.2|LPDGYEFKFPNRLNLEAINYMAADGDFK.4|LPDGYEFKFPNRLNLEAINYM[Oxi]AADGDFK.4|FPNRLNLEAINYMAADGDFK.3|FPNRLNLEAINYM[Oxi]AADGDFK.3|FPNRLNLEAINYMAADGDFK.2|LPDGYEFK.2|VRGEVAPDAK.2|DGGAWGTEQR.2|AC[CAM]GLVASNLNLKPGEC[CAM]LR.3
SEN / CTL,P25789,Proteasome subunit alpha type-4,PSMA4,2.34,1.65,7.95E-04,7.91E-05,4.10E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,intracellular membrane-bounded organelle,extracellular exosome",12,18,30,LLDEVFFSEK.2|YLLQYQEPIPC[CAM]EQLVTALC[CAM]DIK.3|HEEEEAKAER.3|EVEQLIK.2|QDYKEGEMTLK.3|VEIATLTR.2|LSAEKVEIATLTR.3|LSAEKVEIATLTR.2|QAYTQFGGK.2|TTIFSPEGR.2|ATC[CAM]IGNNSAAAVSMLK.3|ATC[CAM]IGNNSAAAVSMLK.2|ATC[CAM]IGNNSAAAVSM[Oxi]LK.2|HYGFQLYQSDPSGNYGGWK.4|HYGFQLYQSDPSGNYGGWK.3|HYGFQLYQSDPSGNYGGWK.2|RPFGVSLLYIGWDK.3|RPFGVSLLYIGWDK.2|ATC[CAM]IGNNSAAAVSMLKQDYK.3|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAERR.5|LYQVEYAM[Oxi]EAIGHAGTC[CAM]LGILANDGVLLAAERR.4|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAERR.4|ATC[CAM]IGNNSAAAVSMLKQDYKEGEMTLK.4|ATC[CAM]IGNNSAAAVSMLKQDYKEGEMTLK.3|LNEDMAC[CAM]SVAGITSDANVLTNELR.3|LNEDM[Oxi]AC[CAM]SVAGITSDANVLTNELR.3|LYQVEYAM[Oxi]EAIGHAGTC[CAM]LGILANDGVLLAAER.4|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAER.4|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAER.3|IYKLNEDMAC[CAM]SVAGITSDANVLTNELR.3
SEN / CTL,Q9UKY7,Protein CDV3 homolog,CDV3,2.34,1.58,1.24E-05,1.61E-06,5.79E+00,cell proliferation,molecular_function,"nucleolus,cytoplasm,plasma membrane",24,15,28,AASAAGAAGSAGGSSGAAGAAGGGAGAGTRPGDGGTASAGAAGPGAATK.4|AASAAGAAGSAGGSSGAAGAAGGGAGAGTRPGDGGTASAGAAGPGAATK.5|AASAAGAAGSAGGSSGAAGAAGGGAGAGTRPGDGGTASAGAAGPGAATK.6|KTPQGPPEIYSDTQFPSLQSTAK.3|TAPVQAPPAPVIVTETPEPAMTSGVYRPPGAR.4|TAPVQAPPAPVIVTETPEPAMTSGVYRPPGAR.5|TAPVQAPPAPVIVTETPEPAM[Oxi]TSGVYRPPGAR.4|TAPVQAPPAPVIVTETPEPAMTSGVYRPPGAR.3|AVTKDEDEWK.3|AVTKDEDEWK.2|AVTKDEDEWKELEQK.4|AVTKDEDEWKELEQK.3|SLDNFFAK.2|VQAMQISSEKEEDDNEKR.4|LQLDNQYAVLENQK.3|LQLDNQYAVLENQK.2|VQAMQISSEK.2|QDPGDNWEEGGGGGGGMEK.3|QDPGDNWEEGGGGGGGMEK.2|VQAMQISSEKEEDDNEK.3|VQAM[Oxi]QISSEKEEDDNEK.3|VQAMQISSEKEEDDNEK.2|RQDPGDNWEEGGGGGGGMEK.3|RQDPGDNWEEGGGGGGGMEK.2|AASAAGAAGSAGGSSGAAGAAGGGAGAGTR.3|PGDGGTASAGAAGPGAATK.2|TPQGPPEIYSDTQFPSLQSTAK.3|TPQGPPEIYSDTQFPSLQSTAK.2
SEN / CTL,P61981,14-3-3 protein gamma,YWHAG,2.34,1.29,2.52E-08,4.46E-09,8.35E+00,"G2/M transition of mitotic cell cycle,negative regulation of protein kinase activity,protein targeting,regulation of signal transduction,cellular response to insulin stimulus,regulation of neuron differentiation,regulation of synaptic plasticity,membrane organization,negative regulation of protein serine/threonine kinase activity,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein kinase C binding,insulin-like growth factor receptor binding,protein binding,protein kinase C inhibitor activity,protein domain specific binding,receptor tyrosine kinase binding,poly(A) RNA binding","mitochondrion,cytosol,focal adhesion,membrane,cytoplasmic vesicle membrane,myelin sheath,extracellular exosome",30,21,36,NVTELNEPLSNEER.2|NVTELNEPLSNEER.3|LGLALNYSVFYYEIQNAPEQAC[CAM]HLAK.3|LGLALNYSVFYYEIQNAPEQAC[CAM]HLAK.4|LGLALNYSVFYYEIQNAPEQAC[CAM]HLAK.5|NVTELNEPLSNEERNLLSVAYK.3|YLAEVATGEK.2|YLAEVATGEK.1|YLAEVATGEKR.3|YLAEVATGEKR.2|EHM[Oxi]QPTHPIR.3|EHMQPTHPIR.3|EHMQPTHPIR.2|EHM[Oxi]QPTHPIR.2|ATVVESSEK.2|AYSEAHEISKEHM[Oxi]QPTHPIR.5|AYSEAHEISKEHMQPTHPIR.5|AYSEAHEISKEHMQPTHPIR.4|TSADGNEKKIEMVR.3|TSADGNEKKIEMVR.2|RATVVESSEK.2|AYSEAHEISK.2|VISSIEQKTSADGNEK.3|VISSIEQKTSADGNEK.2|MVDREQLVQK.2|NC[CAM]SETQYESK.2|ATVVESSEKAYSEAHEISKEHMQPTHPIR.5|ARLAEQAERYDDMAAAMK.3|TAFDDAIAELDTLNEDSYK.3|TAFDDAIAELDTLNEDSYK.2|DNLTLWTSDQQDDDGGEGNN.3|ELEAVC[CAM]QDVLSLLDNYLIK.3|ELEAVC[CAM]QDVLSLLDNYLIK.2|NVTELNEPLSNEERNLLSVAYKNVVGAR.4|TAFDDAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.4|TAFDDAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.3
SEN / CTL,P49589,"Cysteine--tRNA ligase, cytoplasmic",CARS,2.33,1.48,2.67E-05,3.31E-06,5.48E+00,"tRNA aminoacylation for protein translation,cysteinyl-tRNA aminoacylation","tRNA binding,cysteine-tRNA ligase activity,protein binding,ATP binding,protein homodimerization activity,metal ion binding","cytoplasm,cytosol",12,42,56,VSEYVPEIVNFVQK.2|VSEYVPEIVNFVQK.3|IQHAVQLATEPLEK.3|IQHAVQLATEPLEK.2|YFLHTGHLTIAGC[CAM]K.4|YFLHTGHLTIAGC[CAM]K.3|YFLHTGHLTIAGC[CAM]K.2|QNHLFEQYR.3|QNHLFEQYR.2|RSPNDFALWK.3|RSPNDFALWK.2|FEDHEGLPTVVK.3|EKRPEAAQLLEDVQAALKPFSVK.5|EKRPEAAQLLEDVQAALKPFSVK.4|LNETTDPDK.2|ALC[CAM]DNVDTR.2|FDENGLPTHDMEGK.3|LVPEAVGDQK.2|SPNDFALWK.2|RPNQALLENIALYLTHMLK.4|RPNQALLENIALYLTHMLK.3|SYISFDILR.2|ASKPGEPSWPC[CAM]PWGK.3|DNILPELGVR.2|LAFLMHSWK.2|DILRAPVDITGQFEK.3|VQPQWSPPAGTQPC[CAM]R.3|VQPQWSPPAGTQPC[CAM]R.2|LNETTDPDKK.2|RPEAAQLLEDVQAALKPFSVK.4|RPEAAQLLEDVQAALKPFSVK.3|RPEAAQLLEDVQAALK.3|RPEAAQLLEDVQAALK.2|KRPNQALLENIALYLTHMLK.4|VTWYC[CAM]C[CAM]GPTVYDASHMGHAR.4|APVDITGQFEK.2|WGEEEAELNK.2|VPEILQLSDALRDNILPELGVR.4|VPEILQLSDALRDNILPELGVR.3|IPPSEMFLSETDKYSK.3|FLNEFFLNVK.2|ALQEGEGDLSISADRLSEK.3|LTGEEVNSC[CAM]VEVLLEEAK.3|LTGEEVNSC[CAM]VEVLLEEAK.2|VPEILQLSDALR.2|FPHHDNELAQSEAYFENDC[CAM]WVR.4|EQKVPEILQLSDALRDNILPELGVR.4|EQKVPEILQLSDALRDNILPELGVR.3|ALVSQC[CAM]NLYMAAR.2|IPPSEMFLSETDK.2|ALQEGEGDLSISADR.2|LAFLMHSWKDTLDYSSNTMESALQYEK.4|DMEALNVLPPDVLTR.2|DLLSDWLDSTLGC[CAM]DVTDNSIFSK.3|DTLDYSSNTMESALQYEK.2|IVDNGYGYVSNGSVYFDTAK.2
SEN / CTL,P42025;P61163,Beta-centractin;Alpha-centractin,ACTR1B;ACTR1A,2.31,0.51,1.02E-04,1.15E-05,4.94E+00,"antigen processing and presentation of exogenous peptide antigen via MHC class II;G2/M transition of mitotic cell cycle,vesicle-mediated transport,antigen processing and presentation of exogenous peptide antigen via MHC class II",ATP binding;ATP binding,"cytoplasm,centrosome,cytosol,dynactin complex,microtubule cytoskeleton,membrane,extracellular exosome,microtubule end;cytoplasm,centrosome,cytosol,dynactin complex,microtubule associated complex,microtubule cytoskeleton,myelin sheath,extracellular exosome,microtubule end",6,1,5,TTGVVLDSGDGVTHAVPIYEGFAMPHSIMR.4|TTGVVLDSGDGVTHAVPIYEGFAMPHSIMR.5|TTGVVLDSGDGVTHAVPIYEGFAM[Oxi]PHSIMR.4|TTGVVLDSGDGVTHAVPIYEGFAMPHSIM[Oxi]R.4|TTGVVLDSGDGVTHAVPIYEGFAMPHSIMR.3
SEN / CTL,P60842,Eukaryotic initiation factor 4A-I,EIF4A1,2.31,1.88,4.44E-22,3.00E-22,2.15E+01,"nuclear-transcribed mRNA poly(A) tail shortening,translational initiation,regulation of translational initiation,regulation of gene expression,RNA secondary structure unwinding,viral process","RNA cap binding,double-stranded RNA binding,mRNA binding,translation initiation factor activity,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,translation factor activity, RNA binding,poly(A) RNA binding","cytoplasm,cytosol,membrane,eukaryotic translation initiation factor 4F complex,extracellular matrix,extracellular exosome,nucleus",84,39,86,VLITTDLLAR.2|GIYAYGFEKPSAIQQR.3|GIYAYGFEKPSAIQQR.2|GIDVQQVSLVINYDLPTNRENYIHR.4|GIDVQQVSLVINYDLPTNRENYIHR.3|AEVQKLQMEAPHIIVGTPGR.4|TLRDIETFYNTSIEEMPLNVADLI.3|MFVLDEADEMLSR.2|MFVLDEADEMLSR.3|M[Oxi]FVLDEADEMLSR.3|MFVLDEADEM[Oxi]LSR.3|M[Oxi]FVLDEADEMLSR.2|MFVLDEADEM[Oxi]LSR.2|M[Oxi]FVLDEADEM[Oxi]LSR.2|KGVAINMVTEEDKR.3|KGVAINM[Oxi]VTEEDKR.4|KGVAINM[Oxi]VTEEDKR.3|KGVAINMVTEEDKR.2|GVAINMVTEEDKR.3|GVAINMVTEEDKR.2|GVAINM[Oxi]VTEEDKR.3|GVAINM[Oxi]VTEEDKR.2|GFKDQIYDIFQK.3|GFKDQIYDIFQK.2|LQMEAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.2|LQMEAPHIIVGTPGR.2|GYDVIAQAQSGTGK.2|GYDVIAQAQSGTGK.3|PSAIQQR.2|AILPC[CAM]IK.2|ILVKKEELTLEGIR.4|ILVKKEELTLEGIR.3|ILVKKEELTLEGIR.2|VDWLTEK.2|VFDMLNR.2|VFDM[Oxi]LNR.2|DFTVSAMHGDMDQKER.4|DFTVSAMHGDMDQKER.3|ELAQQIQK.2|KVDWLTEK.2|GIYAYGFEK.2|DFTVSAMHGDMDQK.3|DFTVSAM[Oxi]HGDM[Oxi]DQK.3|DFTVSAM[Oxi]HGDMDQK.3|DFTVSAMHGDM[Oxi]DQK.3|DFTVSAMHGDMDQK.2|DFTVSAM[Oxi]HGDMDQK.2|DFTVSAMHGDM[Oxi]DQK.2|EELTLEGIR.2|QFYINVER.2|QFYINVEREEWK.3|QFYINVEREEWK.2|ATQALVLAPTR.2|DQIYDIFQK.2|RKVDWLTEK.2|KEELTLEGIR.2|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|TATFAISILQQIELDLK.3|TATFAISILQQIELDLK.2|GVAINMVTEEDK.2|GVAINM[Oxi]VTEEDK.2|LNSNTQVVLLSATMPSDVLEVTKK.4|LNSNTQVVLLSATMPSDVLEVTKK.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTKK.3|ATQALVLAPTRELAQQIQK.3|GIDVQQVSLVINYDLPTNR.3|GIDVQQVSLVINYDLPTNR.2|KGVAINMVTEEDK.2|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVRAEVQK.4|DIETFYNTSIEEM[Oxi]PLNVADLI.3|DIETFYNTSIEEMPLNVADLI.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTK.3|LNSNTQVVLLSATMPSDVLEVTK.3|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.5|SRDNGPDGM[Oxi]EPEGVIESNWNEIVDSFDDMNLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDM[Oxi]NLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.4
SEN / CTL,P15311,Ezrin,EZR,2.31,1.85,2.78E-13,8.63E-14,1.31E+01,"negative regulation of transcription from RNA polymerase II promoter,intestinal D-glucose absorption,sphingosine-1-phosphate signaling pathway,cytoskeletal anchoring at plasma membrane,leukocyte cell-cell adhesion,axon guidance,regulation of cell shape,positive regulation of gene expression,protein kinase A signaling,membrane to membrane docking,microvillus assembly,astral microtubule organization,actin cytoskeleton reorganization,receptor internalization,regulation of microvillus length,cellular protein complex localization,positive regulation of multicellular organism growth,cortical microtubule organization,filopodium assembly,phosphatidylinositol-mediated signaling,positive regulation of protein secretion,negative regulation of T cell receptor signaling pathway,actin filament bundle assembly,establishment of centrosome localization,establishment of endothelial barrier,negative regulation of ERK1 and ERK2 cascade,cellular response to cAMP,protein localization to cell cortex,establishment of protein localization to plasma membrane,positive regulation of establishment of protein localization to plasma membrane,negative regulation of interleukin-2 secretion,regulation of organelle assembly,terminal web assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,negative regulation of p38MAPK cascade,positive regulation of early endosome to late endosome transport,regulation of cell size,gland morphogenesis,regulation of actin cytoskeleton organization,establishment of epithelial cell apical/basal polarity,regulation of NIK/NF-kappaB signaling","actin binding,protein binding,microtubule binding,protein domain specific binding,protein kinase A catalytic subunit binding,protein kinase A regulatory subunit binding,S100 protein binding,poly(A) RNA binding,cell adhesion molecule binding,actin filament binding,ATPase binding,cadherin binding involved in cell-cell adhesion","ruffle,immunological synapse,uropod,extracellular space,nucleolus,cytoplasm,endosome,cytosol,actin filament,plasma membrane,microvillus,brush border,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,T-tubule,cortical cytoskeleton,microvillus membrane,vesicle,ruffle membrane,ciliary basal body,cell projection,myelin sheath,cell body,microspike,plasma membrane raft,apical part of cell,perinuclear region of cytoplasm,cell tip,extracellular exosome,cell periphery,astrocyte projection,Schwann cell microvillus,cytoplasmic side of apical plasma membrane,TCR signalosome",60,50,90,QRIDEFEAL.2|QLLTLSSELSQARDENKR.4|QAVDQIKSQEQLAAELAEYTAK.3|QAVDQIKSQEQLAAELAEYTAK.4|GMLKDNAMLEYLK.3|GMLKDNAMLEYLK.2|SQEQLAAELAEYTAK.2|SQEQLAAELAEYTAK.3|AKFYPEDVAEELIQDITQK.3|AKFYPEDVAEELIQDITQK.4|AKFYPEDVAEELIQDITQK.2|QQLETEK.2|QLLTLSSELSQAR.2|QLLTLSSELSQAR.3|GTDLWLGVDALGLNIYEKDDKLTPK.4|GTDLWLGVDALGLNIYEKDDKLTPK.3|LTRDQWEDR.3|QAVDQIK.2|AKEELERQAVDQIK.4|AKEELERQAVDQIK.3|RKEDEVEEWQHR.4|RKEDEVEEWQHR.3|RTHNDIIHNENMR.4|RTHNDIIHNENM[Oxi]R.4|RTHNDIIHNENMR.3|RTHNDIIHNENM[Oxi]R.3|RTHNDIIHNENMR.2|RITEAEKNER.3|RITEAEKNER.2|ALQLEEERKR.3|SGYLSSER.2|AERELSEQIQR.3|AERELSEQIQR.2|EDEVEEWQHR.3|EDEVEEWQHR.2|IALLEEAR.2|KVSAQEVR.2|LQDYEEK.2|AQEEAERLEADR.3|AQEEAERLEADR.2|RILQLC[CAM]MGNHELYMR.4|RILQLC[CAM]M[Oxi]GNHELYMR.4|RILQLC[CAM]MGNHELYMR.3|RILQLC[CAM]M[Oxi]GNHELYMR.3|RILQLC[CAM]MGNHELYM[Oxi]R.3|AQEEAERLEADRMAALR.4|ALQLEEER.2|KAERELSEQIQR.3|KEDEVEEWQHR.3|KEDEVEEWQHR.2|DQWEDRIQVWHAEHR.4|DQWEDRIQVWHAEHR.3|ELSEQIQR.2|SGYLSSERLIPQR.3|THNDIIHNENMR.3|THNDIIHNENM[Oxi]R.3|THNDIIHNENM[Oxi]R.2|THNDIIHNENMR.2|RAQEEAERLEADR.3|IALLEEARR.2|ITEAEKNER.2|DNAMLEYLK.2|DNAM[Oxi]LEYLK.2|AKEAQDDLVK.2|ALQLEEERK.2|EVWYFGLHYVDNK.3|EVWYFGLHYVDNK.2|ILQLC[CAM]MGNHELYMR.3|ILQLC[CAM]M[Oxi]GNHELYMR.3|ILQLC[CAM]MGNHELYM[Oxi]R.3|ILQLC[CAM]M[Oxi]GNHELYMR.2|ILQLC[CAM]MGNHELYMR.2|IQVWHAEHR.2|FGDYNKEVHK.2|QLLTLSSELSQARDENK.3|IAQDLEMYGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.2|IAQDLEMYGINYFEIK.2|GTDLWLGVDALGLNIYEK.3|GTDLWLGVDALGLNIYEK.2|FYPEDVAEELIQDITQK.3|FYPEDVAEELIQDITQK.2|KGTDLWLGVDALGLNIYEK.3|KGTDLWLGVDALGLNIYEK.2|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.4|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.3|GTDLWLGVDALGLNIYEKDDK.3|GTDLWLGVDALGLNIYEKDDK.2|KGTDLWLGVDALGLNIYEKDDK.3
SEN / CTL,Q3ZCM7,Tubulin beta-8 chain,TUBB8,2.31,1.26,6.70E-12,1.78E-12,1.17E+01,"oocyte maturation,spindle assembly involved in female meiosis,biological_process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule,extracellular exosome,meiotic spindle",30,4,13,LPTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.3|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.6|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3|ALTVAELTQQM[Oxi]FDAK.3
SEN / CTL,P61978,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,2.31,2.14,2.10E-13,6.62E-14,1.32E+01,"mRNA splicing, via spliceosome,transcription from RNA polymerase II promoter,RNA processing,signal transduction,gene expression,regulation of low-density lipoprotein particle clearance,viral process,protein sumoylation,negative regulation of apoptotic process,positive regulation of low-density lipoprotein particle receptor biosynthetic process,positive regulation of transcription from RNA polymerase II promoter,negative regulation of mRNA splicing, via spliceosome,positive regulation of receptor-mediated endocytosis,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,cell-cell adhesion,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator","RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,single-stranded DNA binding,RNA binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nuclear chromatin,podosome,nucleus,nucleoplasm,cytoplasm,cell-cell adherens junction,focal adhesion,membrane,extracellular matrix,cell projection,extracellular exosome,catalytic step 2 spliceosome",84,41,76,ALRTDYNASVSVPDSSGPER.3|ALRTDYNASVSVPDSSGPER.4|ALRTDYNASVSVPDSSGPER.2|TDYNASVSVPDSSGPER.2|TDYNASVSVPDSSGPER.3|TDYNASVSVPDSSGPER.4|LLIHQSLAGGIIGVK.3|LLIHQSLAGGIIGVK.2|HESGASIKIDEPLEGSEDRIITITGTQDQIQNAQYLLQNSVK.5|HESGASIKIDEPLEGSEDRIITITGTQDQIQNAQYLLQNSVK.4|IILDLISESPIKGR.3|IILDLISESPIK.2|IILDLISESPIK.3|NTDEMVELR.2|NTDEM[Oxi]VELR.2|GSYGDLGGPIITTQVTIPK.2|GSYGDLGGPIITTQVTIPK.3|GSYGDLGGPIITTQVTIPK.4|IITITGTQDQIQNAQYLLQNSVK.3|IITITGTQDQIQNAQYLLQNSVK.4|ILSISADIETIGEILKK.3|ILSISADIETIGEILKK.2|HESGASIK.2|QIRHESGASIK.3|QIRHESGASIK.2|RPAEDMEEEQAFKR.4|RPAEDM[Oxi]EEEQAFKR.4|RPAEDMEEEQAFKR.3|RPAEDM[Oxi]EEEQAFKR.3|DLAGSIIGK.2|ELRENTQTTIK.3|ELRENTQTTIK.2|SRNTDEMVELR.3|SRNTDEM[Oxi]VELR.3|SRNTDEMVELR.2|DYDDMSPR.2|DYDDM[Oxi]SPR.2|GGDLMAYDR.2|GGDLM[Oxi]AYDR.2|LFQEC[CAM]C[CAM]PHSTDR.3|LFQEC[CAM]C[CAM]PHSTDR.2|LFQEC[CAM]C[CAM]PHSTDRVVLIGGKPDR.5|LFQEC[CAM]C[CAM]PHSTDRVVLIGGKPDR.4|LFQEC[CAM]C[CAM]PHSTDRVVLIGGKPDR.3|HESGASIKIDEPLEGSEDR.4|HESGASIKIDEPLEGSEDR.3|HESGASIKIDEPLEGSEDR.2|PAEDMEEEQAFKR.3|RPAEDM[Oxi]EEEQAFK.3|RPAEDMEEEQAFK.3|RPAEDMEEEQAFK.2|RPAEDM[Oxi]EEEQAFK.2|VVLIGGKPDR.2|GSDFDC[CAM]ELR.2|ILSISADIETIGEILK.3|ILSISADIETIGEILK.2|VVEC[CAM]IKIILDLISESPIKGR.4|GGDLMAYDRR.2|RDYDDMSPR.2|VVLIGGKPDRVVEC[CAM]IK.3|NLPLPPPPPPR.2|QIRHESGASIKIDEPLEGSEDR.4|IDEPLEGSEDR.2|IIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.6|IIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.5|IIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.4|VVEC[CAM]IKIILDLISESPIK.3|KIIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.6|KIIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.5|KIIPTLEEGLQLPSPTATSQLPLESDAVEC[CAM]LNYQHYK.4|PAEDMEEEQAFK.2|NAGAVIGK.1|IDEPLEGSEDRIITITGTQDQIQNAQYLLQNSVK.5|IDEPLEGSEDRIITITGTQDQIQNAQYLLQNSVK.4|GRAQPYDPNFYDETYDYGGFTMMFDDRR.4|AQPYDPNFYDETYDYGGFTMMFDDRR.3
SEN / CTL,P35611,Alpha-adducin,ADD1,2.31,1.67,8.04E-03,7.01E-04,3.15E+00,"cell morphogenesis,in utero embryonic development,cell volume homeostasis,hemoglobin metabolic process,actin cytoskeleton organization,erythrocyte differentiation,positive regulation of protein binding,multicellular organism growth,IRE1-mediated unfolded protein response,homeostasis of number of cells within a tissue,barbed-end actin filament capping,actin filament bundle assembly,transmembrane transport,cell-cell adhesion","actin binding,structural molecule activity,calmodulin binding,transcription factor binding,spectrin binding,protein homodimerization activity,poly(A) RNA binding,protein heterodimerization activity,actin filament binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,F-actin capping protein complex",6,36,50,SLVQGELVTASK.2|NMAPDLR.2|IREQNLQDIK.3|IREQNLQDIK.2|AAVVTSPPPTTAPHKER.4|AAVVTSPPPTTAPHKER.3|C[CAM]VVHIHTPAGAAVSAMK.4|C[CAM]VVHIHTPAGAAVSAMK.3|TGYPYRYPALR.3|AAVVTSPPPTTAPHK.3|AAVVTSPPPTTAPHK.2|MLDNLGYR.2|M[Oxi]LDNLGYR.2|ERYFDRVDENNPEYLR.4|LADLFGWSQLIYNHITTR.4|LADLFGWSQLIYNHITTR.3|LADLFGWSQLIYNHITTR.2|SRSPGSPVGEGTGSPPK.3|GSEENLDEAR.2|INLQGDIVDR.2|QDFNMMEQK.2|YFDRVDENNPEYLR.3|SPPDQPAVPHPPPSTPIK.3|EDGHRTSTSAVPNLFVPLNTNPK.4|VDENNPEYLR.2|GSDSIAYDKGEK.2|TSTSAVPNLFVPLNTNPK.3|TSTSAVPNLFVPLNTNPK.2|GSTNLGVNQAGFTLHSAIYAARPDVK.4|GSTNLGVNQAGFTLHSAIYAARPDVK.3|SPGSPVGEGTGSPPK.2|EYQPHVIVSTTGPNPFTTLTDRELEEYRR.5|EYQPHVIVSTTGPNPFTTLTDRELEEYRR.4|TLASAGGPDNLVLLNPEKYK.3|VSMILQSPAFC[CAM]EELESMIQEQFKK.4|VSMILQSPAFC[CAM]EELESMIQEQFKK.3|VNSEQEHFLIVPFGLLYSEVTASSLVK.4|VNSEQEHFLIVPFGLLYSEVTASSLVK.3|RVSM[Oxi]ILQSPAFC[CAM]EELESMIQEQFKK.4|RVSMILQSPAFC[CAM]EELESMIQEQFKK.4|RVSMILQSPAFC[CAM]EELESMIQEQFKK.3|SRSPGSPVGEGTGSPPKWQIGEQEFEALMR.4|WQIGEQEFEALMR.2|EYQPHVIVSTTGPNPFTTLTDR.3|C[CAM]GLLPISPEALSLGEVAYHDYHGILVDEEEK.4|NHGLVSVGESVEEAFYYIHNLVVAC[CAM]EIQVR.4|TAGPQSQVLC[CAM]GVVMDR.2|TLASAGGPDNLVLLNPEK.2|YSDVEVPASVTGYSFASDGDSGTC[CAM]SPLR.3|KYSDVEVPASVTGYSFASDGDSGTC[CAM]SPLR.3
SEN / CTL,Q05682,Caldesmon,CALD1,2.30,1.92,7.11E-11,1.69E-11,1.08E+01,"movement of cell or subcellular component,muscle contraction,cell-cell adhesion","actin binding,calmodulin binding,tropomyosin binding,myosin binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,actin cytoskeleton,myofibril,actin cap",72,61,87,QKEFDPTITDASLSLPSRR.4|QKEFDPTITDASLSLPSR.3|SAKPTKPAASDLPVPAEGVR.4|SAKPTKPAASDLPVPAEGVR.3|IDSRLEQYTSAIEGTK.3|IDSRLEQYTSAIEGTK.2|EFDPTITDASLSLPSRR.3|YEIEETETVTK.2|QERYEIEETETVTK.3|QERYEIEETETVTK.2|QKQEEESLGQVTDQVEVNAQNSVPDEEAK.4|QKQEEESLGQVTDQVEVNAQNSVPDEEAK.3|LEQYTSAIEGTK.2|GNVFSSPTAAGTPNKETAGLK.3|LKHTENTFSRPGGR.4|MPEDGLSDDKKPFK.4|MPEDGLSDDKKPFK.3|M[Oxi]PEDGLSDDKKPFK.3|PSDLRPGDVSSK.3|PSDLRPGDVSSK.2|LQEALER.2|SPAPKPSDLRPGDVSSK.4|SPAPKPSDLRPGDVSSK.3|REEMRLEAER.3|RKVLEEEEQR.3|EAEGAPQVEAGKR.3|EAEGAPQVEAGKR.2|QKQQEAALELEELKK.4|QKQQEAALELEELKK.3|RGETESEEFEK.3|RGETESEEFEK.2|HTENTFSRPGGR.3|HTENTFSRPGGR.2|INEWLTK.2|EKEEEEEEKPK.3|QQEAALELEELK.3|QQEAALELEELK.2|TPDGNKSPAPKPSDLRPGDVSSK.5|TPDGNKSPAPKPSDLRPGDVSSK.4|SPAPKPSDLRPGDVSSKR.4|GNVFSSPTAAGTPNK.3|GNVFSSPTAAGTPNK.2|NDDDEEEAARER.3|ASVDTKEAEGAPQVEAGKR.4|ASVDTKEAEGAPQVEAGKR.3|RRGETESEEFEK.3|TPDGNKSPAPKPSDLRPGDVSSKR.5|GSSLKIEER.2|QQEAALELEELKK.3|QQEAALELEELKK.2|RLQEALER.2|RMQNDTAENETTEKEEK.4|RMQNDTAENETTEKEEK.3|VLEEEEQR.2|IAYQRNDDDEEEAARER.4|STHQAAIVSK.2|RGETESEEFEKLK.3|LQEDKPTFK.2|MPEDGLSDDK.2|M[Oxi]PEDGLSDDK.2|RMQNDTAENETTEK.3|PTKPAASDLPVPAEGVR.3|PTKPAASDLPVPAEGVR.2|KVLEEEEQR.2|EFDPTITDASLSLPSR.3|EFDPTITDASLSLPSR.2|NDDDEEEAAR.2|EAEGAPQVEAGK.2|GETESEEFEK.2|MQNDTAENETTEKEEKSESR.4|SQNGEFMTHK.2|ASVDTKEAEGAPQVEAGK.3|IAYQRNDDDEEEAAR.3|RGSIGENQVEVM[Oxi]VEEK.3|RGSIGENQVEVMVEEK.3|M[Oxi]QNDTAENETTEKEEK.3|MQNDTAENETTEKEEK.3|MQNDTAENETTEKEEK.2|QSVDKVTSPTKV.2|PAASDLPVPAEGVR.2|TTTTNTQVEGDDEAAFLER.3|TTTTNTQVEGDDEAAFLER.2|MQNDTAENETTEK.2|M[Oxi]QNDTAENETTEK.2|NGQISSEEPKQEEEREQGSDEISHHEK.4|TTESQEETVVMSLK.2|QEEESLGQVTDQVEVNAQNSVPDEEAK.3
SEN / CTL,Q15121,Astrocytic phosphoprotein PEA-15,PEA15,2.30,0.87,2.56E-06,3.62E-07,6.44E+00,"DNA damage checkpoint,MAPK cascade,activation of MAPK activity,transport,apoptotic process,carbohydrate transport,response to morphine,negative regulation of glucose import,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors",protein binding,"cytosol,microtubule associated complex",12,11,16,RPDLLTMVVDYR.3|RPDLLTMVVDYR.2|SAC[CAM]KEDIPSEK.3|SAC[CAM]KEDIPSEK.2|VLKISEEDELDTK.3|QPSEEEIIK.2|DNLSYIEHIFEISR.3|DNLSYIEHIFEISR.2|ISEEDELDTK.2|SEEITTGSAWFSFLESHNKLDK.4|LDKDNLSYIEHIFEISR.3|SEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISR.6|SEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISR.5|SEEITTGSAWFSFLESHNK.3|SEEITTGSAWFSFLESHNK.2|DIIRQPSEEEIIK.2
SEN / CTL,P27348,14-3-3 protein theta,YWHAQ,2.30,1.98,1.40E-10,3.17E-11,1.05E+01,"protein targeting,small GTPase mediated signal transduction,substantia nigra development,negative regulation of ion transmembrane transport,negative regulation of transcription, DNA-templated,membrane organization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein binding,protein C-terminus binding,protein domain specific binding,ion channel binding,protein N-terminus binding,14-3-3 protein binding","cytoplasm,mitochondrion,cytosol,focal adhesion,membrane,cytoplasmic vesicle membrane,protein complex,extracellular exosome",66,23,46,SIC[CAM]TTVLELLDKYLIANATNPESK.3|SIC[CAM]TTVLELLDKYLIANATNPESK.4|AVTEQGAELSNEERNLLSVAYK.3|AVTEQGAELSNEERNLLSVAYKNVVGGR.4|AKLAEQAERYDDMATC[CAM]MK.4|AKLAEQAERYDDMATC[CAM]MK.3|LAEQAERYDDMATC[CAM]MK.3|LAEQAERYDDMATC[CAM]MK.2|LAEQAERYDDM[Oxi]ATC[CAM]MK.3|LAEQAERYDDMATC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]ATC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]ATC[CAM]MK.2|LAEQAERYDDMATC[CAM]M[Oxi]K.2|YLAEVAC[CAM]GDDR.2|AVTEQGAELSNEER.2|AVTEQGAELSNEER.3|QTIDNSQGAYQEAFDISKK.3|QTIDNSQGAYQEAFDISKK.4|QTIDNSQGAYQEAFDISKK.2|YLIANATNPESK.3|YLIANATNPESK.2|SIC[CAM]TTVLELLDK.3|SIC[CAM]TTVLELLDK.2|YLAEVAC[CAM]GDDRK.3|YLAEVAC[CAM]GDDRK.2|VISSIEQKTDTSDKK.3|YDDMATC[CAM]MK.2|YDDM[Oxi]ATC[CAM]MK.2|YDDMATC[CAM]M[Oxi]K.2|YDDM[Oxi]ATC[CAM]M[Oxi]K.2|KQTIDNSQGAYQEAFDISKK.4|KQTIDNSQGAYQEAFDISKK.3|KQTIDNSQGAYQEAFDISKK.2|KLQLIKDYR.2|QTIDNSQGAYQEAFDISK.3|QTIDNSQGAYQEAFDISK.2|DYREKVESELR.2|KQTIDNSQGAYQEAFDISK.3|KQTIDNSQGAYQEAFDISK.2|TAFDEAIAELDTLNEDSYK.3|TAFDEAIAELDTLNEDSYK.2|NLLSVAYKNVVGGR.2|DNLTLWTSDSAGEEC[CAM]DAAEGAEN.3|TAFDEAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.4|TAFDEAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.3|YLAEVAC[CAM]GDDRKQTIDNSQGAYQEAFDISK.4
SEN / CTL,P63104,14-3-3 protein zeta/delta,YWHAZ,2.29,2.08,4.12E-14,1.36E-14,1.39E+01,"protein targeting,signal transduction,platelet activation,negative regulation of apoptotic process,regulation of mRNA stability,establishment of Golgi localization,membrane organization,Golgi reassembly,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein binding,transcription factor binding,protein kinase binding,protein domain specific binding,ubiquitin protein ligase binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,cytoplasmic vesicle membrane,melanosome,extracellular exosome,blood microparticle",120,22,53,SVTEQGAELSNEERNLLSVAYK.3|SVTEQGAELSNEERNLLSVAYKNVVGAR.4|SVTEQGAELSNEERNLLSVAYKNVVGAR.3|SVTEQGAELSNEER.2|SVTEQGAELSNEER.3|AKLAEQAERYDDMAAC[CAM]MK.4|AKLAEQAERYDDMAAC[CAM]MK.3|AKLAEQAERYDDM[Oxi]AAC[CAM]MK.3|AKLAEQAERYDDMAAC[CAM]M[Oxi]K.3|LAEQAERYDDMAAC[CAM]MK.3|LAEQAERYDDMAAC[CAM]MK.2|LAEQAERYDDM[Oxi]AAC[CAM]MK.3|LAEQAERYDDMAAC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]AAC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]AAC[CAM]MK.2|LAEQAERYDDMAAC[CAM]M[Oxi]K.2|IETELRDIC[CAM]NDVLSLLEK.3|IETELRDIC[CAM]NDVLSLLEK.2|IETELRDIC[CAM]NDVLSLLEK.4|GIVDQSQQAYQEAFEISKK.3|GIVDQSQQAYQEAFEISKK.2|GIVDQSQQAYQEAFEISKK.4|FLIPNASQAESK.2|FLIPNASQAESK.3|DIC[CAM]NDVLSLLEK.2|DIC[CAM]NDVLSLLEK.3|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.4|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.3|EKIETELRDIC[CAM]NDVLSLLEK.4|EKIETELRDIC[CAM]NDVLSLLEK.3|GIVDQSQQAYQEAFEISK.3|GIVDQSQQAYQEAFEISK.2|VVSSIEQK.2|TAFDEAIAELDTLSEESYK.3|TAFDEAIAELDTLSEESYK.2|VVSSIEQKTEGAEKK.4|VVSSIEQKTEGAEKK.3|VVSSIEQKTEGAEKK.2|YLAEVAAGDDKK.3|YLAEVAAGDDKK.2|VVSSIEQKTEGAEK.3|VVSSIEQKTEGAEK.2|KGIVDQSQQAYQEAFEISK.4|KGIVDQSQQAYQEAFEISK.3|KGIVDQSQQAYQEAFEISK.2|YDDMAAC[CAM]MK.2|YDDM[Oxi]AAC[CAM]MK.2|YDDMAAC[CAM]M[Oxi]K.2|YDDM[Oxi]AAC[CAM]M[Oxi]K.2|KGIVDQSQQAYQEAFEISKK.4|KGIVDQSQQAYQEAFEISKK.3|YLAEVAAGDDK.2|DNLTLWTSDTQGDEAEAGEGGEN.3
SEN / CTL,P04179,"Superoxide dismutase [Mn], mitochondrial",SOD2,2.29,1.28,2.73E-04,2.89E-05,4.54E+00,"response to reactive oxygen species,response to superoxide,age-dependent response to reactive oxygen species,release of cytochrome c from mitochondria,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,regulation of transcription from RNA polymerase II promoter,superoxide metabolic process,regulation of blood pressure,negative regulation of cell proliferation,removal of superoxide radicals,oxygen homeostasis,negative regulation of neuron apoptotic process,protein homotetramerization,oxidation-reduction process,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","superoxide dismutase activity,manganese ion binding","mitochondrion,mitochondrial matrix,extracellular exosome",12,23,42,AIWNVINWENVTER.2|AIWNVINWENVTER.3|DFGSFDK.2|YQEALAK.2|GELLEAIK.2|HHAAYVNNLNVTEEK.4|HHAAYVNNLNVTEEK.3|HHAAYVNNLNVTEEK.2|GDVTAQIALQPALK.3|GDVTAQIALQPALK.2|RDFGSFDK.2|NVRPDYLK.2|HHAAYVNNLNVTEEKYQEALAK.5|HHAAYVNNLNVTEEKYQEALAK.4|HHAAYVNNLNVTEEKYQEALAK.3|GELLEAIKR.2|HSLPDLPYDYGALEPHINAQIMQLHHSK.6|HSLPDLPYDYGALEPHINAQIM[Oxi]QLHHSK.6|HSLPDLPYDYGALEPHINAQIMQLHHSK.5|HSLPDLPYDYGALEPHINAQIMQLHHSK.4|HSLPDLPYDYGALEPHINAQIMQLHHSK.3|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.6|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.5|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.4|AIWNVINWENVTERYM[Oxi]AC[CAM]KK.4|FNGGGHINHSIFWTNLSPNGGGEPK.4|FNGGGHINHSIFWTNLSPNGGGEPK.3|DFGSFDKFKEK.2|LTAASVGVQGSGWGWLGFNK.3|LTAASVGVQGSGWGWLGFNK.2|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIK.5|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIK.4|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.6|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.5|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.4|YQEALAKGDVTAQIALQPALK.3|EKLTAASVGVQGSGWGWLGFNK.3|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.6|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.5|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.4|LTAASVGVQGSGWGWLGFNKER.3|HHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALK.5
SEN / CTL,P04217,Alpha-1B-glycoprotein,A1BG,2.29,2.07,7.19E-02,5.72E-03,2.24E+00,"platelet degranulation,biological_process",molecular_function,"extracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle",6,21,40,GVTFLLR.2|RGEKELLVPR.3|LELHVDGPPPR.3|LELHVDGPPPRPQLR.4|LELHVDGPPPRPQLR.3|LLELTGPK.2|HQFLLTGDTQGR.3|HQFLLTGDTQGR.2|VTLTC[CAM]VAPLSGVDFQLR.4|VTLTC[CAM]VAPLSGVDFQLR.3|VTLTC[CAM]VAPLSGVDFQLR.2|C[CAM]LAPLEGAR.2|IFFHLNAVALGDGGHYTC[CAM]R.4|IFFHLNAVALGDGGHYTC[CAM]R.3|ATWSGAVLAGR.2|ATWSGAVLAGRDAVLR.3|C[CAM]EGPIPDVTFELLR.3|C[CAM]EGPIPDVTFELLR.2|NGVAQEPVHLDSPAIK.3|NGVAQEPVHLDSPAIK.2|TPGAAANLELIFVGPQHAGNYR.4|TPGAAANLELIFVGPQHAGNYR.3|TPGAAANLELIFVGPQHAGNYR.2|SSTSPDRIFFHLNAVALGDGGHYTC[CAM]R.5|SSTSPDRIFFHLNAVALGDGGHYTC[CAM]R.4|NGVAQEPVHLDSPAIKHQFLLTGDTQGR.5|NGVAQEPVHLDSPAIKHQFLLTGDTQGR.4|SGLSTGWTQLSK.2|SLPAPWLSM[Oxi]APVSWITPGLK.3|SLPAPWLSMAPVSWITPGLK.3|SLPAPWLSM[Oxi]APVSWITPGLK.2|SLPAPWLSMAPVSWITPGLK.2|TDGEGALSEPSATVTIEELAAPPPPVLM[Oxi]HHGESSQVLHPGNK.6|TDGEGALSEPSATVTIEELAAPPPPVLMHHGESSQVLHPGNK.6|TDGEGALSEPSATVTIEELAAPPPPVLM[Oxi]HHGESSQVLHPGNK.5|TDGEGALSEPSATVTIEELAAPPPPVLMHHGESSQVLHPGNK.5|TDGEGALSEPSATVTIEELAAPPPPVLM[Oxi]HHGESSQVLHPGNK.4|TDGEGALSEPSATVTIEELAAPPPPVLMHHGESSQVLHPGNK.4|SWVPHTFESELSDPVELLVAES.3|LHDNQNGWSGDSAPVELILSDETLPAPEFSPEPESGR.4
SEN / CTL,Q16610,Extracellular matrix protein 1,ECM1,2.29,1.36,5.40E-30,6.08E-30,2.92E+01,"ossification,angiogenesis,positive regulation of endothelial cell proliferation,negative regulation of cytokine-mediated signaling pathway,platelet degranulation,regulation of type 2 immune response,regulation of transcription from RNA polymerase II promoter,inflammatory response,signal transduction,negative regulation of peptidase activity,negative regulation of bone mineralization,biomineral tissue development,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of angiogenesis,regulation of T cell migration","protease binding,signal transducer activity,interleukin-2 receptor binding,protein binding,protein C-terminus binding,enzyme binding,laminin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosome",102,22,28,FC[CAM]EAEFSVK.2|QGETLNFLEIGYSR.2|QGETLNFLEIGYSR.3|NIWRDPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3|LVWEEAMSR.2|QHVVYGPWNLPQSSYSHLTR.4|QHVVYGPWNLPQSSYSHLTR.3|ELLALIQLER.2|LLPAQLPAEKEVGPPLPQEAVPLQK.3|SLPMDHPDSSQHGPPFEGQSQVQPPPSQEATPLQQEK.4|FSC[CAM]FQEEAPQPHYQLR.3|FSC[CAM]FQEEAPQPHYQLR.4|QLRPEHFQEVGYAAPPSPPLSR.4|QLRPEHFQEVGYAAPPSPPLSR.3|RAPYPNYDRDILTIDIGR.4|AC[CAM]PSHQPDISSGLELPFPPGVPTLDNIK.3|VTPNLMGHLC[CAM]GNQR.3|DILTIDIGR.2|AWEDTLDKYC[CAM]DR.3|AWEDTLDKYC[CAM]DR.2|EVGPPLPQEAVPLQK.3|EVGPPLPQEAVPLQK.2|LTFINDLC[CAM]GPR.2|NVALVSGDTENAK.2|PSPDNLNQIC[CAM]LPNR.2|LDGFPPGRPSPDNLNQIC[CAM]LPNR.3|DPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3|C[CAM]C[CAM]DLPFPEQAC[CAM]C[CAM]AEEEK.2
SEN / CTL,P09651,Heterogeneous nuclear ribonucleoprotein A1,HNRNPA1,2.29,1.73,4.66E-09,9.11E-10,9.04E+00,"mRNA splicing, via spliceosome,mRNA processing,RNA export from nucleus,fibroblast growth factor receptor signaling pathway,gene expression,viral process,negative regulation of telomere maintenance via telomerase,positive regulation of telomere maintenance via telomerase,mRNA transport,nuclear export,nuclear import","nucleotide binding,single-stranded DNA binding,RNA binding,single-stranded RNA binding,protein binding,poly(A) RNA binding,telomeric repeat-containing RNA binding,G-rich strand telomeric DNA binding","nucleus,nucleoplasm,spliceosomal complex,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome,catalytic step 2 spliceosome",48,41,92,GFAFVTFDDHDSVDKIVIQK.4|GFAFVTFDDHDSVDKIVIQK.3|GFAFVTFDDHDSVDKIVIQK.2|GFGFVTYATVEEVDAAMNARPHKVDGR.5|GFGFVTYATVEEVDAAMNARPHKVDGR.4|GFGFVTYATVEEVDAAM[Oxi]NARPHKVDGR.5|GFGFVTYATVEEVDAAMNARPHKVDGR.3|KLFIGGLSFETTDESLR.3|KLFIGGLSFETTDESLR.2|LFIGGLSFETTDESLR.2|LFIGGLSFETTDESLR.3|SRGFGFVTYATVEEVDAAMNARPHKVDGR.6|SRGFGFVTYATVEEVDAAMNARPHKVDGR.5|IEVIEIMTDR.2|IEVIEIMTDR.3|IEVIEIM[Oxi]TDR.2|KIFVGGIKEDTEEHHLR.5|KIFVGGIKEDTEEHHLR.4|KIFVGGIKEDTEEHHLR.3|YHTVNGHNC[CAM]EVRK.4|YHTVNGHNC[CAM]EVRK.3|YHTVNGHNC[CAM]EVRK.2|PGAHLTVK.2|SESPKEPEQLR.3|SESPKEPEQLR.2|EPEQLRK.2|SGSGNFGGGR.2|AVSREDSQRPGAHLTVK.4|RGFAFVTFDDHDSVDK.4|RGFAFVTFDDHDSVDK.3|RGFAFVTFDDHDSVDK.2|SSGPYGGGGQYFAK.3|SSGPYGGGGQYFAK.2|IFVGGIKEDTEEHHLR.4|IFVGGIKEDTEEHHLR.3|SESPKEPEQLRK.3|SESPKEPEQLRK.2|EDSQRPGAHLTVK.3|EDSQRPGAHLTVK.2|IFVGGIKEDTEEHHLRDYFEQYGK.6|IFVGGIKEDTEEHHLRDYFEQYGK.5|IFVGGIKEDTEEHHLRDYFEQYGK.4|IFVGGIKEDTEEHHLRDYFEQYGK.3|RGFAFVTFDDHDSVDKIVIQK.5|RGFAFVTFDDHDSVDKIVIQK.4|RGFAFVTFDDHDSVDKIVIQK.3|KRGFAFVTFDDHDSVDK.4|KRGFAFVTFDDHDSVDK.3|YHTVNGHNC[CAM]EVR.3|YHTVNGHNC[CAM]EVR.2|GFGFVTYATVEEVDAAMNARPHK.5|GFGFVTYATVEEVDAAMNARPHK.4|GFGFVTYATVEEVDAAM[Oxi]NARPHK.4|GFGFVTYATVEEVDAAMNARPHK.3|IEVIEIMTDRGSGK.3|EDSQRPGAHLTVKK.3|EDSQRPGAHLTVKK.2|DYFEQYGK.2|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.5|SHFEQWGTLTDC[CAM]VVMRDPNTKR.5|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.4|SHFEQWGTLTDC[CAM]VVMRDPNTKR.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.3|SHFEQWGTLTDC[CAM]VVMRDPNTKR.3|SSGPYGGGGQYFAKPR.3|SSGPYGGGGQYFAKPR.2|EDTEEHHLRDYFEQYGK.4|EDTEEHHLRDYFEQYGK.3|SRGFGFVTYATVEEVDAAMNARPHK.5|SRGFGFVTYATVEEVDAAMNARPHK.4|GFAFVTFDDHDSVDK.3|GFAFVTFDDHDSVDK.2|NQGGYGGSSSSSSYGSGR.3|NQGGYGGSSSSSSYGSGR.2|GGGFGGNDNFGR.2|EDTEEHHLR.2|QEMASASSSQR.2|SHFEQWGTLTDC[CAM]VVMRDPNTK.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTK.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTK.3|SHFEQWGTLTDC[CAM]VVMRDPNTK.3|PRNQGGYGGSSSSSSYGSGR.3|SHFEQWGTLTDC[CAM]VVMR.3|SHFEQWGTLTDC[CAM]VVM[Oxi]R.3|SHFEQWGTLTDC[CAM]VVM[Oxi]R.2|SHFEQWGTLTDC[CAM]VVMR.2|GFGFVTYATVEEVDAAM[Oxi]NAR.3|GFGFVTYATVEEVDAAMNAR.3|GFGFVTYATVEEVDAAM[Oxi]NAR.2|GFGFVTYATVEEVDAAMNAR.2|LFIGGLSFETTDESLRSHFEQWGTLTDC[CAM]VVMRDPNTK.5|GGGGYGGSGDGYNGFGNDGGYGGGGPGYSGGSR.3
SEN / CTL,P26641,Elongation factor 1-gamma,EEF1G,2.29,2.29,8.68E-05,1.00E-05,5.00E+00,"translational elongation,glutathione metabolic process,response to virus,cell-cell adhesion","translation elongation factor activity,glutathione transferase activity,protein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular exosome,endoplasmic reticulum",30,36,59,KAAAPAPEEEMDEC[CAM]EQALAAEPK.3|KAAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|ALIAAQYSGAQVR.2|ALIAAQYSGAQVR.3|ILGLLDAYLK.2|VLSAPPHFHFGQTNRTPEFLR.5|FAETQPK.2|STFVLDEFKR.3|STFVLDEFKR.2|TFLVGER.2|EYFSWEGAFQHVGK.4|EYFSWEGAFQHVGK.3|EYFSWEGAFQHVGK.2|QATENAKEEVR.3|QATENAKEEVR.2|RILGLLDAYLK.3|RILGLLDAYLK.2|VLSAPPHFHFGQTNR.4|VLSAPPHFHFGQTNR.3|VLSAPPHFHFGQTNR.2|TPEFLRK.2|DPFAHLPK.2|KFAETQPK.2|QAFPNTNR.2|QATENAKEEVRR.3|LDPGSEETQTLVR.3|LDPGSEETQTLVR.2|QVLEPSFR.2|KLDPGSEETQTLVR.3|KLDPGSEETQTLVR.2|WFLTC[CAM]INQPQFR.3|WFLTC[CAM]INQPQFR.2|STFVLDEFK.2|AKDPFAHLPK.2|YSNEDTLSVALPYFWEHFDK.4|YSNEDTLSVALPYFWEHFDK.3|FPEELTQTFMSC[CAM]NLITGMFQR.4|FPEELTQTFM[Oxi]SC[CAM]NLITGMFQR.3|FPEELTQTFMSC[CAM]NLITGMFQR.3|KYSNEDTLSVALPYFWEHFDK.4|KYSNEDTLSVALPYFWEHFDK.3|RKYSNEDTLSVALPYFWEHFDK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.5|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.4|DGWSLWYSEYR.2|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|AAAPAPEEEMDEC[CAM]EQALAAEPK.3|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.2|AAAPAPEEEMDEC[CAM]EQALAAEPK.2|KLDPGSEETQTLVREYFSWEGAFQHVGK.4|QAFPNTNRWFLTC[CAM]INQPQFR.3|NAFASVILFGTNNSSSISGVWVFR.3|GQELAFPLSPDWQVDYESYTWR.3|GQELAFPLSPDWQVDYESYTWRK.3|KFPAGKVPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.4|VPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.3
SEN / CTL,P80303,Nucleobindin-2,NUCB2,2.28,2.06,6.98E-06,9.28E-07,6.03E+00,,"DNA binding,calcium ion binding","extracellular space,nuclear envelope,endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cytosol,plasma membrane,extracellular exosome",30,26,37,LVTLEEFLK.2|LHDVNSDGFLDEQELEALFTK.3|VYDPKNEEDDMVEMEEERLR.4|QFDHLNHLNPDKFESTDLDMLIK.5|QFDHLNHLNPDKFESTDLDMLIK.4|AKLDSLQDIGMDHQALLK.4|AKLDSLQDIGMDHQALLK.3|ELDLVSHHVR.3|ELDLVSHHVR.2|ADIEEIK.2|VQNIHPVESAK.3|VQNIHPVESAK.2|AATSDLEHYDK.3|AATSDLEHYDK.2|DRLVTLEEFLK.3|DRLVTLEEFLK.2|QFDHLNHLNPDK.3|QFDHLNHLNPDK.2|QVIDVLETDKHFR.3|QHDQLEAQK.2|LEYHQVIQQMEQK.3|LEYHQVIQQM[Oxi]EQK.3|LEYHQVIQQMEQK.2|KLQQGIPPSGPAGELKFEPHI.4|QVIDVLETDK.2|LDSLQDIGMDHQALLK.3|LDSLQDIGM[Oxi]DHQALLK.3|LDSLQDIGMDHQALLK.2|EYENIIALQENELKK.3|QHDQLEAQKLEYHQVIQQMEQK.4|VYDPKNEEDDMVEMEEER.3|DQLKEVWEETDGLDPNDFDPK.3|NEEDDMVEMEEER.2|EYENIIALQENELK.2|IEPPDTGLYYDEYLK.2|EVWEETDGLDPNDFDPK.2|KEFLEPDSWETLDQQQFFTEEELK.3
SEN / CTL,Q04446,"1,4-alpha-glucan-branching enzyme",GBE1,2.28,1.60,3.92E-07,6.13E-08,7.21E+00,"glycogen metabolic process,glycogen biosynthetic process,generation of precursor metabolites and energy","1,4-alpha-glucan branching enzyme activity,hydrolase activity, hydrolyzing O-glycosyl compounds,carbohydrate binding,cation binding","cytosol,extracellular exosome",30,32,48,VALILQNVDLPN.2|LLEIDPYLKPYAVDFQR.3|LLEIDPYLKPYAVDFQR.2|LDHSTDFFSEAFEHNGRPYSLLVYIPSR.5|LDHSTDFFSEAFEHNGRPYSLLVYIPSR.4|LAMAIPDKWIQLLK.3|LAM[Oxi]AIPDKWIQLLK.3|LAMAIPDKWIQLLK.2|LITHGLGGEGYLNFMGNEFGHPEWLDFPR.4|LITHGLGGEGYLNFM[Oxi]GNEFGHPEWLDFPR.4|GNNESYHYAR.3|SGEILYR.2|LAMAIPDK.2|QFSQILK.2|KGNNESYHYAR.3|KGNNESYHYAR.2|SVLVPHGSK.2|AGLLFIFNFHPSK.3|AGLLFIFNFHPSK.2|PYAVDFQR.2|RQFHLTDDDLLR.3|RQFHLTDDDLLR.2|IYESHVGISSHEGK.3|IYESHVGISSHEGK.2|NIGENEGGIDKFSR.3|NIGENEGGIDKFSR.2|C[CAM]ADGGLYC[CAM]K.2|WELYIPPK.2|GYESFGVHR.2|YGWLAAPQAYVSEKHEGNK.4|YGWLAAPQAYVSEKHEGNK.3|GTHDLWDSR.2|IVLDSDAAEYGGHQR.3|IVLDSDAAEYGGHQR.2|LLEIDPYLK.2|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.6|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.5|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.4|NIGENEGGIDK.2|C[CAM]IAYAESHDQALVGDK.3|EGDNVNYDWIHWDPEHSYEFK.4|EGDNVNYDWIHWDPEHSYEFK.3|YGTPEELQELVDTAHSM[Oxi]GIIVLLDVVHSHASK.5|YGTPEELQELVDTAHSMGIIVLLDVVHSHASK.5|EFKDEDWNMGDIVYTLTNR.3|YGWLAAPQAYVSEK.2|NSADGLNMFDGTDSC[CAM]YFHSGPR.3|EWAPGAEGVFLTGDFNGWNPFSYPYK.3
SEN / CTL,Q9UHD8,Septin-9,9-Sep,2.28,1.24,4.60E-18,2.14E-18,1.77E+01,"cell cycle,protein heterooligomerization,cell division,cell-cell adhesion,positive regulation of nonmotile primary cilium assembly","GTPase activity,protein binding,GTP binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,microtubule,cell-cell adherens junction,axoneme,actin cytoskeleton,septin complex,perinuclear region of cytoplasm",48,46,76,FINDQYEKYLQEEVNINR.3|YLQEEVNINR.2|RTELSIDISSK.2|SQEATEAAPSC[CAM]VGDMADTPR.3|SQEATEAAPSC[CAM]VGDMADTPR.2|SQEATEAAPSC[CAM]VGDM[Oxi]ADTPR.3|SQEATEAAPSC[CAM]VGDM[Oxi]ADTPR.2|SFEVEEVETPNSTPPR.2|SFEVEEVETPNSTPPR.3|MKLTVIDTPGFGDHINNENC[CAM]WQPIMK.4|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.4|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.6|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.5|RVEIQM[Oxi]PKPAEAPTAPSPAQTLENSEPAPVSQLQSR.4|FQDLGVK.2|RTEITIVKPQESAHR.4|RTEITIVKPQESAHR.3|RVELSGPK.2|HVDSLSQR.2|LGDSSGPALK.2|YLQEEVNINRK.3|YLQEEVNINRK.2|DITSSIHFEAYR.3|DITSSIHFEAYR.2|VPEVPTAPATDAAPK.3|VPEVPTAPATDAAPK.2|SVQPTSEER.2|ADTLTLEER.2|STLINTLFK.2|FINDQYEK.2|VVNIVPVIAK.2|RSFEVEEVETPNSTPPRR.4|RSFEVEEVETPNSTPPRR.3|SITHDIEEK.2|LEPKPQPPVAEATPR.3|LEPKPQPPVAEATPR.2|LGDSSGPALKR.2|EFDEDSEDR.2|THMQNIKDITSSIHFEAYR.4|EFDEDSEDRLVNEK.3|EFDEDSEDRLVNEK.2|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.5|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFM[Oxi]K.5|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFM[Oxi]K.4|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.4|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.3|ITADLLSNGIDVYPQK.3|ITADLLSNGIDVYPQK.2|QVENAGAIGPSR.2|FREMIPFAVVGSDHEYQVNGK.4|FREMIPFAVVGSDHEYQVNGK.3|TKWGTIEVENTTHC[CAM]EFAYLR.4|TKWGTIEVENTTHC[CAM]EFAYLR.3|RSFEVEEVETPNSTPPR.3|RSFEVEEVETPNSTPPR.2|SFEVEEVETPNSTPPRR.3|APVDFGYVGIDSILEQM[Oxi]R.3|APVDFGYVGIDSILEQMR.3|APVDFGYVGIDSILEQM[Oxi]R.2|APVDFGYVGIDSILEQMR.2|QRITADLLSNGIDVYPQK.3|QRITADLLSNGIDVYPQK.2|SVQPTSEERIPK.2|EM[Oxi]IPFAVVGSDHEYQVNGK.3|EMIPFAVVGSDHEYQVNGK.3|WGTIEVENTTHC[CAM]EFAYLR.3|WGTIEVENTTHC[CAM]EFAYLR.2|LNEGSSAMANGMEEKEPEAPEM.3|NEKAPVDFGYVGIDSILEQMR.3|ITADLLSNGIDVYPQKEFDEDSEDRLVNEK.4|QGFEFNIM[Oxi]VVGQSGLGK.2|QGFEFNIMVVGQSGLGK.2|LTVIDTPGFGDHINNENC[CAM]WQPIM[Oxi]K.3|LTVIDTPGFGDHINNENC[CAM]WQPIMK.3|ITADLLSNGIDVYPQKEFDEDSEDR.3|PAEAPTAPSPAQTLENSEPAPVSQLQSR.3
SEN / CTL,Q14767,Latent-transforming growth factor beta-binding protein 2,LTBP2,2.28,1.39,3.19E-05,3.94E-06,5.40E+00,"protein targeting,transforming growth factor beta receptor signaling pathway,protein secretion,extracellular fibril organization","calcium ion binding,protein binding,heparin binding,growth factor binding","proteinaceous extracellular matrix,extracellular space,intracellular,extracellular exosome,extracellular matrix",12,8,8,SSEVYAQLC[CAM]NVAR.2|ALLEAPLKQSTFTLPLSNQLASVNPSLVK.3|RSTPLGQQQPAPR.3|SSAAGEGTLAR.2|IVFTPTIC[CAM]K.2|STPLGQQQPAPR.2|GC[CAM]QDVDEC[CAM]ASR.2|EQDAPVAGLQPVER.2
SEN / CTL,P35637,RNA-binding protein FUS,FUS,2.28,1.91,2.31E-02,1.91E-03,2.72E+00,"mRNA splicing, via spliceosome,cellular response to calcium ion,regulation of nucleic acid-templated transcription","nucleotide binding,DNA binding,transcription coactivator activity,RNA binding,protein binding,zinc ion binding,estrogen receptor binding,myosin V binding,ionotropic glutamate receptor binding,poly(A) RNA binding,retinoid X receptor binding,thyroid hormone receptor binding","nucleus,nucleoplasm,polysome,perikaryon,dendritic spine head,perinuclear region of cytoplasm",12,17,37,LKGEATVSFDDPPSAK.3|LKGEATVSFDDPPSAK.4|LKGEATVSFDDPPSAK.2|AAIDWFDGKEFSGNPIK.3|AAIDWFDGKEFSGNPIK.2|EFSGNPIK.2|TGQPMINLYTDR.3|TGQPMINLYTDR.2|TGQPM[Oxi]INLYTDR.2|GEATVSFDDPPSAK.3|GEATVSFDDPPSAK.2|APKPDGPGGGPGGSHMGGNYGDDRR.5|APKPDGPGGGPGGSHMGGNYGDDRR.4|KTGQPMINLYTDRETGK.4|KTGQPM[Oxi]INLYTDRETGK.4|KTGQPMINLYTDRETGK.3|AAIDWFDGK.2|KTGQPMINLYTDR.3|KTGQPM[Oxi]INLYTDR.3|KTGQPMINLYTDR.2|APKPDGPGGGPGGSHMGGNYGDDR.4|APKPDGPGGGPGGSHM[Oxi]GGNYGDDR.4|APKPDGPGGGPGGSHM[Oxi]GGNYGDDR.3|APKPDGPGGGPGGSHMGGNYGDDR.3|APKPDGPGGGPGGSHMGGNYGDDR.2|C[CAM]PNPTC[CAM]ENMNFSWR.3|C[CAM]PNPTC[CAM]ENM[Oxi]NFSWR.2|C[CAM]PNPTC[CAM]ENMNFSWR.2|GGSGGGGGGGGGGYNR.2|TGQPM[Oxi]INLYTDRETGK.3|TGQPMINLYTDRETGK.3|TGQPMINLYTDRETGK.2|AAIDWFDGKEFSGNPIKVSFATR.4|TGQPMINLYTDRETGKLK.3|HDSEQDNSDNNTIFVQGLGENVTIESVADYFK.4|HDSEQDNSDNNTIFVQGLGENVTIESVADYFK.3|DQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFK.4
SEN / CTL,Q96AY3,Peptidyl-prolyl cis-trans isomerase FKBP10,FKBP10,2.28,1.24,4.18E-08,7.25E-09,8.14E+00,"protein peptidyl-prolyl isomerization,chaperone-mediated protein folding","peptidyl-prolyl cis-trans isomerase activity,calcium ion binding,FK506 binding","endoplasmic reticulum lumen,endoplasmic reticulum membrane",30,34,53,GMDQGLLGMC[CAM]PGER.2|GM[Oxi]DQGLLGMC[CAM]PGER.2|GGTYDTYVGSGWLIK.2|IIIPPFLAYGEK.2|GLMGMC[CAM]VNER.2|GLM[Oxi]GMC[CAM]VNER.2|GLMGM[Oxi]C[CAM]VNER.2|VIEGLDTGLQGMC[CAM]VGER.2|VIEGLDTGLQGMC[CAM]VGER.3|VIEGLDTGLQGM[Oxi]C[CAM]VGER.3|VIEGLDTGLQGM[Oxi]C[CAM]VGER.2|AGAGDFMR.2|AGAGDFM[Oxi]R.2|QLIVPPHLAHGESGAR.4|QLIVPPHLAHGESGAR.3|RQLIVPPHLAHGESGAR.4|KIIIPPFLAYGEK.3|KIIIPPFLAYGEK.2|EDTVQVSTLLRPPHC[CAM]PR.4|EDTVQVSTLLRPPHC[CAM]PR.3|LMPGQDPEK.2|MVQDGDFVR.2|M[Oxi]VQDGDFVR.2|DPPANLFEDMDLNK.3|DPPANLFEDMDLNK.2|EVQMGDFVR.2|EVQM[Oxi]GDFVR.2|KFDSSYDRNTLVAIVVGVGR.4|KFDSSYDRNTLVAIVVGVGR.3|RKIIIPPFLAYGEK.3|EDGLPTGYLFVWHK.3|EDGLPTGYLFVWHK.2|LKSDEDEERVHEEL.3|LKSDEDEERVHEEL.2|DAVQLETLELPPGC[CAM]VR.3|DAVQLETLELPPGC[CAM]VR.2|NTLVAIVVGVGR.2|GRLMPGQDPEK.2|TIGDMFQNQDRNQDGK.3|TIGDMFQNQDR.2|TIGDM[Oxi]FQNQDR.2|TIGDMFQNQDRNQDGKITVDELK.4|GYGTVIPPQASLVFHVLLIDVHNPK.4|GYGTVIPPQASLVFHVLLIDVHNPK.3|NQDGKITVDELK.2|FDSSYDRNTLVAIVVGVGR.3|IPGSAVLIFNVHVIDFHNPADVVEIR.4|SDEDEERVHEEL.2|ASPAGGPLEDVVIER.2|ITIPPHLAYGENGTGDKIPGSAVLIFNVHVIDFHNPADVVEIR.6|DGEVPPEEFSTFIK.2|GVPGSAVLLFEVELVSR.2|GYGTVIPPQASLVFHVLLIDVHNPKDAVQLETLELPPGC[CAM]VR.5
SEN / CTL,Q02952,A-kinase anchor protein 12,AKAP12,2.27,1.69,9.73E-05,1.11E-05,4.95E+00,"protein targeting,G-protein coupled receptor signaling pathway,positive regulation of protein kinase A signaling,positive regulation of cAMP biosynthetic process,regulation of protein kinase C signaling","adenylate cyclase binding,protein kinase A binding","cytoplasm,cytoskeleton,plasma membrane,focal adhesion,cell cortex",12,84,109,VKEESQLPGTGGPEDVLQPVQR.3|WKSDEVDEQVAC[CAM]QEVK.3|DKTEKPDTVQLLTVK.4|DKTEKPDTVQLLTVK.3|GSVEEPKPEEPK.3|GSVEEPKPEEPK.2|AATIIEER.2|KDDALELQSHAK.3|RTQEVLQAVAEK.3|RTQEVLQAVAEK.2|AEAERPEEQAEASGLKK.4|AEAERPEEQAEASGLKK.3|KPKEDEVEASEK.3|TEAEPTHVNEEK.3|TEAEPTHVNEEK.2|QSTEKPEETLKR.3|EMVVQVER.2|SVPEDDGHALLAER.3|SVPEDDGHALLAER.2|GLSSDLEGEK.2|QLLQTVNVPIIDGAK.3|QLLQTVNVPIIDGAK.2|VHSESDKAITPQAQEELQK.4|EKEDAQEVELQEGK.3|EKEDAQEVELQEGK.2|EQEPEKVDTEEDGK.3|ESAKSELTES.2|LEHETAVTVSEEVSK.3|LEHETAVTVSEEVSK.2|LTASEQAHPQEPAESAHEPR.4|LTASEQAHPQEPAESAHEPR.3|STPVIVSATTK.2|VDAQEAKTEPFTQGK.3|EGVTPWASFK.2|AEAERPEEQAEASGLK.3|ERPPAPSSFVFQEETKEQSK.4|ERPPAPSSFVFQEETKEQSK.3|IEVHQEEVVAEVHVSTVEER.4|IEVHQEEVVAEVHVSTVEER.3|EQEPEKVDTEEDGKAEVASEK.4|KGLSSDLEGEK.2|LVQNIIQTAVDQFVR.3|LVQNIIQTAVDQFVR.2|AITPQAQEELQKQER.3|EESESTAVGQAHSDISK.3|KDEGEGAAGAGDHKDPSLGAGEAASK.4|KDEGEGAAGAGDHKDPSLGAGEAASK.3|TQEVLQAVAEK.2|GEGTEEAEC[CAM]KKDDALELQSHAK.4|MEDTLEHTDK.2|ERPPAPSSFVFQEETK.3|VTEVALKGEGTEEAEC[CAM]K.3|FFTQGWAGWR.2|ADSQDAGQETEK.2|SEDSIAGSGVEHSTPDTEPGKEESWVSIKK.5|VHSESDKAITPQAQEELQKQER.4|EVSVETVSILSK.2|SAESPTSPVTSETGSTFKK.3|EKTEAEPTHVNEEKLEHETAVTVSEEVSK.5|EKTEAEPTHVNEEKLEHETAVTVSEEVSK.4|PAPLATEVFDEK.2|ELSESQVHMMAAAVADGTR.3|VVGQTTPESFEK.2|AITPQAQEELQK.2|SATLSSTESTASEMQEEMK.3|SATLSSTESTASEMQEEMK.2|EDAQEVELQEGK.2|SSEKNEDFAAHPGEDAVPTGPDC[CAM]QAK.4|SSEKNEDFAAHPGEDAVPTGPDC[CAM]QAK.3|SEDSIAGSGVEHSTPDTEPGK.3|DVPFFEGLEGSIDTGITVSR.3|ETC[CAM]VSGEDPTQGADLSPDEK.3|ETC[CAM]VSGEDPTQGADLSPDEK.2|GLAEVQQDGEAEEGATSDGEK.3|GLAEVQQDGEAEEGATSDGEK.2|VLGETANILETGETLEPAGAHLVLEEK.4|VLGETANILETGETLEPAGAHLVLEEK.3|EVIAEEEPPTVTEPLPENR.3|EVIAEEEPPTVTEPLPENR.2|DEGEGAAGAGDHKDPSLGAGEAASK.3|SEDSIAGSGVEHSTPDTEPGKEESWVSIK.4|VLSKPPEGVVSEVEMLSSQER.3|VLSKPPEGVVSEVEM[Oxi]LSSQER.3|NEDFAAHPGEDAVPTGPDC[CAM]QAK.3|NEDFAAHPGEDAVPTGPDC[CAM]QAK.2|EVSSLEGSPPPC[CAM]LGQEEAVC[CAM]TK.3|TEETATEMLTSELQTQAHVIK.3|TEETATEM[Oxi]LTSELQTQAHVIK.3|TKDVPFFEGLEGSIDTGITVSR.3|LKETC[CAM]VSGEDPTQGADLSPDEK.3|TEGTQEADQYADEK.2|SDEVDEQVAC[CAM]QEVK.2|VELPSEEQVSGSQGPSEEKPAPLATEVFDEK.4|VELPSEEQVSGSQGPSEEKPAPLATEVFDEK.3|GALNGQGALNSQEEEEVIVTEVGQR.3|GGGDEESGEHTQVPADSPDSQEEQK.3|APQVTESIESSELVTTC[CAM]QAETLAGVK.3|QEQAPVEDAGPTGANEDDSDVPAVVPLSEYDAVER.4|SAESPTSPVTSETGSTFK.2|SLVEPKEDEKGDDVDDPENQNSALADTDASGGLTK.4|VDTSVSWEALIC[CAM]VGSSK.2|EDEKGDDVDDPENQNSALADTDASGGLTK.3|GESSASSPEEPEEITC[CAM]LEK.2|SPEQPPEGSSTPAEPEPSGGGPSAEAAPDTTADPAIAASDPATK.4|TEEQKTEVEETAGSVPAEELVEMDAEPQEAEPAKELVK.4|VELPSEEQVSGSQGPSEEK.2|EESQLPGTGGPEDVLQPVQR.2|IQVQSSEASFTLTAAAEEEK.2|VSVAIEDLEPENGILELETK.2
SEN / CTL,Q14847,LIM and SH3 domain protein 1,LASP1,2.27,1.35,1.79E-16,7.09E-17,1.61E+01,"ion transport,positive regulation of signal transduction,ion transmembrane transport,cell-cell adhesion","SH3/SH2 adaptor activity,protein binding,zinc ion binding,ion transmembrane transporter activity,actin filament binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cell-cell adherens junction,focal adhesion,cortical actin cytoskeleton,extracellular exosome",54,20,35,GFSVVADTPELQR.2|GFSVVADTPELQR.3|QSFTMVADTPENLR.2|QSFTMVADTPENLR.3|QSFTM[Oxi]VADTPENLR.2|TGDTGMLPANYVEAI.2|TGDTGM[Oxi]LPANYVEAI.2|GKGFSVVADTPELQR.3|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.5|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.7|TQDQISNIKYHEEFEK.4|TQDQISNIKYHEEFEK.3|AC[CAM]FHC[CAM]ETC[CAM]K.3|AC[CAM]FHC[CAM]ETC[CAM]K.2|KPYC[CAM]NAHYPK.3|KPYC[CAM]NAHYPK.2|LKQQSELQSQVR.3|LKQQSELQSQVR.2|YKEEFEK.2|YHEEFEK.2|M[Oxi]GPSGGEGMEPERR.3|MGPSGGEGM[Oxi]EPERR.3|MGPSGGEGMEPERR.3|M[Oxi]GPSGGEGM[Oxi]EPERR.3|DSQDGSSYR.2|TQDQISNIK.2|EPAAPVSIQR.2|KTQDQISNIK.2|QQSELQSQVR.2|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.5|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.4|MGPSGGEGMEPER.2|DSQDGSSYRRPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6
SEN / CTL,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,2.26,1.84,2.38E-05,2.99E-06,5.52E+00,"retinoid metabolic process,receptor-mediated endocytosis,protein kinase C-activating G-protein coupled receptor signaling pathway,aging,cell proliferation,regulation of extracellular matrix disassembly,positive regulation of cholesterol efflux,negative regulation of neuron projection development,negative regulation of smooth muscle cell migration,cerebral cortex development,negative regulation of Wnt signaling pathway,positive regulation of lipid transport,regulation of cholesterol transport,regulation of phospholipase A2 activity,regulation of actin cytoskeleton organization,aorta morphogenesis,lipoprotein metabolic process,lipoprotein transport,apoptotic cell clearance,negative regulation of neuron apoptotic process,positive regulation of protein transport,beta-amyloid clearance,negative regulation of platelet-derived growth factor receptor-beta signaling pathway","protease binding,receptor activity,low-density lipoprotein receptor activity,calcium ion binding,protein binding,protein complex binding,apolipoprotein binding,lipoprotein transporter activity,poly(A) RNA binding,lipoprotein particle receptor binding","nucleolus,cytoplasm,lysosomal membrane,endosome,plasma membrane,integral component of plasma membrane,clathrin-coated pit,focal adhesion,clathrin-coated vesicle,dendrite,endocytic vesicle membrane,neuronal cell body,receptor complex",24,65,72,SGFHTVPGQPGC[CAM]QDINEC[CAM]LR.3|AALSGANVLTLIEKDIR.3|AVTDEEPFLIFANR.2|VFFTDYGQIPK.2|SERPPIFEIR.3|YDGSGHMEVLR.3|TTLLAGDIEHPR.3|TTLLAGDIEHPR.2|IDLHKGDYSVLVPGLR.4|IDLHKGDYSVLVPGLR.3|YVVISQGLDKPR.3|SGFSLGSDGK.2|ADGSGSVVLR.2|C[CAM]PTGFTGPK.2|ETVITMSGDDHPR.3|GIALDPAMGK.2|KPEHELFLVYGK.3|KPEHELFLVYGK.2|ATALAIMGDK.2|TAC[CAM]GVGEFR.2|RITIVENVGSVEGLAYHR.4|RITIVENVGSVEGLAYHR.3|KLSGC[CAM]SQDC[CAM]EDLK.3|NAVVQGLEQPHGLVVHPLR.4|NAVVQGLEQPHGLVVHPLR.3|IVFPHGITLDLVSR.3|LYFSDATLDKIER.3|IEAASMSGAGR.2|LDGLC[CAM]IPLR.2|C[CAM]TAYFEGSR.2|YTGDKC[CAM]ELDQC[CAM]WEHC[CAM]R.4|YTGDKC[CAM]ELDQC[CAM]WEHC[CAM]R.3|TPNGLAIDHR.2|SLDPFKPFIIFSNR.3|C[CAM]LEGAC[CAM]VVNK.2|SHAC[CAM]ENDQYGKPGGC[CAM]SDIC[CAM]LLANSHK.5|SHAC[CAM]ENDQYGKPGGC[CAM]SDIC[CAM]LLANSHK.4|GDYSVLVPGLR.2|IETAAMDGTLR.2|TNTQPFDLQVYHPSR.3|C[CAM]LC[CAM]VEGYAPR.2|MMPEC[CAM]QC[CAM]PPHMTGPR.3|GC[CAM]HINEC[CAM]LSR.2|GVGGAPPTVTLLR.2|ITIVENVGSVEGLAYHR.3|NLNAPVQPFEDPEHMK.3|VPDEHMIPIENLMNPR.3|AITVHPEKGYLFWTEWGQYPR.4|SC[CAM]MC[CAM]TAGYSLR.2|GPVGLAIDFPESK.2|EYAGYLLYSER.2|SEPVHPFGLAVYGEHIFWTDWVR.4|AALSGANVLTLIEK.2|LSGC[CAM]SQDC[CAM]EDLK.2|TC[CAM]GPSSFSC[CAM]PGTHVC[CAM]VPER.3|C[CAM]PLNYFAC[CAM]PSGR.2|LC[CAM]NGVQDC[CAM]MDGSDEGPHC[CAM]R.3|MYDAQQQQVGTNK.2|NLFWTSYDTNKK.2|NLNAPVQPFEDPEHMKNVIALAFDYR.4|SC[CAM]EGVTHVC[CAM]DPSVK.2|SGQQAC[CAM]EGVGSFLLYSVHEGIR.3|C[CAM]AC[CAM]PTNFYLGSDGR.2|EDYIEFASLDGSNR.2|AIALDPRDGILFWTDWDASLPR.3|ELLGRGPEDEIGDPLA.2|GYLFWTEWGQYPR.2|TVLWPNGLSLDIPAGR.2|ITWPNGLTLDYVTER.2|C[CAM]DNDNDC[CAM]GDNSDEAGC[CAM]SHSC[CAM]SSTQFK.3|NEPVDRPPVLLIANSQNILATYLSGAQVSTITPTSTR.4|AKNEPVDRPPVLLIANSQNILATYLSGAQVSTITPTSTR.4
SEN / CTL,Q16555,Dihydropyrimidinase-related protein 2,DPYSL2,2.25,1.59,2.87E-23,2.27E-23,2.26E+01,"response to amphetamine,nucleobase-containing compound metabolic process,endocytosis,cytoskeleton organization,signal transduction,nervous system development,axon guidance,positive regulation of glutamate secretion,spinal cord development,olfactory bulb development,regulation of axon extension,response to cocaine,response to drug,synaptic vesicle transport","dihydropyrimidinase activity,protein binding,microtubule binding,protein kinase binding","mitochondrion,cytosol,dendrite,growth cone,neuronal cell body,terminal bouton,myelin sheath,protein complex,extracellular exosome,microtubule,membrane",84,34,71,GLYDGPVC[CAM]EVSVTPK.2|GLYDGPVC[CAM]EVSVTPK.3|AITIANQTNC[CAM]PLYITK.2|AITIANQTNC[CAM]PLYITK.3|IVLEDGTLHVTEGSGR.3|IVLEDGTLHVTEGSGR.2|ILDLGITGPEGHVLSRPEEVEAEAVNR.4|ILDLGITGPEGHVLSRPEEVEAEAVNR.3|KKGTVVYGEPITASLGTDGSHYWSK.4|KKGTVVYGEPITASLGTDGSHYWSK.5|NLHQSGFSLSGAQIDDNIPR.3|NLHQSGFSLSGAQIDDNIPR.4|NLHQSGFSLSGAQIDDNIPR.2|SSAEVIAQAR.2|THNSSLEYNIFEGMEC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.2|THNSSLEYNIFEGMEC[CAM]R.2|AVGKDNFTLIPEGTNGTEER.3|AVGKDNFTLIPEGTNGTEER.2|FQLTDC[CAM]QIYEVLSVIR.3|FQLTDC[CAM]QIYEVLSVIR.2|MVIPGGIDVHTR.3|M[Oxi]VIPGGIDVHTR.3|MVIPGGIDVHTR.2|KPFPDFVYKR.3|VFNLYPR.2|DHGVNSFLVYMAFKDR.4|DHGVNSFLVYMAFKDR.3|SC[CAM]C[CAM]DYSLHVDISEWHK.4|SC[CAM]C[CAM]DYSLHVDISEWHK.3|SC[CAM]C[CAM]DYSLHVDISEWHK.2|DHGVNSFLVYMAFK.3|DHGVNSFLVYM[Oxi]AFK.3|DHGVNSFLVYMAFK.2|DHGVNSFLVYM[Oxi]AFK.2|GSPLVVISQGK.2|KPFPDFVYK.2|NLHQSGFSLSGAQIDDNIPRR.4|DIGAIAQVHAENGDIIAEEQQR.4|DIGAIAQVHAENGDIIAEEQQR.3|DIGAIAQVHAENGDIIAEEQQR.2|DNFTLIPEGTNGTEER.3|DNFTLIPEGTNGTEER.2|GTVVYGEPITASLGTDGSHYWSK.4|GTVVYGEPITASLGTDGSHYWSK.3|GIQEEMEALVK.2|IAVGSDADLVIWDPDSVK.3|IAVGSDADLVIWDPDSVK.2|KGTVVYGEPITASLGTDGSHYWSK.4|KGTVVYGEPITASLGTDGSHYWSK.3|QIGENLIVPGGVK.2|GRIAVGSDADLVIWDPDSVK.3|FQM[Oxi]PDQGMTSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.3|FQMPDQGMTSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.2|FQMPDQGMTSADDFFQGTK.2|DRFQLTDC[CAM]QIYEVLSVIR.3|DRFQLTDC[CAM]QIYEVLSVIR.2|AVVTGKM[Oxi]DENQFVAVTSTNAAK.3|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.6|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.5|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.4|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWR.3|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.3|IVNDDQSFYADIYMEDGLIK.3|IVNDDQSFYADIYMEDGLIK.2
SEN / CTL,O75083,WD repeat-containing protein 1,WDR1,2.25,1.68,4.10E-28,4.26E-28,2.74E+01,"platelet degranulation,sensory perception of sound,regulation of actin filament depolymerization,positive regulation of actin filament depolymerization,apical junction assembly,maintenance of epithelial cell apical/basal polarity,sarcomere organization,regulation of oligodendrocyte differentiation,regulation of ventricular cardiac muscle cell membrane repolarization",actin filament binding,"podosome,extracellular region,cytoplasm,cytosol,actin filament,cell-cell junction,cell projection,myelin sheath,extracellular exosome",108,47,76,NIDNPALADIYTEHAHQVVVAK.4|NIDNPALADIYTEHAHQVVVAK.3|AHDGGIYAISWSPDSTHLLSASGDKTSK.5|AHDGGIYAISWSPDSTHLLSASGDKTSK.4|AHDGGIYAISWSPDSTHLLSASGDKTSK.3|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3|LYSILGTTLKDEGK.3|LYSILGTTLKDEGK.2|YAPSGFYIASGDVSGK.2|YAPSGFYIASGDVSGK.3|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3|IWDTTQKEHLLKYEYQPFAGK.5|IWDTTQKEHLLKYEYQPFAGK.4|PYEIKKVFASLPQVER.4|MTVDESGQLISC[CAM]SMDDTVR.2|MTVDESGQLISC[CAM]SMDDTVR.3|M[Oxi]TVDESGQLISC[CAM]SMDDTVR.3|MTVDESGQLISC[CAM]SM[Oxi]DDTVR.3|YAPSGFYIASGDVSGKLR.3|GPVTDVAYSHDGAFLAVC[CAM]DASK.3|GPVTDVAYSHDGAFLAVC[CAM]DASK.4|GPVTDVAYSHDGAFLAVC[CAM]DASK.2|VVTVFSVADGYSENNVFYGHHAK.4|VVTVFSVADGYSENNVFYGHHAK.5|VVTVFSVADGYSENNVFYGHHAK.3|IAVVGEGR.2|TGEKVC[CAM]ALGGSK.3|KVFASLPQVER.3|KVFASLPQVER.2|IKDIAWTEDSK.3|IKDIAWTEDSK.2|VINSVDIK.2|YTSLMLR.2|IWDTTQK.2|LHHVSSLAWLDEHTLVTTSHDASVK.6|LHHVSSLAWLDEHTLVTTSHDASVK.5|LHHVSSLAWLDEHTLVTTSHDASVK.4|LHHVSSLAWLDEHTLVTTSHDASVK.3|FTIGDHSR.2|DYSGQGVVK.2|RIAVVGEGR.2|IKDIAWTEDSKR.3|IKDIAWTEDSKR.2|IWDTTQKEHLLK.3|DIAWTEDSK.2|DHLLSVSLSGYINYLDRNNPSKPLHVIK.6|DHLLSVSLSGYINYLDRNNPSKPLHVIK.5|SIQC[CAM]LTVHK.2|YEYQPFAGK.2|LYSILGTTLK.2|GNNFLYTNGK.2|EHLLKYEYQPFAGK.3|EHLLKYEYQPFAGK.2|VFASLPQVER.2|DIAWTEDSKR.2|EKFGAVFLWDSGSSVGEITGHNK.4|NNPSKPLHVIK.2|DHLLSVSLSGYINYLDRNNPSK.4|AHDGGIYAISWSPDSTHLLSASGDK.4|AHDGGIYAISWSPDSTHLLSASGDK.3|DHLLSVSLSGYINYLDR.3|LATGSDDNC[CAM]AAFFEGPPFK.3|LATGSDDNC[CAM]AAFFEGPPFK.2|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLKDQRK.4|LHHVSSLAWLDEHTLVTTSHDASVKEWTITY.5|FGAVFLWDSGSSVGEITGHNK.3|FGAVFLWDSGSSVGEITGHNK.2|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.3|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.2|SYIYSGSHDGHINYWDSETGENDSFAGK.4|SYIYSGSHDGHINYWDSETGENDSFAGK.3|FATASADGQIYIYDGK.2|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.4|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.3
SEN / CTL,Q01105,Protein SET,SET,2.24,1.68,1.77E-06,2.57E-07,6.59E+00,"DNA replication,nucleosome assembly,nucleosome disassembly,nucleocytoplasmic transport,viral process,regulation of protein phosphatase type 2A activity,negative regulation of histone acetylation,negative regulation of catalytic activity,regulation of mRNA stability,negative regulation of neuron apoptotic process,negative regulation of transcription, DNA-templated","DNA binding,protein phosphatase inhibitor activity,protein binding,protein phosphatase type 2A regulator activity,histone binding","nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,cytosol,protein complex,perinuclear region of cytoplasm",30,18,30,IPNFWVTTFVNHPQVSALLGEEDEEALHYLTR.4|IPNFWVTTFVNHPQVSALLGEEDEEALHYLTR.5|VEVTEFEDIK.2|VEVTEFEDIKSGYR.3|SGYRIDFYFDENPYFENK.3|SGYRIDFYFDENPYFENK.2|IDFYFDENPYFENK.2|IDFYFDENPYFENK.3|LRQPFFQKR.3|RSELIAK.2|KKPRPPPALGPEETSASAGLPK.5|KKPRPPPALGPEETSASAGLPK.4|KKPRPPPALGPEETSASAGLPK.3|VLSKEFHLNESGDPSSK.4|VLSKEFHLNESGDPSSK.3|EFHLNESGDPSSK.3|EFHLNESGDPSSK.2|KPRPPPALGPEETSASAGLPK.4|KPRPPPALGPEETSASAGLPK.3|LNEQASEEILKVEQK.3|LNEQASEEILKVEQK.2|LNEQASEEILK.2|PRPPPALGPEETSASAGLPK.3|EQQEAIEHIDEVQNEIDR.3|EQQEAIEHIDEVQNEIDR.2|EQQEAIEHIDEVQNEIDRLNEQASEEILKVEQK.5|EQQEAIEHIDEVQNEIDRLNEQASEEILKVEQK.4|EQQEAIEHIDEVQNEIDRLNEQASEEILK.4|EQQEAIEHIDEVQNEIDRLNEQASEEILK.3|IPNFWVTTFVNHPQVSALLGEEDEEALHYLTRVEVTEFEDIK.5
SEN / CTL,Q86V81,THO complex subunit 4,ALYREF,2.24,0.84,4.00E-06,5.50E-07,6.26E+00,"regulation of DNA recombination,mRNA splicing, via spliceosome,osteoblast differentiation,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,mRNA 3'-end processing,replication fork processing,positive regulation of DNA-templated transcription, elongation,viral mRNA export from host cell nucleus","nucleotide binding,protein binding,poly(A) RNA binding","transcription export complex,nucleus,nucleoplasm,cytosol,membrane,nuclear speck,intracellular membrane-bounded organelle,extracellular exosome,catalytic step 2 spliceosome,nuclear chromosome, telomeric region,exon-exon junction complex",12,12,20,QQLSAEELDAQLDAYNAR.3|QQLSAEELDAQLDAYNAR.2|SLGTADVHFER.3|SLGTADVHFER.2|AAVHYDR.2|GAGGFGGGGGTR.2|PMNIQLVTSQIDAQR.3|PM[Oxi]NIQLVTSQIDAQR.3|PMNIQLVTSQIDAQR.2|MDMSLDDIIK.2|QLPDKWQHDLFDSGFGGGAGVETGGK.4|QLPDKWQHDLFDSGFGGGAGVETGGK.3|SLGTADVHFERK.2|QYNGVPLDGRPMNIQLVTSQIDAQR.4|QYNGVPLDGRPMNIQLVTSQIDAQR.3|WQHDLFDSGFGGGAGVETGGK.3|WQHDLFDSGFGGGAGVETGGK.2|LLVSNLDFGVSDADIQELFAEFGTLKK.4|LLVSNLDFGVSDADIQELFAEFGTLKK.3|NSKQQLSAEELDAQLDAYNAR.3
SEN / CTL,Q15366,Poly(rC)-binding protein 2,PCBP2,2.24,1.72,2.01E-06,2.89E-07,6.54E+00,"mRNA splicing, via spliceosome,gene expression,mRNA metabolic process,negative regulation of type I interferon production,viral RNA genome replication,proteasome-mediated ubiquitin-dependent protein catabolic process,innate immune response,negative regulation of defense response to virus,defense response to virus,IRES-dependent viral translational initiation","RNA binding,protein binding,enzyme binding,ubiquitin protein ligase binding,poly(A) RNA binding,C-rich single-stranded DNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular exosome",18,22,53,IITLAGPTNAIFK.2|IITLAGPTNAIFK.3|AITIAGIPQSIIEC[CAM]VK.3|AITIAGIPQSIIEC[CAM]VK.2|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.6|AFAM[Oxi]IIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDISSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.5|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDISSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.3|INISEGNC[CAM]PER.3|INISEGNC[CAM]PER.2|QMSGAQIK.2|AFAMIIDK.2|AFAM[Oxi]IIDK.2|LVVPASQC[CAM]GSLIGK.3|LVVPASQC[CAM]GSLIGK.2|PSSSPVIFAGGQDR.3|PSSSPVIFAGGQDR.2|LSSETGGMGSS.2|LSSETGGM[Oxi]GSS.2|PKPSSSPVIFAGGQDR.3|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.6|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.5|LHQLAM[Oxi]QQSHFPMTHGNTGFSGIESSSPEVK.5|LHQLAMQQSHFPM[Oxi]THGNTGFSGIESSSPEVK.5|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.4|LHQLAM[Oxi]QQSHFPM[Oxi]THGNTGFSGIESSSPEVK.4|LHQLAM[Oxi]QQSHFPMTHGNTGFSGIESSSPEVK.4|LHQLAMQQSHFPM[Oxi]THGNTGFSGIESSSPEVK.4|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.3|IANPVEGSTDR.2|GVTIPYRPKPSSSPVIFAGGQDR.4|GVTIPYRPKPSSSPVIFAGGQDR.3|LEEDISSSMTNSTAASRPPVTLR.4|LEEDISSSM[Oxi]TNSTAASRPPVTLR.3|LEEDISSSMTNSTAASRPPVTLR.3|LVVPASQC[CAM]GSLIGKGGC[CAM]K.3|QIC[CAM]VVMLETLSQSPPK.3|QIC[CAM]VVMLETLSQSPPK.2|IKEIRESTGAQVQVAGDM[Oxi]LPNSTER.4|QVTITGSAASISLAQYLINVR.3|QVTITGSAASISLAQYLINVR.2|GYWGLDASAQTTSHELTIPNDLIGC[CAM]IIGR.4|GYWGLDASAQTTSHELTIPNDLIGC[CAM]IIGR.3|EIRESTGAQVQVAGDMLPNSTER.3|IANPVEGSTDRQVTITGSAASISLAQYLINVR.4|IANPVEGSTDRQVTITGSAASISLAQYLINVR.3|YSTGSDSASFPHTTPSMC[CAM]LNPDLEGPPLEAYTIQGQYAIPQPDLTK.5
SEN / CTL,P06753,Tropomyosin alpha-3 chain,TPM3,2.23,1.52,2.23E-25,1.98E-25,2.47E+01,"movement of cell or subcellular component,muscle contraction,muscle filament sliding","molecular_function,actin binding,protein binding","stress fiber,cytosol,cytoskeleton,muscle thin filament tropomyosin,extracellular exosome",96,33,55,IQLVEEELDRAQER.3|IQLVEEELDRAQER.2|RIQLVEEELDRAQER.4|RIQLVEEELDRAQER.3|LATALQKLEEAEKAADESER.3|LATALQKLEEAEKAADESER.4|LATALQKLEEAEKAADESER.2|ALKDEEKMELQEIQLK.4|ALKDEEKMELQEIQLK.3|ALKDEEKM[Oxi]ELQEIQLK.4|ALKDEEKM[Oxi]ELQEIQLK.3|IQLVEEELDR.2|SLEAQAEK.2|AADAEAEVASLNR.2|AADAEAEVASLNR.3|AADAEAEVASLNRR.3|HIAEEADRKYEEVAR.4|HIAEEADRKYEEVAR.3|HIAEEADRKYEEVAR.2|KLVIIEGDLER.2|KLVIIEGDLER.3|LATALQKLEEAEK.3|LATALQKLEEAEK.2|YSQKEDKYEEEIK.4|YSQKEDKYEEEIK.3|YSQKEDKYEEEIK.2|DAQEKLELAEK.3|DAQEKLELAEK.2|EAETRAEFAER.3|KLVIIEGDLERTEER.4|KLVIIEGDLERTEER.3|KLVIIEGDLERTEER.2|KYEEVAR.2|GTEDELDK.2|LKGTEDELDKYSEALK.4|DAQEKLELAEKK.3|HIAEEADR.2|RIQLVEEELDR.3|RIQLVEEELDR.2|ILTDKLKEAETR.3|LEEAEKAADESER.3|LEEAEKAADESER.2|GTEDELDKYSEALK.3|GTEDELDKYSEALK.2|LDKENALDR.2|HIAEEADRK.2|LVIIEGDLERTEER.3|MELQEIQLK.2|M[Oxi]ELQEIQLK.2|LVIIEGDLER.2|AISEELDHALNDMTSI.3|AISEELDHALNDMTSI.2|EDKYEEEIK.2|GTEDELDKYSEALKDAQEK.3|TIDDLEDELYAQK.2
SEN / CTL,Q15149,Plectin,PLEC,2.23,1.72,1.24E-129,1.34E-128,1.28E+02,"hemidesmosome assembly,cell-cell adhesion","actin binding,protein binding,structural constituent of muscle,ankyrin binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,sarcoplasm,hemidesmosome,extracellular matrix,sarcolemma,costamere,intermediate filament cytoskeleton,extracellular exosome",534,489,728,QVQVALETAQR.2|SQVEEELFSVR.2|SIQEELQQLR.2|LRAETEQGEQQRQLLEEELAR.4|APVPASELLASGVLSR.2|APVPASELLASGVLSR.3|LKAEAELLQQQKELAQEQAR.4|LKAEAELLQQQKELAQEQAR.3|IISLETYNLLR.2|LTVDEAVR.2|IAEQQKAQAEVEGLGKGVAR.4|IAEQQKAQAEVEGLGKGVAR.3|LQEAGILSAEELQR.2|LQEAGILSAEELQR.3|LGFHLPLEVAYQR.3|LGFHLPLEVAYQR.2|LTAEDLFEAR.2|AELELELGR.2|SLVPAAELLESR.2|SLVPAAELLESR.3|AYSDPSTGEPATYGELQQR.3|AYSDPSTGEPATYGELQQR.2|LLDPEDVDVPQPDEK.2|LLDPEDVDVPQPDEK.3|VQSGSESVIQEYVDLR.2|VQSGSESVIQEYVDLR.3|C[CAM]ITDPQTGLC[CAM]LLPLKEK.3|C[CAM]ITDPQTGLC[CAM]LLPLKEK.2|QTNLENLDQAFSVAERDLGVTR.3|WQAVLAQTDVR.2|HISDLYEDLRDGHNLISLLEVLSGDSLPR.5|HISDLYEDLRDGHNLISLLEVLSGDSLPR.4|FLEGTSC[CAM]IAGVFVDATKER.3|FLEGTSC[CAM]IAGVFVDATKER.2|QVEEEILALK.2|LQLEAC[CAM]ETR.2|RDDGTGQLLLPLSDAR.3|RDDGTGQLLLPLSDAR.2|ESADPLGAWLQDAR.2|ESADPLGAWLQDAR.3|AVTGYKDPYTGQQISLFQAMQK.3|AVTGYKDPYTGQQISLFQAM[Oxi]QK.3|RLQEDKEQMAQQLAEETQGFQR.4|RLQEDKEQMAQQLAEETQGFQR.3|RLQEDKEQM[Oxi]AQQLAEETQGFQR.4|AALAHSEEVTASQVAATK.3|AALAHSEEVTASQVAATK.4|AALAHSEEVTASQVAATK.2|C[CAM]VEDPETGLC[CAM]LLPLTDK.2|C[CAM]VEDPETGLC[CAM]LLPLTDK.3|AGEVERDLDKADSMIR.3|AGEVERDLDKADSMIR.4|LAEVEAALEK.2|YYRESADPLGAWLQDAR.3|ELIPTEEALRLLDAQLATGGIVDPR.3|TISLVIR.2|C[CAM]RPDQLTGLSLLPLSEK.3|C[CAM]RPDQLTGLSLLPLSEK.2|VLADPSDDTKGFFDPNTHENLTYR.4|LRLQAEEVAQQK.3|LRLQAEEVAQQK.2|AEMEVLLASK.2|NLVDNITGQR.2|LAAEQELIR.2|VLADPSDDTKGFFDPNTHENLTYLQLLER.4|LSVAAQEAAR.2|QYINAIKDYELQLVTYK.3|QYINAIKDYELQLVTYK.2|ARQEELYSELQAR.3|ARQEELYSELQAR.2|LREQLQLLEEQHR.3|LREQLQLLEEQHR.4|LREQLQLLEEQHR.2|LLEAQIATGGIIDPVHSHRVPVDVAYQR.5|LLEAQIATGGIIDPVHSHRVPVDVAYQR.4|LLEAQIATGGIIDPVHSHRVPVDVAYQR.3|DLLPSDMAVALLEAQAGTGHIIDPATSAR.4|DLLPSDMAVALLEAQAGTGHIIDPATSAR.3|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.4|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.3|DDGTGQLLLPLSDAR.2|DDGTGQLLLPLSDAR.3|LQNVQIALDYLR.2|LQNVQIALDYLR.3|LLDAQLATGGIVDPR.2|LLDAQLATGGIVDPR.3|ELIPTEEALR.2|AQAEAQQPTFDALRDELR.3|AQAEAQQPTFDALRDELR.2|LSAEAEKVLALPEPSPAAPTLR.3|LSAEAEKVLALPEPSPAAPTLR.4|LSAEAEKVLALPEPSPAAPTLR.2|QEELYSELQAR.2|SELELTLGKLEQVR.3|SELELTLGKLEQVR.2|LTVEEAVR.2|AVTGYRDPYTEQTISLFQAMKK.4|VLALPEPSPAAPTLRSELELTLGKLEQVR.4|ALQALEELR.2|SLSAIYLEK.2|GGAEGELQALR.2|QLEMSAEAER.2|QLEM[Oxi]SAEAER.2|QAEVELASR.2|LLEAQIATGGIIDPEESHRLPVEVAYKR.5|LLEAQIATGGIIDPEESHRLPVEVAYKR.6|LLEAQIATGGIIDPEESHRLPVEVAYKR.4|LLEAQIATGGIIDPEESHRLPVEVAYKR.3|AGTLSITEFADMLSGNAGGFR.3|AGTLSITEFADM[Oxi]LSGNAGGFR.3|AGTLSITEFADMLSGNAGGFR.2|SIITYVSSLYDAMPR.2|SIITYVSSLYDAMPR.3|SIITYVSSLYDAM[Oxi]PR.3|SIITYVSSLYDAM[Oxi]PR.2|AVTGYRDPYSGSTISLFQAMQK.3|AVTGYRDPYSGSTISLFQAMQK.4|AVTGYRDPYSGSTISLFQAM[Oxi]QK.3|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.3|AKLEQLFQDEVAK.3|AKLEQLFQDEVAK.2|QTNLENLDQAFSVAER.3|QTNLENLDQAFSVAER.2|LKAEAELLQQQK.3|LKAEAELLQQQK.2|LTVNEAVKEGVVGPELHHK.4|LTVNEAVKEGVVGPELHHK.3|AVTGYRDPYTGQSVSLFQALKK.4|AVTGYRDPYTGQSVSLFQALKK.3|EGVVGPELHHK.3|EGVVGPELHHK.2|GLHQSIEEFR.3|GLHQSIEEFR.2|HKPLLIDMNK.3|HKPLLIDMNK.2|KGLVGPELHDR.3|KGLVGPELHDR.2|LREAIAELER.3|LREAIAELER.2|MGIVGPEFKDK.3|MGIVGPEFKDK.2|RLEEQAAQHK.3|RLEEQAAQHK.2|RPELEDSTLR.3|RPELEDSTLR.2|RQHEAEEGVR.3|VKAEAEAAREK.3|ERLSVYQAMK.3|ERLSVYQAMK.2|HGERDVEVER.3|LQLEETDHQK.3|LQLEETDHQK.2|QLQLAQEAAQK.3|QLQLAQEAAQK.2|QRELAEQELEKQR.4|QRELAEQELEKQR.3|RLAEDEAFQR.3|RLAEDEAFQR.2|SKEQAELEAAR.3|SKEQAELEAAR.2|VAQLLER.2|ARAEEAEAQKR.3|ARAEEAEAQKR.2|FLQEEAEKMK.3|FLQEEAEKMK.2|HISDLYEDLR.3|HISDLYEDLR.2|LPLDKEPAREC[CAM]AQR.4|RQVEEAERLK.3|AHEEQLK.2|ANELQLR.2|EDVRHYLQGR.3|EQLNEYKGHLSGLAK.4|GAQEVGER.2|HGEKVEEC[CAM]QR.3|KQEELQQLEQQRR.4|KQEELQQLEQQRR.3|KQEELQQLEQQRR.2|LDLQYAK.2|QYINAIK.2|RKQEELQQLEQQR.4|RKQEELQQLEQQR.3|RKQEELQQLEQQR.2|SALDQYR.2|AQFEQLK.2|AQQLREEQQR.3|AQQLREEQQR.2|AQVEQELTTLR.3|AQVEQELTTLR.2|AVTGYKDPYSGK.3|AVTGYKDPYSGK.2|FAEQTLR.2|FISETLR.2|KASDSELERQK.3|LRLPLDKEPAR.3|QTLSIYQALKK.3|QTLSIYQALKK.2|ALAEEAKR.2|ATVSAPFGK.2|GLVGPELHDRLLSAER.4|LHRTELATQEK.3|LHRTELATQEK.2|LTVNEAVK.2|QVAEEAAR.2|RLTAEDLFEAR.3|RLTAEDLFEAR.2|RQVEEEILALK.3|RQVEEEILALK.2|TEAEIALK.2|VAGMLMPR.2|LC[CAM]FEGLR.2|QRQLAEAHAQAK.3|QRQLAEAHAQAK.2|SVRDVAEVDTVR.3|SVRDVAEVDTVR.2|VPPGYHPLDVEK.3|VPPGYHPLDVEK.2|VRAEMEVLLASK.3|VRAEMEVLLASK.2|AGLVGPEFHEKLLSAEK.4|AGLVGPEFHEKLLSAEK.3|ASDSELER.2|AVVQLKPR.2|EAEGQLQK.2|ELQNAGDR.2|GLVEDTLR.2|LAAIGEATR.2|LAEVEAALEKQR.3|LKQSAEEQAQAR.3|LKQSAEEQAQAR.2|QALHSLELHYQAFLR.4|QALHSLELHYQAFLR.3|QALHSLELHYQAFLR.2|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.6|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.5|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.4|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.3|RQHEAEEGVRR.3|SNAEDTLR.2|SSIAGLLLK.2|AALEEVER.2|AQAEVEGLGKGVAR.3|AQAEVEGLGKGVAR.2|AREEAERELER.3|ARSDEGQLSPATR.3|ARSDEGQLSPATR.2|EAIAELER.2|ELAEQELEKQR.3|GLLSAEVAR.2|LKTEAEIALKEK.3|LLLWSQR.2|LSIYNALK.2|QLQLAQEAAQKR.3|QRELAEQELEK.3|QRELAEQELEK.2|QRGGAEGELQALR.3|QRGGAEGELQALR.2|QRQLAEGTAQQR.3|REEAAVDAQQQK.3|REEAAVDAQQQK.2|SHRVPLDVAC[CAM]AR.3|SHRVPLDVAC[CAM]AR.2|TELATQEK.2|VPPGYHPLDVEKEWGK.4|VPVDVAYR.2|ELAQEQAR.2|EQLRQEQALLEEIERHGEK.5|GRLPLLAVC[CAM]DYK.3|GRLPLLAVC[CAM]DYK.2|LAQGHTTVDELAR.3|LAQGHTTVDELAR.2|LEDLLQDAQDEK.3|LEDLLQDAQDEK.2|LSVYQAMK.2|PLLIDMNK.2|RSIQEELQQLR.3|RSIQEELQQLR.2|TTVKDLSELGSVR.3|TTVKDLSELGSVR.2|VKAEAEAAR.2|AAAGKAELELELGR.3|AAAGKAELELELGR.2|EQLQLLEEQHR.3|EQLQLLEEQHR.2|GAYRDC[CAM]LGRLDLQYAK.4|GAYRDC[CAM]LGRLDLQYAK.3|IIITVVEEQEQK.3|IIITVVEEQEQK.2|KGLVGPELHDRLLSAER.4|LHVAILER.2|LQAEEAER.2|QLAAEEER.2|SLAQAEAEK.2|AQAEQAALR.2|ARIEAENR.2|ESYSALMR.2|LEAQHQALVTLWHQLHVDMK.5|LEAQHQALVTLWHQLHVDMK.4|LEAQHQALVTLWHQLHVDM[Oxi]K.4|LEAQHQALVTLWHQLHVDM[Oxi]K.3|LQLEATER.2|LRAETEQGEQQR.3|LRAETEQGEQQR.2|LYVHEAVK.2|QRQLEMSAEAER.3|RLEEQAAQHKADIEER.4|RLEEQAAQHKADIEER.3|SAEAELQSK.2|SGRQYDIDDAIAK.3|SWSLATFR.2|VLAEKLAAIGEATR.3|VQMEELSK.2|VQM[Oxi]EELSK.2|VSIYEAMR.2|VSIYEAM[Oxi]R.2|AAEEAEEAR.2|ARQVQVALETAQR.3|ARQVQVALETAQR.2|DLSELGSVR.2|LREAIAELEREK.3|MGIVGPEFK.2|QQGLASYDYVRR.3|SLESLHSFVAAATK.3|SLESLHSFVAAATK.2|SQVMDEATALQLR.3|SQVMDEATALQLR.2|SQVM[Oxi]DEATALQLR.2|TLARPGPEPAPATDERDR.4|TLARPGPEPAPATDERDR.3|DGRHPQGEQMYR.3|DGRHPQGEQM[Oxi]YR.3|FPVTDAVNK.2|LFNAIIHR.2|QAADAEMEK.2|QAADAEM[Oxi]EK.2|QQEELLAEENQR.3|QQEELLAEENQR.2|QVQDESQR.2|SELELTLGK.2|SLQEEHVAVAQLR.3|SLQEEHVAVAQLR.2|VPDVQDGVR.2|AHAFAVQQK.2|AQAEVEGLGK.2|DVAEVDTVR.2|FLQEEAEK.2|LSYTQLLR.2|LVASMEEAR.2|LVASM[Oxi]EEAR.2|QLAEEDAAR.2|SVRDVAEVDTVRR.3|TLKPEEQR.2|VPLDVAC[CAM]AR.2|AIYEVLFR.2|DTHDQLSEPSEVR.3|DTHDQLSEPSEVR.2|EQAELEAAR.2|ILITIVEEVETLR.3|ILITIVEEVETLR.2|LLEAQIATGGIIDPVHSHR.4|LLEAQIATGGIIDPVHSHR.3|LLEAQIATGGIIDPVHSHR.2|LLEAQIATGGVIDPVHSHR.4|LLEAQIATGGVIDPVHSHR.3|LLEAQIATGGVIDPVHSHR.2|REEAAVDAQQQKR.3|RQVEEAER.2|AQQQAEAER.2|FKEMELPAKEADK.3|LLEAAAQSTK.2|LLEAQIATGGVIDPVHSHRVPVDVAYRR.6|LLEAQIATGGVIDPVHSHRVPVDVAYRR.5|LLEAQIATGGVIDPVHSHRVPVDVAYRR.4|LSVYAALQR.2|LTVDEAVRK.2|MQAVQEATR.2|M[Oxi]QAVQEATR.2|QRLEAEAGR.2|RLTVNEAVK.2|VLALPEPSPAAPTLR.3|VLALPEPSPAAPTLR.2|AAEEAEEARVQAER.3|AQAEREAKELQQR.3|ATNEKLSVYAALQR.3|ATNEKLSVYAALQR.2|GYLNKDTHDQLSEPSEVR.4|GYLNKDTHDQLSEPSEVR.3|KAALEEVER.2|KASDSELER.2|KGLLSAEVAR.2|KQEELQQLEQQR.3|KQEELQQLEQQR.2|LAQGHTTVDELARR.3|LRQLAEEDLAQQR.3|LRQLAEEDLAQQR.2|SLAAEEEAAR.2|SLQEEHVAVAQLREEAER.4|SLQEEHVAVAQLREEAER.3|VAQLLERWQAVLAQTDVR.4|VAQLLERWQAVLAQTDVR.3|VIDRELYQQLQR.3|VIDRELYQQLQR.2|VPLDEALQR.2|VPVDVAYQR.2|VSITEAMHR.2|GTQGAEEVLR.2|LISLFQAMK.2|LISLFQAM[Oxi]K.2|LKAEATEAAR.2|LRIEEEIR.2|MVEGYQGLR.2|M[Oxi]VEGYQGLR.2|NDDIADGNPK.2|QHEAEEGVR.2|RRQEQIQAMPLADSQAVR.4|RRQEQIQAMPLADSQAVR.3|RRQEQIQAMPLADSQAVR.2|VLADPSDDTK.2|VVIVDPETGK.2|ELYQQLQR.2|GC[CAM]LDEETSR.2|LAEDEAFQR.2|LLDAQLSTGGIVDPSK.3|LLDAQLSTGGIVDPSK.2|QLAEAHAQAK.2|QRSQVEEELFSVR.3|QRSQVEEELFSVR.2|SLLAWQSLR.2|SMVEEGTGLR.2|SM[Oxi]VEEGTGLR.2|TPHVQAVQGPLGSPPK.3|ELAEQELEK.2|ISYKDALDR.2|KESYSALMR.2|QSSEAEIQAK.2|YYRESADPLGAWLQDARR.4|AFC[CAM]GFEDPR.2|DPYTGQSVSLFQALK.3|DPYTGQSVSLFQALK.2|GLVGPELHDR.2|HHTAAFEER.2|IIITVVEEQEQKGR.3|LVNIRNDDIADGNPK.3|LVNIRNDDIADGNPK.2|QLAAEEERR.2|QLAEGTAQQR.2|QLLEEELAR.2|RLTVNEAVKEGVVGPELHHK.4|RQQEELLAEENQR.3|RQQEELLAEENQR.2|AQLEPVASPAK.2|EAQAVPATLPELEATK.3|EAQAVPATLPELEATK.2|GIYQSLEGAVQAGQLK.3|GIYQSLEGAVQAGQLK.2|QITMEELVR.2|QSAEEQAQAR.2|RAQAEQAALR.2|TLARPGPEPAPATDER.3|AGEVERDLDK.2|C[CAM]ISELKDIR.2|DALDGPAAEAEPEHSFDGLRR.4|DALDGPAAEAEPEHSFDGLRR.3|DDGTGQLLLPLSDARK.3|ESADPLGAWLQDARR.3|GYFSEEMNR.2|NLLDEELQR.2|QRELEQLGR.2|RAAEEAEEAR.2|RKELEEVSPETPVVPATTQR.4|SLQEEHVAVAQLREEAERR.4|SLQEEHVAVAQLREEAERR.3|TPVEVPVGGFK.2|EMSVYEAYR.2|GFFDPNTHENLTYR.3|GFFDPNTHENLTYR.2|HPQGEQMYR.2|IKELQNAGDR.2|KGIIRPGTAFELLEAQAATGYVIDPIK.5|KGIIRPGTAFELLEAQAATGYVIDPIK.4|KGIIRPGTAFELLEAQAATGYVIDPIK.3|LQAEEVAQQK.2|RAAEEAEEARVQAER.3|AEAELLQQQK.2|AVTGYRDPYTGQSVSLFQALK.4|AVTGYRDPYTGQSVSLFQALK.3|AVTGYRDPYTGQSVSLFQALK.2|C[CAM]ITDPQTGLC[CAM]LLPLK.3|C[CAM]ITDPQTGLC[CAM]LLPLK.2|DVAEVDTVRR.2|GFFDPNTHENLTYLQLLER.4|GFFDPNTHENLTYLQLLER.3|GFFDPNTHENLTYLQLLER.2|GYFDEEMNR.2|GYFDEEM[Oxi]NR.2|LRSLESLHSFVAAATK.3|LVASMEEARR.2|QYDIDDAIAK.2|RQAEVELASR.2|SDEGQLSPATR.2|SYVDPSTDERLSYTQLLRR.4|TLPNGRDALDGPAAEAEPEHSFDGLRR.5|TLPNGRDALDGPAAEAEPEHSFDGLRR.4|VVIVDPETGKEMSVYEAYRK.4|VVIVDPETGKEMSVYEAYRK.3|AETEQGEQQR.2|AQFEQLKDGK.2|C[CAM]DNFTSSWR.2|C[CAM]VEDPETGLR.2|IRSNAEDTLR.2|LLEAQIATGGVIDPVHSHRVPVDVAYR.5|LLEAQIATGGVIDPVHSHRVPVDVAYR.4|LLEAQIATGGVIDPVHSHRVPVDVAYR.3|LRAQAEAQQPTFDALRDELR.4|LRAQAEAQQPTFDALRDELR.3|LRAQAEAQQPTFDALRDELR.2|QTLSIYQALK.2|SSSVGSSSSYPISPAVSR.3|SSSVGSSSSYPISPAVSR.2|SYVDPSTDER.2|AGLVGPEFHEK.2|AGVVGPELHEQLLSAEK.3|AGVVGPELHEQLLSAEK.2|DPYSGSTISLFQAMQK.3|DPYSGSTISLFQAMQK.2|DPYTGQSVSLFQALKK.3|DPYTGQSVSLFQALKK.2|EAIAELEREK.2|ETFEKTPVEVPVGGFK.3|ETFEKTPVEVPVGGFK.2|LLEAQIATGGIIDPEESHRLPVEVAYK.5|LLEAQIATGGIIDPEESHRLPVEVAYK.4|LLEAQIATGGIIDPEESHRLPVEVAYK.3|RAQQQAEAER.2|RGPLPTEEQR.2|RQELEAELAK.2|FRELAEEAAR.2|LLFNDVQTLK.2|LLLEAQAATGFLLDPVK.3|LLLEAQAATGFLLDPVK.2|LPLLAVC[CAM]DYK.2|QEQIQAMPLADSQAVR.3|QEQIQAMPLADSQAVR.2|THYSELTTLTSQYIK.3|THYSELTTLTSQYIK.2|VAQLLERWQAVLAQTDVRQR.4|AQLMADFQAGR.2|AQLM[Oxi]ADFQAGR.2|AVTGYRDPYTEQTISLFQAMK.4|AVTGYRDPYTEQTISLFQAM[Oxi]K.3|AVTGYRDPYTEQTISLFQAMK.3|EGLTSIEEVTK.2|FLEGTSC[CAM]IAGVFVDATK.3|FLEGTSC[CAM]IAGVFVDATK.2|GDEC[CAM]QLVGPAQPSHWK.3|GDEC[CAM]QLVGPAQPSHWK.2|QQQQMEQER.2|SLAQAEAEKQKEEAER.3|EEAAVDAQQQK.2|GIIRPGTAFELLEAQAATGYVIDPIKGLK.5|GIIRPGTAFELLEAQAATGYVIDPIKGLK.4|GIIRPGTAFELLEAQAATGYVIDPIKGLK.3|DPYTGQQISLFQAMQK.3|DPYTGQQISLFQAM[Oxi]QK.2|DPYTGQQISLFQAMQK.2|GWLYYEAGQR.2|KQITMEELVR.2|LEDLLQDAQDEKEQLNEYKGHLSGLAK.5|LEDLLQDAQDEKEQLNEYKGHLSGLAK.4|LEDLLQDAQDEKEQLNEYKGHLSGLAK.3|QYLHLPPEIVPASLQR.3|QYLHLPPEIVPASLQR.2|RDDGTGQLLLPLSDARK.3|VQAEREAAQSR.2|AHEEQLKEAQAVPATLPELEATK.4|AHEEQLKEAQAVPATLPELEATK.3|EQELQQTLQQEQSVLDQLRGEAEAARR.5|EQELQQTLQQEQSVLDQLRGEAEAARR.4|EQLRQEQALLEEIER.3|EQLRQEQALLEEIER.2|SKGIYQSLEGAVQAGQLK.3|SKGIYQSLEGAVQAGQLK.2|DYELQLVTYK.2|EMSVYEAYRK.2|EQM[Oxi]AQQLAEETQGFQR.3|EQMAQQLAEETQGFQR.3|EQM[Oxi]AQQLAEETQGFQR.2|EQMAQQLAEETQGFQR.2|GGELVYTDSEARDVFEK.3|GGELVYTDSEARDVFEK.2|GTQGAEEVLRAHEEQLK.3|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.5|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.4|YLQDLLAWVEENQHR.3|YLQDLLAWVEENQHR.2|QRQLAEEDAAR.2|TLLQGSGC[CAM]LAGIYLEDTK.3|TLLQGSGC[CAM]LAGIYLEDTK.2|GGELVYTDSEAR.2|ILITIVEEVETLRQER.3|QLAEEDLAQQR.2|QQGLASYDYVR.2|RQEQIQAMPLADSQAVR.3|RQEQIQAMPLADSQAVR.2|VTLVQTLEIQR.2|ALQALEELRLQAEEAER.3|ATTAALLLEAQAATGFLVDPVRNQR.4|ATTAALLLEAQAATGFLVDPVRNQR.3|LEQLFQDEVAK.2|QAEEIGEKLHR.2|RGYFDEEMNR.2|AEQESARQLQLAQEAAQK.3|AGVAAPATQVAQVTLQSVQR.3|AGVAAPATQVAQVTLQSVQR.2|GANVIAGVWLEEAGQKLSIYNALKK.4|LLEAQAC[CAM]TGGIIDPSTGER.3|LLEAQAC[CAM]TGGIIDPSTGER.2|DSQDAGGFGPEDR.2|SATVTRLEDLLQDAQDEK.3|SATVTRLEDLLQDAQDEK.2|AEVVETTQVYTEEETRR.3|AEVVETTQVYTEEETRR.2|ASDSELERQKGLVEDTLR.3|DGHNLISLLEVLSGDSLPR.3|DGHNLISLLEVLSGDSLPR.2|EEAAVDAQQQKR.2|ERLAEVEAALEK.2|GIIRPGTAFELLEAQAATGYVIDPIK.4|GIIRPGTAFELLEAQAATGYVIDPIK.3|KGWLYYEAGQR.2|LLEAQIATGGIIDPEESHR.3|LLEAQIATGGIIDPEESHR.2|QEQALLEEIER.2|TLPNGRDALDGPAAEAEPEHSFDGLR.4|TLPNGRDALDGPAAEAEPEHSFDGLR.3|DALDGPAAEAEPEHSFDGLR.3|DALDGPAAEAEPEHSFDGLR.2|FLEVQYLTGGLIEPDTPGR.3|FLEVQYLTGGLIEPDTPGR.2|ELVLLLLQWMR.2|LLLEAQAATGFLLDPVKGER.3|LLLEAQAATGFLLDPVKGER.2|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.5|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|QEELQQLEQQR.2|SYVDPSTDERLSYTQLLR.3|AEQESARQLQLAQEAAQKR.3|AQAEAQQPTFDALRDELRGAQEVGER.4|GLFDEEMNEILTDPSDDTK.3|GLFDEEMNEILTDPSDDTK.2|TVTVWELISSEYFTAEQR.3|TVTVWELISSEYFTAEQR.2|AAEEAEEARVQAEREAAQSR.3|GYFDEEMNRVLADPSDDTK.3|QVEEAERLKQSAEEQAQAR.3|SATVTRLEDLLQDAQDEKEQLNEYK.4|TLLQGSGC[CAM]LAGIYLEDTKEK.3|TVTIWEIINSEYFTAEQR.3|TVTIWEIINSEYFTAEQR.2|VVIVDPETGKEMSVYEAYR.3|ATTAALLLEAQAATGFLVDPVR.3|ATTAALLLEAQAATGFLVDPVR.2|C[CAM]VEDPETGLC[CAM]LLPLTDKAAK.3|LKAGVAAPATQVAQVTLQSVQR.3|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.4|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.3|VDGAEWGVDLPSVEAQLGSHR.3|VDGAEWGVDLPSVEAQLGSHR.2|EEEEVGFDWSDR.2|EEEEVGFDWSDRNTNMTAK.3|EQELQQTLQQEQSVLDQLRGEAEAAR.4|EQELQQTLQQEQSVLDQLRGEAEAAR.3|GRTVTVWELISSEYFTAEQRQELLR.4|MQEEVVRREEAAVDAQQQK.3|RFPSSFEEIEILWSQFLK.3|VYRQTNLENLDQAFSVAER.3|YASGSSASLGGPESAVA.2|FIEQEKAKLEQLFQDEVAK.3|KDLLPSDMAVALLEAQAGTGHIIDPATSAR.4|AQAEAQQPTFDALR.2|EQELQQTLQQEQSVLDQLR.3|EQELQQTLQQEQSVLDQLR.2|GFFDPNTEENLTYLQLM[Oxi]ER.3|GFFDPNTEENLTYLQLMER.3|GFFDPNTEENLTYLQLMER.2|LEDLLQDAQDEKEQLNEYK.3|LSFSGLRAPVPASELLASGVLSR.3|QKAQVEQELTTLR.2|RGLFDEEMNEILTDPSDDTK.3|RGLFDEEM[Oxi]NEILTDPSDDTK.3|RGLFDEEMNEILTDPSDDTK.2|SIQEELQQLRQSSEAEIQAK.3|FLEVQYLTGGLIEPDTPGRVPLDEALQR.4|FLEVQYLTGGLIEPDTPGRVPLDEALQR.3|GRTVTVWELISSEYFTAEQR.3|LQLEETDHQKNLLDEELQR.3|QALHSLELHYQAFLRDSQDAGGFGPEDR.4|AHAFAVQQKEQELQQTLQQEQSVLDQLRGEAEAAR.5|ENAAYFQFFSDVR.2|QYINAIKDYELQLVTYKAQLEPVASPAK.4|SEEMQTVQQEQLLQETQALQQSFLSEK.4|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEK.3|SEEMQTVQQEQLLQETQALQQSFLSEK.3|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.4|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.3|ENAAYFQFFSDVREAEGQLQK.3|GANVIAGVWLEEAGQK.2|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.5|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.4|LQEDKEQMAQQLAEETQGFQR.3|RYASGSSASLGGPESAVA.2|VLALPEPSPAAPTLRSELELTLGK.3|IAEQQKAQAEVEGLGK.2|SQVMDEATALQLREGLTSIEEVTK.3|GYYSPYSVSGSGSTAGSR.2|LQM[Oxi]EAGLC[CAM]EEQLNQADALLQSDVR.3|LQMEAGLC[CAM]EEQLNQADALLQSDVR.3|RGSFDATGSGFSMTFSSSSYSSSGYGR.3|TVTVWELISSEYFTAEQRQELLR.3|AEVVETTQVYTEEETR.2|EALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3|TQLASWSDPTEETGPVAGILDTETLEK.3|AFEETQIDIPGGGSHGGSTMSLWEVMQSDLIPEEQR.4|ELEEVSPETPVVPATTQR.2|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SEEMQTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SLREALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3
SEN / CTL,P13667,Protein disulfide-isomerase A4,PDIA4,2.22,1.99,4.93E-08,8.40E-09,8.08E+00,"protein folding,protein secretion,response to endoplasmic reticulum stress,cell redox homeostasis,chaperone-mediated protein folding","protein disulfide isomerase activity,protein binding,poly(A) RNA binding","endoplasmic reticulum lumen,cell surface,melanosome",42,69,125,IDATSASVLASR.2|FDVSGYPTLK.2|FDVSGYPTIK.2|VDATAETDLAK.2|YGIVDYMIEQSGPPSKEILTLK.3|YGIVDYMIEQSGPPSKEILTLK.4|KGQAVDYEGSRTQEEIVAK.4|KGQAVDYEGSRTQEEIVAK.3|SHMMDVQGSTQDSAIKDFVLK.4|SHM[Oxi]M[Oxi]DVQGSTQDSAIKDFVLK.4|SHM[Oxi]MDVQGSTQDSAIKDFVLK.4|SHMM[Oxi]DVQGSTQDSAIKDFVLK.4|SHM[Oxi]M[Oxi]DVQGSTQDSAIKDFVLK.3|SHM[Oxi]MDVQGSTQDSAIKDFVLK.3|SHMMDVQGSTQDSAIKDFVLK.3|KGQAVDYEGSR.3|KGQAVDYEGSR.2|SPPIPLAK.2|DLEHLSK.2|LAPEYEK.2|RFDVSGYPTLK.3|RFDVSGYPTLK.2|TFDSIVMDPKK.3|TFDSIVMDPKK.2|IANILKDKDPPIPVAK.4|IANILKDKDPPIPVAK.3|VDATAETDLAKR.3|VDATAETDLAKR.2|AATQFWR.2|FHHTFSTEIAK.3|FHHTFSTEIAK.2|QVQEFLK.2|TQEEIVAK.2|VSQGQLVVMQPEK.3|VSQGQLVVMQPEK.2|VSQGQLVVM[Oxi]QPEK.2|FIEEHATK.2|KLAPEYEK.2|RSPPIPLAK.2|KDVLIEFYAPWC[CAM]GHC[CAM]K.4|KDVLIEFYAPWC[CAM]GHC[CAM]K.3|KDVLIEFYAPWC[CAM]GHC[CAM]K.2|QFAPEYEK.2|EKYGIVDYMIEQSGPPSK.4|EKYGIVDYMIEQSGPPSK.3|EKYGIVDYMIEQSGPPSK.2|YALPLVGHR.2|YKVEGFPTIYFAPSGDKK.4|YKVEGFPTIYFAPSGDKK.3|YKVEGFPTIYFAPSGDKK.2|MDATANDVPSDRYK.3|M[Oxi]DATANDVPSDRYK.3|EVSQPDWTPPPEVTLVLTK.4|EVSQPDWTPPPEVTLVLTK.3|EVSQPDWTPPPEVTLVLTK.2|DKDPPIPVAK.2|GQAVDYEGSR.2|VEGFPTIYFAPSGDK.3|VEGFPTIYFAPSGDK.2|VEGFPTIYFAPSGDKKNPVK.4|DLGLSESGEDVNAAILDESGKK.4|DLGLSESGEDVNAAILDESGKK.3|DLGLSESGEDVNAAILDESGKK.2|FAMEPEEFDSDTLR.3|FAMEPEEFDSDTLR.2|FAM[Oxi]EPEEFDSDTLR.2|SHMMDVQGSTQDSAIK.3|SHM[Oxi]MDVQGSTQDSAIK.3|SHMM[Oxi]DVQGSTQDSAIK.3|SHM[Oxi]M[Oxi]DVQGSTQDSAIK.3|SHMM[Oxi]DVQGSTQDSAIK.2|SHMMDVQGSTQDSAIK.2|TFDSIVMDPK.2|TFDSIVM[Oxi]DPK.2|VEGFPTIYFAPSGDKK.3|VEGFPTIYFAPSGDKK.2|YGIVDYMIEQSGPPSK.3|YGIVDYMIEQSGPPSK.2|YGIVDYM[Oxi]IEQSGPPSK.2|GRPYDYNGPR.2|VREVSQPDWTPPPEVTLVLTK.4|VREVSQPDWTPPPEVTLVLTK.3|VREVSQPDWTPPPEVTLVLTK.2|KFAMEPEEFDSDTLR.3|KFAM[Oxi]EPEEFDSDTLR.3|KFAMEPEEFDSDTLR.2|EDYKFHHTFSTEIAK.3|EDYKFHHTFSTEIAK.2|FAMEPEEFDSDTLREFVTAFK.4|FAM[Oxi]EPEEFDSDTLREFVTAFK.3|FAMEPEEFDSDTLREFVTAFK.3|QLEPVYNSLAK.2|DVLIEFYAPWC[CAM]GHC[CAM]K.3|DVLIEFYAPWC[CAM]GHC[CAM]K.2|TFDSIVMDPKKDVLIEFYAPWC[CAM]GHC[CAM]K.5|TFDSIVMDPKKDVLIEFYAPWC[CAM]GHC[CAM]K.4|DGDDVIIIGVFK.2|MDATANDVPSDR.2|M[Oxi]DATANDVPSDR.2|VSQGQLVVMQPEKFQSK.3|YKVEGFPTIYFAPSGDK.3|YKVEGFPTIYFAPSGDK.2|FAMEPEEFDSDTLREFVTAFKK.4|FAM[Oxi]EPEEFDSDTLREFVTAFKK.4|GQAVDYEGSRTQEEIVAK.3|KFAMEPEEFDSDTLREFVTAFK.4|DTVLLEFYAPWC[CAM]GHC[CAM]K.3|DTVLLEFYAPWC[CAM]GHC[CAM]K.2|GESDPAYQQYQDAANNLR.3|GESDPAYQQYQDAANNLR.2|DLGLSESGEDVNAAILDESGK.3|DLGLSESGEDVNAAILDESGK.2|QVQEFLKDGDDVIIIGVFK.3|QVQEFLKDGDDVIIIGVFK.2|FEGGDRDLEHLSK.2|IDATSASVLASRFDVSGYPTIK.3|DFPEYTFAIADEEDYAGEVK.3|DFPEYTFAIADEEDYAGEVK.2|GESDPAYQQYQDAANNLREDYK.3|EKYGIVDYMIEQSGPPSKEILTLK.3|DGDDVIIIGVFKGESDPAYQQYQDAANNLREDYK.4|VLEVAKDFPEYTFAIADEEDYAGEVK.3|ENAIEDEEEEEEEDDDEEEDDLEVK.3|ENFDEVVNDADIILVEFYAPWC[CAM]GHC[CAM]K.3|EENGVLVLNDANFDNFVADK.2
SEN / CTL,P55209,Nucleosome assembly protein 1-like 1,NAP1L1,2.22,1.32,1.07E-09,2.21E-10,9.66E+00,"DNA replication,nucleosome assembly,positive regulation of cell proliferation","protein binding,poly(A) RNA binding","nucleus,membrane,melanosome",24,18,36,LDGLVETPTGYIESLPR.2|LDGLVETPTGYIESLPR.3|FYEEVHDLER.3|FYEEVHDLER.2|NVDLLSDMVQEHDEPILK.3|NVDLLSDM[Oxi]VQEHDEPILK.3|NVDLLSDMVQEHDEPILK.2|NVDLLSDM[Oxi]VQEHDEPILK.2|C[CAM]AQIEAK.2|KYAVLYQPLFDKR.4|KYAVLYQPLFDKR.3|KYAVLYQPLFDKR.2|GIPEFWLTVFK.3|GIPEFWLTVFK.2|KYAVLYQPLFDK.3|KYAVLYQPLFDK.2|YAVLYQPLFDKR.3|YAVLYQPLFDKR.2|YAVLYQPLFDK.2|QLTVQM[Oxi]MQNPQILAALQER.3|QLTVQMM[Oxi]QNPQILAALQER.3|QLTVQMMQNPQILAALQER.3|QLTVQMMQNPQILAALQER.2|QLTVQM[Oxi]M[Oxi]QNPQILAALQER.2|QLTVQM[Oxi]MQNPQILAALQER.2|RFEIINAIYEPTEEEC[CAM]EWKPDEEDEISEELK.5|RFEIINAIYEPTEEEC[CAM]EWKPDEEDEISEELK.4|FSDAGQPMSFVLEFHFEPNEYFTNEVLTK.4|FSDAGQPMSFVLEFHFEPNEYFTNEVLTK.3|MRSEPDDSDPFSFDGPEIMGC[CAM]TGC[CAM]QIDWKK.4|EQSELDQDLDDVEEVEEEETGEETK.3|FEIINAIYEPTEEEC[CAM]EWKPDEEDEISEELKEK.4|SEPDDSDPFSFDGPEIM[Oxi]GC[CAM]TGC[CAM]QIDWK.3|SEPDDSDPFSFDGPEIMGC[CAM]TGC[CAM]QIDWK.3|SEPDDSDPFSFDGPEIMGC[CAM]TGC[CAM]QIDWKK.3|MRSEPDDSDPFSFDGPEIMGC[CAM]TGC[CAM]QIDWK.3
SEN / CTL,P62249,40S ribosomal protein S16,RPS16,2.21,1.37,1.00E-05,1.32E-06,5.88E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal small subunit biogenesis,liver regeneration","RNA binding,structural constituent of ribosome,poly(A) RNA binding","nucleoplasm,cytosol,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",18,14,19,LLEPVLLLGK.2|EIKDILIQYDR.3|EIKDILIQYDR.2|GGGHVAQIYAIR.3|GGGHVAQIYAIR.2|TLLVADPR.2|LLEPVLLLGKER.3|VNGRPLEMIEPR.3|VNGRPLEM[Oxi]IEPR.3|VNGRPLEMIEPR.2|YVDEASKK.2|ALVAYYQK.2|TATAVAHC[CAM]K.2|VKGGGHVAQIYAIR.3|PLEMIEPR.2|PSKGPLQSVQVFGR.3|PSKGPLQSVQVFGR.2|DILIQYDR.2|GPLQSVQVFGR.2
SEN / CTL,P07951,Tropomyosin beta chain,TPM2,2.21,1.82,3.25E-10,7.16E-11,1.01E+01,"muscle contraction,muscle filament sliding,regulation of ATPase activity","actin binding,structural constituent of muscle","cytosol,muscle thin filament tropomyosin",48,29,46,AMKDEEKMELQEMQLK.4|AMKDEEKMELQEMQLK.3|KLVILEGELER.3|KLVILEGELER.2|LVILEGELER.2|KATDAEADVASLNR.3|KATDAEADVASLNR.2|ATDAEADVASLNR.2|ATDAEADVASLNR.3|HIAEDSDRKYEEVAR.4|HIAEDSDRKYEEVAR.3|KATDAEADVASLNRR.4|KATDAEADVASLNRR.3|KATDAEADVASLNRR.2|SEERAEVAESK.3|ENAIDRAEQAEADKK.4|ENAIDRAEQAEADKK.3|C[CAM]KQLEEEQQALQKK.4|C[CAM]KQLEEEQQALQKK.3|QLEEEQQALQK.3|QLEEEQQALQK.2|SLEAQADKYSTK.3|SLEAQADKYSTK.2|GTEDEVEK.2|HIAEDSDR.2|EAQEKLEQAEKK.3|QLEEEQQALQKK.3|QLEEEQQALQKK.2|ATDAEADVASLNRR.3|ATDAEADVASLNRR.2|ENAIDRAEQAEADK.3|LDKENAIDR.2|C[CAM]KQLEEEQQALQK.3|C[CAM]KQLEEEQQALQK.2|C[CAM]GDLEEELK.2|AISEELDNALNDITSL.3|AISEELDNALNDITSL.2|LKGTEDEVEK.2|MELQEMQLK.2|M[Oxi]ELQEMQLK.2|MELQEM[Oxi]QLK.2|KLVILEGELERSEER.3|EAQEKLEQAEK.2|YSESVKEAQEK.2|TIDDLEDEVYAQK.2|GTEDEVEKYSESVK.2
SEN / CTL,Q14974,Importin subunit beta-1,KPNB1,2.21,1.46,3.08E-10,6.88E-11,1.02E+01,"protein import into nucleus, docking,protein import into nucleus, translocation,apoptotic DNA fragmentation,protein import into nucleus,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,mitotic chromosome movement towards spindle pole,mitotic metaphase plate congression,modulation by virus of host process,astral microtubule organization,Ran protein signal transduction,establishment of mitotic spindle localization,establishment of protein localization,intracellular transport of virus,mitotic spindle assembly","protein binding,nuclear localization sequence binding,zinc ion binding,Ran GTPase binding,protein transporter activity,enzyme binding,protein domain specific binding,poly(A) RNA binding,Hsp90 protein binding","nuclear envelope,nuclear pore,nucleoplasm,cytoplasm,cytosol,membrane,nuclear membrane,nuclear periphery,extracellular exosome,endoplasmic reticulum tubular network",36,54,109,AAVENLPTFLVELSR.2|AAVENLPTFLVELSR.3|LAATNALLNSLEFTK.2|LAATNALLNSLEFTK.3|VAAGLQIK.2|ALQSNIIPFC[CAM]DEVMQLLLENLGNENVHR.4|ALQSNIIPFC[CAM]DEVM[Oxi]QLLLENLGNENVHR.4|ALQSNIIPFC[CAM]DEVM[Oxi]QLLLENLGNENVHR.3|ALQSNIIPFC[CAM]DEVMQLLLENLGNENVHR.3|NSLTSKDPDIK.3|NSLTSKDPDIK.2|VLANPGNSQVAR.3|VLANPGNSQVAR.2|PFLGIGLK.2|PMIHELLTEGR.3|PM[Oxi]IHELLTEGR.3|PMIHELLTEGR.2|PM[Oxi]IHELLTEGR.2|LELEAAQK.2|SSAYESLMEIVK.3|SSAYESLM[Oxi]EIVK.2|SSAYESLMEIVK.2|NSAKDC[CAM]YPAVQK.3|NSAKDC[CAM]YPAVQK.2|LLETTDRPDGHQNNLR.4|LLETTDRPDGHQNNLR.3|PMIHELLTEGRR.3|PM[Oxi]IHELLTEGRR.3|SNEILTAIIQGMR.3|SNEILTAIIQGMR.2|SNEILTAIIQGM[Oxi]R.2|TTLVIMER.2|VAALQNLVK.2|DTAAWTVGR.2|DC[CAM]YPAVQK.2|NSLTSKDPDIKAQYQQR.4|NSLTSKDPDIKAQYQQR.3|WLAIDANAR.2|KEEPSNNVK.2|NYVLQTLGTETYR.3|NYVLQTLGTETYR.2|SNEILTAIIQGMRK.3|SNEILTAIIQGMRK.2|VQHQDALQISDVVMASLLR.4|VQHQDALQISDVVM[Oxi]ASLLR.3|VQHQDALQISDVVMASLLR.3|VQHQDALQISDVVMASLLR.2|YMEAFKPFLGIGLK.3|YM[Oxi]EAFKPFLGIGLK.3|YM[Oxi]EAFKPFLGIGLK.2|YMEAFKPFLGIGLK.2|SDYDMVDYLNELR.3|SDYDMVDYLNELR.2|SDYDM[Oxi]VDYLNELR.2|ANFDKESER.2|ESC[CAM]LEAYTGIVQGLK.3|ESC[CAM]LEAYTGIVQGLK.2|KVQHQDALQISDVVM[Oxi]ASLLR.4|KVQHQDALQISDVVMASLLR.4|KVQHQDALQISDVVM[Oxi]ASLLR.3|KVQHQDALQISDVVMASLLR.3|PLVIQAMPTLIELMK.3|PLVIQAMPTLIELM[Oxi]K.3|PLVIQAM[Oxi]PTLIELMK.2|PLVIQAMPTLIELM[Oxi]K.2|PLVIQAMPTLIELMK.2|GALQYLVPILTQTLTK.3|GALQYLVPILTQTLTK.2|QDENDDDDDWNPC[CAM]K.3|QDENDDDDDWNPC[CAM]K.2|SVKPQILSVFGDIALAIGGEFKK.4|SVKPQILSVFGDIALAIGGEFKK.3|GDQENVHPDVMLVQPR.3|GDQENVHPDVM[Oxi]LVQPR.3|GDQENVHPDVMLVQPR.2|LVEARPMIHELLTEGR.3|ESTLEAIGYIC[CAM]QDIDPEQLQDK.4|ESTLEAIGYIC[CAM]QDIDPEQLQDK.3|ESERHFIMQVVC[CAM]EATQC[CAM]PDTR.4|LQQVLQMESHIQSTSDR.3|LQQVLQM[Oxi]ESHIQSTSDR.3|LQQVLQMESHIQSTSDR.2|ESC[CAM]LEAYTGIVQGLKGDQENVHPDVMLVQPR.5|ESC[CAM]LEAYTGIVQGLKGDQENVHPDVMLVQPR.4|ESC[CAM]LEAYTGIVQGLKGDQENVHPDVMLVQPR.3|HFIM[Oxi]QVVC[CAM]EATQC[CAM]PDTR.3|HFIMQVVC[CAM]EATQC[CAM]PDTR.3|HFIMQVVC[CAM]EATQC[CAM]PDTR.2|HFIM[Oxi]QVVC[CAM]EATQC[CAM]PDTR.2|DAAVMAFGC[CAM]ILEGPEPSQLK.3|DAAVMAFGC[CAM]ILEGPEPSQLK.2|YLEVVLNTLQQASQAQVDK.3|YLEVVLNTLQQASQAQVDK.2|AAGVC[CAM]LMLLATC[CAM]C[CAM]EDDIVPHVLPFIK.4|AAGVC[CAM]LM[Oxi]LLATC[CAM]C[CAM]EDDIVPHVLPFIK.3|AAGVC[CAM]LMLLATC[CAM]C[CAM]EDDIVPHVLPFIK.3|KYLEVVLNTLQQASQAQVDK.3|KYLEVVLNTLQQASQAQVDK.2|NYAEYQVC[CAM]LAAVGLVGDLC[CAM]R.3|SVKPQILSVFGDIALAIGGEFK.3|TVSPDRLELEAAQK.2|IQFNDLQSLLC[CAM]ATLQNVLRK.3|PLVIQAMPTLIELMKDPSVVVR.3|YRDAAVMAFGC[CAM]ILEGPEPSQLK.3|YRDAAVM[Oxi]AFGC[CAM]ILEGPEPSQLK.3|GALQYLVPILTQTLTKQDENDDDDDWNPC[CAM]K.4|LQQVLQMESHIQSTSDRIQFNDLQSLLC[CAM]ATLQNVLRK.5|YLEVVLNTLQQASQAQVDKSDYDMVDYLNELR.4|LQQVLQMESHIQSTSDRIQFNDLQSLLC[CAM]ATLQNVLR.4
SEN / CTL,P13693,Translationally-controlled tumor protein,TPT1,2.21,1.11,7.39E-11,1.75E-11,1.08E+01,"calcium ion transport,cellular calcium ion homeostasis,response to virus,cell differentiation,regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage","calcium ion binding,protein binding,microtubule binding,poly(A) RNA binding","extracellular space,nucleus,cytoplasm,multivesicular body,extracellular exosome,tubulin complex",30,14,26,IREIADGLC[CAM]LEVEGK.3|IREIADGLC[CAM]LEVEGK.2|MIIYRDLISHDEMFSDIYK.4|MIIYRDLISHDEMFSDIYK.3|DLISHDEMFSDIYK.3|DLISHDEMFSDIYK.2|DLISHDEM[Oxi]FSDIYK.3|DLISHDEM[Oxi]FSDIYK.2|VKPFMTGAAEQIK.3|VKPFM[Oxi]TGAAEQIK.3|VKPFMTGAAEQIK.2|VKPFM[Oxi]TGAAEQIK.2|DGLEMEK.2|DGLEM[Oxi]EK.2|HILANFK.2|EIADGLC[CAM]LEVEGK.3|EIADGLC[CAM]LEVEGK.2|VKPFMTGAAEQIKHILANFK.4|PFMTGAAEQIK.2|PFM[Oxi]TGAAEQIK.2|GKLEEQRPER.2|EDGVTPYMIFFK.2|EDGVTPYMIFFKDGLEMEK.3|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.6|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.5|NYQFFIGENMNPDGMVALLDYR.3
SEN / CTL,P10599,Thioredoxin,TXN,2.21,1.60,2.35E-06,3.34E-07,6.48E+00,"sulfate assimilation,negative regulation of transcription from RNA polymerase II promoter,response to reactive oxygen species,transcription, DNA-templated,protein folding,glycerol ether metabolic process,movement of cell or subcellular component,signal transduction,cell-cell signaling,cell proliferation,response to radiation,nucleobase-containing small molecule interconversion,protein repair,activation of protein kinase B activity,positive regulation of peptidyl-serine phosphorylation,regulation of protein import into nucleus, translocation,positive regulation of DNA binding,cell redox homeostasis,negative regulation of protein export from nucleus,positive regulation of protein kinase B signaling,oxidation-reduction process,negative regulation of hydrogen peroxide-induced cell death","protein binding,protein disulfide oxidoreductase activity,peptide disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",30,12,20,TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.4|TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.3|VGEFSGANKEKLEATINELV.3|VGEFSGANKEKLEATINELV.2|C[CAM]MPTFQFFK.2|C[CAM]M[Oxi]PTFQFFK.2|EKLEATINELV.2|C[CAM]MPTFQFFKK.3|TAFQEALDAAGDK.3|TAFQEALDAAGDK.2|VGEFSGANK.2|MIKPFFHSLSEK.3|M[Oxi]IKPFFHSLSEK.3|MIKPFFHSLSEK.2|M[Oxi]IKPFFHSLSEK.2|LEATINELV.2|PFFHSLSEK.2|LVVVDFSATWC[CAM]GPC[CAM]K.3|LVVVDFSATWC[CAM]GPC[CAM]K.2|VGEFSGANKEK.2
SEN / CTL,Q9NR45,Sialic acid synthase,NANS,2.21,1.36,2.08E-08,3.72E-09,8.43E+00,lipopolysaccharide biosynthetic process,"N-acylneuraminate cytidylyltransferase activity,N-acylneuraminate-9-phosphate synthase activity,N-acetylneuraminate synthase activity","cytoplasm,cytosol,extracellular exosome",24,23,39,PLELELC[CAM]PGR.2|GSDHSASLEPGELAELVR.3|GSDHSASLEPGELAELVR.2|VKIPEGTILTMDMLTVK.3|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAKR.5|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAKR.4|VISEYQK.2|HLEFSHDQYR.3|HLEFSHDQYR.2|RHLEFSHDQYR.3|RHLEFSHDQYR.2|QLLPC[CAM]EMAC[CAM]NEK.3|QLLPC[CAM]EM[Oxi]AC[CAM]NEK.2|QLLPC[CAM]EMAC[CAM]NEK.2|RHLEFSHDQYRELQR.4|VGSGDTNNFPYLEK.3|VGSGDTNNFPYLEK.2|ALERPYTSK.2|GYPPEDIFNLVGKK.3|GYPPEDIFNLVGKK.2|TWKGSDHSASLEPGELAELVR.4|TWKGSDHSASLEPGELAELVR.3|GRPMVISSGMQSMDTMK.3|GRPM[Oxi]VISSGMQSMDTMK.3|VLVTVEEDDTIMEELVDNHGKK.4|VLVTVEEDDTIMEELVDNHGKK.3|LFPDIPIGYSGHETGIAISVAAVALGAK.4|LFPDIPIGYSGHETGIAISVAAVALGAK.3|GYPPEDIFNLVGK.2|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAK.4|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAK.3|PLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.4|PLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.3|QVYQIVKPLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.5|QVYQIVKPLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.4|VLVTVEEDDTIMEELVDNHGK.3|IPEGTILTMDMLTVK.2|IPEGTILTMDM[Oxi]LTVK.2|PMVISSGMQSMDTMK.2
SEN / CTL,P63244,Guanine nucleotide-binding protein subunit beta-2-like 1,GNB2L1,2.20,1.56,1.47E-03,1.42E-04,3.85E+00,"positive regulation of protein phosphorylation,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,cell cycle,gastrulation,negative regulation of gene expression,regulation of tumor necrosis factor-mediated signaling pathway,viral process,negative regulation of translation,negative regulation of Wnt signaling pathway,negative regulation of cell growth,positive regulation of cell migration,positive regulation of cAMP catabolic process,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein homooligomerization,regulation of protein localization,negative regulation of peptidyl-serine phosphorylation,positive regulation of Golgi to plasma membrane protein transport,positive regulation of apoptotic process,positive regulation of GTPase activity,rhythmic process,negative regulation of phagocytosis,regulation of cell division,positive regulation of cyclic-nucleotide phosphodiesterase activity,regulation of cell cycle,negative regulation of protein kinase B signaling,positive regulation of mitochondrial depolarization,negative regulation of protein tyrosine kinase activity,cellular response to glucose stimulus,cellular response to growth factor stimulus,cell-cell adhesion,negative regulation of endoplasmic reticulum unfolded protein response,negative regulation of hydrogen peroxide-induced neuron death,regulation of establishment of cell polarity,positive regulation of ceramide biosynthetic process,positive regulation of gastrulation,positive regulation of intrinsic apoptotic signaling pathway","protein kinase C binding,receptor binding,protein binding,ion channel inhibitor activity,cysteine-type endopeptidase activator activity involved in apoptotic process,enzyme binding,protein phosphatase binding,protein tyrosine kinase inhibitor activity,receptor tyrosine kinase binding,protein complex scaffold,signaling adaptor activity,SH2 domain binding,protein homodimerization activity,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","phagocytic cup,nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,small ribosomal subunit,dendrite,midbody,neuronal cell body,perikaryon,perinuclear region of cytoplasm,extracellular exosome,IRE1-RACK1-PP2A complex",30,30,51,DGQAMLWDLNEGK.2|DGQAMLWDLNEGK.3|DGQAM[Oxi]LWDLNEGK.2|VWQVTIGTR.2|IIVDELKQEVISTSSK.3|IIVDELKQEVISTSSK.2|YWLC[CAM]AATGPSIK.2|YWLC[CAM]AATGPSIK.3|GTLKGHNGWVTQIATTPQFPDMILSASR.4|GTLKGHNGWVTQIATTPQFPDMILSASR.3|IIVDELK.2|IWDLEGK.2|DVLSVAFSSDNR.3|DVLSVAFSSDNR.2|LWDLTTGTTTRR.3|QEVISTSSK.2|YTVQDESHSEWVSC[CAM]VR.4|YTVQDESHSEWVSC[CAM]VR.3|YTVQDESHSEWVSC[CAM]VR.2|VWNLANC[CAM]K.2|LTRDETNYGIPQR.3|LTRDETNYGIPQR.2|GHNGWVTQIATTPQFPDMILSASR.5|GHNGWVTQIATTPQFPDMILSASR.4|GHNGWVTQIATTPQFPDM[Oxi]ILSASR.4|GHNGWVTQIATTPQFPDM[Oxi]ILSASR.3|GHNGWVTQIATTPQFPDMILSASR.3|LWNTLGVC[CAM]K.2|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.5|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.3|HLYTLDGGDIINALC[CAM]FSPNR.4|HLYTLDGGDIINALC[CAM]FSPNR.3|HLYTLDGGDIINALC[CAM]FSPNR.2|DETNYGIPQR.2|FSPNSSNPIIVSC[CAM]GWDK.3|FSPNSSNPIIVSC[CAM]GWDK.2|LWDLTTGTTTR.2|IWDLEGKIIVDELKQEVISTSSK.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.6|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.5|GHNGWVTQIATTPQFPDMILSASRDK.4|GHSHFVSDVVISSDGQFALSGSWDGTLR.4|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.6|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.5|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.4|AEPPQC[CAM]TSLAWSADGQTLFAGYTDNLVR.4|AEPPQC[CAM]TSLAWSADGQTLFAGYTDNLVR.3|HLYTLDGGDIINALC[CAM]FSPNRYWLC[CAM]AATGPSIK.4|DGQAMLWDLNEGKHLYTLDGGDIINALC[CAM]FSPNR.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGKHLYTLDGGDIINALC[CAM]FSPNR.6
SEN / CTL,P07737,Profilin-1,PFN1,2.20,2.16,1.85E-18,9.00E-19,1.80E+01,"neural tube closure,positive regulation of epithelial cell migration,actin cytoskeleton organization,negative regulation of actin filament polymerization,positive regulation of actin filament polymerization,negative regulation of actin filament bundle assembly,positive regulation of actin filament bundle assembly,positive regulation of ATPase activity,positive regulation of transcription from RNA polymerase II promoter,positive regulation of viral transcription,protein stabilization,positive regulation of DNA metabolic process,positive regulation of stress fiber assembly,negative regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,cellular response to growth factor stimulus,cell-cell adhesion,positive regulation of ruffle assembly","adenyl-nucleotide exchange factor activity,actin binding,actin monomer binding,receptor binding,protein binding,phosphatidylinositol-4,5-bisphosphate binding,Rho GTPase binding,poly(A) RNA binding,proline-rich region binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cytoskeleton,cell-cell adherens junction,focal adhesion,cell cortex,membrane,neuron projection,synapse,extracellular exosome,blood microparticle",102,19,37,TFVNITPAEVGVLVGKDR.3|TFVNITPAEVGVLVGKDR.2|STGGAPTFNVTVTKTDK.3|STGGAPTFNVTVTKTDK.2|STGGAPTFNVTVTK.2|STGGAPTFNVTVTK.3|TFVNITPAEVGVLVGK.2|TFVNITPAEVGVLVGK.3|SSFYVNGLTLGGQK.2|SSFYVNGLTLGGQK.3|TKSTGGAPTFNVTVTK.3|TKSTGGAPTFNVTVTK.2|C[CAM]SVIRDSLLQDGEFSMDLR.3|C[CAM]SVIRDSLLQDGEFSMDLR.4|C[CAM]SVIRDSLLQDGEFSM[Oxi]DLR.3|C[CAM]SVIRDSLLQDGEFSMDLR.2|DSPSVWAAVPGK.2|DSPSVWAAVPGK.3|DRSSFYVNGLTLGGQK.3|DRSSFYVNGLTLGGQK.4|DRSSFYVNGLTLGGQK.2|DSLLQDGEFSMDLR.2|DSLLQDGEFSMDLR.3|DSLLQDGEFSM[Oxi]DLR.3|DSLLQDGEFSM[Oxi]DLR.2|TLVLLMGK.2|TLVLLM[Oxi]GK.2|TDKTLVLLMGK.3|TDKTLVLLMGK.2|KC[CAM]YEMASHLR.3|C[CAM]YEMASHLRR.3|EGVHGGLINK.2|EGVHGGLINKK.2|C[CAM]YEMASHLR.2|C[CAM]YEM[Oxi]ASHLR.2|C[CAM]SVIRDSLLQDGEFSM[Oxi]DLRTK.3|TFVNITPAEVGVLVGKDRSSFYVNGLTLGGQK.4
SEN / CTL,O00170,AH receptor-interacting protein,AIP,2.20,0.75,6.76E-04,6.81E-05,4.17E+00,"protein targeting to mitochondrion,xenobiotic metabolic process,signal transduction,regulation of protein kinase A signaling,protein maturation by protein folding,negative regulation of cyclic-nucleotide phosphodiesterase activity,regulation of nucleic acid-templated transcription","transcription coactivator activity,signal transducer activity,protein binding,transcription factor binding,aryl hydrocarbon receptor binding,GAF domain binding,unfolded protein binding","nucleoplasm,cytoplasm,cytosol,aryl hydrocarbon receptor complex,plasma membrane",6,19,29,VLELDPALAPVVSR.2|VLELDPALAPVVSR.3|AVPLIHQEGNR.3|AVPLIHQEGNR.2|NIAVGKDPLEGQR.3|NIAVGKDPLEGQR.2|LPVWETIVC[CAM]TMR.3|LPVWETIVC[CAM]TMR.2|RVIQEGRGELPDFQDGTK.4|RVIQEGRGELPDFQDGTK.3|GKPMELIIGK.2|TLHSDDEGTVLDDSR.3|TLHSDDEGTVLDDSR.2|HC[CAM]C[CAM]GVAQMR.2|YYDAIAC[CAM]LK.2|HVVLYPLVAK.2|FKLPVWETIVC[CAM]TMR.3|GELPDFQDGTK.2|AHAAVWNAQEAQADFAK.3|AHAAVWNAQEAQADFAK.2|EHSSLGHADLDALQQNPQPLIFHMEMLK.5|EHSSLGHADLDALQQNPQPLIFHMEMLK.4|EHSSLGHADLDALQQNPQPLIFHMEMLK.3|EGEIAQFLC[CAM]DIK.2|LVVEEYYEVLDHC[CAM]SSILNKYDDNVK.4|LVVEEYYEVLDHC[CAM]SSILNK.3|LVVEEYYEVLDHC[CAM]SSILNK.2|EQPGSPEWIQLDQQITPLLLNYC[CAM]QC[CAM]K.3|VESPGTYQQDPWAMTDEEK.2
SEN / CTL,P05387,60S acidic ribosomal protein P2,RPLP2,2.19,2.68,9.78E-06,1.29E-06,5.89E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,large ribosomal subunit rRNA binding","cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,preribosome, large subunit precursor,extracellular exosome",48,13,30,YVASYLLAALGGNSSPSAK.3|YVASYLLAALGGNSSPSAK.2|YVASYLLAALGGNSSPSAK.4|NIEDVIAQGIGK.2|NIEDVIAQGIGK.3|ILDSVGIEADDDRLNK.3|ILDSVGIEADDDRLNK.2|VISELNGKNIEDVIAQGIGK.3|VISELNGKNIEDVIAQGIGK.2|ILDSVGIEADDDRLNKVISELNGK.4|ILDSVGIEADDDRLNKVISELNGK.3|KILDSVGIEADDDRLNK.3|KILDSVGIEADDDRLNK.4|KILDSVGIEADDDRLNK.2|ILDSVGIEADDDR.3|ILDSVGIEADDDR.2|KILDSVGIEADDDR.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.6|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.5|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.5|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.3|RYVASYLLAALGGNSSPSAK.3|RYVASYLLAALGGNSSPSAK.2|M[Oxi]RYVASYLLAALGGNSSPSAK.3|MRYVASYLLAALGGNSSPSAK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.3
SEN / CTL,O43852,Calumenin,CALU,2.19,1.27,1.01E-13,3.23E-14,1.35E+01,biological_process,"calcium ion binding,protein binding","extracellular region,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,membrane,sarcoplasmic reticulum lumen,melanosome",60,34,62,WIYEDVER.2|IDGDKDGFVTVDELKDWIK.4|IDGDKDGFVTVDELKDWIK.3|MDKEETKDWILPSDYDHAEAEAR.5|MDKEETKDWILPSDYDHAEAEAR.4|M[Oxi]DKEETKDWILPSDYDHAEAEAR.4|TFDQLTPEESKER.3|EEIVDKYDLFVGSQATDFGEALVRHDEF.4|EEIVDKYDLFVGSQATDFGEALVRHDEF.3|RWIYEDVER.3|RWIYEDVER.2|DWILPSDYDHAEAEAR.3|DWILPSDYDHAEAEAR.2|HLVYESDQNK.3|HLVYESDQNK.2|DGDLIATK.2|MADKDGDLIATK.3|M[Oxi]ADKDGDLIATK.3|MADKDGDLIATK.2|TEREQFVEFR.3|TEREQFVEFR.2|HLVYESDQNKDGKLTK.4|HLVYESDQNKDGKLTK.3|EQFVEFR.2|DRVHHEPQLSDK.3|DRVHHEPQLSDK.2|DIVVQETMEDIDK.3|DIVVQETM[Oxi]EDIDK.2|DIVVQETMEDIDK.2|HLVYESDQNKDGK.3|TEREQFVEFRDK.3|IDGDKDGFVTVDELK.3|IDGDKDGFVTVDELK.2|DGFVTVDELK.2|DGFVTVDELK.1|EETKDWILPSDYDHAEAEAR.4|VHHEPQLSDK.2|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.6|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.5|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.4|VHNDAQSFDYDHDAFLGAEEAK.4|VHNDAQSFDYDHDAFLGAEEAK.3|GHDLNEDGLVSWEEYK.3|GHDLNEDGLVSWEEYK.2|TFDQLTPEESK.2|DRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.6|DRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.5|MADKDGDLIATKEEFTAFLHPEEYDYMK.5|MADKDGDLIATKEEFTAFLHPEEYDYMK.4|YDLFVGSQATDFGEALVR.3|YDLFVGSQATDFGEALVR.2|EEIVDKYDLFVGSQATDFGEALVR.4|EEIVDKYDLFVGSQATDFGEALVR.3|EEFTAFLHPEEYDYMK.3|EEFTAFLHPEEYDYM[Oxi]K.3|EEFTAFLHPEEYDYMK.2|DGDLIATKEEFTAFLHPEEYDYMK.4|LTKEEIVDKYDLFVGSQATDFGEALVR.4|LTKEEIVDKYDLFVGSQATDFGEALVR.3|NADGFIDLEEYIGDMYSHDGNTDEPEWVK.4|NADGFIDLEEYIGDMYSHDGNTDEPEWVK.3|YDLFVGSQATDFGEALVRHDEF.3
SEN / CTL,Q15165,Serum paraoxonase/arylesterase 2,PON2,2.19,0.89,2.05E-03,1.94E-04,3.71E+00,"response to oxidative stress,response to toxic substance,aromatic compound catabolic process","arylesterase activity,identical protein binding,metal ion binding,acyl-L-homoserine-lactone lactonohydrolase activity","extracellular region,nucleus,mitochondrion,lysosome,plasma membrane",6,14,29,FPGLHSFAPDKPGGILMMDLK.3|FPGLHSFAPDKPGGILM[Oxi]MDLK.4|FPGLHSFAPDKPGGILMM[Oxi]DLK.4|FPGLHSFAPDKPGGILMMDLK.4|EVESVDLPHC[CAM]HLIK.4|EVESVDLPHC[CAM]HLIK.3|EVESVDLPHC[CAM]HLIK.2|FEEAENSLLHLK.3|FPGLHSFAPDKPGGILMMDLKEEKPR.6|FPGLHSFAPDKPGGILMMDLKEEKPR.5|YIYVADILAHEIHVLEK.4|YIYVADILAHEIHVLEK.3|LLIGTLYHR.2|NTVEIFKFEEAENSLLHLK.4|NTVEIFKFEEAENSLLHLK.3|NTVEIFKFEEAENSLLHLK.2|LFVYDPNNPPSSEVLR.3|LFVYDPNNPPSSEVLR.2|VVAEGFDSANGINISPDDK.3|VVAEGFDSANGINISPDDK.2|TVKHELLPSVNDITAVGPAHFYATNDHYFSDPFLK.6|TVKHELLPSVNDITAVGPAHFYATNDHYFSDPFLK.5|HELLPSVNDITAVGPAHFYATNDHYFSDPFLK.5|HELLPSVNDITAVGPAHFYATNDHYFSDPFLK.4|VVAEGFDSANGINISPDDKYIYVADILAHEIHVLEK.5|VVAEGFDSANGINISPDDKYIYVADILAHEIHVLEK.4|GIEAGSEDIDILPNGLAFFSVGLK.3|VLELDTLVDNLSIDPSSGDIWVGC[CAM]HPNGQK.4|VLELDTLVDNLSIDPSSGDIWVGC[CAM]HPNGQK.3
SEN / CTL,P29401,Transketolase,TKT,2.18,1.87,2.67E-09,5.36E-10,9.27E+00,"xylulose biosynthetic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch,regulation of growth,glyceraldehyde-3-phosphate biosynthetic process","transketolase activity,protein homodimerization activity,metal ion binding,cofactor binding","nucleus,nucleoplasm,peroxisome,cytosol,vesicle,myelin sheath,extracellular exosome",54,53,103,ILATPPQEDAPSVDIANIR.2|ILATPPQEDAPSVDIANIR.3|ILATPPQEDAPSVDIANIR.4|NMAEQIIQEIYSQIQSK.3|NMAEQIIQEIYSQIQSK.2|NM[Oxi]AEQIIQEIYSQIQSK.3|NM[Oxi]AEQIIQEIYSQIQSK.2|TSRPENAIIYNNNEDFQVGQAK.3|TSRPENAIIYNNNEDFQVGQAK.4|TVPFC[CAM]STFAAFFTR.2|TVPFC[CAM]STFAAFFTR.3|MFGIDRDAIAQAVR.3|M[Oxi]FGIDRDAIAQAVR.3|MFGIDRDAIAQAVR.2|VLDPFTIKPLDR.3|VLDPFTIKPLDR.2|LDNLVAILDINR.2|LDNLVAILDINR.3|NSTFSEIFKK.3|NSTFSEIFKK.2|AYGQALAK.2|GITGVEDK.2|LGHASDRIIALDGDTK.4|LGHASDRIIALDGDTK.3|DAIAQAVR.2|ISSDLDGHPVPK.3|ISSDLDGHPVPK.2|GRGITGVEDKESWHGKPLPK.5|NPHNDRFVLSK.3|AVELAANTK.2|KISSDLDGHPVPK.3|KISSDLDGHPVPK.2|KLILDSAR.2|MPSLPSYK.2|M[Oxi]PSLPSYK.2|SKDDQVTVIGAGVTLHEALAAAELLKK.6|SKDDQVTVIGAGVTLHEALAAAELLKK.5|SKDDQVTVIGAGVTLHEALAAAELLKK.4|SKDDQVTVIGAGVTLHEALAAAELLKK.3|SGKPAELLK.2|VLDPFTIK.2|IIALDGDTK.2|KAYGQALAK.2|HQPTAIIAK.2|GITGVEDKESWHGKPLPK.4|GITGVEDKESWHGKPLPK.3|GRGITGVEDK.2|VLDPFTIKPLDRK.3|VLDPFTIKPLDRK.2|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.5|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|IIALDGDTKNSTFSEIFKK.4|SKDDQVTVIGAGVTLHEALAAAELLK.5|SKDDQVTVIGAGVTLHEALAAAELLK.4|SKDDQVTVIGAGVTLHEALAAAELLK.3|NSTFSEIFK.2|LGQSDPAPLQHQMDIYQKR.4|LQALKDTANR.2|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.7|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.4|ESWHGKPLPK.2|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.5|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTM[Oxi]R.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTMR.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|SVPTSTVFYPSDGVATEK.3|SVPTSTVFYPSDGVATEK.2|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.4|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.3|QAFTDVATGSLGQGLGAAC[CAM]GM[Oxi]AYTGK.3|NRTVPFC[CAM]STFAAFFTR.3|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|LGQSDPAPLQHQM[Oxi]DIYQK.3|LGQSDPAPLQHQMDIYQK.3|LGQSDPAPLQHQM[Oxi]DIYQK.2|LGQSDPAPLQHQMDIYQK.2|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|KILATPPQEDAPSVDIANIR.3|KILATPPQEDAPSVDIANIR.2|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.4|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.5|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQM[Oxi]ALEDLAMFR.4|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.4|DDQVTVIGAGVTLHEALAAAELLK.3|FIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3|SVPTSTVFYPSDGVATEKAVELAANTK.3|VYC[CAM]LLGDGELSEGSVWEAMAFASIYK.3|GHAAPILYAVWAEAGFLAEAELLNLRK.3
SEN / CTL,P53999,Activated RNA polymerase II transcriptional coactivator p15,SUB1,2.18,1.05,3.05E-03,2.81E-04,3.55E+00,"regulation of transcription from RNA polymerase II promoter,transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter,SMAD protein signal transduction","transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,single-stranded DNA binding,transcription coactivator activity,poly(A) RNA binding","nucleus,transcription factor complex,nucleolus,extracellular exosome",6,13,28,GISLNPEQWSQLKEQISDIDDAVR.3|EQISDIDDAVR.3|EQISDIDDAVR.2|EQISDIDDAVRK.3|EYWMDPEGEMKPGRK.4|EYWM[Oxi]DPEGEMKPGRK.4|EYWMDPEGEM[Oxi]KPGRK.4|EYWM[Oxi]DPEGEMKPGRK.3|EYWMDPEGEM[Oxi]KPGRK.3|EYWMDPEGEMKPGRK.3|EYWMDPEGEMKPGRK.2|GISLNPEQWSQLK.3|GISLNPEQWSQLK.2|QVAPEKPVK.2|VLIDIREYWMDPEGEMKPGRK.5|DDNMFQIGK.2|DDNM[Oxi]FQIGK.2|KGISLNPEQWSQLK.3|KGISLNPEQWSQLK.2|QSSSSRDDNMFQIGK.3|QSSSSRDDNMFQIGK.2|QVAPEKPVKK.2|EYWM[Oxi]DPEGEMKPGR.3|EYWMDPEGEM[Oxi]KPGR.3|EYWMDPEGEMKPGR.3|EYWMDPEGEMKPGR.2|KGISLNPEQWSQLKEQISDIDDAVR.4|KGISLNPEQWSQLKEQISDIDDAVR.3
SEN / CTL,P07195,L-lactate dehydrogenase B chain,LDHB,2.17,2.59,1.70E-14,5.80E-15,1.42E+01,"carbohydrate metabolic process,lactate metabolic process,pyruvate metabolic process,NAD metabolic process,oxidation-reduction process","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding","cytoplasm,mitochondrion,cytosol,membrane,myelin sheath,membrane raft,extracellular exosome",90,35,73,SADTLWDIQKDLKDL.3|SADTLWDIQKDLKDL.2|IVVVTAGVR.2|GLTSVINQK.2|SLADELALVDVLEDKLKGEMM[Oxi]DLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.4|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.4|SLADELALVDVLEDKLKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.5|GMYGIENEVFLSLPC[CAM]ILNAR.3|GMYGIENEVFLSLPC[CAM]ILNAR.2|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.2|GMYGIENEVFLSLPC[CAM]ILNAR.4|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.3|MVVESAYEVIK.2|MVVESAYEVIK.3|M[Oxi]VVESAYEVIK.2|LIAPVAEEEATVPNNK.2|LIAPVAEEEATVPNNK.3|GEM[Oxi]M[Oxi]DLQHGSLFLQTPK.3|GEMMDLQHGSLFLQTPK.4|GEMMDLQHGSLFLQTPK.3|GEM[Oxi]MDLQHGSLFLQTPK.3|GEMM[Oxi]DLQHGSLFLQTPK.3|GEMMDLQHGSLFLQTPK.2|GEM[Oxi]MDLQHGSLFLQTPK.2|KSADTLWDIQK.3|KSADTLWDIQK.2|LKDDEVAQLKK.3|LKDDEVAQLKK.2|DDEVAQLK.2|FIIPQIVK.2|DYSVTANSK.2|MVVESAYEVIKLK.3|IHPVSTMVK.2|IHPVSTM[Oxi]VK.1|IVADKDYSVTANSK.3|IVADKDYSVTANSK.2|HRVIGSGC[CAM]NLDSAR.3|HRVIGSGC[CAM]NLDSAR.2|SADTLWDIQKDLK.3|SADTLWDIQKDLK.2|LKGEMMDLQHGSLFLQTPK.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.4|LKGEM[Oxi]MDLQHGSLFLQTPK.4|LKGEMM[Oxi]DLQHGSLFLQTPK.4|LKGEMMDLQHGSLFLQTPK.3|LKGEM[Oxi]MDLQHGSLFLQTPK.3|LKGEMM[Oxi]DLQHGSLFLQTPK.3|LKGEMMDLQHGSLFLQTPK.2|SLADELALVDVLEDK.3|SLADELALVDVLEDK.2|NVNVFKFIIPQIVK.3|IVVVTAGVRQQEGESR.3|LKDDEVAQLK.2|SADTLWDIQK.2|IVVVTAGVRQQEGESRLNLVQR.4|SLADELALVDVLEDKLK.3|SLADELALVDVLEDKLK.2|EKLIAPVAEEEATVPNNK.3|EKLIAPVAEEEATVPNNK.2|ITVVGVGQVGMAC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.2|ITVVGVGQVGMAC[CAM]AISILGK.2|GYTNWAIGLSVADLIESM[Oxi]LK.3|LKGYTNWAIGLSVADLIESM[Oxi]LKNLSR.4|LKGYTNWAIGLSVADLIESM[Oxi]LK.3|YSPDC[CAM]IIIVVSNPVDILTYVTWK.3|LIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|EKLIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|LGIHPSSC[CAM]HGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWK.5
SEN / CTL,P07237,Protein disulfide-isomerase,P4HB,2.17,1.79,4.20E-26,4.12E-26,2.54E+01,"response to reactive oxygen species,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,response to endoplasmic reticulum stress,lipoprotein biosynthetic process,cell redox homeostasis,positive regulation of viral entry into host cell,cellular response to hypoxia,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","protein disulfide isomerase activity,integrin binding,protein binding,enzyme binding,poly(A) RNA binding,protein heterodimerization activity,procollagen-proline 4-dioxygenase activity","extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,focal adhesion,external side of plasma membrane,procollagen-proline 4-dioxygenase complex,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",216,62,113,EADDIVNWLK.2|VDATEESDLAQQYGVR.2|VDATEESDLAQQYGVR.3|LITLEEEMTKYKPESEELTAER.4|LITLEEEMTKYKPESEELTAER.3|MDSTANEVEAVKVHSFPTLK.4|MDSTANEVEAVKVHSFPTLK.3|M[Oxi]DSTANEVEAVKVHSFPTLK.4|M[Oxi]DSTANEVEAVKVHSFPTLK.3|LAKVDATEESDLAQQYGVR.3|LAKVDATEESDLAQQYGVR.2|QLAPIWDKLGETYKDHENIVIAK.5|QLAPIWDKLGETYKDHENIVIAK.4|QLAPIWDKLGETYKDHENIVIAK.3|EYTAGREADDIVNWLK.3|EYTAGREADDIVNWLK.2|ILEFFGLKKEEC[CAM]PAVR.4|ILEFFGLKKEEC[CAM]PAVR.3|ILEFFGLK.2|LITLEEEMTK.2|LITLEEEM[Oxi]TK.2|ILFIFIDSDHTDNQR.3|ILFIFIDSDHTDNQR.2|FDEGRNNFEGEVTKENLLDFIK.4|FDEGRNNFEGEVTKENLLDFIK.3|NFEDVAFDEK.2|QFLQAAEAIDDIPFGITSNSDVFSK.3|QFLQAAEAIDDIPFGITSNSDVFSK.4|HNQLPLVIEFTEQTAPK.3|HNQLPLVIEFTEQTAPK.2|HNQLPLVIEFTEQTAPK.4|TGPAATTLPDGAAAESLVESSEVAVIGFFK.3|TGPAATTLPDGAAAESLVESSEVAVIGFFK.4|THILLFLPK.2|YKPESEELTAERITEFC[CAM]HR.5|YKPESEELTAERITEFC[CAM]HR.4|M[Oxi]DSTANEVEAVK.2|MDSTANEVEAVK.3|MDSTANEVEAVK.2|IKPHLMSQELPEDWDKQPVK.5|IKPHLMSQELPEDWDKQPVK.4|IKPHLM[Oxi]SQELPEDWDKQPVK.5|IKPHLM[Oxi]SQELPEDWDKQPVK.4|IKPHLM[Oxi]SQELPEDWDKQPVK.3|IKPHLMSQELPEDWDKQPVK.3|YQLDKDGVVLFK.3|YQLDKDGVVLFK.2|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.4|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.5|YKPESEELTAER.3|YKPESEELTAER.2|SVSDYDGKLSNFK.3|SVSDYDGKLSNFK.2|TLDGFKK.2|ALAPEYAK.2|KSNFAEALAAHK.3|KSNFAEALAAHK.2|LGETYKDHENIVIAK.4|LGETYKDHENIVIAK.3|LGETYKDHENIVIAK.2|EADDIVNWLKK.3|EADDIVNWLKK.2|KFDEGRNNFEGEVTK.4|KFDEGRNNFEGEVTK.3|KFDEGRNNFEGEVTK.2|NFEDVAFDEKK.3|NFEDVAFDEKK.2|FFPASADR.2|IFGGEIKTHILLFLPK.4|IFGGEIKTHILLFLPK.3|VHSFPTLK.2|TAAESFKGK.2|ITEFC[CAM]HR.2|NGDTASPKEYTAGR.3|NGDTASPKEYTAGR.2|QLAPIWDK.2|ENLLDFIK.2|IKPHLM[Oxi]SQELPEDWDK.4|IKPHLMSQELPEDWDK.4|IKPHLMSQELPEDWDK.3|IKPHLM[Oxi]SQELPEDWDK.3|IKPHLMSQELPEDWDK.2|KEEC[CAM]PAVR.2|LKAEGSEIR.2|KNVFVEFYAPWC[CAM]GHC[CAM]K.4|KNVFVEFYAPWC[CAM]GHC[CAM]K.3|KNVFVEFYAPWC[CAM]GHC[CAM]K.2|DHENIVIAK.2|NNFEGEVTK.2|YQLDKDGVVLFKK.3|YQLDKDGVVLFKK.2|TVIDYNGER.2|FDEGRNNFEGEVTK.3|FDEGRNNFEGEVTK.2|ILEFFGLKK.2|SNFAEALAAHK.2|NVFVEFYAPWC[CAM]GHC[CAM]K.3|NVFVEFYAPWC[CAM]GHC[CAM]K.2|FFPASADRTVIDYNGER.3|YLLVEFYAPWC[CAM]GHC[CAM]K.3|YLLVEFYAPWC[CAM]GHC[CAM]K.2|AAGKLKAEGSEIR.2|NNFEGEVTKENLLDFIK.3|NNFEGEVTKENLLDFIK.2|LAKVDATEESDLAQQYGVRGYPTIK.4|ENLLDFIKHNQLPLVIEFTEQTAPK.4|PHLMSQELPEDWDKQPVK.3|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|NNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPK.5|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|VDATEESDLAQQYGVRGYPTIK.3
SEN / CTL,Q16527,Cysteine and glycine-rich protein 2,CSRP2,2.17,1.56,5.56E-05,6.59E-06,5.18E+00,"multicellular organism development,cell differentiation","molecular_function,zinc ion binding","nucleus,focal adhesion",12,10,14,GFGYGQGAGALVHAQ.2|SLESTTLTEKEGEIYC[CAM]KGC[CAM]YAK.4|LGIKPESVQPHRPTTNPNTSK.5|LGIKPESVQPHRPTTNPNTSK.4|TVYHAEEVQC[CAM]DGR.3|TVYHAEEVQC[CAM]DGR.2|C[CAM]GDSVYAAEK.2|SLESTTLTEK.2|GYGYGQGAGTLNMDRGER.3|C[CAM]C[CAM]FLC[CAM]MVC[CAM]R.2|C[CAM]C[CAM]FLC[CAM]M[Oxi]VC[CAM]R.2|NLDSTTVAIHDEEIYC[CAM]K.3|NLDSTTVAIHDEEIYC[CAM]K.2|GYGYGQGAGTLNMDR.2
SEN / CTL,P42785,Lysosomal Pro-X carboxypeptidase,PRCP,2.17,0.50,1.34E-04,1.49E-05,4.83E+00,"regulation of thyroid hormone mediated signaling pathway,plasma kallikrein-kinin cascade,negative regulation of systemic arterial blood pressure,proteolysis,blood coagulation, intrinsic pathway,glucose homeostasis,regulation of blood vessel endothelial cell migration,angiogenesis involved in wound healing,energy homeostasis,regulation of reactive oxygen species metabolic process","serine-type carboxypeptidase activity,dipeptidyl-peptidase activity","lysosome,plasma membrane,basal part of cell,extracellular exosome",6,11,19,NALDPMSVLLAR.2|NALDPMSVLLAR.3|NALDPM[Oxi]SVLLAR.2|SGPHC[CAM]SESIHR.3|SGPHC[CAM]SESIHR.2|AMLVFAEHR.2|HLNFLTSEQALADFAELIK.4|HLNFLTSEQALADFAELIK.3|HLNFLTSEQALADFAELIK.2|DITDTLVAVTISEGAHHLDLR.4|DITDTLVAVTISEGAHHLDLR.3|DITDTLVAVTISEGAHHLDLR.2|VDHFGFNTVK.2|PSWITTMYGGK.2|ALGSLHLPTNPTSLPAVAK.3|YYGESLPFGDNSFKDSR.3|YYGESLPFGDNSFK.2|LSNTGSGLQWLTGALHLC[CAM]SPLTSQDIQHLK.4|LSNTGSGLQWLTGALHLC[CAM]SPLTSQDIQHLK.3
SEN / CTL,P53814,Smoothelin,SMTN,2.17,2.09,2.19E-02,1.82E-03,2.74E+00,"smooth muscle contraction,muscle organ development","actin binding,structural constituent of muscle","nucleoplasm,cytoplasm,cytoskeleton,actin cytoskeleton",6,22,24,LAGQLESMNDVEELTALLR.3|LAGQLESMNDVEELTALLR.2|AGSLAALEK.2|EGAAGSPGGPR.2|MLDQSTDFEERK.3|QELEREEEALASK.3|GNTATETTTR.2|GVAQPLAQLR.2|SC[CAM]PQEEGPR.2|AADGSAVSTVTK.2|TTTVESSFVR.2|ENWLHSQQR.2|APPTLLSTSSGGK.2|AQEIEAATLAGR.2|LLEVTADLAER.2|LGSVTHVTSFSHAPPSSR.3|MLDQSTDFEER.2|SPLSAEELMTIEDEGVLDK.3|SPLSAEELMTIEDEGVLDK.2|ESTPLASGPSSFQR.2|LQDGTPQAALSPLTPAR.2|C[CAM]VFTYVQSLYNHLR.2|LLGPSLTSTTPASSSSGSSSR.2|SEEPGAPLPVAVGTAEPGGSMK.2
SEN / CTL,P42224,Signal transducer and activator of transcription 1-alpha/beta,STAT1,2.16,1.29,4.91E-08,8.40E-09,8.08E+00,"negative regulation of transcription from RNA polymerase II promoter,negative regulation of endothelial cell proliferation,positive regulation of mesenchymal cell proliferation,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,transcription, DNA-templated,apoptotic process,JAK-STAT cascade,response to nutrient,blood circulation,response to mechanical stimulus,macrophage derived foam cell differentiation,negative regulation of angiogenesis,cellular response to insulin stimulus,tumor necrosis factor-mediated signaling pathway,response to cytokine,response to interferon-beta,cellular response to interferon-beta,response to drug,response to hydrogen peroxide,regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to peptide hormone,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,negative regulation by virus of viral protein levels in host cell,positive regulation of smooth muscle cell proliferation,response to cAMP,defense response to virus,interferon-gamma-mediated signaling pathway,regulation of interferon-gamma-mediated signaling pathway,type I interferon signaling pathway,regulation of type I interferon-mediated signaling pathway,renal tubule development,cellular response to organic cyclic compound,metanephric mesenchymal cell proliferation involved in metanephros development,metanephric mesenchymal cell differentiation,negative regulation of metanephric nephron tubule epithelial cell differentiation,cell-cell adhesion,endothelial cell migration","RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II core promoter sequence-specific DNA binding,transcription factor activity, RNA polymerase II core promoter sequence-specific,double-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,signal transducer activity,tumor necrosis factor receptor binding,protein binding,enzyme binding,CCR5 chemokine receptor binding,nuclear hormone receptor binding,protein homodimerization activity,protein phosphatase 2A binding,cadherin binding involved in cell-cell adhesion","nuclear chromatin,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,cell-cell adherens junction,axon,dendrite,perinuclear region of cytoplasm",18,47,63,ELSAVTFPDIIR.2|GLNVDQLNMLGEK.2|FHDLLSQLDDQYSR.3|FHDLLSQLDDQYSR.2|YLYPNIDKDHAFGK.4|YLYPNIDKDHAFGK.3|ILENAQR.2|YTYEHDPITK.3|YTYEHDPITK.2|FSLENNFLLQHNIR.4|FSLENNFLLQHNIR.3|FSLENNFLLQHNIR.2|TGVQFTVK.2|FSLENNFLLQHNIRK.4|FSLENNFLLQHNIRK.3|SDQKQEQLLLKK.3|TELISVSEVHPSR.3|TELISVSEVHPSR.2|SQNGGEPDFHAVEPYTKK.4|KLEELEQK.2|FNILGTHTK.2|MYLMLDNK.2|YLYPNIDK.2|GTGYIKTELISVSEVHPSR.4|RGLNVDQLNMLGEK.3|RGLNVDQLNMLGEK.2|ALLKDQQPGTFLLR.3|LLGPNASPDGLIPWTR.3|LLGPNASPDGLIPWTR.2|LQELNYNLK.2|KMYLMLDNK.2|VMC[CAM]IEHEIK.2|DQQPGTFLLR.2|QYLAQWLEK.2|QDWEHAANDVSFATIR.3|QDWEHAANDVSFATIR.2|VLFDKDVNER.2|SQNGGEPDFHAVEPYTK.3|EAPEPMELDGPK.2|EAPEPM[Oxi]ELDGPK.2|EGAITFTWVER.2|HLLPLWNDGC[CAM]IMGFISK.3|HLLPLWNDGC[CAM]IM[Oxi]GFISK.3|HLLPLWNDGC[CAM]IMGFISK.2|SDQKQEQLLLK.2|TFSLFQQLIQSSFVVER.3|FNQAQSGNIQSTVMLDKQK.3|NLSFFLTPPC[CAM]AR.2|VMAAENIPENPLK.2|VM[Oxi]AAENIPENPLK.2|FLEQVHQLYDDSFPMEIR.3|FLEQVHQLYDDSFPMEIR.2|KLEELEQKYTYEHDPITK.3|SLEDLQDEYDFK.2|LQTTDNLLPMSPEEFDEVSR.3|LQTTDNLLPMSPEEFDEVSR.2|NLQDNFQEDPIQMSMIIYSC[CAM]LK.3|FNQAQSGNIQSTVMLDK.2|IIELLNVTELTQNALINDELVEWK.3|RNLQDNFQEDPIQMSMIIYSC[CAM]LK.3|RQQSAC[CAM]IGGPPNAC[CAM]LDQLQNWFTIVAESLQQVR.4|WAQLSEVLSWQFSSVTK.2|NLQDNFQEDPIQMSMIIYSC[CAM]LKEER.3
SEN / CTL,O15511,Actin-related protein 2/3 complex subunit 5,ARPC5,2.16,2.15,1.27E-01,9.85E-03,2.01E+00,"movement of cell or subcellular component,smooth muscle cell migration,cell migration,orbitofrontal cortex development,maintenance of cell polarity,actin cytoskeleton organization,microtubule organizing center organization,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,actin filament network formation,lamellipodium organization","structural constituent of cytoskeleton,protein binding,actin filament binding","cytoplasm,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,neuron projection,extracellular exosome",12,13,23,ALAAGGVGSIVR.2|QGNMTAALQAALKNPPINTK.3|QGNMTAALQAALK.3|QGNMTAALQAALK.2|QGNM[Oxi]TAALQAALK.2|NGVDLLMK.2|NGVDLLM[Oxi]K.2|KVDVDEYDENK.3|KVDVDEYDENK.2|AVQSLDKNGVDLLMK.3|AVQSLDKNGVDLLM[Oxi]K.3|AVQSLDKNGVDLLMK.2|GFESPSDNSSAMLLQWHEK.4|GFESPSDNSSAMLLQWHEK.3|GFESPSDNSSAM[Oxi]LLQWHEK.3|GFESPSDNSSAMLLQWHEK.2|FRKVDVDEYDENK.3|VDVDEYDENK.2|FVDEEDGGDGQAGPDEGEVDSC[CAM]LR.4|FVDEEDGGDGQAGPDEGEVDSC[CAM]LR.3|YIYKGFESPSDNSSAMLLQWHEK.4|VDVDEYDENKFVDEEDGGDGQAGPDEGEVDSC[CAM]LR.4|KVDVDEYDENKFVDEEDGGDGQAGPDEGEVDSC[CAM]LR.4
SEN / CTL,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,2.16,1.99,2.50E-25,2.18E-25,2.47E+01,"protein peptidyl-prolyl isomerization,RNA-dependent DNA biosynthetic process,protein folding,viral life cycle,uncoating of virus,fusion of virus membrane with host plasma membrane,virion assembly,viral release from host cell,entry into host cell,lipid particle organization,regulation of viral genome replication,positive regulation of viral genome replication,positive regulation of protein secretion,leukocyte migration,establishment of integrated proviral latency","peptidyl-prolyl cis-trans isomerase activity,protein binding,peptide binding,poly(A) RNA binding,virion binding,unfolded protein binding","extracellular region,extracellular space,nucleus,cytosol,focal adhesion,membrane,extracellular exosome",156,24,52,VNPTVFFDIAVDGEPLGR.3|VNPTVFFDIAVDGEPLGR.2|VSFELFADKVPK.3|VSFELFADKVPK.2|KITIADC[CAM]GQLE.2|KITIADC[CAM]GQLE.3|SIYGEKFEDENFILK.3|SIYGEKFEDENFILK.2|SIYGEKFEDENFILK.4|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.3|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.4|HTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.3|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.5|HTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.4|IIPGFMC[CAM]QGGDFTR.2|IIPGFMC[CAM]QGGDFTR.3|IIPGFM[Oxi]C[CAM]QGGDFTR.2|IIPGFM[Oxi]C[CAM]QGGDFTR.3|VSFELFADKVPKTAENFR.4|TEWLDGKHVVFGK.3|TEWLDGKHVVFGK.2|ITIADC[CAM]GQLE.2|VSFELFADK.2|EGMNIVEAMER.2|EGMNIVEAMER.3|EGM[Oxi]NIVEAMER.2|EGMNIVEAM[Oxi]ER.2|EGM[Oxi]NIVEAM[Oxi]ER.2|VKEGMNIVEAMER.3|VKEGMNIVEAMER.2|VKEGM[Oxi]NIVEAMER.3|VKEGMNIVEAM[Oxi]ER.3|VKEGM[Oxi]NIVEAM[Oxi]ER.3|VKEGM[Oxi]NIVEAMER.2|VKEGMNIVEAM[Oxi]ER.2|VKEGM[Oxi]NIVEAM[Oxi]ER.2|ALSTGEKGFGYKGSC[CAM]FHR.5|ALSTGEKGFGYKGSC[CAM]FHR.4|ALSTGEKGFGYK.3|TEWLDGK.2|TEWLDGKHVVFGKVK.4|TAENFRALSTGEK.3|TAENFRALSTGEKGFGYK.4|IIPGFM[Oxi]C[CAM]QGGDFTRHNGTGGK.4|IIPGFMC[CAM]QGGDFTRHNGTGGK.3|FEDENFILK.2|GFGYKGSC[CAM]FHR.2|MVNPTVFFDIAVDGEPLGR.3|M[Oxi]VNPTVFFDIAVDGEPLGR.3|MVNPTVFFDIAVDGEPLGR.2|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAKTEWLDGK.4|SIYGEKFEDENFILKHTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.5
SEN / CTL,P41091,Eukaryotic translation initiation factor 2 subunit 3,EIF2S3,2.16,2.04,5.58E-05,6.60E-06,5.18E+00,"formation of translation preinitiation complex,translational initiation,transmembrane transport,cell-cell adhesion","translation initiation factor activity,GTPase activity,protein binding,GTP binding,translation factor activity, RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,extracellular exosome,nucleus",24,8,12,SC[CAM]GSSTPDEFPTDIPGTK.2|SC[CAM]GSSTPDEFPTDIPGTK.3|QDLTTLDVTK.2|DFTSEPR.2|VGQEIEVRPGIVSK.3|VGQEIEVRPGIVSK.2|IYKLDDPSC[CAM]PRPEC[CAM]YR.4|LDDPSC[CAM]PRPEC[CAM]YR.3|IDLVKESQAKEQYEQILAFVQGTVAEGAPIIPISAQLK.5|IDLVKESQAKEQYEQILAFVQGTVAEGAPIIPISAQLK.4|ESQAKEQYEQILAFVQGTVAEGAPIIPISAQLK.4|ESQAKEQYEQILAFVQGTVAEGAPIIPISAQLK.3
SEN / CTL,O94826,Mitochondrial import receptor subunit TOM70,TOMM70A,2.15,1.62,1.20E-02,1.02E-03,2.99E+00,"protein targeting to mitochondrion,macroautophagy,protein transmembrane transport","protein binding,protein transmembrane transporter activity","mitochondrion,mitochondrial outer membrane,mitochondrial outer membrane translocase complex,membrane,integral component of membrane,extracellular exosome",6,29,43,AIEIDNK.2|GFEEVIK.2|SDEDKDKEGEALEVK.4|SDEDKDKEGEALEVK.3|SDEDKDKEGEALEVK.2|LRPESALAQAQK.3|LRPESALAQAQK.2|YGLKPPTL.2|NVDLSTFYQNR.3|NVDLSTFYQNR.2|GLLQLQWK.2|AAAFEQLQK.2|NREPLMPSPQFIK.3|NREPLM[Oxi]PSPQFIK.3|NREPLMPSPQFIK.2|YMAEALLLR.2|ASPAPGSGHPEGPGAHLDMNSLDR.4|ASPAPGSGHPEGPGAHLDMNSLDR.3|C[CAM]IDLEPDNATTYVHK.3|C[CAM]IDLEPDNATTYVHK.2|GLLQLQWKQDLDRGLELISK.4|WKEVAQDC[CAM]TK.2|ATFYLLIGNANAAKPDLDKVISLK.4|SEMEMAHLYSLC[CAM]DAAHAQTEVAK.4|SYFSSFTDDIISQPMLK.3|SYFSSFTDDIISQPMLK.2|QYMEEENYDK.2|ATFYLLIGNANAAKPDLDK.3|ATFYLLIGNANAAKPDLDK.2|PVEAAVVAAAVPSSGSGVGGGGTAGPGTGGLPR.4|QDLDRGLELISK.2|ILLDQVEEAVADFDEC[CAM]IR.3|ILLDQVEEAVADFDEC[CAM]IR.2|C[CAM]AEGYALYAQALTDQQQFGK.3|C[CAM]AEGYALYAQALTDQQQFGK.2|SYFSSFTDDIISQPMLKGEK.3|YEQAIQC[CAM]YTEAISLC[CAM]PTEK.3|YEQAIQC[CAM]YTEAISLC[CAM]PTEK.2|AGKYEQAIQC[CAM]YTEAISLC[CAM]PTEK.3|QAYTGNNSSQIQAAM[Oxi]K.2|QAYTGNNSSQIQAAMK.2|LDNKKEC[CAM]LEDVTAVC[CAM]ILEGFQNQQSMLLADK.4|RGSMYMQQQQPLLSTQDFNMAADIDPQNADVYHHR.4
SEN / CTL,Q15084,Protein disulfide-isomerase A6,PDIA6,2.15,1.51,1.02E-20,5.91E-21,2.02E+01,"protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,apoptotic cell clearance,cell redox homeostasis","protein disulfide isomerase activity,protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",72,32,56,TGEAIVDAALSALR.2|TGEAIVDAALSALR.3|LAAVDATVNQVLASR.2|LAAVDATVNQVLASR.3|NLEPEWAAAASEVKEQTK.3|NLEPEWAAAASEVKEQTK.2|VGAVDADKHHSLGGQYGVQGFPTIK.5|VGAVDADKHHSLGGQYGVQGFPTIK.4|VGAVDADKHHSLGGQYGVQGFPTIK.6|VGAVDADKHHSLGGQYGVQGFPTIK.3|VKLAAVDATVNQVLASR.3|VKLAAVDATVNQVLASR.2|NRPEDYQGGRTGEAIVDAALSALR.4|GSFSEQGINEFLR.2|GSFSEQGINEFLR.3|ALDLFSDNAPPPELLEIINEDIAKR.3|ALDLFSDNAPPPELLEIINEDIAKR.4|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|ALDLFSDNAPPPELLEIINEDIAK.3|ALDLFSDNAPPPELLEIINEDIAK.4|NSYLEVLLKLADKYK.4|NSYLEVLLKLADKYK.3|HHSLGGQYGVQGFPTIK.4|HHSLGGQYGVQGFPTIK.3|HHSLGGQYGVQGFPTIK.2|AATALKDVVK.2|KDVIELTDDSFDK.3|KDVIELTDDSFDK.2|NLEPEWAAAASEVK.3|NLEPEWAAAASEVK.2|TGEAIVDAALSALRQLVKDR.4|GSTAPVGGGAFPTIVER.3|GSTAPVGGGAFPTIVER.2|NSYLEVLLK.2|IFQKGESPVDYDGGR.3|IFQKGESPVDYDGGR.2|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.5|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|GESPVDYDGGR.2|GSTAPVGGGAFPTIVEREPWDGR.4|GSTAPVGGGAFPTIVEREPWDGR.3|NRPEDYQGGR.2|TGEAIVDAALSALRQLVK.3|DVIELTDDSFDK.2|SDSSSKKDVIELTDDSFDK.3|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.4|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.3|GSFSEQGINEFLRELSFGR.3|DGELPVEDDIDLSDVELDDLGK.3|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.4|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.3|NVLDSEDVWMVEFYAPWC[CAM]GHC[CAM]K.3|NVLDSEDVWM[Oxi]VEFYAPWC[CAM]GHC[CAM]K.3|DGELPVEDDIDLSDVELDDLGKDEL.3
SEN / CTL,Q12979,Active breakpoint cluster region-related protein,ABR,2.14,2.27,1.87E-02,1.57E-03,2.80E+00,"negative regulation of cellular extravasation,small GTPase mediated signal transduction,brain development,actin cytoskeleton organization,response to lipopolysaccharide,regulation of Rho protein signal transduction,inner ear morphogenesis,positive regulation of apoptotic process,regulation of vascular permeability,negative regulation of neutrophil degranulation,positive regulation of GTPase activity,negative regulation of inflammatory response,positive regulation of phagocytosis,neuromuscular process controlling balance,regulation of small GTPase mediated signal transduction,negative regulation of blood vessel remodeling","guanyl-nucleotide exchange factor activity,Rho guanyl-nucleotide exchange factor activity,GTPase activator activity","cytosol,plasma membrane,membrane",6,16,22,EFYDNLC[CAM]PK.2|DGFLVEVSESSRK.3|LASQLGVYK.2|HTPVDHPDYPLLQDALR.4|HTPVDHPDYPLLQDALR.3|HTPVDHPDYPLLQDALR.2|DSHTSVTMEALLYKPIDR.4|DSHTSVTMEALLYKPIDR.3|HVFLFTDVLLC[CAM]AK.3|HVFLFTDVLLC[CAM]AK.2|ELPEPLLTDR.2|ISGVATDIQALK.2|C[CAM]SQSNNQFQK.2|ISQNFLSSINEDIDPR.3|MSLHNLATVFGPTLLRPSEVESK.4|VQQWDSQVTMGHLFQK.3|VQQWDSQVTMGHLFQK.2|GQIQLDPQTVETK.2|SYLFLLSSDYER.2|ATATTSQPVLTIQQIETIFYK.3|ATATTSQPVLTIQQIETIFYK.2|LYPAFMEGIALSDPAAK.2
SEN / CTL,Q8NC51,Plasminogen activator inhibitor 1 RNA-binding protein,SERBP1,2.14,1.07,4.85E-05,5.83E-06,5.23E+00,"regulation of apoptotic process,regulation of mRNA stability,cell-cell adhesion","mRNA 3'-UTR binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,plasma membrane,cell-cell adherens junction,membrane,perinuclear region of cytoplasm,extracellular exosome",12,39,65,TDKSSASAPDVDDPEAFPALA.2|PGHLQEGFGC[CAM]VVTNRFDQLFDDESDPFEVLK.4|PGHLQEGFGC[CAM]VVTNRFDQLFDDESDPFEVLK.5|PGHLQEGFGC[CAM]VVTNRFDQLFDDESDPFEVLK.3|EETQPPVALKK.3|EETQPPVALKK.2|KEETQPPVALK.3|KEETQPPVALK.2|KPNEGADGQWK.3|KPNEGADGQWK.2|PGHLQEGFGC[CAM]VVTNR.4|PGHLQEGFGC[CAM]VVTNR.3|PGHLQEGFGC[CAM]VVTNR.2|RPDQQLQGEGK.3|RPDQQLQGEGK.2|SKSEEAHAEDSVMDHHFR.5|SKSEEAHAEDSVMDHHFR.4|SKSEEAHAEDSVMDHHFR.3|KNPLPPSVGVVDK.3|KNPLPPSVGVVDK.2|NPLPPSVGVVDKK.3|NPLPPSVGVVDKK.2|RGGSGSHNWGTVK.3|RGGSGSHNWGTVKDELTESPK.5|RGGSGSHNWGTVKDELTESPK.4|RGGSGSHNWGTVKDELTESPK.3|SKSEEAHAEDSVMDHHFRK.5|SSFSHYSGLKHEDKR.4|SSFSHYSGLKHEDKR.3|KEETQPPVALKK.3|KEETQPPVALKK.2|KPNEGADGQWKK.3|KPNEGADGQWKK.2|SEEAHAEDSVMDHHFR.4|SEEAHAEDSVM[Oxi]DHHFR.4|SEEAHAEDSVM[Oxi]DHHFR.3|SEEAHAEDSVMDHHFR.3|ENEVEEVK.2|SAAQAAAQTNSNAAGK.3|SAAQAAAQTNSNAAGK.2|EAGGGGVGGPGAK.2|ENEVEEVKEEGPK.3|ENEVEEVKEEGPK.2|FEKPLEEK.2|GGSGSHNWGTVKDELTESPK.4|GGSGSHNWGTVKDELTESPK.3|VGRRPDQQLQGEGK.3|EMTLDEWK.2|EM[Oxi]TLDEWK.2|GEGGEFSVDR.2|SSFSHYSGLKHEDK.3|GEGGEFSVDRPIIDR.3|EETQPPVALK.2|SSFSHYSGLK.2|GGSGSHNWGTVK.2|RFEKPLEEK.2|NPLPPSVGVVDK.2|NPLPPSVGVVDKKEETQPPVALK.4|FDQLFDDESDPFEVLK.3|FDQLFDDESDPFEVLK.2|KPANDITSQLEINFGDLGR.3|KPANDITSQLEINFGDLGR.2|QISYNYSDLDQSNVTEETPEGEEHHPVADTENKENEVEEVKEEGPK.6|SSASAPDVDDPEAFPALA.2|QISYNYSDLDQSNVTEETPEGEEHHPVADTENK.4
SEN / CTL,Q14766,Latent-transforming growth factor beta-binding protein 1,LTBP1,2.14,1.58,5.86E-21,3.52E-21,2.05E+01,"ventricular septum development,transmembrane receptor protein serine/threonine kinase signaling pathway,sequestering of TGFbeta in extracellular matrix,aorta development,coronary vasculature development","transforming growth factor beta-activated receptor activity,calcium ion binding,protein binding,transforming growth factor beta binding,microfibril binding","microfibril,extracellular region,proteinaceous extracellular matrix,extracellular matrix,protein complex",90,35,44,VQEGYTC[CAM]DC[CAM]FDGYHLDTAK.3|C[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.3|MTC[CAM]VDVNEC[CAM]DELNNR.2|TQTIHSTYSHQQVIPHVYPVAAK.4|KC[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.4|KC[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.3|EAQPGQSQVSYQGLPVQK.2|ALGTHVIHSTHTLPLTVTSQQGVK.4|ALGTHVIHSTHTLPLTVTSQQGVK.3|C[CAM]FQETIGSQC[CAM]GK.2|DALVDFSEQYTPEADPYFIQDR.3|ASGLGDHC[CAM]EDINEC[CAM]LEDK.3|ASGLGDHC[CAM]EDINEC[CAM]LEDK.2|GISGEQSTEGSFPLR.2|LC[CAM]QIPVHGASVPK.3|LC[CAM]QIPVHGASVPK.2|TSTDLDVDVDQPKEEK.2|TSTDLDVDVDQPKEEK.3|SKVPQETQSGGGSR.3|HPPEASVQIHQVSR.3|DQC[CAM]EDIDEC[CAM]QHR.3|DQC[CAM]EDIDEC[CAM]QHR.2|QGTYYDPVK.2|EIC[CAM]PGGMGYTVSGVHR.3|LYQHSQQPGK.2|C[CAM]EYC[CAM]DSGYR.2|VPQETQSGGGSR.2|DSDDYAQLC[CAM]NIPVTGR.3|DSDDYAQLC[CAM]NIPVTGR.2|EEPVEALTFSR.2|TKLEPGQPQLSPGISTIHLHPQFPVVIEK.5|QQLQGVNVC[CAM]GGR.2|C[CAM]TC[CAM]GQGYQLSAAK.2|TSTDLDVDVDQPK.2|LEPGQPQLSPGISTIHLHPQFPVVIEK.4|C[CAM]LC[CAM]LPGYVPSDKPNYC[CAM]TPLNTALNLEK.4|C[CAM]LC[CAM]LPGYVPSDKPNYC[CAM]TPLNTALNLEK.3|IGFGPDPTFSSC[CAM]VPDPPVISEEK.3|GFVPAGESSSEAGGENYKDADEC[CAM]LLFGQEIC[CAM]K.4|GFVPAGESSSEAGGENYKDADEC[CAM]LLFGQEIC[CAM]K.3|FLNSFEELQAEEC[CAM]GILNGC[CAM]ENGR.3|GFVPAGESSSEAGGENYK.2|QEDC[CAM]C[CAM]GTVGTSWGFNK.2|C[CAM]IRPAESNEQIEETDVYQDLC[CAM]WEHLSDEYVC[CAM]SR.4
SEN / CTL,O60701,UDP-glucose 6-dehydrogenase,UGDH,2.14,1.98,2.62E-05,3.25E-06,5.49E+00,"gastrulation with mouth forming second,carbohydrate metabolic process,UDP-glucose metabolic process,glycosaminoglycan biosynthetic process,UDP-glucuronate biosynthetic process,oxidation-reduction process","UDP-glucose 6-dehydrogenase activity,electron carrier activity,NAD binding","nucleus,nucleoplasm,cytosol,extracellular exosome",18,46,76,VPREQIVVDLSHPGVSEDDQVSR.4|VLDGLHNELQTIGFQIETIGKK.4|VLDGLHNELQTIGFQIETIGKK.3|EQIVVDLSHPGVSEDDQVSR.3|EQIVVDLSHPGVSEDDQVSR.4|EQIVVDLSHPGVSEDDQVSR.2|MLKPAFIFDGR.3|RIPYAPSGEIPK.3|RIPYAPSGEIPK.2|AVQALC[CAM]AVYEHWVPR.4|AVQALC[CAM]AVYEHWVPR.3|AVQALC[CAM]AVYEHWVPR.2|AADLKYIEAC[CAM]AR.3|PAFIFDGR.2|IAILGFAFK.2|IIDSLFNTVTDKK.3|IIDSLFNTVTDKK.2|ESSSIYISK.2|EADLVFISVNTPTK.3|EADLVFISVNTPTK.2|IVQNSNGYK.2|FSLQDPPNK.2|RVLDGLHNELQTIGFQIETIGKK.5|RVLDGLHNELQTIGFQIETIGKK.4|RVLDGLHNELQTIGFQIETIGKK.3|LAANAFLAQR.2|DTGDTRESSSIYISK.3|DTGDTRESSSIYISK.2|VTVVDVNESR.2|IPYAPSGEIPK.2|VLDGLHNELQTIGFQIETIGK.4|VLDGLHNELQTIGFQIETIGK.3|VLDGLHNELQTIGFQIETIGK.2|RIVQNSNGYK.2|YLMDEGAHLHIYDPK.3|ASVGFGGSC[CAM]FQK.2|RVLDGLHNELQTIGFQIETIGK.4|RVLDGLHNELQTIGFQIETIGK.3|ILTTNTWSSELSKLAANAFLAQR.4|ILTTNTWSSELSKLAANAFLAQR.3|INAWNSPTLPIYEPGLK.3|INAWNSPTLPIYEPGLK.2|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.5|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.4|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.3|AVQALC[CAM]AVYEHWVPREK.3|IIDSLFNTVTDK.2|VLIGGDETPEGQR.2|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.4|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHM[Oxi]C[CAM]PEIR.3|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.3|INAWNSPTLPIYEPGLKEVVESC[CAM]R.4|INAWNSPTLPIYEPGLKEVVESC[CAM]R.3|DVLNLVYLC[CAM]EALNLPEVAR.3|DVLNLVYLC[CAM]EALNLPEVAR.2|KIC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.4|KIC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.3|ILTTNTWSSELSK.2|NLFFSTNIDDAIK.2|PNLNLQVLSNPEFLAEGTAIK.3|PNLNLQVLSNPEFLAEGTAIK.2|IFDANTKPNLNLQVLSNPEFLAEGTAIK.4|IFDANTKPNLNLQVLSNPEFLAEGTAIK.3|ISSINSISALC[CAM]EATGADVEEVATAIGMDQR.4|ISSINSISALC[CAM]EATGADVEEVATAIGM[Oxi]DQR.3|ISSINSISALC[CAM]EATGADVEEVATAIGMDQR.3|IFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDR.5|LVTISKDPYEAC[CAM]DGAHAVVIC[CAM]TEWDM[Oxi]FK.4|LVTISKDPYEAC[CAM]DGAHAVVIC[CAM]TEWDMFK.4|IFDANTKPNLNLQVLSNPEFLAEGTAIKDLK.4|DPYEAC[CAM]DGAHAVVIC[CAM]TEWDM[Oxi]FK.3|DPYEAC[CAM]DGAHAVVIC[CAM]TEWDMFK.3|YWQQVIDMNDYQR.2|YWQQVIDM[Oxi]NDYQR.2|NPDRVLIGGDETPEGQR.2|NLFFSTNIDDAIKEADLVFISVNTPTK.3
SEN / CTL,O15371,Eukaryotic translation initiation factor 3 subunit D,EIF3D,2.14,2.25,9.86E-04,9.70E-05,4.01E+00,"formation of translation preinitiation complex,formation of cytoplasmic translation initiation complex,cap-dependent translational initiation,translational initiation,regulation of translational initiation,IRES-dependent viral translational initiation,viral translational termination-reinitiation","RNA binding,protein binding,poly(A) RNA binding,mRNA cap binding,translation initiation factor activity","cytosol,eukaryotic translation initiation factor 3 complex,membrane,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex,eukaryotic translation initiation factor 3 complex, eIF3m",18,36,62,TQGNVFATDAILATLMSC[CAM]TR.3|TQGNVFATDAILATLM[Oxi]SC[CAM]TR.3|TQGNVFATDAILATLM[Oxi]SC[CAM]TR.2|TQGNVFATDAILATLMSC[CAM]TR.2|YNFPNPNPFVEDDMDKNEIASVAYR.3|YNFPNPNPFVEDDM[Oxi]DKNEIASVAYR.3|SVYSWDIVVQR.2|SVYSWDIVVQR.3|IFHTVTTTDDPVIRK.4|IFHTVTTTDDPVIRK.3|RIFHTVTTTDDPVIR.4|RIFHTVTTTDDPVIR.3|RIFHTVTTTDDPVIR.2|GAVIATELK.2|RIFHTVTTTDDPVIRK.4|RIFHTVTTTDDPVIRK.3|WKLGDDIDLIVR.3|WKLGDDIDLIVR.2|NMLQFNLQILPK.3|NMLQFNLQILPK.2|NM[Oxi]LQFNLQILPK.2|GAVIATELKNNSYK.3|VADWTGATYQDKR.3|VADWTGATYQDKR.2|NEIASVAYR.2|TLNEWDSR.2|C[CAM]VIDIC[CAM]MK.2|HC[CAM]NGVDWR.2|IFHTVTTTDDPVIR.3|IFHTVTTTDDPVIR.2|LEEGKYLILKDPNK.3|YLILKDPNK.2|DMPYQPFSK.2|WTC[CAM]C[CAM]ALLAGSEYLK.3|WTC[CAM]C[CAM]ALLAGSEYLK.2|LGDDIDLIVR.2|NLAMEATYINHNFSQQC[CAM]LR.4|NLAM[Oxi]EATYINHNFSQQC[CAM]LR.3|NLAMEATYINHNFSQQC[CAM]LR.3|NLAMEATYINHNFSQQC[CAM]LR.2|EEMDFPQLMK.2|SDWEVKEEMDFPQLM[Oxi]K.3|SDWEVKEEMDFPQLMK.3|SDWEVKEEMDFPQLMK.2|VADWTGATYQDK.2|C[CAM]EHDGVM[Oxi]TGANGEVSFINIK.3|C[CAM]EHDGVMTGANGEVSFINIK.3|C[CAM]EHDGVMTGANGEVSFINIK.2|DNSDFDLLTVSETANEPPQDEGNSFNSPR.4|DNSDFDLLTVSETANEPPQDEGNSFNSPR.3|ERYNFPNPNPFVEDDMDKNEIASVAYR.4|ERYNFPNPNPFVEDDMDKNEIASVAYR.3|HVILGTQQFKPNEFASQINLSVENAWGILR.4|HVILGTQQFKPNEFASQINLSVENAWGILR.3|YLEVSEPQDIEC[CAM]C[CAM]GALEYYDK.3|FM[Oxi]TPVIQDNPSGWGPC[CAM]AVPEQFR.3|FMTPVIQDNPSGWGPC[CAM]AVPEQFR.3|FMTPVIQDNPSGWGPC[CAM]AVPEQFRDMPYQPFSK.4|YLEVSEPQDIEC[CAM]C[CAM]GALEYYDKAFDR.3|YSSQFGGGSQYAYFHEEDESSFQLVDTAR.3|ERYNFPNPNPFVEDDMDK.2|RDNSDFDLLTVSETANEPPQDEGNSFNSPR.3
SEN / CTL,Q92598,Heat shock protein 105 kDa,HSPH1,2.13,1.56,1.59E-06,2.33E-07,6.63E+00,"receptor-mediated endocytosis,response to unfolded protein,positive regulation of MHC class I biosynthetic process,positive regulation of transcription from RNA polymerase II promoter,chaperone mediated protein folding requiring cofactor,positive regulation of NK T cell activation,positive regulation of protein tyrosine kinase activity,regulation of cellular response to heat,negative regulation of establishment of protein localization to mitochondrion,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,negative regulation of p38MAPK cascade","adenyl-nucleotide exchange factor activity,ATP binding,alpha-tubulin binding","extracellular region,nucleoplasm,cytoplasm,cytosol,microtubule,extracellular exosome,endocytic vesicle lumen",24,66,104,RGPFELEAFYSDPQGVPYPEAK.3|RGPFELEAFYSDPQGVPYPEAK.4|AGGIETIANEFSDR.2|AGGIETIANEFSDR.3|SVLDAAQIVGLNC[CAM]LR.2|SVLDAAQIVGLNC[CAM]LR.3|LVEHFC[CAM]AEFK.3|LVEHFC[CAM]AEFK.2|YNHIDESEM[Oxi]K.3|YNHIDESEMK.3|YNHIDESEMK.2|YNHIDESEM[Oxi]K.2|LC[CAM]GPYEK.2|QDLPSLDEKPR.3|VLGTAFDPFLGGK.3|VLGTAFDPFLGGK.2|NSVNMDLD.2|VRFQEAEERPK.3|VRFQEAEERPK.2|NKDEKYNHIDESEMK.4|NKDEKYNHIDESEMK.3|NAVEEYVYEFR.3|NAVEEYVYEFR.2|TPNGPNIDK.2|QAYVDKLEELMK.3|QAYVDKLEELMK.2|TPNGPNIDKKEEDLEDK.4|TPNGPNIDKKEEDLEDK.3|VEDVSAVEIVGGATR.3|VEDVSAVEIVGGATR.2|KVDQPPEAK.2|MFEELGQR.2|EKENLSYDLVPLK.3|EKENLSYDLVPLK.2|SLDQDPVVR.2|IKELNNTC[CAM]EPVVTQPKPK.4|IKELNNTC[CAM]EPVVTQPKPK.3|LKVLGTAFDPFLGGK.3|SQFEELC[CAM]AELLQK.3|SQFEELC[CAM]AELLQK.2|FIC[CAM]EQDHQNFLR.3|FIC[CAM]EQDHQNFLR.2|AFNDPFIQK.2|ELNNTC[CAM]EPVVTQPK.3|ELNNTC[CAM]EPVVTQPK.2|KPVTDC[CAM]VISVPSFFTDAER.4|KPVTDC[CAM]VISVPSFFTDAER.3|KPVTDC[CAM]VISVPSFFTDAER.2|TPNGPNIDKK.2|DKLC[CAM]GPYEK.2|FVVQNVSAQK.2|FQEAEERPK.2|LKETAENSLK.2|NQQITHANNTVSNFK.3|NQQITHANNTVSNFK.2|KPVTDC[CAM]VISVPSFFTDAERR.4|KPVTDC[CAM]VISVPSFFTDAERR.3|KSLDQDPVVR.2|C[CAM]TPSVISFGSK.2|IEVPLYSLLEQTHLK.3|IEVPLYSLLEQTHLK.2|RSVLDAAQIVGLNC[CAM]LR.3|LMNDMTAVALNYGIYK.3|LMNDMTAVALNYGIYK.2|VNTHGIFTISTASMVEK.3|VNTHGIFTISTASM[Oxi]VEK.3|VNTHGIFTISTASMVEK.2|VNTHGIFTISTASM[Oxi]VEK.2|ELNNTC[CAM]EPVVTQPKPK.3|ELNNTC[CAM]EPVVTQPKPK.2|NAVEEYVYEFRDKLC[CAM]GPYEK.4|NQQITHANNTVSNFKR.3|ETAENSLKKPVTDC[CAM]VISVPSFFTDAERR.5|NFDEKLVEHFC[CAM]AEFK.3|ENLSYDLVPLK.2|VEDVSAVEIVGGATRIPAVK.3|VVNVELPIEANLVWQLGK.3|VVNVELPIEANLVWQLGK.2|SVNEVMEWMNNVMNAQAK.3|SVNEVMEWMNNVMNAQAK.2|DLLNMYIETEGK.2|DLLNM[Oxi]YIETEGK.2|LLTETEDWLYEEGEDQAK.3|LLTETEDWLYEEGEDQAK.2|KLMSSNSTDLPLNIEC[CAM]FMNDKDVSGK.4|KLMSSNSTDLPLNIEC[CAM]FMNDKDVSGK.3|NNFGAEPPHQNGEC[CAM]YPNEK.3|NNFGAEPPHQNGEC[CAM]YPNEK.2|IKVVNVELPIEANLVWQLGK.3|EEDLEDKNNFGAEPPHQNGEC[CAM]YPNEK.4|LM[Oxi]NDMTAVALNYGIYKQDLPSLDEKPR.4|LMNDMTAVALNYGIYKQDLPSLDEKPR.4|LMSSNSTDLPLNIEC[CAM]FMNDK.3|LMSSNSTDLPLNIEC[CAM]FMNDK.2|GPFELEAFYSDPQGVPYPEAK.3|VREFSVTDAVPFPISLIWNHDSEDTEGVHEVFSR.5|VREFSVTDAVPFPISLIWNHDSEDTEGVHEVFSR.4|IEVPLYSLLEQTHLKVEDVSAVEIVGGATR.4|KLMSSNSTDLPLNIEC[CAM]FMNDK.3|LKETAENSLKKPVTDC[CAM]VISVPSFFTDAER.4|VMYMGEEHLFSVEQITAMLLTK.3|EFSVTDAVPFPISLIWNHDSEDTEGVHEVFSR.4|LMSSNSTDLPLNIEC[CAM]FMNDKDVSGK.3|FFGKDISTTLNADEAVAR.2
SEN / CTL,P31153,S-adenosylmethionine synthase isoform type-2,MAT2A,2.13,1.53,3.59E-06,4.97E-07,6.30E+00,"S-adenosylmethionine biosynthetic process,one-carbon metabolic process,methylation,protein hexamerization,protein heterooligomerization","methionine adenosyltransferase activity,protein binding,ATP binding,metal ion binding","cytosol,methionine adenosyltransferase complex",18,24,40,FVIGGPQGDAGLTGR.2|FVIGGPQGDAGLTGR.3|YLDEDTIYHLQPSGR.3|YLDEDTIYHLQPSGR.4|YLDEDTIYHLQPSGR.2|TQVTVQYMQDR.2|TQVTVQYM[Oxi]QDR.2|DSFPWEVPKK.3|ELLEIVK.2|NFDLRPGVIVR.3|VAC[CAM]ETVAK.2|TGMILLAGEITSR.3|TGMILLAGEITSR.2|TGM[Oxi]ILLAGEITSR.2|DLDLKKPIYQR.3|NGTLPWLRPDSK.3|NGTLPWLRPDSK.2|ELLEIVKK.2|IIVDTYGGWGAHGGGAFSGK.4|IIVDTYGGWGAHGGGAFSGK.3|IIVDTYGGWGAHGGGAFSGK.2|TAAYGHFGR.2|HIGYDDSSK.2|KIIVDTYGGWGAHGGGAFSGK.4|KIIVDTYGGWGAHGGGAFSGK.3|FVIGGPQGDAGLTGRK.3|FVIGGPQGDAGLTGRK.2|HIGYDDSSKGFDYK.3|DSFPWEVPK.2|IC[CAM]DQISDAVLDAHLQQDPDAK.4|IC[CAM]DQISDAVLDAHLQQDPDAK.3|IC[CAM]DQISDAVLDAHLQQDPDAK.2|VHTIVISVQHDEEVC[CAM]LDEMR.4|VHTIVISVQHDEEVC[CAM]LDEMR.3|TC[CAM]NVLVALEQQSPDIAQGVHLDR.4|TC[CAM]NVLVALEQQSPDIAQGVHLDR.3|VHTIVISVQHDEEVC[CAM]LDEMRDALK.4|VLVQVSYAIGVSHPLSISIFHYGTSQK.4|VLVQVSYAIGVSHPLSISIFHYGTSQK.3|RVLVQVSYAIGVSHPLSISIFHYGTSQK.4
SEN / CTL,P00491,Purine nucleoside phosphorylase,PNP,2.13,1.76,5.24E-07,8.09E-08,7.09E+00,"nucleobase-containing compound metabolic process,inosine catabolic process,purine nucleotide catabolic process,nicotinamide riboside catabolic process,immune response,NAD biosynthesis via nicotinamide riboside salvage pathway,urate biosynthetic process,positive regulation of T cell proliferation,response to drug,purine-containing compound salvage,positive regulation of alpha-beta T cell differentiation,interleukin-2 secretion","nucleoside binding,purine nucleobase binding,purine-nucleoside phosphorylase activity,drug binding,phosphate ion binding","intracellular,nucleus,cytoplasm,cytosol,cytoskeleton,extracellular exosome",24,26,53,HRPQVAIIC[CAM]GSGLGGLTDKLTQAQIFDYGEIPNFPR.5|HRPQVAIIC[CAM]GSGLGGLTDKLTQAQIFDYGEIPNFPR.4|VFGFSLITNK.2|LGADAVGMSTVPEVIVAR.2|LGADAVGMSTVPEVIVAR.3|LGADAVGM[Oxi]STVPEVIVAR.2|FGDRFPAMSDAYDR.3|FGDRFPAM[Oxi]SDAYDR.3|FGDRFPAMSDAYDR.2|DHINLPGFSGQNPLR.4|DHINLPGFSGQNPLR.3|DHINLPGFSGQNPLR.2|NTAEWLLSHTK.3|NTAEWLLSHTK.2|AC[CAM]VMMQGR.2|AC[CAM]VM[Oxi]MQGR.2|AC[CAM]VM[Oxi]M[Oxi]QGR.2|FHM[Oxi]YEGYPLWK.3|FHMYEGYPLWK.3|FHMYEGYPLWK.2|HRPQVAIIC[CAM]GSGLGGLTDK.4|HRPQVAIIC[CAM]GSGLGGLTDK.3|HRPQVAIIC[CAM]GSGLGGLTDK.2|LTQAQIFDYGEIPNFPR.4|LTQAQIFDYGEIPNFPR.3|LTQAQIFDYGEIPNFPR.2|LVFGFLNGR.2|VFHLLGVDTLVVTNAAGGLNPK.4|VFHLLGVDTLVVTNAAGGLNPK.3|VFHLLGVDTLVVTNAAGGLNPK.2|ANHEEVLAAGK.2|DHINLPGFSGQNPLRGPNDER.4|DHINLPGFSGQNPLRGPNDER.3|FPAMSDAYDR.2|FPAM[Oxi]SDAYDR.2|FEVGDIMLIR.2|FEVGDIM[Oxi]LIR.2|VIMDYESLEK.2|VIM[Oxi]DYESLEK.2|LEQFVSILM[Oxi]ASIPLPDK.3|LEQFVSILMASIPLPDK.3|LEQFVSILM[Oxi]ASIPLPDK.2|LEQFVSILMASIPLPDK.2|QAAQKLEQFVSILMASIPLPDKAS.4|QAAQKLEQFVSILMASIPLPDKAS.3|LEQFVSILMASIPLPDKAS.3|FEVGDIM[Oxi]LIRDHINLPGFSGQNPLRGPNDER.5|FEVGDIMLIRDHINLPGFSGQNPLRGPNDER.5|FEVGDIMLIRDHINLPGFSGQNPLR.4|VTFPVRVFHLLGVDTLVVTNAAGGLNPK.4|VFGFSLITNKVIMDYESLEK.3|QAAQKLEQFVSILMASIPLPDK.3|ELQEGTYVMVAGPSFETVAEC[CAM]R.3
SEN / CTL,P46782,40S ribosomal protein S5,RPS5,2.11,2.11,3.19E-07,5.04E-08,7.30E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,regulation of translational fidelity,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,mRNA binding,structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,extracellular exosome",30,15,20,TIAEC[CAM]LADELINAAK.2|TIAEC[CAM]LADELINAAK.3|NIKTIAEC[CAM]LADELINAAK.3|YLPHSAGR.2|VNQAIWLLC[CAM]TGAR.2|VNQAIWLLC[CAM]TGAR.3|LTNSM[Oxi]M[Oxi]M[Oxi]HGR.3|LTNSMMMHGR.2|LTNSMM[Oxi]MHGR.2|GSSNSYAIK.2|AQC[CAM]PIVER.2|QAVDVSPLR.2|KAQC[CAM]PIVER.2|RVNQAIWLLC[CAM]TGAR.3|RQAVDVSPLR.2|EAAFRNIKTIAEC[CAM]LADELINAAK.4|NIKTIAEC[CAM]LADELINAAKGSSNSYAIK.4|WSTDDVQINDISLQDYIAVK.3|WSTDDVQINDISLQDYIAVK.2|IVKHAFEIIHLLTGENPLQVLVNAIINSGPREDSTR.5
SEN / CTL,P31943,Heterogeneous nuclear ribonucleoprotein H,HNRNPH1,2.11,0.91,1.84E-10,4.12E-11,1.04E+01,"mRNA splicing, via spliceosome,RNA processing,fibroblast growth factor receptor signaling pathway,gene expression,regulation of RNA splicing","nucleotide binding,RNA binding,protein binding,poly(U) RNA binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,membrane,catalytic step 2 spliceosome",24,27,53,ATENDIYNFFSPLNPVR.3|ATENDIYNFFSPLNPVR.2|STGEAFVQFASQEIAEK.2|STGEAFVQFASQEIAEK.3|SNNVEMDWVLK.2|SNNVEM[Oxi]DWVLK.2|HTGPNSPDTANDGFVR.4|HTGPNSPDTANDGFVR.3|HTGPNSPDTANDGFVR.2|THYDPPR.2|IQNGAQGIR.2|GLPWSC[CAM]SADEVQR.3|GLPWSC[CAM]SADEVQR.2|THYDPPRK.2|EGRPSGEAFVELESEDEVK.4|EGRPSGEAFVELESEDEVK.3|EGRPSGEAFVELESEDEVK.2|YGDGGSTFQSTTGHC[CAM]VHM[Oxi]R.4|YGDGGSTFQSTTGHC[CAM]VHMR.4|YGDGGSTFQSTTGHC[CAM]VHM[Oxi]R.3|YGDGGSTFQSTTGHC[CAM]VHMR.3|YGDGGSTFQSTTGHC[CAM]VHMR.2|DLNYC[CAM]FSGMSDHR.3|DLNYC[CAM]FSGM[Oxi]SDHR.3|DLNYC[CAM]FSGMSDHR.2|DLNYC[CAM]FSGM[Oxi]SDHR.2|EGRPSGEAFVELESEDEVKLALKK.5|EGRPSGEAFVELESEDEVKLALKK.4|YVELFLNSTAGASGGAYEHR.4|YVELFLNSTAGASGGAYEHR.3|YVELFLNSTAGASGGAYEHR.2|VHIEIGPDGR.2|VRGLPWSC[CAM]SADEVQR.3|VRGLPWSC[CAM]SADEVQR.2|DLNYC[CAM]FSGMSDHRYGDGGSTFQSTTGHC[CAM]VHMR.6|DLNYC[CAM]FSGM[Oxi]SDHRYGDGGSTFQSTTGHC[CAM]VHMR.6|DLNYC[CAM]FSGMSDHRYGDGGSTFQSTTGHC[CAM]VHM[Oxi]R.6|DLNYC[CAM]FSGMSDHRYGDGGSTFQSTTGHC[CAM]VHMR.5|MLGTEGGEGFVVK.2|EEIVQFFSGLEIVPNGITLPVDFQGR.4|EEIVQFFSGLEIVPNGITLPVDFQGR.3|VTGEADVEFATHEDAVAAM[Oxi]SK.3|VTGEADVEFATHEDAVAAMSK.3|VTGEADVEFATHEDAVAAMSK.2|GLPFGC[CAM]SKEEIVQFFSGLEIVPNGITLPVDFQGR.5|GLPFGC[CAM]SKEEIVQFFSGLEIVPNGITLPVDFQGR.4|ATENDIYNFFSPLNPVRVHIEIGPDGR.4|GLPYRATENDIYNFFSPLNPVR.3|PSGEAFVELESEDEVK.2|GAYGGGYGGYDDYNGYNDGYGFGSDR.3|RGAYGGGYGGYDDYNGYNDGYGFGSDR.3|GAYGGGYGGYDDYNGYNDGYGFGSDRFGR.3|LRGLPFGC[CAM]SKEEIVQFFSGLEIVPNGITLPVDFQGR.4
SEN / CTL,O14773,Tripeptidyl-peptidase 1,TPP1,2.11,1.57,2.82E-06,3.95E-07,6.40E+00,"proteolysis,lipid metabolic process,lysosome organization,nervous system development,central nervous system development,protein catabolic process,epithelial cell differentiation,IRE1-mediated unfolded protein response,peptide catabolic process,bone resorption,neuromuscular process controlling balance","endopeptidase activity,serine-type endopeptidase activity,protein binding,peptidase activity,serine-type peptidase activity,tripeptidyl-peptidase activity,peptide binding,metal ion binding","mitochondrion,lysosome,melanosome,lysosomal lumen,extracellular exosome",24,16,26,QRPEPQVTGTVGLHLGVTPSVIR.4|QAELLLPGAEFHHYVGGPTETHVVR.5|LSELVQAVSDPSSPQYGK.2|LFGGNFAHQASVAR.3|LFGGNFAHQASVAR.2|VNTELMK.2|SPHPYQLPQALAPHVDFVGGLHR.5|SPHPYQLPQALAPHVDFVGGLHR.4|SPHPYQLPQALAPHVDFVGGLHR.3|ILSGRPPLGFLNPR.3|ILSGRPPLGFLNPR.2|LYQQHGAGLFDVTR.3|LYQQHGAGLFDVTR.2|PSYQEEAVTK.2|YLTLENVADLVRPSPLTLHTVQK.4|AYPDVAALSDGYWVVSNR.3|AYPDVAALSDGYWVVSNR.2|GLTLLFASGDSGAGC[CAM]WSVSGR.3|GLTLLFASGDSGAGC[CAM]WSVSGR.2|C[CAM]HSVITQDFLTC[CAM]WLSIR.3|C[CAM]HSVITQDFLTC[CAM]WLSIR.2|VPIPWVSGTSASTPVFGGILSLINEHR.4|VPIPWVSGTSASTPVFGGILSLINEHR.3|AYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHR.5|AYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHR.4|GC[CAM]HESC[CAM]LDEEVEGQGFC[CAM]SGPGWDPVTGWGTPNFPALLK.4
SEN / CTL,Q07065,Cytoskeleton-associated protein 4,CKAP4,2.10,1.94,6.56E-12,1.75E-12,1.18E+01,cellular protein metabolic process,poly(A) RNA binding,"endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytoskeleton,plasma membrane,membrane,integral component of membrane,extracellular matrix,lamellar body,perinuclear region of cytoplasm,extracellular exosome",66,55,81,VQSLQATFGTFESILR.2|VQSLQATFGTFESILR.3|SLGETQLVLYGDVEELKR.3|SLGETQLVLYGDVEELKR.2|LEGLGSSEADQDGLASTVR.3|LEGLGSSEADQDGLASTVR.2|EWDMEALR.2|SINDNIAIFTEVQKR.3|LQHVEDGVLSMQVASAR.3|LQHVEDGVLSMQVASAR.4|LQHVEDGVLSM[Oxi]QVASAR.3|LQHVEDGVLSMQVASAR.2|TAVDSLVAYSVK.2|TAVDSLVAYSVK.3|ERDFTSLENTVEER.3|ERDFTSLENTVEER.2|VQEQVHTLLSQDQAQAAR.3|VQEQVHTLLSQDQAQAAR.4|VQEQVHTLLSQDQAQAAR.2|ISEVLQK.2|HSEAFEALQQK.3|HSEAFEALQQK.2|LQNEILK.2|SREWDMEALR.3|SREWDMEALR.2|SSQHKQDLTEK.3|SHQDFSR.2|LSSLDNLK.2|QGESEVSR.2|AKVASLEESEGNKQDLK.4|AKVASLEESEGNKQDLK.3|SDSHGPKEDGGFR.3|GLLDDLRNDLDR.3|RLEEELR.2|LLRSEESVSRLPEEIR.4|LLRSEESVSRLPEEIR.3|LQNEILKDLSDGIHVVK.4|LQNEILKDLSDGIHVVK.3|LALQALTEK.2|SVGELPSTVESLQK.3|SVGELPSTVESLQK.2|GGHGAASPSEK.2|KPPPAPQQPPPPPAPHPQQHPQQHPQNQAHGK.7|KPPPAPQQPPPPPAPHPQQHPQQHPQNQAHGK.6|ALKEAVKEIQTSAK.3|ELVSLKQEQQAFK.3|ELVSLKQEQQAFK.2|SEESVSRLPEEIR.3|SINDNIAIFTEVQK.3|SINDNIAIFTEVQK.2|DLSDGIHVVK.2|RSVGELPSTVESLQK.3|RSVGELPSTVESLQK.2|LPPQDFLDR.2|QEQQAFKEAADTER.3|VASLEESEGNKQDLK.3|VASLEESEGNKQDLK.2|LQNEILKDLSDGIHVVKDAR.4|QREELGQGLQGVEQK.3|QREELGQGLQGVEQK.2|ASVSQVEADLK.2|ELVSLKQEQQAFKEAADTER.4|ELVSLKQEQQAFKEAADTER.3|VASLEESEGNK.2|GAHPSGGADDVAK.2|LLRSEESVSR.2|STLQTMESDIYTEVR.3|STLQTM[Oxi]ESDIYTEVR.2|STLQTMESDIYTEVR.2|EAVKEIQTSAK.2|ERDFTSLENTVEERLTELTK.4|QTESLESLLSK.2|GLLDDLRNDLDRLFVK.3|EDGGFRHSEAFEALQQK.3|LPPQDFLDRLSSLDNLK.3|IETNENNLESAK.2|SSSSSSASAAAAAAAASSSASC[CAM]SR.3|SSSSSSASAAAAAAAASSSASC[CAM]SR.2|EELGQGLQGVEQK.2|DFTSLENTVEER.2|SLGETQLVLYGDVEELK.2
SEN / CTL,Q8N1N4,"Keratin, type II cytoskeletal 78",KRT78,2.10,3.23,2.49E-01,1.87E-02,1.73E+00,,structural molecule activity,"extracellular space,keratin filament,extracellular exosome",6,13,14,TLNNQFASFIDKVR.3|VQISQLHQEIQR.3|VQISQLHQEIQR.2|TQETQEIR.2|VDELEAALR.2|QLEQLQGER.2|TQETQEIRTLNNQFASFIDKVR.4|IEIDPQFQVVR.2|SLNSFGGC[CAM]LEGSR.2|TLNNQFASFIDK.2|YLDFSSIITEVR.2|LLC[CAM]EYQELTSTK.2|QNASLQAAITDAEQR.2|HLNEEELGQLQTQASDTSVVLSMDNNR.3
SEN / CTL,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,2.09,2.08,1.08E-02,9.22E-04,3.04E+00,"lactose biosynthetic process,protein complex assembly,response to osmotic stress,glucose transport,L-ascorbic acid metabolic process,cellular response to glucose starvation,xenobiotic transport,regulation of insulin secretion,dehydroascorbic acid transport,glucose transmembrane transport","glucose transmembrane transporter activity,protein binding,kinase binding,dehydroascorbic acid transporter activity,xenobiotic transporter activity,protein self-association,D-glucose transmembrane transporter activity","Golgi membrane,female pronucleus,cytosol,plasma membrane,integral component of plasma membrane,caveola,cell-cell junction,membrane,basolateral plasma membrane,apical plasma membrane,midbody,cortical actin cytoskeleton,melanosome,extracellular exosome,blood microparticle",6,10,17,LRGTADVTHDLQEMKEESR.4|LRGTADVTHDLQEMKEESR.5|LRGTADVTHDLQEM[Oxi]KEESR.4|LRGTADVTHDLQEM[Oxi]KEESR.3|LRGTADVTHDLQEMKEESR.3|GTADVTHDLQEMK.3|GTADVTHDLQEMK.2|GTADVTHDLQEMKEESR.4|GTADVTHDLQEMKEESR.3|GTADVTHDLQEM[Oxi]KEESR.3|VTILELFR.2|SFEMLILGR.2|KVTILELFR.2|TFDEIASGFR.2|GRTFDEIASGFR.2|QGGASQSDKTPEELFHPLGADSQV.3|TPEELFHPLGADSQV.2
SEN / CTL,P30101,Protein disulfide-isomerase A3,PDIA3,2.09,2.16,6.54E-15,2.35E-15,1.46E+01,"antigen processing and presentation of peptide antigen via MHC class I,protein folding,proteolysis,protein import into nucleus,protein retention in ER lumen,signal transduction,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,cell redox homeostasis,oxidation-reduction process,positive regulation of extrinsic apoptotic signaling pathway","protein disulfide isomerase activity,cysteine-type endopeptidase activity,phospholipase C activity,protein binding,disulfide oxidoreductase activity,poly(A) RNA binding","nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,focal adhesion,cell surface,melanosome,myelin sheath,extracellular exosome",144,62,120,FLQDYFDGNLKR.3|FLQDYFDGNLKR.2|KTFSHELSDFGLESTAGEIPVVAIR.4|KTFSHELSDFGLESTAGEIPVVAIR.3|KTFSHELSDFGLESTAGEIPVVAIR.5|VDC[CAM]TANTNTC[CAM]NKYGVSGYPTLK.3|FVMQEEFSRDGK.3|MDATANDVPSPYEVR.2|MDATANDVPSPYEVR.3|M[Oxi]DATANDVPSPYEVR.2|KYEGGRELSDFISYLQR.4|KYEGGRELSDFISYLQR.3|ELSDFISYLQR.2|ELSDFISYLQR.3|GFPTIYFSPANK.2|GFPTIYFSPANK.3|FISDKDASIVGFFDDSFSEAHSEFLK.4|FISDKDASIVGFFDDSFSEAHSEFLK.3|IFRDGEEAGAYDGPR.3|IFRDGEEAGAYDGPR.2|TFSHELSDFGLESTAGEIPVVAIR.3|TFSHELSDFGLESTAGEIPVVAIR.4|TFSHELSDFGLESTAGEIPVVAIR.5|YEGGRELSDFISYLQR.3|FVMQEEFSR.2|FVM[Oxi]QEEFSR.2|FLQDYFDGNLK.2|YGVSGYPTLK.2|LAPEYEAAATR.2|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|FIQENIFGIC[CAM]PHM[Oxi]TEDNKDLIQGK.4|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|KFLDAGHKLNFAVASR.4|KFLDAGHKLNFAVASR.3|LSKDPNIVIAK.3|LSKDPNIVIAK.2|DGEEAGAYDGPR.3|DGEEAGAYDGPR.2|FLDAGHKLNFAVASR.4|FLDAGHKLNFAVASR.3|EATNPPVIQEEKPKK.4|EATNPPVIQEEKPKK.3|DPNIVIAK.2|LNFAVASR.2|PSHLTNKFEDK.3|PSHLTNKFEDK.2|RLAPEYEAAATR.3|RLAPEYEAAATR.2|SEPIPESNDGPVK.3|SEPIPESNDGPVK.2|TEEEFKK.2|KFLDAGHK.2|KQAGPASVPLRTEEEFK.4|KQAGPASVPLRTEEEFK.3|LKGIVPLAK.2|TVAYTEQK.2|VDC[CAM]TANTNTC[CAM]NK.3|VDC[CAM]TANTNTC[CAM]NK.2|RYLKSEPIPESNDGPVK.4|RYLKSEPIPESNDGPVK.3|FEDKTVAYTEQK.3|FEDKTVAYTEQK.2|GFPTIYFSPANKK.3|GFPTIYFSPANKK.2|QAGPASVPLR.2|TADGIVSHLK.2|EATNPPVIQEEKPK.3|EATNPPVIQEEKPK.2|FIQENIFGIC[CAM]PHMTEDNK.4|FIQENIFGIC[CAM]PHMTEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.2|FIQENIFGIC[CAM]PHMTEDNK.2|PSHLTNKFEDKTVAYTEQK.4|KQAGPASVPLR.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.7|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.4|KFIQENIFGIC[CAM]PHMTEDNK.4|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.4|KFIQENIFGIC[CAM]PHMTEDNK.3|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|KFIQENIFGIC[CAM]PHMTEDNK.2|DASIVGFFDDSFSEAHSEFLK.4|DASIVGFFDDSFSEAHSEFLK.3|DASIVGFFDDSFSEAHSEFLK.2|QAGPASVPLRTEEEFK.3|QAGPASVPLRTEEEFK.2|TADGIVSHLKK.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.4|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.3|YLKSEPIPESNDGPVK.3|YLKSEPIPESNDGPVK.2|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.5|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|KFISDKDASIVGFFDDSFSEAHSEFLK.5|KFISDKDASIVGFFDDSFSEAHSEFLK.4|VVVAENFDEIVNNENK.3|VVVAENFDEIVNNENK.2|QAGPASVPLRTEEEFKK.3|QAGPASVPLRTEEEFKK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.3|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.3|EATNPPVIQEEK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.3|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.7|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.6|GEKFVMQEEFSR.2|DLLIAYYDVDYEK.2|FAHTNVESLVNEYDDNGEGIILFR.3|VVVAENFDEIVNNENKDVLIEFYAPWC[CAM]GHC[CAM]K.4|SEPIPESNDGPVKVVVAENFDEIVNNENK.3
SEN / CTL,Q15370,Transcription elongation factor B polypeptide 2,TCEB2,2.08,1.42,2.23E-02,1.85E-03,2.73E+00,"transcription from RNA polymerase II promoter,transcription elongation from RNA polymerase II promoter,protein complex assembly,protein ubiquitination,regulation of transcription from RNA polymerase II promoter in response to hypoxia","protein binding,ubiquitin protein ligase binding","nucleoplasm,cytosol,VCB complex,Cul2-RING ubiquitin ligase complex,Cul5-RING ubiquitin ligase complex,extracellular exosome,elongin complex",6,12,18,LYKDDQLLDDGKTLGEC[CAM]GFTSQTARPQAPATVGLAFR.5|LYKDDQLLDDGKTLGEC[CAM]GFTSQTARPQAPATVGLAFR.6|LYKDDQLLDDGKTLGEC[CAM]GFTSQTARPQAPATVGLAFR.4|PQAPATVGLAFR.3|PQAPATVGLAFR.2|RPPDEQR.2|TTIFTDAK.2|RIVEGILK.2|LYKDDQLLDDGK.3|LYKDDQLLDDGK.2|DDQLLDDGK.2|ESSTVFELK.2|TLGEC[CAM]GFTSQTARPQAPATVGLAFR.4|TLGEC[CAM]GFTSQTARPQAPATVGLAFR.3|TLGEC[CAM]GFTSQTAR.2|LYKDDQLLDDGKTLGEC[CAM]GFTSQTAR.3|ADDTFEALC[CAM]IEPFSSPPELPDVM[Oxi]KPQDSGSSANEQAVQ.4|ADDTFEALC[CAM]IEPFSSPPELPDVMKPQDSGSSANEQAVQ.4
SEN / CTL,P60033,CD81 antigen,CD81,2.08,0.73,7.77E-04,7.74E-05,4.11E+00,"activation of MAPK activity,cell surface receptor signaling pathway,protein localization,cell proliferation,positive regulation of cell proliferation,positive regulation of B cell proliferation,receptor internalization,regulation of protein stability,positive regulation of 1-phosphatidylinositol 4-kinase activity,positive regulation of transcription from RNA polymerase II promoter,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,protein localization to lysosome,cellular response to low-density lipoprotein particle stimulus,positive regulation of protein catabolic process in the vacuole,regulation of cell motility","protein binding,MHC class II protein complex binding,transferrin receptor binding","immunological synapse,plasma membrane,integral component of plasma membrane,focal adhesion,membrane,vesicle,extracellular exosome",6,5,8,TFHETLDC[CAM]C[CAM]GSSTLTALTTSVLK.3|TFHETLDC[CAM]C[CAM]GSSTLTALTTSVLK.4|NNLC[CAM]PSGSNIISNLFK.3|NNLC[CAM]PSGSNIISNLFK.2|NNLC[CAM]PSGSNIISNLFKEDC[CAM]HQK.4|QFYDQALQQAVVDDDANNAK.3|QFYDQALQQAVVDDDANNAK.2|DVKQFYDQALQQAVVDDDANNAK.3
SEN / CTL,P05067,Amyloid beta A4 protein,APP,2.07,0.96,4.49E-08,7.73E-09,8.11E+00,"response to yeast,suckling behavior,platelet degranulation,mRNA polyadenylation,regulation of translation,protein phosphorylation,cellular copper ion homeostasis,endocytosis,response to oxidative stress,cell adhesion,regulation of epidermal growth factor-activated receptor activity,Notch signaling pathway,axonogenesis,mating behavior,locomotory behavior,axo-dendritic transport,cholesterol metabolic process,adult locomotory behavior,visual learning,cellular process,response to lead ion,negative regulation of endopeptidase activity,positive regulation of peptidase activity,positive regulation of G2/M transition of mitotic cell cycle,axon midline choice point recognition,neuron remodeling,dendrite development,antibacterial humoral response,antifungal humoral response,extracellular matrix organization,forebrain development,neuron projection development,ionotropic glutamate receptor signaling pathway,regulation of multicellular organism growth,regulation of protein binding,cellular protein metabolic process,innate immune response,negative regulation of neuron differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,collateral sprouting in absence of injury,regulation of synapse structure or activity,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,neuromuscular process controlling balance,synaptic growth at neuromuscular junction,neuron apoptotic process,smooth endoplasmic reticulum calcium ion homeostasis,cellular response to cAMP,cellular response to norepinephrine stimulus,amyloid fibril formation,cellular response to nerve growth factor stimulus","DNA binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,peptidase activator activity,enzyme binding,identical protein binding,transition metal ion binding,PTB domain binding,growth factor receptor binding","extracellular region,extracellular space,nuclear envelope lumen,cytoplasm,endosome,smooth endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,cell-cell junction,cell surface,integral component of membrane,ER to Golgi transport vesicle,axon,platelet alpha granule lumen,neuromuscular junction,endosome lumen,trans-Golgi network membrane,ciliary rootlet,terminal bouton,dendritic spine,dendritic shaft,intracellular membrane-bounded organelle,receptor complex,main axon,membrane raft,apical part of cell,synapse,perinuclear region of cytoplasm,spindle midzone,extracellular exosome,astrocyte projection,growth cone lamellipodium,growth cone filopodium",18,21,26,WYFDVTEGK.2|ISYGNDALMPSLTETK.2|AVIQHFQEKVESLEQEAANER.3|QQLVETHMAR.3|THPHFVIPYR.3|HDSGYEVHHQK.3|YLETPGDENEHAHFQK.4|YLETPGDENEHAHFQK.3|WDSDPSGTK.2|AVIQHFQEK.2|LNMHMNVQNGKWDSDPSGTK.4|LNMHMNVQNGKWDSDPSGTK.3|C[CAM]LVGEFVSDALLVPDK.3|C[CAM]LVGEFVSDALLVPDK.2|QYTSIHHGVVEVDAAVTPEER.4|QYTSIHHGVVEVDAAVTPEER.3|STNLHDYGMLLPC[CAM]GIDK.3|STNLHDYGMLLPC[CAM]GIDK.2|LVFFAEDVGSNK.2|LALENYITALQAVPPRPR.3|VESLEQEAANER.2|C[CAM]APFFYGGC[CAM]GGNR.2|MQQNGYENPTYK.2|EVC[CAM]SEQAETGPC[CAM]R.2|EGILQYC[CAM]QEVYPELQITNVVEANQPVTIQNWC[CAM]K.4|EQNYSDDVLANMISEPR.2
SEN / CTL,O00468,Agrin,AGRN,2.07,1.84,8.94E-20,4.83E-20,1.93E+01,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,cytoskeleton organization,signal transduction,G-protein coupled acetylcholine receptor signaling pathway,extracellular matrix organization,glycosaminoglycan metabolic process,receptor clustering,positive regulation of GTPase activity,clustering of voltage-gated sodium channels,positive regulation of synaptic growth at neuromuscular junction,positive regulation of transcription from RNA polymerase II promoter,synapse organization,positive regulation of filopodium assembly","dystroglycan binding,structural constituent of cytoskeleton,calcium ion binding,protein binding,sialic acid binding,chondroitin sulfate binding,laminin binding,heparan sulfate proteoglycan binding","extracellular region,basal lamina,cytoplasm,Golgi lumen,plasma membrane,integral component of membrane,cell junction,extracellular matrix,lysosomal lumen,synapse,extracellular exosome",90,54,64,SIESTLDDLFR.2|KSPC[CAM]PSVVAPVC[CAM]GSDASTYSNEC[CAM]ELQR.3|SAGDVDTLAFDGR.2|LLDVNNQRLELGIGPGAATR.3|LLDVNNQRLELGIGPGAATR.2|AIVDVHFDPTTAFRAPDVAR.4|GAPEGTVC[CAM]GSDGADYPGEC[CAM]QLLRR.3|SFLAFPTLR.2|AYGTGFVGC[CAM]LR.2|EGSLQVGNEAPVTGSSPLGATQLDTDGALWLGGLPELPVGPALPK.4|TEATQGLVLWSGK.2|KFDGPC[CAM]DPC[CAM]QGALPDPSR.3|KFDGPC[CAM]DPC[CAM]QGALPDPSR.2|VLGAPVPAFEGR.2|ALQSNHFELSLR.3|ASC[CAM]YNSALGC[CAM]C[CAM]SDGKTPSLDAEGSNC[CAM]PATK.3|SELFGETAR.2|QLLTPEHVLR.3|QLLTPEHVLR.2|TDGKGDFVSLALRDR.4|GKDFLALALLDGR.3|SREPVTLGAWTR.3|TDGKGDFVSLALR.3|LLDVNNQR.2|RPLQEHVR.2|AIVDVHFDPTTAFR.3|AIVDVHFDPTTAFR.2|DQC[CAM]PEPC[CAM]R.2|QVDVTSFAGHPC[CAM]TR.3|QVDVTSFAGHPC[CAM]TR.2|ALEPQGLLLYNGNAR.3|ALEPQGLLLYNGNAR.2|EAAC[CAM]LQQTQIEEAR.3|EAAC[CAM]LQQTQIEEAR.2|TYDSDC[CAM]WR.2|LELGIGPGAATR.2|GLYVAAQGAC[CAM]R.2|DFLALALLDGR.2|FGALC[CAM]EAETGR.2|HPLHLLEDAVTKPELRPC[CAM]PTP.4|AYGTGFVGC[CAM]LRDVVVGR.3|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]R.3|VTC[CAM]DGAYRPVC[CAM]AQDGR.3|GPSGLLLYNGQK.2|AAAVSSGFDGAIQLVSLGGR.3|AAAVSSGFDGAIQLVSLGGR.2|IFFVNPAPPYLWPAHK.3|VGPTC[CAM]ADEKSPC[CAM]QPNPC[CAM]HGAAPC[CAM]R.4|EPLYVGGAPDFSK.2|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]RFNAVC[CAM]LSR.4|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.3|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.2|FDTGSGPAVLTSAVPVEPGQWHRLELSR.4|TPSLDAEGSNC[CAM]PATK.2|GSGVGEC[CAM]GDHPC[CAM]LPNPC[CAM]HGGAPC[CAM]QNLEAGR.4|VVISGFGDPLIC[CAM]DNQVSTGDTR.3|VVISGFGDPLIC[CAM]DNQVSTGDTR.2|FDTGSGPAVLTSAVPVEPGQWHR.3|VLPEGGAQC[CAM]EC[CAM]PLGR.2|SADGLTASC[CAM]LC[CAM]PATC[CAM]R.2|VC[CAM]GSDGVTYGNEC[CAM]QLK.2|HQGPC[CAM]DQAPSPC[CAM]LGVQC[CAM]AFGATC[CAM]AVK.3|GMLC[CAM]GFGAVC[CAM]EPNAEGPGR.2|ESLLDGGNKVVISGFGDPLIC[CAM]DNQVSTGDTR.3
SEN / CTL,Q17RC7,Exocyst complex component 3-like protein 4,EXOC3L4,2.07,2.12,5.51E-02,4.46E-03,2.35E+00,"exocytosis,exocyst localization",SNARE binding,exocyst,6,2,2,ALGLFVPR.2|AAAGAAGAEAPR.2
SEN / CTL,Q8N2S1,Latent-transforming growth factor beta-binding protein 4,LTBP4,2.06,1.59,2.65E-03,2.48E-04,3.61E+00,"regulation of cell growth,protein folding,transmembrane receptor protein serine/threonine kinase signaling pathway,multicellular organism development,regulation of transforming growth factor beta receptor signaling pathway,regulation of proteolysis,growth hormone secretion,regulation of cell differentiation","transforming growth factor beta-activated receptor activity,integrin binding,calcium ion binding,protein binding,glycosaminoglycan binding,transforming growth factor beta binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome",18,10,11,GGYTC[CAM]VC[CAM]PDGFLLDSSR.2|VSGPWEEADAEAVAR.2|GAGLAWGVHDC[CAM]QLC[CAM]SER.3|SSC[CAM]ISQHVISEAK.3|SSC[CAM]ISQHVISEAK.2|NPQVC[CAM]GPGR.2|SRGPGAPC[CAM]QDVDEC[CAM]AR.3|EIC[CAM]PAGPGYHYSASDLR.3|C[CAM]ISRPSGYTC[CAM]AC[CAM]DSGFR.3|GPGAPC[CAM]QDVDEC[CAM]AR.2|IQQC[CAM]PGTETAEYQSLC[CAM]PHGR.3
SEN / CTL,P50995,Annexin A11,ANXA11,2.05,1.59,7.54E-05,8.84E-06,5.05E+00,"phagocytosis,cell cycle,cell division,response to calcium ion","calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylethanolamine binding,MHC class II protein complex binding,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding","nuclear envelope,nucleoplasm,cytoplasm,spindle,membrane,midbody,melanosome,specific granule,azurophil granule,phagocytic vesicle,extracellular exosome",18,29,45,GVGTDEAC[CAM]LIEILASR.3|GVGTDEAC[CAM]LIEILASR.2|NTPAFFAER.2|TLEEAIR.2|SRAHLVAVFNEYQR.4|SRAHLVAVFNEYQR.3|DAQELYAAGENR.3|DAQELYAAGENR.2|TPVLFDIYEIK.3|TPVLFDIYEIK.2|SLYHDISGDTSGDYRK.4|SLYHDISGDTSGDYRK.3|SLYHDISGDTSGDYRK.2|TLEEAIRSDTSGHFQR.4|TLEEAIRSDTSGHFQR.3|AHLVAVFNEYQR.3|AHLVAVFNEYQR.2|FNAVLC[CAM]SR.2|AYKAEFKK.2|SDTSGHFQR.2|SETDLLDIRSEYK.3|SETDLLDIR.2|GTITDAPGFDPLRDAEVLRK.4|GTITDAPGFDPLRDAEVLRK.3|LLISLSQGNR.2|LGTDESKFNAVLC[CAM]SR.3|LGTDESKFNAVLC[CAM]SR.2|SLYHDISGDTSGDYR.3|SLYHDISGDTSGDYR.2|GFGTDEQAIIDC[CAM]LGSR.3|GFGTDEQAIIDC[CAM]LGSR.2|TPVLFDIYEIKEAIK.3|LLISLSQGNRDESTNVDMSLAQR.4|LLISLSQGNRDESTNVDM[Oxi]SLAQR.3|LLISLSQGNRDESTNVDMSLAQR.3|DLKSELSGNFEK.2|GTITDAPGFDPLR.2|GTITDAPGFDPLRDAEVLR.3|DAQELYAAGENRLGTDESK.3|EAIKGVGTDEAC[CAM]LIEILASR.3|DESTNVDMSLAQR.2|EMSGDLEEGMLAVVK.2|EM[Oxi]SGDLEEGMLAVVK.2|EMSGDLEEGM[Oxi]LAVVK.2|TPVLFDIYEIKEAIKGVGTDEAC[CAM]LIEILASR.4
SEN / CTL,Q9H4B7,Tubulin beta-1 chain,TUBB1,2.05,1.79,2.60E-04,2.76E-05,4.56E+00,spindle assembly,"GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule,extracellular exosome",12,21,38,NSSC[CAM]FVEWIPNNVK.2|NSSC[CAM]FVEWIPNNVK.3|AVLVDLEPGTMDSIR.2|AVLVDLEPGTM[Oxi]DSIR.2|IMNSFSVMPSPK.3|IMNSFSVMPSPK.2|GASALQLER.2|GHYTEGAELIENVLEVVR.4|GHYTEGAELIENVLEVVR.3|GHYTEGAELIENVLEVVR.2|NTMAAC[CAM]DLR.2|ALSVAELTQQMFDAR.3|ALSVAELTQQMFDAR.2|YLTVAC[CAM]IFR.2|VSEHFSAMFK.2|EIVHIQIGQC[CAM]GNQIGAK.3|EIVHIQIGQC[CAM]GNQIGAK.2|ISVYYNEAYGR.2|FWEM[Oxi]IGEEHGIDLAGSDR.3|FWEMIGEEHGIDLAGSDR.3|FWEMIGEEHGIDLAGSDR.2|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.5|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGM[Oxi]GTLLMNK.4|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.4|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.3|EVDQQLLSVQTR.2|GLSMAATFIGNNTAIQEIFNR.3|GLSM[Oxi]AATFIGNNTAIQEIFNR.3|GLSM[Oxi]AATFIGNNTAIQEIFNR.2|GLSMAATFIGNNTAIQEIFNR.2|LHFFMPGFAPLTAQGSQQYR.3|LHFFMPGFAPLTAQGSQQYR.2|LGALFQPDSFVHGNSGAGNNWAK.3|AVLEEDEEVTEEAEMEPEDKGH.3|LTTPTYGDLNHLVSLTMSGITTSLR.3|AFVHWYTSEGM[Oxi]DINEFGEAENNIHDLVSEYQQFQDAK.4|AFVHWYTSEGMDINEFGEAENNIHDLVSEYQQFQDAK.4|AVLEEDEEVTEEAEMEPEDK.2
SEN / CTL,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,2.05,1.66,2.83E-11,6.98E-12,1.12E+01,"peptidyl-proline hydroxylation to 4-hydroxy-L-proline,collagen fibril organization,oxidation-reduction process","procollagen-proline 4-dioxygenase activity,iron ion binding,protein binding,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,L-ascorbic acid binding","mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,membrane,procollagen-proline 4-dioxygenase complex,intracellular membrane-bounded organelle",36,32,47,FILAPAKQEDEWDKPR.4|FILAPAKQEDEWDKPR.3|SAWLSGYENPVVSR.2|SAWLSGYENPVVSR.3|FHDIISDAEIEIVKDLAKPR.4|FHDIISDAEIEIVKDLAKPR.3|LTSTATKDPEGFVGHPVNAFK.4|LTSTATKDPEGFVGHPVNAFK.3|QEDEWDKPR.3|LLELDPEHQR.3|LLELDPEHQR.2|AEEDKLEQIKK.3|KKGVAVDYLPER.3|KLLELDPEHQR.3|KLLELDPEHQR.2|KDEPDAFK.2|SASDDQSDQKTTPK.3|DPEGFVGHPVNAFK.3|DPEGFVGHPVNAFK.2|RATISNPITGDLETVHYR.4|RATISNPITGDLETVHYR.3|LDRLTSTATKDPEGFVGHPVNAFK.5|LDRLTSTATKDPEGFVGHPVNAFK.4|FHDIISDAEIEIVK.3|FHDIISDAEIEIVK.2|RPC[CAM]TLSELE.2|GVAVDYLPER.2|KDEPDAFKELGTGNR.3|KDEPDAFKELGTGNR.2|LNTEWSELENLVLK.3|LNTEWSELENLVLK.2|HAAC[CAM]PVLVGNK.2|RLNTEWSELENLVLK.3|RLNTEWSELENLVLK.2|ATISNPITGDLETVHYR.3|ATISNPITGDLETVHYR.2|DLVTSLKDYIK.2|QLDEGEISTIDK.2|FHDIISDAEIEIVKDLAK.3|VSVLDYLSYAVYQQGDLDK.3|VSVLDYLSYAVYQQGDLDK.2|SFLTAEDC[CAM]FELGK.2|KGTAVFWYNLFASGEGDYSTR.3|QYFPNDEDQVGAAK.2|LQDTYNLDTDTISK.2|VAYTEADYYHTELWMEQALR.3|IQDLTGLDVSTAEELQVANYGVGGQYEPHFDFAR.4
SEN / CTL,Q02543,60S ribosomal protein L18a,RPL18A,2.05,2.27,5.07E-06,6.84E-07,6.16E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","cytosol,membrane,cytosolic large ribosomal subunit",18,17,25,EYRDLTTAGAVTQC[CAM]YR.3|AHSIQIMKVEEIAASK.4|AHSIQIMKVEEIAASK.3|AHSIQIM[Oxi]KVEEIAASK.4|AHSIQIM[Oxi]KVEEIAASK.3|AHSIQIMKVEEIAASK.2|VEEIAASK.2|FWYFVSQLKK.3|NFGIWLR.2|AHSIQIMK.2|AHSIQIM[Oxi]K.2|ASGTLREYKVVGR.3|SGTHNMYR.2|DLTTAGAVTQC[CAM]YR.3|DLTTAGAVTQC[CAM]YR.2|SRFWYFVSQLK.3|SRFWYFVSQLK.2|C[CAM]HTPPLYR.2|SRFWYFVSQLKK.3|IFAPNHVVAK.2|KSSGEIVYC[CAM]GQVFEK.3|KSSGEIVYC[CAM]GQVFEK.2|FWYFVSQLK.2|SSGEIVYC[CAM]GQVFEKSPLR.3|SSGEIVYC[CAM]GQVFEK.2
SEN / CTL,Q32P28,Prolyl 3-hydroxylase 1,LEPRE1,2.04,0.71,7.64E-04,7.64E-05,4.12E+00,"protein folding,negative regulation of cell proliferation,protein hydroxylation,peptidyl-proline hydroxylation,collagen metabolic process,regulation of protein secretion,protein stabilization,oxidation-reduction process,bone development,chaperone-mediated protein folding,negative regulation of post-translational protein modification","molecular_function,iron ion binding,procollagen-proline 3-dioxygenase activity,L-ascorbic acid binding,protein complex binding,collagen binding","proteinaceous extracellular matrix,endoplasmic reticulum,endoplasmic reticulum lumen,membrane,macromolecular complex,extracellular exosome",6,29,36,GDWPGVVLSMER.2|TAIEEVQAERK.3|LTNVAATSGDGYR.3|LTNVAATSGDGYR.2|VQADDLVK.2|FYGVTVFK.2|AVGFSSGTENPHGVK.3|QNC[CAM]VTELASHPSR.3|QNC[CAM]VTELASHPSR.2|DLETQPHMQEFR.3|EADFKDLETQPHMQEFR.4|EIETLVEEK.2|RSPYNYLQVAYFK.3|RSPYNYLQVAYFK.2|DLSFFGGLLR.2|ISQEIGNLMK.2|TAIEEVQAER.2|C[CAM]LGPPAAHSLSEEMELEFRK.4|GQTSPHTPNEK.2|LDTPLYFSYSHLVC[CAM]R.3|LDTPLYFSYSHLVC[CAM]R.2|LTNVAATSGDGYRGQTSPHTPNEK.4|KDDSHPVHVDNC[CAM]ILNAETLVC[CAM]VK.4|KDDSHPVHVDNC[CAM]ILNAETLVC[CAM]VK.3|TVTAEVQPQC[CAM]GR.2|VVMDGVISDHEC[CAM]QELQR.3|C[CAM]LGPPAAHSLSEEMELEFR.3|ISQEIGNLMKEIETLVEEK.3|SPYNYLQVAYFK.2|TYLLFFPNDEVMNQNLAYYAAMLGEEHTR.4|TYLLFFPNDEVMNQNLAYYAAMLGEEHTR.3|LYSEEQPQEAVPHLEAALQEYFVAYEEC[CAM]R.4|LYSEEQPQEAVPHLEAALQEYFVAYEEC[CAM]R.3|AVAAAHTFFVGNPEHMEMQQNLDYYQTMSGVK.4|EGGPLLYEGISLTMNSK.2|TQC[CAM]AADFPWELDPDWSPSPAQASGAAALR.3
SEN / CTL,P20700,Lamin-B1,LMNB1,2.03,1.38,3.79E-06,5.23E-07,6.28E+00,,"structural molecule activity,phospholipase binding","nuclear envelope,nuclear inner membrane,lamin filament,nucleoplasm,membrane,nuclear matrix,nuclear membrane",24,59,97,SLEGDLEDLKDQIAQLEASLAAAKK.4|SLEGDLEDLKDQIAQLEASLAAAKK.3|C[CAM]QSLTEDLEFR.2|SMYEEEINETR.2|SMYEEEINETR.3|SM[Oxi]YEEEINETR.2|MRIESLSSQLSNLQK.3|M[Oxi]RIESLSSQLSNLQK.3|M[Oxi]RIESLSSQLSNLQK.2|MRIESLSSQLSNLQK.2|KESDLNGAQIK.3|KESDLNGAQIK.2|LAQALHEMREQHDAQVR.5|LAQALHEM[Oxi]REQHDAQVR.5|LAQALHEMREQHDAQVR.4|LAQALHEM[Oxi]REQHDAQVR.4|LAQALHEMREQHDAQVR.3|LQIELGK.2|LAVYIDK.2|LYKEELEQTYHAK.4|LYKEELEQTYHAK.3|LYKEELEQTYHAK.2|EELEQTYHAK.3|EELEQTYHAK.2|C[CAM]KAEHDQLLLNYAK.4|C[CAM]KAEHDQLLLNYAK.3|C[CAM]KAEHDQLLLNYAK.2|LREYEAALNSK.3|LREYEAALNSK.2|LVEVDSGR.2|RALDDTAR.2|AEHDQLLLNYAK.3|AEHDQLLLNYAK.2|ALYETELADARR.3|LALDMEISAYRK.3|LALDMEISAYRK.2|DQIAQLEASLAAAK.3|DQIAQLEASLAAAK.2|IESLSSQLSNLQK.3|IESLSSQLSNLQK.2|IGDTSVSYK.2|QIEYEYK.2|C[CAM]QSLTEDLEFRK.3|C[CAM]QSLTEDLEFRK.2|KSMYEEEINETR.3|EYEAALNSK.2|QLADETLLK.2|DAALATALGDK.2|DQIAQLEASLAAAKK.3|DQIAQLEASLAAAKK.2|SMYEEEINETRR.3|ESDLNGAQIK.2|LAQALHEMR.2|LAQALHEM[Oxi]R.2|KIGDTSVSYK.2|NSQGEEVAQR.2|SLEGDLEDLK.2|LKNTSEQDQPMGGWEMIRK.4|AGGPTTPLSPTR.2|KQLADETLLK.2|DAALATALGDKK.2|IQELEDLLAK.2|QLADETLLKVDLENR.3|NQNSWGTGEDVKVILK.3|SLETENSALQLQVTER.3|SLETENSALQLQVTER.2|LVEVDSGRQIEYEYK.3|ALYETELADAR.2|KQLADETLLKVDLENR.3|NTSEQDQPMGGWEMIR.3|NTSEQDQPMGGWEMIR.2|SLEGDLEDLKDQIAQLEASLAAAK.4|SLEGDLEDLKDQIAQLEASLAAAK.3|LALDMEISAYR.2|KSLEGDLEDLKDQIAQLEASLAAAK.4|KSLEGDLEDLKDQIAQLEASLAAAK.3|NQNSWGTGEDVK.2|NTSEQDQPMGGWEMIRK.3|NTSEQDQPM[Oxi]GGWEMIRK.3|NTSEQDQPMGGWEM[Oxi]IRK.3|NTSEQDQPMGGWEMIRK.2|DQMQQQLNDYEQLLDVK.3|DQM[Oxi]QQQLNDYEQLLDVK.3|DQM[Oxi]QQQLNDYEQLLDVK.2|DQMQQQLNDYEQLLDVK.2|LKNTSEQDQPMGGWEMIR.3|LKNTSEQDQPMGGWEMIR.2|LSSEM[Oxi]NTSTVNSAR.2|LSSEMNTSTVNSAR.2|SLETENSALQLQVTEREEVR.3|EREMAEIRDQMQQQLNDYEQLLDVK.4|EREMAEIRDQMQQQLNDYEQLLDVK.3|LSSEMNTSTVNSAREELMESR.3|AGQTVTIWAANAGVTASPPTDLIWK.3|TTIPEEEEEEEEAAGVVVEEELFHQQGTPR.4|TTIPEEEEEEEEAAGVVVEEELFHQQGTPR.3|EMAEIRDQMQQQLNDYEQLLDVK.3
SEN / CTL,P05121,Plasminogen activator inhibitor 1,SERPINE1,2.03,1.91,3.68E-02,3.03E-03,2.52E+00,"chronological cell aging,angiogenesis,platelet degranulation,circadian rhythm,regulation of receptor activity,negative regulation of plasminogen activation,negative regulation of endopeptidase activity,negative regulation of smooth muscle cell migration,positive regulation of blood coagulation,negative regulation of blood coagulation,extracellular matrix organization,negative regulation of cell migration,positive regulation of interleukin-8 production,negative regulation of cell adhesion mediated by integrin,positive regulation of leukotriene production involved in inflammatory response,fibrinolysis,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of receptor-mediated endocytosis,positive regulation of inflammatory response,defense response to Gram-negative bacterium,negative regulation of fibrinolysis,negative regulation of vascular wound healing,negative regulation of wound healing,cellular response to lipopolysaccharide,positive regulation of monocyte chemotaxis,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of smooth muscle cell-matrix adhesion,negative regulation of endothelial cell apoptotic process","protease binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding","extracellular region,extracellular space,plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome",36,9,10,HNPTGTVLFMGQVMEP.2|MAPEEIIMDRPFLFVVR.3|QFQADFTSLSDQEPLHVAQALQK.3|ELMGPWNKDEISTTDAIFVQR.3|EVPLSALTNILSAQLISHWK.3|EVPLSALTNILSAQLISHWK.2|LVQGFMPHFFR.3|VFQQVAQASK.2|TPFPDSSTHR.2|LVLVNALYFNGQWK.2
SEN / CTL,O95336,6-phosphogluconolactonase,PGLS,2.02,1.89,1.10E-04,1.24E-05,4.91E+00,"carbohydrate metabolic process,pentose-phosphate shunt",6-phosphogluconolactonase activity,"cytosol,extracellular exosome",42,19,31,LC[CAM]WFLDEAAAR.2|WTLGFC[CAM]DER.2|LPIPESQVITINPELPVEEAAEDYAK.3|LPIPESQVITINPELPVEEAAEDYAK.4|VTLTLPVLNAAR.2|VTLTLPVLNAAR.3|ELPAAVAPAGPASLAR.2|ELPAAVAPAGPASLAR.3|TVIFVATGEGK.2|ILEDQEENPLPAALVQPHTGK.3|ILEDQEENPLPAALVQPHTGK.4|EKIVAPISDSPKPPPQR.4|EKIVAPISDSPKPPPQR.3|AAC[CAM]C[CAM]LAGAR.2|LLTVPFEK.2|RILEDQEENPLPAALVQPHTGK.5|RILEDQEENPLPAALVQPHTGK.4|RILEDQEENPLPAALVQPHTGK.3|FALGLSGGSLVSM[Oxi]LAR.3|FALGLSGGSLVSMLAR.3|FALGLSGGSLVSMLAR.2|FALGLSGGSLVSM[Oxi]LAR.2|IVAPISDSPKPPPQR.3|LVPFDHAESTYGLYR.3|LVPFDHAESTYGLYR.2|IVAPISDSPKPPPQRVTLTLPVLNAAR.4|LRQAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.5|LRQAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.4|ILEDQEENPLPAALVQPHTGKLC[CAM]WFLDEAAAR.4|LPIPESQVITINPELPVEEAAEDYAKK.3|QAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.4
SEN / CTL,P61160,Actin-related protein 2,ACTR2,2.00,1.28,7.06E-15,2.51E-15,1.46E+01,"movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,cytosolic transport,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,cilium assembly,ephrin receptor signaling pathway,spindle localization","structural constituent of cytoskeleton,ATP binding,actin filament binding","cytoplasm,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,actin cap,cell projection,extracellular exosome",42,23,52,C[CAM]GYAGSNFPEHIFPALVGRPIIR.4|C[CAM]GYAGSNFPEHIFPALVGRPIIR.3|C[CAM]GYAGSNFPEHIFPALVGRPIIR.5|VGNIEIKDLMVGDEASELR.3|VVVC[CAM]DNGTGFVK.2|VVVC[CAM]DNGTGFVK.3|SMLEVNYPMENGIVR.2|SMLEVNYPMENGIVR.3|SM[Oxi]LEVNYPMENGIVR.2|SMLEVNYPM[Oxi]ENGIVR.2|HIVLSGGSTMYPGLPSRLER.4|HIVLSGGSTMYPGLPSRLER.3|HIVLSGGSTMYPGLPSR.3|HIVLSGGSTMYPGLPSR.4|HIVLSGGSTM[Oxi]YPGLPSR.3|HIVLSGGSTM[Oxi]YPGLPSR.2|HIVLSGGSTMYPGLPSR.2|RLDIAGRDITR.3|ILLTEPPM[Oxi]NPTK.3|ILLTEPPMNPTK.3|ILLTEPPMNPTK.2|ILLTEPPM[Oxi]NPTK.2|HLWDYTFGPEK.3|HLWDYTFGPEK.2|KVVVC[CAM]DNGTGFVK.3|KVVVC[CAM]DNGTGFVK.2|DNFWMTR.2|C[CAM]GYAGSNFPEHIFPALVGR.4|C[CAM]GYAGSNFPEHIFPALVGR.3|C[CAM]GYAGSNFPEHIFPALVGR.2|GYAFNHSADFETVR.3|GYAFNHSADFETVR.2|HMVFLGGAVLADIMK.3|HM[Oxi]VFLGGAVLADIM[Oxi]K.3|HM[Oxi]VFLGGAVLADIMK.3|HMVFLGGAVLADIM[Oxi]K.3|HMVFLGGAVLADIMK.2|HM[Oxi]VFLGGAVLADIMK.2|HMVFLGGAVLADIM[Oxi]K.2|LC[CAM]YVGYNIEQEQK.3|LC[CAM]YVGYNIEQEQK.2|DKDNFWMTR.2|VLKGDVEKLSK.2|HMVFLGGAVLADIMKDK.3|EKLC[CAM]YVGYNIEQEQK.3|LALETTVLVESYTLPDGR.3|LALETTVLVESYTLPDGR.2|DLMVGDEASELR.2|DLM[Oxi]VGDEASELR.2|HLWDYTFGPEKLNIDTR.3|HMVFLGGAVLADIM[Oxi]KDKDNFWMTR.4|HMVFLGGAVLADIMKDKDNFWMTR.4
SEN / CTL,P53634,Dipeptidyl peptidase 1,CTSC,2.00,0.93,4.41E-08,7.64E-09,8.12E+00,"T cell mediated cytotoxicity,proteolysis,ER to Golgi vesicle-mediated transport,apoptotic process,immune response,aging,response to organic substance,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,positive regulation of proteolysis involved in cellular protein catabolic process,positive regulation of apoptotic signaling pathway","cysteine-type endopeptidase activity,serine-type endopeptidase activity,cysteine-type peptidase activity,peptidase activator activity involved in apoptotic process,phosphatase binding,chloride ion binding,identical protein binding,protein self-association,chaperone binding","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum lumen,membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",18,16,31,RGTDEC[CAM]AIESIAVAATPIPKL.3|ILHLPTSWDWR.3|ILHLPTSWDWR.2|GTDEC[CAM]AIESIAVAATPIPK.3|GTDEC[CAM]AIESIAVAATPIPK.2|VVVYLQK.2|NVHGINFVSPVR.3|NVHGINFVSPVR.2|LELVHHGPMAVAFEVYDDFLHYKK.6|LELVHHGPMAVAFEVYDDFLHYKK.5|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.5|LELVHHGPMAVAFEVYDDFLHYKK.4|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.4|LELVHHGPMAVAFEVYDDFLHYKK.3|KVVVYLQK.2|RGTDEC[CAM]AIESIAVAATPIPK.4|RGTDEC[CAM]AIESIAVAATPIPK.3|RGTDEC[CAM]AIESIAVAATPIPK.2|PAPLTAEIQQK.2|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.4|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.3|LELVHHGPMAVAFEVYDDFLHYK.4|LELVHHGPMAVAFEVYDDFLHYK.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.2|NSWGTGWGENGYFR.2|YYSSEYHYVGGFYGGC[CAM]NEALM[Oxi]K.3|YYSSEYHYVGGFYGGC[CAM]NEALMK.3|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.4|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.3|GTDEC[CAM]AIESIAVAATPIPKL.2
SEN / CTL,O43432,Eukaryotic translation initiation factor 4 gamma 3,EIF4G3,1.99,0.97,1.31E-03,1.28E-04,3.89E+00,"translational initiation,regulation of translational initiation,viral process","RNA cap binding,translation initiation factor activity,translation factor activity, RNA binding,poly(A) RNA binding","cytosol,eukaryotic translation initiation factor 4F complex",6,48,63,FMLQDVIDLR.2|FM[Oxi]LQDVIDLR.2|ESAKPEISAMSAHDK.4|ESAKPEISAMSAHDK.3|ESAKPEISAMSAHDK.2|LKGVIDLVFEK.3|AALSEEELERK.3|FIGELFK.2|LHDELEEAKDK.3|TRLHDELEEAK.3|RDSQADDPENIK.3|VGVESTLER.2|LLTTIGKDLDFEK.3|LLTTIGKDLDFEK.2|GVIDLVFEK.2|AEEELSIDK.2|MLTEAIMHDC[CAM]VVK.3|M[Oxi]LTEAIMHDC[CAM]VVK.3|MLTEAIMHDC[CAM]VVK.2|M[Oxi]LTEAIMHDC[CAM]VVK.2|AGVLLSEILHLLC[CAM]K.3|AGVLLSEILHLLC[CAM]K.2|LDQPANLLR.2|NHDEESLEC[CAM]LC[CAM]R.3|NHDEESLEC[CAM]LC[CAM]R.2|SIIDEFLHINDFK.3|SIIDEFLHINDFK.2|QLTGGVDVER.2|ELSAEELYK.2|LHDELEEAK.2|VLEEDESIR.2|ELTIEFSKPLLPVGR.3|ELTIEFSKPLLPVGR.2|AALSEEELER.2|AAIIADSSTFR.2|DHMGQLLYQLVQSEK.3|DHMGQLLYQLVQSEK.2|ELEAASAPEER.2|DSQADDPENIK.2|SVTAFFTWLR.2|LDFIESDSPC[CAM]SSEALSK.3|LDFIESDSPC[CAM]SSEALSK.2|LLKNHDEESLEC[CAM]LC[CAM]R.3|LSATESIVEIVK.2|SPVPAQIAITVPK.2|DSQADDPENIKTQELFR.3|MDQYFNQMEK.2|M[Oxi]DQYFNQMEK.2|MDQYFNQM[Oxi]EK.2|QVSGLTVDTEER.2|DFLPEGEDVHNFLLEQK.3|DITEEIMSGGGSR.2|LTPQMFNQLMK.2|VDEGGWNTVQGAK.2|GPDFTPAFADFGR.2|AVEENGEEAEPVR.2|DLLDNQSQEEQR.2|ELQALYALQASIVK.2|EAMQC[CAM]VEELNAQGLLHVFVR.3|FSALQPPAPSGSTPSTPVEFDSR.3|IEVEADGQTEEILDSQNLNSR.3|TRLHDELEEAKDK.2|AIDEPSFSVAYANMC[CAM]R.2
SEN / CTL,P05976;P08590,"Myosin light chain 1/3, skeletal muscle isoform;Myosin light chain 3",MYL1;MYL3,1.98,1.52,1.75E-03,1.67E-04,3.78E+00,"muscle contraction,muscle filament sliding,cardiac muscle contraction;regulation of the force of heart contraction,regulation of striated muscle contraction,skeletal muscle tissue development,muscle filament sliding,positive regulation of ATPase activity,ventricular cardiac muscle tissue morphogenesis,cardiac muscle contraction","calcium ion binding,structural constituent of muscle;motor activity,actin monomer binding,calcium ion binding,structural constituent of muscle,myosin II heavy chain binding","cytosol,muscle myosin complex,myofibril,sarcomere;cytosol,muscle myosin complex,sarcomere,A band,I band",12,1,3,VFDKEGNGTVMGAELR.3|VFDKEGNGTVMGAELR.2|VFDKEGNGTVM[Oxi]GAELR.3
SEN / CTL,Q13185,Chromobox protein homolog 3,CBX3,1.98,1.68,2.54E-02,2.09E-03,2.68E+00,"chromatin remodeling,transcription, DNA-templated,chromatin modification,negative regulation of transcription, DNA-templated,rhythmic process","protein binding,enzyme binding,protein domain specific binding,histone methyltransferase binding","chromosome, centromeric region,condensed chromosome, centromeric region,nuclear chromosome, telomeric region,chromatin,nucleus,nuclear envelope,nuclear inner membrane,nuclear euchromatin,nuclear heterochromatin,spindle,nuclear pericentric heterochromatin",6,13,22,WKDSDEADLVLAK.3|WKDSDEADLVLAK.2|SLSDSESDDSKSK.3|SLSDSESDDSKSK.2|SKKVEEAEPEEFVVEK.4|SKKVEEAEPEEFVVEK.3|C[CAM]PQIVIAFYEER.3|C[CAM]PQIVIAFYEER.2|KVEEAEPEEFVVEK.3|KVEEAEPEEFVVEK.2|IIGATDSSGELMFLMK.3|IIGATDSSGELM[Oxi]FLMK.2|IIGATDSSGELMFLM[Oxi]K.2|IIGATDSSGELMFLMK.2|DSDEADLVLAK.2|SLSDSESDDSK.2|VVNGKVEYFLK.2|LTWHSC[CAM]PEDEAQ.2|VEEAEPEEFVVEK.2|GLDPERIIGATDSSGELMFLMK.3|GFTDADNTWEPEENLDC[CAM]PELIEAFLNSQK.4|GFTDADNTWEPEENLDC[CAM]PELIEAFLNSQK.3
SEN / CTL,Q99798,"Aconitate hydratase, mitochondrial",ACO2,1.98,1.75,7.12E-02,5.69E-03,2.25E+00,"generation of precursor metabolites and energy,tricarboxylic acid cycle,citrate metabolic process,isocitrate metabolic process","aconitate hydratase activity,iron ion binding,3 iron, 4 sulfur cluster binding,4 iron, 4 sulfur cluster binding","nucleus,mitochondrion,mitochondrial matrix,myelin sheath",18,75,142,NAVTQEFGPVPDTAR.2|NAVTQEFGPVPDTAR.3|NDANPETHAFVTSPEIVTALAIAGTLK.3|NDANPETHAFVTSPEIVTALAIAGTLK.4|C[CAM]KSQFTITPGSEQIR.2|C[CAM]KSQFTITPGSEQIR.3|VAGILTVK.2|QALAHGLK.2|IHETNLK.2|YGVGFWK.2|GKC[CAM]TTDHISAAGPWLK.4|GKC[CAM]TTDHISAAGPWLK.3|GKC[CAM]TTDHISAAGPWLK.2|LTIQGLKDFTPGKPLK.4|RLNRPLTLSEK.3|EHAALEPR.2|GEKNTIVTSYNR.3|IVYGHLDDPASQEIER.4|IVYGHLDDPASQEIER.3|IVYGHLDDPASQEIER.2|DGYAQILR.2|VAEKEGWPLDIR.3|VAEKEGWPLDIR.2|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.6|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.5|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.4|AKDINQEVYNFLATAGAK.4|AKDINQEVYNFLATAGAK.3|AKDINQEVYNFLATAGAK.2|KRLNRPLTLSEK.3|SQFTITPGSEQIR.3|SQFTITPGSEQIR.2|EGWPLDIR.2|ATIERDGYAQILR.3|ATIERDGYAQILR.2|DFTPGKPLK.2|FRLEAPDADELPK.3|FRLEAPDADELPK.2|IVYGHLDDPASQEIERGK.4|IVYGHLDDPASQEIERGK.3|KGEKNTIVTSYNR.3|C[CAM]TTDHISAAGPWLK.3|C[CAM]TTDHISAAGPWLK.2|PHINGPFTPDLAHPVAEVGK.4|PHINGPFTPDLAHPVAEVGK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.5|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.4|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.3|LQLLEPFDKWDGK.3|LQLLEPFDKWDGK.2|TGREDIANLADEFK.3|TGREDIANLADEFK.2|VAVPSTIHC[CAM]DHLIEAQVGGEKDLR.5|VAVPSTIHC[CAM]DHLIEAQVGGEKDLR.4|DSSGQHVDVSPTSQR.3|DSSGQHVDVSPTSQR.2|FRLEAPDADELPKGEFDPGQDTYQHPPK.6|FRLEAPDADELPKGEFDPGQDTYQHPPK.5|FRLEAPDADELPKGEFDPGQDTYQHPPK.4|NTIVTSYNR.2|KFRLEAPDADELPK.3|LQLLEPFDK.2|GHLDNISNNLLIGAINIENGK.4|GHLDNISNNLLIGAINIENGK.3|GHLDNISNNLLIGAINIENGK.2|WVVIGDENYGEGSSR.3|WVVIGDENYGEGSSR.2|FNPETDYLTGTDGKK.3|FNPETDYLTGTDGKK.2|VAVPSTIHC[CAM]DHLIEAQVGGEK.4|VAVPSTIHC[CAM]DHLIEAQVGGEK.3|VAVPSTIHC[CAM]DHLIEAQVGGEK.2|GEFDPGQDTYQHPPK.3|GEFDPGQDTYQHPPK.2|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.4|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.2|DINQEVYNFLATAGAK.3|DINQEVYNFLATAGAK.2|LNRPLTLSEK.2|VAMSHFEPNEYIHYDLLEK.4|VAM[Oxi]SHFEPNEYIHYDLLEK.4|VAM[Oxi]SHFEPNEYIHYDLLEK.3|VAMSHFEPNEYIHYDLLEK.3|VAMSHFEPNEYIHYDLLEK.2|QGLLPLTFADPADYNK.3|QGLLPLTFADPADYNK.2|DLEDLQILIK.2|LEAPDADELPK.2|LNRPLTLSEKIVYGHLDDPASQEIER.5|LTGSLSGWSSPKDVILK.3|LTGSLSGWSSPKDVILK.2|FRGHLDNISNNLLIGAINIENGKANSVR.5|FRGHLDNISNNLLIGAINIENGKANSVR.4|FRGHLDNISNNLLIGAINIENGKANSVR.3|LTGSLSGWSSPK.2|QGLLPLTFADPADYNKIHPVDK.4|VAM[Oxi]SHFEPNEYIHYDLLEKNINIVR.5|FRGHLDNISNNLLIGAINIENGK.4|FRGHLDNISNNLLIGAINIENGK.3|KQGLLPLTFADPADYNK.3|KQGLLPLTFADPADYNK.2|RLNRPLTLSEKIVYGHLDDPASQEIER.5|RLNRPLTLSEKIVYGHLDDPASQEIER.4|EDIANLADEFK.2|QGLLPLTFADPADYNKIHPVDKLTIQGLK.5|WVVIGDENYGEGSSREHAALEPR.4|WVVIGDENYGEGSSREHAALEPR.3|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.5|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.4|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.3|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.7|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.6|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.5|C[CAM]IIKHPNGTQETILLNHTFNETQIEWFR.5|C[CAM]IIKHPNGTQETILLNHTFNETQIEWFR.4|GHLDNISNNLLIGAINIENGKANSVR.4|GHLDNISNNLLIGAINIENGKANSVR.3|LQLLEPFDKWDGKDLEDLQILIK.4|LQLLEPFDKWDGKDLEDLQILIK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDR.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDR.2|LEAPDADELPKGEFDPGQDTYQHPPK.4|LEAPDADELPKGEFDPGQDTYQHPPK.3|HPNGTQETILLNHTFNETQIEWFR.4|HPNGTQETILLNHTFNETQIEWFR.3|LEAPDADELPKGEFDPGQDTYQHPPKDSSGQHVDVSPTSQR.6|LEAPDADELPKGEFDPGQDTYQHPPKDSSGQHVDVSPTSQR.5|VAMQDATAQMAMLQFISSGLSK.3|VAM[Oxi]QDATAQM[Oxi]AMLQFISSGLSK.3|VAM[Oxi]QDATAQMAMLQFISSGLSK.3|VAMQDATAQM[Oxi]AMLQFISSGLSK.3|VAMQDATAQMAM[Oxi]LQFISSGLSK.3|VAM[Oxi]QDATAQMAMLQFISSGLSK.2|VAMQDATAQMAMLQFISSGLSK.2|FNPETDYLTGTDGK.2|DGYAQILRDLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.4|NDANPETHAFVTSPEIVTALAIAGTLKFNPETDYLTGTDGKK.5|GGTGAIVEYHGPGVDSISC[CAM]TGMATIC[CAM]NMGAEIGATTSVFPYNHR.5|GGTGAIVEYHGPGVDSISC[CAM]TGMATIC[CAM]NMGAEIGATTSVFPYNHR.4|VGLIGSC[CAM]TNSSYEDM[Oxi]GR.2|VGLIGSC[CAM]TNSSYEDMGR.2
SEN / CTL,P43487,Ran-specific GTPase-activating protein,RANBP1,1.97,1.42,1.34E-05,1.73E-06,5.76E+00,"G1/S transition of mitotic cell cycle,RNA export from nucleus,ubiquitin-dependent protein catabolic process,protein import into nucleus,spindle organization,signal transduction,viral process,positive regulation of GTPase activity,positive regulation of mitotic centrosome separation,cell-cell adhesion","GDP-dissociation inhibitor activity,Ran GTPase binding,cadherin binding involved in cell-cell adhesion,GTPase activator activity","nucleus,nuclear envelope,cytoplasm,centrosome,cell-cell adherens junction",18,10,21,FASENDLPEWKER.3|AWVWNTHADFADEC[CAM]PKPELLAIR.4|AWVWNTHADFADEC[CAM]PKPELLAIR.5|AWVWNTHADFADEC[CAM]PKPELLAIR.3|IC[CAM]ANHYITPMMELKPNAGSDR.4|IC[CAM]ANHYITPM[Oxi]M[Oxi]ELKPNAGSDR.4|IC[CAM]ANHYITPM[Oxi]MELKPNAGSDR.4|IC[CAM]ANHYITPMM[Oxi]ELKPNAGSDR.4|IC[CAM]ANHYITPM[Oxi]MELKPNAGSDR.3|IC[CAM]ANHYITPMM[Oxi]ELKPNAGSDR.3|IC[CAM]ANHYITPMMELKPNAGSDR.3|LEALSVKEETK.3|TLEEDEEELFK.3|TLEEDEEELFK.2|FLNAENAQK.2|VAEKLEALSVK.2|DTHEDHDTSTENTDESNHDPQFEPIVSLPEQEIK.6|DTHEDHDTSTENTDESNHDPQFEPIVSLPEQEIK.5|DTHEDHDTSTENTDESNHDPQFEPIVSLPEQEIK.4|EETKEDAEEKQ.2|FASENDLPEWK.2
SEN / CTL,Q9NX55,Huntingtin-interacting protein K,HYPK,1.96,0.82,3.14E-03,2.88E-04,3.54E+00,,protein binding,"nucleoplasm,cytoplasm,microtubule cytoskeleton",6,11,15,SLREHMGNVVEALIALTN.3|KHDSGAADLER.3|KHDSGAADLER.2|HDSGAADLER.2|VTIKKEDLELIMTEMEISR.4|KEDLELIMTEMEISR.3|KEDLELIMTEMEISR.2|EIQSSNLETAMSVIGDR.3|EIQSSNLETAMSVIGDR.2|EIQSSNLETAMSVIGDRR.3|VTDYAEEKEIQSSNLETAMSVIGDRR.4|EHMGNVVEALIALTN.2|EHM[Oxi]GNVVEALIALTN.2|EDLELIMTEMEISR.2|VTDYAEEKEIQSSNLETAMSVIGDR.3
SEN / CTL,P30048,"Thioredoxin-dependent peroxide reductase, mitochondrial",PRDX3,1.96,2.18,8.93E-05,1.03E-05,4.99E+00,"response to reactive oxygen species,maternal placenta development,apoptotic process,response to oxidative stress,mitochondrion organization,positive regulation of cell proliferation,peptidyl-cysteine oxidation,myeloid cell differentiation,response to lipopolysaccharide,negative regulation of kinase activity,cellular response to oxidative stress,cellular response to reactive oxygen species,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,positive regulation of NF-kappaB transcription factor activity,regulation of mitochondrial membrane potential,cellular oxidant detoxification","protein binding,protein C-terminus binding,thioredoxin peroxidase activity,alkyl hydroperoxide reductase activity,kinase binding,protein kinase binding,identical protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process","cytoplasm,mitochondrion,mitochondrial matrix,early endosome,cytosol,myelin sheath,extracellular exosome,IkappaB kinase complex",24,19,41,GLFIIDPNGVIK.2|QISRDYGVLLEGSGLALR.3|QISRDYGVLLEGSGLALR.4|DYGVLLEGSGLALR.2|DYGVLLEGSGLALR.3|GLFIIDPNGVIKHLSVNDLPVGR.4|GLFIIDPNGVIKHLSVNDLPVGR.3|HLSVNDLPVGR.3|HLSVNDLPVGR.2|SVEETLR.2|DLSLDDFK.2|KNGGLGHM[Oxi]NIALLSDLTK.4|KNGGLGHMNIALLSDLTK.3|KNGGLGHM[Oxi]NIALLSDLTK.3|KNGGLGHMNIALLSDLTK.2|GTAVVNGEFK.2|GTAVVNGEFKDLSLDDFKGK.4|GTAVVNGEFKDLSLDDFKGK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.3|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.5|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.4|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.3|NGGLGHMNIALLSDLTK.3|NGGLGHM[Oxi]NIALLSDLTK.3|NGGLGHMNIALLSDLTK.2|NGGLGHM[Oxi]NIALLSDLTK.2|SVEETLRLVK.2|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.4|GTAVVNGEFKDLSLDDFK.3|GTAVVNGEFKDLSLDDFK.2|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQKVNQ.6
SEN / CTL,P01024,Complement C3,C3,1.96,1.70,3.24E-12,8.88E-13,1.21E+01,"positive regulation of type IIa hypersensitivity,positive regulation of protein phosphorylation,positive regulation of activation of membrane attack complex,proteolysis,fatty acid metabolic process,inflammatory response,immune response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,signal transduction,G-protein coupled receptor signaling pathway,positive regulation of vascular endothelial growth factor production,positive regulation of glucose transport,regulation of triglyceride biosynthetic process,positive regulation of lipid storage,negative regulation of endopeptidase activity,regulation of complement activation,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,regulation of immune response,positive regulation of apoptotic cell clearance","serine-type endopeptidase activity,endopeptidase inhibitor activity,receptor binding,protein binding,C5L2 anaphylatoxin chemotactic receptor binding","extracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticle",54,130,202,YYGGGYGSTQATFMVFQALAQYQK.3|GYTQQLAFR.2|ILLQGTPVAQMTEDAVDAERLK.3|ILLQGTPVAQM[Oxi]TEDAVDAERLK.3|SGIPIVTSPYQIHFTK.3|SGIPIVTSPYQIHFTK.2|IPIEDGSGEVVLSR.2|IPIEDGSGEVVLSR.3|IPIEDGSGEVVLSRK.3|ILLQGTPVAQMTEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.2|ILLQGTPVAQMTEDAVDAER.2|VYAYYNLEESC[CAM]TR.2|VYAYYNLEESC[CAM]TR.3|VQLSNDFDEYIMAIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.2|VQLSNDFDEYIMAIEQTIK.2|AAVYHHFISDGVRK.4|AAVYHHFISDGVRK.3|FYHPEKEDGKLNK.4|FYHPEKEDGKLNK.3|IHWESASLLR.3|IHWESASLLR.2|KGYTQQLAFR.3|KGYTQQLAFR.2|SVQLTEK.2|TFISPIK.2|VTIKPAPETEK.3|VTIKPAPETEK.2|ASHLGLAR.2|KVLLDGVQNPR.3|KVLLDGVQNPR.2|FYHPEKEDGK.3|VVLVAVDK.2|TRFISLGEAC[CAM]K.3|QGALELIK.2|QLANGVDR.2|SGSDEVQVGQQR.3|SGSDEVQVGQQR.2|VVLVAVDKGVFVLNKK.4|VVLVAVDKGVFVLNKK.3|ISLPESLK.2|LMNIFLK.2|NEQVEIR.2|RIPIEDGSGEVVLSRK.4|RIPIEDGSGEVVLSRK.3|APSTWLTAYVVK.3|APSTWLTAYVVK.2|AVLYNYR.2|IWDVVEK.2|KLVLSSEK.2|KQELSEAEQATR.3|KQELSEAEQATR.2|VHQYFNVELIQPGAVK.4|VHQYFNVELIQPGAVK.3|VHQYFNVELIQPGAVK.2|SSLSVPYVIVPLK.3|SSLSVPYVIVPLK.2|TRFISLGEAC[CAM]KK.3|TRFISLGEAC[CAM]KK.2|VSHSEDDC[CAM]LAFK.3|VSHSEDDC[CAM]LAFK.2|LSINTHPSQKPLSITVR.4|LSINTHPSQKPLSITVR.3|LSINTHPSQKPLSITVR.2|VTIKPAPETEKRPQDAK.4|VTIKPAPETEKRPQDAK.3|EALKLEEK.2|GLEVTITAR.2|KVLLDGVQNPRAEDLVGK.4|KVLLDGVQNPRAEDLVGK.3|AAVYHHFISDGVR.3|AAVYHHFISDGVR.2|IRYYTYLIMNK.3|IRYYTYLIM[Oxi]NK.3|GQGTLSVVTMYHAK.3|KVFLDC[CAM]C[CAM]NYITELRR.4|PNLSYIIGK.2|RAPSTWLTAYVVK.3|RAPSTWLTAYVVK.2|TGLQEVEVK.2|LVAYYTLIGASGQR.3|LVAYYTLIGASGQR.2|FISLGEAC[CAM]K.2|LKGPLLNKFLTTAK.3|RQGALELIK.2|VRVELLHNPAFC[CAM]SLATTK.4|VRVELLHNPAFC[CAM]SLATTK.3|ADIGC[CAM]TPGSGK.2|DSC[CAM]VGSLVVK.2|KC[CAM]C[CAM]EDGMR.2|VVLVAVDKGVFVLNK.3|RIPIEDGSGEVVLSR.3|RIPIEDGSGEVVLSR.2|TKKQELSEAEQATR.3|AGDFLEANYM[Oxi]NLQR.3|AGDFLEANYMNLQR.3|AGDFLEANYM[Oxi]NLQR.2|AGDFLEANYMNLQR.2|FVTVQATFGTQVVEK.3|FVTVQATFGTQVVEK.2|LDKAC[CAM]EPGVDYVYK.3|NTLIIYLDK.2|TVMVNIENPEGIPVK.3|TVM[Oxi]VNIENPEGIPVK.2|TVMVNIENPEGIPVK.2|SYTVAIAGYALAQMGR.3|SYTVAIAGYALAQM[Oxi]GR.3|SYTVAIAGYALAQM[Oxi]GR.2|SYTVAIAGYALAQMGR.2|VLLDGVQNPR.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.6|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.5|LSINTHPSQK.2|FYYIYNEK.2|VFLDC[CAM]C[CAM]NYITELR.3|VFLDC[CAM]C[CAM]NYITELR.2|QPSSAFAAFVK.2|KGYTQQLAFRQPSSAFAAFVK.4|GYTQQLAFRQPSSAFAAFVKR.4|DFDFVPPVVR.2|DIC[CAM]EEQVNSLPGSITK.3|DIC[CAM]EEQVNSLPGSITK.2|SDDKVTLEER.2|VELLHNPAFC[CAM]SLATTK.3|VELLHNPAFC[CAM]SLATTK.2|SNLDEDIIAEENIVSR.3|SNLDEDIIAEENIVSR.2|VLLDGVQNPRAEDLVGK.3|YYTYLIMNK.2|YYTYLIM[Oxi]NK.2|KVFLDC[CAM]C[CAM]NYITELR.3|HYLMWGLSSDFWGEK.3|SEETKENEGFTVTAEGK.3|SEETKENEGFTVTAEGK.2|VFLDC[CAM]C[CAM]NYITELRR.3|EYVLPSFEVIVEPTEK.3|EYVLPSFEVIVEPTEK.2|NTMILEIC[CAM]TR.2|NTM[Oxi]ILEIC[CAM]TR.2|QELSEAEQATR.2|TELRPGETLNVNFLLR.3|TELRPGETLNVNFLLR.2|SYTVAIAGYALAQMGRLKGPLLNK.4|DSITTWEILAVSMSDKK.3|ENEGFTVTAEGK.2|QKPDGVFQEDAPVIHQEM[Oxi]IGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.3|TMQALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.3|TMQALPYSTVGNSNNYLHLSVLR.3|AC[CAM]EPGVDYVYK.2|C[CAM]AEENC[CAM]FIQK.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.5|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.4|KVEGTAFVIFGIQDGEQR.3|KVEGTAFVIFGIQDGEQR.2|SGQSEDRQPVPGQQMTLK.3|EVVADSVWVDVK.2|TIYTPGSTVLYR.2|EGVQKEDIPPADLSDQVPDTESETR.4|EGVQKEDIPPADLSDQVPDTESETR.3|QVREPGQDLVVLPLSITTDFIPSFR.4|QVREPGQDLVVLPLSITTDFIPSFR.3|AYYENSPQQVFSTEFEVK.3|AYYENSPQQVFSTEFEVK.2|DAPDHQELNLDVSLQLPSR.3|QLYNVEATSYALLALLQLK.3|QLYNVEATSYALLALLQLK.2|SEFPESWLWNVEDLKEPPKNGISTK.4|VPVAVQGEDTVQSLTQGDGVAK.3|VPVAVQGEDTVQSLTQGDGVAK.2|AEDLVGKSLYVSATVILHSGSDMVQAER.4|EDIPPADLSDQVPDTESETR.3|EDIPPADLSDQVPDTESETR.2|GYTQQLAFRQPSSAFAAFVK.3|KHYLMWGLSSDFWGEKPNLSYIIGK.4|VFSLAVNLIAIDSQVLC[CAM]GAVK.3|VFSLAVNLIAIDSQVLC[CAM]GAVK.2|SLYVSATVILHSGSDMVQAER.3|PGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLKEPPK.3|NNNEKDMALTAFVLISLQEAK.3|SSLSVPYVIVPLKTGLQEVEVK.3|EPGQDLVVLPLSITTDFIPSFR.3|IRAYYENSPQQVFSTEFEVK.3|DYAGVFSDAGLTFTSSSGQQTAQR.3|DMALTAFVLISLQEAK.2|DTWVEHWPEEDEC[CAM]QDEENQK.3|YFKPGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLK.2|VVLVSLQSGYLFIQTDK.2|HLIVTPSGC[CAM]GEQNMIGM[Oxi]TPTVIAVHYLDETEQWEK.4|HLIVTPSGC[CAM]GEQNMIGMTPTVIAVHYLDETEQWEK.4|NNNEKDM[Oxi]ALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|NNNEKDMALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|QDSLSSQNQLGVLPLSWDIPELVNM[Oxi]GQWK.3|QDSLSSQNQLGVLPLSWDIPELVNMGQWK.3
SEN / CTL,P28799,Granulins,GRN,1.96,1.14,1.05E-02,8.98E-04,3.05E+00,signal transduction,"cytokine activity,protein binding,growth factor activity,poly(A) RNA binding","extracellular space,intracellular membrane-bounded organelle,extracellular exosome",6,18,23,HLGGPC[CAM]QVDAHC[CAM]SAGHSC[CAM]IFTVSGTSSC[CAM]C[CAM]PFPEAVAC[CAM]GDGHHC[CAM]C[CAM]PR.7|HLGGPC[CAM]QVDAHC[CAM]SAGHSC[CAM]IFTVSGTSSC[CAM]C[CAM]PFPEAVAC[CAM]GDGHHC[CAM]C[CAM]PR.6|QGVC[CAM]C[CAM]ADR.2|APAHLSLPDPQALK.3|VHC[CAM]C[CAM]PHGAFC[CAM]DLVHTR.4|VHC[CAM]C[CAM]PHGAFC[CAM]DLVHTR.3|GFHC[CAM]SADGR.2|GSEIVAGLEK.2|HC[CAM]C[CAM]PAGFR.2|QHC[CAM]C[CAM]PAGYTC[CAM]NVK.3|QHC[CAM]C[CAM]PAGYTC[CAM]NVK.2|DVEC[CAM]GEGHFC[CAM]HDNQTC[CAM]C[CAM]R.4|DVEC[CAM]GEGHFC[CAM]HDNQTC[CAM]C[CAM]R.3|GTC[CAM]EQGPHQVPWMEK.3|QGWAC[CAM]C[CAM]PYR.2|SRC[CAM]PDGSTC[CAM]C[CAM]ELPSGK.3|EVVSAQPATFLAR.2|AVALSSSVMC[CAM]PDAR.2|C[CAM]PDGSTC[CAM]C[CAM]ELPSGK.2|C[CAM]DM[Oxi]EVSC[CAM]PDGYTC[CAM]C[CAM]R.2|C[CAM]DMEVSC[CAM]PDGYTC[CAM]C[CAM]R.2|LQSGAWGC[CAM]C[CAM]PFTQAVC[CAM]C[CAM]EDHIHC[CAM]C[CAM]PAGFTC[CAM]DTQK.4|DIGC[CAM]DQHTSC[CAM]PVGQTC[CAM]C[CAM]PSLGGSWAC[CAM]C[CAM]QLPHAVC[CAM]C[CAM]EDR.4
SEN / CTL,Q9UHV9,Prefoldin subunit 2,PFDN2,1.96,1.57,1.28E-02,1.08E-03,2.97E+00,"protein folding,positive regulation of cytoskeleton organization","protein binding,protein binding involved in protein folding,unfolded protein binding","nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrion,prefoldin complex,extracellular exosome",12,9,15,IIETLTQQLQAK.2|IIETLTQQLQAK.3|MVGGVLVER.2|M[Oxi]VGGVLVER.2|LM[Oxi]GEDEKPAAK.3|LMGEDEKPAAK.2|GAVSAEQVIAGFNR.3|GAVSAEQVIAGFNR.2|EVLPALENNK.2|EVLPALENNKEQIQK.3|AAELEMELNEHSLVIDTLKEVDETRK.5|AAELEMELNEHSLVIDTLKEVDETRK.4|TVKEVLPALENNKEQIQK.3|AAELEM[Oxi]ELNEHSLVIDTLK.3|AAELEMELNEHSLVIDTLK.3
SEN / CTL,Q96CN7,Isochorismatase domain-containing protein 1,ISOC1,1.95,2.33,6.15E-02,4.93E-03,2.31E+00,"biological_process,metabolic process","molecular_function,catalytic activity","cytoplasm,peroxisome,extracellular exosome",6,16,25,FSM[Oxi]VLPEVEAALAEIPGVR.3|FSMVLPEVEAALAEIPGVR.3|FSM[Oxi]VLPEVEAALAEIPGVR.2|FSMVLPEVEAALAEIPGVR.2|FLSLYGDQIDMHRK.4|FLSLYGDQIDMHRK.3|FLSLYGDQIDMHRK.2|GVEVHIVADATSSR.3|GVEVHIVADATSSR.2|GLGSTVQEIDLTGVK.3|GLGSTVQEIDLTGVK.2|ILGIPVIVTEQYPK.3|ILGIPVIVTEQYPK.2|ASAPESGLLSK.2|FLSLYGDQIDMHR.3|PSSVPHGAGYELLIQK.3|TKFSMVLPEVEAALAEIPGVR.4|TKFSMVLPEVEAALAEIPGVR.3|ASAPESGLLSKV.2|TGIIVTTSEAVLLQLVADKDHPK.4|YFGDIISVGQR.2|TGIIVTTSEAVLLQLVADK.3|FVVQLFAEEWGQYVDLPK.3|SVVLFGVETHVC[CAM]IQQTALELVGR.3|LVPLQIQLTTLGNLTPSSTVFFC[CAM]C[CAM]DMQER.3
SEN / CTL,Q02878,60S ribosomal protein L6,RPL6,1.95,2.03,3.41E-04,3.57E-05,4.45E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,regulation of transcription, DNA-templated,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cell-cell adhesion","DNA binding,RNA binding,structural constituent of ribosome,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytosol,cell-cell adherens junction,focal adhesion,membrane,cytosolic large ribosomal subunit,cytoplasmic ribonucleoprotein granule",12,30,42,HQEGEIFDTEKEKYEITEQR.4|HQEGEIFDTEKEKYEITEQR.5|HQEGEIFDTEKEKYEITEQR.3|AGEKVEKPDTK.3|AGEKVEKPDTK.2|VLATVTKPVGGDK.3|VLATVTKPVGGDK.2|YYPTEDVPRK.3|YYPTEDVPRK.2|FVIATSTK.2|EKYEITEQRK.3|VLATVTKPVGGDKNGGTR.4|VLATVTKPVGGDKNGGTR.3|HQEGEIFDTEK.3|HQEGEIFDTEK.2|IKAIPQLQGYLR.3|YEITEQR.2|SVFALTNGIYPHK.3|SVFALTNGIYPHK.2|AVDSQILPK.2|HLTDAYFK.2|KPFSQHVR.2|ASITPGTILIILTGR.3|ASITPGTILIILTGR.2|EKVLATVTKPVGGDK.3|HQEGEIFDTEKEK.3|HQEGEIFDTEKEK.2|PRHQEGEIFDTEK.3|PRHQEGEIFDTEK.2|HLTDAYFKK.2|YYPTEDVPR.2|AIPQLQGYLR.2|QLASGLLLVTGPLVLNR.3|QLASGLLLVTGPLVLNR.2|EKYEITEQR.2|LRASITPGTILIILTGR.3|QLASGLLLVTGPLVLNRVPLRR.4|SVFALTNGIYPHKLVF.3|VVFLKQLASGLLLVTGPLVLNRVPLR.4|AIPQLQGYLRSVFALTNGIYPHKLVF.4|QLASGLLLVTGPLVLNRVPLR.3|VVFLKQLASGLLLVTGPLVLNR.3
SEN / CTL,Q07020,60S ribosomal protein L18,RPL18,1.95,0.93,4.91E-05,5.89E-06,5.23E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit",12,14,20,ILTFDQLALDSPK.2|TAVVVGTITDDVR.2|TAVVVGTITDDVR.3|GVDIRHNKDR.3|HFGKAPGTPHSHTKPYVR.5|HFGKAPGTPHSHTKPYVR.4|TNSTFNQVVLK.3|TNSTFNQVVLK.2|SQDIYLR.2|RTNSTFNQVVLK.3|RTNSTFNQVVLK.2|TNSTFNQVVLKR.3|TNSTFNQVVLKR.2|APGTPHSHTKPYVR.3|APGTPHSHTKPYVR.2|GC[CAM]GTVLLSGPR.2|TNRPPLSLSR.2|AGGKILTFDQLALDSPK.3|GC[CAM]GTVLLSGPRK.2|TAVVVGTITDDVRVQEVPK.3
SEN / CTL,P35052,Glypican-1,GPC1,1.94,1.33,7.72E-07,1.16E-07,6.94E+00,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,axon guidance,Schwann cell differentiation,heparan sulfate proteoglycan catabolic process,glycosaminoglycan metabolic process,myelin assembly,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of skeletal muscle cell differentiation","copper ion binding,fibroblast growth factor binding,laminin binding,heparan sulfate proteoglycan binding","proteinaceous extracellular matrix,extracellular space,endosome,Golgi lumen,plasma membrane,integral component of plasma membrane,anchored component of membrane,lysosomal lumen,membrane raft,extracellular exosome",30,13,13,GFSLSDVPQAEISGEHLR.3|VLQAMLATQLR.2|SFVQGLGVASDVVR.2|LVYC[CAM]AHC[CAM]LGVPGARPC[CAM]PDYC[CAM]R.4|DVQDFWISLPGTLC[CAM]SEK.3|QAEALRPFGEAPR.3|SFVQGLGVASDVVRK.3|SHAELETALR.2|VAQVPLGPEC[CAM]SR.2|NLLDSMVLITDK.2|QLHPQLLLPDDYLDC[CAM]LGK.3|GC[CAM]LANQADLDAEWR.2|TLQATFPGAFGELYTQNAR.2
SEN / CTL,Q96FQ6,Protein S100-A16,S100A16,1.94,1.29,2.40E-02,1.98E-03,2.70E+00,response to calcium ion,"calcium ion binding,protein binding,protein homodimerization activity,poly(A) RNA binding","nucleolus,cytoplasm,cytosol,plasma membrane,extracellular exosome",6,8,13,AVIVLVENFYK.2|AVIVLVENFYK.3|LIQNLDANHDGR.3|LIQNLDANHDGR.2|ELNHMLSDTGNRK.3|ELNHM[Oxi]LSDTGNRK.3|ELNHMLSDTGNRK.2|AADKLIQNLDANHDGR.3|KAADKLIQNLDANHDGR.3|LIHEQEQQSSS.2|ELNHMLSDTGNR.2|ISFDEYWTLIGGITGPIAK.3|ISFDEYWTLIGGITGPIAK.2
SEN / CTL,P08253,72 kDa type IV collagenase,MMP2,1.94,0.49,2.28E-04,2.44E-05,4.61E+00,"angiogenesis,response to hypoxia,blood vessel maturation,intramembranous ossification,proteolysis,embryo implantation,extracellular matrix disassembly,collagen catabolic process,endodermal cell differentiation,cellular protein metabolic process,positive regulation of innate immune response,ephrin receptor signaling pathway,face morphogenesis,bone trabecula formation,cellular response to amino acid stimulus,positive regulation of vascular smooth muscle cell proliferation","metalloendopeptidase activity,serine-type endopeptidase activity,metallopeptidase activity,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,nucleus,mitochondrion,plasma membrane,sarcomere,extracellular matrix",6,2,2,IIGYTPDLDPETVDDAFAR.2|IDAVYEAPQEEK.2
SEN / CTL,P12110,Collagen alpha-2(VI) chain,COL6A2,1.94,1.91,1.17E-33,1.54E-33,3.28E+01,"cell adhesion,response to glucose,extracellular matrix organization,collagen catabolic process,protein heterotrimerization",,"extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,protein complex,extracellular exosome,extracellular vesicle",174,42,57,SKGTVHFAVVITDGHVTGSPC[CAM]GGIK.4|VFAVVITDGRHDPRDDDLNLR.5|VFAVVITDGRHDPRDDDLNLR.4|AAVFHEKDYDSLAQPGFFDR.4|AAVFHEKDYDSLAQPGFFDR.3|NFVINVVNR.2|EQGLRDIASTPHELYRNDYATMLPDSTEIDQDTINR.5|LFAVAPNQNLKEQGLR.3|NLEWIAGGTWTPSALK.3|NLEWIAGGTWTPSALK.2|QFVPQFISQLQNEFYLDQVALSWR.3|QFVPQFISQLQNEFYLDQVALSWR.4|AAVFHEKDYDSLAQPGFFDRFIR.5|AAVFHEKDYDSLAQPGFFDRFIR.4|AREEGIRLFAVAPNQNLK.4|VFAVVITDGR.2|GTVHFAVVITDGHVTGSPC[CAM]GGIK.4|GTVHFAVVITDGHVTGSPC[CAM]GGIK.3|YGGLHFSDQVEVFSPPGSDR.3|YGGLHFSDQVEVFSPPGSDR.2|YGGLHFSDQVEVFSPPGSDR.4|NDYATMLPDSTEIDQDTINR.3|LFAVAPNQNLKEQGLRDIASTPHELYR.5|LFAVAPNQNLKEQGLRDIASTPHELYR.4|QNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.3|QNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.4|DYDSLAQPGFFDR.2|LFAVAPNQNLK.2|EQGLRDIASTPHELYR.3|KQNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.4|KQNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.3|DIASTPHELYR.3|DIASTPHELYR.2|AAVFHEK.2|FVEQVAR.2|TRVFAVVITDGR.3|TRVFAVVITDGR.2|HDPRDDDLNLR.3|LGEQNFHK.2|ETC[CAM]GC[CAM]C[CAM]DC[CAM]EKR.3|RFVEQVAR.2|GPQGALGEPGK.2|NLQGISSFR.2|ASFIKNLQGISSFR.3|RDDDPLNAR.2|HESENLYSIAC[CAM]DKPQQVR.4|HESENLYSIAC[CAM]DKPQQVR.3|DVTVTAIGIGDMFHEK.3|HEAYGEC[CAM]YK.2|ALC[CAM]DRDVTVTAIGIGDMFHEK.4|ALC[CAM]DRDVTVTAIGIGDMFHEK.3|ETC[CAM]GC[CAM]C[CAM]DC[CAM]EK.2|VGVVQYSHEGTFEAIQLDDERIDSLSSFKEAVK.5|YGGLHFSDQVEVFSPPGSDRASFIKNLQGISSFR.5|HESENLYSIAC[CAM]DK.2|VGVVQYSHEGTFEAIQLDDER.3|VGVVQYSHEGTFEAIQLDDERIDSLSSFK.4
SEN / CTL,P34932,Heat shock 70 kDa protein 4,HSPA4,1.93,1.58,1.13E-24,9.72E-25,2.40E+01,"response to unfolded protein,protein import into mitochondrial outer membrane,chaperone-mediated protein complex assembly","protein binding,ATP binding","cytosol,extracellular exosome",102,85,157,EFSITDVVPYPISLR.2|EFSITDVVPYPISLR.3|AGGIETIANEYSDR.2|AGGIETIANEYSDR.3|FLEMC[CAM]NDLLAR.2|FLEM[Oxi]C[CAM]NDLLAR.2|GC[CAM]ALQC[CAM]AILSPAFK.2|GC[CAM]ALQC[CAM]AILSPAFK.3|ELSTTLNADEAVTR.2|ELSTTLNADEAVTR.3|SVMDATQIAGLNC[CAM]LR.2|SVMDATQIAGLNC[CAM]LR.3|SVM[Oxi]DATQIAGLNC[CAM]LR.3|SVM[Oxi]DATQIAGLNC[CAM]LR.2|VREFSITDVVPYPISLR.3|VREFSITDVVPYPISLR.4|VREFSITDVVPYPISLR.2|VLATAFDTTLGGR.2|VLATAFDTTLGGR.3|AFSDPFVEAEKSNLAYDIVQLPTGLTGIK.3|AFSDPFVEAEKSNLAYDIVQLPTGLTGIK.4|SVLEQTK.2|LFEELGK.2|LMNETTAVALAYGIYKQDLPALEEKPR.4|LMNETTAVALAYGIYKQDLPALEEKPR.5|LM[Oxi]NETTAVALAYGIYKQDLPALEEKPR.4|LMNETTAVALAYGIYKQDLPALEEKPR.3|NAVEEYVYEMR.2|NAVEEYVYEMR.3|NAVEEYVYEM[Oxi]R.2|WNSPAEEGSSDC[CAM]EVFSK.3|WNSPAEEGSSDC[CAM]EVFSK.2|IKELTSTC[CAM]SPIISKPKPK.5|IKELTSTC[CAM]SPIISKPKPK.4|IKELTSTC[CAM]SPIISKPKPK.3|LSGEYEK.2|NHAAPFSK.2|QDLPALEEKPR.3|QDLPALEEKPR.2|ETAESVLK.2|ELTSTC[CAM]SPIISKPKPK.4|ELTSTC[CAM]SPIISKPKPK.3|MDQPPQAK.2|M[Oxi]DQPPQAK.2|LKKEDIYAVEIVGGATR.4|LKKEDIYAVEIVGGATR.3|LKKEDIYAVEIVGGATR.2|QIQQYMK.2|QIQQYM[Oxi]K.2|IRFQESEERPK.3|IRFQESEERPK.2|NKEDQYDHLDAADMTK.4|NKEDQYDHLDAADM[Oxi]TK.4|NKEDQYDHLDAADM[Oxi]TK.3|NKEDQYDHLDAADMTK.3|NKEDQYDHLDAADMTK.2|KLPEMDID.2|KLPEM[Oxi]DID.2|VLATAFDTTLGGRK.3|AESEEMETSQAGSK.3|AESEEMETSQAGSK.2|AESEEM[Oxi]ETSQAGSK.2|EDIYAVEIVGGATR.3|EDIYAVEIVGGATR.2|KFDEVLVNHFC[CAM]EEFGK.4|KFDEVLVNHFC[CAM]EEFGK.3|KFDEVLVNHFC[CAM]EEFGK.2|VNVHGIFSVSSASLVEVHK.4|VNVHGIFSVSSASLVEVHK.3|VNVHGIFSVSSASLVEVHK.2|ELTSTC[CAM]SPIISKPK.3|FVSEDDRNSFTLK.3|FVSEDDRNSFTLK.2|GKFLEMC[CAM]NDLLAR.3|KMDQPPQAK.2|QDLPALEEK.2|IKELTSTC[CAM]SPIISK.3|IKELTSTC[CAM]SPIISK.2|KFDEVLVNHFC[CAM]EEFGKK.4|KFDEVLVNHFC[CAM]EEFGKK.3|NFTTEQVTAMLLSK.3|NFTTEQVTAMLLSK.2|NFTTEQVTAM[Oxi]LLSK.2|VTYMEEER.2|VTYM[Oxi]EEER.2|DKLSGEYEK.2|KEDIYAVEIVGGATR.3|KEDIYAVEIVGGATR.2|EDQYDHLDAADMTK.3|EDQYDHLDAADMTK.2|VTPQSDGSSSK.2|LKETAESVLK.2|QSLTMDPVVK.2|QSLTM[Oxi]DPVVK.2|MIMQDKLEK.2|M[Oxi]IMQDKLEK.2|FQESEERPK.2|LMNETTAVALAYGIYK.3|LM[Oxi]NETTAVALAYGIYK.3|LMNETTAVALAYGIYK.2|LM[Oxi]NETTAVALAYGIYK.2|SEENEEPM[Oxi]ETDQNAK.3|SEENEEPM[Oxi]ETDQNAK.2|SEENEEPMETDQNAK.2|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.4|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.3|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.2|NVVFVDMGHSAYQVSVC[CAM]AFNR.4|NVVFVDM[Oxi]GHSAYQVSVC[CAM]AFNR.3|NVVFVDMGHSAYQVSVC[CAM]AFNR.3|RSVMDATQIAGLNC[CAM]LR.3|AFSDPFVEAEK.2|C[CAM]TPAC[CAM]ISFGPK.2|FDEVLVNHFC[CAM]EEFGK.3|FDEVLVNHFC[CAM]EEFGK.2|SNLAYDIVQLPTGLTGIK.3|SNLAYDIVQLPTGLTGIK.2|ETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAERR.5|EDIYAVEIVGGATRIPAVK.3|ELTSTC[CAM]SPIISK.2|FFGKELSTTLNADEAVTR.3|LKETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAER.5|LKETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAER.4|LEDTENWLYEDGEDQPK.3|LEDTENWLYEDGEDQPK.2|LMNETTAVALAYGIYKQDLPALEEK.4|MIMQDKLEKER.2|TSTVDLPIENQLLWQIDR.3|TSTVDLPIENQLLWQIDR.2|VNVHGIFSVSSASLVEVHKSEENEEPMETDQNAKEEEK.6|VNVHGIFSVSSASLVEVHKSEENEEPMETDQNAKEEEK.5|STNEAMEWMNNKLNLQNK.3|EM[Oxi]LNLYIENEGK.2|EMLNLYIENEGK.2|STNEAM[Oxi]EWMNNK.2|STNEAMEWM[Oxi]NNK.2|STNEAMEWMNNK.2|KPVVDC[CAM]VVSVPC[CAM]FYTDAER.3|KPVVDC[CAM]VVSVPC[CAM]FYTDAER.2|SEENEEPMETDQNAKEEEK.3|LMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.4|LMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.3|VKTSTVDLPIENQLLWQIDR.3|EPFTLEAYYSSPQDLPYPDPAIAQFSVQK.4|EPFTLEAYYSSPQDLPYPDPAIAQFSVQK.3|KEPFTLEAYYSSPQDLPYPDPAIAQFSVQK.4|KEPFTLEAYYSSPQDLPYPDPAIAQFSVQK.3|M[Oxi]QVDQEEPHVEEQQQQTPAENK.3|MQVDQEEPHVEEQQQQTPAENK.3|MQVDQEEPHVEEQQQQTPAENKAESEEMETSQAGSKDK.5|VTYMEEERNFTTEQVTAMLLSK.3|VKTSTVDLPIENQLLWQIDREMLNLYIENEGK.4|MQVDQEEPHVEEQQQQTPAENKAESEEMETSQAGSK.4|KLMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.3|VEPPKEEQKNAEQNGPVDGQGDNPGPQAAEQGTDTAVPSDSDK.4|NAEQNGPVDGQGDNPGPQAAEQGTDTAVPSDSDK.3|TSTVDLPIENQLLWQIDREMLNLYIENEGK.3
SEN / CTL,P07339,Cathepsin D,CTSD,1.92,1.54,1.42E-11,3.66E-12,1.14E+01,"proteolysis,autophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein catabolic process,collagen catabolic process","aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,serine-type endopeptidase activity","extracellular region,extracellular space,lysosome,melanosome,lysosomal lumen,membrane raft,extracellular exosome,extracellular matrix",48,30,62,FDGILGMAYPR.2|FDGILGM[Oxi]AYPR.2|AIGAVPLIQGEYMIPC[CAM]EK.3|AIGAVPLIQGEYMIPC[CAM]EK.2|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.3|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.2|ISVNNVLPVFDNLMQQK.3|ISVNNVLPVFDNLMQQK.2|ISVNNVLPVFDNLM[Oxi]QQK.3|ISVNNVLPVFDNLM[Oxi]QQK.2|TMSEVGGSVEDLIAK.2|TMSEVGGSVEDLIAK.3|TM[Oxi]SEVGGSVEDLIAK.2|QVFGEATKQPGITFIAAK.3|QVFGEATKQPGITFIAAK.2|QVFGEATKQPGITFIAAKFDGILGMAYPR.4|QVFGEATKQPGITFIAAKFDGILGMAYPR.3|VGFAEAAR.2|VGFAEAAR.1|LGGKGYKLSPEDYTLK.4|LGGKGYKLSPEDYTLK.3|GYKLSPEDYTLK.3|GYKLSPEDYTLK.2|LLDIAC[CAM]WIHHK.3|LLDIAC[CAM]WIHHK.2|YYTVFDR.2|YYTVFDRDNNR.3|YYTVFDRDNNR.2|GYKLSPEDYTLKVSQAGK.4|GYKLSPEDYTLKVSQAGK.3|QPGITFIAAK.2|VSTLPAITLK.2|LSPEDYTLK.2|LVDQNIFSFYLSR.3|LVDQNIFSFYLSR.2|LSPEDYTLKVSQAGK.3|LSPEDYTLKVSQAGK.2|YYTVFDRDNNRVGFAEAAR.4|YYTVFDRDNNRVGFAEAAR.3|AYWQVHLDQVEVASGLTLC[CAM]K.4|AYWQVHLDQVEVASGLTLC[CAM]K.3|AYWQVHLDQVEVASGLTLC[CAM]K.2|DPDAQPGGELMLGGTDSK.3|DPDAQPGGELMLGGTDSK.2|DPDAQPGGELM[Oxi]LGGTDSK.2|KAYWQVHLDQVEVASGLTLC[CAM]K.4|KAYWQVHLDQVEVASGLTLC[CAM]K.3|YSQAVPAVTEGPIPEVLK.3|YSQAVPAVTEGPIPEVLK.2|YNSDKSSTYVK.2|QPGITFIAAKFDGILGMAYPR.3|EGC[CAM]EAIVDTGTSLMVGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.2|EGC[CAM]EAIVDTGTSLMVGPVDEVR.2|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.4|LVDQNIFSFYLSRDPDAQPGGELM[Oxi]LGGTDSK.3|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.3|QVFGEATK.1|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVRELQK.3|EGC[CAM]EAIVDTGTSLMVGPVDEVRELQK.3|TLC[CAM]LSGFM[Oxi]GM[Oxi]DIPPPSGPLWILGDVFIGR.3
SEN / CTL,Q99439,Calponin-2,CNN2,1.92,1.56,1.18E-09,2.43E-10,9.61E+00,"cytoskeleton organization,actomyosin structure organization,regulation of actin filament-based process,cellular response to mechanical stimulus,cell-cell adhesion","actin binding,calmodulin binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoskeleton,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,extracellular exosome",48,17,33,GLQSGVDIGVK.2|GPSYGLSAEVK.2|TWIEGLTGLSIGPDFQK.2|TWIEGLTGLSIGPDFQK.3|GLKDGTILC[CAM]TLMNK.3|GLKDGTILC[CAM]TLMNK.2|AGQC[CAM]VIGLQMGTNK.2|AGQC[CAM]VIGLQM[Oxi]GTNK.2|SMQNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.2|SMQNWHQLENLSNFIK.2|TKGLQSGVDIGVK.3|TKGLQSGVDIGVK.2|LLSKYDPQKEAELR.4|C[CAM]ASQVGMTAPGTR.3|C[CAM]ASQVGMTAPGTR.2|C[CAM]ASQVGM[Oxi]TAPGTR.2|C[CAM]ASQSGMTAYGTR.3|C[CAM]ASQSGMTAYGTR.2|C[CAM]ASQSGM[Oxi]TAYGTR.2|NFDDATMK.2|C[CAM]ASQVGMTAPGTRR.3|NHILPPMDHSTISLQMGTNK.4|NHILPPM[Oxi]DHSTISLQMGTNK.4|NHILPPMDHSTISLQM[Oxi]GTNK.4|NHILPPMDHSTISLQMGTNK.3|NHILPPMDHSTISLQMGTNK.2|DGTILC[CAM]TLMNK.2|DGTILC[CAM]TLM[Oxi]NK.2|C[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3|YC[CAM]PQGTVADGAPSGTGDC[CAM]PDPGEVPEYPPYYQEEAGY.4|LGTDKC[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3
SEN / CTL,P21333,Filamin-A,FLNA,1.92,1.61,7.87E-81,3.54E-80,7.95E+01,"platelet degranulation,adenylate cyclase-inhibiting dopamine receptor signaling pathway,negative regulation of transcription from RNA polymerase I promoter,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,cell junction assembly,protein localization to cell surface,negative regulation of protein catabolic process,cilium assembly,mRNA transcription from RNA polymerase II promoter,positive regulation of transcription factor import into nucleus,negative regulation of apoptotic process,receptor clustering,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of sequence-specific DNA binding transcription factor activity,wound healing, spreading of cells,establishment of protein localization,protein stabilization,cytoplasmic sequestering of protein,actin crosslink formation,platelet aggregation,semaphorin-plexin signaling pathway,mitotic spindle assembly,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of integrin-mediated signaling pathway","G-protein coupled receptor binding,glycoprotein binding,signal transducer activity,protein binding,transcription factor binding,Rho GTPase binding,Ral GTPase binding,kinase binding,small GTPase binding,mu-type opioid receptor binding,Fc-gamma receptor I complex binding,protein homodimerization activity,poly(A) RNA binding,SMAD binding,Rac GTPase binding,actin filament binding,GTPase binding,cadherin binding involved in cell-cell adhesion","extracellular region,nucleus,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular matrix,Myb complex,neuronal cell body,dendritic shaft,perinuclear region of cytoplasm,extracellular exosome,apical dendrite,filamentous actin",672,206,385,AGGPGLERAEAGVPAEFSIWTR.3|TGVAVNKPAEFTVDAK.3|TGVAVNKPAEFTVDAK.2|EATTEFSVDAR.2|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.3|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|LSPFMADIRDAPQDFHPDRVK.5|AWGPGLEGGVVGK.2|GAGTGGLGLAVEGPSEAK.2|GAGTGGLGLAVEGPSEAK.3|LYSVSYLLK.2|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.3|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.5|VASKIVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|VHGPGIQSGTTNKPNKFTVETR.5|VHGPGIQSGTTNKPNKFTVETR.4|ANLPQSFQVDTSKAGVAPLQVK.3|ANLPQSFQVDTSKAGVAPLQVK.2|EGPYSISVLYGDEEVPRSPFK.3|EGPYSISVLYGDEEVPRSPFK.2|AEAGVPAEFSIWTR.2|AEAGVPAEFSIWTR.3|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.4|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.5|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.6|VSGLGEKVDVGKDQEFTVK.4|VSGLGEKVDVGKDQEFTVK.3|IANLQTDLSDGLR.2|IANLQTDLSDGLR.3|VRVHGPGIQSGTTNKPNKFTVETR.5|VRVHGPGIQSGTTNKPNKFTVETR.6|VRVHGPGIQSGTTNKPNKFTVETR.4|VRVHGPGIQSGTTNKPNKFTVETR.3|GLVEPVDVVDNADGTQTVNYVPSR.3|GLVEPVDVVDNADGTQTVNYVPSR.4|SPFSVAVSPSLDLSK.2|SPFSVAVSPSLDLSK.3|LVSNHSLHETSSVFVDSLTK.4|LVSNHSLHETSSVFVDSLTK.3|LVSNHSLHETSSVFVDSLTK.2|YTPVQQGPVGVNVTYGGDPIPK.3|YTPVQQGPVGVNVTYGGDPIPK.2|YGGDEIPFSPYR.2|YGGQPVPNFPSKLQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|VANPSGNLTETYVQDR.2|VANPSGNLTETYVQDR.3|TGVELGKPTHFTVNAK.4|TGVELGKPTHFTVNAK.3|TGVELGKPTHFTVNAK.2|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|YWPQEAGEYAVHVLC[CAM]NSEDIR.3|YWPQEAGEYAVHVLC[CAM]NSEDIR.4|GKLDVQFSGLTK.3|GKLDVQFSGLTK.2|TPC[CAM]EEILVK.2|FGGEHVPNSPFQVTALAGDQPSVQPPLR.3|FGGEHVPNSPFQVTALAGDQPSVQPPLR.4|FGGEHVPNSPFQVTALAGDQPSVQPPLR.5|EGPYSISVLYGDEEVPR.2|EGPYSISVLYGDEEVPR.3|HTAMVSWGGVSIPNSPFR.3|HTAMVSWGGVSIPNSPFR.2|HTAM[Oxi]VSWGGVSIPNSPFR.2|HTAM[Oxi]VSWGGVSIPNSPFR.3|FNEEHIPDSPFVVPVASPSGDAR.3|FNEEHIPDSPFVVPVASPSGDAR.4|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.4|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.3|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|VGSAADIPINISETDLSLLTATVVPPSGR.3|VGSAADIPINISETDLSLLTATVVPPSGR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.3|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.5|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.3|EAGAGGLAIAVEGPSKAEISFEDRK.4|EAGAGGLAIAVEGPSKAEISFEDRK.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|VSGQGLHEGHTFEPAEFIIDTR.4|VSGQGLHEGHTFEPAEFIIDTR.3|MDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.3|FNEEHIPDSPFVVPVASPSGDARR.4|LTVSSLQESGLK.2|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.5|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.6|EAM[Oxi]QQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|DGSC[CAM]GVAYVVQEPGDYEVSVK.3|DGSC[CAM]GVAYVVQEPGDYEVSVK.2|LIALLEVLSQKK.3|LIALLEVLSQKK.2|VQVQDNEGC[CAM]PVEALVK.2|VQVQDNEGC[CAM]PVEALVK.3|VTVLFAGQHIAK.3|VTVLFAGQHIAK.2|GAGSYTIMVLFADQATPTSPIR.3|GAGSYTIMVLFADQATPTSPIR.2|GAGSYTIM[Oxi]VLFADQATPTSPIR.3|GAGSYTIM[Oxi]VLFADQATPTSPIR.2|LPQLPITNFSR.2|LPQLPITNFSR.3|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.4|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.5|KTHIQDNHDGTYTVAYVPDVTGR.5|KTHIQDNHDGTYTVAYVPDVTGR.3|KTHIQDNHDGTYTVAYVPDVTGR.4|RLTVSSLQESGLKVNQPASFAVSLNGAK.4|RLTVSSLQESGLKVNQPASFAVSLNGAK.3|YNEQHVPGSPFTAR.3|YNEQHVPGSPFTAR.2|C[CAM]SGPGLSPGMVR.2|C[CAM]SGPGLSPGM[Oxi]VR.2|LDVQFSGLTK.2|IANLQTDLSDGLRLIALLEVLSQKK.4|AEFTVETR.2|VDVGKDQEFTVK.3|VDVGKDQEFTVK.2|LSPFMADIRDAPQDFHPDR.4|LSPFM[Oxi]ADIRDAPQDFHPDR.4|LSPFMADIRDAPQDFHPDR.3|AGNNMLLVGVHGPR.3|AGNNM[Oxi]LLVGVHGPR.3|AGNNMLLVGVHGPR.2|AGNNM[Oxi]LLVGVHGPR.2|ANLPQSFQVDTSK.2|ANLPQSFQVDTSK.3|TFSVWYVPEVTGTHK.3|TFSVWYVPEVTGTHK.2|SAGQGEVLVYVEDPAGHQEEAK.3|SAGQGEVLVYVEDPAGHQEEAK.4|SAGQGEVLVYVEDPAGHQEEAK.2|ASGPGLNTTGVPASLPVEFTIDAK.3|ASGPGLNTTGVPASLPVEFTIDAK.2|DAGEGLLAVQITDPEGKPK.3|DAGEGLLAVQITDPEGKPK.4|DAGEGLLAVQITDPEGKPK.2|SPYTVTVGQAC[CAM]NPSAC[CAM]R.2|SPYTVTVGQAC[CAM]NPSAC[CAM]R.3|RLTVSSLQESGLK.3|RLTVSSLQESGLK.2|VAQPTITDNKDGTVTVR.3|VAQPTITDNKDGTVTVR.2|VTYC[CAM]PTEPGNYIINIK.2|VTYC[CAM]PTEPGNYIINIK.3|SPFSVAVSPSLDLSKIK.3|SPFSVAVSPSLDLSKIK.2|VTYTPMAPGSYLISIK.2|VTYTPMAPGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.2|DAPQDFHPDR.3|DAPQDFHPDR.2|VKVEPSHDASK.3|VKVEPSHDASK.2|AHVVPC[CAM]FDASK.3|AHVVPC[CAM]FDASK.2|KRAEFTVETR.3|VHGPGIQSGTTNKPNK.4|VHGPGIQSGTTNKPNK.3|VHGPGIQSGTTNKPNK.2|ETGEHLVHVKK.3|ETGEHLVHVKK.2|FNGTHIPGSPFK.3|FNGTHIPGSPFK.2|VNVGAGSHPNKVK.3|VNVGAGSHPNKVK.2|AGVAPLQVK.2|C[CAM]SGPGLER.2|MSC[CAM]MDNK.2|VEPGLGADNSVVR.3|VEPGLGADNSVVR.2|VTGDDSMR.2|ATC[CAM]APQHGAPGPGPADASK.4|ATC[CAM]APQHGAPGPGPADASK.3|ATC[CAM]APQHGAPGPGPADASK.2|DVDIIDHHDNTYTVK.4|DVDIIDHHDNTYTVK.3|DVDIIDHHDNTYTVK.2|GKLDVQFSGLTKGDAVR.4|GKLDVQFSGLTKGDAVR.3|GDAVRDVDIIDHHDNTYTVK.5|GDAVRDVDIIDHHDNTYTVK.4|GDAVRDVDIIDHHDNTYTVK.3|GDAVRDVDIIDHHDNTYTVK.2|RAPSVANVGSHC[CAM]DLSLK.4|RAPSVANVGSHC[CAM]DLSLK.3|RAPSVANVGSHC[CAM]DLSLK.2|AGVAPLQVKVQGPK.3|YGGPYHIGGSPFK.3|YGGPYHIGGSPFK.2|VKETADFK.2|WGDEHIPGSPYR.3|WGDEHIPGSPYR.2|AFGPGLQGGSAGSPAR.3|AFGPGLQGGSAGSPAR.2|EAGAGGLAIAVEGPSK.3|EAGAGGLAIAVEGPSK.2|LRNGHVGISFVPK.3|VKETADFKVYTK.3|VRVHGPGIQSGTTNKPNK.4|VRVHGPGIQSGTTNKPNK.3|YKGQHVPGSPFQFTVGPLGEGGAHKVR.6|YKGQHVPGSPFQFTVGPLGEGGAHKVR.5|YKGQHVPGSPFQFTVGPLGEGGAHKVR.4|AEISFEDR.2|AGQSAAGAAPGGGVDTR.3|AGQSAAGAAPGGGVDTR.2|AYGPGIEPTGNMVK.3|AYGPGIEPTGNM[Oxi]VK.2|AYGPGIEPTGNMVK.2|MDC[CAM]QEC[CAM]PEGYR.3|MDC[CAM]QEC[CAM]PEGYR.2|M[Oxi]DC[CAM]QEC[CAM]PEGYR.2|VLPTHDASK.2|PAEFTVDAK.2|PATFTVNTK.2|DAEMPATEK.2|DAEM[Oxi]PATEK.2|KGEITGEVR.2|RRAPSVANVGSHC[CAM]DLSLK.4|VGTEC[CAM]GNQK.2|VRAWGPGLEGGVVGK.3|VRAWGPGLEGGVVGK.2|DAGEGGLSLAIEGPSK.3|DAGEGGLSLAIEGPSK.2|FVPAEMGTHTVSVK.3|FVPAEM[Oxi]GTHTVSVK.3|FVPAEMGTHTVSVK.2|FVPAEM[Oxi]GTHTVSVK.2|VNQPASFAVSLNGAK.3|VNQPASFAVSLNGAK.2|FADQHVPGSPFSVK.3|FADQHVPGSPFSVK.2|NRTFSVWYVPEVTGTHK.4|VKAEGPGLSR.2|DAGEGLLAVQITDPEGKPKK.4|DAGEGLLAVQITDPEGKPKK.3|DAGEGLLAVQITDPEGKPKK.2|DNGNGTYSC[CAM]SYVPRKPVK.4|SSFTVDC[CAM]SK.2|THEAEIVEGENHTYC[CAM]IR.4|THEAEIVEGENHTYC[CAM]IR.3|THEAEIVEGENHTYC[CAM]IR.2|RIANLQTDLSDGLR.3|RIANLQTDLSDGLR.2|YKGQHVPGSPFQFTVGPLGEGGAHK.5|YKGQHVPGSPFQFTVGPLGEGGAHK.4|YKGQHVPGSPFQFTVGPLGEGGAHK.3|LSPFMADIR.2|LSPFM[Oxi]ADIR.2|NDNDTFTVK.2|YAPSEAGLHEMDIR.3|YAPSEAGLHEM[Oxi]DIR.3|YAPSEAGLHEMDIR.2|DAEMPATEKDLAEDAPWKK.4|DAEMPATEKDLAEDAPWKK.3|LKPGAPLRPK.2|IEC[CAM]DDKGDGSC[CAM]DVR.3|IEC[CAM]DDKGDGSC[CAM]DVR.2|SPFEVYVDK.2|VAQPTITDNK.2|VDINTEDLEDGTC[CAM]R.3|VDINTEDLEDGTC[CAM]R.2|VNVGAGSHPNK.2|VRVSGQGLHEGHTFEPAEFIIDTR.5|VRVSGQGLHEGHTFEPAEFIIDTR.4|AEISFEDRK.2|APSVANVGSHC[CAM]DLSLK.3|APSVANVGSHC[CAM]DLSLK.2|GTVEPQLEAR.2|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.6|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.4|VKAFGPGLQGGSAGSPAR.3|VTAQGPGLEPSGNIANK.3|VTAQGPGLEPSGNIANK.2|YGGDEIPFSPYRVR.3|ALTQTGGPHVK.2|FIPRENGVYLIDVK.3|LLGWIQNKLPQLPITNFSR.4|LLGWIQNKLPQLPITNFSR.3|LLGWIQNKLPQLPITNFSR.2|RAEFTVETR.2|SPFEVKVGTEC[CAM]GNQK.3|SPFEVKVGTEC[CAM]GNQK.2|VKMDC[CAM]QEC[CAM]PEGYR.3|VKMDC[CAM]QEC[CAM]PEGYR.2|ETGEHLVHVK.2|GAGSGELKVTVK.2|VHSPSGALEEC[CAM]YVTEIDQDK.4|VHSPSGALEEC[CAM]YVTEIDQDK.3|VHSPSGALEEC[CAM]YVTEIDQDK.2|DKGEYTLVVK.2|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.3|ENGVYLIDVK.2|IVGPSGAAVPC[CAM]K.2|NGHVGISFVPK.2|SPFEVYVDKSQGDASK.3|SPFEVYVDKSQGDASK.2|VPVHDVTDASK.2|NGQHVASSPIPVVISQSEIGDASR.4|NGQHVASSPIPVVISQSEIGDASR.3|THIQDNHDGTYTVAYVPDVTGR.4|THIQDNHDGTYTVAYVPDVTGR.3|QRLLGWIQNKLPQLPITNFSR.4|VGTEC[CAM]GNQKVR.2|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.6|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.5|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|KNGQHVASSPIPVVISQSEIGDASR.4|KNGQHVASSPIPVVISQSEIGDASR.3|VKASGPGLNTTGVPASLPVEFTIDAK.4|VKASGPGLNTTGVPASLPVEFTIDAK.3|YGGQPVPNFPSK.2|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.3|ARVANPSGNLTETYVQDR.3|GAIDAKVHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|IPEISIQDMTAQVTSPSGK.3|IPEISIQDMTAQVTSPSGK.2|IPEISIQDM[Oxi]TAQVTSPSGK.2|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.5|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.4|C[CAM]APGVVGPAEADIDFDIIR.3|C[CAM]APGVVGPAEADIDFDIIR.2|DAEMPATEKDLAEDAPWK.3|DAEMPATEKDLAEDAPWK.2|DAPQDFHPDRVK.2|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.6|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.4|AHVVPC[CAM]FDASKVK.2|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|APLRVQVQDNEGC[CAM]PVEALVK.3|LLGWIQNKLPQLPITNFSRDWQSGR.4|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.7|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.6|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.5|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.4|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.3|DAGYGGLSLSIEGPSK.2|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.6|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.4|EAGAGGLAIAVEGPSKAEISFEDR.3|EAGAGGLAIAVEGPSKAEISFEDR.2|AGQSAAGAAPGGGVDTRDAEMPATEK.3|DNGNGTYSC[CAM]SYVPR.2|KDGSC[CAM]GVAYVVQEPGDYEVSVK.3|KDGSC[CAM]GVAYVVQEPGDYEVSVK.2|VANPSGNLTETYVQDRGDGMYK.3|VGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSK.6|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.4|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.3|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.5|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.4|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.4|SPFEVYVDKSQGDASKVTAQGPGLEPSGNIANK.4|AHEPTYFTVDC[CAM]AEAGQGDVSIGIK.3|DAGEGLLAVQITDPEGK.2|VKMDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.4|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.3|SADFVVEAIGDDVGTLGFSVEGPSQAK.3|APSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|LTVSSLQESGLKVNQPASFAVSLNGAK.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFREATTEFSVDAR.4|ASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPK.4|DAGYGGLSLSIEGPSKVDINTEDLEDGTC[CAM]R.3|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|VQVQDNEGC[CAM]PVEALVKDNGNGTYSC[CAM]SYVPR.3
SEN / CTL,P58546,Myotrophin,MTPN,1.91,2.19,1.27E-04,1.41E-05,4.85E+00,"regulation of translation,catecholamine metabolic process,positive regulation of macromolecule biosynthetic process,positive regulation of cardiac muscle hypertrophy,cell growth,regulation of striated muscle tissue development,cerebellar granule cell differentiation,neuron differentiation,positive regulation of cell growth,skeletal muscle tissue regeneration,positive regulation of NF-kappaB transcription factor activity,striated muscle cell differentiation,positive regulation of protein metabolic process,cellular response to mechanical stimulus,regulation of barbed-end actin filament capping",sequence-specific DNA binding,"nucleus,cytosol,F-actin capping protein complex,axon,perinuclear region of cytoplasm,extracellular exosome",42,13,27,GADKTVKGPDGLTAFEATDNQAIK.4|NGDLDEVKDYVAKGEDVNR.3|NGDLDEVKDYVAKGEDVNR.4|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.4|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.6|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.5|GPDGLTAFEATDNQAIK.2|GPDGLTAFEATDNQAIK.3|TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.4|TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.5|TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.3|DYVAKGEDVNR.3|DYVAKGEDVNR.2|HHITPLLSAVYEGHVSC[CAM]VK.5|HHITPLLSAVYEGHVSC[CAM]VK.4|HHITPLLSAVYEGHVSC[CAM]VK.3|HHITPLLSAVYEGHVSC[CAM]VK.2|GADINAPDK.2|NGDLDEVK.2|NGDLDEVKDYVAK.3|NGDLDEVKDYVAK.2|KPLHYAADC[CAM]GQLEILEFLLLK.5|KPLHYAADC[CAM]GQLEILEFLLLK.4|KPLHYAADC[CAM]GQLEILEFLLLK.3|PLHYAADC[CAM]GQLEILEFLLLK.4|PLHYAADC[CAM]GQLEILEFLLLK.3|TVKGPDGLTAFEATDNQAIK.3
SEN / CTL,Q14247,Src substrate cortactin,CTTN,1.90,1.03,4.21E-05,5.13E-06,5.29E+00,"intracellular protein transport,receptor-mediated endocytosis,substrate-dependent cell migration, cell extension,actin filament polymerization,regulation of axon extension,positive regulation of actin filament polymerization,actin cytoskeleton reorganization,positive regulation of smooth muscle contraction,focal adhesion assembly,neuron projection morphogenesis,cell motility,dendritic spine maintenance,lamellipodium organization,cell-cell adhesion,regulation of mitophagy,negative regulation of extrinsic apoptotic signaling pathway","protein binding,profilin binding,cadherin binding involved in cell-cell adhesion","ruffle,podosome,cytoplasm,Golgi apparatus,cytoskeleton,plasma membrane,clathrin-coated pit,cell-cell adherens junction,focal adhesion,cell cortex,lamellipodium,cortical cytoskeleton,dendritic spine,intracellular membrane-bounded organelle,extracellular exosome,mitotic spindle midzone,actin filament,voltage-gated potassium channel complex,growth cone",12,43,57,ASAGHAVSIAQDDAGADDWETDPDFVNDVSEKEQR.4|YGLFPANYVELRQ.2|C[CAM]ALGWDHQEK.3|C[CAM]ALGWDHQEK.2|LRENVFQEHQTLK.4|LRENVFQEHQTLK.3|LRENVFQEHQTLK.2|TVQGSGHQEHINIHK.4|TVQGSGHQEHINIHK.3|TVQGSGHQEHINIHK.2|FGVEQDR.2|ANFENLAK.2|ENVFQEHQTLK.3|ENVFQEHQTLK.2|VDQSAVGFEYQGK.3|VDQSAVGFEYQGK.2|LAKHESQQDYSK.3|HASQKDYSSGFGGK.3|QDSAAVGFDYKEK.3|LQLHESQK.2|MDKSAVGHEYQSK.3|TEKHESQKDYVK.3|TVPVEAVTSK.2|SAVGFDYQGK.2|HC[CAM]SQVDSVR.2|SAVGFEYQGK.2|GRYGLFPANYVELR.3|GRYGLFPANYVELR.2|SAVGHEYQSK.2|HESQQDYSK.2|TQTPPVSPAPQPTEER.3|TQTPPVSPAPQPTEER.2|YGVQADRVDK.2|GRYGLFPANYVELRQ.3|GRYGLFPANYVELRQ.2|YGIDKDKVDK.2|FGVQTDRQDK.2|QDSAAVGFDYK.2|FGVEQDRMDK.2|LRENVFQEHQTLKEK.3|AKTQTPPVSPAPQPTEER.3|AKTQTPPVSPAPQPTEERLPSSPVYEDAASFK.5|AKTQTPPVSPAPQPTEERLPSSPVYEDAASFK.4|LQLHESQKDYK.2|SAVGFDYQGKTEK.2|VDKSAVGFEYQGK.2|GPVSGTEPEPVYSMEAADYR.3|GPVSGTEPEPVYSMEAADYR.2|YGLFPANYVELR.2|LPSSPVYEDAASFK.2|MDKNASTFEDVTQVSSAYQK.3|TQTPPVSPAPQPTEERLPSSPVYEDAASFK.4|TQTPPVSPAPQPTEERLPSSPVYEDAASFK.3|ASAGHAVSIAQDDAGADDWETDPDFVNDVSEK.4|ASAGHAVSIAQDDAGADDWETDPDFVNDVSEK.3|NASTFEDVTQVSSAYQK.2|AELSYRGPVSGTEPEPVYSMEAADYR.3
SEN / CTL,P99999,Cytochrome c,CYCS,1.90,2.17,5.69E-02,4.59E-03,2.34E+00,"response to reactive oxygen species,mitochondrial electron transport, ubiquinol to cytochrome c,mitochondrial electron transport, cytochrome c to oxygen,protein dephosphorylation,mitochondrion organization,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,cellular respiration,intrinsic apoptotic signaling pathway","protein binding,heme binding,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,metal ion binding,protein serine/threonine phosphatase activity","protein phosphatase type 2A complex,nucleus,mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space,cytosol,respiratory chain",12,13,27,GIIWGEDTLMEYLENPKK.3|GIIWGEDTLMEYLENPKK.4|GIIWGEDTLM[Oxi]EYLENPKK.3|GIIWGEDTLMEYLENPKK.2|ADLIAYLK.2|ADLIAYLK.1|KYIPGTK.2|MIFVGIK.2|M[Oxi]IFVGIK.2|MIFVGIK.1|M[Oxi]IFVGIK.1|TGPNLHGLFGRK.3|KTGQAPGYSYTAANKNK.4|KTGQAPGYSYTAANKNK.3|TGQAPGYSYTAANK.3|TGQAPGYSYTAANK.2|KTGQAPGYSYTAANK.3|KTGQAPGYSYTAANK.2|TGQAPGYSYTAANKNK.3|TGPNLHGLFGR.2|NKGIIWGEDTLMEYLENPKK.4|NKGIIWGEDTLMEYLENPKK.3|GIIWGEDTLM[Oxi]EYLENPK.3|GIIWGEDTLMEYLENPK.3|GIIWGEDTLMEYLENPK.2|GIIWGEDTLM[Oxi]EYLENPK.2|NKGIIWGEDTLMEYLENPK.3
SEN / CTL,Q96RF0,Sorting nexin-18,SNX18,1.89,1.71,8.07E-02,6.37E-03,2.20E+00,"mitotic cytokinesis,intracellular protein transport,endocytosis,mitotic nuclear division,vesicle organization,endosomal transport,cleavage furrow formation,positive regulation of GTPase activity","protein binding,phosphatidylinositol-4,5-bisphosphate binding","nucleoplasm,endosome,endosome membrane,cytoplasmic, membrane-bounded vesicle,cytoplasmic vesicle membrane,extrinsic component of cytoplasmic side of plasma membrane,intracellular membrane-bounded organelle,extracellular exosome,clathrin-coated vesicle",6,9,13,GLFPASYVQVIR.2|SDLSLGSR.2|FPVISVPHLPEK.3|FPVISVPHLPEK.2|LAEKFPVISVPHLPEK.4|LAEKFPVISVPHLPEK.3|LVPTHTQVPVHR.3|APEPGPAGDGGPGAPAR.3|APEPGPAGDGGPGAPAR.2|KMDDSALQLNHTANEFAR.4|SGGEAFVLGEASGFVK.3|SGGEAFVLGEASGFVK.2|SENPGEISLR.2
SEN / CTL,O00151,PDZ and LIM domain protein 1,PDLIM1,1.89,1.86,1.38E-08,2.58E-09,8.59E+00,"response to hypoxia,regulation of transcription, DNA-templated,response to oxidative stress,cell-cell adhesion","transcription coactivator activity,zinc ion binding,cadherin binding involved in cell-cell adhesion","transcription factor complex,cytoplasm,cytoskeleton,cell-cell adherens junction,focal adhesion",78,27,50,GHFFVEDQIYC[CAM]EK.3|GHFFVEDQIYC[CAM]EK.2|ERVTPPEGYEVVTVFPK.3|VTPPEGYEVVTVFPK.2|VTPPEGYEVVTVFPK.3|IKGC[CAM]TDNLTLTVAR.3|IKGC[CAM]TDNLTLTVAR.2|LVGGKDFEQPLAISR.3|LVGGKDFEQPLAISR.2|GC[CAM]TDNLTLTVAR.2|GC[CAM]TDNLTLTVAR.3|C[CAM]GTGIVGVFVK.2|VITNQYNNPAGLYSSENISNFNNALESK.3|VITNQYNNPAGLYSSENISNFNNALESK.4|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.5|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.4|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.3|MNLASEPQEVLHIGSAHNR.4|M[Oxi]NLASEPQEVLHIGSAHNR.4|MNLASEPQEVLHIGSAHNR.3|MNLASEPQEVLHIGSAHNR.2|VWSPLVTEEGKR.3|VWSPLVTEEGKR.2|QELNEPPK.2|VAASIGNAQK.2|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.4|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|PLDHAQPPSSLVIDK.3|DFEQPLAISR.2|QSTSFLVLQEILESEEKGDPNKPSGFR.5|QSTSFLVLQEILESEEKGDPNKPSGFR.4|QSTSFLVLQEILESEEKGDPNKPSGFR.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.2|VWSPLVTEEGK.2|SEHKVWSPLVTEEGKR.3|QKGHFFVEDQIYC[CAM]EK.3|QSTSFLVLQEILESEEK.3|QSTSFLVLQEILESEEK.2|TAASGVEANSRPLDHAQPPSSLVIDK.4|TAASGVEANSRPLDHAQPPSSLVIDK.3|SAMPFTASPASSTTAR.2|SAM[Oxi]PFTASPASSTTAR.2|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.5|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.4|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.3|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.3|QELNEPPKQSTSFLVLQEILESEEK.3
SEN / CTL,Q9NQH7,Probable Xaa-Pro aminopeptidase 3,XPNPEP3,1.89,2.25,1.17E-01,9.14E-03,2.04E+00,"glomerular filtration,protein processing","aminopeptidase activity,metallopeptidase activity,manganese ion binding","mitochondrion,extracellular exosome",6,10,14,AILFVPR.2|GVQQLIQR.2|YC[CAM]PHHVGHYLGMDVHDTPDMPR.5|APVEEAFLYAK.2|FTAPQAELYEAVLEIQR.3|FTAPQAELYEAVLEIQR.2|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.5|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.4|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.3|IEDDVVVTQDSPLILSADC[CAM]PK.3|IEDDVVVTQDSPLILSADC[CAM]PK.2|GADILAYPPVVAGGNR.2|LTSQAFIETMFTSK.2|SGTDGAIALTGVDEAYTLEEFQHLLPK.3
SEN / CTL,P07437,Tubulin beta chain,TUBB,1.88,2.26,4.64E-06,6.35E-07,6.20E+00,"G2/M transition of mitotic cell cycle,movement of cell or subcellular component,microtubule-based process,cellular process,cytoskeleton-dependent intracellular transport,natural killer cell mediated cytotoxicity,spindle assembly,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding,ubiquitin protein ligase binding,protein complex binding,GTPase activating protein binding,MHC class I protein binding","extracellular region,nucleus,nuclear envelope lumen,cytoskeleton,microtubule,extracellular matrix,cytoplasmic ribonucleoprotein granule,protein complex,cell body,extracellular exosome",54,8,21,ALTVPELTQQVFDAK.2|ALTVPELTQQVFDAK.3|ISVYYNEATGGKYVPR.3|FWEVISDEHGIDPTGTYHGDSDLQLDR.4|FWEVISDEHGIDPTGTYHGDSDLQLDR.3|FWEVISDEHGIDPTGTYHGDSDLQLDR.5|ISVYYNEATGGK.2|ISVYYNEATGGK.3|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.7|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.5|MAVTFIGNSTAIQELFKR.3|MAVTFIGNSTAIQELFKR.4|M[Oxi]AVTFIGNSTAIQELFKR.3|M[Oxi]AVTFIGNSTAIQELFKR.2|MAVTFIGNSTAIQELFKR.2|MAVTFIGNSTAIQELFK.3|M[Oxi]AVTFIGNSTAIQELFK.3|MAVTFIGNSTAIQELFK.2|M[Oxi]AVTFIGNSTAIQELFK.2|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.5|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.4
SEN / CTL,Q8WX93,Palladin,PALLD,1.88,0.84,4.46E-08,7.69E-09,8.11E+00,"keratinocyte development,epithelial cell morphogenesis,cytoskeleton organization,cell migration,actin cytoskeleton organization","actin binding,protein binding,muscle alpha-actinin binding","ruffle,podosome,nucleus,cytoplasm,mitochondrion,actin filament,plasma membrane,focal adhesion,actin cytoskeleton,Z disc,lamellipodium,axon,growth cone",18,43,57,IASDEEIQGTKDAVIQDLER.3|FFRPHFLQAPGDLTVQEGK.4|FFRPHFLQAPGDLTVQEGK.3|IFEGMPVTFTC[CAM]R.2|IFEGM[Oxi]PVTFTC[CAM]R.2|EAHKPPVFIEK.3|EAHKPPVFIEK.2|ENESLTHSTDR.3|ENESLTHSTDR.2|VLGVPPPQIFWK.3|VLGVPPPQIFWK.2|KENESLTHSTDR.3|SDHYTIQR.2|LISEIEYR.2|LDVYTQWHQQSQSTKPK.4|DAVIQDLER.2|LMVQAVNQR.2|LM[Oxi]VQAVNQR.2|VSGLPTPDLSWQLDGKPVRPDSAHK.5|VSGLPTPDLSWQLDGKPVRPDSAHK.4|VSGLPTPDLSWQLDGKPVRPDSAHK.3|ENGVHSLIIEPVTSR.3|LQQLQNQIR.2|VSMHQDNHGYIC[CAM]LLIQGATK.4|VSM[Oxi]HQDNHGYIC[CAM]LLIQGATK.4|VSMHQDNHGYIC[CAM]LLIQGATK.3|VSM[Oxi]HQDNHGYIC[CAM]LLIQGATK.3|EDLLNNGQPR.2|IASDEEIQGTK.2|SAPAMQSSGSFNYARPK.3|SLPTPAVLLSPTKEPPPLLAKPK.4|EDAGWYTVSAK.2|KPSEIQQVNNPELGLSR.3|KPSEIQQVNNPELGLSR.2|YAALSDQGLDIK.2|GAPPLQVQWFR.2|LQNTGVADGYPVRLEC[CAM]R.3|SLPTPAVLLSPTK.2|AALQMQFNAAER.2|DAGIYTC[CAM]IATNR.2|TTSVSLTIGSSSPK.2|LQNTGVADGYPVR.2|QGSEIQDSPDFR.2|FKEDLLNNGQPR.2|EISQIFSTSPASLC[CAM]EHPSHK.3|FGHSQTPAAFLSALLPSQPPPAAVNALGLPK.4|FGHSQTPAAFLSALLPSQPPPAAVNALGLPK.3|SAPAMQSSGSFNYAR.2|AAFQPEANPSHLTLNTALVESEDL.3|TGVTTAVIQPLSVPVQQVHSPTSYLC[CAM]RPDGTTTAYFPPVFTK.5|TGVTTAVIQPLSVPVQQVHSPTSYLC[CAM]RPDGTTTAYFPPVFTK.4|LLGADSATVFNIQEPEEETANQEYK.3|RLLGADSATVFNIQEPEEETANQEYK.3|SPVDESGDEVQYGDVPVENGMAPFFEMK.3|DLDGTC[CAM]SLHTTASTLDDDGNYTIMAANPQGR.3|STAEPEEIC[CAM]TLVIAETFPEDAGIFTC[CAM]SAR.3|QFIAAQNLGPASGHGTPASSPSSSSLPSPMSPTPR.3
SEN / CTL,P69905,Hemoglobin subunit alpha,HBA1,1.87,2.66,1.11E-07,1.84E-08,7.74E+00,"receptor-mediated endocytosis,positive regulation of cell death,oxygen transport,bicarbonate transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,protein heterooligomerization,cellular oxidant detoxification","oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding,peroxidase activity,haptoglobin binding","extracellular region,cytosol,hemoglobin complex,membrane,cytosolic small ribosomal subunit,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticle",54,23,78,TYFPHFDLSHGSAQVK.4|TYFPHFDLSHGSAQVK.3|TYFPHFDLSHGSAQVK.2|VGAHAGEYGAEALER.3|VGAHAGEYGAEALER.2|MFLSFPTTK.2|M[Oxi]FLSFPTTK.2|AAWGKVGAHAGEYGAEALER.4|AAWGKVGAHAGEYGAEALER.3|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.4|VGAHAGEYGAEALERMFLSFPTTK.4|VGAHAGEYGAEALERMFLSFPTTK.5|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.5|VGAHAGEYGAEALERMFLSFPTTK.3|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.3|FLASVSTVLTSK.3|FLASVSTVLTSK.2|VLSPADKTNVKAAWGK.4|VLSPADKTNVKAAWGK.3|TYFPHFDLSHGSAQVKGHGK.5|TYFPHFDLSHGSAQVKGHGK.4|TYFPHFDLSHGSAQVKGHGK.3|TYFPHFDLSHGSAQVKGHGKK.5|TYFPHFDLSHGSAQVKGHGKK.4|TYFPHFDLSHGSAQVKGHGKK.3|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.6|VADALTNAVAHVDDMPNALSALSDLHAHK.6|VADALTNAVAHVDDMPNALSALSDLHAHK.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.4|VADALTNAVAHVDDMPNALSALSDLHAHK.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.3|VADALTNAVAHVDDMPNALSALSDLHAHK.3|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.5|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.4|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.3|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.6|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.5|AAWGKVGAHAGEYGAEALERMFLSFPTTK.5|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.4|AAWGKVGAHAGEYGAEALERMFLSFPTTK.4|AAWGKVGAHAGEYGAEALERMFLSFPTTK.3|FLASVSTVLTSKYR.3|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.6|KVADALTNAVAHVDDMPNALSALSDLHAHK.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.5|KVADALTNAVAHVDDMPNALSALSDLHAHK.5|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.4|KVADALTNAVAHVDDMPNALSALSDLHAHK.4|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.3|KVADALTNAVAHVDDMPNALSALSDLHAHK.3|LRVDPVNFK.2|VADALTNAVAHVDDMPNALSALSDLHAHKLR.6|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.6|VADALTNAVAHVDDMPNALSALSDLHAHKLR.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.5|VADALTNAVAHVDDMPNALSALSDLHAHKLR.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.3|KVADALTNAVAHVDDMPNALSALSDLHAHKLR.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.5|KVADALTNAVAHVDDMPNALSALSDLHAHKLR.5|MFLSFPTTKTYFPHFDLSHGSAQVK.5|MFLSFPTTKTYFPHFDLSHGSAQVK.4|M[Oxi]FLSFPTTKTYFPHFDLSHGSAQVK.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLRVDPVNFK.7|VADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFK.6|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLRVDPVNFK.5|VLSPADKTNVK.2|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.7|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.5|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.4|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSK.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSK.5|VGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVK.6
SEN / CTL,Q58FF8,Putative heat shock protein HSP 90-beta 2,HSP90AB2P,1.86,2.06,1.83E-02,1.54E-03,2.81E+00,"protein folding,response to stress,biological_process","molecular_function,ATP binding,unfolded protein binding","cytoplasm,extracellular exosome",12,2,6,HSQFLGYPITLYLEK.3|HSQFLGYPITLYLEK.4|HSQFLGYPITLYLEK.2|HSQFLGYPITLYLEKER.4|HSQFLGYPITLYLEKER.3|HSQFLGYPITLYLEKER.2
SEN / CTL,P19338,Nucleolin,NCL,1.86,1.60,1.74E-14,5.91E-15,1.42E+01,"angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter","nucleotide binding,RNA binding,protein binding,protein C-terminus binding,telomeric DNA binding,identical protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cell cortex,membrane,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,extracellular exosome",72,63,97,NLPYKVTQDELKEVFEDAAEIR.4|NLPYKVTQDELKEVFEDAAEIR.3|TGISDVFAKNDLAVVDVR.3|TGISDVFAKNDLAVVDVR.2|KQKVEGTEPTTAFNLFVGNLNFNK.4|KQKVEGTEPTTAFNLFVGNLNFNK.3|NDLAVVDVR.2|VTQDELKEVFEDAAEIR.3|VTQDELKEVFEDAAEIR.2|GFGFVDFNSEEDAK.2|KFGYVDFESAEDLEK.3|KFGYVDFESAEDLEK.2|KFGYVDFESAEDLEKALELTGLK.4|KFGYVDFESAEDLEKALELTGLK.3|FGYVDFESAEDLEKALELTGLK.3|GYAFIEFASFEDAKEALNSC[CAM]NKR.4|GYAFIEFASFEDAKEALNSC[CAM]NKR.3|LELQGPR.2|VTLDWAK.2|VTLDWAK.1|VTQDELK.2|ALELTGLK.2|ALELTGLK.1|KVVVSPTK.2|ALVATPGKK.2|GLSEDTTEETLK.3|GLSEDTTEETLK.2|KVAVATPAK.2|QGTEIDGR.2|VAVATPAKK.2|ESFDGSVR.2|EALNSC[CAM]NK.2|GIAYIEFK.2|TEADAEKTFEEK.3|TEADAEKTFEEK.2|TGISDVFAK.2|VFGNEIKLEKPK.3|VFGNEIKLEKPK.2|SKGIAYIEFKTEADAEK.4|SKGIAYIEFKTEADAEK.3|ATFIKVPQNQNGK.3|ATFIKVPQNQNGK.2|NLPYKVTQDELK.3|NLPYKVTQDELK.2|KVVVSPTKK.2|NSTWSGESK.2|KVAVATPAKK.2|AAKEAMEDGEIDGNKVTLDWAKPK.5|AAKEAMEDGEIDGNKVTLDWAKPK.4|GYAFIEFASFEDAK.3|GYAFIEFASFEDAK.2|VTLDWAKPK.2|ALELTGLKVFGNEIK.3|ALELTGLKVFGNEIK.2|EALNSC[CAM]NKR.2|FGYVDFESAEDLEK.3|FGYVDFESAEDLEK.2|GLSEDTTEETLKESFDGSVR.4|GLSEDTTEETLKESFDGSVR.3|GLSEDTTEETLKESFDGSVR.2|GIAYIEFKTEADAEK.3|SISLYYTGEKGQNQDYRGGK.4|TEADAEKTFEEKQGTEIDGR.4|TEADAEKTFEEKQGTEIDGR.3|AIRLELQGPR.2|GIAYIEFKTEADAEKTFEEK.4|GIAYIEFKTEADAEKTFEEK.3|SISLYYTGEK.2|SKGIAYIEFK.2|EAMEDGEIDGNKVTLDWAKPK.4|EAM[Oxi]EDGEIDGNKVTLDWAKPK.4|EAM[Oxi]EDGEIDGNKVTLDWAKPK.3|EAMEDGEIDGNKVTLDWAKPK.3|EAMEDGEIDGNKVTLDWAKPK.2|EVFEDAAEIR.2|VFGNEIKLEK.2|IVTDRETGSSK.2|SKGYAFIEFASFEDAK.3|SKGYAFIEFASFEDAK.2|GFGFVDFNSEEDAKAAK.3|TLVLSNLSYSATEETLQEVFEK.4|TLVLSNLSYSATEETLQEVFEK.3|QKVEGTEPTTAFNLFVGNLNFNK.4|QKVEGTEPTTAFNLFVGNLNFNK.3|EAMEDGEIDGNK.2|EAM[Oxi]EDGEIDGNK.2|SISLYYTGEKGQNQDYR.3|SISLYYTGEKGQNQDYR.2|SKGYAFIEFASFEDAKEALNSC[CAM]NK.4|SKGYAFIEFASFEDAKEALNSC[CAM]NK.3|EAMEDGEIDGNKVTLDWAK.3|TFEEKQGTEIDGR.2|VEGTEPTTAFNLFVGNLNFNK.3|VEGTEPTTAFNLFVGNLNFNK.2|IGMTRKFGYVDFESAEDLEK.3|FGYVDFESAEDLEKALELTGLKVFGNEIK.4|GYAFIEFASFEDAKEALNSC[CAM]NK.3
SEN / CTL,P60660,Myosin light polypeptide 6,MYL6,1.86,1.40,3.93E-10,8.56E-11,1.01E+01,"muscle contraction,skeletal muscle tissue development,muscle filament sliding","motor activity,calcium ion binding,structural constituent of muscle,actin-dependent ATPase activity","cytosol,brush border,membrane,myosin complex,unconventional myosin complex,extracellular matrix,vesicle,extracellular exosome",60,14,29,NKDQGTYEDYVEGLR.3|NKDQGTYEDYVEGLR.2|NKDQGTYEDYVEGLR.4|VLDFEHFLPMLQTVAK.3|VLDFEHFLPMLQTVAK.2|VLDFEHFLPM[Oxi]LQTVAK.3|VLDFEHFLPMLQTVAK.4|VLDFEHFLPM[Oxi]LQTVAK.2|HVLVTLGEK.2|ALGQNPTNAEVLK.2|ALGQNPTNAEVLK.3|DQGTYEDYVEGLR.2|DQGTYEDYVEGLR.3|ILYSQC[CAM]GDVMR.2|ILYSQC[CAM]GDVMR.3|ILYSQC[CAM]GDVM[Oxi]R.2|VFDKEGNGTVMGAEIR.3|VFDKEGNGTVM[Oxi]GAEIR.3|VFDKEGNGTVMGAEIR.2|SDEMNVK.2|EAFQLFDRTGDGK.3|EAFQLFDRTGDGK.2|EAFQLFDR.2|EGNGTVMGAEIR.2|EGNGTVM[Oxi]GAEIR.2|DQGTYEDYVEGLRVFDK.3|VLGNPKSDEM[Oxi]NVK.2|MTEEEVEM[Oxi]LVAGHEDSNGC[CAM]INYEAFVR.3|MTEEEVEMLVAGHEDSNGC[CAM]INYEAFVR.3
SEN / CTL,P67936,Tropomyosin alpha-4 chain,TPM4,1.86,1.33,5.51E-17,2.33E-17,1.66E+01,"osteoblast differentiation,movement of cell or subcellular component,muscle contraction,muscle filament sliding","actin binding,calcium ion binding,protein binding,structural constituent of muscle","stress fiber,podosome,cytosol,cytoskeleton,muscle thin filament tropomyosin,focal adhesion,membrane,cortical cytoskeleton,filamentous actin,extracellular exosome",78,25,42,KIQALQQQADEAEDRAQGLQR.4|KIQALQQQADEAEDRAQGLQR.3|KIQALQQQADEAEDRAQGLQR.5|TIDDLEEKLAQAKEENVGLHQTLDQTLNELNC[CAM]I.4|KLVILEGELERAEER.4|KLVILEGELERAEER.3|IQALQQQADEAEDRAQGLQR.3|IQALQQQADEAEDRAQGLQR.4|IQALQQQADEAEDRAQGLQR.2|C[CAM]GDLEEELKNVTNNLK.3|C[CAM]GDLEEELKNVTNNLK.2|LAQAKEENVGLHQTLDQTLNELNC[CAM]I.3|LVILEGELERAEER.3|LVILEGELERAEER.2|AEVSELKC[CAM]GDLEEELKNVTNNLK.4|AEVSELKC[CAM]GDLEEELKNVTNNLK.3|KIQALQQQADEAEDR.3|KIQALQQQADEAEDR.2|AEERAEVSELK.3|SLEAASEK.2|EKAEGDVAALNR.3|EKAEGDVAALNR.2|YSEKEDKYEEEIK.4|YSEKEDKYEEEIK.3|YSEKEDKYEEEIK.2|LLSDKLKEAETR.3|REKAEGDVAALNR.3|RKIQALQQQADEAEDR.4|RKIQALQQQADEAEDR.3|TIDDLEEK.2|AEGDVAALNR.2|IQALQQQADEAEDR.3|IQALQQQADEAEDR.2|MEIQEMQLK.2|M[Oxi]EIQEMQLK.2|MEIQEM[Oxi]QLK.2|AEGDVAALNRR.2|SLEAASEKYSEK.2|TIDDLEEKLAQAK.2|EENVGLHQTLDQTLNELNC[CAM]I.3|EENVGLHQTLDQTLNELNC[CAM]I.2|AEVSELKC[CAM]GDLEEELK.2
SEN / CTL,O00462,Beta-mannosidase,MANBA,1.86,2.14,2.72E-03,2.53E-04,3.60E+00,"carbohydrate metabolic process,cellular protein modification process,oligosaccharide catabolic process","beta-mannosidase activity,mannose binding","lysosomal lumen,intracellular membrane-bounded organelle",12,10,12,VNLILEGVDTVSK.2|YSFDITNVVR.2|VHTWSSLEPVC[CAM]SR.3|VHTWSSLEPVC[CAM]SR.2|INGFPIFLK.2|LLLQSVVDANMNTLR.3|LLLQSVVDANMNTLR.2|FQSAVLYAAQQSK.2|TILFYPWEPTSK.2|IEAYNIC[CAM]HLNYFTFSPIYDK.3|DTIYLTQVMQAQC[CAM]VK.2|FASEYGYQSWPSFSTLEK.2
SEN / CTL,P02538;P48668,"Keratin, type II cytoskeletal 6A;Keratin, type II cytoskeletal 6C",KRT6A;KRT6C,1.85,1.69,3.11E-06,4.34E-07,6.36E+00,"morphogenesis of an epithelium,cytoskeleton organization,positive regulation of cell proliferation,cell differentiation,wound healing;intermediate filament cytoskeleton organization","structural constituent of cytoskeleton,protein binding;structural molecule activity,protein binding","nucleus,membrane,keratin filament,extracellular exosome;intermediate filament,keratin filament,extracellular exosome",24,4,6,NLDLDSIIAEVK.2|NLDLDSIIAEVK.3|NLDLDSIIAEVKAQYEEIAQR.3|NLDLDSIIAEVKAQYEEIAQR.4|AIGGGLSSVGGGSSTIKYTTTSSSSR.3|SLYGLGGSK.2
SEN / CTL,P13645,"Keratin, type I cytoskeletal 10",KRT10,1.85,1.90,5.36E-18,2.47E-18,1.76E+01,keratinocyte differentiation,structural constituent of epidermis,"extracellular space,nucleus,cytoplasm,intermediate filament,membrane,extracellular exosome",126,52,104,TIDDLKNQILNLTTDNANILLQIDNAR.4|TIDDLKNQILNLTTDNANILLQIDNAR.3|SQYEQLAEQNRKDAEAWFNEK.4|SQYEQLAEQNRKDAEAWFNEK.3|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.2|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.3|LKYENEVALR.3|LKYENEVALR.2|YYKTIDDLKNQILNLTTDNANILLQIDNAR.4|DAEAWFNEK.2|NVSTGDVNVEMNAAPGVDLTQLLNNMR.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.3|NVSTGDVNVEMNAAPGVDLTQLLNNM[Oxi]R.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.4|NVSTGDVNVEMNAAPGVDLTQLLNNMR.4|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.4|IRLENEIQTYR.3|IRLENEIQTYR.2|GSLGGGFSSGGFSGGSFSR.2|GSLGGGFSSGGFSGGSFSR.3|ALEESNYELEGK.2|ALEESNYELEGK.3|ISSSKGSLGGGFSSGGFSGGSFSR.3|QSVEADINGLRR.3|QSVEADINGLRR.2|VTMQNLNDRLASYLDKVR.4|VTM[Oxi]QNLNDRLASYLDKVR.4|VTMQNLNDRLASYLDKVR.3|VTM[Oxi]QNLNDRLASYLDKVR.3|QSVEADINGLR.3|QSVEADINGLR.2|KDAEAWFNEK.3|KDAEAWFNEK.2|SLLEGEGSSGGGGR.3|SLLEGEGSSGGGGR.2|SEITELR.2|NHEEEMKDLR.3|NHEEEM[Oxi]KDLR.3|NHEEEMKDLR.2|NHEEEM[Oxi]KDLR.2|YSSSKHYSSSR.3|SQYEQLAEQNR.3|SQYEQLAEQNR.2|NHEEEMK.2|QSLEASLAETEGR.3|QSLEASLAETEGR.2|KNHEEEMKDLR.3|KNHEEEM[Oxi]KDLR.3|KNHEEEMKDLR.2|IKEWYEK.2|SEITELRR.2|SQYEQLAEQNRK.3|SQYEQLAEQNRK.2|SSSSGSVGESSSKGPR.3|YENEVALR.2|SGGGGGGGGC[CAM]GGGGGVSSLR.3|SGGGGGGGGC[CAM]GGGGGVSSLR.2|VLDELTLTK.2|IKEWYEKHGNSHQGEPR.4|IKEWYEKHGNSHQGEPR.3|KNHEEEMK.2|VRALEESNYELEGK.3|VRALEESNYELEGK.2|ADLEM[Oxi]QIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.2|ADLEMQIESLTEELAYLKK.2|HGNSHQGEPR.2|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.4|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.3|LENEIQTYR.2|ALEESNYELEGKIKEWYEK.4|RVLDELTLTK.2|SSSSGSVGESSSK.2|NVQALEIELQSQLALK.3|NVQALEIELQSQLALK.2|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.5|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.4|VLDELTLTKADLEMQIESLTEELAYLKK.4|VLDELTLTKADLEMQIESLTEELAYLKK.3|ELTTEIDNNIEQISSYK.3|ELTTEIDNNIEQISSYK.2|AETEC[CAM]QNTEYQQLLDIK.3|AETEC[CAM]QNTEYQQLLDIK.2|YC[CAM]VQLSQIQAQISALEEQLQQIR.4|YC[CAM]VQLSQIQAQISALEEQLQQIR.3|ADLEM[Oxi]QIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.2|ADLEM[Oxi]QIESLTEELAYLK.2|ELTTEIDNNIEQISSYKSEITELR.4|ELTTEIDNNIEQISSYKSEITELR.3|SKELTTEIDNNIEQISSYK.3|SKELTTEIDNNIEQISSYK.2|ELTTEIDNNIEQISSYKSEITELRR.4|ELTTEIDNNIEQISSYKSEITELRR.3|SKELTTEIDNNIEQISSYKSEITELR.4|SKELTTEIDNNIEQISSYKSEITELR.3|NQILNLTTDNANILLQIDNAR.3|NQILNLTTDNANILLQIDNAR.2|NVQALEIELQSQLALKQSLEASLAETEGR.4
SEN / CTL,Q04760,Lactoylglutathione lyase,GLO1,1.85,0.79,1.64E-07,2.66E-08,7.58E+00,"carbohydrate metabolic process,pyruvate metabolic process,regulation of transcription from RNA polymerase II promoter,glutathione metabolic process,methylglyoxal metabolic process,osteoclast differentiation,negative regulation of apoptotic process","lactoylglutathione lyase activity,zinc ion binding","cytoplasm,cytosol,extracellular exosome",18,16,31,GLAFIQDPDGYWIEILNPNK.3|GLAFIQDPDGYWIEILNPNK.2|GFGHIGIAVPDVYSAC[CAM]K.3|GFGHIGIAVPDVYSAC[CAM]K.4|GFGHIGIAVPDVYSAC[CAM]K.2|FEELGVK.2|IAWALSR.2|DFLLQQTMLR.3|DFLLQQTMLR.2|DFLLQQTM[Oxi]LR.2|C[CAM]DFPIMK.2|C[CAM]DFPIM[Oxi]K.2|SLDFYTR.2|GFGHIGIAVPDVYSAC[CAM]KR.4|GFGHIGIAVPDVYSAC[CAM]KR.3|GFGHIGIAVPDVYSAC[CAM]KR.2|RFEELGVK.2|VLGMTLIQK.2|VLGM[Oxi]TLIQK.2|FSLYFLAYEDKNDIPKEK.4|FSLYFLAYEDKNDIPKEK.3|ATLELTHNWGTEDDETQSYHNGNSDPR.5|ATLELTHNWGTEDDETQSYHNGNSDPR.4|ATLELTHNWGTEDDETQSYHNGNSDPR.3|KATLELTHNWGTEDDETQSYHNGNSDPR.5|KATLELTHNWGTEDDETQSYHNGNSDPR.4|KATLELTHNWGTEDDETQSYHNGNSDPR.3|FSLYFLAYEDKNDIPK.3|FSLYFLAYEDKNDIPK.2|GFGHIGIAVPDVYSAC[CAM]KRFEELGVK.4|FSLYFLAYEDK.2
SEN / CTL,P11940,Polyadenylate-binding protein 1,PABPC1,1.85,2.19,4.37E-05,5.29E-06,5.28E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,nuclear-transcribed mRNA poly(A) tail shortening,mRNA splicing, via spliceosome,mRNA polyadenylation,translational initiation,gene silencing by RNA,regulation of mRNA stability,positive regulation of viral genome replication,positive regulation of translation,mRNA stabilization,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay","nucleotide binding,mRNA 3'-UTR binding,protein binding,protein C-terminus binding,poly(A) binding,poly(U) RNA binding,translation activator activity,poly(A) RNA binding","nucleus,cytoplasm,cytosol,focal adhesion,cytoplasmic stress granule,membrane,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,extracellular exosome,catalytic step 2 spliceosome",36,45,81,SLGYAYVNFQQPADAER.2|SLGYAYVNFQQPADAER.3|IVATKPLYVALAQR.3|IVATKPLYVALAQR.2|GFGFVC[CAM]FSSPEEATK.2|SKGFGFVC[CAM]FSSPEEATK.3|SKGFGFVC[CAM]FSSPEEATK.2|ALYDTFSAFGNILSC[CAM]K.2|ALYDTFSAFGNILSC[CAM]K.3|ALDTMNFDVIK.2|ALDTM[Oxi]NFDVIK.2|AKEFTNVYIK.3|AKEFTNVYIK.2|M[Oxi]NGMLLNDRK.3|MNGMLLNDRK.2|FGPALSVK.2|LFPLIQAMHPTLAGK.4|LFPLIQAM[Oxi]HPTLAGK.3|LFPLIQAMHPTLAGK.3|LFPLIQAMHPTLAGK.2|LFPLIQAM[Oxi]HPTLAGK.2|SKGFGFVSFER.3|EFSPFGTITSAK.3|EFSPFGTITSAK.2|SKVDEAVAVLQAHQAK.4|SKVDEAVAVLQAHQAK.3|SKVDEAVAVLQAHQAK.2|AVDEMNGK.2|AVTEMNGR.2|QAHLTNQYMQR.3|QAHLTNQYM[Oxi]QR.3|QAHLTNQYMQR.2|QAHLTNQYM[Oxi]QR.2|AVDEMNGKELNGK.3|KEFSPFGTITSAK.3|KEFSPFGTITSAK.2|SGVGNIFIK.2|NLDDGIDDERLR.3|NFGEDMDDERLK.3|NFGEDM[Oxi]DDERLK.3|VDEAVAVLQAHQAK.3|VDEAVAVLQAHQAK.2|AVNSATGVPTV.2|EFTNVYIK.2|VVC[CAM]DENGSK.2|EREAELGAR.2|PLYVALAQR.2|GFGFVSFER.2|HEDAQKAVDEMNGK.3|MNGMLLNDR.2|M[Oxi]NGMLLNDR.2|MNGM[Oxi]LLNDR.2|YQGVNLYVK.2|PAAAAAAATPAVR.2|FSPAGPILSIR.2|GYGFVHFETQEAAER.3|GYGFVHFETQEAAER.2|NLDDGIDDER.2|GFGFVSFERHEDAQK.3|GFGFVSFERHEDAQK.2|NFGEDMDDER.2|NFGEDM[Oxi]DDER.2|VANTSTQTM[Oxi]GPR.2|VANTSTQTMGPR.2|NFGEDMDDERLKDLFGK.3|ITGMLLEIDNSELLHMLESPESLR.4|ITGM[Oxi]LLEIDNSELLHMLESPESLR.4|ITGMLLEIDNSELLHMLESPESLR.3|ITGM[Oxi]LLEIDNSELLHMLESPESLR.3|ITGMLLEIDNSELLHM[Oxi]LESPESLR.3|RSLGYAYVNFQQPADAER.3|RSLGYAYVNFQQPADAER.2|NPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQK.6|NPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQK.5|NPQQHLNAQPQVTMQQPAVHVQGQEPLTASM[Oxi]LASAPPQEQK.4|NPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQK.4|AVPNPVINPYQPAPPSGYFM[Oxi]AAIPQTQNR.4|AVPNPVINPYQPAPPSGYFMAAIPQTQNR.4|AVPNPVINPYQPAPPSGYFMAAIPQTQNR.3|VANTSTQTMGPRPAAAAAAATPAVR.3|YAAGVRNPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQK.5
SEN / CTL,Q9Y281,Cofilin-2,CFL2,1.85,0.42,1.01E-08,1.91E-09,8.72E+00,"actin filament depolymerization,positive regulation of actin filament depolymerization,sarcomere organization,muscle cell cellular homeostasis","protein binding,actin filament binding","extracellular space,actin cytoskeleton,nuclear matrix,Z disc,I band,extracellular exosome",12,14,19,QILVGDIGDTVEDPYTSFVK.3|QILVGDIGDTVEDPYTSFVK.2|HEWQVNGLDDIKDR.4|HEWQVNGLDDIKDR.3|AVLFC[CAM]LSDDKR.3|AVLFC[CAM]LSDDKR.2|QIIVEEAK.2|SSTQEEIK.2|KAVLFC[CAM]LSDDKR.3|HEWQVNGLDDIK.3|HEWQVNGLDDIK.2|LLPLNDC[CAM]R.2|KFTGIKHEWQVNGLDDIK.4|RQIIVEEAK.2|AVLFC[CAM]LSDDK.2|EDLVFIFWAPESAPLK.3|EDLVFIFWAPESAPLK.2|M[Oxi]IYASSKDAIKK.2|LGGNVVVSLEGKPL.2
SEN / CTL,P12277,Creatine kinase B-type,CKB,1.84,1.14,1.11E-04,1.24E-05,4.91E+00,"creatine metabolic process,phosphorylation,substantia nigra development,cellular chloride ion homeostasis","creatine kinase activity,protein binding,ATP binding,ubiquitin protein ligase binding","extracellular space,cytoplasm,mitochondrion,cytosol,myelin sheath,extracellular exosome",12,33,80,VLTPELYAELR.2|VLTPELYAELR.3|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.4|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGMAR.5|SMTEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.5|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.5|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.4|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGMAR.4|SMTEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.4|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.3|AGVHIKLPNLGKHEK.4|GFC[CAM]LPPHC[CAM]SR.3|GFC[CAM]LPPHC[CAM]SR.2|HGGYKPSDEHK.3|FPAEDEFPDLSAHNNHMAK.5|FPAEDEFPDLSAHNNHMAK.4|FPAEDEFPDLSAHNNHM[Oxi]AK.4|FPAEDEFPDLSAHNNHMAK.3|FPAEDEFPDLSAHNNHM[Oxi]AK.3|FPAEDEFPDLSAHNNHMAK.2|FSEVLKR.2|PVSPLLLASGMAR.3|PVSPLLLASGMAR.2|PVSPLLLASGM[Oxi]AR.2|LRFPAEDEFPDLSAHNNHMAK.5|LRFPAEDEFPDLSAHNNHM[Oxi]AK.5|LRFPAEDEFPDLSAHNNHM[Oxi]AK.4|LRFPAEDEFPDLSAHNNHMAK.4|LRFPAEDEFPDLSAHNNHM[Oxi]AK.3|LRFPAEDEFPDLSAHNNHMAK.3|GIWHNDNK.2|VLTPELYAELRAK.3|LLIEMEQR.2|LLIEM[Oxi]EQR.2|FC[CAM]TGLTQIETLFK.3|FC[CAM]TGLTQIETLFK.2|LPNLGKHEK.2|LAVEALSSLDGDLAGR.3|LAVEALSSLDGDLAGR.2|RGTGGVDTAAVGGVFDVSNADR.4|RGTGGVDTAAVGGVFDVSNADR.3|RGTGGVDTAAVGGVFDVSNADR.2|LEQGQAIDDLMPAQK.3|LEQGQAIDDLM[Oxi]PAQK.3|LEQGQAIDDLMPAQK.2|LEQGQAIDDLM[Oxi]PAQK.2|TFLVWVNEEDHLR.3|TFLVWVNEEDHLR.2|PFSNSHNALK.2|DLFDPIIEDR.2|LGFSEVELVQM[Oxi]VVDGVK.3|LGFSEVELVQMVVDGVK.3|LGFSEVELVQM[Oxi]VVDGVK.2|LGFSEVELVQMVVDGVK.2|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.6|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.5|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.4|TDLNPDNLQGGDDLDPNYVLSSR.4|TDLNPDNLQGGDDLDPNYVLSSR.3|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.5|SKDYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.4|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.4|SKDYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.3|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.3|GTGGVDTAAVGGVFDVSNADR.3|GTGGVDTAAVGGVFDVSNADR.2|AIEKLAVEALSSLDGDLAGRYYALK.4|DYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.4|DYEFMWNPHLGYILTC[CAM]PSNLGTGLR.4|DYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.3|DYEFMWNPHLGYILTC[CAM]PSNLGTGLR.3|LAVEALSSLDGDLAGRYYALK.3|SMTEAEQQQLIDDHFLFDK.3|SM[Oxi]TEAEQQQLIDDHFLFDK.3|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVK.5|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQM[Oxi]VVDGVK.4|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVK.4|PSDEHKTDLNPDNLQGGDDLDPNYVLSSR.4|LLIEMEQRLEQGQAIDDLMPAQK.3|STPSGFTLDDVIQTGVDNPGHPYIMTVGC[CAM]VAGDEESYEVFK.4
SEN / CTL,P12081,"Histidine--tRNA ligase, cytoplasmic",HARS,1.84,2.33,1.16E-05,1.50E-06,5.82E+00,"translation,tRNA aminoacylation for protein translation,histidyl-tRNA aminoacylation,mitochondrial translation","histidine-tRNA ligase activity,ATP binding","cytoplasm,mitochondrion,cytosol",24,37,50,ASAELIEEEVAK.2|VPC[CAM]VGLSIGVER.2|HGAEVIDTPVFELK.3|HGAEVIDTPVFELK.2|YDLTVPFAR.2|RHGAEVIDTPVFELK.4|RHGAEVIDTPVFELK.3|RHGAEVIDTPVFELK.2|AALEELVK.2|VFDVIIR.2|VSWEEVK.2|TIC[CAM]SSVDK.2|GLAPEVADR.2|TTETQVLVASAQK.3|TTETQVLVASAQK.2|AQLGPDESK.2|KVPC[CAM]VGLSIGVER.3|KVPC[CAM]VGLSIGVER.2|AALEELVKLQGER.3|EDLVEEIK.2|IFSIVEQR.2|TTETQVLVASAQKK.3|ISFDLSLAR.2|QALEGLGDLK.2|ILDGMFAIC[CAM]GVSDSK.3|ILDGMFAIC[CAM]GVSDSK.2|DQGGELLSLR.2|ASAELIEEEVAKLLK.3|IRTTETQVLVASAQK.3|REDLVEEIK.2|AQLGPDESKQK.2|IGDYVQQHGGVSLVEQLLQDPK.4|IGDYVQQHGGVSLVEQLLQDPK.3|LVSELWDAGIK.2|YDGLVGMFDPK.2|YDGLVGM[Oxi]FDPK.2|REDLVEEIKR.2|IMC[CAM]EILSSLQIGDFLVK.3|IM[Oxi]C[CAM]EILSSLQIGDFLVK.3|IM[Oxi]C[CAM]EILSSLQIGDFLVK.2|IMC[CAM]EILSSLQIGDFLVK.2|LLNQLQYC[CAM]EEAGIPLVAIIGEQELK.4|LLNQLQYC[CAM]EEAGIPLVAIIGEQELK.3|YGEDSKLIYDLK.2|LKLVSELWDAGIK.2|GLAPEVADRIGDYVQQHGGVSLVEQLLQDPK.4|LLFEYLTLFGIDDK.2|LLNQLQYC[CAM]EEAGIPLVAIIGEQELKDGVIK.4|LLNQLQYC[CAM]EEAGIPLVAIIGEQELKDGVIK.3|GLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGR.4
SEN / CTL,P36955,Pigment epithelium-derived factor,SERPINF1,1.83,1.60,2.79E-08,4.89E-09,8.31E+00,"kidney development,multicellular organism development,aging,short-term memory,cell proliferation,response to acidic pH,negative regulation of endothelial cell migration,negative regulation of gene expression,negative regulation of endopeptidase activity,positive regulation of neuron projection development,negative regulation of angiogenesis,ovulation cycle,response to arsenic-containing substance,negative regulation of inflammatory response,positive regulation of neurogenesis,retina development in camera-type eye,negative regulation of epithelial cell proliferation involved in prostate gland development,cellular response to cobalt ion,cellular response to retinoic acid,cellular response to glucose stimulus,cellular response to dexamethasone stimulus,negative regulation of neuron death","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,basement membrane,extracellular space,melanosome,axon hillock,perinuclear region of cytoplasm,extracellular exosome,extracellular matrix",54,20,26,DTDTGALLFIGK.2|SSTSPTTNVLLSPLSVATALSALSLGAEQR.3|LAAAVSNFGYDLYR.2|LAAAVSNFGYDLYR.3|TSLEDFYLDEER.2|KTSLEDFYLDEER.3|KTSLEDFYLDEER.2|LQSLFDSPDFSK.2|YGLDSDLSC[CAM]K.2|LKLSYEGEVTK.3|TESIIHR.2|SSFVAPLEK.2|LSYEGEVTK.2|TVQAVLTVPK.2|ELLDTVTAPQK.2|LDLQEINNWVQAQMK.3|LDLQEINNWVQAQMK.2|EIPDEISILLLGVAHFK.3|ALYYDLISSPDIHGTYK.3|ALYYDLISSPDIHGTYK.2|IAQLPLTGSMSIIFFLPLK.3|IAQLPLTGSMSIIFFLPLK.2|ALYYDLISSPDIHGTYKELLDTVTAPQK.4|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.5|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.4|SSTSPTTNVLLSPLSVATALSALSLGAEQRTESIIHR.4
SEN / CTL,O60888,Protein CutA,CUTA,1.83,1.41,4.02E-05,4.91E-06,5.31E+00,"protein localization,response to metal ion","copper ion binding,enzyme binding","membrane,extracellular exosome",30,7,14,SVHPYEVAEVIALPVEQGNFPYLQWVR.3|SVHPYEVAEVIALPVEQGNFPYLQWVR.4|SVHPYEVAEVIALPVEQGNFPYLQWVR.5|TQSSLVPALTDFVR.2|TQSSLVPALTDFVR.3|LAAC[CAM]VNLIPQITSIYEWK.3|LAAC[CAM]VNLIPQITSIYEWK.2|GKIEEDSEVLMMIK.3|GKIEEDSEVLMMIK.2|RLAAC[CAM]VNLIPQITSIYEWK.4|RLAAC[CAM]VNLIPQITSIYEWK.3|RLAAC[CAM]VNLIPQITSIYEWK.2|IEEDSEVLMMIK.2|QVTESVSDSITVLP.2
SEN / CTL,P60900,Proteasome subunit alpha type-6,PSMA6,1.83,1.44,1.43E-07,2.34E-08,7.63E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,regulation of inflammatory response,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,proteolysis involved in cellular protein catabolic process,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","RNA binding,endopeptidase activity,threonine-type endopeptidase activity,protein binding,purine ribonucleoside triphosphate binding,NF-kappaB binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,polysome,nuclear matrix,proteasome core complex, alpha-subunit complex,myofibril,sarcomere,extracellular exosome",30,20,30,ITENIGC[CAM]VMTGMTADSR.2|ITENIGC[CAM]VMTGMTADSR.3|ITENIGC[CAM]VM[Oxi]TGMTADSR.2|LYQVEYAFK.2|AINQGGLTSVAVR.2|AINQGGLTSVAVR.3|YGYEIPVDMLC[CAM]K.2|YGYEIPVDM[Oxi]LC[CAM]K.2|GKDC[CAM]AVIVTQK.3|GKDC[CAM]AVIVTQK.2|YEAANWK.2|LLDSSTVTHLFK.3|LLDSSTVTHLFK.2|GSSAGFDRHITIFSPEGR.4|KVPDKLLDSSTVTHLFK.4|KVPDKLLDSSTVTHLFK.3|DC[CAM]AVIVTQK.2|HITIFSPEGR.2|QTESTSFLEK.2|ILTEAEIDAHLVALAER.3|ILTEAEIDAHLVALAER.2|RIADISQVYTQNAEMR.3|ILTEAEIDAHLVALAERD.3|ILTEAEIDAHLVALAERD.2|C[CAM]DPAGYYC[CAM]GFK.2|PSEIEVGVVTVENPK.2|RIADISQVYTQNAEMRPLGC[CAM]C[CAM]MILIGIDEEQGPQVYK.5|RIADISQVYTQNAEMRPLGC[CAM]C[CAM]MILIGIDEEQGPQVYK.4|IADISQVYTQNAEMR.2|YKYGYEIPVDMLC[CAM]K.2
SEN / CTL,O15144,Actin-related protein 2/3 complex subunit 2,ARPC2,1.83,1.78,8.08E-08,1.35E-08,7.87E+00,"movement of cell or subcellular component,positive regulation of lamellipodium assembly,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,positive regulation of substrate adhesion-dependent cell spreading","structural constituent of cytoskeleton,protein binding,actin filament binding","cytoplasm,endosome,Golgi apparatus,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,cell leading edge,muscle cell projection membrane,neuron projection,synapse,extracellular exosome",36,36,60,MILLEVNNR.2|M[Oxi]ILLEVNNR.2|NC[CAM]FASVFEKYFQFQEEGKEGENR.4|NC[CAM]FASVFEKYFQFQEEGKEGENR.3|VYGSFLVNPESGYNVSLLYDLENLPASKDSIVHQAGMLKR.5|YFQFQEEGKEGENR.3|YFQFQEEGKEGENR.2|ASHTAPQVLFSHREPPLELKDTDAAVGDNIGYITFVLFPR.6|ASHTAPQVLFSHREPPLELKDTDAAVGDNIGYITFVLFPR.5|AVIHYRDDETMYVESK.4|AVIHYRDDETM[Oxi]YVESK.4|AVIHYRDDETMYVESK.3|AVIHYRDDETM[Oxi]YVESK.3|DSIVHQAGMLK.3|DSIVHQAGMLK.2|DSIVHQAGM[Oxi]LK.2|RASHTAPQVLFSHR.4|RNC[CAM]FASVFEK.3|RNC[CAM]FASVFEK.2|ELQAHGADELLK.3|ELQAHGADELLK.2|DDETMYVESKK.3|DNTINLIHTFR.3|DNTINLIHTFR.2|VM[Oxi]VSISLK.2|ASHTAPQVLFSHREPPLELK.5|ASHTAPQVLFSHREPPLELK.4|ASHTAPQVLFSHREPPLELK.3|ASHTAPQVLFSHREPPLELK.2|DSIVHQAGMLKR.3|DSIVHQAGMLKR.2|VFMQEFK.2|ASHTAPQVLFSHR.3|ASHTAPQVLFSHR.2|RASHTAPQVLFSHREPPLELK.5|DDDDVVIGK.2|ELQAHGADELLKR.3|ELQAHGADELLKR.2|IIEETLALK.2|AVIHYRDDETMYVESKK.4|AVIHYRDDETMYVESKK.3|DYLHYHIK.2|NC[CAM]FASVFEK.2|VTVVFSTVFK.2|YFQFQEEGK.2|DNTINLIHTFRDYLHYHIK.4|DDETMYVESK.2|DDETM[Oxi]YVESK.2|FYKELQAHGADELLKR.3|VTVVFSTVFKDDDDVVIGK.3|DTDAAVGDNIGYITFVLFPR.3|DTDAAVGDNIGYITFVLFPR.2|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDK.5|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDK.4|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDKTK.5|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDKTK.4|RVYGSFLVNPESGYNVSLLYDLENLPASK.4|RVYGSFLVNPESGYNVSLLYDLENLPASK.3|EPPLELKDTDAAVGDNIGYITFVLFPR.3|VYGSFLVNPESGYNVSLLYDLENLPASK.3
SEN / CTL,P06396,Gelsolin,GSN,1.82,1.51,3.50E-17,1.50E-17,1.68E+01,"phagocytosis, engulfment,positive regulation of gene expression,striated muscle atrophy,actin filament polymerization,protein destabilization,sequestering of actin monomers,cellular protein metabolic process,actin nucleation,negative regulation of viral entry into host cell,actin filament severing,barbed-end actin filament capping,positive regulation of actin nucleation,actin filament capping,cilium morphogenesis,regulation of podosome assembly,actin filament reorganization,renal protein absorption,hepatocyte apoptotic process,positive regulation of keratinocyte apoptotic process,regulation of wound healing, spreading of epidermal cells,regulation of establishment of T cell polarity,regulation of plasma membrane raft polarization,regulation of receptor clustering,positive regulation of protein processing in phagocytic vesicle,amyloid fibril formation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,extracellular matrix disassembly","actin binding,calcium ion binding,protein binding,protein domain specific binding,myosin II binding","podosome,extracellular region,extracellular space,cytoplasm,cytosol,plasma membrane,focal adhesion,actin cytoskeleton,sarcoplasm,actin cap,cortical actin cytoskeleton,extracellular exosome,blood microparticle,nucleus",102,53,102,QTQVSVLPEGGETPLFK.2|QTQVSVLPEGGETPLFK.3|MDYPKQTQVSVLPEGGETPLFK.3|AQPVQVAEGSEPDGFWEALGGK.3|AQPVQVAEGSEPDGFWEALGGK.2|AQPVQVAEGSEPDGFWEALGGK.4|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.4|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.3|AGALNSNDAFVLK.2|AGALNSNDAFVLK.3|TPSAAYLWVGTGASEAEKTGAQELLR.3|TPSAAYLWVGTGASEAEKTGAQELLR.4|GGVASGFKHVVPNEVVVQR.3|NWRDPDQTDGLGLSYLSSHIANVER.4|NWRDPDQTDGLGLSYLSSHIANVER.5|NWRDPDQTDGLGLSYLSSHIANVER.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.5|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.5|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.4|EVQGFESATFLGYFK.2|EVQGFESATFLGYFK.3|TPSAAYLWVGTGASEAEK.2|TPSAAYLWVGTGASEAEK.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGMDDDGTGQK.5|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.3|SEDC[CAM]FILDHGKDGK.4|SEDC[CAM]FILDHGKDGK.3|SEDC[CAM]FILDHGKDGK.2|RYIETDPANR.3|AGKEPGLQIWR.3|AGKEPGLQIWR.2|DSQEEEKTEALTSAK.4|DSQEEEKTEALTSAK.3|DSQEEEKTEALTSAK.2|HVVPNEVVVQR.3|HVVPNEVVVQR.2|KGGVASGFK.2|DSQEEEK.2|EPAHLM[Oxi]SLFGGK.3|EPAHLMSLFGGK.2|SEDC[CAM]FILDHGK.3|SEDC[CAM]FILDHGK.2|TASDFITK.2|TGAQELLR.2|VVQGKEPAHLMSLFGGK.4|VVQGKEPAHLMSLFGGK.3|RTPITVVK.2|KMDAHPPR.2|KM[Oxi]DAHPPR.2|PALPAGTEDTAKEDAANRK.4|PALPAGTEDTAKEDAANRK.3|EPGLQIWR.2|GASQAGAPQGR.2|RYIETDPANRDR.3|EPAHLMSLFGGKPMIIYK.4|EPAHLMSLFGGKPMIIYK.3|EPAHLMSLFGGKPMIIYK.2|PNSMVVEHPEFLK.3|PNSM[Oxi]VVEHPEFLK.3|PNSMVVEHPEFLK.2|VPEARPNSMVVEHPEFLK.4|VPEARPNSMVVEHPEFLK.3|EGGQTAPASTR.2|VHVSEEGTEPEAMLQVLGPK.4|VHVSEEGTEPEAM[Oxi]LQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.2|YIETDPANR.2|AVQHREVQGFESATFLGYFK.4|PALPAGTEDTAK.2|ARVHVSEEGTEPEAMLQVLGPK.4|ARVHVSEEGTEPEAMLQVLGPK.3|DPDQTDGLGLSYLSSHIANVER.4|DPDQTDGLGLSYLSSHIANVER.3|DPDQTDGLGLSYLSSHIANVER.2|PALPAGTEDTAKEDAANR.3|VSNGAGTMSVSLVADENPFAQGALK.4|VSNGAGTM[Oxi]SVSLVADENPFAQGALK.3|VSNGAGTMSVSLVADENPFAQGALK.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|VHVSEEGTEPEAM[Oxi]LQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.3|VPVDPATYGQFYGGDSYIILYNYR.4|VPVDPATYGQFYGGDSYIILYNYR.3|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VEKFDLVPVPTNLYGDFFTGDAYVILK.4|VEKFDLVPVPTNLYGDFFTGDAYVILK.3|VSNGAGTMSVSLVADENPFAQGALKSEDC[CAM]FILDHGKDGK.5|FDLVPVPTNLYGDFFTGDAYVILK.3|NWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQK.6|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNR.4|QGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSR.4|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNRYER.4
SEN / CTL,P06865,Beta-hexosaminidase subunit alpha,HEXA,1.81,1.72,2.70E-08,4.77E-09,8.32E+00,"carbohydrate metabolic process,glycosaminoglycan biosynthetic process,glycosphingolipid metabolic process,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein heterodimerization activity","membrane,azurophil granule,lysosomal lumen,extracellular exosome",30,21,32,ALLSAPWYLNR.2|GLETFSQLVWK.2|RGVQAQPLNVGFC[CAM]EQEFEQT.3|RGVQAQPLNVGFC[CAM]EQEFEQT.2|SNPEIQDFMR.2|GYVVWQEVFDNKVK.3|GYVVWQEVFDNKVK.2|GLLLDTSR.2|IQPDTIIQVWR.3|IQPDTIIQVWR.2|ISYGPDWK.2|GYVVWQEVFDNK.3|GYVVWQEVFDNK.2|TEIEDFPR.2|HYLPLSSILDTLDVMAYNK.4|HYLPLSSILDTLDVMAYNK.3|HYLPLSSILDTLDVM[Oxi]AYNK.3|HYLPLSSILDTLDVM[Oxi]AYNK.2|HYLPLSSILDTLDVMAYNK.2|EDIPVNYMK.2|YRDLLFGSGSWPRPYLTGK.4|GSYNPVTHIYTAQDVK.3|GSYNPVTHIYTAQDVK.2|IQPDTIIQVWREDIPVNYMK.4|IQPDTIIQVWREDIPVNYMK.3|DLLFGSGSWPRPYLTGK.3|KGSYNPVTHIYTAQDVK.3|LTSDLTFAYER.2|LNVFHWHLVDDPSFPYESFTFPELMR.4|LNVFHWHLVDDPSFPYESFTFPELMR.3|YVLYPNNFQFQYDVSSAAQPGC[CAM]SVLDEAFQR.4|GVQAQPLNVGFC[CAM]EQEFEQT.2
SEN / CTL,Q9UNW1,Multiple inositol polyphosphate phosphatase 1,MINPP1,1.81,2.27,9.84E-02,7.71E-03,2.11E+00,"ossification,polyphosphate metabolic process,dephosphorylation,bone mineralization,inositol phosphate metabolic process","acid phosphatase activity,phosphohistidine phosphatase activity,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,bisphosphoglycerate 3-phosphatase activity,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,inositol phosphate phosphatase activity,inositol hexakisphosphate 2-phosphatase activity","endoplasmic reticulum,endoplasmic reticulum lumen,extracellular exosome",12,12,13,LASLFPALFSR.2|TRYEDVNPVLLSGPEAPWRDPELLEGTC[CAM]TPVQLVALIR.4|DKEPLTAYNYK.3|VLEYLNDLK.2|TGPEMQNILK.2|SSC[CAM]TLFQDIFQHLDK.3|SSC[CAM]TLFQDIFQHLDK.2|DPVASSLSPYFGTK.2|SPWC[CAM]DVFDIDDAK.2|SGLIVPYASNLIFVLYHC[CAM]ENAK.3|DILQSC[CAM]QTSEEC[CAM]ELAR.2|YEDVNPVLLSGPEAPWR.2|VLPLAYSQETVSFYEDLK.2
SEN / CTL,Q15019,Septin-2,2-Sep,1.80,1.50,3.81E-12,1.03E-12,1.20E+01,"regulation of L-glutamate transport,mitotic nuclear division,smoothened signaling pathway,neuron projection development,regulation of protein localization,cilium assembly,regulation of catalytic activity,cell division,cell-cell adhesion","protein binding,GTP binding,enzyme regulator activity,protein complex scaffold,cadherin binding involved in cell-cell adhesion","exocyst,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,cell-cell adherens junction,axoneme,actin cytoskeleton,midbody,septin complex,cleavage furrow,photoreceptor connecting cilium,myelin sheath,synapse,perinuclear region of cytoplasm,ciliary membrane,extracellular exosome,cell cortex",48,30,53,TIISYIDEQFER.2|ASIPFSVVGSNQLIEAK.2|ASIPFSVVGSNQLIEAK.3|GRLYPWGVVEVENPEHNDFLKLR.5|TVQIEASTVEIEER.2|TVQIEASTVEIEER.3|GRLYPWGVVEVENPEHNDFLK.4|GRLYPWGVVEVENPEHNDFLK.3|MQAQMQMQMQGGDGDGGALGHHV.3|M[Oxi]QAQMQMQMQGGDGDGGALGHHV.3|MQAQM[Oxi]QMQMQGGDGDGGALGHHV.3|LYPWGVVEVENPEHNDFLK.3|LYPWGVVEVENPEHNDFLK.4|LYPWGVVEVENPEHNDFLK.2|YLHDESGLNR.3|YLHDESGLNR.2|DQILLEK.2|MQEMIAR.2|ILDEIEEHNIK.3|ILDEIEEHNIK.2|YLHDESGLNRR.3|YLHDESGLNRR.2|PLDVAFMK.2|VNIVPVIAK.2|KVENEDMNKDQILLEK.4|KVENEDMNKDQILLEK.3|VHC[CAM]C[CAM]FYFISPFGHGLK.4|VHC[CAM]C[CAM]FYFISPFGHGLK.3|RILDEIEEHNIK.3|AIHNKVNIVPVIAK.3|RMQEMIAR.2|KVENEDMNK.2|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.4|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.4|LTVVDTPGYGDAINC[CAM]R.3|LTVVDTPGYGDAINC[CAM]R.2|QQPTQFINPETPGYVGFANLPNQVHR.5|QQPTQFINPETPGYVGFANLPNQVHR.4|QQPTQFINPETPGYVGFANLPNQVHR.3|KGFEFTLMVVGESGLGK.3|VENEDMNKDQILLEK.3|LRTMLITHMQDLQEVTQDLHYENFR.5|STLINSLFLTDLYPER.3|STLINSLFLTDLYPER.2|LRLTVVDTPGYGDAINC[CAM]R.3|TM[Oxi]LITHMQDLQEVTQDLHYENFR.4|TMLITHM[Oxi]QDLQEVTQDLHYENFR.4|TMLITHMQDLQEVTQDLHYENFR.4|TM[Oxi]LITHMQDLQEVTQDLHYENFR.3|TMLITHMQDLQEVTQDLHYENFR.3|QQPTQFINPETPGYVGFANLPNQVHRK.4
SEN / CTL,Q08431,Lactadherin,MFGE8,1.80,1.31,1.12E-07,1.84E-08,7.74E+00,"angiogenesis,phagocytosis, recognition,phagocytosis, engulfment,cell adhesion,single fertilization,viral process,cellular protein metabolic process,positive regulation of apoptotic cell clearance","phosphatidylserine binding,integrin binding,phosphatidylethanolamine binding","extracellular region,extracellular space,external side of plasma membrane,membrane,extrinsic component of plasma membrane,extracellular exosome,extracellular vesicle,extracellular matrix",36,15,19,VTFLGLQHWVPELAR.3|VTFLGLQHWVPELAR.2|NLFETPILAR.2|NAVHVNLFETPVEAQYVR.3|NAVHVNLFETPVEAQYVR.2|MWVTGVVTQGASR.2|LASHEYLK.2|LYPTSC[CAM]HTAC[CAM]TLR.3|VAYSLNGHEFDFIHDVNKK.4|VAYSLNGHEFDFIHDVNKK.3|EVTGIITQGAR.2|TWGLHLFSWNPSYAR.3|NPC[CAM]HNGGLC[CAM]EEISQEVR.3|NPC[CAM]HNGGLC[CAM]EEISQEVR.2|NFGSVQFVASYK.2|GDVFPSYTC[CAM]TC[CAM]LK.2|C[CAM]VEPLGMENGNIANSQIAASSVR.3|AGM[Oxi]VNAWTPSSNDDNPWIQVNLLR.3|FELLGC[CAM]ELNGC[CAM]ANPLGLK.2
SEN / CTL,Q9P2E9,Ribosome-binding protein 1,RRBP1,1.78,1.38,7.14E-10,1.52E-10,9.82E+00,"osteoblast differentiation,translation,protein transport","receptor activity,poly(A) RNA binding","endoplasmic reticulum,ribosome,membrane,integral component of endoplasmic reticulum membrane",54,99,145,SIEALLEAGQAR.2|SIEALLEAGQAR.3|SILAETEGMLRDLQK.3|QLLLESQSQLDAAKSEAQKQSDELALVR.4|LREAEETQSTLQAEC[CAM]DQYR.3|LREAEETQSTLQAEC[CAM]DQYR.4|TLQEQLENGPNTQLAR.2|TLQEQLENGPNTQLAR.3|LLATEQEDAAVAK.2|QKLTAEFEEAQTSAC[CAM]R.3|QKLTAEFEEAQTSAC[CAM]R.2|TLVSTVGSMVFNEGEAQR.3|TLVSTVGSM[Oxi]VFNEGEAQR.2|TLVSTVGSMVFNEGEAQR.2|SILAETEGMLR.2|SILAETEGM[Oxi]LR.2|ELESQVSGLEK.3|ELESQVSGLEK.2|GDPVAILK.2|ATQKGDPVAILK.3|AKVGAAEEELQK.3|AKVGAAEEELQK.2|QQLSEMK.2|LQEQLEK.2|RLDEVSR.2|KLQEQLEKAEDGSSSK.4|KLQEQLEKAEDGSSSK.3|KLQEQLEKAEDGSSSK.2|SEAVRQDEQQR.3|AAILETAPK.2|LKGELESSDQVR.3|LKGELESSDQVR.2|AMEALATAEQAC[CAM]K.3|AM[Oxi]EALATAEQAC[CAM]K.2|AMEALATAEQAC[CAM]K.2|EVQQLQGK.2|ATQKGDPVAILKR.3|ESEEALQK.2|LIEILSEK.2|TESASVQGR.2|EHTSHLEAELEK.3|EHTSHLEAELEK.2|EHVKEVQQLQGK.3|EHVKEVQQLQGK.2|TTQEQLAR.2|VEGITNQGK.2|LKELESQVSGLEK.3|LKELESQVSGLEK.2|SKC[CAM]EELSGLHGQLQEAR.4|SKC[CAM]EELSGLHGQLQEAR.3|KGEGAPIQGK.2|SEAVRQDEQQRK.3|HLEEIVEK.2|HPPAPAEPSSDLASK.3|HPPAPAEPSSDLASK.2|NTDVAQSPEAPKQEAPAKK.4|ELC[CAM]HTQSSHASLR.3|IRSIEALLEAGQAR.3|KLQEQLEK.2|LQSSEAEVR.2|ETSYEEALANQRK.3|KADSVANQGTKVEGITNQGK.4|KADSVANQGTKVEGITNQGK.3|KKGEPGPPDADGPLYLPYK.4|KKGEPGPPDADGPLYLPYK.3|PNGKIPDHDPAPNVTVLLR.4|PNGKIPDHDPAPNVTVLLR.3|QLLLESQSQLDAAK.3|QLLLESQSQLDAAK.2|QSDELALVR.2|AENSQLTER.2|HM[Oxi]AAASAEC[CAM]QNYAK.3|HMAAASAEC[CAM]QNYAK.3|HMAAASAEC[CAM]QNYAK.2|HM[Oxi]AAASAEC[CAM]QNYAK.2|KVEGAPTQGR.2|GPTLLKHPPAPAEPSSDLASK.4|GPTLLKHPPAPAEPSSDLASK.3|SEAQKQSDELALVR.3|SEAQKQSDELALVR.2|EKLLATEQEDAAVAK.3|IPDHDPAPNVTVLLREPVR.4|VGAAEEELQK.2|ADAEKAQEQQQQMAELHSK.4|ADAEKAQEQQQQM[Oxi]AELHSK.4|ESEEALQKR.2|KVDTTPNQGK.2|AMEALATAEQAC[CAM]KEK.3|AM[Oxi]EALATAEQAC[CAM]KEK.3|AMEALATAEQAC[CAM]KEK.2|AQEQQQQMAELHSK.3|AQEQQQQM[Oxi]AELHSK.3|IPDHDPAPNVTVLLR.3|LKGELESSDQVREHTSHLEAELEK.5|LKGELESSDQVREHTSHLEAELEK.3|LQQENSILR.2|GELESSDQVR.2|GNTPATGTTQGK.2|EQEITAVQAR.2|C[CAM]EELSGLHGQLQEAR.3|C[CAM]EELSGLHGQLQEAR.2|AGIIQDTWHK.2|LRTAGPLESSETEEASQLKER.4|QVLQLQASHR.2|TAGPLESSETEEASQLK.3|TAGPLESSETEEASQLK.2|TAGPLESSETEEASQLKERLEK.4|LQQENSILRDALNQATSQVESK.4|LQQENSILRDALNQATSQVESK.3|VEPAVSSVVNSIQVLTSK.3|VEPAVSSVVNSIQVLTSK.2|AEDGSSSKEGTSV.2|NTDVAQSPEAPK.2|NTDVAQSPEAPKQEAPAK.3|AEGAQNQGQKGEGAQNQGK.3|KGEPGPPDADGPLYLPYK.3|KGEPGPPDADGPLYLPYK.2|SVEEEEQVWR.2|DAQDVQASQAEADQQQTR.3|DAQDVQASQAEADQQQTR.2|EVPMVVVPPVGAK.2|EAEETQSTLQAEC[CAM]DQYR.3|EAEETQSTLQAEC[CAM]DQYR.2|ELC[CAM]HTQSSHASLRADAEK.3|LRTAGPLESSETEEASQLK.3|DALNQATSQVESK.2|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.5|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.4|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.3|IRTLQEQLENGPNTQLAR.3|QLLLESQSQLDAAKSEAQK.3|TAGPLESSETEEASQLKER.3|ETSYEEALANQR.2|TQLEWTEAILEDEQTQR.3|TQLEWTEAILEDEQTQR.2|LQEQLEKAEDGSSSKEGTSV.3|LKELESQVSGLEKEAIELR.3|VAKVEPAVSSVVNSIQVLTSK.3|SHVEDGDIAGAPASSPEAPPAEQDPVQLK.4|SHVEDGDIAGAPASSPEAPPAEQDPVQLK.3|APAVAVAPTPVQPPIIVAPVATVPAMPQEK.4|APAVAVAPTPVQPPIIVAPVATVPAM[Oxi]PQEK.3|APAVAVAPTPVQPPIIVAPVATVPAMPQEK.3|LTAEFEEAQTSAC[CAM]R.2|GEPGPPDADGPLYLPYK.2
SEN / CTL,P35613,Basigin,BSG,1.78,1.77,2.32E-06,3.31E-07,6.48E+00,"pyruvate metabolic process,cell surface receptor signaling pathway,embryo implantation,monocarboxylic acid transport,extracellular matrix disassembly,extracellular matrix organization,odontogenesis of dentin-containing tooth,response to peptide hormone,response to mercury ion,decidualization,leukocyte migration,response to cAMP,protein targeting to plasma membrane,cell-cell adhesion","protein binding,mannose binding,monocarboxylic acid transmembrane transporter activity,cadherin binding involved in cell-cell adhesion","Golgi membrane,acrosomal membrane,mitochondrion,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion,membrane,sarcolemma,melanosome,membrane raft,extracellular exosome",18,11,22,SSEHINEGETAMLVC[CAM]K.3|SSEHINEGETAM[Oxi]LVC[CAM]K.3|SSEHINEGETAM[Oxi]LVC[CAM]K.2|SSEHINEGETAMLVC[CAM]K.2|SELHIENLNMEADPGQYR.3|SELHIENLNM[Oxi]EADPGQYR.3|SELHIENLNMEADPGQYR.2|SESVPPVTDWAWYK.2|SESVPPVTDWAWYK.3|GGVVLKEDALPGQK.3|GGVVLKEDALPGQK.2|RKPEDVLDDDDAGSAPLK.4|RKPEDVLDDDDAGSAPLK.3|FFVSSSQGR.2|RRKPEDVLDDDDAGSAPLK.4|RRKPEDVLDDDDAGSAPLK.3|GSDQAIITLR.2|GSDQAIITLR.1|KPEDVLDDDDAGSAPLK.3|KPEDVLDDDDAGSAPLK.2|TEFKVDSDDQWGEYSC[CAM]VFLPEPMGTANIQLHGPPR.4|VDSDDQWGEYSC[CAM]VFLPEPMGTANIQLHGPPR.3
SEN / CTL,Q9BSJ8,Extended synaptotagmin-1,ESYT1,1.77,1.49,4.59E-03,4.11E-04,3.39E+00,lipid transport,"lipid binding,metal ion binding","plasma membrane,membrane,integral component of endoplasmic reticulum membrane,organelle membrane contact site",12,52,75,VQLDLAETDLSQGVAR.2|VQLDLAETDLSQGVAR.3|QLLDDEEQLTAK.2|HLSPYATLTVGDSSHK.4|HLSPYATLTVGDSSHK.3|HLSPYATLTVGDSSHK.2|ALTLGALTLPLAR.3|ALTLGALTLPLAR.2|SHVVREDLNPR.3|IHVLEAQDLIAK.3|IHVLEAQDLIAK.2|SDPYALVR.2|AEDLPLRK.2|KPHTESLELQVR.3|KPHTESLELQVR.2|LTHVDSPLEAPAGPLGQVK.4|LTHVDSPLEAPAGPLGQVK.3|LTHVDSPLEAPAGPLGQVK.2|GSNPHLQTFTFTR.3|GSNPHLQTFTFTR.2|GMQLHGVLR.2|LVSIVHGC[CAM]R.2|VELGEKPLR.2|LGTQTFC[CAM]SR.2|IHVLEAQDLIAKDR.3|WYDLMDNK.2|SAELAAALLSIYMER.3|SAELAAALLSIYMER.2|TLSPEFNER.2|QRLTHVDSPLEAPAGPLGQVK.4|QRLTHVDSPLEAPAGPLGQVK.3|QRLTHVDSPLEAPAGPLGQVK.2|GSSVDAPPRPC[CAM]HTTPDSQFGTEHVLR.5|GSSVDAPPRPC[CAM]HTTPDSQFGTEHVLR.4|LLAETVAPAVR.2|IHVLEAQDLIAKDRFLGGLVK.4|LLVPLVPDLQDVAQLR.3|LLVPLVPDLQDVAQLR.2|IVAQVWPFLGQYMEK.3|IVAQVWPFLGQYM[Oxi]EK.2|IVAQVWPFLGQYMEK.2|AVYSTNC[CAM]PVWEEAFR.3|AVYSTNC[CAM]PVWEEAFR.2|RTLSPEFNER.2|FFLQDPQSQELDVQVK.3|FFLQDPQSQELDVQVK.2|LLTAPELILDQWFQLSSSGPNSR.4|LLTAPELILDQWFQLSSSGPNSR.3|VLQASVLDDWFPLQGGQGQVHLR.4|VLQASVLDDWFPLQGGQGQVHLR.3|DPPDPYVSLLLLPDKNR.3|LTPRPTAAELEEVLQVNSLIQTQK.4|LTPRPTAAELEEVLQVNSLIQTQK.3|LTLWYYSEER.2|LEWLSLLSDAEK.2|TISQTSAPVWDESASFLIR.3|TISQTSAPVWDESASFLIR.2|QNGRDPPDPYVSLLLLPDK.3|LTLWYYSEERK.2|PTAAELEEVLQVNSLIQTQK.3|ELPAWVSFPDVEKAEWLNK.3|ELPAWVSFPDVEK.2|FEWELPLDEAQR.2|GNKEPNPMVQLSIQDVTQESK.3|FFLQDPQSQELDVQVKDDSR.3|WFTLSSGQGQVLLR.2|PDPGSGGQPAGPGAAGEALAVLTSFGR.3|SAELAAALLSIYMERAEDLPLR.3|AQLGILVSQHSGVEAHSHSYSHSSSSLSEEPELSGGPPHITSSAPELR.6|KGNKEPNPMVQLSIQDVTQESK.3|DPPDPYVSLLLLPDK.2|ILYLDSSEIC[CAM]FPTVPGC[CAM]PGAWDVDSENPQR.4|ILYLDSSEIC[CAM]FPTVPGC[CAM]PGAWDVDSENPQR.3|LTTVLNSGFLDEWLTLEDVPSGR.3|GEGTGVLGSLSLPLSELLVADQLC[CAM]LDR.3
SEN / CTL,P12814,Alpha-actinin-1,ACTN1,1.77,2.13,5.65E-23,4.18E-23,2.24E+01,"platelet degranulation,actin filament organization,platelet formation,platelet morphogenesis,regulation of apoptotic process,focal adhesion assembly,actin filament bundle assembly,negative regulation of cellular component movement,actin filament network formation,actin crosslink formation,regulation of nucleic acid-templated transcription,platelet activation,platelet aggregation","double-stranded RNA binding,integrin binding,calcium ion binding,protein binding,vinculin binding,ligand-dependent nuclear receptor transcription coactivator activity,protein homodimerization activity,ion channel binding,actin filament binding","stress fiber,ruffle,extracellular region,extracellular space,intracellular,cytoplasm,cytosol,plasma membrane,brush border,cell-cell junction,fascia adherens,focal adhesion,Z disc,platelet alpha granule lumen,pseudopodium,cell projection,extracellular exosome,actin filament",204,84,179,LLETIDQLYLEYAKR.3|ILAGDKNYITMDELRR.4|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.5|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.6|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.4|IC[CAM]DQWDNLGALTQK.2|IC[CAM]DQWDNLGALTQK.3|LAILGIHNEVSK.3|LAILGIHNEVSK.2|MLDAEDIVGTARPDEK.3|M[Oxi]LDAEDIVGTARPDEK.3|MLDAEDIVGTARPDEK.2|M[Oxi]LDAEDIVGTARPDEK.2|KQFGAQANVIGPWIQTK.3|KQFGAQANVIGPWIQTK.2|AGTQIENIEEDFRDGLK.3|AGTQIENIEEDFRDGLK.2|ASIHEAWTDGKEAMLR.4|ASIHEAWTDGKEAMLR.3|ASIHEAWTDGKEAMLR.2|ASIHEAWTDGKEAM[Oxi]LR.4|ASIHEAWTDGKEAM[Oxi]LR.3|ETADTDTADQVMASFK.2|ETADTDTADQVMASFK.3|ETADTDTADQVM[Oxi]ASFK.3|ETADTDTADQVM[Oxi]ASFK.2|QFGAQANVIGPWIQTK.2|QFGAQANVIGPWIQTK.3|TIPWLENRVPENTMHAMQQK.4|TIPWLENRVPENTMHAMQQK.3|DGLGFC[CAM]ALIHR.2|DGLGFC[CAM]ALIHR.3|QKASIHEAWTDGKEAMLR.4|IDQLEGDHQLIQEALIFDNK.3|IDQLEGDHQLIQEALIFDNK.4|IDQLEGDHQLIQEALIFDNK.2|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.6|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.5|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.4|LRKDDPLTNLNTAFDVAEK.4|LRKDDPLTNLNTAFDVAEK.3|LRKDDPLTNLNTAFDVAEK.2|ISIEMHGTLEDQLSHLR.4|ISIEMHGTLEDQLSHLR.3|ISIEM[Oxi]HGTLEDQLSHLR.4|ISIEM[Oxi]HGTLEDQLSHLR.3|ISIEMHGTLEDQLSHLR.2|KAGTQIENIEEDFRDGLK.3|KAGTQIENIEEDFRDGLK.4|KAGTQIENIEEDFRDGLK.2|QKDYETATLSEIK.3|QKDYETATLSEIK.2|KDDPLTNLNTAFDVAEK.3|KDDPLTNLNTAFDVAEK.2|MVSDINNAWGC[CAM]LEQVEK.3|M[Oxi]VSDINNAWGC[CAM]LEQVEK.3|M[Oxi]VSDINNAWGC[CAM]LEQVEK.2|MVSDINNAWGC[CAM]LEQVEK.2|VLAVNQENEQLMEDYEK.3|VLAVNQENEQLM[Oxi]EDYEK.3|VLAVNQENEQLM[Oxi]EDYEK.2|VLAVNQENEQLMEDYEK.2|ASIHEAWTDGK.3|ASIHEAWTDGK.2|HEAFESDLAAHQDR.4|HEAFESDLAAHQDR.3|HEAFESDLAAHQDR.2|HRPELIDYGK.3|HRPELIDYGK.2|KTFTAWC[CAM]NSHLRK.4|KTFTAWC[CAM]NSHLRK.3|KTFTAWC[CAM]NSHLRK.2|LDHLAEK.2|LERLDHLAEK.3|LERLDHLAEK.2|ATLPDADK.2|DYETATLSEIK.3|DYETATLSEIK.2|ALDFIASK.2|EGLLLWC[CAM]QRK.3|HTNYTMEHIR.3|HTNYTM[Oxi]EHIR.3|HTNYTMEHIR.2|HTNYTM[Oxi]EHIR.2|LRLSNRPAFMPSEGR.4|DHSGTLGPEEFK.3|DHSGTLGPEEFK.2|KHEAFESDLAAHQDR.4|KHEAFESDLAAHQDR.3|KHEAFESDLAAHQDR.2|NYITMDELRR.3|NYITMDELRR.2|RDQALTEEHAR.3|RDQALTEEHAR.2|ASFNHFDRDHSGTLGPEEFK.5|ASFNHFDRDHSGTLGPEEFK.4|ASFNHFDRDHSGTLGPEEFK.3|TFTAWC[CAM]NSHLR.3|TFTAWC[CAM]NSHLR.2|VPENTMHAMQQK.3|VPENTM[Oxi]HAMQQK.3|VPENTMHAM[Oxi]QQK.3|VPENTM[Oxi]HAM[Oxi]QQK.3|VPENTMHAMQQK.2|SIVNYKPK.2|LSNRPAFMPSEGR.3|LSNRPAFM[Oxi]PSEGR.3|LSNRPAFMPSEGR.2|ASFNHFDR.2|NVNIQNFHISWK.3|NVNIQNFHISWK.2|AGTQIENIEEDFR.3|AGTQIENIEEDFR.2|KTFTAWC[CAM]NSHLR.3|KTFTAWC[CAM]NSHLR.2|TFTAWC[CAM]NSHLRK.3|TFTAWC[CAM]NSHLRK.2|TIPWLENR.2|IMSIVDPNR.2|IM[Oxi]SIVDPNR.2|ERLAILGIHNEVSK.3|ERLAILGIHNEVSK.2|GYEEWLLNEIRR.3|GYEEWLLNEIRR.2|RDQALTEEHARQQHNER.4|KAGTQIENIEEDFR.3|KAGTQIENIEEDFR.2|ATLPDADKER.2|TEKLLETIDQLYLEYAKR.4|TEKLLETIDQLYLEYAKR.3|LLETIDQLYLEYAK.3|LLETIDQLYLEYAK.2|RELPPDQAEYC[CAM]IAR.3|IVQTYHVNMAGTNPYTTITPQEINGK.5|IVQTYHVNMAGTNPYTTITPQEINGK.4|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGK.4|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGK.3|IVQTYHVNMAGTNPYTTITPQEINGK.3|LGVVTFQAFIDFMSR.3|LGVVTFQAFIDFMSR.2|NYITMDELR.2|NYITM[Oxi]DELR.2|DDPLTNLNTAFDVAEK.3|DDPLTNLNTAFDVAEK.2|DQALTEEHAR.2|EGLLLWC[CAM]QR.2|ILAGDKNYITMDELR.3|ILAGDKNYITM[Oxi]DELR.3|ILAGDKNYITMDELR.2|DLLLDPAWEK.2|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.6|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGKWDHVR.5|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.5|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.4|IC[CAM]DQWDNLGALTQKR.3|KDDPLTNLNTAFDVAEKYLDIPK.4|KDDPLTNLNTAFDVAEKYLDIPK.3|GISQEQM[Oxi]NEFR.2|GISQEQMNEFR.2|TEKLLETIDQLYLEYAK.3|VEQIAAIAQELNELDYYDSPSVNAR.4|VEQIAAIAQELNELDYYDSPSVNAR.3|VQEKC[CAM]QLEINFNTLQTK.3|MTLGMIWTIILR.2|M[Oxi]TLGMIWTIILR.2|MTLGM[Oxi]IWTIILR.2|M[Oxi]TLGM[Oxi]IWTIILR.2|ASFNHFDRDHSGTLGPEEFKAC[CAM]LISLGYDIGNDPQGEAEFAR.6|LVSIGAEEIVDGNVK.2|AC[CAM]LISLGYDIGNDPQGEAEFAR.3|AC[CAM]LISLGYDIGNDPQGEAEFAR.2|DDPLTNLNTAFDVAEKYLDIPK.3|VLAVNQENEQLM[Oxi]EDYEKLASDLLEWIRR.4|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.5|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.4|FAIQDISVEETSAKEGLLLWC[CAM]QR.3|RAAPFNNWM[Oxi]EGAM[Oxi]EDLQDTFIVHTIEEIQGLTTAHEQFK.5|RAAPFNNWM[Oxi]EGAM[Oxi]EDLQDTFIVHTIEEIQGLTTAHEQFK.4|MAPYTGPDSVPGALDYMSFSTALYGESDL.3
SEN / CTL,O75368,SH3 domain-binding glutamic acid-rich-like protein,SH3BGRL,1.76,1.92,2.35E-01,1.77E-02,1.75E+00,positive regulation of signal transduction,"SH3/SH2 adaptor activity,SH3 domain binding","extracellular space,nucleus,cytoplasm,extracellular exosome",18,12,17,VYIASSSGSTAIK.2|ENNAVYAFLGLTAPPGSK.2|ENNAVYAFLGLTAPPGSK.3|IGFEEKDIAANEENRK.4|IGFEEKDIAANEENRK.3|VYIASSSGSTAIKK.3|VYIASSSGSTAIKK.2|KQQDVLGFLEANK.3|KQQDVLGFLEANK.2|DIAANEENR.2|DIAANEENRK.2|GDYDAFFEAR.2|QQDVLGFLEANK.2|ENVPENSRPATGYPLPPQIFNESQYR.4|ENVPENSRPATGYPLPPQIFNESQYR.3|ENVPENSRPATGYPLPPQIFNESQYRGDYDAFFEAR.4|PATGYPLPPQIFNESQYR.2
SEN / CTL,P35579,Myosin-9,MYH9,1.76,1.67,2.07E-155,5.58E-154,1.53E+02,"meiotic spindle organization,cytokinesis,angiogenesis,in utero embryonic development,establishment of T cell polarity,membrane protein ectodomain proteolysis,phagocytosis, engulfment,integrin-mediated signaling pathway,myoblast fusion,regulation of cell shape,protein transport,actin filament-based movement,platelet formation,monocyte differentiation,actomyosin structure organization,actin cytoskeleton reorganization,uropod organization,blood vessel endothelial cell migration,leukocyte migration,establishment of meiotic spindle localization,platelet aggregation,negative regulation of actin filament severing,positive regulation of protein processing in phagocytic vesicle","microfilament motor activity,motor activity,actin binding,protein binding,calmodulin binding,ATP binding,ATPase activity,protein domain specific binding,actin-dependent ATPase activity,protein homodimerization activity,protein anchor,ADP binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,ruffle,uropod,nucleus,cytoplasm,spindle,actomyosin contractile ring,cytosol,plasma membrane,brush border,cell-cell adherens junction,actin cytoskeleton,membrane,myosin II complex,extracellular matrix,cell leading edge,neuromuscular junction,cleavage furrow,actomyosin,protein complex,extracellular exosome,myosin II filament,immunological synapse,focal adhesion,COP9 signalosome,integrin complex",768,244,485,DLGEELEALKTELEDTLDSTAAQQELR.4|DLGEELEALKTELEDTLDSTAAQQELR.3|QLLQANPILEAFGNAK.3|QLLQANPILEAFGNAK.2|IAQLEEQLDNETKER.3|IAQLEEQLDNETKER.2|LQQELDDLLVDLDHQR.3|LQQELDDLLVDLDHQR.2|ANLQIDQINTDLNLER.2|ANLQIDQINTDLNLER.3|VISGVLQLGNIVFKK.3|VISGVLQLGNIVFKK.2|ALELDSNLYR.2|IAQLEEELEEEQGNTELINDRLK.3|IAQLEEELEEEQGNTELINDRLK.4|IRELESQISELQEDLESERASR.4|MEDSVGC[CAM]LETAEEVKR.3|M[Oxi]EDSVGC[CAM]LETAEEVKR.3|QKHSQAVEELAEQLEQTKR.5|QKHSQAVEELAEQLEQTKR.3|QKHSQAVEELAEQLEQTKR.4|TRLQQELDDLLVDLDHQR.4|TRLQQELDDLLVDLDHQR.3|GDLPFVVPR.2|VSHLLGINVTDFTR.3|VSHLLGINVTDFTR.2|LKKLEEEQIILEDQNC[CAM]K.3|LKKLEEEQIILEDQNC[CAM]K.4|LKKLEEEQIILEDQNC[CAM]K.2|LQVELDNVTGLLSQSDSK.3|LQVELDNVTGLLSQSDSK.2|KLEEEQIILEDQNC[CAM]K.3|KLEEEQIILEDQNC[CAM]K.2|VEDMAELTC[CAM]LNEASVLHNLKER.4|HSQAVEELAEQLEQTKR.4|HSQAVEELAEQLEQTKR.3|HSQAVEELAEQLEQTKR.2|TLEEEAKTHEAQIQEMR.4|TLEEEAKTHEAQIQEMR.3|TLEEEAKTHEAQIQEM[Oxi]R.4|TLEEEAKTHEAQIQEM[Oxi]R.2|DFSALESQLQDTQELLQEENRQK.3|DFSALESQLQDTQELLQEENRQK.4|LDPHLVLDQLR.2|LDPHLVLDQLR.3|KANLQIDQINTDLNLER.3|KANLQIDQINTDLNLER.2|KANLQIDQINTDLNLER.4|LTKDFSALESQLQDTQELLQEENRQK.4|LTKDFSALESQLQDTQELLQEENRQK.3|IAEFTTNLTEEEEKSK.3|IAEFTTNLTEEEEKSK.2|ALEQQVEEMKTQLEELEDELQATEDAKLR.4|MQQNIQELEEQLEEEESAR.2|MQQNIQELEEQLEEEESAR.3|M[Oxi]QQNIQELEEQLEEEESAR.3|M[Oxi]QQNIQELEEQLEEEESAR.2|ALEEAMEQKAELER.3|ALEEAMEQKAELER.2|ALEEAM[Oxi]EQKAELER.3|ALEEAM[Oxi]EQKAELER.2|IMGIPEEEQMGLLR.2|IMGIPEEEQMGLLR.3|IM[Oxi]GIPEEEQMGLLR.2|IMGIPEEEQM[Oxi]GLLR.2|IM[Oxi]GIPEEEQM[Oxi]GLLR.2|IRELESQISELQEDLESER.3|IRELESQISELQEDLESER.4|IRELESQISELQEDLESER.2|IAQLEEELEEEQGNTELINDR.3|IAQLEEELEEEQGNTELINDR.4|AGKLDPHLVLDQLR.3|AGKLDPHLVLDQLR.2|ELEDATETADAMNREVSSLK.3|ELEDATETADAM[Oxi]NREVSSLK.3|LLEDRIAEFTTNLTEEEEKSK.4|LLEDRIAEFTTNLTEEEEKSK.3|IAQLEEELEEEQGNTELINDRLKK.4|IAQLEEELEEEQGNTELINDRLKK.3|FSKVEDMAELTC[CAM]LNEASVLHNLKER.5|FSKVEDMAELTC[CAM]LNEASVLHNLKER.4|AQTKEQADFAIEALAK.3|QLEEAEEEAQRANASR.3|KTLEEEAKTHEAQIQEMR.4|KTLEEEAKTHEAQIQEM[Oxi]R.4|KTLEEEAKTHEAQIQEMR.3|SMEAEMIQLQEELAAAER.3|SMEAEMIQLQEELAAAER.2|SM[Oxi]EAEMIQLQEELAAAER.3|SMEAEM[Oxi]IQLQEELAAAER.3|SM[Oxi]EAEMIQLQEELAAAER.2|SMEAEM[Oxi]IQLQEELAAAER.2|KAGKLDPHLVLDQLR.4|KAGKLDPHLVLDQLR.3|KAGKLDPHLVLDQLR.2|VIQYLAYVASSHK.3|VIQYLAYVASSHK.2|RKLEGDSTDLSDQIAELQAQIAELK.4|RKLEGDSTDLSDQIAELQAQIAELK.3|KVIQYLAYVASSHK.3|KVIQYLAYVASSHK.4|ELESQISELQEDLESER.2|ELESQISELQEDLESER.3|YEILTPNSIPK.2|NLPIYSEEIVEMYKGK.3|KVEAQLQELQVK.3|KVEAQLQELQVK.2|IIGLDQVAGMSETALPGAFK.3|IIGLDQVAGMSETALPGAFK.2|IIGLDQVAGM[Oxi]SETALPGAFK.3|IIGLDQVAGM[Oxi]SETALPGAFK.2|ALEQQVEEMKTQLEELEDELQATEDAK.4|ALEQQVEEMKTQLEELEDELQATEDAK.3|ALEQQVEEM[Oxi]KTQLEELEDELQATEDAK.3|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.4|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.3|LTKDFSALESQLQDTQELLQEENR.3|LTKDFSALESQLQDTQELLQEENR.4|KMEDSVGC[CAM]LETAEEVKR.4|KM[Oxi]EDSVGC[CAM]LETAEEVKR.3|KM[Oxi]EDSVGC[CAM]LETAEEVKR.4|KMEDSVGC[CAM]LETAEEVKR.3|KMEDSVGC[CAM]LETAEEVKR.2|HSQAVEELAEQLEQTK.3|HSQAVEELAEQLEQTK.2|ELEDATETADAMNR.2|ELEDATETADAMNR.3|ELEDATETADAM[Oxi]NR.2|KLEGDSTDLSDQIAELQAQIAELK.3|KLEGDSTDLSDQIAELQAQIAELK.4|VEAQLQELQVK.2|VEAQLQELQVK.3|VISGVLQLGNIVFK.2|VISGVLQLGNIVFK.3|RQLEEAEEEAQRANASR.4|RQLEEAEEEAQRANASR.3|SMMQDREDQSILC[CAM]TGESGAGKTENTK.4|SMM[Oxi]QDREDQSILC[CAM]TGESGAGKTENTK.4|SMMQDREDQSILC[CAM]TGESGAGKTENTK.3|FLSNGHVTIPGQQDKDMFQETMEAMR.4|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAM[Oxi]R.4|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAMR.4|FLSNGHVTIPGQQDKDMFQETM[Oxi]EAMR.4|FLSNGHVTIPGQQDKDMFQETMEAM[Oxi]R.4|FLSNGHVTIPGQQDKDMFQETMEAMR.3|QIATLHAQVADMK.3|QIATLHAQVADMK.2|QIATLHAQVADM[Oxi]K.3|QIATLHAQVADM[Oxi]K.2|KMQQNIQELEEQLEEEESAR.3|KM[Oxi]QQNIQELEEQLEEEESAR.3|KMQQNIQELEEQLEEEESAR.4|DQGELERQLLQANPILEAFGNAK.3|IAEFTTNLTEEEEK.2|IAEFTTNLTEEEEK.3|KLEEEQIILEDQNC[CAM]KLAK.3|LQRELEDATETADAMNR.3|LQRELEDATETADAMNR.4|EMEAELEDER.2|EM[Oxi]EAELEDER.2|QGFPNRVVFQEFR.3|AGVLAHLEEERDLKITDVIIGFQAC[CAM]C[CAM]R.4|NLPIYSEEIVEMYK.2|NLPIYSEEIVEMYK.3|NLPIYSEEIVEM[Oxi]YK.2|MQQNIQELEEQLEEEESARQK.3|MQQNIQELEEQLEEEESARQK.4|M[Oxi]QQNIQELEEQLEEEESARQK.3|DVDRIIGLDQVAGMSETALPGAFK.3|DVDRIIGLDQVAGMSETALPGAFK.4|DVDRIIGLDQVAGM[Oxi]SETALPGAFK.3|KFDQLLAEEKTISAK.4|KFDQLLAEEKTISAK.3|KFDQLLAEEKTISAK.2|KQELEEIC[CAM]HDLEAR.3|KQELEEIC[CAM]HDLEAR.4|KQELEEIC[CAM]HDLEAR.2|LKDVLLQVDDERR.4|LKDVLLQVDDERR.3|LKDVLLQVDDERR.2|NFINNPLAQADWAAK.2|NFINNPLAQADWAAK.3|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.5|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.5|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.4|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.4|QTLENERGELANEVK.3|QTLENERGELANEVK.2|KKVEAQLQELQVK.3|KKVEAQLQELQVK.2|KFDQLLAEEK.3|KFDQLLAEEK.2|LTEMETLQSQLMAEK.2|LTEMETLQSQLMAEK.3|LTEM[Oxi]ETLQSQLMAEK.3|LTEM[Oxi]ETLQSQLMAEK.2|LTEMETLQSQLM[Oxi]AEK.2|ASREEILAQAK.3|ASREEILAQAK.2|DLEAHIDSANK.3|DLEAHIDSANK.2|NKHEAM[Oxi]ITDLEER.4|NKHEAMITDLEER.3|NKHEAM[Oxi]ITDLEER.3|NKHEAM[Oxi]ITDLEER.2|NKHEAMITDLEER.2|QLAAENR.2|TDLLLEPYNK.3|TDLLLEPYNK.2|RHEMPPHIYAITDTAYR.5|RHEM[Oxi]PPHIYAITDTAYR.4|RHEMPPHIYAITDTAYR.4|RHEM[Oxi]PPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.2|THEAQIQEMR.3|THEAQIQEM[Oxi]R.3|THEAQIQEMR.2|THEAQIQEM[Oxi]R.2|TLEEEAK.2|GALALEEK.2|QVEDEKNSFR.3|QVEDEKNSFR.2|REQEVNILKK.3|SVHELEK.2|VKLQEMEGTVK.3|VKLQEM[Oxi]EGTVK.3|VKLQEMEGTVK.2|VKLQEM[Oxi]EGTVK.2|VRTELADKVTK.3|DQGELER.2|ASREEILAQAKENEK.4|ASREEILAQAKENEK.3|GELANEVK.2|NAEQYKDQADKASTR.4|NAEQYKDQADKASTR.3|DC[CAM]MRELDDTR.3|KLEMDLK.2|LRLEVNLQAM[Oxi]K.3|LRLEVNLQAMK.3|LRLEVNLQAMK.2|LRLEVNLQAM[Oxi]K.2|NAEQYKDQADK.3|NAEQYKDQADK.2|DELADEIANSSGK.3|DELADEIANSSGK.2|HEAMITDLEER.3|HEAM[Oxi]ITDLEER.3|HEAMITDLEER.2|HEAM[Oxi]ITDLEER.2|QLEEAEEEAQR.3|QLEEAEEEAQR.2|SKREQEVNILK.3|ASITALEAK.2|DVLLQVDDERR.3|DVLLQVDDERR.2|FVSELWK.2|KGAGDGSDEEVDGK.3|LKNKHEAMITDLEER.4|LKNKHEAM[Oxi]ITDLEER.4|LKNKHEAM[Oxi]ITDLEER.3|LKNKHEAMITDLEER.3|LKNKHEAMITDLEER.2|RALEQQVEEMK.3|RALEQQVEEM[Oxi]K.3|RALEQQVEEMK.2|RALEQQVEEM[Oxi]K.2|VEEEAAQK.2|DLEGLSQR.2|EM[Oxi]EAELEDERK.3|EMEAELEDERK.3|EMEAELEDERK.2|EM[Oxi]EAELEDERK.2|EQLEEEEEAKHNLEK.4|EQLEEEEEAKHNLEK.3|EQLEEEEEAKHNLEK.2|TVGQLYKEQLAK.3|TVGQLYKEQLAK.2|VVFQEFR.2|LVWVPSDK.2|SGFEPASLK.2|SKYKASITALEAK.3|KTLEEEAK.2|LRRGDLPFVVPR.3|QSAC[CAM]NLEK.2|ADGAEAKPAE.2|AKQTLENERGELANEVK.4|AKQTLENERGELANEVK.3|DLQGRDEQSEEK.3|DLQGRDEQSEEK.2|HEM[Oxi]PPHIYAITDTAYR.4|HEMPPHIYAITDTAYR.4|HEMPPHIYAITDTAYR.3|HEM[Oxi]PPHIYAITDTAYR.3|HEMPPHIYAITDTAYR.2|LKDVLLQVDDER.3|LKDVLLQVDDER.2|QAC[CAM]VLMIK.2|QAC[CAM]VLM[Oxi]IK.2|VNKDDIQK.2|EQEVNILK.2|KDQGELER.2|RNAEQYKDQADK.3|VLLQGKGDSEHKR.3|VLLQGKGDSEHKR.2|DLEAHIDSANKNR.3|GALALEEKR.2|LKQVEDEK.2|RQLEEAEEEAQR.3|RQLEEAEEEAQR.2|YRFLSNGHVTIPGQQDK.4|YRFLSNGHVTIPGQQDK.3|KKLEMDLK.2|LKQVEDEKNSFR.3|LKQVEDEKNSFR.2|QLEEAEEEAQRANASRR.4|TELADKVTK.2|TFHIFYYLLSGAGEHLK.4|TFHIFYYLLSGAGEHLK.3|TFHIFYYLLSGAGEHLK.2|C[CAM]QHLQAEK.2|TDLLLEPYNKYR.3|TDLLLEPYNKYR.2|IAQLEEQLDNETK.3|IAQLEEQLDNETK.2|ALEEAMEQK.2|ALEEAM[Oxi]EQK.2|KLEMDLKDLEAHIDSANK.4|KLKDVLLQVDDER.3|LEVNLQAMK.2|LEVNLQAM[Oxi]K.2|LQEMEGTVK.2|LQEM[Oxi]EGTVK.2|QAQQERDELADEIANSSGK.4|QAQQERDELADEIANSSGK.3|QAQQERDELADEIANSSGK.2|QIATLHAQVADM[Oxi]KK.3|QIATLHAQVADMKK.3|QIATLHAQVADMKK.2|QKHSQAVEELAEQLEQTK.4|QKHSQAVEELAEQLEQTK.3|QKHSQAVEELAEQLEQTK.2|QRYEILTPNSIPK.3|QRYEILTPNSIPK.2|VAAYDKLEK.2|VKPLLQVSR.2|FDQLLAEEKTISAK.3|QFRTEMEDLMSSKDDVGK.4|QFRTEMEDLMSSKDDVGK.3|KLVWVPSDK.2|KVEAQLQELQVKFNEGER.4|QFRTEMEDLMSSK.3|TENTKKVIQYLAYVASSHK.4|EQEVNILKK.2|FLSNGHVTIPGQQDK.3|FLSNGHVTIPGQQDK.2|KRHEMPPHIYAITDTAYR.4|KRHEM[Oxi]PPHIYAITDTAYR.4|KRHEMPPHIYAITDTAYR.3|QELEEIC[CAM]HDLEAR.3|QELEEIC[CAM]HDLEAR.2|REQEVNILK.2|RQAQQERDELADEIANSSGK.4|RQAQQERDELADEIANSSGK.3|TEM[Oxi]EDLMSSKDDVGK.3|TEMEDLM[Oxi]SSKDDVGK.3|TEMEDLMSSKDDVGK.3|TEM[Oxi]EDLM[Oxi]SSKDDVGK.3|TEMEDLMSSKDDVGK.2|C[CAM]IIPNHEKK.2|QEEEMMAKEEELVK.3|QEEEM[Oxi]MAKEEELVK.3|QEEEMM[Oxi]AKEEELVK.3|QEEEMMAKEEELVK.2|KGAGDGSDEEVDGKADGAEAKPAE.4|KGAGDGSDEEVDGKADGAEAKPAE.3|NSFREQLEEEEEAK.3|NSFREQLEEEEEAK.2|RGDLPFVVPR.2|VMQEQGTHPK.2|VM[Oxi]QEQGTHPK.2|EEVGEEAIVELVENGK.3|EEVGEEAIVELVENGK.2|LEEEQIILEDQNC[CAM]K.3|LEEEQIILEDQNC[CAM]K.2|TEMEDLMSSK.2|TEM[Oxi]EDLMSSK.2|TEMEDLM[Oxi]SSK.2|TEM[Oxi]EDLM[Oxi]SSK.2|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.6|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.5|NSFREQLEEEEEAKHNLEK.4|VKVNKDDIQK.2|NFINNPLAQADWAAKK.3|YKASITALEAK.2|ALEQQVEEMK.2|ALEQQVEEM[Oxi]K.2|DVLLQVDDER.2|KIRELESQISELQEDLESER.4|KIRELESQISELQEDLESER.3|KM[Oxi]EDSVGC[CAM]LETAEEVK.3|KMEDSVGC[CAM]LETAEEVK.3|KMEDSVGC[CAM]LETAEEVK.2|KM[Oxi]EDSVGC[CAM]LETAEEVK.2|TKTRLQQELDDLLVDLDHQR.4|DFSALESQLQDTQELLQEENR.4|DFSALESQLQDTQELLQEENR.3|EQLEEEEEAK.2|GAGDGSDEEVDGK.2|LEGDSTDLSDQIAELQAQIAELK.4|LEGDSTDLSDQIAELQAQIAELK.3|EEVGEEAIVELVENGKK.3|EEVGEEAIVELVENGKK.2|GAGDGSDEEVDGKADGAEAK.3|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.5|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|DLKITDVIIGFQAC[CAM]C[CAM]R.3|VEEEEERC[CAM]QHLQAEK.3|LQKDLEGLSQR.2|TELEDTLDSTAAQQELR.3|TELEDTLDSTAAQQELR.2|ELDDTRASREEILAQAK.3|EQADFAIEALAK.2|KKMEDSVGC[CAM]LETAEEVK.3|KKM[Oxi]EDSVGC[CAM]LETAEEVK.3|KKM[Oxi]QQNIQELEEQLEEEESAR.4|KKM[Oxi]QQNIQELEEQLEEEESAR.3|LQRELEDATETADAMNREVSSLK.4|LQRELEDATETADAMNREVSSLK.3|VLLQGKGDSEHK.2|KQELEEIC[CAM]HDLEARVEEEEER.4|ASITALEAKIAQLEEQLDNETKER.4|KDQGELERQLLQANPILEAFGNAK.4|DLEAHIDSANKNRDEAIK.3|KMQQNIQELEEQLEEEESARQK.4|KMQQNIQELEEQLEEEESARQK.3|AQFERDLQGRDEQSEEK.3|DMFQETMEAMR.2|DMFQETM[Oxi]EAMR.2|DMFQETMEAM[Oxi]R.2|LEEEQIILEDQNC[CAM]KLAK.3|TVGQLYKEQLAKLMATLR.3|DVLLQVDDERRNAEQYK.3|PAGPPGILALLDEEC[CAM]WFPK.3|PAGPPGILALLDEEC[CAM]WFPK.2|SGFEPASLKEEVGEEAIVELVENGKK.4|SGFEPASLKEEVGEEAIVELVENGKK.3|KEEELQAALARVEEEAAQK.3|NM[Oxi]DPLNDNIATLLHQSSDK.3|NMDPLNDNIATLLHQSSDK.3|NM[Oxi]DPLNDNIATLLHQSSDK.2|NMDPLNDNIATLLHQSSDK.2|DLEGLSQRHEEK.2|GAGDGSDEEVDGKADGAEAKPAE.3|GAGDGSDEEVDGKADGAEAKPAE.2|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.3|QAQQERDELADEIANSSGKGALALEEK.4|QAQQERDELADEIANSSGKGALALEEK.3|TELADKVTKLQVELDNVTGLLSQSDSK.4|TELADKVTKLQVELDNVTGLLSQSDSK.3|NMDPLNDNIATLLHQSSDKFVSELWK.4|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWK.4|NMDPLNDNIATLLHQSSDKFVSELWK.3|LKSMEAEMIQLQEELAAAER.3|SMMQDREDQSILC[CAM]TGESGAGK.3|SM[Oxi]MQDREDQSILC[CAM]TGESGAGK.3|SMM[Oxi]QDREDQSILC[CAM]TGESGAGK.3|SMMQDREDQSILC[CAM]TGESGAGK.2|ITDVIIGFQAC[CAM]C[CAM]R.2|ELESQISELQEDLESERASR.3|INFDVNGYIVGANIETYLLEK.3|INFDVNGYIVGANIETYLLEK.2|RDLGEELEALKTELEDTLDSTAAQQELR.4|RDLGEELEALKTELEDTLDSTAAQQELR.3|YLYVDKNFINNPLAQADWAAK.3|RALEQQVEEMKTQLEELEDELQATEDAK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.3|LQLQEQLQAETELC[CAM]AEAEELR.3|MEDSVGC[CAM]LETAEEVK.2|M[Oxi]EDSVGC[CAM]LETAEEVK.2|QLAAENRLTEMETLQSQLMAEK.3|SGFEPASLKEEVGEEAIVELVENGK.3|LQLQEQLQAETELC[CAM]AEAEELRAR.3
SEN / CTL,P17066,Heat shock 70 kDa protein 6,HSPA6,1.76,1.54,2.21E-03,2.09E-04,3.68E+00,"response to unfolded protein,cellular response to heat,protein refolding,cellular heat acclimation","ATP binding,enzyme binding,heat shock protein binding,ATPase activity, coupled,unfolded protein binding","cytoplasm,centriole,cytosol,extracellular exosome,blood microparticle,COP9 signalosome",12,2,3,VEILANDQGNRTTPSYVAFTDTER.3|VEILANDQGNR.2|VEILANDQGNR.3
SEN / CTL,Q08380,Galectin-3-binding protein,LGALS3BP,1.76,1.79,1.32E-11,3.44E-12,1.15E+01,"platelet degranulation,receptor-mediated endocytosis,cellular defense response,cell adhesion,signal transduction",scavenger receptor activity,"extracellular region,proteinaceous extracellular matrix,extracellular space,membrane,platelet dense granule lumen,extracellular exosome,blood microparticle,extracellular matrix",66,23,30,GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3|SDLAVPSELALLK.2|LADGGATNQGRVEIFYR.3|YSSDYFQAPSDYR.2|IYTSPTWSAFVTDSSWSAR.2|IYTSPTWSAFVTDSSWSAR.3|ELSEALGQIFDSQR.2|ELSEALGQIFDSQR.3|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.3|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.4|TLQALEFHTVPFQLLAR.3|TLQALEFHTVPFQLLAR.2|IDITLSSVK.2|TIAYENK.2|ASHEEVEGLVEK.3|ASHEEVEGLVEK.2|SQLVYQSR.2|STHTLDLSR.2|KTLQALEFHTVPFQLLAR.4|KTLQALEFHTVPFQLLAR.3|LADGGATNQGR.2|KSQLVYQSR.2|RIDITLSSVK.2|STSSFPC[CAM]PAGHFNGFR.3|STSSFPC[CAM]PAGHFNGFR.2|AVDTWSWGER.2|STHTLDLSRELSEALGQIFDSQR.4|YYPYQSFQTPQHPSFLFQDKR.4|IYTSPTWSAFVTDSSWSARK.3|YYPYQSFQTPQHPSFLFQDK.3
SEN / CTL,P61916,Epididymal secretory protein E1,NPC2,1.76,1.04,9.45E-03,8.19E-04,3.09E+00,"cholesterol metabolic process,response to virus,phospholipid transport,regulation of isoprenoid metabolic process,cholesterol transport,intracellular sterol transport,intracellular cholesterol transport,cholesterol efflux,cholesterol homeostasis,glycolipid transport","protein binding,cholesterol binding,enzyme binding","lysosome,endoplasmic reticulum,extracellular exosome",6,12,19,AVVHGILMGVPVPFPIPEPDGC[CAM]K.3|AVVHGILMGVPVPFPIPEPDGC[CAM]K.4|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.4|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.3|LPVKSEYPSIK.3|TYSYLNK.2|SGINC[CAM]PIQK.2|DKTYSYLNKLPVK.3|DC[CAM]GSVDGVIK.2|DKTYSYLNK.2|EVNVSPC[CAM]PTQPC[CAM]QLSK.3|EVNVSPC[CAM]PTQPC[CAM]QLSK.2|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.5|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|LVVEWQLQDDK.2|NQSLFC[CAM]WEIPVQIVSHL.3|NQSLFC[CAM]WEIPVQIVSHL.2|DC[CAM]GSVDGVIKEVNVSPC[CAM]PTQPC[CAM]QLSK.3
SEN / CTL,Q6NYC8,Phostensin,PPP1R18,1.75,1.01,8.60E-03,7.48E-04,3.13E+00,,"actin binding,protein binding,phosphatase binding","cytoplasm,cytoskeleton",6,16,16,ETAELSETLTR.2|LGLTEAHK.2|QSPGEVGDR.2|SEELLAER.2|RLGIGGAQELSLRPLEAR.4|LSPGETPER.2|LSPGESAYQK.2|LGIGGAQELSLRPLEAR.3|RYPTAEEILVLGGYLR.3|DIEAQTQKPEPPESAEK.3|KRYPTAEEILVLGGYLR.3|LLESPGVEAGEGEAEKEEAGAQGRPLR.4|EAQGNSSAGVEAAEQRPVEDGER.3|LLESPGVEAGEGEAEK.2|ESQEQSLVQLEATEWR.2|LGLSPGEPSPVLGTVEAGPPDPDESAVLLEAIGPVHQNR.4
SEN / CTL,P05388,60S acidic ribosomal protein P0,RPLP0,1.75,1.82,1.77E-06,2.57E-07,6.59E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,lactation,response to selenium ion,viral transcription,cellular response to cAMP,cellular response to interleukin-4,cellular response to Thyroid stimulating hormone,cellular response to phorbol 13-acetate 12-myristate","structural constituent of ribosome,protein binding,peptide binding,poly(A) RNA binding,large ribosomal subunit rRNA binding","nucleus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,dendrite,intracellular ribonucleoprotein complex,preribosome, large subunit precursor,cytoplasmic ribonucleoprotein granule,extracellular exosome",36,26,48,IIQLLDDYPK.2|TSFFQALGITTK.2|TSFFQALGITTK.3|AGAIAPC[CAM]EVTVPAQNTGLGPEK.3|AGAIAPC[CAM]EVTVPAQNTGLGPEK.2|AGAIAPC[CAM]EVTVPAQNTGLGPEK.4|GTIEILSDVQLIK.2|GTIEILSDVQLIK.3|VLALSVETDYTFPLAEKVK.3|VLALSVETDYTFPLAEKVK.2|DMLLANK.2|DM[Oxi]LLANK.2|GHLENNPALEK.3|GHLENNPALEK.2|EDLTEIR.2|DMLLANKVPAAAR.3|DM[Oxi]LLANKVPAAAR.3|DMLLANKVPAAAR.2|GNVGFVFTK.2|AIRGHLENNPALEK.3|AFLADPSAFVAAAPVAAATTAAPAAAAAPAK.5|AFLADPSAFVAAAPVAAATTAAPAAAAAPAK.4|AFLADPSAFVAAAPVAAATTAAPAAAAAPAK.3|EDLTEIRDMLLANK.3|EDLTEIRDMLLANK.2|EDLTEIRDMLLANKVPAAAR.4|EDLTEIRDMLLANKVPAAAR.3|ISRGTIEILSDVQLIK.3|GNVGFVFTKEDLTEIR.3|GNVGFVFTKEDLTEIR.2|AFLADPSAFVAAAPVAAATTAAPAAAAAPAKVEAK.5|AFLADPSAFVAAAPVAAATTAAPAAAAAPAKVEAK.4|AFLADPSAFVAAAPVAAATTAAPAAAAAPAKVEAK.3|C[CAM]FIVGADNVGSK.2|VLALSVETDYTFPLAEK.3|VLALSVETDYTFPLAEK.2|GNVGFVFTKEDLTEIRDMLLANK.4|GNVGFVFTKEDLTEIRDM[Oxi]LLANK.4|GNVGFVFTKEDLTEIRDMLLANK.3|RVLALSVETDYTFPLAEK.3|RVLALSVETDYTFPLAEK.2|NVASVC[CAM]LQIGYPTVASVPHSIINGYK.4|NVASVC[CAM]LQIGYPTVASVPHSIINGYK.3|NVASVC[CAM]LQIGYPTVASVPHSIINGYKR.4|NVASVC[CAM]LQIGYPTVASVPHSIINGYKR.3|VKAFLADPSAFVAAAPVAAATTAAPAAAAAPAKVEAK.4|AGAIAPC[CAM]EVTVPAQNTGLGPEKTSFFQALGITTK.4|VKAFLADPSAFVAAAPVAAATTAAPAAAAAPAK.3
SEN / CTL,P20908,Collagen alpha-1(V) chain,COL5A1,1.74,0.78,3.62E-22,2.51E-22,2.16E+01,"blood vessel development,heart morphogenesis,cell adhesion,cell migration,extracellular matrix organization,collagen fibril organization,collagen catabolic process,collagen biosynthetic process,wound healing, spreading of epidermal cells,tendon development,extracellular fibril organization,skin development,integrin biosynthetic process,eye morphogenesis,regulation of cellular component organization,negative regulation of endodermal cell differentiation","integrin binding,extracellular matrix structural constituent,heparin binding,proteoglycan binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type V trimer,basement membrane,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",54,15,18,FGGGGDAGSKGPM[Oxi]VSAQESQAQAILQQAR.3|SPVFLYEDHTGKPGPEDYPLFR.4|FLGSNDEEMSYDNNPYIR.2|VLDFHNLPDGITK.3|VLDFHNLPDGITK.2|QLYPASAFPEDFSILTTVK.2|TVLEIDTPKVEQVPIVDIMFNDFGEASQK.3|LLSYVDAEGNPVGVVQMTFLR.3|LLSYVDAEGNPVGVVQMTFLR.2|DLQLC[CAM]HPDFPDGEYWVDPNQGC[CAM]SR.3|RPLGTQQNPAR.3|DAQLSAPTK.2|GPAGPMGLTGR.2|TGPIGPQGAPGKPGPDGLR.3|GHPGPPGPPGEQGLPGLAGK.3|FGFEVGPAC[CAM]FMG.2|GPMVSAQESQAQAILQQAR.3|GPMVSAQESQAQAILQQAR.2
SEN / CTL,P06748,Nucleophosmin,NPM1,1.74,1.49,7.61E-12,2.01E-12,1.17E+01,"DNA repair,nucleosome assembly,intracellular protein transport,nucleocytoplasmic transport,response to stress,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,centrosome cycle,signal transduction,cell aging,protein localization,positive regulation of cell proliferation,negative regulation of cell proliferation,negative regulation of centrosome duplication,viral process,regulation of endodeoxyribonuclease activity,CENP-A containing nucleosome assembly,ribosome assembly,negative regulation of apoptotic process,positive regulation of catalytic activity,regulation of neuron apoptotic process,negative regulation of protein kinase activity by regulation of protein phosphorylation,positive regulation of translation,positive regulation of DNA replication,positive regulation of transcription, DNA-templated,regulation of centriole replication,positive regulation of NF-kappaB transcription factor activity,protein oligomerization,protein homooligomerization,regulation of endoribonuclease activity,regulation of eIF2 alpha phosphorylation by dsRNA,positive regulation of cell cycle G2/M phase transition","DNA binding,transcription coactivator activity,RNA binding,protein kinase inhibitor activity,protein binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,Tat protein binding,histone binding,protein homodimerization activity,ribosomal large subunit binding,ribosomal small subunit binding,poly(A) RNA binding,protein heterodimerization activity,NF-kappaB binding,unfolded protein binding","nucleus,nucleoplasm,nucleolus,cytoplasm,centrosome,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,spindle pole centrosome",60,26,61,MSVQPTVSLGGFEITPPVVLR.3|MSVQPTVSLGGFEITPPVVLR.2|M[Oxi]SVQPTVSLGGFEITPPVVLR.2|MSVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.3|MTDQEAIQDLWQWRK.3|M[Oxi]TDQEAIQDLWQWRK.3|MTDQEAIQDLWQWRK.2|MTDQEAIQDLWQWR.3|MTDQEAIQDLWQWR.2|M[Oxi]TDQEAIQDLWQWR.3|M[Oxi]TDQEAIQDLWQWR.2|ADKDYHFKVDNDENEHQLSLR.5|ADKDYHFKVDNDENEHQLSLR.4|ADKDYHFKVDNDENEHQLSLR.6|ADKDYHFKVDNDENEHQLSLR.3|TVSLGAGAKDELHIVEAEAMNYEGSPIK.4|TVSLGAGAKDELHIVEAEAMNYEGSPIK.5|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.3|TVSLGAGAKDELHIVEAEAMNYEGSPIK.3|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.4|MQASIEK.2|M[Oxi]QASIEK.2|SNQNGKDSKPSSTPR.4|SNQNGKDSKPSSTPR.2|SAPGGGSKVPQKK.3|SAPGGGSKVPQKK.2|TPKGPSSVEDIK.3|RSAPGGGSKVPQK.3|SIRDTPAK.2|MQASIEKGGSLPK.3|DYHFKVDNDENEHQLSLR.5|DYHFKVDNDENEHQLSLR.4|DYHFKVDNDENEHQLSLR.3|DYHFKVDNDENEHQLSLR.2|FINYVKNC[CAM]FR.3|GPSSVEDIK.2|DSKPSSTPR.2|TPKGPSSVEDIKAK.3|TPKGPSSVEDIKAK.2|ADKDYHFK.2|VDNDENEHQLSLR.3|VDNDENEHQLSLR.2|DELHIVEAEAMNYEGSPIK.4|DELHIVEAEAM[Oxi]NYEGSPIK.3|DELHIVEAEAMNYEGSPIK.3|DELHIVEAEAM[Oxi]NYEGSPIK.2|DELHIVEAEAMNYEGSPIK.2|SAPGGGSKVPQK.2|GPSSVEDIKAK.2|NAQKSNQNGKDSKPSSTPR.3|PQNYLFGC[CAM]ELK.2|DELHIVEAEAMNYEGSPIKVTLATLK.4|DELHIVEAEAMNYEGSPIKVTLATLK.3
SEN / CTL,P14543,Nidogen-1,NID1,1.74,1.74,8.52E-11,2.00E-11,1.07E+01,"cell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix disassembly,extracellular matrix organization,glomerular basement membrane development,basement membrane organization","calcium ion binding,collagen binding,laminin binding,laminin-1 binding,proteoglycan binding","extracellular region,basement membrane,basal lamina,extracellular matrix,extracellular exosome,cell periphery",108,38,50,VLFETDLVNPR.2|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.4|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.5|VYYREDLSPSITQR.3|RVLFETDLVNPR.3|RVLFETDLVNPR.2|KALEGLQYPFAVTSYGK.3|KALEGLQYPFAVTSYGK.2|ALEGLQYPFAVTSYGK.2|ALEGLQYPFAVTSYGK.3|NIFWTDSNLDRIEVAK.3|NIFWTDSNLDRIEVAK.2|LYGITTALSQC[CAM]PQGHNYC[CAM]SVNNGGC[CAM]THLC[CAM]LATPGSR.4|GFPEISFQPSSAVVVTWESVAPYQGPSRDPDQK.4|MVYWTDITEPSIGR.2|M[Oxi]VYWTDITEPSIGR.2|VIIGLAFDC[CAM]VDK.2|QAEVTFVGHPGNLVIK.3|QAEVTFVGHPGNLVIK.2|QDLGSPEGIAVDHLGR.3|QDLGSPEGIAVDHLGR.2|IFVGSSQVPIVFENTDLHSYVVMNHGR.4|IFVGSSQVPIVFENTDLHSYVVM[Oxi]NHGR.4|GIVTDSVR.2|HQC[CAM]SVHAEC[CAM]R.3|ASLHGGEPTTIIR.3|ASLHGGEPTTIIR.2|ETDAFQPHK.2|RGGADTYSVPSVLSPR.3|EYTVTEPER.2|QC[CAM]VAEGSPQR.2|GNLYWTDWNRDNPK.3|GNLYWTDWNRDNPK.2|YALSNSIGPVR.2|EYTVTEPERDGASPSR.3|AEC[CAM]LNPSQPSR.2|IETSYMDGTNR.2|NGFSITGGEFTR.2|MNSVVALDLAISK.2|M[Oxi]NSVVALDLAISK.2|NIFWTDSNLDR.2|FSGIDEHGHLTIDTELEGR.3|SNGAYNIFANDRESVENLAK.3|TQFTC[CAM]EC[CAM]SIGFR.2|EGSPDALQNPC[CAM]YIGTHGC[CAM]DTNAAC[CAM]RPGPR.4|KENNQVPAVVAFSQGSVGFLWK.3|C[CAM]PDNTLGVDC[CAM]IEQK.2|VPQIPFGSSVHIEPYTELYHYSTSVITSSSTR.4|ESHPGLFPPTFGAVAPFLADLDTTDGLGK.3|QELFPFGPGQGDLELEDGDDFVSPALELSGALR.3
SEN / CTL,P26599,Polypyrimidine tract-binding protein 1,PTBP1,1.73,1.75,8.31E-03,7.23E-04,3.14E+00,"alternative mRNA splicing, via spliceosome,regulation of alternative mRNA splicing, via spliceosome,mRNA splicing, via spliceosome,mRNA processing,RNA splicing,fibroblast growth factor receptor signaling pathway,gene expression,negative regulation of RNA splicing,negative regulation of mRNA splicing, via spliceosome,negative regulation of muscle cell differentiation,IRES-dependent viral translational initiation","nucleotide binding,RNA binding,protein binding,poly-pyrimidine tract binding,pre-mRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,membrane,extracellular exosome",12,35,87,KLPIDVTEGEVISLGLPFGK.3|KLPIDVTEGEVISLGLPFGK.4|KLPIDVTEGEVISLGLPFGK.2|LSLDGQNIYNAC[CAM]C[CAM]TLR.2|LSLDGQNIYNAC[CAM]C[CAM]TLR.3|ELKTDSSPNQAR.3|ELKTDSSPNQAR.2|GQPIYIQFSNHKELK.4|VTNLLMLK.2|VTNLLM[Oxi]LK.2|GQPIYIQFSNHK.3|GQPIYIQFSNHK.2|TDSSPNQAR.2|HQNVQLPR.2|ENALVQMADGNQAQLAMSHLNGHK.5|ENALVQMADGNQAQLAMSHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.4|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.3|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.3|ENALVQMADGNQAQLAMSHLNGHK.3|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.3|HQNVQLPREGQEDQGLTK.4|HQNVQLPREGQEDQGLTK.3|DYGNSPLHR.2|EGQEDQGLTKDYGNSPLHR.4|EGQEDQGLTKDYGNSPLHR.3|KENALVQMADGNQAQLAM[Oxi]SHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.4|EGQEDQGLTK.2|VLFSSNGGVVK.2|NNQFQALLQYADPVSAQHAK.4|NNQFQALLQYADPVSAQHAK.3|NNQFQALLQYADPVSAQHAK.2|IAIPGLAGAGNSVLLVSNLNPER.4|IAIPGLAGAGNSVLLVSNLNPER.3|IAIPGLAGAGNSVLLVSNLNPER.2|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.3|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.6|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAM[Oxi]AGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.4|HQNVQLPREGQEDQGLTKDYGNSPLHR.5|LPIDVTEGEVISLGLPFGK.3|LPIDVTEGEVISLGLPFGK.2|IDFSKLTSLNVK.2|VTPQSLFILFGVYGDVQR.3|VTPQSLFILFGVYGDVQR.2|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NFQNIFPPSATLHLSNIPPSVSEEDLK.4|NFQNIFPPSATLHLSNIPPSVSEEDLK.3|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|SRDYTRPDLPSGDSQPSLDQTM[Oxi]AAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NQAFIEMNTEEAANTMVNYYTSVTPVLR.4|NQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|NQAFIEMNTEEAANTMVNYYTSVTPVLR.3|IIVENLFYPVTLDVLHQIFSK.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.4|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.4|GKNQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.4|GQPIYIQFSNHKELKTDSSPNQAR.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.3
SEN / CTL,Q9BRK5,45 kDa calcium-binding protein,SDF4,1.73,1.24,6.34E-08,1.07E-08,7.97E+00,"UV protection,calcium ion regulated exocytosis,cerebellum development,fat cell differentiation,response to ethanol,zymogen granule exocytosis","calcium ion binding,identical protein binding","cytoplasm,late endosome,Golgi apparatus,Golgi lumen,membrane,bleb,extracellular exosome,plasma membrane",24,20,30,WYQADSPPADLLLTEEEFLSFLHPEHSR.4|DLGGFDEDAEPR.2|LNEELKVDEETQEVLENLKDR.4|LNEELKVDEETQEVLENLKDR.3|AVDPDGDGHVSWDEYK.3|AVDPDGDGHVSWDEYK.2|GHSEKEVADAIR.3|GHSEKEVADAIR.2|VDVNTDRK.2|DLGGFDEDAEPRR.3|DLGGFDEDAEPRR.2|TAEHFQEAMEESK.3|TAEHFQEAM[Oxi]EESK.3|TAEHFQEAMEESK.2|VANREENEILPPDHLNGVK.4|VANREENEILPPDHLNGVK.3|VANREENEILPPDHLNGVKLEMDGHLNR.6|YSEFFTGSK.2|LEMDGHLNR.2|EENEILPPDHLNGVK.3|GFHQEVFLGK.2|VDEETQEVLENLKDR.3|QM[Oxi]IAVADENQNHHLEPEEVLK.4|QMIAVADENQNHHLEPEEVLK.4|QMIAVADENQNHHLEPEEVLK.3|EIVRDLDQDGDK.2|DRWYQADSPPADLLLTEEEFLSFLHPEHSR.5|DRWYQADSPPADLLLTEEEFLSFLHPEHSR.4|LNEELKVDEETQEVLENLK.3|VDEETQEVLENLK.2
SEN / CTL,Q6S8J3,POTE ankyrin domain family member E,POTEE,1.72,1.37,4.02E-13,1.21E-13,1.29E+01,"retina homeostasis,substantia nigra development",molecular_function,"extracellular space,extracellular exosome,blood microparticle",48,7,15,LC[CAM]YVALDFEQEMATAASSSSLEK.3|LC[CAM]YVALDFEQEMATAASSSSLEK.4|LC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|EKLC[CAM]YVALDFEQEMATAASSSSLEK.3|EKLC[CAM]YVALDFEQEMATAASSSSLEK.4|EKLC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|DIKEKLC[CAM]YVALDFEQEMATAASSSSLEK.4|DIKEKLC[CAM]YVALDFEQEMATAASSSSLEK.3|C[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.4|ANLNALDR.2|VAPEEHPILLTEAPLNPK.4|VAPEEHPILLTEAPLNPK.3|VAPEEHPILLTEAPLNPK.2
SEN / CTL,P05997,Collagen alpha-2(V) chain,COL5A2,1.71,1.67,1.83E-04,1.97E-05,4.71E+00,"skeletal system development,ossification,extracellular matrix organization,collagen fibril organization,collagen catabolic process,skin development,eye morphogenesis,cellular response to amino acid stimulus,negative regulation of endodermal cell differentiation","molecular_function,extracellular matrix structural constituent,SMAD binding,metal ion binding","extracellular region,collagen type V trimer,endoplasmic reticulum lumen,extracellular matrix",30,14,15,SPDNKPVWYGLDMNR.3|GSQFAYGDHQSPNTAITQMTFLR.3|QSGEYWIDPNQGSVEDAIK.2|SGLGSQVGLM[Oxi]PGSVGPVGPR.2|SGLGSQVGLMPGSVGPVGPR.2|GPEGPQGQR.2|LGPQGAPGQR.2|GMAGGHGPDGPK.2|NSVGYMDDQAK.2|YIVLQDTC[CAM]SK.2|GEPGPHGIQGPIGPPGEEGK.3|GLTGNPGVQGPEGK.2|PAPC[CAM]QIC[CAM]VC[CAM]DNGAILC[CAM]DK.3|GTQGPPGATGFPGSAGR.2|GPQGIDGEPGVPGQPGAPGPPGHPSHPGPDGLSRPFSAQMAGLDEK.5
SEN / CTL,P15313;P21281,"V-type proton ATPase subunit B, kidney isoform;V-type proton ATPase subunit B, brain isoform",ATP6V1B1;ATP6V1B2,1.71,2.25,1.90E-02,1.59E-03,2.80E+00,"ossification,regulation of pH,excretion,sensory perception of sound,insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,inner ear morphogenesis,pH reduction,ATP metabolic process,calcium ion homeostasis,phagosome acidification;insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,ATP metabolic process,phagosome acidification","ATP binding,hydrogen ion transmembrane transporter activity,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,protein complex binding;ATP binding,hydrogen ion transmembrane transporter activity,proton-transporting ATPase activity, rotational mechanism","cytoplasm,cytosol,microvillus,endomembrane system,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,vacuolar proton-transporting V-type ATPase complex,proton-transporting V-type ATPase, V1 domain,extracellular exosome;ruffle,lysosomal membrane,cytosol,plasma membrane,microvillus,endomembrane system,integral component of membrane,proton-transporting V-type ATPase, V1 domain,melanosome,myelin sheath,intracellular membrane-bounded organelle,extracellular exosome",6,1,2,GQKIPIFSAAGLPHNEIAAQIC[CAM]R.4|GQKIPIFSAAGLPHNEIAAQIC[CAM]R.3
SEN / CTL,Q15262,Receptor-type tyrosine-protein phosphatase kappa,PTPRK,1.71,1.51,7.87E-03,6.87E-04,3.16E+00,"protein dephosphorylation,cell adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,cell migration,negative regulation of cell migration,neuron projection development,protein localization to cell surface,cellular response to reactive oxygen species,cellular response to UV,peptidyl-tyrosine dephosphorylation,negative regulation of cell cycle,negative regulation of transcription, DNA-templated,focal adhesion assembly","protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,beta-catenin binding,protein kinase binding,gamma-catenin binding","photoreceptor outer segment,integral component of plasma membrane,cell-cell junction,adherens junction,cell surface,integral component of membrane,axon,dendrite,leading edge membrane,neuronal cell body",12,12,13,VLLTRPGEGGTGLPGPPLITR.3|GLNPGTLNILVR.2|YENHSATAESSR.3|VADLLQHINLMK.3|VADLLQHINLMK.2|GAPISAYQIVVEELHPHR.4|ADC[CAM]LDMDPK.2|NGEDIPVAQTK.2|MTSGSWTETHAVNAPTYK.3|GSGVSNFAQLIVR.2|TYQGFWNPPLAPR.2|YLC[CAM]EGTESPYQTGQLHPAIR.3|IFLNWKEPLDPNGIITQYEISYSSIR.3
SEN / CTL,P00734,Prothrombin,F2,1.71,1.30,7.27E-05,8.56E-06,5.07E+00,"positive regulation of protein phosphorylation,signal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,acute-phase response,cell surface receptor signaling pathway,multicellular organism development,blood coagulation,blood coagulation, intrinsic pathway,positive regulation of cell proliferation,regulation of cell shape,response to wounding,regulation of gene expression,negative regulation of platelet activation,positive regulation of phosphatidylinositol 3-kinase signaling,peptidyl-glutamic acid carboxylation,platelet activation,regulation of blood coagulation,positive regulation of blood coagulation,positive regulation of cell growth,positive regulation of collagen biosynthetic process,fibrinolysis,cellular protein metabolic process,negative regulation of proteolysis,negative regulation of astrocyte differentiation,leukocyte migration,positive regulation of release of sequestered calcium ion into cytosol,regulation of cytosolic calcium ion concentration,negative regulation of fibrinolysis,positive regulation of lipid kinase activity,positive regulation of protein localization to nucleus,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of reactive oxygen species metabolic process","serine-type endopeptidase activity,receptor binding,calcium ion binding,protein binding,growth factor activity,thrombospondin receptor activity","extracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,extracellular exosome,blood microparticle",18,42,86,SPQELLC[CAM]GASLISDR.2|SPQELLC[CAM]GASLISDR.3|KSPQELLC[CAM]GASLISDR.3|KSPQELLC[CAM]GASLISDR.4|KSPQELLC[CAM]GASLISDR.2|VIDQFGE.2|ENLDRDIALMK.3|ENLDRDIALMK.2|VTGWGNLK.2|ITDNMFC[CAM]AGYKPDEGK.4|ITDNMFC[CAM]AGYKPDEGK.3|ITDNM[Oxi]FC[CAM]AGYKPDEGK.3|TFGSGEADC[CAM]GLRPLFEK.4|TFGSGEADC[CAM]GLRPLFEK.3|TFGSGEADC[CAM]GLRPLFEK.2|RQEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.5|RQEC[CAM]SIPVC[CAM]GQDQVTVAM[Oxi]TPR.3|RQEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.3|YTAC[CAM]ETAR.2|HQDFNSAVQLVENFC[CAM]R.4|HQDFNSAVQLVENFC[CAM]R.3|HQDFNSAVQLVENFC[CAM]R.2|ETWTANVGK.2|ITDNMFC[CAM]AGYKPDEGKR.4|ITDNM[Oxi]FC[CAM]AGYKPDEGKR.4|ITDNMFC[CAM]AGYKPDEGKR.3|ITDNM[Oxi]FC[CAM]AGYKPDEGKR.3|TFGSGEADC[CAM]GLRPLFEKK.4|TFGSGEADC[CAM]GLRPLFEKK.3|GDAC[CAM]EGDSGGPFVMK.3|GDAC[CAM]EGDSGGPFVMK.2|GDAC[CAM]EGDSGGPFVM[Oxi]K.2|KPVAFSDYIHPVC[CAM]LPDR.4|KPVAFSDYIHPVC[CAM]LPDR.3|SEGSSVNLSPPLEQC[CAM]VPDR.4|SEGSSVNLSPPLEQC[CAM]VPDR.3|SEGSSVNLSPPLEQC[CAM]VPDR.2|TATSEYQTFFNPR.3|TATSEYQTFFNPR.2|NPDSSTTGPWC[CAM]YTTDPTVR.4|NPDSSTTGPWC[CAM]YTTDPTVR.3|NPDSSTTGPWC[CAM]YTTDPTVR.2|SLEDKTERELLESYIDGR.4|SLEDKTERELLESYIDGR.3|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.4|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.3|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.2|KSLEDKTER.2|GQPSVLQVVNLPIVERPVC[CAM]K.4|GQPSVLQVVNLPIVERPVC[CAM]K.3|GQPSVLQVVNLPIVERPVC[CAM]K.2|LKKPVAFSDYIHPVC[CAM]LPDR.4|LKKPVAFSDYIHPVC[CAM]LPDR.3|RGDAC[CAM]EGDSGGPFVM[Oxi]K.3|RGDAC[CAM]EGDSGGPFVMK.3|RGDAC[CAM]EGDSGGPFVMK.2|SGIEC[CAM]QLWR.2|GQPSVLQVVNLPIVER.3|GQPSVLQVVNLPIVER.2|YGFYTHVFR.2|ELLESYIDGR.2|WYQMGIVSWGEGC[CAM]DR.3|WYQMGIVSWGEGC[CAM]DR.2|VTGWGNLKETWTANVGK.3|ETAASLLQAGYK.2|PVAFSDYIHPVC[CAM]LPDR.3|KPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.5|KPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.4|LAAC[CAM]LEGNC[CAM]AEGLGTNYR.3|LAAC[CAM]LEGNC[CAM]AEGLGTNYR.2|WVLTAAHC[CAM]LLYPPWDK.3|WVLTAAHC[CAM]LLYPPWDK.2|LAVTTHGLPC[CAM]LAWASAQAK.3|LAVTTHGLPC[CAM]LAWASAQAK.2|LKKPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.5|IVEGSDAEIGMSPWQVMLFR.3|IVEGSDAEIGM[Oxi]SPWQVMLFR.3|IVEGSDAEIGMSPWQVM[Oxi]LFR.3|IVEGSDAEIGM[Oxi]SPWQVMLFR.2|IVEGSDAEIGMSPWQVM[Oxi]LFR.2|IVEGSDAEIGMSPWQVMLFR.2|QEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.3|QEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.2|PVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.4|NPDGDEEGVWC[CAM]YVAGK.2|SEGSSVNLSPPLEQC[CAM]VPDRGQQYQGR.3
SEN / CTL,P22692,Insulin-like growth factor-binding protein 4,IGFBP4,1.71,0.74,1.88E-11,4.81E-12,1.13E+01,"skeletal system development,regulation of cell growth,DNA metabolic process,inflammatory response,signal transduction,cell proliferation,regulation of glucose metabolic process,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space",24,3,5,GELDC[CAM]HQLADSFRE.3|GELDC[CAM]HQLADSFRE.2|THEDLYIIPIPNC[CAM]DR.3|THEDLYIIPIPNC[CAM]DR.2|EDARPVPQGSC[CAM]QSELHR.4
SEN / CTL,P14866,Heterogeneous nuclear ribonucleoprotein L,HNRNPL,1.71,1.34,2.96E-04,3.12E-05,4.51E+00,"regulation of alternative mRNA splicing, via spliceosome,mRNA splicing, via spliceosome,RNA processing,gene expression","nucleotide binding,RNA binding,protein binding,transcription regulatory region DNA binding,poly(A) RNA binding,pre-mRNA intronic binding","nucleus,nucleoplasm,cytoplasm,membrane,intracellular ribonucleoprotein complex,ribonucleoprotein granule,pronucleus,extracellular exosome",18,42,89,LNVFKNDQDTWDYTNPNLSGQGDPGSNPNKR.4|LNVFKNDQDTWDYTNPNLSGQGDPGSNPNKR.3|VFNVFC[CAM]LYGNVEK.2|VFNVFC[CAM]LYGNVEK.3|SKPGAAMVEMADGYAVDR.3|SKPGAAM[Oxi]VEMADGYAVDR.3|SKPGAAMVEM[Oxi]ADGYAVDR.3|SKPGAAM[Oxi]VEM[Oxi]ADGYAVDR.3|SKPGAAMVEMADGYAVDR.2|SKPGAAMVEM[Oxi]ADGYAVDR.2|ISRPGDSDDSR.3|ISRPGDSDDSR.2|NPNGPYPYTLK.3|NPNGPYPYTLK.2|YYGGGSEGGRAPK.3|YYGGGSEGGRAPK.2|MGPPVGGHR.2|NNRFSTPEQAAK.3|NNRFSTPEQAAK.2|MAAAGGGGGGGR.2|FSTPEQAAK.2|IEYAKPTR.2|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.6|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.5|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.4|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.3|YYGGGSEGGR.2|TPASPVVHIR.2|AITHLNNNFMFGQK.3|AITHLNNNFM[Oxi]FGQK.3|AITHLNNNFMFGQK.2|AITHLNNNFM[Oxi]FGQK.2|LC[CAM]FSTAQHAS.2|ASLNGADIYSGC[CAM]C[CAM]TLK.3|ASLNGADIYSGC[CAM]C[CAM]TLK.2|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.7|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.6|TDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.5|QPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.7|QPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.6|QPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.5|LKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.7|LKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.6|LKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHKTPASPVVHIR.5|SSSGLLEWESK.2|NGVQAMVEFDSVQSAQR.3|NGVQAMVEFDSVQSAQR.2|QPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGRR.7|SDALETLGFLNHYQMK.3|SDALETLGFLNHYQM[Oxi]K.3|SDALETLGFLNHYQMK.2|SDALETLGFLNHYQM[Oxi]K.2|QRQPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.7|QRQPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.6|QRQPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.5|LKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.5|LKTDNAGDQHGGGGGGGGGAGAAGGGGGGENYDDPHK.4|KNGVQAMVEFDSVQSAQR.3|NDQDTWDYTNPNLSGQGDPGSNPNK.4|NDQDTWDYTNPNLSGQGDPGSNPNK.3|NDQDTWDYTNPNLSGQGDPGSNPNKR.4|NDQDTWDYTNPNLSGQGDPGSNPNKR.3|QPAIM[Oxi]PGQSYGLEDGSC[CAM]SYK.3|QPAIMPGQSYGLEDGSC[CAM]SYK.3|QPAIM[Oxi]PGQSYGLEDGSC[CAM]SYK.2|QPAIMPGQSYGLEDGSC[CAM]SYK.2|IQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVKRPSSVK.6|IQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVKRPSSVK.5|IQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVK.5|IQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVK.4|MNC[CAM]DRVFNVFC[CAM]LYGNVEK.3|RQALVEFEDVLGAC[CAM]NAVNYAADNQIYIAGHPAFVNYSTSQK.6|RQALVEFEDVLGAC[CAM]NAVNYAADNQIYIAGHPAFVNYSTSQK.5|RQALVEFEDVLGAC[CAM]NAVNYAADNQIYIAGHPAFVNYSTSQK.4|YGPQYGHPPPPPPPPEYGPHADSPVLMVYGLDQSK.5|YGPQYGHPPPPPPPPEYGPHADSPVLM[Oxi]VYGLDQSK.4|YGPQYGHPPPPPPPPEYGPHADSPVLMVYGLDQSK.4|SDALETLGFLNHYQMKNPNGPYPYTLK.4|SSSGLLEWESKSDALETLGFLNHYQM[Oxi]K.4|SSSGLLEWESKSDALETLGFLNHYQMK.4|SSSGLLEWESKSDALETLGFLNHYQMK.3|NRIQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVK.5|NRIQHPSNVLHFFNAPLEVTEENFFEIC[CAM]DELGVK.4|PGAAMVEMADGYAVDR.2|LNVFKNDQDTWDYTNPNLSGQGDPGSNPNK.4|LNVFKNDQDTWDYTNPNLSGQGDPGSNPNK.3|QPAIMPGQSYGLEDGSC[CAM]SYKDFSESR.3|QPAIM[Oxi]PGQSYGLEDGSC[CAM]SYKDFSESR.3|QALVEFEDVLGAC[CAM]NAVNYAADNQIYIAGHPAFVNYSTSQK.4
SEN / CTL,Q12805,EGF-containing fibulin-like extracellular matrix protein 1,EFEMP1,1.70,2.43,4.96E-01,3.65E-02,1.44E+00,"regulation of transcription, DNA-templated,epidermal growth factor receptor signaling pathway,visual perception,peptidyl-tyrosine phosphorylation,negative regulation of chondrocyte differentiation,camera-type eye development,embryonic eye morphogenesis,post-embryonic eye morphogenesis","epidermal growth factor-activated receptor activity,epidermal growth factor receptor binding,calcium ion binding,protein binding,growth factor activity","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,extracellular matrix",24,16,18,ADQVC[CAM]INLR.2|SVPSDIFQIQATTIYANTINTFR.3|IQC[CAM]AAGYEQSEHNVC[CAM]QDIDEC[CAM]TAGTHNC[CAM]R.4|RGEQC[CAM]VDIDEC[CAM]TIPPYC[CAM]HQR.4|DIDEC[CAM]DIVPDAC[CAM]K.3|DIDEC[CAM]DIVPDAC[CAM]K.2|C[CAM]VNHYGGYLC[CAM]LPK.3|LTIIVGPFSF.2|SGNENGEFYLR.2|LNC[CAM]EDIDEC[CAM]R.2|C[CAM]VC[CAM]PVSNAMC[CAM]R.2|C[CAM]VC[CAM]PVSNAM[Oxi]C[CAM]R.2|EHIVDLEMLTVSSIGTFR.3|QTSPVSAMLVLVK.2|GSFAC[CAM]QC[CAM]PPGYQK.2|GEQC[CAM]VDIDEC[CAM]TIPPYC[CAM]HQR.3|FSC[CAM]MC[CAM]PQGYQVVR.2|NPC[CAM]QDPYILTPENR.2
SEN / CTL,O00743,Serine/threonine-protein phosphatase 6 catalytic subunit,PPP6C,1.70,0.73,1.43E-03,1.39E-04,3.86E+00,"G1/S transition of mitotic cell cycle,protein dephosphorylation,COPII vesicle coating","protein serine/threonine phosphatase activity,protein binding,metal ion binding","Golgi membrane,cytosol",6,12,16,APLDLDKYVEIAR.3|GAGWLFGAK.2|VTNEFVHINNLK.3|VTNEFVHINNLK.2|YGNANAWR.2|LVTVWSAPNYC[CAM]YR.3|LVTVWSAPNYC[CAM]YR.2|AHQLVHEGYK.2|C[CAM]GNIASIMVFKDVNTR.3|C[CAM]GNIASIMVFK.2|C[CAM]GNIASIM[Oxi]VFK.2|GAFC[CAM]DLVWSDPEDVDTWAISPR.4|GAFC[CAM]DLVWSDPEDVDTWAISPR.3|GYYSLETFTYLLALK.2|QITQVYGFYDEC[CAM]QTK.2|TGGQVPDTNYIFMGDFVDR.2
SEN / CTL,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,1.70,2.27,5.67E-08,9.60E-09,8.02E+00,"pentose-phosphate shunt,pentose-phosphate shunt, oxidative branch,pentose biosynthetic process,D-gluconate metabolic process,oxidation-reduction process",phosphogluconate dehydrogenase (decarboxylating) activity,"nucleus,cytosol,extracellular exosome",36,36,73,GILFVGSGVSGGEEGAR.2|GILFVGSGVSGGEEGAR.3|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.3|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.4|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.2|TVSKVDDFLANEAK.3|TVSKVDDFLANEAK.2|GTGKWTAISALEYGVPVTLIGEAVFAR.3|GTGKWTAISALEYGVPVTLIGEAVFAR.4|WTAISALEYGVPVTLIGEAVFAR.3|WTAISALEYGVPVTLIGEAVFAR.4|EAWPHIK.2|SFLEDIR.2|SAVENC[CAM]QDSWR.3|SAVENC[CAM]QDSWR.2|FQDTDGKHLLPK.3|IISYAQGFMLLR.3|IISYAQGFMLLR.2|IISYAQGFM[Oxi]LLR.2|TIFQGIAAK.2|FQFDGDKK.2|HEMLPASLIQAQR.3|HEM[Oxi]LPASLIQAQR.3|HEM[Oxi]LPASLIQAQR.2|HEMLPASLIQAQR.2|SAVENC[CAM]QDSWRR.3|SAVENC[CAM]QDSWRR.2|DYFGAHTYELLAK.3|DYFGAHTYELLAK.2|SFLEDIRK.2|C[CAM]LSSLKDER.2|VDDFLANEAK.2|YGPSLMPGGNK.2|YGPSLM[Oxi]PGGNK.2|NPELQNLLLDDFFK.3|NPELQNLLLDDFFK.2|DAFDRNPELQNLLLDDFFK.4|DAFDRNPELQNLLLDDFFK.3|DAFDRNPELQNLLLDDFFK.2|AGQAVDDFIEK.2|AKGILFVGSGVSGGEEGAR.3|PGQFIHTNWTGHGGTVSSSSYNA.4|PGQFIHTNWTGHGGTVSSSSYNA.3|IKDAFDRNPELQNLLLDDFFK.4|IKDAFDRNPELQNLLLDDFFK.3|LVPLLDTGDIIIDGGNSEYRDTTR.4|LVPLLDTGDIIIDGGNSEYRDTTR.3|M[Oxi]VHNGIEYGDMQLIC[CAM]EAYHLMK.4|MVHNGIEYGDM[Oxi]QLIC[CAM]EAYHLMK.4|MVHNGIEYGDMQLIC[CAM]EAYHLM[Oxi]K.4|MVHNGIEYGDMQLIC[CAM]EAYHLMK.4|M[Oxi]VHNGIEYGDMQLIC[CAM]EAYHLMK.3|MVHNGIEYGDMQLIC[CAM]EAYHLMK.3|VVGAQSLKEMVSK.2|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.4|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.3|AVSTGVQAGIPM[Oxi]PC[CAM]FTTALSFYDGYR.3|LVPLLDTGDIIIDGGNSEYRDTTRR.4|LVPLLDTGDIIIDGGNSEYRDTTRR.3|LVPLLDTGDIIIDGGNSEYR.3|LVPLLDTGDIIIDGGNSEYR.2|DVLGMAQDEMAQAFEDWNK.3|DVLGM[Oxi]AQDEM[Oxi]AQAFEDWNK.3|DVLGM[Oxi]AQDEMAQAFEDWNK.3|DVLGMAQDEM[Oxi]AQAFEDWNK.3|DVLGM[Oxi]AQDEMAQAFEDWNK.2|DVLGMAQDEMAQAFEDWNK.2|DYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA.5|DYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA.4|RAVSTGVQAGIPMPC[CAM]FTTALSFYDGYRHEMLPASLIQAQR.5|RAVSTGVQAGIPM[Oxi]PC[CAM]FTTALSFYDGYR.3|RAVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.3|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYRHEMLPASLIQAQR.4
SEN / CTL,P02647,Apolipoprotein A-I,APOA1,1.70,1.15,2.99E-03,2.76E-04,3.56E+00,"retinoid metabolic process,regulation of protein phosphorylation,endothelial cell proliferation,platelet degranulation,negative regulation of cytokine secretion involved in immune response,phospholipid metabolic process,phosphatidylcholine biosynthetic process,cholesterol biosynthetic process,receptor-mediated endocytosis,G-protein coupled receptor signaling pathway,integrin-mediated signaling pathway,response to nutrient,cholesterol metabolic process,glucocorticoid metabolic process,negative regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of cholesterol esterification,positive regulation of triglyceride catabolic process,negative regulation of very-low-density lipoprotein particle remodeling,peripheral nervous system axon regeneration,protein oxidation,peptidyl-methionine modification,triglyceride catabolic process,lipid storage,regulation of intestinal cholesterol absorption,cholesterol transport,adrenal gland development,animal organ regeneration,neuron projection regeneration,regulation of Cdc42 protein signal transduction,cholesterol efflux,phospholipid efflux,negative regulation of heterotypic cell-cell adhesion,high-density lipoprotein particle remodeling,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,positive regulation of Rho protein signal transduction,lipoprotein metabolic process,lipoprotein biosynthetic process,response to drug,cholesterol homeostasis,blood vessel endothelial cell migration,response to estrogen,reverse cholesterol transport,cellular protein metabolic process,positive regulation of fatty acid biosynthetic process,negative regulation of interleukin-1 beta secretion,negative regulation of inflammatory response,protein stabilization,negative chemotaxis,positive regulation of lipoprotein lipase activity,vitamin transport,positive regulation of hydrolase activity,positive regulation of stress fiber assembly,transmembrane transport,phospholipid homeostasis,negative regulation of lipase activity,negative regulation of cell adhesion molecule production,negative regulation of response to cytokine stimulus,triglyceride homeostasis,cholesterol import,positive regulation of substrate adhesion-dependent cell spreading,transforming growth factor beta receptor signaling pathway,ERK1 and ERK2 cascade","beta-amyloid binding,protein binding,phospholipid binding,phospholipid transporter activity,high-density lipoprotein particle binding,cholesterol binding,cholesterol transporter activity,enzyme binding,phosphatidylcholine binding,apolipoprotein receptor binding,apolipoprotein A-I receptor binding,identical protein binding,chemorepellent activity,lipase inhibitor activity,phosphatidylcholine-sterol O-acyltransferase activator activity,high-density lipoprotein particle receptor binding","extracellular region,extracellular space,nucleus,early endosome,endoplasmic reticulum lumen,cytosol,plasma membrane,cell surface,endocytic vesicle,cytoplasmic vesicle,very-low-density lipoprotein particle,high-density lipoprotein particle,discoidal high-density lipoprotein particle,spherical high-density lipoprotein particle,secretory granule lumen,chylomicron,extracellular exosome,endocytic vesicle lumen,blood microparticle,extracellular vesicle",12,43,68,EQLGPVTQEFWDNLEK.3|EQLGPVTQEFWDNLEK.2|ATEHLSTLSEK.3|ATEHLSTLSEK.2|LAEYHAK.2|VQPYLDDFQK.3|VQPYLDDFQK.2|WQEEMELYR.3|WQEEMELYR.2|WQEEM[Oxi]ELYR.2|QKVEPLRAELQEGAR.4|QKVEPLRAELQEGAR.3|THLAPYSDELR.3|THLAPYSDELR.2|AELQEGAR.2|LHELQEK.2|QEMSKDLEEVK.3|AHVDALRTHLAPYSDELRQR.5|AHVDALRTHLAPYSDELRQR.4|AHVDALRTHLAPYSDELRQR.3|DYVSQFEGSALGK.3|DYVSQFEGSALGK.2|KWQEEMELYR.3|KWQEEM[Oxi]ELYR.3|KWQEEMELYR.2|VEPLRAELQEGAR.3|VEPLRAELQEGAR.2|VKDLATVYVDVLK.3|VKDLATVYVDVLK.2|AKPALEDLR.2|ARAHVDALR.2|ETEGLRQEMSKDLEEVK.4|VSFLSALEEYTKK.3|VSFLSALEEYTKK.2|AHVDALRTHLAPYSDELR.4|AHVDALRTHLAPYSDELR.3|LSPLGEEMR.2|LSPLGEEM[Oxi]R.2|LAARLEALKENGGAR.3|THLAPYSDELRQR.3|THLAPYSDELRQR.2|LLDNWDSVTSTFSK.3|LLDNWDSVTSTFSK.2|DLATVYVDVLKDSGR.3|LREQLGPVTQEFWDNLEK.4|LREQLGPVTQEFWDNLEK.3|LREQLGPVTQEFWDNLEK.2|AKPALEDLRQGLLPVLESFK.4|AKPALEDLRQGLLPVLESFK.3|AKPALEDLRQGLLPVLESFK.2|DSGRDYVSQFEGSALGK.3|DSGRDYVSQFEGSALGK.2|QGLLPVLESFK.2|DLATVYVDVLK.2|LLDNWDSVTSTFSKLR.3|VKDLATVYVDVLKDSGR.3|EQLGPVTQEFWDNLEKETEGLR.4|EQLGPVTQEFWDNLEKETEGLR.3|ETEGLRQEMSK.2|VQPYLDDFQKKWQEEMELYR.4|LAEYHAKATEHLSTLSEK.3|QGLLPVLESFKVSFLSALEEYTKK.4|VQPYLDDFQKK.2|VSFLSALEEYTK.2|LREQLGPVTQEFWDNLEKETEGLR.4|QLNLKLLDNWDSVTSTFSK.3|DLATVYVDVLKDSGRDYVSQFEGSALGK.4|EQLGPVTQEFWDNLEKETEGLRQEMSK.4
SEN / CTL,Q03252,Lamin-B2,LMNB2,1.69,2.02,2.05E-02,1.71E-03,2.77E+00,biological_process,"molecular_function,structural molecule activity","nuclear inner membrane,lamin filament",12,59,82,TVLVNADGEEVAMR.2|TVLVNADGEEVAM[Oxi]R.2|MRLESLSYQLSGLQK.3|M[Oxi]RLESLSYQLSGLQK.3|MRLESLSYQLSGLQK.2|LLEGEEERLK.3|LQIEIGK.2|IRELEEAMAGERDK.4|IRELEEAMAGERDK.3|LSPSPSSR.2|RGLESDVAELR.3|RGLESDVAELR.2|LAHYIDR.2|KLLEGEEERLK.3|KREGELTVAQGR.3|KREGELTVAQGR.2|ISEKEEVTTREVSGIK.4|LVEVDSSR.2|AELDEVNK.2|ALYESELADARR.3|ALYESELADARR.2|SEVELAAALSDKR.3|SEVELAAALSDKR.2|ALELENDRLLLK.3|ALELENDRLLLK.2|ALELENDR.2|LALDMEINAYRK.3|LALDM[Oxi]EINAYRK.3|LALDMEINAYRK.2|RQVLEGEEIAYK.3|RQVLEGEEIAYK.2|RVLDETAR.2|DQSLGNWR.2|LESLSYQLSGLQK.3|LESLSYQLSGLQK.2|LLEGEEER.2|SVFEEEVR.2|DLESLFHR.2|MAQALEELRSQHDEQVR.4|MAQALEELRSQHDEQVR.3|NNSDKDQSLGNWR.3|NNSDKDQSLGNWR.2|AASAAREELK.2|C[CAM]QSLQEELDFRK.3|C[CAM]QSLQEELDFRK.2|EGELTVAQGR.2|MAQALEELR.2|M[Oxi]AQALEELR.2|RLVEVDSSR.2|EQEM[Oxi]TEM[Oxi]R.2|GLESDVAELR.2|LYKLELEQTYQAK.3|LYKLELEQTYQAK.2|KLLEGEEER.2|LQEKEELRELNDR.3|AGGPATPLSPTR.2|ELEEAMAGER.2|QVLEGEEIAYKFTPK.3|LRAELDEVNK.2|DLESLFHRSEVELAAALSDKR.4|ISEKEEVTTR.2|LELEQTYQAK.2|ALYESELADAR.2|SEVELAAALSDK.2|AGQMVTVWAAGAGVAHSPPSTLVWK.4|AGQM[Oxi]VTVWAAGAGVAHSPPSTLVWK.4|AGQM[Oxi]VTVWAAGAGVAHSPPSTLVWK.3|AGQMVTVWAAGAGVAHSPPSTLVWK.3|ATSSSSGSLSATGR.2|QVLEGEEIAYK.2|RQVLEGEEIAYKFTPK.3|GQSSWGTGESFR.2|LALDMEINAYR.2|RLVEVDSSRQQEYDFK.3|DVMQQQLAEYQELLDVK.3|DVMQQQLAEYQELLDVK.2|IRELEEAMAGER.2|C[CAM]QSLQEELDFR.2|DLESLFHRSEVELAAALSDK.3|EQEMTEMRDVMQQQLAEYQELLDVK.4|EQEMTEMRDVMQQQLAEYQELLDVK.3|ENENGEEEEEEAEFGEEDLFHQQGDPR.3
SEN / CTL,P09211,Glutathione S-transferase P,GSTP1,1.68,1.89,4.54E-07,7.05E-08,7.15E+00,"response to reactive oxygen species,negative regulation of acute inflammatory response,negative regulation of protein kinase activity,glutathione metabolic process,xenobiotic metabolic process,central nervous system development,negative regulation of biosynthetic process,negative regulation of tumor necrosis factor-mediated signaling pathway,oligodendrocyte development,animal organ regeneration,response to estradiol,negative regulation of interleukin-1 beta production,negative regulation of tumor necrosis factor production,cellular response to insulin stimulus,regulation of stress-activated MAPK cascade,negative regulation of stress-activated MAPK cascade,positive regulation of superoxide anion generation,response to L-ascorbic acid,common myeloid progenitor cell proliferation,nitric oxide storage,negative regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to amino acid,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of JUN kinase activity,linoleic acid metabolic process,response to ethanol,negative regulation of fibroblast proliferation,negative regulation of nitric-oxide synthase biosynthetic process,regulation of ERK1 and ERK2 cascade,negative regulation of ERK1 and ERK2 cascade,negative regulation of leukocyte proliferation,cellular response to lipopolysaccharide,cellular response to epidermal growth factor stimulus,cellular response to glucocorticoid stimulus,cellular response to cell-matrix adhesion,negative regulation of monocyte chemotactic protein-1 production,negative regulation of smooth muscle cell chemotaxis,cellular oxidant detoxification,glutathione derivative biosynthetic process,negative regulation of vascular smooth muscle cell proliferation,negative regulation of extrinsic apoptotic signaling pathway","glutathione transferase activity,glutathione peroxidase activity,protein binding,drug binding,JUN kinase binding,kinase regulator activity,S-nitrosoglutathione binding,dinitrosyl-iron complex binding,glutathione binding,nitric oxide binding","extracellular space,intracellular,nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,vesicle,extracellular exosome,TRAF2-GSTP1 complex",78,20,44,FQDGDLTLYQSNTILR.2|FQDGDLTLYQSNTILR.3|PPYTVVYFPVR.2|PPYTVVYFPVR.3|TLGLYGKDQQEAALVDMVNDGVEDLRC[CAM]K.4|ALPGQLKPFETLLSQNQGGK.3|ALPGQLKPFETLLSQNQGGK.2|ALPGQLKPFETLLSQNQGGK.4|MLLADQGQSWKEEVVTVETWQEGSLK.4|MLLADQGQSWKEEVVTVETWQEGSLK.3|M[Oxi]LLADQGQSWKEEVVTVETWQEGSLK.3|TLGLYGKDQQEAALVDMVNDGVEDLR.3|TLGLYGKDQQEAALVDMVNDGVEDLR.4|TLGLYGKDQQEAALVDM[Oxi]VNDGVEDLR.3|ASC[CAM]LYGQLPK.2|MLLADQGQSWK.3|MLLADQGQSWK.2|M[Oxi]LLADQGQSWK.2|MPPYTVVYFPVR.3|M[Oxi]PPYTVVYFPVR.3|MPPYTVVYFPVR.2|M[Oxi]PPYTVVYFPVR.2|DQQEAALVDMVNDGVEDLR.4|DQQEAALVDMVNDGVEDLR.3|DQQEAALVDM[Oxi]VNDGVEDLR.3|DQQEAALVDM[Oxi]VNDGVEDLR.2|DQQEAALVDMVNDGVEDLR.2|YISLIYTNYEAGKDDYVK.4|YISLIYTNYEAGKDDYVK.3|YISLIYTNYEAGKDDYVK.2|EEVVTVETWQEGSLK.3|EEVVTVETWQEGSLK.2|AFLASPEYVNLPINGNGK.3|AFLASPEYVNLPINGNGK.2|AFLASPEYVNLPINGNGKQ.3|AFLASPEYVNLPINGNGKQ.2|PFETLLSQNQGGK.2|LKAFLASPEYVNLPINGNGK.3|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.4|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.3|LKAFLASPEYVNLPINGNGKQ.3|LKAFLASPEYVNLPINGNGKQ.2|YISLIYTNYEAGK.2|DQQEAALVDMVNDGVEDLRC[CAM]K.3
SEN / CTL,P29279,Connective tissue growth factor,CTGF,1.67,0.77,4.54E-05,5.48E-06,5.26E+00,"cartilage condensation,ossification,angiogenesis,regulation of cell growth,tissue homeostasis,transcription initiation from RNA polymerase II promoter,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,cell-cell signaling,aging,positive regulation of cell proliferation,fibroblast growth factor receptor signaling pathway,epidermis development,response to wounding,response to glucose,positive regulation of gene expression,negative regulation of gene expression,cell migration,cell differentiation,lung development,regulation of chondrocyte differentiation,response to estradiol,positive regulation of collagen biosynthetic process,response to anoxia,intracellular signal transduction,chondrocyte proliferation,response to amino acid,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to peptide hormone,positive regulation of cell differentiation,positive regulation of JNK cascade,positive regulation of cell activation,response to mineralocorticoid,positive regulation of stress fiber assembly,cytosolic calcium ion transport,positive regulation of cardiac muscle contraction,negative regulation of cell death,extracellular matrix constituent secretion,positive regulation of G0 to G1 transition,positive regulation of ERK1 and ERK2 cascade,response to fatty acid,DNA biosynthetic process,reactive oxygen species metabolic process","fibronectin binding,integrin binding,protein binding,insulin-like growth factor binding,protein C-terminus binding,growth factor activity,heparin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi apparatus,cis-Golgi network,cytosol,plasma membrane,cell cortex,intracellular membrane-bounded organelle,perinuclear region of cytoplasm",12,8,8,DGAPC[CAM]IFGGTVYR.2|C[CAM]PAGVSLVLDGC[CAM]GC[CAM]C[CAM]R.2|C[CAM]PDEPAPR.2|TTTLPVEFK.2|FC[CAM]GVC[CAM]TDGR.2|SGESFQSSC[CAM]K.2|LEDTFGPDPTMIR.2|ANC[CAM]LVQTTEWSAC[CAM]SK.2
SEN / CTL,Q14315,Filamin-C,FLNC,1.64,1.76,6.53E-34,9.05E-34,3.30E+01,"cell junction assembly,muscle fiber development","protein binding,cytoskeletal protein binding,ankyrin binding,actin filament binding","cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,sarcoplasm,Z disc,sarcolemma,costamere",246,148,214,VAVGQEQAFSVNTR.2|GVAGVPAEFSIWTR.2|GVAGVPAEFSIWTR.3|LIALLEVLSQK.2|WGDESVPGSPFK.2|GAGTGGLGLAIEGPSEAK.2|GAGTGGLGLAIEGPSEAK.3|YGGDEIPYSPFR.2|FNDEHIPDSPFVVPVASLSDDAR.3|EC[CAM]PEGHVVTYTPMAPGNYLIAIK.3|EC[CAM]PEGHVVTYTPM[Oxi]APGNYLIAIK.3|EAGAGGLSIAVEGPSKAEIAFEDRK.4|FVPQEMGPHTVAVK.3|FVPQEMGPHTVAVK.2|GDYILIVK.2|YRGQHVPGSPFQFTVGPLGEGGAHK.4|YRGQHVPGSPFQFTVGPLGEGGAHK.5|YRGQHVPGSPFQFTVGPLGEGGAHK.3|LSGGHSLHETSTVLVETVTK.4|LSGGHSLHETSTVLVETVTK.3|LSGGHSLHETSTVLVETVTK.2|GQHVPGSPFQFTVGPLGEGGAHK.4|GQHVPGSPFQFTVGPLGEGGAHK.3|GQHVPGSPFQFTVGPLGEGGAHK.2|IPGNWFQMVSAQER.2|IPGNWFQMVSAQER.3|VEESTQVGGDPFPAVFGDFLGR.3|VEESTQVGGDPFPAVFGDFLGR.2|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.3|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.4|SPFVVNVAPPLDLSK.2|SPFVVNVAPPLDLSK.3|RDTVEVALEDKGDSTFR.4|RDTVEVALEDKGDSTFR.3|QAPSIATIGSTC[CAM]DLNLK.2|QAPSIATIGSTC[CAM]DLNLK.3|APLQVAVLGPTGVAEPVEVRDNGDGTHTVHYTPATDGPYTVAVK.5|LIALLEVLSQKR.3|LIALLEVLSQKR.2|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.4|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.5|YDGNHIPGSPLQFYVDAINSR.3|SPFEVQVSPEAGVQK.2|VYNVTYTVK.2|VQLDC[CAM]REC[CAM]PEGHVVTYTPMAPGNYLIAIK.4|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.5|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.4|C[CAM]TYRPAM[Oxi]EGPHTVHVAFAGAPITR.5|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.3|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.5|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.6|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.4|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.3|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.4|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.4|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.5|ITESDLSQLTASIR.2|ITESDLSQLTASIR.3|GAGTGGLGLTVEGPC[CAM]EAK.2|GAGTGGLGLTVEGPC[CAM]EAK.3|APLQVAVLGPTGVAEPVEVR.3|APLQVAVLGPTGVAEPVEVR.2|ARVPQTFTVDC[CAM]SQAGR.3|ARVPQTFTVDC[CAM]SQAGR.2|ATIRPVFDPSK.3|AKLDVQFAGTAK.3|LEPGGGAEAQAVR.3|LEPGGGAEAQAVR.2|SPFRVNVGEGSHPER.4|FNGAHIPGSPFK.3|FNGAHIPGSPFK.2|SLTATGGNHVTAR.3|SLTATGGNHVTAR.2|GELTGEVR.2|TGVEVGKPTHFTVLTK.4|TGVEVGKPTHFTVLTK.3|TGVEVGKPTHFTVLTK.2|VSGPGVEPHGVLR.3|VSGPGVEPHGVLR.2|GLHQMGIK.2|ITGDDSMR.2|ITGDDSM[Oxi]R.2|VHVQPAVDTSGVK.3|VHVQPAVDTSGVK.2|RLTDLQR.2|GSSYSSIPK.2|HVTNSPFK.2|YGGPQHIVGSPFK.3|YGGPQHIVGSPFK.2|LGSFGSITR.2|TARPNITDNKDGTITVR.4|TARPNITDNKDGTITVR.3|VLPAHDASK.2|AEIAFEDR.2|AGTNMMMVGVHGPK.3|AGTNMM[Oxi]MVGVHGPK.3|AGTNM[Oxi]M[Oxi]M[Oxi]VGVHGPK.3|RLTVTSLQETGLK.3|RLTVTSLQETGLK.2|VC[CAM]AYGPGLK.2|PATFTIVTK.2|YADQEVPR.2|APSGNEEPC[CAM]LLKR.3|HIGISFTPK.2|RPIPC[CAM]KLEPGGGAEAQAVR.4|RPIPC[CAM]KLEPGGGAEAQAVR.3|HTIIISWGGVNVPK.3|HTIIISWGGVNVPK.2|LENVSVALEFLER.3|LENVSVALEFLER.2|LENVSVALEFLEREHIK.4|C[CAM]SGPGLGAGVR.2|PAMEGPHTVHVAFAGAPITR.4|TYAVSYVPK.2|HVSAYGPGLSHGMVNKPATFTIVTK.5|HVSAYGPGLSHGMVNKPATFTIVTK.4|VPQTFTVDC[CAM]SQAGR.3|VPQTFTVDC[CAM]SQAGR.2|VRAWGPGLETGQVGK.3|FIPHENGVHSIDVK.3|GAGGQGQLDVR.2|LDVQFAGTAK.2|NSFTVDC[CAM]SK.2|AEIAFEDRK.2|VIPNGDGTFR.2|HVSAYGPGLSHGMVNK.3|VVTRGPGLSQAFVGQK.3|VVTRGPGLSQAFVGQK.2|EVGEHVVSVR.2|IHALPTGDASK.2|TARPNITDNK.2|TPC[CAM]EEVYVK.2|YTIMVLFANQEIPASPFHIK.4|YTIMVLFANQEIPASPFHIK.3|YTIM[Oxi]VLFANQEIPASPFHIK.3|YTIMVLFANQEIPASPFHIK.2|DTVEVALEDKGDSTFR.3|DTVEVALEDKGDSTFR.2|EKGDYILIVK.2|GPGLSQAFVGQK.2|VNVGEGSHPER.2|C[CAM]SYVPTKPIK.2|VGVTEGC[CAM]DPTR.2|VEAAEIVEGEDSAYSVR.3|VEAAEIVEGEDSAYSVR.2|AFGPGLEGGLVNK.2|DNGDGTHTVHYTPATDGPYTVAVK.4|DNGDGTHTVHYTPATDGPYTVAVK.3|EVTTEFTVDAR.2|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.3|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.2|GLHQMGIKYDGNHIPGSPLQFYVDAINSR.5|ILVGPSEIGDASK.2|LTVTSLQETGLK.2|AWGPGLETGQVGK.2|DRTYAVSYVPK.2|RQAPSIATIGSTC[CAM]DLNLK.3|SPFPVHVSEAC[CAM]NPNAC[CAM]R.3|VPQLPITNFNR.2|APSGNEEPC[CAM]LLK.2|DAGEGLLTVQILDPEGKPK.3|DAGEGLLTVQILDPEGKPK.2|C[CAM]APGVVGPAEADIDFDIIK.3|GLSEGHTFQVAEFIVDTR.3|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.6|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.4|FNDEHIPDSPFVVPVASLSDDARR.4|VPQLPITNFNRDWQDGK.3|VTVLFAGQNIER.2|PFNLVIPFAVQK.2|VQYTAYEEGVHLVEVLYDEVAVPK.4|VQYTAYEEGVHLVEVLYDEVAVPK.3|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.4|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.3|QQEGEASSQDMTAQVTSPSGK.3|QQEGEASSQDMTAQVTSPSGK.2|DAGEGGLSLAVEGPSKAEITC[CAM]K.3|GGLVGTPAPFSIDTK.2|DAGEGGLSLAVEGPSK.2|VHTPSGAVEEC[CAM]YVSELDSDK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.2|DGTC[CAM]TVSYLPTAPGDYSIIVR.3|DGTC[CAM]TVSYLPTAPGDYSIIVR.2|NAGYGGLGLSIEGPSK.2|VREAGDGVFEC[CAM]EYYPVVPGK.3|VREAGDGVFEC[CAM]EYYPVVPGK.2|TSQLNVGTSTDVSLK.2|ASGPGLNASGIPASLPVEFTIDAR.3|ASGPGLNASGIPASLPVEFTIDAR.2|FDDKHIPGSPFTAK.2|LYAQDADGC[CAM]PIDIK.2|TDTYVTDNGDGTYR.2|VNQPASFAVQLNGAR.2|YVVTITWGGYAIPR.2|AEVLIHNNADGTYHITYSPAFPGTYTITIK.4|AEVLIHNNADGTYHITYSPAFPGTYTITIK.3|QPYAPPRPGARPTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.6|SPFEVNVGMALGDANK.2|DNKDGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DNKDGTC[CAM]TVSYLPTAPGDYSIIVR.3|VRASGPGLNASGIPASLPVEFTIDAR.3|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFR.4|EVRVEESTQVGGDPFPAVFGDFLGR.3|VTYC[CAM]PTEPGTYIINIK.2|YWPTEPGEYAVHVIC[CAM]DDEDIRDSPFIAHILPAPPDC[CAM]FPDK.5|ARVPQTFTVDC[CAM]SQAGRAPLQVAVLGPTGVAEPVEVR.4|PTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.4|YMPPEEGPYKVDITYDGHPVPGSPFAVEGVLPPDPSK.4|AIAYGPGIEPQGNTVLQPAHFTVQTVDAGVGEVLVYIEDPEGHTEEAK.5|EAGDGVFEC[CAM]EYYPVVPGK.2|GPGLEPVGNVANKPTYFDIYTAGAGTGDVAVVIVDPQGRR.4|IEC[CAM]QDNGDGSC[CAM]AVSYLPTEPGEYTINILFAEAHIPGSPFK.4
SEN / CTL,P25788,Proteasome subunit alpha type-3,PSMA3,1.62,2.10,1.56E-03,1.50E-04,3.82E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of endopeptidase activity,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",24,15,25,AVENSSTAIGIR.2|VFQVEYAMK.2|VFQVEYAM[Oxi]K.2|SLADIAREEASNFR.3|SLADIAREEASNFR.2|HVGMAVAGLLADAR.3|HVGM[Oxi]AVAGLLADAR.3|HVGMAVAGLLADAR.2|HVGM[Oxi]AVAGLLADAR.2|C[CAM]KDGVVFGVEK.3|C[CAM]KDGVVFGVEK.2|IIYIVHDEVK.3|IIYIVHDEVK.2|DIREEAEKYAK.3|DIREEAEKYAK.2|RLFNVDR.2|DGVVFGVEK.2|IIYIVHDEVKDK.3|IIYIVHDEVKDK.2|LFNVDRHVGMAVAGLLADAR.4|LYEEGSNKR.2|SNFGYNIPLK.2|AFELELSWVGELTNGRHEIVPK.4|AFELELSWVGELTNGRHEIVPK.3|AFELELSWVGELTNGR.2
SEN / CTL,P14625,Endoplasmin,HSP90B1,1.61,1.48,3.81E-22,2.60E-22,2.16E+01,"response to hypoxia,toll-like receptor signaling pathway,receptor-mediated endocytosis,protein transport,ER-associated ubiquitin-dependent protein catabolic process,retrograde protein transport, ER to cytosol,actin rod assembly,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,ATF6-mediated unfolded protein response,negative regulation of apoptotic process,regulation of phosphoprotein phosphatase activity,sequestering of calcium ion,cellular response to ATP","RNA binding,calcium ion binding,protein binding,ATP binding,protein phosphatase binding,virion binding,low-density lipoprotein particle receptor binding,unfolded protein binding","extracellular region,nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,cytosol,plasma membrane,focal adhesion,membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumen",126,85,166,SILFVPTSAPR.2|FAFQAEVNR.2|FQSSHHPTDITSLDQYVER.4|FQSSHHPTDITSLDQYVER.3|FQSSHHPTDITSLDQYVER.2|FQSSHHPTDITSLDQYVER.5|GVVDSDDLPLNVSR.2|GVVDSDDLPLNVSR.3|SEKFAFQAEVNR.3|SEKFAFQAEVNR.2|GYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.3|GYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.4|EAVEKEFEPLLNWMKDK.4|EAVEKEFEPLLNWMKDK.2|LTESPC[CAM]ALVASQYGWSGNMER.3|LTESPC[CAM]ALVASQYGWSGNMER.2|LTESPC[CAM]ALVASQYGWSGNMER.4|LTESPC[CAM]ALVASQYGWSGNM[Oxi]ER.3|LTESPC[CAM]ALVASQYGWSGNM[Oxi]ER.2|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.4|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.5|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.3|EGSRTDDEVVQREEEAIQLDGLNASQIR.4|EGSRTDDEVVQREEEAIQLDGLNASQIR.5|EGSRTDDEVVQREEEAIQLDGLNASQIR.3|YSQFINFPIYVWSSK.3|YSQFINFPIYVWSSK.2|EAVEKEFEPLLNWMK.3|EAVEKEFEPLLNWM[Oxi]K.3|EAVEKEFEPLLNWMK.2|NLLHVTDTGVGMTREELVK.4|NLLHVTDTGVGM[Oxi]TREELVK.4|NLLHVTDTGVGMTREELVK.3|NLLHVTDTGVGM[Oxi]TREELVK.3|NLLHVTDTGVGMTREELVK.2|KYSQFINFPIYVWSSK.3|KYSQFINFPIYVWSSK.4|KYSQFINFPIYVWSSK.2|KIADDKYNDTFWK.4|KIADDKYNDTFWK.3|KEAESSPFVER.3|KEAESSPFVER.2|KTLDMIK.2|TLDMIKK.2|DISTNYYASQK.3|DISTNYYASQK.2|RFQNVAK.2|ETLQQHK.2|RVFITDDFHDMM[Oxi]PK.4|RVFITDDFHDMMPK.4|RVFITDDFHDMMPK.3|RVFITDDFHDM[Oxi]MPK.3|RVFITDDFHDMM[Oxi]PK.3|RVFITDDFHDMMPK.2|TFEINPR.2|EGSRTDDEVVQR.3|EGSRTDDEVVQR.2|EGVKFDESEKTK.3|EGVKFDESEKTK.2|LGVIEDHSNRTR.3|LIINSLYKNKEIFLR.4|QDKIYFMAGSSR.3|QDKIYFMAGSSR.2|DISTNYYASQKK.3|DISTNYYASQKK.2|GTTITLVLK.2|LIINSLYK.2|TDDEVVQR.2|KTLDMIKK.2|SGYLLPDTKAYGDRIER.4|YNDTFWK.2|SGTSEFLNK.2|KTFEINPR.2|SGYLLPDTK.2|EEASDYLELDTIK.3|EEASDYLELDTIK.2|GLFDEYGSK.2|IADDKYNDTFWK.3|IADDKYNDTFWK.2|NLLHVTDTGVGM[Oxi]TR.3|NLLHVTDTGVGMTR.3|NLLHVTDTGVGM[Oxi]TR.2|NLLHVTDTGVGMTR.2|PIWQRPSKEVEEDEYK.4|PIWQRPSKEVEEDEYK.3|ESTAEKDEL.2|EVEEDEYKAFYK.3|EVEEDEYKAFYK.2|IYFMAGSSR.2|IYFM[Oxi]AGSSR.2|TVWDWELMNDIK.3|TVWDWELMNDIK.2|TVWDWELM[Oxi]NDIK.2|EEKEESDDEAAVEEEEEEKKPK.5|EEKEESDDEAAVEEEEEEKKPK.4|EVEEDEYK.2|VFITDDFHDMMPK.3|VFITDDFHDM[Oxi]MPK.3|VFITDDFHDMM[Oxi]PK.3|VFITDDFHDM[Oxi]M[Oxi]PK.3|VFITDDFHDM[Oxi]MPK.2|VFITDDFHDMM[Oxi]PK.2|VFITDDFHDMMPK.2|VFITDDFHDM[Oxi]M[Oxi]PK.2|LSLNIDPDAK.2|SREGSRTDDEVVQR.3|IKEDEDDKTVLDLAVVLFETATLR.5|IKEDEDDKTVLDLAVVLFETATLR.4|IKEDEDDKTVLDLAVVLFETATLR.3|EESDDEAAVEEEEEEKKPK.4|EESDDEAAVEEEEEEKKPK.3|EESDDEAAVEEEEEEKKPK.2|AQAYQTGKDISTNYYASQKK.4|AQAYQTGKDISTNYYASQKK.3|GLFDEYGSKK.2|LGVIEDHSNR.2|TETVEEPMEEEEAAK.3|TETVEEPMEEEEAAK.2|TETVEEPM[Oxi]EEEEAAK.2|EAESSPFVER.2|IADDKYNDTFWKEFGTNIK.4|IADDKYNDTFWKEFGTNIK.3|IADDKYNDTFWKEFGTNIK.2|EGVKFDESEK.2|EKNLLHVTDTGVGMTR.3|EKNLLHVTDTGVGMTREELVK.4|EEEAIQLDGLNASQIR.3|EEEAIQLDGLNASQIR.2|GTTITLVLKEEASDYLELDTIK.4|GTTITLVLKEEASDYLELDTIK.3|EESDDEAAVEEEEEEK.3|EESDDEAAVEEEEEEK.2|TVWDWELMNDIKPIWQRPSK.4|TVWDWELM[Oxi]NDIKPIWQRPSK.4|TVWDWELMNDIKPIWQRPSK.3|EFEPLLNWMK.2|EFEPLLNWM[Oxi]K.2|FDESEKTKESR.2|HNNDTQHIWESDSNEFSVIADPR.4|HNNDTQHIWESDSNEFSVIADPR.3|LISLTDENALSGNEELTVK.3|LISLTDENALSGNEELTVK.2|TDDEVVQREEEAIQLDGLNASQIR.4|TDDEVVQREEEAIQLDGLNASQIR.3|TVWDWELMNDIKPIWQRPSKEVEEDEYKAFYK.6|TVWDWELMNDIKPIWQRPSKEVEEDEYKAFYK.5|TETVEEPMEEEEAAKEEK.3|TETVEEPM[Oxi]EEEEAAKEEK.3|TETVEEPMEEEEAAKEEK.2|AQAYQTGKDISTNYYASQK.3|GTTITLVLKEEASDYLELDTIKNLVK.4|GYEVIYLTEPVDEYC[CAM]IQALPEFDGK.4|GYEVIYLTEPVDEYC[CAM]IQALPEFDGK.3|TVWDWELMNDIKPIWQR.3|TVWDWELMNDIKPIWQR.2|EEKEESDDEAAVEEEEEEK.3|ESDDPMAYIHFTAEGEVTFK.3|ESDDPM[Oxi]AYIHFTAEGEVTFK.3|ESDDPMAYIHFTAEGEVTFK.2|IRLISLTDENALSGNEELTVK.3|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGK.4|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGK.3|TVLDLAVVLFETATLR.2|TETVEEPM[Oxi]EEEEAAKEEKEESDDEAAVEEEEEEK.4|TETVEEPMEEEEAAKEEKEESDDEAAVEEEEEEK.4|VEEEPEEEPEETAEDTTEDTEQDEDEEMDVGTDEEEETAK.4
SEN / CTL,P37802,Transgelin-2,TAGLN2,1.61,1.43,2.78E-14,9.34E-15,1.40E+01,"epithelial cell differentiation,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"cell-cell adherens junction,vesicle,extracellular exosome",84,26,53,NFSDNQLQEGKNVIGLQMGTNR.3|NFSDNQLQEGKNVIGLQM[Oxi]GTNR.3|TLMNLGGLAVARDDGLFSGDPNWFPKK.4|QMEQISQFLQAAER.3|QMEQISQFLQAAER.2|QM[Oxi]EQISQFLQAAER.2|YGINTTDIFQTVDLWEGK.3|YGINTTDIFQTVDLWEGK.2|DDGLFSGDPNWFPK.2|DDGLFSGDPNWFPK.3|IEKQYDADLEQILIQWITTQC[CAM]R.3|QYDADLEQILIQWITTQC[CAM]RK.3|TLMNLGGLAVAR.2|TLMNLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.2|NVIGLQMGTNR.2|NVIGLQMGTNR.3|NVIGLQM[Oxi]GTNR.2|QYDADLEQILIQWITTQC[CAM]R.3|QYDADLEQILIQWITTQC[CAM]R.2|DDGLFSGDPNWFPKK.2|DDGLFSGDPNWFPKK.3|DGTVLC[CAM]ELINALYPEGQAPVKK.3|DGTVLC[CAM]ELINALYPEGQAPVKK.5|DGTVLC[CAM]ELINALYPEGQAPVKK.4|GPAYGLSR.2|NFSDNQLQEGK.3|NFSDNQLQEGK.2|NMAC[CAM]VQR.2|NM[Oxi]AC[CAM]VQR.2|GASQAGMTGYGMPR.3|GASQAGM[Oxi]TGYGMPR.3|GASQAGMTGYGMPR.2|GASQAGM[Oxi]TGYGMPR.2|GASQAGMTGYGM[Oxi]PR.2|GASQAGM[Oxi]TGYGM[Oxi]PR.2|DVGRPQPGR.2|IQASTMAFK.2|IQASTM[Oxi]AFK.2|DVGRPQPGRENFQNWLK.4|DVGRPQPGRENFQNWLK.3|ENFQNWLK.2|KIQASTMAFK.2|KIQASTM[Oxi]AFK.2|DGTVLC[CAM]ELINALYPEGQAPVK.4|DGTVLC[CAM]ELINALYPEGQAPVK.3|DGTVLC[CAM]ELINALYPEGQAPVK.2|ENPRNFSDNQLQEGK.3|TLMNLGGLAVARDDGLFSGDPNWFPK.4|TLMNLGGLAVARDDGLFSGDPNWFPK.3|NVIGLQM[Oxi]GTNRGASQAGMTGYGMPR.3|YGINTTDIFQTVDLWEGKNMAC[CAM]VQR.3
SEN / CTL,P00338,L-lactate dehydrogenase A chain,LDHA,1.61,2.11,2.72E-18,1.31E-18,1.79E+01,"response to hypoxia,lactate metabolic process,pyruvate metabolic process,glycolytic process,response to nutrient,response to glucose,NAD metabolic process,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,response to estrogen,post-embryonic animal organ development,response to cAMP,oxidation-reduction process,cell-cell adhesion","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding,cadherin binding involved in cell-cell adhesion","nucleus,cytosol,cell-cell adherens junction,membrane,extracellular exosome",168,38,92,SADTLWGIQKELQF.2|VTLTSEEEAR.2|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.4|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.6|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.4|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.6|LVIITAGAR.2|VTLTSEEEARLK.3|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.3|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.4|IVSGKDYNVTANSKLVIITAGAR.4|IVSGKDYNVTANSKLVIITAGAR.3|LLIVSNPVDILTYVAWK.3|LLIVSNPVDILTYVAWK.2|SADTLWGIQK.2|QVVESAYEVIK.2|QVVESAYEVIK.3|NVNIFKFIIPNVVK.3|NVNIFKFIIPNVVK.2|LLIVSNPVDILTYVAWKISGFPKNR.4|FIIPNVVK.2|FIIPNVVK.1|VIGSGC[CAM]NLDSAR.2|VIGSGC[CAM]NLDSAR.3|DQLIYNLLKEEQTPQNK.3|DQLIYNLLKEEQTPQNK.4|DQLIYNLLKEEQTPQNK.2|EVHKQVVESAYEVIK.3|EVHKQVVESAYEVIK.4|EVHKQVVESAYEVIK.2|GYTSWAIGLSVADLAESIMK.3|GYTSWAIGLSVADLAESIM[Oxi]K.3|GYTSWAIGLSVADLAESIM[Oxi]K.2|GYTSWAIGLSVADLAESIMK.2|LKGEMMDLQHGSLFLR.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.4|LKGEMM[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.3|LKGEMM[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.3|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.2|LKGEMM[Oxi]DLQHGSLFLR.2|GEMMDLQHGSLFLR.4|GEMMDLQHGSLFLR.3|GEM[Oxi]MDLQHGSLFLR.3|GEMM[Oxi]DLQHGSLFLR.3|GEM[Oxi]M[Oxi]DLQHGSLFLR.3|GEMMDLQHGSLFLR.2|GEM[Oxi]MDLQHGSLFLR.2|GEMM[Oxi]DLQHGSLFLR.2|KSADTLWGIQK.3|KSADTLWGIQK.2|TLHPDLGTDKDK.3|TLHPDLGTDKDK.2|TLHPDLGTDKDKEQWK.4|TLHPDLGTDKDKEQWK.3|TLHPDLGTDKDKEQWK.2|EEQTPQNK.2|IVSGKDYNVTANSK.3|IVSGKDYNVTANSK.2|DYNVTANSK.2|NRVIGSGC[CAM]NLDSAR.3|NRVIGSGC[CAM]NLDSAR.2|VHPVSTMIK.2|QQEGESRLNLVQR.3|DLADELALVDVIEDK.3|DLADELALVDVIEDK.2|TLHPDLGTDK.2|DQLIYNLLK.2|DDVFLSVPC[CAM]ILGQNGISDLVK.4|DDVFLSVPC[CAM]ILGQNGISDLVK.3|DDVFLSVPC[CAM]ILGQNGISDLVK.2|DLADELALVDVIEDKLK.3|DLADELALVDVIEDKLK.2|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.3|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGMAC[CAM]AISILMK.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.2|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.2|ITVVGVGAVGMAC[CAM]AISILMK.2|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.2|LKGYTSWAIGLSVADLAESIM[Oxi]K.3|LKGYTSWAIGLSVADLAESIMK.3|LKGYTSWAIGLSVADLAESIMK.2|NVNIFKFIIPNVVKYSPNC[CAM]K.3|YSPNC[CAM]KLLIVSNPVDILTYVAWKISGFPK.4|YSPNC[CAM]KLLIVSNPVDILTYVAWK.3
SEN / CTL,P15121,Aldose reductase,AKR1B1,1.60,1.80,7.41E-07,1.12E-07,6.95E+00,"tissue homeostasis,carbohydrate metabolic process,sorbitol biosynthetic process,C21-steroid hormone biosynthetic process,response to stress,response to water deprivation,naphthalene metabolic process,stress-activated protein kinase signaling cascade,norepinephrine metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,fructose biosynthetic process,positive regulation of JAK-STAT cascade,positive regulation of smooth muscle cell proliferation,oxidation-reduction process,maternal process involved in female pregnancy,cellular response to hydrogen peroxide,inner medullary collecting duct development,response to thyroid hormone,cellular response to methylglyoxal,cellular response to peptide","alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,electron carrier activity,glyceraldehyde oxidoreductase activity","extracellular space,nucleoplasm,cytoplasm,cytosol,cell projection cytoplasm,paranodal junction,mast cell granule,Schmidt-Lanterman incisure,perinuclear region of cytoplasm,extracellular exosome,Schwann cell microvillus",60,26,42,MPILGLGTWK.2|M[Oxi]PILGLGTWK.2|VAIDVGYR.2|VC[CAM]ALLSC[CAM]TSHKDYPFHEEF.4|VC[CAM]ALLSC[CAM]TSHKDYPFHEEF.3|HIDC[CAM]AHVYQNENEVGVAIQEK.3|HIDC[CAM]AHVYQNENEVGVAIQEK.4|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPR.4|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPR.3|TTAQVLIR.2|AIGISNFNHLQVEM[Oxi]ILNKPGLK.4|AIGISNFNHLQVEMILNKPGLK.4|AIGISNFNHLQVEM[Oxi]ILNKPGLK.3|AIGISNFNHLQVEMILNKPGLK.3|YKPAVNQIEC[CAM]HPYLTQEK.4|YKPAVNQIEC[CAM]HPYLTQEK.3|YKPAVNQIEC[CAM]HPYLTQEK.2|LLLNNGAK.2|VC[CAM]ALLSC[CAM]TSHK.3|VC[CAM]ALLSC[CAM]TSHK.2|EELFIVSK.2|LIQYC[CAM]QSK.2|DYPFHEEF.2|REELFIVSK.2|SPPGQVTEAVK.2|LDYLDLYLIHWPTGFKPGK.4|LDYLDLYLIHWPTGFKPGK.3|LDYLDLYLIHWPTGFKPGK.2|LWC[CAM]TYHEK.2|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIK.6|PWAKPEDPSLLEDPR.3|TLSDLKLDYLDLYLIHWPTGFKPGK.5|TLSDLKLDYLDLYLIHWPTGFKPGK.4|TLSDLKLDYLDLYLIHWPTGFKPGK.3|PEDPSLLEDPR.2|PAVNQIEC[CAM]HPYLTQEK.3|YKPAVNQIEC[CAM]HPYLTQEKLIQYC[CAM]QSK.5|LDYLDLYLIHWPTGFK.3|GIVVTAYSPLGSPDRPWAK.3|VFDFELSSQDMTTLLSYNR.3|VFDFELSSQDM[Oxi]TTLLSYNR.2|VFDFELSSQDMTTLLSYNR.2
SEN / CTL,Q04756,Hepatocyte growth factor activator,HGFAC,1.60,1.21,3.06E-03,2.81E-04,3.55E+00,proteolysis,"serine-type endopeptidase activity,serine-type peptidase activity","extracellular region,extracellular space",12,15,16,VANYVDWINDR.2|TTDVTQTFGIEK.2|MLHAC[CAM]TSEGSAHR.3|QGHVEQC[CAM]EC[CAM]FGGR.3|YEYLEGGDR.2|LC[CAM]NIEPDER.2|NPDNDERPWC[CAM]YVVK.3|C[CAM]FDETRYEYLEGGDR.3|DSALSWEYC[CAM]R.2|VQLSPDLLATLPEPASPGR.3|VQLSPDLLATLPEPASPGR.2|SQFVQPIC[CAM]LPEPGSTFPAGHK.3|C[CAM]QIAGWGHLDENVSGYSSSLR.3|SDAC[CAM]QGDSGGPLAC[CAM]EK.2|YIPYTLYSVFNPSDHDLVLIR.3|GVASTSASGLSC[CAM]LAWNSDLLYQELHVDSVGAAALLGLGPHAYC[CAM]R.4
SEN / CTL,P31942,Heterogeneous nuclear ribonucleoprotein H3,HNRNPH3,1.60,1.81,1.04E-04,1.18E-05,4.93E+00,"mRNA splicing, via spliceosome,RNA processing,RNA splicing,epithelial cell differentiation","nucleotide binding,RNA binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex",24,14,32,ATENDIANFFSPLNPIR.2|ATENDIANFFSPLNPIR.3|STGEAFVQFASK.2|VHIDIGADGR.2|GFYDPPR.2|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHMR.6|GMGGHGYGGAGDASSGFHGGHFVHM[Oxi]R.6|GMGGHGYGGAGDASSGFHGGHFVHMR.6|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHM[Oxi]R.6|GMGGHGYGGAGDASSGFHGGHFVHMR.5|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHM[Oxi]R.5|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHMR.5|GMGGHGYGGAGDASSGFHGGHFVHM[Oxi]R.5|GMGGHGYGGAGDASSGFHGGHFVHMR.4|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHMR.4|GMGGHGYGGAGDASSGFHGGHFVHM[Oxi]R.4|GM[Oxi]GGHGYGGAGDASSGFHGGHFVHMR.3|HNGPNDASDGTVR.3|HNGPNDASDGTVR.2|EIAENALGK.2|GGGGSGGYYGQGGMSGGGWR.3|GGGGSGGYYGQGGMSGGGWR.2|DGM[Oxi]DNQGGYGSVGR.2|DGMDNQGGYGSVGR.2|ATGEADVEFVTHEDAVAAM[Oxi]SK.3|ATGEADVEFVTHEDAVAAMSK.3|ATENDIANFFSPLNPIRVHIDIGADGR.4|YIELFLNSTPGGGSGM[Oxi]GGSGMGGYGR.3|YIELFLNSTPGGGSGMGGSGMGGYGR.3|M[Oxi]GMGNNYSGGYGTPDGLGGYGR.2|MGMGNNYSGGYGTPDGLGGYGR.2|RGGDGYDGGYGGFDDYGGYNNYGYGNDGFDDR.3
SEN / CTL,P98160,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,1.60,1.75,9.00E-17,3.74E-17,1.64E+01,"retinoid metabolic process,angiogenesis,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,lipoprotein metabolic process,cellular protein metabolic process","calcium ion binding,protein binding,protein C-terminus binding","extracellular region,basement membrane,extracellular space,Golgi lumen,plasma membrane,focal adhesion,extracellular matrix,lysosomal lumen,extracellular exosome",96,163,239,AGLSSGFIGC[CAM]VR.2|FSSGITGC[CAM]VK.2|LVSEDPINDGEWHR.3|MASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAM[Oxi]DTTVTHATSHGR.4|SQSVRPGADVTFIC[CAM]TAK.3|SQSVRPGADVTFIC[CAM]TAK.2|TPSGLYLGTC[CAM]ER.2|LHLVSPADSGEYVC[CAM]R.3|LHLVSPADSGEYVC[CAM]R.2|LC[CAM]NEC[CAM]ADGSFHLSTR.3|LC[CAM]NEC[CAM]ADGSFHLSTR.2|LLSGPYFWSLPSR.2|LLSGPYFWSLPSR.3|HLISTHFAPGDFQGFALVNPQR.4|HLISTHFAPGDFQGFALVNPQR.3|YELGSGLAVLR.2|LHQMSVADSGEYVC[CAM]R.3|LHQMSVADSGEYVC[CAM]R.2|LHQM[Oxi]SVADSGEYVC[CAM]R.2|VISSGSVASYVTSPQGFQFR.3|VISSGSVASYVTSPQGFQFR.2|LPAVEPTDQAQYLC[CAM]R.2|LPAVEPTDQAQYLC[CAM]R.3|IAHVELADAGQYR.3|IAHVELADAGQYR.2|LRLHHVSPADSGEYVC[CAM]R.5|LRLHHVSPADSGEYVC[CAM]R.4|LRLHHVSPADSGEYVC[CAM]R.3|RGGSLPAR.2|ISSTPAKLEQR.3|ISSTPAKLEQR.2|SIVPQGGSHSLR.3|VQVSPER.2|C[CAM]RPVNQEIVR.3|RVPGSPTNLANR.3|RVPGSPTNLANR.2|VGGHLRPGIVQSGGVVR.4|VGGHLRPGIVQSGGVVR.3|LHHVSPADSGEYVC[CAM]R.4|LHHVSPADSGEYVC[CAM]R.3|LNWGHIPSHPR.3|RGGSLPSHHQTR.3|AAGVPSATITWRK.3|AAGVPSATITWRK.2|SAEPLALGR.2|VTVTSEGGR.2|GHTPTQPGALNQR.3|GHTPTQPGALNQR.2|VKAFAHLQVPER.3|RGGSLPVRHQTHGSLLR.4|SKSPAYTLVWTR.3|SKSPAYTLVWTR.2|EDGRPVPSGTQQR.3|VDSYGGSLR.2|AGFFGDAM[Oxi]K.2|AQIHGGILR.2|GGSLPSRHQIVGSR.3|HPTPLALGHFHTVTLLR.4|LRSPLPWQHRLEGDTLIIPR.5|LSGSHSQGVAYPVR.3|LSGSHSQGVAYPVR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.6|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.4|RPEEVC[CAM]GPTQFR.3|VTSYGGELR.2|ALEVEEC[CAM]R.2|RPDGQPATR.2|C[CAM]FC[CAM]MGVSR.2|EGGSLPPQAR.2|LGTVPQFPR.2|PGAPPPQPLDLQHR.3|FLGDKVTSYGGELR.3|FLGDKVTSYGGELR.2|HQTHGSLLR.2|SIEYSPQLEDAGSR.3|SIEYSPQLEDAGSR.2|LDGSLPPDSR.2|RGGSLPPHTQVHGSR.3|SPLPWQHRLEGDTLIIPR.4|C[CAM]SATGSPAPTIHWSK.3|C[CAM]SATGSPAPTIHWSK.2|VAEGQTLDLK.2|EQAWQRPDGQPATR.3|GC[CAM]VGEVSVNGK.2|WFKEGGQLPPGHSVQDGVLR.4|AHSSAGQQVAR.2|HC[CAM]TSSSWSR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHK.5|FDAGSGMATIR.2|FDAGSGM[Oxi]ATIR.2|GSM[Oxi]GTSGEAC[CAM]R.2|LEGDTLIIPR.2|C[CAM]LIHDGAAPISLEWK.3|DFISLGLQDGHLVFR.3|GGSLPVRHQTHGSLLR.3|IQVVVLSASDASPPPVK.3|IQVVVLSASDASPPPVK.2|LLQVTPADSGEYVC[CAM]R.3|LLQVTPADSGEYVC[CAM]R.2|LYQASPADSGEYVC[CAM]R.3|LYQASPADSGEYVC[CAM]R.2|RPDGQPATREHLLM[Oxi]ALADLDELLIR.5|RPDGQPATREHLLMALADLDELLIR.4|RPDGQPATREHLLM[Oxi]ALADLDELLIR.4|SIGASVEFHC[CAM]AVPSDRGTQLR.4|SIGASVEFHC[CAM]AVPSDRGTQLR.3|SYEIM[Oxi]FREEFWR.3|VISSGSVASYVTSPQGFQFRR.4|VISSGSVASYVTSPQGFQFRR.3|AELLVTEAPSK.2|AELLVTEAPSKPITVTVEEQR.4|AELLVTEAPSKPITVTVEEQR.3|AELLVTEAPSKPITVTVEEQR.2|AVLHVHGGGGPR.2|RFLVHDSFWALPEQFLGNK.4|RFLVHDSFWALPEQFLGNK.3|SIGASVEFHC[CAM]AVPSDR.3|SIGASVEFHC[CAM]AVPSDR.2|AFAHLQVPER.2|EGGQLPPGHSVQDGVLR.3|QVQFSEEHWVHESGRPVQR.4|TC[CAM]ESLGAGGYR.2|EHLLMALAGIDTLLIR.3|EHLLM[Oxi]ALAGIDTLLIR.3|EHLLMALAGIDTLLIR.2|SPAYTLVWTR.2|ASYAQQPAESR.2|EASITVSVLHGTHSGPSYTPVPGSTRPIR.5|EVSEAVVDTLESEYLK.3|EVSEAVVDTLESEYLK.2|AAGVPSATITWR.2|AQAGANTRPC[CAM]PS.2|GM[Oxi]VFGIPDGVLELVPQR.3|GMVFGIPDGVLELVPQR.3|GMVFGIPDGVLELVPQR.2|GM[Oxi]VFGIPDGVLELVPQR.2|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHKR.6|C[CAM]QVSGSPPHYFYWSR.3|C[CAM]QVSGSPPHYFYWSR.2|EHLLMALADLDELLIR.3|EHLLM[Oxi]ALADLDELLIR.3|EHLLMALADLDELLIR.2|AMDFNGILTIR.2|AM[Oxi]DFNGILTIR.2|QPQAIITWYK.2|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.5|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.4|C[CAM]LC[CAM]LPGFSGPR.2|RVPGSPTNLANRQPDFISFGLVGGRPEFR.5|RVPGSPTNLANRQPDFISFGLVGGRPEFR.4|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.7|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.6|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.5|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.4|LRFDQPDDFK.2|QPDFISFGLVGGRPEFR.3|LRLPQVSPADSGEYVC[CAM]R.3|LRLPQVSPADSGEYVC[CAM]R.2|LYIFQASPADAGQYVC[CAM]R.3|LYIFQASPADAGQYVC[CAM]R.2|RFLVHDSFWALPEQFLGNKVDSYGGSLR.5|RFLVHDSFWALPEQFLGNKVDSYGGSLR.4|VVGSSGTQEASVLVTIQQR.3|VVGSSGTQEASVLVTIQQR.2|LRLLQVTPADSGEYVC[CAM]R.3|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.5|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.4|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.3|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.4|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.3|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.4|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.3|ITFRPDSADGMLLYNGQK.3|ITFRPDSADGM[Oxi]LLYNGQK.3|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.4|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.3|LRLPQVSPADSGEYVC[CAM]RVENGSGPK.4|ATATSC[CAM]RPC[CAM]PC[CAM]PYIDASR.3|AVTLEC[CAM]VSAGEPR.2|RC[CAM]ESC[CAM]APGYEGNPIQPGGK.3|AQASAQLVIQALPSVLINIR.3|AQASAQLVIQALPSVLINIR.2|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.5|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.4|IPGDQVVSVVFIK.2|LDVEFKPLAPDGVLLFSGGK.3|LDVEFKPLAPDGVLLFSGGK.2|VVPYFTQTPYSFLPLPTIKDAYRK.4|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.5|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.4|FLVHDSFWALPEQFLGNK.3|SGPVEDFVSLAMVGGHLEFR.3|ATARNELLHFER.2|ATFSSVPLAASISAVSLEVAQPGPSNRPR.4|ATFSSVPLAASISAVSLEVAQPGPSNRPR.3|C[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.3|VVPYFTQTPYSFLPLPTIK.3|VVPYFTQTPYSFLPLPTIK.2|EFREVSEAVVDTLESEYLK.3|FLGDKVTSYGGELRFTVTQR.3|GPSC[CAM]QDC[CAM]DTGYTR.2|SPVISIDPPSSTVQQGQDASFK.3|SPVISIDPPSSTVQQGQDASFK.2|VPGSPTNLANRQPDFISFGLVGGRPEFR.4|AFAHLQVPERVVPYFTQTPYSFLPLPTIKDAYR.5|FLVHDSFWALPEQFLGNKVDSYGGSLR.4|GQTVTFTC[CAM]VAIGVPTPIINWR.3|GQTVTFTC[CAM]VAIGVPTPIINWR.2|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGRR.4|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.3|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.2|IESSSPTVVEGQTLDLNC[CAM]VVAR.3|IESSSPTVVEGQTLDLNC[CAM]VVAR.2|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.6|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.5|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.4|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.4|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.3|RGSIQVDGEELVSGR.2|ETSLIVTIQGSGSSHVPSVSPPIR.3|TSVQTVVVGHAVEFEC[CAM]LALGDPKPQVTWSK.4|ESDQGAYTC[CAM]EAMNAR.2|FQGLDLNEELYLGGYPDYGAIPK.3|IQNLDQSC[CAM]QGTYIC[CAM]QAHGPWGK.3|LRSPVISIDPPSSTVQQGQDASFK.3|VPAGSAAVFPC[CAM]IASGYPTPDISWSK.3|AASGPGPEQEASFTVTVPPSEGSSYR.3|C[CAM]EQC[CAM]QPGYYGDAQR.2|IESSSASLANGHTLDLNC[CAM]LVASQAPHTITWYK.4|VVPYFTQTPYSFLPLPTIKDAYR.3|GPC[CAM]PDGHFYLEHSAAC[CAM]LPC[CAM]FC[CAM]FGITSVC[CAM]QSTR.4|C[CAM]APGYYGNPSQGQPC[CAM]QR.2|TYGLMDSHAVLQISSAKPSDAGTYVC[CAM]LAQNALGTAQK.4|LENNMLMLPSVRPQDAGTYVC[CAM]TATNR.3|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGR.3|ALEVEEC[CAM]RC[CAM]PPGYIGLSC[CAM]QDC[CAM]APGYTR.3|LTGEFTVEPVPEGAQLSFGNFAQLGHESFYWQLPETYQGDK.4
SEN / CTL,Q02818,Nucleobindin-1,NUCB1,1.59,1.60,5.85E-12,1.57E-12,1.18E+01,"response to cisplatin,regulation of protein targeting","G-protein alpha-subunit binding,DNA binding,calcium ion binding","extracellular space,nucleus,early endosome,rough endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cis-Golgi network,trans-Golgi network,microtubule cytoskeleton,membrane,Golgi cisterna membrane,extracellular exosome,extrinsic component of Golgi membrane,lumenal side of Golgi membrane",96,33,46,LLERLPEVEVPQHL.3|ELQQAVLHMEQR.3|ELQQAVLHMEQR.2|YLQEVIDVLETDGHFREK.4|YLQEVIDVLETDGHFREK.3|DLELLIQTATR.2|VNVPGSQAQLKEVWEELDGLDPNRFNPK.4|LVTLEEFLASTQR.2|LVTLEEFLASTQR.3|LVTLEEFLASTQRK.3|LVTLEEFLASTQRK.2|YLQEVIDVLETDGHFR.3|FHPDTDDVPVPAPAGDQKEVDTSEK.4|EVWEELDGLDPNRFNPK.3|LSQETEALGR.2|MDAEQDPNVQVDHLNLLK.3|MDAEQDPNVQVDHLNLLK.2|QFEHLDPQNQHTFEAR.4|QFEHLDPQNQHTFEAR.3|ELDFVSHHVR.3|ELDFVSHHVR.2|RELQQAVLHMEQR.4|RELQQAVLHMEQR.3|RELQQAVLHMEQR.2|DLAQYDAAHHEEFK.4|DLAQYDAAHHEEFK.3|DLAQYDAAHHEEFK.2|LQAANAEDIKSGK.3|YLESLGEEQRK.3|YLESLGEEQRK.2|DLAQYDAAHHEEFKR.4|QQQQQQQGHKAPAAHPEGQLK.5|FEEELAAR.2|LQAANAEDIK.2|APAAHPEGQLK.2|RFEEELAAR.2|AKMDAEQDPNVQVDHLNLLK.4|AKMDAEQDPNVQVDHLNLLK.3|NEEDDMREMEEER.3|VNVPGSQAQLK.2|LPEVEVPQHL.2|YLESLGEEQR.2|FHPDTDDVPVPAPAGDQK.3|EFGDTGEGWETVEMHPAYTEEELRR.4|EVWEELDGLDPNR.2|TFFILHDINSDGVLDEQELEALFTK.3
SEN / CTL,P09960,Leukotriene A-4 hydrolase,LTA4H,1.58,1.56,4.80E-06,6.52E-07,6.19E+00,"proteolysis,leukotriene metabolic process,leukotriene biosynthetic process,peptide catabolic process","aminopeptidase activity,epoxide hydrolase activity,leukotriene-A4 hydrolase activity,peptidase activity,zinc ion binding,peptide binding,poly(A) RNA binding,metalloaminopeptidase activity","nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,extracellular exosome",24,45,79,PEIVDTC[CAM]SLASPASVC[CAM]R.2|PEIVDTC[CAM]SLASPASVC[CAM]R.3|WITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQR.5|WITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQR.4|SAYEFSETESMLK.2|SAYEFSETESM[Oxi]LK.2|TLVWSEK.2|ASMHPVTAMLVGK.3|ASM[Oxi]HPVTAMLVGK.3|ASMHPVTAM[Oxi]LVGK.3|ASMHPVTAMLVGK.2|ASM[Oxi]HPVTAMLVGK.2|ASMHPVTAM[Oxi]LVGK.2|APLPLGHIK.2|DGETPDPEDPSRK.3|DGETPDPEDPSRK.2|GSPMEISLPIALSK.3|GSPMEISLPIALSK.2|GSPM[Oxi]EISLPIALSK.2|SITTDDWK.2|EHPYLFSQC[CAM]QAIHC[CAM]R.4|EHPYLFSQC[CAM]QAIHC[CAM]R.3|EHPYLFSQC[CAM]QAIHC[CAM]R.2|SLVLDTKDLTIEK.3|VVINGQEVK.2|DLSSHQLNEFLAQTLQR.4|DLSSHQLNEFLAQTLQR.3|DLSSHQLNEFLAQTLQR.2|FRHFNALGGWGELQNSVK.4|FRHFNALGGWGELQNSVK.3|DLAAFDKSHDQAVR.3|DLAAFDKSHDQAVR.2|DFLYSYFK.2|SSALQWLTPEQTSGK.3|SSALQWLTPEQTSGK.2|ELVALMSAIR.2|ELVALM[Oxi]SAIR.2|TWDHFWLNEGHTVYLER.4|TWDHFWLNEGHTVYLER.3|SITTDDWKDFLYSYFKDK.4|SITTDDWKDFLYSYFKDK.3|WEDAIPLALK.2|HFNALGGWGELQNSVK.3|HFNALGGWGELQNSVK.2|LVVDLTDIDPDVAYSSVPYEK.4|LVVDLTDIDPDVAYSSVPYEK.3|LVVDLTDIDPDVAYSSVPYEK.2|TFGETHPFTK.2|LTYTAEVSVPK.2|SLSNVIAHEISHSWTGNLVTNK.4|SLSNVIAHEISHSWTGNLVTNK.3|LC[CAM]IQSKWEDAIPLALK.3|ELVALM[Oxi]SAIRDGETPDPEDPSRK.4|ELVALMSAIRDGETPDPEDPSRK.4|TLTGTAALTVQSQEDNLR.3|TLTGTAALTVQSQEDNLR.2|M[Oxi]QEVYNFNAINNSEIR.3|MQEVYNFNAINNSEIR.3|M[Oxi]QEVYNFNAINNSEIR.2|MQEVYNFNAINNSEIR.2|QSYKGSPMEISLPIALSK.3|DGETPDPEDPSR.2|VPIPC[CAM]YLIALVVGALESR.3|AILPC[CAM]QDTPSVK.2|SITTDDWKDFLYSYFK.3|RTLTGTAALTVQSQEDNLR.3|WITAKEDDLNSFNATDLK.3|RM[Oxi]QEVYNFNAINNSEIR.3|RMQEVYNFNAINNSEIR.3|RMQEVYNFNAINNSEIR.2|SSALQWLTPEQTSGKEHPYLFSQC[CAM]QAIHC[CAM]R.5|SSALQWLTPEQTSGKEHPYLFSQC[CAM]QAIHC[CAM]R.4|EDDLNSFNATDLK.2|TLVWSEKEQVEK.2|DLAAFDK.1|ELVALMSAIRDGETPDPEDPSR.3|EDDLNSFNATDLKDLSSHQLNEFLAQTLQR.4|EDDLNSFNATDLKDLSSHQLNEFLAQTLQR.3|PNYDMTLTNAC[CAM]IALSQR.2
SEN / CTL,P53618,Coatomer subunit beta,COPB1,1.58,1.11,7.55E-02,5.99E-03,2.22E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,viral process","structural molecule activity,protein binding","Golgi membrane,cytoplasm,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cytosol,plasma membrane,membrane,COPI vesicle coat,transport vesicle,intracellular membrane-bounded organelle",6,73,120,VLQDLVMDILR.2|VLQDLVMDILR.3|VLQDLVM[Oxi]DILR.2|DLQHPNEFIR.3|DLQHPNEFIR.2|NVEELVIVLKK.3|NVEELVIVLKK.2|TNNVSEHEDTDKYR.4|TNNVSEHEDTDKYR.3|TNNVSEHEDTDKYR.2|RNAFMMLIHADQDR.4|RNAFMMLIHADQDR.3|RNAFMM[Oxi]LIHADQDR.3|FVLPLQDHTIK.3|LLHEMILVC[CAM]DAYRK.4|LLHEM[Oxi]ILVC[CAM]DAYRK.4|LLHEMILVC[CAM]DAYRK.3|LLHEMILVC[CAM]DAYRK.2|EAADPLASK.2|AAAQC[CAM]YIDLIIK.3|AAAQC[CAM]YIDLIIK.2|TNNVSEHEDTDK.3|TNNVSEHEDTDK.2|KDLQHPNEFIR.3|KPITDDDVDRISLC[CAM]LK.4|KPITDDDVDRISLC[CAM]LK.3|YVALVQEK.2|KTLQLALDLVSSR.3|TLHSC[CAM]SVR.2|RNAVLAIYTIYR.3|EDIQSVMTEIRR.3|LIELKEHPAHER.3|GALWILGEYC[CAM]STK.3|GALWILGEYC[CAM]STK.2|KEAADPLASK.2|SLGEIPIVESEIKK.3|SLGEIPIVESEIKK.2|KEAGELKPEEEITVGPVQK.4|KEAGELKPEEEITVGPVQK.3|LVEKPSPLTLAPHDFANIK.4|LVEKPSPLTLAPHDFANIK.3|LVEKPSPLTLAPHDFANIK.2|NAFMMLIHADQDR.3|PIHQGPDAAVTGHIR.3|C[CAM]IYNLLQSSSPAVK.3|C[CAM]IYNLLQSSSPAVK.2|VC[CAM]HANPSER.2|EVIKTNNVSEHEDTDKYR.4|EVIKTNNVSEHEDTDKYR.3|LLHEMILVC[CAM]DAYR.3|MLEVFHAIK.2|PSPLTLAPHDFANIK.3|PSPLTLAPHDFANIK.2|QSLSHMLSAK.2|SQGMALSLGDK.2|SQGM[Oxi]ALSLGDK.2|LVTEMGTYATQSALSSSRPTK.4|LVTEMGTYATQSALSSSRPTK.3|LVTEM[Oxi]GTYATQSALSSSRPTK.3|VTVNTNMVDLNDYLQHILK.4|VTVNTNMVDLNDYLQHILK.3|VTVNTNM[Oxi]VDLNDYLQHILK.3|VTVNTNMVDLNDYLQHILK.2|LPGLLMTIIR.2|VIIMILNGEK.2|VLSTPDLEVR.2|LKEAELLEPLMPAIR.3|LKEAELLEPLM[Oxi]PAIR.3|NVEELVIVLK.2|KPITDDDVDR.2|ALSGYC[CAM]GFM[Oxi]AANLYAR.3|ALSGYC[CAM]GFMAANLYAR.3|ALSGYC[CAM]GFMAANLYAR.2|ALSGYC[CAM]GFM[Oxi]AANLYAR.2|LVTEMGTYATQSALSSSRPTKK.4|VLSEC[CAM]SPLMNDIFNK.3|VLSEC[CAM]SPLM[Oxi]NDIFNK.2|VLSEC[CAM]SPLMNDIFNK.2|SQGMALSLGDKINLSQK.3|SQGMALSLGDKINLSQK.2|YEAAGTLVTLSSAPTAIK.3|YEAAGTLVTLSSAPTAIK.2|LEEEKLSQKK.2|NFEHLIPDAPELIHDFLVNEK.4|NFEHLIPDAPELIHDFLVNEK.3|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.5|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.4|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.3|EDQFQLSLLAAMGNTQR.3|EDQFQLSLLAAMGNTQR.2|IYRGALWILGEYC[CAM]STK.3|NFEHLIPDAPELIHDFLVNEKDASC[CAM]KR.5|NFEHLIPDAPELIHDFLVNEKDASC[CAM]KR.4|EAGELKPEEEITVGPVQK.3|EAGELKPEEEITVGPVQK.2|NAVLAIYTIYR.2|EDIQSVMTEIR.2|TLQLALDLVSSR.2|NVTVQPDDPISFMQLTAK.3|NVTVQPDDPISFMQLTAK.2|LLLVFWEIVPK.2|SLGEIPIVESEIKKEAGELKPEEEITVGPVQK.5|SLGEIPIVESEIK.2|AAAQC[CAM]YIDLIIKESDNNVK.3|RNVTVQPDDPISFMQLTAK.3|RNVTVQPDDPISFMQLTAK.2|QNSFVAEAMLLM[Oxi]ATILHLGK.3|QNSFVAEAM[Oxi]LLM[Oxi]ATILHLGK.3|EAELLEPLMPAIR.2|EAELLEPLM[Oxi]PAIR.2|GALWILGEYC[CAM]STKEDIQSVMTEIRR.4|VLSEC[CAM]SPLMNDIFNKEC[CAM]R.3|QMWAEFEWENK.2|VIIMILNGEKLPGLLMTIIR.3|SIFGEDALANVSIEK.2|VASTENGIIFGNIVYDVSGAASDR.3|C[CAM]IYNLLQSSSPAVKYEAAGTLVTLSSAPTAIK.4|C[CAM]IYNLLQSSSPAVKYEAAGTLVTLSSAPTAIK.3|NEMNC[CAM]KEDQFQLSLLAAMGNTQR.3|LVTEMGTYATQSALSSSR.2
SEN / CTL,P63220,40S ribosomal protein S21,RPS21,1.58,1.97,1.80E-06,2.60E-07,6.59E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding,protein N-terminus binding","nucleoplasm,cytoplasm,cytosol,small ribosomal subunit,cytosolic small ribosomal subunit",30,7,18,TYAIC[CAM]GAIR.2|IIGAKDHASIQMNVAEVDKVTGR.4|DHASIQMNVAEVDKVTGR.3|DHASIQMNVAEVDKVTGR.4|DHASIQM[Oxi]NVAEVDKVTGR.4|DHASIQM[Oxi]NVAEVDKVTGR.3|DHASIQMNVAEVDKVTGR.2|MGESDDSILR.2|M[Oxi]GESDDSILR.2|RMGESDDSILR.3|RM[Oxi]GESDDSILR.3|RMGESDDSILR.2|RM[Oxi]GESDDSILR.2|ADGIVSKNF.2|DHASIQMNVAEVDK.3|DHASIQM[Oxi]NVAEVDK.3|DHASIQMNVAEVDK.2|DHASIQM[Oxi]NVAEVDK.2
SEN / CTL,P49720,Proteasome subunit beta type-3,PSMB3,1.57,1.50,3.15E-03,2.88E-04,3.54E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,mitochondrion,Golgi apparatus,cytosol,proteasome core complex,actin cytoskeleton,proteasome core complex, beta-subunit complex,extracellular exosome",12,13,31,FGPYYTEPVIAGLDPK.2|FGPYYTEPVIAGLDPK.3|DAVSGMGVIVHIIEKDK.4|DAVSGMGVIVHIIEKDK.3|NC[CAM]VAIAADR.2|DAVSGMGVIVHIIEK.3|DAVSGMGVIVHIIEK.2|DAVSGM[Oxi]GVIVHIIEK.2|FGIQAQMVTTDFQK.3|FGIQAQM[Oxi]VTTDFQK.2|FGIQAQMVTTDFQK.2|NC[CAM]VAIAADRR.2|QIKPYTLM[Oxi]SMVANLLYEKR.4|QIKPYTLMSM[Oxi]VANLLYEKR.4|QIKPYTLMSMVANLLYEKR.4|PYTLMSMVANLLYEK.3|PYTLMSM[Oxi]VANLLYEK.3|PYTLM[Oxi]SMVANLLYEK.2|PYTLMSM[Oxi]VANLLYEK.2|PYTLMSMVANLLYEK.2|RFGIQAQMVTTDFQK.3|FRLNLYELK.2|LYIGLAGLATDVQTVAQR.3|LYIGLAGLATDVQTVAQR.2|RFGPYYTEPVIAGLDPK.3|RFGPYYTEPVIAGLDPK.2|QIKPYTLMSMVANLLYEK.3|QIKPYTLM[Oxi]SM[Oxi]VANLLYEK.3|QIKPYTLM[Oxi]SMVANLLYEK.3|QIKPYTLMSM[Oxi]VANLLYEK.3|QIKPYTLMSMVANLLYEK.2
SEN / CTL,P24844,Myosin regulatory light polypeptide 9,MYL9,1.57,1.40,4.39E-04,4.54E-05,4.34E+00,"muscle contraction,regulation of muscle contraction,platelet aggregation","calcium ion binding,structural constituent of muscle,myosin heavy chain binding","stress fiber,cytosol,muscle myosin complex,Z disc",18,6,10,GNFNYVEFTR.2|NAFAC[CAM]FDEEASGFIHEDHLR.4|NAFAC[CAM]FDEEASGFIHEDHLR.3|ELLTTMGDRFTDEEVDEMYR.3|KGNFNYVEFTR.3|KGNFNYVEFTR.2|FTDEEVDEM[Oxi]YREAPIDK.3|FTDEEVDEMYREAPIDK.2|FTDEEVDEM[Oxi]YR.2|FTDEEVDEMYR.2
SEN / CTL,P30086,Phosphatidylethanolamine-binding protein 1,PEBP1,1.57,1.30,8.48E-17,3.55E-17,1.64E+01,"MAPK cascade,negative regulation of endopeptidase activity","serine-type endopeptidase inhibitor activity,protein binding,ATP binding,phosphatidylethanolamine binding,enzyme binding,protein kinase binding,poly(A) RNA binding","nucleus,cytosol,extracellular exosome",66,25,48,YVWLVYEQDRPLKC[CAM]DEPILSNR.3|YVWLVYEQDRPLKC[CAM]DEPILSNR.4|APVAGTC[CAM]YQAEWDDYVPK.3|APVAGTC[CAM]YQAEWDDYVPK.2|GNDISSGTVLSDYVGSGPPK.3|GNDISSGTVLSDYVGSGPPK.2|GNDISSGTVLSDYVGSGPPKGTGLHR.4|GNDISSGTVLSDYVGSGPPKGTGLHR.3|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.6|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.6|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.7|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.4|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.3|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.4|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.3|VLTPTQVK.2|YREWHHFLVVNMK.4|YREWHHFLVVNM[Oxi]K.4|YREWHHFLVVNMK.3|YREWHHFLVVNM[Oxi]K.3|LYEQLSGK.2|EWHHFLVVNMK.3|EWHHFLVVNMK.2|LYTLVLTDPDAPSRKDPK.4|LYTLVLTDPDAPSRKDPK.3|LYTLVLTDPDAPSRKDPK.2|LYTLVLTDPDAPSR.3|LYTLVLTDPDAPSR.2|NRPTSISWDGLDSGK.3|NRPTSISWDGLDSGK.2|C[CAM]DEPILSNR.2|LYTLVLTDPDAPSRK.3|LYTLVLTDPDAPSRK.2|YVWLVYEQDRPLK.3|YVWLVYEQDRPLK.2|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.5|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.4|PTSISWDGLDSGK.2|YVWLVYEQDR.2|KYELRAPVAGTC[CAM]YQAEWDDYVPK.4|KYELRAPVAGTC[CAM]YQAEWDDYVPK.3|YREWHHFLVVNMKGNDISSGTVLSDYVGSGPPK.5|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.4|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.3|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5
SEN / CTL,P01344,Insulin-like growth factor II,IGF2,1.57,1.21,1.42E-04,1.56E-05,4.81E+00,"skeletal system development,ossification,positive regulation of protein phosphorylation,platelet degranulation,glucose metabolic process,regulation of gene expression by genetic imprinting,regulation of transcription, DNA-templated,multicellular organism development,positive regulation of cell proliferation,insulin receptor signaling pathway,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,positive regulation of activated T cell proliferation,positive regulation of catalytic activity,positive regulation of MAPK cascade,cellular protein metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of mitotic nuclear division,positive regulation of insulin receptor signaling pathway,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of cell division,positive regulation of protein kinase B signaling,positive regulation of protein serine/threonine kinase activity,positive regulation of receptor activity,positive regulation of glycogen (starch) synthase activity","insulin receptor binding,insulin-like growth factor receptor binding,hormone activity,protein binding,growth factor activity,receptor activator activity,protein serine/threonine kinase activator activity","extracellular region,extracellular space,plasma membrane,platelet alpha granule lumen,extracellular exosome",18,2,3,GIVEEC[CAM]C[CAM]FR.2|SC[CAM]DLALLETYC[CAM]ATPAK.2|SC[CAM]DLALLETYC[CAM]ATPAK.3
SEN / CTL,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,1.56,1.74,4.98E-04,5.09E-05,4.29E+00,"protein peptidyl-prolyl isomerization,heart morphogenesis,protein folding,'de novo' protein folding,transforming growth factor beta receptor signaling pathway,SMAD protein complex assembly,protein maturation by protein folding,positive regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of protein phosphatase type 2B activity,regulation of protein localization,regulation of activin receptor signaling pathway,protein refolding,T cell activation,positive regulation of I-kappaB kinase/NF-kappaB signaling,extracellular fibril organization,regulation of immune response,ventricular cardiac muscle tissue morphogenesis,regulation of ryanodine-sensitive calcium-release channel activity,heart trabecula formation,chaperone-mediated protein folding,calcium ion transmembrane transport,regulation of amyloid precursor protein catabolic process,amyloid fibril formation,negative regulation of release of sequestered calcium ion into cytosol,negative regulation of ryanodine-sensitive calcium-release channel activity","peptidyl-prolyl cis-trans isomerase activity,signal transducer activity,transforming growth factor beta receptor binding,protein binding,macrolide binding,FK506 binding,type I transforming growth factor beta receptor binding,ion channel binding,SMAD binding,activin binding,calcium channel inhibitor activity","cytoplasm,endoplasmic reticulum membrane,cytosol,terminal cisterna,membrane,Z disc,extracellular matrix,extracellular exosome",24,8,23,GVQVETISPGDGRTFPK.3|GWEEGVAQMSVGQR.2|GWEEGVAQMSVGQR.3|GWEEGVAQM[Oxi]SVGQR.2|GVQVETISPGDGR.2|GVQVETISPGDGR.3|RGQTC[CAM]VVHYTGMLEDGKK.5|RGQTC[CAM]VVHYTGM[Oxi]LEDGKK.4|RGQTC[CAM]VVHYTGMLEDGKK.4|RGQTC[CAM]VVHYTGMLEDGKK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGKK.3|RGQTC[CAM]VVHYTGMLEDGK.4|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.4|RGQTC[CAM]VVHYTGMLEDGK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.2|RGQTC[CAM]VVHYTGMLEDGK.2|GQTC[CAM]VVHYTGMLEDGK.3|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.5|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.4|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.3|QEVIRGWEEGVAQMSVGQR.3|QEVIRGWEEGVAQMSVGQR.2
SEN / CTL,Q96AE4,Far upstream element-binding protein 1,FUBP1,1.56,2.15,6.27E-02,5.03E-03,2.30E+00,"regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,positive regulation of gene expression","single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,poly(A) RNA binding","nucleus,nucleoplasm",18,39,63,IGGNEGIDVPIPR.2|IGGNEGIDVPIPR.3|C[CAM]QHAAEIITDLLR.3|C[CAM]QHAAEIITDLLR.2|GRPAPGFHHGDGPGNAVQEIMIPASK.5|GRPAPGFHHGDGPGNAVQEIMIPASK.6|GRPAPGFHHGDGPGNAVQEIM[Oxi]IPASK.5|GRPAPGFHHGDGPGNAVQEIMIPASK.4|GRPAPGFHHGDGPGNAVQEIM[Oxi]IPASK.4|GRPAPGFHHGDGPGNAVQEIMIPASK.3|IQNDAGVR.2|ITGDPYKVQQAK.3|RPLEDGDQPDAK.3|RPLEDGDQPDAK.2|IQIAPDSGGLPER.3|IQIAPDSGGLPER.2|FAVGIVIGR.2|SISQQSGAR.2|IQQESGC[CAM]K.2|LLDQIVEK.2|RPLEDGDQPDAKK.3|AWEEYYK.2|MVMIQDGPQNTGADKPLR.4|MVMIQDGPQNTGADKPLR.3|M[Oxi]VM[Oxi]IQDGPQNTGADKPLR.3|M[Oxi]VMIQDGPQNTGADKPLR.3|MVM[Oxi]IQDGPQNTGADKPLR.3|SVMTEEYK.2|SVM[Oxi]TEEYK.2|EMVLELIR.2|IQFKPDDGTTPER.3|IQFKPDDGTTPER.2|KIQNDAGVR.2|IAQITGPPDR.2|AWEEYYKK.2|EMVLELIRDQGGFR.3|RLLDQIVEK.2|GTPQQIDYAR.2|SC[CAM]MLTGTPESVQSAKR.3|NPPPNADPNMK.2|NPPPNADPNM[Oxi]K.2|KVAPQNDSFGTQLPPMHQQQSR.4|VPDGMVGFIIGR.2|VPDGM[Oxi]VGFIIGR.2|QQAAYYAQTSPQGMPQHPPAPQGQ.4|QQAAYYAQTSPQGMPQHPPAPQGQ.3|QQAAYYAQTSPQGM[Oxi]PQHPPAPQGQ.3|IGGDAGTSLNSNDYGYGGQK.3|IGGDAGTSLNSNDYGYGGQK.2|SVQAGNPGGPGPGGR.2|SVMTEEYKVPDGMVGFIIGR.3|SVM[Oxi]TEEYKVPDGMVGFIIGR.3|SVMTEEYKVPDGMVGFIIGR.2|VAPQNDSFGTQLPPMHQQQSR.3|MVMIQDGPQNTGADK.2|SC[CAM]M[Oxi]LTGTPESVQSAK.2|SC[CAM]MLTGTPESVQSAK.2|IGGDAGTSLNSNDYGYGGQKRPLEDGDQPDAK.4|GQGNWNMGPPGGLQEFNFIVPTGK.3|GRGQGNWNMGPPGGLQEFNFIVPTGK.3|MGQAVPAPTGAPPGGQPDYSAAWAEYYR.3|M[Oxi]GQAVPAPTGAPPGGQPDYSAAWAEYYR.3|KMGQAVPAPTGAPPGGQPDYSAAWAEYYR.3
SEN / CTL,Q9Y4K0,Lysyl oxidase homolog 2,LOXL2,1.55,1.71,6.86E-03,6.02E-04,3.22E+00,"response to hypoxia,epithelial to mesenchymal transition,endothelial cell proliferation,sprouting angiogenesis,transcription, DNA-templated,cellular protein modification process,receptor-mediated endocytosis,cell adhesion,aging,histone modification,protein deamination,collagen fibril organization,positive regulation of chondrocyte differentiation,endothelial cell migration,negative regulation of transcription, DNA-templated,response to copper ion,oxidation-reduction process","chromatin binding,transcription corepressor activity,protein-lysine 6-oxidase activity,scavenger receptor activity,copper ion binding,protein binding,electron carrier activity,methylated histone binding,oligosaccharide binding","basement membrane,extracellular space,nucleus,nucleoplasm,chromosome,membrane,extracellular matrix",30,16,19,LGQGIGPIHLNEIQC[CAM]TGNEK.3|VVC[CAM]GMFGFPGER.2|NGEWGTVC[CAM]DDKWDLVSASVVC[CAM]R.3|ASFC[CAM]LEDTEC[CAM]EGDIQK.2|FDNSLINQIENLNIQVEDIR.3|FDNSLINQIENLNIQVEDIR.2|AYKPEQPLVR.3|C[CAM]SGTELSLAHC[CAM]R.3|C[CAM]SGTELSLAHC[CAM]R.2|HTEDVGVVC[CAM]SDKR.3|C[CAM]NTPAMGLQK.2|C[CAM]NTPAM[Oxi]GLQK.2|KFEHFSGLLNNQLSPQ.3|FNAESQGC[CAM]NHEEDAGVR.3|QRYWPFSMDC[CAM]TGTEAHISSC[CAM]K.4|HTEDVGVVC[CAM]SDK.2|RTPVMEGYVEVK.2|HAWIWHDC[CAM]HR.2|IWMYNC[CAM]HIGGSFSEETEK.3
SEN / CTL,Q15056,Eukaryotic translation initiation factor 4H,EIF4H,1.55,2.17,1.08E-02,9.22E-04,3.04E+00,"formation of translation preinitiation complex,cytoplasmic translation,translational initiation,regulation of translational initiation,viral process,sexual reproduction,developmental growth,eukaryotic translation initiation factor 4F complex assembly,cell-cell adhesion","nucleotide binding,RNA binding,translation initiation factor activity,helicase activity,translation factor activity, RNA binding,RNA strand annealing activity,RNA strand-exchange activity,ribosomal small subunit binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytosol,polysome,cell-cell adherens junction,membrane,eukaryotic translation initiation factor 4F complex,perinuclear region of cytoplasm",18,16,23,SQKELPTEPPYTAYVGNLPFNTVQGDIDAIFKDLSIR.4|TVATPLNQVANPNSAIFGGARPR.3|TVATPLNQVANPNSAIFGGARPR.4|AYSSFGGGR.2|TGPPMGSR.2|GSNM[Oxi]DFR.2|DDFNSGFR.2|EEVVQKEQE.2|SLRVDIAEGR.2|GSNMDFREPTEEER.3|GSNM[Oxi]DFREPTEEER.3|GFC[CAM]YVEFDEVDSLK.3|GFC[CAM]YVEFDEVDSLK.2|EALTYDGALLGDR.2|TVATPLNQVANPNSAIFGGAR.3|TVATPLNQVANPNSAIFGGAR.2|TVATPLNQVANPNSAIFGGARPREEVVQK.4|TVATPLNQVANPNSAIFGGARPREEVVQK.3|ELPTEPPYTAYVGNLPFNTVQGDIDAIFK.4|ELPTEPPYTAYVGNLPFNTVQGDIDAIFK.3|SQKELPTEPPYTAYVGNLPFNTVQGDIDAIFK.4|SQKELPTEPPYTAYVGNLPFNTVQGDIDAIFK.3|GFC[CAM]YVEFDEVDSLKEALTYDGALLGDR.3
SEN / CTL,P16035,Metalloproteinase inhibitor 2,TIMP2,1.54,1.54,3.48E-07,5.48E-08,7.26E+00,"central nervous system development,aging,negative regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,regulation of Rap protein signal transduction,response to cytokine,response to drug,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of adenylate cyclase activity,negative regulation of mitotic cell cycle,negative regulation of Ras protein signal transduction,negative regulation of membrane protein ectodomain proteolysis","protease binding,integrin binding,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,cell surface,growth cone,extracellular matrix,neuronal cell body,extracellular exosome",42,8,11,GAAPPKQEFLDIEDP.2|AVSEKEVDSGNDIYGNPIKR.4|AVSEKEVDSGNDIYGNPIKR.3|MHITLC[CAM]DFIVPWDTLSTTQKK.4|MHITLC[CAM]DFIVPWDTLSTTQKK.3|C[CAM]PMIPC[CAM]YISSPDEC[CAM]LWMDWVTEK.3|MHITLC[CAM]DFIVPWDTLSTTQK.3|M[Oxi]HITLC[CAM]DFIVPWDTLSTTQK.3|EVDSGNDIYGNPIKR.3|EVDSGNDIYGNPIK.2|DIEFIYTAPSSAVC[CAM]GVSLDVGGKK.3
SEN / CTL,Q02388,Collagen alpha-1(VII) chain,COL7A1,1.54,1.54,4.24E-05,5.16E-06,5.29E+00,"ER to Golgi vesicle-mediated transport,cell adhesion,epidermis development,negative regulation of endopeptidase activity,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,COPII vesicle coating","serine-type endopeptidase inhibitor activity,protein binding,identical protein binding","Golgi membrane,extracellular region,collagen type VII trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular matrix",30,34,44,SFLEGLVLPFSGAASAQGVR.3|SFLEGLVLPFSGAASAQGVR.2|VLGPELSSYHLDGLEPATQYR.3|QHVPGVMVLLVDEPLRGDIFSPIR.4|LSVLGPAGEGPSAEVTAR.2|GLADVVFLPHATQDNAHR.4|GLADVVFLPHATQDNAHR.3|GLADVVFLPHATQDNAHR.2|GPEASVTQTPVC[CAM]PR.3|GPEASVTQTPVC[CAM]PR.2|EGSASVLTVR.2|TGAAILHVADHVFLPQLAR.4|TGAAILHVADHVFLPQLAR.3|TGAAILHVADHVFLPQLAR.2|GLEGGVSYSVR.2|GEMGQPGPSGER.2|RVC[CAM]TTAGGVPVTRPPDDSTSAPR.4|VVQSQGTGTAQD.2|FATVQYSDDPR.2|VAWGPVPGASGFR.2|QEVNVPAGETSVR.2|ITWVGVTGATAYR.2|DLVLSEPSSQSLR.2|PLPSYAADTAGSQLHAVPVLR.3|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.5|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.4|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.3|EIVETWDESSGSFLPVPER.3|VQWTAASGPVTGYK.2|VLSGGPTQQQELGPGQGSVLLR.3|VLSGGPTQQQELGPGQGSVLLR.2|DMPYMDPSGNNLGTAVVTAHR.3|HQILPGNTDSAEIR.2|VTGLEPGVSYIFSLTPVLDGVR.3|VTGLEPGVSYIFSLTPVLDGVR.2|AVTGSTEAC[CAM]HPFVYGGC[CAM]GGNANR.3|TEFGLDALGSGGDVIR.2|EGTPVSIVVTTPPEAPPALGTLHVVQR.3|VQYTPLTGLGQPLPSER.2|VTGLEPGVSYIFSLTPVLDGVRGPEASVTQTPVC[CAM]PR.4|VVDTSIDSVTLAWTPVSR.2|AQGFLLHWQPEGGQEQSR.2|GPGQEVPGSPQTLPGISSSQR.2|QEMSQHC[CAM]AC[CAM]QGQFIASGSRPLPSYAADTAGSQLHAVPVLR.4
SEN / CTL,P07093,Glia-derived nexin,SERPINE2,1.53,1.55,9.98E-02,7.81E-03,2.11E+00,"blood coagulation,negative regulation of cell proliferation,negative regulation of plasminogen activation,negative regulation of sodium ion transport,negative regulation of endopeptidase activity,negative regulation of protein processing,negative regulation of phosphatidylinositol 3-kinase signaling,cerebellar granular layer morphogenesis,negative regulation of blood coagulation,negative regulation of cell growth,regulation of cell migration,secretion by cell,secretory granule organization,negative regulation of protein catabolic process,mating plug formation,negative regulation of proteolysis,negative regulation of smoothened signaling pathway,regulation of timing of cell differentiation,positive regulation of astrocyte differentiation,detection of mechanical stimulus involved in sensory perception,regulation of synaptic transmission, glutamatergic,long-term synaptic potentiation,innervation,seminal vesicle epithelium development,negative regulation of platelet aggregation","serine-type endopeptidase inhibitor activity,receptor binding,protein binding,glycosaminoglycan binding,heparin binding","extracellular region,extracellular space,cytosol,extracellular matrix,platelet alpha granule,extrinsic component of external side of plasma membrane,neuromuscular junction,extracellular vesicle",6,11,14,ASAATTAILIAR.2|NKDIVTVANAVFVK.3|NKDIVTVANAVFVK.2|LVLVNAVYFK.2|SRPHDNIVISPHGIASVLGMLQLGADGR.5|SRPHDNIVISPHGIASVLGMLQLGADGR.4|AKIEVSEDGTK.2|ITTGSENLHVSHILQK.3|DIVTVANAVFVK.2|VLGITDMFDSSK.2|DMIDNLLSPDLIDGVLTR.3|DMIDNLLSPDLIDGVLTR.2|TIDSWMSIMVPK.2|SYQVPMLAQLSVFR.2
SEN / CTL,O14950;P19105,Myosin regulatory light chain 12B;Myosin regulatory light chain 12A,MYL12B;MYL12A,1.53,1.70,5.96E-06,7.96E-07,6.10E+00,"muscle contraction,regulation of cell shape;muscle contraction,ephrin receptor signaling pathway,platelet aggregation","calcium ion binding,myosin heavy chain binding;calcium ion binding","stress fiber,cytosol,brush border,myosin II complex,Z disc,apical part of cell,extracellular exosome;cytosol,myosin complex,extracellular exosome",30,18,38,GNFNYIEFTR.2|ELLTTMGDRFTDEEVDELYR.3|ELLTTM[Oxi]GDRFTDEEVDELYR.3|ATSNVFAMFDQSQIQEFK.2|ATSNVFAMFDQSQIQEFK.3|ATSNVFAM[Oxi]FDQSQIQEFK.3|ATSNVFAM[Oxi]FDQSQIQEFK.2|LNGTDPEDVIR.2|EDLHDMLASLGK.3|EDLHDMLASLGK.2|KGNFNYIEFTR.3|KGNFNYIEFTR.2|FTDEEVDELYR.3|FTDEEVDELYR.2|DGFIDKEDLHDMLASLGK.4|DGFIDKEDLHDM[Oxi]LASLGK.4|DGFIDKEDLHDMLASLGK.3|DGFIDKEDLHDMLASLGK.2|ELLTTMGDR.2|ELLTTM[Oxi]GDR.2|EAFNMIDQNR.2|EAFNM[Oxi]IDQNR.2|EAFNMIDQNRDGFIDK.3|EAFNMIDQNRDGFIDK.2|EAFNMIDQNRDGFIDKEDLHDMLASLGK.5|EAFNMIDQNRDGFIDKEDLHDMLASLGK.4|EAFNM[Oxi]IDQNRDGFIDKEDLHDMLASLGK.4|EAPIDKKGNFNYIEFTR.3|FTDEEVDELYREAPIDK.3|FTDEEVDELYREAPIDK.2|ELLTTM[Oxi]GDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.3|NAFAC[CAM]FDEEATGTIQEDYLR.3|NAFAC[CAM]FDEEATGTIQEDYLR.2|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.4|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.3|ATSNVFAMFDQSQIQEFKEAFNMIDQNR.3
SEN / CTL,O14579,Coatomer subunit epsilon,COPE,1.53,0.69,2.50E-03,2.35E-04,3.63E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,protein transport","structural molecule activity,protein binding","Golgi membrane,nucleoplasm,endoplasmic reticulum membrane,Golgi apparatus,cytosol,COPI vesicle coat,transport vesicle",6,23,43,KFGVVLDEIKPSSAPELQAVR.4|KFGVVLDEIKPSSAPELQAVR.3|DVERDVFLYR.3|MFADYLAHESR.3|M[Oxi]FADYLAHESR.3|MFADYLAHESR.2|LVLQYAPSA.2|LSSPERDVERDVFLYR.4|LSSPERDVERDVFLYR.3|MFADYLAHESRR.3|M[Oxi]FADYLAHESRR.3|DSIVAELDR.2|DSIVAELDREMSR.3|WEAAEGLLQEALDK.3|WEAAEGLLQEALDK.2|FGVVLDEIKPSSAPELQAVR.4|FGVVLDEIKPSSAPELQAVR.3|FGVVLDEIKPSSAPELQAVR.2|C[CAM]SPTLLLLNGQAAC[CAM]HMAQGR.4|C[CAM]SPTLLLLNGQAAC[CAM]HMAQGR.3|C[CAM]SPTLLLLNGQAAC[CAM]HM[Oxi]AQGR.3|C[CAM]SPTLLLLNGQAAC[CAM]HMAQGR.2|RDSIVAELDREMSR.3|LQDAYYIFQEMADK.3|LQDAYYIFQEMADK.2|PSSAPELQAVR.2|RDSIVAELDR.2|DSGYPETLVNLIVLSQHLGKPPEVTNR.5|DSGYPETLVNLIVLSQHLGKPPEVTNR.4|DSGYPETLVNLIVLSQHLGKPPEVTNR.3|NAFYIGSYQQC[CAM]INEAQR.3|NAFYIGSYQQC[CAM]INEAQR.2|APPAPGPASGGSGEVDELFDVK.3|APPAPGPASGGSGEVDELFDVK.2|RMQDLDEDATLTQLATAWVSLATGGEK.4|RM[Oxi]QDLDEDATLTQLATAWVSLATGGEK.3|RMQDLDEDATLTQLATAWVSLATGGEK.3|ALHQGDSLEC[CAM]TAMTVQILLK.3|WEAAEGLLQEALDKDSGYPETLVNLIVLSQHLGKPPEVTNR.6|WEAAEGLLQEALDKDSGYPETLVNLIVLSQHLGKPPEVTNR.5|SVDVTNTTFLLMAASIYLHDQNPDAALR.4|SVDVTNTTFLLMAASIYLHDQNPDAALR.3|ENDFDRLVLQYAPSA.2
SEN / CTL,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,1.52,1.91,5.22E-05,6.23E-06,5.21E+00,"negative regulation of endopeptidase activity,hyaluronan metabolic process","endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity","extracellular region,extracellular exosome,blood microparticle",54,38,62,FYNQVSTPLLR.2|VQFELHYQEVK.3|VQFELHYQEVK.2|IQPSGGTNINEALLR.2|KLWAYLTINQLLAER.3|SILQMSLDHHIVTPLTSLVIENEAGDER.4|SILQMSLDHHIVTPLTSLVIENEAGDER.3|SILQM[Oxi]SLDHHIVTPLTSLVIENEAGDER.4|LWAYLTINQLLAER.2|LWAYLTINQLLAER.3|DKHADPDFTR.3|LSNENHGIAQR.3|LSNENHGIAQR.2|SLAPTAAAK.2|IYLQPGR.2|TILDDLR.2|LGSYEHR.2|TWRNDLISATK.3|HLEVDVWVIEPQGLR.4|HLEVDVWVIEPQGLR.3|HLEVDVWVIEPQGLR.2|VQSTITSR.2|AEDHFSVIDFNQNIR.4|AEDHFSVIDFNQNIR.3|AEDHFSVIDFNQNIR.2|RLSNENHGIAQR.3|HADPDFTR.2|AHVSFKPTVAQQR.3|AHVSFKPTVAQQR.2|KFYNQVSTPLLR.3|KFYNQVSTPLLR.2|IYGNQDTSSQLKK.3|IYGNQDTSSQLKK.2|KLGSYEHR.2|MATTMIQSK.2|M[Oxi]ATTMIQSK.2|TEVNVLPGAK.2|VVNNSPQPQNVVFDVQIPK.4|VVNNSPQPQNVVFDVQIPK.3|VVNNSPQPQNVVFDVQIPK.2|FLHVPDTFEGHFDGVPVISKGQQK.5|HADPDFTRK.2|ETAVDGELVVLYDVK.3|ETAVDGELVVLYDVK.2|FLHVPDTFEGHFDGVPVISK.4|FLHVPDTFEGHFDGVPVISK.3|SSALDMENFR.2|SSALDM[Oxi]ENFR.2|MLADAPPQDPSC[CAM]C[CAM]SGALYYGSK.4|M[Oxi]LADAPPQDPSC[CAM]C[CAM]SGALYYGSK.3|MLADAPPQDPSC[CAM]C[CAM]SGALYYGSK.3|MLADAPPQDPSC[CAM]C[CAM]SGALYYGSK.2|TILDDLRAEDHFSVIDFNQNIR.4|TILDDLRAEDHFSVIDFNQNIR.3|IYGNQDTSSQLK.2|YIEKIQPSGGTNINEALLR.3|AGELEVFNGYFVHFFAPDNLDPIPK.4|AGELEVFNGYFVHFFAPDNLDPIPK.3|SLPGESEEMMEEVDQVTLYSYK.3|NILFVIDVSGSMWGVK.2|NILFVIDVSGSM[Oxi]WGVK.2|NVQFNYPHTSVTDVTQNNFHNYFGGSEIVVAGK.4
SEN / CTL,P12111,Collagen alpha-3(VI) chain,COL6A3,1.50,1.84,8.35E-86,5.01E-85,8.43E+01,"cell adhesion,muscle organ development,negative regulation of endopeptidase activity,extracellular matrix organization,collagen catabolic process",serine-type endopeptidase inhibitor activity,"extracellular region,proteinaceous extracellular matrix,collagen type VI trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,extracellular exosome,extracellular vesicle",750,165,233,ALGSAIEYTIENVFESAPNPR.3|QINVGNALEYVSR.2|QINVGNALEYVSR.3|LVDYLDVGFDTTR.2|EAVLKLSDAGITPLFLTR.3|LLPSFVSSENAFYLSPDIRK.3|ALILVGLER.2|RGGAVPIGIGIGNADITEMQTISFIPDFAVAIPTFR.4|RGGAVPIGIGIGNADITEM[Oxi]QTISFIPDFAVAIPTFR.4|LLVLITGGK.2|LVDKSTELNEEPLMR.3|AC[CAM]NLDVILGFDGSRDQNVFVAQK.3|SVEDAQDVSLALTQR.2|SVEDAQDVSLALTQR.3|IAVAQYSDDVKVESR.3|IAVAQYSDDVKVESR.2|NADPAELEQIVLSPAFILAAESLPK.3|NADPAELEQIVLSPAFILAAESLPK.4|IEEGVPQFLVLISSGKSDDEVDDPAVELKQFGVAPFTIAR.4|IEEGVPQFLVLISSGKSDDEVDDPAVELKQFGVAPFTIAR.5|VVIHFTDGADGDLADLHR.4|VVIHFTDGADGDLADLHR.3|GFESKVDAILNR.2|GFESKVDAILNR.3|AELQHIATDDNLVFTVPEFR.3|QFGVAPFTIAR.2|LDQRVPQIAFVITGGK.3|VPQIAFVITGGK.2|IGDLHPQIVNLLK.3|IGDLHPQIVNLLK.2|VSVVANTPSGPVEAFDFDEYQPEMLEK.3|IREHVPQLLLLLTAGQSEDSYLQAANALTR.4|NIDSEEVGKIASNSATAFR.3|QSGVVPFIFQAK.2|VC[CAM]APVLAKPGVISVMGT.2|IVVLMLTGEVPEQQLEEAQR.3|NNLFTSSAGYR.2|VVESLDVGQDRVR.3|LLTPITTLTSEQIQK.2|LLTPITTLTSEQIQK.3|LSDAGITPLFLTR.2|LLPSFVSSENAFYLSPDIR.3|VGLVQFSDTPVTEFSLNTYQTK.3|SLDEISQPAQELKR.3|SLDEISQPAQELKR.2|EVQVFEITENSAK.2|DVVFLIDGSQSAGPEFQYVR.3|DVVFLIDGSQSAGPEFQYVR.2|SQHPYVLTEDTLKVYLNKFR.4|SQHPYVLTEDTLKVYLNKFR.5|SQHPYVLTEDTLKVYLNKFR.3|LNLLDLDYELAEQLDNIAEK.3|LNLLDLDYELAEQLDNIAEK.2|IEDGVPQHLVLVLGGK.3|IEDGVPQHLVLVLGGK.2|MKPLDGSALYTGSALDFVR.3|M[Oxi]KPLDGSALYTGSALDFVR.3|SAGSRIEDGVPQHLVLVLGGK.4|SAGSRIEDGVPQHLVLVLGGK.3|VGVVQFSNDVFPEFYLK.3|VGVVQFSNDVFPEFYLK.2|AAPLQGMLPGLLAPLR.2|AAPLQGMLPGLLAPLR.3|AAPLQGM[Oxi]LPGLLAPLR.3|AAPLQGM[Oxi]LPGLLAPLR.2|ISLSPEYVFSVSTFR.2|ISLSPEYVFSVSTFR.3|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.5|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.4|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.3|GADQAELEEIAFDSSLVFIPAEFR.3|EFRELPNIEER.3|IIDELNVKPEGTR.3|IIDELNVKPEGTR.2|LLPYIVGVAQR.2|SSGIVSLGVGDR.2|VVESLDVGQDR.2|DSFQEVLR.2|VGNVQELSELSEQVLETLHDAMHETLC[CAM]PGVTDAAK.4|VGNVQELSELSEQVLETLHDAM[Oxi]HETLC[CAM]PGVTDAAK.4|NIDRTELQTITNDPR.3|NIDRTELQTITNDPR.2|ALNLGYALDYAQR.2|ALNLGYALDYAQR.3|QLGTVQQVISER.2|QLGTVQQVISER.3|QLTLLGGPTPNTGAALEFVLR.3|QLTLLGGPTPNTGAALEFVLR.2|QLQLQGGSGLNTGSALSYVYANHFTEAGGSR.3|QLQLQGGSGLNTGSALSYVYANHFTEAGGSR.4|SQHPYVLTEDTLK.3|SQHPYVLTEDTLK.2|AC[CAM]NLDVILGFDGSR.2|RDVVFLIDGSQSAGPEFQYVR.3|GDSIDQC[CAM]ALIQSIK.2|SSIMAFAIGNK.2|SSIM[Oxi]AFAIGNK.2|ITEGVPQLLIVLTADR.2|ITEGVPQLLIVLTADR.3|IEEGVPQFLVLISSGKSDDEVDDPAVELK.3|IEEGVPQFLVLISSGKSDDEVDDPAVELK.4|EVYTFASEPNDVFFK.2|EVYTFASEPNDVFFK.3|SAGSRIEDGVPQHLVLVLGGKSQDDVSR.4|QASVFSFGLGAQAASR.2|ITEGVPQLLIVLTADRSGDDVRNPSVVVK.4|SDDEVDDPAVELKQFGVAPFTIAR.3|SQHPYVLTEDTLKVYLNK.4|YIAYLVR.2|VGVVQFSDEPR.2|NLQVALTSK.2|VAVFFSNTPTR.2|QIIDAINKVVYK.3|VAVVQYSDR.2|SVHNGAPAPVSGEKDVVFLLDGSEGVR.3|SVHNGAPAPVSGEKDVVFLLDGSEGVR.4|LQPVLQPLPSPGVGGK.2|LQPVLQPLPSPGVGGK.3|GAQGPAGPAGPPGLIGEQGISGPR.2|GAQGPAGPAGPPGLIGEQGISGPR.3|SLDEISQPAQELK.2|SLDEISQPAQELK.3|MRDVVLSIVNDLTIAESNC[CAM]PR.4|MRDVVLSIVNDLTIAESNC[CAM]PR.3|M[Oxi]RDVVLSIVNDLTIAESNC[CAM]PR.3|FDEHQSKPEILNLVK.4|FDEHQSKPEILNLVK.3|FDEHQSKPEILNLVK.2|VAVVTYNNEVTTEIR.2|VAVVTYNNEVTTEIR.3|IEEGVPQFLVLISSGK.2|IEEGVPQFLVLISSGK.3|RDILFLFDGSANLVGQFPVVR.3|KVAVFFSNTPTR.3|SDDEVDDPAVELK.2|IAVAQYSDDVK.2|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.5|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.6|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.4|QQSLETAMSFVAR.2|QQSLETAMSFVAR.3|QQSLETAM[Oxi]SFVAR.2|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.6|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.5|TRPEFYLNSYMNK.3|TRPEFYLNSYM[Oxi]NK.3|TRPEFYLNSYMNK.2|VDAILNR.2|VNHFVPEAGSR.3|VNHFVPEAGSR.2|SQAPVLDAIRR.3|VGLEHLR.2|ASENLRQEGVR.3|QIIDAINKVVYKGGR.4|QIIDAINKVVYKGGR.3|GETGDDGRDGVGSEGRR.4|GETGDDGRDGVGSEGRR.3|LQPVLQPLPSPGVGGKR.4|LQPVLQPLPSPGVGGKR.2|RSSIMAFAIGNK.3|RLNIGPSK.2|SSDRVDGPASNLK.3|SSDRVDGPASNLK.2|SVHNGAPAPVSGEK.3|SVHNGAPAPVSGEK.2|VTQLTREELSR.3|SDILGHLR.2|SGDDVRNPSVVVK.3|SGDDVRNPSVVVK.2|GLEYIMQSHLTK.3|SGFPLLKEFVQR.3|GIPGEDGYR.2|GMTQLQGTR.2|ELPNIEER.2|NILVSSAGSR.2|SGDDVRNPSVVVKR.3|LPIGTQQIR.2|DQNVFVAQK.2|GETGDDGRDGVGSEGR.3|IASNSATAFR.2|NADQEELVK.2|DEVQNAVQR.2|DGVPGGPGETGK.2|RQIIDAINK.2|SQAPVLDAIR.2|LRGGSPLNTGK.2|VEFLLNAHSSKDEVQNAVQR.4|VEFLLNAHSSKDEVQNAVQR.3|GDRGPIGSIGPK.2|RDSFQEVLR.2|VAVIQFSDDPK.2|VAVIQFSDDPKVEFLLNAHSSK.4|KADIVFLLDGSINFRR.3|SVLLDKIKNLQVALTSK.3|GNRGDSIDQC[CAM]ALIQSIK.3|GNRGDSIDQC[CAM]ALIQSIK.2|GPRGETGDDGRDGVGSEGR.3|VVIHFTDGADGDLADLHRASENLRQEGVR.5|TELQTITNDPR.2|TRPEFYLNSYM[Oxi]NKQDVVNAVR.4|ASPQLREAVLKLSDAGITPLFLTR.4|ASPQLREAVLKLSDAGITPLFLTR.3|STELNEEPLMR.2|GDPGNPGQDSQER.2|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.6|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.5|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.5|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.4|DVVFLLDGSEGVR.2|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTK.5|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTK.4|SFGDLQEKLLPYIVGVAQR.3|LVFTVREFRELPNIEER.3|VAVVQYSDRTRPEFYLNSYM[Oxi]NKQDVVNAVR.5|DIIFLLDGSANVGK.2|DIVFLVDGSSALGLANFNAIR.3|VIGGLLAGQTYHVAVVC[CAM]YLR.3|GGPGQPGFEGEQGTR.2|QC[CAM]DWFQGDQPTK.2|VRVGVVQFSNDVFPEFYLK.3|VEEGVPQVLVLISAGPSSDEIR.3|VEEGVPQVLVLISAGPSSDEIR.2|AGILTFC[CAM]VGASQANK.2|RDIVFLVDGSSALGLANFNAIR.3|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.5|ELPSLEQKLLTPITTLTSEQIQK.3|SSDRVDGPASNLKQSGVVPFIFQAK.3|ISLSPEYVFSVSTFRELPSLEQK.3|PLDGSALYTGSALDFVR.2|ALGFAGGELANIGLALDFVVENHFTR.3|C[CAM]PC[CAM]C[CAM]YGPLEC[CAM]PVFPTELAFALDTSEGVNQDTFGR.4|EHVPQLLLLLTAGQSEDSYLQAANALTR.3|ISLSPEYVFSVSTFRELPSLEQKLLTPITTLTSEQIQK.4
SEN / CTL,P23528,Cofilin-1,CFL1,1.49,1.89,3.50E-13,1.06E-13,1.30E+01,"cytoskeleton organization,Rho protein signal transduction,response to virus,regulation of cell morphogenesis,actin cytoskeleton organization,actin filament depolymerization,negative regulation of apoptotic process,positive regulation by host of viral process,regulation of dendritic spine morphogenesis","protein binding,actin filament binding","extracellular space,nucleus,cytoplasm,focal adhesion,actin cytoskeleton,membrane,nuclear matrix,extracellular matrix,lamellipodium membrane,vesicle,ruffle membrane,extracellular exosome",102,25,48,ESKKEDLVFIFWAPESAPLK.4|ESKKEDLVFIFWAPESAPLK.3|ESKKEDLVFIFWAPESAPLK.2|LGGSAVISLEGKPL.2|LGGSAVISLEGKPL.3|LTGIKHELQANC[CAM]YEEVKDR.4|LTGIKHELQANC[CAM]YEEVKDR.5|LTGIKHELQANC[CAM]YEEVKDR.3|YALYDATYETK.2|YALYDATYETK.3|NIILEEGKEILVGDVGQTVDDPYATFVK.4|NIILEEGKEILVGDVGQTVDDPYATFVK.3|NIILEEGKEILVGDVGQTVDDPYATFVK.5|AVLFC[CAM]LSEDKK.3|AVLFC[CAM]LSEDKK.2|NIILEEGK.2|KEDLVFIFWAPESAPLK.3|KEDLVFIFWAPESAPLK.4|KEDLVFIFWAPESAPLK.2|KAVLFC[CAM]LSEDK.3|SSTPEEVK.2|HELQANC[CAM]YEEVKDR.4|HELQANC[CAM]YEEVKDR.3|HELQANC[CAM]YEEVKDR.2|KAVLFC[CAM]LSEDKK.3|KAVLFC[CAM]LSEDKK.2|DRC[CAM]TLAEK.2|KSSTPEEVK.2|SSTPEEVKK.2|HELQANC[CAM]YEEVK.3|HELQANC[CAM]YEEVK.2|LTGIKHELQANC[CAM]YEEVK.4|LTGIKHELQANC[CAM]YEEVK.3|LTGIKHELQANC[CAM]YEEVK.2|KNIILEEGK.2|MLPDKDC[CAM]R.2|M[Oxi]LPDKDC[CAM]R.2|EILVGDVGQTVDDPYATFVK.4|EILVGDVGQTVDDPYATFVK.3|EILVGDVGQTVDDPYATFVK.2|KLTGIKHELQANC[CAM]YEEVK.4|KLTGIKHELQANC[CAM]YEEVK.3|KLTGIKHELQANC[CAM]YEEVK.2|AVLFC[CAM]LSEDKKNIILEEGK.4|LGGSAVISLEGK.2|AVLFC[CAM]LSEDK.2|KNIILEEGKEILVGDVGQTVDDPYATFVK.4|KNIILEEGKEILVGDVGQTVDDPYATFVK.3
SEN / CTL,Q12765,Secernin-1,SCRN1,1.49,1.71,7.07E-03,6.19E-04,3.21E+00,"proteolysis,exocytosis","molecular_function,dipeptidase activity","nucleus,cytoplasm,nuclear membrane",18,21,30,C[CAM]IC[CAM]SQLSLTTK.2|SIFKPFIFVDDVK.3|SIFKPFIFVDDVK.2|SSPC[CAM]IHYFTGTPDPSR.3|SSPC[CAM]IHYFTGTPDPSR.2|DGLVVFGK.2|AIIESDQEQGRK.3|AIIESDQEQGRK.2|STMLELEK.2|TYAIMISR.2|TQSPC[CAM]FGDDDPAKKEPR.4|TQSPC[CAM]FGDDDPAKKEPR.3|SIFKPFIFVDDVKLVPK.4|SIFKPFIFVDDVKLVPK.3|TQSPC[CAM]FGDDDPAKK.3|VEC[CAM]TYISIDQVPR.3|VEC[CAM]TYISIDQVPR.2|PFIFVDDVK.2|MDAEHPELR.2|EPAAEIEALLGM[Oxi]DLVR.3|EPAAEIEALLGMDLVR.3|EPAAEIEALLGMDLVR.2|AIIESDQEQGR.2|DEAWVLETIGK.2|TQSPC[CAM]FGDDDPAK.2|DEVQEVVYFSAADHEPESK.3|DEVQEVVYFSAADHEPESK.2|QEESITVQTMMNTLR.2|PAWLWGAEMGANEHGVC[CAM]IANEAINTR.3|QGLEAMEEILTSSEPLDPAEVGDLFYDC[CAM]VDTEIK.4
SEN / CTL,P35580,Myosin-10,MYH10,1.49,1.58,6.02E-02,4.84E-03,2.32E+00,"mitotic cytokinesis,in utero embryonic development,neuron migration,plasma membrane repair,cardiac septum development,exocytosis,substrate-dependent cell migration, cell extension,nuclear migration,cell adhesion,axon guidance,adult heart development,cell proliferation,regulation of cell shape,fourth ventricle development,lateral ventricle development,third ventricle development,cerebellar Purkinje cell layer development,actin filament-based movement,actomyosin structure organization,aorta development,neuromuscular process controlling balance,cardiac myofibril assembly,ventricular cardiac muscle cell development,retina development in camera-type eye,coronary vasculature development","microfilament motor activity,actin binding,protein binding,calmodulin binding,ATP binding,actin-dependent ATPase activity,ADP binding,actin filament binding","stress fiber,nucleus,cytoplasm,mitochondrion,spindle,cytosol,plasma membrane,brush border,cell cortex,actin cytoskeleton,myosin complex,myosin II complex,lamellipodium,axon,growth cone,midbody,neuromuscular junction,cleavage furrow,actomyosin,neuronal cell body,dendritic spine,extracellular exosome,myosin II filament",6,181,303,SLEAEILQLQEELASSER.3|SLEAEILQLQEELASSER.2|AGVLAHLEEER.3|AGVLAHLEEER.2|ELEAELEDERKQR.4|ELEAELEDERKQR.3|KEEELQGALAR.3|KEEELQGALAR.2|LLKDAEALSQR.3|LLKDAEALSQR.2|NHEAQIQDMR.3|NHEAQIQDM[Oxi]R.3|NHEAQIQDMR.2|NHEAQIQDM[Oxi]R.2|REQEVAELKK.3|ASRDEIFAQSK.3|ASRDEIFAQSK.2|LDAQVQELHAK.3|LDAQVQELHAK.2|LKEIFMQVEDERR.4|ADFC[CAM]IIHYAGK.3|ADFC[CAM]IIHYAGK.2|ASRDEIFAQSKESEK.4|KDHNIPGELER.3|KFDQLLAEEKSISAR.4|KQELEEILHDLESR.4|KQELEEILHDLESR.3|KQELEEILHDLESR.2|LLKDAEALSQRLEEK.4|LLKDAEALSQRLEEK.3|RAGKLDPHLVLDQLR.4|KMEIDLK.2|ADEWLMK.2|ADEWLM[Oxi]K.2|ADFC[CAM]IIHYAGKVDYK.4|ADFC[CAM]IIHYAGKVDYK.3|ADFC[CAM]IIHYAGKVDYK.2|DAEALSQR.2|LRLEVNMQAMK.3|QVASNLEK.2|VEGELEEMERK.3|ATISALEAK.2|ELEAELEDERK.3|ELEAELEDERK.2|TVGQLYKESLTK.3|DAEALSQRLEEK.3|DAEALSQRLEEK.2|HGFEAASIKEER.3|HGFEAASIKEER.2|KLDAQVQELHAK.3|KLDAQVQELHAK.2|QQQLSALK.2|RALEQQVEEMR.3|RALEQQVEEM[Oxi]R.3|RALEQQVEEMR.2|TGLEDPER.2|VEEEEER.2|DEIFAQSK.2|HADQYKEQMEK.3|HADQYKEQM[Oxi]EK.3|SALLDEKR.2|VDYKADEWLMK.3|VDYKADEWLMK.2|VDYKADEWLM[Oxi]K.2|EQEVAELK.2|KKVDDDLGTIESLEEAK.4|KKVDDDLGTIESLEEAK.3|KKVDDDLGTIESLEEAK.2|QLKDKADFC[CAM]IIHYAGK.4|QLKDKADFC[CAM]IIHYAGK.2|DELADEITNSASGK.3|DELADEITNSASGK.2|EERGDEVMVELAENGKK.4|HEM[Oxi]PPHIYAISESAYR.4|HEM[Oxi]PPHIYAISESAYR.3|HEMPPHIYAISESAYR.3|HGFEAASIK.2|NTNPNFVR.2|SDLLLEGFNNYR.3|SDLLLEGFNNYR.2|HATALEELSEQLEQAKR.4|HATALEELSEQLEQAKR.3|RQLEEAEEEATR.3|RQLEEAEEEATR.2|VIQYLAHVASSHK.3|VIQYLAHVASSHK.2|LQELEGAVK.2|NKQGLETDNKELAC[CAM]EVK.4|NKQGLETDNKELAC[CAM]EVK.3|NKQGLETDNKELAC[CAM]EVK.2|NQILQNEK.2|TFHIFYQLLSGAGEHLK.4|TFHIFYQLLSGAGEHLK.3|DLQTRDEQNEEK.3|GGPISFSSSR.2|KKLDAQVQELHAK.3|LVWIPSER.2|ALEEALEAKEEFERQNK.4|ALEEALEAKEEFERQNK.3|ELDDATEANEGLSR.3|ELDDATEANEGLSR.2|GDEVMVELAENGKK.3|GDEVMVELAENGKK.2|IGQLEEQLEQEAK.3|IGQLEEQLEQEAK.2|VVSSVLQFGNISFK.3|VVSSVLQFGNISFK.2|ALEEETKNHEAQIQDM[Oxi]R.4|ALEEETKNHEAQIQDMR.4|ALEEETKNHEAQIQDMR.3|ALEEETKNHEAQIQDMR.2|DKADFC[CAM]IIHYAGK.3|DKADFC[CAM]IIHYAGK.2|DKADFC[CAM]IIHYAGKVDYK.4|HQQLLEEK.2|KMEIDLKDLEAQIEAANK.4|LKEIFMQVEDER.3|QRYEILTPNAIPK.3|QVLALQSQLADTKK.3|RHEMPPHIYAISESAYR.4|ATDKTFVEK.2|KQQQLSALK.2|YAEERDRAEAEAR.3|YAEERDRAEAEAR.2|AGVLAHLEEERDLK.3|AGVLAHLEEERDLK.2|ALAYDKLEK.2|KVIQYLAHVASSHK.3|LEVNMQAMK.2|LEVNMQAM[Oxi]K.2|NKQEVMISDLEER.3|NKQEVM[Oxi]ISDLEER.3|NKQEVMISDLEER.2|EQEVAELKK.2|NTDQASMPENTVAQK.3|NTDQASMPENTVAQK.2|NTDQASM[Oxi]PENTVAQK.2|ADMEDLM[Oxi]SSKDDVGK.3|ADMEDLMSSKDDVGK.3|ADMEDLMSSKDDVGK.2|AVIYNPATQADWTAK.3|AVIYNPATQADWTAK.2|HAEQERDELADEITNSASGK.4|HAEQERDELADEITNSASGK.3|HAEQERDELADEITNSASGK.2|NRLQQELDDLTVDLDHQR.4|VVSSVLQFGNISFKK.3|VVSSVLQFGNISFKK.2|ALEEALEAKEEFER.3|ALEEALEAKEEFER.2|EEELQGALAR.2|LVQEQGSHSK.2|QRHATALEELSEQLEQAKR.4|ADMEDLMSSK.2|ADMEDLM[Oxi]SSK.2|ADM[Oxi]EDLM[Oxi]SSK.2|KLVWIPSER.2|MEEEILLLEDQNSK.3|MEEEILLLEDQNSK.2|M[Oxi]EEEILLLEDQNSK.2|DLSEELEALK.2|LC[CAM]HLLGMNVMEFTR.3|LC[CAM]HLLGM[Oxi]NVMEFTR.3|LC[CAM]HLLGMNVM[Oxi]EFTR.3|LC[CAM]HLLGMNVMEFTR.2|QEEELQAKDEELLK.3|QEEELQAKDEELLK.2|TGLEDPERYLFVDR.3|VEDMAELTC[CAM]LNEASVLHNLK.4|VEDMAELTC[CAM]LNEASVLHNLK.3|VEDM[Oxi]AELTC[CAM]LNEASVLHNLK.3|VEDMAELTC[CAM]LNEASVLHNLK.2|AMVNKDDIQK.2|QGLETDNKELAC[CAM]EVK.3|QGLETDNKELAC[CAM]EVK.2|QLLQANPILESFGNAK.3|QLLQANPILESFGNAK.2|RGGPISFSSSR.2|KVDDDLGTIESLEEAK.3|KVDDDLGTIESLEEAK.2|NLPIYSENIIEMYR.3|NLPIYSENIIEM[Oxi]YR.3|NLPIYSENIIEMYR.2|NLPIYSENIIEM[Oxi]YR.2|NSLQEQQEEEEEARKNLEK.4|TTLQVDTLNAELAAER.3|TTLQVDTLNAELAAER.2|AKLQELEGAVK.2|ASKLQNELDNVSTLLEEAEKK.4|AVIYNPATQADWTAKK.3|DHNIPGELER.2|FKATISALEAK.2|KMQAHIQDLEEQLDEEEGAR.4|KMQAHIQDLEEQLDEEEGAR.3|LQNELDNVSTLLEEAEKKGIK.4|RHAEQERDELADEITNSASGK.4|RHAEQERDELADEITNSASGK.3|HATALEELSEQLEQAK.3|HATALEELSEQLEQAK.2|IGQLEEQLEQEAKER.3|IGQLEEQLEQEAKER.2|DLEAQIEAANK.2|IAEC[CAM]SSQLAEEEEKAK.3|IAEC[CAM]SSQLAEEEEKAK.2|KMEEEILLLEDQNSK.3|KM[Oxi]EEEILLLEDQNSK.3|KMEEEILLLEDQNSK.2|QLEEAEEEATRANASR.3|NSLQEQQEEEEEARK.3|TKNRLQQELDDLTVDLDHQR.4|VEGELEEMER.2|VEGELEEM[Oxi]ER.2|ALEQQVEEMR.2|ALEQQVEEM[Oxi]R.2|ELEAELEDER.2|IRNKQEVMISDLEER.3|KTTLQVDTLNAELAAER.3|KTTLQVDTLNAELAAER.2|KVDDDLGTIESLEEAKK.3|VEEEEERNQILQNEK.3|YEILTPNAIPK.2|IAQLEEELEEEQSNMELLNDR.4|IAQLEEELEEEQSNMELLNDR.3|IAQLEEELEEEQSNM[Oxi]ELLNDR.3|VEDMAELTC[CAM]LNEASVLHNLKDR.4|VEDM[Oxi]AELTC[CAM]LNEASVLHNLKDR.4|VEDMAELTC[CAM]LNEASVLHNLKDR.3|AGKLDPHLVLDQLRC[CAM]NGVLEGIR.4|AGKLDPHLVLDQLRC[CAM]NGVLEGIR.3|ERNTDQASMPENTVAQK.3|LQQELDDLTVDLDHQR.3|LQQELDDLTVDLDHQR.2|MEIDLKDLEAQIEAANK.3|M[Oxi]EIDLKDLEAQIEAANK.3|TELEDTLDTTAAQQELR.3|TELEDTLDTTAAQQELR.2|EIFMQVEDER.2|LQNELDNVSTLLEEAEK.3|LQNELDNVSTLLEEAEK.2|QLEEAEEEATR.2|QLEEEKNSLQEQQEEEEEARK.4|RQLEEAEEEATRANASR.3|DAASLESQLQDTQELLQEETRQK.4|DAASLESQLQDTQELLQEETRQK.3|ELQAQIAELQEDFESEK.3|ELQAQIAELQEDFESEK.2|FSKVEDM[Oxi]AELTC[CAM]LNEASVLHNLK.4|FSKVEDMAELTC[CAM]LNEASVLHNLK.4|FSKVEDMAELTC[CAM]LNEASVLHNLK.3|VVRELQAQIAELQEDFESEKASR.4|VVRELQAQIAELQEDFESEKASR.3|QEVMISDLEER.2|QEVM[Oxi]ISDLEER.2|KLDGETTDLQDQIAELQAQIDELK.4|KLDGETTDLQDQIAELQAQIDELK.3|GDEVMVELAENGK.2|LQNELDNVSTLLEEAEKK.3|LQNELDNVSTLLEEAEKK.2|QLHLEGASLELSDDDTESK.3|IVGLDQVTGM[Oxi]TETAFGSAYK.3|IVGLDQVTGMTETAFGSAYK.3|IVGLDQVTGMTETAFGSAYK.2|IVGLDQVTGM[Oxi]TETAFGSAYK.2|NMDPLNDNVATLLHQSSDR.3|NM[Oxi]DPLNDNVATLLHQSSDR.3|NM[Oxi]DPLNDNVATLLHQSSDR.2|NMDPLNDNVATLLHQSSDR.2|QVLALQSQLADTK.2|PANPPGVLALLDEEC[CAM]WFPK.3|PANPPGVLALLDEEC[CAM]WFPK.2|RKLDGETTDLQDQIAELQAQIDELK.4|RKLDGETTDLQDQIAELQAQIDELK.3|TSDVNETQPPQSE.2|FSKVEDMAELTC[CAM]LNEASVLHNLKDR.4|GDDETLHKNNALK.2|DNFQETMEAMHIMGFSHEEILSMLK.4|DNFQETMEAMHIMGFSHEEILSMLK.3|IAQLEEELEEEQSNM[Oxi]ELLNDRFRK.4|QKKFDQLLAEEK.2|M[Oxi]QAHIQDLEEQLDEEEGAR.3|MQAHIQDLEEQLDEEEGAR.3|MQAHIQDLEEQLDEEEGAR.2|DLSEELEALKTELEDTLDTTAAQQELR.4|DLSEELEALKTELEDTLDTTAAQQELR.3|LKSLEAEILQLQEELASSER.3|ELQAQIAELQEDFESEKASR.3|C[CAM]M[Oxi]LQDREDQSILC[CAM]TGESGAGK.3|C[CAM]MLQDREDQSILC[CAM]TGESGAGK.3|C[CAM]MLQDREDQSILC[CAM]TGESGAGK.2|DAASLESQLQDTQELLQEETR.3|ITDIIIFFQAVC[CAM]R.2|IAEC[CAM]SSQLAEEEEK.2|KLDGETTDLQDQIAELQAQIDELKLQLAK.4|NILAEQLQAETELFAEAEEM[Oxi]R.3|NILAEQLQAETELFAEAEEMR.3|VDDDLGTIESLEEAK.2|DAASLESQLQDTQELLQEETRQKLNLSSR.4|QLEEEKNSLQEQQEEEEEAR.3|FLSNGYIPIPGQQDK.2|DVDRIVGLDQVTGMTETAFGSAYK.3|LDGETTDLQDQIAELQAQIDELK.3|NSLQEQQEEEEEAR.2|IRQLEEEKNSLQEQQEEEEEAR.3
SEN / CTL,O15347,High mobility group protein B3,HMGB3,1.49,1.49,1.98E-01,1.51E-02,1.82E+00,"DNA recombination,transcription, DNA-templated,regulation of transcription, DNA-templated,multicellular organism development,DNA geometric change,innate immune response,negative regulation of cell differentiation","four-way junction DNA binding,double-stranded DNA binding,protein binding,DNA binding, bending,poly(A) RNA binding","nucleus,chromosome,cytoplasm",6,15,26,M[Oxi]SAYAFFVQTC[CAM]R.2|MSAYAFFVQTC[CAM]R.3|M[Oxi]SAYAFFVQTC[CAM]R.3|MSAYAFFVQTC[CAM]R.2|KKNPEVPVNFAEFSK.4|KKNPEVPVNFAEFSK.3|STNPGISIGDVAKK.3|SKFDEMAK.2|RPPSGFFLFC[CAM]SEFRPK.4|RPPSGFFLFC[CAM]SEFRPK.3|MSAYAFFVQTC[CAM]REEHK.4|MSAYAFFVQTC[CAM]REEHK.3|KNPEVPVNFAEFSK.3|KNPEVPVNFAEFSK.2|KLGEMWNNLNDSEK.3|KLGEM[Oxi]WNNLNDSEK.3|KLGEMWNNLNDSEK.2|KNPEVPVNFAEFSKK.3|KLGEMWNNLNDSEKQPYITK.4|KLGEMWNNLNDSEKQPYITK.3|STNPGISIGDVAK.2|NPEVPVNFAEFSK.2|IKSTNPGISIGDVAK.2|LGEMWNNLNDSEKQPYITK.3|LGEMWNNLNDSEK.2|LGEM[Oxi]WNNLNDSEK.2
SEN / CTL,Q96D15,Reticulocalbin-3,RCN3,1.49,1.40,5.33E-07,8.21E-08,7.09E+00,,calcium ion binding,endoplasmic reticulum lumen,24,13,20,AGDGDGWVSLAELR.2|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.6|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.5|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.4|EVAKEFDQLTPEESQAR.3|EVAKEFDQLTPEESQAR.2|EELTAFLHPEEFPHMR.4|EELTAFLHPEEFPHMR.3|DIVIAETLEDLDR.3|DIVIAETLEDLDR.2|FRVADQDGDSMATR.3|AWIAHTQQR.2|DIVIAETLEDLDRNK.3|DIVIAETLEDLDRNK.2|VADQDGDSMATR.2|VADQDGDSM[Oxi]ATR.2|DSVSAAWDTYDTDRDGR.3|EFDQLTPEESQAR.2|DSVSAAWDTYDTDR.2|DGYVQVEEYIADLYSAEPGEEEPAWVQTER.3
SEN / CTL,Q9Y678,Coatomer subunit gamma-1,COPG1,1.48,1.71,2.78E-09,5.54E-10,9.26E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,establishment of Golgi localization,organelle transport along microtubule",structural molecule activity,"Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,cytosol,COPI vesicle coat,transport vesicle",42,59,97,SSPEPVALTESETEYVIR.2|SSPEPVALTESETEYVIR.3|SDKVPDNKNTHTLLLAGVFR.4|SLEELPVDIILASVG.2|SLEELPVDIILASVG.3|VAATRQEIFQEQLAAVPEFR.3|FGAQNEEMLPSILVLLKR.3|SIATLAITTLLK.2|SIATLAITTLLK.3|ILHLLGQEGPK.3|ILHLLGQEGPK.2|C[CAM]SFDVVK.2|DMTGKEDNYRGPAVR.4|DMTGKEDNYRGPAVR.3|GGHDILVR.2|LFQSNDPTLRR.3|NTHTLLLAGVFR.3|NTHTLLLAGVFR.2|KDEESGGGSNPFQHLEK.4|KDEESGGGSNPFQHLEK.3|KDEESGGGSNPFQHLEK.2|RC[CAM]VMDDDNEVR.3|RC[CAM]VMDDDNEVR.2|TGSESSIDR.2|EEGGFEYK.2|ALQQYTLEPSEKPFDLK.4|ALQQYTLEPSEKPFDLK.3|ALQQYTLEPSEKPFDLK.2|C[CAM]SFDVVKR.2|TESTPITAVKQPEK.3|TESTPITAVKQPEK.2|ALNAGYILNGLTVSIPGLER.4|ALNAGYILNGLTVSIPGLER.3|ALNAGYILNGLTVSIPGLER.2|TESTPITAVK.2|LLLLDTVTMQVTAR.3|LLLLDTVTMQVTAR.2|LLLLDTVTM[Oxi]QVTAR.2|DSPLFDFIESC[CAM]LR.3|DSPLFDFIESC[CAM]LR.2|QISSFMSEISDEFK.3|QISSFMSEISDEFK.2|RC[CAM]VMDDDNEVRDR.3|VVLEHEEVR.2|FDKKDEESGGGSNPFQHLEK.4|FLGMHPC[CAM]ER.2|DEESGGGSNPFQHLEK.3|DEESGGGSNPFQHLEK.2|VPSVSSSALVSSLHLLK.3|VPSVSSSALVSSLHLLK.2|EETFTLSTIK.2|TLEEAVGNIVK.2|VFNETPINPR.2|LFQSNDPTLR.2|QAIVDKVPSVSSSALVSSLHLLK.4|QAIVDKVPSVSSSALVSSLHLLK.3|QEIFQEQLAAVPEFR.3|QEIFQEQLAAVPEFR.2|ALC[CAM]QITDSTMLQAIER.3|ALC[CAM]QITDSTMLQAIER.2|NKHEMVVYEAASAIVNLPGC[CAM]SAK.4|NKHEM[Oxi]VVYEAASAIVNLPGC[CAM]SAK.4|NKHEMVVYEAASAIVNLPGC[CAM]SAK.3|C[CAM]VMDDDNEVR.2|FGAQNEEMLPSILVLLK.3|FGAQNEEM[Oxi]LPSILVLLK.2|FGAQNEEMLPSILVLLK.2|LNFEAAWDEVGDEFEK.3|LNFEAAWDEVGDEFEK.2|SPFAYC[CAM]MMIR.2|SPFAYC[CAM]MM[Oxi]IR.2|AIVDC[CAM]IISIIEENSESK.3|AIVDC[CAM]IISIIEENSESK.2|ETGLSHLC[CAM]EFIEDC[CAM]EFTVLATR.4|ETGLSHLC[CAM]EFIEDC[CAM]EFTVLATR.3|ATFYLNVLEQK.2|EMSC[CAM]IAEDVIIVTSSLTK.3|EMSC[CAM]IAEDVIIVTSSLTK.2|SLPYNQPGTC[CAM]YTLVALPK.3|SLPYNQPGTC[CAM]YTLVALPK.2|SVPLATAPMAEQR.2|SVPLATAPM[Oxi]AEQR.2|RAIVDC[CAM]IISIIEENSESK.3|RAIVDC[CAM]IISIIEENSESK.2|VAMKHPSAVTAC[CAM]NLDLENLVTDSNR.4|ALQQYTLEPSEK.2|ILYLINQGEHLGTTEATEAFFAMTK.4|ILYLINQGEHLGTTEATEAFFAM[Oxi]TK.3|ILYLINQGEHLGTTEATEAFFAMTK.3|HEMVVYEAASAIVNLPGC[CAM]SAK.3|HEMVVYEAASAIVNLPGC[CAM]SAK.2|HPSAVTAC[CAM]NLDLENLVTDSNR.3|WVNEAQEAASSDNIMVQYHALGLLYHVR.4|EDPTAVAC[CAM]TFSC[CAM]MMK.2|QLEEEDGSRDSPLFDFIESC[CAM]LR.3|DC[CAM]DPTTGETDDEGYEDEYVLEDLEVTVADHIQK.4|LNFEAAWDEVGDEFEKEETFTLSTIK.3
SEN / CTL,P62277,40S ribosomal protein S13,RPS13,1.48,3.55,2.49E-02,2.06E-03,2.69E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,negative regulation of RNA splicing","mRNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,small ribosomal subunit rRNA binding,5.8S rRNA binding","nucleus,nucleoplasm,nucleolus,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",12,14,22,GLTPSQIGVILR.2|GLTPSQIGVILR.3|KGLTPSQIGVILR.3|KGLTPSQIGVILR.2|GLSQSALPYRR.3|LILIESR.2|GLAPDLPEDLYHLIKK.4|GLAPDLPEDLYHLIKK.3|GLAPDLPEDLYHLIKK.2|KGLTPSQIGVILRDSHGVAQVR.5|KGLTPSQIGVILRDSHGVAQVR.4|DSHGVAQVR.2|LTSDDVKEQIYK.3|LTSDDVKEQIYK.2|SKGLAPDLPEDLYHLIKK.4|GLSQSALPYR.2|GLTPSQIGVILRDSHGVAQVR.4|YESSTASALVA.2|GLAPDLPEDLYHLIK.3|GLAPDLPEDLYHLIK.2|SVPTWLKLTSDDVKEQIYK.4|SVPTWLKLTSDDVKEQIYK.3
SEN / CTL,Q13813,"Spectrin alpha chain, non-erythrocytic 1",SPTAN1,1.46,1.99,3.57E-06,4.95E-07,6.31E+00,"MAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,positive regulation of GTPase activity,actin filament capping,cell-cell adhesion","actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,calcium ion binding,protein binding,calmodulin binding,cadherin binding involved in cell-cell adhesion","cytosol,cell-cell adherens junction,spectrin,microtubule cytoskeleton,membrane,intracellular membrane-bounded organelle,extracellular exosome,extracellular vesicle",60,282,447,ELPTAFDYVEFTR.2|ELPTAFDYVEFTR.3|ETENVKSSEEIESAFR.3|VLETAEDIQER.2|VLETAEDIQER.3|LLEATELK.2|DLTSWVTEMK.2|SSLSSAQADFNQLAELDR.2|SSLSSAQADFNQLAELDR.3|MTLVASEDYGDTLAAIQGLLK.3|M[Oxi]TLVASEDYGDTLAAIQGLLK.3|MTLVASEDYGDTLAAIQGLLK.2|GRELPTAFDYVEFTR.3|GRELPTAFDYVEFTR.2|ALSSEGKPYVTKEELYQNLTR.4|ALSSEGKPYVTKEELYQNLTR.3|KVEDLFLTFAK.3|KVEDLFLTFAK.2|EKEPIAASTNR.3|HQAFEAELHANADR.4|HQAFEAELHANADR.3|HQAFEAELHANADR.2|HQKHQAFEAELHANADR.5|LLEATELKGIK.3|AKLGDSHDLQR.3|AKLGDSHDLQR.2|HQLLEADISAHEDR.4|HQLLEADISAHEDR.3|HQLLEADISAHEDR.2|KLLVGSEDYGR.3|KLLVGSEDYGR.2|DAEELEK.2|GEIDAHEDSFK.3|GEIDAHEDSFK.2|KHALLEADVAAHQDR.4|KHQALQAEIAGHEPR.4|KHQALQAEIAGHEPR.3|KHQALQAEIAGHEPR.2|ALSSEGKPYVTK.3|ALSSEGKPYVTK.2|KFDDFQKDLK.3|KFDDFQKDLK.2|DPTNLQGK.2|ENSLKTDDYGR.3|ENSLKTDDYGR.2|GKDLIGVQNLLK.3|GKDLIGVQNLLK.2|LIDVNHYAKDEVAAR.4|LIDVNHYAKDEVAAR.3|LIDVNHYAKDEVAAR.2|QGKLFGAAEVQR.3|YEALKEPMVAR.3|YEALKEPM[Oxi]VAR.3|DLAALEDK.2|DLAALEDK.1|KHQLLEADISAHEDR.4|KHQLLEADISAHEDR.3|LHELNQK.2|NNHHEENISSK.3|QFQDAGHFDAENIKK.4|QFQDAGHFDAENIKK.3|SQLLGSAHEVQR.3|SQLLGSAHEVQR.2|KLLEATELKGIK.3|AALLELWELRR.3|AALLELWELRR.2|ALC[CAM]AEADR.2|EQADYC[CAM]VSHMK.3|EQADYC[CAM]VSHMK.2|HQKHQAFEAELHANADRIR.5|HQKHQAFEAELHANADRIR.4|KHEGFER.2|KQEALVAR.2|QKLDILDQERADLEK.4|QKLDILDQERADLEK.3|RNEVLDR.2|RQQVLDR.2|AINVQEEK.2|HQEHRTEIDAR.3|KFDDFQK.2|KHEAFETDFTVHKDR.4|KHEDFDKAINVQEEK.4|LGESQTLQQFSR.3|LGESQTLQQFSR.2|LIQEQHPEEELIKTK.4|LMELHRQWELLLEK.4|LNHQEFK.2|RWSQLLANSAAR.3|RWSQLLANSAAR.2|DRVNDVC[CAM]TNGQDLIKK.4|DRVNDVC[CAM]TNGQDLIKK.3|HQAFEAELHANADRIR.4|HQLLEADISAHEDRLK.4|HQLLEADISAHEDRLK.3|KFEEFQTDMAAHEER.4|KFEEFQTDMAAHEER.3|KFEEFQTDM[Oxi]AAHEER.3|KLSDDNTIGKEEIQQR.4|KLSDDNTIGKEEIQQR.3|RAQLADSFHLQQFFR.4|RAQLADSFHLQQFFR.3|RLEAELAAHEPAIQGVLDTGKK.5|RLEAELAAHEPAIQGVLDTGKK.4|RLEAELAAHEPAIQGVLDTGKK.3|GKDLIGVQNLLKK.3|GKDLIGVQNLLKK.2|HQEHKGEIDAHEDSFK.4|HQEHKGEIDAHEDSFK.3|KGDILTLLNSTNK.3|KGDILTLLNSTNK.2|LTVLSEER.2|DSDELKSWVNEK.3|DSDELKSWVNEK.2|EPIAASTNR.2|FHRDADETKEWIEEK.4|GNAM[Oxi]VEEGHFAAEDVKAK.4|KVEDLFLTFAKK.3|KVEDLFLTFAKK.2|LIQNNHYAMEDVATRR.4|LIQNNHYAM[Oxi]EDVATRR.4|LIQNNHYAMEDVATRR.3|LSDDNTIGK.2|TKQDEVNAAWQR.3|TKQDEVNAAWQR.2|HEAFETDFTVHK.3|LMVHTVATFNSIK.3|LM[Oxi]VHTVATFNSIK.3|LMVHTVATFNSIK.2|LM[Oxi]VHTVATFNSIK.2|VLETAEDIQERR.3|C[CAM]NSLEEIK.2|ENLLEEQGSIALR.3|ENLLEEQGSIALR.2|IAALQAFADQLIAAGHYAK.4|IAALQAFADQLIAAGHYAK.3|IAALQAFADQLIAAGHYAK.2|IDGITIQAR.2|KIEDLGAAMEEALILDNK.4|KIEDLGAAMEEALILDNK.3|KIEDLGAAMEEALILDNK.2|LFGAAEVQR.2|DADETKEWIEEK.3|DADETKEWIEEK.2|KHQLLEADISAHEDRLK.4|KHQLLEADISAHEDRLK.3|LDILDQER.2|LHELNQKWEALK.3|LHELNQKWEALK.2|LRQEFAQHANAFHQWIQETR.5|LRQEFAQHANAFHQWIQETR.4|MQHNLEQQIQAR.3|M[Oxi]QHNLEQQIQAR.3|M[Oxi]QHNLEQQIQAR.2|MQHNLEQQIQAR.2|DLTGVQNLR.2|EKEQLMASDDFGR.3|EQADYC[CAM]VSHMKPYVDGK.4|EQADYC[CAM]VSHMKPYVDGK.3|GLVSSDELAK.2|KGDILTLLNSTNKDWWK.4|KGDILTLLNSTNKDWWK.3|LAQFVEHWKELK.3|ALC[CAM]AEADRLQQSHPLSATQIQVK.5|ALC[CAM]AEADRLQQSHPLSATQIQVK.4|ALC[CAM]AEADRLQQSHPLSATQIQVK.3|HALLEADVAAHQDR.3|HALLEADVAAHQDR.2|LREANQQQQFNR.3|LREANQQQQFNR.2|HQALQAEIAGHEPR.3|KLLEATELK.2|LDILDQERADLEK.3|LGDSHDLQR.2|GAC[CAM]AGSEDAVK.2|HQAFEAELSANQSR.3|HQAFEAELSANQSR.2|KHALLEADVAAHQDRIDGITIQAR.5|KHALLEADVAAHQDRIDGITIQAR.4|KHALLEADVAAHQDRIDGITIQAR.3|KHEAFETDFTVHK.3|LLVGSEDYGRDLTGVQNLR.4|LLVGSEDYGRDLTGVQNLR.3|LMVHTVATFNSIKELNER.4|LMVHTVATFNSIKELNER.3|QQNFNTGIK.2|QWELLLEK.2|REELITNWEQIR.3|REELITNWEQIR.2|KLDPAQSASR.2|LAQFVEHWKELKQLAAAR.4|LAQFVEHWKELKQLAAAR.3|LIDVNHYAK.2|LIQEQHPEEELIK.3|LIQEQHPEEELIK.2|SKLGESQTLQQFSR.3|SKLGESQTLQQFSR.2|SLQQLAEER.2|VNDVC[CAM]TNGQDLIKK.3|VNSLGETAER.2|DEDSAEALLK.2|DLASVNNLLK.2|DLASVQALLR.2|FNRDVDETISWIK.3|FNRDVDETISWIK.2|GLVSSDELAKDVTGAEALLER.4|GLVSSDELAKDVTGAEALLER.3|GLVSSDELAKDVTGAEALLER.2|KHEALMSDLSAYGSSIQALR.4|KHEALM[Oxi]SDLSAYGSSIQALR.4|KHEALM[Oxi]SDLSAYGSSIQALR.3|KHEALMSDLSAYGSSIQALR.3|KHEALM[Oxi]SDLSAYGSSIQALR.2|KHEALMSDLSAYGSSIQALR.2|KLSDDNTIGK.2|LAALADQWQFLVQK.3|LAALADQWQFLVQK.2|QFQDAGHFDAENIK.3|QFQDAGHFDAENIK.2|QGFVPAAYVK.2|DLAALEDKVK.2|LEAELAAHEPAIQGVLDTGKK.4|LLEAQSHFR.2|ALINADELASDVAGAEALLDRHQEHK.5|ALINADELASDVAGAEALLDRHQEHK.4|DLIGVQNLLK.2|ITALDEFATK.2|KLLVGSEDYGRDLTGVQNLR.4|KLLVGSEDYGRDLTGVQNLR.3|LLVGSEDYGR.2|LLVGSEDYGRDLTGVQNLRK.4|LLVGSEDYGRDLTGVQNLRK.3|LQQSHPLSATQIQVK.3|LQQSHPLSATQIQVK.2|MNEVISLWK.2|M[Oxi]NEVISLWK.2|QEFAQHANAFHQWIQETR.4|RLEAELAAHEPAIQGVLDTGK.4|RLEAELAAHEPAIQGVLDTGK.3|VNEVNQFAAK.2|QEQIDNQTR.2|ALINADELASDVAGAEALLDRHQEHKGEIDAHEDSFK.7|ALINADELASDVAGAEALLDRHQEHKGEIDAHEDSFK.6|AQLADSFHLQQFFR.3|AQLADSFHLQQFFR.2|GNAM[Oxi]VEEGHFAAEDVK.3|GNAMVEEGHFAAEDVK.3|GNAMVEEGHFAAEDVK.2|LQTASDESYK.2|AGTFQAFEQFGQQLLAHGHYASPEIK.5|AGTFQAFEQFGQQLLAHGHYASPEIK.4|AGTFQAFEQFGQQLLAHGHYASPEIK.3|FEEFQTDMAAHEER.3|HEAFETDFTVHKDR.3|LAQFVEHWK.2|LIQSHPESAEDLQEK.3|LIQSHPESAEDLQEK.2|SSEEIESAFR.2|TATDEAYKDPSNLQGK.3|TATDEAYKDPSNLQGK.2|DLTNVQNLQK.2|DRVNDVC[CAM]TNGQDLIK.3|DRVNDVC[CAM]TNGQDLIK.2|DVTGAEALLER.2|EELYQNLTR.2|EPIVGSTDYGK.2|LSDDNTIGKEEIQQR.3|LSDDNTIGKEEIQQR.2|NTTGVTEEALK.2|EAIVTSEELGQDLEHVEVLQK.4|EAIVTSEELGQDLEHVEVLQK.3|EAIVTSEELGQDLEHVEVLQK.2|KFEEFQTDMAAHEERVNEVNQFAAK.5|KFEEFQTDMAAHEERVNEVNQFAAK.4|KFEEFQTDM[Oxi]AAHEERVNEVNQFAAK.4|LIQNNHYAMEDVATR.3|LIQNNHYAMEDVATR.2|LQIASDENYK.2|VEDLFLTFAK.2|HQAFEAEVQANSGAIVK.3|HQAFEAEVQANSGAIVK.2|QVEELYHSLLELGEK.3|QVEELYHSLLELGEK.2|SLQQLAEERSQLLGSAHEVQR.4|SLQQLAEERSQLLGSAHEVQR.3|VEVNDRQGFVPAAYVK.3|AALLELWELR.2|ADVVESWIGEKENSLK.3|AKLDENSAFLQFNWK.3|AKLDENSAFLQFNWK.2|DLMSWINGIR.2|DLSSVQTLLTK.2|DVDETISWIK.2|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.5|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.4|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.3|SADESGQALLAAGHYASDEVREK.4|SADESGQALLAAGHYASDEVREK.3|HEDFDKAINVQEEKIAALQAFADQLIAAGHYAK.6|MMLDQC[CAM]LELQLFHR.3|MM[Oxi]LDQC[CAM]LELQLFHR.3|MMLDQC[CAM]LELQLFHR.2|QDEVNAAWQR.2|WSQLLANSAAR.2|ADVVESWIGEK.2|ARLAALADQWQFLVQK.3|DLAALGDKVNSLGETAER.3|DLAALGDKVNSLGETAER.2|DLIGVQNLLKK.2|DVEDEETWIREKEPIAASTNR.4|DVEDEETWIREKEPIAASTNR.3|ENSLKTDDYGRDLSSVQTLLTK.4|GDSLDSVEALIK.2|QETFDAGLQAFQQEGIANITALK.4|QETFDAGLQAFQQEGIANITALK.3|QQVAPTDDETGKELVLALYDYQEKSPR.5|QQVAPTDDETGKELVLALYDYQEKSPR.4|ADVVESWIGEKENSLKTDDYGR.4|DGHVSLQEYMAFMISR.3|EKEPIVGSTDYGKDEDSAEALLK.4|EKEPIVGSTDYGKDEDSAEALLK.3|HALLEADVAAHQDRIDGITIQAR.4|HALLEADVAAHQDRIDGITIQAR.3|QKLDILDQER.2|DMDDEESWIK.2|DM[Oxi]DDEESWIK.2|EANQQQQFNR.2|EQLMASDDFGR.2|EQLM[Oxi]ASDDFGR.2|GDILTLLNSTNKDWWK.3|GDILTLLNSTNKDWWK.2|KLDPAQSASRENLLEEQGSIALR.4|KLDPAQSASRENLLEEQGSIALR.3|TDDYGRDLSSVQTLLTK.3|DVEDEETWIR.2|GAC[CAM]AGSEDAVKAR.2|GDILTLLNSTNK.2|QQVAPTDDETGK.2|EKEQLMASDDFGRDLASVQALLR.4|FLADFRDLTSWVTEMK.3|FLADFRDLTSWVTEM[Oxi]K.3|GVIDMGNSLIER.2|GVIDM[Oxi]GNSLIER.2|VQKHQAFEAELSANQSR.3|FLSDFRDLMSWINGIR.3|MKTATDEAYKDPSNLQGK.3|RMMLDQC[CAM]LELQLFHR.3|SLSAQEEKITALDEFATK.3|SLSAQEEKITALDEFATK.2|DTEQVDNWMSK.2|HQEHKGEIDAHEDSFKSADESGQALLAAGHYASDEVR.6|HQEHKGEIDAHEDSFKSADESGQALLAAGHYASDEVR.5|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGKR.5|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGKR.4|LQTASDESYKDPTNIQSK.3|LQTASDESYKDPTNIQSK.2|NVEDIELWLYEVEGHLASDDYGK.4|NVEDIELWLYEVEGHLASDDYGK.3|ALC[CAM]AEADRLQQSHPLSATQIQVKR.4|HEALMSDLSAYGSSIQALR.3|HEALMSDLSAYGSSIQALR.2|LQIASDENYKDPTNLQGK.3|LQIASDENYKDPTNLQGK.2|MKQVEELYHSLLELGEK.3|M[Oxi]KQVEELYHSLLELGEK.3|M[Oxi]KQVEELYHSLLELGEK.2|LQQLFRDVEDEETWIR.3|NTTGVTEEALKEFSM[Oxi]MFK.3|NTTGVTEEALKEFSMM[Oxi]FK.3|NTTGVTEEALKEFSMMFK.3|NTTGVTEEALKEFSMMFK.2|TATDEAYKDPSNLQGKVQK.3|ALINADELASDVAGAEALLDR.3|ALINADELASDVAGAEALLDR.2|AINVQEEKIAALQAFADQLIAAGHYAK.4|AINVQEEKIAALQAFADQLIAAGHYAK.3|DVDEIEAWISEK.2|EELITNWEQIR.2|SADESGQALLAAGHYASDEVR.3|SADESGQALLAAGHYASDEVR.2|DC[CAM]EQAENWMAAR.2|ELVLALYDYQEK.2|LDETGNLM[Oxi]ISEGHFASETIR.3|LDETGNLMISEGHFASETIR.3|VNDVC[CAM]TNGQDLIK.2|C[CAM]TELNQAWSSLGK.2|DLNSQADSLM[Oxi]TSSAFDTSQVK.3|DLNSQADSLMTSSAFDTSQVK.3|DLNSQADSLM[Oxi]TSSAFDTSQVK.2|DLNSQADSLMTSSAFDTSQVK.2|EAALTSEEVGADLEQVEVLQK.3|EAALTSEEVGADLEQVEVLQK.2|EANELQQWINEK.2|EPIVGSTDYGKDEDSAEALLK.3|EPIVGSTDYGKDEDSAEALLK.2|HQAFEAELSANQSRIDALEK.3|ASAFNSWFENAEEDLTDPVR.3|ASAFNSWFENAEEDLTDPVR.2|DADETKEWIEEKNQALNTDNYGHDLASVQALQR.5|DADETKEWIEEKNQALNTDNYGHDLASVQALQR.4|DAEELEKWIQEK.2|EAFLNTEDKGDSLDSVEALIK.3|EAFLNTEDKGDSLDSVEALIK.2|LIQEQHPEEELIKTKQDEVNAAWQR.4|EC[CAM]EDVMDWINDK.2|NQALNTDNYGHDLASVQALQR.3|NQALNTDNYGHDLASVQALQR.2|SSLSSAQADFNQLAELDRQIK.3|VASNPYTWFTMEALEETWR.3|VASNPYTWFTMEALEETWR.2|EQLM[Oxi]ASDDFGRDLASVQALLR.3|EQLMASDDFGRDLASVQALLR.3|MTLVASEDYGDTLAAIQGLLKK.3|DLAALGDK.1|EAALTSEEVGADLEQVEVLQKK.3|LDENSAFLQFNWK.2|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGK.4|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGK.3|NVEDIELWLYEVEGHLASDDYGKDLTNVQNLQKK.5|KASAFNSWFENAEEDLTDPVR.3|QEAFLLNEDLGDSLDSVEALLK.3|QETFDAGLQAFQQEGIANITALKDQLLAAK.4|QETFDAGLQAFQQEGIANITALKDQLLAAK.3|LKDLNSQADSLMTSSAFDTSQVK.3|LKDLNSQADSLM[Oxi]TSSAFDTSQVK.3|DVDEIEAWISEKLQTASDESYKDPTNIQSK.4|ENLLEEQGSIALRQEQIDNQTR.3|KASAFNSWFENAEEDLTDPVRC[CAM]NSLEEIK.4|QEAFLLNEDLGDSLDSVEALLKK.3|YTEHSTVGLAQQWDQLDQLGM[Oxi]R.3|YTEHSTVGLAQQWDQLDQLGMR.3|DLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAK.5|DLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAK.4|TYLLDGSC[CAM]MVEESGTLESQLEATK.3|QQVAPTDDETGKELVLALYDYQEK.3|EANELQQWINEKEAALTSEEVGADLEQVEVLQK.4|IEDLGAAMEEALILDNK.2|TYLLDGSC[CAM]MVEESGTLESQLEATKR.3|VASNPYTWFTMEALEETWRNLQK.3|NVEDIELWLYEVEGHLASDDYGKDLTNVQNLQK.4|QQYEQC[CAM]MDLQLFYR.2|LEESLEYQQFVANVEEEEAWINEK.3|RQDLEDSLQAQQYFADANEAESWMR.3|RQDLEDSLQAQQYFADANEAESWM[Oxi]R.3|ASAFNSWFENAEEDLTDPVRC[CAM]NSLEEIK.3|GQRLEESLEYQQFVANVEEEEAWINEK.3|SLGYDLPMVEEGEPDPEFEAILDTVDPNR.3|VAEDLESEGLMAEEVQAVQQQEVYGMMPR.3
SEN / CTL,Q9Y224,UPF0568 protein C14orf166,C14orf166,1.46,1.62,8.48E-02,6.66E-03,2.18E+00,"transcription, DNA-templated,tRNA splicing, via endonucleolytic cleavage and ligation,viral process,positive regulation of transcription from RNA polymerase II promoter,RNA transport","RNA polymerase II core binding,RNA binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,microtubule organizing center,cytosol,perinuclear region of cytoplasm,tRNA-splicing ligase complex",6,22,36,EGLPVALDKHILGFDTGDAVLNEAAQILR.4|EGLPVALDKHILGFDTGDAVLNEAAQILR.3|LTQDAVAK.2|DVNC[CAM]PFK.2|YLRDVNC[CAM]PFK.3|YLRDVNC[CAM]PFK.2|KLTALDYHNPAGFNC[CAM]K.4|EGLPVALDK.2|QEAIDWLLGLAVR.3|QEAIDWLLGLAVR.2|AGVMALANLLQIQR.3|AGVM[Oxi]ALANLLQIQR.3|AGVMALANLLQIQR.2|AGVM[Oxi]ALANLLQIQR.2|IQDRQEAIDWLLGLAVR.4|IQDRQEAIDWLLGLAVR.3|LLHIEELR.2|LEYGDNAEK.2|HILGFDTGDAVLNEAAQILR.4|HILGFDTGDAVLNEAAQILR.3|HILGFDTGDAVLNEAAQILR.2|LLHIEELRELQTK.3|NIHSSDWPK.2|INEAIVAVQAIIADPK.3|INEAIVAVQAIIADPK.2|HDDYLVMLK.2|HDDYLVM[Oxi]LK.2|LTALDYHNPAGFNC[CAM]K.3|LTALDYHNPAGFNC[CAM]K.2|NAEPLINLDVNNPDFK.3|NAEPLINLDVNNPDFK.2|LTALDYHNPAGFNC[CAM]KDETEFR.4|LTALDYHNPAGFNC[CAM]KDETEFR.3|NFIVWLEDQK.2|AGVMALANLLQIQRHDDYLVMLK.4|KLTALDYHNPAGFNC[CAM]KDETEFR.4
SEN / CTL,Q15843,NEDD8,NEDD8,1.45,1.05,2.02E-05,2.57E-06,5.59E+00,"regulation of transcription from RNA polymerase II promoter,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,transforming growth factor beta receptor signaling pathway,protein localization,anatomical structure morphogenesis,response to organic cyclic compound,protein neddylation","protein binding,ubiquitin protein ligase binding","nucleus,cytosol,extracellular exosome",18,4,7,TLTGKEIEIDIEPTDKVER.4|TLTGKEIEIDIEPTDKVER.3|EIEIDIEPTDKVER.3|EIEIDIEPTDKVER.2|ILGGSVLHLVLALR.3|ILGGSVLHLVLALR.2|EIEIDIEPTDK.2
SEN / CTL,Q9H4A4,Aminopeptidase B,RNPEP,1.44,2.08,2.21E-05,2.78E-06,5.56E+00,"proteolysis,peptide catabolic process,negative regulation of blood pressure","aminopeptidase activity,epoxide hydrolase activity,metalloexopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","extracellular region,extracellular space,plasma membrane,secretory granule,extracellular exosome",30,48,80,VKIEPGVDPDDTYNETPYEK.3|LQVLLTYR.2|KPFVYTQGQAVLNR.3|KPFVYTQGQAVLNR.2|AFFPC[CAM]FDTPAVK.2|AFFPC[CAM]FDTPAVK.3|VGEGPGVC[CAM]WLAPEQTAGK.2|VGEGPGVC[CAM]WLAPEQTAGK.3|AEFGPPGPGAGSR.3|AEFGPPGPGAGSR.2|NDHQEDFWK.3|NDHQEDFWK.2|WGQIVLK.2|KKPFVYTQGQAVLNR.4|KKPFVYTQGQAVLNR.3|AYVHEFK.2|LDSHPC[CAM]LEVTAAALRR.4|LDSHPC[CAM]LEVTAAALRR.3|LDSHPC[CAM]LEVTAAALRR.2|SPLPPGNVK.2|KLGDTYPSISNAR.3|KLGDTYPSISNAR.2|AAERLQVLLTYR.3|RPLHSAQAVDVASASNFR.4|RPLHSAQAVDVASASNFR.3|RPLHSAQAVDVASASNFR.2|EFLHNQGK.2|RVDIIPGFEFDR.3|RVDIIPGFEFDR.2|AFELLHLHLDLR.3|PFVYTQGQAVLNR.3|PFVYTQGQAVLNR.2|KRVDIIPGFEFDR.3|KRVDIIPGFEFDR.2|QHMDITGEENPLNK.3|QHM[Oxi]DITGEENPLNK.3|QHMDITGEENPLNK.2|GLSGTAVLDLR.2|LDSHPC[CAM]LEVTAAALR.3|LDSHPC[CAM]LEVTAAALR.2|LFGPYVWGR.2|YTLPLYHAMMGGSEVAQTLAK.4|YTLPLYHAM[Oxi]MGGSEVAQTLAK.3|YTLPLYHAMM[Oxi]GGSEVAQTLAK.3|YTLPLYHAMMGGSEVAQTLAK.3|YTLPLYHAMMGGSEVAQTLAK.2|AIEAVAISPWK.2|TYQLVYFLDKILQK.3|C[CAM]LEPEGAAELRLDSHPC[CAM]LEVTAAALRR.5|C[CAM]LEPEGAAELRLDSHPC[CAM]LEVTAAALRR.4|EEYNGVIEEFLATGEK.3|EEYNGVIEEFLATGEK.2|C[CAM]LEPEGAAELR.2|QKYTLPLYHAMMGGSEVAQTLAK.4|QKYTLPLYHAMMGGSEVAQTLAK.3|LGDTYPSISNAR.2|TYQLVYFLDK.2|PAEELAQLWAAEELDMK.3|PAEELAQLWAAEELDMK.2|SILADDFLDFYLEYFPELKKK.4|VDIIPGFEFDR.2|VGEGPGVC[CAM]WLAPEQTAGKK.3|GFC[CAM]FVSYLAHLVGDQDQFDSFLK.4|GFC[CAM]FVSYLAHLVGDQDQFDSFLK.3|ISTILFGAAYTC[CAM]LEAATGR.3|ISTILFGAAYTC[CAM]LEAATGR.2|ETFASTASQLHSNVVNYVQQIVAPK.4|ETFASTASQLHSNVVNYVQQIVAPK.3|VWAEPC[CAM]LIDAAK.2|ERPGSEEPPAEPVSFYTQPFSHYGQALC[CAM]VSFPQPC[CAM]R.6|ERPGSEEPPAEPVSFYTQPFSHYGQALC[CAM]VSFPQPC[CAM]R.5|ERPGSEEPPAEPVSFYTQPFSHYGQALC[CAM]VSFPQPC[CAM]R.4|IEPGVDPDDTYNETPYEK.3|IEPGVDPDDTYNETPYEK.2|C[CAM]LEPEGAAELRLDSHPC[CAM]LEVTAAALR.4|RISTILFGAAYTC[CAM]LEAATGR.3|VWAEPC[CAM]LIDAAKEEYNGVIEEFLATGEK.4|VWAEPC[CAM]LIDAAKEEYNGVIEEFLATGEK.3|YSALIEVPDGFTAVMSASTWEK.3|SRVWAEPC[CAM]LIDAAKEEYNGVIEEFLATGEK.4
SEN / CTL,P78371,T-complex protein 1 subunit beta,CCT2,1.43,2.27,3.96E-16,1.51E-16,1.58E+01,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone mediated protein folding independent of cofactor,chaperone-mediated protein complex assembly,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,ubiquitin protein ligase binding,protein binding involved in protein folding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,myelin sheath,cell body,extracellular exosome",72,49,108,LTSFIGAIAIGDLVK.2|LTSFIGAIAIGDLVK.3|GATQQILDEAERSLHDALC[CAM]VLAQTVKDSR.5|GATQQILDEAERSLHDALC[CAM]VLAQTVKDSR.4|LIEEVMIGEDKLIHFSGVALGEAC[CAM]TIVLR.4|LIEEVMIGEDKLIHFSGVALGEAC[CAM]TIVLR.3|GATQQILDEAER.2|GATQQILDEAER.3|ILIANTGMDTDKIK.3|ILIANTGM[Oxi]DTDKIK.3|ILIANTGMDTDKIK.2|MLPTIIADNAGYDSADLVAQLR.3|M[Oxi]LPTIIADNAGYDSADLVAQLR.3|MLPTIIADNAGYDSADLVAQLR.4|M[Oxi]LPTIIADNAGYDSADLVAQLR.2|MLPTIIADNAGYDSADLVAQLR.2|LGGSLADSYLDEGFLLDKK.3|LGGSLADSYLDEGFLLDKK.2|LALVTGGEIASTFDHPELVK.3|LALVTGGEIASTFDHPELVK.4|LALVTGGEIASTFDHPELVK.2|KLGGSLADSYLDEGFLLDKK.4|KLGGSLADSYLDEGFLLDKK.3|SLHDALC[CAM]VLAQTVK.3|SLHDALC[CAM]VLAQTVK.2|LKGSGNLEAIHIIKK.4|VLVDMSR.2|VLVDM[Oxi]SR.2|GSGNLEAIHIIK.3|GSGNLEAIHIIK.2|AGADEERAETAR.3|AGADEERAETAR.2|VAEIEHAEKEK.3|VAEIEHAEKEK.2|IHPQTIIAGWR.3|IHPQTIIAGWR.2|LAVEAVLR.2|KIGVNQPK.2|KIHPQTIIAGWR.3|SLHDALC[CAM]VLAQTVKDSR.4|SLHDALC[CAM]VLAQTVKDSR.3|SLHDALC[CAM]VLAQTVKDSR.2|EALLSSAVDHGSDEVKFR.4|EALLSSAVDHGSDEVKFR.3|QDLMNIAGTTLSSK.3|QDLMNIAGTTLSSK.2|QDLM[Oxi]NIAGTTLSSK.2|TPGKEAVAMESYAK.3|TPGKEAVAMESYAK.2|LKGSGNLEAIHIIK.3|NIGVDNPAAK.2|AAHSEGNTTAGLDM[Oxi]R.3|AAHSEGNTTAGLDMR.3|AAHSEGNTTAGLDMR.2|AAHSEGNTTAGLDM[Oxi]R.2|VAEIEHAEK.2|QVLLSAAEAAEVILR.3|QVLLSAAEAAEVILR.2|EALLSSAVDHGSDEVK.3|EALLSSAVDHGSDEVK.2|EAVAMESYAK.2|EAVAM[Oxi]ESYAK.2|HGINC[CAM]FINR.2|VQDDEVGDGTTSVTVLAAELLR.4|VQDDEVGDGTTSVTVLAAELLR.3|VQDDEVGDGTTSVTVLAAELLR.2|RQVLLSAAEAAEVILR.3|RQVLLSAAEAAEVILR.2|FRQDLMNIAGTTLSSK.3|FRQDLM[Oxi]NIAGTTLSSK.3|FRQDLMNIAGTTLSSK.2|FRQDLM[Oxi]NIAGTTLSSK.2|TVYGGGC[CAM]SEMLMAHAVTQLANR.4|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.4|TVYGGGC[CAM]SEMLMAHAVTQLANR.3|TVYGGGC[CAM]SEM[Oxi]LM[Oxi]AHAVTQLANR.3|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.3|TVYGGGC[CAM]SEMLM[Oxi]AHAVTQLANR.3|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.2|TVYGGGC[CAM]SEMLMAHAVTQLANR.2|RQVLLSAAEAAEVILRVDNIIK.4|RQVLLSAAEAAEVILRVDNIIK.3|LGGSLADSYLDEGFLLDK.3|LGGSLADSYLDEGFLLDK.2|LIEEVMIGEDK.2|LIEEVM[Oxi]IGEDK.2|ILIANTGMDTDK.2|ILIANTGM[Oxi]DTDK.2|LIHFSGVALGEAC[CAM]TIVLR.3|LIHFSGVALGEAC[CAM]TIVLR.2|EGTIGDM[Oxi]AILGITESFQVK.3|EGTIGDMAILGITESFQVK.3|EGTIGDMAILGITESFQVK.2|EGTIGDM[Oxi]AILGITESFQVK.2|EALLSSAVDHGSDEVKFRQDLMNIAGTTLSSK.5|EALLSSAVDHGSDEVKFRQDLMNIAGTTLSSK.4|KLGGSLADSYLDEGFLLDK.3|KLGGSLADSYLDEGFLLDK.2|GSGNLEAIHIIKK.2|EGTIGDMAILGITESFQVKR.3|QVLLSAAEAAEVILRVDNIIK.3|DASLMVTNDGATILK.2|DASLM[Oxi]VTNDGATILK.2|QLIYNYPEQLFGAAGVMAIEHADFAGVER.4|QLIYNYPEQLFGAAGVM[Oxi]AIEHADFAGVER.4|QLIYNYPEQLFGAAGVM[Oxi]AIEHADFAGVER.3|QLIYNYPEQLFGAAGVMAIEHADFAGVER.3|VLVDM[Oxi]SRVQDDEVGDGTTSVTVLAAELLR.3
SEN / CTL,P51991,Heterogeneous nuclear ribonucleoprotein A3,HNRNPA3,1.43,1.01,5.71E-04,5.78E-05,4.24E+00,"mRNA splicing, via spliceosome,gene expression,mRNA transport","nucleotide binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,RNA transmembrane transporter activity","nucleus,nucleoplasm,cytoplasm,intracellular ribonucleoprotein complex,ribonucleoprotein granule,neuron projection,catalytic step 2 spliceosome,messenger ribonucleoprotein complex",12,32,62,GFAFVTFDDHDTVDKIVVQK.3|GFAFVTFDDHDTVDKIVVQK.4|GEEGHDPKEPEQLR.4|GEEGHDPKEPEQLR.3|YHTINGHNC[CAM]EVKK.4|YHTINGHNC[CAM]EVKK.3|YHTINGHNC[CAM]EVKK.2|GEEGHDPKEPEQLRK.4|GEEGHDPKEPEQLRK.3|AVSREDSVKPGAHLTVK.4|RGEEGHDPKEPEQLR.4|RGEEGHDPKEPEQLR.3|WGTLTDC[CAM]VVMR.3|WGTLTDC[CAM]VVMR.2|WGTLTDC[CAM]VVM[Oxi]R.2|EDSVKPGAHLTVK.3|EDSVKPGAHLTVK.2|RGFAFVTFDDHDTVDK.4|RGFAFVTFDDHDTVDK.3|RGFAFVTFDDHDTVDK.2|RGFAFVTFDDHDTVDKIVVQK.5|YGKIETIEVMEDRQSGK.4|YHTINGHNC[CAM]EVK.3|YHTINGHNC[CAM]EVK.2|EDSVKPGAHLTVKK.3|EDSVKPGAHLTVKK.2|KIFVGGIKEDTEEYNLR.4|KIFVGGIKEDTEEYNLR.3|KRGFAFVTFDDHDTVDK.4|KLFIGGLSFETTDDSLREHFEK.5|KLFIGGLSFETTDDSLREHFEK.4|KLFIGGLSFETTDDSLREHFEK.3|YGKIETIEVMEDR.3|YGKIETIEVMEDR.2|QEMQSAGSQR.2|GFAFVTFDDHDTVDK.3|GFAFVTFDDHDTVDK.2|SRGFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.5|EDTEEYNLR.2|LFIGGLSFETTDDSLR.3|LFIGGLSFETTDDSLR.2|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHKVDGR.5|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHKVDGR.4|LFIGGLSFETTDDSLREHFEK.4|LFIGGLSFETTDDSLREHFEK.3|EDTEEYNLRDYFEK.3|IETIEVMEDR.2|IETIEVM[Oxi]EDR.2|IFVGGIKEDTEEYNLR.3|IFVGGIKEDTEEYNLR.2|KLFIGGLSFETTDDSLR.3|SSGSPYGGGYGSGGGSGGYGSR.3|SSGSPYGGGYGSGGGSGGYGSR.2|WGTLTDC[CAM]VVMRDPQTK.3|WGTLTDC[CAM]VVM[Oxi]RDPQTK.3|WGTLTDC[CAM]VVM[Oxi]RDPQTK.2|WGTLTDC[CAM]VVMRDPQTK.2|IFVGGIKEDTEEYNLRDYFEK.4|IFVGGIKEDTEEYNLRDYFEK.3|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.4|GFGFVTYSC[CAM]VEEVDAAM[Oxi]C[CAM]ARPHK.4|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.3
SEN / CTL,P60174,Triosephosphate isomerase,TPI1,1.43,2.00,3.70E-21,2.27E-21,2.06E+01,"gluconeogenesis,glycolytic process,pentose-phosphate shunt,multicellular organism development,glycerol catabolic process,glyceraldehyde-3-phosphate biosynthetic process,canonical glycolysis","triose-phosphate isomerase activity,ubiquitin protein ligase binding","extracellular space,nucleus,cytosol,extracellular exosome",186,37,70,KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.5|VVLAYEPVWAIGTGK.2|VVLAYEPVWAIGTGK.3|VPADTEVVC[CAM]APPTAYIDFAR.3|VPADTEVVC[CAM]APPTAYIDFAR.2|VPADTEVVC[CAM]APPTAYIDFAR.4|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.3|HVFGESDELIGQK.3|HVFGESDELIGQK.2|IAVAAQNC[CAM]YK.2|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.5|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.4|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.3|IIYGGSVTGATC[CAM]K.2|IIYGGSVTGATC[CAM]K.3|QSLGELIGTLNAAK.2|QSLGELIGTLNAAK.3|KQSLGELIGTLNAAK.3|KQSLGELIGTLNAAK.2|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.4|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.3|DC[CAM]GATWVVLGHSER.3|DC[CAM]GATWVVLGHSER.2|ELASQPDVDGFLVGGASLKPEFVDIINAK.3|ELASQPDVDGFLVGGASLKPEFVDIINAK.4|VIADNVKDWSKVVLAYEPVWAIGTGK.4|VAHALAEGLGVIAC[CAM]IGEKLDER.4|VAHALAEGLGVIAC[CAM]IGEKLDER.3|VAHALAEGLGVIAC[CAM]IGEK.3|VAHALAEGLGVIAC[CAM]IGEK.4|VAHALAEGLGVIAC[CAM]IGEK.2|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSER.4|DC[CAM]GATWVVLGHSERR.4|DC[CAM]GATWVVLGHSERR.3|DC[CAM]GATWVVLGHSERR.2|VTNGAFTGEISPGMIK.2|VTNGAFTGEISPGMIK.3|VTNGAFTGEISPGM[Oxi]IK.3|VTNGAFTGEISPGM[Oxi]IK.2|SNVSDAVAQSTR.2|SNVSDAVAQSTR.3|RHVFGESDELIGQK.4|RHVFGESDELIGQK.3|RHVFGESDELIGQK.2|LDEREAGITEK.3|LDEREAGITEK.2|VIADNVKDWSK.3|VIADNVKDWSK.2|VVFEQTK.2|TATPQQAQEVHEKLR.4|TATPQQAQEVHEKLR.3|TATPQQAQEVHEKLRGWLK.5|TATPQQAQEVHEKLRGWLK.4|FFVGGNWK.2|TATPQQAQEVHEK.3|TATPQQAQEVHEK.2|LDEREAGITEKVVFEQTK.4|KFFVGGNWK.2|GWLKSNVSDAVAQSTR.3|PEFVDIINAK.2|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|VTNGAFTGEISPGM[Oxi]IKDC[CAM]GATWVVLGHSERR.5|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSERR.5|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|IIYGGSVTGATC[CAM]KELASQPDVDGFLVGGASLKPEFVDIINAKQ.6|SNVSDAVAQSTRIIYGGSVTGATC[CAM]K.3
SEN / CTL,P14174,Macrophage migration inhibitory factor,MIF,1.43,1.51,5.73E-07,8.77E-08,7.06E+00,"prostaglandin biosynthetic process,negative regulation of mature B cell apoptotic process,inflammatory response,cell surface receptor signaling pathway,cell aging,cell proliferation,negative regulation of gene expression,positive regulation of protein kinase A signaling,carboxylic acid metabolic process,DNA damage response, signal transduction by p53 class mediator,positive regulation of B cell proliferation,positive regulation of lipopolysaccharide-mediated signaling pathway,negative regulation of cellular protein metabolic process,negative regulation of myeloid cell apoptotic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of phosphorylation,regulation of macrophage activation,negative regulation of apoptotic process,positive regulation of MAP kinase activity,negative regulation of DNA damage response, signal transduction by p53 class mediator,innate immune response,positive regulation of fibroblast proliferation,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive chemotaxis,positive regulation of prostaglandin secretion involved in immune response,positive regulation of myeloid leukocyte cytokine production involved in immune response,protein homotrimerization,positive regulation of ERK1 and ERK2 cascade,negative regulation of cell cycle arrest,positive regulation of arachidonic acid secretion,negative regulation of cell aging,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,positive regulation of chemokine (C-X-C motif) ligand 2 production","dopachrome isomerase activity,receptor binding,cytokine activity,cytokine receptor binding,protein binding,chemoattractant activity,phenylpyruvate tautomerase activity","extracellular region,extracellular space,nucleoplasm,cytoplasm,cell surface,vesicle,myelin sheath,extracellular exosome",66,10,22,LLC[CAM]GLLAER.2|PMFIVNTNVPR.2|PMFIVNTNVPR.3|PM[Oxi]FIVNTNVPR.2|PM[Oxi]FIVNTNVPR.3|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.5|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|SYSKLLC[CAM]GLLAER.3|SYSKLLC[CAM]GLLAER.2|LLC[CAM]GLLAERLR.3|SYSKLLC[CAM]GLLAERLR.4|SYSKLLC[CAM]GLLAERLR.3|MPMFIVNTNVPR.2|MPM[Oxi]FIVNTNVPR.2|ASVPDGFLSELTQQLAQATGK.3|ASVPDGFLSELTQQLAQATGK.2|VYINYYDM[Oxi]NAANVGWNNSTFA.3|VYINYYDMNAANVGWNNSTFA.3|ISPDRVYINYYDMNAANVGWNNSTFA.3
SEN / CTL,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1.43,1.37,9.82E-03,8.50E-04,3.07E+00,"regulation of the force of heart contraction,regulation of sodium ion transport,cellular sodium ion homeostasis,regulation of blood pressure,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,ATP hydrolysis coupled proton transport,dephosphorylation,cellular potassium ion homeostasis,negative regulation of glucocorticoid biosynthetic process,ion transmembrane transport,sodium ion export from cell,response to drug,negative regulation of heart contraction,positive regulation of heart contraction,positive regulation of striated muscle contraction,relaxation of cardiac muscle,cardiac muscle contraction,membrane hyperpolarization,cellular response to mechanical stimulus,cellular response to steroid hormone stimulus,regulation of cardiac muscle cell contraction,membrane repolarization,membrane repolarization during cardiac muscle cell action potential,cell communication by electrical coupling involved in cardiac conduction,response to glycoside,regulation of cardiac conduction,potassium ion import across plasma membrane","sodium:potassium-exchanging ATPase activity,protein binding,ATP binding,phosphatase activity,protein kinase binding,protein domain specific binding,ankyrin binding,potassium ion binding,sodium ion binding,ADP binding,phosphatidylinositol 3-kinase binding,chaperone binding,steroid hormone binding","endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,intercalated disc,membrane,integral component of membrane,basolateral plasma membrane,apical plasma membrane,T-tubule,sarcolemma,melanosome,myelin sheath,intracellular membrane-bounded organelle,protein complex,extracellular exosome,extracellular vesicle",6,62,112,IISANGC[CAM]KVDNSSLTGESEPQTR.3|AAVPDAVGK.2|AVAGDASESALLK.3|AVAGDASESALLK.2|LNIPVSQVNPR.3|LNIPVSQVNPR.2|DKYEPAAVSEQGDKK.4|DKYEPAAVSEQGDKK.3|DKYEPAAVSEQGDKK.2|NMVPQQALVIR.3|NMVPQQALVIR.2|NM[Oxi]VPQQALVIR.2|AVFQANQENLPILKR.4|AVFQANQENLPILKR.3|AVFQANQENLPILKR.2|LIFDNLK.2|TGTLTQNR.2|YQLSIHK.2|RAVAGDASESALLK.3|RAVAGDASESALLK.2|RPGGWVEK.2|VIMVTGDHPITAK.3|VIM[Oxi]VTGDHPITAK.3|VIMVTGDHPITAK.2|VIM[Oxi]VTGDHPITAK.2|YEPAAVSEQGDKK.3|YEPAAVSEQGDKK.2|GIVVYTGDR.2|QGAIVAVTGDGVNDSPALKK.4|QGAIVAVTGDGVNDSPALKK.3|LIFDNLKK.2|LSLDELHR.2|YQLSIHKNPNTSEPQHLLVMK.5|YQLSIHKNPNTSEPQHLLVMK.4|ADIGVAM[Oxi]GIAGSDVSK.3|ADIGVAMGIAGSDVSK.3|ADIGVAMGIAGSDVSK.2|ADIGVAM[Oxi]GIAGSDVSK.2|C[CAM]SSILLHGK.2|GIVVYTGDRTVMGR.3|SPDFTNENPLETR.3|SPDFTNENPLETR.2|DKYEPAAVSEQGDK.3|DKYEPAAVSEQGDK.2|NSVFQQGMK.2|NSVFQQGM[Oxi]K.2|AVFQANQENLPILK.3|AVFQANQENLPILK.2|IVEIPFNSTNKYQLSIHK.4|IVEIPFNSTNKYQLSIHK.3|NPNTSEPQHLLVMK.3|NPNTSEPQHLLVM[Oxi]K.3|NPNTSEPQHLLVMK.2|NPNTSEPQHLLVM[Oxi]K.2|AC[CAM]VVHGSDLK.2|KADIGVAM[Oxi]GIAGSDVSK.3|KADIGVAMGIAGSDVSK.3|KADIGVAMGIAGSDVSK.2|LIIVEGC[CAM]QR.2|VDNSSLTGESEPQTR.3|VDNSSLTGESEPQTR.2|EQPLDEELK.2|TSATWLALSR.2|LSLDELHRK.2|NIAFFSTNC[CAM]VEGTAR.3|NIAFFSTNC[CAM]VEGTAR.2|YHTEIVFAR.2|DAFQNAYLELGGLGER.3|DAFQNAYLELGGLGER.2|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.6|AC[CAM]VVHGSDLKDM[Oxi]TSEQLDDILKYHTEIVFAR.6|AC[CAM]VVHGSDLKDM[Oxi]TSEQLDDILKYHTEIVFAR.5|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.5|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.4|QGAIVAVTGDGVNDSPALK.3|QGAIVAVTGDGVNDSPALK.2|C[CAM]IELC[CAM]C[CAM]GSVK.2|GVGIISEGNETVEDIAAR.3|GVGIISEGNETVEDIAAR.2|M[Oxi]SINAEEVVVGDLVEVK.3|MSINAEEVVVGDLVEVK.3|MSINAEEVVVGDLVEVK.2|M[Oxi]SINAEEVVVGDLVEVK.2|SAGIKVIMVTGDHPITAK.3|AC[CAM]VVHGSDLKDMTSEQLDDILK.4|AC[CAM]VVHGSDLKDMTSEQLDDILK.3|IVEIPFNSTNKYQLSIHKNPNTSEPQHLLVM[Oxi]K.6|IVEIPFNSTNKYQLSIHKNPNTSEPQHLLVM[Oxi]K.5|IVEIPFNSTNK.2|NLEAVETLGSTSTIC[CAM]SDK.3|NLEAVETLGSTSTIC[CAM]SDK.2|YEPAAVSEQGDK.2|DMTSEQLDDILK.2|DM[Oxi]TSEQLDDILK.2|NLEAVETLGSTSTIC[CAM]SDKTGTLTQNR.4|NLEAVETLGSTSTIC[CAM]SDKTGTLTQNR.3|EQPLDEELKDAFQNAYLELGGLGER.4|EQPLDEELKDAFQNAYLELGGLGER.3|MSINAEEVVVGDLVEVKGGDRIPADLR.4|C[CAM]SSILLHGKEQPLDEELKDAFQNAYLELGGLGER.5|C[CAM]SSILLHGKEQPLDEELKDAFQNAYLELGGLGER.4|DGPNALTPPPTTPEWIKFC[CAM]R.3|GVGIISEGNETVEDIAARLNIPVSQVNPR.4|GVGIISEGNETVEDIAARLNIPVSQVNPR.3|WINDVEDSYGQQWTYEQR.3|MTVAHMWFDNQIHEADTTENQSGVSFDK.4|QAADM[Oxi]ILLDDNFASIVTGVEEGR.3|QAADMILLDDNFASIVTGVEEGR.3|QAADM[Oxi]ILLDDNFASIVTGVEEGRLIFDNLKK.4|QAADMILLDDNFASIVTGVEEGRLIFDNLKK.4|DGPNALTPPPTTPEWIK.2|SPDFTNENPLETRNIAFFSTNC[CAM]VEGTAR.3
SEN / CTL,P19022,Cadherin-2,CDH2,1.42,1.48,1.43E-01,1.10E-02,1.96E+00,"cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,glial cell differentiation,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,cell migration,cerebral cortex development,adherens junction organization,positive regulation of MAPK cascade,cell-cell adhesion mediated by cadherin,blood vessel morphogenesis,brain morphogenesis,homeostasis of number of cells,striated muscle cell differentiation,positive regulation of muscle cell differentiation,radial glial cell differentiation,neuroepithelial cell differentiation,regulation of oligodendrocyte progenitor proliferation,establishment of protein localization to plasma membrane,negative regulation of canonical Wnt signaling pathway,neuroligin clustering involved in postsynaptic membrane assembly,neuronal stem cell population maintenance,regulation of postsynaptic density protein 95 clustering,positive regulation of synaptic vesicle clustering","calcium ion binding,beta-catenin binding,protein phosphatase binding,alpha-catenin binding,gamma-catenin binding","cytoplasm,plasma membrane,cell-cell junction,cell-cell adherens junction,fascia adherens,focal adhesion,intercalated disc,integral component of membrane,basolateral plasma membrane,apical plasma membrane,catenin complex,lamellipodium,plasma membrane raft,synapse,extracellular exosome,cortical actin cytoskeleton",6,17,22,FAIQTDPNSNDGLVTVVKPIDFETNR.3|FAIQTDPNSNDGLVTVVKPIDFETNR.4|RMDERPIHAEPQYPVR.4|RMDERPIHAEPQYPVR.3|LADMYGGGDD.2|LADM[Oxi]YGGGDD.2|LSDPANWLK.2|KLADMYGGGDD.2|SAAPHPGDIGDFINEGLK.3|SAAPHPGDIGDFINEGLK.2|LNGDFAQLNLK.2|QLLIDPEDDVRDNILK.3|QLLIDPEDDVR.2|FLEAGIYEVPIIITDSGNPPK.3|FLEAGIYEVPIIITDSGNPPK.2|IDPVNGQITTIAVLDRESPNVK.3|IDPVNGQITTIAVLDR.2|YSVTGPGADQPPTGIFIINPISGQLSVTKPLDR.4|MFVLTVAAENQVPLAK.2|VC[CAM]QC[CAM]DSNGDC[CAM]TDVDR.2|YSVTGPGADQPPTGIFIINPISGQLSVTK.3|YSVTGPGADQPPTGIFIINPISGQLSVTKPLDREQIAR.4
SEN / CTL,P07910,Heterogeneous nuclear ribonucleoproteins C1/C2,HNRNPC,1.42,1.74,4.06E-03,3.68E-04,3.43E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA splicing,gene expression,protein sumoylation,negative regulation of telomere maintenance via telomerase,ATP-dependent chromatin remodeling,3'-UTR-mediated mRNA stabilization","nucleotide binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,RNA binding,mRNA 3'-UTR binding,protein binding,poly(U) RNA binding,nucleosomal DNA binding,identical protein binding,poly(A) RNA binding,telomerase RNA binding,N6-methyladenosine-containing RNA binding","nuclear chromatin,nucleus,nucleoplasm,spliceosomal complex,cytosol,membrane,protein complex,extracellular exosome,catalytic step 2 spliceosome,telomerase holoenzyme complex",18,30,47,GFAFVQYVNER.2|GFAFVQYVNER.3|MIAGQVLDINLAAEPK.3|M[Oxi]IAGQVLDINLAAEPK.3|MIAGQVLDINLAAEPK.2|M[Oxi]IAGQVLDINLAAEPK.2|VFIGNLNTLVVK.2|VFIGNLNTLVVK.3|LKGDDLQAIKK.3|LKGDDLQAIKK.2|NDKSEEEQSSSSVKK.4|NDKSEEEQSSSSVKK.3|NDKSEEEQSSSSVKK.2|AAVAGEDGR.2|GDDLQAIK.2|MYSYPAR.2|SEEEQSSSSVKK.3|SEEEQSSSSVKK.2|IVGC[CAM]SVHK.2|QKVDSLLENLEKIEK.4|QKVDSLLENLEKIEK.3|QKVDSLLENLEK.3|QKVDSLLENLEK.2|VPPPPPIAR.2|VFIGNLNTLVVKK.3|GDDLQAIKK.2|SDVEAIFSK.2|SEEEQSSSSVKKDETNVK.4|SEEEQSSSSVKKDETNVK.3|GDDQLELIK.2|NDKSEEEQSSSSVK.3|NDKSEEEQSSSSVK.2|EAEEGEDDR.2|LKGDDLQAIK.2|QAVEMKNDKSEEEQSSSSVK.4|QAVEM[Oxi]KNDKSEEEQSSSSVK.4|QAVEMKNDKSEEEQSSSSVK.3|QAVEMKNDKSEEEQSSSSVK.2|KSDVEAIFSK.2|VDSLLENLEK.2|SEEEQSSSSVK.2|GDDQLELIKDDEK.2|AAVAGEDGRM[Oxi]IAGQVLDINLAAEPK.3|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQRDYYDR.5|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQR.4|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQR.3|EAEEGEDDRDSANGEDDS.2
SEN / CTL,P21399,Cytoplasmic aconitate hydratase,ACO1,1.42,2.09,6.42E-04,6.48E-05,4.19E+00,"tricarboxylic acid cycle,citrate metabolic process,regulation of translation,cellular iron ion homeostasis,post-embryonic development,response to iron(II) ion,intestinal absorption","RNA binding,aconitate hydratase activity,protein binding,iron-responsive element binding,metal ion binding,4 iron, 4 sulfur cluster binding","cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,extracellular exosome",24,42,66,EFNSYGSR.2|VILQDFTGVPAVVDFAAMR.3|VILQDFTGVPAVVDFAAM[Oxi]R.3|VILQDFTGVPAVVDFAAMR.2|IIPPGSGIIHQVNLEYLAR.3|IIPPGSGIIHQVNLEYLAR.4|IIPPGSGIIHQVNLEYLAR.2|ANYLASPPLVIAYAIAGTIR.3|ANYLASPPLVIAYAIAGTIR.2|KQDIENILHWNVTQHK.5|KQDIENILHWNVTQHK.4|KQDIENILHWNVTQHK.3|GPFLLGIK.2|VLLEAAIR.2|FFNLNKLEDSR.3|FFNLNKLEDSR.2|IDFEKEPLGVNAK.3|IDFEKEPLGVNAK.2|RGNDAVMAR.2|YQQAGLPLIVLAGK.3|YQQAGLPLIVLAGK.2|GFQVAPEHHNDHK.3|GFQVAPEHHNDHK.2|KAVDAGLNVMPYIK.3|KAVDAGLNVM[Oxi]PYIK.3|DFESC[CAM]LGAK.2|NC[CAM]DEFLVK.2|AVLAESYER.2|KQDIENILHWNVTQHKNIEVPFKPAR.6|NQDLEFER.2|LMGKPHPLVTSTDIVLTITK.4|LMGKPHPLVTSTDIVLTITK.3|QYVIPGMFK.2|YLQAVGMFR.2|YLQAVGM[Oxi]FR.2|TVVPC[CAM]C[CAM]SGPK.2|YTIIIPENLKPQMK.3|YTIIIPENLKPQMK.2|DIWPTRDEIQAVER.3|PHPLVTSTDIVLTITK.3|PHPLVTSTDIVLTITK.2|NIEVPFKPAR.2|QAPQTIHLPSGEILDVFDAAER.4|QAPQTIHLPSGEILDVFDAAER.3|SPPFFENLTLDLQPPK.3|SPPFFENLTLDLQPPK.2|FVEFFGPGVAQLSIADR.3|FVEFFGPGVAQLSIADR.2|IETVNESWNALATPSDK.3|IETVNESWNALATPSDK.2|GQQVFLKDIWPTRDEIQAVER.4|AVDAGLNVMPYIK.2|AVDAGLNVM[Oxi]PYIK.2|SIVDAYVLLNLGDSVTTDHISPAGNIAR.4|SIVDAYVLLNLGDSVTTDHISPAGNIAR.3|YQQAGLPLIVLAGKEYGAGSSR.3|DFNDPSQDPDFTQVVELDLK.3|DFNDPSQDPDFTQVVELDLK.2|INPVC[CAM]PADLVIDHSIQVDFNR.3|EVYQKIETVNESWNALATPSDKLFFWNSK.4|IETVNESWNALATPSDKLFFWNSK.3|QAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGKEYGAGSSR.5|QAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGK.4|ATIANMC[CAM]PEYGATAAFFPVDEVSITYLVQTGRDEEK.4|SNLVGMGVIPLEYLPGENADALGLTGQER.3|SNLVGM[Oxi]GVIPLEYLPGENADALGLTGQER.3
SEN / CTL,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,1.41,2.50,2.01E-01,1.53E-02,1.82E+00,"formation of translation preinitiation complex,translational initiation,regulation of translational initiation,IRES-dependent viral translational initiation,viral translational termination-reinitiation","nucleotide binding,RNA binding,translation initiation factor activity,protein binding,translation initiation factor binding,protein complex scaffold","nucleoplasm,cytoplasm,cytosol,eukaryotic translation initiation factor 3 complex,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex,extracellular exosome,eukaryotic translation initiation factor 3 complex, eIF3m",6,51,83,FSHQGVQLIDFSPC[CAM]ER.3|FSHQGVQLIDFSPC[CAM]ER.2|GFHC[CAM]ESSAHWPIFK.4|GFHC[CAM]ESSAHWPIFK.3|GFHC[CAM]ESSAHWPIFK.2|NADGYKLDKQHTFR.4|NADGYKLDKQHTFR.3|AQAVSEDAGGNEGR.3|AQAVSEDAGGNEGR.2|GIALWGGEK.2|DPVSIEER.2|EKQVPVDVVEMK.3|KMAQELYMEQK.3|KMAQELYMEQK.2|ITNDFYPEEDGK.3|ITNDFYPEEDGK.2|NGDYLC[CAM]VK.2|GTQGVVTNFEIFR.3|GTQGVVTNFEIFR.2|YVVTSVSWWSHK.3|YVVTSVSWWSHK.2|PRPPTLLSQEQIK.3|PRPPTLLSQEQIK.2|FC[CAM]QLLWR.2|NADGYKLDK.2|NNGKIELIK.2|TMMEDFRK.2|VTLMQLPTR.2|VTLM[Oxi]QLPTR.2|ISVSFYHVK.2|FAVLHGEAPR.2|ITNDFYPEEDGKTK.3|ITNDFYPEEDGKTK.2|VDNAYWLWTFQGR.3|VDNAYWLWTFQGR.2|VNLFTDFDK.2|DRFC[CAM]QLLWRPRPPTLLSQEQIK.5|NLFNVVDC[CAM]K.2|TSIFWNDVK.2|QVPVDVVEMK.2|QVPVDVVEM[Oxi]K.2|GTYLATFHQR.2|DRPQEADGIDSVIVVDNVPQVGPDRLEK.5|DRPQEADGIDSVIVVDNVPQVGPDRLEK.4|DRPQEADGIDSVIVVDNVPQVGPDRLEK.3|YWLEEAEC[CAM]R.2|MAQELYMEQK.2|M[Oxi]AQELYMEQK.2|MAQELYM[Oxi]EQK.2|M[Oxi]AQELYM[Oxi]EQK.2|GYIFLEYASPAHAVDAVK.3|GYIFLEYASPAHAVDAVK.2|DRPQEADGIDSVIVVDNVPQVGPDR.4|DRPQEADGIDSVIVVDNVPQVGPDR.3|AEPGQQQPAAEPPPAEGLLR.3|AEPGQQQPAAEPPPAEGLLR.2|TSIFWNDVKDPVSIEER.3|TSIFWNDVKDPVSIEER.2|DQYSVIFESGDR.2|MTLDTLSIYETPSMGLLDK.3|MTLDTLSIYETPSMGLLDK.2|YMTISDEWDIPEKQPFK.3|DFSWSPGGNIIAFWVPEDK.3|DFSWSPGGNIIAFWVPEDK.2|MTLDTLSIYETPSMGLLDKK.3|M[Oxi]TLDTLSIYETPSMGLLDKK.3|MTLDTLSIYETPSM[Oxi]GLLDKK.3|MTLDTLSIYETPSMGLLDKK.2|ETIIAFAWEPNGSK.2|QQANTIFWSPQGQFVVLAGLR.3|QQANTIFWSPQGQFVVLAGLR.2|ISGIKDFSWSPGGNIIAFWVPEDKDIPAR.4|ISGIKDFSWSPGGNIIAFWVPEDKDIPAR.3|VNLFTDFDKYMTISDEWDIPEKQPFK.4|YMTISDEWDIPEK.2|YLVTFSPLMDTQDDPQAIIIWDILTGHKK.4|YWLEEAEC[CAM]RDQYSVIFESGDR.3|DFSWSPGGNIIAFWVPEDKDIPAR.3|M[Oxi]FDKQQANTIFWSPQGQFVVLAGLR.3|MFDKQQANTIFWSPQGQFVVLAGLR.3|YLVTFSPLM[Oxi]DTQDDPQAIIIWDILTGHK.3|YLVTFSPLMDTQDDPQAIIIWDILTGHK.3|TEPAAEAEAASGPSESPSPPAAEELPGSHAEPPVPAQGEAPGEQAR.4
SEN / CTL,P06744,Glucose-6-phosphate isomerase,GPI,1.41,1.94,3.74E-07,5.88E-08,7.23E+00,"angiogenesis,in utero embryonic development,mesoderm formation,carbohydrate metabolic process,gluconeogenesis,humoral immune response,hemostasis,learning or memory,methylglyoxal biosynthetic process,response to estradiol,response to progesterone,response to testosterone,erythrocyte homeostasis,response to immobilization stress,response to muscle stretch,glucose homeostasis,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to morphine,negative regulation of neuron apoptotic process,aldehyde catabolic process,response to cadmium ion,glucose 6-phosphate metabolic process,canonical glycolysis","glucose-6-phosphate isomerase activity,cytokine activity,growth factor activity,intramolecular transferase activity,ubiquitin protein ligase binding,monosaccharide binding","extracellular space,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,neuron projection,myelin sheath,ciliary membrane,extracellular exosome",72,49,107,TLAQLNPESSLFIIASK.3|TLAQLNPESSLFIIASK.2|ILLANFLAQTEALMR.2|ILLANFLAQTEALMR.3|ILLANFLAQTEALM[Oxi]R.3|ILLANFLAQTEALM[Oxi]R.2|MIPC[CAM]DFLIPVQTQHPIRK.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIRK.4|MIPC[CAM]DFLIPVQTQHPIRK.3|KIEPELDGSAQVTSHDASTNGLINFIK.4|KIEPELDGSAQVTSHDASTNGLINFIK.3|VWYVSNIDGTHIAK.3|VWYVSNIDGTHIAK.4|VWYVSNIDGTHIAK.2|AVLHVALR.2|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|SNTPILVDGKDVMPEVNKVLDK.4|SNTPILVDGKDVMPEVNKVLDK.3|MIPC[CAM]DFLIPVQTQHPIR.3|MIPC[CAM]DFLIPVQTQHPIR.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.3|MIPC[CAM]DFLIPVQTQHPIR.2|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.5|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.3|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.3|HFVALSTNTTK.3|HFVALSTNTTK.2|M[Oxi]LVDLAK.2|KELQAAGKSPEDLER.4|KELQAAGKSPEDLER.3|INYTEGR.2|KELQAAGK.2|SPEDLER.2|RLFDANK.2|NRSNTPILVDGK.3|NRSNTPILVDGK.2|DRFNHFSLTLNTNHGHILVDYSK.6|DRFNHFSLTLNTNHGHILVDYSK.5|DRFNHFSLTLNTNHGHILVDYSK.4|DRFNHFSLTLNTNHGHILVDYSK.3|LTPFMLGALVAMYEHK.4|LTPFMLGALVAMYEHK.3|LTPFM[Oxi]LGALVAMYEHK.3|LTPFMLGALVAM[Oxi]YEHK.3|LTPFM[Oxi]LGALVAM[Oxi]YEHK.3|LTPFMLGALVAMYEHK.2|LTPFM[Oxi]LGALVAMYEHK.2|LTPFMLGALVAM[Oxi]YEHK.2|VRSGDWKGYTGK.3|DVM[Oxi]PEVNK.2|SPEDLERLLPHK.3|EWFLQAAK.2|FNHFSLTLNTNHGHILVDYSK.5|FNHFSLTLNTNHGHILVDYSK.4|FNHFSLTLNTNHGHILVDYSK.3|STEEARKELQAAGK.3|STEEARKELQAAGK.2|ELQAAGKSPEDLER.3|ELQAAGKSPEDLER.2|SNTPILVDGK.2|NLVTEDVMR.2|NLVTEDVM[Oxi]R.2|SGDWKGYTGK.2|TFTTQETITNAETAK.3|TFTTQETITNAETAK.2|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.3|EWFLQAAKDPSAVAK.3|EWFLQAAKDPSAVAK.2|FAAYFQQGDMESNGK.3|FAAYFQQGDM[Oxi]ESNGK.3|FAAYFQQGDMESNGK.2|FAAYFQQGDM[Oxi]ESNGK.2|GLHHKILLANFLAQTEALM[Oxi]R.4|GLHHKILLANFLAQTEALMR.4|LFDANKDRFNHFSLTLNTNHGHILVDYSK.6|LFDANKDRFNHFSLTLNTNHGHILVDYSK.5|LFDANKDRFNHFSLTLNTNHGHILVDYSK.4|RLFDANKDR.2|VFEGNRPTNSIVFTK.3|VFEGNRPTNSIVFTK.2|SNTPILVDGKDVMPEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.2|SNTPILVDGKDVMPEVNK.2|TFTTQETITNAETAKEWFLQAAK.4|TFTTQETITNAETAKEWFLQAAK.3|IEPELDGSAQVTSHDASTNGLINFIK.4|IEPELDGSAQVTSHDASTNGLINFIK.3|FAAYFQQGDMESNGKYITK.3|FAAYFQQGDM[Oxi]ESNGKYITK.3|NRSNTPILVDGKDVMPEVNK.3|KIEPELDGSAQVTSHDASTNGLINFIKQQR.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.3|TITDVINIGIGGSDLGPLM[Oxi]VTEALK.3|TITDVINIGIGGSDLGPLMVTEALK.3|IFVQGIIWDINSFDQWGVELGK.3|VKEFGIDPQNMFEFWDWVGGR.3|EFGIDPQNMFEFWDWVGGR.2
SEN / CTL,P24821,Tenascin,TNC,1.40,2.21,5.68E-31,6.82E-31,3.02E+01,"osteoblast differentiation,cell adhesion,negative regulation of cell adhesion,neuromuscular junction development,positive regulation of cell proliferation,response to wounding,response to mechanical stimulus,positive regulation of gene expression,peripheral nervous system axon regeneration,extracellular matrix organization,wound healing,odontogenesis of dentin-containing tooth,response to ethanol,bud outgrowth involved in lung branching,mesenchymal-epithelial cell signaling involved in prostate gland development,prostate gland epithelium morphogenesis,cellular response to retinoic acid,cellular response to vitamin D,response to fibroblast growth factor,cellular response to prostaglandin D stimulus",syndecan binding,"extracellular region,basement membrane,interstitial matrix,extracellular space,focal adhesion,membrane,extracellular matrix",246,77,105,C[CAM]VDGQC[CAM]IC[CAM]HEGFTGLDC[CAM]GQHSC[CAM]PSDC[CAM]NNLGQC[CAM]VSGR.4|TAHISGLPPSTDFIVYLSGLAPSIR.3|TAHISGLPPSTDFIVYLSGLAPSIR.4|C[CAM]VNGQC[CAM]VC[CAM]DEGYTGEDC[CAM]SQLR.3|WQPAIATVDSYVISYTGEKVPEITR.3|WQPAIATVDSYVISYTGEKVPEITR.4|GLEPGQEYNVLLTAEKGR.3|GLEPGQEYNVLLTAEKGR.2|AGTPYTVTLHGEVR.3|AGTPYTVTLHGEVR.2|SFSTFDKDTDSAITNC[CAM]ALSYK.3|TVSGNTVEYALTDLEPATEYTLR.3|TVSGNTVEYALTDLEPATEYTLR.4|GLEPGQEYNVLLTAEK.2|AVDIPGLEAATPYR.2|AVDIPGLEAATPYR.3|VSQTDNSITLEWR.2|ITAQGQYELR.2|LEELENLVSSLR.2|VSIYGVIR.2|QSEPLEITLLAPER.2|AATPYTVSIYGVIQGYR.2|AATPYTVSIYGVIQGYR.3|IKYAPISGGDHAEVDVPK.4|AYAAGFGDRREEFWLGLDNLNK.4|DLAPPSEPSESFQEHTVDGENQIVFTHR.4|GHSTRPLAVEVVTEDLPQLGDLAVSEVGWDGLR.4|IKYAPISGGDHAEVDVPKSQQATTK.4|KQSEPLEITLLAPER.3|KQSEPLEITLLAPER.2|RVSQTDNSITLEWR.3|DVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|YGDNNHSQGVNWFHWK.4|YGDNNHSQGVNWFHWK.3|YAPISGGDHAEVDVPK.3|YAPISGGDHAEVDVPK.2|FTTDLDSPR.2|REEFWLGLDNLNK.3|ETFTTGLDAPR.2|YAPISGGDHAEVDVPKSQQATTK.3|C[CAM]VNGMC[CAM]VC[CAM]DDGYTGEDC[CAM]RDR.3|EVIVGPDTTSYSLADLSPSTHYTAK.3|EVIVGPDTTSYSLADLSPSTHYTAK.4|DLTATEVQSETALLTWRPPR.3|DLTATEVQSETALLTWRPPR.4|QTGLAPGQEYEISLHIVK.3|QTGLAPGQEYEISLHIVK.2|AVDIPGLK.2|STDLPGLK.2|RAC[CAM]GC[CAM]AAAPDVK.3|RPETSYR.2|AYAAGFGDR.2|VDLRDHGETAFAVYDK.4|VDLRDHGETAFAVYDK.3|GHEHSIQFAEMK.3|GHEHSIQFAEMK.2|IQALNGPLR.2|C[CAM]VC[CAM]EQGFK.2|VATYLPAPEGLKFK.3|VFAILENKK.2|APTAQVESFR.2|LDAPSQIEVK.2|VTTTRLDAPSQIEVK.3|LIPGVEYLVSIIAM[Oxi]K.3|LIPGVEYLVSIIAM[Oxi]K.2|LIPGVEYLVSIIAMK.2|RGDM[Oxi]SSNPAKETFTTGLDAPR.4|RGDM[Oxi]SSNPAKETFTTGLDAPR.3|TPVLSAEASTAK.2|C[CAM]VNGQC[CAM]VC[CAM]HEGFMGK.3|C[CAM]VNGQC[CAM]VC[CAM]HEGFM[Oxi]GK.3|ESNPATINAATELDTPK.3|ESNPATINAATELDTPK.2|VPGDQTSTIIQELEPGVEYFIR.4|VPGDQTSTIIQELEPGVEYFIR.3|VATYLPAPEGLK.2|TRDITGLREATEYEIELYGISK.4|VDLRDHGETAFAVYDKFSVGDAK.4|DHGETAFAVYDK.2|TTLTGLRPGTEYGIGVSAVK.3|TTLTGLRPGTEYGIGVSAVK.2|ITYVPITGGTPSM[Oxi]VTVDGTK.3|ITYVPITGGTPSMVTVDGTK.3|ITYVPITGGTPSMVTVDGTK.2|WQPAIATVDSYVISYTGEK.3|WQPAIATVDSYVISYTGEK.2|SNM[Oxi]IQTIFTTIGLLYPFPK.3|EEFWLGLDNLNK.2|DVTDTTALITWFK.2|SQTVSAIATTAMGSPK.2|SQTVSAIATTAM[Oxi]GSPK.2|DTDSAITNC[CAM]ALSYK.2|PLAEIDGIELTYGIK.2|FTTDLDSPRDLTATEVQSETALLTWRPPR.4|TTLTGLRPGTEYGIGVSAVKEDKESNPATINAATELDTPK.5|VTEYLVVYTPTHEGGLEM[Oxi]QFR.3|VTEYLVVYTPTHEGGLEMQFR.3|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.3|EQC[CAM]TAGAGC[CAM]C[CAM]LQPATGR.2|LPVGSQC[CAM]SVDLESASGEK.2|LSWTADEGVFDNFVLK.2|DVTDTTALITWFKPLAEIDGIELTYGIK.3|TPVLSAEASTGETPNLGEVVVAEVGWDALK.3|C[CAM]IC[CAM]NEGYSGEDC[CAM]SEVSPPK.2
SEN / CTL,Q08629,Testican-1,SPOCK1,1.40,1.60,7.01E-02,5.61E-03,2.25E+00,"regulation of cell growth,neuron migration,cell adhesion,signal transduction,nervous system development,negative regulation of cell-substrate adhesion,negative regulation of endopeptidase activity,negative regulation of neuron projection development,central nervous system neuron differentiation,neurogenesis","serine-type endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,calcium ion binding,metalloendopeptidase inhibitor activity","proteinaceous extracellular matrix,extracellular space,cytoplasm,postsynaptic density,sarcoplasm,neuromuscular junction,node of Ranvier",6,2,2,SLLGAFIPR.2|ATQC[CAM]HGSTGQC[CAM]WC[CAM]VDK.3
SEN / CTL,P40926,"Malate dehydrogenase, mitochondrial",MDH2,1.40,1.54,1.90E-14,6.40E-15,1.42E+01,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,internal protein amino acid acetylation,NADH metabolic process","L-malate dehydrogenase activity,protein self-association,poly(A) RNA binding,malate dehydrogenase (NADP+) activity","nucleus,nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,plasma membrane,myelin sheath,extracellular exosome",108,31,62,SQETEC[CAM]TYFSTPLLLGK.2|SQETEC[CAM]TYFSTPLLLGK.3|LTLYDIAHTPGVAADLSHIETK.4|LTLYDIAHTPGVAADLSHIETK.3|LTLYDIAHTPGVAADLSHIETK.2|AGAGSATLSMAYAGAR.2|AGAGSATLSMAYAGAR.3|AGAGSATLSM[Oxi]AYAGAR.3|AGAGSATLSM[Oxi]AYAGAR.2|ANTFVAELK.2|VAVLGASGGIGQPLSLLLK.2|VAVLGASGGIGQPLSLLLK.3|VAVLGASGGIGQPLSLLLK.4|HGVYNPNKIFGVTTLDIVR.4|HGVYNPNKIFGVTTLDIVR.3|HGVYNPNKIFGVTTLDIVR.2|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.3|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|AAVKGYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|SQETEC[CAM]TYFSTPLLLGKK.3|SQETEC[CAM]TYFSTPLLLGKK.4|SQETEC[CAM]TYFSTPLLLGKK.2|VDFPQDQLTALTGR.2|VDFPQDQLTALTGR.3|IFGVTTLDIVR.2|IFGVTTLDIVR.3|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.3|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.4|AKAGAGSATLSMAYAGAR.3|AKAGAGSATLSM[Oxi]AYAGAR.3|ANTFVAELKGLDPAR.3|ANTFVAELKGLDPAR.2|KGEDFVK.2|IQEAGTEVVKAK.3|FVFSLVDAMNGK.3|FVFSLVDAM[Oxi]NGK.3|FVFSLVDAMNGK.2|FVFSLVDAM[Oxi]NGK.2|GLDPARVNVPVIGGHAGK.4|GLDPARVNVPVIGGHAGK.3|GC[CAM]DVVVIPAGVPR.3|GC[CAM]DVVVIPAGVPR.2|TIIPLISQC[CAM]TPK.3|TIIPLISQC[CAM]TPK.2|HGVYNPNK.2|GYLGPEQLPDC[CAM]LK.3|GYLGPEQLPDC[CAM]LK.2|IQEAGTEVVK.2|ANTFVAELKGLDPARVNVPVIGGHAGK.5|ANTFVAELKGLDPARVNVPVIGGHAGK.4|MISDAIPELK.2|M[Oxi]ISDAIPELK.2|VNVPVIGGHAGK.2|EGVVEC[CAM]SFVK.2|FVFSLVDAMNGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.3|FVFSLVDAMNGKEGVVEC[CAM]SFVK.3|VSSFEEKM[Oxi]ISDAIPELK.3|VSSFEEKMISDAIPELK.3|VDFPQDQLTALTGRIQEAGTEVVK.3|DDLFNTNATIVATLTAAC[CAM]AQHC[CAM]PEAMIC[CAM]VIANPVNSTIPITAEVFKK.5
SEN / CTL,P06899;P23527;P33778;Q16778,Histone H2B type 1-J;Histone H2B type 1-O;Histone H2B type 1-B;Histone H2B type 2-E,HIST1H2BJ;HIST1H2BO;HIST1H2BB;HIST2H2BE,1.39,2.87,3.93E-06,5.41E-07,6.27E+00,"innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly;nucleosome assembly;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium","DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity","nucleosome,nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm;nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm;nucleosome,nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm,extracellular exosome",42,4,12,AMGIMNSFVNDIFER.2|AMGIMNSFVNDIFER.3|AM[Oxi]GIMNSFVNDIFER.2|AM[Oxi]GIMNSFVNDIFER.3|AMGIM[Oxi]NSFVNDIFER.3|AM[Oxi]GIM[Oxi]NSFVNDIFER.3|AMGIM[Oxi]NSFVNDIFER.2|AM[Oxi]GIM[Oxi]NSFVNDIFER.2|LLLPGELAK.2|EIQTAVRLLLPGELAK.3|EIQTAVRLLLPGELAK.2|ESYSIYVYK.2
SEN / CTL,O00622,Protein CYR61,CYR61,1.39,1.19,3.69E-04,3.84E-05,4.42E+00,"regulation of cell growth,osteoblast differentiation,positive regulation of protein phosphorylation,intussusceptive angiogenesis,atrioventricular valve morphogenesis,apoptotic process involved in heart morphogenesis,ventricular septum development,chemotaxis,cell adhesion,cell-cell signaling,cell proliferation,anatomical structure morphogenesis,positive regulation of phospholipase activity,positive regulation of cell-substrate adhesion,extracellular matrix organization,positive regulation of cell migration,positive regulation of BMP signaling pathway,positive regulation of osteoblast proliferation,negative regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,wound healing, spreading of cells,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of transcription from RNA polymerase II promoter,atrial septum morphogenesis,negative regulation of cell death,chondroblast differentiation,chorio-allantoic fusion,labyrinthine layer blood vessel development,positive regulation of cartilage development,regulation of ERK1 and ERK2 cascade,reactive oxygen species metabolic process,positive regulation of ceramide biosynthetic process","integrin binding,insulin-like growth factor binding,heparin binding,extracellular matrix binding","proteinaceous extracellular matrix,extracellular matrix",18,17,20,GLEC[CAM]NFGASSTALK.2|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.3|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.4|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.5|C[CAM]APGVGLVR.2|NNELIAVGK.2|AQSEGRPC[CAM]EYNSR.3|C[CAM]C[CAM]TPQLTR.2|C[CAM]EDGETFSK.2|YC[CAM]GSC[CAM]VDGR.2|VTNDNPEC[CAM]R.2|NVMMIQSC[CAM]K.2|NVMM[Oxi]IQSC[CAM]K.2|FTYAGC[CAM]LSVK.2|IC[CAM]EVRPC[CAM]GQPVYSSLK.3|FRC[CAM]EDGETFSK.2|C[CAM]NYNC[CAM]PHANEAAFPFYR.3|ELGFDASEVELTR.2|C[CAM]IVQTTSWSQC[CAM]SK.2|IYQNGESFQPNC[CAM]K.2
SEN / CTL,P35555,Fibrillin-1,FBN1,1.38,1.46,1.57E-04,1.72E-05,4.76E+00,"skeletal system development,metanephros development,heart development,extracellular matrix disassembly,extracellular matrix organization,cell adhesion mediated by integrin,sequestering of BMP in extracellular matrix,sequestering of TGFbeta in extracellular matrix,camera-type eye development,negative regulation of osteoclast differentiation,embryonic eye morphogenesis,post-embryonic eye morphogenesis,cellular response to transforming growth factor beta stimulus,regulation of cellular response to growth factor stimulus,cellular response to insulin-like growth factor stimulus,negative regulation of osteoclast development","integrin binding,hormone activity,extracellular matrix structural constituent,calcium ion binding,protein binding,heparin binding,extracellular matrix constituent conferring elasticity,protein complex binding","microfibril,extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrix,extracellular exosome",78,32,32,TLPGGNQC[CAM]IVPIC[CAM]R.2|ILELLPALTTLTNHNR.3|TC[CAM]VDINEC[CAM]LLEPR.2|NLIGTYMC[CAM]IC[CAM]GPGYQR.2|C[CAM]LC[CAM]PEGFSLSSSGR.2|C[CAM]EC[CAM]FPGLAVGLDGR.2|AC[CAM]EDIDEC[CAM]SLPNIC[CAM]VFGTC[CAM]HNLPGLFR.3|C[CAM]QC[CAM]PSGMTLDATGR.2|GWGPHC[CAM]EIC[CAM]PFQGTVAFK.3|C[CAM]IC[CAM]KPGFQLASDGR.3|TGC[CAM]TDINEC[CAM]EIGAHNC[CAM]GK.3|C[CAM]EC[CAM]EIGYELDR.2|GYILQEDGR.2|C[CAM]VNLIGK.2|NGLC[CAM]VNTR.2|C[CAM]PVGYVLR.2|AWGHPC[CAM]EMC[CAM]PAQPHPC[CAM]R.4|PGFQLASDGR.2|MC[CAM]KDEDEC[CAM]EEGKHDC[CAM]TEK.4|YQC[CAM]AC[CAM]NPGYHSTPDR.3|C[CAM]SNQLPQSITK.2|YNAYC[CAM]C[CAM]PGWK.2|GEC[CAM]IDVDEC[CAM]EK.2|RPDGEGC[CAM]VDENEC[CAM]QTKPGIC[CAM]ENGR.4|NC[CAM]EDMDEC[CAM]SIR.2|C[CAM]SC[CAM]SPGWIGDGIK.2|C[CAM]PPGFYTSPDGTR.2|C[CAM]PTGYYLNEDTR.2|C[CAM]EC[CAM]PVGFFYNDK.2|YEDEEC[CAM]TLPIAGR.2|C[CAM]IC[CAM]NSGYEVDSTGK.2|DINEC[CAM]ETPGIC[CAM]MNGR.2
SEN / CTL,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,1.38,1.43,2.76E-03,2.56E-04,3.59E+00,"cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding","nucleus,cytoplasm,microtubule,vesicle",30,5,14,TIQFVDWC[CAM]PTGFK.2|TIQFVDWC[CAM]PTGFK.3|RTIQFVDWC[CAM]PTGFK.3|RTIQFVDWC[CAM]PTGFK.2|AVC[CAM]MLSNTTAVAEAWAR.3|AVC[CAM]MLSNTTAVAEAWAR.2|AVC[CAM]M[Oxi]LSNTTAVAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAVAEAWAR.2|AYHEQLTVAEITNAC[CAM]FEPANQM[Oxi]VK.4|AYHEQLTVAEITNAC[CAM]FEPANQMVK.4|AYHEQLTVAEITNAC[CAM]FEPANQM[Oxi]VK.3|AYHEQLTVAEITNAC[CAM]FEPANQMVK.3|DYEEVGADSADGEDEGEEY.3|DYEEVGADSADGEDEGEEY.2
SEN / CTL,Q15113,Procollagen C-endopeptidase enhancer 1,PCOLCE,1.37,0.53,1.46E-03,1.41E-04,3.85E+00,"proteolysis,multicellular organism development,positive regulation of peptidase activity","protein binding,collagen binding,heparin binding,peptidase activator activity","extracellular space,extracellular exosome,extracellular matrix",6,9,10,YDALEVFAGSGTSGQR.2|ATSGTEHQFC[CAM]GGR.3|ATSGTEHQFC[CAM]GGR.2|MTTDEGTGGR.2|FDLEPDTYC[CAM]R.2|PAPLVAPGNQVTLR.2|TGGLDLPSPPTGASLK.2|GVSYLLMGQVEENR.2|TEESPSAPDAPTC[CAM]PK.2|GESGYVASEGFPNLYPPNK.2
SEN / CTL,Q15393,Splicing factor 3B subunit 3,SF3B3,1.36,1.31,1.62E-02,1.37E-03,2.86E+00,"RNA splicing, via transesterification reactions,mRNA splicing, via spliceosome,mRNA processing,protein complex assembly,RNA splicing,negative regulation of protein catabolic process",RNA binding,"nucleus,nucleoplasm,spliceosomal complex,U12-type spliceosomal complex,nucleolus,small nuclear ribonucleoprotein complex,catalytic step 2 spliceosome",12,61,96,FLAVGLVDNTVR.2|TVLDPVTGDLSDTR.2|TVLDPVTGDLSDTR.3|HIANYISGIQTIGHR.4|HIANYISGIQTIGHR.3|HIANYISGIQTIGHR.2|QDELGER.2|MFLYNLTLQR.3|MFLYNLTLQR.2|M[Oxi]FLYNLTLQR.2|RRNDLDDPER.3|GLLNGASQK.2|LVYILNR.2|SYYFPVK.2|MQGQEAVLAMSSR.3|MQGQEAVLAMSSR.2|M[Oxi]QGQEAVLAMSSR.2|AVMISAIEK.2|AVM[Oxi]ISAIEK.2|FGNIC[CAM]VVR.2|IHQETFGK.2|LGAVFNQVAFPLQYTPR.4|LGAVFNQVAFPLQYTPR.3|LGAVFNQVAFPLQYTPR.2|NVSEELDR.2|RIVPGQFLAVDPK.3|RIVPGQFLAVDPK.2|ILELLRPDPNTGK.3|NDLDDPER.2|QKNVSEELDRTPPEVSK.4|NFGDQPDIR.2|SEHPPLC[CAM]GR.2|VHTLLTVEVFGVIR.3|VHTLLTVEVFGVIR.2|ATGISFAIHGNFSGTK.3|ATGISFAIHGNFSGTK.2|VIVSDVQESFIWVR.3|VIVSDVQESFIWVR.2|NVSEELDRTPPEVSK.3|NVSEELDRTPPEVSK.2|TPVEEVPAAIAPFQGR.3|TPVEEVPAAIAPFQGR.2|YFDTVPVAAAMC[CAM]VLK.3|YFDTVPVAAAMC[CAM]VLK.2|AGNGQWASVIR.2|DYIVVGSDSGR.2|IVILEYQPSK.2|LTISSPLEAHK.2|SVAGGFVYTYK.2|NENQLIIFADDTYPR.3|NENQLIIFADDTYPR.2|IVILEYQPSKNMFEK.3|LPPNTNDEVDEDPTGNK.3|LPPNTNDEVDEDPTGNK.2|GMIFVC[CAM]SATHK.2|GM[Oxi]IFVC[CAM]SATHK.2|ELAAEMAAAFLNENLPESIFGAPK.4|ELAAEMAAAFLNENLPESIFGAPK.3|SMFFFLAQTEQGDIFK.3|SM[Oxi]FFFLAQTEQGDIFK.2|SMFFFLAQTEQGDIFK.2|SWLSYSYQSR.2|IVPGQFLAVDPK.2|LKYFDTVPVAAAMC[CAM]VLK.3|LKYFDTVPVAAAMC[CAM]VLK.2|HGLEVSEMAVSELPGNPNAVWTVR.4|HGLEVSEMAVSELPGNPNAVWTVR.3|HGLEVSEM[Oxi]AVSELPGNPNAVWTVR.3|KQQMAEEMVEAAGEDER.3|RNENQLIIFADDTYPR.3|RNENQLIIFADDTYPR.2|AEVIMNYHVGETVLSLQK.3|AEVIM[Oxi]NYHVGETVLSLQK.3|AEVIMNYHVGETVLSLQK.2|HGLEVSEMAVSELPGNPNAVWTVRR.4|HGLEVSEMAVSELPGNPNAVWTVRR.3|NVIDGDLC[CAM]EQFNSMEPNK.3|NVIDGDLC[CAM]EQFNSMEPNK.2|FVIHPESNNLIIIETDHNAYTEATK.4|FVIHPESNNLIIIETDHNAYTEATK.3|KFVIHPESNNLIIIETDHNAYTEATK.4|KFVIHPESNNLIIIETDHNAYTEATK.3|FHLTPLSYETLEFASGFASEQC[CAM]PEGIVAISTNTLR.5|FHLTPLSYETLEFASGFASEQC[CAM]PEGIVAISTNTLR.4|LVNNGEKLEFLHK.2|NVIDGDLC[CAM]EQFNSMEPNKQK.3|TTLIPGGSESLVYTTLSGGIGILVPFTSHEDHDFFQHVEMHLR.6|TTLIPGGSESLVYTTLSGGIGILVPFTSHEDHDFFQHVEMHLR.5|ITLETDEDMVTEIR.2|FSNTGEDWYVLVGVAKDLILNPR.3|FSNTGEDWYVLVGVAK.2|QQMAEEMVEAAGEDER.2|IISLDPSDC[CAM]LQPLSMQALPAQPESLC[CAM]IVEMGGTEK.4|WVTTASLLDYDTVAGADK.2|WVTTASLLDYDTVAGADKFGNIC[CAM]VVR.3|VMNPIQGNTLDLVQLEQNEAAFSVAVC[CAM]R.3
SEN / CTL,P26022,Pentraxin-related protein PTX3,PTX3,1.36,1.71,5.28E-04,5.38E-05,4.27E+00,"response to yeast,inflammatory response,opsonization,negative regulation by host of viral exo-alpha-sialidase activity,negative regulation by host of viral glycoprotein metabolic process,innate immune response,positive regulation of nitric oxide biosynthetic process,negative regulation of viral entry into host cell,positive regulation of phagocytosis,negative regulation of exo-alpha-sialidase activity,negative regulation of glycoprotein metabolic process","complement component C1q binding,(1->3)-beta-D-glucan binding,protein binding,identical protein binding,virion binding","extracellular region,extracellular space",30,7,7,LTSALDELLQATR.2|SWLPAGC[CAM]ETAILFPMR.2|ALAAVLEELR.2|ADLHAVQGWAAR.3|LAESLARPC[CAM]APGAPAEAR.3|ETGGAESC[CAM]HIR.3|MEGAEAQRPEEAGR.3
SEN / CTL,P55058,Phospholipid transfer protein,PLTP,1.36,0.91,4.14E-04,4.29E-05,4.37E+00,"lipid metabolic process,lipid transport,vitamin E biosynthetic process,positive regulation of cholesterol efflux,flagellated sperm motility,high-density lipoprotein particle remodeling",lipid binding,"extracellular region,extracellular space",12,6,7,FLEQELETITIPDLR.3|FLEQELETITIPDLR.2|AGALQLLLVGDK.2|AVEPQLQEEER.2|GVQIPLPEGINFVHEVVTNHAGFLTIGADLHFAK.5|DPVASTSNLDMDFR.2|ATYFGSIVLLSPAVIDSPLKLELR.3
SEN / CTL,O14737,Programmed cell death protein 5,PDCD5,1.35,1.32,6.01E-03,5.32E-04,3.27E+00,"apoptotic process,negative regulation of cell proliferation,positive regulation of gene expression,positive regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to transforming growth factor beta stimulus,positive regulation of release of cytochrome c from mitochondria,positive regulation of protein import into mitochondrial outer membrane,negative regulation of chaperone-mediated protein folding","DNA binding,protein binding,heparin binding,acetyltransferase activator activity,beta-tubulin binding","nucleus,cytoplasm,cytosol,extracellular exosome",18,9,16,NSILAQVLDQSAR.2|NSILAQVLDQSAR.3|AVENYLIQMAR.2|AVENYLIQMAR.3|AVENYLIQM[Oxi]AR.2|LSNLALVKPEK.3|LSNLALVKPEK.2|YGQLSEK.2|HGDPGDAAQQEAK.3|HGDPGDAAQQEAK.2|VSEQGLIEILKK.3|VSEQGLIEILKK.2|VMDSDEDDDY.2|VM[Oxi]DSDEDDDY.2|VSEQGLIEILK.2|KVMDSDEDDDY.2
SEN / CTL,P31949,Protein S100-A11,S100A11,1.35,1.93,4.94E-04,5.06E-05,4.30E+00,"signal transduction,negative regulation of DNA replication,negative regulation of cell proliferation,cell-cell adhesion","calcium ion binding,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular space,nucleus,cytoplasm,cell-cell adherens junction,extracellular exosome",30,8,13,ISSPTETERC[CAM]IESLIAVFQK.3|TEFLSFMNTELAAFTK.2|TEFLSFMNTELAAFTK.3|TEFLSFM[Oxi]NTELAAFTK.2|C[CAM]IESLIAVFQK.2|C[CAM]IESLIAVFQK.3|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.4|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.3|YAGKDGYNYTLSK.3|YAGKDGYNYTLSK.2|ISSPTETER.2|DGYNYTLSK.2|NQKDPGVLDR.2
SEN / CTL,Q9ULV4,Coronin-1C,CORO1C,1.35,1.03,9.60E-08,1.59E-08,7.80E+00,"neural crest cell migration,regulation of protein phosphorylation,negative regulation of protein phosphorylation,phagocytosis,signal transduction,regulation of epithelial cell migration,negative regulation of epithelial cell migration,regulation of fibroblast migration,actin cytoskeleton organization,negative regulation of protein kinase activity by regulation of protein phosphorylation,establishment of protein localization,regulation of focal adhesion assembly,negative regulation of focal adhesion assembly,activation of GTPase activity,regulation of substrate adhesion-dependent cell spreading,negative regulation of substrate adhesion-dependent cell spreading,regulation of ruffle assembly,positive regulation of lamellipodium morphogenesis","protein binding,Rac GTPase binding,actin filament binding","cytoplasm,focal adhesion,actin cytoskeleton,lateral plasma membrane,flotillin complex,lamellipodium,vesicle",36,36,54,VTWDSSFC[CAM]AVNPR.2|AIFLADGNVFTTGFSR.2|AIFLADGNVFTTGFSR.3|YFEITDESPYVHYLNTFSSKEPQR.4|YFEITDESPYVHYLNTFSSKEPQR.3|KC[CAM]EPIIMTVPR.3|KC[CAM]EPIIM[Oxi]TVPR.3|KC[CAM]EPIIMTVPR.2|KC[CAM]EPIIM[Oxi]TVPR.2|KQEIVAEKEK.3|KQEIVAEKEK.2|NDQC[CAM]YDDIR.3|NDQC[CAM]YDDIR.2|NILDSKPTANK.3|NILDSKPTANK.2|VGIVAWHPTAR.3|VGIVAWHPTAR.2|GLDVNKC[CAM]EIAR.3|GLDVNKC[CAM]EIAR.2|LEQQMAK.2|HVFGQAVK.2|NILDSKPTANKK.3|RVGIVAWHPTAR.3|KTTDTASVQNEAK.3|KTTDTASVQNEAK.2|KQEIVAEK.2|C[CAM]DLISIPK.2|RGLDVNKC[CAM]EIAR.3|QLALWNPK.2|SIKDTIC[CAM]NQDER.3|SIKDTIC[CAM]NQDER.2|HVFGQAVKNDQC[CAM]YDDIR.4|HVFGQAVKNDQC[CAM]YDDIR.3|KTTDTASVQNEAKLDEILK.4|KTTDTASVQNEAKLDEILK.3|NGSLIC[CAM]TASK.2|C[CAM]DLISIPKK.2|KC[CAM]DLISIPK.2|NADPILISLK.2|DTIC[CAM]NQDER.2|TTDTASVQNEAKLDEILKEIK.4|ISKLEQQMAK.2|C[CAM]EPIIMTVPR.2|YFEITDESPYVHYLNTFSSK.4|YFEITDESPYVHYLNTFSSK.3|TTDTASVQNEAK.2|NGSLIC[CAM]TASKDK.2|FRHVFGQAVKNDQC[CAM]YDDIR.3|SDLFQDDLYPDTAGPEAALEAEEWFEGK.4|SDLFQDDLYPDTAGPEAALEAEEWFEGK.3|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.4|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.3|NM[Oxi]QEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4|NMQEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4
SEN / CTL,P08758,Annexin A5,ANXA5,1.34,2.11,1.82E-02,1.53E-03,2.82E+00,"signal transduction,blood coagulation,response to organic substance,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of coagulation","phospholipase inhibitor activity,calcium ion binding,phospholipid binding,calcium-dependent phospholipid binding","intracellular,cytoplasm,focal adhesion,external side of plasma membrane,membrane,extracellular exosome,endothelial microparticle",72,45,70,GLGTDEESILTLLTSR.3|GLGTDEESILTLLTSR.2|GTVTDFPGFDERADAETLR.3|AM[Oxi]KGLGTDEESILTLLTSR.3|GTVTDFPGFDERADAETLRK.4|GTVTDFPGFDERADAETLRK.3|VLTEIIASR.2|SEIDLFNIR.2|ALLLLC[CAM]GEDD.2|NFATSLYSMIKGDTSGDYKK.4|WGTDEEKFITIFGTR.3|WGTDEEKFITIFGTR.2|NFATSLYSMIK.2|NFATSLYSMIK.3|NFATSLYSM[Oxi]IK.3|NFATSLYSM[Oxi]IK.2|SEIDLFNIRK.3|SEIDLFNIRK.2|DLLDDLK.2|WGTDEEK.2|GTVTDFPGFDER.3|GTVTDFPGFDER.2|QEISAAFK.2|ADAETLRK.2|DLLDDLKSELTGKFEK.4|DLLDDLKSELTGKFEK.3|DLLDDLKSELTGKFEK.2|KNFATSLYSMIK.3|KNFATSLYSMIK.2|FITIFGTR.2|DLLDDLKSELTGK.3|DLLDDLKSELTGK.2|SNAQRQEISAAFK.3|SNAQRQEISAAFK.2|LYDAYELKHALK.3|LYDAYELK.2|SELTGKFEK.2|LYDAYELKHALKGAGTNEK.4|LYDAYELKHALKGAGTNEK.3|ETSGNLEQLLLAVVK.3|ETSGNLEQLLLAVVK.2|GAGTNEKVLTEIIASR.3|GAGTNEKVLTEIIASR.2|HALKGAGTNEK.2|LIVALMKPSR.2|GAGTDDHTLIR.2|MLVVLLQANR.2|M[Oxi]LVVLLQANR.2|SIPAYLAETLYYAMK.3|SIPAYLAETLYYAM[Oxi]K.3|SIPAYLAETLYYAM[Oxi]K.2|SIPAYLAETLYYAMK.2|VLTEIIASRTPEELR.3|GAGTNEKVLTEIIASRTPEELR.4|YMTISGFQIEETIDR.3|YMTISGFQIEETIDR.2|KALLLLC[CAM]GEDD.2|DPDAGIDEAQVEQDAQALFQAGELK.4|DPDAGIDEAQVEQDAQALFQAGELK.3|TLFGRDLLDDLKSELTGK.3|TLFGRDLLDDLK.2|QVYEEEYGSSLEDDVVGDTSGYYQR.4|QVYEEEYGSSLEDDVVGDTSGYYQR.3|SIPAYLAETLYYAMKGAGTDDHTLIR.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.5|M[Oxi]LVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEK.5|VFDKYMTISGFQIEETIDRETSGNLEQLLLAVVK.4|AIKQVYEEEYGSSLEDDVVGDTSGYYQR.3
SEN / CTL,P26038,Moesin,MSN,1.34,1.87,1.55E-18,7.60E-19,1.81E+01,"movement of cell or subcellular component,cytoskeleton organization,leukocyte cell-cell adhesion,regulation of cell shape,regulation of cell size,positive regulation of gene expression,gland morphogenesis,membrane to membrane docking,establishment of epithelial cell apical/basal polarity,leukocyte migration,establishment of endothelial barrier,cellular response to testosterone stimulus,positive regulation of podosome assembly,regulation of organelle assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,regulation of lymphocyte migration,positive regulation of early endosome to late endosome transport","double-stranded RNA binding,actin binding,receptor binding,structural constituent of cytoskeleton,protein binding,protein kinase binding,cell adhesion molecule binding","uropod,extracellular space,nucleus,cytoplasm,cytoskeleton,plasma membrane,microvillus,focal adhesion,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,pseudopodium,microvillus membrane,vesicle,myelin sheath,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,cell periphery,blood microparticle",204,64,123,IGFPWSEIR.2|APDFVFYAPR.2|DQKKTQEQLALEMAELTAR.4|DQKKTQEQLALEMAELTAR.3|DQKKTQEQLALEMAELTAR.2|KTQEQLALEMAELTAR.3|KTQEQLALEMAELTAR.2|KTQEQLALEMAELTAR.4|KTQEQLALEM[Oxi]AELTAR.2|LFFLQVK.2|QRIDEFESM.2|AKFYPEDVSEELIQDITQR.3|AKFYPEDVSEELIQDITQR.4|AKFYPEDVSEELIQDITQR.2|ERQEAEEAKEALLQASR.4|ERQEAEEAKEALLQASR.3|ERQEAEEAKEALLQASR.2|EGILNDDIYC[CAM]PPETAVLLASYAVQSK.3|EGILNDDIYC[CAM]PPETAVLLASYAVQSK.4|TQEQLALEMAELTAR.3|TQEQLALEMAELTAR.2|TQEQLALEM[Oxi]AELTAR.2|GMLREDAVLEYLK.3|GMLREDAVLEYLK.2|GM[Oxi]LREDAVLEYLK.3|GM[Oxi]LREDAVLEYLK.2|FYPEDVSEELIQDITQR.3|FYPEDVSEELIQDITQR.2|SGYLAGDKLLPQR.3|SGYLAGDKLLPQR.2|ESEAVEWQQK.2|AQMVQEDLEKTRAELK.3|AQM[Oxi]VQEDLEKTRAELK.4|AQM[Oxi]VQEDLEKTRAELK.3|GSELWLGVDALGLNIYEQNDRLTPK.3|QEAEEAKEALLQASR.3|QEAEEAKEALLQASR.2|ALELEQER.2|ILALC[CAM]MGNHELYMR.3|ILALC[CAM]MGNHELYMR.2|ILALC[CAM]M[Oxi]GNHELYMR.3|ILALC[CAM]MGNHELYM[Oxi]R.3|ILALC[CAM]M[Oxi]GNHELYM[Oxi]R.3|ILALC[CAM]M[Oxi]GNHELYMR.2|ILALC[CAM]MGNHELYM[Oxi]R.2|FVIKPIDKKAPDFVFYAPR.4|FVIKPIDKKAPDFVFYAPR.5|FVIKPIDKKAPDFVFYAPR.3|TAMSTPHVAEPAENEQDEQDENGAEASADLR.4|TAMSTPHVAEPAENEQDEQDENGAEASADLR.3|TAM[Oxi]STPHVAEPAENEQDEQDENGAEASADLR.3|KGSELWLGVDALGLNIYEQNDRLTPK.4|KGSELWLGVDALGLNIYEQNDRLTPK.3|KPDTIEVQQMK.3|KPDTIEVQQMK.2|SGYLAGDK.2|ALTSELANARDESKK.4|ALTSELANARDESKK.3|ALTSELANARDESKK.2|AQQELEEQTR.3|AQQELEEQTR.2|IQVWHEEHR.3|IQVWHEEHR.2|YGDFNKEVHK.3|YGDFNKEVHK.2|AMLENEK.2|AM[Oxi]LENEK.2|ESPLLFK.2|ESPLLFK.1|LKQIEEQTKK.3|LKQIEEQTKK.2|EALLQASR.2|QIEEQTK.2|KAQQELEEQTR.3|KAQQELEEQTR.2|KESEAVEWQQK.3|KESEAVEWQQK.2|AQQELEEQTRR.3|AQQELEEQTRR.2|KVTAQDVR.2|TANDMIHAENMR.3|TANDM[Oxi]IHAENMR.3|TANDMIHAENM[Oxi]R.3|TANDMIHAENMR.2|ISQLEMAR.2|ISQLEM[Oxi]AR.2|AQMVQEDLEKTR.3|AQM[Oxi]VQEDLEKTR.3|KESPLLFK.2|VLEQHKLNKDQWEER.4|VLEQHKLNKDQWEER.3|ALTSELANARDESK.3|ALTSELANARDESK.2|KAQQELEEQTRR.3|KAQQELEEQTRR.2|KTANDM[Oxi]IHAENMR.3|KTANDMIHAENM[Oxi]R.3|KTANDMIHAENMR.3|KTANDMIHAENMR.2|ALTSELANAR.2|KVTAQDVRK.2|DRSEEERTTEAEK.3|EDAVLEYLK.2|ALELEQERK.2|EVWFFGLQYQDTK.3|EVWFFGLQYQDTK.2|LKQIEEQTK.2|VLEQHKLNK.2|RALELEQER.2|SEEERTTEAEKNER.3|AQMVQEDLEK.2|AQM[Oxi]VQEDLEK.2|LNKDQWEER.2|IAQDLEMYGVNYFSIK.3|IAQDLEM[Oxi]YGVNYFSIK.2|IAQDLEMYGVNYFSIK.2|RALELEQERK.2|AKFYPEDVSEELIQDITQRLFFLQVK.4|GSELWLGVDALGLNIYEQNDR.3|GSELWLGVDALGLNIYEQNDR.2|KGSELWLGVDALGLNIYEQNDR.3|GFSTWLK.1|TAMSTPHVAEPAENEQDEQDENGAEASADLRADAMAK.4
SEN / CTL,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,1.33,2.01,6.05E-06,8.06E-07,6.09E+00,"negative regulation of transcription from RNA polymerase II promoter,mRNA splicing, via spliceosome,mRNA processing,mRNA export from nucleus,gene expression,primary miRNA processing,negative regulation of mRNA splicing, via spliceosome,RNA transport,miRNA transport","nucleotide binding,RNA binding,mRNA 3'-UTR binding,protein binding,miRNA binding,single-stranded telomeric DNA binding,poly(A) RNA binding,pre-mRNA intronic binding,N6-methyladenosine-containing RNA binding","nucleus,nucleoplasm,spliceosomal complex,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome,catalytic step 2 spliceosome",66,47,96,GFGFVTFDDHDPVDKIVLQK.4|GFGFVTFDDHDPVDKIVLQK.3|GFGFVTFDDHDPVDKIVLQK.2|KLFIGGLSFETTEESLRNYYEQWGK.4|KLFIGGLSFETTEESLRNYYEQWGK.3|KLFIGGLSFETTEESLR.3|KLFIGGLSFETTEESLR.2|RGFGFVTFDDHDPVDKIVLQK.4|RGFGFVTFDDHDPVDKIVLQK.3|IDTIEIITDR.2|LFIGGLSFETTEESLRNYYEQWGK.3|LFIGGLSFETTEESLRNYYEQWGK.4|LFIGGLSFETTEESLR.3|LFIGGLSFETTEESLR.2|GGGGNFGPGPGSNFR.2|GGGGNFGPGPGSNFR.3|GFGFVTFSSMAEVDAAMAARPHSIDGR.4|GFGFVTFSSMAEVDAAMAARPHSIDGR.5|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.4|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.3|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.3|GFGFVTFSSMAEVDAAMAARPHSIDGR.3|KLFVGGIKEDTEEHHLR.5|KLFVGGIKEDTEEHHLR.4|KLFVGGIKEDTEEHHLR.3|KLFVGGIKEDTEEHHLR.2|PGAHVTVK.2|LTDC[CAM]VVMRDPASKR.4|LTDC[CAM]VVM[Oxi]RDPASKR.4|LTDC[CAM]VVMRDPASKR.3|QEMQEVQSSR.3|QEMQEVQSSR.2|QEM[Oxi]QEVQSSR.2|AVAREESGKPGAHVTVK.4|AVAREESGKPGAHVTVK.3|KLFVGGIK.2|SGRGGNFGFGDSR.3|EESGKPGAHVTVK.3|EESGKPGAHVTVK.2|GGSDGYGSGR.2|RGFGFVTFDDHDPVDK.4|RGFGFVTFDDHDPVDK.3|RGFGFVTFDDHDPVDK.2|LFVGGIKEDTEEHHLR.4|LFVGGIKEDTEEHHLR.3|PGAHVTVKK.2|YHTINGHNAEVR.3|YHTINGHNAEVR.2|RAVAREESGKPGAHVTVK.4|EESGKPGAHVTVKK.3|EESGKPGAHVTVKK.2|KRGFGFVTFDDHDPVDK.4|LTDC[CAM]VVMR.2|LTDC[CAM]VVM[Oxi]R.2|LTDC[CAM]VVM[Oxi]RDPASK.3|LTDC[CAM]VVMRDPASK.3|LTDC[CAM]VVM[Oxi]RDPASK.2|LTDC[CAM]VVMRDPASK.2|GGNFGFGDSR.2|YHTINGHNAEVRK.3|YHTINGHNAEVRK.2|DYFEEYGK.2|IDTIEIITDRQSGK.3|TLETVPLER.2|NYYEQWGK.2|ALSRQEMQEVQSSR.3|ALSRQEM[Oxi]QEVQSSR.3|ALSRQEMQEVQSSR.2|EDTEEHHLRDYFEEYGK.4|EDTEEHHLRDYFEEYGK.3|EDTEEHHLRDYFEEYGK.2|NMGGPYGGGNYGPGGSGGSGGYGGR.4|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.3|NMGGPYGGGNYGPGGSGGSGGYGGR.3|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.2|NMGGPYGGGNYGPGGSGGSGGYGGR.2|GFGFVTFDDHDPVDK.3|GFGFVTFDDHDPVDK.2|LFVGGIKEDTEEHHLRDYFEEYGK.5|LFVGGIKEDTEEHHLRDYFEEYGK.4|LFVGGIKEDTEEHHLRDYFEEYGK.3|TLETVPLERK.2|SRGFGFVTFSSMAEVDAAMAARPHSIDGR.5|SRGFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.5|EDTEEHHLRDYFEEYGKIDTIEIITDR.5|EDTEEHHLRDYFEEYGKIDTIEIITDR.4|GFGFVTFSSMAEVDAAMAAR.3|GFGFVTFSSMAEVDAAMAAR.2|DYFEEYGKIDTIEIITDR.3|DYFEEYGKIDTIEIITDR.2|GGGGNFGPGPGSNFRGGSDGYGSGR.3|GGNFGFGDSRGGGGNFGPGPGSNFR.3|GFGDGYNGYGGGPGGGNFGGSPGYGGGR.3|SGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGR.3
SEN / CTL,P52565,Rho GDP-dissociation inhibitor 1,ARHGDIA,1.33,1.62,6.74E-10,1.44E-10,9.84E+00,"movement of cell or subcellular component,negative regulation of cell adhesion,regulation of Rho protein signal transduction,negative regulation of apoptotic process,positive regulation of GTPase activity,negative regulation of axonogenesis,positive regulation of axonogenesis,regulation of small GTPase mediated signal transduction,semaphorin-plexin signaling pathway,regulation of actin cytoskeleton reorganization","Rho GDP-dissociation inhibitor activity,GTPase activator activity,protein binding","cytosol,cytoskeleton,extracellular exosome",66,15,29,SIQEIQELDKDDESLR.2|SIQEIQELDKDDESLR.3|AEEYEFLTPVEEAPK.2|AEEYEFLTPVEEAPK.3|SIQEIQELDKDDESLRK.4|SIQEIQELDKDDESLRK.3|SIQEIQELDKDDESLRK.2|QSFVLKEGVEYR.3|QSFVLKEGVEYR.2|IDKTDYMVGSYGPRAEEYEFLTPVEEAPK.4|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.4|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.5|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.6|GVKIDKTDYMVGSYGPR.4|YIQHTYR.2|FTDDDKTDHLSWEWNLTIKK.5|FTDDDKTDHLSWEWNLTIKK.4|SRFTDDDKTDHLSWEWNLTIK.5|SRFTDDDKTDHLSWEWNLTIK.4|IDKTDYMVGSYGPR.3|IDKTDYM[Oxi]VGSYGPR.3|IDKTDYMVGSYGPR.2|FTDDDKTDHLSWEWNLTIK.4|FTDDDKTDHLSWEWNLTIK.3|FTDDDKTDHLSWEWNLTIK.2|SIQEIQELDK.2|TDYMVGSYGPR.2|TDYM[Oxi]VGSYGPR.2|AEEYEFLTPVEEAPKGM[Oxi]LAR.3
SEN / CTL,Q99715,Collagen alpha-1(XII) chain,COL12A1,1.33,1.83,9.42E-22,6.06E-22,2.12E+01,"skeletal system development,cell adhesion,collagen fibril organization,collagen catabolic process,endodermal cell differentiation",extracellular matrix structural constituent conferring tensile strength,"extracellular region,collagen type XII trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome,extracellular vesicle",222,96,114,NVGVEVFSLGIK.2|MIATDPDDTHAYNVADFESLSR.3|IVEVFDIGPK.2|NSDVEIFAVGVK.2|QHALSVGPQTTTLSVR.3|QHALSVGPQTTTLSVR.2|VLVVVTDGR.2|ALALGALQNIR.2|VSWDPSPSPVLGYK.2|RVQIALAQYSGDPR.3|LGELVVGPYDNTVVLEELR.2|LGELVVGPYDNTVVLEELR.3|LLPETPSDPFAIWQITDRDYKPQVGVIADPSSK.4|FNQMLNQIPNDYQSSR.2|LQPQTTYDITVLPIYK.2|LQPQTTYDITVLPIYK.3|AYVPPKDLSFSEVTSYGFK.3|SLLQAVANLPYKGGNTLTGMALNFIR.3|SELEAIASPPAETHVFTVEDFDAFQR.3|SELEAIASPPAETHVFTVEDFDAFQR.4|NAFVNQPTADLHPNGLPPSYTIILLFR.4|NAFVNQPTADLHPNGLPPSYTIILLFR.3|RLQPQTTYDITVLPIYK.3|RLQPQTTYDITVLPIYK.2|LKDEGVELFAIGIK.3|LKDEGVELFAIGIK.2|FTKVEDIIEAINTFPYR.3|IIDENTVHMSWAKPVDPIVGYR.4|TYQIGWDTFC[CAM]VK.2|LNWNPSPSPVTGYK.2|TNWSPAGENVFSYHITYK.3|VAIIITDGKSQDEVEIPAR.3|TEFNLNQYYQR.2|SLLQAVANLPYK.2|VQISLVQYSR.2|QVC[CAM]EQLISGQMNR.2|IEQELAAIK.2|NSDVEIFAVGVKDAVR.3|NSDVEIFAVGVKDAVR.2|VEDIIEAINTFPYR.2|VEDIIEAINTFPYR.3|SQDDVEAPSKK.3|YRIIYRPVAGGESR.4|VPPTVTSTVLKR.3|VTFHPTGDDRR.3|IIYRPVAGGESR.3|GGNTLTGMALNFIR.3|GGNTLTGMALNFIR.2|GGNTLTGM[Oxi]ALNFIR.2|VTWKPAPGK.2|EVTTPPNQR.2|GTWDHGASDVSLYR.3|VTWEPAPGEVKGYK.3|EVEVDRSETSTSLK.3|NTFTESAGAR.2|SQDDVEAPSK.2|VSDPTTSTMK.2|GISGAIGPPGPR.2|KFTKVEDIIEAINTFPYR.4|LRDVTHSTMNVFWEPVPGK.4|TSDPTMSSFR.2|ITEVTSEGFR.2|SQDEVEIPAR.2|VPPTVTSTVLK.2|VTDETTDSFK.2|VILTPM[Oxi]TAGSR.2|IIYSPTVGDPIDEYTTVPGRR.4|IIYSPTVGDPIDEYTTVPGRR.3|VVYSPVDGTRPSESIVVPGNTR.4|VVYSPVDGTRPSESIVVPGNTR.3|SSDAFRDPAIK.2|VGVVQYSSDTR.2|VTWEPAPGEVK.2|FRVSWDPSPSPVLGYK.3|VDEETENTMR.2|ITVDPTTDGPTK.2|SLYDDVDTGEK.2|RNNVILQPLQPDTPYK.3|VYDPSTSTLNVR.2|ITVIAVYEDGDGGHLTGNGR.3|GMTSSEPISIMEK.2|ITYQPSTGEGNEQTTTIGGR.3|ITYQPSTGEGNEQTTTIGGR.2|LLPETPSDPFAIWQITDR.3|LLPETPSDPFAIWQITDR.2|LKPDTPYTITVSSLYPDGEGGRM[Oxi]TGR.4|VQIALAQYSGDPR.2|VTDETTDSFKITWTQAPGR.3|IIYSPTVGDPIDEYTTVPGR.3|IIYSPTVGDPIDEYTTVPGR.2|IYIDC[CAM]YEIIEK.2|DLSFSEVTSYGFK.2|EVTLPLPRPQDLK.2|TVGLLPPQNIHISDEWYTR.3|SAAFQIQSFDIVC[CAM]SPVWTSR.3|NVQVYNPTPNSLDVRWDPAPGPVLQYR.4|NVQVYNPTPNSLDVRWDPAPGPVLQYR.3|LKPDTPYTITVSSLYPDGEGGR.3|HVFIVDDFESFEK.2|NQPGPPGPPGPPGSAGAR.2|YRITYQPSTGEGNEQTTTIGGR.3|GPGDLEAPSNLVISER.2|NLQPDTSYTVTVVPVYTEGDGGR.3|DLKPETEYVVNVYSVVEDEYSEPLKGTEK.4|DLKPETEYVVNVYSVVEDEYSEPLKGTEK.3|NVQVYNPTPNSLDVR.2|NNVILQPLQPDTPYK.2|VFGETTNSLSVAWDHADGPVQQYR.3|LFYAPAAGGPEELVPIPGNTNYAILR.3|LIPDTLYSVNLVALYSDGEGNPSPAQGR.3|LGPTVNDMQLTDLVPNTEYAVTVQAVLHDLTSEPVTVR.4|DLFSQTLYTVSVSAVHDEGESPPVTAQETTRPVPAPTNLK.4|QYLVTYTPVAGGETQEVTVR.2|IEDNLITFVC[CAM]ETATSSC[CAM]PLIYLDGYTSPGFK.3
SEN / CTL,P13611,Versican core protein,VCAN,1.32,1.56,2.19E-07,3.50E-08,7.46E+00,"skeletal system development,osteoblast differentiation,cell adhesion,multicellular organism development,central nervous system development,cell recognition,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process","extracellular matrix structural constituent,calcium ion binding,glycosaminoglycan binding,hyaluronic acid binding,carbohydrate binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi lumen,membrane,extracellular matrix,lysosomal lumen,intracellular membrane-bounded organelle",48,17,23,NGFDQC[CAM]DYGWLSDASVRHPVTVAR.4|VSVPTHPEAVGDASLTVVK.3|YTLNFEAAQK.2|LATVGELQAAWR.2|LQGAHLTSILSHEEQMFVNR.4|LQGAHLTSILSHEEQMFVNR.3|LQGAHLTSILSHEEQM[Oxi]FVNR.3|YEINSLIR.2|LLASDAGLYR.2|VGHDYQWIGLNDK.3|VGHDYQWIGLNDK.2|TQEEYEDK.2|GRVSVPTHPEAVGDASLTVVK.4|GRVSVPTHPEAVGDASLTVVK.3|AQC[CAM]GGGLLGVR.2|KGTVAC[CAM]GQPPVVENAK.3|AATSRYTLNFEAAQK.3|AATSRYTLNFEAAQK.2|LGEPNYGAEIR.2|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.5|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.4|ETTVLVAQNGNIK.2|GTVAC[CAM]GQPPVVENAK.2
SEN / CTL,Q8IUX7,Adipocyte enhancer-binding protein 1,AEBP1,1.32,0.30,9.09E-05,1.04E-05,4.98E+00,"negative regulation of transcription from RNA polymerase II promoter,skeletal system development,transcription, DNA-templated,peptide metabolic process,muscle organ development,protein processing","RNA polymerase II regulatory region sequence-specific DNA binding,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,transcription factor activity, sequence-specific DNA binding,transcription corepressor activity,carboxypeptidase activity,metallocarboxypeptidase activity,serine-type carboxypeptidase activity,calmodulin binding,zinc ion binding","extracellular space,nucleus,cytoplasm,extracellular exosome,extracellular matrix",6,9,11,YLSPDATVSTEVR.2|VTAHAEGYTPSAK.3|VTAHAEGYTPSAK.2|YTAGIHGNEVLGR.3|YTAGIHGNEVLGR.2|APAPAPEER.2|FTGVITQGR.2|EALLTFMEQVHR.3|VVNEEC[CAM]PTITR.2|NPFVLGANLNGGER.2|KGEELEEEWTPTEK.2
SEN / CTL,Q9UBX5,Fibulin-5,FBLN5,1.31,1.72,7.51E-02,5.98E-03,2.22E+00,"regulation of cell growth,cell-matrix adhesion,extracellular matrix organization,protein localization to cell surface,secretion,elastic fiber assembly,regulation of removal of superoxide radicals","integrin binding,calcium ion binding,protein binding,protein C-terminus binding,protein homodimerization activity","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome,elastic fiber",18,9,10,DQPFTILYR.2|YPGAYYIFQIK.2|SVPADIFQMQATTR.2|DMDVVSGR.2|SC[CAM]QDINEC[CAM]EHR.3|IYVSQYPF.2|C[CAM]MC[CAM]PAENPGC[CAM]R.2|QSGQC[CAM]LDIDEC[CAM]R.2|GPYSNPYSTPYSGPYPAAAPPLSAPNYPTISRPLIC[CAM]R.5|GPYSNPYSTPYSGPYPAAAPPLSAPNYPTISRPLIC[CAM]R.4
SEN / CTL,P40121,Macrophage-capping protein,CAPG,1.31,1.47,3.57E-03,3.25E-04,3.49E+00,"protein complex assembly,barbed-end actin filament capping,cell-cell adhesion,extracellular matrix disassembly,positive regulation of podosome assembly","actin binding,protein binding,protein domain specific binding,protein complex binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,nucleolus,cytoplasm,centriole,cell-cell adherens junction,F-actin capping protein complex,melanosome,extracellular exosome,mitotic spindle,Flemming body",12,22,39,QAALQVAEGFISR.2|QAALQVAEGFISR.3|MQYAPNTQVEILPQGHESPIFK.3|MQYAPNTQVEILPQGHESPIFK.4|M[Oxi]QYAPNTQVEILPQGHESPIFK.3|GLKYQEGGVESAFHK.4|GLKYQEGGVESAFHK.3|GLKYQEGGVESAFHK.2|YQEGGVESAFHK.3|YQEGGVESAFHK.2|TSTGAPAAIK.2|ARDLALAIR.2|GLKYQEGGVESAFHKTSTGAPAAIK.5|ANAQAAALYK.2|TSTGAPAAIKK.2|ANEKERQAALQVAEGFISR.4|ANEKERQAALQVAEGFISR.3|AQVEIVTDGEEPAEMIQVLGPKPALK.5|AQVEIVTDGEEPAEMIQVLGPKPALK.4|AQVEIVTDGEEPAEMIQVLGPKPALK.3|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.5|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.4|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.3|ERQAALQVAEGFISR.3|ERQAALQVAEGFISR.2|EVQGNESDLFMSYFPR.3|EVQGNESDLFM[Oxi]SYFPR.2|EVQGNESDLFMSYFPR.2|VSDATGQMNLTK.2|VSDATGQM[Oxi]NLTK.2|EGNPEEDLTADK.2|EGNPEEDLTADKANAQAAALYK.3|AQVEIVTDGEEPAEMIQVLGPK.3|AQVEIVTDGEEPAEMIQVLGPK.2|LKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSR.6|LKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSR.5|VADSSPFALELLISDDC[CAM]FVLDNGLC[CAM]GK.3|AQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADK.4|AQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADKANAQAAALYK.5
SEN / CTL,P61088;Q5JXB2,Ubiquitin-conjugating enzyme E2 N;Putative ubiquitin-conjugating enzyme E2 N-like,UBE2N;UBE2NL,1.31,3.32,2.34E-01,1.76E-02,1.75E+00,"double-strand break repair via homologous recombination,DNA double-strand break processing,stimulatory C-type lectin receptor signaling pathway,regulation of DNA repair,postreplication repair,double-strand break repair via nonhomologous end joining,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,protein ubiquitination,histone ubiquitination,positive regulation of histone modification,regulation of histone ubiquitination,Fc-epsilon receptor signaling pathway,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of DNA repair,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,positive regulation of ubiquitin-protein transferase activity,nucleotide-binding oligomerization domain containing signaling pathway,protein K63-linked ubiquitination,global genome nucleotide-excision repair;postreplication repair,protein K63-linked ubiquitination","ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin protein ligase binding,ubiquitin binding,poly(A) RNA binding,ubiquitin protein ligase activity,ubiquitin conjugating enzyme activity;ubiquitin protein ligase binding,ubiquitin protein ligase activity","ubiquitin ligase complex,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,UBC13-MMS2 complex,UBC13-UEV1A complex,protein complex,extracellular exosome;nucleus,cytoplasm,extracellular exosome",6,1,2,LLAEPVPGIKAEPDESNAR.3|LLAEPVPGIKAEPDESNAR.2
SEN / CTL,P08134,Rho-related GTP-binding protein RhoC,RHOC,1.31,2.00,6.68E-03,5.88E-04,3.23E+00,"cytokinesis,small GTPase mediated signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,apical junction assembly,wound healing, spreading of cells,regulation of small GTPase mediated signal transduction,positive regulation of lipase activity,skeletal muscle satellite cell migration","signal transducer activity,protein binding,GTP binding","cytosol,plasma membrane,cleavage furrow,extracellular exosome",12,5,7,EGVREVFEMATR.3|EGVREVFEMATR.2|ISAFGYLEC[CAM]SAK.2|ISAFGYLEC[CAM]SAK.3|QEPVRSEEGRDMANR.4|DLRQDEHTR.2|DQFPEVYVPTVFENYIADIEVDGK.3
SEN / CTL,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,1.31,1.21,1.23E-01,9.59E-03,2.02E+00,"G1/S transition of mitotic cell cycle,regulation of transcription involved in G1/S transition of mitotic cell cycle,DNA replication,deoxyribonucleotide biosynthetic process,nucleobase-containing small molecule interconversion,protein heterotetramerization,oxidation-reduction process","ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,protein binding,metal ion binding","nucleus,nucleoplasm,cytoplasm,cytosol,ribonucleoside-diphosphate reductase complex",6,22,27,FSQEVQITEAR.2|HLVHKPSEER.3|RIFQEPTEPK.3|RIFQEPTEPK.2|EIIINAVR.2|LM[Oxi]LELGFSK.2|IFQEPTEPK.2|DIQHWESLKPEER.3|EFLFNAIETMPC[CAM]VK.3|EFLFNAIETMPC[CAM]VK.2|ENTPPALSGTR.2|QYIEFVADR.2|DEGLHC[CAM]DFAC[CAM]LMFK.3|LIGMNC[CAM]TLM[Oxi]K.2|GLSLVDKENTPPALSGTR.3|GLSLVDKENTPPALSGTR.2|VPLAPITDPQQLQLSPLK.3|VPLAPITDPQQLQLSPLK.2|AAAPGVEDEPLLR.2|EREFLFNAIETMPC[CAM]VK.3|FVIFPIEYHDIWQMYK.3|IEQEFLTEALPVK.2|VFRVENPFDFMENISLEGK.3|GLMPGLTFSNELISR.2|GLM[Oxi]PGLTFSNELISR.2|YFISHVLAFFAASDGIVNENLVER.3|VENPFDFMENISLEGK.2
SEN / CTL,P12004,Proliferating cell nuclear antigen,PCNA,1.30,1.57,1.10E-03,1.08E-04,3.97E+00,"G1/S transition of mitotic cell cycle,regulation of transcription involved in G1/S transition of mitotic cell cycle,telomere maintenance via recombination,telomere maintenance,DNA strand elongation involved in DNA replication,leading strand elongation,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,mismatch repair,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,heart development,cell proliferation,protein sumoylation,translesion synthesis,epithelial cell differentiation,replication fork processing,positive regulation of deoxyribonuclease activity,response to estradiol,nucleotide-excision repair, DNA incision,cellular response to UV,error-prone translesion synthesis,DNA damage response, detection of DNA damage,estrous cycle,positive regulation of DNA repair,positive regulation of DNA replication,response to cadmium ion,cellular response to hydrogen peroxide,error-free translesion synthesis,response to dexamethasone,liver regeneration,response to L-glutamate,mitotic telomere maintenance via semi-conservative replication","purine-specific mismatch base pair DNA N-glycosylase activity,chromatin binding,damaged DNA binding,protein binding,enzyme binding,estrogen receptor binding,DNA polymerase processivity factor activity,receptor tyrosine kinase binding,dinucleotide insertion or deletion binding,MutLalpha complex binding,histone acetyltransferase binding,identical protein binding,DNA polymerase binding","nuclear chromosome, telomeric region,nucleus,nucleoplasm,replication fork,DNA replication factor C complex,cytoplasm,centrosome,replisome,nuclear replication fork,PCNA complex,extracellular exosome,PCNA-p21 complex",18,21,41,YYLAPKIEDEEGS.2|DLSHIGDAVVISC[CAM]AK.3|DLSHIGDAVVISC[CAM]AK.2|LMDLDVEQLGIPEQEYSC[CAM]VVK.3|LM[Oxi]DLDVEQLGIPEQEYSC[CAM]VVK.3|FSASGELGNGNIK.3|FSASGELGNGNIK.2|LVQGSILK.2|VSDYEMK.2|VSDYEM[Oxi]K.2|IADMGHLK.2|IADM[Oxi]GHLK.2|MPSGEFAR.2|M[Oxi]PSGEFAR.2|NLAMGVNLTSMSK.3|NLAMGVNLTSMSK.2|NLAM[Oxi]GVNLTSMSK.2|NLAMGVNLTSM[Oxi]SK.2|NLAM[Oxi]GVNLTSM[Oxi]SK.2|YLNFFTK.2|SEGFDTYR.2|LSQTSNVDK.2|LVQGSILKK.2|IC[CAM]RDLSHIGDAVVISC[CAM]AK.4|IC[CAM]RDLSHIGDAVVISC[CAM]AK.3|C[CAM]DRNLAMGVNLTSMSK.3|C[CAM]DRNLAM[Oxi]GVNLTSMSK.3|C[CAM]DRNLAMGVNLTSM[Oxi]SK.3|C[CAM]DRNLAMGVNLTSMSK.2|C[CAM]AGNEDIITLR.2|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.5|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.4|LSQTSNVDKEEEAVTIEM[Oxi]NEPVQLTFALR.3|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.3|AEDNADTLALVFEAPNQEK.3|AEDNADTLALVFEAPNQEK.2|ATPLSSTVTLSMSADVPLVVEYK.3|ATPLSSTVTLSM[Oxi]SADVPLVVEYK.3|C[CAM]AGNEDIITLRAEDNADTLALVFEAPNQEK.4|C[CAM]AGNEDIITLRAEDNADTLALVFEAPNQEK.3|AEDNADTLALVFEAPNQEKVSDYEMK.3
SEN / CTL,P09936,Ubiquitin carboxyl-terminal hydrolase isozyme L1,UCHL1,1.30,1.76,1.01E-04,1.15E-05,4.94E+00,"response to ischemia,axon target recognition,adult walking behavior,cell proliferation,regulation of macroautophagy,protein deubiquitination,sensory perception of pain,axonal transport of mitochondrion,eating behavior,proteasome-mediated ubiquitin-dependent protein catabolic process,negative regulation of MAP kinase activity,muscle fiber development,neuromuscular process","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,omega peptidase activity,ligase activity,ubiquitin protein ligase binding,alpha-2A adrenergic receptor binding,ubiquitin binding","nucleoplasm,cytoplasm,endoplasmic reticulum membrane,cytosol,neuronal cell body,myelin sheath,neuron projection terminus,extracellular exosome,axon cytoplasm,plasma membrane",60,20,39,C[CAM]FEKNEAIQAAHDAVAQEGQC[CAM]R.4|C[CAM]FEKNEAIQAAHDAVAQEGQC[CAM]R.3|FVDVLGLEEESLGSVPAPAC[CAM]ALLLLFPLTAQHENFRK.4|MPFPVNHGASSEDTLLKDAAK.4|MPFPVNHGASSEDTLLKDAAK.3|M[Oxi]PFPVNHGASSEDTLLKDAAK.4|LGVAGQWR.2|FSAVALC[CAM]K.2|MQLKPMEINPEMLNK.3|MQLKPMEINPEMLNK.2|M[Oxi]QLKPMEINPEMLNK.3|MQLKPM[Oxi]EINPEMLNK.3|MQLKPMEINPEM[Oxi]LNK.3|MQLKPM[Oxi]EINPEMLNK.2|QTIGNSC[CAM]GTIGLIHAVANNQDKLGFEDGSVLK.4|QTIGNSC[CAM]GTIGLIHAVANNQDKLGFEDGSVLK.3|KQIEELKGQEVSPK.4|KQIEELKGQEVSPK.3|VC[CAM]REFTEREQGEVR.4|VC[CAM]REFTEREQGEVR.3|EFTEREQGEVR.3|NEAIQAAHDAVAQEGQC[CAM]R.4|NEAIQAAHDAVAQEGQC[CAM]R.3|NEAIQAAHDAVAQEGQC[CAM]R.2|QFLSETEK.2|QIEELKGQEVSPK.3|QIEELKGQEVSPK.2|LGFEDGSVLK.2|VDDKVNFHFILFNNVDGHLYELDGR.5|VDDKVNFHFILFNNVDGHLYELDGR.4|NEAIQAAHDAVAQEGQC[CAM]RVDDK.4|MPFPVNHGASSEDTLLK.3|M[Oxi]PFPVNHGASSEDTLLK.3|MPFPVNHGASSEDTLLK.2|VNFHFILFNNVDGHLYELDGR.4|VNFHFILFNNVDGHLYELDGR.3|PMEINPEMLNK.2|QTIGNSC[CAM]GTIGLIHAVANNQDK.3|QTIGNSC[CAM]GTIGLIHAVANNQDK.2
SEN / CTL,Q15417,Calponin-3,CNN3,1.30,1.20,1.98E-03,1.88E-04,3.73E+00,"epithelial cell differentiation,actomyosin structure organization,negative regulation of ATPase activity,cell-cell adhesion","actin binding,calmodulin binding,microtubule binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cell-cell adherens junction,focal adhesion,postsynaptic density,actin cytoskeleton,neuronal cell body,dendritic spine",12,21,39,MQTDKPFDQTTISLQMGTNK.3|M[Oxi]QTDKPFDQTTISLQMGTNK.3|AGQSVIGLQMGTNK.2|AGQSVIGLQM[Oxi]GTNK.2|IASKYDHQAEEDLR.4|YDHQAEEDLR.3|YDHQAEEDLR.2|AIQAYGMK.2|GASQAGMLAPGTRR.3|GMSVYGLGR.2|TKGFHTTIDIGVK.3|KVNESSLNWPQLENIGNFIK.4|KVNESSLNWPQLENIGNFIK.3|KVNESSLNWPQLENIGNFIK.2|GFHTTIDIGVK.2|GASQAGMLAPGTR.2|GASQAGM[Oxi]LAPGTR.2|DGIILC[CAM]ELINK.2|DYQYSDQGIDY.2|C[CAM]ASQAGM[Oxi]TAYGTR.2|C[CAM]ASQAGMTAYGTR.2|LTLQPVDNSTISLQMGTNK.3|LTLQPVDNSTISLQM[Oxi]GTNK.2|LTLQPVDNSTISLQMGTNK.2|AIQAYGMKPHDIFEANDLFENGNMTQVQTTLVALAGLAK.6|AIQAYGMKPHDIFEANDLFENGNMTQVQTTLVALAGLAK.5|AIQAYGM[Oxi]KPHDIFEANDLFENGNM[Oxi]TQVQTTLVALAGLAK.4|AIQAYGM[Oxi]KPHDIFEANDLFENGNMTQVQTTLVALAGLAK.4|AIQAYGMKPHDIFEANDLFENGNM[Oxi]TQVQTTLVALAGLAK.4|AIQAYGMKPHDIFEANDLFENGNMTQVQTTLVALAGLAK.4|VNESSLNWPQLENIGNFIK.3|VNESSLNWPQLENIGNFIK.2|NWIEEVTGMSIGPNFQLGLK.3|PFDQTTISLQMGTNK.2|PHDIFEANDLFENGNMTQVQTTLVALAGLAK.4|PHDIFEANDLFENGNMTQVQTTLVALAGLAK.3|YDHQAEEDLRNWIEEVTGM[Oxi]SIGPNFQLGLK.4|YDHQAEEDLRNWIEEVTGMSIGPNFQLGLK.4|YDHQAEEDLRNWIEEVTGMSIGPNFQLGLK.3
SEN / CTL,Q14192,Four and a half LIM domains protein 2,FHL2,1.29,1.01,4.64E-02,3.79E-03,2.42E+00,"negative regulation of transcription from RNA polymerase II promoter,osteoblast differentiation,transcription, DNA-templated,response to hormone,androgen receptor signaling pathway,negative regulation of apoptotic process,positive regulation of transcription, DNA-templated,atrial cardiac muscle cell development,ventricular cardiac muscle cell development,heart trabecula formation","transcription coactivator activity,protein binding,transcription factor binding,zinc ion binding,androgen receptor binding","nucleus,nucleoplasm,focal adhesion,actin cytoskeleton,Z disc,M band",12,26,39,GFLTERDDILC[CAM]PDC[CAM]GKDI.3|SFIPKDNQNFC[CAM]VPC[CAM]YEK.3|FDC[CAM]HHC[CAM]NESLFGK.4|FDC[CAM]HHC[CAM]NESLFGK.3|DRHWHEAC[CAM]FHC[CAM]SQC[CAM]R.5|DRHWHEAC[CAM]FHC[CAM]SQC[CAM]R.4|GSSWHETC[CAM]FIC[CAM]HR.4|GSSWHETC[CAM]FIC[CAM]HR.3|GSSWHETC[CAM]FIC[CAM]HR.2|QHAM[Oxi]QC[CAM]VQC[CAM]K.3|QHAMQC[CAM]VQC[CAM]K.3|QHAMQC[CAM]VQC[CAM]K.2|QHAM[Oxi]QC[CAM]VQC[CAM]K.2|C[CAM]SLSLVGR.2|FDC[CAM]HHC[CAM]NESLFGKK.4|FDC[CAM]HHC[CAM]NESLFGKK.3|HWHEAC[CAM]FHC[CAM]SQC[CAM]R.4|C[CAM]QQPIGTK.2|QWHNDC[CAM]FNC[CAM]K.3|QWHNDC[CAM]FNC[CAM]K.2|YISFEER.2|KC[CAM]AGC[CAM]TNPISGLGGTK.3|DDILC[CAM]PDC[CAM]GK.2|KPITTGGVTYR.2|NSLVDKPFAAK.2|EC[CAM]FVC[CAM]TAC[CAM]R.2|GFLTERDDILC[CAM]PDC[CAM]GK.3|GFLTERDDILC[CAM]PDC[CAM]GK.2|EC[CAM]FVC[CAM]TAC[CAM]RK.2|DDFAYC[CAM]LNC[CAM]FC[CAM]DLYAK.3|DDFAYC[CAM]LNC[CAM]FC[CAM]DLYAK.2|EDQLLC[CAM]TDC[CAM]YSNEYSSK.3|EDQLLC[CAM]TDC[CAM]YSNEYSSK.2|C[CAM]AGC[CAM]TNPISGLGGTK.2|DNQNFC[CAM]VPC[CAM]YEK.2|NSLVDKPFAAKEDQLLC[CAM]TDC[CAM]YSNEYSSK.4|NSLVDKPFAAKEDQLLC[CAM]TDC[CAM]YSNEYSSK.3|EESPYC[CAM]VVC[CAM]FETLFANTC[CAM]EEC[CAM]GKPIGC[CAM]DC[CAM]K.4|YILREESPYC[CAM]VVC[CAM]FETLFANTC[CAM]EEC[CAM]GKPIGC[CAM]DC[CAM]K.4
SEN / CTL,P54725,UV excision repair protein RAD23 homolog A,RAD23A,1.28,0.73,8.09E-05,9.39E-06,5.03E+00,"nucleotide-excision repair,viral process,regulation of proteasomal ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,positive regulation of viral genome replication","damaged DNA binding,single-stranded DNA binding,protein binding,polyubiquitin binding,ubiquitin-specific protease binding","proteasome complex,nucleus",12,16,20,QVIQQNPALLPALLQQLGQENPQLLQQISR.4|QVIQQNPALLPALLQQLGQENPQLLQQISR.3|IRMEPDETVK.3|IRMEPDETVK.2|DAFPVAGQK.2|ASYNNPHR.2|TLQQQTFK.2|ILSDDVPIR.2|NFVVVMVTK.2|GRDAFPVAGQK.2|DQPQFQNMR.2|NENLAANFLLSQNFDDE.3|NENLAANFLLSQNFDDE.2|ALGFPESLVIQAYFAC[CAM]EK.3|ALGFPESLVIQAYFAC[CAM]EK.2|SPSEESAPTTSPESVSGSVPSSGSSGR.3|AGQGTSAPPEASPTAAPESSTSFPPAPTSGMSHPPPAAR.4|EDKSPSEESAPTTSPESVSGSVPSSGSSGR.3|EEDAASTLVTGSEYETMLTEIMSMGYER.3|AVEYLLTGIPGSPEPEHGSVQESQVSEQPATEAAGENPLEFLR.4
SEN / CTL,P63241;Q6IS14;Q9GZV4,Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1-like;Eukaryotic translation initiation factor 5A-2,EIF5A;EIF5AL1;EIF5A2,1.28,2.25,5.99E-09,1.16E-09,8.94E+00,"mRNA export from nucleus,translational frameshifting,protein export from nucleus,nucleocytoplasmic transport,apoptotic process,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,positive regulation of translational elongation,positive regulation of translational termination;translational frameshifting,protein transport,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport;translational frameshifting,spermatogenesis,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,polyamine homeostasis,protein transport,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport","RNA binding,translation elongation factor activity,protein binding,U6 snRNA binding,ribosome binding,poly(A) RNA binding,protein N-terminus binding;translation elongation factor activity,ribosome binding;translation elongation factor activity,protein binding,ribosome binding","nucleus,annulate lamellae,nuclear pore,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,extracellular exosome;nuclear pore,endoplasmic reticulum membrane;nuclear pore,endoplasmic reticulum membrane,cytosol,intracellular membrane-bounded organelle",48,5,18,VHLVGIDIFTGK.3|VHLVGIDIFTGK.2|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.5|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.6|KYEDIC[CAM]PSTHNMDVPNIKR.5|KYEDIC[CAM]PSTHNMDVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.5|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIK.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.4|KYEDIC[CAM]PSTHNMDVPNIK.3|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.3|KYEDIC[CAM]PSTHNMDVPNIK.2|YEDIC[CAM]PSTHNMDVPNIKR.4|YEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|YEDIC[CAM]PSTHNMDVPNIKR.3
SEN / CTL,Q15785,Mitochondrial import receptor subunit TOM34,TOMM34,1.27,1.19,2.15E-02,1.80E-03,2.75E+00,protein targeting to mitochondrion,heat shock protein binding,"nucleus,nucleoplasm,cytoplasm,mitochondrial outer membrane,membrane,integral component of membrane",6,22,32,VLQAQGSSDPEEESVLYSNR.2|VLQAQGSSDPEEESVLYSNR.3|VLKEEGNELVK.3|VLKEEGNELVK.2|AAGNESFR.2|LPSIPLVPVSAQK.3|LPSIPLVPVSAQK.2|VLKEEGNELVKK.3|NGQYAEASALYGR.3|NGQYAEASALYGR.2|ALC[CAM]YLVLK.2|ASAYEALEK.2|DC[CAM]TSALALVPFSIKPLLR.4|DC[CAM]TSALALVPFSIKPLLR.3|DC[CAM]TSALALVPFSIKPLLR.2|DC[CAM]TSALALVPFSIK.3|DC[CAM]TSALALVPFSIK.2|LKLPSIPLVPVSAQK.3|FPDSVEELR.2|QYTEAVKDC[CAM]TEALK.3|QYTEAVKDC[CAM]TEALK.2|SSFADISNLLQIEPR.3|SSFADISNLLQIEPR.2|YPMAYVDYK.2|NRVPSAGDVEK.2|WNSLPSENHK.2|DC[CAM]IKDC[CAM]TSALALVPFSIKPLLR.4|ALMDSLGPEWR.2|TVLQIDDNVTSAVEGINR.3|TVLQIDDNVTSAVEGINR.2|ASAYEALEKYPMAYVDYK.3|YSESLLC[CAM]SNLESATYSNR.2
SEN / CTL,P24592,Insulin-like growth factor-binding protein 6,IGFBP6,1.25,0.83,3.90E-05,4.77E-06,5.32E+00,"regulation of cell growth,signal transduction,negative regulation of cell proliferation,regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,Golgi apparatus,extracellular exosome",18,4,4,HLDSVLQQLQTEVYR.3|EGQEC[CAM]GVYTPNC[CAM]APGLQC[CAM]HPPKDDEAPLR.4|GAQTLYVPNC[CAM]DHR.2|APAVAEENPK.2
SEN / CTL,Q13740,CD166 antigen,ALCAM,1.25,1.67,1.61E-04,1.75E-05,4.76E+00,"adaptive immune response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,motor neuron axon guidance,retinal ganglion cell axon guidance,axon extension involved in axon guidance,neuron projection extension","receptor binding,protein binding","immunological synapse,integral component of plasma membrane,focal adhesion,external side of plasma membrane,axon,dendrite,intrinsic component of plasma membrane,neuronal cell body,extracellular exosome,T cell receptor complex",30,30,45,ESLTLIVEGKPQIK.3|ESLTLIVEGKPQIK.2|FVC[CAM]MLVTEDNVFEAPTIVK.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.4|QIGDALPVSC[CAM]TISASR.2|QIGDALPVSC[CAM]TISASR.3|EMDPVTQLYTMTSTLEYK.3|EMDPVTQLYTMTSTLEYK.2|VLHPLEGAVVIIFKK.4|VLHPLEGAVVIIFKK.3|TIIC[CAM]HVEGFPK.3|ALFLETEQLKK.3|ALFLETEQLKK.2|KTDPSGLSK.2|SSNTYTLTDVRR.3|WKYEKPDGSPVFIAFR.4|WKYEKPDGSPVFIAFR.3|VLHPLEGAVVIIFK.3|VLHPLEGAVVIIFK.2|DLGNMEENK.2|YEKPDGSPVFIAFR.3|YEKPDGSPVFIAFR.2|QPSKPEIVSK.2|KSVQYDDVPEYKDR.3|RFVC[CAM]MLVTEDNVFEAPTIVK.4|RFVC[CAM]MLVTEDNVFEAPTIVK.3|RFVC[CAM]M[Oxi]LVTEDNVFEAPTIVK.3|RFVC[CAM]MLVTEDNVFEAPTIVK.2|ALFLETEQLK.2|PDGSPVFIAFR.2|LDVPQNLMFGK.2|LDVPQNLM[Oxi]FGK.2|SSNTYTLTDVR.2|SVQYDDVPEYK.2|KSVQYDDVPEYK.2|ADIQMPFTC[CAM]SVTYYGPSGQK.3|ADIQMPFTC[CAM]SVTYYGPSGQK.2|TIHSEQAVFDIYYPTEQVTIQVLPPK.4|TIHSEQAVFDIYYPTEQVTIQVLPPK.3|SVQYDDVPEYKDR.2|TTKADIQMPFTC[CAM]SVTYYGPSGQK.3|SMIASTAITVHYLDLSLNPSGEVTR.3|C[CAM]LGNGNPPPEEFLFYLPGQPEGIR.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLKK.3
SEN / CTL,P28072,Proteasome subunit beta type-6,PSMB6,1.24,2.31,6.84E-01,4.95E-02,1.31E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,cell-cell adhesion","endopeptidase activity,threonine-type endopeptidase activity,cadherin binding involved in cell-cell adhesion","proteasome complex,nucleus,nucleoplasm,cytoplasm,Golgi apparatus,cytosol,proteasome core complex,cell-cell adherens junction,extracellular exosome",6,11,17,LAAIAESGVER.2|DGSSGGVIR.2|VTDKLTPIHDR.3|VTDKLTPIHDR.2|FAVATLPPA.2|TTTGSYIANR.2|QVLLGDQIPK.2|EEC[CAM]LQFTANALALAMER.3|EEC[CAM]LQFTANALALAMER.2|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.6|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.5|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.4|LAAIAESGVERQVLLGDQIPK.3|QSFAIGGSGSSYIYGYVDATYR.3|QSFAIGGSGSSYIYGYVDATYR.2|EGM[Oxi]TKEEC[CAM]LQFTANALALAMER.3|EGMTKEEC[CAM]LQFTANALALAMER.3
SEN / CTL,Q15436,Protein transport protein Sec23A,SEC23A,1.23,2.22,2.55E-01,1.90E-02,1.72E+00,"antigen processing and presentation of peptide antigen via MHC class I,intracellular protein transport,ER to Golgi vesicle-mediated transport,vesicle-mediated transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,COPII vesicle coating","protein binding,zinc ion binding","Golgi membrane,endoplasmic reticulum,endoplasmic reticulum membrane,cytosol,ER to Golgi transport vesicle membrane,COPII vesicle coat,smooth endoplasmic reticulum membrane,perinuclear region of cytoplasm",30,36,56,FSWNVWPSSR.2|LAIYRAETEEGPDVLR.3|SGYQDMPEYENFR.2|SGYQDMPEYENFR.3|HLLQAPVDDAQEILHSR.4|HLLQAPVDDAQEILHSR.3|MVVPVAALFTPLK.2|MVVPVAALFTPLK.3|M[Oxi]VVPVAALFTPLK.2|SWHDIDKDNAK.3|YIDTEHGGSQAR.3|YIDTEHGGSQAR.2|ISGAIGPC[CAM]VSLNSK.3|ISGAIGPC[CAM]VSLNSK.2|LWAC[CAM]NFC[CAM]YQR.3|LWAC[CAM]NFC[CAM]YQR.2|AVLNPLC[CAM]QVDYR.3|AVLNPLC[CAM]QVDYR.2|HFEALANR.2|DPWPVPQGK.2|FGEYHKDDPSSFR.3|MGFGGTLEIK.2|MVQVHELGC[CAM]EGISK.3|MVQVHELGC[CAM]EGISK.2|IDMNLTDLLGELQR.3|IDMNLTDLLGELQR.2|IDM[Oxi]NLTDLLGELQR.2|QLQEMLGLSK.2|AETEEGPDVLR.2|GAIQFVTQYQHSSGQR.3|GAIQFVTQYQHSSGQR.2|AATTGHVIDIYAC[CAM]ALDQTGLLEMK.4|AATTGHVIDIYAC[CAM]ALDQTGLLEMK.3|GPQVQQPPPSNR.2|IDMNLTDLLGELQRDPWPVPQGK.4|IDMNLTDLLGELQRDPWPVPQGK.3|FSETFSLYPQFMFHLR.3|FSETFSLYPQFM[Oxi]FHLR.3|FSETFSLYPQFMFHLR.2|ERPDLPPIQYEPVLC[CAM]SR.3|ERPDLPPIQYEPVLC[CAM]SR.2|SSFLQVFNNSPDESSYYR.3|SSFLQVFNNSPDESSYYR.2|IMMFIGGPATQGPGMVVGDELK.3|IMMFIGGPATQGPGMVVGDELK.2|RSSFLQVFNNSPDESSYYR.3|SSGVALSIAVGLLEC[CAM]TFPNTGAR.3|IC[CAM]GLSPTTTLAIYFEVVNQHNAPIPQGGR.4|IC[CAM]GLSPTTTLAIYFEVVNQHNAPIPQGGR.3|C[CAM]C[CAM]PNLTGGYMVMGDSFNTSLFK.3|VNPSQTHNNMYAWGQESGAPILTDDVSLQVFMDHLKK.5|MVVPVAALFTPLKERPDLPPIQYEPVLC[CAM]SR.4|IMMFIGGPATQGPGMVVGDELKTPIR.3|NQFPPSYAGISELNQPAELLPQFSSIEYVVLR.4|GPC[CAM]VSENEIGTGGTC[CAM]QWK.2|VNPSQTHNNMYAWGQESGAPILTDDVSLQVFMDHLK.4
SEN / CTL,Q9C037,E3 ubiquitin-protein ligase TRIM4,TRIM4,1.23,1.32,1.75E-01,1.34E-02,1.87E+00,"protein ubiquitination,innate immune response,protein trimerization","zinc ion binding,ligase activity","cytoplasm,plasma membrane",6,11,13,KVM[Oxi]HLQDVEVK.2|KVMHLQDVEVK.3|RFQVAVNLAEDTAHPK.4|RFQVAVNLAEDTAHPK.3|FQVAVNLAEDTAHPK.3|HYWEVESR.2|LGPVPPGLC[CAM]GR.2|LHNFLVEEEDLFLQR.3|LFC[CAM]EDDQRPVC[CAM]LVC[CAM]R.3|GTGNVSFYSAVDGVHLHTFSC[CAM]SSVSR.4|SQAPTLELLQNPK.2|SEIQDVNYSLEAVK.2|NWAPGGGPFPC[CAM]PEC[CAM]R.2
SEN / CTL,P50502;Q8NFI4,Hsc70-interacting protein;Putative protein FAM10A5,ST13;ST13P5,1.22,1.92,8.27E-02,6.51E-03,2.19E+00,"protein folding,protein homooligomerization,negative regulation of protein refolding,chaperone cofactor-dependent protein refolding;","protein domain specific binding,Hsp70 protein binding,protein binding, bridging,protein complex binding,dATP binding,identical protein binding,unfolded protein binding,chaperone binding;","cytoplasm,cytosol,protein complex,extracellular exosome;cytoplasm",18,3,4,AIDLFTDAIKLNPR.3|AIDLFTDAIK.2|AIEINPDSAQPYKWR.3|AIEINPDSAQPYKWR.2
SEN / CTL,P28300,Protein-lysine 6-oxidase,LOX,1.21,1.71,1.09E-01,8.50E-03,2.07E+00,"cellular protein modification process,heart development,extracellular matrix organization,collagen fibril organization,lung development,aorta development,wound healing,response to drug,elastic fiber assembly,response to steroid hormone,oxidation-reduction process","protein-lysine 6-oxidase activity,copper ion binding,protein binding","extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,nucleus",12,2,3,YTGHHAYASGC[CAM]TISPY.3|YTGHHAYASGC[CAM]TISPY.2|NQGTSDFLPSRPR.3
SEN / CTL,P16070,CD44 antigen,CD44,1.20,1.77,4.80E-04,4.93E-05,4.31E+00,"cell-matrix adhesion,single organismal cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,hyaluronan catabolic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of heterotypic cell-cell adhesion,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of DNA damage response, signal transduction by p53 class mediator,cellular response to fibroblast growth factor stimulus,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,cartilage development,interferon-gamma-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,monocyte aggregation,positive regulation of monocyte aggregation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator","collagen binding,hyaluronic acid binding,cytokine receptor activity","cytoplasm,Golgi apparatus,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,macrophage migration inhibitory factor receptor complex,extracellular exosome",24,12,18,YGFIEGHVVIPR.3|YGFIEGHVVIPR.2|ALSIGFETC[CAM]R.2|SQEMVHLVNKESSETPDQFMTADETR.4|SQEM[Oxi]VHLVNK.3|SQEMVHLVNK.2|SQEM[Oxi]VHLVNK.2|TEAADLC[CAM]K.2|NLQNVDMK.2|NLQNVDM[Oxi]K.2|KLVINSGNGAVEDR.3|KLVINSGNGAVEDR.2|FAGVFHVEK.2|KPSGLNGEASK.2|LVINSGNGAVEDRKPSGLNGEASK.4|LVINSGNGAVEDR.2|ESSETPDQFM[Oxi]TADETR.2|ESSETPDQFMTADETR.2
SEN / CTL,P05155,Plasma protease C1 inhibitor,SERPING1,1.20,1.89,3.67E-01,2.72E-02,1.57E+00,"negative regulation of complement activation, lectin pathway,platelet degranulation,complement activation, classical pathway,aging,blood coagulation, intrinsic pathway,blood circulation,negative regulation of endopeptidase activity,fibrinolysis,innate immune response","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle",12,19,34,FQPTLLTLPR.2|HRLEDMEQALSPSVFK.3|HRLEDMEQALSPSVFK.4|HRLEDM[Oxi]EQALSPSVFK.3|HRLEDMEQALSPSVFK.2|DFTC[CAM]VHQALK.3|DFTC[CAM]VHQALK.2|FPVFMGR.2|NSVIKVPMMNSK.3|GVTSVSQIFHSPDLAIR.4|GVTSVSQIFHSPDLAIR.3|GVTSVSQIFHSPDLAIR.2|TLYSSSPR.2|YPVAHFIDQTLK.3|YPVAHFIDQTLK.2|VTTSQDMLSIMEK.3|VTTSQDMLSIMEK.2|VTTSQDM[Oxi]LSIMEK.2|VTTSQDMLSIM[Oxi]EK.2|VTTSQDM[Oxi]LSIM[Oxi]EK.2|KYPVAHFIDQTLK.3|KYPVAHFIDQTLK.2|LEDMEQALSPSVFK.3|LEDM[Oxi]EQALSPSVFK.2|LEDMEQALSPSVFK.2|LYHAFSAMK.2|LLDSLPSDTR.2|IKVTTSQDMLSIMEK.3|TNLESILSYPKDFTC[CAM]VHQALK.4|TNLESILSYPK.2|LVLLNAIYLSAK.2|TLLVFEVQQPFLFVLWDQQHK.4|TLLVFEVQQPFLFVLWDQQHK.3|LLDSLPSDTRLVLLNAIYLSAK.3
SEN / CTL,P55854;P61956;Q6EEV6,Small ubiquitin-related modifier 3;Small ubiquitin-related modifier 2;Small ubiquitin-related modifier 4,SUMO3;SUMO2;SUMO4,1.16,1.37,1.39E-01,1.07E-02,1.97E+00,"protein sumoylation,global genome nucleotide-excision repair;protein sumoylation,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of transcription from RNA polymerase II promoter,global genome nucleotide-excision repair;protein sumoylation","protein binding,protein tag;protein binding,SUMO transferase activity,protein tag,ubiquitin protein ligase binding,poly(A) RNA binding;protein tag","kinetochore,nucleus,nucleoplasm,cytoplasm,PML body,extracellular exosome;nucleus,nucleoplasm,PML body;nucleus",6,1,2,VAGQDGSVVQFK.2|VAGQDGSVVQFK.3
SEN / CTL,P02787,Serotransferrin,TF,1.16,1.98,1.27E-01,9.82E-03,2.01E+00,"retina homeostasis,platelet degranulation,cellular iron ion homeostasis,regulation of protein stability,transferrin transport,positive regulation of receptor-mediated endocytosis,iron ion homeostasis,cellular response to iron ion,ferrous iron import into cell","protein binding,ferrous iron binding,ferric iron binding,ferric iron transmembrane transporter activity,transferrin receptor binding","extracellular region,extracellular space,early endosome,late endosome,clathrin-coated pit,basal plasma membrane,cell surface,endosome membrane,cytoplasmic, membrane-bounded vesicle,apical plasma membrane,endocytic vesicle,extrinsic component of external side of plasma membrane,vesicle,secretory granule lumen,basal part of cell,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,HFE-transferrin receptor complex",12,86,160,C[CAM]LVEKGDVAFVK.3|C[CAM]LVEKGDVAFVK.2|NPDPWAK.2|DC[CAM]HLAQVPSHTVVAR.4|DC[CAM]HLAQVPSHTVVAR.3|EFQLFSSPHGK.3|EFQLFSSPHGK.2|HSTIFENLANK.3|HSTIFENLANK.2|KPVDEYKDC[CAM]HLAQVPSHTVVAR.6|KPVDEYKDC[CAM]HLAQVPSHTVVAR.5|KPVDEYKDC[CAM]HLAQVPSHTVVAR.4|KPVDEYKDC[CAM]HLAQVPSHTVVAR.3|DSAHGFLK.2|KDSGFQMNQLR.3|KDSGFQM[Oxi]NQLR.3|KDSGFQMNQLR.2|KDSGFQM[Oxi]NQLR.2|KPVDEYK.2|WC[CAM]AVSEHEATK.3|WC[CAM]AVSEHEATK.2|DYELLC[CAM]LDGTR.3|DYELLC[CAM]LDGTR.2|C[CAM]LKDGAGDVAFVK.3|C[CAM]LKDGAGDVAFVK.2|DDTVC[CAM]LAK.2|KSASDLTWDNLK.3|KSASDLTWDNLK.2|ADRDQYELLC[CAM]LDNTR.4|ADRDQYELLC[CAM]LDNTR.3|ADRDQYELLC[CAM]LDNTR.2|EFQLFSSPHGKDLLFK.4|APNHAVVTR.2|DGAGDVAFVK.2|HQTVPQNTGGKNPDPWAK.4|HQTVPQNTGGKNPDPWAK.3|MYLGYEYVTAIR.3|M[Oxi]YLGYEYVTAIR.3|MYLGYEYVTAIR.2|M[Oxi]YLGYEYVTAIR.2|ADRDQYELLC[CAM]LDNTRK.4|ASYLDC[CAM]IR.2|DLLFKDSAHGFLK.3|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.4|SETKDLLFRDDTVC[CAM]LAK.4|SETKDLLFRDDTVC[CAM]LAK.3|SKEFQLFSSPHGK.3|SKEFQLFSSPHGK.2|YLGEEYVK.2|LKC[CAM]DEWSVNSVGK.3|LKC[CAM]DEWSVNSVGK.2|SM[Oxi]GGKEDLIWELLNQAQEHFGK.5|SMGGKEDLIWELLNQAQEHFGK.5|SM[Oxi]GGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.3|C[CAM]STSSLLEAC[CAM]TFR.3|C[CAM]STSSLLEAC[CAM]TFR.2|DQYELLC[CAM]LDNTR.3|DQYELLC[CAM]LDNTR.2|SVIPSDGPSVAC[CAM]VKK.3|SVIPSDGPSVAC[CAM]VKK.2|DLLFRDDTVC[CAM]LAK.3|DLLFRDDTVC[CAM]LAK.2|EDLIWELLNQAQEHFGK.4|EDLIWELLNQAQEHFGK.3|EDLIWELLNQAQEHFGK.2|SASDLTWDNLKGKK.3|FDEFFSEGC[CAM]APGSK.3|FDEFFSEGC[CAM]APGSK.2|KPVEEYANC[CAM]HLAR.3|KPVEEYANC[CAM]HLAR.2|SKEFQLFSSPHGKDLLFK.4|TAGWNIPM[Oxi]GLLYNK.3|TAGWNIPMGLLYNK.3|TAGWNIPMGLLYNK.2|TAGWNIPM[Oxi]GLLYNK.2|GDVAFVKHQTVPQNTGGKNPDPWAK.5|HSTIFENLANKADR.3|EDPQTFYYAVAVVK.3|EDPQTFYYAVAVVK.2|SAGWNIPIGLLYC[CAM]DLPEPR.4|SAGWNIPIGLLYC[CAM]DLPEPR.3|SAGWNIPIGLLYC[CAM]DLPEPR.2|ADRDQYELLC[CAM]LDNTRKPVDEYK.5|ADRDQYELLC[CAM]LDNTRKPVDEYK.4|APNHAVVTRK.2|KC[CAM]STSSLLEAC[CAM]TFR.3|KC[CAM]STSSLLEAC[CAM]TFR.2|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.4|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.3|PVVAEFYGSK.2|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.5|SMGGKEDLIWELLNQAQEHFGKDK.5|SMGGKEDLIWELLNQAQEHFGKDK.4|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSK.3|KASYLDC[CAM]IR.2|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|FDEFFSEGC[CAM]APGSKK.3|FDEFFSEGC[CAM]APGSKK.2|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.3|LC[CAM]MGSGLNLC[CAM]EPNNK.3|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.2|LC[CAM]MGSGLNLC[CAM]EPNNK.2|EDLIWELLNQAQEHFGKDK.4|IEC[CAM]VSAETTEDC[CAM]IAK.3|IEC[CAM]VSAETTEDC[CAM]IAK.2|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.3|EDPQTFYYAVAVVKK.3|EDPQTFYYAVAVVKK.2|HQTVPQNTGGK.2|LHDRNTYEK.2|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.6|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|DSGFQMNQLR.2|DSGFQM[Oxi]NQLR.2|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.3|WC[CAM]ALSHHER.2|EGTC[CAM]PEAPTDEC[CAM]KPVK.3|EGTC[CAM]PEAPTDEC[CAM]KPVK.2|C[CAM]LVEKGDVAFVKHQTVPQNTGGK.4|HSTIFENLANKADRDQYELLC[CAM]LDNTR.5|HSTIFENLANKADRDQYELLC[CAM]LDNTR.4|SASDLTWDNLK.2|C[CAM]DEWSVNSVGK.2|EGYYGYTGAFR.2|NLNEKDYELLC[CAM]LDGTR.3|NLNEKDYELLC[CAM]LDGTR.2|NLNEKDYELLC[CAM]LDGTRK.3|SVIPSDGPSVAC[CAM]VK.2|IMNGEADAMSLDGGFVYIAGK.3|IM[Oxi]NGEADAM[Oxi]SLDGGFVYIAGK.3|IMNGEADAM[Oxi]SLDGGFVYIAGK.2|IMNGEADAMSLDGGFVYIAGK.2|LHDRNTYEKYLGEEYVK.3|LHDRNTYEKYLGEEYVK.2|SASDLTWDNLKGK.2|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.4|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|LC[CAM]MGSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.5|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.4|LKC[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.4|NTYEKYLGEEYVK.2|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.6|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.5|QQQHLFGSNVTDC[CAM]SGNFC[CAM]LFR.3|PVVAEFYGSKEDPQTFYYAVAVVK.3|AIAANEADAVTLDAGLVYDAYLAPNNLK.3|C[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.3|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVK.5
SEN / CTL,P55083,Microfibril-associated glycoprotein 4,MFAP4,1.16,1.23,7.60E-02,6.03E-03,2.22E+00,"cell adhesion,UV protection,regulation of collagen metabolic process,extracellular fibril organization,elastic fiber assembly,cellular response to UV-B","molecular_function,protein binding","microfibril,extracellular region,extracellular matrix,extracellular exosome,elastic fiber",12,4,9,ADGEYWLGLQNMHLLTLK.3|ADGEYWLGLQNMHLLTLK.2|ADGEYWLGLQNMHLLTLK.4|ADGEYWLGLQNM[Oxi]HLLTLK.3|GFYYSLK.2|FSTFDRDQDLFVQNC[CAM]AALSSGAFWFR.4|FSTFDRDQDLFVQNC[CAM]AALSSGAFWFR.3|SC[CAM]HFANLNGFYLGGSHLSYANGINWAQWK.4|SC[CAM]HFANLNGFYLGGSHLSYANGINWAQWK.3
SEN / CTL,P00747,Plasminogen,PLG,1.14,1.62,5.45E-02,4.42E-03,2.35E+00,"platelet degranulation,proteolysis,blood coagulation,negative regulation of cell proliferation,negative regulation of cell-substrate adhesion,extracellular matrix disassembly,fibrinolysis,cellular protein metabolic process,tissue remodeling,negative regulation of fibrinolysis,positive regulation of fibrinolysis,negative regulation of cell-cell adhesion mediated by cadherin","serine-type endopeptidase activity,receptor binding,protein binding,serine-type peptidase activity,protein domain specific binding,apolipoprotein binding","extracellular region,extracellular space,plasma membrane,cell surface,platelet alpha granule lumen,extrinsic component of external side of plasma membrane,extracellular exosome,blood microparticle",12,58,96,TPENYPNAGLTMNYC[CAM]R.3|TPENYPNAGLTMNYC[CAM]R.2|TPENYPNAGLTM[Oxi]NYC[CAM]R.3|TPENYPNAGLTM[Oxi]NYC[CAM]R.2|KDIALLK.2|RAPWC[CAM]HTTNSQVR.4|RAPWC[CAM]HTTNSQVR.3|RAPWC[CAM]HTTNSQVR.2|HSIFTPETNPR.3|HSIFTPETNPR.2|NLDENYC[CAM]RNPDGKR.4|VYLSEC[CAM]K.2|ELRPWC[CAM]FTTDPNKR.4|ELRPWC[CAM]FTTDPNKR.3|C[CAM]QSWSSMTPHR.3|GNVAVTVSGHTC[CAM]QHWSAQTPHTHNR.6|GNVAVTVSGHTC[CAM]QHWSAQTPHTHNR.5|APWC[CAM]HTTNSQVR.3|APWC[CAM]HTTNSQVR.2|KQLGAGSIEEC[CAM]AAK.3|KQLGAGSIEEC[CAM]AAK.2|TPENFPC[CAM]K.2|EQQC[CAM]VIMAENRK.3|KC[CAM]QSWSSMTPHR.3|VILGAHQEVNLEPHVQEIEVSR.5|VILGAHQEVNLEPHVQEIEVSR.4|VILGAHQEVNLEPHVQEIEVSR.3|WEYC[CAM]NLK.2|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.6|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.5|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.4|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.3|KVYLSEC[CAM]K.2|LSSPAVITDK.2|NPDADKGPWC[CAM]FTTDPSVR.4|NPDADKGPWC[CAM]FTTDPSVR.3|ATTVTGTPC[CAM]QDWAAQEPHR.4|ATTVTGTPC[CAM]QDWAAQEPHR.3|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.6|TM[Oxi]SGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.5|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.5|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.5|TM[Oxi]SGLEC[CAM]QAWDSQSPHAHGYIPSK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.3|NLDENYC[CAM]R.2|VVGGC[CAM]VAHPHSWPWQVSLR.4|VVGGC[CAM]VAHPHSWPWQVSLR.3|WELC[CAM]DIPR.2|ELRPWC[CAM]FTTDPNK.3|YILQGVTSWGLGC[CAM]AR.3|YILQGVTSWGLGC[CAM]AR.2|EAQLPVIENK.2|NPDNDPQGPWC[CAM]YTTDPEKR.4|NPDNDPQGPWC[CAM]YTTDPEKR.3|RATTVTGTPC[CAM]QDWAAQEPHR.4|DKYILQGVTSWGLGC[CAM]ARPNKPGVYVR.5|VIPAC[CAM]LPSPNYVVADR.3|VIPAC[CAM]LPSPNYVVADR.2|C[CAM]TTPPPSSGPTYQC[CAM]LK.3|C[CAM]TTPPPSSGPTYQC[CAM]LK.2|FVTWIEGVMR.2|FVTWIEGVM[Oxi]R.2|RWELC[CAM]DIPR.2|DKYILQGVTSWGLGC[CAM]AR.3|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.5|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.4|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.3|FSPATHPSEGLEENYC[CAM]R.3|FSPATHPSEGLEENYC[CAM]R.2|QLGAGSIEEC[CAM]AAK.2|YILQGVTSWGLGC[CAM]ARPNKPGVYVR.4|SPRPSSYKVILGAHQEVNLEPHVQEIEVSR.5|C[CAM]EEDEEFTC[CAM]R.2|EQQC[CAM]VIMAENR.2|EQQC[CAM]VIM[Oxi]AENR.2|KQLGAGSIEEC[CAM]AAKC[CAM]EEDEEFTC[CAM]R.4|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEKDK.5|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEKDK.4|GPWC[CAM]FTTDPSVR.2|FGM[Oxi]HFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.4|FGMHFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.4|FGMHFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.3|LYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.4|LYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.3|TEC[CAM]FITGWGETQGTFGAGLLK.3|TEC[CAM]FITGWGETQGTFGAGLLK.2|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GK.3|NLDENYC[CAM]RNPDGK.2|FSPATHPSEGLEENYC[CAM]RNPDNDPQGPWC[CAM]YTTDPEKR.5|QLGAGSIEEC[CAM]AAKC[CAM]EEDEEFTC[CAM]R.3|NPDGDVGGPWC[CAM]YTTNPR.2|YDYC[CAM]DILEC[CAM]EEEC[CAM]MHC[CAM]SGENYDGK.3|NPDNDPQGPWC[CAM]YTTDPEK.2|C[CAM]SGTEASVVAPPPVVLLPDVETPSEEDC[CAM]MFGNGK.3
SEN / CTL,P62158,Calmodulin,CALM1,1.14,1.87,1.44E-01,1.11E-02,1.96E+00,"G2/M transition of mitotic cell cycle,MAPK cascade,response to amphetamine,regulation of heart rate,platelet degranulation,detection of calcium ion,glycogen catabolic process,muscle contraction,G-protein coupled receptor signaling pathway,activation of adenylate cyclase activity,Wnt signaling pathway, calcium modulating pathway,positive regulation of peptidyl-threonine phosphorylation,negative regulation of peptidyl-threonine phosphorylation,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,substantia nigra development,regulation of rhodopsin mediated signaling pathway,positive regulation of cyclic nucleotide metabolic process,positive regulation of protein autophosphorylation,regulation of cytokinesis,positive regulation of phosphoprotein phosphatase activity,ion transmembrane transport,positive regulation of protein dephosphorylation,Fc-epsilon receptor signaling pathway,positive regulation of DNA binding,positive regulation of GTPase activity,inositol phosphate metabolic process,regulation of nitric-oxide synthase activity,positive regulation of nitric-oxide synthase activity,positive regulation of cyclic-nucleotide phosphodiesterase activity,response to corticosterone,response to calcium ion,regulation of cardiac muscle contraction,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of protein serine/threonine kinase activity,regulation of high voltage-gated calcium channel activity,regulation of cell communication by electrical coupling involved in cardiac conduction","Ras guanyl-nucleotide exchange factor activity,calcium ion binding,protein binding,adenylate cyclase binding,inositol-1,4,5-trisphosphate 3-kinase activity,ligand-gated ion channel activity,protein kinase binding,protein domain specific binding,nitric-oxide synthase regulator activity,titin binding,type 3 metabotropic glutamate receptor binding,thioesterase binding,N-terminal myristoylation domain binding,phospholipase binding,protein serine/threonine kinase activator activity,phosphatidylinositol 3-kinase binding,ion channel binding,calcium-dependent protein binding,nitric-oxide synthase binding,protein phosphatase activator activity","spindle pole,extracellular region,nucleus,nucleoplasm,cytoplasm,centrosome,cytosol,spindle microtubule,plasma membrane,voltage-gated potassium channel complex,sarcomere,growth cone,vesicle,extracellular exosome,calcium channel complex",36,13,30,VFDKDGNGYISAAELR.3|VFDKDGNGYISAAELR.2|EAFSLFDKDGDGTITTK.3|EAFSLFDKDGDGTITTK.2|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDM[Oxi]INEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]M[Oxi]AR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]MAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMM[Oxi]AR.4|MKDTDSEEEIREAFR.3|MKDTDSEEEIREAFR.4|M[Oxi]KDTDSEEEIREAFR.4|M[Oxi]KDTDSEEEIREAFR.3|MKDTDSEEEIREAFR.2|DGDGTITTK.2|M[Oxi]KDTDSEEEIR.3|MKDTDSEEEIR.3|MKDTDSEEEIR.2|M[Oxi]KDTDSEEEIR.2|KMKDTDSEEEIR.3|KM[Oxi]KDTDSEEEIR.3|HVMTNLGEK.2|DTDSEEEIREAFR.3|DTDSEEEIREAFR.2|DTDSEEEIR.2|DGNGYISAAELR.2|LTDEEVDEMIR.2|EADIDGDGQVNYEEFVQMMTAK.3|EADIDGDGQVNYEEFVQM[Oxi]MTAK.3|EADIDGDGQVNYEEFVQMM[Oxi]TAK.3
SEN / CTL,P23246,"Splicing factor, proline- and glutamine-rich",SFPQ,1.10,1.27,4.56E-03,4.09E-04,3.39E+00,"negative regulation of transcription from RNA polymerase II promoter,alternative mRNA splicing, via spliceosome,double-strand break repair via homologous recombination,transcription, DNA-templated,mRNA processing,RNA splicing,regulation of circadian rhythm,negative regulation of circadian rhythm,positive regulation of sister chromatid cohesion,negative regulation of transcription, DNA-templated,rhythmic process,chromosome organization,histone H3 deacetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","nucleotide binding,transcription regulatory region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,core promoter binding,chromatin binding,protein binding,histone deacetylase binding,transcription regulatory region DNA binding,poly(A) RNA binding","chromatin,nucleus,nucleoplasm,cytoplasm,nuclear matrix,extracellular matrix,paraspeckles,RNA polymerase II transcription factor complex",18,49,90,LFVGNLPADITEDEFKR.3|LFVGNLPADITEDEFKR.2|FAQHGTFEYEYSQR.3|FAQHGTFEYEYSQR.2|ALAEIAKAELDDTPMR.3|ALAEIAKAELDDTPM[Oxi]R.3|ALAEIAKAELDDTPMR.2|RM[Oxi]EELHNQEM[Oxi]QK.4|RM[Oxi]EELHNQEMQK.3|RMEELHNQEM[Oxi]QK.3|RMEELHNQEMQK.3|RM[Oxi]EELHNQEM[Oxi]QK.3|RMEELHNQEMQK.2|RQREESYSR.3|QREMEEQMR.3|QREMEEQMR.2|GIVEFASKPAAR.3|GIVEFASKPAAR.2|RREEEMMIR.3|GIVEFASK.2|SLDEMEK.2|GGKMPGGPKPGGGPGLSTPGGHPKPPHR.6|GGKMPGGPKPGGGPGLSTPGGHPKPPHR.5|MGYMDPR.2|M[Oxi]GYMDPR.2|M[Oxi]GYM[Oxi]DPR.2|EEYEGPNKKPR.3|EEYEGPNKKPR.2|FGQGGAGPVGGQGPR.3|FGQGGAGPVGGQGPR.2|SEEKISDSEGFK.3|SEEKISDSEGFK.2|MEELHNQEMQK.3|M[Oxi]EELHNQEM[Oxi]QK.3|M[Oxi]EELHNQEMQK.3|MEELHNQEM[Oxi]QK.3|MEELHNQEMQK.2|VRFATHAAALSVR.3|EMEEQMR.2|MPGGPKPGGGPGLSTPGGHPKPPHR.5|MPGGPKPGGGPGLSTPGGHPKPPHR.4|EEYEGPNK.2|QHHPPYHQQHHQGPPPGGPGGR.5|QHHPPYHQQHHQGPPPGGPGGR.4|QHHPPYHQQHHQGPPPGGPGGRSEEK.6|YGEPGEVFINKGK.3|ALAEIAKAELDDTPMRGR.4|DKLESEMEDAYHEHQANLLR.5|DKLESEMEDAYHEHQANLLR.4|DKLESEM[Oxi]EDAYHEHQANLLR.4|DKLESEMEDAYHEHQANLLR.3|AELDDTPMR.2|AELDDTPM[Oxi]R.2|GREEYEGPNKKPR.3|QREESYSR.2|SEEKISDSEGFKANLSLLR.4|SEEKISDSEGFKANLSLLR.3|DAKDKLESEMEDAYHEHQANLLR.5|DAKDKLESEMEDAYHEHQANLLR.4|ISDSEGFKANLSLLR.3|ISDSEGFKANLSLLR.2|LESEMEDAYHEHQANLLR.4|LESEMEDAYHEHQANLLR.3|REEEMMIR.2|GMGPGTPAGYGR.2|GM[Oxi]GPGTPAGYGR.2|FATHAAALSVR.2|GREEYEGPNK.2|LFVGNLPADITEDEFK.3|LFVGNLPADITEDEFK.2|LFVGNLPADITEDEFKRLFAK.4|LFVGNLPADITEDEFKRLFAK.3|PGGGPGLSTPGGHPKPPHR.3|DKLESEMEDAYHEHQANLLRQDLMR.5|DKLESEMEDAYHEHQANLLRQDLMR.4|YGEPGEVFINK.2|SPPPGMGLNQNR.2|SPPPGM[Oxi]GLNQNR.2|NLSPYVSNELLEEAFSQFGPIER.4|NLSPYVSNELLEEAFSQFGPIER.3|PVIVEPLEQLDDEDGLPEK.3|PVIVEPLEQLDDEDGLPEK.2|C[CAM]SEGVFLLTTTPR.2|FPPLGGGGGIGYEANPGVPPATMSGSMMGSDMR.4|FPPLGGGGGIGYEANPGVPPATMSGSMMGSDMR.3|M[Oxi]GGGGAMNMGDPYGSGGQK.2|MGGGGAMNMGDPYGSGGQK.2|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEK.4|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEK.3|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQK.4
SEN / CTL,P55145,Mesencephalic astrocyte-derived neurotrophic factor,MANF,1.10,1.30,1.29E-02,1.09E-03,2.96E+00,"response to unfolded protein,biological_process,neuron projection development,dopaminergic neuron differentiation","growth factor activity,poly(A) RNA binding","extracellular space,nucleus,endoplasmic reticulum",18,16,22,FYQDLKDRDVTFSPATIENELIK.4|LC[CAM]YYIGATDDAATK.2|LC[CAM]YYIGATDDAATK.3|IINEVSKPLAHHIPVEK.4|IINEVSKPLAHHIPVEK.3|QIDLSTVDLKK.3|QIDLSTVDLKK.2|INELMPK.2|KILDDWGETC[CAM]K.3|KILDDWGETC[CAM]K.2|KINELMPK.2|DSQIC[CAM]ELK.2|QIDLSTVDLK.2|PLAHHIPVEK.2|ILDDWGETC[CAM]KGC[CAM]AEK.3|ILDDWGETC[CAM]KGC[CAM]AEK.2|ILDDWGETC[CAM]K.2|KILDDWGETC[CAM]KGC[CAM]AEK.3|DRDVTFSPATIENELIK.3|DRDVTFSPATIENELIK.2|DSQIC[CAM]ELKYDK.2|DVTFSPATIENELIK.2
SEN / CTL,Q92820,Gamma-glutamyl hydrolase,GGH,1.08,1.70,2.39E-01,1.79E-02,1.75E+00,"proteolysis,glutamine metabolic process,response to zinc ion,response to insulin,response to drug,response to ethanol,tetrahydrofolylpolyglutamate metabolic process","exopeptidase activity,omega peptidase activity,gamma-glutamyl-peptidase activity","extracellular space,nucleus,lysosome,vacuole,cytosol,melanosome,extracellular exosome",18,19,26,VVPVRLDLTEKDYEILFK.4|YYIAASYVK.2|SINGILFPGGSVDLR.2|SINGILFPGGSVDLR.3|YLESAGAR.2|NLDGISHAPNAVK.3|NLDGISHAPNAVK.2|DYEILFK.2|DYEILFK.1|YPVYGVQWHPEK.3|YPVYGVQWHPEK.2|APYEWKNLDGISHAPNAVK.4|LDLTEKDYEILFK.3|LDLTEKDYEILFK.2|TAFYLAEFFVNEAR.3|TAFYLAEFFVNEAR.2|SINGILFPGGSVDLRR.3|KPIIGILMQK.2|TAFYLAEFFVNEARK.3|VVPVRLDLTEK.2|IEFISTMEGYK.2|FFNVLTTNTDGK.2|IEFISTMEGYKYPVYGVQWHPEK.4|FFNVLTTNTDGKIEFISTMEGYKYPVYGVQWHPEK.5|M[Oxi]FQNFPTELLLSLAVEPLTANFHK.3|MFQNFPTELLLSLAVEPLTANFHK.3
SEN / CTL,A6NIZ1;P61224;P62834,Ras-related protein Rap-1b-like protein;Ras-related protein Rap-1b;Ras-related protein Rap-1A,;RAP1B;RAP1A,1.08,2.68,9.70E-02,7.61E-03,2.12E+00,"small GTPase mediated signal transduction;cell proliferation,response to carbohydrate,Rap protein signal transduction,cellular response to drug,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,cellular response to gonadotropin-releasing hormone,regulation of cell junction assembly,regulation of establishment of cell polarity,negative regulation of synaptic vesicle exocytosis,microvillus assembly;activation of MAPKK activity,signal transduction,positive regulation of neuron projection development,protein transport,Rap protein signal transduction,negative regulation of collagen biosynthetic process,cellular response to drug,nerve growth factor signaling pathway,positive regulation of GTPase activity,positive regulation of protein kinase activity,positive regulation of glucose import,positive regulation of phagocytosis,regulation of insulin secretion,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,cellular response to glucose stimulus,response to antineoplastic agent,liver regeneration,regulation of cell junction assembly,cellular response to nerve growth factor stimulus,negative regulation of synaptic vesicle exocytosis,positive regulation of vasculogenesis,microvillus assembly","GTP binding;GTPase activity,protein binding,GTP binding,GDP binding,protein complex binding;GTPase activity,protein binding,GTP binding,protein transporter activity,Ras GTPase binding,Rap guanyl-nucleotide exchange factor activity,protein complex binding","cytosol,plasma membrane;intracellular,lipid particle,cytosol,plasma membrane,cell-cell junction,membrane,extracellular exosome,membrane raft;cytoplasm,early endosome,late endosome,cytosol,plasma membrane,cell junction,guanyl-nucleotide exchange factor complex,neuron projection,myelin sheath,perinuclear region of cytoplasm,extracellular exosome",12,2,4,INVNEIFYDLVR.2|INVNEIFYDLVR.3|SKINVNEIFYDLVR.3|SKINVNEIFYDLVR.2
SEN / CTL,O95967,EGF-containing fibulin-like extracellular matrix protein 2,EFEMP2,1.06,1.85,1.31E-01,1.01E-02,2.00E+00,,"extracellular matrix structural constituent,calcium ion binding,protein binding","extracellular region,basement membrane,extracellular exosome,extracellular vesicle",12,6,6,C[CAM]INHYGGYLC[CAM]LPR.3|LC[CAM]QDIDEC[CAM]ESGAHQC[CAM]SEAQTC[CAM]VNFHGGYR.4|AGNSQGDFYIR.2|C[CAM]LC[CAM]PASNPLC[CAM]R.2|DVNEC[CAM]LTIPEAC[CAM]K.2|SC[CAM]VDVNEC[CAM]DMGAPC[CAM]EQR.2
SEN / CTL,P04156,Major prion protein,PRNP,1.05,0.49,3.23E-03,2.96E-04,3.53E+00,"negative regulation of protein phosphorylation,cellular copper ion homeostasis,response to oxidative stress,cell cycle arrest,learning or memory,metabolic process,negative regulation of interferon-gamma production,negative regulation of interleukin-17 production,negative regulation of interleukin-2 production,regulation of protein localization,cellular response to drug,negative regulation of apoptotic process,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of activated T cell proliferation,response to cadmium ion,negative regulation of T cell receptor signaling pathway,protein homooligomerization,negative regulation of calcineurin-NFAT signaling cascade,cellular response to copper ion,regulation of potassium ion transmembrane transport","copper ion binding,lamin binding,microtubule binding,tubulin binding,identical protein binding,ATP-dependent protein binding,ion channel binding,chaperone binding","nucleus,cytoplasm,endoplasmic reticulum,Golgi apparatus,plasma membrane,cell surface,extrinsic component of membrane,anchored component of membrane,membrane raft,extracellular exosome",6,4,5,VVEQMC[CAM]ITQYER.2|VVEQM[Oxi]C[CAM]ITQYER.2|PIIHFGSDYEDR.3|ESQAYYQR.2|HMAGAAAAGAVVGGLGGYMLGSAMSR.3
SEN / CTL,Q13442,28 kDa heat- and acid-stable phosphoprotein,PDAP1,1.05,2.73,4.51E-01,3.33E-02,1.48E+00,"signal transduction,cell proliferation",poly(A) RNA binding,,6,15,23,KGVEGLIDIENPNR.3|KGVEGLIDIENPNR.2|KVTQLDLDGPK.3|KVTQLDLDGPK.2|KVTQLDLDGPKELSR.4|KVTQLDLDGPKELSR.3|MQSLSLNK.2|M[Oxi]QSLSLNK.2|EEEEQKEGGDGAAGDPKK.4|GVEGLIDIENPNR.3|GVEGLIDIENPNR.2|AREEEEQKEGGDGAAGDPK.4|AREEEEQKEGGDGAAGDPK.3|AKDDATLSGK.2|RMQSLSLNK.2|VTQLDLDGPK.2|RKGVEGLIDIENPNR.3|RKGVEGLIDIENPNR.2|EEEEQKEGGDGAAGDPK.3|QYTSPEEIDAQLQAEK.3|QYTSPEEIDAQLQAEK.2|GVEGLIDIENPNRVAQTTK.3|QYTSPEEIDAQLQAEKQK.3
SEN / CTL,O14979,Heterogeneous nuclear ribonucleoprotein D-like,HNRNPDL,1.05,1.28,1.62E-04,1.76E-05,4.75E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated","nucleotide binding,DNA binding,poly(A) RNA binding","nucleoplasm,cytoplasm,extracellular exosome",36,22,35,FGEVVDC[CAM]TIKTDPVTGR.3|FGEVVDC[CAM]TIKTDPVTGR.2|RGFC[CAM]FITYTDEEPVKK.4|RGFC[CAM]FITYTDEEPVKK.3|FGEVVDC[CAM]TIK.2|GFGFVLFK.2|GFGFVLFK.1|YHQIGSGK.2|YHQIGSGKC[CAM]EIK.3|MFIGGLSWDTSKK.3|M[Oxi]FIGGLSWDTSKK.3|MFIGGLSWDTSKK.2|M[Oxi]FIGGLSWDTSKK.2|DLTEYLSR.2|VFVGGLSPDTSEEQIK.3|VFVGGLSPDTSEEQIK.2|GFC[CAM]FITYTDEEPVKK.3|GFC[CAM]FITYTDEEPVKK.2|KVFVGGLSPDTSEEQIK.3|RGFC[CAM]FITYTDEEPVK.3|RGFC[CAM]FITYTDEEPVK.2|DAASVDKVLELK.2|LSHVPPPLFPSAPATLASR.3|GGGNHQNNYQPY.2|MFIGGLSWDTSK.2|M[Oxi]FIGGLSWDTSK.2|EVYRQQQQQQK.2|EYFGAFGEIENIELPMDTK.3|EYFGAFGEIENIELPM[Oxi]DTK.3|EYFGAFGEIENIELPM[Oxi]DTK.2|EYFGAFGEIENIELPMDTK.2|NQQDDGKMFIGGLSWDTSKK.3|QLAPLLPSLAPSSAR.2|GFC[CAM]FITYTDEEPVK.2|VFVGGLSPDTSEEQIKEYFGAFGEIENIELPMDTK.4
SEN / CTL,P98179,RNA-binding protein 3,RBM3,1.04,0.52,5.66E-03,5.03E-04,3.30E+00,"RNA processing,regulation of translation,positive regulation of translation","nucleotide binding,RNA binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,dendrite,large ribosomal subunit",6,10,18,GFGFITFTNPEHASVAMR.3|GFGFITFTNPEHASVAMR.4|GFGFITFTNPEHASVAM[Oxi]R.3|GFGFITFTNPEHASVAM[Oxi]R.2|GFGFITFTNPEHASVAMR.2|PGGYGYGYGR.2|AMNGESLDGR.2|AM[Oxi]NGESLDGR.2|NQGGYDRYSGGNYR.3|SRGFGFITFTNPEHASVAMR.4|YYDSRPGGYGYGYGR.3|YYDSRPGGYGYGYGR.2|LFVGGLNFNTDEQALEDHFSSFGPISEVVVVK.5|LFVGGLNFNTDEQALEDHFSSFGPISEVVVVK.4|LFVGGLNFNTDEQALEDHFSSFGPISEVVVVK.3|YSGGNYRDNYDN.2|NQGGYDRYSGGNYRDNYDN.3|LFVGGLNFNTDEQALEDHFSSFGPISEVVVVKDR.4
SEN / CTL,Q9NRX4,14 kDa phosphohistidine phosphatase,PHPT1,1.03,1.58,2.20E-01,1.67E-02,1.78E+00,"protein dephosphorylation,positive regulation of insulin secretion involved in cellular response to glucose stimulus,peptidyl-histidine dephosphorylation,negative regulation of T cell receptor signaling pathway,negative regulation of lyase activity,positive regulation of cell motility,regulation of actin cytoskeleton reorganization,negative regulation of ATP citrate synthase activity","phosphoprotein phosphatase activity,phosphohistidine phosphatase activity,calcium channel inhibitor activity,ion channel binding","cytosol,extracellular exosome",12,8,18,IHVYGYSM[Oxi]AYGPAQHAISTEK.4|IHVYGYSM[Oxi]AYGPAQHAISTEK.3|IHVYGYSMAYGPAQHAISTEK.4|IHVYGYSMAYGPAQHAISTEK.3|IHVYGYSM[Oxi]AYGPAQHAISTEK.2|IHVYGYSMAYGPAQHAISTEK.2|SGAPAAESK.2|WAEYHADIYDK.3|WAEYHADIYDK.2|KIHVYGYSM[Oxi]AYGPAQHAISTEK.5|KIHVYGYSMAYGPAQHAISTEK.4|KIHVYGYSM[Oxi]AYGPAQHAISTEK.4|KIHVYGYSMAYGPAQHAISTEK.3|KIHVYGYSM[Oxi]AYGPAQHAISTEK.3|SGAPAAESKEIVR.2|QGC[CAM]DC[CAM]EC[CAM]LGGGR.2|YPDYEVTWANDGY.2|AKYPDYEVTWANDGY.2
SEN / CTL,P35556,Fibrillin-2,FBN2,0.99,1.23,7.80E-02,6.17E-03,2.21E+00,"extracellular matrix disassembly,extracellular matrix organization,embryonic limb morphogenesis,positive regulation of bone mineralization,sequestering of TGFbeta in extracellular matrix,camera-type eye development,positive regulation of osteoblast differentiation,embryonic eye morphogenesis,bone trabecula formation,regulation of cellular response to growth factor stimulus","extracellular matrix structural constituent,calcium ion binding,protein binding,extracellular matrix constituent conferring elasticity","microfibril,extracellular region,extracellular matrix",12,5,5,LSSTGLIC[CAM]IDSLK.2|C[CAM]WGIGTIPEAC[CAM]PVR.2|RPDGEGC[CAM]VDENEC[CAM]R.3|GWGHQC[CAM]ELC[CAM]PLPGTAQYK.3|SATAGSEGGFLAPEYR.2
SEN / CTL,Q15293,Reticulocalbin-1,RCN1,0.99,1.99,2.82E-06,3.95E-07,6.40E+00,"in utero embryonic development,camera-type eye development",calcium ion binding,"endoplasmic reticulum,endoplasmic reticulum lumen",48,29,48,IVDRIDNDGDGFVTTEELK.3|IVDRIDNDGDGFVTTEELK.2|LTKEEILENWNMFVGSQATNYGEDLTKNHDEL.4|HWILPQDYDHAQAEAR.4|HWILPQDYDHAQAEAR.3|HWILPQDYDHAQAEAR.2|HLVYESDK.2|AADLNGDLTATR.2|VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.6|VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.5|HLVYESDKNKDEK.4|HLVYESDKNKDEK.3|ISWEEYK.2|QATYGYYLGNPAEFHDSSDHHTFKK.6|QATYGYYLGNPAEFHDSSDHHTFKK.5|QATYGYYLGNPAEFHDSSDHHTFKK.4|QATYGYYLGNPAEFHDSSDHHTFKK.3|YIFDNVAK.2|FKAADLNGDLTATR.3|EEFTAFLHPEEFEHM[Oxi]K.4|EEFTAFLHPEEFEHMK.4|EEFTAFLHPEEFEHMK.3|EIVVLETLEDIDK.3|EIVVLETLEDIDK.2|TFDQLTPDESKER.3|TFDQLTPDESKER.2|QATYGYYLGNPAEFHDSSDHHTFK.5|QATYGYYLGNPAEFHDSSDHHTFK.4|QATYGYYLGNPAEFHDSSDHHTFK.3|RYIFDNVAK.2|DGKLDKDEIR.2|ERVVRPDSELGERPPEDNQSFQYDHEAFLGK.6|ERVVRPDSELGERPPEDNQSFQYDHEAFLGK.5|DEIRHWILPQDYDHAQAEAR.4|HLVYESDKNK.2|AADLNGDLTATREEFTAFLHPEEFEHMK.5|AADLNGDLTATREEFTAFLHPEEFEHM[Oxi]K.5|AADLNGDLTATREEFTAFLHPEEFEHMK.4|TFDQLTPDESK.2|VVRPDSELGERPPEDNQSFQYDHEAFLGK.5|VVRPDSELGERPPEDNQSFQYDHEAFLGK.4|ERVVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.6|ERVVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.5|EQFNEFRDLNK.2|IDNDGDGFVTTEELK.2|EEILENWNMFVGSQATNYGEDLTK.3|NGDGFVDQDEYIADMFSHEENGPEPDWVLSER.4|LTKEEILENWNMFVGSQATNYGEDLTK.3
SEN / CTL,P0C0L4,Complement C4-A,C4A,0.98,2.08,5.60E-02,4.53E-03,2.34E+00,"proteolysis,inflammatory response,complement activation,complement activation, classical pathway,negative regulation of endopeptidase activity,regulation of complement activation,innate immune response,positive regulation of apoptotic cell clearance","complement component C1q binding,serine-type endopeptidase activity,endopeptidase inhibitor activity","extracellular region,extracellular space,plasma membrane,cell junction,axon,dendrite,neuronal cell body,synapse,extracellular exosome,blood microparticle",12,104,175,DSSTWLTAFVLK.2|LLATLC[CAM]SAEVC[CAM]QC[CAM]AEGK.3|LLATLC[CAM]SAEVC[CAM]QC[CAM]AEGK.2|YIYGKPVQGVAYVR.4|YIYGKPVQGVAYVR.3|YIYGKPVQGVAYVR.2|DFALLSLQVPLKDAK.4|DFALLSLQVPLKDAK.3|DFALLSLQVPLKDAK.2|KYVLPNFEVK.3|KYVLPNFEVK.2|VFALDQK.2|VHYTVC[CAM]IWR.3|VHYTVC[CAM]IWR.2|EMSGSPASGIPVK.3|EMSGSPASGIPVK.2|EM[Oxi]SGSPASGIPVK.2|FGLLDEDGKKTFFR.4|FGLLDEDGKKTFFR.3|LVNGQSHISLSK.3|LVNGQSHISLSK.2|ANSFLGEK.2|MRPSTDTITVMVENSHGLR.5|MRPSTDTITVMVENSHGLR.4|M[Oxi]RPSTDTITVMVENSHGLR.4|MRPSTDTITVM[Oxi]VENSHGLR.4|MRPSTDTITVMVENSHGLR.3|M[Oxi]RPSTDTITVMVENSHGLR.3|MRPSTDTITVM[Oxi]VENSHGLR.3|KADGSYAAWLSR.3|KADGSYAAWLSR.2|GSFEFPVGDAVSK.3|GSFEFPVGDAVSK.2|RHLVPGAPFLLQALVR.4|RHLVPGAPFLLQALVR.3|EGAIHREELVYELNPLDHR.5|EGAIHREELVYELNPLDHR.4|EGAIHREELVYELNPLDHR.3|NNVPC[CAM]SPK.2|LELSVDGAK.2|AEMADQASAWLTR.3|AEMADQASAWLTR.2|AEM[Oxi]ADQASAWLTR.2|FAC[CAM]YYPR.2|VEYGFQVK.2|VVEEQESR.2|PVQGVAYVR.2|QGSFQGGFR.2|TYNVLDMK.2|TYNVLDM[Oxi]K.2|C[CAM]C[CAM]QDGVTR.2|FGLLDEDGK.2|LTVAAPPSGGPGFLSIERPDSRPPR.5|LTVAAPPSGGPGFLSIERPDSRPPR.4|LTVAAPPSGGPGFLSIERPDSRPPR.3|VLSLAQEQVGGSPEK.3|VLSLAQEQVGGSPEK.2|ASAGLLGAHAAAITAYALTLTK.4|ASAGLLGAHAAAITAYALTLTK.3|ASAGLLGAHAAAITAYALTLTK.2|DHAVDLIQK.2|GPEVQLVAHSPWLK.3|GPEVQLVAHSPWLK.2|LGQYASPTAK.2|TTNIQGINLLFSSR.3|TTNIQGINLLFSSR.2|AEFQDALEK.2|GLQDEDGYR.2|GPEVQLVAHSPWLKDSLSR.4|SHALQLNNR.2|VDFTLSSER.2|VGLSGMAIADVTLLSGFHALR.4|VGLSGM[Oxi]AIADVTLLSGFHALR.3|VGLSGMAIADVTLLSGFHALR.3|VGLSGMAIADVTLLSGFHALR.2|RGHLFLQTDQPIYNPGQR.4|RGHLFLQTDQPIYNPGQR.3|EELVYELNPLDHR.3|EELVYELNPLDHR.2|HLVPGAPFLLQALVR.3|HLVPGAPFLLQALVR.2|PVAFSVVPTAAAAVSLK.3|PVAFSVVPTAAAAVSLK.2|SC[CAM]GLHQLLR.2|RFEQLELRPVLYNYLDK.4|RFEQLELRPVLYNYLDK.3|ALEILQEEDLIDEDDIPVR.4|ALEILQEEDLIDEDDIPVR.3|ALEILQEEDLIDEDDIPVR.2|C[CAM]SVFYGAPSK.2|FGLLDEDGKK.2|VGDTLNLNLR.2|YVLPNFEVK.2|VDVQAGAC[CAM]EGK.2|RC[CAM]C[CAM]QDGVTR.2|AINEKLGQYASPTAKR.3|EPFLSC[CAM]C[CAM]QFAESLR.3|EPFLSC[CAM]C[CAM]QFAESLR.2|YLDKTEQWSTLPPETKDHAVDLIQK.5|YLDKTEQWSTLPPETKDHAVDLIQK.4|ADGSYAAWLSR.2|LGQYASPTAKR.2|VDFTLSSERDFALLSLQVPLK.4|VDFTLSSERDFALLSLQVPLK.3|VLQIEKEGAIHREELVYELNPLDHR.5|GLC[CAM]VATPVQLR.2|PSTDTITVMVENSHGLR.3|PSTDTITVMVENSHGLR.2|VTASDPLDTLGSEGALSPGGVASLLR.4|VTASDPLDTLGSEGALSPGGVASLLR.3|EPFLSC[CAM]C[CAM]QFAESLRK.3|RC[CAM]SVFYGAPSK.2|GC[CAM]GEQTMIYLAPTLAASR.3|GC[CAM]GEQTM[Oxi]IYLAPTLAASR.3|GC[CAM]GEQTMIYLAPTLAASR.2|GC[CAM]GEQTM[Oxi]IYLAPTLAASR.2|YLDKTEQWSTLPPETK.3|YLDKTEQWSTLPPETK.2|GHLFLQTDQPIYNPGQR.3|GHLFLQTDQPIYNPGQR.2|LNMGITDLQGLR.2|LNM[Oxi]GITDLQGLR.2|TLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLR.6|TLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLR.5|TLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLR.4|AVGSGATFSHYYYMILSR.3|DFALLSLQVPLK.2|YVSHFETEGPHVLLYFDSVPTSR.4|YVSHFETEGPHVLLYFDSVPTSR.3|FEQLELRPVLYNYLDK.3|FEQLELRPVLYNYLDK.2|VDVQAGAC[CAM]EGKLELSVDGAK.3|VDVQAGAC[CAM]EGKLELSVDGAK.2|LLLFSPSVVHLGVPLSVGVQLQDVPR.4|LLLFSPSVVHLGVPLSVGVQLQDVPR.3|LTSLSDRYVSHFETEGPHVLLYFDSVPTSR.5|LTSLSDRYVSHFETEGPHVLLYFDSVPTSR.4|RTLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLR.6|RTLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLR.5|SFFPENWLWR.2|STQDTVIALDALSAYWIASHTTEER.4|STQDTVIALDALSAYWIASHTTEER.3|VQQPDC[CAM]REPFLSC[CAM]C[CAM]QFAESLRK.4|DDPDAPLQPVTPLQLFEGR.3|ITPGKPYILTVPGHLDEM[Oxi]QLDIQAR.4|ITPGKPYILTVPGHLDEMQLDIQAR.4|ITPGKPYILTVPGHLDEM[Oxi]QLDIQAR.3|ITPGKPYILTVPGHLDEMQLDIQAR.3|TEQWSTLPPETK.2|GLEEELQFSLGSK.2|EVYMPSSIFQDDFVIPDISEPGTWK.4|EVYMPSSIFQDDFVIPDISEPGTWK.3|AAC[CAM]AQLNDFLQEYGTQGC[CAM]QV.3|AAC[CAM]AQLNDFLQEYGTQGC[CAM]QV.2|LLATLC[CAM]SAEVC[CAM]QC[CAM]AEGKC[CAM]PR.3|PYILTVPGHLDEMQLDIQAR.3|AEFQDALEKLNMGITDLQGLR.3|AEFQDALEKLNM[Oxi]GITDLQGLR.3|LQETSNWLLSQQQADGSFQDPC[CAM]PVLDR.4|LQETSNWLLSQQQADGSFQDPC[CAM]PVLDR.3|ADLEKLTSLSDRYVSHFETEGPHVLLYFDSVPTSR.5|KKEVYM[Oxi]PSSIFQDDFVIPDISEPGTWK.4|NGESVKLHLETDSLALVALGALDTALYAAGSK.4|TLEIPGNSDPNM[Oxi]IPDGDFNSYVR.3|TLEIPGNSDPNMIPDGDFNSYVR.3|EC[CAM]VGFEAVQEVPVGLVQPASATLYDYYNPER.4|EC[CAM]VGFEAVQEVPVGLVQPASATLYDYYNPER.3|SM[Oxi]QGGLVGNDETVALTAFVTIALHHGLAVFQDEGAEPLKQR.5|VETVDRFQILTLWLPDSLTTWEIHGLSLSK.4|VQQPDC[CAM]REPFLSC[CAM]C[CAM]QFAESLR.3|LTVAAPPSGGPGFLSIER.2|FQILTLWLPDSLTTWEIHGLSLSK.3|LEPGKEYLIMGLDGATYDLEGHPQYLLDSNSWIEEMPSER.5|VFEAMNSYDLGC[CAM]GPGGGDSALQVFQAAGLAFSDGDQWTLSR.4|VSATVSSPGSVPEVQDIQQNTDGSGQVSIPIIIPQTISELQLSVSAGSPHPAIAR.5
SEN / CTL,Q9Y2B0,Protein canopy homolog 2,CNPY2,0.98,1.44,4.33E-03,3.91E-04,3.41E+00,"enzyme linked receptor protein signaling pathway,tissue development,negative regulation of gene expression,regulation of low-density lipoprotein particle clearance,positive regulation of low-density lipoprotein particle receptor biosynthetic process",protein binding,"endoplasmic reticulum,integral component of plasma membrane",18,15,27,INPDGSQSVVEVPYAR.2|INPDGSQSVVEVPYAR.3|SEAHLTELLEEIC[CAM]DR.3|SEAHLTELLEEIC[CAM]DR.2|SQDLHC[CAM]GAC[CAM]R.3|SQDLHC[CAM]GAC[CAM]R.2|MKEYGEQIDPSTHR.4|MKEYGEQIDPSTHR.3|MKEYGEQIDPSTHRK.4|MKEYGEQIDPSTHRK.3|TIQMGSFR.2|NGESSELDLQGIR.3|NGESSELDLQGIR.2|EYGEQIDPSTHR.3|EYGEQIDPSTHR.2|RTDLC[CAM]DHALHISHDEL.4|RTDLC[CAM]DHALHISHDEL.3|RTDLC[CAM]DHALHISHDEL.2|EYGEQIDPSTHRK.3|EYGEQIDPSTHRK.2|IDSDISGTLK.2|TDLC[CAM]DHALHISHDEL.3|TDLC[CAM]DHALHISHDEL.2|ALVDELEWEIAQVDPK.3|ALVDELEWEIAQVDPK.2|ALVDELEWEIAQVDPKK.3|NGESSELDLQGIRIDSDISGTLK.3
SEN / CTL,P02774,Vitamin D-binding protein,GC,0.97,1.33,6.24E-11,1.50E-11,1.08E+01,"vitamin D metabolic process,vitamin transport","actin binding,vitamin D binding,vitamin transporter activity,calcidiol binding","extracellular region,extracellular space,cytosol,lysosomal lumen,extracellular exosome,blood microparticle",72,46,77,ELSSFIDKGQELC[CAM]ADYSENTFTEYK.3|HQPQEFPTYVEPTNDEIC[CAM]EAFR.3|HQPQEFPTYVEPTNDEIC[CAM]EAFR.4|HQPQEFPTYVEPTNDEIC[CAM]EAFRKDPK.5|HQPQEFPTYVEPTNDEIC[CAM]EAFRKDPK.4|HQPQEFPTYVEPTNDEIC[CAM]EAFRK.4|HQPQEFPTYVEPTNDEIC[CAM]EAFRK.3|GQELC[CAM]ADYSENTFTEYKK.3|GQELC[CAM]ADYSENTFTEYKK.4|GQELC[CAM]ADYSENTFTEYK.2|GQELC[CAM]ADYSENTFTEYK.3|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.4|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.3|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.5|VLEPTLK.2|EFSHLGK.2|HLSLLTTLSNR.3|HLSLLTTLSNR.2|RTHLPEVFLSK.3|RTHLPEVFLSK.2|AKLPDATPKELAK.3|VMDKYTFELSR.3|VM[Oxi]DKYTFELSR.3|VMDKYTFELSR.2|YTFELSR.2|ELSSFIDK.2|KLC[CAM]MAALK.2|ELPEHTVK.2|LC[CAM]DNLSTK.2|C[CAM]C[CAM]ESASEDC[CAM]MAK.3|C[CAM]C[CAM]ESASEDC[CAM]M[Oxi]AK.3|C[CAM]C[CAM]ESASEDC[CAM]MAK.2|C[CAM]C[CAM]ESASEDC[CAM]M[Oxi]AK.2|NSKFEDC[CAM]C[CAM]QEK.3|NSKFEDC[CAM]C[CAM]QEK.2|DVC[CAM]DPGNTK.2|EDFTSLSLVLYSR.3|EDFTSLSLVLYSR.2|RTHLPEVFLSKVLEPTLK.4|KELSSFIDK.2|FEDC[CAM]C[CAM]QEK.2|KFPSGTFEQVSQLVK.3|KFPSGTFEQVSQLVK.2|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.4|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.3|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.2|EFSHLGKEDFTSLSLVLYSR.4|EFSHLGKEDFTSLSLVLYSR.3|EFSHLGKEDFTSLSLVLYSR.2|THLPEVFLSK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.4|SYLSM[Oxi]VGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.3|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.3|SYLSM[Oxi]VGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.2|C[CAM]C[CAM]ESASEDC[CAM]MAKELPEHTVK.4|EVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.4|EVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.3|VC[CAM]SQYAAYGEK.2|VC[CAM]KEFSHLGKEDFTSLSLVLYSR.4|LAQKVPTADLEDVLPLAEDITNILSK.4|LAQKVPTADLEDVLPLAEDITNILSK.3|SLGEC[CAM]C[CAM]DVEDSTTC[CAM]FNAK.3|SLGEC[CAM]C[CAM]DVEDSTTC[CAM]FNAK.2|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TKEGLER.4|SDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.4|SDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.3|KELSSFIDKGQELC[CAM]ADYSENTFTEYK.4|FPSGTFEQVSQLVK.2|RSDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.4|RSDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.3|VPTADLEDVLPLAEDITNILSK.3|VPTADLEDVLPLAEDITNILSK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLKER.3|KFPSGTFEQVSQLVKEVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.4|EYANQFMWEYSTNYGQAPLSLLVSYTK.3|TAMDVFVC[CAM]TYFMPAAQLPELPDVELPTNK.3
SEN / CTL,O00391,Sulfhydryl oxidase 1,QSOX1,0.97,2.08,1.97E-08,3.54E-09,8.45E+00,"platelet degranulation,negative regulation of macroautophagy,cell redox homeostasis,oxidation-reduction process","protein disulfide isomerase activity,flavin-linked sulfhydryl oxidase activity","extracellular region,extracellular space,Golgi apparatus,integral component of Golgi membrane,platelet alpha granule lumen,intracellular membrane-bounded organelle,intercellular bridge,extracellular exosome",120,23,29,SALYSPSDPLTLLQADTVR.2|SALYSPSDPLTLLQADTVR.3|LAGAPSEDPQFPK.2|AHFSPSNIILDFPAAGSAAR.3|AHFSPSNIILDFPAAGSAAR.2|AHFSPSNIILDFPAAGSAAR.4|NNEEYLALIFEK.2|FGVTDFPSC[CAM]YLLFR.2|DFNIPGFPTVR.2|DTGAALLAESR.2|SFYTAYLQR.2|VGSPNAAVLWLWSSHNR.3|KFGVTDFPSC[CAM]YLLFR.3|VLNTEANVVR.2|DC[CAM]ASHFEQMAAASMHR.4|DC[CAM]ASHFEQMAAASMHR.3|DC[CAM]ASHFEQMAAASM[Oxi]HR.3|NGSGAVFPVAGADVQTLR.2|GYVHYFFGC[CAM]R.3|LDVPVWDVEATLNFLK.2|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.3|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.4|ELC[CAM]SAC[CAM]HNER.3|KVNWIGC[CAM]QGSEPHFR.4|VPVLMESR.2|LEEIDGFFAR.2|RVLNTEANVVR.2|DVQNVAAAPELAMGALELESR.3|AAPGQEPPEHMAELQR.2
SEN / CTL,P09871,Complement C1s subcomponent,C1S,0.95,1.91,1.97E-01,1.50E-02,1.82E+00,"proteolysis,complement activation,complement activation, classical pathway,innate immune response","serine-type endopeptidase activity,calcium ion binding","extracellular region,extracellular exosome,blood microparticle",54,26,38,TNFDNDIALVR.2|SSNNPHSPIVEEFQVPYNK.3|SSNNPHSPIVEEFQVPYNK.4|MGPTVSPIC[CAM]LPGTSSDYNLMDGDLGLISGWGR.3|YHGDPMPC[CAM]PKEDTPNSVWEPAK.4|SNALDIIFQTDLTGQK.3|SNALDIIFQTDLTGQK.2|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.3|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.4|VEKPTADAEAYVFTPNM[Oxi]IC[CAM]AGGEK.3|LLEVPEGR.2|M[Oxi]LTPEHVFIHPGWK.4|MLTPEHVFIHPGWK.4|MLTPEHVFIHPGWK.2|GFQVVVTLR.2|VEDPESTLFGSVIR.3|VEDPESTLFGSVIR.2|TMQENSTPR.2|NYVDWIMK.2|GDSGGAFAVQDPNDKTK.3|GDSGGAFAVQDPNDKTK.2|GMDSC[CAM]KGDSGGAFAVQDPNDKTK.4|YHGDPMPC[CAM]PK.2|DVVQITC[CAM]LDGFEVVEGR.3|DVVQITC[CAM]LDGFEVVEGR.2|TMQENSTPRED.2|TM[Oxi]QENSTPRED.2|EDTPNSVWEPAK.2|QFGPYC[CAM]GHGFPGPLNIETK.3|QFGPYC[CAM]GHGFPGPLNIETK.2|GMDSC[CAM]KGDSGGAFAVQDPNDK.3|GDSGGAFAVQDPNDK.2|FYAAGLVSWGPQC[CAM]GTYGLYTR.3|FYAAGLVSWGPQC[CAM]GTYGLYTR.2|VGATSFYSTC[CAM]QSNGK.2|EPTMYVGSTSVQTSR.2|REDFDVEAADSAGNC[CAM]LDSLVFVAGDR.3|C[CAM]QPVDC[CAM]GIPESIENGKVEDPESTLFGSVIR.3
SEN / CTL,P02788,Lactotransferrin,LTF,0.91,2.31,6.89E-01,4.98E-02,1.30E+00,"ossification,regulation of cytokine production,retina homeostasis,innate immune response in mucosa,transcription, DNA-templated,proteolysis,ion transport,humoral immune response,antibacterial humoral response,antifungal humoral response,negative regulation of lipopolysaccharide-mediated signaling pathway,regulation of tumor necrosis factor production,negative regulation of ATPase activity,iron assimilation by chelation and transport,positive regulation of osteoblast proliferation,positive regulation of toll-like receptor 4 signaling pathway,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,cellular protein metabolic process,negative regulation by host of viral process,negative regulation of viral genome replication,cell redox homeostasis,positive regulation of osteoblast differentiation,negative regulation of viral process,positive regulation of NF-kappaB transcription factor activity,bone morphogenesis,positive regulation of protein serine/threonine kinase activity,positive regulation of bone mineralization involved in bone maturation,negative regulation of single-species biofilm formation in or on host organism,positive regulation of chondrocyte proliferation,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,negative regulation of osteoclast development","DNA binding,serine-type endopeptidase activity,iron ion binding,protein binding,heparin binding,protein serine/threonine kinase activator activity","extracellular region,extracellular space,nucleus,cytoplasm,cell surface,secretory granule,specific granule,protein complex,extracellular exosome,phagocytic vesicle lumen",24,76,117,C[CAM]GLVPVLAENYK.2|YYGYTGAFR.2|C[CAM]LAENAGDVAFVKDVTVLQNTDGNNNEAWAK.4|C[CAM]LAENAGDVAFVKDVTVLQNTDGNNNEAWAK.3|KPVDKFKDC[CAM]HLAR.4|SC[CAM]HLAMAPNHAVVSR.4|SC[CAM]HLAM[Oxi]APNHAVVSR.4|SC[CAM]HLAMAPNHAVVSR.3|SC[CAM]HLAM[Oxi]APNHAVVSR.3|SC[CAM]HLAM[Oxi]APNHAVVSR.2|YLGPQYVAGITNLKK.4|YLGPQYVAGITNLKK.3|DSAIGFSR.2|VRGPPVSC[CAM]IKR.3|VRGPPVSC[CAM]IKR.2|LKQVLLHQQAK.3|LKQVLLHQQAK.2|SEEEVAAR.2|C[CAM]LAENAGDVAFVK.3|C[CAM]LAENAGDVAFVK.2|LRPVAAEVYGTERQPR.4|LRPVAAEVYGTERQPR.3|RSDTSLTWNSVK.3|RSDTSLTWNSVK.2|VPSHAVVAR.2|LC[CAM]AGTGENK.2|SC[CAM]HTAVDR.2|C[CAM]LRDGAGDVAFIR.3|DLLFKDSAIGFSR.3|DLLFKDSAIGFSR.2|KC[CAM]STSPLLEAC[CAM]EFLRK.4|KC[CAM]STSPLLEAC[CAM]EFLRK.3|LRPVAAEVYGTER.3|LRPVAAEVYGTER.2|LADFALLC[CAM]LDGKR.3|GPPVSC[CAM]IKR.2|KGGSFQLNELQGLK.3|KGGSFQLNELQGLK.2|KSEEEVAAR.2|DGAGDVAFIR.2|YLGPQYVAGITNLK.3|YLGPQYVAGITNLK.2|FKDC[CAM]HLAR.2|IDSGLYLGSGYFTAIQNLR.4|IDSGLYLGSGYFTAIQNLR.3|IDSGLYLGSGYFTAIQNLR.2|NLLFNDNTEC[CAM]LAR.3|NLLFNDNTEC[CAM]LAR.2|VVWC[CAM]AVGEQELRK.3|VVWC[CAM]AVGEQELRK.2|DSPIQC[CAM]IQAIAENR.3|DSPIQC[CAM]IQAIAENR.2|KSC[CAM]HTAVDR.2|QVLLHQQAK.2|SVNGKEDAIWNLLR.3|SVNGKEDAIWNLLR.2|IDSGLYLGSGYFTAIQNLRK.4|IDSGLYLGSGYFTAIQNLRK.3|IDSGLYLGSGYFTAIQNLRK.2|VRGPPVSC[CAM]IK.2|EDAIWNLLR.2|FC[CAM]LFQSETK.2|THYYAVAVVK.2|KSEEEVAARR.2|RSVQWC[CAM]AVSQPEATK.3|RSVQWC[CAM]AVSQPEATK.2|RDSPIQC[CAM]IQAIAENR.3|FQLFGSPSGQK.2|C[CAM]STSPLLEAC[CAM]EFLRK.3|FQLFGSPSGQKDLLFK.3|FQLFGSPSGQKDLLFK.2|GEADAMSLDGGYVYTAGK.3|GEADAM[Oxi]SLDGGYVYTAGK.2|GEADAMSLDGGYVYTAGK.2|KC[CAM]STSPLLEAC[CAM]EFLR.3|KC[CAM]STSPLLEAC[CAM]EFLR.2|FDEYFSQSC[CAM]APGSDPR.3|FDEYFSQSC[CAM]APGSDPR.2|SDTSLTWNSVK.2|THYYAVAVVKK.2|VPPRIDSGLYLGSGYFTAIQNLR.4|VPPRIDSGLYLGSGYFTAIQNLR.3|FFSASC[CAM]VPGADK.2|DVTVLQNTDGNNNEAWAK.3|DVTVLQNTDGNNNEAWAK.2|FQLFGSPSGQKDLLFKDSAIGFSR.4|FQLFGSPSGQKDLLFKDSAIGFSR.3|LADFALLC[CAM]LDGK.2|VPPRIDSGLYLGSGYFTAIQNLRK.4|NGSDC[CAM]PDKFC[CAM]LFQSETK.3|NGSDC[CAM]PDKFC[CAM]LFQSETK.2|ADAVTLDGGFIYEAGLAPYK.3|ADAVTLDGGFIYEAGLAPYK.2|GGSFQLNELQGLK.2|SNLC[CAM]ALC[CAM]IGDEQGENKC[CAM]VPNSNER.4|SNLC[CAM]ALC[CAM]IGDEQGENKC[CAM]VPNSNER.3|SQQSSDPDPNC[CAM]VDRPVEGYLAVAVVR.4|SQQSSDPDPNC[CAM]VDRPVEGYLAVAVVR.3|VVWC[CAM]AVGEQELR.2|ESTVFEDLSDEAERDEYELLC[CAM]PDNTRKPVDK.5|ESTVFEDLSDEAERDEYELLC[CAM]PDNTRKPVDK.4|FFSASC[CAM]VPGADKGQFPNLC[CAM]R.3|ESTVFEDLSDEAERDEYELLC[CAM]PDNTR.4|ESTVFEDLSDEAERDEYELLC[CAM]PDNTR.3|SVQWC[CAM]AVSQPEATK.2|TAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.4|TAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.3|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.4|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.3|C[CAM]STSPLLEAC[CAM]EFLR.2|RTAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.4|DSPIQC[CAM]IQAIAENRADAVTLDGGFIYEAGLAPYK.4|SNLC[CAM]ALC[CAM]IGDEQGENK.2|LC[CAM]AGTGENKC[CAM]AFSSQEPYFSYSGAFK.3|C[CAM]AFSSQEPYFSYSGAFK.2|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLKGEADAMSLDGGYVYTAGK.5|C[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.3
SEN / CTL,P05386,60S acidic ribosomal protein P1,RPLP1,0.91,1.87,2.03E-05,2.57E-06,5.59E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,activation of protein kinase activity,positive regulation of protein kinase activity","structural constituent of ribosome,protein binding,protein kinase activator activity,large ribosomal subunit rRNA binding","cytoplasm,cytosol,focal adhesion,cytosolic large ribosomal subunit,preribosome, large subunit precursor,extracellular exosome",42,5,12,AAGVNVEPFWPGLFAK.2|AAGVNVEPFWPGLFAK.3|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.4|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.5|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.6|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.4|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.5|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.7|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.6|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKK.4|KEESEESDDDM[Oxi]GFGLFD.2|KEESEESDDDMGFGLFD.2
SEN / CTL,P62805,Histone H4,HIST1H4A,0.90,1.97,4.04E-03,3.66E-04,3.44E+00,"chromatin silencing at rDNA,double-strand break repair via nonhomologous end joining,nucleosome assembly,DNA replication-dependent nucleosome assembly,DNA replication-independent nucleosome assembly,DNA-templated transcription, initiation,telomere capping,gene silencing by RNA,telomere organization,CENP-A containing nucleosome assembly,cellular protein metabolic process,negative regulation of megakaryocyte differentiation,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,protein heterotetramerization,beta-catenin-TCF complex assembly","DNA binding,protein binding,protein domain specific binding,histone binding,poly(A) RNA binding,protein heterodimerization activity","nuclear chromosome,nuclear chromosome, telomeric region,nucleosome,extracellular region,nucleus,nucleoplasm,membrane,extracellular matrix,protein complex,extracellular exosome",12,24,44,ISGLIYEETR.2|VFLENVIRDAVTYTEHAK.4|VFLENVIRDAVTYTEHAK.3|VFLENVIRDAVTYTEHAK.2|KTVTAM[Oxi]DVVYALKR.4|KTVTAMDVVYALKR.3|KTVTAM[Oxi]DVVYALKR.3|VLRDNIQGITKPAIR.4|VLRDNIQGITKPAIR.3|DAVTYTEHAKR.3|DAVTYTEHAKR.2|DNIQGITKPAIR.3|DNIQGITKPAIR.2|TVTAM[Oxi]DVVYALK.3|TVTAMDVVYALK.3|TVTAMDVVYALK.2|TVTAM[Oxi]DVVYALK.2|DNIQGITK.2|RISGLIYEETR.3|RISGLIYEETR.2|TVTAM[Oxi]DVVYALKRQGR.4|TVTAMDVVYALKRQGR.4|VLRDNIQGITKPAIRR.4|KTVTAMDVVYALK.3|KTVTAM[Oxi]DVVYALK.3|KTVTAMDVVYALK.2|KTVTAM[Oxi]DVVYALK.2|TVTAMDVVYALKR.3|TVTAM[Oxi]DVVYALKR.3|TVTAMDVVYALKR.2|TVTAM[Oxi]DVVYALKR.2|DNIQGITKPAIRR.3|VFLENVIR.2|ISGLIYEETRGVLK.3|ISGLIYEETRGVLK.2|QGRTLYGFGG.2|RKTVTAMDVVYALK.3|DAVTYTEHAK.2|VFLENVIRDAVTYTEHAKR.4|RISGLIYEETRGVLK.3|GVLKVFLENVIRDAVTYTEHAK.4|ISGLIYEETRGVLKVFLENVIR.4|ISGLIYEETRGVLKVFLENVIR.3|TLYGFGG.1
SEN / CTL,Q9H0H5,Rac GTPase-activating protein 1,RACGAP1,0.89,0.56,9.20E-03,7.99E-04,3.10E+00,"mitotic cytokinesis,actomyosin contractile ring assembly,retrograde vesicle-mediated transport, Golgi to ER,microtubule-based movement,spermatogenesis,neuroblast proliferation,sulfate transport,embryo development,antigen processing and presentation of exogenous peptide antigen via MHC class II,positive regulation of cytokinesis,intracellular signal transduction,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,mitotic spindle midzone assembly,regulation of attachment of spindle microtubules to kinetochore","GTPase activator activity,protein binding,phosphatidylinositol-3,4,5-trisphosphate binding,microtubule binding,protein kinase binding,alpha-tubulin binding,gamma-tubulin binding,metal ion binding,beta-tubulin binding","acrosomal vesicle,nucleus,nucleoplasm,cytoplasm,cytosol,microtubule,midbody,extrinsic component of cytoplasmic side of plasma membrane,cleavage furrow,spindle midzone,extracellular exosome,mitotic spindle,centralspindlin complex",6,33,48,DTLAFLMIHLQR.2|NLKEPLLTFR.3|QFVDGPPGPVKK.3|QFVDGPPGPVKK.2|MDVANLAK.2|SALAFLNR.2|NQVDVEIK.2|TVIKPESC[CAM]VPC[CAM]GK.3|TVIKPESC[CAM]VPC[CAM]GK.2|VVSHPEC[CAM]R.2|QRAEADC[CAM]EKLER.3|GLTETGLYR.2|NLFEQLVR.2|SIGSAVDQGNESIVAK.3|SIGSAVDQGNESIVAK.2|TPSSSSLSQR.2|TDHELGKYKDLLMK.3|TDHELGKYKDLLMK.2|QFVDGPPGPVK.2|VSLLGPVTTPEHQLLK.3|VSLLGPVTTPEHQLLK.2|TGTLQPWNSDSTLNSR.3|TGTLQPWNSDSTLNSR.2|AEADC[CAM]EKLER.2|QGNFFASPMLK.2|QGNFFASPM[Oxi]LK.2|KTGTLQPWNSDSTLNSR.3|KTGTLQPWNSDSTLNSR.2|DRC[CAM]PLPC[CAM]IPTLIGTPVK.3|DRC[CAM]PLPC[CAM]IPTLIGTPVK.2|VFGPTIVAHAVPNPDPVTMLQDIK.4|VFGPTIVAHAVPNPDPVTM[Oxi]LQDIK.3|VFGPTIVAHAVPNPDPVTMLQDIK.3|VFGPTIVAHAVPNPDPVTMLQDIKR.4|RKTGTLQPWNSDSTLNSR.3|RVEILSEGNEVQFIQLAK.3|RVEILSEGNEVQFIQLAK.2|RVEILSEGNEVQFIQLAKDFEDFR.4|RVEILSEGNEVQFIQLAKDFEDFR.3|TDESLDWDSSLVK.2|TETDSVGTPQSNGGMR.2|TETDSVGTPQSNGGM[Oxi]R.2|C[CAM]PLPC[CAM]IPTLIGTPVK.2|IGEGMLADFVSQTSPMIPSIVVHC[CAM]VNEIEQR.4|IGEGMLADFVSQTSPMIPSIVVHC[CAM]VNEIEQR.3|TTVTVPNDGGPIEAVSTIETVPYWTR.3|AFMEAAEITDEDNSIAAMYQAVGELPQANR.3|LSTIDESGSILSDISFDKTDESLDWDSSLVK.3
SEN / CTL,Q14257,Reticulocalbin-2,RCN2,0.86,0.57,1.58E-02,1.33E-03,2.88E+00,,calcium ion binding,"nucleolus,endoplasmic reticulum,endoplasmic reticulum lumen",6,22,34,WDPTANEDPEWILVEKDR.3|AEELHYPLGER.3|AEELHYPLGER.2|FVNDYDKDNDGR.3|FVNDYDKDNDGR.2|HYAMQEAK.2|HYAM[Oxi]QEAK.2|QLHDDYFYHDEL.3|QLHDDYFYHDEL.2|QQFVEYDK.2|EALLGVQEDVDEYVK.3|EALLGVQEDVDEYVK.2|DRFVNDYDK.2|NGDGFVSLEEFLGDYR.3|NGDGFVSLEEFLGDYR.2|RSDYDREALLGVQEDVDEYVK.4|RSDYDREALLGVQEDVDEYVK.3|WDPTANEDPEWILVEK.3|WDPTANEDPEWILVEK.2|KLSEEEILENPDLFLTSEATDYGR.4|KLSEEEILENPDLFLTSEATDYGR.3|VIDFDENTALDDAEEESFR.3|VIDFDENTALDDAEEESFR.2|NSDDTVTWDEYNIQMYDR.3|NSDDTVTWDEYNIQMYDR.2|SDYDREALLGVQEDVDEYVK.3|VIDFDENTALDDAEEESFRK.3|VIDFDENTALDDAEEESFRK.2|LSEEEILENPDLFLTSEATDYGR.3|DNDGRLDPQELLPWVVPNNQGIAQEEALHLIDEMDLNGDKK.5|KIDLDSDGFLTESELSSWIQMSFK.3|LDPQELLPWVVPNNQGIAQEEALHLIDEMDLNGDK.4|LDPQELLPWVVPNNQGIAQEEALHLIDEMDLNGDKK.4|DNDGRLDPQELLPWVVPNNQGIAQEEALHLIDEMDLNGDK.4
SEN / CTL,O00148;Q13838,ATP-dependent RNA helicase DDX39A;Spliceosome RNA helicase DDX39B,DDX39A;DDX39B,0.83,1.97,5.87E-02,4.73E-03,2.33E+00,"mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,cellular response to DNA damage stimulus,regulation of gene expression,RNA secondary structure unwinding,mRNA 3'-end processing;spliceosomal complex assembly,mRNA splicing, via spliceosome,liver development,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,RNA splicing,RNA secondary structure unwinding,mRNA 3'-end processing,positive regulation of DNA-templated transcription, elongation,positive regulation of translation,viral mRNA export from host cell nucleus,positive regulation of cell growth involved in cardiac muscle cell development,positive regulation of vascular smooth muscle cell proliferation,negative regulation of DNA damage checkpoint,positive regulation of DNA biosynthetic process","ATP-dependent RNA helicase activity,protein binding,ATP binding,ATPase activity,poly(A) RNA binding;ATP-dependent RNA helicase activity,protein binding,ATP binding,RNA-dependent ATPase activity,ATPase activity,U6 snRNA binding,U4 snRNA binding,protein complex binding,identical protein binding,ATP-dependent protein binding,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex,membrane,cytoplasm;transcription export complex,nucleus,nucleoplasm,spliceosomal complex,nuclear matrix,nuclear speck,U4 snRNP,U6 snRNP,cytoplasm",18,3,6,ILVATNLFGR.2|GLAITFVSDENDAK.2|GLAITFVSDENDAK.3|GSYVSIHSSGFRDFLLKPELLR.5|GSYVSIHSSGFRDFLLKPELLR.4|GSYVSIHSSGFRDFLLKPELLR.3
SEN / CTL,P62979,Ubiquitin-40S ribosomal protein S27a,RPS27A,0.82,1.70,1.58E-03,1.52E-04,3.82E+00,"G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator","structural constituent of ribosome,protein binding,poly(A) RNA binding,metal ion binding","extracellular space,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,endosome membrane,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,endocytic vesicle membrane,myelin sheath,extracellular exosome",54,8,16,TITLEVEPSDTIENVK.2|TITLEVEPSDTIENVK.3|TITLEVEPSDTIENVKAK.3|TITLEVEPSDTIENVKAK.2|EC[CAM]PSDEC[CAM]GAGVFMASHFDR.3|EC[CAM]PSDEC[CAM]GAGVFM[Oxi]ASHFDR.3|EC[CAM]PSDEC[CAM]GAGVFMASHFDR.2|ESTLHLVLR.2|TLSDYNIQKESTLHLVLR.4|TLSDYNIQKESTLHLVLR.3|TLSDYNIQKESTLHLVLR.2|REC[CAM]PSDEC[CAM]GAGVFMASHFDR.4|REC[CAM]PSDEC[CAM]GAGVFMASHFDR.3|C[CAM]C[CAM]LTYC[CAM]FNKPEDK.3|C[CAM]C[CAM]LTYC[CAM]FNKPEDK.2|YYKVDENGK.2
SEN / CTL,P62826,GTP-binding nuclear protein Ran,RAN,0.81,2.11,1.09E-01,8.50E-03,2.07E+00,"ribosomal large subunit export from nucleus,ribosomal small subunit export from nucleus,protein import into nucleus, translocation,DNA metabolic process,tRNA export from nucleus,protein import into nucleus,protein export from nucleus,mitotic spindle organization,mitotic nuclear division,signal transduction,small GTPase mediated signal transduction,viral process,androgen receptor signaling pathway,gene silencing by RNA,positive regulation of protein binding,pre-miRNA export from nucleus,positive regulation of transcription, DNA-templated,cell division,protein transmembrane transport,intracellular transport of virus,cell-cell adhesion,protein localization to nucleolus","chromatin binding,transcription coactivator activity,GTPase activity,protein binding,GTP binding,GDP binding,poly(A) RNA binding,androgen receptor binding,cadherin binding involved in cell-cell adhesion,protein transmembrane transporter activity,pre-miRNA binding,pre-miRNA transporter activity","nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,centriole,cytosol,cell-cell adherens junction,membrane,midbody,extracellular matrix,melanosome,RNA nuclear export complex,recycling endosome,extracellular exosome,Flemming body,chromatin",24,19,35,SNYNFEKPFLWLAR.3|SNYNFEKPFLWLAR.2|SNYNFEKPFLWLAR.4|NLQYYDISAK.2|NLQYYDISAK.3|GPIKFNVWDTAGQEK.3|GPIKFNVWDTAGQEK.2|FNVWDTAGQEK.3|FNVWDTAGQEK.2|KYVATLGVEVHPLVFHTNR.5|KYVATLGVEVHPLVFHTNR.4|KYVATLGVEVHPLVFHTNR.3|KYVATLGVEVHPLVFHTNR.2|LVLVGDGGTGKTTFVKR.4|KNLQYYDISAK.3|KNLQYYDISAK.2|PFLWLAR.2|SNYNFEK.2|HLTGEFEK.2|KKNLQYYDISAK.3|KKNLQYYDISAK.2|LVLVGDGGTGK.2|VC[CAM]ENIPIVLC[CAM]GNK.3|VC[CAM]ENIPIVLC[CAM]GNK.2|YVATLGVEVHPLVFHTNR.4|YVATLGVEVHPLVFHTNR.3|YVATLGVEVHPLVFHTNR.2|HLTGEFEKK.2|RHLTGEFEK.2|VC[CAM]ENIPIVLC[CAM]GNKVDIKDR.4|VC[CAM]ENIPIVLC[CAM]GNKVDIKDR.3|VC[CAM]ENIPIVLC[CAM]GNKVDIK.3|VC[CAM]ENIPIVLC[CAM]GNKVDIK.2|DGYYIQAQC[CAM]AIIMFDVTSR.3|DGYYIQAQC[CAM]AIIMFDVTSR.2
SEN / CTL,P15374,Ubiquitin carboxyl-terminal hydrolase isozyme L3,UCHL3,0.81,0.73,5.16E-02,4.20E-03,2.38E+00,"ubiquitin-dependent protein catabolic process,protein deubiquitination,protein catabolic process","thiol-dependent ubiquitin-specific protease activity,peptidase activity,ubiquitin binding","nucleus,cytoplasm,extracellular exosome",6,15,26,FLEESVSMSPEER.2|FLEESVSM[Oxi]SPEER.2|MHFESGSTLKK.3|FNAIALSAA.2|KFMERDPDELR.3|PVC[CAM]AVLLLFPITEK.3|PVC[CAM]AVLLLFPITEK.2|VTHETSAHEGQTEAPSIDEK.4|VTHETSAHEGQTEAPSIDEK.3|VTHETSAHEGQTEAPSIDEK.2|KFLEESVSMSPEER.3|KFLEESVSMSPEER.2|KPFPINHGETSDETLLEDAIEVC[CAM]KK.5|KPFPINHGETSDETLLEDAIEVC[CAM]KK.4|KPFPINHGETSDETLLEDAIEVC[CAM]KK.3|MHFESGSTLK.2|YLENYDAIR.2|WLPLEANPEVTNQFLK.3|WLPLEANPEVTNQFLK.2|KPFPINHGETSDETLLEDAIEVC[CAM]K.4|KPFPINHGETSDETLLEDAIEVC[CAM]K.3|QTISNAC[CAM]GTIGLIHAIANNK.3|QTISNAC[CAM]GTIGLIHAIANNK.2|QTISNAC[CAM]GTIGLIHAIANNKDK.3|SQGQDVTSSVYFMK.2|SQGQDVTSSVYFM[Oxi]K.2
SEN / CTL,P02545,Prelamin-A/C,LMNA,0.80,1.67,9.49E-15,3.33E-15,1.45E+01,"mitotic nuclear envelope disassembly,mitotic nuclear envelope reassembly,regulation of cell migration,establishment or maintenance of microtubule cytoskeleton polarity,protein localization to nucleus,sterol regulatory element binding protein import into nucleus,IRE1-mediated unfolded protein response,ventricular cardiac muscle cell development,cellular response to hypoxia,negative regulation of mesenchymal cell proliferation,negative regulation of release of cytochrome c from mitochondria,positive regulation of cell aging,regulation of protein localization to nucleus,negative regulation of extrinsic apoptotic signaling pathway","structural molecule activity,protein binding","nucleus,nuclear envelope,lamin filament,nucleoplasm,cytoplasm,cytosol,nuclear speck,extracellular matrix,nuclear membrane",168,85,142,IRIDSLSAQLSQLQK.3|IRIDSLSAQLSQLQK.2|IRIDSLSAQLSQLQK.4|VAVEEVDEEGKFVR.3|VAVEEVDEEGKFVR.2|LRITESEEVVSR.3|LRITESEEVVSR.2|NSNLVGAAHEELQQSR.3|NSNLVGAAHEELQQSR.2|NSNLVGAAHEELQQSR.4|LADALQELR.2|MQQQLDEYQELLDIK.2|MQQQLDEYQELLDIK.3|M[Oxi]QQQLDEYQELLDIK.3|M[Oxi]QQQLDEYQELLDIK.2|LQLELSK.2|LQEKEDLQELNDRLAVYIDR.4|EAALSTALSEK.2|AAYEAELGDAR.2|LAVYIDR.2|LAVYIDR.1|LQEKEDLQELNDR.3|LQEKEDLQELNDR.2|SVGGSGGGSFGDNLVTR.2|SVGGSGGGSFGDNLVTR.3|ASASGSGAQVGGPISSGSSASSVTVTR.3|ASASGSGAQVGGPISSGSSASSVTVTR.2|ASASGSGAQVGGPISSGSSASSVTVTR.4|TLEGELHDLRGQVAKLEAALGEAK.4|TALINSTGEEVAMR.2|TALINSTGEEVAMR.3|TALINSTGEEVAM[Oxi]R.2|TLEGELHDLRGQVAK.3|TLEGELHDLRGQVAK.4|TLEGELHDLRGQVAK.2|IDSLSAQLSQLQK.2|IDSLSAQLSQLQK.3|AGQVVTIWAAGAGATHSPPTDLVWK.3|AGQVVTIWAAGAGATHSPPTDLVWK.4|LQTMKEELDFQK.3|LQTM[Oxi]KEELDFQK.3|LQTMKEELDFQK.2|LQTM[Oxi]KEELDFQK.2|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.4|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.6|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.5|LKDLEALLNSK.3|LKDLEALLNSK.2|ASSHSSQTQGGGSVTKK.4|EAALSTALSEKR.3|EAALSTALSEKR.2|AAYEAELGDARK.3|AAYEAELGDARK.2|GRASSHSSQTQGGGSVTK.4|GRASSHSSQTQGGGSVTK.3|LVEIDNGK.2|LALDM[Oxi]EIHAYR.3|LALDMEIHAYR.3|LALDMEIHAYR.2|RTLEGELHDLR.3|RTLEGELHDLR.2|AQNTWGC[CAM]GNSLR.3|AQNTWGC[CAM]GNSLR.2|LEAALGEAK.2|RTLEGELHDLRGQVAK.4|RTLEGELHDLRGQVAK.3|RTLEGELHDLRGQVAK.2|SGAQASSTPLSPTR.3|SGAQASSTPLSPTR.2|AQHEDQVEQYK.3|AQHEDQVEQYK.2|DLEDSLAR.2|NIYSEELRETK.3|NIYSEELRETK.2|SSFSQHAR.2|VAVEEVDEEGKFVRLR.4|KLESTESR.2|QREFESR.2|NKSNEDQSMGNWQIKR.4|NKSNEDQSM[Oxi]GNWQIKR.4|NKSNEDQSMGNWQIKR.3|NKSNEDQSM[Oxi]GNWQIKR.3|RQNGDDPLLTYR.3|RQNGDDPLLTYR.2|RQNGDDPLLTYRFPPK.4|RQNGDDPLLTYRFPPK.3|LALDMEIHAYRK.3|LALDM[Oxi]EIHAYRK.3|LALDMEIHAYRK.2|LSPSPTSQR.2|AQHEDQVEQYKK.3|AQHEDQVEQYKK.2|AQHEDQVEQYKKELEK.4|AQHEDQVEQYKKELEK.3|DLEALLNSK.2|LADALQELRAQHEDQVEQYKK.5|LADALQELRAQHEDQVEQYKK.4|LADALQELRAQHEDQVEQYKK.3|TSGRVAVEEVDEEGKFVR.4|TSGRVAVEEVDEEGKFVR.3|ASSHSSQTQGGGSVTK.3|ASSHSSQTQGGGSVTK.2|LRITESEEVVSREVSGIK.4|NTKKEGDLIAAQAR.3|TLDSVAKER.2|LEAALGEAKK.2|NIYSEELR.2|QLQDEMLR.2|SNEDQSMGNWQIK.3|SNEDQSM[Oxi]GNWQIK.2|SNEDQSMGNWQIK.2|EGDLIAAQAR.2|EREMAEMR.2|SLETENAGLR.2|TALINSTGEEVAM[Oxi]RK.3|TALINSTGEEVAMRK.3|TALINSTGEEVAMRK.2|IRIDSLSAQLSQLQKQLAAK.4|SRTVLC[CAM]GTC[CAM]GQPADK.3|SYLLGNSSPR.2|EDLQELNDR.2|SNEDQSMGNWQIKR.3|SNEDQSM[Oxi]GNWQIKR.3|ITESEEVVSR.2|KQLQDEMLR.2|ITESEEVVSREVSGIK.3|KEGDLIAAQAR.2|LKDLEALLNSKEAALSTALSEK.4|LRDLEDSLAR.2|TLEGELHDLR.2|LVEIDNGKQREFESR.3|VAVEEVDEEGK.2|LQTMKEELDFQKNIYSEELR.4|LQTMKEELDFQKNIYSEELR.3|QNGDDPLLTYR.2|EDLQELNDRLAVYIDR.3|KLLEGEEERLR.2|GQVAKLEAALGEAK.2|SVTVVEDDEDEDGDDLLHHHHGSHC[CAM]SSSGDPAEYNLR.6|TVLC[CAM]GTC[CAM]GQPADK.2|VDAENRLQTMKEELDFQK.3|NKSNEDQSMGNWQIK.2
SEN / CTL,P62258,14-3-3 protein epsilon,YWHAE,0.80,1.93,3.28E-08,5.74E-09,8.24E+00,"G2/M transition of mitotic cell cycle,neuron migration,regulation of heart rate by hormone,protein targeting,viral process,substantia nigra development,hippocampus development,cerebral cortex development,hippo signaling,intracellular signal transduction,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,regulation of membrane repolarization,membrane organization,membrane repolarization during cardiac muscle cell action potential,regulation of heart rate by cardiac conduction,cell-cell adhesion,regulation of cellular response to heat,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of potassium ion transmembrane transporter activity,negative regulation of peptidyl-serine dephosphorylation","protein binding,potassium channel regulator activity,enzyme binding,protein domain specific binding,MHC class II protein complex binding,ubiquitin protein ligase binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,protein heterodimerization activity,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","mitochondrion,cytosol,kinesin complex,cell-cell adherens junction,focal adhesion,membrane,axon,cytoplasmic vesicle membrane,melanosome,extracellular exosome",96,36,102,YLAEFATGNDRKEAAENSLVAYK.4|YLAEFATGNDRKEAAENSLVAYK.3|NLLSVAYKNVIGAR.3|NLLSVAYKNVIGAR.2|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.3|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.5|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.4|EAAENSLVAYK.2|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|LAEQAERYDEMVESMK.3|LAEQAERYDEMVESMK.2|LAEQAERYDEM[Oxi]VESM[Oxi]K.3|LAEQAERYDEM[Oxi]VESMK.3|LAEQAERYDEMVESM[Oxi]K.3|LAEQAERYDEM[Oxi]VESM[Oxi]K.2|LAEQAERYDEM[Oxi]VESMK.2|LAEQAERYDEMVESM[Oxi]K.2|LAEQAERYDEMVESMKK.4|LAEQAERYDEMVESMKK.3|LAEQAERYDEM[Oxi]VESM[Oxi]KK.4|LAEQAERYDEM[Oxi]VESMKK.4|LAEQAERYDEMVESM[Oxi]KK.4|LAEQAERYDEM[Oxi]VESMKK.3|LAEQAERYDEMVESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESMKK.2|LAEQAERYDEMVESM[Oxi]KK.2|LAEQAERYDEMVESMKK.2|YLAEFATGNDRK.3|YLAEFATGNDRK.2|LIC[CAM]C[CAM]DILDVLDK.2|LIC[CAM]C[CAM]DILDVLDK.3|VAGMDVELTVEERNLLSVAYKNVIGAR.4|VAGM[Oxi]DVELTVEERNLLSVAYKNVIGAR.4|VAGMDVELTVEERNLLSVAYKNVIGAR.3|HLIPAANTGESK.3|HLIPAANTGESK.2|EENKGGEDKLK.3|EENKGGEDKLK.2|YDEMVESMKK.3|YDEM[Oxi]VESMKK.3|YDEMVESM[Oxi]KK.3|YDEM[Oxi]VESM[Oxi]KK.3|YDEMVESMKK.2|YDEM[Oxi]VESMKK.2|YDEMVESM[Oxi]KK.2|YDEM[Oxi]VESM[Oxi]KK.2|KEAAENSLVAYK.3|KEAAENSLVAYK.2|AASDIAMTELPPTHPIR.4|AASDIAM[Oxi]TELPPTHPIR.4|AASDIAMTELPPTHPIR.3|AASDIAM[Oxi]TELPPTHPIR.3|AASDIAM[Oxi]TELPPTHPIR.2|AASDIAMTELPPTHPIR.2|IISSIEQK.2|IISSIEQKEENK.3|IISSIEQKEENK.2|IISSIEQKEENKGGEDK.4|IISSIEQKEENKGGEDK.3|IISSIEQKEENKGGEDK.2|EDLVYQAK.2|EDLVYQAK.1|QMVETELK.2|QM[Oxi]VETELK.2|QMVETELK.1|VAGM[Oxi]DVELTVEER.3|VAGMDVELTVEER.2|VAGM[Oxi]DVELTVEER.2|KVAGM[Oxi]DVELTVEER.3|KVAGMDVELTVEER.3|KVAGMDVELTVEER.2|KVAGM[Oxi]DVELTVEER.2|NLLSVAYKNVIGARR.3|YDEMVESMK.2|YDEM[Oxi]VESMK.2|YDEMVESM[Oxi]K.2|YDEM[Oxi]VESM[Oxi]K.2|YLAEFATGNDR.2|EALQDVEDENQ.2|HLIPAANTGESKVFYYK.3|DDREDLVYQAK.2|AAFDDAIAELDTLSEESYK.3|AAFDDAIAELDTLSEESYK.2|DNLTLWTSDM[Oxi]QGDGEEQNK.3|DNLTLWTSDMQGDGEEQNK.3|DNLTLWTSDM[Oxi]QGDGEEQNK.2|DNLTLWTSDMQGDGEEQNK.2|LGLALNFSVFYYEILNSPDR.3|LGLALNFSVFYYEILNSPDR.2|LAKAAFDDAIAELDTLSEESYK.3|AAFDDAIAELDTLSEESYKDSTLIMQLLR.4|AAFDDAIAELDTLSEESYKDSTLIMQLLR.3|QMVETELKLIC[CAM]C[CAM]DILDVLDK.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.3
SEN / CTL,Q14103,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,0.77,2.33,6.07E-01,4.43E-02,1.35E+00,"mRNA splicing, via spliceosome,liver development,transcription, DNA-templated,regulation of transcription, DNA-templated,RNA processing,RNA catabolic process,gene expression,cerebellum development,regulation of circadian rhythm,regulation of mRNA stability,positive regulation of translation,positive regulation of transcription, DNA-templated,mRNA stabilization,response to calcium ion,response to electrical stimulus,3'-UTR-mediated mRNA destabilization,cellular response to amino acid stimulus,cellular response to estradiol stimulus,cellular response to nitric oxide,circadian regulation of translation,response to rapamycin,response to sodium phosphate,cellular response to putrescine,hepatocyte dedifferentiation","nucleotide binding,AT DNA binding,chromatin binding,RNA binding,protein binding,transcription factor binding,mRNA 3'-UTR AU-rich region binding,telomeric DNA binding,histone deacetylase binding,poly(A) RNA binding","nucleus,nucleoplasm,cytosol,intracellular ribonucleoprotein complex,extracellular exosome",18,25,51,FGEVVDC[CAM]TLK.2|FGEVVDC[CAM]TLKLDPITGR.3|FGEVVDC[CAM]TLKLDPITGR.2|IFVGGLSPDTPEEK.2|IFVGGLSPDTPEEK.3|ESESVDKVMDQKEHK.4|ESESVDKVMDQKEHK.3|ESESVDKVMDQKEHK.2|ESESVDKVMDQK.3|ESESVDKVM[Oxi]DQK.3|ESESVDKVM[Oxi]DQK.2|ESESVDKVMDQK.2|GFC[CAM]FITFKEEEPVKK.4|GFC[CAM]FITFKEEEPVKK.3|GFC[CAM]FITFKEEEPVKK.2|YHNVGLSK.2|NEEDEGHSNSSPR.3|NEEDEGHSNSSPR.2|IDASKNEEDEGHSNSSPR.4|IDASKNEEDEGHSNSSPR.3|IDASKNEEDEGHSNSSPR.2|MFIGGLSWDTTKK.3|M[Oxi]FIGGLSWDTTKK.3|MFIGGLSWDTTKK.2|M[Oxi]FIGGLSWDTTKK.2|GFC[CAM]FITFK.2|HSEAATAQREEWK.3|HSEAATAQREEWK.2|KYHNVGLSK.2|KIFVGGLSPDTPEEK.3|KIFVGGLSPDTPEEK.2|GFGFVLFKESESVDK.3|GFGFVLFKESESVDK.2|GFGFVLFKESESVDKVMDQK.4|GFC[CAM]FITFKEEEPVK.3|GFC[CAM]FITFKEEEPVK.2|IFVGGLSPDTPEEKIR.3|RGFC[CAM]FITFKEEEPVK.3|M[Oxi]FIGGLSWDTTK.2|MFIGGLSWDTTK.2|IREYFGGFGEVESIELPMDNKTNK.4|IREYFGGFGEVESIELPM[Oxi]DNKTNK.4|IREYFGGFGEVESIELPMDNKTNK.3|EYFGGFGEVESIELPMDNK.3|EYFGGFGEVESIELPM[Oxi]DNK.3|EYFGGFGEVESIELPM[Oxi]DNK.2|EYFGGFGEVESIELPMDNK.2|EQYQQQQQWGSR.2|IREYFGGFGEVESIELPM[Oxi]DNK.3|IREYFGGFGEVESIELPMDNK.3|EYFGGFGEVESIELPMDNKTNK.3
SEN / CTL,Q14019,Coactosin-like protein,COTL1,0.77,2.15,5.31E-02,4.32E-03,2.36E+00,"biological_process,defense response to fungus","actin binding,enzyme binding","nucleus,cytoplasm,cytoskeleton,extracellular exosome",24,20,26,SKFALITWIGENVSGLQR.3|SKFALITWIGENVSGLQR.2|EFVISDR.2|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVR.3|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVR.4|FALITWIGENVSGLQR.3|FALITWIGENVSGLQR.2|AAYNLVR.2|EVVQNFAK.2|FTTGDAMSK.2|FTTGDAM[Oxi]SK.2|TGTDKTLVK.2|EFVISDRK.2|ELEEDFIK.2|ELEEDFIKSELKK.3|ELEEDFIKSELKK.2|AGGANYDAQTE.2|FTTGDAMSKR.2|KELEEDFIK.2|KAGGANYDAQTE.2|DDGSAVIWVTFK.2|TLVKEVVQNFAK.2|AAYNLVRDDGSAVIWVTFK.3|AAYNLVRDDGSAVIWVTFK.2|ELEEDFIKSELK.2|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVRLFAFVR.4
SEN / CTL,O43491,Band 4.1-like protein 2,EPB41L2,0.76,0.96,7.13E-02,5.69E-03,2.25E+00,"cortical actin cytoskeleton organization,actomyosin structure organization","actin binding,structural constituent of cytoskeleton,spectrin binding,PH domain binding","nucleus,nucleoplasm,plasma membrane,focal adhesion,spectrin,extrinsic component of membrane,cell junction,extracellular exosome,COP9 signalosome",6,68,99,IVITGDGDIDHDQALAQAIR.3|IVITGDGDIDHDQALAQAIR.2|EQHPDMSVTR.3|EQHPDMSVTR.2|VKETQEDKLEGGAAK.4|VKETQEDKLEGGAAK.3|VKETQEDKLEGGAAK.2|APHLQLIEGKK.3|SVHEGALK.2|TTEVGSVSEVKK.3|DSEGVDIK.2|QAKGDAEEMAQK.3|QASTLIDRPAPHFER.4|QASTLIDRPAPHFER.3|QASTLIDRPAPHFER.2|SYTLVVAK.2|EEKPSVSKEEKPSVSK.4|VC[CAM]VEHHTFYR.3|VC[CAM]VEHHTFYR.2|VEVKEEKPSVSK.3|ETQEDKLEGGAAK.3|ETQEDKLEGGAAK.2|KVEPVTQK.2|EVQTNELK.2|GDAEEMAQK.2|GDAEEM[Oxi]AQK.2|LVSPEQPPK.2|HQASISELK.2|SPTKAPHLQLIEGK.3|NSLRVEGDNIYVR.3|NSLRVEGDNIYVR.2|VITEEMNGK.2|HSNLMLEELDKAQEDILK.4|HSNLMLEELDKAQEDILK.3|VEGDNIYVR.2|RNFMESTPEPRPNEWEK.4|RNFM[Oxi]ESTPEPRPNEWEK.4|RNFMESTPEPRPNEWEK.3|APHLQLIEGK.2|GLSPAQADSQFLENAK.3|GLSPAQADSQFLENAK.2|GSQPPPAAESQSSLRR.3|YFLC[CAM]LQLR.2|DSSQLGTDATK.2|DYFGLLFQESPEQK.3|DYFGLLFQESPEQK.2|EEPLPEEQR.2|VEVKEEKPSVSKEEKPSVSK.4|VVVHKETELAEEGED.3|VVVHKETELAEEGED.2|EVPIVQTETK.2|RIVITGDGDIDHDQALAQAIR.4|RIVITGDGDIDHDQALAQAIR.3|VTLLDGTEYSC[CAM]DLEK.3|VTLLDGTEYSC[CAM]DLEK.2|FYPPDPSQLTEDITR.3|FYPPDPSQLTEDITR.2|VTEGTIREEQEYEEEVEEEPRPAAK.5|VTEGTIREEQEYEEEVEEEPRPAAK.4|VTEGTIREEQEYEEEVEEEPRPAAK.3|EISPGSGPGEIR.2|GLSPAQADSQFLENAKR.3|VRPAELEQFESTIGFK.3|VRPAELEQFESTIGFK.2|VRPAELEQFESTIGFKLPNHR.4|VEMQPTELVSK.2|VEM[Oxi]QPTELVSK.2|EVQTNELKAEK.2|EVAENQQNQSSDPEEEK.3|LGVC[CAM]ANGLLIYK.2|HSNLMLEELDK.2|HSNLM[Oxi]LEELDK.2|NFMESTPEPRPNEWEK.3|TEMVTISDASQR.2|TEM[Oxi]VTISDASQR.2|EPTQAVVEEQVLDKEEPLPEEQR.4|EPTQAVVEEQVLDKEEPLPEEQR.3|NLPWLFTFNVK.2|KEPTQAVVEEQVLDKEEPLPEEQR.4|KEPTQAVVEEQVLDKEEPLPEEQR.3|DFPGAAGEISAYGPGLVSIAVVQDGDGRR.4|DFPGAAGEISAYGPGLVSIAVVQDGDGRR.3|EEQEYEEEVEEEPRPAAK.3|VITEEMNGKEISPGSGPGEIR.3|GSQPPPAAESQSSLR.2|VVEREEAVPEASPVTQAGASVITVETVIQENVGAQK.5|VVEREEAVPEASPVTQAGASVITVETVIQENVGAQK.4|QDMGEEAEEEPQK.2|QDM[Oxi]GEEAEEEPQK.2|EKPKEVAENQQNQSSDPEEEKGSQPPPAAESQSSLR.5|PAELEQFESTIGFK.2|EEAVPEASPVTQAGASVITVETVIQENVGAQK.4|EEAVPEASPVTQAGASVITVETVIQENVGAQK.3|ITPLSLQTQGSSHETLNIVEEK.3|SLDGAPIGVMDQSLMK.2|EVAENQQNQSSDPEEEKGSQPPPAAESQSSLRR.4|VNGEVSHVDIDVLPQIIC[CAM]C[CAM]SEPPVVK.3|TITYESPQIDGGAGGDSGTLLTAQTITSESVSTTTTTHITK.4|VVEREEAVPEASPVTQAGASVITVETVIQENVGAQKIPGEK.4
SEN / CTL,P18206,Vinculin,VCL,0.76,2.03,2.45E-16,9.47E-17,1.60E+01,"morphogenesis of an epithelium,platelet degranulation,movement of cell or subcellular component,muscle contraction,cell adhesion,cell-matrix adhesion,lamellipodium assembly,negative regulation of cell migration,adherens junction assembly,protein localization to cell surface,apical junction assembly,axon extension,platelet aggregation,epithelial cell-cell adhesion","dystroglycan binding,actin binding,structural molecule activity,protein binding,beta-catenin binding,ubiquitin protein ligase binding,alpha-catenin binding,cadherin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,plasma membrane,cell-cell junction,adherens junction,cell-cell adherens junction,fascia adherens,focal adhesion,actin cytoskeleton,cell-substrate junction,costamere,protein complex,extracellular exosome,extracellular vesicle",186,102,192,VGKETVQTTEDQILKR.4|VGKETVQTTEDQILKR.3|VGKETVQTTEDQILKR.2|WIDNPTVDDRGVGQAAIR.3|AIPDLTAPVAAVQAAVSNLVR.3|AIPDLTAPVAAVQAAVSNLVR.2|MSAEINEIIR.2|M[Oxi]SAEINEIIR.2|VLQLTSWDEDAWASKDTEAMKR.4|GWLRDPSASPGDAGEQAIR.3|GWLRDPSASPGDAGEQAIR.2|STVEGIQASVK.2|ALASQLQDSLKDLK.3|ALASQLQDSLKDLK.2|LVQAAQMLQSDPYSVPARDYLIDGSR.3|LVQAAQMLQSDPYSVPARDYLIDGSR.4|LVQAAQM[Oxi]LQSDPYSVPARDYLIDGSR.3|ELTPQVVSAAR.2|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.4|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.3|MLGQMTDQVADLR.2|MLGQMTDQVADLR.3|M[Oxi]LGQM[Oxi]TDQVADLR.2|M[Oxi]LGQMTDQVADLR.2|MLGQM[Oxi]TDQVADLR.2|LLAVAATAPPDAPNREEVFDER.3|LLAVAATAPPDAPNREEVFDER.4|LLAVAATAPPDAPNREEVFDER.2|GILSGTSDLLLTFDEAEVRK.3|GILSGTSDLLLTFDEAEVRK.4|GILSGTSDLLLTFDEAEVRK.2|ELLPVLISAMK.2|ELLPVLISAM[Oxi]K.2|TDAGFTLR.2|MALLMAEMSR.2|M[Oxi]ALLMAEMSR.2|MALLM[Oxi]AEMSR.2|C[CAM]DRVDQLTAQLADLAAR.3|C[CAM]DRVDQLTAQLADLAAR.4|C[CAM]DRVDQLTAQLADLAAR.2|MTGLVDEAIDTK.2|MTGLVDEAIDTK.3|M[Oxi]TGLVDEAIDTK.2|VAMANIQPQMLVAGATSIAR.2|VAMANIQPQMLVAGATSIAR.3|VAM[Oxi]ANIQPQMLVAGATSIAR.3|VAMANIQPQM[Oxi]LVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.2|VAM[Oxi]ANIQPQMLVAGATSIAR.2|VAMANIQPQM[Oxi]LVAGATSIAR.2|MQEAMTQEVSDVFSDTTTPIK.3|M[Oxi]QEAMTQEVSDVFSDTTTPIK.3|M[Oxi]QEAMTQEVSDVFSDTTTPIK.2|MQEAM[Oxi]TQEVSDVFSDTTTPIK.2|MQEAMTQEVSDVFSDTTTPIK.2|AQQVSQGLDVLTAKVENAAR.3|AQQVSQGLDVLTAKVENAAR.2|KIDAAQNWLADPNGGPEGEEQIR.3|KIDAAQNWLADPNGGPEGEEQIR.4|QILDEAGKVGELC[CAM]AGK.3|QILDEAGKVGELC[CAM]AGK.2|RMALLMAEMSR.3|RMALLMAEMSR.2|AAAVGTANK.2|ALASIDSK.2|ALIQC[CAM]AK.2|REVENSEDPK.3|REVENSEDPK.2|AAVHLEGK.2|ALIQC[CAM]AKDIAK.3|NLGPGMTK.2|GLVAEGHR.2|VGELC[CAM]AGK.2|AVAGNISDPGLQK.3|AVAGNISDPGLQK.2|NQGIEEALKNR.3|NQGIEEALKNR.2|ETVREAEAASIK.3|ETVREAEAASIK.2|GNDIIAAAK.2|QQELTHQEHR.3|QQELTHQEHR.2|SLLDASEEAIKK.3|SLLDASEEAIKK.2|AANFENHSGKLGATAEK.4|AANFENHSGKLGATAEK.3|ALASQLQDSLKDLKAR.4|ALASQLQDSLKDLKAR.3|EVENSEDPKFR.3|EVENSEDPKFR.2|IAELC[CAM]DDPKER.3|IAELC[CAM]DDPKER.2|ALASIDSKLNQAK.3|ALASIDSKLNQAK.2|EEVFDER.2|GEGESPQAR.2|DYLIDGSR.2|SFLDSGYR.2|RALASIDSK.2|RALIQC[CAM]AK.2|AQQVSQGLDVLTAK.3|AQQVSQGLDVLTAK.2|IAELC[CAM]DDPKERDDILR.4|IAELC[CAM]DDPKERDDILR.3|MIDERQQELTHQEHR.4|DPSASPGDAGEQAIR.3|DPSASPGDAGEQAIR.2|KIAELC[CAM]DDPKER.3|KIAELC[CAM]DDPKER.2|LLAVAATAPPDAPNR.3|LLAVAATAPPDAPNR.2|LVQAAQMLQSDPYSVPAR.4|LVQAAQMLQSDPYSVPAR.3|LVQAAQM[Oxi]LQSDPYSVPAR.3|LVQAAQM[Oxi]LQSDPYSVPAR.2|LVQAAQMLQSDPYSVPAR.2|QILDEAGKVGELC[CAM]AGKER.4|QILDEAGKVGELC[CAM]AGKER.3|VDQLTAQLADLAAR.3|VDQLTAQLADLAAR.2|IPTISTQLK.2|NQGIEEALK.2|AGEVINQPMMMAAR.3|AGEVINQPMMMAAR.2|AGEVINQPM[Oxi]MMAAR.2|AGEVINQPMM[Oxi]MAAR.2|AGEVINQPMMM[Oxi]AAR.2|AGEVINQPM[Oxi]M[Oxi]M[Oxi]AAR.2|AAVHLEGKIEQAQR.3|DEEFPEQK.2|KLEAMTNSK.2|ETVQTTEDQILKR.3|ETVQTTEDQILKR.2|EVENSEDPK.2|IAELC[CAM]DDPK.2|AANFENHSGK.2|GQGSSPVAMQK.2|GQGSSPVAM[Oxi]QK.2|SLGEISALTSK.2|TISPMVMDAK.2|ILLRNPGNQAAYEHFETMK.4|TNLLQVC[CAM]ER.2|NQWIDNVEK.2|IRTDAGFTLR.2|LANVMMGPYR.2|LANVM[Oxi]MGPYR.2|LANVMM[Oxi]GPYR.2|NPGNQAAYEHFETMK.3|NPGNQAAYEHFETM[Oxi]K.3|NPGNQAAYEHFETMK.2|ALASQLQDSLK.2|VLQLTSWDEDAWASK.3|VLQLTSWDEDAWASK.2|KIAELC[CAM]DDPK.2|SLLDASEEAIK.2|SLLDASEEAIKKDLDK.3|LANVMMGPYRQDLLAK.3|LANVM[Oxi]MGPYRQDLLAK.3|LANVMM[Oxi]GPYRQDLLAK.3|LANVMMGPYRQDLLAK.2|WIDNPTVDDR.2|VMLVNSMNTVK.2|VM[Oxi]LVNSMNTVK.2|VMLVNSM[Oxi]NTVK.2|VM[Oxi]LVNSM[Oxi]NTVK.2|AAAVGTANKSTVEGIQASVK.3|QVATALQNLQTK.2|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.6|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.5|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.4|VREAFQPQEPDFPPPPPDLEQLR.4|VREAFQPQEPDFPPPPPDLEQLR.3|GILSGTSDLLLTFDEAEVR.3|GILSGTSDLLLTFDEAEVR.2|LLAVAATAPPDAPNREEVFDERAANFENHSGK.5|ETVQTTEDQILK.2|TNLLQVC[CAM]ERIPTISTQLK.3|LTDELAPPKPPLPEGEVPPPRPPPPEEK.4|LTDELAPPKPPLPEGEVPPPRPPPPEEK.3|TNISDEESEQATEMLVHNAQNLMQSVK.4|TNISDEESEQATEM[Oxi]LVHNAQNLMQSVK.3|TNISDEESEQATEMLVHNAQNLM[Oxi]QSVK.3|TNISDEESEQATEMLVHNAQNLMQSVK.3|TIESILEPVAQQISHLVIMHEEGEVDGK.4|TIESILEPVAQQISHLVIM[Oxi]HEEGEVDGK.4|TIESILEPVAQQISHLVIMHEEGEVDGK.3|IDAAQNWLADPNGGPEGEEQIR.3|IDAAQNWLADPNGGPEGEEQIR.2|KIDAAQNWLADPNGGPEGEEQIRGALAEAR.4|EAFQPQEPDFPPPPPDLEQLR.3|VLQLTSWDEDAWASKDTEAMK.3
SEN / CTL,O76061,Stanniocalcin-2,STC2,0.76,2.82,1.04E-01,8.15E-03,2.09E+00,"cellular calcium ion homeostasis,response to oxidative stress,embryo implantation,negative regulation of gene expression,endoplasmic reticulum unfolded protein response,response to vitamin D,negative regulation of multicellular organism growth,response to peptide hormone,decidualization,regulation of hormone biosynthetic process,cellular response to hypoxia,regulation of store-operated calcium entry","hormone activity,enzyme binding,heme binding,protein homodimerization activity","extracellular space,endoplasmic reticulum,Golgi apparatus,perinuclear region of cytoplasm",12,2,2,VIVEMIHFK.2|HDLC[CAM]AAAQENTR.2
SEN / CTL,Q86VP6,Cullin-associated NEDD8-dissociated protein 1,CAND1,0.76,1.56,1.20E-02,1.02E-03,2.99E+00,"SCF complex assembly,protein ubiquitination,cell differentiation,negative regulation of catalytic activity,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly","protein binding,TBP-class protein binding","ubiquitin ligase complex,nucleus,nucleoplasm,cytoplasm,Golgi apparatus,membrane,cullin-RING ubiquitin ligase complex,extracellular exosome",12,81,119,NVVAEC[CAM]LGK.2|EGPAVVGQFIQDVK.2|HC[CAM]EC[CAM]AEEGTR.3|HC[CAM]EC[CAM]AEEGTR.2|AADIDQEVKER.3|HTVDDGLDIRK.3|IGEYLEK.2|DSIKLDDDSER.3|DSIKLDDDSER.2|TYIQC[CAM]IAAISR.3|TYIQC[CAM]IAAISR.2|AVAALLTIPEAEK.3|AVAALLTIPEAEK.2|C[CAM]LGPLVSK.2|TLEDPDLNVRR.3|ANSVKQEFEKQDELK.4|ANSVKQEFEKQDELK.3|ADVFHAYLSLLK.3|ADVFHAYLSLLK.2|EVEMGPFK.2|LKGYLISGSSYAR.3|TVSPALISR.2|DSIKLDDDSERK.3|NC[CAM]IGDFLK.2|QEFEKQDELKR.3|QSYYSIAK.2|VALVTFNSAAHNKPSLIR.4|VALVTFNSAAHNKPSLIR.3|AADIDQEVK.2|EENVKADVFHAYLSLLK.4|EENVKADVFHAYLSLLK.3|ISGSILNELIGLVR.3|ISGSILNELIGLVR.2|DLFTC[CAM]TIK.2|LKAADIDQEVKER.3|C[CAM]LDAVVSTR.2|IDLRPVLGEGVPILASFLR.4|IDLRPVLGEGVPILASFLR.3|IDLRPVLGEGVPILASFLR.2|ITSEALLVTQQLVK.3|ITSEALLVTQQLVK.2|VIRPLDQPSSFDATPYIK.4|VIRPLDQPSSFDATPYIK.3|VIRPLDQPSSFDATPYIK.2|IGEYLEKIIPLVVK.3|NGEVQNLAVK.2|ALTLIAGSPLK.2|SVILEAFSSPSEEVK.3|SVILEAFSSPSEEVK.2|C[CAM]LDAVVSTRHEMLPEFYK.4|IDLRPVLGEGVPILASFLRK.4|IDLRPVLGEGVPILASFLRK.3|LLEDKNGEVQNLAVK.3|LLEDKNGEVQNLAVK.2|MLTFLMLVR.2|M[Oxi]LTFLMLVR.2|MLTFLM[Oxi]LVR.2|M[Oxi]LTFLM[Oxi]LVR.2|FTISDHPQPIDPLLK.3|FTISDHPQPIDPLLK.2|HTVDDGLDIR.2|MLTGPVYSQSTALTHK.3|M[Oxi]LTGPVYSQSTALTHK.3|MLTGPVYSQSTALTHK.2|GYLISGSSYAR.2|TLEDPDLNVR.2|ANSVKQEFEK.2|DLLDTVLPHLYNETK.3|DLLDTVLPHLYNETK.2|EVYPHVSTIINIC[CAM]LK.3|EVYPHVSTIINIC[CAM]LK.2|HEMLPEFYK.2|HEM[Oxi]LPEFYK.2|LDIFEFLNHVEDGLK.3|LDIFEFLNHVEDGLK.2|LKAADIDQEVK.2|LLALLSLGEVGHHIDLSGQLELK.4|VALVTFNSAAHNKPSLIRDLLDTVLPHLYNETK.6|LGTLSALDILIK.2|VIRPLDQPSSFDATPYIKDLFTC[CAM]TIKR.5|FC[CAM]NVDDDELR.2|FTISDHPQPIDPLLKNC[CAM]IGDFLK.4|QGGLLVNFHPSILTC[CAM]LLPQLTSPR.4|QGGLLVNFHPSILTC[CAM]LLPQLTSPR.3|LSTLC[CAM]PSAVLQR.2|DSSSTNLESMDTS.2|DSSSTNLESM[Oxi]DTS.2|EQLRDISSIGLK.2|TVIGELPPASSGSALAANVC[CAM]K.3|TVIGELPPASSGSALAANVC[CAM]K.2|LTLIDPETLLPR.2|ELIREVEMGPFK.2|SPLMSEFQSQISSNPELAAIFESIQK.4|SPLM[Oxi]SEFQSQISSNPELAAIFESIQK.3|SPLMSEFQSQISSNPELAAIFESIQK.3|TVIGELPPASSGSALAANVC[CAM]KK.3|PYVENIWALLLK.2|EYQVETIVDTLC[CAM]TNMLSDK.3|EYQVETIVDTLC[CAM]TNMLSDK.2|QEDVSVQLEALDIMADMLSR.3|QEDVSVQLEALDIMADMLSR.2|VKEYQVETIVDTLC[CAM]TNMLSDKEQLR.4|IDALSC[CAM]LYVILC[CAM]NHSPQVFHPHVQALVPPVVAC[CAM]VGDPFYK.6|IDALSC[CAM]LYVILC[CAM]NHSPQVFHPHVQALVPPVVAC[CAM]VGDPFYK.5|VIRPLDQPSSFDATPYIKDLFTC[CAM]TIK.4|EYC[CAM]IQAFESFVR.2|FMATNDLMTELQK.2|FM[Oxi]ATNDLMTELQK.2|FMATNDLM[Oxi]TELQK.2|NVVAEC[CAM]LGKLTLIDPETLLPR.3|PVLGEGVPILASFLR.2|VKEYQVETIVDTLC[CAM]TNMLSDK.3|EIISSASVVGLKPYVENIWALLLK.3|EYQVETIVDTLC[CAM]TNMLSDKEQLR.3|FC[CAM]NVDDDELREYC[CAM]IQAFESFVR.3|AAFEC[CAM]MYTLLDSC[CAM]LDR.2|QTRPVQSWLC[CAM]DPDAMEQGETPLTMLQSQVPNIVK.4|AVAALLTIPEAEKSPLM[Oxi]SEFQSQISSNPELAAIFESIQK.4|AVAALLTIPEAEKSPLMSEFQSQISSNPELAAIFESIQK.4
SEN / CTL,P07585,Decorin,DCN,0.74,2.43,6.38E-01,4.64E-02,1.33E+00,"kidney development,placenta development,negative regulation of protein kinase activity,skeletal muscle tissue development,aging,response to mechanical stimulus,animal organ morphogenesis,positive regulation of autophagy,negative regulation of endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of macroautophagy,negative regulation of angiogenesis,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,response to lipopolysaccharide,wound healing,positive regulation of transcription from RNA polymerase II promoter,negative regulation of JAK-STAT cascade,positive regulation of mitochondrial depolarization,positive regulation of mitochondrial fission,negative regulation of vascular endothelial growth factor signaling pathway","protein kinase inhibitor activity,protein binding,collagen binding,glycosaminoglycan binding,poly(A) RNA binding,protein N-terminus binding,extracellular matrix binding","extracellular region,collagen type VI trimer,extracellular space,cytoplasm,Golgi lumen,lysosomal lumen,extracellular matrix",84,22,33,VSPGAFTPLVKLER.3|NLHALILVNNKISK.3|NLHALILVNNK.3|NLHALILVNNK.2|KASYSGVSLFSNPVQYWEIQPSTFR.3|KASYSGVSLFSNPVQYWEIQPSTFR.4|KASYSGVSLFSNPVQYWEIQPSTFR.5|ASYSGVSLFSNPVQYWEIQPSTFR.3|VSPGAFTPLVK.2|KVTFNGLNQMIVIELGTNPLK.3|VVQC[CAM]SDLGLDKVPK.3|VVQC[CAM]SDLGLDKVPK.2|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.4|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.3|VDAASLKGLNNLAK.3|VDAASLKGLNNLAK.2|LTRVPGGLAEHK.3|VPGGLAEHK.2|AHENEITK.2|ELHLDNNK.2|SAIQLGNYK.2|DLPPDTTLLDLQNNK.3|DLPPDTTLLDLQNNK.2|TLQELRAHENEITK.3|ITEIKDGDFK.2|VVQC[CAM]SDLGLDK.2|SSGIENGAFQGMK.2|SSGIENGAFQGM[Oxi]K.2|VTFNGLNQMIVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.2|VTFNGLNQMIVIELGTNPLK.2|LGLSFNSISAVDNGSLANTPHLR.3
SEN / CTL,O43707,Alpha-actinin-4,ACTN4,0.72,2.05,1.47E-16,5.89E-17,1.62E+01,"response to hypoxia,platelet degranulation,protein transport,vesicle transport along actin filament,positive regulation of cell migration,positive regulation of sodium:proton antiporter activity,peroxisome proliferator activated receptor signaling pathway,regulation of apoptotic process,retinoic acid receptor signaling pathway,positive regulation of pinocytosis,actin filament bundle assembly,negative regulation of cellular component movement,positive regulation of cellular component movement,bicellular tight junction assembly,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,protein localization to bicellular tight junction,regulation of nucleic acid-templated transcription","RNA polymerase II regulatory region sequence-specific DNA binding,nucleoside binding,actin binding,integrin binding,calcium ion binding,protein binding,ligand-dependent nuclear receptor transcription coactivator activity,chromatin DNA binding,nuclear hormone receptor binding,protein homodimerization activity,retinoic acid receptor binding,ion channel binding,poly(A) RNA binding,protein N-terminus binding,actin filament binding","stress fiber,extracellular region,extracellular space,intracellular,nucleus,cytoplasm,brush border,cell-cell junction,focal adhesion,Z disc,intracellular ribonucleoprotein complex,cortical cytoskeleton,platelet alpha granule lumen,pseudopodium,neuron projection,protein complex,perinuclear region of cytoplasm,extracellular exosome,actin cytoskeleton",204,85,170,C[CAM]QLEINFNTLQTK.2|C[CAM]QLEINFNTLQTK.3|VGWEQLLTTIAR.2|VGWEQLLTTIAR.3|VLAGDKNFITAEELRR.4|VLAGDKNFITAEELRR.3|TINEVENQILTR.2|TINEVENQILTR.3|VLAVNQENEHLMEDYEKLASDLLEWIR.4|MAPYQGPDAVPGALDYK.2|MAPYQGPDAVPGALDYK.3|M[Oxi]APYQGPDAVPGALDYK.3|M[Oxi]APYQGPDAVPGALDYK.2|ETTDTDTADQVIASFK.2|ETTDTDTADQVIASFK.3|ELPPDQAEYC[CAM]IAR.2|ELPPDQAEYC[CAM]IAR.3|GYEEWLLNEIR.2|GYEEWLLNEIR.3|LSGSNPYTTVTPQIINSKWEK.3|VLAVNQENEHLMEDYEKLASDLLEWIRR.5|VLAVNQENEHLM[Oxi]EDYEKLASDLLEWIRR.5|VLAVNQENEHLMEDYEKLASDLLEWIRR.4|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.7|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.6|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.5|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.4|AC[CAM]LISLGYDVENDRQGEAEFNR.3|AC[CAM]LISLGYDVENDRQGEAEFNR.4|LASDLLEWIR.2|LASDLLEWIR.3|IC[CAM]DQWDALGSLTHSR.3|IC[CAM]DQWDALGSLTHSR.2|LSGSNPYTTVTPQIINSK.2|LSGSNPYTTVTPQIINSK.3|FAIQDISVEETSAK.2|FAIQDISVEETSAK.3|AIMTYVSSFYHAFSGAQK.3|AIMTYVSSFYHAFSGAQK.4|AIM[Oxi]TYVSSFYHAFSGAQK.3|AIMTYVSSFYHAFSGAQK.2|AIM[Oxi]TYVSSFYHAFSGAQK.2|IMSLVDPNHSGLVTFQAFIDFMSR.3|IMSLVDPNHSGLVTFQAFIDFMSR.4|IM[Oxi]SLVDPNHSGLVTFQAFIDFMSR.3|NVNVQNFHISWK.3|NVNVQNFHISWK.2|QFASQANVVGPWIQTK.2|QFASQANVVGPWIQTK.3|IC[CAM]DQWDALGSLTHSRR.4|IC[CAM]DQWDALGSLTHSRR.3|LMLLLEVISGER.2|LM[Oxi]LLLEVISGER.2|AGTQIENIDEDFRDGLK.3|AGTQIENIDEDFRDGLK.2|KAGTQIENIDEDFRDGLK.4|KAGTQIENIDEDFRDGLK.3|LASDLLEWIRR.3|LASDLLEWIRR.2|VQQLVPK.2|DGLAFNALIHR.3|DGLAFNALIHR.2|DHGGALGPEEFK.3|DHGGALGPEEFK.2|NFITAEELRR.3|HRPELIEYDK.3|HRPELIEYDK.2|ASFNHFDKDHGGALGPEEFK.5|ASFNHFDKDHGGALGPEEFK.4|ASFNHFDKDHGGALGPEEFK.3|RDHALLEEQSK.3|RDHALLEEQSK.2|TEKQLEAIDQLHLEYAKR.5|TEKQLEAIDQLHLEYAKR.4|ASIHEAWTDGKEAMLK.4|ASIHEAWTDGKEAMLK.3|EAILAIHK.2|GISQEQMQEFR.3|GISQEQMQEFR.2|GISQEQM[Oxi]QEFR.2|IAESNHIK.2|QLEAIDQLHLEYAKR.4|QLEAIDQLHLEYAKR.3|QLEAIDQLHLEYAKR.2|DHALLEEQSKQQSNEHLRR.5|DHALLEEQSKQQSNEHLRR.4|RDHALLEEQSKQQSNEHLR.5|RDHALLEEQSKQQSNEHLR.4|ASFNHFDK.2|LSNRPAFM[Oxi]PSEGK.3|LSNRPAFMPSEGK.3|LSNRPAFM[Oxi]PSEGK.2|LSNRPAFMPSEGK.2|TIPWLEDRVPQK.3|TIPWLEDRVPQK.2|TIQEMQQK.2|TIQEM[Oxi]QQK.2|LVSIGAEEIVDGNAK.3|LVSIGAEEIVDGNAK.2|QQSNEHLR.2|TEKQLEAIDQLHLEYAK.4|TEKQLEAIDQLHLEYAK.3|HRDYETATLSDIK.3|HRDYETATLSDIK.2|HRPELIEYDKLR.3|HRPELIEYDKLR.2|LMLLLEVISGERLPKPER.4|LM[Oxi]LLLEVISGERLPKPER.4|LMLLLEVISGERLPKPER.3|NVNVQNFHISWKDGLAFNALIHR.5|NVNVQNFHISWKDGLAFNALIHR.4|NVNVQNFHISWKDGLAFNALIHR.3|AC[CAM]LISLGYDVENDR.3|AC[CAM]LISLGYDVENDR.2|DHALLEEQSKQQSNEHLR.4|KAGTQIENIDEDFR.3|LRKDDPVTNLNNAFEVAEK.4|LRKDDPVTNLNNAFEVAEK.3|LRKDDPVTNLNNAFEVAEK.2|TAPYKNVNVQNFHISWKDGLAFNALIHR.6|NFITAEELR.2|RTIPWLEDRVPQK.3|QLEAIDQLHLEYAK.3|QLEAIDQLHLEYAK.2|VLAGDKNFITAEELR.3|VLAGDKNFITAEELR.2|DHALLEEQSK.2|DDPVTNLNNAFEVAEK.3|DDPVTNLNNAFEVAEK.2|MLDAEDIVNTARPDEK.3|M[Oxi]LDAEDIVNTARPDEK.3|M[Oxi]LDAEDIVNTARPDEK.2|MLDAEDIVNTARPDEK.2|DYETATLSDIK.2|ISIEMNGTLEDQLSHLKQYER.4|ISIEMNGTLEDQLSHLKQYER.3|KDDPVTNLNNAFEVAEK.3|KDDPVTNLNNAFEVAEK.2|ISIEMNGTLEDQLSHLK.3|ISIEM[Oxi]NGTLEDQLSHLK.3|ISIEMNGTLEDQLSHLK.2|RQFASQANVVGPWIQTK.3|SFSTALYGESDL.2|IAESNHIKLSGSNPYTTVTPQIINSKWEK.5|KDDPVTNLNNAFEVAEKYLDIPK.4|KDDPVTNLNNAFEVAEKYLDIPK.3|PNLDLLEQQHQLIQEALIFDNK.4|PNLDLLEQQHQLIQEALIFDNK.3|MVSDINNGWQHLEQAEK.3|M[Oxi]VSDINNGWQHLEQAEK.3|MVSDINNGWQHLEQAEK.2|M[Oxi]VSDINNGWQHLEQAEK.2|SIVDYKPNLDLLEQQHQLIQEALIFDNK.5|SIVDYKPNLDLLEQQHQLIQEALIFDNK.4|SIVDYKPNLDLLEQQHQLIQEALIFDNK.3|MLDAEDIVNTAR.2|QKASIHEAWTDGKEAMLK.3|VLAVNQENEHLM[Oxi]EDYEK.3|VLAVNQENEHLMEDYEK.3|VLAVNQENEHLMEDYEK.2|IAESNHIKLSGSNPYTTVTPQIINSK.4|VEQIAAIAQELNELDYYDSHNVNTR.4|VEQIAAIAQELNELDYYDSHNVNTR.3|AGTQIENIDEDFR.2|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.6|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.5|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.4|SIVDYKPNLDLLEQQHQLIQEALIFDNKHTNYTMEHIR.6|DDPVTNLNNAFEVAEKYLDIPK.3|M[Oxi]VSDINNGWQHLEQAEKGYEEWLLNEIR.4
SEN / CTL,Q7Z406,Myosin-14,MYH14,0.71,1.26,6.51E-01,4.72E-02,1.33E+00,"skeletal muscle contraction,skeletal muscle tissue development,sensory perception of sound,regulation of cell shape,neuronal action potential,actin filament-based movement,actomyosin structure organization,mitochondrion morphogenesis,vocalization behavior","microfilament motor activity,calmodulin binding,ATP binding,actin-dependent ATPase activity,actin filament binding","stress fiber,cytosol,brush border,membrane,myosin II complex,axon,growth cone,actomyosin,myelin sheath,extracellular exosome,myosin II filament",6,131,182,AQTKEQADFALEALAK.3|AQTKEQADFALEALAK.2|DAEVERDEER.3|LVLDQLR.2|GLEAEVLR.2|AQLGRKEEELQAALAR.4|AQLGRKEEELQAALAR.3|AQLGRKEEELQAALAR.2|GPLTFTTR.2|TSREEIFSQNR.3|TSREEIFSQNR.2|DLQGRDEAGEER.3|DLQGRDEAGEER.2|EAEALTQR.2|EVVLQVEEERR.3|EVVLQVEEERR.2|HLRDQADFSVLHYAGK.4|HLRDQADFSVLHYAGK.3|HLRDQADFSVLHYAGK.2|LGEEDAGAR.2|ALRAELEALLSSK.3|RLQQHIQELEAHLEAEEGAR.5|RLQQHIQELEAHLEAEEGAR.4|RLQQHIQELEAHLEAEEGAR.3|VIQYLAHVASSPK.3|VIQYLAHVASSPK.2|HGQALGELAEQLEQARR.4|HGQALGELAEQLEQARR.3|ILFQEFR.2|ALRAELEALLSSKDDVGK.4|ALRAELEALLSSKDDVGK.3|DQADFSVLHYAGK.3|DQADFSVLHYAGK.2|MTIAALESK.2|QDEVLQAR.2|RQLEEAEEEASR.3|RQLEEAEEEASR.2|RLELQLQEVQGR.3|RLELQLQEVQGR.2|VAQLEEER.2|ADLLLEPC[CAM]SHYR.3|ADLLLEPC[CAM]SHYR.2|RHEVPPHVYAVTEGAYR.4|RHEVPPHVYAVTEGAYR.3|TRLALEAEVSELR.3|AQMASAGQGKEEAVK.3|AQM[Oxi]ASAGQGKEEAVK.3|AQMASAGQGKEEAVK.2|C[CAM]IVPNHEK.2|AMEAEAAGLR.2|AM[Oxi]EAEAAGLR.2|TLEEETRIHEAAVQELR.4|TLEEETRIHEAAVQELR.3|TQHERDLQGRDEAGEER.4|LAQAEEQLEQETR.3|LAQAEEQLEQETR.2|AGVLAQLEEERDLK.3|AGVLAQLEEERDLK.2|LAEFSSQAAEEEEK.3|LAEFSSQAAEEEEK.2|LAEKTETVDRLER.3|LKYEATIADMEDR.3|AELEALLSSK.2|AELEALLSSKDDVGK.3|KRHEVPPHVYAVTEGAYR.4|YEATIADMEDRLR.3|AELSSLQTAR.2|ALEEEQEAR.2|ELEDVTESAESMNR.3|ELEDVTESAESMNR.2|KTLEEETRIHEAAVQELR.4|NTDQATMPDNTAAQK.3|NTDQATMPDNTAAQK.2|NTDQATM[Oxi]PDNTAAQK.2|RRLELQLQEVQGR.3|VAEQAANDLR.2|VLGFSHEEIISMLR.3|EQEVTELKK.2|KQELELVVSELEAR.3|LQQHIQELEAHLEAEEGAR.4|LQQHIQELEAHLEAEEGAR.3|VGEEEEC[CAM]SR.2|AEAELC[CAM]AEAEETRGR.3|LQEELAASDR.2|EQLEEEAAAR.2|KAPPRPGPVPEAAQPFLFTPR.4|ALEEEQEAREELER.3|DEC[CAM]SFHIFYQLLGGAGEQLK.4|DEC[CAM]SFHIFYQLLGGAGEQLK.3|DEC[CAM]SFHIFYQLLGGAGEQLK.2|QLPIYTEAIVEMYR.3|QLPIYTEAIVEMYR.2|HGQALGELAEQLEQAR.3|HGQALGELAEQLEQAR.2|IHEAAVQELR.2|RQEEEAGALEAGEEAR.3|KLEGELEELK.2|LLGLGVTDFSR.2|VQELQQQSAR.2|LAEFSSQAAEEEEKVK.3|LAEQLRAEAELC[CAM]AEAEETRGR.4|AGVLAQLEEER.2|ELSSTEAQLHDAQELLQEETR.4|ELSSTEAQLHDAQELLQEETR.3|KFEEDLLLLEDQNSK.3|LLLQVESLTTELSAER.3|LLLQVESLTTELSAER.2|AGRELQTAQAQLSEWR.3|AQVTELEDELTAAEDAK.3|AQVTELEDELTAAEDAK.2|EVVLQVEEER.2|HEVPPHVYAVTEGAYR.3|LALEAEVSELR.2|LQQLFNHTMFVLEQEEYQR.4|LQQLFNHTM[Oxi]FVLEQEEYQR.4|LQQLFNHTMFVLEQEEYQR.3|LQQLFNHTM[Oxi]FVLEQEEYQR.3|RRLDGESSELQEQMVEQQQR.4|AQAELENVSGALNEAESK.3|AQAELENVSGALNEAESK.2|EAQAALAEAQEDLESER.3|EAQAALAEAQEDLESER.2|ERNTDQATMPDNTAAQK.3|LRLEVTVQALK.2|LVWVPSELHGFEAAALR.3|RQEEEAGALEAGEEARR.3|RRQEEEAGALEAGEEAR.3|SLREAQAALAEAQEDLESERVAR.4|TRLALEAEVSELRAELSSLQTAR.4|TRLALEAEVSELRAELSSLQTAR.3|AEDMAELTC[CAM]LNEASVLHNLRER.4|GELEDTLDSTNAQQELR.3|GELEDTLDSTNAQQELR.2|LQQELDDATMDLEQQR.3|LQQELDDATMDLEQQR.2|QLEEAEEEASR.2|EQADFALEALAK.2|GPSAGGGPGSGTSPQVEWTAR.3|GPSAGGGPGSGTSPQVEWTAR.2|LELQLQEVQGR.2|VADQLRDQLEK.2|YEATIADMEDR.2|YEATIADM[Oxi]EDR.2|FSKAEDMAELTC[CAM]LNEASVLHNLR.4|GLEAEVLRLQEELAASDR.3|ELFQETLESLR.2|RLVWVPSELHGFEAAALR.3|VTDIIVSFQAAAR.2|NMDPLNDNVAALLHQSTDR.3|AM[Oxi]EAEAAGLREQLEEEAAAR.3|AMEAEAAGLREQLEEEAAAR.3|APPRPGPVPEAAQPFLFTPR.3|PANPPGLLALLDEEC[CAM]WFPK.3|PANPPGLLALLDEEC[CAM]WFPK.2|EAQAALAEAQEDLESERVAR.3|LGQLEEELEEEQSNSELLNDRYRK.4|LLEDRLAEFSSQAAEEEEK.3|AEAELC[CAM]AEAEETR.2|FLTNGPSSSPGQER.2|MVSAVLQFGNIALK.2|M[Oxi]VSAVLQFGNIALK.2|QAQQDRDEMADEVANGNLSK.3|SLREAQAALAEAQEDLESER.3|DEMADEVANGNLSK.2|LVWVPSELHGFEAAALRDEGEEEAEVELAESGRR.5|AEDMAELTC[CAM]LNEASVLHNLR.3|LALEAEVSELRAELSSLQTAR.3|RLDGESSELQEQMVEQQQR.3|LMATLSNTNPSFVR.2|LM[Oxi]ATLSNTNPSFVR.2|ELQTAQAQLSEWR.2|MIQALELDPNLYR.2|M[Oxi]IQALELDPNLYR.2|RQAQQDRDEMADEVANGNLSK.3|DVEGIVGLEQVSSLGDGPPGGRPR.3|QEEEAGALEAGEEAR.2|LGQLEEELEEEQSNSELLNDR.3|FLTNGPSSSPGQERELFQETLESLR.3|VAEQAANDLRAQVTELEDELTAAEDAK.3|DLGEELEALRGELEDTLDSTNAQQELR.3|RLQQELDDATMDLEQQR.2|LDGESSELQEQMVEQQQR.2
SEN / CTL,P09493,Tropomyosin alpha-1 chain,TPM1,0.70,1.56,6.56E-03,5.79E-04,3.24E+00,"in utero embryonic development,positive regulation of heart rate by epinephrine,movement of cell or subcellular component,muscle contraction,regulation of muscle contraction,cytoskeleton organization,regulation of heart contraction,regulation of cell shape,muscle filament sliding,negative regulation of cell migration,ruffle organization,positive regulation of ATPase activity,cellular response to reactive oxygen species,wound healing,sarcomere organization,positive regulation of cell adhesion,positive regulation of stress fiber assembly,ventricular cardiac muscle tissue morphogenesis,cardiac muscle contraction,negative regulation of vascular smooth muscle cell proliferation,negative regulation of vascular associated smooth muscle cell migration","actin binding,structural constituent of cytoskeleton,cytoskeletal protein binding,structural constituent of muscle","stress fiber,cytosol,cytoskeleton,muscle thin filament tropomyosin,sarcomere,filamentous actin,bleb,ruffle membrane",24,24,36,QLEDELVSLQK.2|AQKDEEKMEIQEIQLK.4|AQKDEEKMEIQEIQLK.3|KLVIIESDLERAEER.4|KLVIIESDLERAEER.3|AEERAELSEGK.3|SKQLEDELVSLQKK.4|SKQLEDELVSLQKK.3|ENALDRAEQAEADKK.4|ENALDRAEQAEADKK.3|ENALDRAEQAEADKK.2|KLVIIESDLER.3|KLVIIESDLER.2|HIAEDADRKYEEVAR.4|HIAEDADRKYEEVAR.3|HIAEDADR.2|QLEDELVSLQKK.3|SKQLEDELVSLQK.3|SKQLEDELVSLQK.2|AEQAEADKKAAEDR.3|ENALDRAEQAEADK.3|ENALDRAEQAEADK.2|DEEKMEIQEIQLK.3|DEEKMEIQEIQLK.2|C[CAM]AELEEELK.2|LVIIESDLERAEER.3|MEIQEIQLK.2|M[Oxi]EIQEIQLK.2|YSQKEDRYEEEIK.3|YSQKEDRYEEEIK.2|LVIIESDLER.2|EDRYEEEIK.2|C[CAM]AELEEELKTVTNNLK.3|VLSDKLKEAETR.2|SIDDLEDELYAQK.2|LVIIESDLERAEERAELSEGK.3
SEN / CTL,P17936,Insulin-like growth factor-binding protein 3,IGFBP3,0.68,1.56,6.46E-01,4.69E-02,1.33E+00,"regulation of cell growth,osteoblast differentiation,negative regulation of protein phosphorylation,protein phosphorylation,apoptotic process,negative regulation of cell proliferation,negative regulation of signal transduction,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,regulation of apoptotic process,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,positive regulation of myoblast differentiation,negative regulation of smooth muscle cell proliferation","fibronectin binding,protein binding,insulin-like growth factor binding,protein tyrosine phosphatase activator activity,insulin-like growth factor I binding,insulin-like growth factor II binding,metal ion binding","extracellular region,extracellular space,nucleus,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex,extracellular exosome",30,10,13,C[CAM]QPSPDEARPLQALLDGR.3|FLNVLSPR.2|EPGC[CAM]GC[CAM]C[CAM]LTC[CAM]ALSEGQPC[CAM]GIYTER.3|EMEDTLNHLK.3|EM[Oxi]EDTLNHLK.3|ALAQC[CAM]APPPAVC[CAM]AELVR.2|ALAQC[CAM]APPPAVC[CAM]AELVR.3|SAGSVESPSVSSTHR.3|SAGSVESPSVSSTHR.2|GKEDVHC[CAM]YSMQSK.3|GFC[CAM]WC[CAM]VDK.2|YGQPLPGYTTK.2|YKVDYESQSTDTQNFSSESK.3
SEN / CTL,P13987,CD59 glycoprotein,CD59,0.68,2.14,1.19E-03,1.17E-04,3.93E+00,"cell activation,negative regulation of activation of membrane attack complex,ER to Golgi vesicle-mediated transport,cell surface receptor signaling pathway,blood coagulation,regulation of complement activation,positive regulation of T cell proliferation,negative regulation of apoptotic process,COPII vesicle coating",complement binding,"Golgi membrane,extracellular space,endoplasmic reticulum membrane,plasma membrane,focal adhesion,cell surface,ER to Golgi transport vesicle membrane,membrane,anchored component of external side of plasma membrane,vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,sarcolemma,compact myelin,extracellular exosome",12,6,9,C[CAM]WKFEHC[CAM]NFNDVTTR.4|C[CAM]WKFEHC[CAM]NFNDVTTR.3|FEHC[CAM]NFNDVTTR.3|FEHC[CAM]NFNDVTTR.2|AGLQVYNK.2|LRENELTYYC[CAM]C[CAM]K.3|LRENELTYYC[CAM]C[CAM]K.2|LRENELTYYC[CAM]C[CAM]KK.3|ENELTYYC[CAM]C[CAM]K.2
SEN / CTL,P07196,Neurofilament light polypeptide,NEFL,0.67,3.32,2.42E-01,1.81E-02,1.74E+00,"MAPK cascade,microtubule cytoskeleton organization,anterograde axonal transport,retrograde axonal transport,response to toxic substance,peripheral nervous system axon regeneration,axonal transport of mitochondrion,spinal cord development,hippocampus development,cerebral cortex development,regulation of axon diameter,neurofilament bundle assembly,locomotion,response to peptide hormone,negative regulation of neuron apoptotic process,positive regulation of GTPase activity,intermediate filament polymerization or depolymerization,intermediate filament organization,neuron projection morphogenesis,positive regulation of axonogenesis,neuromuscular process controlling balance,protein polymerization,response to corticosterone,response to sodium arsenite,response to acrylamide","Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,protein C-terminus binding,protein domain specific binding,protein binding, bridging,identical protein binding,phospholipase binding,protein heterodimerization activity","cytoplasm,cytosol,neurofilament,axon,growth cone,myelin sheath,axon cytoplasm,TSC1-TSC2 complex",12,17,20,TLEIEAC[CAM]R.2|KGADEAALAR.2|KVEGAGEEQAAK.3|KVEGAGEEQAAK.2|ALYEQEIR.2|RIDSLMDEISFLK.3|RIDSLMDEISFLK.2|LAAEDATNEK.2|YEEEVLSREDAEGR.3|VHELEQQNK.2|VLEAELLVLR.2|AQLQDLNDRFASFIER.3|NMQNAEEWFK.2|SRFTVLTESAAK.2|IDSLMDEISFLK.2|QLQELEDKQNADISAMQDTINKLENELR.4|SAYGGLQTSSYLMSTR.2|SAYGGLQTSSYLM[Oxi]STR.2|SAYSSYSAPVSSSLSVR.2|LSFTSVGSITSGYSQSSQVFGR.2
SEN / CTL,P51884,Lumican,LUM,0.66,1.65,5.78E-01,4.23E-02,1.37E+00,"visual perception,response to organic cyclic compound,keratan sulfate biosynthetic process,extracellular matrix organization,collagen fibril organization,positive regulation of transforming growth factor beta1 production,keratan sulfate catabolic process,positive regulation of transcription from RNA polymerase II promoter,cartilage development,response to growth factor,axonogenesis","extracellular matrix structural constituent,collagen binding","extracellular region,proteinaceous extracellular matrix,fibrillar collagen trimer,extracellular space,Golgi lumen,lysosomal lumen,extracellular exosome,extracellular matrix",72,21,29,FNALQYLR.2|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.4|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.5|SLEYLDLSFNQIAR.2|SLEYLDLSFNQIAR.3|LPSGLPVSLLTLYLDNNKISNIPDEYFK.3|LPSGLPVSLLTLYLDNNKISNIPDEYFK.4|NIPTVNENLENYYLEVNQLEK.3|NIPTVNENLENYYLEVNQLEKFDIK.3|VANEVTLN.2|ISETSLPPDMYEC[CAM]LR.2|ISETSLPPDM[Oxi]YEC[CAM]LR.2|LPSGLPVSLLTLYLDNNK.3|LPSGLPVSLLTLYLDNNK.2|NNQIDHIDEK.3|NNQIDHIDEK.2|SLEDLQLTHNKITK.4|SLEDLQLTHNKITK.3|SLEDLQLTHNK.3|SLEDLQLTHNK.2|ISNIPDEYFKR.3|EDAVSAAFK.2|ILGPLSYSK.2|LKEDAVSAAFKGLK.3|SVPMVPPGIK.2|LKEDAVSAAFK.2|RFNALQYLR.2|ISNIPDEYFK.2|AFENVTDLQWLILDHNLLENSK.3
SEN / CTL,Q06033,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,0.66,1.77,4.79E-01,3.53E-02,1.45E+00,"platelet degranulation,negative regulation of endopeptidase activity,hyaluronan metabolic process","endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity","extracellular region,platelet dense granule lumen,extracellular exosome",6,19,24,EVSFDVELPK.2|KGHVSFKPSLDQQR.4|KGHVSFKPSLDQQR.3|DFLGFYVVDSHR.3|GHVSFKPSLDQQR.3|ADTAKEVSFDVELPK.3|VTFELTYEELLKR.3|EHLVQATPENLQEAR.3|EHLVQATPENLQEAR.2|GHGATNDLTFTEEVDM[Oxi]KEMEK.4|GHGATNDLTFTEEVDMKEMEK.4|LVDEDMNSFK.2|LVDEDM[Oxi]NSFK.2|GMTNINDGLLR.2|GHGATNDLTFTEEVDMK.3|ALQERDYIFGNYIER.3|DYIFGNYIER.2|YHFVTPLTSMVVTKPEDNEDER.4|YHFVTPLTSM[Oxi]VVTKPEDNEDER.4|VTFELTYEELLK.2|STSIVIMLTDGDANVGESRPEK.3|LWAYLTIEQLLEK.2|SLPEGVANGIEVYSTK.2|FPLYNLGFGNNLNYNFLENMALENHGFAR.4
SEN / CTL,P50454,Serpin H1,SERPINH1,0.64,1.74,1.38E-03,1.34E-04,3.87E+00,"chondrocyte development involved in endochondral bone morphogenesis,response to unfolded protein,negative regulation of endopeptidase activity,collagen fibril organization,collagen biosynthetic process,protein maturation","serine-type endopeptidase inhibitor activity,collagen binding,poly(A) RNA binding,unfolded protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,membrane raft,extracellular exosome,extracellular space",102,33,71,AVLSAEQLRDEEVHAGLGELLR.4|AVLSAEQLRDEEVHAGLGELLR.3|DTQSGSLLFIGR.2|LYGPSSVSFADDFVR.2|LYGPSSVSFADDFVR.3|HLAGLGLTEAIDKNKADLSR.4|HLAGLGLTEAIDKNKADLSR.3|DQAVENILVSPVVVASSLGLVSLGGK.3|DQAVENILVSPVVVASSLGLVSLGGK.4|LFYADHPFIFLVR.3|LFYADHPFIFLVR.2|LFYADHPFIFLVR.4|LSSLIILMPHHVEPLERLEK.4|SAGLAFSLYQAMAK.2|SAGLAFSLYQAMAK.3|SAGLAFSLYQAM[Oxi]AK.3|SAGLAFSLYQAM[Oxi]AK.2|TGLYNYYDDEKEKLQIVEMPLAHK.5|TGLYNYYDDEKEKLQIVEMPLAHK.4|HLAGLGLTEAIDKNK.3|HLAGLGLTEAIDKNK.2|SYTVGVMMMHR.3|SYTVGVM[Oxi]MMHR.3|SYTVGVMM[Oxi]MHR.3|SYTVGVMMMHR.2|SYTVGVM[Oxi]MMHR.2|SALQSINEWAAQTTDGKLPEVTKDVER.4|SALQSINEWAAQTTDGKLPEVTKDVER.3|AVAISLPK.2|GVVEVTHDLQK.3|GVVEVTHDLQK.2|LQIVEMPLAHK.3|LQIVEM[Oxi]PLAHK.3|LQIVEMPLAHK.2|LQIVEM[Oxi]PLAHK.2|HLAGLGLTEAIDK.3|HLAGLGLTEAIDK.2|KAVAISLPK.2|DEEVHAGLGELLR.3|DEEVHAGLGELLR.2|AVLSAEQLR.2|LSSLIILMPHHVEPLER.4|LSSLIILM[Oxi]PHHVEPLER.4|LSSLIILM[Oxi]PHHVEPLER.3|LSSLIILMPHHVEPLER.3|LSSLIILM[Oxi]PHHVEPLER.2|LSSLIILMPHHVEPLER.2|DVERTDGALLVNAMFFKPHWDEK.5|DVERTDGALLVNAM[Oxi]FFKPHWDEK.4|DVERTDGALLVNAMFFKPHWDEK.4|TGLYNYYDDEKEK.3|TGLYNYYDDEKEK.2|TDGALLVNAM[Oxi]FFKPHWDEK.4|TDGALLVNAMFFKPHWDEK.4|TDGALLVNAMFFKPHWDEK.3|TDGALLVNAMFFKPHWDEK.2|KPAAAAAPGTAEK.2|SALQSINEWAAQTTDGK.3|SALQSINEWAAQTTDGK.2|SALQSINEWAAQTTDGKLPEVTK.4|SALQSINEWAAQTTDGKLPEVTK.3|RSALQSINEWAAQTTDGK.3|RSALQSINEWAAQTTDGK.2|RSALQSINEWAAQTTDGKLPEVTK.4|RSALQSINEWAAQTTDGKLPEVTK.3|LPEVTKDVERTDGALLVNAMFFKPHWDEK.5|TGLYNYYDDEK.2|TDGALLVNAMFFK.2|EKLQIVEMPLAHK.2|DLYLASVFHATAFELDTDGNPFDQDIYGREELRSPK.5|DLYLASVFHATAFELDTDGNPFDQDIYGREELRSPK.4
SEN / CTL,P09429,High mobility group protein B1,HMGB1,0.59,2.22,7.75E-02,6.14E-03,2.21E+00,"negative regulation of transcription from RNA polymerase II promoter,myeloid dendritic cell activation,activation of innate immune response,dendritic cell chemotaxis,inflammatory response to antigenic stimulus,regulation of tolerance induction,regulation of T cell mediated immune response to tumor cell,DNA topological change,apoptotic DNA fragmentation,DNA recombination,regulation of transcription from RNA polymerase II promoter,autophagy,inflammatory response,positive regulation of cytosolic calcium ion concentration,regulation of autophagy,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,neuron projection development,regulation of restriction endodeoxyribonuclease activity,DNA geometric change,positive regulation of mismatch repair,negative regulation of interferon-gamma production,positive regulation of interleukin-10 production,positive regulation of interleukin-12 production,V(D)J recombination,positive regulation of toll-like receptor 9 signaling pathway,T-helper 1 cell activation,positive regulation of activated T cell proliferation,positive regulation of apoptotic process,apoptotic cell clearance,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of CD4-positive, alpha-beta T cell differentiation,positive regulation of DNA binding,positive regulation of MAPK cascade,negative regulation of blood vessel endothelial cell migration,T-helper 1 cell differentiation,innate immune response,positive regulation of transcription from RNA polymerase II promoter,positive regulation of JNK cascade,positive regulation of interleukin-1 secretion,positive chemotaxis,DNA ligation involved in DNA repair,positive regulation of DNA ligation,positive regulation of ERK1 and ERK2 cascade,positive regulation of monocyte chemotaxis,neutrophil clearance,tumor necrosis factor secretion,positive regulation of interleukin-6 secretion,positive regulation of dendritic cell differentiation","four-way junction DNA binding,bubble DNA binding,lipopolysaccharide binding,phosphatidylserine binding,damaged DNA binding,double-stranded DNA binding,single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,cytokine activity,protein binding,transcription factor binding,DNA binding, bending,lyase activity,C-X-C chemokine binding,chemoattractant activity,poly(A) RNA binding,RAGE receptor binding,DNA polymerase binding,repressing transcription factor binding,supercoiled DNA binding","condensed chromosome,extracellular region,extracellular space,nucleus,nucleoplasm,endosome,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,cell surface,transcriptional repressor complex",30,26,57,RPPSAFFLFC[CAM]SEYRPK.3|RPPSAFFLFC[CAM]SEYRPK.4|RPPSAFFLFC[CAM]SEYRPK.2|MSSYAFFVQTC[CAM]REEHKK.4|MSSYAFFVQTC[CAM]REEHKK.3|MSSYAFFVQTC[CAM]R.2|MSSYAFFVQTC[CAM]R.3|M[Oxi]SSYAFFVQTC[CAM]R.2|KHPDASVNFSEFSKK.4|KHPDASVNFSEFSKK.3|IKGEHPGLSIGDVAKK.4|IKGEHPGLSIGDVAKK.3|GEHPGLSIGDVAK.3|GEHPGLSIGDVAK.2|KKHPDASVNFSEFSK.4|KKHPDASVNFSEFSK.3|FKDPNAPK.2|GKFEDMAK.2|GKFEDM[Oxi]AK.2|GEHPGLSIGDVAKK.3|HPDASVNFSEFSK.3|HPDASVNFSEFSK.2|IKGEHPGLSIGDVAK.3|IKGEHPGLSIGDVAK.2|M[Oxi]SSYAFFVQTC[CAM]REEHK.4|MSSYAFFVQTC[CAM]REEHK.4|MSSYAFFVQTC[CAM]REEHK.3|M[Oxi]SSYAFFVQTC[CAM]REEHK.3|MSSYAFFVQTC[CAM]REEHK.2|KFKDPNAPK.2|HPDASVNFSEFSKK.3|HPDASVNFSEFSKK.2|KHPDASVNFSEFSK.3|KHPDASVNFSEFSK.2|KLGEMWNNTAADDK.3|KLGEM[Oxi]WNNTAADDK.3|KLGEM[Oxi]WNNTAADDK.2|KLGEMWNNTAADDK.2|KLGEMWNNTAADDKQPYEK.4|KLGEM[Oxi]WNNTAADDKQPYEK.4|KLGEM[Oxi]WNNTAADDKQPYEK.3|KLGEMWNNTAADDKQPYEK.3|KLGEMWNNTAADDKQPYEK.2|LGEMWNNTAADDKQPYEKK.4|LGEM[Oxi]WNNTAADDKQPYEKK.4|LGEMWNNTAADDKQPYEKK.3|LGEMWNNTAADDKQPYEKK.2|TYIPPKGETK.2|YEKDIAAYR.2|FKDPNAPKRPPSAFFLFC[CAM]SEYRPK.5|EKYEKDIAAYR.2|LGEMWNNTAADDKQPYEK.3|LGEM[Oxi]WNNTAADDKQPYEK.3|LGEMWNNTAADDKQPYEK.2|LGEMWNNTAADDK.2|LGEM[Oxi]WNNTAADDK.2|GKMSSYAFFVQTC[CAM]R.2
SEN / CTL,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,0.56,2.07,4.21E-01,3.12E-02,1.51E+00,"regulation of cell growth,cell adhesion,embryo implantation,negative regulation of cell proliferation,response to heat,response to retinoic acid,cellular response to hormone stimulus,regulation of steroid biosynthetic process,response to cortisol","protein binding,insulin-like growth factor binding","extracellular region,extracellular space,extracellular exosome,extracellular matrix",42,12,15,SRYPVC[CAM]GSDGTTYPSGC[CAM]QLR.3|TELLPGDRDNLAIQTR.3|TELLPGDRDNLAIQTR.2|AGAAAGGPGVSGVC[CAM]VC[CAM]K.2|AGAAAGGPGVSGVC[CAM]VC[CAM]K.3|ITVVDALHEIPVK.3|GYC[CAM]APGMEC[CAM]VK.2|GGPEKHEVTGWVLVSPLSK.4|HEVTGWVLVSPLSK.3|HEVTGWVLVSPLSK.2|GEGEPC[CAM]GGGGAGR.2|DAC[CAM]GC[CAM]C[CAM]PMC[CAM]AR.2|GTC[CAM]EQGPSIVTPPK.2|EDAGEYEC[CAM]HASNSQGQASASAK.3|HEVTGWVLVSPLSKEDAGEYEC[CAM]HASNSQGQASASAK.5
SEN / CTL,P27797,Calreticulin,CALR,0.51,1.34,1.00E-07,1.66E-08,7.78E+00,"negative regulation of transcription from RNA polymerase II promoter,antigen processing and presentation of peptide antigen via MHC class I,peptide antigen assembly with MHC class I protein complex,regulation of transcription, DNA-templated,protein folding,protein export from nucleus,cellular calcium ion homeostasis,receptor-mediated endocytosis,cell cycle arrest,spermatogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of translation,protein maturation by protein folding,cortical actin cytoskeleton organization,response to estradiol,negative regulation of intracellular steroid hormone receptor signaling pathway,response to testosterone,protein localization to nucleus,protein folding in endoplasmic reticulum,ATF6-mediated unfolded protein response,regulation of meiotic nuclear division,response to drug,glucocorticoid receptor signaling pathway,regulation of apoptotic process,negative regulation of neuron differentiation,positive regulation of DNA replication,positive regulation of cell cycle,negative regulation of transcription, DNA-templated,negative regulation of retinoic acid receptor signaling pathway,positive regulation of phagocytosis,protein stabilization,sequestering of calcium ion,cardiac muscle cell differentiation,chaperone-mediated protein folding,cellular response to lithium ion,cellular senescence,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,positive regulation of dendritic cell chemotaxis","complement component C1q binding,glycoprotein binding,DNA binding,mRNA binding,integrin binding,iron ion binding,calcium ion binding,protein binding,zinc ion binding,carbohydrate binding,ubiquitin protein ligase binding,peptide binding,hormone binding,protein binding involved in protein folding,poly(A) RNA binding,androgen receptor binding,unfolded protein binding,chaperone binding","acrosomal vesicle,extracellular region,proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,Golgi apparatus,cytosol,polysome,focal adhesion,external side of plasma membrane,cell surface,membrane,sarcoplasmic reticulum lumen,MHC class I peptide loading complex,perinuclear region of cytoplasm,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane,endocytic vesicle lumen",84,52,95,EQFLDGDGWTSR.2|SGTIFDNFLITNDEAYAEEFGNETWGVTK.3|SGTIFDNFLITNDEAYAEEFGNETWGVTK.4|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.5|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.4|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.3|IDNSQVESGSLEDDWDFLPPKK.3|IDNSQVESGSLEDDWDFLPPKK.4|FYGDEEKDKGLQTSQDAR.4|FYGDEEKDKGLQTSQDAR.3|FYGDEEKDKGLQTSQDAR.2|FYALSASFEPFSNK.2|FYALSASFEPFSNK.3|VHVIFNYK.2|VHVIFNYK.1|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.3|IKDPDASKPEDWDER.4|IKDPDASKPEDWDER.3|IKDPDASKPEDWDER.2|DKGLQTSQDAR.3|DKGLQTSQDAR.2|IKDPDASKPEDWDERAK.5|IKDPDASKPEDWDERAK.4|IKDPDASKPEDWDERAK.3|IKDPDASKPEDWDERAK.2|HKSDFGK.2|FYGDEEK.2|GKNVLINK.2|FVLSSGKFYGDEEKDK.4|FVLSSGKFYGDEEKDK.3|KIKDPDASKPEDWDER.4|KIKDPDASKPEDWDER.3|KIKDPDASKPEDWDER.2|GLQTSQDAR.2|AKIDDPTDSKPEDWDKPEHIPDPDAK.6|AKIDDPTDSKPEDWDKPEHIPDPDAK.5|AKIDDPTDSKPEDWDKPEHIPDPDAK.4|AKIDDPTDSKPEDWDKPEHIPDPDAK.3|HEQNIDC[CAM]GGGYVK.3|HEQNIDC[CAM]GGGYVK.2|QIDNPDYK.2|LKEEEEDK.2|HKSDFGKFVLSSGK.3|HKSDFGKFVLSSGK.2|DPDASKPEDWDER.3|DPDASKPEDWDER.2|FVLSSGKFYGDEEK.3|FVLSSGKFYGDEEK.2|NVLINKDIR.2|IDDPTDSKPEDWDKPEHIPDPDAK.5|IDDPTDSKPEDWDKPEHIPDPDAK.4|IDDPTDSKPEDWDKPEHIPDPDAK.3|KEEEEAEDK.2|FYGDEEKDK.2|EEEEAEDKEDDEDK.3|KVHVIFNYK.2|IDNSQVESGSLEDDWDFLPPK.4|IDNSQVESGSLEDDWDFLPPK.3|IDNSQVESGSLEDDWDFLPPK.2|GQTLVVQFTVK.2|KEEEEAEDKEDDEDK.3|DEDEEDEEDK.2|GKNVLINKDIR.2|SDFGKFVLSSGK.2|DDEFTHLYTLIVRPDNTYEVK.4|DDEFTHLYTLIVRPDNTYEVK.3|EDDEDKDEDEEDEEDK.3|KVHVIFNYKGK.2|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.4|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.3|EEEEAEDKEDDEDKDEDEEDEEDK.4|EEDEEEDVPGQAK.2|FVLSSGK.1|KPEDWDEEMDGEWEPPVIQNPEYK.4|KPEDWDEEM[Oxi]DGEWEPPVIQNPEYK.3|KPEDWDEEMDGEWEPPVIQNPEYK.3|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.5|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.4|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.5|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.4|EDDEDKDEDEEDEEDKEEDEEEDVPGQAK.4|DEDEEDEEDKEEDEEEDVPGQAK.3|EEDEEEDVPGQAKDEL.2|FYALSASFEPFSNKGQTLVVQFTVK.3|DEDEEDEEDKEEDEEEDVPGQAKDEL.3
SEN / CTL,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,0.49,1.04,2.55E-01,1.90E-02,1.72E+00,"activation of MAPKK activity,membrane protein ectodomain proteolysis,cell adhesion,cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,response to manganese ion,cell migration,keratinocyte differentiation,cell adhesion mediated by integrin,positive regulation of cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,positive regulation of macrophage fusion,response to tumor necrosis factor,response to laminar fluid shear stress,monocyte activation,response to hydrogen peroxide,positive regulation of protein secretion,positive regulation of membrane protein ectodomain proteolysis,PMA-inducible membrane protein ectodomain proteolysis,response to glucocorticoid,positive regulation of keratinocyte migration,response to calcium ion,cellular response to lipopolysaccharide","metalloendopeptidase activity,protein kinase C binding,integrin binding,protein binding,collagen binding,metallopeptidase activity,SH3 domain binding,laminin binding,metal ion binding","extracellular space,focal adhesion,cell surface,integral component of membrane,basolateral plasma membrane,intrinsic component of external side of plasma membrane,extracellular exosome",6,22,24,QVSYVIQAEGK.2|EGTLITDHPNIQNHC[CAM]HYR.5|EGTLITDHPNIQNHC[CAM]HYR.4|FAVPTYAAK.2|HDSAQLVLK.2|FLPGGTLC[CAM]R.2|C[CAM]ATGNALC[CAM]GK.2|QPQQFPSRPPPPQPK.3|SQTYESDGKNQANPSR.3|SC[CAM]IMNSGASGSR.2|NC[CAM]HC[CAM]ENGWAPPNC[CAM]ETK.3|FGNC[CAM]GFSGNEYK.2|SFAEC[CAM]AYGDC[CAM]C[CAM]K.2|FGNC[CAM]GFSGNEYKK.2|PGFQQTSHLSSYEIITPWR.3|LVDAGEEC[CAM]DC[CAM]GTPK.2|NFQC[CAM]VDASVLNYDC[CAM]DVQKK.3|VSSQGNLIPARPAPAPPLYSSLT.3|VSSQGNLIPARPAPAPPLYSSLT.2|GGNC[CAM]LLNIPKPDEAYSAPSC[CAM]GNK.3|GFGGTAGMAFVGTVC[CAM]SR.2|EC[CAM]ELDPC[CAM]C[CAM]EGSTC[CAM]K.2|LQC[CAM]ENVQEIPVFGIVPAIIQTPSR.3|LVDAGEEC[CAM]DC[CAM]GTPKEC[CAM]ELDPC[CAM]C[CAM]EGSTC[CAM]K.3
SEN / CTL,P37837,Transaldolase,TALDO1,0.48,0.88,5.21E-01,3.82E-02,1.42E+00,"carbohydrate metabolic process,xylulose biosynthetic process,fructose 6-phosphate metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch","sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,protein binding,monosaccharide binding","nucleus,cytoplasm,cytosol,extracellular exosome",6,31,43,ALAGC[CAM]DFLTISPK.2|ALAGC[CAM]DFLTISPK.3|KLGGSQEDQIK.3|KLGGSQEDQIK.2|LLGELLQDNAK.3|LLGELLQDNAK.2|LIELYKEAGISKDR.4|AAQASDLEKIHLDEK.4|KFAADAVKLER.3|LSFDKDAMVAR.3|LSFDKDAMVAR.2|KFAADAVK.2|ILDWHVANTDK.3|ILDWHVANTDK.2|VSTEVDAR.2|LIELYKEAGISK.3|MFNAENGK.2|LFVLFGAEILKK.3|AAQASDLEK.2|RLIELYK.2|ILDWHVANTDKK.3|ILDWHVANTDKK.2|NAIDKLFVLFGAEILKK.4|NAIDKLFVLFGAEILKK.3|TIVMGASFR.2|TIVM[Oxi]GASFR.2|WLHNEDQMAVEK.3|WLHNEDQM[Oxi]AVEK.3|WLHNEDQMAVEK.2|RLIELYKEAGISK.3|MESALDQLK.2|M[Oxi]ESALDQLK.2|LGGSQEDQIK.2|LGGSQEDQIKNAIDK.3|KLGGSQEDQIKNAIDK.3|NAIDKLFVLFGAEILK.3|SYEPLEDPGVK.2|LFVLFGAEILK.2|LSSTWEGIQAGK.2|QRMESALDQLK.2|LLGELLQDNAKLVPVLSAK.3|LLGELLQDNAKLVPVLSAK.2|QFTTVVADTGDFHAIDEYKPQDATTNPSLILAAAQMPAYQELVEEAIAYGR.5
SEN / CTL,Q9Y5V0,Zinc finger protein 706,ZNF706,0.47,1.83,5.21E-01,3.82E-02,1.42E+00,"regulation of translation,negative regulation of transcription, DNA-templated,negative regulation of stem cell population maintenance",metal ion binding,"nucleus,cytoplasm",6,2,2,AALIYTC[CAM]TVC[CAM]R.2|TPLPPELADVQA.2
SEN / CTL,P0CG39,POTE ankyrin domain family member J,POTEJ,0.45,2.24,6.12E-01,4.46E-02,1.35E+00,retina homeostasis,,"extracellular space,extracellular exosome",6,2,3,LC[CAM]YVALDFEQEMAMVASSSSLEK.3|LC[CAM]YVALDFEQEMAMVASSSSLEK.4|EKLC[CAM]YVALDFEQEMAMVASSSSLEK.4
SEN / CTL,Q01995,Transgelin,TAGLN,0.44,1.33,5.46E-02,4.43E-03,2.35E+00,"muscle organ development,epithelial cell differentiation",actin binding,cytoplasm,48,24,41,EFTESQLQEGKHVIGLQMGSNR.4|EFTESQLQEGK.2|QMEQVAQFLK.2|QM[Oxi]EQVAQFLK.2|LGFQVWLK.2|TLMALGSLAVTK.2|TLMALGSLAVTK.3|TLM[Oxi]ALGSLAVTK.2|HVIGLQMGSNR.3|HVIGLQMGSNR.2|HVIGLQM[Oxi]GSNR.2|LVNSLYPDGSKPVKVPENPPSMVFK.4|LVNSLYPDGSKPVKVPENPPSM[Oxi]VFK.4|LVNSLYPDGSKPVKVPENPPSMVFK.3|TDMFQTVDLFEGK.2|TDMFQTVDLFEGK.3|TDM[Oxi]FQTVDLFEGK.2|GPSYGMSR.2|NDGHYRGDPNWFMK.4|NDGHYRGDPNWFM[Oxi]K.4|NDGHYRGDPNWFMK.3|NDGHYRGDPNWFM[Oxi]K.2|GASQAGMTGYGRPR.3|AAEDYGVIK.2|REFTESQLQEGK.3|REFTESQLQEGK.2|GDPNWFMK.2|LVNSLYPDGSKPVK.3|LVNSLYPDGSKPVK.2|PVKVPENPPSMVFK.3|LVEWIIVQC[CAM]GPDVGRPDR.4|LVEWIIVQC[CAM]GPDVGRPDR.3|LVEWIIVQC[CAM]GPDVGRPDR.2|YDEELEER.2|GASQAGMTGYGR.2|LVNSLYPDGSK.2|KYDEELEER.2|VPENPPSMVFK.2|VPENPPSM[Oxi]VFK.2|TDMFQTVDLFEGKDMAAVQR.3|AAEDYGVIKTDMFQTVDLFEGK.3
SEN / CTL,O60506,Heterogeneous nuclear ribonucleoprotein Q,SYNCRIP,0.44,1.41,9.41E-04,9.27E-05,4.03E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA processing,RNA splicing,viral process,negative regulation of translation,CRD-mediated mRNA stabilization,cellular response to interferon-gamma","nucleotide binding,RNA binding,poly(A) binding,poly(A) RNA binding","nucleus,nucleoplasm,endoplasmic reticulum,membrane,intracellular ribonucleoprotein complex,CRD-mediated mRNA stability complex,catalytic step 2 spliceosome,histone pre-mRNA 3'end processing complex,GAIT complex",24,48,77,TGYTLDVTTGQR.2|TGYTLDVTTGQR.3|KYGGPPPDSVYSGQQPSVGTEIFVGKIPR.4|LMMDPLTGLNR.2|LM[Oxi]MDPLTGLNR.2|LMM[Oxi]DPLTGLNR.2|DLFEDELVPLFEK.2|DLFEDELVPLFEK.3|VADSSKGPDEAK.3|VADSSKGPDEAK.2|KADGYNQPDSK.3|KADGYNQPDSK.2|EAAQEAVK.2|LFVGSIPK.2|NRGFC[CAM]FLEYEDHK.4|NRGFC[CAM]FLEYEDHK.3|NRGFC[CAM]FLEYEDHK.2|DYAFIHFDER.3|DYAFIHFDER.2|DYAFIHFDERDGAVK.4|DYAFIHFDERDGAVK.3|HIGVC[CAM]ISVANNR.3|HIGVC[CAM]ISVANNR.2|AMEEMNGK.2|TKEQILEEFSK.3|TKEQILEEFSK.2|AGPIWDLR.2|RKADGYNQPDSK.3|RKADGYNQPDSK.2|GFC[CAM]FLEYEDHK.3|GFC[CAM]FLEYEDHK.2|TGYTLDVTTGQRK.3|TGYTLDVTTGQRK.2|NLANTVTEEILEK.3|NLANTVTEEILEK.2|LKDYAFIHFDERDGAVK.4|SAFLC[CAM]GVMK.2|SAFLC[CAM]GVM[Oxi]K.2|LKDYAFIHFDER.3|VTEGLTDVILYHQPDDKK.4|LYNNHEIR.2|ADGYNQPDSK.2|VTEGLTDVILYHQPDDKKK.4|VTEGLTDVILYHQPDDKKK.3|KLKDYAFIHFDER.3|EQILEEFSK.2|DSDLSHVQNK.2|EFNEDGALAVLQQFK.3|EFNEDGALAVLQQFK.2|GYAFVTFC[CAM]TK.2|VAEKLDEIYVAGLVAHSDLDER.4|VAEKLDEIYVAGLVAHSDLDER.3|IPRDLFEDELVPLFEK.3|VTEGLTDVILYHQPDDK.3|VTEGLTDVILYHQPDDK.2|NLANTVTEEILEKAFSQFGKLER.4|LDEIYVAGLVAHSDLDER.3|LDEIYVAGLVAHSDLDER.2|DLEGENIEIVFAKPPDQK.3|DLEGENIEIVFAKPPDQK.2|SENQEFYQDTFGQQWK.3|SENQEFYQDTFGQQWK.2|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.5|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.4|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.3|EFNEDGALAVLQQFKDSDLSHVQNK.4|AMEEMNGKDLEGENIEIVFAKPPDQK.4|AIEALKEFNEDGALAVLQQFK.3|AIEALKEFNEDGALAVLQQFK.2|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.4|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.3|YGGPPPDSVYSGQQPSVGTEIFVGK.3|KYGGPPPDSVYSGQQPSVGTEIFVGK.3|VWGNVGTVEWADPIEDPDPEVM[Oxi]AK.3|VWGNVGTVEWADPIEDPDPEVMAK.3|VKVWGNVGTVEWADPIEDPDPEVMAK.3|YGGPPPDSVYSGQQPSVGTEIFVGKIPR.3
SEN / CTL,P60981,Destrin,DSTN,0.43,2.06,8.15E-02,6.43E-03,2.19E+00,"actin polymerization or depolymerization,actin filament depolymerization,positive regulation of actin filament depolymerization,actin filament severing","protein binding,actin filament binding","actin cytoskeleton,cortical actin cytoskeleton,extracellular exosome",18,22,34,YALYDASFETK.2|KEELMFFLWAPELAPLK.3|KEELM[Oxi]FFLWAPELAPLK.3|KEELMFFLWAPELAPLK.2|AVIFC[CAM]LSADKK.3|AVIFC[CAM]LSADKK.2|KC[CAM]STPEEIKK.3|C[CAM]STPEEIKKR.3|KAVIFC[CAM]LSADKK.3|C[CAM]IIVEEGK.2|C[CAM]STPEEIK.2|HFVGMLPEKDC[CAM]R.3|HFVGM[Oxi]LPEKDC[CAM]R.3|HFVGMLPEKDC[CAM]R.2|HEC[CAM]QANGPEDLNR.3|HEC[CAM]QANGPEDLNR.2|FQGIKHEC[CAM]QANGPEDLNR.4|FQGIKHEC[CAM]QANGPEDLNR.3|HFVGMLPEK.2|HFVGM[Oxi]LPEK.2|KC[CAM]IIVEEGK.2|C[CAM]STPEEIKK.2|KC[CAM]STPEEIK.2|KFQGIKHEC[CAM]QANGPEDLNR.4|KFQGIKHEC[CAM]QANGPEDLNR.3|AVIFC[CAM]LSADK.2|EILVGDVGVTITDPFK.3|EILVGDVGVTITDPFK.2|ESRKEELMFFLWAPELAPLK.4|ESRKEELMFFLWAPELAPLK.3|EELMFFLWAPELAPLK.3|EELMFFLWAPELAPLK.2|LGGSLIVAFEGC[CAM]PV.2|C[CAM]IIVEEGKEILVGDVGVTITDPFK.3
SEN / CTL,Q15582,Transforming growth factor-beta-induced protein ig-h3,TGFBI,0.43,2.06,5.69E-02,4.59E-03,2.34E+00,"angiogenesis,chondrocyte differentiation,cell adhesion,negative regulation of cell adhesion,visual perception,cell proliferation,extracellular matrix organization,cellular protein metabolic process,response to stimulus","integrin binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,trans-Golgi network,plasma membrane,extracellular matrix,extracellular exosome",252,38,60,EGVYTVFAPTNEAFR.2|STVISYEC[CAM]C[CAM]PGYEKVPGEK.3|GDELADSALEIFK.2|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.4|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.3|LLGDAKELANILK.3|LTLLAPLNSVFKDGTPPIDAHTR.4|LTLLAPLNSVFKDGTPPIDAHTR.3|SPYQLVLQHSR.3|SPYQLVLQHSR.2|YHIGDEILVSGGIGALVR.3|STVISYEC[CAM]C[CAM]PGYEK.2|SLQGDKLEVSLK.3|SLQGDKLEVSLK.2|YGTLFTMDR.2|AIISNKDILATNGVIHYIDELLIPDSAK.4|AIISNKDILATNGVIHYIDELLIPDSAK.3|ILGDPEALRDLLNNHILK.4|ILGDPEALRDLLNNHILK.3|YLYHGQTLETLGGK.3|YLYHGQTLETLGGK.2|LTLLAPLNSVFK.2|LTLLAPLNSVFK.3|VISTITNNIQQIIEIEDTFETLR.3|VISTITNNIQQIIEIEDTFETLR.4|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDR.3|NSLC[CAM]IENSC[CAM]IAAHDKR.4|NSLC[CAM]IENSC[CAM]IAAHDKR.3|VLTPPMGTVMDVLK.2|VLTPPMGTVM[Oxi]DVLK.2|VLTPPM[Oxi]GTVMDVLK.2|FSMLVAAIQSAGLTETLNR.3|FSM[Oxi]LVAAIQSAGLTETLNR.3|FSMLVAAIQSAGLTETLNR.2|YLYHGQTLETLGGKK.4|YLYHGQTLETLGGKK.3|ILGDPEALR.2|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.3|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.4|TLFELAAESDVSTAIDLFR.3|DILATNGVIHYIDELLIPDSAK.3|DILATNGVIHYIDELLIPDSAK.4|GDNRFSMLVAAIQSAGLTETLNR.3|GDNRFSM[Oxi]LVAAIQSAGLTETLNR.3|HGMTLTSMYQNSNIQIHHYPNGIVTVNC[CAM]AR.4|NSLC[CAM]IENSC[CAM]IAAHDK.3|ADHHATNGVVHLIDK.4|ADHHATNGVVHLIDK.3|ADHHATNGVVHLIDK.2|QHGPNVC[CAM]AVQK.3|QHGPNVC[CAM]AVQK.2|NNVVSVNK.2|QAGLGNHLSGSER.3|QAGLGNHLSGSER.2|IPSETLNR.2|GRQHGPNVC[CAM]AVQK.3|DGTPPIDAHTR.2|NHIIKDQLASK.2|EPVAEPDIMATNGVVHVITNVLQPPANRPQER.4|NNVVSVNKEPVAEPDIMATNGVVHVITNVLQPPANRPQER.5
SEN / CTL,O43670,BUB3-interacting and GLEBS motif-containing protein ZNF207,ZNF207,0.40,2.70,3.17E-01,2.36E-02,1.63E+00,"mitotic sister chromatid segregation,microtubule bundle formation,regulation of transcription, DNA-templated,mitotic spindle assembly checkpoint,attachment of spindle microtubules to kinetochore,microtubule polymerization,protein stabilization,cell division,regulation of chromosome segregation,mitotic spindle assembly","DNA binding,transcription factor activity, sequence-specific DNA binding,protein binding,microtubule binding,heparin binding,zinc ion binding,poly(A) RNA binding","kinetochore,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,microtubule,spindle matrix",12,10,12,LIHPDEDISLEER.3|LIHPDEDISLEER.2|ETIDAVPNAIPGR.2|LIHPDEDISLEERR.4|LYTGPGLAIHC[CAM]MQVHK.4|LYTGPGLAIHC[CAM]MQVHK.3|PATLTTTSATSK.2|LYTGPGLAIHC[CAM]MQVHKETIDAVPNAIPGR.5|PAASITSKPATLTTTSATSK.3|TDIELEIYGMEGIPEKDMDER.3|TDIELEIYGMEGIPEK.2|ETIDAVPNAIPGRTDIELEIYGMEGIPEK.3
SEN / CTL,P30040,Endoplasmic reticulum resident protein 29,ERP29,0.39,1.93,2.00E-01,1.52E-02,1.82E+00,"activation of MAPK activity,positive regulation of protein phosphorylation,protein folding,intracellular protein transport,protein secretion,positive regulation of gene expression,negative regulation of gene expression,protein unfolding,negative regulation of protein secretion,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway","protein homodimerization activity,chaperone binding,protein disulfide isomerase activity","endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,cell surface,membrane,transport vesicle,melanosome,extracellular exosome",12,22,35,SLNILTAFQK.2|GALPLDTVTFYK.2|GALPLDTVTFYK.3|QGQDNLSSVKETQKK.4|QGQDNLSSVKETQKK.3|WAEQYLK.2|LNMELSEK.2|LNM[Oxi]ELSEK.2|YKLDKESYPVFYLFR.4|YKLDKESYPVFYLFR.3|FDTQYPYGEKQDEFKR.4|FDTQYPYGEKQDEFKR.3|QGQDNLSSVKETQK.3|DGDFENPVPYTGAVK.3|DGDFENPVPYTGAVK.2|KWAEQYLK.2|QGQDNLSSVK.2|LDKESYPVFYLFR.3|ILDQGEDFPASEMTR.3|ILDQGEDFPASEM[Oxi]TR.2|ILDQGEDFPASEMTR.2|FDTQYPYGEK.2|FDTQYPYGEKQDEFK.3|FDTQYPYGEKQDEFK.2|GQGVYLGMPGC[CAM]LPVYDALAGEFIR.4|GQGVYLGMPGC[CAM]LPVYDALAGEFIR.3|GQGVYLGM[Oxi]PGC[CAM]LPVYDALAGEFIR.3|MSDGKKEELQK.2|ESYPVFYLFR.2|LAENSASSDDLLVAEVGISDYGDK.3|LAENSASSDDLLVAEVGISDYGDKLNM[Oxi]ELSEK.4|LAENSASSDDLLVAEVGISDYGDKLNMELSEK.4|LAENSASSDDLLVAEVGISDYGDKLNMELSEK.3|RLAENSASSDDLLVAEVGISDYGDK.3|ESYPVFYLFRDGDFENPVPYTGAVK.3
SEN / CTL,P61769,Beta-2-microglobulin,B2M,0.36,1.21,2.44E-01,1.83E-02,1.74E+00,"retina homeostasis,positive regulation of T cell mediated cytotoxicity,antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,positive regulation of T cell cytokine production,regulation of membrane depolarization,negative regulation of neuron projection development,antibacterial humoral response,antigen processing and presentation of endogenous peptide antigen via MHC class I,positive regulation of protein binding,T cell differentiation in thymus,protein refolding,response to drug,cellular protein metabolic process,innate immune response,response to cadmium ion,positive regulation of receptor-mediated endocytosis,regulation of defense response to virus by virus,regulation of immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,iron ion homeostasis,interferon-gamma-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to iron ion,negative regulation of receptor binding,positive regulation of receptor binding,positive regulation of ferrous iron import into cell,positive regulation of ferrous iron binding,positive regulation of transferrin receptor binding","glycoprotein binding,protein binding,identical protein binding","Golgi membrane,extracellular region,extracellular space,cytoplasm,endoplasmic reticulum lumen,Golgi apparatus,plasma membrane,focal adhesion,external side of plasma membrane,ER to Golgi transport vesicle membrane,membrane,phagocytic vesicle membrane,early endosome membrane,early endosome lumen,MHC class I protein complex,extracellular exosome,HFE-transferrin receptor complex",18,7,9,SNFLNC[CAM]YVSGFHPSDIEVDLLK.3|SNFLNC[CAM]YVSGFHPSDIEVDLLK.4|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.4|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.3|IQVYSRHPAENGK.3|IEKVEHSDLSFSK.3|VNHVTLSQPK.2|VEHSDLSFSK.2|DEYAC[CAM]RVNHVTLSQPK.3
SEN / CTL,Q14112,Nidogen-2,NID2,0.35,2.03,2.18E-08,3.90E-09,8.41E+00,"cell adhesion,cell-matrix adhesion,extracellular matrix organization,basement membrane organization","calcium ion binding,protein binding,collagen binding","extracellular region,basement membrane,extracellular matrix,extracellular exosome",168,46,60,VLYREDTSPAVLGLAAR.3|ESYNVQLQLPAR.2|AGLELGAEPETIVNSGLISPEGLAIDHIRR.4|SDFC[CAM]WC[CAM]VDKDGREVQGTR.4|DGVVSVNKHSGQFTDEYLPEQR.4|VLFYTDLVNPR.2|SHLYGITAVYPYC[CAM]PTGR.3|AIAVDPIRGNLYWTDWNR.3|SGYEFADDRHTC[CAM]ILITPPANPC[CAM]EDGSHTC[CAM]APAGQAR.5|FTPTHAFLATWEQVGAYEEVKR.4|KVLFYTDLVNPR.2|KVLFYTDLVNPR.3|AGLELGAEPETIVNSGLISPEGLAIDHIR.4|AGLELGAEPETIVNSGLISPEGLAIDHIR.3|HPSFPTTQQLNVDRVFALYNDEER.4|GNLYWTDWNR.2|ITQTAEGLDPENYLSIK.2|ITQTAEGLDPENYLSIK.3|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.5|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.6|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.4|MVYWTDVAGR.2|M[Oxi]VYWTDVAGR.2|FSNLYVGTNGIISTQDFPR.3|VFALYNDEER.2|C[CAM]HPGTGVDYTC[CAM]EC[CAM]ASGYQGDGR.3|ILINTDIGLPNGLTFDPFSK.3|ILINTDIGLPNGLTFDPFSK.2|HSGQFTDEYLPEQR.3|HSGQFTDEYLPEQR.2|C[CAM]VHHGGSTFSC[CAM]AC[CAM]LPGYAGDGHQC[CAM]TDVDEC[CAM]SENR.5|C[CAM]VHHGGSTFSC[CAM]AC[CAM]LPGYAGDGHQC[CAM]TDVDEC[CAM]SENR.4|HPSFPTTQQLNVDR.3|HPSFPTTQQLNVDR.2|DGVVSVNK.2|AIAVDPIR.2|HAQAQYAYPGAR.3|HAQAQYAYPGAR.2|IETSSLDGENRR.3|VFALYNDEERVLR.3|VIQNNLKYPFSIVSYADHFYHTDWRR.6|LLC[CAM]WADAGTK.2|NC[CAM]VDENEC[CAM]ATGFHR.3|YPFSIVSYADHFYHTDWR.4|YPFSIVSYADHFYHTDWR.3|FAVTNQIGPVK.2|IESALLDGSER.2|ELYHYSDSTVTSTSSR.3|ELYHYSDSTVTSTSSR.2|IETSSLDGENR.2|SDFC[CAM]WC[CAM]VDK.2|AIAVDPIRGNLYWTDWNREAPK.4|AIAVDPIRGNLYWTDWNREAPK.3|EDTSPAVLGLAAR.2|HPSFPTTQQLNVDRVFALYNDEERVLR.5|KLEC[CAM]TLPDGTGR.2|EGTSLGEVGGPDLK.2|TMYWTDSVLDK.2|C[CAM]GPNSVC[CAM]INLPGSYR.2|SEGPYFSLTSTEQSVK.2
SEN / CTL,Q16531,DNA damage-binding protein 1,DDB1,0.34,1.42,1.97E-01,1.50E-02,1.82E+00,"nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,DNA repair,transcription-coupled nucleotide-excision repair,nucleotide-excision repair,nucleotide-excision repair, preincision complex stabilization,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 3'-to lesion,nucleotide-excision repair, DNA incision, 5'-to lesion,viral process,Wnt signaling pathway,nucleotide-excision repair, DNA incision,histone H2A monoubiquitination,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,positive regulation of viral genome replication,positive regulation by virus of viral protein levels in host cell,interaction with symbiont,global genome nucleotide-excision repair,UV-damage excision repair,regulation of mitotic cell cycle phase transition,positive regulation of viral release from host cell","DNA binding,protein binding,damaged DNA binding","nuclear chromosome, telomeric region,extracellular space,nucleus,nucleoplasm,cytoplasm,Cul4A-RING E3 ubiquitin ligase complex,Cul4B-RING E3 ubiquitin ligase complex,extracellular exosome,Cul4-RING E3 ubiquitin ligase complex",12,71,100,ALYYLQIHPQELR.3|ALYYLQIHPQELR.2|IGRPSETGIIGIIDPEC[CAM]R.3|IAVM[Oxi]ELFRPK.3|IAVMELFRPK.3|IAVMELFRPK.2|IAVM[Oxi]ELFRPK.2|LYDGLFK.2|VVEELTR.2|LGDSQLVK.2|TYEVSLR.2|NGIGIHEHASIDLPGIK.4|NGIGIHEHASIDLPGIK.3|NGIGIHEHASIDLPGIK.2|ALVSEWKEPQAK.3|ALVSEWKEPQAK.2|GESKDLLFILTAK.3|GESKDLLFILTAK.2|ILKLPSFELLHK.3|EATADDLIK.2|IAVMELFR.2|IEHSFWR.2|LYEWTTEKELR.3|TKGDFILVGDLMR.3|TKGDFILVGDLMR.2|LFMLLLEK.2|LFM[Oxi]LLLEK.2|DLLFILTAK.2|LVFSNVNLK.2|NTRLEIYVVTAEGLRPVK.4|NTRLEIYVVTAEGLRPVK.3|TVPLYESPR.2|YLLGDMEGR.2|LLASINSTVR.2|LYEWTTEK.2|LPSFELLHK.2|DSAATTDEER.2|YLAIAPPIIK.2|EMLGGEIIPR.2|EM[Oxi]LGGEIIPR.2|QSTIVC[CAM]HNR.2|LEIYVVTAEGLRPVK.3|LEIYVVTAEGLRPVK.2|NTRLEIYVVTAEGLRPVKEVGMYGK.5|NTRLEIYVVTAEGLRPVKEVGMYGK.4|REATADDLIK.2|ELRTEC[CAM]NHYNNIMALYLK.4|ELRTEC[CAM]NHYNNIMALYLK.3|IVVFQYSDGKLQTVAEKEVK.4|IVVFQYSDGK.2|YNAC[CAM]ILEYK.2|VTLGTQPTVLR.2|LEELHVIDVK.2|EATADDLIKVVEELTR.3|EATADDLIKVVEELTR.2|LEIYVVTAEGLRPVKEVGMYGK.4|NISVASC[CAM]NSSQVVVAVGR.3|NISVASC[CAM]NSSQVVVAVGR.2|QSGESIDIITR.2|GDFILVGDLMR.2|EEQMDGTVTLK.2|TEC[CAM]NHYNNIMALYLK.3|TEC[CAM]NHYNNIM[Oxi]ALYLK.3|TEC[CAM]NHYNNIMALYLK.2|TEPATGFIDGDLIESFLDISRPK.4|TEPATGFIDGDLIESFLDISRPK.3|IC[CAM]YQEVSQC[CAM]FGVLSSR.3|IC[CAM]YQEVSQC[CAM]FGVLSSR.2|IVVFQYSDGKLQTVAEK.3|PMEGNFEEIAR.2|SLSTTNVFAC[CAM]SDRPTVIYSSNHK.4|SLSTTNVFAC[CAM]SDRPTVIYSSNHK.3|GAVYSMVEFNGK.2|KTEPATGFIDGDLIESFLDISRPK.4|KTEPATGFIDGDLIESFLDISRPK.3|QGQGQLVTC[CAM]SGAFKEGSLR.3|M[Oxi]QEVVANLQYDDGSGMKR.3|MQEVVANLQYDDGSGMKR.3|KIC[CAM]YQEVSQC[CAM]FGVLSSR.3|KIC[CAM]YQEVSQC[CAM]FGVLSSR.2|IEVQDTSGGTTALR.2|SVLLLAYKPM[Oxi]EGNFEEIAR.3|SVLLLAYKPMEGNFEEIAR.3|SVLLLAYKPM[Oxi]EGNFEEIAR.2|SVLLLAYKPMEGNFEEIAR.2|GLWPLRSDPNRETDDTLVLSFVGQTR.4|IEVQDTSGGTTALRPSASTQALSSSVSSSK.4|IEVQDTSGGTTALRPSASTQALSSSVSSSK.3|QGQGQLVTC[CAM]SGAFK.2|LFMLLLEKEEQMDGTVTLK.3|SDPNRETDDTLVLSFVGQTR.3|PSASTQALSSSVSSSK.2|DPNTYFIVGTAMVYPEEAEPK.3|FLYGC[CAM]QAPTIC[CAM]FVYQDPQGR.3|KTEPATGFIDGDLIESFLDISR.3|PSETGIIGIIDPEC[CAM]R.2|ETDDTLVLSFVGQTR.2|LGKDPNTYFIVGTAMVYPEEAEPK.3|MQEVVANLQYDDGSGMK.2|QISHTEMEHEVAC[CAM]LDITPLGDSNGLSPLC[CAM]AIGLWTDISAR.4
SEN / CTL,P0C0S8;P20671;Q16777;Q6FI13;Q96KK5;Q99878;Q9BTM1,Histone H2A type 1;Histone H2A type 1-D;Histone H2A type 2-C;Histone H2A type 2-A;Histone H2A type 1-H;Histone H2A type 1-J;Histone H2A.J,HIST1H2AG;HIST1H2AD;HIST2H2AC;HIST2H2AA3;HIST1H2AH;HIST1H2AJ;H2AFJ,0.31,2.75,3.87E-02,3.17E-03,2.50E+00,"chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process","DNA binding,protein binding,enzyme binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity","nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome",30,4,10,VTIAQGGVLPNIQAVLLPK.3|VTIAQGGVLPNIQAVLLPK.2|VTIAQGGVLPNIQAVLLPK.4|AGLQFPVGR.2|HLQLAIRNDEELNKLLGK.4|HLQLAIRNDEELNKLLGK.3|HLQLAIRNDEELNKLLGK.2|HLQLAIRNDEELNK.4|HLQLAIRNDEELNK.3|HLQLAIRNDEELNK.2
SEN / CTL,Q9BYZ2,L-lactate dehydrogenase A-like 6B,LDHAL6B,0.28,2.65,3.32E-01,2.46E-02,1.61E+00,"carbohydrate metabolic process,pyruvate metabolic process,oxidation-reduction process",L-lactate dehydrogenase activity,"nucleus,mitochondrial matrix",12,1,2,LIIVSNPVDILTYVAWK.3|LIIVSNPVDILTYVAWK.2
SEN / CTL,Q14118,Dystroglycan,DAG1,0.25,1.32,6.45E-01,4.69E-02,1.33E+00,"morphogenesis of an epithelial sheet,protein O-linked glycosylation,membrane protein ectodomain proteolysis,NLS-bearing protein import into nucleus,cytoskeletal anchoring at plasma membrane,regulation of gastrulation,regulation of epithelial to mesenchymal transition,calcium-dependent cell-matrix adhesion,regulation of embryonic cell shape,modulation by virus of host morphology or physiology,nerve maturation,myelination in peripheral nervous system,extracellular matrix organization,negative regulation of cell migration,microtubule anchoring,negative regulation of MAPK cascade,response to peptide hormone,viral entry into host cell,negative regulation of protein kinase B signaling,epithelial tube branching involved in lung morphogenesis,branching involved in salivary gland morphogenesis,commissural neuron axon guidance,basement membrane organization,positive regulation of basement membrane assembly involved in embryonic body morphogenesis","virus receptor activity,dystroglycan binding,actin binding,calcium ion binding,protein binding,structural constituent of muscle,tubulin binding,vinculin binding,protein complex binding,SH2 domain binding,laminin-1 binding,alpha-actinin binding","extracellular region,basement membrane,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,focal adhesion,cell outer membrane,dystrophin-associated glycoprotein complex,dystroglycan complex,integral component of membrane,basolateral plasma membrane,lamellipodium,filopodium,node of Ranvier,sarcolemma,costamere,membrane raft,postsynaptic membrane,extracellular exosome,contractile ring",6,17,21,VTIPTDLIASSGDIIK.2|GGLSAVDAFEIHVHR.4|GGLSAVDAFEIHVHR.3|GGLSAVDAFEIHVHR.2|LREQQLVGEK.3|LREQQLVGEK.2|FVGDPALVLNDIHKK.4|FVGDPALVLNDIHKK.3|FVGDPALVLNDIHK.3|IAEDDGKPRPAFSNALEPDFK.4|RIAEDDGKPRPAFSNALEPDFK.4|IPSDTFYDHEDTTTDK.3|LTLEDQATFIK.2|ATSITVTGSGSC[CAM]R.2|PAFSNALEPDFK.2|EGAMSAQLGYPVVGWHIANK.3|VDAWVGTYFEVK.2|LGC[CAM]SLNQNSVPDIHGVEAPAR.3|SWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDK.5|SWVQFNSNSQLMYGLPDSSHVGK.3|GVPIIFADELDDSKPPPSSSMPLILQEEK.3
SEN / CTL,P68431,Histone H3.1,HIST1H3A,0.21,1.77,5.38E-01,3.94E-02,1.40E+00,"chromatin silencing at rDNA,nucleosome assembly,DNA replication-dependent nucleosome assembly,blood coagulation,gene silencing by RNA,telomere organization,cellular protein metabolic process,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,protein heterotetramerization,regulation of gene silencing,cell-cell adhesion","protein binding,nucleosomal DNA binding,histone binding,protein heterodimerization activity,cadherin binding involved in cell-cell adhesion","nuclear chromosome,nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,extracellular region,nucleus,nucleoplasm,cell-cell adherens junction,membrane,protein complex,extracellular exosome",18,15,24,EIAQDFKTDLR.3|EIAQDFKTDLR.2|FQSSAVMALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.4|FQSSAVM[Oxi]ALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.6|FQSSAVMALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.6|FQSSAVM[Oxi]ALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.5|FQSSAVMALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.5|FQSSAVM[Oxi]ALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.4|FQSSAVMALQEAC[CAM]EAYLVGLFEDTNLC[CAM]AIHAK.3|LVREIAQDFK.3|STELLIR.2|EIAQDFK.2|LVREIAQDFKTDLR.4|LVREIAQDFKTDLR.3|SAPATGGVKKPHR.3|KSTGGKAPR.2|KSAPATGGVK.2|VTIMPKDIQLAR.3|VTIM[Oxi]PKDIQLAR.3|RYQKSTELLIR.3|KSAPATGGVKKPHR.3|STELLIRK.2|YRPGTVALR.2|STELLIRKLPFQR.3
SEN / CTL,P10909,Clusterin,CLU,0.07,1.62,2.24E-02,1.86E-03,2.73E+00,"cell morphogenesis,microglial cell activation,release of cytochrome c from mitochondria,platelet degranulation,lipid metabolic process,complement activation,complement activation, classical pathway,response to virus,protein import,central nervous system myelin maintenance,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,negative regulation of protein homooligomerization,positive regulation of tumor necrosis factor production,reverse cholesterol transport,innate immune response,positive regulation of nitric oxide biosynthetic process,protein stabilization,positive regulation of NF-kappaB transcription factor activity,chaperone-mediated protein complex assembly,response to misfolded protein,chaperone-mediated protein folding,microglial cell proliferation,regulation of beta-amyloid clearance,regulation of neuron death,positive regulation of neuron death,positive regulation of beta-amyloid formation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,negative regulation of beta-amyloid formation,regulation of neuronal signal transduction,positive regulation of tau-protein kinase activity,positive regulation of neurofibrillary tangle assembly,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process","protein binding,ubiquitin protein ligase binding,chaperone binding,misfolded protein binding,ATPase activity","extracellular region,extracellular space,nucleus,cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,cell surface,extracellular matrix,platelet alpha granule lumen,mitochondrial membrane,spherical high-density lipoprotein particle,chromaffin granule,protein complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle,neurofibrillary tangle,apical dendrite",96,25,42,ASSIIDELFQDRFFTREPQDTYHYLPFSLPHR.5|LFDSDPITVTVPVEVSR.2|LFDSDPITVTVPVEVSR.3|RELDESLQVAER.3|ELDESLQVAER.2|ELDESLQVAER.3|VTTVASHTSDSDVPSGVTEVVVK.3|VTTVASHTSDSDVPSGVTEVVVK.2|VTTVASHTSDSDVPSGVTEVVVK.4|ASSIIDELFQDR.2|C[CAM]REILSVDC[CAM]STNNPSQAK.3|EILSVDC[CAM]STNNPSQAK.2|EILSVDC[CAM]STNNPSQAK.3|EPQDTYHYLPFSLPHR.4|ASSIIDELFQDRFFTR.3|FFTREPQDTYHYLPFSLPHR.5|FFTREPQDTYHYLPFSLPHR.4|FFTREPQDTYHYLPFSLPHR.3|KTLLSNLEEAK.3|KTLLSNLEEAK.2|TLLSNLEEAKK.3|TLLSNLEEAKK.2|KYNELLK.2|KTLLSNLEEAKK.3|KTLLSNLEEAKK.2|QQTHMLDVMQDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.4|QQTHMLDVM[Oxi]QDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.3|QQTHMLDVM[Oxi]QDHFSR.3|QQTHMLDVMQDHFSR.3|FMETVAEK.2|FM[Oxi]ETVAEK.2|LFDSDPITVTVPVEVSRK.4|LFDSDPITVTVPVEVSRK.3|EIQNAVNGVK.2|IDSLLENDR.2|RPHFFFPK.2|TLLSNLEEAK.2|IDSLLENDRQQTHMLDVMQDHFSR.4|YVNKEIQNAVNGVK.2|LANLTQGEDQYYLR.2
SEN / CTL,P43251,Biotinidase,BTD,0.07,0.93,5.97E-01,4.36E-02,1.36E+00,"biotin metabolic process,nitrogen compound metabolic process,central nervous system development","hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,biotinidase activity","extracellular region,extracellular space,mitochondrial matrix,extracellular exosome",18,11,16,LSSGLVTAALYGR.2|LSSGLVTAALYGR.3|TSIYPFLDFMPSPQVVR.2|TSIYPFLDFMPSPQVVR.3|TSIYPFLDFM[Oxi]PSPQVVR.3|KHNLYFEAAFDVPLK.4|DAQEVHC[CAM]DEATK.3|DAQEVHC[CAM]DEATK.2|SHLIIAQVAK.2|ILSGDPYC[CAM]EK.2|ILSGDPYC[CAM]EKDAQEVHC[CAM]DEATK.4|EGYLHVC[CAM]SNGLC[CAM]C[CAM]YLLYERPTLSK.4|EGYLHVC[CAM]SNGLC[CAM]C[CAM]YLLYERPTLSK.3|VDLITFDTPFAGR.2|HNLYFEAAFDVPLK.2|HVVYPTAWMNQLPLLAAIEIQK.3
SEN / CTL,B1AK53,Espin,ESPN,-0.24,3.18,1.33E-01,1.03E-02,1.99E+00,"sensory perception of sound,locomotory behavior,parallel actin filament bundle assembly,positive regulation of filopodium assembly,negative regulation of cytoskeleton organization","SH3 domain binding,actin filament binding","cytoplasm,microvillus,brush border,filamentous actin,stereocilium tip",6,1,1,TLGYDESK.2
SEN / CTL,P20742,Pregnancy zone protein,PZP,-0.29,2.02,4.61E-01,3.40E-02,1.47E+00,"female pregnancy,negative regulation of endopeptidase activity","endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity","extracellular region,extracellular exosome,blood microparticle",6,23,26,DLFHC[CAM]VSFTLPR.3|DLFHC[CAM]VSFTLPR.2|SGTHTLPVESGDMK.3|TLLVEAEGIEQEK.3|TLLVEAEGIEQEK.2|VVVQTESGGR.2|IREEGTDLEVTANR.3|ISEITNIVSK.2|IQHPFTVEEFVLPK.3|SLFTDLVAEK.2|YNILPEKEDSPFALK.3|ASPAFLASQNTK.2|AVGYLITGYQR.2|GSFALSFPVESDVAPIAR.3|GSFALSFPVESDVAPIAR.2|HQDGSYSTFGER.2|MLQITNTGFEMK.2|VFSLSGSYIHLEPVAGTLPC[CAM]GHTETITAHYTLNR.5|LEAGINQLSFPLSSEPIQGSYR.3|NELIPLIYLENPR.2|QQNAQGGFSSTQDTVVALHALSR.3|NALFC[CAM]LESAWNVAK.2|QGIPFFAQVLLVDGK.2|VDLSFSPAQSPPASHAHLQVAAAPQSLC[CAM]ALR.4|DLTNFPDNVDQQEEEQGHC[CAM]PR.3|PYVPQLGTYNVIPLNNEQSSGPVPETVR.3
SEN / CTL,P12259,Coagulation factor V,F5,-0.30,1.04,2.30E-01,1.74E-02,1.76E+00,"platelet degranulation,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,blood circulation,platelet activation,COPII vesicle coating","serine-type endopeptidase activity,copper ion binding,protein binding","Golgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,plasma membrane,membrane,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular vesicle",6,40,46,AEVDDVIQVR.2|FC[CAM]ENPDEVKR.3|SQHLDNFSNQIGK.3|SQHLDNFSNQIGK.2|PYSLHAHGLSYEK.3|SHEFHAINGMIYSLPGLK.4|SHEFHAINGMIYSLPGLK.3|EDGILGPIIR.2|ITAIITQGC[CAM]K.2|SGPESPGSAC[CAM]R.2|DIHSGLIGPLLIC[CAM]QK.3|DPPSDLLLLK.2|KGTLTEGGTQK.2|GEYEEHLGILGPIIR.3|GEYEEHLGILGPIIR.2|LELFGC[CAM]DIY.2|QHQLGVWPLLPGSFK.3|KVMYTQYEDESFTK.3|LSEGASYLDHTFPAEK.3|LSEGASYLDHTFPAEK.2|SEAYNTFSER.2|KITAIITQGC[CAM]K.2|AVQPGETYTYK.2|FTVNNLAEPQK.2|AADIEQQAVFAVFDENK.3|AADIEQQAVFAVFDENK.2|DGTDYIEIIPK.2|ENQFDPPIVAR.2|SWYLEDNINK.2|EFNPLVIVGLSK.2|LAAEFASKPWIQVDMQK.3|DPDNIAAWYLR.2|ASEFLGYWEPR.2|EVIITGIQTQGAK.2|HEDTLTLFPMR.2|ASKPGWWLLNTEVGENQR.3|AWAYYSAVNPEK.2|ETDIEDSDDIPEDTTYKK.3|SYTIHYSEQGVEWKPYR.3|DIASGLIGLLLIC[CAM]K.2|HLSQDTGSPSGMRPWEDLPSQDTGSPSR.4|VM[Oxi]YTQYEDESFTK.2|VMYTQYEDESFTK.2|EKPQSTISGLLGPTLYAEVGDIIK.3|MPMGLSTGIISDSQIK.2|ETDIEDSDDIPEDTTYK.2
SEN / CTL,P02462,Collagen alpha-1(IV) chain,COL4A1,-0.37,1.08,4.10E-03,3.71E-04,3.43E+00,"patterning of blood vessels,brain development,neuromuscular junction development,extracellular matrix organization,collagen catabolic process,epithelial cell differentiation,blood vessel morphogenesis,retinal blood vessel morphogenesis,renal tubule morphogenesis,cellular response to amino acid stimulus,basement membrane organization","extracellular matrix structural constituent,extracellular matrix constituent conferring elasticity,platelet-derived growth factor binding","extracellular region,collagen type IV trimer,basement membrane,endoplasmic reticulum lumen,extracellular matrix",24,7,11,ILYHGYSLLYVQGNER.3|ILYHGYSLLYVQGNER.2|GTC[CAM]NYYANAYSFWLATIER.3|FSTMPFLFC[CAM]NINNVC[CAM]NFASR.3|FSTM[Oxi]PFLFC[CAM]NINNVC[CAM]NFASR.3|AHGQDLGTAGSC[CAM]LR.3|AHGQDLGTAGSC[CAM]LR.2|AHGQDLGTAGSC[CAM]LRK.3|GPPGGVGFPGSR.2|HSQTIDDPQC[CAM]PSGTK.3|HSQTIDDPQC[CAM]PSGTK.2
SEN / CTL,P30085,UMP-CMP kinase,CMPK1,-0.44,2.86,2.31E-01,1.74E-02,1.76E+00,"nucleoside diphosphate phosphorylation,'de novo' pyrimidine nucleobase biosynthetic process,UMP biosynthetic process,nucleoside triphosphate biosynthetic process,pyrimidine ribonucleotide biosynthetic process,nucleobase-containing small molecule interconversion,nucleoside monophosphate phosphorylation","cytidylate kinase activity,nucleoside diphosphate kinase activity,uridine kinase activity,ATP binding,uridylate kinase activity,nucleoside phosphate kinase activity","nucleus,cytoplasm,cytosol,extracellular exosome",18,19,38,SVDEVFDEVVQIFDKEG.3|SVDEVFDEVVQIFDKEG.2|FLIDGFPR.2|IVPVEITISLLKR.3|IVPVEITISLLKR.2|NKFLIDGFPR.3|PLVVFVLGGPGAGK.3|PLVVFVLGGPGAGK.2|YGYTHLSAGELLRDER.4|YGYTHLSAGELLRDER.3|YGYTHLSAGELLR.3|YGYTHLSAGELLR.2|REMDQTMAANAQK.3|REM[Oxi]DQTMAANAQK.3|REMDQTM[Oxi]AANAQK.3|REMDQTMAANAQK.2|YGYTHLSAGELLRDERK.4|KNPDSQYGELIEK.3|KNPDSQYGELIEK.2|MKPLVVFVLGGPGAGK.3|M[Oxi]KPLVVFVLGGPGAGK.3|MKPLVVFVLGGPGAGK.2|SVDEVFDEVVQIFDK.3|SVDEVFDEVVQIFDK.2|NQDNLQGWNK.2|RIQTYLQSTKPIIDLYEEM[Oxi]GK.4|RIQTYLQSTKPIIDLYEEMGK.4|RIQTYLQSTKPIIDLYEEM[Oxi]GK.3|RIQTYLQSTKPIIDLYEEMGK.3|PIIDLYEEMGK.2|EMDQTMAANAQK.2|EM[Oxi]DQTMAANAQK.2|EMDQTM[Oxi]AANAQK.2|EM[Oxi]DQTM[Oxi]AANAQK.2|IVPVEITISLLK.2|NPDSQYGELIEK.2|IQTYLQSTKPIIDLYEEMGK.3|IQTYLQSTKPIIDLYEEMGK.2
SEN / CTL,O60565;Q9H772,Gremlin-1;Gremlin-2,GREM1;GREM2,-0.45,0.69,4.77E-02,3.89E-03,2.41E+00,"cell morphogenesis,branching involved in ureteric bud morphogenesis,cell migration involved in sprouting angiogenesis,positive regulation of receptor internalization,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,mesenchymal to epithelial transition involved in metanephros morphogenesis,apoptotic process,signal transduction,activation of transmembrane receptor protein tyrosine kinase activity,cell-cell signaling,positive regulation of cell proliferation,proximal/distal pattern formation,regulation of epithelial to mesenchymal transition,collagen fibril organization,negative regulation of cell growth,embryonic limb morphogenesis,negative regulation of bone mineralization,negative regulation of BMP signaling pathway,negative regulation of chondrocyte differentiation,negative regulation of osteoblast proliferation,positive regulation of NF-kappaB import into nucleus,negative regulation of apoptotic process,positive regulation of angiogenesis,negative regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,negative regulation of bone remodeling,determination of dorsal identity,positive regulation of NF-kappaB transcription factor activity,regulation of focal adhesion assembly,positive regulation of telomerase activity,limb development,negative regulation of pathway-restricted SMAD protein phosphorylation,ureteric bud formation,positive regulation of protein tyrosine kinase activity,negative regulation of monocyte chemotaxis,negative regulation of canonical Wnt signaling pathway,positive regulation of branching involved in ureteric bud morphogenesis,negative regulation of branching involved in ureteric bud morphogenesis,negative regulation of osteoclast proliferation,positive regulation of peptidyl-tyrosine autophosphorylation,negative regulation of bone trabecula formation,negative regulation of bone mineralization involved in bone maturation,positive regulation of receptor activity,positive regulation of cardiac muscle cell differentiation,regulation of stress-activated MAPK cascade,signal transduction by p53 class mediator;embryonic body morphogenesis,cytokine-mediated signaling pathway,BMP signaling pathway,sequestering of BMP from receptor via BMP binding,determination of dorsal identity,regulation of cytokine activity","cytokine activity,protein binding,morphogen activity,transmembrane receptor protein tyrosine kinase activator activity,BMP binding,vascular endothelial growth factor receptor 2 binding,receptor agonist activity;cytokine activity,heparin binding,BMP binding,protein homodimerization activity","extracellular space,cell surface;extracellular region,extracellular space",6,1,1,FC[CAM]YGQC[CAM]NSFYIPR.2
SEN / CTL,P09486,SPARC,SPARC,-0.48,2.00,3.01E-01,2.24E-02,1.65E+00,"ossification,negative regulation of endothelial cell proliferation,platelet degranulation,receptor-mediated endocytosis,signal transduction,heart development,response to gravity,response to lead ion,positive regulation of endothelial cell migration,negative regulation of angiogenesis,regulation of cell morphogenesis,extracellular matrix organization,lung development,response to lipopolysaccharide,response to L-ascorbic acid,response to cytokine,wound healing,response to peptide hormone,response to ethanol,response to cadmium ion,inner ear development,response to glucocorticoid,response to cAMP,response to calcium ion,bone development,cellular response to growth factor stimulus","calcium ion binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,basement membrane,extracellular space,cytoplasm,cell surface,nuclear matrix,platelet alpha granule,platelet alpha granule membrane,platelet alpha granule lumen,endocytic vesicle lumen,mitochondrion,plasma membrane",96,14,22,YIPPC[CAM]LDSELTEFPLR.3|YIPPC[CAM]LDSELTEFPLR.2|NVLVTLYERDEDNNLLTEK.3|FFETC[CAM]DLDNDKYIALDEWAGC[CAM]FGIK.3|RLEAGDHPVELLAR.3|LEAGDHPVELLAR.3|LEAGDHPVELLAR.2|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.3|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.4|LHLDYIGPC[CAM]K.3|LHLDYIGPC[CAM]K.2|NVLVTLYER.2|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.5|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.4|APLIPMEHC[CAM]TTR.3|APLIPM[Oxi]EHC[CAM]TTR.3|APLIPMEHC[CAM]TTR.2|TFDSSC[CAM]HFFATK.3|TFDSSC[CAM]HFFATK.2|DEDNNLLTEK.2|FFETC[CAM]DLDNDK.2|YIALDEWAGC[CAM]FGIK.2
SEN / CTL,P16949,Stathmin,STMN1,-0.66,2.89,1.92E-01,1.46E-02,1.83E+00,"mitotic cytokinesis,microtubule depolymerization,mitotic spindle organization,signal transduction,axonogenesis,brain development,response to virus,negative regulation of microtubule polymerization,neuron projection development,intracellular signal transduction,positive regulation of cellular component movement,regulation of cytoskeleton organization","signal transducer activity,tubulin binding","intracellular,cytoplasm,cytosol,microtubule,membrane,neuron projection,extracellular exosome",24,18,24,DLSLEEIQK.2|ASGQAFELILSPR.2|ASGQAFELILSPR.3|RASGQAFELILSPR.3|RASGQAFELILSPR.2|DLSLEEIQKK.3|DLSLEEIQKK.2|LEAAEER.2|REHEKEVLQK.3|KKDLSLEEIQK.3|KKDLSLEEIQK.2|HIEEVRK.2|SHEAEVLK.2|KLEAAEER.2|NKESKDPADETEAD.3|NKESKDPADETEAD.2|SKESVPEFPLSPPK.3|SKESVPEFPLSPPK.2|KSHEAEVLK.2|EHEKEVLQK.2|ENREAQMAAK.2|AIEENNNFSK.2|ESKDPADETEAD.2|ESVPEFPLSPPK.2
SEN / CTL,Q12841,Follistatin-related protein 1,FSTL1,-1.27,1.43,1.62E-03,1.55E-04,3.81E+00,"BMP signaling pathway,response to starvation","calcium ion binding,protein binding,heparin binding","extracellular region,extracellular space,extracellular exosome",24,12,12,IIQWLEAEIIPDGWFSK.3|LSFQEFLK.2|IC[CAM]ANVFC[CAM]GAGR.2|C[CAM]VC[CAM]AC[CAM]GNWVC[CAM]TAMTC[CAM]DGK.2|C[CAM]LNPSFNPPEKK.3|GEPTC[CAM]LC[CAM]IEQC[CAM]KPHK.3|IQVDYDGHC[CAM]K.2|C[CAM]LNPSFNPPEK.2|TYLNHC[CAM]ELHR.2|GAQTQTEEEMTR.2|GEPTC[CAM]LC[CAM]IEQC[CAM]K.2|SVSPSASPVVC[CAM]YQSNR.2
SEN / CTL,P02765,Alpha-2-HS-glycoprotein,AHSG,-1.32,2.46,2.09E-01,1.58E-02,1.80E+00,"skeletal system development,ossification,platelet degranulation,pinocytosis,acute-phase response,negative regulation of endopeptidase activity,regulation of bone mineralization,negative regulation of bone mineralization,negative regulation of phosphorylation,negative regulation of insulin receptor signaling pathway,regulation of inflammatory response,positive regulation of phagocytosis,negative regulation of biomineral tissue development","endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,kinase inhibitor activity","extracellular region,extracellular space,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticle",18,15,28,C[CAM]DSSPDSAEDVR.2|C[CAM]NLLAEK.2|C[CAM]DSSPDSAEDVRK.3|C[CAM]DSSPDSAEDVRK.2|EHAVEGDC[CAM]DFQLLK.4|EHAVEGDC[CAM]DFQLLK.3|EHAVEGDC[CAM]DFQLLK.2|HTFMGVVSLGSPSGEVSHPR.5|HTFMGVVSLGSPSGEVSHPR.4|HTFM[Oxi]GVVSLGSPSGEVSHPR.4|HTFMGVVSLGSPSGEVSHPR.3|HTFM[Oxi]GVVSLGSPSGEVSHPR.3|HTFMGVVSLGSPSGEVSHPR.2|QLKEHAVEGDC[CAM]DFQLLK.4|QLKEHAVEGDC[CAM]DFQLLK.3|TVVQPSVGAAAGPVVPPC[CAM]PGR.4|TVVQPSVGAAAGPVVPPC[CAM]PGR.3|TVVQPSVGAAAGPVVPPC[CAM]PGR.2|EHAVEGDC[CAM]DFQLLKLDGK.4|EHAVEGDC[CAM]DFQLLKLDGK.3|HTLNQIDEVK.2|QLKEHAVEGDC[CAM]DFQLLKLDGK.4|VWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.5|VWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.4|AALAAFNAQNNGSNFQLEEISR.3|AQLVPLPPSTYVEFTVSGTDC[CAM]VAK.3|HTLNQIDEVKVWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.5|QPNC[CAM]DDPETEEAALVAIDYINQNLPWGYK.3
SEN / CTL,P02461,Collagen alpha-1(III) chain,COL3A1,-1.37,1.81,1.83E-07,2.95E-08,7.53E+00,"skeletal system development,cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,heart development,aging,response to radiation,response to mechanical stimulus,peptide cross-linking,cerebral cortex development,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,response to cytokine,positive regulation of Rho protein signal transduction,wound healing,extracellular fibril organization,skin development,digestive tract development,regulation of immune response,negative regulation of immune response,aorta smooth muscle tissue morphogenesis,cellular response to amino acid stimulus,negative regulation of neuron migration","integrin binding,extracellular matrix structural constituent,protein binding,SMAD binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type III trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix",66,25,27,SVNGQIESLISPDGSR.2|VFC[CAM]NMETGETC[CAM]ISANPLNVPR.3|FTYTVLEDGC[CAM]TK.2|NSIAYMDQASGNVK.2|LMGSNEGEFKAEGNSK.3|NSIAYMDQASGNVKK.3|NSIAYMDQASGNVKK.2|LPIVDIAPYDIGGPDQEFGVDVGPVC[CAM]FL.3|SGEYWVDPNQGC[CAM]K.2|INTDEIMTSLK.2|INTDEIM[Oxi]TSLK.2|AGGFAPYYGDEPMDFKINTDEIMTSLK.3|KHWWTDSSAEK.3|GPVGPSGPPGK.2|DGTSGHPGPIGPPGPR.3|GPPGLAGAPGLR.2|GAAGEPGRDGVPGGPGMR.3|GPAGPNGIPGEK.2|LMGSNEGEFK.2|GGPGGPGPQGPPGK.2|HWWTDSSAEK.2|GSPGGPGAAGFPGAR.2|SGDRGESGPAGPAGAPGPAGSR.3|GPPGPAGANGAPGLR.2|GENGSPGAPGAPGHPGPPGPVGPAGK.3|NGETGPQGPPGPTGPGGDK.2|AGGFAPYYGDEPMDFK.2
SEN / CTL,P02452,Collagen alpha-1(I) chain,COL1A1,-1.61,2.00,5.15E-15,1.88E-15,1.47E+01,"skeletal system development,blood vessel development,osteoblast differentiation,intramembranous ossification,endochondral ossification,blood coagulation,visual perception,sensory perception of sound,positive regulation of epithelial to mesenchymal transition,negative regulation of cell-substrate adhesion,protein transport,platelet activation,extracellular matrix organization,collagen fibril organization,positive regulation of cell migration,collagen catabolic process,response to corticosteroid,response to estradiol,collagen biosynthetic process,protein localization to nucleus,tooth mineralization,response to drug,response to hydrogen peroxide,response to peptide hormone,skin morphogenesis,cellular response to fibroblast growth factor stimulus,tooth eruption,positive regulation of transcription, DNA-templated,embryonic skeletal system development,regulation of immune response,leukocyte migration,response to cAMP,response to hyperoxia,face morphogenesis,bone trabecula formation,cartilage development involved in endochondral bone morphogenesis,protein heterotrimerization,cellular response to amino acid stimulus,cellular response to mechanical stimulus,cellular response to retinoic acid,cellular response to vitamin E,cellular response to tumor necrosis factor,cellular response to epidermal growth factor stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of canonical Wnt signaling pathway,cellular response to fluoride","extracellular matrix structural constituent,protein binding,identical protein binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,Golgi apparatus,secretory granule,extracellular matrix",108,46,54,FTYSVTVDGC[CAM]TSHTGAWGK.3|FTYSVTVDGC[CAM]TSHTGAWGK.2|VFC[CAM]NMETGETC[CAM]VYPTQPSVAQK.3|VLC[CAM]DDVIC[CAM]DETK.2|DRDLEVDTTLK.3|DRDLEVDTTLK.2|SGEYWIDPNQGC[CAM]NLDAIK.2|SGEYWIDPNQGC[CAM]NLDAIK.3|ALLLQGSNEIEIR.2|SLSQQIENIRSPEGSR.3|SLSQQIENIR.2|YHDRDVWKPEPC[CAM]R.4|NSVAYMDQQTGNLK.2|NSVAYMDQQTGNLKK.3|NSVAYMDQQTGNLKK.2|NSVAYM[Oxi]DQQTGNLKK.3|STGGISVPGPMGPSGPR.2|STGGISVPGPM[Oxi]GPSGPR.2|GVPGPPGAVGPAGK.2|GFSGLDGAK.2|NGDDGEAGKPGRPGER.4|NGDDGEAGKPGRPGER.3|GPAGPQGPR.2|ADDANVVR.2|GEAGPQGPR.2|GSEGPQGVR.2|GVVGLPGQR.2|GPPGSAGAPGK.2|QGPSGASGER.2|IC[CAM]VC[CAM]DNGK.2|GPAGPQGPRGDKGETGEQGDR.4|GPAGPQGPRGDKGETGEQGDR.3|GRPGAPGPAGAR.2|GFPGADGVAGPK.2|EGAPGAEGSPGR.2|GVQGPPGPAGPR.2|GADGSPGKDGVR.2|GQAGVM[Oxi]GFPGPK.2|GLTGSPGSPGPDGK.2|GPSGPQGPGGPPGPK.2|GESGPSGPAGPTGAR.2|GEPGPVGVQGPPGPAGEEGKR.3|TGPPGPAGQDGRPGPPGPPGAR.3|GEPGPTGLPGPPGER.2|GSAGPPGATGFPGAAGR.2|GETGPAGRPGEVGPPGPPGPAGEK.3|GANGAPGIAGAPGFPGAR.2|GDRGETGPAGPPGAPGAPGAPGPVGPAGK.3|DGEAGAQGPPGPAGPAGER.2|VGPPGPSGNAGPPGPPGPAGK.2|GFSGLQGPPGPPGSPGEQGPSGASGPAGPR.3|GPPGPMGPPGLAGPPGESGR.2|GLTGPIGPPGPAGAPGDKGESGPSGPAGPTGAR.3|GVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGER.3
SEN / CTL,P05543,Thyroxine-binding globulin,SERPINA7,-1.65,1.96,4.40E-03,3.96E-04,3.40E+00,"negative regulation of endopeptidase activity,thyroid hormone transport",serine-type endopeptidase inhibitor activity,"extracellular region,extracellular space,extracellular exosome",12,15,20,NALALFVLPK.2|GWVDLFVPK.2|AVLHIGEK.2|FTVETPDK.2|QEINSHVEMQTK.3|EGQMESVEAAMSSK.3|EGQMESVEAAMSSK.2|EGQM[Oxi]ESVEAAMSSK.2|EGQMESVEAAM[Oxi]SSK.2|KELELQIGNALFIGK.3|SFMLLILER.2|SFM[Oxi]LLILER.2|TEDSSSFLIDK.2|AQWANPFDPSK.2|VVGLIQDLKPNTIMVLVNYIHFK.4|FSISATYDLGATLLK.2|AQWANPFDPSKTEDSSSFLIDK.3|MGIQHAYSENADFSGLTEDNGLK.3|M[Oxi]GIQHAYSENADFSGLTEDNGLK.3|GTEAAAVPEVELSDQPENTFLHPIIQIDR.3
SEN / CTL,Q99729,Heterogeneous nuclear ribonucleoprotein A/B,HNRNPAB,-1.77,2.20,2.35E-01,1.77E-02,1.75E+00,"epithelial to mesenchymal transition,positive regulation of transcription, DNA-templated","nucleotide binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,transcription factor activity, sequence-specific DNA binding,sequence-specific DNA binding","nucleus,nucleoplasm,cytoplasm,intracellular ribonucleoprotein complex,RNA polymerase II transcription factor complex",6,14,26,GFGFILFK.2|FHTVSGSK.2|GFVFITFKEEEPVKK.4|GFVFITFKEEEPVKK.3|GFVFITFKEEEPVKK.2|RGGHQNNYKPY.3|GFVFITFK.2|MFVGGLSWDTSKK.3|M[Oxi]FVGGLSWDTSKK.3|M[Oxi]FVGGLSWDTSKK.2|MFVGGLSWDTSKK.2|KFHTVSGSK.2|EVYQQQQYGSGGR.3|EVYQQQQYGSGGR.2|GFGFILFKDAASVEK.3|GFGFILFKDAASVEK.2|GFVFITFKEEEPVK.3|GFVFITFKEEEPVK.2|GGHQNNYKPY.2|MFVGGLSWDTSK.2|M[Oxi]FVGGLSWDTSK.2|EYFGEFGEIEAIELPM[Oxi]DPK.3|EYFGEFGEIEAIELPMDPK.3|EYFGEFGEIEAIELPMDPK.2|EYFGEFGEIEAIELPM[Oxi]DPK.2|IREYFGEFGEIEAIELPMDPK.3
SEN / CTL,P02042,Hemoglobin subunit delta,HBD,-1.79,2.77,2.73E-01,2.03E-02,1.69E+00,"blood coagulation,oxygen transport","oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding","cytosol,hemoglobin complex,blood microparticle",18,15,32,LLVVYPWTQR.2|LLVVYPWTQR.3|VNVDAVGGEALGR.3|VNVDAVGGEALGR.2|VHLTPEEKTAVNALWGK.4|VHLTPEEKTAVNALWGK.3|EFTPQMQAAYQK.3|EFTPQMQAAYQK.2|EFTPQM[Oxi]QAAYQK.2|TAVNALWGK.2|GTFSQLSELHC[CAM]DK.3|GTFSQLSELHC[CAM]DK.2|FFESFGDLSSPDAVMGNPK.4|FFESFGDLSSPDAVMGNPK.3|FFESFGDLSSPDAVM[Oxi]GNPK.3|FFESFGDLSSPDAVM[Oxi]GNPK.2|FFESFGDLSSPDAVMGNPK.2|TAVNALWGKVNVDAVGGEALGR.4|TAVNALWGKVNVDAVGGEALGR.3|VLGAFSDGLAHLDNLKGTFSQLSELHC[CAM]DKLHVDPENFR.7|VLGAFSDGLAHLDNLKGTFSQLSELHC[CAM]DKLHVDPENFR.6|NFGKEFTPQMQAAYQK.3|NFGKEFTPQM[Oxi]QAAYQK.3|VHLTPEEKTAVNALWGKVNVDAVGGEALGR.5|VHLTPEEKTAVNALWGKVNVDAVGGEALGR.4|VHLTPEEKTAVNALWGKVNVDAVGGEALGR.3|GTFSQLSELHC[CAM]DKLHVDPENFR.4|GTFSQLSELHC[CAM]DKLHVDPENFR.3|KVLGAFSDGLAHLDNLKGTFSQLSELHC[CAM]DK.5|LLGNVLVC[CAM]VLAR.2|LLVVYPWTQRFFESFGDLSSPDAVM[Oxi]GNPK.4|LLVVYPWTQRFFESFGDLSSPDAVM[Oxi]GNPK.3
SEN / CTL,P20962,Parathymosin,PTMS,-2.01,2.75,1.28E-01,9.89E-03,2.00E+00,"immune system process,DNA replication",zinc ion binding,"nucleus,cytosol",6,5,8,SVEAAAELSAK.2|AAEEEDEADPKR.3|AAEEEDEADPKR.2|RAAEEEDEADPK.3|RAAEEEDEADPK.2|RAAEEEDEADPKR.3|RAAEEEDEADPKR.2|AAEEEDEADPK.2
SEN / CTL,P08123,Collagen alpha-2(I) chain,COL1A2,-2.34,1.63,4.96E-26,4.78E-26,2.53E+01,"skeletal system development,blood vessel development,transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,blood coagulation,regulation of blood pressure,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,odontogenesis,skin morphogenesis,regulation of immune response,leukocyte migration,protein heterotrimerization,cellular response to amino acid stimulus","extracellular matrix structural constituent,protein binding,protein binding, bridging,identical protein binding,SMAD binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",150,44,57,VYC[CAM]DFSTGETC[CAM]IR.2|LSHPEWSSGYYWIDPNQGC[CAM]TMDAIK.3|SLNNQIETLLTPEGSR.2|SLNNQIETLLTPEGSR.3|FTYTVLVDGC[CAM]SK.2|EMATQLAFMR.2|FTYTVLVDGC[CAM]SKK.3|NSIAYMDEETGNLKK.3|NSIAYMDEETGNLKK.2|NSIAYM[Oxi]DEETGNLKK.3|DYEVDATLK.2|KAVILQGSNDVELVAEGNSR.3|GIPGPVGAAGATGAR.2|GLHGEFGLPGPAGPRGER.4|GLPGVAGAVGEPGPLGIAGPPGAR.3|GYPGNIGPVGAAGAPGPHGPVGPAGK.3|AVILQGSNDVELVAEGNSR.2|GPSGPPGPDGNKGEPGVVGAVGTAGPSGPSGLPGER.3|SLNNQIETLLTPEGSRK.3|GAPGAVGAPGPAGATGDRGEAGAAGPAGPAGPR.4|GAPGAVGAPGPAGATGDRGEAGAAGPAGPAGPR.3|HGNRGETGPSGPVGPAGAVGPR.4|HGNRGETGPSGPVGPAGAVGPR.3|HGNRGETGPSGPVGPAGAVGPR.5|HGNRGETGPSGPVGPAGAVGPR.2|GVGLGPGPMGLMGPR.2|GVGLGPGPMGLMGPR.3|GVGLGPGPM[Oxi]GLMGPR.2|GVGLGPGPMGLM[Oxi]GPR.2|GVGLGPGPM[Oxi]GLM[Oxi]GPR.2|GPPGESGAAGPTGPIGSR.2|AGEDGHPGKPGRPGER.4|AGEDGHPGKPGRPGER.3|GHAGLAGAR.2|GVVGPQGAR.2|VGAPGPAGAR.2|GPSGPQGIR.2|GPAGPSGPAGK.2|GHNGLDGLK.2|AGVMGPPGSR.2|GLHGEFGLPGPAGPR.3|DGNPGNDGPPGRDGQPGHKGER.4|DGNPGNDGPPGR.2|GEPGNIGFPGPK.2|GLPGSPGNIGPAGK.2|GPAGPSGPAGKDGR.2|TGHPGTVGPAGIR.2|GEAGAAGPAGPAGPR.2|GERGPPGESGAAGPTGPIGSR.3|GEVGPAGPNGFAGPAGAAGQPGAK.3|GHNGLQGLPGIAGHHGDQGAPGSVGPAGPR.4|GDGGPPGMTGFPGAAGR.2|GDGGPPGM[Oxi]TGFPGAAGR.2|GAAGLPGVAGAPGLPGPR.2|GEIGAVGNAGPAGPAGPR.2|GETGPSGPVGPAGAVGPR.2|GPSGEAGTAGPPGTPGPQGLLGAPGILGLPGSR.3
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,